Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	O
Drugs	VB	B-TREATMENT

Chief	NNP	O
Complaint:	NNP	O
recent	JJ	B-PROBLEM
mild	JJ	I-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
exertion	NN	O

emergency	NN	B-TREATMENT
CABG	NNP	I-TREATMENT
X	NNP	O
3	CD	O
(	(	O
2017-06-13	JJ	O
)(	NNP	O
LIMA	NNP	B-TREATMENT
to	TO	I-TREATMENT
LAD	NNP	I-TREATMENT
,	,	O
SVG	NNP	B-TREATMENT
to	TO	I-TREATMENT
ramus	VB	I-TREATMENT
,	,	O
SVG	NNP	B-TREATMENT
to	TO	I-TREATMENT
OM	NNP	I-TREATMENT
)	)	O

61	CD	O
yo	JJ	O
African-American-Hispanic	JJ	O
male	NN	O
had	VBD	O
abnormal	JJ	B-PROBLEM
EKG	NNP	I-PROBLEM
found	VBD	O
as	IN	O
part	NN	O
of	IN	O
pre-op	JJ	B-TEST
eval.	NN	I-TEST
for	IN	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

Had	NNP	O
subsequent	JJ	O
abnormal	JJ	B-PROBLEM
stress	NN	I-PROBLEM
test	NN	I-PROBLEM
and	CC	O
pefusion	NN	B-TEST
imaging	NN	I-TEST
showed	VBD	O
EF	NNP	B-TEST
38%	CD	O
with	IN	O
perfusion	NN	B-PROBLEM
defects	NNS	I-PROBLEM
.	.	O

Echo	NNP	B-TEST
prior	RB	O
to	TO	O
scheduled	VBN	B-TEST
cath	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
LVH	NNP	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
HK	NNP	I-PROBLEM
,	,	O
EF	NNP	B-TEST
40%	CD	O
,	,	O
mild	JJ	B-PROBLEM
MR	NNP	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
LAE	NNP	I-PROBLEM
.	.	O

Cath	NN	B-TEST
at	IN	O
Kindred/North	NNP	O
Shore	NNP	O
today	NN	O
showed	VBD	O
80%	CD	B-PROBLEM
LM	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
normal	JJ	O
LAD	NNP	O
,	,	O
CX	NNP	O
,	,	O
RCA	NNP	O
.	.	O

Severe	NNP	B-PROBLEM
systolic	JJ	I-PROBLEM
HTN	NNP	I-PROBLEM
also	RB	O
noted	VBD	O
.	.	O

Transferred	VBN	O
in	IN	O
urgently	RB	O
for	IN	O
cabg	NN	B-TREATMENT
with	IN	O
Dr.	NNP	O
Howard	NNP	O
.	.	O

ventral	JJ	B-PROBLEM
hernia	NN	I-PROBLEM

HTN	NNP	B-PROBLEM
elev.	VBP	B-PROBLEM
chol.	NN	I-PROBLEM
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
with	IN	O
metal	NN	B-TREATMENT
plate	NN	I-TREATMENT
secondary	NN	O
to	TO	O
GSW	NNP	B-PROBLEM
to	TO	O
face	VB	B-TREATMENT
right	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT

2017-06-14	JJ	O
02:06AM	CD	O
BLOOD	NN	B-TEST

WBC	NNP	B-TEST
-	:	O
9.4	CD	O
RBC	NNP	B-TEST
-	:	O
3.61*	CD	O
Hgb	NNP	B-TEST
-	:	O
10.4*	CD	O
Hct	NNP	B-TEST
-	:	O
29.9*	CD	O
MCV	NNP	B-TEST
-	:	O
83	CD	O
MCH	NNP	B-TEST
-	:	O
28.8	CD	O
MCHC	NNP	B-TEST
-	:	O
34.8	CD	O
RDW	NNP	B-TEST
-	:	O
14.3	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
154	CD	O

2017-06-17	JJ	O
05:14AM	CD	O
BLOOD	NN	B-TEST

Hct	NNP	B-TEST
-	:	O
25.2*	CD	O

2017-06-14	JJ	O
02:06AM	CD	O
BLOOD	NN	B-TEST

Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
154	CD	O

2017-06-13	JJ	O
08:05PM	CD	O
BLOOD	NN	B-TEST

PT	NNP	B-TEST
-	:	O
13.6*	CD	O
PTT	NNP	B-TEST
-	:	O
33.3	CD	O
INR	NNP	B-TEST
(	(	O
PT	NNP	B-TEST
)	)	O
-	:	O
1.2*	CD	O

2017-06-17	JJ	O
05:14AM	CD	O
BLOOD	NN	B-TEST

UreaN	NNP	B-TEST
-	:	O
25*	CD	O
Creat	NNP	B-TEST
-	:	O
1.0	CD	O
K	NNP	B-TEST
-	:	O
3.9	CD	O

2017-06-15	JJ	O
02:02PM	CD	O
BLOOD	NN	B-TEST

Mg	NNP	B-TEST
-	:	O
2.1	CD	O

TWO	NNP	B-TEST
VIEW	NNP	I-TEST
CHEST	NNP	I-TEST
,	,	O
2017-06-17	JJ	O

Status	NNP	O
post	NN	O
coronary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

There	EX	O
has	VBZ	O
been	VBN	O
removal	NN	O
of	IN	O
a	DT	B-TREATMENT
Swan-Ganz	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
jugular	NN	I-TREATMENT
vascular	NN	I-TREATMENT
catheter	NN	I-TREATMENT
,	,	O
with	IN	O
the	DT	O
tip	NN	O
terminating	NN	O
in	IN	O
the	DT	O
proximal	JJ	O
right	JJ	O
atrium	NN	O
just	RB	O
below	IN	O
the	DT	O
junction	NN	O
with	IN	O
the	DT	O
superior	JJ	O
vena	NN	O
cava	NN	O
.	.	O

Previously	RB	O
reported	VBN	O
interstitial	JJ	B-PROBLEM
edema	NN	I-PROBLEM
has	VBZ	O
resolved	VBN	O
.	.	O

There	EX	O
has	VBZ	O
been	VBN	O
interval	JJ	O
improvement	NN	O
in	IN	O
left	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

Right	RB	B-PROBLEM
basilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
has	VBZ	O
slightly	RB	O
worsened	VBN	O
.	.	O

Bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

1.	CD	O
Vascular	JJ	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
terminates	NNS	O
in	IN	O
proximal	JJ	O
right	JJ	O
atrium	NN	O
.	.	O

2.	CD	O
Bibasilar	NNP	B-PROBLEM
minor	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
,	,	O
worse	JJR	O
on	IN	O
the	DT	O
right	NN	O
and	CC	O
improved	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

Persistent	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

The	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

No	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
.	.	O

No	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
or	CC	O
thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

No	DT	O
mass/thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

No	DT	O
atrial	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
by	IN	O
2D	CD	B-TEST
or	CC	O
color	NN	B-TEST
Doppler	NNP	I-TEST
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
normal	JJ	O
cavity	NN	O
size	NN	O
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

No	DT	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
regional	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

Overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
ventricular	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

Resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

The	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
aortic	JJ	O
root	NN	O
.	.	O

There	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
ascending	NN	O
aorta	NN	O
.	.	O

There	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
aortic	JJ	O
arch	NN	O
.	.	O

There	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
descending	NN	O
thoracic	NN	O
aorta	NN	O
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

No	DT	O
masses	NNS	B-PROBLEM
or	CC	O
vegetations	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
on	IN	O
the	DT	O
aortic	JJ	O
valve	NN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Trace	NNP	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

The	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

No	DT	O
mass	NN	B-PROBLEM
or	CC	O
vegetation	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
mitral	JJ	O
valve	NN	O
.	.	O

Trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Preserved	VBN	O
LV	NNP	O
systolic	JJ	O
function	NN	O
on	IN	O
phenylephrine	NN	B-TREATMENT
.	.	O

LVEF	NNP	B-TEST
now	RB	O
50%	CD	O
.	.	O

Trace	NNP	B-PROBLEM
MR	NNP	I-PROBLEM
,	,	O
AI	NNP	B-PROBLEM
as	IN	O
described	NN	O
.	.	O

I	PRP	O
certify	VBP	O
that	IN	O
I	PRP	O
was	VBD	O
present	JJ	O
for	IN	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
in	IN	O
compliance	NN	O
with	IN	O
HCFA	NNP	O
regulations	NNS	O
.	.	O

Admitted	VBN	O
directly	RB	O
to	TO	O
OR	NNP	O
from	IN	O
ambulance	NN	O
transfer	NN	O
and	CC	O
underwent	JJ	O
cabg	NN	B-TREATMENT
x3	NN	O
with	IN	O
Dr.	NNP	O
Howard	NNP	O
on	IN	O
06-13	NNP	O
.	.	O

Transferred	VBN	O
to	TO	O
the	DT	O
CSRU	NNP	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
phenylephrine	NN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

Extubated	VBN	O
early	RB	O
the	DT	O
next	JJ	O
morning	NN	O
and	CC	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
removed	VBD	O
.	.	O

Gentle	NNP	B-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
beta	NN	B-TREATMENT
blockade	NN	I-TREATMENT
started	VBD	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
to	TO	O
begin	VB	O
increasing	VBG	O
his	PRP$	O
activity	NN	O
level	NN	O
.	.	O

Foley	NNP	B-TREATMENT
removed	VBD	O
on	IN	O
POD	NNP	O
#2	NNP	O
and	CC	O
had	VBD	O
scattered	VBN	B-PROBLEM
rales	NNS	I-PROBLEM
with	IN	O
temp	JJ	B-TEST
101.2	CD	O
.	.	O

Afebrile	IN	B-PROBLEM
the	DT	O
next	JJ	O
day	NN	O
and	CC	O
pacing	NN	B-TREATMENT
wires	NNS	I-TREATMENT
removed	VBD	O
without	IN	O
incident	NN	O
.	.	O

bisoprolol	NN	B-TREATMENT
5	CD	O
mg	JJ	O
daily	JJ	O
crestor	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

HCTZ	$	B-TREATMENT
25	CD	O
mg	JJ	O
daily	JJ	O
lisinopril	VBZ	B-TREATMENT
40	CD	O
mg	JJ	O
daily	JJ	O

1.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
Potassium	NNP	B-TREATMENT
Chloride	NNP	I-TREATMENT
10	CD	O
mEq	NN	O
Capsule	NNP	O
,	,	O
Sustained	VBD	O
Release	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Capsule	NN	O
,	,	O
Sustained	VBD	O
Release	NNP	O
PO	NNP	O
Q12H	NNP	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

3.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
Ranitidine	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
150	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Oxycodone-Acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
Rosuvastatin	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

8.	CD	O
Furosemide	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

CAD	NN	B-PROBLEM

HTN	NNP	B-PROBLEM
ventral	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
right	RB	B-TREATMENT
nephrectomy	JJ	I-TREATMENT
s/p	RB	O
right	JJ	B-TREATMENT
facial	NN	I-TREATMENT
plating	NN	I-TREATMENT

Discharge	NN	O
Instructions	NNS	O
:	:	O
may	MD	O
shower	VB	O
,	,	O
no	DT	O
bathing	NN	O
or	CC	O
swimming	NN	O
for	IN	O
1	CD	O
month	NN	O
no	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
any	DT	B-PROBLEM
incisions	NNS	I-PROBLEM
no	DT	O
driving	NN	O
for	IN	O
1	CD	O
month	NN	O
no	DT	O
lifting	VBG	O
>	RB	O
10	CD	O
#	#	O
for	IN	O
10	CD	O
weeks	NNS	O

Chest	NNP	B-PROBLEM
pain	NN	I-PROBLEM

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
91	CD	O
yo	NN	O
woman	NN	O
with	IN	O
h/o	JJ	O
HTN	NNP	B-PROBLEM
who	WP	O
came	VBD	O
from	IN	O
Bridgewater	NNP	O
State	NNP	O
Hospital	NNP	O
Rehab	NNP	O
with	IN	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
after	IN	O
exercise	NN	O
.	.	O

After	IN	O
returning	VBG	O
to	TO	O
her	PRP$	O
room	NN	O
she	PRP	O
w	VBD	O
noted	JJ	O
SSCP	NNP	B-PROBLEM
without	IN	O
radiation	NN	O
.	.	O

No	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
.	.	O

They	PRP	O
did	VBD	O
an	DT	B-TEST
ECG	NN	I-TEST
at	IN	O
Bridgewater	NNP	O
State	NNP	O
Hospital	NNP	O
rehab	NN	O
which	WDT	O
demonstarted	VBD	O
new	JJ	B-PROBLEM
ST	NNP	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
V1-V4	NNP	I-PROBLEM
.	.	O

She	PRP	O
received	VBD	O
ASA	NNP	B-TREATMENT
81	CD	O
mg	NN	O
x	NN	O
2	CD	O
and	CC	O
nitro	JJ	B-TREATMENT
SL	NNP	I-TREATMENT
x	VBD	O
2	CD	O
with	IN	O
partial	JJ	O
relief	NN	O
at	IN	O
nursing	NN	O
home	NN	O
.	.	O

On	IN	O
presentation	NN	O
to	TO	O
Providence	NNP	O
Behavioral	NNP	O
Health	NNP	O
Hospital	NNP	O
Amanda	NNP	O
,	,	O
her	PRP$	B-TEST
vitals	NNS	I-TEST
were	VBD	O
HR	NNP	B-TEST
68	CD	O
,	,	O
BP	NNP	B-TEST
142/68	CD	O
,	,	O
RR	NNP	B-TEST
28	CD	O
,	,	O
O2	NNP	B-TEST
sat	VBD	I-TEST
100%	CD	O
RA	NNP	O
.	.	O

Exam	NNP	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
RRR	NNP	O
with	IN	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
bibasilar	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
,	,	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

EKG	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
brady	NN	I-PROBLEM
,	,	O
with	IN	O
old	JJ	B-PROBLEM
LAD	NNP	I-PROBLEM
and	CC	I-PROBLEM
new	JJ	I-PROBLEM
ST	NNP	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
V1-V4	NNP	I-PROBLEM
.	.	O

Troponin	NNP	B-TEST
was	VBD	O
0.07	CD	O
.	.	O

She	PRP	O
received	VBD	O
ASA	NNP	B-TREATMENT
,	,	O
nitro	RB	B-TREATMENT
SL	NNP	I-TREATMENT
then	RB	O
gtt	VBD	O
,	,	O
morphine	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
heparin	NN	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

Cardiology	NNP	O
discussed	VBD	O
cath	NN	B-TEST
however	RB	O
,	,	O
patient	NN	O
's	POS	O
family	NN	O
turned	VBD	O
down	RB	O
.	.	O

Transferred	VBN	O
to	TO	O
CCU	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
and	CC	O
observation	NN	O
.	.	O

HTN	NN	B-PROBLEM

Hearing	VBG	B-PROBLEM
difficulty	NN	I-PROBLEM

Blindness	NNP	B-PROBLEM
02-26	JJ	O
macular	JJ	B-PROBLEM
degeneration	NN	I-PROBLEM

R	NNP	B-PROBLEM
ankle	NN	I-PROBLEM
fx	NN	I-PROBLEM
2002	CD	O

S/p	NNP	O
hysterectomy	NN	B-TREATMENT

T	NNP	B-TEST
97.8	CD	O
,	,	O
HR	NNP	B-TEST
53	CD	O
,	,	O
BP	NNP	B-TEST
156/58	CD	O
,	,	O
RR	NNP	B-TEST
16	CD	O
,	,	O
O2	NNP	B-TEST
sat	VBD	I-TEST
94%	CD	O
on	IN	O
2.5	CD	O
L	NN	O

NAD	NNP	B-PROBLEM
,	,	O
awake	NN	O
,	,	O
alert	NN	O
,	,	O
blind	NN	B-PROBLEM
,	,	O
able	JJ	O
to	TO	O
hear	VB	O
loud	JJ	O
voices	NNS	O
at	IN	O
L	NNP	O
ear	VBP	O

JVP	NNP	B-TEST
11	CD	O
cm	NN	O

Reg	NNP	O
rate	NN	O
,	,	O
nl	CC	O
S1	NNP	O
&	CC	O
S2	NNP	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

Crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
base	NN	I-PROBLEM
and	CC	I-PROBLEM
mid-lungs	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

Soft	NNP	O
,	,	O
NT	NNP	B-PROBLEM
,	,	O
ND	NNP	B-PROBLEM
,	,	O
BS	NNP	O
present	NN	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM

Trace	NNP	B-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM

WBC	NNP	B-TEST
-	:	O
11.4*	CD	O
RBC	NNP	B-TEST
-	:	O
3.61*	CD	O
Hgb	NNP	B-TEST
-	:	O
11.4*	CD	O
Hct	NNP	B-TEST
-	:	O
32.6*	CD	O
MCV	NNP	B-TEST
-	:	O
90	CD	O
MCH	NNP	B-TEST
-	:	O
31.7	CD	O

MCHC	NNP	B-TEST
-	:	O
35.1*	CD	O
RDW	NNP	B-TEST
-	:	O
14.7	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
281	CD	O

Glucose	NNP	B-TEST
-	:	O
124*	CD	O
UreaN	NNP	B-TEST
-	:	O
30*	CD	O
Creat	NNP	B-TEST
-	:	O
1.3*	CD	O
Na	NNP	B-TEST
-	:	O
137	CD	O
K	NNP	B-TEST
-	:	O
4.2	CD	O
Cl	NNP	B-TEST
-	:	O
102	CD	O
HCO3	NNP	B-TEST
-	:	O
27	CD	O

AnGap	NNP	B-TEST
-	:	O
12	CD	O

CK	NNP	B-TEST
(	(	O
CPK	NNP	B-TEST
)	)	O
-	:	O
42	CD	O
cTropnT	NN	B-TEST
-	:	O
0.07*	CD	O

EKG	NN	B-TEST
:	:	O

sinus	NN	B-PROBLEM
brady	JJ	I-PROBLEM
@	VBZ	O
48	CD	O
bpm	NN	O
,	,	O
LAD	NNP	O
,	,	O
LVH	NNP	B-PROBLEM
,	,	O
RBBB	NNP	B-PROBLEM
,	,	O
Q	NNP	B-PROBLEM
wave	VBP	I-PROBLEM
in	IN	I-PROBLEM
I	PRP	I-PROBLEM
,	,	O
ST	NNP	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
V1-V4	NNP	I-PROBLEM
,	,	O
ST	NNP	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
III	NNP	I-PROBLEM
,	,	O
aVF	NN	B-PROBLEM
,	,	O
TWI	NNP	B-PROBLEM
in	IN	I-PROBLEM
III	NNP	I-PROBLEM
,	,	O
V5	NNP	O
.	.	O

CXR	JJ	B-TEST
10-07	NNS	O
:	:	O

There	EX	O
is	VBZ	O
slight	JJ	B-PROBLEM
worsening	NN	I-PROBLEM
of	IN	O
the	DT	B-PROBLEM
still	RB	I-PROBLEM
mild	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

Small	JJ	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

Echo	NN	B-TEST
:	:	O

LVEF	NNP	B-TEST
>70%	NNP	O
,	,	O
LA	NNP	B-TEST
6.1	CD	O
cm	NN	O
,	,	O
no	DT	O
regional	JJ	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

Cardiac	NNP	B-TEST
Enzymes	NNP	I-TEST

2015-10-05	JJ	O
09:00PM	CD	O
BLOOD	NN	B-TEST

CK	NNP	B-TEST
(	(	O
CPK	NNP	B-TEST
)	)	O
-	:	O
1471*	CD	O
CK-MB	JJ	B-TEST
-	:	O
207*	CD	O
MB	NNP	B-TEST
Indx	NNP	I-TEST
-	:	O
14.1*	CD	O
cTropnT	NN	B-TEST
-	:	O
6.00*	CD	O

2015-10-06	JJ	O
04:47PM	CD	O
BLOOD	NN	B-TEST

CK	NNP	B-TEST
(	(	O
CPK	NNP	B-TEST
)	)	O
-	:	O
1288*	CD	O
CK-MB	JJ	B-TEST
-	:	O
158*	CD	O
MB	NNP	B-TEST
Indx	NNP	I-TEST
-	:	O
12.3*	CD	O
cTropnT	NN	B-TEST
-	:	O
6.88*	CD	O

2015-10-07	JJ	O
07:30AM	CD	O
BLOOD	NN	B-TEST

CK	NNP	B-TEST
(	(	O
CPK	NNP	B-TEST
)	)	O
-	:	O
627*	CD	O
CK-MB	JJ	B-TEST
-	:	O
55*	CD	O
MB	NNP	B-TEST
Indx	NNP	I-TEST
-	:	O
8.8*	CD	O
cTropnT	NN	B-TEST
-	:	O
4.46*	CD	O

Labs	NNS	B-TEST
on	IN	O
Discharge	NNP	O
2015-10-08	JJ	O
08:35AM	CD	O

WBC	NNP	B-TEST
-	:	O
13.8*	CD	O
RBC	NNP	B-TEST
-	:	O
3.39*	CD	O
Hgb	NNP	B-TEST
-	:	O
10.7*	CD	O
Hct	NNP	B-TEST
-	:	O
30.2*	CD	O
MCV	NNP	B-TEST
-	:	O
89	CD	O
MCH	NNP	B-TEST
-	:	O
31.5	CD	O

MCHC	NNP	B-TEST
-	:	O
35.3*	CD	O
RDW	NNP	B-TEST
-	:	O
14.8	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
214	CD	O

Glucose	NNP	B-TEST
-	:	O
120*	CD	O
UreaN	NNP	B-TEST
-	:	O
30*	CD	O
Creat	NNP	B-TEST
-	:	O
1.2*	CD	O
Na	NNP	B-TEST
-	:	O
134	CD	O
K	NNP	B-TEST
-	:	O
4.2	CD	O
Cl	NNP	B-TEST
-	:	O
100	CD	O
HCO3	NNP	B-TEST
-	:	O
25	CD	O

AnGap	NNP	B-TEST
-	:	O
13	CD	O

Calcium	NNP	B-TEST
-	:	O
8.7	CD	O
Phos	NNP	B-TEST
-	:	O
2.5*	CD	O
Mg	NNP	B-TEST
-	:	O
2.1	CD	O

90	CD	O
year-old	JJ	O
woman	NN	O
with	IN	O
h/o	NN	O
of	IN	O
HTN	NNP	B-PROBLEM
p/w	VBP	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
shortly	RB	O
after	IN	O
exercise	NN	O
at	IN	O
nursing	NN	O
home	NN	O
,	,	O
with	IN	O
EKG	NNP	B-TEST
showing	VBG	O
ST	NNP	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
V1-V4	NNP	I-PROBLEM
and	CC	O
troponin	$	B-TEST
0.07.	CD	O

Likely	JJ	O
NSTEMI	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
's	POS	O
family	NN	O
refused	VBD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
ASA	NNP	B-TREATMENT
,	,	O
Plavix	NNP	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
x	VBD	O
24	CD	O
hours	NNS	O
,	,	O
nitro	JJ	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
atorvastatin	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

Her	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
morphine	NN	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
SBP	NNP	I-TEST
remained	VBD	O
in	IN	O
the	DT	O
160s-170s	NNS	O
on	IN	O
hospital	JJ	O
day	NN	O
1	CD	O
and	CC	O
she	PRP	O
was	VBD	O
gently	RB	O
diuresed	VBN	O
.	.	O

On	IN	O
hospital	JJ	O
day	NN	O
2	CD	O
she	PRP	O
experienced	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
HR	NNP	B-TEST
in	IN	O
the	DT	O
140s	CD	O
.	.	O

Her	PRP$	B-TREATMENT
metoprolol	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
from	IN	O
25	CD	O
mg	NNS	O
PO	NNP	O
bid	NN	O
to	TO	O
50	CD	O
mg	NNS	O
PO	NNP	O
bid	NN	O
then	RB	O
75	CD	O
mg	NNS	O
PO	NNP	O
tid	NN	O
.	.	O

Her	PRP$	B-TEST
HR	NNP	I-TEST
decreased	VBD	O
to	TO	O
70s-80s	NNS	O
.	.	O

Her	PRP$	B-TEST
BP	NNP	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

An	DT	B-TEST
ECHO	NNP	I-TEST
showed	VBD	O
that	IN	O
she	PRP	O
had	VBD	O
preserved	VBN	O
EF	NNP	O
and	CC	O
no	DT	O
wall	NN	B-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

We	PRP	O
decided	VBD	O
given	VBN	O
her	PRP$	O
age	NN	O
that	IN	O
she	PRP	O
would	MD	O
not	RB	O
be	VB	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
cardioversion	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
afib	JJ	I-PROBLEM
nor	CC	O
would	MD	O
she	PRP	O
be	VB	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
coumadin	NN	B-TREATMENT
.	.	O

Therefore	IN	O
we	PRP	O
will	MD	O
continue	VB	O
rate	NN	O
control	NN	O
with	IN	O
metoprolol	NN	B-TREATMENT
this	DT	O
can	MD	O
be	VB	O
titrated	VBN	O
if	IN	O
needed	VBN	O
,	,	O
and	CC	O
aspirin	NN	B-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
for	IN	O
anti-coagulation	NN	B-TREATMENT
.	.	O

She	PRP	O
should	MD	O
also	RB	O
continue	VB	O
on	IN	O
lipitor	NN	B-TREATMENT
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

She	PRP	O
should	MD	O
have	VB	O
her	PRP$	B-TEST
chem	NN	I-TEST
7	CD	I-TEST
checked	VBD	O
next	JJ	O
week	NN	O
given	VBN	O
the	DT	O
start	NN	O
of	IN	O
her	PRP$	B-TREATMENT
new	JJ	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

Will	NNP	O
also	RB	O
need	VBP	O
LFT	NNP	B-TEST
's	POS	I-TEST
checked	VBN	O
in	IN	O
3-6	JJ	O
months	NNS	O
.	.	O

Bilateral	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
bases	NNS	I-PROBLEM
and	CC	I-PROBLEM
midlungs	NNS	I-PROBLEM
,	,	O
elevated	VBD	B-PROBLEM
JVP	NNP	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
bilateral	JJ	I-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
CXR	NNP	B-TEST
with	IN	O
diffuse	NN	B-PROBLEM
opacities	NNS	I-PROBLEM
suggest	VBP	O
possible	JJ	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
likely	RB	O
secondary	JJ	O
to	TO	O
acute	VB	B-PROBLEM
MI	NNP	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
O2	NNP	I-TEST
sat	NN	I-TEST
was	VBD	O
stable	JJ	O
at	IN	O
94-97%	CD	O
on	IN	O
2.5L	CD	O
of	IN	O
supplemental	JJ	B-TREATMENT
O2	NNP	I-TREATMENT
.	.	O

She	PRP	O
experienced	VBD	O
no	DT	O
respiratory	NN	B-PROBLEM
difficulty	NN	I-PROBLEM
during	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

Her	PRP$	B-TEST
CXR	NNP	I-TEST
prior	NN	O
to	TO	O
discharge	VB	O
showed	JJ	O
mild	JJ	B-PROBLEM
pulm	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
thus	RB	O
was	VBD	O
given	VBN	O
40	CD	O
of	IN	O
lasix	NN	B-TREATMENT
prior	NN	O
to	TO	O
going	VBG	O
to	TO	O
rehab	VB	O
.	.	O

She	PRP	O
can	MD	O
be	VB	O
given	VBN	O
prn	JJ	O
lasix	NN	B-TREATMENT
for	IN	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

*	JJ	O
Leukocytosis-	NNP	B-PROBLEM
She	PRP	O
developed	VBD	O
mild	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
WBC	NNP	I-PROBLEM
.	.	O

UA	NNP	B-TEST
had	VBD	O
12-14	NNS	O

WBC	NNP	B-TEST
's	POS	I-TEST
,	,	O
few	JJ	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
Bactrim	NNP	B-TREATMENT
,	,	O
but	CC	O
this	DT	O
was	VBD	O
stopped	VBN	O
as	IN	O
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

SHe	NNP	O
has	VBZ	O
a	DT	B-TEST
culture	NN	I-TEST
pending	VBG	O
which	WDT	O
needs	VBZ	O
to	TO	O
be	VB	O
followed	VBN	O
up	RP	O
at	IN	O
the	DT	O
nursing	NN	O
home	NN	O
and	CC	O
treated	VBD	O
if	IN	O
positive	JJ	B-PROBLEM
.	.	O

tylenol	NN	B-TREATMENT
PRN	NNP	O
lisinopril	VBZ	B-TREATMENT
5	CD	O
mg	NN	O
PO	NNP	O
qd	NN	O
protonix	NN	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
qd	RB	O
artifical	JJ	B-TREATMENT
tears	NNS	I-TREATMENT
bid	VBD	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	JJ	O
PO	NNP	O
bid	NN	O

1.	CD	O
Senna	NNP	B-TREATMENT
8.6	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

3.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

4.	CD	O
Clopidogrel	NNP	B-TREATMENT
75	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

5.	CD	O
Atorvastatin	NNP	B-TREATMENT
80	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

7.	CD	O
Polyvinyl	NNP	B-TREATMENT
Alcohol	NNP	I-TREATMENT
1.4	CD	O
%	NN	O
Drops	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Drops	NNP	O
Ophthalmic	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
Lisinopril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

9.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

11.	CD	O
Maalox	NNP	B-TREATMENT
225-200	JJ	O
mg/5	NN	O
mL	NN	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
Five	CD	O
(	(	O
5	CD	O
)	)	O
mL	NN	O
PO	NNP	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
.	.	O

12.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
wheezing	NN	B-PROBLEM
:	:	O

Can	MD	O
give	VB	O
40	CD	O
lasix	NN	B-TREATMENT
PO	NNP	O
if	IN	O
having	VBG	O
any	DT	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

NSTEMI	NN	B-PROBLEM

Atrial	JJ	B-PROBLEM
Fibrillation	NN	I-PROBLEM

HTN	NN	B-PROBLEM

Patient	NN	O
without	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
and	CC	O
BP	NNP	B-TEST
stable	JJ	O
.	.	O

Please	NNP	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
instructed	VBN	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
started	VBN	O
on	IN	O
several	JJ	B-TREATMENT
new	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
which	WDT	O
are	VBP	O
important	JJ	O
to	TO	O
protect	VB	O
her	PRP$	O
heart	NN	O
.	.	O

If	IN	O
the	DT	O
patient	NN	O
experiences	VBZ	O
any	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
1,770	JJ	O
gram	NN	O
male	NN	O
infant	NN	O
born	VBN	O
by	IN	O
stat	JJ	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
for	IN	O
fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
at	IN	O
30-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
to	TO	O
a	DT	O
29-year-old	JJ	O
gravida	NN	O
3	CD	O
,	,	O
para	VBZ	O
0	CD	O
now	RB	O
1	CD	O
mother	NN	O
.	.	O

The	DT	O
pregnancy	NN	O
was	VBD	O
unremarkable	JJ	O
until	IN	O
2015-06-01	JJ	O
when	WRB	O
the	DT	O
mother	NN	O
presented	VBD	O
to	TO	O
Shriner	NNP	O
's	POS	O
Hospital	NNP	O
for	IN	O
Crippled	NNP	O
Children	NNP	O
for	IN	O
increased	VBN	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
proteinuria	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
Charles	NNP	O
River	NNP	O
Hospital	NNP	O
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
and	CC	O
betamethasone	NN	B-TREATMENT
.	.	O

The	DT	O
morning	NN	O
of	IN	O
admission	NN	O
the	DT	O
mother	NN	O
developed	VBD	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

Therefore	RB	O
,	,	O
a	DT	B-TREATMENT
stat	JJ	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

The	DT	O
infant	NN	O
emerged	VBD	O
limp	NN	B-PROBLEM
and	CC	O
without	IN	O
spontaneous	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
effort	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
bag	JJ	B-TREATMENT
mask	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

Apgar	NNP	B-TEST
scores	NNS	I-TEST
were	VBD	O
6	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

O+	NNP	O
,	,	O
hepatitis	NN	B-TEST
B	NNP	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O

RPR	NNP	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-PROBLEM
immune	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
mild	NN	B-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
defects	NNS	B-PROBLEM
.	.	O

The	DT	O
lungs	NNS	O
were	VBD	O
coarse	JJ	B-PROBLEM
bilaterally	RB	I-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
retractions	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
cardiovascular	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
S1	NNP	B-TEST
and	CC	O
S2	NNP	B-TEST
regular	JJ	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
benign	JJ	O
,	,	O
flat	JJ	O
,	,	O
nontender	FW	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Hips	NNS	O
were	VBD	O
stable	JJ	O
without	IN	O
clunk	NN	B-PROBLEM
.	.	O

The	DT	O
skin	NN	O
was	VBD	O
without	IN	O
lesions	NNS	B-PROBLEM
.	.	O

The	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
appropriate	JJ	O
for	IN	O
age	NN	O
with	IN	O
normal	JJ	O
tone	NN	O
and	CC	O
strength	NN	O
and	CC	O
appropriate	JJ	O
reflexes	NNS	O
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
bradycardic	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
and	CC	O
was	VBD	O
therefore	RB	O
started	VBN	O
on	IN	O
caffeine	NN	B-TREATMENT
.	.	O

With	IN	O
the	DT	O
initiation	NN	O
of	IN	O
caffeine	NN	B-TREATMENT
therapy	NN	I-TREATMENT
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
more	RBR	O
apnea	NN	B-PROBLEM
or	CC	O
bradycardic	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
nasal	NN	B-TREATMENT
prong	JJ	I-TREATMENT
CPAP	NNP	I-TREATMENT
at	IN	O
6	CD	O
and	CC	O
required	VBD	O
additional	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
35%	CD	O
.	.	O

However	RB	O
by	IN	O
24	CD	O
hours	NNS	O
he	PRP	O
transitioned	VBD	O
to	TO	O
low-flow	JJ	B-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
transitioned	VBN	O
to	TO	O
room	NN	O
air	NN	O
where	WRB	O
he	PRP	O
currently	RB	O
remains	VBZ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
only	RB	O
and	CC	O
when	WRB	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
resolved	VBD	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

The	DT	O
morning	NN	O
of	IN	O
transfer	NN	O
his	PRP$	B-TREATMENT
IV	NNP	I-TREATMENT
came	VBD	O
out	RP	O
so	RB	O
he	PRP	O
has	VBZ	O
just	RB	O
been	VBN	O
advanced	VBN	O
to	TO	O
120	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
of	IN	O
PE-20	NNP	B-TREATMENT
and	CC	O
his	PRP$	O
tolerating	VBG	O
these	DT	B-TREATMENT
PG	NNP	I-TREATMENT
feedings	NNS	I-TREATMENT
without	IN	O
difficulty	NN	O
.	.	O

Last	JJ	B-TEST
set	NN	I-TEST
of	IN	I-TEST
electrolytes	NNS	I-TEST
on	IN	O
06-08	NN	O
,	,	O
DOL3	NNP	O
:	:	O

Na	RB	B-TEST
145	CD	O
,	,	O
K	NNP	B-TEST
4.3	CD	O
,	,	O
Cl	NNP	B-TEST
110	CD	O
,	,	O
tCO2	VBD	B-TEST
25	CD	O
.	.	O

His	PRP$	B-TEST
admission	NN	I-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
11.8	CD	O
,	,	O
25	CD	B-TEST
polys	NN	I-TEST
and	CC	O
no	DT	O
bands	NNS	B-PROBLEM
.	.	O

Hematocrit	NNP	B-TEST
was	VBD	O
45	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
270	CD	O
.	.	O

He	PRP	O
developed	VBD	O
physiologic	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
(	(	O
peak	JJ	B-TEST
bili	NN	I-TEST
8.6/0.3	CD	O
on	IN	O
06-08	NN	O
,	,	O
DOL3	NNP	O
)	)	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
single	JJ	I-TREATMENT
phototherapy	NN	I-TREATMENT
.	.	O

His	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
bilirubin	NN	I-TEST
was	VBD	O
6.6	CD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
,	,	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
and	CC	O
his	PRP$	B-TREATMENT
phototherapy	NN	I-TREATMENT
was	VBD	O
discontinued.	NN	O
He	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
rebound	NN	I-TEST
bilirubin	NN	I-TEST
level	NN	I-TEST
in	IN	O
am	VBP	O
.	.	O

Blood	NNP	B-TEST
culture	NN	I-TEST
was	VBD	O
sent	VBN	O
but	CC	O
he	PRP	O
was	VBD	O
never	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

The	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
remained	VBD	O
sterile	JJ	O
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
erythematous	JJ	I-PROBLEM
perianal	JJ	I-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
for	IN	O
this	DT	O
was	VBD	O
started	VBN	O
on	IN	O
Nystatin	NNP	B-TREATMENT
powder	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
not	RB	O
had	VBN	O
an	DT	O
CMED	NNP	B-TEST
examination	NN	I-TEST
or	CC	O
hearing	JJ	B-TEST
test	NN	I-TEST
.	.	O

Feeds	NNS	B-TREATMENT
at	IN	O
discharge	NN	O
are	VBP	O
PE-20	NNP	B-TREATMENT
currently	RB	O
at	IN	O
120	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
due	JJ	O
to	TO	O
advance	VB	O
15	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
to	TO	O
a	DT	O
total	NN	O
of	IN	O
150	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
.	.	O

Caffeine	NNP	B-TREATMENT
12	CD	O
mg	NN	O
pg	NN	O
q	NN	O
day.	NN	O
He	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
his	PRP$	O
06-10	JJ	O
dose	NN	O
.	.	O

He	PRP	O
is	VBZ	O
due	JJ	O
to	TO	O
have	VB	O
his	PRP$	B-TEST
state	NN	I-TEST
screen	NN	I-TEST
sent	VBD	O
today	NN	O
.	.	O

Synagis	NNP	B-TREATMENT
RSV	NNP	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
October	NNP	O
through	IN	O
April	NNP	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
criteria	NNS	O
:	:	O

3.	CD	O
With	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Influenza	NNP	B-TREATMENT
vaccination	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
Prematurity	NN	B-PROBLEM
at	IN	O
30-6/7	JJ	O
weeks	NNS	O
.	.	O

2.	CD	O
Rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
,	,	O
off	RB	O
antibiotics	NNS	B-TREATMENT
.	.	O

3.	CD	O
Apnea	NNP	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

4.	CD	O
Hyperbilirubinemia	NNP	B-PROBLEM
.	.	O

5.	CD	O
Feeding	NNP	B-PROBLEM
immaturity	NN	I-PROBLEM
.	.	O

Sulfonamides	NNP	B-TREATMENT
/	NNP	O
Penicillins	NNP	B-TREATMENT
/	NNP	O
Tetracyclines	NNP	B-TREATMENT
/	NNP	O
Azithromycin	NNP	B-TREATMENT
/	NNP	O
Iodine	NNP	B-TREATMENT
/	NNP	O
Shellfish	NNP	O
/	NNP	O
Ace	NNP	B-TREATMENT
Inhibitors	NNP	I-TREATMENT
/	NNP	O
Ciprofloxacin	NNP	B-TREATMENT

Chronic	NNP	B-PROBLEM
prostatitis	NN	I-PROBLEM

TURP	NN	B-TREATMENT

Justin	NNP	O
Searle	NNP	O
a	DT	O
60-year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
prostatitis	NN	I-PROBLEM
status	NN	O
post	NN	O
two	CD	B-TREATMENT
transurethral	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
procedures	NNS	O
in	IN	O
2007	CD	O
and	CC	O
1998	CD	O
.	.	O

He	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
diagnosis	NN	O
of	IN	O
interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
and	CC	O
more	RBR	O
significantly	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
recent	JJ	I-TEST
catheterization	NN	I-TEST
,	,	O
supraventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
progressive	JJ	I-PROBLEM
mitochondrial	NN	I-PROBLEM
myopathy	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
symptoms	NNS	B-PROBLEM
of	IN	O
dribbling	NN	B-PROBLEM
,	,	O
stress	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
but	CC	O
has	VBZ	O
no	DT	O
dysuria	NN	B-PROBLEM
.	.	O

1.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
s/p	JJ	O
stents	NNS	B-TREATMENT
to	TO	I-TREATMENT
LAD	NNP	I-TREATMENT
and	CC	I-TREATMENT
3rd	CD	I-TREATMENT
OM	NNP	I-TREATMENT
)	)	O

2.	CD	O
Supraventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
(	(	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
)	)	O
.	.	O

3.	CD	O
Mitochondrial	NNP	B-PROBLEM
myopathy	NN	I-PROBLEM
.	.	O

4.	CD	O
History	NNP	O
of	IN	O
orthostasis	NN	B-PROBLEM
with	IN	O
tilt	JJ	B-TEST
table	JJ	I-TEST
testing	VBG	I-TEST
done	VBN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

5.	CD	O
Status	NNP	O
post	NN	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
prostate	JJ	I-TREATMENT
times	NNS	O
two	CD	O
(	(	O
in	IN	O
2007	CD	O
and	CC	O
1998	CD	O
)	)	O
.	.	O

6.	CD	O
Interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
.	.	O

7.	CD	O
Pericarditis	NNP	B-PROBLEM
.	.	O

8.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

9.	CD	O
Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

10.	CD	O
Gastrointestinal	NNP	B-PROBLEM
bleed	NN	I-PROBLEM

Father	NNP	O
had	VBD	O
MI	NNP	B-PROBLEM
at	IN	O
42	CD	O

Mother	NNP	O
died	VBD	O
of	IN	O
MI	NNP	B-PROBLEM
at	IN	O
76	CD	O

NAD	NN	B-PROBLEM

RRR	NNP	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

Abd	NNS	O
:	:	O
soft	JJ	O
,	,	O
+distension	NN	B-PROBLEM
with	IN	O
tympany	NN	B-PROBLEM
,	,	O
no	DT	O
HSM	NNP	B-PROBLEM
,	,	O
hyperactive	JJ	B-PROBLEM
BS	NNP	I-PROBLEM

Ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM

ECG	NN	B-TEST
:	:	O

NSR	NNP	B-TEST
at	IN	O
62	CD	O
,	,	O
nl	RB	O
axis	NN	O
,	,	O
nl	JJ	O
intervals	NNS	O
,	,	O
Q	NNP	B-PROBLEM
waves	VBZ	I-PROBLEM
in	IN	I-PROBLEM
III	NNP	I-PROBLEM
,	,	O
avR	NN	B-TEST
,	,	I-TEST
V1	NNP	B-TEST
.	.	O

TWI	NNP	B-PROBLEM
's	POS	O
in	IN	O
III	NNP	O
,	,	O
V1	NNP	O
.	.	O

GLUCOSE	NNP	B-TEST
-	:	O
94	CD	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
22*	CD	O
CREAT	NNP	B-TEST
-	:	O
1.4*	CD	O
SODIUM	NNP	B-TEST
-	:	O
142	CD	O

POTASSIUM	NNP	B-TEST
-	:	O
5.9*	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
108	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
23	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
17	CD	O

CALCIUM	NNP	B-TEST
-	:	O
9.7	CD	O
PHOSPHATE	NNP	B-TEST
-	:	O
3.9	CD	O
MAGNESIUM	NNP	B-TEST
-	:	O
1.9	CD	O

WBC	NNP	B-TEST
-	:	O
7.5	CD	O
RBC	NNP	B-TEST
-	:	O
5.09	CD	O
HGB	NNP	B-TEST
-	:	O
15.4	CD	O
HCT	NNP	B-TEST
-	:	O
43.7	CD	O
MCV	NNP	B-TEST
-	:	O
86	CD	O

MCH	NNP	B-TEST
-	:	O
30.2	CD	O
MCHC	NNP	B-TEST
-	:	O
35.2*	CD	O
RDW	NNP	B-TEST
-	:	O
13.6	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
257#	CD	O

PT	NNP	B-TEST
-	:	O
12.2	CD	O
PTT	NNP	B-TEST
-	:	O
23.8	CD	O
INR	NNP	B-TEST
(	(	I-TEST
PT	NNP	I-TEST
)	)	I-TEST
-	:	O
0.9	CD	O

On	IN	O
HD2	NNP	O
,	,	O
cardiac	JJ	B-TEST
clearance	NN	I-TEST
was	VBD	O
obtained	VBN	O
by	IN	O
Dr.	NNP	O
Sanchez	NNP	O
.	.	O

Patient	NNP	O
tolerated	VBD	O
procedure	NN	B-TREATMENT
on	IN	O
2018-03-05	JJ	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O

ICU	NNP	O
for	IN	O
24hr	CD	O
post-op	JJ	O
cardiac	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

Catheter	NN	B-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Pyridium	NN	B-TREATMENT
.	.	O

1.	CD	O
Hydroxyzine	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

2.	CD	O
Atorvastatin	NNP	B-TREATMENT
Calcium	NNP	I-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

3.	CD	O
Ezetimibe	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

4.	CD	O
Simethicone	CD	B-TREATMENT
80	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Chewable	JJ	O
Sig	NN	O
:	:	O
0.5-1	JJ	O
Tablet	NNP	O
,	,	O
Chewable	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion/gas	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

5.	CD	O
Aluminum-Magnesium	JJ	B-TREATMENT
Hydroxide	NNP	I-TREATMENT
225-200	CD	O
mg/5	NN	O
mL	NN	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
15-30	JJ	O
MLs	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
.	.	O

6.	CD	O
Atenolol	NNP	B-TREATMENT
100	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

7.	CD	O
Hyoscyamine	NNP	B-TREATMENT
Sulfate	NNP	I-TREATMENT
0.125	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
Phenazopyridine	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

Chronic	NNP	B-PROBLEM
prostatitis	NN	I-PROBLEM

Interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM

Go	NNP	O
to	TO	O
an	DT	O
Emergency	NNP	O
Room	NNP	O
if	IN	O
you	PRP	O
experience	VBP	O
symptoms	NNS	B-PROBLEM
including	VBG	O
,	,	O
but	CC	O
not	RB	O
necessarily	RB	O
limited	VBN	O
to	TO	O
:	:	O
new	JJ	B-PROBLEM
and	CC	I-PROBLEM
continuing	VBG	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
(	(	O
>101.5	NNP	O
F	NNP	O
)	)	O
,	,	O
chills	NNS	B-PROBLEM
,	,	O
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Proceed	VB	O
to	TO	O
the	DT	O
ER/EW/Monica	NNP	O
if	IN	O
your	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
becomes	RB	O
red	JJ	B-PROBLEM
,	,	O
swollen	VBN	B-PROBLEM
,	,	O
warm	JJ	B-PROBLEM
,	,	O
or	CC	O
produces	VBZ	O
pus	NN	B-PROBLEM
.	.	O

You	PRP	O
may	MD	O
remove	VB	O
your	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
2	CD	O
days	NNS	O
after	IN	O
your	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
if	IN	O
they	PRP	O
were	VBD	O
not	RB	O
removed	VBN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

Leave	VB	O
the	DT	B-TREATMENT
steri	JJ	I-TREATMENT
strips	NNS	I-TREATMENT
on	IN	O
until	IN	O
they	PRP	O
begin	VBP	O
to	TO	O
peel	VB	O
,	,	O
then	RB	O
you	PRP	O
may	MD	O
remove	VB	O
them.	NN	O
Staples	NNP	B-TREATMENT
and	CC	O
stitches	NNS	B-TREATMENT
will	MD	O
remain	VB	O
until	IN	O
your	PRP$	O
follow-up	JJ	O
appointment	NN	O
.	.	O

If	IN	O
you	PRP	O
experience	VBP	O
clear	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
,	,	O
cover	VB	O
them	PRP	O
with	IN	O
a	DT	B-TREATMENT
clean	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
and	CC	O
stop	VB	O
showering	NN	O
until	IN	O
the	DT	B-PROBLEM
drainage	NN	I-PROBLEM
subsides	VBZ	O
for	IN	O
at	IN	O
least	JJS	O
2	CD	O
days	NNS	O
.	.	O

No	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
pain	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

Narcotics	NNS	B-TREATMENT
can	MD	O
cause	VB	O
constipation	NN	B-PROBLEM
.	.	O

Please	NNP	O
take	VB	O
an	DT	B-TREATMENT
over	IN	I-TREATMENT
the	DT	I-TREATMENT
counter	JJ	I-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
such	JJ	O
as	IN	O
Colace	NNP	B-TREATMENT
or	CC	O
a	DT	B-TREATMENT
gentle	JJ	I-TREATMENT
laxative	NN	I-TREATMENT
such	JJ	O
as	IN	O
Milk	NNP	B-TREATMENT
of	IN	I-TREATMENT
Magnesia	NNP	I-TREATMENT
if	IN	O
you	PRP	O
experience	VBP	O
constipation	NN	B-PROBLEM
.	.	O

You	PRP	O
may	MD	O
take	VB	O
showers	NNS	O
(	(	O
no	DT	O
baths	NN	O
)	)	O
after	IN	O
your	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
removed	VBN	O
from	IN	O
your	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
.	.	O

Continue	NNP	O
taking	VBG	O
your	PRP$	B-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
unless	IN	O
otherwise	RB	O
contraindicated	VBN	O
and	CC	O
follow	VB	O
up	RP	O
with	IN	O
PCP	NNP	O
.	.	O

Mr.	NNP	O
Jackson	NNP	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
male	NN	O
with	IN	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
the	DT	O
floor	NN	O
of	IN	O
mouth	NN	O
(	(	O
stage	NN	B-PROBLEM
T2	NNP	I-PROBLEM
N0	NNP	I-PROBLEM
)	)	O
that	WDT	O
was	VBD	O
biopsied	VBN	O
by	IN	O
his	PRP$	O
dentist	NN	O
.	.	O

Pathology	NNP	B-TEST
was	VBD	O
reviewed	VBN	O
revealing	VBG	O
invasive	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

He	PRP	O
presented	VBD	O
on	IN	O
2016-11-21	JJ	O
for	IN	O
resection	NN	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2016-11-21	JJ	O
following	VBG	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

He	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
joint	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
by	IN	O
Otolaryngology	NNP	O
and	CC	O
Plastic	NNP	O
Surgery	NNP	O
.	.	O

Includes	NNS	O
hypertension	NN	B-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Polypectomy	NN	B-TREATMENT
in	IN	O
2011	CD	O
,	,	O
tooth	DT	B-TREATMENT
extraction	NN	I-TREATMENT
(	(	O
all	DT	O
)	)	O
in	IN	O
1980	CD	O
,	,	O
and	CC	O
hernia	NN	B-PROBLEM
in	IN	O
1977	CD	O
.	.	O

TOMATO	NNP	O
(	(	O
causing	VBG	O
anaphylaxis	NN	B-PROBLEM
)	)	O
and	CC	O
TETANUS	NNP	B-TREATMENT
SHOT	NNP	I-TREATMENT
.	.	O

Triamterene/hydrochlorothiazide	RB	B-TREATMENT
37.5/25	CD	O
mg	NN	O
one	CD	O
tablet	NN	O
by	IN	O
mouth	NN	O
once	RB	O
daily	JJ	O
and	CC	O
lorazepam	JJ	B-TREATMENT
1	CD	O
mg	NN	O
three	CD	O
times	NNS	O
daily	RB	O
as	IN	O
needed	VBN	O
(	(	O
for	IN	O
anxiety	NN	B-PROBLEM
)	)	O
.	.	O

1.	CD	O
Tracheostomy	NNP	B-TREATMENT
.	.	O

2.	CD	O
Diagnostic	JJ	B-TEST
laryngoscopy	NN	I-TEST
and	CC	O
biopsy	NN	B-TEST
.	.	O

3.	CD	O
Bilateral	NNP	B-TREATMENT
supraomohyoid	NN	I-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

4.	CD	O
Resection	NNP	B-TREATMENT
of	IN	O
floor	NN	O
of	IN	O
mouth	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

Frozen	JJ	B-TEST
section	NN	I-TEST
sent	VBD	O
to	TO	O
pathology	VB	O
revealing	VBG	O
invasive	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

No	DT	O
complications	NNS	B-PROBLEM
.	.	O

The	DT	O
Plastic	NNP	O
Team	NNP	O
then	RB	O
took	VBD	O
over	RP	O
for	IN	O
reconstruction	NN	B-TREATMENT
consisting	NN	O
of	IN	O
radial	JJ	B-TREATMENT
forearm	NN	I-TREATMENT
free	JJ	I-TREATMENT
flap	NN	I-TREATMENT
to	TO	O
floor	NN	O
of	IN	O
mouth	NN	O
.	.	O

Total	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
of	IN	O
7300	CD	O
cc	NN	O
.	.	O

Estimated	VBN	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	O
300	CD	O
cc	NN	O
.	.	O

Urine	NNP	B-TEST
output	NN	I-TEST
of	IN	O
900	CD	O
cc	NN	O
.	.	O

No	DT	O
complications	NNS	B-PROBLEM
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
prepared	VBN	O
for	IN	O
an	DT	B-TREATMENT
attempted	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
was	VBD	O
unsuccessful	JJ	O
,	,	O
and	CC	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
converted	VBN	O
to	TO	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
which	WDT	O
then	RB	O
proceeded	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
sedated	VBN	O
and	CC	O
ventilated	VBN	O
by	IN	O
his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
6	CD	I-TREATMENT
cuff	NN	I-TREATMENT
Shiley	NNP	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
three	CD	O
Westwood-Pocasset	NNP	B-TREATMENT
drains	NNS	I-TREATMENT
-	:	O
two	CD	O
in	IN	O
the	DT	O
neck	NN	O
and	CC	O
one	CD	O
in	IN	O
his	PRP$	O
right	JJ	O
arm	NN	O
.	.	O

G-tube	NNP	B-TREATMENT
was	VBD	O
to	TO	O
gravity	NN	O
,	,	O
Foley	NNP	B-TREATMENT
to	TO	O
gravity	NN	O
,	,	O
left	VBD	B-TREATMENT
radial	JJ	I-TREATMENT
A-line	NNP	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
flap	NN	I-TREATMENT
was	VBD	O
pink	VBN	O
with	IN	O
a	DT	B-TEST
strong	JJ	I-TEST
Doppler	NNP	I-TEST
signal	NN	I-TEST
.	.	O

He	PRP	O
underwent	JJ	O
flap	JJ	B-TEST
checks	NNS	I-TEST
every	DT	O
15	CD	O
minutes	NNS	O
initially	RB	O
with	IN	O
a	DT	B-TREATMENT
dextran	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
Unasyn	NNP	B-TREATMENT
3	CD	O
grams	NNS	O
IV	NNP	B-TREATMENT
q.6h.	NN	O

Nothing	NN	O
by	IN	O
mouth	NN	O
initially	RB	O
with	IN	O
morphine	NN	B-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
Ativan	NNP	B-TREATMENT
around	IN	O
the	DT	O
clock	NN	O
for	IN	O
delirium	NN	B-TREATMENT
tremens	NNS	I-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
received	VBD	O
metoprolol	JJ	B-TREATMENT
q.4.h.	NN	O
,	,	O
a	DT	B-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
,	,	O
and	CC	O
adequate	JJ	O
gastrointestinal	JJ	O
prophylaxis	NN	O
with	IN	O
Protonix	NNP	B-TREATMENT
.	.	O

Postoperative	JJ	B-TEST
laboratories	NNS	I-TEST
revealed	VBD	O
sodium	NN	B-TEST
was	VBD	O
134	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
4.1	CD	O
,	,	O
chloride	NN	B-TEST
was	VBD	O
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
was	VBD	O
28	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
was	VBD	O
18	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
0.8	CD	O
,	,	O
and	CC	O
glucose	NN	B-TEST
was	VBD	O
148	CD	O
.	.	O

Calcium	NN	B-TEST
was	VBD	O
7.6	CD	O
.	.	O

Magnesium	NN	B-TEST
was	VBD	O
2.2	CD	O
.	.	O

Complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
revealed	VBD	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
5.4	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
31.3	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
were	VBD	O
160	CD	O
.	.	O

ALT	NNP	B-TEST
was	VBD	O
14	CD	O
,	,	O
AST	NNP	B-TEST
was	VBD	O
31	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
42	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.9	CD	O
,	,	O
albumin	NN	B-TEST
was	VBD	O
2.2	CD	O
.	.	O

A	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
postoperatively	RB	O
showed	VBD	O
clear	JJ	O
lung	NN	O
fields	NNS	O
.	.	O

Tracheostomy	NNP	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
good	JJ	O
position	NN	O
.	.	O

No	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

CMED	NNP	O
CSRU	NNP	O
and	CC	O
Plastic	NNP	O
Surgery	NNP	O
flap	NN	B-TEST
checks	NNS	I-TEST
,	,	O
tracheostomy	EX	B-TREATMENT
care	NN	I-TREATMENT
,	,	O
and	CC	O
Westwood-Pocasset	NNP	B-TREATMENT
management.	NN	I-TREATMENT

Lopressor	NNP	B-TREATMENT
5	CD	O
intravenously	RB	O
q.4.h.	JJ	O

Nebulizers	NNS	B-TREATMENT
as	IN	O
needed	VBN	O
,	,	O
weaning	VBG	O
from	IN	O
ventilation	NN	B-TREATMENT
.	.	O

Medications	NNS	B-TREATMENT
per	IN	O
gastrostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
.	.	O

Foley	NNP	B-TREATMENT
catheter	NN	I-TREATMENT
for	IN	O
strict	JJ	B-TEST
monitoring	NN	I-TEST
of	IN	I-TEST
ins	NNS	I-TEST
and	CC	I-TEST
outs	NNS	I-TEST
.	.	O

Hematocrit	NNP	B-TEST
stable	JJ	O
.	.	O

Unasyn	NNP	B-TREATMENT
for	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

Flap	NNP	B-TEST
checks	NNS	I-TEST
carried	VBD	O
out	RP	O
q.2h.	NN	O
initially	RB	O
in	IN	O
the	DT	O
Surgical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
showing	VBG	O
positive	JJ	B-PROBLEM
biphasic	JJ	I-PROBLEM
Doppler	NNP	I-PROBLEM
signals	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
ventilation	NN	B-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
to	TO	O
pressure	VB	B-TREATMENT
support	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
and	CC	O
then	RB	O
to	TO	O
spontaneous	JJ	O
breathing	VBG	O
on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
.	.	O

His	PRP$	B-TEST
Westwood-Pocasset	JJ	I-TEST
output	NN	I-TEST
for	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
on	IN	O
the	DT	O
left	NN	O
was	VBD	O
60	CD	O
,	,	O
right	RB	O
neck	NN	O
93	CD	O
,	,	O
in	IN	O
the	DT	O
arm	NN	O
20	CD	O
.	.	O

Tube	NNP	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
48	CD	O
hours	NNS	O
after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

The	DT	O
cuff	NN	O
on	IN	O
his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
put	VBN	O
down	RP	O
on	IN	O
11-23	JJ	O
,	,	O
postoperative	JJ	O
day	NN	O
two	CD	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
with	IN	O
minimal	JJ	B-PROBLEM
secretions	NNS	I-PROBLEM
and	CC	O
a	DT	O
strong	JJ	O
adequate	JJ	O
cough	NN	O
.	.	O

His	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
advanced	VBN	O
.	.	O

He	PRP	O
continued	VBD	O
with	IN	O
pulmonary	JJ	B-TREATMENT
toilet	NN	I-TREATMENT
and	CC	O
q.2h.	NN	B-TEST
flap	NN	I-TEST
checks	NNS	I-TEST
.	.	O

The	DT	B-TREATMENT
Westwood-Pocasset	NNP	I-TREATMENT
in	IN	I-TREATMENT
his	PRP$	I-TREATMENT
right	JJ	I-TREATMENT
arm	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
2016-11-25	JJ	O
.	.	O

His	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
6	CD	I-TREATMENT
cuffless	NN	I-TREATMENT
Shiley	NNP	I-TREATMENT
on	IN	O
2016-11-26	JJ	O
and	CC	O
sutures	NNS	B-TREATMENT
in	IN	O
place	NN	O
with	IN	O
a	DT	B-TREATMENT
3-0	JJ	I-TREATMENT
silk	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

Mrs.	NNP	O
Wisniewski	NNP	O
is	VBZ	O
a	DT	O
45-year-old	JJ	O
woman	NN	O
with	IN	O
multiple	JJ	B-PROBLEM
familial	JJ	I-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
.	.	O

She	PRP	O
developed	VBD	O
an	DT	B-PROBLEM
ear	JJ	I-PROBLEM
ache	NN	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
she	PRP	O
saw	VBD	O
her	PRP	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Evelyn	NNP	O
was	VBD	O
prescribed	VBN	O
cortisone	JJ	B-TREATMENT
drops	NNS	I-TREATMENT
.	.	O

A	DT	O
few	JJ	O
days	NNS	O
later	RB	O
she	PRP	O
complained	VBD	O
of	IN	O
dizziness	NN	B-PROBLEM
.	.	O

This	DT	O
was	VBD	O
mostly	RB	O
described	VBN	O
as	IN	O
feeling	VBG	O
unsteady	JJ	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
seen	VBN	O
again	RB	O
by	IN	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Roderick	NNP	O
since	IN	O
she	PRP	O
had	VBD	O
complaints	NNS	O
of	IN	O
dizziness	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
new	JJ	O
complaint	NN	O
of	IN	O
decreased	JJ	B-PROBLEM
hearing	NN	I-PROBLEM
and	CC	O
the	DT	O
sensation	NN	O
of	IN	O
static	JJ	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
ears	NNS	I-PROBLEM
,	,	O
meniere	EX	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
.	.	O

She	PRP	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
prednisone	NN	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

This	DT	B-PROBLEM
unsteady	JJ	I-PROBLEM
gait	NN	I-PROBLEM
progressed	VBN	O
,	,	O
and	CC	O
then	RB	O
she	PRP	O
subsequently	RB	O
started	VBD	O
to	TO	O
develop	VB	O
a	DT	B-PROBLEM
pins	NNS	I-PROBLEM
and	CC	I-PROBLEM
needle	JJ	I-PROBLEM
feeling	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
face	NN	I-PROBLEM
,	,	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
feet	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

Her	PRP$	O
hearing	NN	O
got	VBD	O
progressively	RB	B-PROBLEM
worse	JJR	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
sound	NN	I-PROBLEM
of	IN	I-PROBLEM
static	JJ	I-PROBLEM
increased	VBN	O
.	.	O

She	PRP	O
was	VBD	O
very	RB	B-PROBLEM
fatigued	VBN	I-PROBLEM
.	.	O

At	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
head	NN	B-TEST
CT	NNP	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
1.5	CD	I-PROBLEM
cm	NN	I-PROBLEM
diameter	NN	I-PROBLEM
hyperdense	NN	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pons	NNS	I-PROBLEM
,	,	O
slightly	RB	O
off	IN	O
center	NN	O
to	TO	O
the	DT	O
right	NN	O
.	.	O

Notable	JJ	O
for	IN	O
multiple	JJ	B-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBN	O
at	IN	B-PROBLEM
least	JJS	I-PROBLEM
two	CD	I-PROBLEM
bleeding	VBG	I-PROBLEM
episodes	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
mostly	RB	O
described	VBN	O
as	IN	O
being	VBG	O
accompanied	VBN	O
by	IN	O
generalized	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBN	O
at	IN	B-PROBLEM
least	JJS	I-PROBLEM
two	CD	I-PROBLEM
generalized	JJ	I-PROBLEM
seizures	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
,	,	O
but	CC	O
she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
one	CD	O
since	IN	O
she	PRP	O
was	VBD	O
26	CD	O
years	NNS	O
old	JJ	O
.	.	O

She	PRP	O
was	VBD	O
never	RB	O
on	IN	O
an	DT	B-TREATMENT
anticonvulsant	JJ	I-TREATMENT
due	JJ	O
to	TO	O
her	PRP$	O
former	JJ	O
beliefs	NN	O
as	IN	O
N.	NNP	O
Derk	NNP	O
Scientist	NNP	O
.	.	O

Prednisone	NNP	B-TREATMENT
taper	NN	I-TREATMENT
as	IN	O
above	NN	O
.	.	O

Strong	JJ	O
maternal	JJ	O
history	NN	O
of	IN	O
hemangiomas	NN	B-PROBLEM
.	.	O

Temperature	NN	B-TEST
99.2	CD	O
.	.	O

Pulse	RB	B-TEST
60	CD	O
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
120/80	CD	O
.	.	O

Respiratory	JJ	B-TEST
rate	NN	I-TEST
14	CD	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
a	DT	O
thin	JJ	O
well-appearing	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Sclera	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

Cardiovascular	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Abdomen	NNP	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
distended	VBD	B-PROBLEM
.	.	O

Extremities	NNS	O
showed	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

Neurologically	RB	O
,	,	O
she	PRP	O
was	VBD	O
awoken	VBN	O
from	IN	O
sleep	NN	O
by	IN	O
voice	NN	O
,	,	O
cooperative	JJ	O
,	,	O
but	CC	O
mildly	RB	B-PROBLEM
drowsy	NNS	I-PROBLEM
.	.	O

She	PRP	O
became	VBD	O
more	RBR	O
alert	JJ	O
during	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	B-TEST
exam	NN	I-TEST
.	.	O

Speech	NN	O
was	VBD	O
fluent	JJ	O
but	CC	O
slow	JJ	B-PROBLEM
,	,	O
and	CC	O
there	RB	O
was	VBD	O
long	JJ	B-PROBLEM
response	NN	I-PROBLEM
latencies	NNS	I-PROBLEM
before	IN	O
she	PRP	O
would	MD	O
initiate	VB	O
speech	NN	O
.	.	O

She	PRP	O
otherwise	RB	O
had	VBD	O
normal	JJ	O
spontaneous	JJ	O
movements	NNS	O
and	CC	O
facial	JJ	O
expression	NN	O
and	CC	O
did	VBD	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
abulic	JJ	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
dysarthria	NN	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
special	JJ	I-PROBLEM
neglect	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
sustained	VBN	B-PROBLEM
gaze	JJ	I-PROBLEM
holding	VBG	I-PROBLEM
nystagmus	NN	I-PROBLEM
in	IN	O
both	DT	O
horizontal	JJ	O
directions	NNS	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
rotary	JJ	B-PROBLEM
component	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
widened	VBN	I-PROBLEM
right	RB	I-PROBLEM
palpable	JJ	I-PROBLEM
fissure	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
decreased	VBN	B-PROBLEM
excursion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
mouth	NN	I-PROBLEM
and	CC	O
flattening	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
nasolabial	JJ	I-PROBLEM
fold	NN	I-PROBLEM
(	(	I-PROBLEM
mild	JJ	I-PROBLEM
)	)	I-PROBLEM
.	.	O

Light	NNP	O
touch	NN	O
was	VBD	O
subjectively	RB	B-PROBLEM
abnormal	JJ	I-PROBLEM
on	IN	O
both	DT	O
sides	NNS	O
of	IN	O
the	DT	O
face	NN	O
.	.	O

Hearing	NN	O
was	VBD	O
diminished	VBN	B-PROBLEM
for	IN	O
conversational	JJ	O
speech	NN	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
.	.	O

Finger	NNP	B-TEST
tapping	VBG	I-TEST
and	CC	O
rapid	JJ	B-TEST
alternating	VBG	I-TEST
movements	NNS	I-TEST
were	VBD	O
slow	JJ	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
she	PRP	O
had	VBD	O
trouble	NN	B-PROBLEM
isolating	VBG	I-PROBLEM
individual	JJ	I-PROBLEM
finger	NN	I-PROBLEM
movements	NNS	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
finger-to-nose	JJ	I-PROBLEM
dysmetria	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

Power	NN	O
was	VBD	O
mildly	RB	B-PROBLEM
diminished	VBN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
finger	NN	I-PROBLEM
extensors	NNS	I-PROBLEM
and	CC	O
hand	NN	O
intrinsics	NNS	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
otherwise	RB	O
,	,	O
power	NN	O
was	VBD	O
full	JJ	O
throughout	IN	O
.	.	O

Reflexes	NNS	B-TEST
were	VBD	O
brisk	VBN	O
in	IN	O
the	DT	O
legs	NN	O
with	IN	O
4-5	JJ	O
beats	NNS	O
of	IN	O
clonus	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
upgoing	NN	I-PROBLEM
toes	NNS	I-PROBLEM
.	.	O

She	PRP	O
made	VBD	O
mistakes	NNS	B-PROBLEM
with	IN	I-PROBLEM
position	NN	I-PROBLEM
sense	NN	I-PROBLEM
,	,	O
roughly	RB	O
at	IN	O
chance	NN	O
level	NN	O
with	IN	O
both	DT	O
great	JJ	O
toes	NNS	O
and	CC	O
the	DT	O
left	NN	O
first	RB	O
finger	NN	O
,	,	O
position	NN	O
sense	NN	O
in	IN	O
the	DT	O
right	JJ	O
limb	NN	O
seems	VBZ	O
preserved	VBN	O
.	.	O

Gait	NNP	O
was	VBD	O
wide	JJ	B-PROBLEM
based	VBN	I-PROBLEM
,	,	O
very	RB	B-PROBLEM
unsteady	JJ	I-PROBLEM
,	,	O
veering	VBG	O
to	TO	O
the	DT	O
left	NN	O
and	CC	O
to	TO	O
the	DT	O
right	NN	O
.	.	O

She	PRP	O
retropulsed	VBD	B-PROBLEM
and	CC	O
would	MD	O
have	VB	O
pitched	VBN	O
backwards	NNS	O
without	IN	O
the	DT	O
assistance	NN	O
of	IN	O
the	DT	O
examiner	NN	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
7.8	CD	O
with	IN	O
86%	CD	O
polymorphonuclear	JJ	B-TEST
cells	NNS	I-TEST
,	,	O
11.1	CD	O
lymphocytes	NNS	B-TEST
,	,	O
hemoglobin	NN	B-TEST
14.3	CD	O
,	,	O
hematocrit	NN	B-TEST
40.5	CD	O
,	,	O
MCV	NNP	B-TEST
88	CD	O
,	,	O
INR	NNP	B-TEST
1.0	CD	O
,	,	O
PTT	NNP	B-TEST
24.7	CD	O
,	,	O
PT	NNP	B-TEST
12.3	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
295,000	CD	O
,	,	O
glucose	RB	B-TEST
81	CD	O
,	,	O
BUN	NNP	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
sodium	NN	B-TEST
142	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
CO2	NNP	B-TEST
26	CD	O
,	,	O
calcium	NN	B-TEST
9.3	CD	O
,	,	O
phosphate	NN	B-TEST
4.8	CD	O
,	,	O
magnesium	NN	B-TEST
2.3	CD	O
.	.	O

MRI	NNP	B-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
revealed	VBD	O
multiple	JJ	B-PROBLEM
foci	JJ	I-PROBLEM
susceptibility	NN	I-PROBLEM
artifact	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
.	.	O

These	DT	O
were	VBD	O
seen	VBN	O
best	JJS	O
in	IN	O
gradient	NN	B-TEST
echocardiogram	NN	I-TEST
images	NNS	I-TEST
.	.	O

There	EX	O
was	VBD	O
a	DT	O
large	JJ	O
focus	NN	O
of	IN	O
subacute	JJ	B-PROBLEM
blood	NN	I-PROBLEM
products	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
low	JJ	I-PROBLEM
pons	NNS	I-PROBLEM
suggesting	VBG	O
recent	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
into	IN	I-PROBLEM
a	DT	I-PROBLEM
cavernous	JJ	I-PROBLEM
angioma	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
also	RB	O
tiny	JJ	B-PROBLEM
foci	NNS	I-PROBLEM
artifact	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
cerebellum	NN	I-PROBLEM
and	CC	I-PROBLEM
base	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pons	NNS	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
a	DT	O
larger	JJR	O
area	NN	O
of	IN	O
susceptibility	NN	B-PROBLEM
artifact	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
splenius	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
corpus	NN	I-PROBLEM
collasum	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
enhancement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
but	CC	O
none	NN	O
elsewhere	RB	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
areas	NNS	B-PROBLEM
of	IN	I-PROBLEM
restricted	JJ	I-PROBLEM
diffusion	NN	I-PROBLEM
to	TO	O
indicate	VB	O
infarction	NN	B-PROBLEM
.	.	O

MRA	NNP	B-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
communication	NN	O
>.......<	VBZ	O
in	IN	O
the	DT	O
visualized	JJ	O
vessels	NNS	O
and	CC	O
the	DT	O
angiomas	NN	B-PROBLEM
.	.	O

Follow-up	NNP	B-TEST
CT	NNP	I-TEST
was	VBD	O
obtained	VBN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
developing	VBG	B-PROBLEM
hydrocephalus	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
a	DT	O
concern	NN	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
possible	JJ	O
suppression	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
fourth	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
size	NN	I-PROBLEM
of	IN	O
the	DT	B-PROBLEM
subacute	JJ	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

Mrs.	NNP	O
Wisniewski	NNP	O
is	VBZ	O
a	DT	O
45	CD	O
-	:	O
year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
strong	JJ	O
family	NN	O
history	NN	O
of	IN	O
cavernous	JJ	B-PROBLEM
angiomas	NNS	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
several	JJ	B-PROBLEM
prior	RB	I-PROBLEM
bleeding	VBG	I-PROBLEM
events	NNS	I-PROBLEM
and	CC	O
presented	VBN	O
with	IN	O
a	DT	B-PROBLEM
subacute	NN	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
lower	JJR	I-PROBLEM
pons	NNS	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
relatively	RB	O
central	JJ	O
in	IN	O
location	NN	O
,	,	O
with	IN	O
only	RB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
predominance	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
remained	VBD	O
relatively	RB	O
unchanged	JJ	O
,	,	O
with	IN	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
subtle	NN	I-PROBLEM
left	VBD	I-PROBLEM
hand	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

Her	PRP$	O
gait	NN	O
remained	VBD	O
severely	RB	B-PROBLEM
ataxic	JJ	I-PROBLEM
,	,	O
likely	JJ	O
secondary	JJ	O
to	TO	O
sensory	JJ	B-PROBLEM
deafferentation	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
involvement	NN	O
of	IN	O
crossing	VBG	B-PROBLEM
pontine	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
fibers	NNS	I-PROBLEM
.	.	O

Therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
recommended	VBN	O
that	IN	O
she	PRP	O
have	VBP	O
aggressive	JJ	B-TREATMENT
Physical	NNP	I-TREATMENT
Therapy	NNP	I-TREATMENT
at	IN	O
an	DT	O
Acute	NNP	O
Rehabilitation	NNP	O
Center	NNP	O
.	.	O

We	PRP	O
will	MD	O
arrange	VB	O
to	TO	O
have	VB	O
a	DT	O
copy	NN	O
of	IN	O
the	DT	B-TEST
MRI	NNP	I-TEST
scans	VBZ	I-TEST
sent	VBN	O
to	TO	O
him	PRP	O
.	.	O

1.	CD	O
Familial	NNP	B-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
a	DT	B-PROBLEM
subacute	NN	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
Severe	NNP	B-PROBLEM
gait	NN	I-PROBLEM
ataxia	NN	I-PROBLEM
.	.	O

1.	CD	O
Gabapentin	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
for	IN	O
paresthesias	NN	B-PROBLEM
.	.	O

2.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O

3.	CD	O
Zantac	NNP	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O

4.	CD	O
Prednisone	NNP	B-TREATMENT
taper	NN	I-TREATMENT
completed	VBD	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
85	CD	O
year	NN	O
old	JJ	O
man	NN	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
Plastic	NNP	O
Surgery	NNP	O
Service	NNP	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

His	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
radiation	NN	B-TREATMENT
for	IN	O
non	JJ	B-PROBLEM
Hodgkin	NNP	I-PROBLEM
's	POS	I-PROBLEM
lymphoma	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
painless	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
,	,	O
degenerative	JJ	B-PROBLEM
joint	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

Last	JJ	O
colonoscopy	NN	B-TEST
,	,	O
five	CD	O
years	NNS	O
ago	RB	O
.	.	O

Dementia	NNP	B-PROBLEM
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Levothyroxine	NNP	B-TREATMENT
.	.	O

2.	CD	O
Lasix	NNP	B-TREATMENT
.	.	O

3.	CD	O
Proscar	NNP	B-TREATMENT
.	.	O

4.	CD	O
Aeroseb	NNP	B-TREATMENT
.	.	O

5.	CD	O
Ancef	NNP	B-TREATMENT
.	.	O

On	IN	O
examination	NN	B-TEST
,	,	O
he	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
,	,	O
stable	JJ	O
.	.	O

Elderly	JJ	O
man	NN	O
,	,	O
somewhat	RB	B-PROBLEM
cachectic	JJ	I-PROBLEM
.	.	O

Head	NN	O
,	,	O
eyes	NNS	O
,	,	O
ears	NNS	O
,	,	O
nose	RB	O
and	CC	O
throat	NN	O
,	,	O
polypoid	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
just	RB	O
inferior	RB	O
to	TO	O
the	DT	O
left	NN	O
zygoma	NN	O
,	,	O
elevated	VBD	O
superiorly	RB	O
,	,	O
with	IN	O
visible	JJ	B-PROBLEM
bone	NN	I-PROBLEM
.	.	O

No	DT	O
exudate	NN	B-PROBLEM
.	.	O

Minimal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

Nontender	NNP	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
CMED	NNP	O
for	IN	O
resection	NN	B-TREATMENT
and	CC	O
repair	NN	B-TREATMENT
of	IN	O
this	DT	B-PROBLEM
left	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
consults	NNS	O
from	IN	O
Urology	NNP	O
for	IN	O
his	PRP$	B-PROBLEM
hematuria	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
Medicine	NNP	O
preoperatively	RB	O
and	CC	O
CMED	NNP	O
CCU	NNP	O
.	.	O

He	PRP	O
went	VBD	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
on	IN	O
2016-03-10	JJ	O
with	IN	O
Urology	NNP	O
for	IN	O
hematuria	NN	B-PROBLEM
where	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
cystoscopy	JJ	I-TREATMENT
transurethral	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
prostate	JJ	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

He	PRP	O
then	RB	O
went	VBD	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
on	IN	O
2016-03-14	JJ	O
where	WRB	O
he	PRP	O
had	VBD	O
resection	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
face	NN	I-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
cancer	NN	I-PROBLEM
by	IN	O
Dr.	NNP	O
Langhorne	NNP	O
and	CC	O
split	NN	B-TREATMENT
thickness	NN	I-TREATMENT
and	CC	I-TREATMENT
full	JJ	I-TREATMENT
thickness	NN	I-TREATMENT
skin	VBD	I-TREATMENT
grafting	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
defects	NNS	I-PROBLEM
on	IN	O
2016-03-14	JJ	O
.	.	O

He	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
with	IN	O
no	DT	O
complications	NNS	B-PROBLEM
except	IN	O
postoperatively	RB	O
,	,	O
his	PRP$	O
voice	NN	O
was	VBD	O
hoarse	NN	B-PROBLEM
.	.	O

On	IN	O
scoping	VBG	B-TEST
him	PRP	O
he	PRP	O
had	VBD	O
significant	JJ	B-PROBLEM
supraglottic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
kept	VBN	O
in	IN	O
the	DT	O
Unit	NNP	O
for	IN	O
observation	NN	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
airway	NN	I-TEST
and	CC	O
b.i.d.	NN	O
laryngoscopy	NN	B-TEST
.	.	O

This	DT	O
revealed	VBD	O
some	DT	B-PROBLEM
supraglottic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
which	WDT	O
revealed	VBD	O
with	IN	O
time	NN	O
,	,	O
without	IN	O
further	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
Plastic	NNP	O
Surgery	NNP	O
for	IN	O
his	PRP$	B-TREATMENT
split	NN	I-TREATMENT
thickness	NN	I-TREATMENT
skin	NN	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
bolster	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#5	IN	O
with	IN	O
good	JJ	O
take	VB	O
up	IN	O
of	IN	O
his	PRP$	B-TREATMENT
skin	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

Urology	NNP	O
also	RB	O
followed	VBD	O
him	PRP	O
and	CC	O
kept	VBD	O
him	PRP	O
on	IN	O
antibiotics	NNS	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
#7	NNP	O
at	IN	O
which	WDT	O
point	NN	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

Foley	NNP	B-TREATMENT
was	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

He	PRP	O
is	VBZ	O
being	VBG	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	O
to	TO	O
follow	VB	O
up	RP	O
for	IN	O
XRT	NNP	B-TREATMENT
given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
his	PRP$	B-TEST
pathology	NN	I-TEST
revealed	VBD	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
cancer	NN	I-PROBLEM
extending	VBG	O
deep	JJ	O
to	TO	O
the	DT	O
margin	NN	O
as	RB	O
well	RB	O
as	IN	O
positive	JJ	B-PROBLEM
level	NN	I-PROBLEM
II	NNP	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

Dr.	NNP	O
Navarrete	NNP	O
has	VBZ	O
been	VBN	O
e-mailed	JJ	O
and	CC	O
his	PRP$	O
secretary	NN	O
contacted	VBD	O
for	IN	O
as	RB	O
soon	RB	O
as	IN	O
possible	JJ	O
appointment	NN	O
for	IN	O
XRT	NNP	B-TREATMENT
follow	VBP	O
up	RP	O
.	.	O

Keflex	NNP	B-TREATMENT
/	NNP	O
Heparin	NNP	B-TREATMENT
Agents	NNS	I-TREATMENT

Chief	JJ	O
Complaint	NN	O
:	:	O
pt	NN	O
sent	VBD	O
to	TO	O
ER	NNP	O
after	IN	O
routine	JJ	O
F/U	NNP	O
for	IN	O
UE	NNP	B-PROBLEM
DVT	NNP	I-PROBLEM
with	IN	O
vascular	JJ	O
surgery	NN	O
.	.	O

In	IN	O
ER	NNP	O
c/o	NN	O
dyspnea	NN	B-PROBLEM
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

AVR	NNP	B-TREATMENT
(	(	I-TREATMENT
tissue	NN	I-TREATMENT
)	)	I-TREATMENT
05-14	NN	O

s/p	JJ	O
AVR	NNP	B-TREATMENT
05-14	NN	O
.	.	O

Postop	NNP	O
course	NN	O
c/b	NN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
DVT	NNP	I-PROBLEM
and	CC	O
postop	JJ	B-PROBLEM
Afib	NNP	I-PROBLEM
.	.	O

At	IN	O
that	DT	O
time	NN	O
had	VBD	O
UE	NNP	B-TEST
duplex	NN	I-TEST
which	WDT	O
revealed	VBD	O
RUE	NNP	B-PROBLEM
DVT	NNP	I-PROBLEM
involving	VBG	O
IJ	NNP	O
,	,	O
Axillary	NNP	O
,	,	O
subclav	NN	O
,	,	O
brachial	JJ	O
,	,	O
and	CC	O
basilic	JJ	O
veins	NNS	O
.	.	O

Then	RB	O
referred	VBD	O
to	TO	O
ER	NNP	O
for	IN	O
Tx	NNP	B-TREATMENT

s/p	NN	O
AVR	NNP	B-TREATMENT
(	(	O
#27	NNP	O
pericardial	NN	O
)	)	O

post-op	JJ	B-PROBLEM
Afib	NNP	I-PROBLEM

HTN	NN	B-PROBLEM

renal	JJ	B-PROBLEM
calculi	NN	I-PROBLEM

?	.	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM

seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

s/p	NN	O
2	CD	B-TREATMENT
surgs.	NN	I-TREATMENT
for	IN	O
spermatocele	NN	B-PROBLEM

s/p	JJ	O
oral	JJ	B-TREATMENT
surgery	NN	I-TREATMENT

non-contributory	NN	O
for	IN	O
premature	NN	B-PROBLEM
CAD	NNP	I-PROBLEM
;	:	O
father	NN	O
had	VBD	O
MI	NNP	B-PROBLEM
in	IN	O
his	PRP$	O
70	CD	O
's	POS	O

admission	NN	B-TEST
PE	NNP	I-TEST

VS	NN	B-TEST
:	:	O
HR	$	B-TEST
103	CD	O
BP	NNP	B-TEST
162/69	CD	O
RR	NNP	B-TEST
14	CD	O
Sat	NNP	B-TEST
92%	CD	O
RA	NNP	O

Neuro	NN	O
:	:	O
MAE	NNP	O
,	,	O
Follows	NNP	O
commands	VBZ	O
,	,	O
slightly	RB	B-PROBLEM
confused	VBD	I-PROBLEM

Heent	NN	O
:	:	O
PERRL/EOMI	NNP	O
,	,	O
no	DT	O
JVD	NNP	B-PROBLEM

CV	NN	O
:	:	O
RRR	NNP	O
S1-S2	NNP	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

Abdm	NNS	O
:	:	O
soft	JJ	O
NT	NNP	B-PROBLEM
/	NNP	O
ND	NNP	B-PROBLEM
/	NNP	O
NABS	NNP	O

Ext	NN	O
:	:	O
+	JJ	O
distal	JJ	B-TEST
pulses	NNS	I-TEST
,	,	O
no	DT	O
edema	NN	B-PROBLEM

Discharge	NNP	B-TEST
PE	NNP	I-TEST

VS	NN	B-TEST
:	:	O
T	$	B-TEST
99	CD	O
HR	NNP	B-TEST
68	CD	O
BP	NNP	B-TEST
113/72	CD	O
RR	NNP	B-TEST
18	CD	O
Sat	NNP	B-TEST
98%	CD	O
RA	NNP	O

CV:RRR	NNP	O
S1-S2	NNP	O
,	,	O
no	DT	O
MRG	NNP	B-PROBLEM

Abdm	NNS	O
:	:	O
soft	JJ	O
,	,	O
NT/ND/NABS	NNP	B-PROBLEM

Ext	NN	O
:	:	O
warm	NN	O
well	RB	O
perfused	VBD	O
No	DT	O
CCE	NNP	B-PROBLEM

GLUCOSE	NNP	B-TEST
-	:	O
193	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
23	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
1.2	CD	O
SODIUM	NNP	B-TEST
-	:	O
138	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.6	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
101	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
21	CD	O
*	JJ	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
21	CD	O
*	NN	O

CALCIUM	NNP	B-TEST
-	:	O
8.8	CD	O
PHOSPHATE	NNP	B-TEST
-	:	O
3.9	CD	O
MAGNESIUM	NNP	B-TEST
-	:	O
2.4	CD	O

PT	NNP	B-TEST
-	:	O
15.0	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
107.1	CD	O
*	JJ	O
INR	NNP	B-TEST
(	(	I-TEST
PT	NNP	I-TEST
)-	CD	I-TEST
1.3	CD	O
*	NN	O

WBC	NNP	B-TEST
-	:	O
13.3	CD	O
*#	NN	O
RBC	NNP	B-TEST
-	:	O
3.45	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
10.6	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
30.5	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
88	CD	O
MCH	NNP	B-TEST
-	:	O
30.6	CD	O
MCHC	NNP	B-TEST
-	:	O
34.7	CD	O
RDW	NNP	B-TEST
-	:	O
12.7	CD	O

BLOOD	NNP	B-TEST
WBC	NNP	I-TEST
-	:	O
12.9	CD	O
*	NN	O
RBC	NNP	B-TEST
-	:	O
3.37	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
10.4	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
29.4	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
87	CD	O
MCH	NNP	B-TEST
-	:	O
30.8	CD	O
MCHC	NNP	B-TEST
-	:	O
35.3	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
13.3	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
345	CD	O

BLOOD	NNP	B-TEST
PT	NNP	I-TEST
-	:	O
39.1	CD	O
*	JJ	O
INR	NNP	B-TEST
(	(	I-TEST
PT	NNP	I-TEST
)-	CD	I-TEST
4.4	CD	O
*	NN	O

BLOOD	NNP	B-TEST
HEPARIN	NNP	I-TEST
DEPENDENT	NNP	I-TEST
ANTIBODIES	NNP	I-TEST
-	:	O
positive	JJ	O

Pt	NNP	O
admitted	VBD	O
05-24	CD	O
from	IN	O
ER	NNP	O
after	IN	O
positive	JJ	B-PROBLEM
RUE	NNP	I-PROBLEM
DVT	NNP	I-PROBLEM
finding	VBG	O
in	IN	O
vascular	JJ	O
lab	NN	O
.	.	O

During	IN	O
ER	NNP	B-TEST
evaluation	NN	I-TEST
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	O
degree	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
including	VBG	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
short	JJ	I-PROBLEM
term	NN	I-PROBLEM
memory	NN	I-PROBLEM
and	CC	O
brief	JJ	B-PROBLEM
unresponsive	JJ	I-PROBLEM
period	NN	I-PROBLEM
after	IN	O
one	CD	O
dose	NN	O
of	IN	O
IV	NNP	B-TREATMENT
Benadry	NNP	I-TREATMENT
and	CC	O
steroids	NNS	B-TREATMENT
prior	RB	O
to	TO	O
CT	NNP	B-TEST
scan	NN	I-TEST
.	.	O

The	DT	B-TEST
CT	NNP	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
CVA	NNP	B-PROBLEM
but	CC	O
positive	JJ	O
for	IN	O
Pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
CSRU	NNP	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

Neurology	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
pt	NN	O
also	RB	O
had	VBD	O
MRI	NNP	B-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

The	DT	O
pt	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
platelet	VBN	B-PROBLEM
drop	NN	I-PROBLEM
>	NN	O
50%	CD	O
after	IN	O
infusion	NN	B-TREATMENT
began	VBD	O
,	,	O
hepain	NN	B-TREATMENT
was	VBD	O
d/c	JJ	O
'd.	NNS	O

Argatroban	NNP	B-TREATMENT
was	VBD	O
started	VBN	O
abd	RP	O
a	DT	B-TEST
HIT	NNP	I-TEST
panel	NN	I-TEST
was	VBD	O
sent	VBN	O
,	,	O
HIT	NNP	B-TEST
panel	NN	I-TEST
was	VBD	O
positive	JJ	B-PROBLEM
.	.	O

By	IN	O
the	DT	O
following	JJ	O
mornig	NN	O
all	DT	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
had	VBD	O
cleared	VBN	O
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floors	NNS	O
for	IN	O
continued	JJ	O
care	NN	O
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
Argatrobanwhile	NNP	B-TREATMENT
coumadin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
.	.	O

On	IN	O
HD#6	NNP	O
the	DT	O
pt	NN	O
had	VBD	O
a	DT	B-TEST
therapeudic	JJ	I-TEST
INR	NNP	I-TEST
(	(	O
4.4	CD	O
)	)	O
off	IN	O
Argatroban	NNP	B-TREATMENT
and	CC	O
wad	VB	O
discharged	VBN	O
home	NN	O
.	.	O

He	PRP	O
was	VBD	O
to	TO	O
have	VB	O
f/u	VBN	O
INR	NNP	B-TEST
check	NN	I-TEST
with	IN	O
Dr	NNP	O
Lewis	NNP	O
on	IN	O
05-31	NNP	O
.	.	O

ASA	RB	B-TREATMENT
81	CD	O
'	''	O

Atorvastatin	RB	B-TREATMENT
10	CD	O
'	''	O

Lisinopril	RB	B-TREATMENT
5	CD	O
'	''	O

Lopressor	NNP	B-TREATMENT
50	CD	O
"	NN	O

Amiodarone	RB	B-TREATMENT
200	CD	O
'	''	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

2.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

3.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
50	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:One	NNP	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
Amoxicillin-Pot	JJ	B-TREATMENT
Clavulanate	NNP	I-TREATMENT
875-125	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
10	CD	O
days	NNS	O
.	.	O

5.	CD	O
Amiodarone	$	B-TREATMENT
200	CD	O
mg	JJ	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Warfarin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
as	IN	O
directed	VBN	O
:	:	O
3	CD	O
mg	RBS	O
1943-05-29	JJ	O
and	CC	O
6/1	CD	O
then	RB	O
as	IN	O
directed	VBN	O
by	IN	O
Dr	NNP	O
Mace	NNP	O
.	.	O

Discharge	NN	O
Diagnosis	NN	O
:	:	O
s/p	JJ	O
AVR	NNP	B-TREATMENT
05-14	NN	O
(	(	O
tissue	NN	O
)	)	O
readmitted	VBD	O
05-24	JJ	O
w/	NN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
,	,	O
RUE	NNP	B-PROBLEM
DVT	NNP	I-PROBLEM
,	,	O
HIT	NNP	B-PROBLEM
positive	JJ	I-PROBLEM

PMH	NN	O
:	:	O
HTN	NNP	B-PROBLEM
,	,	O
Renal	NNP	B-PROBLEM
calculi	NN	I-PROBLEM
,	,	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
,	,	O

Discharge	NN	O
Instructions	NNS	O
:	:	O
keep	VB	O
wounds	NNS	B-PROBLEM
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

Take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

Follow-up	JJ	B-TEST
INR	NNP	I-TEST
to	TO	O
be	VB	O
drawn	VBN	O
06-01	JJ	O
,	,	O
by	IN	O
Dr	NNP	O
Lewis	NNP	O
@	NNP	O
597-4427	JJ	O

Haldol	NNP	B-TREATMENT
/	NNP	O
Compazine	NNP	B-TREATMENT
/	NNP	O
Phenergan	NNP	B-TREATMENT
/	NNP	O
Tigan	NNP	B-TREATMENT
/	NNP	O
Flagyl	NNP	B-TREATMENT

Chest	NNP	B-PROBLEM
Pain	NN	I-PROBLEM

Removal	NN	B-TREATMENT
of	IN	I-TREATMENT
tunneled	JJ	I-TREATMENT
cath	NN	I-TREATMENT
(	(	O
previously	RB	O
used	VBN	O
for	IN	O
tPN	NN	B-TREATMENT
)	)	O

54	CD	O
yo	NNS	O
F	NNP	O
with	IN	O
Crohn	NNP	B-PROBLEM
's	POS	I-PROBLEM
s/p	JJ	O
ileostomy	NN	B-TREATMENT
and	CC	O
subsequent	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
port-a-cath	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
TPN	NNP	B-TREATMENT
who	WP	O
presents	VBZ	O
with	IN	O
progressive	JJ	B-PROBLEM
right	NN	I-PROBLEM
sided	VBD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
that	WDT	O
comes	VBZ	O
in	IN	O
waves	NNS	O
.	.	O

The	DT	O
pt	NN	O
reports	NNS	O
sharp	JJ	B-PROBLEM
10/10	CD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
under	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
breast	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
getting	VBG	O
progressively	RB	O
worse	JJR	O
.	.	O

The	DT	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
worsened	VBN	O
with	IN	O
deep	JJ	O
inspiration	NN	O
or	CC	O
movement	NN	O
.	.	O

It	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
SOB	NNP	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
.	.	O

The	DT	O
pt	NN	O
denies	VBZ	O
abd	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
n/v	NN	B-PROBLEM
or	CC	O
increased	JJ	B-PROBLEM
ostomy	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

Given	VBN	O
her	PRP$	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
sx	NN	B-PROBLEM
of	IN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
SOB	NNP	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
WBC	NNP	I-PROBLEM
count	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
initially	RB	O
thought	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
PNA	NNP	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
therefore	RB	O
given	VBN	O
ceftriaxone	NN	B-TREATMENT
1	CD	O
g	NN	O
IV	NNP	O
x1	NNP	O
and	CC	O
azithromycin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
PO	NNP	O
x1	NN	O
in	IN	O
the	DT	O
Deanna	NNP	O
.	.	O

As	IN	O
the	DT	B-TEST
CXR	NNP	I-TEST
was	VBD	O
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
PNA	NNP	B-PROBLEM
,	,	O
or	CC	O
PTX	NNP	B-PROBLEM
,	,	O
the	DT	O
pt	NN	O
subsequently	RB	O
received	VBD	O
a	DT	B-TEST
CTA	NNP	I-TEST
to	TO	O
evaluate	VB	O
for	IN	O
PE	NNP	B-PROBLEM
which	WDT	O
revealed	VBD	O
multifocal	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
PNA	NNP	I-PROBLEM
but	CC	O
no	DT	O
PE	NNP	B-PROBLEM
.	.	O

At	IN	O
this	DT	O
time	NN	O
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
Vancomycin	NNP	B-TREATMENT
1	CD	O
g	NN	O
IV	NNP	O
x1	NNP	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
morphine	NN	B-TREATMENT
2	CD	O
mg	NN	O
x3	NN	O
,	,	O
4	CD	O
mg	NN	O
IV	NNP	O
x2	NNP	O
,	,	O
dolasetron	VBZ	B-TREATMENT
12.5	CD	O
mg	NN	O
x2	NN	O
and	CC	O
ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
IV	NNP	O
x1	NNP	O
.	.	O

1.	CD	O
Crohn	NNP	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
dx	NN	O
1974	CD	O
s/p	NN	O
three	CD	B-TREATMENT
bowel	NN	I-TREATMENT
resections	NNS	I-TREATMENT
and	CC	O
eventual	JJ	B-TREATMENT
ileostomy	NN	I-TREATMENT
,	,	O
resulting	VBG	O
in	IN	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM

2.	CD	O
Restless	NNP	B-PROBLEM
leg	VBD	I-PROBLEM
syndrome	NN	I-PROBLEM

3.	CD	O
?	.	O
Parkinsons	NNS	B-PROBLEM
vs.	IN	O
EPS	NNP	B-PROBLEM
side	JJ	I-PROBLEM
effects	NNS	I-PROBLEM
from	IN	O
risperdal	NN	B-TREATMENT

4.	CD	O
Chronic	NNP	B-PROBLEM
idiopathic	JJ	I-PROBLEM
pancreatitis	NN	I-PROBLEM
,	,	O
as	IN	O
demonstrated	VBN	O
on	IN	O
CT	NNP	B-TEST
in	IN	O
09-01	NN	O

5.	CD	O
Arthritis	NNP	B-PROBLEM
s/p	NN	O
"	NNP	B-TREATMENT
pin	NN	I-TREATMENT
placement	NN	I-TREATMENT
"	NN	I-TREATMENT
in	IN	I-TREATMENT
left	JJ	I-TREATMENT
foot	NN	I-TREATMENT
05-01	NN	O

6.	CD	O
Degenerative	JJ	B-PROBLEM
disc	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
two	CD	B-TREATMENT
back	JJ	I-TREATMENT
surgeries	NNS	I-TREATMENT
in	IN	O
80	CD	O
's	POS	O

7.	CD	O
Benzo	NNP	B-TREATMENT
and	CC	O
opiod	JJ	B-TREATMENT
addiction	NN	O

8.	CD	O
Paranoia	NNP	B-PROBLEM
/	NNP	O
Depression	NNP	B-PROBLEM
,	,	O
h/o	JJ	O
auditory	NN	B-PROBLEM
hallucinations	NNS	I-PROBLEM
,	,	O
?	.	O
mania	NN	B-PROBLEM

9.	CD	O
Port-a-Cath	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
IV	NNP	B-TREATMENT
hydration	NN	I-TREATMENT
in	IN	O
setting	VBG	O
of	IN	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
complicated	VBN	O
by	IN	O
clotting	VBG	B-PROBLEM
x	JJ	O
4	CD	O
,	,	O
requiring	VBG	O
replacement	NN	B-TREATMENT

Abd	NNP	B-TEST
CT	NNP	I-TEST
performed	VBD	O
09-01	JJ	O
showed	JJ	O
multiple	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
body	NN	I-PROBLEM
and	CC	I-PROBLEM
tail	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreas	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
larger	JJR	I-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
tail	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreas	NNS	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
second	JJ	I-PROBLEM
9	CD	I-PROBLEM
mm	NN	I-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
head	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
with	IN	O
pseudocyst	NN	B-PROBLEM
formation	NN	I-PROBLEM

Social	NNP	O
History:	NNP	O
lives	VBZ	O
w/	VBD	O
her	PRP$	O
husband	NN	O
in	IN	O
John	NNP	O
area	NN	O
;	:	O
smokes	VBZ	O
05-04	JJ	O
cig	NN	O
/d	NNP	O
(	(	O
30	CD	O
pack	NN	O
year	NN	O
history	NN	O
);	NNP	O
no	DT	O
alcohol	NN	O
or	CC	O
recreational	JJ	O
drug	NN	O
use	NN	O
,	,	O
has	VBZ	O
had	VBN	O
addiction	NN	O
to	TO	O
benzodiazepines	NNS	B-TREATMENT
and	CC	O
opioids	NNS	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O

Mother-Crohn	NNP	B-PROBLEM
's	POS	I-PROBLEM
;	:	O
Daugher-IBS	NNP	B-PROBLEM
,	,	O
colitis	NN	B-PROBLEM
;	:	O
Mother	NNP	O
--	:	O
breast	NN	B-PROBLEM
CA	NNP	I-PROBLEM
,;	NN	O

Father	NNP	O
-	:	O
Stephanie	NNP	B-PROBLEM
tumor	NN	I-PROBLEM
,	,	O
no	DT	O
DM	NNP	B-PROBLEM
,	,	O
no	DT	O
CAD	NNP	B-PROBLEM

V	NN	B-TEST
:	:	O
101.4	CD	O
,	,	O
102	CD	O
,	,	O
167/54	CD	O
->	NN	O
159/77	CD	O
,	,	O
24	CD	O
->	NN	O
16	CD	O
,	,	O
98%	CD	O
RA	NNP	O
->	VBD	O
96%	CD	O
RA	NNP	O

CV	NN	O
:	:	O
RRR	NNP	O
,	,	O
s1	NN	O
,	,	O
s2	NN	B-PROBLEM
distant	NN	I-PROBLEM

Chest	NN	O
:	:	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
with	IN	O
dec.	NNP	B-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

tender	NN	B-PROBLEM
over	IN	I-PROBLEM
right	JJ	I-PROBLEM
chest	NN	I-PROBLEM

Abd	NN	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
surgical	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
.	.	O

Ileostomy	NNP	B-TREATMENT
bag	VBD	I-TREATMENT
present	JJ	O
with	IN	O
gas	NN	O
and	CC	O
stool	NN	O
.	.	O

absomen	NNS	O
soft	JJ	O
,	,	O
tender	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
over	IN	I-TEST
RUQ	NNP	I-TEST
,	,	O
but	CC	O
no	DT	O
guarding	NN	B-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM

Ext	NN	O
:	:	O
tr	NN	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
2+	CD	O
DP	NNP	B-TEST
bilaterally	RB	I-TEST

GLUCOSE	NNP	B-TEST
-	:	O
208	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
21	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
1.3	CD	O
*	JJ	O
SODIUM	NNP	B-TEST
-	:	O
138	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.2	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
104	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
23	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
15	CD	O

CK	NNP	B-TEST
(	(	I-TEST
CPK	NNP	I-TEST
)-	CD	I-TEST
31	CD	O

cTropnT	NN	B-TEST
-<	VBZ	O
0.01	CD	O

WBC	NNP	B-TEST
-	:	O
14.4	CD	O
*#	NN	O
RBC	NNP	B-TEST
-	:	O
3.82	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
11.5	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
33.5	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
88	CD	O
MCH	NNP	B-TEST
-	:	O
30.2	CD	O
MCHC	NNP	B-TEST
-	:	O
34.5	CD	O
RDW	NNP	B-TEST
-	:	O
14.7	CD	O

NEUTS	NNP	B-TEST
-	:	O
78.0	CD	O
*	NN	O
LYMPHS	NNP	B-TEST
-	:	O
17.0	CD	O
*	JJ	O
MONOS	NNP	B-TEST
-	:	O
4.6	CD	O
EOS	NNP	B-TEST
-	:	O
0.3	CD	O
BASOS	NNP	B-TEST
-	:	O
0.1	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
128	CD	O
*	NN	O

PT	NNP	B-TEST
-	:	O
12.3	CD	O
PTT	NNP	B-TEST
-	:	O
26.1	CD	O
INR	NNP	B-TEST
(	(	I-TEST
PT	NNP	I-TEST
)-	CD	I-TEST
1.0	CD	O

CTA	NNP	B-TEST
2013-12-24	JJ	O
-	:	O
IMPRESSION	NN	O
:	:	O

1.	CD	O
No	NNP	O
definite	NN	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolism	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

2.	CD	O
Peripheral	NNP	B-PROBLEM
patchy	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
bilaterally	RB	O
,	,	O
most	JJS	O
consistent	JJ	O
with	IN	O
multifocal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

CXR	NNP	B-TEST
2013-12-24	JJ	O
-	:	O
There	EX	O
are	VBP	O
faint	JJ	B-PROBLEM
ill-defined	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
within	IN	O
the	DT	O
right	NN	O
lower	RBR	O
lung	NN	O
zone	NN	O
and	CC	O
left	VBD	O
upper	JJ	O
lung	NN	O
zone	NN	O
could	MD	O
represent	VB	O
a	DT	B-PROBLEM
multifocal	JJ	I-PROBLEM
pneumonic	NN	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

CXR	NNP	B-TEST
2014-01-02	JJ	O
-	:	O
IMPRESSION	NN	O
:	:	O

Multilobar	NNP	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
interval	JJ	B-PROBLEM
worsening	VBG	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
but	CC	O
slight	JJ	O
improvement	NN	O
in	IN	O
the	DT	O
right	NN	O
lower	JJR	O
lobe	NN	O
.	.	O

Head	NNP	B-TEST
CT	NNP	I-TEST
2014-01-09	JJ	O
-	:	O
Ordered	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
changes	NNS	O
to	TO	O
explain	VB	O
delta	JJ	B-PROBLEM
MS	NNP	I-PROBLEM

Left	NNP	B-PROBLEM
parietal	JJ	I-PROBLEM
subcortical	JJ	I-PROBLEM
hypodensity	NN	I-PROBLEM
,	,	O
likely	JJ	O
ischemic	NN	B-PROBLEM
.	.	O

No	DT	O
definite	NN	B-PROBLEM
changes	NNS	I-PROBLEM
since	IN	O
the	DT	B-TEST
MR	NNP	I-TEST
of	IN	O
in	IN	O
2011-05-15	JJ	O
.	.	O

CXR	NNP	B-TEST
2014-01-09	JJ	O

54	CD	O
yo	NNS	O
F	NNP	O
with	IN	O
Crohn	NNP	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
ileostomy	NN	B-TREATMENT
with	IN	O
subsequent	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
port-o-cath	NN	B-TREATMENT
for	IN	O
TPN	NNP	B-TREATMENT
presents	NNS	O
with	IN	O
acute	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
pleuritic	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
and	CC	O
sob	NN	B-PROBLEM
.	.	O

1.	CD	O
Chest	NNP	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
Fever	NNP	B-PROBLEM
/	NNP	O
Chills	NNP	B-PROBLEM
:	:	O

The	DT	B-PROBLEM
acute	JJ	I-PROBLEM
onset	NN	I-PROBLEM
of	IN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
initially	RB	O
very	RB	O
concerning	VBG	O
for	IN	O
a	DT	B-PROBLEM
PE	NNP	I-PROBLEM
,	,	O
however	RB	O
the	DT	B-TEST
Chest	NNP	I-TEST
CT	NNP	I-TEST
demonstrated	VBD	O
multifocal	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
bacterial	JJ	I-PROBLEM
PNA	NNP	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
pt	NN	O
's	POS	O
history	NN	O
including	VBG	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
and	CC	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
WBC	NNP	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

The	DT	O
pt	NN	O
was	VBD	O
given	VBN	O
ceftriaxone	NN	B-TREATMENT
/	NN	O
azithromycin	NN	B-TREATMENT
/	NNP	O
vancomycin	NN	B-TREATMENT
in	IN	O
Deanna	NNP	O
.	.	O

Blood	NN	B-TEST
,	,	I-TEST
urine	JJ	I-TEST
and	CC	I-TEST
sputum	JJ	I-TEST
culutres	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

Pt	NNP	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
positive	JJ	O
for	IN	O
Staph	NNP	B-PROBLEM
Aureus	NNP	I-PROBLEM
and	CC	O
Enterococcus	NNP	B-PROBLEM
,	,	O
both	DT	O
were	VBD	O
pansensitive	JJ	O
.	.	O

Sputum	NNP	B-TEST
culture	NN	I-TEST
also	RB	O
returned	VBD	O
with	IN	O
Staph.	NNP	B-PROBLEM
Aureus	NNP	I-PROBLEM
.	.	O

Ceftriaxone	NN	B-TREATMENT
and	CC	O
azithro	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
,	,	O
and	CC	O
Vacomycin	NNP	B-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

Pt	NNP	O
initially	RB	O
was	VBD	O
hypoxic	JJ	B-PROBLEM
requiring	VBG	O
NRB	NNP	B-TREATMENT
for	IN	O
O2	NNP	B-TEST
sat	NN	I-TEST
of	IN	O
94%	CD	O
,	,	O
with	IN	O
any	DT	O
attempt	NN	O
to	TO	O
wean	VB	O
she	PRP	O
would	MD	O
desat	VB	O
.	.	O

Pt	NNP	O
was	VBD	O
intubated	VBN	O
prior	RB	O
to	TO	O
tunneled	VB	B-TREATMENT
catheter	NN	I-TREATMENT
removal	NN	I-TREATMENT
,	,	O
see	VBP	O
below	IN	O
.	.	O

(	(	O
The	DT	B-TREATMENT
tunneled	VBN	I-TREATMENT
catheter	NN	I-TREATMENT
later	RBR	O
came	VBD	O
back	RB	O
for	IN	O
negative	JJ	O
for	IN	O
culture.	NN	B-TEST
)	)	O

Earlier	RBR	O
that	DT	O
day	NN	O
pt	VB	O
had	VBD	O
a	DT	B-TEST
chest	NN	I-TEST
x	NN	I-TEST
ray	NN	I-TEST
which	WDT	O
showed	VBD	O
diffuse	IN	B-PROBLEM
infiltrative	JJ	I-PROBLEM
process	NN	I-PROBLEM
concerning	VBG	O
for	IN	O
ARDS	NNP	B-PROBLEM
.	.	O

Post	NNP	O
procedure	NN	B-TREATMENT
pt	NN	O
remained	VBD	O
intubated	VBN	B-TREATMENT
on	IN	O
ARDSnet	NNP	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

She	PRP	O
self	PRP	O
extubated	VBD	O
the	DT	O
first	JJ	O
day	NN	O
and	CC	O
was	VBD	O
reintubated	VBN	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

Her	PRP$	B-PROBLEM
O2	NNP	I-PROBLEM
requirement	NN	I-PROBLEM
improved	VBD	O
on	IN	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
she	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
on	IN	O
2013-01-01	JJ	O
.	.	O

After	IN	O
extubation	NN	O
her	PRP$	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
was	VBD	O
down	RB	O
to	TO	O
1L	CD	B-TREATMENT
NC	NNP	I-TREATMENT
with	IN	O
sats	NNS	B-TEST
in	IN	O
mid	JJ	O
90s	CD	O
.	.	O

The	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
when	WRB	O
she	PRP	O
transferred	VBD	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
.	.	O

She	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
for	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
course	NN	O
her	PRP$	B-TEST
O2sats	NNS	I-TEST
were	VBD	O
stable	JJ	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
completed	VBN	O
her	PRP$	B-TREATMENT
antibiotic	JJ	I-TREATMENT
course	NN	I-TREATMENT
while	IN	O
in	IN	O
house	NN	O
.	.	O

2.	CD	O
Hx	NNP	O
of	IN	O
multiple	JJ	B-PROBLEM
port-o-cath	JJ	I-PROBLEM
clots	NNS	I-PROBLEM
:	:	O

Although	IN	O
the	DT	O
pt	NN	O
is	VBZ	O
on	IN	O
warfarin	NN	B-TREATMENT
chronically	RB	O
,	,	O
her	PRP	B-TEST
INR	NNP	I-TEST
was	VBD	O
subtherapeutic	JJ	O
.	.	O

Goal	NNP	O
INR	NNP	B-TEST
01-31	NN	O
.	.	O

Initially	RB	O
coumadin	NN	B-TREATMENT
was	VBD	O
increased	VBN	O
,	,	O
however	RB	O
given	VBN	O
concern	NN	O
for	IN	O
infected	JJ	B-PROBLEM
line	NN	I-PROBLEM
,	,	O
general	JJ	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
who	WP	O
removed	VBD	O
the	DT	B-TREATMENT
line	NN	I-TREATMENT
in	IN	O
the	DT	O
ICU	NNP	O
.	.	O

3.	CD	O
ARF	NNS	B-PROBLEM
:	:	O

Pt	NNP	O
initially	RB	O
with	IN	O
mild	JJ	B-PROBLEM
ARI	NNP	I-PROBLEM
,	,	O
this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
dehydration	NN	B-PROBLEM
,	,	O
after	IN	O
initial	JJ	B-TREATMENT
volume	NN	I-TREATMENT
repletion	NN	I-TREATMENT
her	PRP$	O
renal	JJ	O
function	NN	O
improved	VBD	O
to	TO	O
her	PRP$	O
baseline	NN	O
.	.	O

The	DT	O
pt	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
paranoia	NN	B-PROBLEM
/	NNP	O
depression	NN	B-PROBLEM
.	.	O

ON	JJ	O
admission	NN	O
she	PRP	O
was	VBD	O
taking	VBG	O
Quetiapine	JJ	B-TREATMENT
300	CD	O
mg	NN	O
QHS	NNP	O
and	CC	O
Clonazepam	NNP	B-TREATMENT
1	CD	O
mg	NN	O
QAM	NNP	O
,	,	O
1	CD	O
mg	NN	O
Q3PM	NNP	O
,	,	O
2	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O
.	.	O

Quetiapine	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
however	RB	O
clonipin	NN	B-TREATMENT
was	VBD	O
initially	RB	O
held	VBN	O
when	WRB	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
on	IN	O
fentynyl	NN	B-TREATMENT
/	NN	O
versed	VBD	B-TREATMENT
.	.	O

This	DT	O
was	VBD	O
restarted	VBN	O
post	NN	O
extubation	NN	B-TREATMENT
.	.	O

Her	PRP$	O
course	NN	O
later	RB	O
became	VBD	O
complicated	VBN	O
by	IN	O
visual	JJ	B-PROBLEM
and	CC	I-PROBLEM
auditory	JJ	I-PROBLEM
hallucinations	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
unable	JJ	B-PROBLEM
to	TO	I-PROBLEM
sleep	VB	I-PROBLEM
at	IN	O
night	NN	O
,	,	O
often	RB	O
pacing	VBG	O
the	DT	O
halls	NNS	O
.	.	O

She	PRP	O
required	VBD	O
a	DT	B-TREATMENT
1:1	CD	I-TREATMENT
sitter	NN	I-TREATMENT
.	.	O

They	PRP	O
felt	VBD	O
that	IN	O
her	PRP$	O
presentation	NN	O
was	VBD	O
secondary	JJ	O
to	TO	O
delirium	VB	B-PROBLEM
and	CC	O
was	VBD	O
multifactorial	JJ	O
.	.	O

They	PRP	O
attributed	VBD	O
it	PRP	O
to	TO	O
polypharmacy	VB	B-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
infection	NN	I-PROBLEM
(	(	I-PROBLEM
pneumonia	NN	I-PROBLEM
)	)	I-PROBLEM
and	CC	O
insomnia	NN	B-PROBLEM
.	.	O

A	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
ruled	VBD	O
out	RP	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
refused	VBD	O
an	DT	B-TEST
LP	NNP	I-TEST
.	.	O

They	PRP	O
made	VBD	O
recommendations	NNS	O
for	IN	O
adjustments	NNS	O
to	TO	O
her	PRP$	B-TREATMENT
anti-psychotic	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

At	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
tid	NN	O
,	,	O
seroquel	JJ	B-TREATMENT
300	CD	O
BID	NNP	O
and	CC	O
neurontin	$	B-TREATMENT
600	CD	O
QAM	NNP	O
,	,	O
1200	CD	O
QPM	NNP	O
and	CC	O
1200	CD	O
QHS	NNP	O
.	.	O

The	DT	O
Kindred	NNP	O
Hospital	NNP	O
hospital	NN	O
course	NN	O
was	VBD	O
prolonged	VBN	O
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

5.	CD	O
?	.	O
Parkinson	NNP	B-PROBLEM
's	POS	I-PROBLEM
Disease	NNP	I-PROBLEM
/	NNP	O
Akithesia	NNP	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
Sinemet	NNP	B-TREATMENT
.	.	O

6.	CD	O
Pain	NN	B-PROBLEM
:	:	O

In	IN	O
addition	NN	O
to	TO	O
her	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
neuropathy	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
the	DT	O
pt	NN	O
initially	RB	O
appeared	VBD	O
to	TO	O
have	VB	O
significant	JJ	B-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
the	DT	B-PROBLEM
multi-focal	JJ	I-PROBLEM
PNA	NNP	I-PROBLEM
as	IN	O
well	RB	O
.	.	O

(	(	O
Home	NNP	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
Gabapentin	NNP	B-TREATMENT
800	CD	O
mg	NN	O
PO	NNP	O
QAM	NNP	O
,	,	O
1600	CD	O
mg	NN	O
PO	NNP	O
Q3PM	NNP	O
,	,	O
1600	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O
.	.	O

This	DT	O
was	VBD	O
held	VBN	O
in	IN	O
the	DT	O
ICU	NNP	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
diluadid	JJ	B-TREATMENT
prn	NN	O
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
narcotic	JJ	I-TREATMENT
and	CC	O
CMED	NNP	B-TREATMENT
CCU	NNP	I-TREATMENT
regimen	NN	I-TREATMENT
was	VBD	O
evaluated	VBN	O
by	IN	O
psychiatry	NN	O
during	IN	O
her	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

Given	VBN	O
her	PRP$	O
hx	NN	O
of	IN	O
ileostomy	JJ	B-TREATMENT
secondary	JJ	O
to	TO	O
crohn	VB	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
resultant	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
the	DT	O
pt	NN	O
requires	VBZ	O
nutritional	JJ	B-TREATMENT
support	NN	I-TREATMENT
via	IN	O
TPN	NNP	B-TREATMENT
.	.	O

After	IN	O
removal	NN	O
of	IN	O
tunneled	JJ	B-TREATMENT
line	NN	I-TREATMENT
pt	NN	O
was	VBD	O
given	VBN	O
tube	RP	B-TREATMENT
feeds	NNS	I-TREATMENT
while	IN	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
,	,	I-TREATMENT
low	JJ	I-TREATMENT
residue	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

PPX	NN	O
:	:	O
PPI	NNP	B-TREATMENT
and	CC	O
heparin	NN	B-TREATMENT
SC	NNP	I-TREATMENT

1.	CD	O
Quetiapine	NNP	B-TREATMENT
300	CD	O
mg	NN	O
QHS	NNP	O

2.	CD	O
Clonazepam	NNP	B-TREATMENT
1	CD	O
mg	NN	O
QAM	NNP	O
,	,	O
1	CD	O
mg	NN	O
Q3PM	NNP	O
,	,	O
2	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O

3.	CD	O
Ferrous	JJ	B-TREATMENT
Sulfate	NNP	I-TREATMENT
325	CD	O
PO	NNP	O
Daily	NNP	O

4.	CD	O
Carbidopa-Levodopa	JJ	B-TREATMENT
25-250	JJ	O
mg	NN	O
PO	NNP	O
5	CD	O
TIMES	NNP	O
PER	NNP	O
DAY	NNP	O
.	.	O

5.	CD	O
Gabapentin	NNP	B-TREATMENT
800	CD	O
mg	NN	O
PO	NNP	O
QAM	NNP	O
,	,	O
1600	CD	O
mg	NN	O
PO	NNP	O
Q3PM	NNP	O
,	,	O
1600	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O

6.	CD	O
Heparin	NNP	B-TREATMENT
Lock	NNP	I-TREATMENT
Flush	NNP	I-TREATMENT
10	CD	O
unit	NN	O
/	JJ	O
mL	JJ	O
Daily	NNP	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
Saline	NNP	B-TREATMENT
Flush	NNP	I-TREATMENT

8.	CD	O
Prevacid	NNP	B-TREATMENT
30	CD	O
mg	NN	O
PO	NNP	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
Vistaril	NNP	B-TREATMENT
50	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
nausea	NN	B-PROBLEM
.	.	O

10.	CD	O
Zofran	NNP	B-TREATMENT
4	CD	O
mg	NN	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
nausea	NN	B-PROBLEM
.	.	O

11.	CD	O
Vitamin	NNP	B-TREATMENT
B-12	NNP	I-TREATMENT
1,000	CD	O
mcg	NN	O
/	NNP	O
mL	VBZ	O
One	CD	O
Injection	NN	O
every	DT	O
other	JJ	O
week	NN	O
.	.	O

12.	CD	O
Vicodin	NNP	B-TREATMENT
5-500	JJ	O
mg	NN	O
1-2	JJ	O
Tablets	NNP	O
PO	NNP	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
PRN	NNP	O

13.	CD	O
Warfarin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
PO	NNP	O
HS	NNP	O
.	.	O

14.	CD	O
TPN	NN	B-TREATMENT

1.	CD	O
Amylase-Lipase-Protease	JJ	B-TREATMENT
33,200	CD	O
-	:	O
10,000	CD	O
-	:	O
37,500	CD	O
unit	NN	O
Capsule	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NNP	O
:	:	O
Four	CD	O
(	(	O
4	CD	O
)	)	O
Cap	NNP	O
PO	NNP	O
W/	NNP	O
MEALS	NNP	O
AND	NNP	O
SNACKS	NNP	O
(	(	O
)	)	O
.	.	O

2.	CD	O
Carbidopa-Levodopa	JJ	B-TREATMENT
25	CD	O
-	:	O
250	CD	O
mg	JJ	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
5	CD	O
TIMES	NNP	O
A	NNP	O
DAY	NNP	O
(	(	O
)	)	O
.	.	O

3.	CD	O
Pramipexole	NNP	B-TREATMENT
0.125	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
Clonazepam	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
Ferrous	JJ	B-TREATMENT
Sulfate	NNP	I-TREATMENT
300	CD	O
mg	NN	O
/	VBD	O
5	CD	O
mL	NN	O
Liquid	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Nystatin	NNP	B-TREATMENT
100,000	CD	O
unit	NN	O
/	JJ	O
g	NN	O
Cream	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
Lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
Capsule	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
Quetiapine	NNP	B-TREATMENT
100	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

9.	CD	O
Propranolol	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
Neurontin	NNP	B-TREATMENT
300	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Capsule	NN	O
PO	NNP	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
take	VB	O
2	CD	O
tabs	NNS	O
in	IN	O
the	DT	O
morining	NN	O
,	,	O
4	CD	O
tabs	NN	O
in	IN	O
the	DT	O
afternoon	NN	O
,	,	O
and	CC	O
4	CD	O
tabs	NNS	O
in	IN	O
the	DT	O
evening	NN	O
.	.	O

Pneumonia	NN	B-PROBLEM

You	PRP	O
are	VBP	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
immediately	RB	O
if	IN	O
you	PRP	O
should	MD	O
experience	VB	O
any	DT	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
worrisome	JJ	I-PROBLEM
symptom	NN	I-PROBLEM
.	.	O

Please	NNP	O
continue	VBP	O
taking	VBG	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	O
Drugs	VB	B-TREATMENT

Shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
Breath	NNP	I-PROBLEM

Coronary	JJ	B-TREATMENT
Artery	NNP	I-TREATMENT
Bypass	NNP	I-TREATMENT
Graft	NNP	I-TREATMENT
x3	NNP	O
(	(	O
Left	NNP	B-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
->	NN	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphaneous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
->	NNP	I-TREATMENT
obtuse	IN	I-TREATMENT
marginal	JJ	I-TREATMENT
,	,	O
saphaneous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
->	NNP	I-TREATMENT
posterior	NN	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
)	)	O
2018-10-25	CD	O

67	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath.	NN	I-PROBLEM
Had	NNP	O
abnormal	JJ	B-PROBLEM
ETT	NNP	I-PROBLEM
and	CC	O
referred	VBD	O
for	IN	O
cath	NN	B-TEST
.	.	O

Cath	NNP	B-TEST
revealed	VBD	O
severe	JJ	B-PROBLEM
3	CD	I-PROBLEM
vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Then	RB	O
referred	VBN	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

Carpal	NNP	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
Hypertension	NNP	B-PROBLEM
,	,	O
Hyperlipidemia	NNP	B-PROBLEM
,	,	O
Arthritis	NNP	B-PROBLEM
,	,	O
h/o	NN	O
Bell's	NNP	B-PROBLEM
Palsy	NNP	I-PROBLEM
,	,	O
HOH	NNP	B-PROBLEM
,	,	O
s/p	NN	O
Tonsillectomy	NNP	B-TREATMENT

Father	NN	O
with	IN	O
MI	NNP	B-PROBLEM
in	IN	O
50	CD	O
's	POS	O
and	CC	O
underwent	JJ	O
CABG	NNP	B-TREATMENT
.	.	O

VS	NN	B-TEST
:	:	O
65	CD	O
20	CD	O
160/100	CD	O
5	CD	O
'	POS	O
7	CD	O
"	JJ	O
180	CD	O
#	#	O

General	NNP	O
:	:	O
WD/WN	NNP	O
male	NN	O
in	IN	O
NAD	NNP	B-PROBLEM

HEENT	NN	O
:	:	O
EOMI	NNP	O
,	,	O
PERRL	NNP	O
,	,	O
NC/AT	NNP	B-PROBLEM

Neck	NN	O
:	:	O
Supple	NN	O
,	,	O
FROM	NNP	O
,	,	O
-	:	O
JVD	NN	B-PROBLEM
,	,	O
-	:	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM

Chest	NN	O
:	:	O
CTAB	NNP	O
-	:	O
w/r/r	NN	B-PROBLEM

Heart	NN	O
:	:	O
RRR	NNP	O
-	:	O
c/r/m/g	NN	B-PROBLEM

Abd	NNS	O
:	:	O
Soft	NNP	O
,	,	O
NT/ND	NNP	B-PROBLEM
+BS	NNP	O

Ext	NN	O
:	:	O
Warm	JJ	O
,	,	O
well-perfused	JJ	O
-	:	O
edema	NN	B-PROBLEM
,	,	O
-	:	O
varicosities	NNS	B-PROBLEM

Echo	JJ	B-TEST
10-25	JJ	O
:	:	O
PRE-BYPASS	NN	O
:	:	O
Left	NNP	B-TEST
ventricular	VBZ	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
akinesis	JJ	B-PROBLEM
/	JJ	O
dyskinesis	NN	B-PROBLEM
and	CC	O
thinning	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
distal	VB	I-PROBLEM
inferior	JJ	I-PROBLEM
septum	NN	I-PROBLEM
and	CC	O
the	DT	O
apex	NN	O
.	.	O

Overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

Right	RB	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	B-TEST
wall	NN	I-TEST
motion	NN	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

The	DT	O
descending	VBG	O
thoracic	NN	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
descending	NN	I-PROBLEM
thoracic	NN	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

No	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

The	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

Trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

POST-BYPASS	NN	B-TREATMENT
:	:	O
LV	NNP	B-TEST
and	CC	I-TEST
RV	NNP	I-TEST
function	NN	I-TEST
is	VBZ	O
unchanged	JJ	O
.	.	O

CXR	JJ	B-TEST
10-30	JJ	O
:	:	O
Left	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
has	VBZ	O
partially	RB	O
cleared	VBN	O
.	.	O

Mild	NNP	B-PROBLEM
postoperative	JJ	I-PROBLEM
widening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiomediastinal	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

No	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

2018-10-25	JJ	O
11:15	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
18.3	CD	O
*#	NN	O
RBC	NNP	B-TEST
-	:	O
3.42	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
10.9	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
31.6	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
92	CD	O
MCH	NNP	B-TEST
-	:	O
31.7	CD	O
MCHC	NNP	B-TEST
-	:	O
34.4	CD	O
RDW	NNP	B-TEST
-	:	O
13.3	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
134	CD	O
*	NN	O

2018-10-31	JJ	O
06:25	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
13.6	CD	O
*	NN	O
RBC	NNP	B-TEST
-	:	O
2.72	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
8.6	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
24.6	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
91	CD	O
MCH	NNP	B-TEST
-	:	O
31.7	CD	O
MCHC	NNP	B-TEST
-	:	O
35.0	CD	O
RDW	NNP	B-TEST
-	:	O
14.0	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
314	CD	O

2018-10-25	JJ	O
11:15	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
13.3	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
30.0	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.2	CD	O
*	NN	O

2018-10-29	JJ	O
06:50	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
11.9	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.0	CD	O

2018-10-25	JJ	O
12:36	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
UreaN	NNP	B-TEST
-	:	O
17	CD	O
Creat	NNP	B-TEST
-	:	O
0.7	CD	O
Cl	NNP	B-TEST
-	:	O
111	CD	O
*	NN	O
HCO3	NNP	B-TEST
-	:	O
23	CD	O

2018-10-31	JJ	O
06:25	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
91	CD	O
UreaN	NNP	B-TEST
-	:	O
19	CD	O
Creat	NNP	B-TEST
-	:	O
0.8	CD	O
Na	NNP	B-TEST
-	:	O
134	CD	O
K	NNP	B-TEST
-	:	O
4.0	CD	O
Cl	NNP	B-TEST
-	:	O
98	CD	O
HCO3	NNP	B-TEST
-	:	O
26	CD	O
AnGap	NNP	B-TEST
-	:	O
14	CD	O

Mr.	NNP	O
Kammerer	NNP	O
was	VBD	O
a	DT	O
same	JJ	O
day	NN	O
admit	NN	O
and	CC	O
on	IN	O
10-25	NNS	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
3	CD	O
.	.	O

He	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
CSRU	NNP	O
for	IN	O
invasive	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

Later	RB	O
on	IN	O
op	NNS	O
day	NN	O
he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
sedation	NN	B-TREATMENT
,	,	O
awoke	VBD	O
neurologically	RB	O
intact	JJ	O
,	,	O
and	CC	O

Beta	NNP	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
diuretics	NNS	B-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
one	CD	O
.	.	O

He	PRP	O
was	VBD	O
diuresed	VBN	B-TREATMENT
towards	IN	O
his	PRP$	B-TEST
pre-op	JJ	I-TEST
weight	NN	I-TEST
.	.	O

He	PRP	O
did	VBD	O
have	VB	O
burst	NN	B-PROBLEM
of	IN	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
Amiodarone	NNP	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

His	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blockers	NNS	I-TREATMENT
were	VBD	O
also	RB	O
titrated	VBN	O
for	IN	O
maximal	JJ	B-TREATMENT
BP	NNP	I-TREATMENT
and	CC	I-TREATMENT
HR	NNP	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

Chest	NNP	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
two	CD	O
and	CC	O
epicardial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
on	IN	O
post-op	JJ	O
day	NN	O
three	CD	O
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
he	PRP	O
continued	VBD	O
to	TO	O
improve	VB	O
his	PRP$	O
ambulation	NN	O
and	CC	O
mobility	NN	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
of	IN	I-PROBLEM
AFIB	NNP	I-PROBLEM
while	IN	O
on	IN	O
po	NN	B-TREATMENT
Amiodarone	NNP	I-TREATMENT
.	.	O

On	IN	O
post-op	JJ	O
day	NN	O
five	CD	O
he	PRP	O
appeared	VBD	O
to	TO	O
have	VB	O
left	VBN	B-PROBLEM
arm	JJ	I-PROBLEM
phlebitis	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
post-op	JJ	O
day	NN	O
six	CD	O
with	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
appropriate	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

He	PRP	O
will	MD	O
have	VB	O
VNA	NNP	B-TREATMENT
services	NNS	I-TREATMENT
and	CC	O
make	VB	O
the	DT	O
appropriate	JJ	O
follow-up	JJ	O
appointments	NNS	O
.	.	O

Aspirin	$	B-TREATMENT
81	CD	O
mg	NN	O
qd	NN	O
,	,	O
Toprol	NNP	B-TREATMENT
XL	NNP	O
50	CD	O
mg	NN	O
qd	NN	O
,	,	O
MVI	NNP	B-TREATMENT
,	,	O
Flexeril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
qhs	NN	O
,	,	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
qd	NN	O
(	(	O
last	JJ	O
on	IN	O
10-18	NNS	O
)	)	O

1.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

3.	CD	O
Ranitidine	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
150	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
Oxycodone	NNP	B-TREATMENT
-	:	I-TREATMENT
Acetaminophen	NNP	I-TREATMENT
5-325	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

6.	CD	O
Amiodarone	$	B-TREATMENT
200	CD	O
mg	JJ	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
):	JJ	O
please	NN	O
take	VB	O
400	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
until	IN	O
11-02	JJ	O
then	RB	O
decrease	NN	O
to	TO	O
400	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
1	CD	O
week	NN	O
and	CC	O
then	RB	O
decrease	VB	O
to	TO	O
200	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
Metoprolol	NNP	B-TREATMENT
Succinate	NNP	I-TREATMENT
50	CD	O
mg	NN	O
Tablet	NNP	O
Sustained	NNP	O
Release	NNP	O
24	CD	O
HR	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
Sustained	VBD	O
Release	NNP	O
24	CD	O
HR	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

8.	CD	O
Ferrous	JJ	B-TREATMENT
Gluconate	NNP	I-TREATMENT
300	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

9.	CD	O
Ascorbic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
Cephalexin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
for	IN	O
6	CD	O
days	NNS	O
:	:	O
please	VB	O
complete	JJ	O
full	JJ	O
course	NN	O
.	.	O

11.	CD	O
Furosemide	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

12.	CD	O
Potassium	NNP	B-TREATMENT
Chloride	NNP	I-TREATMENT
10	CD	O
mEq	NN	O
Capsule	NNP	O
,	,	O
Sustained	VBD	O
Release	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NN	O
,	,	O
Sustained	VBD	O
Release	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

13.	CD	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
Coronary	NNP	B-TREATMENT
Artery	NNP	I-TREATMENT
Bypass	NNP	I-TREATMENT
Graft	NNP	I-TREATMENT
x3	NN	O

PMH	NN	O
:	:	O
Carpal	JJ	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
Hypertension	NNP	B-PROBLEM
,	,	O
Hyperlipidemia	NNP	B-PROBLEM
,	,	O
Arthritis	NNP	B-PROBLEM

Monitor	NNP	O
wounds	VBZ	B-PROBLEM
for	IN	O
infection	NN	B-PROBLEM
-	:	O
redness	NN	B-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
,	,	O
or	CC	O
increased	VBD	B-PROBLEM
pain	NN	I-PROBLEM

Report	NNP	O
any	DT	B-PROBLEM
fever	RB	I-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM

Report	NNP	O
any	DT	B-PROBLEM
weight	JJ	I-PROBLEM
gain	NN	I-PROBLEM
of	IN	O
greater	JJR	O
than	IN	O
2	CD	O
pounds	NNS	O
in	IN	O
24	CD	O
hours	NNS	O
or	CC	O
5	CD	O
pounds	NNS	O
in	IN	O
a	DT	O
week	NN	O

No	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
,	,	O
powders	NNS	B-TREATMENT
,	,	O
or	CC	O
ointments	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM

Left	NNP	O
Arm	NNP	O
continue	VBP	O
with	IN	O
elevation	NN	B-TREATMENT
,	,	O
ice	NN	B-TREATMENT
,	,	O
and	CC	O
complete	JJ	O
all	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT

For	IN	O
surgical	JJ	B-PROBLEM
incision	NN	I-PROBLEM
and	CC	O
left	VBD	O
arm	NN	O

This	DT	O
is	VBZ	O
an	DT	O
83	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
slurred	JJ	B-PROBLEM
speech	NN	I-PROBLEM
when	WRB	O
dehydrated	VBN	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
paraplegia	VBN	B-PROBLEM
secondary	JJ	O
to	TO	O
HTLV	NNP	B-PROBLEM
exposure	NN	I-PROBLEM
while	IN	O
on	IN	O
vacation	NN	O
in	IN	O
the	DT	O
Bahamas	NNPS	O
six	CD	O
years	NNS	O
ago	RB	O
.	.	O

She	PRP	O
presented	VBD	O
with	IN	O
three	CD	O
days	NNS	O
of	IN	O
general	JJ	B-PROBLEM
malaise	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
cough	JJ	B-PROBLEM
productive	NN	O
of	IN	O
white	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

She	PRP	O
awoke	VBD	O
with	IN	O
nausea	NN	B-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
and	CC	O
pleuritic	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
some	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
talking	VBG	O
and	CC	O
grasping	VBG	O
right	JJ	O
hand	NN	O
.	.	O

She	PRP	O
came	VBD	O
to	TO	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
on	IN	O
the	DT	O
2011-03-10	JJ	O
,	,	O
with	IN	O
temperature	NN	B-TEST
of	IN	O
99.0	CD	O
F	NNP	O
.;	NNP	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
97/50	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
100	CD	O
;	:	O
respirations	NNS	B-TEST
27	CD	O
;	:	O
O2	NNP	B-TEST
saturation	NN	I-TEST
84%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
94%	CD	O
on	IN	O
two	CD	O
liters	NNS	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
coarse	VBN	B-PROBLEM
rhonchi	NNS	I-PROBLEM
on	IN	O
examination	NN	B-TEST
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
but	CC	O
positive	JJ	O
for	IN	O
consolidation	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Levofloxacin	NNP	B-TREATMENT
but	CC	O
the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
at	IN	O
that	DT	O
point	NN	O
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
70/45	CD	O
and	CC	O
received	VBD	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
bolus	NN	I-TREATMENT
to	TO	O
boost	VB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
99/60	CD	O
;	:	O
however	RB	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Medical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
overnight	JJ	B-TEST
observation	NN	I-TEST
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
somnolence	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
.	.	O

1.	CD	O
Positive	JJ	B-PROBLEM
lupus	NN	I-PROBLEM
anti-coagulant	NN	I-PROBLEM
.	.	O

2.	CD	O
Basilar	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

3.	CD	O
Prior	NNP	B-PROBLEM
transient	NN	I-PROBLEM
ischemic	JJ	I-PROBLEM
attacks	NNS	I-PROBLEM
.	.	O

4.	CD	O
Right	JJ	B-TREATMENT
medial	JJ	I-TREATMENT
malleolus	NN	I-TREATMENT
repair	NN	I-TREATMENT
in	IN	O
2004-08-05	JJ	O
.	.	O

5.	CD	O
Paraplegia	NNP	B-PROBLEM
secondary	JJ	O
to	TO	O
HTLV	NNP	B-PROBLEM
from	IN	O
a	DT	O
trip	NN	O
to	TO	O
the	DT	O
Bahamas	NNPS	O
five	CD	O
to	TO	O
six	CD	O
years	NNS	O
ago	RB	O
.	.	O

6.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

7.	CD	O
Chronic	NNP	B-PROBLEM
diarrhea	NN	I-PROBLEM
with	IN	O
multiple	JJ	O
admissions	NNS	O
for	IN	O
dehydration	NN	B-PROBLEM
with	IN	O
most	RBS	O
recent	JJ	O
one	CD	O
on	IN	O
2011-02-26	JJ	O
.	.	O

8.	CD	O
Venous	JJ	B-PROBLEM
stasis	NN	I-PROBLEM
.	.	O

9.	CD	O
Depression	NNP	B-PROBLEM
.	.	O

10.	CD	O
Seizure	NNP	B-PROBLEM
history	NN	I-PROBLEM
on	IN	O
Neurontin	NNP	B-TREATMENT
.	.	O

11.	CD	O
Left	NNP	B-TREATMENT
CMED	NNP	I-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
2009-10-05	JJ	O
.	.	O

12.	CD	O
Chronic	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
spasms	NNS	I-PROBLEM
.	.	O

Penicillin	NNP	B-TREATMENT
for	IN	O
which	WDT	O
she	PRP	O
reports	VBZ	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
dyspepsia	NN	B-PROBLEM
when	WRB	O
taking	VBG	O
uncoated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
a	DT	O
questionable	JJ	O
sensitivity	NN	B-PROBLEM
to	TO	O
iodine	VB	B-TREATMENT
.	.	O

1.	CD	O
Enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

2.	CD	O
Aggrenox	NNP	B-TREATMENT
.	.	O

3.	CD	O
Zanaflex	NNP	B-TREATMENT
.	.	O

4.	CD	O
Neurontin	NNP	B-TREATMENT
300	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
Celexa	NNP	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
.	.	O

On	IN	O
admission	NN	B-TEST
examination	NN	I-TEST
she	PRP	O
was	VBD	O
a	DT	O
well	NN	O
developed	NN	O
,	,	O
well	RB	O
nourished	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Her	PRP$	O
lungs	NNS	O
revealed	VBD	O
coarse	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
rhonchi	NN	I-PROBLEM
from	IN	O
base	NN	O
to	TO	O
midline	VB	O
.	.	O

Cardiovascular	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
;	:	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

Extremities	NNS	O
notable	JJ	O
for	IN	O
two	CD	B-PROBLEM
plus	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
the	DT	O
ankles	NNS	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
pressure	NN	B-TREATMENT
stockings	NNS	I-TREATMENT
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
were	VBD	O
11.8	CD	O
,	,	O
hematocrit	NN	B-TEST
31.5	CD	O
,	,	O
platelets	NNS	B-TEST
151	CD	O
.	.	O

Chem-7	NNP	B-TEST
was	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
3.0	CD	O
,	,	O
chloride	RB	B-TEST
108	CD	O
,	,	O
bicarbonate	NN	B-TEST
24	CD	O
,	,	O
BUN	NNP	B-TEST
22	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
and	CC	O
glucose	JJ	B-TEST
117	CD	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
in	IN	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
before	IN	O
coming	VBG	O
to	TO	O
the	DT	O
Unit	NNP	O
which	WDT	O
reported	VBD	O
no	DT	O
recent	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
no	DT	O
change	NN	B-PROBLEM
from	IN	O
a	DT	B-TEST
prior	JJ	I-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
done	VBN	O
on	IN	O
2011-03-04	JJ	O
.	.	O

EKG	NNP	B-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
100	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
,	,	O
normal	JJ	O
axis	NN	O
.	.	O

.....	RB	O
done	VBN	O
on	IN	O
02-24	NN	O
,	,	O
notable	JJ	O
for	IN	O
mid-basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
high-grade	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

After	IN	O
transfer	NN	O
to	TO	O
the	DT	O
Floor	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
Levofloxacin	NNP	B-TREATMENT
for	IN	O
a	DT	O
ten	NN	O
to	TO	O
14	CD	O
day	NN	O
course	NN	O
for	IN	O
presumptive	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

Due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
diarrhea	NN	I-PROBLEM
she	PRP	O
was	VBD	O
repleted	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

For	IN	O
her	PRP$	B-PROBLEM
depression	NN	I-PROBLEM
,	,	O
continued	VBD	O
on	IN	O
Citalopram	NNP	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
.	.	O

For	IN	O
her	PRP$	B-PROBLEM
paraplegia	NN	I-PROBLEM
and	CC	O
associated	JJ	O
muscle	NN	B-PROBLEM
spasticity	NN	I-PROBLEM
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
Zanaflex	NNP	I-TREATMENT
.	.	O

For	IN	O
deep	JJ	B-TREATMENT
vein	NN	I-TREATMENT
thrombosis	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
subcutaneous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
and	CC	O
for	IN	O
gastrointestinal	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
Protonix	NNP	B-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
evaluated	VBN	O
by	IN	O
Physical	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
and	CC	O
Speech	NNP	B-TREATMENT
and	CC	O
Swallow	NNP	B-TREATMENT
because	IN	O
of	IN	O
some	DT	O
report	NN	O
of	IN	O
dysphagia	NN	B-PROBLEM
.	.	O

Physical	JJ	B-TREATMENT
Therapy	NNP	I-TREATMENT
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
cleared	VBN	O
for	IN	O
transfer	NN	O
home	NN	O
with	IN	O
services	NNS	O
.	.	O

Occupational	JJ	B-TREATMENT
Therapy	NNP	I-TREATMENT
was	VBD	O
also	RB	O
in	IN	O
agreement	NN	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
disposition	NN	O
home	NN	O
with	IN	O
services	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
advance	VB	O
her	PRP$	O
diet	JJ	O
well	NN	O
from	IN	O
liquids	NNS	O
to	TO	O
solids	NNS	O
,	,	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
plagued	VBN	O
with	IN	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
fevers	NNS	I-PROBLEM
to	TO	O
99.0	CD	O
F	NNP	O
.	.	O

Speech	NN	B-TREATMENT
and	CC	O
Swallow	NNP	B-TREATMENT
evaluated	VBD	O
the	DT	O
patient	NN	O
at	IN	O
bedside	NN	O
and	CC	O
recommended	VBD	O
advancing	VBG	O
to	TO	O
regular	VB	O
diet	JJ	O
with	IN	O
regular	JJ	O
consistency	NN	O
and	CC	O
saw	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
dysphagia	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
some	DT	O
question	NN	O
regarding	VBG	O
restarting	NN	O
of	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
Coumadin	NNP	I-TREATMENT
given	VBN	O
her	PRP$	B-PROBLEM
positive	JJ	I-PROBLEM
lupus	NN	I-PROBLEM
anti-coagulant	JJ	I-PROBLEM
status	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
the	DT	O
presence	NN	O
of	IN	O
her	PRP$	B-PROBLEM
basilar	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
the	DT	O
2011-03-15	JJ	O
on	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
Levofloxacin	NNP	B-TREATMENT
250	CD	O
mg	NN	O
q.	NNS	O
day	NN	O
for	IN	O
ten	JJ	O
days	NNS	O
.	.	O

2.	CD	O
Aspirin	NNP	B-TREATMENT
/	NNP	O
dipyridamole	VBD	B-TREATMENT
25/200	CD	O
mg	NN	O
capsules	NNS	O
taken	VBN	O
two	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
Neurontin	NNP	B-TREATMENT
300	CD	O
mg	NN	O
taken	VBN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
Subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
taken	VBN	O
5000	CD	O
units	NNS	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
Albuterol	NNP	B-TREATMENT
multiple	NN	I-TREATMENT
dose	NN	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
Atrovent	NNP	B-TREATMENT
multiple	NN	I-TREATMENT
dose	NN	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
Citalopram	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

8.	CD	O
Lisinopril	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
Trazodone	CD	B-TREATMENT
25	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

10.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

11.	CD	O
Zanaflex	NNP	B-TREATMENT
2	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

12.	CD	O
Tylenol	NNP	B-TREATMENT
325	CD	O
mg	NN	O
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

13.	CD	O
The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
discharged	VBN	O
with	IN	O
the	DT	O
restarting	NN	O
of	IN	O
warfarin	$	B-TREATMENT
2	CD	O
mg	JJ	O
daily	RB	O
.	.	O

1.	CD	O
She	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
have	VB	O
blood	VBN	B-TEST
drawn	VBN	O
by	IN	O
the	DT	O
Visiting	NNP	O
Nurses	NNP	O
Association	NNP	O
the	DT	O
day	NN	O
after	IN	O
discharge	NN	O
and	CC	O
then	RB	O
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
discharge	VBP	O
the	DT	O
same	JJ	O
week	NN	O
to	TO	O
have	VB	O
INR	NNP	B-TEST
.	.	O

Will	NNP	O
also	RB	O
have	VBP	O
INR	NNP	B-TEST
checked	VBN	O
at	IN	O
once	RB	O
weekly	JJ	O
until	IN	O
target	NN	O
of	IN	O
INR	NNP	B-TEST
of	IN	O
2.0	CD	O
to	TO	O
3.0	CD	O
is	VBZ	O
reached	VBN	O
.	.	O

2.	CD	O
The	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
contact	VB	O
Dr.	NNP	O
Ralph	NNP	O
at	IN	O
(	(	O
428	CD	O
)	)	O
678-6930	CD	O
,	,	O
who	WP	O
is	VBZ	O
covering	VBG	O
for	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Erika	NNP	O
Witt	NNP	O
,	,	O
to	TO	O
adjust	VB	O
her	PRP$	B-TREATMENT
dosages	NNS	I-TREATMENT
based	VBN	O
on	IN	O
the	DT	B-TEST
INR	NNP	I-TEST
levels	NNS	I-TEST
.	.	O

4.	CD	O
She	PRP	O
was	VBD	O
also	RB	O
instructed	VBN	O
to	TO	O
follow-up	JJ	O
with	IN	O
Dr.	NNP	O
Reid	NNP	O
from	IN	O
Neurology	NNP	O
within	IN	O
a	DT	O
month	NN	O
at	IN	O
(	(	O
382	CD	O
)	)	O
716	CD	O
4151	CD	O
,	,	O
given	VBN	O
her	PRP$	B-PROBLEM
neurological	JJ	I-PROBLEM
deficits	NNS	I-PROBLEM
during	IN	O
this	DT	O
presentation	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
2-vessel	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
in	IN	O
2005	CD	O
,	,	O
3-vessel	JJ	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
in	IN	O
2009	CD	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
new	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
type	NN	I-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
the	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
status	NN	O
post	NN	O
exercise	NN	O
.	.	O

The	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
Bournewood	NNP	O
Hospital	NNP	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
substernal	JJ	B-PROBLEM
burning	NN	I-PROBLEM
without	IN	O
radiation	NN	O
which	WDT	O
developed	VBD	O
while	IN	O
doing	VBG	O
exercise	NN	O
.	.	O

The	DT	B-PROBLEM
pain	NN	I-PROBLEM
became	VBD	O
worse	JJR	O
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
minutes	NNS	O
to	TO	O
07-12	JJ	O
and	CC	O
increased	VBD	O
to	TO	O
10-12	JJ	O
while	IN	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
ambulance	NN	O
.	.	O

His	PRP$	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT
patch	NN	I-TREATMENT
did	VBD	O
not	RB	O
help	VB	O
,	,	O
and	CC	O
he	PRP	O
only	RB	O
had	VBD	O
slight	JJ	O
relief	NN	O
with	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
times	NNS	O
three	CD	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
had	VBD	O
slight	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
denies	VBZ	O
headache	NN	B-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
urinary	JJ	I-PROBLEM
habits	NNS	I-PROBLEM
,	,	O
or	CC	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
and	CC	O
sweats	NNS	B-PROBLEM
.	.	O

In	IN	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
he	PRP	O
received	VBD	O
aspirin	RB	B-TREATMENT
,	,	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
Dilaudid	NNP	B-TREATMENT
,	,	O
and	CC	O
TNK	NNP	B-TREATMENT
with	IN	O
decreased	VBN	O
in	IN	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
but	CC	O
without	IN	O
resolution	NN	O
of	IN	O
symptoms	NNS	B-PROBLEM
.	.	O

Electrocardiogram	NN	B-TEST
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
ST	NNP	B-PROBLEM
elevations	NNS	I-PROBLEM
and	CC	O
J	NNP	B-PROBLEM
point	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
V2	NNP	I-PROBLEM
through	IN	I-PROBLEM
V4	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Sturdy	NNP	O
Memorial	NNP	O
where	WRB	O
he	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
.	.	O

Catheterization	NN	B-TEST
results	NNS	I-TEST
showed	VBD	O
100%	CD	B-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
first	JJ	I-PROBLEM
diagonal	NN	I-PROBLEM
.	.	O

Angio-Jet	NNP	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stenting	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
proximal	JJ	O
left	VBN	O
anterior	JJ	O
descending	VBG	O
artery	NN	O
and	CC	O
the	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
first	JJ	O
diagonal	JJ	O
with	IN	O
good	JJ	O
results	NNS	O
.	.	O

An	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
this	DT	O
time	NN	O
as	RB	O
well	RB	O
.	.	O

1.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
times	NNS	O
three	CD	O
in	IN	O
2009	CD	O
at	IN	O
Clinton	NNP	O
Hospital	NNP	O
;	:	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	JJ	I-TREATMENT
times	NNS	O
two	CD	O
in	IN	O
2005	CD	O
at	IN	O
Waltham/Weston	NNP	O
Hospital	NNP	O
.	.	O

2.	CD	O
Type	NNP	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

3.	CD	O
Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

4.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
's	POS	O
father	NN	O
died	VBD	O
of	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
at	IN	O
age	NN	O
40	CD	O
,	,	O
and	CC	O
a	DT	O
brother	NN	O
who	WP	O
died	VBD	O
of	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
at	IN	O
age	NN	O
40	CD	O
.	.	O

Diltiazem	NNP	B-TREATMENT
180	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
Glyset	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
Prevacid	NNP	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
Glucophage	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

Allergies	NNS	B-PROBLEM
included	VBD	O
PENICILLIN	NNP	B-TREATMENT
and	CC	O
IODINE	NNP	B-TREATMENT
.	.	O

Temperature	NN	B-TEST
maximum	JJ	I-TEST
98.7	CD	O
,	,	O
temperature	NN	B-TEST
current	JJ	I-TEST
98.3	CD	O
,	,	O
pulse	RB	B-TEST
ranged	VBD	O
from	IN	O
82	CD	O
to	TO	O
92	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
104	CD	O
to	TO	O
124/67	CD	O
to	TO	O
74	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
86	CD	O
to	TO	O
99	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
11	CD	O
to	TO	O
16	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
94%	CD	O
to	TO	O
98%	CD	O
on	IN	O
2	CD	O
liters	NNS	O
.	.	O

Pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
29/15	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
22	CD	O
.	.	O

Cardiac	NNP	B-TEST
output	NN	I-TEST
was	VBD	O
7	CD	O
(	(	O
that	WDT	O
was	VBD	O
on	IN	O
6	CD	O
of	IN	O
dopamine	NN	B-TREATMENT
)	)	O
.	.	O

Intra-aortic	JJ	B-TEST
balloon	NN	I-TEST
pump	NN	I-TEST
augmented	VBD	I-TEST
systole	NN	I-TEST
was	VBD	O
109	CD	O
,	,	O
augmented	VBD	B-TEST
diastole	NN	I-TEST
was	VBD	O
111	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
lying	VBG	O
flat	JJ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

No	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
anteriorly	RB	O
and	CC	O
laterally	RB	O
.	.	O

Cardiovascular	NNP	O
revealed	VBD	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
not	RB	O
appreciated	VBN	O
.	.	O

Carotids	NNS	O
had	VBD	O
normal	JJ	O
upstroke	JJ	O
and	CC	O
normal	JJ	O
volume	NN	O
with	IN	O
bilateral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

No	DT	O
S3	NNP	B-PROBLEM
or	CC	O
S4	NNP	B-PROBLEM
.	.	O

No	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Abdomen	NNS	O
had	VBD	O
decreased	VBN	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

No	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Extremities	NNS	O
had	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

The	DT	O
right	JJ	O
groin	NN	O
revealed	VBD	O
intra-aortic	JJ	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
site	NN	O
and	CC	O
pulmonary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
catheterization	NN	I-TREATMENT
site	NN	O
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
without	IN	O
tenderness	NN	B-PROBLEM
.	.	O

Dorsalis	NNP	B-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

Neurologic	NNP	B-TEST
examination	NN	I-TEST
revealed	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
.	.	O

Laboratories	NNS	B-TEST
on	IN	O
admission	NN	O
revealed	VBN	O
white	JJ	B-TEST
count	NN	I-TEST
7.8	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
41.7	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
252	CD	O
,	,	O
MCV	NNP	B-TEST
89	CD	O
,	,	O
RDW	NNP	B-TEST
12.7	CD	O
.	.	O

Chem-7	NNP	B-TEST
revealed	VBD	O
sodium	NN	B-TEST
of	IN	O
136	CD	O
,	,	O
potassium	NN	B-TEST
4.7	CD	O
,	,	O
chloride	RB	B-TEST
103	CD	O
,	,	O
bicarbonate	NN	B-TEST
22	CD	O
,	,	O
BUN	NNP	B-TEST
16	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
284	CD	O
.	.	O

PT	NNP	B-TEST
14.2	CD	O
,	,	O
PTT	NNP	B-TEST
108.5	CD	O
,	,	O
INR	NNP	B-TEST
1.3	CD	O
.	.	O

Creatine	JJ	B-TEST
kinase	NN	I-TEST
at	IN	O
11	CD	O
a.m.	NN	O
was	VBD	O
83	CD	O
,	,	O
at	IN	O
5	CD	O
p.m.	NN	O
was	VBD	O
3021	CD	O
.	.	O

Arterial	NNP	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
11	CD	O
a.m.	NN	O
was	VBD	O
7.33/46/115	CD	O
.	.	O

Creatine	NNP	B-TEST
kinases	NNS	I-TEST
trended	VBD	O
from	IN	O
11:15	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
from	IN	O
83	CD	O
to	TO	O
3021	CD	O
at	IN	O
5	CD	O
p.m.	NN	O
to	TO	O
3450	CD	O
at	IN	O
11	CD	O
p.m.	NN	O
,	,	O
to	TO	O
1734	CD	O
at	IN	O
5:30	CD	O
a.m.	RB	O
on	IN	O
11-07	JJ	O
,	,	O
to	TO	O
1277	CD	O
at	IN	O
11:30	CD	O
a.m.	RB	O
on	IN	O
11-07	JJ	O
,	,	O
to	TO	O
83	CD	O
at	IN	O
9:30	CD	O
a.m.	RB	O
on	IN	O
11-11	NNS	O
.	.	O

Electrocardiogram	NNP	B-TEST
post	NN	O
catheterization	NN	B-TEST
showed	VBD	O
continued	JJ	B-PROBLEM
ST	NNP	I-PROBLEM
elevations	NNS	I-PROBLEM
and	CC	O
J	NNP	B-PROBLEM
point	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
V2	NNP	I-PROBLEM
through	IN	I-PROBLEM
V3	NNP	I-PROBLEM
.	.	O

Post	NNP	B-TEST
catheterization	NN	I-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
30%	CD	O
,	,	O
moderate	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
basal	NN	B-PROBLEM
anterior	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
mid	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
basal	JJ	B-PROBLEM
anteroseptal	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
mid	JJ	B-PROBLEM
anteroseptal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

Anterior	NNP	B-PROBLEM
apex	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
apex	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
and	CC	O
apex	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

The	DT	O
was	VBD	O
trace	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
trace	NN	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
47	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	JJ	I-TREATMENT
times	NNS	O
two	CD	O
,	,	O
who	WP	O
presented	VBD	O
with	IN	O
acute	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
refractory	NN	O
to	TO	O
medical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
and	CC	O
TNK	NNP	B-TREATMENT
,	,	O
now	RB	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
Angio-Jet	NNP	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stent	NN	B-TREATMENT
of	IN	I-TREATMENT
proximal	JJ	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
and	CC	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	O
first	JJ	O
diagonal	JJ	O
with	IN	O
intra-aortic	JJ	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

Dopamine	NNP	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
one	CD	O
.	.	O

The	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
two	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
and	CC	O
transitioned	VBD	O
to	TO	O
Coumadin	NNP	B-TREATMENT
on	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
Lipitor	NNP	B-TREATMENT
and	CC	O
aspirin	NN	B-TREATMENT
,	,	O
and	CC	O
Plavix	NNP	B-TREATMENT
was	VBD	O
added	VBN	O
and	CC	O
will	MD	O
be	VB	O
continued	VBN	O
for	IN	O
30	CD	O
days	NNS	O
post	VBN	O
catheterization	NN	B-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
Lopressor	NNP	B-TREATMENT
and	CC	O
captopril	NN	B-TREATMENT
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
,	,	O
and	CC	O
changed	VBD	O
to	TO	O

Zestril	$	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O
and	CC	O
atenolol	$	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O
at	IN	O
discharge	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
and	CC	O
discharged	VBD	O
from	IN	O
the	DT	O
hospital	NN	O
once	RB	O
his	PRP$	B-TEST
INR	NN	I-TEST
was	VBD	O
within	IN	O
the	DT	O
2	CD	O
to	TO	O
2.5	CD	O
range	NN	O
.	.	O

Primary	NNP	O
care	NN	O
physician	NN	O
was	VBD	O
to	TO	O
check	VB	O
INR	NNP	B-TEST
and	CC	O
titrate	NN	O
Zestril	NNP	B-TREATMENT
up	RB	O
and	CC	O
atenolol	RB	B-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

1.	CD	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
times	NNS	O
30	CD	O
days	NNS	O
.	.	O

4.	CD	O
Prevacid	NNP	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
Atenolol	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
Zestril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
Glyset	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
Glucophage	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
Coumadin	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

MEDICINE	NN	B-TREATMENT

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

Shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
Breath	NNP	I-PROBLEM

Endotracheal	JJ	B-TREATMENT
Intubation	NN	I-TREATMENT

Central	NNP	B-TREATMENT
Venous	NNP	I-TREATMENT
Catheter	NNP	I-TREATMENT
and	CC	O
Swan	NNP	B-TREATMENT
Ganz	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT

Arterial	JJ	B-TREATMENT
Line	NNP	I-TREATMENT
Placement	NNP	I-TREATMENT

Right	RB	B-TREATMENT
sided	VBN	I-TREATMENT
thoracentesis	NN	I-TREATMENT

70	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
h/o	JJ	O
CAD	NNP	B-PROBLEM
s/p	NN	B-TREATMENT
LAD	NNP	I-TREATMENT
PTCA	NNP	I-TREATMENT
33	CD	O
yrs	NN	O
ago	RB	O
,	,	O
COPD	NNP	B-PROBLEM
,	,	O
T2DM	NNP	B-PROBLEM
,	,	O
and	CC	O
AICD	NNP	B-PROBLEM
pocket	NN	I-PROBLEM
infection	NN	I-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
Juan	NNP	O
on	IN	O
2017-09-03	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
SOB	NNP	I-PROBLEM
x	$	O
5	CD	O
days	NNS	O
and	CC	O
feeling	VBG	O
"	NNP	O
cloudy	NN	O
."	NN	O

The	DT	O
patient	NN	O
was	VBD	O
currently	RB	O
at	IN	O
Hubbard	NNP	O
Regional	NNP	O
Hospital	NNP	O
and	CC	O
began	VBD	O
to	TO	O
develop	VB	O
worsening	VBG	B-PROBLEM
SOB	NNP	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
5	CD	O
days	NNS	O
.	.	O

This	DT	O
AM	NNP	O
while	IN	O
talking	VBG	O
with	IN	O
his	PRP$	O
daughter	NN	O
on	IN	O
the	DT	O
phone	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
desaturate	VB	O
into	IN	O
the	DT	O
high	JJ	O
80s	CD	O
and	CC	O
he	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
The	DT	O
Hospital	NNP	O
for	IN	O
Orthopedics	NNP	O
Juan	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
felt	VBN	O
"	NNP	O
cloudy	NN	B-PROBLEM
"	NNP	O
of	IN	O
late	JJ	O
which	WDT	O
seems	VBZ	O
to	TO	O
relate	VB	O
to	TO	O
his	PRP$	B-PROBLEM
worsening	VBG	I-PROBLEM
SOB	NNP	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
not	RB	O
ambulatory	JJ	O
and	CC	O
is	VBZ	O
very	RB	B-PROBLEM
deconditioned	JJ	I-PROBLEM
secondary	JJ	O
to	TO	O
several	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
within	IN	O
the	DT	O
past	JJ	O
two	CD	O
months	NNS	O
related	VBN	O
to	TO	O
an	DT	B-PROBLEM
AICD	NNP	I-PROBLEM
pocket	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

He	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
CP	NNP	I-PROBLEM
,	,	O
N/V/D	NNP	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
HA	NNP	B-PROBLEM
.	.	O

In	IN	O
the	DT	O
Juan	NNP	O
,	,	O
his	PRP$	B-TEST
VS	NNP	I-TEST
were	VBD	O
97.8	CD	O
150/80	CD	O
88	CD	O
12	CD	O
89-94%	JJ	O
3L	CD	B-TREATMENT
NC	NNP	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Percocet	NNP	B-TREATMENT
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
Lasix	NNP	B-TREATMENT
80	CD	O
mg	NN	O
IV	NNP	O
,	,	O
and	CC	O
Combivent	NNP	B-TREATMENT
neb	NN	I-TREATMENT
.	.	O

For	IN	O
unclear	JJ	O
reasons	NNS	O
,	,	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
NRB	NNP	I-TREATMENT
in	IN	O
the	DT	O
Juan	NNP	O
.	.	O

He	PRP	O
was	VBD	O
quickly	RB	O
weaned	VBN	O
to	TO	O
3L	CD	B-TREATMENT
O2	NNP	I-TREATMENT
via	IN	O
NC	NNP	B-TREATMENT
,	,	O
O2	NNP	B-TEST
sats	VBZ	I-TEST
100%	CD	O
.	.	O

-	:	O
AICD	NN	B-PROBLEM
Pocket	NNP	I-PROBLEM
infection	NN	I-PROBLEM
c/b	NN	O
MSSA	NNP	B-PROBLEM
bacteremia	NN	I-PROBLEM
,	,	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
s/p	VBD	B-TEST
mediastinal	JJ	I-TEST
exploration	NN	I-TEST
,	,	O
evacuation	NN	B-TREATMENT
of	IN	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
&	CC	O
hematoma	NN	B-PROBLEM
(	(	O
2017-07-24	CD	O
)	)	O

-	:	O
Ischemic	NNP	B-PROBLEM
colitis	NN	I-PROBLEM
and	CC	O
ischemic	JJ	B-PROBLEM
liver	NN	I-PROBLEM
2017-06-22	JJ	O
(	(	O
post	FW	O
air	NN	B-PROBLEM
embolism	NN	I-PROBLEM
from	IN	O
post	NN	O
mediastinal	JJ	B-TEST
exploration	NN	I-TEST
)	)	O

-	:	O
CAD	NN	B-PROBLEM
s/p	NN	B-TREATMENT
LAD	NNP	I-TREATMENT
PTCA	NNP	I-TREATMENT
33	CD	O
years	NNS	O
ago	RB	O

-	:	O
T2DM	NN	B-PROBLEM
c/b	NN	O
neuropathy	JJ	B-PROBLEM
and	CC	O
nephropathy	JJ	B-PROBLEM

-	:	O
COPD	NN	B-PROBLEM

-	:	O
Hypothyroidism	NN	B-PROBLEM

-	:	O
CVA	NN	B-PROBLEM

-	:	O
s/p	NN	B-TREATMENT
Bovine	NNP	I-TREATMENT
AVR	NNP	I-TREATMENT
1999	CD	O

-	:	O
Hyperlipidemia	NN	B-PROBLEM

-	:	O
GERD	NN	B-PROBLEM

-	:	O
Chronic	NN	B-PROBLEM
LBP	NN	I-PROBLEM

-	:	O
Lumbar	NN	B-PROBLEM
sympathectomy	NN	I-PROBLEM

Sister	NN	O
with	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

97.6	CD	O
95/48	CD	O
71	CD	O
98%	CD	O
4L	CD	B-TREATMENT
NC	NN	I-TREATMENT

Slight	JJ	B-PROBLEM
confustion	NN	I-PROBLEM
with	IN	O
place	NN	O
but	CC	O
oriented	VBN	O
with	IN	O
some	DT	O
re-direction	NN	O
.	.	O

JVD	NNP	B-PROBLEM
difficult	JJ	O
to	TO	O
access	NN	O
02-23	NN	O
increased	VBD	B-PROBLEM
neck	RB	I-PROBLEM
girth	NN	I-PROBLEM
.	.	O

S1	NNP	O
,	,	O
S2	NNP	O
with	IN	O
Grade	NNP	B-PROBLEM
II/VI	NNP	I-PROBLEM
SEM	NNP	I-PROBLEM
.	.	O
+S3	NN	B-PROBLEM
.	.	O

Crackles	NNS	B-PROBLEM
halfway	VBP	I-PROBLEM
up	RP	I-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
B/L	NNP	I-PROBLEM
.	.	O

Soft	NNP	O
,	,	O
NT/ND	NNP	B-PROBLEM
with	IN	O
normoactive	JJ	O
BS	NNP	O
.	.	O

2+	CD	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	VB	I-PROBLEM
B/L	NNP	I-PROBLEM
.	.	O

2017-09-03	JJ	O
PT	NNP	B-TEST
-	:	O
13.8	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
33.1	CD	O
INR	NNP	B-TEST
(	(	I-TEST
PT	NNP	I-TEST
)-	CD	I-TEST
1.2	CD	O
*	NN	O

2017-09-03	JJ	O
PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
124	CD	O
*	NN	O

2017-09-03	JJ	O
HYPOCHROM	NNP	B-TEST
-	:	O
2+	CD	O
ANISOCYT	NNP	B-TEST
-	:	O
1+	CD	O
MACROCYT	NNP	B-TEST
-	:	O
2+	CD	O

2017-09-03	JJ	O
NEUTS	NNP	B-TEST
-	:	O
79.5	CD	O
*	NN	O
LYMPHS	NNP	B-TEST
-	:	O
9.9	CD	O
*	JJ	O
MONOS	NNP	B-TEST
-	:	O
4.9	CD	O
EOS	NNP	B-TEST
-	:	O
5.4	CD	O
*	NN	O
BASOS	NNP	B-TEST
-	:	O
0.2	CD	O

2017-09-03	JJ	O
WBC	NNP	B-TEST
-	:	O
9.1	CD	O
RBC	NNP	B-TEST
-	:	O
2.77	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
8.8	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
27.2	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
99	CD	O
*	NN	O
MCH	NNP	B-TEST
-	:	O
31.9	CD	O
MCHC	NNP	B-TEST
-	:	O
32.4	CD	O
RDW	NNP	B-TEST
-	:	O
18.0	CD	O
*	NN	O

2017-09-03	JJ	O
CK	NNP	B-TEST
-	:	I-TEST
MB	NNP	I-TEST
-	:	O
Not	RB	O
Done	NNP	O
proBNP	NN	B-TEST
-	:	O
2656	CD	O
*	NN	O

2017-09-03	JJ	O
CK	NNP	B-TEST
(	(	I-TEST
CPK	NNP	I-TEST
)-	CD	I-TEST
16	CD	O
*	NN	O

2017-09-03	JJ	O
GLUCOSE	NNP	B-TEST
-	:	O
206	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
28	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
1.8	CD	O
*	JJ	O
SODIUM	NNP	B-TEST
-	:	O
135	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.1	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
85	CD	O
*	JJ	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
42	CD	O
*	JJ	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
12	CD	O

2017-09-03	JJ	O
CK	NNP	B-TEST
-	:	I-TEST
MB	NNP	I-TEST
-	:	O
Not	RB	O
Done	NNP	O
cTropnT	VBD	B-TEST
-	:	O
0.22	CD	O
*	NN	O

2017-09-03	JJ	O
CK	NNP	B-TEST
(	(	I-TEST
CPK	NNP	I-TEST
)-	CD	I-TEST
38	CD	O

INR	NNP	B-TEST
3.5	CD	O
,	,	O
PT	NNP	B-TEST
32.5	CD	O
,	,	O
PTT	NNP	B-TEST
41	CD	O

1.	CD	O
CXR	NNP	B-TEST
(	(	I-TEST
PA/Lateral	NNP	I-TEST
)	)	I-TEST
2017-09-03	CD	O

Congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
bilateral	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
(	(	O
R	NNP	O
>	NNP	O
L	NNP	O
)	)	O
,	,	O
with	IN	O
possible	JJ	O
underlying	VBG	B-PROBLEM
consolidation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
RLL	NNP	I-PROBLEM
and	CC	O
to	TO	O
a	DT	O
lesser	JJR	O
degree	NN	O
the	DT	O
RML	NNP	O
and	CC	O
LLL	NNP	O
.	.	O

2.	CD	O
CXR	NNP	B-TEST
2017-09-04	JJ	O

Compared	VBN	O
to	TO	O
PA	NNP	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
chest	NN	I-TEST
of	IN	O
the	DT	O
prior	JJ	O
day	NN	O
.	.	O

Right-sided	JJ	B-TREATMENT
PICC	NNP	I-TREATMENT
line	NN	I-TREATMENT
with	IN	O
its	PRP$	O
tip	NN	O
in	IN	O
the	DT	O
distal	JJ	O
SVC	NNP	O
.	.	O

The	DT	O
heart	NN	O
is	VBZ	O
markedly	RB	B-PROBLEM
enlarged	VBN	I-PROBLEM
.	.	O

There	EX	O
remains	VBZ	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
small	JJ	I-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
not	RB	O
significantly	RB	O
changed	VBN	O
.	.	O

Patient	NN	O
remains	VBZ	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
though	IN	O
it	PRP	O
may	MD	O
be	VB	O
slightly	RB	O
improved	VBN	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
.	.	O

Underlying	VBG	B-PROBLEM
infectious	JJ	I-PROBLEM
consolidation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
not	RB	O
excluded	VBN	O
.	.	O

3.	CD	O
Echo	NNP	B-TEST
2017-09-04	JJ	O

The	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

LV	NNP	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
appears	VBZ	O
depressed	JJ	B-PROBLEM
.	.	O

Resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
inferior	JJ	B-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

Right	RB	O
ventricular	JJ	O
chamber	NN	O
size	NN	O
is	VBZ	O
normal	JJ	O
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
may	MD	O
be	VB	O
mildly	RB	B-PROBLEM
impaired	JJ	I-PROBLEM
.	.	O

The	DT	O
aortic	JJ	O
root	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

The	DT	O
ascending	VBG	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
bioprosthetic	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
.	.	O

The	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
prosthesis	NN	I-TREATMENT
leaflets	NNS	I-TREATMENT
appear	VBP	O
to	TO	O
move	VB	O
normally	RB	O
.	.	O

The	DT	O
transaortic	JJ	O
gradient	NN	O
is	VBZ	O
normal	JJ	O
for	IN	O
this	DT	B-TREATMENT
prosthesis	NN	I-TREATMENT
.	.	O

The	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
inflow	JJ	I-TEST
pattern	NN	I-TEST
suggests	VBZ	O
a	DT	B-PROBLEM
restrictive	JJ	I-PROBLEM
filling	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
,	,	O
with	IN	O
elevated	JJ	B-PROBLEM
left	VBD	I-PROBLEM
atrial	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
.	.	O

Transmitral	NNP	B-TEST
Doppler	NNP	I-TEST
and	CC	O
tissue	NN	B-TEST
velocity	NN	I-TEST
imaging	VBG	I-TEST
are	VBP	O
consistent	JJ	O
with	IN	O
Grade	NNP	B-PROBLEM
III/IV	NNP	I-PROBLEM
(	(	I-PROBLEM
severe	JJ	I-PROBLEM
)	)	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
diastolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

The	DT	O
tricuspid	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Compared	VBN	O
with	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
reviewed	VBN	O
)	)	O
of	IN	O
2017-08-14	JJ	O
,	,	O
ventricular	JJ	O
function	NN	O
is	VBZ	O
now	RB	O
similar.	JJ	O

EF	NNP	B-TEST
35-40%	CD	O
.	.	O

4.	CD	O
Echo	NNP	B-TEST
2017-09-14	JJ	O

The	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

Overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
cannot	NN	O
be	VB	O
reliably	RB	O
assessed	VBN	O
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

The	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Compared	VBN	O
with	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
reviewed	VBN	O
)	)	O
of	IN	O
2017-09-04	JJ	O
,	,	O
there	EX	O
is	VBZ	O
probably	RB	O
no	DT	O
significant	JJ	O
change	NN	O
.	.	O

All	DT	B-TEST
cultures	NNS	I-TEST
,	,	O
including	VBG	O
BCx	NNP	B-TEST
,	,	O
UCx	NNP	B-TEST
,	,	O
pleural	JJ	B-TEST
fluid	NN	I-TEST
culture	NN	I-TEST
,	,	O
and	CC	O
wound	JJ	B-TEST
culture	NN	I-TEST
have	VBP	O
been	VBN	O
negative	JJ	O
.	.	O

5.	CD	O
CT	NNP	B-TEST
Chest	NNP	I-TEST
2017-09-16	CD	O
:	:	O

1.	CD	O
Increasing	VBG	B-PROBLEM
large	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Scattered	NNP	B-PROBLEM
parenchymal	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
represent	NN	O
superimposed	VBN	B-PROBLEM
infection	NN	I-PROBLEM
vs	NN	O
atelectasis	NN	B-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
abscess	NN	B-PROBLEM
.	.	O

6.	CD	O
2017-09-28	JJ	O
Chest	NNP	B-TEST
X	NN	I-TEST
Ray	NNP	I-TEST
:	:	O

SINGLE	NNP	B-TEST
AP	NNP	I-TEST
VIEW	NNP	I-TEST
OF	IN	I-TEST
THE	NNP	I-TEST
CHEST	NNP	I-TEST
.	.	O

There	EX	O
has	VBZ	O
been	VBN	O
almost	RB	O
complete	JJ	O
resolution	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
has	VBZ	O
decreased	VBN	O
in	IN	O
size	NN	O
.	.	O

Mild	NNP	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

Right	RB	B-TREATMENT
PIC	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
ends	VBZ	O
in	IN	O
the	DT	O
lower	JJR	O
SVC	NNP	O
.	.	O

Patient	NNP	O
is	VBZ	O
post	JJ	O
median	JJ	B-TREATMENT
sternotomy	NN	I-TREATMENT
.	.	O

Almost	RB	O
complete	JJ	O
resolution	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

7.	CD	O
2017-09-29	JJ	O
CT	NNP	B-TEST
Head	NN	I-TEST
:	:	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
intraaxial	JJ	B-PROBLEM
or	CC	I-PROBLEM
extraaxial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
,	,	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
,	,	O
or	CC	O
acute	VB	B-PROBLEM
major	JJ	I-PROBLEM
or	CC	I-PROBLEM
minor	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

The	DT	O
ventricles	NNS	O
and	CC	O
sulci	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
prominent	JJ	I-PROBLEM
,	,	O
but	CC	O
stable	JJ	O
in	IN	O
size	NN	O
and	CC	O
appearance	NN	O
.	.	O

Again	RB	O
seen	VBN	O
are	VBP	O
subtle	JJ	B-PROBLEM
hypodensities	NNS	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
an	DT	O
indication	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
stable	JJ	O
.	.	O

Extensive	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
acute	NN	B-PROBLEM
or	CC	I-PROBLEM
chronic	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Stable	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
.	.	O

8.	CD	O
2017-09-30	JJ	O
EEG	NN	B-TEST
:	:	O

Abnormal	JJ	B-PROBLEM
EEG	NNP	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
moderately	RB	I-PROBLEM
slow	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
background	NN	I-PROBLEM
and	CC	O
occasional	JJ	O
bursts	NNS	O
of	IN	O
generalized	JJ	B-PROBLEM
slowing	NN	I-PROBLEM
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
a	DT	B-PROBLEM
widespread	JJ	I-PROBLEM
encephalopathic	JJ	I-PROBLEM
condition	NN	I-PROBLEM
affecting	VBG	O
both	DT	O
cortical	JJ	O
and	CC	O
subcortical	JJ	O
structures	NNS	O
.	.	O

Medications	NNS	B-TREATMENT
,	,	O
metabolic	JJ	B-PROBLEM
disturbances	NNS	I-PROBLEM
,	,	O
and	CC	O
infection	NN	B-PROBLEM
are	VBP	O
among	IN	O
the	DT	O
most	RBS	O
common	JJ	O
causes	NNS	O
.	.	O

No	DT	O
prominent	JJ	B-PROBLEM
focal	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
evident	JJ	O
,	,	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
epileptiform	NN	B-PROBLEM
features	VBZ	I-PROBLEM
.	.	O

The	DT	B-TEST
cardiac	JJ	I-TEST
monitor	NN	I-TEST
showed	VBD	O
occasional	JJ	B-PROBLEM
irregularities	NNS	I-PROBLEM
in	IN	O
a	DT	B-TREATMENT
PACED	NNP	I-TREATMENT
rhythm	NN	I-TREATMENT
.	.	O

70	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
h/o	JJ	O
CAD	NNP	B-PROBLEM
,	,	O
T2DM	NNP	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
and	CC	O
COPD	NNP	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
Juan	NNP	O
on	IN	O
2017-09-03	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
SOB	NNP	I-PROBLEM
x	$	O
5	CD	O
days	NNS	O
from	IN	O
Morton	NNP	O
Hospital	NNP	O
&	CC	O
Medical	NNP	O
Center	NNP	O
.	.	O

Pt.	NNP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
CCU	VB	O
on	IN	O
2017-09-03	JJ	O
,	,	O
transferred	VBN	O
to	TO	O
Pendleton	NNP	O
on	IN	O
2017-09-05	JJ	O
,	,	O
triggered	VBN	O
on	IN	O
2017-09-10	JJ	O
for	IN	O
hypotension	NN	B-PROBLEM
with	IN	O
BP	NNP	B-TEST
67/38	CD	O
and	CC	O
transferred	VBD	O
back	RB	O
to	TO	O
CCU	NNP	O
on	IN	O
2017-09-10	JJ	O
.	.	O

He	PRP	O
remained	VBD	O
fluid	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
swan	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

Pump	NN	B-TREATMENT

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
admitted	VBN	O
for	IN	O
likely	JJ	O
CHF	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
.	.	O

After	IN	O
several	JJ	O
days	NNS	O
,	,	O
he	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
triggered	VBD	O
for	IN	O
BPs	NNP	B-TEST
60s/30s	CD	O
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
IVF	NNP	B-TREATMENT
without	IN	O
an	DT	O
adequate	JJ	O
response	NN	O
in	IN	O
his	PRP$	B-TEST
pressures	NNS	I-TEST
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
CCU	NNP	O
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

He	PRP	O
diuresed	VBD	O
well	RB	O
on	IN	O
the	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
BP	NNP	I-TEST
was	VBD	O
supported	VBN	O
.	.	O

Gradually	RB	O
,	,	O
the	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
.	.	O

However	RB	O
,	,	O
he	PRP	O
still	RB	O
appeared	VBD	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
with	IN	O
minimal	JJ	O
improvement	NN	O
in	IN	O
his	PRP$	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
swan	NN	I-TEST
was	VBD	O
placed	VBN	O
for	IN	O
a	DT	O
more	RBR	O
accurate	JJ	O
picture	NN	O
of	IN	O
his	PRP$	O
volume	NN	O
status	NN	O
and	CC	O
he	PRP	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
by	IN	O
swan	JJ	B-TEST
numbers	NNS	I-TEST
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
PAD	NNP	I-PROBLEM
and	CC	O
elevated	VBD	B-PROBLEM
CVP	NNP	I-PROBLEM
without	IN	O
an	DT	B-TEST
obtainable	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
CO	NNP	I-PROBLEM
and	CC	O
low	JJ	B-PROBLEM
SVR	NNP	I-PROBLEM
suggestive	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
,	,	O
but	CC	O
he	PRP	O
never	RB	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
WBC	NNP	I-PROBLEM
and	CC	O
was	VBD	O
afebrile	NN	B-PROBLEM
during	IN	O
his	PRP$	O
entire	JJ	O
hospital	NN	O
admission	NN	O
with	IN	O
negative	JJ	O
blood	NN	B-TEST
,	,	I-TEST
urine	NN	I-TEST
,	,	I-TEST
wound	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
pleural	JJ	I-TEST
fluid	NN	I-TEST
cultures	NNS	I-TEST
.	.	O

The	DT	B-TREATMENT
Lasix	NNP	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
eventually	RB	O
changed	VBN	O
to	TO	O
IV	NNP	B-TREATMENT
Lasix	NNP	I-TREATMENT
boluses	NNS	I-TREATMENT
,	,	O
with	IN	O
a	DT	B-TREATMENT
net	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
of	IN	O
over	IN	O
36	CD	O
liters	NNS	O
for	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

He	PRP	O
was	VBD	O
then	RB	O
transitioned	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
for	IN	O
maintainence	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echo	NN	I-TEST
on	IN	O
2017-09-04	JJ	O
with	IN	O
the	DT	O
results	NNS	O
above	IN	O
in	IN	O
detail	NN	O
.	.	O

It	PRP	O
was	VBD	O
unchanged	JJ	O
in	IN	O
comparison	NN	O
to	TO	O
2017-08-14	JJ	O
with	IN	O
similar	JJ	O
ventricular	JJ	B-TEST
function	NN	I-TEST
and	CC	O
inferior	JJ	B-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
another	DT	B-TEST
echo	NN	I-TEST
on	IN	O
2017-09-14	JJ	O
with	IN	O
no	DT	O
new	JJ	O
changes	NNS	O
.	.	O

At	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
euvolemic	JJ	O
,	,	O
satting	VBG	O
well	RB	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
without	IN	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
dry	JJ	I-TEST
weight	NN	I-TEST
is	VBZ	O
70.4	CD	O
kg	NN	O
.	.	O

Ischemia	NN	B-PROBLEM

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
initial	JJ	I-PROBLEM
troponin	NN	I-PROBLEM
bump	NN	I-PROBLEM
on	IN	O
admission	NN	O
which	WDT	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
CHF	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
Aspirin	NNP	B-TREATMENT
,	,	O
Metoprolol	NNP	B-TREATMENT
and	CC	O
Lipitor	NNP	B-TREATMENT
with	IN	O
no	DT	O
further	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

Rhythm	NN	B-TEST

The	DT	O
patient	NN	O
is	VBZ	O
completely	RB	B-PROBLEM
pacer-dependent	JJ	I-PROBLEM
,	,	O
being	VBG	O
epicardially	RB	B-TREATMENT
paced	VBN	I-TREATMENT
at	IN	O
70	CD	O
.	.	O

He	PRP	O
is	VBZ	O
on	IN	O
Amiodarone	NNP	B-TREATMENT
for	IN	O
post-op	JJ	B-PROBLEM
afib	NN	I-PROBLEM
and	CC	O
this	DT	O
was	VBD	O
continued	VBN	O
this	DT	O
entire	JJ	O
admission	NN	O
.	.	O

His	PRP$	B-TEST
underlying	JJ	I-TEST
rhythm	NN	I-TEST
is	VBZ	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
;	:	O
it	PRP	O
was	VBD	O
unclear	JJ	O
whether	IN	O
he	PRP	O
had	VBD	O
previously	RB	O
been	VBN	O
cardioverted	VBN	O
.	.	O

Anti-coagulation	NN	B-TREATMENT
was	VBD	O
started	VBN	O
with	IN	O
Warfarin	NNP	B-TREATMENT
5	CD	O
mg	NN	O
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
2-3	JJ	O
and	CC	O
a	DT	O
plan	NN	O
for	IN	O
cardioversion	NN	B-TREATMENT
in	IN	O
6	CD	O
weeks	NNS	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
INR	NNP	I-TEST
became	VBD	O
supratherapeutic	JJ	B-PROBLEM
and	CC	O
Coumadin	NNP	B-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

His	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
transitioned	VBN	O
to	TO	O
2	CD	O
mg	NNS	O
and	CC	O
then	RB	O
1	CD	O
mg	NNS	O
.	.	O

His	PRP$	B-TEST
INR	NNP	I-TEST
continued	VBD	O
to	TO	O
flucuate	VB	O
.	.	O

His	PRP$	B-TEST
INR	NNP	I-TEST
will	MD	O
have	VB	O
to	TO	O
be	VB	O
monitored	VBN	O
closely	RB	O
unitl	JJ	O
his	PRP$	B-TEST
levels	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

His	PRP$	O
INR	NNP	B-TEST
goal	NN	O
is	VBZ	O
02-24	JJ	O
.	.	O

2#	CD	O
SOB	NNP	B-PROBLEM
on	IN	O
admission	NN	O
:	:	O

Likely	RB	O
due	JJ	O
to	TO	O
CHF	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
,	,	O
with	IN	O
diuresis	NN	B-TREATMENT
of	IN	O
over	IN	O
36	CD	O
L	NNP	O
during	IN	O
his	PRP$	O
admission	NN	O
.	.	O

He	PRP	O
had	VBD	O
4	CD	B-TREATMENT
surgeries	NNS	I-TREATMENT
(	(	O
3	CD	B-TREATMENT
cardiac	NN	I-TREATMENT
surgeries	NNS	I-TREATMENT
)	)	O
earlier	RBR	O
in	IN	O
the	DT	O
summer	NN	O
,	,	O
so	IN	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
he	PRP	O
required	VBD	O
copious	JJ	B-TREATMENT
IVF	NNP	I-TREATMENT
hydration	NN	I-TREATMENT
surrounding	VBG	O
these	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
which	WDT	O
may	MD	O
have	VB	O
been	VBN	O
the	DT	O
cause	NN	O
of	IN	O
his	PRP$	B-PROBLEM
massive	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

It	PRP	O
appears	VBZ	O
that	IN	O
his	PRP$	O
diet	NN	O
was	VBD	O
regulated	VBN	O
at	IN	O
rehab	NN	O
but	CC	O
there	EX	O
is	VBZ	O
concern	NN	O
for	IN	O
medication	NN	B-PROBLEM
non-compliance	NN	I-PROBLEM
at	IN	O
rehab	NN	O
,	,	O
per	IN	O
previous	JJ	O
discharge	NN	O
summaries	NNS	O
.	.	O

On	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
standing	VBG	B-TREATMENT
diuretics	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
PRN	NNP	B-TREATMENT
nebs	NN	I-TREATMENT
and	CC	O
INH	NNP	B-TREATMENT
COPD	NNP	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

3#	CD	O
Metabolic	JJ	B-PROBLEM
Alkalosis	NNP	I-PROBLEM
/	NNP	O
Hypochloremia	NNP	B-PROBLEM
:	:	O

Etiology	NN	O
most	RBS	O
likely	JJ	O
a	DT	O
combination	NN	O
of	IN	O
contraction	NN	B-PROBLEM
alkalosis	NN	I-PROBLEM
and	CC	O
/	NN	O
or	CC	O
post-hypercapnia	NN	B-PROBLEM
.	.	O

This	DT	O
acutely	RB	O
worsened	VBN	O
on	IN	O
2017-09-18	JJ	O
,	,	O
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
an	DT	B-TEST
ABG	NNP	I-TEST
revealed	VBD	O
a	DT	B-TEST
CO2	NNP	I-TEST
of	IN	O
over	IN	O
100	CD	O
,	,	O
likley	NN	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
depressed	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
drive	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
sedatives	VB	B-TREATMENT
given	VBN	O
for	IN	O
agitation	NN	B-PROBLEM
on	IN	O
top	NN	O
of	IN	O
a	DT	B-PROBLEM
preexisting	JJ	I-PROBLEM
alkalosis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
therefore	RB	O
intubated	JJ	B-TREATMENT
for	IN	O
ventilation	NN	B-TREATMENT
,	,	O
and	CC	O
continued	VBD	O
to	TO	O
be	VB	O
diuresed	VBN	O
.	.	O

His	PRP$	B-TEST
CO2	NNP	I-TEST
improved	NN	O
and	CC	O
he	PRP	O
was	VBD	O
extubated	VBN	B-TREATMENT
after	IN	O
a	DT	O
few	JJ	O
days	NNS	O
.	.	O

All	DT	B-TREATMENT
sedating	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
and	CC	O
serial	JJ	B-TEST
ABGs	NNP	I-TEST
were	VBD	O
trended	VBN	O
to	TO	O
follow	VB	O
the	DT	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
metabolic	JJ	I-PROBLEM
alkalosis	NN	I-PROBLEM
.	.	O

4#	CD	O
Pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
:	:	O
s/p	NN	B-TREATMENT
right	JJ	I-TREATMENT
thoracentesis	NN	I-TREATMENT
on	IN	O
2017-09-06	CD	O
,	,	O
1600	CD	O
mL	NN	O
of	IN	O
serosanguinous	JJ	B-PROBLEM
fluid	NNS	I-PROBLEM
removed	VBN	O
from	IN	O
right	JJ	O
pleural	JJ	O
space	NN	O
.	.	O

Gram	NNP	B-TEST
stain	NN	I-TEST
and	CC	O
cultures	NNS	B-TEST
were	VBD	O
negative	JJ	O
,	,	O
cytology	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

The	DT	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
slowly	RB	O
re-accumulated	JJ	O
after	IN	O
tap	NN	B-TREATMENT
but	CC	O
resolved	VBD	O
after	IN	O
continued	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
.	.	O

Repeat	NN	B-TEST
CXR	NNP	I-TEST
showed	VBD	O
improvement	NN	O
of	IN	O
the	DT	B-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
on	IN	O
discharge	NN	O
he	PRP	O
had	VBD	O
been	VBN	O
breathing	VBG	O
well	RB	O
on	IN	O
room	NN	O
air	NN	O
without	IN	O
complications	NNS	B-PROBLEM

5#	CD	O
T2DM	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Glargine	NNP	B-TREATMENT
for	IN	O
tighter	JJR	O
glycemic	JJ	O
control	NN	O
and	CC	O
was	VBD	O
covered	VBN	O
with	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
monitored	VBN	O
with	IN	O
QID	NNP	B-TEST
fingersticks	NNS	I-TEST
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
were	VBD	O
in	IN	O
the	DT	O
100s	CD	O
on	IN	O
discharge	NN	O
.	.	O

6#	CD	O
Hyperlipidemia	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
statin	NN	I-TREATMENT
.	.	O

7#	CD	O
COPD	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
nebs	NNS	B-TREATMENT

8#	CD	O
MS	NNP	B-PROBLEM
changes	NNS	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
baseline	NN	B-PROBLEM
dementia	NN	I-PROBLEM
which	WDT	O
was	VBD	O
confounded	VBN	O
by	IN	O
delerium	NN	B-PROBLEM
in	IN	O
the	DT	O
face	NN	O
of	IN	O
metabolic	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

Neurology	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
and	CC	O
a	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
showed	VBD	O
old	JJ	B-PROBLEM
lacunar	JJ	I-PROBLEM
infarcts	NNS	I-PROBLEM
but	CC	O
no	DT	O
acute	JJ	O
causes	NNS	O
for	IN	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

An	DT	B-TEST
EEG	NNP	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
encephalopathy	JJ	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
other	JJ	O
findings	NNS	O
.	.	O

His	PRP$	O
mental	JJ	O
status	NN	O
did	VBD	O
clear	JJ	O
somewhat	RB	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
standing	VBG	B-TREATMENT
lactulose	NN	I-TREATMENT
;	:	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

9#	CD	O
Hypothyroidism	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	O
outpatient	NN	O
dose	NN	O
of	IN	O
Levothyroxine	NNP	B-TREATMENT
.	.	O

10#	CD	O
?	.	O
UTI	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
at	IN	O
Newton-Wellesley	NNP	O
Hospital	NNP	O
for	IN	O
a	DT	O
question	NN	O
of	IN	O
UTI	NNP	B-PROBLEM
based	VBN	O
on	IN	O
U/A	NNP	B-TEST
positive	JJ	O
for	IN	O
WBC	NNP	B-TEST
.	.	O

UCx	NN	B-TEST
during	IN	O
this	DT	O
hospitalization	NN	O
were	VBD	O
negative	JJ	O
and	CC	O
Levofloxacin	NNP	B-TREATMENT
was	VBD	O
d/c	JJ	O
'd	MD	O
.	.	O

11#	CD	O
Chronic	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
Lidocaine	NNP	I-TREATMENT
patch	NN	I-TREATMENT
and	CC	O
Percocet	NNP	B-TREATMENT
prn	NN	O
.	.	O

Stronger	JJR	B-TREATMENT
narcotics	NNS	I-TREATMENT
were	VBD	O
avoided	VBN	O
given	VBN	O
somnolence	NN	B-PROBLEM
and	CC	O
MS	NNP	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

12#	CD	O
Wound	NNP	B-TREATMENT
Care	NNP	I-TREATMENT
:	:	O

The	DT	O
patient	NN	O
has	VBZ	O
left	VBN	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
gluteal	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

For	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
gluteal	NN	I-PROBLEM
pressure	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
they	PRP	O
recommended	VBD	O
gentle	JJ	B-TREATMENT
cleansing	VBG	I-TREATMENT
with	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
or	CC	O
commercial	JJ	B-TREATMENT
wound	NN	I-TREATMENT
cleaner	JJR	I-TREATMENT
,	,	O
thin	JJ	O
layer	NN	O
of	IN	O
Duoderm	NNP	B-TREATMENT
gel	NN	I-TREATMENT
,	,	O
air	NN	O
dry	JJ	O
,	,	O
allevyn	JJ	B-TREATMENT
foam	NN	I-TREATMENT
adhesive	NN	I-TREATMENT
over	IN	O
the	DT	O
site	NN	O
,	,	O
and	CC	O
change	NN	O
every	DT	O
2	CD	O
days	NNS	O
or	CC	O
prn	NN	O
.	.	O

For	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
they	PRP	O
recommended	VBD	O
cleansing	VBG	O
with	IN	O
commercial	JJ	B-TREATMENT
wound	NN	I-TREATMENT
cleanser	NN	I-TREATMENT
,	,	O
pat	NN	O
dry	NN	O
,	,	O
pack	NN	B-TREATMENT
aquacel	NN	I-TREATMENT
AG	NNP	I-TREATMENT
rope	NN	I-TREATMENT
and	CC	O
moisten	NN	O
with	IN	O
saline	NN	B-TREATMENT
,	,	O
cover	NN	O
with	IN	O
dry	JJ	B-TREATMENT
gauze	NN	I-TREATMENT
and	CC	O
change	NN	O
daily	RB	O
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
finsateride	NN	B-TREATMENT
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

Until	IN	O
then	RB	O
,	,	O
his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
should	MD	O
remain	VB	O
in	IN	O
place	NN	O
.	.	O

Levothyroxine	NNP	B-TREATMENT
100	CD	O
mcg	NN	O
PO	NNP	O
daily	RB	O

Duloxetine	NNP	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O

Ondansetron	NNP	B-TREATMENT
PRN	NNP	O

Percocet	NNP	B-TREATMENT
1	CD	O
tab	NN	O
PRN	NNP	O

Senna	NNP	B-TREATMENT
PRN	NNP	O

Colace	NNP	B-TREATMENT
PRN	NNP	O

Lasix	NNP	B-TREATMENT
80	CD	O
mg	NN	O
PO	NNP	O
BID	NNP	O

Lactulose	NNP	B-TREATMENT
PRN	NNP	O

Lidocaine	NNP	B-TREATMENT
patch	NN	I-TREATMENT

Nystatin	NNP	B-TREATMENT
powder	NN	I-TREATMENT

Gabapentin	NNP	B-TREATMENT
300	CD	O
mg	NN	O
PO	NNP	O
TID	NNP	O

Alb	NNP	B-TREATMENT
nebs	NN	I-TREATMENT

Fluticasone	CD	B-TREATMENT
/	CD	O
Salmeterol	NN	B-TREATMENT

Tiotropium	NN	B-TREATMENT
Bromide	NNP	I-TREATMENT

Spironolactone	CD	B-TREATMENT
25	CD	O
mg	NNS	O
PO	NNP	O
daily	RB	O

Epoetin	JJ	B-TREATMENT
4000	CD	O
units	NNS	O
MWF	NNP	O

RISS	NN	B-TREATMENT

Amiodarone	RB	B-TREATMENT
200	CD	O
mg	NNS	O
PO	NNP	O
daily	RB	O

Calcium	NNP	B-TREATMENT
Acetate	NNP	I-TREATMENT
667	CD	O
mg	NN	O
PO	NNP	O
TID	NNP	O

SubQ	NNP	B-TREATMENT
Heparin	NNP	I-TREATMENT

Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
PO	NNP	O
daily	RB	O

Simvastatin	NNP	B-TREATMENT
40	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O

ASA	$	B-TREATMENT
81	CD	O
mg	JJ	O
PO	NNP	O
daily	NN	O

MVI	NN	B-TREATMENT

Tylenol	NNP	B-TREATMENT
PRN	NNP	O

1.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
Constipation	NNP	B-PROBLEM
.	.	O

2.	CD	O
Levothyroxine	NNP	B-TREATMENT
100	CD	O
mcg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

3.	CD	O
Duloxetine	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Capsule	NNP	O
,	,	O
Delayed	NNP	O
Release(	NNP	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
QHS	NNP	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
)	)	O
.	.	O

4.	CD	O
Lactulose	JJ	B-TREATMENT
10	CD	O
g	NN	O
/	VBD	O
15	CD	O
mL	NN	O
Syrup	NNP	O
Sig	NNP	O
:	:	O
Thirty	NNP	O
(	(	O
30	CD	O
)	)	O
ML	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
Fluticasone	NNP	B-TREATMENT
-	:	O
Salmeterol	NNP	B-TREATMENT
100-50	JJ	O
mcg	NN	O
/	NNP	O
Dose	NNP	O
Disk	NNP	O
with	IN	O
Device	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Disk	NN	O
with	IN	O
Device	NNP	O
Inhalation	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
Tiotropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
18	CD	O
mcg	NN	O
Capsule	NNP	O
,	,	O
w/	JJ	O
Inhalation	NNP	B-TREATMENT
Device	NNP	I-TREATMENT
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Cap	NNP	O
Inhalation	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

7.	CD	O
Amiodarone	$	B-TREATMENT
200	CD	O
mg	JJ	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

8.	CD	O
Calcium	NNP	B-TREATMENT
Acetate	NNP	I-TREATMENT
667	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
TID	NNP	O
W/MEALS	NNP	O
(	(	O
3	CD	O
TIMES	NNP	O
A	NNP	O
DAY	NNP	O
WITH	NNP	O
MEALS	NNP	O
)	)	O
.	.	O

9.	CD	O
Oxycodone	NNP	B-TREATMENT
-	:	O
Acetaminophen	NNP	B-TREATMENT
5-325	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

10.	CD	O
Multivitamin	NNP	B-TREATMENT
Capsule	NNP	I-TREATMENT
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Cap	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

11.	CD	O
Miconazole	NNP	B-TREATMENT
Nitrate	NNP	I-TREATMENT
2	CD	O
%	NN	O
Powder	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

13.	CD	O
Simvastatin	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
QHS	NNP	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
)	)	O
.	.	O

14.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

15.	CD	O
Lidocaine	NNP	B-TREATMENT
5	CD	O
%(	VBD	O
700	CD	O
mg	NN	O
/	NNP	O
patch	NN	O
)	)	O
Adhesive	NNP	O
Patch	NNP	O
,	,	O
Medicated	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Adhesive	NNP	O
Patch	NNP	O
,	,	O
Medicated	NNP	O
Topical	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

16.	CD	O
Furosemide	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

17.	CD	O
Ferrous	JJ	B-TREATMENT
Sulfate	NNP	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

18.	CD	O
Epoetin	NNP	B-TREATMENT
Alfa	NNP	I-TREATMENT
4,000	CD	O
unit/mL	JJ	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Injection	NN	O
QMOWEFR	NNP	O
(	(	O
Monday	NNP	O
-	:	O
Wednesday	NNP	O
-	:	O
Friday	NNP	O
)	)	O
.	.	O

19.	CD	O
Spironolactone	CD	B-TREATMENT
25	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

20.	CD	O
Albuterol	NNP	B-TREATMENT
90	CD	O
mcg/Actuation	NN	O
Aerosol	NNP	O
Sig	NNP	O
:	:	O
4-6	JJ	O
Puffs	NNP	O
Inhalation	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
.	.	O

21.	CD	O
Metoprolol	NNP	B-TREATMENT
Succinate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sustained	NNP	O
Release	NNP	O
24HR	CD	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
Sustained	VBD	O
Release	NNP	O
24HR	CD	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

22.	CD	O
Finasteride	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

23.	CD	O
Gabapentin	NNP	B-TREATMENT
300	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

24.	CD	O
Warfarin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
PO	NNP	O
at	IN	O
bedtime	NN	O
:	:	O
Please	NNP	O
monitor	VB	O
INR	NNP	B-TEST
with	IN	O
goal	NN	O
02-24	NN	O
.	.	O

Congestive	JJ	B-PROBLEM
Heart	NNP	I-PROBLEM
Failure	NNP	I-PROBLEM
exacerbation	NN	I-PROBLEM

Coronary	JJ	B-PROBLEM
Artery	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM

Hypertension	NN	B-PROBLEM

Type	$	B-PROBLEM
2	CD	I-PROBLEM
Diabetes	NNP	I-PROBLEM
Mellitus	NNP	I-PROBLEM

Chronic	NNP	B-PROBLEM
Obstructive	NNP	I-PROBLEM
Pulmonary	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
hemodynamicallly	RB	O
stable	JJ	O
,	,	O
afebrile	JJ	B-PROBLEM
with	IN	O
appropriate	JJ	O
follow	VBP	O
up	RP	O
.	.	O

During	IN	O
this	DT	O
admission	NN	O
you	PRP	O
have	VBP	O
been	VBN	O
treated	VBN	O
for	IN	O
a	DT	B-PROBLEM
CHF	NNP	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

1.	CD	O
Please	NNP	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

3.	CD	O
Please	NNP	O
call	VB	O
your	PRP$	O
PCP	NNP	O
C.	NNP	O
Lettinga	NNP	O
or	CC	O
seek	VB	O
medical	JJ	O
attention	NN	O
in	IN	O
the	DT	O
Juan	NNP	O
if	IN	O
you	PRP	O
experience	VBP	O
worsening	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
passing	VBG	B-PROBLEM
out	RP	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptom	NN	I-PROBLEM
.	.	O

MEDICINE	NN	B-TREATMENT

Sulfonamides	NNS	B-TREATMENT

Transfer	NN	O
from	IN	O
Athol	NNP	O
Memorial	NNP	O
Hospital	NNP	O
for	IN	O
acute	NN	O
on	IN	O
chronic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Lumbar	NNP	B-TEST
puncture	NN	I-TEST
on	IN	O
08-16	NN	O

Mr.	NNP	O
Lockley	NNP	O
is	VBZ	O
a	DT	O
73	CD	O
yo	NN	O
male	NN	O
with	IN	O
a	DT	O
complicated	VBN	O
past	JJ	O
medical	JJ	O
history	NN	O
,	,	O
recently	RB	O
discharged	VBN	O
from	IN	O
St.	NNP	O
Margaret	NNP	O
's	POS	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
on	IN	O
08-02	NNP	O
following	VBG	O
a	DT	O
prolonged	JJ	O
admission	NN	O
for	IN	O
STEMI	NNP	B-PROBLEM
,	,	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
felt	VBD	O
secondary	JJ	O
to	TO	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
requiring	VBG	O
intubation	NN	O
and	CC	O
subsequent	JJ	B-TREATMENT
tracheostomy	NN	I-TREATMENT
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM
,	,	O
sepsis	NN	B-PROBLEM
and	CC	O
C.difficile	NNP	B-PROBLEM
colitis	NN	I-PROBLEM
treated	VBD	O
with	IN	O
Vancomycin	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
with	IN	O
a	DT	O
course	NN	O
of	IN	O
Levophed	NNP	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
Athol	NNP	O
Memorial	NNP	O
Hospital	NNP	O
for	IN	O
continued	JJ	B-TREATMENT
weaning	NN	I-TREATMENT
.	.	O

Per	NNP	O
Dr.	NNP	O
John	NNP	O
C.	NNP	O
Corrigan	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
,	,	O
patient	NN	O
remained	VBD	O
ventilator	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
,	,	O
intermittently	RB	O
on	IN	O
PS	NNP	B-TREATMENT
20/5	CD	O
and	CC	O
back	RB	O
on	IN	O
AC	NNP	B-TREATMENT
15/5/500/0.35	CD	O
on	IN	O
08-08	NN	O
.	.	O

At	IN	O
OSH	NNP	O
,	,	O
sputum	NN	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
Pseudomonas	NNP	B-PROBLEM
and	CC	O
MRSA	NNP	B-PROBLEM
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
Zosyn	NNP	B-TREATMENT
(	(	O
08-08	JJ	O
)	)	O
and	CC	O
Vancomycin	NNP	B-TREATMENT
(	(	O
08-09	CD	O
).	NN	O

He	PRP	O
completed	VBD	O
his	PRP$	O
course	NN	O
of	IN	O
Vancomycin	NNP	B-TREATMENT
on	IN	O
2017-08-10	JJ	O
.	.	O

However	RB	O
,	,	O
today	NN	O
around	IN	O
17:45	CD	O
,	,	O
while	IN	O
being	VBG	O
moved	VBN	O
by	IN	O
the	DT	O
nursing	NN	O
staff	NN	O
,	,	O
Mr.	NNP	O
Lockley	NNP	O
Bosche	NNP	O
started	VBD	O
coughing	VBG	B-PROBLEM
.	.	O

He	PRP	O
then	RB	O
became	VBD	O
dusky	JJ	B-PROBLEM
and	CC	O
cyanotic	JJ	B-PROBLEM
,	,	O
and	CC	O
stopped	VBD	B-PROBLEM
breathing	VBG	I-PROBLEM
on	IN	O
his	PRP$	O
own	JJ	O
.	.	O

A	DT	O
code	NN	O
was	VBD	O
called	VBN	O
,	,	O
+	NNP	O
pulse	NN	B-TEST
.	.	O

Patient	NN	O
placed	VBN	O
on	IN	O
FiO2	NNP	B-TREATMENT
100%	CD	O
.	.	O

Vitals	NNS	B-TEST
reportedly	RB	O
HR	NNP	B-TEST
88-98	CD	O
,	,	O
BP	NNP	B-TEST
150/80	CD	O
.	.	O

ABG	NNP	B-TEST
done	VBN	O
on	IN	O
FiO2	NNP	B-TREATMENT
100%	CD	O
7.36/66/417/98%	CD	O
.	.	O

At	IN	O
Vencor	NNP	O
Hospital	NNP	O
,	,	O
BP	NNP	B-PROBLEM
dropped	VBD	I-PROBLEM
to	TO	O
90	CD	O
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
NS	NNP	B-TREATMENT
IVF	NNP	I-TREATMENT
,	,	O
with	IN	O
improvement	NN	O
in	IN	O
BP	NNP	B-TEST
.	.	O

EKG	NN	B-TEST
without	IN	O
acute	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
St.	NNP	O
Margaret	NNP	O
's	POS	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
John	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
on	IN	O
AC	NNP	B-TEST
,	,	O
RR	NNP	B-TEST
15	CD	O
,	,	O
PEEP	NNP	B-TEST
5	CD	O
,	,	O
Vt	NNP	B-TEST
500	CD	O
,	,	O
Fi02	NNP	B-TEST
1.0	CD	O
.	.	O

In	IN	O
John	NNP	O
,	,	O
BP	NNP	B-TEST
80/60	CD	O
,	,	O
HR	NNP	B-TEST
80	CD	O
.	.	O

Continued	VBN	O
on	IN	O
IVF	NNP	B-TREATMENT
(	(	O
received	VBN	O
total	JJ	O
2300	CD	O
cc	NN	O
)	)	O
,	,	O
with	IN	O
improved	JJ	O
BP	NNP	B-TEST
to	TO	O
SBP	NNP	B-TEST
105-118	CD	O
.	.	O

Stool	NNP	B-TEST
sent	VBD	O
for	IN	O
C.diff	NNP	B-PROBLEM
and	CC	O
given	VBN	O
Flagyl	NNP	B-TREATMENT
500	CD	O
mg	NN	O
PO	NNP	O
X	NNP	O
1	CD	O
dose	NN	O
.	.	O

1.	CD	O
Non-small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
s/p	NN	B-TREATMENT
XRT	NNP	I-TREATMENT
and	CC	O
chemotherapy	NN	B-TREATMENT
in	IN	O
French	JJ	O
Guiana	NNP	O
,	,	O
s/p	RB	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
in	IN	O
2016-09-21	JJ	O
for	IN	O
recurrence	NN	B-PROBLEM
.	.	O

Chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2.	CD	O
SSS	NNP	B-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
PM/ICD	NNP	I-TREATMENT
placement	NN	I-TREATMENT

3.	CD	O
COPD/bronchiectasis	NN	B-PROBLEM

4.	CD	O
Hypertension	NN	B-PROBLEM

5.	CD	O
CAD	NNP	B-PROBLEM
,	,	O
with	IN	O
known	VBN	O
TO	NNP	O
RCA	NNP	O
.	.	O

6.	CD	O
CHF	NNP	B-PROBLEM
with	IN	O
EF	NNP	B-TEST
25%	CD	O
on	IN	O
last	JJ	B-TEST
echo	NN	I-TEST
on	IN	O
2017-07-19	JJ	O

7.	CD	O
BPH	NNP	B-PROBLEM

8.	CD	O
Depression	NN	B-PROBLEM

9.	CD	O
Left	NNP	B-PROBLEM
femoral	JJ	I-PROBLEM
AV	NNP	I-PROBLEM
fistula	NN	I-PROBLEM
2017-04-19	JJ	O

10.	CD	O
Recent	JJ	B-PROBLEM
MRSA	NNP	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
sepsis	NN	B-PROBLEM
2017-07-21	JJ	O
,	,	O
treated	VBN	O
with	IN	O
Vancomycin	NNP	B-TREATMENT

11.	CD	O
C.	NNP	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
Flagyl	NNP	B-TREATMENT
(	(	O
completed	VBN	O
08-10	NN	O
)	)	O

12.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
PEG	NNP	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
2017-07-21	JJ	O

13.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
tracheostomy	NN	I-TREATMENT
2017-07-21	JJ	O
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM

14.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
partial	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
1972	CD	O

Opens	NNS	O
eyes	NNS	O
spontaneously	RB	O
,	,	O
withdraws	NNS	O
to	TO	O
painful	JJ	B-TEST
stimulus	NN	I-TEST
.	.	O

BP	NNP	B-TEST
90s-118/47-59	CD	O
,	,	O
HR	NNP	B-TEST
80-90s	CD	O
.	.	O

AC	NNP	B-TEST
,	,	O
RR	NNP	B-TEST
15	CD	O
,	,	O
PEEP	NNP	B-TEST
5	CD	O
,	,	O
Vt	NNP	B-TEST
500	CD	O
cc	NN	O
,	,	O
FiO2	NNP	B-TEST
1.0	CD	O
.	.	O

Intubated	VBN	B-TREATMENT
,	,	O
opens	VBZ	O
eyes	NNS	O
,	,	O
responds	VBZ	O
to	TO	O
painful	JJ	B-TEST
stimulus	NN	I-TEST
.	.	O

Pupils	NNS	B-PROBLEM
minimally	RB	I-PROBLEM
reactive	VBP	I-PROBLEM
.	.	O

Sclera	NNP	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

Unable	JJ	O
to	TO	O
assess	VB	O
JVP	NNP	B-TEST
.	.	O

Bronchial	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
over	IN	I-PROBLEM
right	JJ	I-PROBLEM
hemithorax	NN	I-PROBLEM
.	.	O

Ronchorous	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

Limited	JJ	B-TEST
examination	NN	I-TEST
.	.	O

+	JJ	O
S4	NNP	B-PROBLEM
.	.	O

No	DT	O
murmur	NN	B-PROBLEM
appreciated	VBD	O
.	.	O

PEG	NNP	B-TREATMENT
in	IN	O
place	NN	O
,	,	O
site	NN	O
without	IN	O
drainage	NN	B-PROBLEM
.	.	O

BS	NNP	O
present	NN	O
,	,	O
hypoactive	NN	B-PROBLEM
.	.	O

No	DT	O
grimacing	VBG	B-PROBLEM
with	IN	O
palpation	NN	B-TEST
.	.	O

Foley	NNP	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

2+	CD	B-PROBLEM
edema	JJ	I-PROBLEM
both	DT	I-PROBLEM
upper	JJ	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
sacral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Cool	JJ	B-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

Limited	JJ	B-TEST
examination	NN	I-TEST
.	.	O

Withdraws	NNP	O
to	TO	O
painful	VB	B-TEST
stimulus	NN	I-TEST
.	.	O

WBC	NNP	B-TEST
-	:	O
4.9	CD	O
RBC	NNP	B-TEST
-	:	O
2.92	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
8.8	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
26.2	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
90	CD	O
MCH	NNP	B-TEST
-	:	O
30.1	CD	O
MCHC	NNP	B-TEST
-	:	O
33.5	CD	O
RDW	NNP	B-TEST
-	:	O
18.5	CD	O
*	NN	O
NEUTS	NNP	B-TEST
-	:	O
86.5	CD	O
*	NN	O
LYMPHS	NNP	B-TEST
-	:	O
7.5	CD	O
*	JJ	O
MONOS	NNP	B-TEST
-	:	O
4.7	CD	O
EOS	NNP	B-TEST
-	:	O
1.2	CD	O
BASOS	NNP	B-TEST
-	:	O
0.1	CD	O
PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
145	CD	O
*	NN	O
GLUCOSE	NNP	B-TEST
-	:	O
91	CD	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
21	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
0.6	CD	O
SODIUM	NNP	B-TEST
-	:	O
143	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.2	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
106	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
32	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
9	CD	O
LACTATE	NNP	B-TEST
-	:	O
1.4	CD	O
K+	NNP	B-TEST
-	:	O
3.9	CD	O

ABG	NN	B-TEST
:	:	O

2017-08-14	JJ	O
07:30	CD	O
PM	NNP	O
TYPE	NNP	O
-	:	O
ART	NNP	B-TEST
PO2	NNP	I-TEST
-	:	O
468	CD	O
*	NN	O
PCO2	NNP	B-TEST
-	:	O
44	CD	O
PH	NNP	B-TEST
-	:	O
7.50	CD	O
*	JJ	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
36	CD	O
*	JJ	O
BASE	NNP	B-TEST
XS	NNP	I-TEST
-	:	O
10	CD	O
INTUBATED	NNP	B-TREATMENT
-	:	O
INTUBATED	NN	B-TREATMENT

EKG	NNP	B-TEST
(	(	O
at	IN	O
Athol	NNP	O
Memorial	NNP	O
Hospital	NNP	O
,	,	O
17:11	CD	O
)	)	O
:	:	O

Atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
occasional	JJ	B-TREATMENT
V-paced	NNP	I-TREATMENT
,	,	O
rate	NN	B-TEST
74	CD	O
.	.	O

Old	NNP	B-PROBLEM
TWI	NNP	I-PROBLEM
V4-6	NNP	I-PROBLEM
.	.	O

EKG	NN	B-TEST
in	IN	O
John	NNP	O
:	:	O

Afib	NNP	B-PROBLEM
,	,	O
occasional	JJ	B-TREATMENT
V-paced	NNP	I-TREATMENT
,	,	O
rate	NN	B-TEST
83	CD	O
bpm	NN	O
.	.	O

Long	RB	B-PROBLEM
QT	NNP	I-PROBLEM
interval	NN	I-PROBLEM
(	(	O
QTc	NNP	B-TEST
462	CD	O
ms	NN	O
).	NN	O

ST	NNP	B-PROBLEM
depressions	NNS	I-PROBLEM
V4	NNP	I-PROBLEM
,	,	I-PROBLEM
5	CD	I-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
ST	NNP	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
V3	NNP	I-PROBLEM
.	.	O

Old	NNP	B-PROBLEM
TWI	NNP	I-PROBLEM
V4-6	NNP	I-PROBLEM
.	.	O

2017-08-14	JJ	O
CXR	NN	B-TEST
:	:	O

ETT	NNP	B-TREATMENT
in	IN	O
correct	JJ	O
position	NN	O
.	.	O

PM	NNP	B-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
good	JJ	O
position	NN	O
.	.	O

S/p	NNP	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
.	.	O

Blunting	NN	B-PROBLEM
of	IN	I-PROBLEM
left	NN	I-PROBLEM
CPA	NNP	I-PROBLEM
likely	JJ	O
effusion	NN	B-PROBLEM
.	.	O

New	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
left	VBD	I-PROBLEM
lateral	JJ	I-PROBLEM
CW	NNP	I-PROBLEM
opacity	NN	I-PROBLEM
,	,	O
likely	RB	O
loculated	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

2017-07-19	JJ	O
ECHO	NN	B-TEST
:	:	O

Left-to-right	JJ	B-PROBLEM
shunt	NN	I-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
interatrial	JJ	I-PROBLEM
septum	NN	I-PROBLEM
.	.	O

LVEF	NNP	B-TEST
25%	CD	O
.	.	O

Resting	VBG	B-TEST
WMA	NNP	I-TEST
include	VBP	O
mid	NN	B-PROBLEM
to	TO	I-PROBLEM
distal	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
akinesis/hypokinesis	NN	I-PROBLEM
,	,	O
and	CC	O
mid	NN	B-PROBLEM
to	TO	I-PROBLEM
distal	JJ	I-PROBLEM
anterolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
/	JJ	O
akinesis	NN	B-PROBLEM
.	.	O

No	DT	O
definite	JJ	O
apical	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
seen	VBN	O
(	(	O
cannot	JJ	O
exclude	NN	O
).	NN	O

01-22+	JJ	O
AR	NNP	B-PROBLEM
.	.	O

Trivial	JJ	B-PROBLEM
MR	NNP	I-PROBLEM
.	.	O

1+	CD	O
TR	NNP	B-PROBLEM
.	.	O

2017-08-16	JJ	O
CT	NNP	B-TEST
head	NN	I-TEST
:	:	O

New	NNP	B-PROBLEM
rounded	VBD	I-PROBLEM
low-density	JJ	I-PROBLEM
area	NN	I-PROBLEM
measuring	VBG	O
2.5	CD	O
cm	NN	O
in	IN	O
left	JJ	O
basal	NN	O
ganglia	NNS	O
,	,	O
which	WDT	O
partially	RB	O
extends	VBZ	O
to	TO	O
the	DT	O
left	NN	O
thalamus	NN	O
,	,	O
probably	RB	O
representing	VBG	O
subacute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

On	IN	O
this	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
without	IN	O
contrast	NN	O
,	,	O
the	DT	B-TEST
evaluation	NN	I-TEST
is	VBZ	O
limited	VBN	O
.	.	O

2017-08-16	JJ	O
CTA	NNP	B-TEST
chest	NN	I-TEST
:	:	O

No	DT	O
evidence	NN	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

Findings	NNS	O
consistent	NN	O
with	IN	O
failure	NN	B-PROBLEM
or	CC	O
fluid	NN	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

Development	NNP	O
of	IN	O
small	JJ	B-PROBLEM
loculated	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
periphery	NN	I-PROBLEM
of	IN	O
the	DT	O
left	NN	O
major	JJ	O
fissure	NN	O
or	CC	O
so-called	JJ	B-PROBLEM
pseudotumor	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
the	DT	B-TEST
recent	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
.	.	O

Unchanged	VBN	O
appearance	NN	O
of	IN	O
right	JJ	B-TREATMENT
pneumonectomy	NN	I-TREATMENT
.	.	O

2017-08-16	JJ	O
ECHO	NN	B-TEST
:	:	O

Overall	JJ	B-TEST
LVEF	NNP	I-TEST
is	VBZ	O
difficult	JJ	O
to	TO	O
assess	VB	O
due	JJ	O
to	TO	O
poor	JJ	O
echo	JJ	B-TEST
windows	NNS	I-TEST
although	IN	O
the	DT	B-TEST
basal	NN	I-TEST
LV	NNP	I-TEST
appeas	RB	O
hyperdynamic	VBZ	B-PROBLEM
without	IN	O
regional	JJ	B-PROBLEM
contraction	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
(	(	O
suspect	JJ	O
significant	JJ	O
improvement	NN	O
compared	VBN	O
to	TO	O
prior	VB	B-TEST
study	NN	I-TEST
dated	VBN	O
2017-07-18	CD	O
).	NNS	O

No	DT	O
masses	NNS	B-PROBLEM
or	CC	O
thrombi	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
ventricle	NN	O
(	(	O
due	JJ	O
to	TO	O
poor	JJ	O
echo	JJ	B-TEST
windows	NNS	I-TEST
cannot	VBP	O
fully	RB	O
exclude	VBP	O
).	NNS	O

The	DT	O
ascending	VBG	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

Trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
inflow	JJ	I-TEST
pattern	NN	I-TEST
suggests	VBZ	O
impaired	JJ	B-PROBLEM
relaxation	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
no	DT	O
echocardiographic	JJ	B-TEST
signs	NNS	I-TEST
of	IN	O
tamponade	NN	B-PROBLEM

2017-08-17	JJ	O
EEG	NN	B-TEST
:	:	O

Markedly	RB	B-PROBLEM
abnormal	JJ	I-PROBLEM
portable	JJ	I-PROBLEM
EEG	NNS	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
voltage	NN	I-PROBLEM
suppression	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
hemisphere	NN	I-PROBLEM
and	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
bursts	NNS	I-PROBLEM
of	IN	I-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
and	CC	O
right	NN	B-PROBLEM
hemisphere	RB	I-PROBLEM
slowing	VBG	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
first	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
raises	VBZ	O
the	DT	O
possibility	NN	O
of	IN	O
material	NN	B-PROBLEM
(	(	I-PROBLEM
such	JJ	I-PROBLEM
as	IN	I-PROBLEM
subdural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
)	)	I-PROBLEM
interposed	VBD	I-PROBLEM
between	IN	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
and	CC	O
recording	VBG	O
electrodes	NNS	O
or	CC	O
widespread	JJ	B-PROBLEM
cortical	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
indicates	VBZ	O
a	DT	B-PROBLEM
non	NN	I-PROBLEM
specific	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
in	IN	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
also	RB	O
evidence	NN	O
of	IN	O
subcortical	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

No	DT	O
epileptiform	NN	B-PROBLEM
features	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
.	.	O

2017-08-17	JJ	O
STOOL	NNP	B-TEST
CLOSTRIDIUM	NNP	I-TEST
DIFFICILE	NNP	I-TEST
TOXIN	NNP	I-TEST
ASSAY	NNP	I-TEST
-	:	O
PENDING	NN	O

2017-08-16	JJ	O
CSF	NNP	O
;	:	O
SPINAL	NNP	B-TEST
FLUID	NNP	I-TEST
GRAM	NNP	I-TEST
STAIN	NNP	I-TEST
-	:	O
neg	NN	O
FLUID	NNP	B-TEST
CULTURE	NNP	I-TEST
-	:	O
neg	NN	O
;	:	O
FUNGAL	NNP	B-TEST
CULTURE	NNP	I-TEST
-	:	O
PENDING	NN	O
;	:	O
ACID	NNP	B-TEST
FAST	NNP	I-TEST
CULTURE	NNP	I-TEST
-	:	O
PENDING	NN	O
;	:	O
VIRAL	NNP	B-TEST
CULTURE	NNP	I-TEST
-	:	O
PENDING	NN	O

2017-08-15	JJ	O
SPUTUM	NNP	B-TEST
CULTURE	NNP	I-TEST
-	:	O
PRELIMINARY	NNP	O
{	(	O
PSEUDOMONAS	NNP	B-PROBLEM
AERUGINOSA	NNP	I-PROBLEM
}	)	O

2017-08-15	JJ	O
BLOOD	NNP	B-TEST
CULTURE	NNP	I-TEST
NGTD	NNP	O

2017-08-15	JJ	O
URINE	NNP	B-TEST
CULTURE	NNP	I-TEST
-	:	O
FINAL	NN	O

2017-08-15	JJ	O
BLOOD	NNP	B-TEST
CULTURE	NNP	I-TEST
NGTD	NNP	O

Mr.	NNP	O
Lockley	NNP	O
was	VBD	O
admitted	VBN	O
with	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
mucus	VB	B-PROBLEM
plugging	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
pseudomonal	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
the	DT	O
issue	NN	O
that	WDT	O
dominated	VBD	O
the	DT	O
admission	NN	O
was	VBD	O
his	PRP$	B-PROBLEM
recent	JJ	I-PROBLEM
acute	JJ	I-PROBLEM
decline	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
thoroughly	RB	O
evaluated	VBN	O
by	IN	O
neurology	NN	O
and	CC	O
underwent	JJ	O
head	NN	B-TEST
CT	NNP	I-TEST
,	,	O
MRI	NNP	B-TEST
,	,	O
LP	NNP	B-TEST
,	,	O
and	CC	O
EEG	NNP	B-TEST
.	.	O

This	DT	B-TEST
work-up	JJ	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
left	NN	I-PROBLEM
basal	NN	I-PROBLEM
ganglia	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
likely	JJ	O
cardioembolic	NN	B-PROBLEM
.	.	O

However	RB	O
,	,	O
they	PRP	O
felt	VBD	O
this	DT	O
event	NN	O
could	MD	O
not	RB	O
account	VB	O
for	IN	O
his	PRP$	B-PROBLEM
new	JJ	I-PROBLEM
,	,	I-PROBLEM
severe	JJ	I-PROBLEM
global	JJ	I-PROBLEM
deficit	NN	I-PROBLEM
;	:	O
this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
more	RBR	I-PROBLEM
pervasive	JJ	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
likely	RB	O
anoxic	JJ	B-PROBLEM
encephalopathy	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
the	DT	O
prognosis	NN	O
is	VBZ	O
extremely	RB	O
grim	JJ	O
.	.	O

The	DT	O
end	NN	O
result	NN	O
of	IN	O
these	DT	O
discussion	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
's	POS	O
wishes	NNS	O
would	MD	O
not	RB	O
be	VB	O
consistent	JJ	O
with	IN	O
this	DT	O
new	JJ	O
level	NN	O
of	IN	O
functioning	VBG	O
from	IN	O
which	WDT	O
he	PRP	O
had	VBD	O
little	JJ	O
hope	NN	O
of	IN	O
recovery	NN	O
;	:	O
the	DT	O
family	NN	O
decided	VBD	O
to	TO	O
make	VB	O
him	PRP	O
comfort	VB	B-TREATMENT
measures	NNS	I-TREATMENT
only	RB	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
disconnected	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
beyond	IN	O
a	DT	B-TREATMENT
morphine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
were	VBD	O
stopped	VBN	O
,	,	O
and	CC	O
he	PRP	O
expired	VBD	O
shortly	RB	O
thereafter	RB	O
.	.	O

Jevity	NNP	B-TREATMENT
1.2	CD	O
65	CD	O
mL	NN	O
/	FW	O
hour	NN	O
continuous	JJ	O
with	IN	O
water	NN	O
240	CD	O
cc	NN	O
q	NN	O
8	CD	O
hours	NNS	O

Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
IV	NNP	O
QAM	NNP	O
(	(	O
given	VBN	O
08-14	NN	O
)	)	O

Vancomycin	NNP	B-TREATMENT
1	CD	O
gm	NN	O
IV	NNP	O
q	VBZ	O
36	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
at	IN	O
2000	CD	O
on	IN	O
08-13	NN	O
)	)	O
.	.	O

ASA	$	B-TREATMENT
325	CD	O
mg	NN	O
PO	NNP	O
QD	NNP	O

Lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
PO	NNP	O
QAM	NNP	O

Heparin	NNP	B-TREATMENT
5000	CD	O
units	NNS	O
SC	NNP	O
TID	NNP	O

Zosyn	$	B-TREATMENT
4.5	CD	O
gm	NN	O
IV	NNP	O
q	VBZ	O
8	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
on	IN	O
08-14	NN	O
at	IN	O
1400	CD	O
)	)	O
,	,	O
started	VBD	O
08-08	CD	O
.	.	O

Metoprolol	NNP	B-TREATMENT
37.5	CD	O
mg	NN	O
q	NN	O
12	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
07/25	CD	O
in	IN	O
AM	NNP	O
)	)	O

Protein	NNP	B-TREATMENT
/	NNP	I-TREATMENT
Soy	NNP	I-TREATMENT
supplement	VBD	I-TREATMENT
2	CD	O
scoops	NNS	O
q	RB	O
12	CD	O
hours	NNS	O

Ipratropium	NNP	B-TREATMENT
/	NNP	O
Albuterol	NNP	B-TREATMENT
inhaler	VBZ	I-TREATMENT
4	CD	O
puffs	NNS	O
QID	NNP	O

Completed	VBN	O
course	NN	O
of	IN	O
Flagyl	NNP	B-TREATMENT
07-25	JJ	O
-->	NNP	O
08-10	NN	O
.	.	O

Anoxic	NNP	B-PROBLEM
encephalopathy	NN	I-PROBLEM

Acute	NNP	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

Chronic	NNP	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

Pseudomonal	NNP	B-PROBLEM
pneumonia	NN	I-PROBLEM

Volume	NN	B-PROBLEM
overload	NN	I-PROBLEM

Chronic	NNP	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

Bronchiectasis	NN	B-PROBLEM

Hyponatremia	NN	B-PROBLEM

Anemia	NNP	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM

1.	CD	O
Non-small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
s/p	NN	B-TREATMENT
XRT	NNP	I-TREATMENT
and	CC	O
chemotherapy	NN	B-TREATMENT
in	IN	O
Western	JJ	O
Sahara	NNP	O
,	,	O
s/p	RB	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
in	IN	O
2016-09-21	JJ	O
for	IN	O
recurrence	NN	B-PROBLEM
.	.	O

Chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2.	CD	O
Sick	NNP	B-PROBLEM
Sinus	NNP	I-PROBLEM
Syndrome	NNP	I-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
PM/ICD	NNP	I-TREATMENT
placement	NN	I-TREATMENT

3.	CD	O
COPD/bronchiectasis	NN	B-PROBLEM

4.	CD	O
Hypertension	NN	B-PROBLEM

5.	CD	O
CAD	NNP	B-PROBLEM
,	,	O
with	IN	O
known	VBN	O
TO	NNP	O
RCA	NNP	O
.	.	O

6.	CD	O
CHF	NNP	B-PROBLEM
with	IN	O
EF	NNP	B-TEST
25%	CD	O
on	IN	O
last	JJ	B-TEST
echo	NN	I-TEST
on	IN	O
2017-07-19	JJ	O

7.	CD	O
BPH	NNP	B-PROBLEM

8.	CD	O
Depression	NN	B-PROBLEM

9.	CD	O
Left	NNP	B-PROBLEM
femoral	JJ	I-PROBLEM
AV	NNP	I-PROBLEM
fistula	NN	I-PROBLEM
2017-04-19	JJ	O

10.	CD	O
Recent	JJ	B-PROBLEM
MRSA	NNP	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
sepsis	NN	B-PROBLEM
2017-07-21	JJ	O
,	,	O
treated	VBN	O
with	IN	O
Vancomycin	NNP	B-TREATMENT

11.	CD	O
C.	NNP	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
Flagyl	NNP	B-TREATMENT
(	(	O
completed	VBN	O
08-10	NN	O
)	)	O

12.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
PEG	NNP	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
2017-07-21	JJ	O

13.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
tracheostomy	NN	I-TREATMENT
2017-07-21	JJ	O
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM

14.	CD	O
Status	NNP	B-TREATMENT
post	NN	I-TREATMENT
partial	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
1972	CD	O

MEDICINE	NN	B-TREATMENT

Losartan	NNP	B-TREATMENT
/	NNP	O
Aspirin	NNP	B-TREATMENT
/	NNP	O
Lisinopril-Hctz	NNP	B-TREATMENT

Chief	JJ	O
Complaint	NN	O
:	:	O
fever	NN	B-PROBLEM

Intubation	NN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
tunneled	VBD	B-TREATMENT
line	NN	I-TREATMENT
change	NN	I-TREATMENT
over	IN	I-TREATMENT
wire	NN	I-TREATMENT
2019-01-08	JJ	O

69	CD	O
y/o	JJ	O
female	NN	O
wtih	NN	O
PMH	NNP	O
significant	JJ	O
for	IN	O
ESRD	NNP	B-PROBLEM
on	IN	O
HD	NNP	B-TREATMENT
,	,	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
DM	NNP	I-PROBLEM
,	,	O
and	CC	O
recent	JJ	B-PROBLEM
PE	NNP	I-PROBLEM
resulting	VBG	O
in	IN	O
PEA	NNP	B-PROBLEM
arrest	NN	I-PROBLEM
admitted	VBD	O
through	IN	O
the	DT	O
Juan	NNP	O
with	IN	O
sepsis	NN	B-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

Pt	NNP	O
was	VBD	O
recently	RB	O
admitted	VBN	O
to	TO	O
The	DT	O
Hospital	NNP	O
for	IN	O
Orthopedics	NNPS	O
from	IN	O
12-07	JJ	O
thorugh	IN	O
12-14	JJ	O
with	IN	O
hypotension	NN	B-PROBLEM
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
overdiuresis	VB	B-PROBLEM
at	IN	O
HD.	NNP	B-TREATMENT

However	RB	O
,	,	O
a	DT	B-PROBLEM
septic	JJ	I-PROBLEM
component	NN	I-PROBLEM
to	TO	O
the	DT	B-PROBLEM
hypotension	NN	I-PROBLEM
was	VBD	O
also	RB	O
considered	VBN	O
as	IN	O
the	DT	O
pt	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
citrobacter	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
and	CC	O
C	NNP	B-PROBLEM
diff	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

Her	PRP$	O
son	NN	O
reports	NNS	O
that	IN	O
she	PRP	O
then	RB	O
developed	VBD	O
a	DT	B-PROBLEM
headache	NN	I-PROBLEM
and	CC	O
fevers	NNS	B-PROBLEM
started	VBD	O
three	CD	O
days	NNS	O
ago	RB	O
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
.	.	O

Then	RB	O
,	,	O
this	DT	O
morning	NN	O
she	PRP	O
developed	VBD	O
fatigue	NN	B-PROBLEM
and	CC	O
did	VBD	O
not	RB	O
eat	VB	O
well	RB	O
.	.	O

He	PRP	O
son	VBZ	O
also	RB	O
notes	NNS	O
that	IN	O
she	PRP	O
appeared	VBD	O
to	TO	O
be	VB	O
working	VBG	B-PROBLEM
hard	JJ	I-PROBLEM
to	TO	I-PROBLEM
breath	VB	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
febrile	JJ	B-PROBLEM
to	TO	O
101.9	CD	O
and	CC	O
received	VBD	O
levoflox	NNS	B-TREATMENT
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

Pt	NNP	O
was	VBD	O
then	RB	O
sent	VBN	O
to	TO	O
the	DT	O
The	DT	O
Hospital	NNP	O
for	IN	O
Orthopedics	NNP	O
Juan	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

Per	NNP	O
notes	NNS	O
,	,	O
pt	NN	O
denied	VBD	O
SOB	NNP	B-PROBLEM
,	,	O
CP	NNP	B-PROBLEM
,	,	O
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
prior	RB	O
to	TO	O
intubation	NN	B-TREATMENT
.	.	O

She	PRP	O
did	VBD	O
complain	NN	O
of	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
frontal	JJ	I-PROBLEM
headache	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
Juan	NNP	O
,	,	O
the	DT	B-TEST
pt	NN	I-TEST
's	POS	I-TEST
VS	NNP	I-TEST
were	VBD	O
singificant	JJ	O
for	IN	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
of	IN	O
103.8	CD	O
,	,	O
tachycardia	NN	B-PROBLEM
in	IN	O
the	DT	O
130s-150s	JJ	O
,	,	O
and	CC	O
initial	JJ	B-PROBLEM
hypertensive	NN	I-PROBLEM
in	IN	O
the	DT	O
140s	CD	O
.	.	O

Her	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
on	IN	O
RA	NNP	O
but	CC	O
she	PRP	O
was	VBD	O
tachypneic	JJ	B-PROBLEM
to	TO	O
31	CD	O
.	.	O

She	PRP	O
was	VBD	O
obtunded	VBN	B-PROBLEM
and	CC	O
was	VBD	O
thus	RB	O
intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

Post-intubation	NN	O
,	,	O
the	DT	B-TEST
pt	NN	I-TEST
's	POS	I-TEST
BP	NNP	I-TEST
acutely	RB	O
dropped	VBD	O
to	TO	O
58/19	CD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
propofol	NN	B-TREATMENT
.	.	O

When	WRB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
her	PRP$	B-TEST
BP	NNP	I-TEST
came	VBD	O
back	RB	O
up	IN	O
to	TO	O
the	DT	O
70s-90s	JJ	O
/	JJ	O
30s-50s	NNS	O
.	.	O

Pt	NNP	O
was	VBD	O
then	RB	O
initiated	VBN	O
on	IN	O
the	DT	B-TREATMENT
sepsis	NN	I-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

In	IN	O
the	DT	O
Juan	NNP	O
,	,	O
she	PRP	O
received	VBD	O
vancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
cefepime	NN	B-TREATMENT
(	(	O
2	CD	O
gm	NN	O
).	NN	O

She	PRP	O
received	VBD	O
a	DT	O
total	NN	O
of	IN	O
4	CD	O
liters	NNS	O
of	IN	O
NS	NNP	B-TREATMENT
then	RB	O
was	VBD	O
started	VBN	O
on	IN	O
levophed	NN	B-TREATMENT
for	IN	O
continued	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

Pt	NNP	O
is	VBZ	O
now	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
FICU	NNP	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

Per	NNP	O
pt	NN	O
's	POS	O
son	NN	O
,	,	O
she	PRP	O
is	VBZ	O
bedbound	VBN	B-PROBLEM
at	IN	O
baseline	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
multiple	JJ	I-PROBLEM
LE	NNP	I-PROBLEM
femur	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

1.	CD	O
Type	NNP	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM

2.	CD	O
Diabetic	NNP	B-PROBLEM
nephropathy	JJ	I-PROBLEM
resulting	VBG	O
in	IN	O
ESRD	NNP	B-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
is	VBZ	O
on	IN	O
HD	NNP	B-TREATMENT
.	.	O

Pt	NNP	O
was	VBD	O
due	JJ	O
for	IN	O
HD	NNP	B-TREATMENT
but	CC	O
missed	VBD	O
it	PRP	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
illness	NN	I-PROBLEM
.	.	O

She	PRP	O
normally	RB	O
receives	VBZ	O
HD	NNP	B-TREATMENT
on	IN	O
Mon	NNP	O
,	,	O
Wed	NNP	O
,	,	O
and	CC	O
Fri	NNP	O
.	.	O

3.	CD	O
Status	NNP	B-PROBLEM
post	NN	I-PROBLEM
left	VBD	I-PROBLEM
femur	JJ	I-PROBLEM
fracture	NN	I-PROBLEM

4.	CD	O
Hyponatremia	NN	B-PROBLEM

5.	CD	O
Hypercholesterolemia	NN	B-PROBLEM

6.	CD	O
Unsteady	JJ	B-PROBLEM
gait	NN	I-PROBLEM

7.	CD	O
Cataracts	NNS	B-PROBLEM

8.	CD	O
Back	NNP	B-PROBLEM
pain	NN	I-PROBLEM

9.	CD	O
Hypertension	NN	B-PROBLEM

10.	CD	O
Anemia	NNP	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM

11.	CD	O
S/P	NNP	B-TREATMENT
L	NNP	I-TREATMENT
shoulder	NN	I-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
following	VBG	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracuture	NN	I-PROBLEM
in	IN	O
2018-11-10-	JJ	O
Dumas	NNP	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
PEA	NNP	I-PROBLEM
arrest	NN	I-PROBLEM
secondary	NN	O
to	TO	O
PE	NNP	B-PROBLEM
.	.	O

12.	CD	O
PE	NNP	B-PROBLEM
2018-11-17	JJ	O
leading	VBG	O
to	TO	O
PEA	NNP	B-PROBLEM
arrest	NN	I-PROBLEM

AC	$	O
500	CD	O
/	$	O
15	CD	O
/	NNP	O
.50	NNP	O
/	NNP	O
PEEP	NNP	B-TREATMENT
5	CD	O

Gen	NNP	O
-	:	O
Sedated	VBD	B-TREATMENT
and	CC	O
intubated	VBD	B-TREATMENT
.	.	O

Anicteric	NNP	B-PROBLEM
sclera	NN	I-PROBLEM
.	.	O

No	DT	O
m,r,g	NN	B-PROBLEM
.	.	O

Abdomen	NNP	O
-	:	O
Obese	NN	B-PROBLEM
.	.	O

NT	NNP	B-PROBLEM
.	.	O

ND	NNP	B-PROBLEM
.	.	O

Extremities	NNS	O
-	:	O
Feet	NNP	B-PROBLEM
mildly	RB	I-PROBLEM
cool	VBP	I-PROBLEM
.	.	O

2+	CD	B-TEST
DP	NNP	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
.	.	O

2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
LE	NNP	I-PROBLEM
.	.	O

Skin	NNP	B-PROBLEM
breakdown	NN	I-PROBLEM
between	IN	I-PROBLEM
toes	NNS	I-PROBLEM
.	.	O

Pressure	NN	B-PROBLEM
ulcers	NNS	I-PROBLEM
under	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
LE	NNP	I-PROBLEM
right	NN	O
above	IN	O
the	DT	O
ankles	NNS	O
.	.	O

Do	NNP	O
not	RB	O
appear	VB	O
infected	VBN	B-PROBLEM
.	.	O

Question	NN	O
mild	NN	B-PROBLEM
erythema	NN	I-PROBLEM
and	CC	O
warmth	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
LE	NNP	I-PROBLEM
.	.	O

Neuro	NNP	O
-	:	O
Sedated	VBD	B-PROBLEM
.	.	O

LACTATE	NNP	B-TEST
-	:	O
1.8	CD	O

CRP	NNP	B-TEST
-	:	O
46.2	CD	O
*	NN	O

SED	NNP	B-TEST
RATE	NNP	I-TEST
-	:	O
33	CD	O
*	NN	O

TYPE	NNP	O
-	:	O
MIX	NNP	B-TEST
TEMP	NNP	I-TEST
-	:	O
35.6	CD	O
RATES	NNPS	B-TEST
-/	VBP	O
15	CD	O
TIDAL	NNP	B-TEST
VOL	NNP	I-TEST
-	:	O
500	CD	O
PEEP	NNP	B-TREATMENT
-	:	O
5	CD	O
O2	NNP	B-TEST
-	:	O
50	CD	O
PO2	NNP	B-TEST
-	:	O
34	CD	O
*	NN	O
PCO2	NNP	B-TEST
-	:	O
39	CD	O
PH	NNP	B-TEST
-	:	O
7.32	CD	O
*	JJ	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
21	CD	O
BASE	NNP	B-TEST
XS	NNP	I-TEST
-	:	O
-6	NN	O

-	:	O
ASSIST	NN	O
/	JJ	O
CON	NNP	O
INTUBATED	NNP	B-TREATMENT
-	:	O
INTUBATED	NN	B-TREATMENT

LACTATE	NNP	B-TEST
-	:	O
1.6	CD	O

GLUCOSE	NNP	B-TEST
-	:	O
210	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
29	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
3.2	CD	O
*	JJ	O
SODIUM	NNP	B-TEST
-	:	O
139	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
3.9	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
112	CD	O
*	JJ	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
17	CD	O
*	JJ	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
14	CD	O

CALCIUM	NNP	B-TEST
-	:	O
6.2	CD	O
*	NN	O
PHOSPHATE	NNP	B-TEST
-	:	O
1.7	CD	O
*	JJ	O
MAGNESIUM	NNP	B-TEST
-	:	O
0.9	CD	O
*	NN	O

CORTISOL	NNP	B-TEST
-	:	O
10.3	CD	O

WBC	NNP	B-TEST
-	:	O
9.0	CD	O
RBC	NNP	B-TEST
-	:	O
2.93	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
9.0	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
29.7	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
101	CD	O
*	NN	O
MCH	NNP	B-TEST
-	:	O
30.8	CD	O
MCHC	NNP	B-TEST
-	:	O
30.4	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
24.1	CD	O
*	NN	O

NEUTS	NNP	B-TEST
-	:	O
65.2	CD	O
LYMPHS	NNP	B-TEST
-	:	O
25.2	CD	O
MONOS	NNP	B-TEST
-	:	O
6.0	CD	O
EOS	NNP	B-TEST
-	:	O
3.3	CD	O
BASOS	NNP	B-TEST
-	:	O
0.4	CD	O

HYPOCHROM	NNP	B-TEST
-	:	O
3+	CD	O
ANISOCYT	NNP	B-TEST
-	:	O
3+	CD	O
POIKILOCY	NNP	B-TEST
-	:	O
1+	CD	O
MACROCYT	NNP	B-TEST
-	:	O
3+	CD	O
MICROCYT	NNP	B-TEST
-	:	O
1+	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
177	CD	O

CORTISOL	NNP	B-TEST
-	:	O
9.3	CD	O

2018-12-26	JJ	O
08:28	CD	O
PM	NNP	B-TEST
URINE	NNP	I-TEST

COLOR	NNP	B-TEST
-	:	O
Yellow	JJ	O
APPEAR	NNP	B-TEST
-	:	O
SlHazy	NNP	O
SP	NNP	O
Barajas	NNP	O
-	:	O
1.005	CD	O

2018-12-26	JJ	O
08:28	CD	O
PM	NNP	B-TEST
URINE	NNP	I-TEST

BLOOD	NNP	B-TEST
-	:	O
LGE	NNP	B-TEST
NITRITE	NNP	I-TEST
-	:	O
NEG	NNP	O
PROTEIN	NNP	B-TEST
-	:	O
500	CD	O
GLUCOSE	NNP	B-TEST
-	:	O
TR	NNP	O
KETONE	NNP	B-TEST
-	:	O
NEG	NNP	O
BILIRUBIN	NNP	B-TEST
-	:	O
NEG	NNP	O
UROBILNGN	NNP	B-TEST
-	:	O
NEG	NNP	O
PH	NNP	B-TEST
-	:	O
7.0	CD	O
LEUK	NNP	B-TEST
-	:	O
NEG	NN	O

2018-12-26	JJ	O
08:28	CD	O
PM	NNP	B-TEST
URINE	NNP	I-TEST

RBC	NNP	B-TEST
-	:	O
225	CD	O
*	NN	O
WBC	NNP	B-TEST
-	:	O
8	CD	O
*	NN	O
BACTERIA	NNP	B-TEST
-	:	O
NONE	NN	O
YEAST	NNP	B-TEST
-	:	O
NONE	NN	O
EPI	NNP	B-TEST
-	:	O
<	NN	O
1	CD	O

CK	NNP	B-TEST
(	(	I-TEST
CPK	NNP	I-TEST
)-	CD	I-TEST
350	CD	O
*	NN	O

CK	NNP	B-TEST
-	:	O
MB	NNP	B-TEST
-	:	O
3	CD	O
cTropnT	NN	B-TEST
-	:	O
0.40	CD	O
*	NN	O

MICRO	NN	O
:	:	O
sputum	JJ	B-TEST
12-27	NNS	O
:	:	O
grm	NN	B-TEST
stn	NN	I-TEST
and	CC	O
cx	NN	B-TEST
negative	JJ	O

infl	VB	B-TEST
A	DT	I-TEST
and	CC	I-TEST
B	NNP	I-TEST
12-27	JJ	O
:	:	O
negative	JJ	O

CSF	NNP	B-TEST
grm	NN	I-TEST
stn	NN	I-TEST
/	NNP	O
cx	NN	B-TEST
:	:	O
negative	JJ	O

urine	JJ	B-TEST
cx	JJ	I-TEST
12-26	JJ	O
:	:	O
>	JJ	O
100K	CD	O
VRE	NNP	B-PROBLEM
likely	JJ	O
colonized	VBN	O
,	,	O
01-03	JJ	O
yest	NN	O
and	CC	O
VRE	NNP	B-PROBLEM

c	NNS	B-TEST
diff	JJ	I-TEST
neg	NNS	O
:	:	O
12-28	JJ	O
,	,	O
12-31	JJ	O
,	,	O
01-01	JJ	O
,	,	O
01-02	JJ	O
.	.	O

bld	NN	B-TEST
cx	NN	I-TEST
12-26	JJ	O
,	,	O
12-27	JJ	O
,	,	O
12-28	JJ	O
,	,	O
12-31	JJ	O
-	:	O
NG	NN	O
.	.	O

Catheter	NNP	B-TREATMENT
tip	NN	I-TREATMENT
01-05	NN	O
,	,	O
NG	NNP	B-TREATMENT
.	.	O

C.	NNP	B-TEST
Diff	NNP	I-TEST
B	NNP	I-TEST
-	:	O
negative	JJ	O

Tunnled	VBN	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
01-08	JJ	O
-	:	O
ngtd	NN	O

HERPES	NNP	B-TEST
SIMPLEX	NNP	I-TEST
VIRUS	NNP	I-TEST
PCR	NNP	I-TEST
-	:	O
PND	NN	O

69	CD	O
y/o	JJ	O
female	NN	O
wtih	NN	O
PMH	NNP	B-PROBLEM
significant	JJ	O
for	IN	O
ESRD	NNP	B-PROBLEM
on	IN	O
HD	NNP	B-TREATMENT
,	,	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
DM	NNP	I-PROBLEM
,	,	O
and	CC	O
recent	JJ	B-PROBLEM
PE	NNP	I-PROBLEM
resulting	VBG	O
in	IN	O
PEA	NNP	B-PROBLEM
arrest	NN	I-PROBLEM
admitted	VBD	O
through	IN	O
the	DT	O
Juan	NNP	O
with	IN	O
sepsis	NN	B-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

1.	CD	O
Sepsis	NNP	B-PROBLEM
/	NNP	O
ID-	NNP	O
Started	NNP	O
on	IN	O
sepsis	NN	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

Unclear	JJ	O
etiology	NN	O
headache	NN	B-PROBLEM
over	IN	O
the	DT	O
three	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
in	IN	O
association	NN	O
with	IN	O
fever	NN	B-PROBLEM
was	VBD	O
concerning	VBG	O
for	IN	O
a	DT	O
CNS	NNP	O
etiology	NN	O
.	.	O

Covered	VBN	O
broadly	RB	O
with	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
cefipime	NN	B-TREATMENT
.	.	O

Given	VBN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
empirically	RB	O
and	CC	O
Sanchez	NNP	B-TEST
stim	NN	I-TEST
showed	VBD	O
cortisol	NN	B-TEST
of	IN	O
9.3	CD	O
-->	JJ	O
10.3	CD	O
therefore	RB	O
steroids	NNS	B-TREATMENT
continued	VBD	O
.	.	O

CXR	NNP	B-TEST
,	,	O
LP	NNP	B-TEST
,	,	O
UA	NNP	B-TEST
and	CC	O
abdominal	JJ	B-TEST
CT	NNP	I-TEST
showed	VBD	O
no	DT	O
sign	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

PICC	NNP	B-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
empirically	RB	O
.	.	O

Tip	NNP	B-TREATMENT
could	MD	O
not	RB	O
be	VB	O
cultured	VBN	O
due	JJ	O
to	TO	O
contamination	NN	B-PROBLEM
.	.	O

Cultures	NNS	B-TEST
drawn	VBN	O
off	RP	O
the	DT	B-TREATMENT
HD	NNP	I-TREATMENT
cath	NN	I-TREATMENT
are	VBP	O
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

Patient	NNP	B-PROBLEM
's	POS	I-PROBLEM
LE	NNP	I-PROBLEM
ulcers	NNPS	I-PROBLEM
appear	VBP	O
chronic	JJ	O
and	CC	O
do	VBP	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
the	DT	O
source	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

Her	PRP$	O
left	JJ	O
knee	NN	O
is	VBZ	O
slightly	RB	B-PROBLEM
erythematous	JJ	I-PROBLEM
compared	VBN	O
to	TO	O
the	DT	O
right	NN	O
but	CC	O
not	RB	O
impressive	JJ	O
.	.	O

Nasal	NNP	B-TEST
washings	NNS	I-TEST
for	IN	O
influenza	NN	B-PROBLEM
were	VBD	O
negative	JJ	O
;	:	O
culture	NN	B-TEST
pending	NN	O
.	.	O

Steroids	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

On	IN	O
12-18	JJ	O
flagyl	NN	B-TREATMENT
and	CC	O
cefepime	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
as	IN	O
all	DT	B-TEST
culture	NN	I-TEST
data	NNS	I-TEST
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

Plan	NN	O
to	TO	O
continue	VB	O
vancomycin	NN	B-TREATMENT
for	IN	O
08-19	JJ	O
day	NN	O
course	NN	O
to	TO	O
treat	VB	O
empiric	JJ	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

Urine	JJ	B-TEST
culture	NN	I-TEST
came	VBD	O
back	RB	O
positive	JJ	O
for	IN	O
VRE	NNP	B-PROBLEM
,	,	O
however	RB	O
,	,	O
since	IN	O
patient	NN	O
improved	VBN	O
without	IN	O
treatement	NN	B-TREATMENT
(	(	O
ie	JJ	O
Linezolid	NNP	B-TREATMENT
)	)	O
initially	RB	O
.	.	O

On	IN	O
the	DT	O
floor	NN	O
the	DT	B-TREATMENT
Vancomycin	NNP	I-TREATMENT
was	VBD	O
discontinued	VBN	O
as	IN	O
the	DT	B-TEST
catheter	NN	I-TEST
tip	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

ID	NNP	O
was	VBD	O
consulted	VBN	O
who	WP	O
suggested	VBD	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
if	IN	O
she	PRP	O
were	VBD	O
to	TO	O
spike	VB	B-PROBLEM
.	.	O

When	WRB	O
pt	NN	O
spiked	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
and	CC	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Linezolid	NNP	B-TREATMENT
was	VBD	O
started	VBN	O
for	IN	O
presumed	JJ	O
VRE	NNP	B-PROBLEM
infection	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
yeast	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
,	,	O
to	TO	O
be	VB	O
treated	VBN	O
with	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
total	JJ	O
7	CD	O
days	NNS	O
.	.	O

She	PRP	O
was	VBD	O
given	VBN	O
Flagyl	NNP	B-TREATMENT
for	IN	O
presumed	JJ	O
C.	NNP	B-PROBLEM
Diff.	NNP	I-PROBLEM
Colitis	NNP	I-PROBLEM
,	,	O
however	RB	O
this	DT	O
was	VBD	O
stopped	VBN	O
when	WRB	O
C.	NNP	B-TEST
Diff	NNP	I-TEST
B	NNP	I-TEST
toxin	NN	I-TEST
came	VBD	O
back	RB	O
negative	JJ	O
on	IN	O
2019-01-10	JJ	O
.	.	O

The	DT	B-TREATMENT
tunneled	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
changed	VBN	O
over	IN	O
a	DT	B-TREATMENT
wire	NN	I-TREATMENT
and	CC	O
the	DT	B-TEST
tip	NN	I-TEST
was	VBD	O
also	RB	O
negative	JJ	O
.	.	O

2.	CD	O
Respiratory	NNP	O
-	:	O
Intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
due	JJ	O
to	TO	O
change	VB	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

Extubated	VBN	B-TREATMENT
12-28	JJ	O
with	IN	O
no	DT	O
incident	NN	O
.	.	O

3.	CD	O
ECG	NNP	B-PROBLEM
changes	NNS	I-PROBLEM
-	:	O
Patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
that	WDT	O
was	VBD	O
both	DT	O
right	JJ	O
and	CC	O
left	VBD	O
sided	VBN	O
with	IN	O
no	DT	O
radiation	NN	O
and	CC	O
no	DT	O
associated	VBN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

ECG	NNP	B-TEST
showed	VBD	O
new	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
TWI	NNP	I-PROBLEM
in	IN	I-PROBLEM
all	DT	I-PROBLEM
leads	NNS	I-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
cycled	VBN	O
and	CC	O
were	VBD	O
normal	JJ	O
.	.	O

Echo	NNP	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
WMA	NNP	B-PROBLEM
and	CC	O
EF	NNP	B-TEST
of	IN	O
35-40%	NNP	O
.	.	O

Pt	NNP	O
was	VBD	O
note	RB	O
started	VBN	O
on	IN	O
ASA	NNP	B-TREATMENT
as	IN	O
she	PRP	O
does	VBZ	O
not	RB	O
tolerate	VB	O
this	DT	O
well	NN	O
,	,	O
BB	NNP	B-TREATMENT
was	VBD	O
also	RB	O
not	RB	O
started	VBD	O
given	VBN	O
SBPs	NNP	B-TEST
in	IN	O
the	DT	O
110s	CD	O
.	.	O

Statin	NNP	B-TREATMENT
was	VBD	O
also	RB	O
deffered	VBN	O
.	.	O

She	PRP	O
may	MD	O
be	VB	O
started	VBN	O
on	IN	O
ASA	NNP	B-TREATMENT
,	,	O
BB	NNP	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
by	IN	O
PCP	NNP	O
as	IN	O
Stephen	NNP	O
.	.	O

4.	CD	O
Shoulder	NNP	B-PROBLEM
fracture	NN	I-PROBLEM
-	:	O
Patient	NN	O
is	VBZ	O
s/p	PDT	B-PROBLEM
a	DT	I-PROBLEM
left	JJ	I-PROBLEM
hip	NN	I-PROBLEM
fracture	NN	I-PROBLEM
(	(	O
decision	NN	O
not	RB	O
to	TO	O
operate	VB	O
)	)	O
and	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
hemiarthroplasty	JJ	B-TREATMENT
11-14	NNS	O
.	.	O

Patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
humerus	NN	I-PROBLEM
fracture	NN	I-PROBLEM
distal	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
hardware	NN	I-PROBLEM
on	IN	O
film	NN	B-TEST
this	DT	O
admission	NN	O
.	.	O

Assumed	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
trauma	VB	B-PROBLEM
when	WRB	O
moving	VBG	O
patient	NN	O
into	IN	O
ambulance	NN	O
.	.	O

CMED	NNP	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
recommended	VBN	O
wtd	NN	B-TREATMENT
woulnd	NN	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
sling	NN	B-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
.	.	O

Wound	NNP	B-TREATMENT
care	NN	I-TREATMENT
should	MD	O
be	VB	O
continued	VBN	O
as	IN	O
described	NN	O
after	IN	O
discharge	NN	O
.	.	O

5.	CD	O
Type	NNP	B-PROBLEM
2	CD	I-PROBLEM
DM	NNP	I-PROBLEM
-	:	O
Patient	NN	O
was	VBD	O
initially	RB	O
covered	VBN	O
with	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
while	IN	O
septic	JJ	B-PROBLEM
and	CC	O
then	RB	O
transitioned	VBD	O
back	RB	O
to	TO	O
insulin	VB	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

6.	CD	O
ESRD	NNP	B-PROBLEM
on	IN	O
HD	NNP	B-TREATMENT
-	:	O
Pt	NN	O
has	VBZ	O
ESRD	NNP	B-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
DM	NNP	I-PROBLEM
and	CC	O
is	VBZ	O
on	IN	O
HD	NNP	B-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
dialysed	VBN	O
but	CC	O
was	VBD	O
slightly	RB	B-PROBLEM
limited	VBN	I-PROBLEM
by	IN	O
hypotension	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TREATMENT
dialysis	NN	I-TREATMENT
was	VBD	O
managed	VBN	O
by	IN	O
renal	JJ	O
service	NN	O
in	IN	O
house	NN	O
.	.	O

7.	CD	O
PE	NNP	B-PROBLEM
(	(	O
11-14	JJ	O
)-	NN	O
On	IN	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

Restared	VBN	O
coumadin	NN	B-TREATMENT
on	IN	O
12-29	JJ	O
.	.	O

Heparin	NNP	B-TREATMENT
discontinued	VBN	O
on	IN	O
01-01	NN	O
when	WRB	O
INR	NNP	B-TEST
was	VBD	O
2.0	CD	O
.	.	O

Coumadin	NNP	B-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
she	PRP	O
received	VBD	O
fFP	NN	B-TREATMENT
for	IN	O
tunneled	JJ	B-TREATMENT
line	NN	I-TREATMENT
change	NN	I-TREATMENT
over	IN	I-TREATMENT
a	DT	I-TREATMENT
wire	NN	I-TREATMENT
.	.	O

Coumadin	NNP	B-TREATMENT
was	VBD	O
restarted	VBN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
2	CD	O
mg	NN	O
qhs	NN	O
.	.	O

This	DT	O
should	MD	O
be	VB	O
titrated	VBN	O
after	IN	O
discharge	NN	O
for	IN	O
INR	NNP	B-TEST
goal	NN	I-TEST
of	IN	O
2-3	JJ	O
.	.	O

8.	CD	O
PVD	NNS	B-PROBLEM
:	:	O

Dry	NNP	B-PROBLEM
gangrene	NN	I-PROBLEM
of	IN	I-PROBLEM
toes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
w/	VBP	O
necrosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
heels	NNS	I-PROBLEM
and	CC	I-PROBLEM
posterior	JJ	I-PROBLEM
calf	NN	I-PROBLEM
.	.	O

Continue	NNP	O
to	TO	O
monitor	VB	B-TEST
for	IN	O
sign	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

On	IN	O
vit	NN	B-TREATMENT
C.	NNP	I-TREATMENT
and	CC	O
zinc	NN	B-TREATMENT
as	RB	O
well	RB	O
to	TO	O
aid	VB	O
w/	NN	O
wound	IN	O
healing	NN	O
.	.	O

Wound	NNP	O
care	NN	O
consult	NN	O
given	VBN	O
anasarca	NN	B-TREATMENT
to	TO	O
prevent	VB	O
decub	NN	B-PROBLEM
.	.	O

9.	CD	O
Left	NNP	O
UE	NNP	O
markedly	RB	O
more	RBR	B-PROBLEM
edematous	JJ	I-PROBLEM
than	IN	O
right	JJ	O
UE	NNP	O
,	,	O
this	DT	O
could	MD	O
be	VB	O
from	IN	O
fracture	NN	B-PROBLEM
,	,	O
or	CC	O
there	EX	O
could	MD	O
be	VB	O
a	DT	B-PROBLEM
clot	NN	I-PROBLEM
,	,	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
area	NN	I-PROBLEM
also	RB	O
a	DT	O
possiblity	NN	O
.	.	O

Ultrasound	IN	B-TEST
without	IN	O
clot	NN	B-PROBLEM
.	.	O

Continue	NNP	O
elevation	NN	B-TREATMENT
and	CC	O
tight	JJ	B-TREATMENT
dressing	VBG	I-TREATMENT
to	TO	I-TREATMENT
LUE	NNP	I-TREATMENT
>	NNP	O

10.	CD	O
Access	NNP	O
-	:	O
Left	VBD	B-TREATMENT
IJ	NNP	I-TREATMENT
placed	VBD	O
12-26	JJ	O
in	IN	O
Juan	NNP	O
was	VBD	O
discontinued	VBN	O
during	IN	O
the	DT	O
hospitilization	NN	O
.	.	O

Right	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
catheter	NN	I-TREATMENT
(	(	O
2018-11-05	JJ	O
)	)	O
was	VBD	O
changed	VBN	O
over	IN	O
a	DT	B-TREATMENT
wire	NN	I-TREATMENT
2019-01-08	JJ	O
.	.	O

PICC	NNP	B-TREATMENT
line	NN	I-TREATMENT
placed	VBD	O
2019-01-08	JJ	O
,	,	O
this	DT	O
should	MD	O
be	VB	O
discontinued	VBN	O
immediately	RB	O
after	IN	O
pt	NN	O
finishes	VBZ	O
the	DT	B-TREATMENT
linezolid	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

1.	CD	O
Ascorbic	NNP	B-TREATMENT
acid	VBD	I-TREATMENT
500	CD	O
mg	NNS	O
BID	NNP	O

2.	CD	O
Folic	NNP	B-TREATMENT
acid	VBD	I-TREATMENT
1	CD	O
mg	NNS	O
daily	RB	O

3.	CD	O
Humulin	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
2	CD	O
units	NNS	O
QAM	NNP	O

4.	CD	O
RISS	NNP	B-TREATMENT

5.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
BID	NN	O

6.	CD	O
Neutra	NNP	B-TREATMENT
phos	NN	I-TREATMENT
2	CD	O
tabs	NNS	O
BID	NNP	O

7.	CD	O
Vitamin	NNP	B-TREATMENT
B	NNP	I-TREATMENT
complex	JJ	I-TREATMENT
1	CD	O
tab	JJ	O
daily	RB	O

8.	CD	O
Coumadin	NNP	B-TREATMENT
-	:	O
Dose	NNP	O
unknown	JJ	O

9.	CD	O
Tylenol	NNP	B-TREATMENT
650	CD	O
mg	NN	O
Q4H	NNP	O
PRN	NNP	O

10.	CD	O
Ondansetron	NNP	B-TREATMENT
4	CD	O
mg	NN	O
Q6H	NNP	O
PRN	NNP	O

1.	CD	O
Ascorbic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
Folic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

3.	CD	O
Zinc	NNP	B-TREATMENT
Sulfate	NNP	I-TREATMENT
220	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

4.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
Papain	NNP	B-TREATMENT
-	:	I-TREATMENT
Urea	VBD	I-TREATMENT
544	CD	O
287	CD	O
0616	CD	O
unit	NN	O
-	:	O
mg	NN	O
/	JJ	O
g	NN	O
Ointment	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Ipratropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
0.02	CD	O
%	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Inhalation	NN	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
.	.	O

7.	CD	O
Calcium	NNP	B-TREATMENT
Acetate	NNP	I-TREATMENT
667	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
W/	NNP	O
MEALS	NNP	O
(	(	O
3	CD	O
TIMES	NNP	O
A	NNP	O
DAY	NNP	O
WITH	NNP	O
MEALS	NNP	O
)	)	O
.	.	O

8.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
:	:	O
Hold	NN	O
for	IN	O
SBP	NNP	O
<	NNP	O
100	CD	O
,	,	O
HR	NNP	O
<	VBZ	O
60	CD	O
.	.	O

9.	CD	O
Fluconazole	NNP	B-TREATMENT
200	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
days	NNS	O
.	.	O

10.	CD	O
Insulin	NNP	B-TREATMENT
Regular	NNP	I-TREATMENT
Human	NNP	I-TREATMENT
300	CD	O
unit	NN	O
/	VBD	O
3	CD	O
mL	JJ	O
Insulin	NNP	O
Pen	NNP	O
Sig	NNP	O
:	:	O
as	IN	O
directed	VBN	O
Subcutaneous	NNP	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
Please	NNP	O
administer	RB	O
8	CD	O
units	NNS	O
glargine	VBP	B-TREATMENT
at	IN	O
dinner	NN	O
and	CC	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

11.	CD	O
Warfarin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
:	:	O
Titrate	NN	O
dose	NN	O
to	TO	O
Goal	NNP	O
INR	NNP	B-TEST
03-15	NN	O
.	.	O

12.	CD	O
Linezolid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
IV	NNP	O
Q12H	NNP	O

13.	CD	O
Heparin	NNP	B-TREATMENT
Flush	NNP	I-TREATMENT
PICC	NNP	I-TREATMENT
(	(	O
100	CD	O
units	NNS	O
/	NNP	O
ml	NN	O
)	)	O
2	CD	O
ml	JJ	O
IV	NNP	O
DAILY	NNP	O
:	:	O
PRN	NNP	O
10	CD	O
ml	NN	O
NS	NNP	O
followed	VBN	O
by	IN	O
2	CD	O
ml	NNS	O
of	IN	O
100	CD	O
Units	NNS	O
/	VBP	O
ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
200	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	JJ	B-TREATMENT
Daily	NNP	O
and	CC	O
PRN	NNP	O
.	.	O

14.	CD	O
Heparin	NNP	B-TREATMENT
Flush	NNP	I-TREATMENT
CVL	NNP	I-TREATMENT
(	(	O
100	CD	O
units	NNS	O
/	NNP	O
ml	NN	O
)	)	O
1	CD	O
ml	JJ	O
IV	NNP	O
DAILY	NNP	O
:	:	O
PRN	NN	O

10ml	CD	O
NS	NNP	B-TREATMENT
followed	VBN	O
by	IN	O
1ml	CD	O
of	IN	O
100	CD	O
units/ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
100	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	NNS	B-TREATMENT
QD	NNP	O
and	CC	O
PRN	NNP	O
.	.	O

15.	CD	O
Dolasetron	NNP	B-TREATMENT
Mesylate	NNP	I-TREATMENT
12.5	CD	O
mg	NN	O
IV	NNP	O
Q8H	NNP	O
:	:	O
PRN	NN	O

16.	CD	O
medication	NN	B-TREATMENT

Please	NNP	O
complete	VB	O
a	DT	O
total	JJ	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
linezolid	JJ	B-TREATMENT
.	.	O

Stop	NNP	O
linezolid	NN	B-TREATMENT
on	IN	O
2019-01-17	JJ	O
.	.	O

The	DT	B-TREATMENT
PICC	NNP	I-TREATMENT
line	NN	I-TREATMENT
should	MD	O
be	VB	O
discontinued	VBN	O
promptly	RB	O
after	IN	O
the	DT	B-TREATMENT
linezolid	JJ	I-TREATMENT
course	NN	I-TREATMENT
is	VBZ	O
completed	VBN	O
.	.	O

Sepsis	NNP	B-PROBLEM
-?	NNP	O
source	NN	O

Chronic	NNP	B-PROBLEM
Kidney	NNP	I-PROBLEM
disease	NN	I-PROBLEM
-	:	O
on	IN	O
hemodialysis	NN	B-TREATMENT
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
hypercholestrolemia	JJ	B-PROBLEM
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chornic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
h/o	NN	O
PE	NNP	B-PROBLEM
,	,	O
s/p	NN	B-PROBLEM
PEA	NNP	I-PROBLEM
arrest	IN	I-PROBLEM
11-14	NN	O

You	PRP	O
were	VBD	O
admitted	VBN	O
with	IN	O
low	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
fevers	NNS	B-PROBLEM
likely	RB	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

Although	IN	O
there	EX	O
was	VBD	O
never	RB	O
any	DT	B-PROBLEM
bacteria	NNS	I-PROBLEM
isolated	VBN	O
from	IN	O
the	DT	B-TEST
blood	NN	I-TEST
you	PRP	O
had	VBD	O
some	DT	B-PROBLEM
bacteria	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
which	WDT	O
you	PRP	O
are	VBP	O
being	VBG	O
treated	VBN	O
for	IN	O
.	.	O

It	PRP	O
is	VBZ	O
important	JJ	O
that	IN	O
you	PRP	O
complete	VBP	O
the	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
course	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

Please	NNP	O
continue	VBP	O
to	TO	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescirbed	NN	O
and	CC	O
follow	VB	O
up	RP	O
with	IN	O
all	DT	O
your	PRP$	O
appointments	NNS	O
.	.	O

If	IN	O
you	PRP	O
have	VBP	O
chest	VBN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
diahrrea	NN	B-PROBLEM
or	CC	O
fevers	NNS	B-PROBLEM
please	VBP	O
contact	VB	O
your	PRP$	O
PCP	NNP	O
.	.	O

Robert	NNP	O
the	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
gets	VBZ	O
worse	JJR	O
please	NN	O
return	VB	O
to	TO	O
emergency	NN	O
room	NN	O
.	.	O

If	IN	O
you	PRP	O
have	VBP	O
fevers	NNS	B-PROBLEM
please	VB	O
contact	VB	O
your	PRP$	O
PCP	NNP	O
or	CC	O
return	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

Medicine	NN	B-TREATMENT

This	DT	O
is	VBZ	O
a	DT	O
59	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
an	DT	B-TREATMENT
atrioseptal	JJ	I-TREATMENT
defect	NN	I-TREATMENT
repair	NN	I-TREATMENT
at	IN	O
age	NN	O
18	CD	O
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
45%	CD	O
and	CC	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
myocardial	NN	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
and	CC	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
and	CC	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
the	DT	O
day	NN	O
before	IN	O
admission	NN	O
and	CC	O
complained	VBN	O
of	IN	O
two	CD	O
weeks	NNS	O
of	IN	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
,	,	O
weight	VBD	B-PROBLEM
gain	NN	I-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
fullness	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
reported	VBD	O
feeling	NN	O
at	IN	O
his	PRP$	O
baseline	NN	O
with	IN	O
chronic	JJ	B-PROBLEM
mild	NNS	I-PROBLEM
dyspnea	VBP	I-PROBLEM
on	IN	O
exertion	NN	O
until	IN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

During	IN	O
this	DT	O
period	NN	O
he	PRP	O
had	VBD	O
also	RB	O
been	VBN	O
weaned	VBN	O
off	IN	O
of	IN	O
his	PRP$	B-TREATMENT
Digoxin	NNP	I-TREATMENT
starting	VBG	O
early	JJ	O
in	IN	O
February	NNP	O
.	.	O

Over	IN	O
the	DT	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
had	VBD	O
noticed	VBN	O
an	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
from	IN	O
his	PRP$	O
baseline	NN	O
in	IN	O
the	DT	O
60s	CD	O
to	TO	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
120s	CD	O
.	.	O

He	PRP	O
had	VBD	O
also	RB	O
some	DT	B-PROBLEM
increased	VBD	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
10	CD	I-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
gain	NN	I-PROBLEM
and	CC	O
new	JJ	O
three	CD	O
to	TO	O
four	CD	O
pillow	NN	B-PROBLEM
orthopnea	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
cough	NN	I-PROBLEM
.	.	O

He	PRP	O
denied	VBD	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
chest	VBP	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

Atrioseptal	JJ	B-TREATMENT
defect	NN	I-TREATMENT
repair	NN	I-TREATMENT
in	IN	O
1970	CD	O
,	,	O
cardiomyopathy	NN	B-PROBLEM
,	,	O
right-sided	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
brachytherapy	NN	I-TREATMENT
,	,	O
history	NN	O
of	IN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM
on	IN	O
CPAP	NNP	B-TREATMENT
.	.	O

ACE	NNP	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
possible	JJ	O
allergy	NN	B-PROBLEM
to	TO	O
barium	NN	B-TREATMENT
reported	VBN	O
by	IN	O
the	DT	O
patient	NN	O
during	IN	O
a	DT	B-TREATMENT
barium	NN	I-TREATMENT
swallow	JJ	I-TREATMENT
25	CD	O
years	NNS	O
ago	RB	O
.	.	O

Digoxin	NNP	B-TREATMENT
0.125	CD	O
,	,	O
discontinued	VBD	O
one	CD	O
month	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
100	CD	O
mg	JJ	O
daily	RB	O
,	,	O
Trazodone	NNP	B-TREATMENT
50	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
,	,	O
Diovan	NNP	B-TREATMENT
40	CD	O
mg	JJ	O
daily	RB	O
,	,	O
Atrovent	NNP	B-TREATMENT
/	NNP	O
Albuterol	NNP	B-TREATMENT
prn	NN	O
,	,	O
Pulmicort	NNP	B-TREATMENT
,	,	O
Coumadin	NNP	B-TREATMENT
2.5	CD	O
mg	JJ	O
daily	RB	O
,	,	O
Vitamin	NNP	B-TREATMENT
E	NNP	I-TREATMENT
,	,	O
Vitamin	NNP	B-TREATMENT
C	NNP	I-TREATMENT
,	,	O
iron	NN	B-TREATMENT
supplement	NN	I-TREATMENT
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10.5	CD	O
,	,	O
hematocrit	NN	B-TEST
38.1	CD	O
,	,	O
platelets	NNS	B-TEST
254	CD	O
,	,	O
INR	NNP	B-TEST
1.8	CD	O
.	.	O

Sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
5.2	CD	O
,	,	O
BUN	NNP	B-TEST
38	CD	O
,	,	O
creatinine	NN	B-TEST
.7	NN	O
,	,	O
TSH	NNP	B-TEST
1.8	CD	O
,	,	O
Digoxin	NNP	B-TEST
level	NN	I-TEST
less	JJR	O
than	IN	O
0.2	CD	O
.	.	O

Serial	JJ	B-TEST
cardiac	JJ	I-TEST
enzymes	NNS	I-TEST
negative	JJ	O
.	.	O

ALT	NNP	B-TEST
14	CD	O
,	,	O
AST	NNP	B-TEST
31	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
283	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
1.0	CD	O
,	,	O
amylase	NN	B-TEST
71	CD	O
,	,	O
glucose	JJ	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
317	CD	O
.	.	O

Electrocardiogram	NNP	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
.	.	O

Echocardiogram	NNP	B-TEST
showed	VBD	O
moderate	JJ	B-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
no	DT	O
atrioseptal	JJ	B-PROBLEM
defect	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
left	VBN	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
and	CC	O
moderately	RB	B-PROBLEM
dilated	VBD	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
global	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
apical	JJ	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
and	CC	O
abnormal	JJ	B-PROBLEM
septal	JJ	I-PROBLEM
motion	NN	I-PROBLEM
consistent	NN	O
with	IN	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

Moderate	NNP	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
3+	CD	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
3+	CD	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
along	IN	O
with	IN	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
early	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

Of	IN	O
note	NN	O
,	,	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
tachycardiac	JJ	B-PROBLEM
.	.	O

1.	CD	O
Hypotension	NNP	B-PROBLEM
-	:	O
The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
mildly	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80s	CD	O
.	.	O

Upon	IN	O
admission	NN	O
it	PRP	O
was	VBD	O
unclear	JJ	O
whether	IN	O
or	CC	O
not	RB	O
the	DT	O
patient	NN	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBD	I-PROBLEM
or	CC	O
volume	NN	B-PROBLEM
depleted	VBN	I-PROBLEM
.	.	O

Initially	RB	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
with	IN	O
a	DT	O
dramatic	JJ	O
response	NN	O
in	IN	O
his	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

However	RB	O
,	,	O
subsequent	VBD	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
hypotension	NN	I-PROBLEM
may	MD	O
have	VB	O
been	VBN	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
rapid	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Therefore	RB	O
the	DT	O
focus	NN	O
of	IN	O
treatment	NN	B-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
controlling	VBG	O
his	PRP$	B-TEST
rate	NN	I-TEST
.	.	O

2.	CD	O
Atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
-	:	O
The	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
Digoxin	NNP	I-TREATMENT
had	VBD	O
been	VBN	O
weaned	VBN	O
off	RP	O
prior	JJ	O
to	TO	O
his	PRP$	O
admission	NN	O
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
potentially	RB	O
had	VBD	O
lead	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
atrial	JJ	I-PROBLEM
flutter	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
loaded	VBN	O
once	RB	O
again	RB	O
with	IN	O
Digoxin	NNP	B-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
100	CD	O
mg	NN	O
of	IN	O
Lopressor	NNP	B-TREATMENT
,	,	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

In	IN	O
addition	NN	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Verapamil	NNP	B-TREATMENT
since	IN	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
had	VBD	O
remained	VBN	O
mildly	RB	B-PROBLEM
tachycardiac	JJ	I-PROBLEM
in	IN	O
the	DT	O
low	JJ	O
100s	CD	O
.	.	O

3.	CD	O
Congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
-	:	O
During	IN	O
the	DT	O
initial	JJ	O
course	NN	O
of	IN	O
the	DT	O
patient	NN	O
's	POS	O
admission	NN	O
,	,	O
it	PRP	O
was	VBD	O
unclear	JJ	O
as	IN	O
to	TO	O
whether	IN	O
or	CC	O
not	RB	O
he	PRP	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBD	I-PROBLEM
or	CC	O
volume	NN	B-PROBLEM
depleted	VBN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
however	RB	O
,	,	O
subsequently	RB	O
he	PRP	O
was	VBD	O
diuresed	VBN	O
when	WRB	O
he	PRP	O
became	VBD	O
symptomatic	JJ	B-PROBLEM
and	CC	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
x-rays	NNS	I-TEST
revealed	VBD	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

The	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
have	VB	O
the	DT	O
patient	NN	O
undergo	VBZ	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
to	TO	O
fully	RB	O
evaluate	VB	O
the	DT	O
hemodynamics	NNS	O
to	TO	O
determine	VB	O
the	DT	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

In	IN	O
addition	NN	O
,	,	O
plans	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
patient	NN	O
's	POS	O
cardiac	JJ	O
arteries	NNS	O
to	TO	O
determine	VB	O
if	IN	O
he	PRP	O
had	VBD	O
any	DT	O
component	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

4.	CD	O
Abnormal	NNP	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	VBZ	I-TEST
-	:	O
The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
isolated	VBN	I-PROBLEM
,	,	I-PROBLEM
elevated	JJ	I-PROBLEM
alkaline	NN	I-PROBLEM
phosphatase	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
confirmatory	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	O
his	PRP$	B-TEST
gamma	NN	I-TEST
glutamyl	NN	I-TEST
transferase	NN	I-TEST
.	.	O

An	DT	B-TEST
ultrasound	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
upper	JJ	I-TEST
quadrant	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
cholelithiasis	NN	I-PROBLEM
or	CC	O
cholecystitis	NN	B-PROBLEM
,	,	O
however	RB	O
,	,	O
an	DT	B-PROBLEM
irregular	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
contour	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
which	WDT	O
is	VBZ	O
suggestive	JJ	O
of	IN	O
underlying	VBG	B-PROBLEM
chronic	JJ	I-PROBLEM
liver	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
some	DT	O
concern	NN	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
have	VB	O
a	DT	B-PROBLEM
partial	JJ	I-PROBLEM
biliary	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
cholangiopancreatography	NN	I-TEST
to	TO	O
further	JJ	O
evaluate	VB	O
the	DT	O
biliary	JJ	O
system	NN	O
.	.	O

Magnetic	JJ	B-TEST
resonance	NN	I-TEST
cholangiopancreatography	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	O
evidence	NN	O
of	IN	O
biliary	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
or	CC	O
of	IN	O
any	DT	B-PROBLEM
obstructing	VBG	I-PROBLEM
pancreatic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

Again	RB	O
seen	VBN	O
was	VBD	O
a	DT	B-PROBLEM
slightly	RB	I-PROBLEM
irregular	JJ	I-PROBLEM
contour	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
with	IN	O
dilated	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
veins	NNS	I-PROBLEM
suggesting	VBG	O
chronic	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
he	PRP	O
may	MD	O
have	VB	O
had	VBD	O
some	DT	O
component	NN	O
of	IN	O
vascular	JJ	B-PROBLEM
congestion	NN	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
possibly	RB	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
cirrhotic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
secondary	VBP	O
to	TO	O
his	PRP$	O
previous	JJ	O
alcohol	NN	O
use	NN	O
.	.	O

He	PRP	O
did	VBD	O
not	RB	O
sleep	VB	O
at	IN	O
all	PDT	O
the	DT	O
night	NN	O
before	IN	O
and	CC	O
was	VBD	O
extremely	RB	B-PROBLEM
fatigued	VBN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
walking	VBG	O
in	IN	O
the	DT	O
hall	NN	O
,	,	O
dragging	VBG	O
his	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
pole	NN	I-TREATMENT
when	WRB	O
he	PRP	O
tripped	VBD	O
over	IN	O
the	DT	O
foot	NN	O
of	IN	O
the	DT	O
pole	NN	O
and	CC	O
lost	VBD	O
his	PRP$	O
balance	NN	O
.	.	O

His	PRP$	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
nonfocal	JJ	O
and	CC	O
the	DT	O
head	NN	O
was	VBD	O
atraumatic	JJ	B-PROBLEM
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
computerized	JJ	I-TEST
axial	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
head	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
extra	JJ	I-PROBLEM
or	CC	I-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

6.	CD	O
Rectal	JJ	B-PROBLEM
bleeding	VBG	I-PROBLEM
-	:	O
The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
ever	RB	O
since	IN	O
his	PRP$	B-TREATMENT
brachytherapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
prostate	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
Argon	NNP	B-TREATMENT
laser	NN	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
for	IN	O
his	PRP$	B-PROBLEM
rectal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
it	PRP	O
is	VBZ	O
recommended	VBN	O
that	IN	O
he	PRP	O
follow	VB	O
up	RP	O
with	IN	O
his	PRP$	O
gastroenterologist	NN	O
for	IN	O
repeat	NN	B-TREATMENT
Argon	NNP	I-TREATMENT
laser	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

Internal	NNP	B-TREATMENT
Medicine	NNP	I-TREATMENT

Her	PRP$	O
renal	JJ	O
function	NN	O
significantly	RB	O
improved	VBN	O
,	,	O
and	CC	O
her	PRP$	B-TEST
discharge	NN	I-TEST
creatinine	NN	I-TEST
was	VBD	O
3.1	CD	O
.	.	O

Of	IN	O
note	NN	O
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
significantly	RB	O
improved	VBN	O
in	IN	O
the	DT	O
120s-130s	JJ	O
which	WDT	O
assured	VBD	O
better	JJR	O
perfusion	NN	O
in	IN	O
her	PRP$	O
kidneys	NNS	O
.	.	O

She	PRP	O
received	VBD	O
intermittent	JJ	O
doses	NNS	O
of	IN	O
Lasix	NNP	B-TREATMENT
to	TO	O
assure	VB	O
overall	JJ	O
negative	JJ	O
intakes	NNS	O
and	CC	O
outputs	NNS	O
.	.	O

She	PRP	O
progressed	VBD	O
beautifully	RB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
ambulate	VB	O
with	IN	O
assistance	NN	O
.	.	O

She	PRP	O
has	VBZ	O
very	RB	B-PROBLEM
mild	JJ	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
largely	RB	O
unchanged	JJ	O
.	.	O

1.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
Congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

3.	CD	O
Acute	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

4.	CD	O
Acute	NNP	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

5.	CD	O
Osteomyelitis	NNP	B-PROBLEM
.	.	O

6.	CD	O
Diabetes	NNPS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

1.	CD	O
Amiodarone	$	B-TREATMENT
200	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

2.	CD	O
Warfarin	NNP	B-TREATMENT
3	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
h.s.	NN	O

3.	CD	O
Renagel	NNP	B-TREATMENT
1600	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

5.	CD	O
Miconazole	NNP	B-TREATMENT
powder	NN	I-TREATMENT
2%	CD	O
t.i.d.	NN	O

6.	CD	O
Levofloxacin	NNP	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q48	NN	O
hours	NNS	O
for	IN	O
the	DT	O
next	JJ	O
five	CD	O
weeks	NNS	O
for	IN	O
osteomyelitis	NN	B-PROBLEM
.	.	O

7.	CD	O
Flagyl	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
the	DT	O
next	JJ	O
five	CD	O
weeks	NNS	O
for	IN	O
osteomyelitis	NN	B-PROBLEM
.	.	O

8.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

9.	CD	O
Magnesium	NNP	B-TREATMENT
Oxide	NNP	I-TREATMENT
800	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

10.	CD	O
Epogen	NN	B-TREATMENT
5000	CD	O
units	NNS	O
two	CD	O
times	NNS	O
weekly	RB	O
,	,	O
on	IN	O
Monday	NNP	O
and	CC	O
Thursday	NNP	O
.	.	O

11.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

12.	CD	O
Lasix	NNP	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
NPH	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
7	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
5	CD	O
units	NNS	O
at	IN	O
night	NN	O
.	.	O

14.	CD	O
Regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

Tape	NN	O
/	VBZ	O
Benadryl	NNP	B-TREATMENT

Chest	NNP	B-PROBLEM
discomfort	NN	I-PROBLEM

2015-10-30	JJ	O
Left	NNP	B-TREATMENT
Carotid	NNP	I-TREATMENT
Stenting	VBG	I-TREATMENT

2015-11-02	JJ	O
Coronary	NNP	B-TREATMENT
Artery	NNP	I-TREATMENT
Bypass	NNP	I-TREATMENT
Graft	NNP	I-TREATMENT
x	VBD	O
2	CD	O
(	(	O
Lima	NNP	B-TREATMENT
to	TO	I-TREATMENT
LAD	NNP	I-TREATMENT
,	,	O
SVG	NNP	B-TREATMENT
to	TO	I-TREATMENT
OM	NNP	I-TREATMENT
)	)	O

Ms.	NNP	O
Bridge	NNP	O
is	VBZ	O
a	DT	O
74	CD	O
y/o	NN	O
female	NN	O
admitted	VBD	O
to	TO	O
outside	JJ	O
hospital	NN	O
on	IN	O
2015-10-21	JJ	O
with	IN	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Initial	JJ	B-TEST
EKG	NNP	I-TEST
showed	VBD	O
ST	NNP	B-PROBLEM
depressions	NNS	I-PROBLEM
,	,	O
but	CC	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
not	RB	O
elevated	VBN	B-PROBLEM
.	.	O

She	PRP	O
eventually	RB	O
underwent	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
cath	NN	I-TEST
to	TO	O
assess	VB	O
coronary	JJ	B-PROBLEM
disease	NN	I-PROBLEM
which	WDT	O
revealed	VBD	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
The	DT	O
Hospital	NNP	O
for	IN	O
Orthopedics	NNP	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

Coronary	JJ	B-PROBLEM
Artery	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM
,	,	O
Hypertension	NNP	B-PROBLEM
,	,	O
Hyperlipidemia	NNP	B-PROBLEM
,	,	O
Diabetes	NNP	B-PROBLEM
Mellitus	NNP	I-PROBLEM
,	,	O
Hypothyroid	NNP	B-PROBLEM
,	,	O
h/o	JJ	O
Bilateral	NNP	B-PROBLEM
DVT	NNP	I-PROBLEM
's	POS	I-PROBLEM
(	(	O
on	IN	O
chronic	NN	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
),	NNP	O
Pleural	NNP	B-PROBLEM
disorder	NN	I-PROBLEM
?	.	O
Sarcoidosis	NNP	B-PROBLEM
,	,	O
Gastritis	NNP	B-PROBLEM
,	,	O
B12	NNP	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
s/p	JJ	O
Appendectomy	NNP	B-TREATMENT
,	,	O
s/p	NN	O
Lap	NNP	B-TREATMENT
cholectomy	NN	I-TREATMENT
,	,	O
s/p	JJ	O
Total	NNP	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT

Mother	NNP	O
died	VBD	O
of	IN	O
MI	NNP	B-PROBLEM
at	IN	O
age	NN	O
55	CD	O
.	.	O

Brother	NNP	O
w/	NN	O
CAD	NNP	B-PROBLEM
since	IN	O
age	NN	O
40	CD	O
and	CC	O
died	VBD	O
in	IN	O
70	CD	O
's	POS	O
after	IN	O
cardiac	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Son	NNP	O
died	VBD	O
at	IN	O
14	CD	O
d/t	NN	O
ASD	NNP	B-PROBLEM
.	.	O

Gen	NN	O
:	:	O
NAD	NN	B-PROBLEM

Neck	NN	O
:	:	O
Supple	NN	O
,	,	O
-	:	O
JVD	NN	B-PROBLEM
,	,	O
-	:	O
Bruits	NNS	B-PROBLEM

Heart	NN	O
:	:	O
RRR	NNP	O
-	:	O
c/r/m/g	NN	B-PROBLEM

Lungs	NNS	O
:	:	O
CTAB	NNP	O
,	,	O
coarse	NN	B-PROBLEM

Abd	NNS	O
:	:	O
Soft	NNP	O
,	,	O
NT/NT	NNP	B-PROBLEM
+	NNP	O
BS	NNP	O

Ext	NN	O
:	:	O
Cool	NNP	O
,	,	O
1	CD	O
+	NN	O
pedal	NN	B-TEST
pulses	NNS	I-TEST
,	,	O
-	:	O
varicosities	NNS	B-PROBLEM
,	,	O
-	:	O
edema	NN	B-PROBLEM

Some	DT	B-PROBLEM
rashes	NNS	I-PROBLEM
on	IN	I-PROBLEM
ACW	NNP	I-PROBLEM
around	IN	O
EKG	NNP	B-TREATMENT
leads	NNS	I-TREATMENT

CNIS	JJ	B-TEST
10-29	NNS	O
:	:	O

1.	CD	O
60-69%	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

2.	CD	O
80-99%	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

Echo	JJ	B-TEST
11-02	JJ	O
:	:	O
PRE-BYPASS	NN	O
:	:	O
Left	NNP	O
ventricular	VBZ	O
wall	NN	O
thickness	NN	O
,	,	O
cavity	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
are	VBP	O
normal	JJ	O
(	(	O
LVEF>55%	NNP	B-TEST
).	NNP	O

Resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
mild	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

The	DT	O
mitral	JJ	O
valve	NN	O
appears	VBZ	O
structurally	RB	O
normal	JJ	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
complex	JJ	B-PROBLEM
(>	$	I-PROBLEM
4	CD	I-PROBLEM
mm	NN	I-PROBLEM
)	)	I-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
descending	NN	I-PROBLEM
thoracic	NN	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

Trivial	JJ	B-PROBLEM
MR	NNP	I-PROBLEM
.	.	O

CT	JJ	B-TEST
11-04	JJ	O
:	:	O
No	DT	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

Findings	NNS	O
consistent	JJ	O
with	IN	O
small	JJ	B-PROBLEM
vessel	NNS	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

MRI	NNP	B-TEST
would	MD	O
be	VB	O
more	RBR	O
sensitive	JJ	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
acute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

CT	NNP	B-TEST
angiogram	NN	I-TEST
demonstrates	VBZ	O
no	DT	O
stenosis	NN	B-PROBLEM
or	CC	O
aneurysm	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
intracranial	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
.	.	O

Slight	NNP	B-PROBLEM
irregularity	NN	I-PROBLEM
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
right	JJ	O
vertebral	JJ	O
artery	NN	O
may	MD	O
be	VB	O
atherosclerotic	JJ	B-PROBLEM
in	IN	O
nature	NN	O
.	.	O

Normal	NNP	O
contrast	NN	O
enhancement	NN	O
seen	VBN	O
in	IN	O
the	DT	B-TREATMENT
left	JJ	I-TREATMENT
common/internal	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
artery	NN	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

Mild	NNP	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

4	CD	B-PROBLEM
mm	NN	I-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
lung	NN	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
absence	NN	O
of	IN	O
history	NN	O
of	IN	O
malignancy	NN	B-PROBLEM
,	,	O
this	DT	O
is	VBZ	O
statistically	RB	O
benign	JJ	O
.	.	O

CXR	JJ	B-TEST
11-06	JJ	O
:	:	O
Allowing	NN	O
for	IN	O
technical	JJ	O
changes	NNS	O
,	,	O
no	DT	O
major	JJ	B-PROBLEM
adverse	JJ	I-PROBLEM
interval	NN	I-PROBLEM
change	NN	I-PROBLEM
has	VBZ	O
occurred	VBN	O
.	.	O

Bibasilar	JJ	B-PROBLEM
subsegmental	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
together	RB	O
with	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
appear	VBP	O
relatively	RB	O
unchanged	JJ	O
.	.	O

Left-sided	JJ	B-TREATMENT
subclavian	JJ	I-TREATMENT
line	NN	I-TREATMENT
is	VBZ	O
unchanged	JJ	O
in	IN	O
position	NN	O
.	.	O

There	EX	O
is	VBZ	O
evidence	NN	O
of	IN	O
prior	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

2015-11-13	JJ	O
06:15	CD	O
AM	NNP	O
BLOOD	NNP	O
WBC	NNP	B-TEST
-	:	O
8.8	CD	O
RBC	NNP	B-TEST
-	:	O
2.79	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
8.6	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
25.4	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
91	CD	O
MCH	NNP	B-TEST
-	:	O
30.9	CD	O
MCHC	NNP	B-TEST
-	:	O
33.8	CD	O
RDW	NNP	B-TEST
-	:	O
15.6	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
583	CD	O
*	NN	O

2015-11-12	JJ	O
06:00	CD	O
AM	NNP	O
BLOOD	NNP	O
WBC	NNP	B-TEST
-	:	O
7.7	CD	O
RBC	NNP	B-TEST
-	:	O
2.73	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
8.3	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	I-TEST
25.1	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
92	CD	O
MCH	NNP	B-TEST
-	:	O
30.4	CD	O
MCHC	NNP	B-TEST
-	:	O
33.1	CD	O
RDW	NNP	B-TEST
-	:	O
15.5	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
528	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
AM	NNP	O
BLOOD	NNP	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
583	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
AM	NNP	O
BLOOD	NNP	O
PT	NNP	B-TEST
-	:	O
18.0	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
62.3	CD	O
*	NN	O
INR(PT)	NNP	B-TEST
-	:	O
1.7	CD	O
*	NN	O

2015-11-12	JJ	O
06:00	CD	O
AM	NNP	O
BLOOD	NNP	O
PT	NNP	B-TEST
-	:	O
15.5	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
62.4	CD	O
*	NN	O
INR(PT)	NNP	B-TEST
-	:	O
1.4	CD	O
*	NN	O

2015-11-11	JJ	O
05:45	CD	O
AM	NNP	O
BLOOD	NNP	O
PT	NNP	B-TEST
-	:	O
14.5	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
51.4	CD	O
*	NN	O
INR(PT)	NNP	B-TEST
-	:	O
1.3	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
AM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
96	CD	O
UreaN	NNP	B-TEST
-	:	O
20	CD	O
Creat	NNP	B-TEST
-	:	O
1.6	CD	O
*	NN	O
Na	NNP	B-TEST
-	:	O
141	CD	O
K	NNP	B-TEST
-	:	O
4.3	CD	O
Cl	NNP	B-TEST
-	:	O
106	CD	O
HCO3	NNP	B-TEST
-	:	O
24	CD	O
AnGap	NNP	B-TEST
-	:	O
15	CD	O

2015-11-12	JJ	O
06:00	CD	O
AM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
85	CD	O
UreaN	NNP	B-TEST
-	:	O
19	CD	O
Creat	NNP	B-TEST
-	:	O
1.6	CD	O
*	NN	O
Na	NNP	B-TEST
-	:	O
140	CD	O
K	NNP	B-TEST
-	:	I-TEST
4.4	CD	O
Cl	NNP	B-TEST
-	:	O
105	CD	O
HCO3	NNP	B-TEST
-	:	O
24	CD	O
AnGap	NNP	B-TEST
-	:	I-TEST
15	CD	O

2015-11-11	JJ	O
05:45	CD	O
AM	NNP	O
BLOOD	NNP	O
Creat	NNP	B-TEST
-	:	O
1.6	CD	O
*	NN	O
K	NNP	B-TEST
-	:	O
4.7	CD	O

2015-10-28	JJ	O
03:30	CD	O
PM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
98	CD	O
UreaN	NNP	B-TEST
-	:	O
26	CD	O
*	NN	O
Creat	NNP	B-TEST
-	:	O
1.6	CD	O
*	NN	O
Na	NNP	B-TEST
-	:	O
140	CD	O
K	NNP	B-TEST
-	:	O
4.6	CD	O
Cl	NNP	B-TEST
-	:	O
104	CD	O
HCO3	NNP	B-TEST
-	:	O
27	CD	O
AnGap	NNP	B-TEST
-	:	O
14	CD	O

Ms.	NNP	O
Bridge	NNP	O
was	VBD	O
admitted	VBN	O
from	IN	O
OSH	NNP	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

She	PRP	O
underwent	JJ	O
usual	JJ	B-TEST
pre-operative	JJ	I-TEST
testing	VBG	I-TEST
along	IN	O
with	IN	O
carotid	NN	B-TEST
ultrasound	NN	I-TEST
.	.	O

CNIS	NNP	B-TEST
revealed	VBD	O
carotid	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
she	PRP	O
ultimately	RB	O
underwent	JJ	O
left	VBD	B-TREATMENT
carotid	JJ	I-TREATMENT
stenting	NN	I-TREATMENT
by	IN	O
vascular	JJ	O
surgery	NN	O
on	IN	O
10-30	NNS	O
.	.	O

On	IN	O
11-02	JJ	O
she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

She	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
CSRU	NNP	O
for	IN	O
invasive	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

Later	RB	O
on	IN	O
op	JJ	O
day	NN	O
sedation	NN	B-TREATMENT
was	VBD	O
weaned	VBN	O
,	,	O
she	PRP	O
awoke	VBD	O
neurologically	RB	O
intact	JJ	O
and	CC	O
was	VBD	O
extubated	VBN	B-TREATMENT
.	.	O

On	IN	O
post-op	JJ	O
day	NN	O
one	CD	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
and	CC	O
beta	JJ	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
diuretics	NNS	B-TREATMENT
were	VBD	O
initiated	VBN	O
.	.	O

Early	RB	O
on	IN	O
post-op	JJ	O
day	NN	O
two	CD	O
Ms.	NNP	O
Bridge	NNP	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
aphasia	NN	B-PROBLEM
.	.	O

She	PRP	O
underwent	VBD	O
an	DT	B-TEST
immediate	JJ	I-TEST
head	NN	I-TEST
CT	NNP	I-TEST
and	CC	O
Neuro	NNP	O
consult	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
CSRU	NNP	O
.	.	O

CT	NNP	B-TEST
was	VBD	O
negative	JJ	O
and	CC	O
she	PRP	O
returned	VBD	O
to	TO	O
baseline	VB	O
neuro	JJ	O
status	NN	O
without	IN	O
deficits	NNS	B-PROBLEM
by	IN	O
arrival	NN	O
to	TO	O
CSRU	NNP	O
.	.	O

Neurology	NNP	O
concluded	VBD	O
episode	NN	B-PROBLEM
was	VBD	O
most	RBS	O
concerning	VBG	O
for	IN	O
TIA	NNP	B-PROBLEM
.	.	O

Epicardial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
four	CD	O
.	.	O

After	IN	O
remaining	VBG	O
stable	JJ	O
in	IN	O
the	DT	O
CSRU	NNP	O
for	IN	O
several	JJ	O
days	NNS	O
without	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
neuro	NN	I-PROBLEM
status	NN	I-PROBLEM
she	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
SDU	NNP	O
on	IN	O
post-op	JJ	O
day	NN	O
four	CD	O
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
started	VBN	O
on	IN	O
Heparin	NNP	B-TREATMENT
with	IN	O
transition	NN	O
to	TO	O
Coumadin	NNP	B-TREATMENT
(	(	O
goal	NN	O
INR	NNP	B-TEST
of	IN	O
2-3	JJ	O
secondary	JJ	O
to	TO	O
h/o	VB	O
bilateral	JJ	B-PROBLEM
DVT	NNP	I-PROBLEM
's).	POS	O

complications	NNS	B-PROBLEM
.	.	O

Meds	NNS	B-TREATMENT
at	IN	O
home	NN	O
:	:	O
Coumadin	NNP	B-TREATMENT
,	,	O
Levoxyl	NNP	B-TREATMENT
,	,	O
Folate	NNP	B-TREATMENT
,	,	O
Colace	NNP	B-TREATMENT
,	,	O
Byetta	NNP	B-TREATMENT
,	,	O
Verapamil	NNP	B-TREATMENT
,	,	O
Lisinopril	NNP	B-TREATMENT
,	,	O
Pravachol	NNP	B-TREATMENT
,	,	O
Nexium	NNP	B-TREATMENT
,	,	O
Lasix	NNP	B-TREATMENT
,	,	O
Celexa	NNP	B-TREATMENT

Meds	NNS	B-TREATMENT
at	IN	O
transfer	NN	O
:	:	O
Levoxyl	NNP	B-TREATMENT
,	,	O
Celexa	NNP	B-TREATMENT
,	,	O
Folate	NNP	B-TREATMENT
,	,	O
Lopressor	NNP	B-TREATMENT
,	,	O
Colace	NNP	B-TREATMENT
,	,	O
RISS	NNP	B-TREATMENT
,	,	O
B12	NNP	B-TREATMENT
,	,	O
Protonix	NNP	B-TREATMENT
,	,	O
Lasix	NNP	B-TREATMENT
,	,	O
Zocor	NNP	B-TREATMENT
,	,	O
Verapamil	NNP	B-TREATMENT
,	,	O
Lovenox	NNP	B-TREATMENT
,	,	O
Lisinopril	NNP	B-TREATMENT

1.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

3.	CD	O
Levothyroxine	NNP	B-TREATMENT
125	CD	O
mcg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

4.	CD	O
Simvastatin	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

5.	CD	O
Citalopram	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

6.	CD	O
Clopidogrel	NNP	B-TREATMENT
75	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

7.	CD	O
Ferrous	JJ	B-TREATMENT
Gluconate	NNP	I-TREATMENT
300	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

8.	CD	O
Ascorbic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
Folic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

10.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

11.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

12.	CD	O
Coumadin	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
Check	VB	O
INR	NNP	B-TEST
11-15	JJ	O
with	IN	O
results	NNS	O
called	VBN	O
to	TO	O
Dr.	NNP	O
Lynn	NNP	O
.	.	O

13.	CD	O
Tramadol	NNP	B-TREATMENT
50	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
40	CD	O
mg	NNS	O
daily	JJ	O
x	RB	O
1	CD	O
week	NN	O
then	RB	O
40	CD	O
mg	NNS	O
every	DT	O
other	JJ	O
day	NN	O
as	IN	O
prior	JJ	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

Coronary	JJ	B-PROBLEM
Artery	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM
s/p	VBD	O
Coronary	NNP	B-TREATMENT
Artery	NNP	I-TREATMENT
Bypass	NNP	I-TREATMENT
Graft	NNP	I-TREATMENT
x	VBD	O
2	CD	O

Post-operative	JJ	B-PROBLEM
Transient	NNP	I-PROBLEM
Ischemic	NNP	I-PROBLEM
Attack	NNP	I-PROBLEM

Carotid	NNP	B-PROBLEM
Stenosis	NNP	I-PROBLEM
s/p	NN	O
Left	NNP	B-TREATMENT
Carotid	NNP	I-TREATMENT
Stenting	VBG	I-TREATMENT

PMH	NN	O
:	:	O
Hypertension	NN	B-PROBLEM
,	,	O
Hyperlipidemia	NNP	B-PROBLEM
,	,	O
Diabetes	NNP	B-PROBLEM
Mellitus	NNP	I-PROBLEM
,	,	O
Hypothyroid	NNP	B-PROBLEM
,	,	O
h/o	JJ	O
Bilateral	NNP	B-PROBLEM
DVT	NNP	I-PROBLEM
's,	POS	I-PROBLEM
Pleural	NNP	B-PROBLEM
disorder	NN	I-PROBLEM
?	.	O
Sarcoidosis	NNP	B-PROBLEM
,	,	O
Gastritis	NNP	B-PROBLEM
,	,	O
B12	NNP	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
s/p	JJ	O
Appendectomy	NNP	B-TREATMENT
,	,	O
s/p	NN	O
Lap	NNP	B-TREATMENT
cholectomy	NN	I-TREATMENT
,	,	O
s/p	JJ	O
Total	NNP	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT

No	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
or	CC	O
ointments	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM
.	.	O

No	DT	O
lifting	VBG	O
more	JJR	O
than	IN	O
10	CD	O
lbs	NN	O
for	IN	O
at	IN	O
least	JJS	O
10	CD	O
weeks	NNS	O
from	IN	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

Monitor	NNP	O
wounds	VBZ	B-PROBLEM
for	IN	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O
Please	VB	O
call	JJ	O
with	IN	O
any	DT	O
concerns	NNS	O
or	CC	O
questions	NNS	O
.	.	O

Briefly	NNP	O
,	,	O
this	DT	O
is	VBZ	O
a	DT	O
57-year-old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
COPD	NNP	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
intubation	NN	B-TREATMENT
six	CD	O
years	NNS	O
ago	RB	O
but	CC	O
not	RB	O
on	IN	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
with	IN	O
recent	JJ	O
FEV1	NNP	B-TEST
27%	CD	O
of	IN	O
predicted	VBN	O
value	NN	O
,	,	O
and	CC	O
FEV1/FVC	NNP	B-TEST
ratio	VBP	I-TEST
56%	CD	O
of	IN	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
for	IN	O
COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
worsening	NN	O
of	IN	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
for	IN	O
a	DT	O
week	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

He	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
on	IN	O
presentation	NN	O
to	TO	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
to	TO	O
CMED	NNP	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
but	CC	O
he	PRP	O
appeared	VBD	O
in	IN	O
more	RBR	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
overnight	NN	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
IV	NNP	B-TREATMENT
Solu-Medrol	NNP	I-TREATMENT
and	CC	O
more	RBR	B-TREATMENT
frequent	JJ	I-TREATMENT
nebulizers	NNS	I-TREATMENT
for	IN	O
COPD	NNP	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
for	IN	O
possible	JJ	O
bronchitis	NN	B-PROBLEM
or	CC	O
community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Given	VBN	O
his	PRP$	B-PROBLEM
tenuous	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
FICU	NNP	O
with	IN	O
closer	JJR	B-TEST
observation	NN	I-TEST
.	.	O

He	PRP	O
did	VBD	O
not	RB	O
require	VB	O
intubation	NN	B-TREATMENT
and	CC	O
improved	VBN	O
with	IN	O
q.	JJ	O
two	CD	O
hour	NN	O
nebulizers	NNS	B-TREATMENT
and	CC	O
chest	JJS	B-TREATMENT
PT	NNP	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
again	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
CMED	NNP	O
Service	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
COPD	NNP	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
prednisone	NN	I-TREATMENT
and	CC	O
frequent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
for	IN	O
COPD	NNP	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
physical	JJ	O
therapist	NN	O
in	IN	O
the	DT	O
hospital	NN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
desaturate	VB	B-PROBLEM
to	TO	O
84%	CD	O
with	IN	O
ambulating	VBG	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Therefore	RB	O
,	,	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
was	VBD	O
recommended	VBN	O
on	IN	O
discharge	NN	O
.	.	O

1.	CD	O
Chronic	NNP	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

2.	CD	O
Bronchitis	NNP	B-PROBLEM
.	.	O

3.	CD	O
Community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

4.	CD	O
Rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

1.	CD	O
Flovent	NNP	B-TREATMENT
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

2.	CD	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
another	DT	O
11	CD	O
days	NNS	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
.	.	O

3.	CD	O
Albuterol	NNP	B-TREATMENT
inhaler	NN	I-TREATMENT
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

4.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
Salmeterol	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

6.	CD	O
Oxygen	NNP	B-TREATMENT
2	CD	I-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
with	IN	O
ambulating	VBG	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
Prednisone	NNP	B-TREATMENT
taper	NN	I-TREATMENT
with	IN	O
40	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NNS	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
year	NN	O
old	JJ	O
male	NN	O
,	,	O
with	IN	O
end	JJ	B-PROBLEM
stage	NN	I-PROBLEM
liver	JJ	I-PROBLEM
disease	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
hepatitis	VB	B-PROBLEM
C	NNP	I-PROBLEM
cirrhosis	NN	I-PROBLEM
diagnosed	VBD	O
about	IN	O
5	CD	O
years	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
undergone	JJ	O
treatment	NN	B-TREATMENT
with	IN	O
interferon	NN	B-TREATMENT
and	CC	O
Ribavirin	NNP	B-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
been	VBN	O
admitted	VBN	O
to	TO	O
the	DT	O
St.	NNP	O
Margaret	NNP	O
's	POS	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
multiple	JJ	O
times	NNS	O
early	RB	O
in	IN	O
2013	CD	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
encephalopathy	NN	B-PROBLEM
and	CC	O
ascites	NNS	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
discharged	VBN	O
from	IN	O
the	DT	O
St.	NNP	O
Margaret	NNP	O
's	POS	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
on	IN	O
2013-05-06	JJ	O
,	,	O
but	CC	O
was	VBD	O
readmitted	VBN	O
on	IN	O
2013-05-09	JJ	O
when	WRB	O
noted	VBN	O
to	TO	O
have	VB	O
worsening	VBG	B-PROBLEM
renal	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
serum	JJ	I-TEST
creatinine	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
on	IN	O
2013-05-06	JJ	O
,	,	O
was	VBD	O
1.9	CD	O
,	,	O
but	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
increase	VB	O
to	TO	O

3.2	CD	O
on	IN	O
2013-05-08	JJ	O
,	,	O
and	CC	O
was	VBD	O
further	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
to	TO	O
3.6	CD	O
on	IN	O
2013-05-09	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
concern	NN	O
for	IN	O
hepatorenal	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

1.	CD	O
Hepatitis	NNP	B-PROBLEM
C	NNP	I-PROBLEM
cirrhosis	NN	I-PROBLEM
for	IN	O
which	WDT	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
the	DT	O
liver	NN	O
transplant	JJ	O
list	NN	O
.	.	O

2.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

3.	CD	O
Nephrolithiasis	NN	B-PROBLEM
.	.	O

4.	CD	O
Hemorrhoids	NNP	B-PROBLEM
.	.	O

5.	CD	O
Knee	NNP	B-TREATMENT
surgeries	NNS	I-TREATMENT
.	.	O

6.	CD	O
Back	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

1.	CD	O
Miconazole	NNP	B-TREATMENT
nitrate	JJ	I-TREATMENT
powder	NN	I-TREATMENT
tid	NN	O
prn	NN	O
for	IN	O
groin	NN	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

2.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

3.	CD	O
Lactulose	JJ	B-TREATMENT
30	CD	O
ml	NN	O
tid	NN	O
(	(	O
titrated	VBN	O
to	TO	O
4	CD	O
to	TO	O
5	CD	O
bowel	NN	O
movements	NNS	O
qd	NN	O
)	)	O
.	.	O

4.	CD	O
Vancomycin	NNP	B-TREATMENT
1	CD	O
gm	NN	O
IV	NNP	O
bid	NN	O
.	.	O

As	IN	O
previously	RB	O
mentioned	VBN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
up	RB	O
to	TO	O
3.6	CD	O
from	IN	O
1.9	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
discharge	NN	O
3	CD	O
days	NNS	O
prior	RB	O
.	.	O

Over	IN	O
the	DT	O
following	JJ	O
5	CD	O
days	NNS	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
improved	VBN	O
marginally	RB	O
to	TO	O
2.7	CD	O
.	.	O

Optimization	NN	O
of	IN	O
his	PRP$	B-TEST
fluid	NN	I-TEST
balance	NN	I-TEST
was	VBD	O
managed	VBN	O
by	IN	O
the	DT	O
medical	JJ	O
service	NN	O
in	IN	O
consultation	NN	O
with	IN	O
hepatology	NN	O
and	CC	O
renal	NN	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
INR	NNP	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
2.4	CD	O
,	,	O
with	IN	O
his	PRP$	B-TEST
PT	NNP	I-TEST
level	NN	I-TEST
being	VBG	O
18.9	CD	O
.	.	O

The	DT	O
patient	NN	O
periodically	RB	O
required	JJ	O
transfusions	NNS	B-TREATMENT
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
platelets	NNS	B-TREATMENT
and	CC	O
red	JJ	B-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
thrombocytopenic	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
of	IN	O
49	CD	O
on	IN	O
the	DT	O
23	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
previously	RB	I-PROBLEM
diagnosed	VBN	I-PROBLEM
Methicillin	NNP	I-PROBLEM
resistant	NN	I-PROBLEM
,	,	I-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	I-PROBLEM
Staph	NNP	I-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
's	POS	O
nutrition	NN	O
was	VBD	O
suboptimal	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeding	NN	I-TREATMENT
.	.	O

The	DT	O
patient	JJ	O
underwent	JJ	O
diagnostic	JJ	O
and	CC	O
therapeutic	JJ	B-TREATMENT
paracentesis	NN	I-TREATMENT
on	IN	O
2013-05-16	JJ	O
,	,	O
2013-05-21	JJ	O
,	,	O
and	CC	O
2013-05-24	JJ	O
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
spontaneous	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
peritonitis	NN	I-PROBLEM
.	.	O

On	IN	O
2013-05-25	JJ	O
,	,	O
a	DT	O
liver	NN	O
became	VBD	O
available	JJ	O
for	IN	O
transplant	NN	B-TREATMENT
to	TO	O
the	DT	O
patient	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
and	CC	O
underwent	JJ	O
an	DT	B-TREATMENT
orthotopic	NN	I-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

In	IN	O
order	NN	O
to	TO	O
aid	NN	O
in	IN	O
optimization	NN	O
of	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
fluid	NN	I-TEST
status	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
continuous	JJ	B-TREATMENT
Baker	NNP	I-TREATMENT
Baker	NNP	I-TREATMENT
dialysis	NN	I-TREATMENT
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

His	PRP$	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
2	CD	O
liters	NNS	O
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
5	CD	O
liters	NNS	O
of	IN	O
crystalloid	NN	B-TREATMENT
,	,	O
9	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
9	CD	O
units	NNS	O
of	IN	O
red	JJ	B-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
6	CD	O
units	NNS	O
of	IN	O
platelets	NNS	B-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
1	CD	O
liter	NN	O
of	IN	O
Cell	NNP	B-TREATMENT
Saver	NNP	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
procedure	NN	I-TREATMENT
proceeded	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
while	IN	O
still	RB	O
intubated	VBN	B-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

By	IN	O
postop	JJ	O
day	NN	O
1	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
in	IN	O
no	DT	O
distress	NN	B-PROBLEM
,	,	O
and	CC	O
appeared	VBD	O
lucid	RB	O
prior	JJ	O
to	TO	O
extubation	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
without	IN	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
on	IN	O
a	DT	B-TREATMENT
Lasix	NNP	I-TREATMENT
drip	NN	I-TREATMENT
to	TO	O
aid	NN	O
in	IN	O
diuresis	NN	B-TREATMENT
,	,	O
and	CC	O
was	VBD	O
ultimately	RB	O
converted	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
pain	NN	I-TREATMENT
control	NN	I-TREATMENT
was	VBD	O
with	IN	O
morphine	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
required	VBD	O
2	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
on	IN	O
the	DT	O
night	NN	O
following	VBG	O
surgery	NN	B-TREATMENT
,	,	O
and	CC	O
1	CD	O
unit	NN	O
of	IN	O
platelets	NNS	B-TREATMENT
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
,	,	O
but	CC	O
otherwise	RB	O
required	JJ	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
advanced	VBN	O
per	IN	O
protocol	NN	O
to	TO	O
an	DT	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT
regimen	NN	I-TREATMENT
of	IN	O
prednisone	NN	B-TREATMENT
,	,	O
Neoral	NNP	B-TREATMENT
,	,	O
and	CC	O
CellCept	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
started	VBD	O
ambulating	VBG	O
with	IN	O
the	DT	O
assistance	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
following	VBG	O
transfer	NN	O
to	TO	O
the	DT	O
surgical	JJ	O
floor	NN	O
.	.	O

The	DT	O
patient	NN	O
's	POS	O
appetite	NN	O
improved	VBD	O
significantly	RB	O
,	,	O
and	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
a	DT	O
regular	JJ	O
diet	NN	O
with	IN	O
no	DT	O
tube	NN	B-TREATMENT
feed	VBD	I-TREATMENT
supplements	NNS	I-TREATMENT
deemed	VBN	O
necessary	JJ	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
all	DT	O
improved	VBN	O
appropriately	RB	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
surgical	JJ	I-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
also	RB	O
healing	VBG	O
well	RB	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

1.	CD	O
Bactrim	NNP	B-TREATMENT
single	JJ	I-TREATMENT
strength	NN	I-TREATMENT
1	CD	O
tablet	NN	O
po	NN	O
qd	NN	O
.	.	O

2.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

3.	CD	O
Metoprolol	NNP	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

4.	CD	O
Fluconazole	NNP	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

5.	CD	O
CellCept	NNP	B-TREATMENT
1	CD	O
gm	NN	O
po	NN	O
bid	NN	O
.	.	O

6.	CD	O
Prednisone	CD	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

7.	CD	O
Dilaudid	NNP	B-TREATMENT
prn	NN	O
.	.	O

8.	CD	O
Neoral	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

9.	CD	O
Valcyte	NNP	B-TREATMENT
450	CD	O
mg	NN	O
po	NN	O
qod	NN	O
.	.	O

10.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
bid	NN	O
x	VBZ	O
21	CD	O
days	NNS	O
.	.	O

11.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

Liver	NNP	B-TREATMENT
transplant	NN	I-TREATMENT
on	IN	O
2013-05-25	JJ	O
.	.	O

Cadaveric	NNP	B-TREATMENT
pancreas	JJ	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
37	CD	O
year	NN	O
old	JJ	O
lady	NN	O
with	IN	O
type	JJ	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RB	I-PROBLEM
,	,	O
who	WP	O
is	VBZ	O
four	CD	O
months	NNS	O
postcadaveric	JJ	B-TREATMENT
kidney	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
and	CC	O
now	RB	O
has	VBZ	O
good	JJ	O
graft	NN	O
function	NN	O
.	.	O

She	PRP	O
presents	VBZ	O
for	IN	O
cadaveric	JJ	B-TREATMENT
pancreas	JJ	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

Her	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
complicated	VBN	O
by	IN	O
retinopathy	NN	B-PROBLEM
and	CC	O
nephropathy	JJ	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

She	PRP	O
takes	VBZ	O
14	CD	O
units	NNS	O
of	IN	O
NPH	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
supplementing	VBG	O
with	IN	O
a	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

On	IN	O
examination	NN	B-TEST
,	,	O
she	PRP	O
is	VBZ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
is	VBZ	O
alert	JJ	O
and	CC	O
oriented	VBN	O
.	.	O

Her	PRP$	B-TEST
chest	NN	I-TEST
and	CC	I-TEST
cardiovascular	JJ	I-TEST
examinations	NNS	I-TEST
are	VBP	O
unremarkable	JJ	O
.	.	O

She	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

Her	PRP$	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
well	NN	I-PROBLEM
healed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	JJ	I-PROBLEM
incision	NN	I-PROBLEM
from	IN	O
her	PRP$	B-TREATMENT
kidney	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

She	PRP	O
underwent	JJ	O
cadaveric	JJ	B-TREATMENT
pancreas	NNS	I-TREATMENT
transplantation	NN	I-TREATMENT
without	IN	O
complication	NN	B-PROBLEM
.	.	O

She	PRP	O
received	VBD	O
induction	NN	B-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
thymoglobulin	JJ	B-TREATMENT
intraoperative	JJ	O
and	CC	O
postoperatively	RB	O
for	IN	O
five	CD	O
days	NNS	O
.	.	O

She	PRP	O
was	VBD	O
kept	VBN	O
on	IN	O
a	DT	B-TREATMENT
similar	JJ	I-TREATMENT
immunosuppressive	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
as	IN	O
with	IN	O
her	PRP$	B-TREATMENT
kidney	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

She	PRP	O
is	VBZ	O
to	TO	O
continue	VB	O
monitoring	VBG	O
her	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
twice	RB	O
a	DT	O
day	NN	O
.	.	O

She	PRP	O
has	VBZ	O
undergone	JJ	O
full	JJ	O
teaching	NN	O
in	IN	O
regards	NNS	O
to	TO	O
immunosuppressant	VB	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
she	PRP	O
will	MD	O
take	VB	O
Valganciclovir	NNP	B-TREATMENT
for	IN	O
three	CD	O
months	NNS	O
posttransplant	VBP	O
.	.	O

1.	CD	O
Status	NNP	O
post	NN	O
cadaveric	NN	B-TREATMENT
pancreas	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

2.	CD	O
Type	NNP	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

3.	CD	O
End	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
kidney	NN	B-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

Penicillins	NNS	B-TREATMENT
/	VBP	O
Sulfonamides	NNS	B-TREATMENT

Benzo	NNP	B-PROBLEM
overdose	NN	I-PROBLEM

Intubation	NN	B-TREATMENT
for	IN	I-TREATMENT
airway	NN	I-TREATMENT
protection	NN	I-TREATMENT

Ms.	NNP	O
Franklin	NNP	O
is	VBZ	O
a	DT	O
34	CD	O
-	:	O
year-old	JJ	O
woman	NN	O
with	IN	O
Bipolar	NNP	B-PROBLEM
disorder	NN	I-PROBLEM
and	CC	O
group	NN	O
home	NN	O
resident	NN	O
who	WP	O
by	IN	O
way	NN	O
of	IN	O
EMS	NNP	O
for	IN	O
apparent	JJ	B-PROBLEM
alprazolam	NN	I-PROBLEM
overdose	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
St.	NNP	O
Margaret	NNP	O
's	POS	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
lethargic	JJ	B-PROBLEM
and	CC	O
unable	JJ	O
to	TO	O
give	VB	O
a	DT	O
history	NN	O
.	.	O

She	PRP	O
was	VBD	O
promptly	RB	O
intubated	VBN	O
for	IN	O
airway	NN	O
protection	NN	O
and	CC	O
in	IN	O
order	NN	O
to	TO	O
administer	VB	O
charcoal	NN	B-TREATMENT
.	.	O

Patient	NN	O
was	VBD	O
found	VBN	O
at	IN	O
group	NN	O
home	NN	O
in	IN	O
am	VBP	O
laying	VBG	O
on	IN	O
floor	NN	O
by	IN	O
bed	NN	O
unresponsive	JJ	B-PROBLEM
,	,	O
last	JJ	O
seen	VBN	O
awake	RB	O
8	CD	O
hours	NNS	O
prior	RB	O
at	IN	O
dinner	NN	O
.	.	O

Group	NNP	O
home	NN	O
states	NNS	O
that	WDT	O
patient	VBP	O
"	NN	O
may	MD	O
have	VB	O
taken	VBN	O
too	RB	O
many	JJ	O
Xanax	NNP	B-TREATMENT
.	.	O

Patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
suicidal	JJ	B-PROBLEM
ideations	NNS	I-PROBLEM
and	CC	O
self	JJ	B-PROBLEM
mutilation	NN	I-PROBLEM
.	.	O

Later	RB	O
patient	JJ	O
told	VBD	O
CMED	NNP	O
CCU	NNP	O
that	IN	O
she	PRP	O
was	VBD	O
feeling	VBG	O
down	RB	O
and	CC	O
impulsively	RB	O
ingested	JJ	O
5	CD	O
days	NNS	O
worth	IN	O
of	IN	O
medications	NNS	B-TREATMENT
,	,	O
she	PRP	O
states	VBZ	O
that	IN	O
her	PRP$	O
intent	NN	O
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
to	TO	O
end	VB	O
her	PRP$	O
life	NN	O
.	.	O

1.	CD	O
Bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

2.	CD	O
Asthma	NNP	B-PROBLEM
.	.	O

3.	CD	O
Posttraumatic	JJ	B-PROBLEM
stress	NN	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

4.	CD	O
GERD	NNP	B-PROBLEM

5.	CD	O
Chronic	JJ	B-PROBLEM
constipation	NN	I-PROBLEM
from	IN	O
laxative	JJ	B-PROBLEM
abuse	NN	I-PROBLEM
.	.	O

Two	CD	O
sisters	NNS	O
with	IN	O
h/o	JJ	O
depression	NN	B-PROBLEM
and	CC	O
suicidality	NN	B-PROBLEM
.	.	O

VS	NNP	B-TEST
95.4	CD	O
HR	NNP	B-TEST
62	CD	O
BP	NNP	B-TEST
99/70	CD	O
RR	NNP	B-TEST
20	CD	O
O2Sat	NNP	B-TEST
100%	CD	O

Intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT

ATNC	NNP	B-PROBLEM
,	,	O
Pupils	NNP	O
dialted	VBD	O
at	IN	O
5	CD	O
mm	NNS	O
but	CC	O
minimally	RB	B-PROBLEM
reactive	JJ	I-PROBLEM
,	,	O
anicteric	JJ	B-PROBLEM

RR	NNP	O
nl	CC	O
S1	NNP	O
S2	NNP	O
no	DT	O
m	NN	B-PROBLEM

Soft	NNP	O
,	,	O
nd	RB	B-PROBLEM
,	,	O
hypoactive	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM

WWP	NNP	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
linear	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
and	CC	O
burns	NNS	B-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
arms	NNS	I-PROBLEM

Sedated	VBN	B-TREATMENT
,	,	O
DTRs	NNP	B-TEST
:	:	O

No	DT	O
rashes	NNS	B-PROBLEM
or	CC	O
petechiae	NN	B-PROBLEM
,	,	O
linear	JJ	B-PROBLEM
and	CC	I-PROBLEM
burn	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
as	IN	O
above	IN	O

WBC	NNP	B-TEST
-	:	O
9.4	CD	O
#	#	O
RBC	NNP	B-TEST
-	:	O
4.75	CD	O
HGB	NNP	B-TEST
-	:	O
14.7	CD	O
HCT	NNP	B-TEST
-	:	O
42.2	CD	O
MCV	NNP	B-TEST
-	:	O
89	CD	O
MCH	NNP	B-TEST
-	:	O
30.9	CD	O
MCHC	NNP	B-TEST
-	:	O
34.8	CD	O
RDW	NNP	B-TEST
-	:	O
13.6	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
330	CD	O

NEUTS	NNP	B-TEST
-	:	O
73.0	CD	O
*	NN	O
LYMPHS	NNP	B-TEST
-	:	O
21.8	CD	O
MONOS	NNP	B-TEST
-	:	O
3.8	CD	O
EOS	NNP	B-TEST
-	:	O
1.1	CD	O
BASOS	NNP	B-TEST
-	:	O
0.3	CD	O

ASA	NNP	B-TEST
-	:	O
NEG	NNP	O
ETHANOL	NNP	B-TEST
-	:	O
NEG	NNP	O
ACETMNPHN	NNP	B-TEST
-	:	O
NEG	NNP	O
bnzodzpn	SYM	B-TEST
-	:	O
NEG	NNP	O
barbitrt	SYM	B-TEST
-	:	O
NEG	NNP	O
tricyclic	JJ	B-TEST
-	:	O
POS	NN	O

LITHIUM	NNP	B-TEST
-	:	O
LESS	JJR	O
THAN	NN	O

DIGOXIN	NNP	B-TEST
-<	VBD	O
0.2	CD	O
*	NN	O

GLUCOSE	NNP	B-TEST
-	:	O
116	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
14	CD	O
CREAT	NNP	B-TEST
-	:	O
1.0	CD	O
SODIUM	NNP	B-TEST
-	:	O
137	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.5	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
105	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
20	CD	O
*	JJ	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
17	CD	O

CALCIUM	NNP	B-TEST
-	:	O
9.7	CD	O
PHOSPHATE	NNP	B-TEST
-	:	O
3.7	CD	O
MAGNESIUM	NNP	B-TEST
-	:	O
2.1	CD	O

ALT	NNP	B-TEST
(	(	I-TEST
SGPT	NNP	I-TEST
)-	CD	I-TEST
21	CD	O
AST	NNP	B-TEST
(	(	I-TEST
SGOT	NNP	I-TEST
)-	RB	O
40	CD	O
ALK	NNP	B-TEST
PHOS	NNP	I-TEST
-	:	O
70	CD	O
AMYLASE	NNP	B-TEST
-	:	O
59	CD	O
TOT	NNP	B-TEST
BILI	NNP	I-TEST
-	:	O
0.4	CD	O

LIPASE	NNP	B-TEST
-	:	O
66	CD	O
*	NN	O

2014-04-23	JJ	O
08:00	CD	O
AM	NNP	O
URINE	NNP	B-TEST

BLOOD	NNP	B-TEST
-	:	O
NEG	NNP	O
NITRITE	NNP	B-TEST
-	:	O
NEG	NNP	O
PROTEIN	NNP	B-TEST
-	:	O
NEG	NNP	O
GLUCOSE	NNP	B-TEST
-	:	O
NEG	NNP	O
KETONE	NNP	B-TEST
-	:	O
TR	NNP	O
BILIRUBIN	NNP	B-TEST
-	:	O
NEG	NNP	O
UROBILNGN	NNP	B-TEST
-	:	O
NEG	NNP	O
PH	NNP	B-TEST
-	:	O
6.5	CD	O
LEUK	NNP	B-TEST
-	:	O
NEG	NN	O

2014-04-23	JJ	O
08:13	CD	O
AM	NNP	O
URINE	NNP	B-TEST
bnzodzpn	SYM	B-TEST
-	:	O
POS	NNP	O
barbitrt	SYM	B-TEST
-	:	O
NEG	NN	O
opiates	VBZ	B-TEST
-	:	O
NEG	NNP	O
cocaine	NN	B-TEST
-	:	O
NEG	NNP	O
amphetmn	SYM	B-TEST
-	:	O
NEG	NNP	O
mthdone	SYM	B-TEST
-	:	O
NEG	NN	O

CK	NNP	B-TEST
(	(	I-TEST
CPK	NNP	I-TEST
)-	JJ	I-TEST
4713	CD	O
*	NN	O

2014-04-23	JJ	O
03:45	CD	O
PM	NNP	O
URINE	NNP	B-TEST

UCG	NNP	B-TEST
-	:	O
NEGATIVE	NN	O

D-DIMER	NNP	B-TEST
-	:	O
7998	CD	O
*	NN	O

CXR	NN	B-TEST
:	:	O

Probable	JJ	O
ateletasis	NN	B-PROBLEM
of	IN	I-PROBLEM
lingula	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
pneumonitis	NN	B-PROBLEM

EKG	NN	B-TEST
:	:	O

NSR	NNP	O
R	NNP	B-TEST
60	CD	O
Normal	NNP	O
axis	NN	O
,	,	O
intervals	NNS	O
,	,	O
incomplete	JJ	B-PROBLEM
RBBB	NNP	I-PROBLEM
,	,	O
flat	JJ	B-PROBLEM
T	NNP	I-PROBLEM
aVL	NN	I-PROBLEM
,	,	O
V2	NNP	O
,	,	O
TWI	NNP	B-PROBLEM
V1	NNP	I-PROBLEM

CT	NNP	B-TEST
Chest	NNP	I-TEST
-	:	O
shows	VBZ	O
bilateral	JJ	B-PROBLEM
segmental	NN	I-PROBLEM
,	,	I-PROBLEM
subsegmental	JJ	I-PROBLEM
PEs	NNP	I-PROBLEM

B/L	NNP	B-TEST
LE	NNP	I-TEST
LENIs	NNP	I-TEST
-	:	O
negative	JJ	O

Patient	NN	O
was	VBD	O
intubated	VBN	O
in	IN	O
John	NNP	O
for	IN	O
airway	NN	O
protection	NN	O
and	CC	O
administation	NN	O
of	IN	O
charcoal	NN	B-TREATMENT
.	.	O

Toxicology	NNP	O
consulted	VBD	O
and	CC	O
felt	VBD	O
that	DT	O
patient	NN	O
most	RBS	O
likely	JJ	O
had	VBD	O
benzo	VBN	B-PROBLEM
overdose	RB	I-PROBLEM
.	.	O

ABG	NNP	B-TEST
revealed	VBD	O
widened	VBD	B-PROBLEM
A-a	NNP	I-PROBLEM
gradient	NN	I-PROBLEM
so	RB	O
a	DT	B-TEST
d-dimer	NN	I-TEST
was	VBD	O
sent	VBN	O
which	WDT	O
was	VBD	O
elevated	VBN	B-PROBLEM
.	.	O

Patient	NN	O
had	VBD	O
CTA	NNP	B-TEST
which	WDT	O
showed	VBD	O
bilateral	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolisms	NNS	I-PROBLEM
.	.	O

Patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TEST
lower	JJR	I-TEST
extremeties	NNS	I-TEST
were	VBD	O
done	VBN	O
which	WDT	O
were	VBD	O
negative	JJ	O
for	IN	O
DVT	NNP	B-PROBLEM
.	.	O

Overnight	NNP	O
in	IN	O
the	DT	O
ICU	NNP	O
patient	NN	O
was	VBD	O
noticed	VBN	O
to	TO	O
have	VB	O
painful	JJ	B-PROBLEM
bullae	NN	I-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
along	IN	O
with	IN	O
swelling	NN	B-PROBLEM
.	.	O

Dermatology	NNP	O
and	CC	O
plastic	NN	O
surgery	NN	O
were	VBD	O
consulted	VBN	O
who	WP	O
felt	VBD	O
that	IN	O
symptoms	NNS	B-PROBLEM
were	VBD	O
due	JJ	O
to	TO	O
trauma	VB	B-PROBLEM
;	:	O
it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
that	IN	O
patient	NN	O
had	VBD	O
compartment	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

Patient	NN	O
was	VBD	O
gradually	RB	O
put	VBN	O
back	RP	O
on	IN	O
her	PRP$	B-TREATMENT
outpatient	JJ	I-TREATMENT
xanax	NN	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
1	CD	O
mg	NNS	O
qid	NN	O
and	CC	O
clozaril	NN	B-TREATMENT
was	VBD	O
restarted	VBN	O
.	.	O

Plastic	NN	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
patient	NN	O
had	VBD	O
any	DT	B-PROBLEM
compartment	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
recommended	VBD	O
aggresive	JJ	B-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
elevation	NN	I-TREATMENT
for	IN	O
swelling	VBG	B-TREATMENT
reduction	NN	I-TREATMENT
.	.	O

While	IN	O
on	IN	O
the	DT	O
floor	NN	O
patient	NN	O
's	POS	O
hands	NNS	O
improved	VBN	O
with	IN	O
good	JJ	O
range	NN	O
of	IN	O
motion	NN	O
of	IN	O
left	JJ	O
hand	NN	O
,	,	O
however	RB	O
Jones	NNP	O
some	DT	B-PROBLEM
poor	JJ	I-PROBLEM
range	NN	I-PROBLEM
of	IN	I-PROBLEM
motion	NN	I-PROBLEM
of	IN	O
right	NN	O
.	.	O

X-ray	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
hands	NNS	I-TEST
and	CC	I-TEST
wrist	NN	I-TEST
were	VBD	O
obtained	VBN	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

Patient	NN	O
seen	VBN	O
by	IN	O
PT	NNP	O
and	CC	O
OT	NNP	O
who	WP	O
recommended	VBD	O
hand	NN	B-TREATMENT
exercises	NNS	I-TREATMENT
and	CC	O
splints	NNS	B-TREATMENT
for	IN	O
patient	NN	O
.	.	O

Patient	NN	O
was	VBD	O
put	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
that	WDT	O
was	VBD	O
bridged	VBN	O
with	IN	O
lovenox	JJ	B-TREATMENT
unti	JJ	O
lINR	JJ	B-TREATMENT
theraputic	JJ	I-TREATMENT
01-23	NN	O
.	.	O

Patient	NNP	O
conitnued	VBD	O
to	TO	O
have	VB	O
SI	NNP	B-PROBLEM
while	IN	O
on	IN	O
floor	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
psychiatry	VB	O
.	.	O

While	IN	O
on	IN	O
the	DT	O
floor	NN	O
patient	NN	B-TEST
's	POS	I-TEST
urinalysis	JJ	I-TEST
suggestive	NN	O
of	IN	O
UTI	NNP	B-PROBLEM
and	CC	O
was	VBD	O
put	VBN	O
on	IN	O
6	CD	O
day	NN	O
course	NN	O
of	IN	O
levofloxacin	NN	B-TREATMENT
.	.	O

Propanolol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
80	CD	O
mg	NN	O
qd	NN	O

Modifinal	JJ	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qd	NN	O

Lamictal	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

Alprazolam	$	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qid	NN	O

Senna	NN	B-TREATMENT

Trazadone	CD	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

Clomipramine	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

Pantopraozle	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O

Clozapine	NNP	B-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

Folate	NNP	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qd	NN	O

Multivitamin	NN	B-TREATMENT

1.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
Lamotrigine	NNP	B-TREATMENT
100	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
Pantoprazole	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

4.	CD	O
Folic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

5.	CD	O
Multivitamin	NNP	B-TREATMENT
Capsule	NNP	I-TREATMENT
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Cap	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

6.	CD	O
Senna	NNP	B-TREATMENT
8.6	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
Clozapine	NNP	B-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

8.	CD	O
Warfarin	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
3	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
PO	NNP	O
at	IN	O
bedtime	NN	O
.	.	O

9.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
Trazodone	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
Alprazolam	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

13.	CD	O
Bisacodyl	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
Nicotine	NNP	B-TREATMENT
14	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
Patch	NNP	O
24	CD	O
HR	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Patch	VB	O
24	CD	O
HR	NNP	O
Transdermal	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
.	.	O

Benzodiazapine	NNP	B-PROBLEM
Overdose	NNP	I-PROBLEM

Traumatic	JJ	B-PROBLEM
/	NNP	I-PROBLEM
pressure	NN	I-PROBLEM
bullae	NN	I-PROBLEM

Bipolar	JJ	B-PROBLEM
Disorder	NN	I-PROBLEM

Stable	JJ	O
-	:	O
Swelling	VBG	B-PROBLEM
in	IN	I-PROBLEM
hands	NNS	I-PROBLEM
reduced	VBN	O
and	CC	O
range	NN	O
of	IN	O
motion	NN	O
continue	NN	O
to	TO	O
improve	VB	O
.	.	O

Please	NNP	O
continue	VBP	O
to	TO	O
take	VB	O
coumadin	NN	B-TREATMENT
as	IN	O
directed	VBN	O
by	IN	O
your	PRP$	O
doctors	NNS	O
until	IN	O
told	VBN	O
to	TO	O
stop	VB	O
for	IN	O
clots	NNS	B-PROBLEM
found	VBN	O
in	IN	O
your	PRP$	O
lungs	NNS	O
.	.	O

Please	NNP	O
continue	VBP	O
to	TO	O
take	VB	O
antibiotics	NNS	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
for	IN	O
3	CD	O
more	JJR	O
days	NNS	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
abdominal	JJ	I-PROBLEM
carcinomatosis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
bloating	NN	B-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
omental	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

Biopsy	NNP	B-TEST
revealed	VBD	O
adenocarcinoma	NN	B-PROBLEM
.	.	O

Histochemical	JJ	B-TEST
stains	NNS	I-TEST
are	VBP	O
consistent	JJ	O
with	IN	O
hepatobiliary	JJ	O
origin	NN	O
.	.	O

Endoscopies	NNS	B-TEST
were	VBD	O
negative	JJ	O
except	IN	O
for	IN	O
an	DT	B-PROBLEM
extrinsic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
present	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
presents	VBZ	O
with	IN	O
increased	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
generalized	VBN	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

On	IN	O
presentation	NN	O
,	,	O
the	DT	O
patient	NN	O
denied	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
and	CC	O
cough	NN	B-PROBLEM
.	.	O

1.	CD	O
Benign	NNP	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

2.	CD	O
Osteoarthritis	NNP	B-PROBLEM
.	.	O

3.	CD	O
Gastrointestinal	NNP	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
(	(	O
as	IN	O
noted	VBN	O
in	IN	O
History	NNP	O
of	IN	O
Present	NNP	O
Illness	NNP	O
)	)	O
.	.	O

Colace	NNP	B-TREATMENT
,	,	O
Senna	NNP	B-TREATMENT
,	,	O
Dulcolax	NNP	B-TREATMENT
,	,	O
Tylenol	NNP	B-TREATMENT
,	,	O
oxycodone	NN	B-TREATMENT
as	IN	O
needed	VBN	O
,	,	O
Ambien	NNP	B-TREATMENT
,	,	O
and	CC	O
Protonix	NNP	B-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Mother	NNP	O
had	VBD	O
adrenal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Father	NNP	O
had	VBD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Review	NNP	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
significant	JJ	O
for	IN	O
progressive	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
,	,	O
and	CC	O
weakness	NN	B-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
nine	CD	O
weeks	NNS	O
.	.	O

Physical	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
temperature	NN	B-TEST
was	VBD	O
96.9	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
121	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
122/86	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
22	CD	O
,	,	O
and	CC	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
looked	VBD	O
acutely	RB	B-PROBLEM
and	CC	I-PROBLEM
chronically	RB	I-PROBLEM
ill	VB	I-PROBLEM
.	.	O

Head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
and	CC	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
oropharynx	NN	O
was	VBD	O
clear	JJ	O
.	.	O

Sclerae	NNP	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

Cardiovascular	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
tachycardic	JJ	B-PROBLEM
first	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
and	CC	I-PROBLEM
second	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
.	.	O

No	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Lungs	NNS	O
revealed	VBD	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
and	CC	O
dullness	NN	B-PROBLEM
to	TO	O
percussion	NN	B-TEST
in	IN	O
the	DT	O
left	NN	O
lung	NN	O
base	NN	O
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
and	CC	O
firm	NN	B-PROBLEM
.	.	O

Extremity	NNP	B-TEST
examination	NN	I-TEST
revealed	VBD	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

This	DT	O
was	VBD	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
abdominal	JJ	I-PROBLEM
carcinomatosis	NN	I-PROBLEM
admitted	VBN	O
with	IN	O
increased	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
O-CMED	NNP	O
Service	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
patient-controlled	JJ	I-TREATMENT
analgesia	NN	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
administered	VBN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
oral	JJ	O
diet	NN	O
as	IN	O
tolerated	VBN	O
.	.	O

On	IN	O
the	DT	O
night	NN	O
of	IN	O
05-01	NN	O
,	,	O
the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
vomiting	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
"	NNP	O
difficulty	NN	B-PROBLEM
catching	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
breath	NN	I-PROBLEM
."	NN	O

On	IN	O
room	NN	O
air	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
80%	CD	O
.	.	O

His	PRP$	B-TEST
saturation	NN	I-TEST
increased	VBD	O
to	TO	O
87%	CD	O
on	IN	O
a	DT	B-TREATMENT
nonrebreather	NN	I-TREATMENT
.	.	O

A	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
disclosed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
bolused	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
due	JJ	O
to	TO	O
concern	NN	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
more	RBR	O
comfortable	JJ	O
being	VBG	O
seated	VBN	O
upright	JJ	O
with	IN	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
.	.	O

An	DT	B-TEST
angiogram	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
disclosed	VBD	O
possible	JJ	O
subsegmental	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
emboli	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
lobes	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
infiltrates	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
Flagyl	NNP	B-TREATMENT
and	CC	O
Levaquin	NNP	B-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

While	IN	O
in	IN	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

On	IN	O
05-03	PDT	O
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ultrasound	NN	I-TEST
with	IN	O
paracentesis	NN	B-TREATMENT
,	,	O
and	CC	O
5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
were	VBD	O
removed	VBN	O
.	.	O

Due	JJ	O
to	TO	O
persistent	JJ	B-PROBLEM
gastric	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
,	,	O
an	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
for	IN	O
decompression	NN	B-TREATMENT
.	.	O

Octreotide	NNP	B-TREATMENT
was	VBD	O
initiated	VBN	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
decrease	VB	O
the	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
not	RB	O
have	VB	O
an	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
left-sided	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
thoracentesis	NN	I-TREATMENT
was	VBD	O
done	VBN	O
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
1.5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
.	.	O

A	DT	B-TREATMENT
paracentesis	NN	I-TREATMENT
was	VBD	O
repeated	VBN	O
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
2.5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
.	.	O

The	DT	O
family	NN	O
decided	VBD	O
to	TO	O
pursue	VB	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
.	.	O

Morphine	NNP	B-TREATMENT
was	VBD	O
administered	VBN	O
to	TO	O
insure	VB	O
patient	NN	O
's	POS	O
comfort	NN	O
.	.	O

1.	CD	O
Gastrointestinal	NNP	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
;	:	O
primary	JJ	O
unknown	NN	O
(	(	O
likely	JJ	O
hepatobiliary	NN	O
)	)	O
.	.	O

2.	CD	O
Aspiration	NNP	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

3.	CD	O
Pulmonary	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

4.	CD	O
Hypoxia	NNP	B-PROBLEM
.	.	O

5.	CD	O
Dehydration	NNP	B-PROBLEM
.	.	O

6.	CD	O
Ileus	NNP	B-PROBLEM
.	.	O

Erythromycin	NNP	B-TREATMENT
Base	NNP	I-TREATMENT

Syncope	NN	B-PROBLEM
.	.	O

45M	CD	O
w/no	JJ	O
PMH	NNP	O
presented	VBD	O
to	TO	O
Chelseahospital	NNP	O
after	IN	O
a	DT	B-PROBLEM
syncopal	JJ	I-PROBLEM
episode	NN	I-PROBLEM
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
.	.	O

Pt	NNP	O
was	VBD	O
preparing	VBG	O
lunch	NN	O
when	WRB	O
suddenly	RB	O
felt	VBD	O
lightheaded	JJ	B-PROBLEM
/	NN	O
faint	NN	B-PROBLEM
and	CC	O
immediately	RB	O
fell	VBD	O
to	TO	O
the	DT	O
kitchen	NN	O
floor	NN	O
face	NN	O
first	RB	O
.	.	O

He	PRP	O
denies	VBZ	O
LOC	NNP	B-PROBLEM
.	.	O

Immediately	RB	O
there	EX	O
after	IN	O
he	PRP	O
was	VBD	O
very	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
felt	VBD	O
lightheaded	VBN	B-PROBLEM
again	RB	O
and	CC	O
called	VBD	O
911	CD	O
.	.	O

At	IN	O
Springfield	NNP	O
,	,	O
CT	NNP	B-TEST
chest	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
saddle	JJ	B-PROBLEM
PE	NNP	I-PROBLEM
.	.	O

VS	NNS	B-TEST
were	VBD	O
with	IN	O
stable	JJ	O
BPs	NNP	O
,	,	O
tachy	NN	B-PROBLEM
to	TO	O
110-120	CD	O
,	,	O
sat	VBD	B-TEST
98%	CD	O
RA	NNP	O
.	.	O

He	PRP	O
received	VBD	O
Lovenox	NNP	B-TREATMENT
91	CD	O
mg	NN	O
SC	NNP	O
prior	RB	O
to	TO	O
transport	VB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
Arbour	NNP	O
Hospital	NNP	O
for	IN	O
further	JJ	O
care	NN	O
.	.	O

He	PRP	O
was	VBD	O
essentially	RB	B-PROBLEM
bed	VBN	I-PROBLEM
bound	NN	I-PROBLEM
for	IN	O
3	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
unable	JJ	B-PROBLEM
to	TO	I-PROBLEM
ambulate	VB	I-PROBLEM
.	.	O

He	PRP	O
started	VBD	O
to	TO	O
notice	VB	O
inflammation	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
L	NNP	I-PROBLEM
calf	NN	I-PROBLEM
/	NNP	I-PROBLEM
leg	VBZ	I-PROBLEM
worse	JJR	O
2	CD	O
days	NNS	O
prior	RB	O
to	TO	O
presentation	NN	O
.	.	O

In	IN	O
this	DT	O
2	CD	O
week	NN	O
interval	NN	O
he	PRP	O
denied	VBD	O
having	VBG	O
CP	NNP	B-PROBLEM
/	NNP	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
or	CC	O
difficulty	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
no	DT	O
cough	NN	B-PROBLEM
or	CC	O
hemoptysis	NN	B-PROBLEM
.	.	O

No	DT	O
f/c/	NN	B-PROBLEM
sweats	NNS	B-PROBLEM
.	.	O

Pt	NNP	O
denied	VBD	O
any	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
or	CC	I-PROBLEM
clotting	VBG	I-PROBLEM
disorders	NNS	I-PROBLEM
and	CC	O
has	VBZ	O
never	RB	O
had	VBD	O
a	DT	B-PROBLEM
clot	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

Left	NNP	B-PROBLEM
knee	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

Seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

HTN	NNP	B-PROBLEM
,	,	O
DM	NNP	B-PROBLEM

COPD	NNP	B-PROBLEM
,	,	O
Prostate	NNP	B-PROBLEM
CA	NNP	I-PROBLEM

-	:	O
Grandfather	NN	O
died	VBD	O
of	IN	O
MI	NNP	B-PROBLEM
at	IN	O
age	NN	O
75	CD	O

VS	NN	B-TEST
:	:	O
99.4	CD	O
HR	NNP	B-TEST
111	CD	O
BP	NNP	B-TEST
110/64	CD	O
RR16	NNP	B-TEST
97%	CD	O
2LNC	CD	B-TREATMENT

GEN	NN	O
:	:	O
NAD	NNP	B-PROBLEM
,	,	O
pleasant	JJ	O
speaking	NN	O
in	IN	O
full	JJ	O
sentences	NNS	O

HEENT	NN	O
:	:	O
MMM	NNP	O
,	,	O
OP	NNP	O
clear	JJ	O
,	,	O
dried	VBD	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
nasal	JJ	I-PROBLEM
mucosa	NN	I-PROBLEM

RESP	NN	O
:	:	O
CTABL	NNP	O
,	,	O
no	DT	O
crackles	NNS	B-PROBLEM
,	,	O
no	DT	O
wheezing	NN	B-PROBLEM
or	CC	O
rhonchi	VB	B-PROBLEM

CV	NN	O
:	:	O
Reg	NNP	O
,	,	O
tachy	NN	B-PROBLEM
Nml	NNP	O
S1	NNP	O
,	,	O
S2	NNP	O
,	,	O
no	DT	O
M/R/G	NNP	B-PROBLEM

ABD	NNS	O
:	:	O
soft	JJ	O
ND/NT	NNP	B-PROBLEM
+BS	NN	O

EXT	NN	O
:	:	O
L	NNP	B-PROBLEM
leg/calf	NN	I-PROBLEM
swollen	NN	I-PROBLEM
,	,	O
+	NNP	O
Johnson	NNP	B-TEST
sign	NN	I-TEST
,	,	O
not	RB	O
tense	VB	B-PROBLEM
,	,	O
no	DT	O
cord	NN	O
palpable	NN	O
,	,	O
L	NNP	O
knee	NNP	O
w/	VBP	O
medial	JJ	B-PROBLEM
meniscus	NN	I-PROBLEM
area	NN	I-PROBLEM
inflammed	VBD	I-PROBLEM
,	,	O
not	RB	O
warm	JJ	B-PROBLEM
,	,	O
no	DT	O
crepitus	NN	B-PROBLEM
,	,	O
feet-2+DP	JJ	B-TEST
pulses	NNS	I-TEST
b/l	NN	O

1.	CD	O
CT	NNP	B-TEST
OF	NNP	I-TEST
HEAD	NNP	I-TEST
WITHOUT	NNP	I-TEST
CONTRAST	NN	I-TEST
:	:	O

No	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
fractures	NNS	B-PROBLEM
.	.	O

2.	CD	O
ECHO	NNP	B-TEST

The	DT	B-TEST
estimated	VBN	I-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
is	VBZ	O
16-20	JJ	O
mmHg	NN	O
.	.	O

Left	NNP	B-TEST
ventricular	NN	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
is	VBZ	O
small	JJ	O
.	.	O

Left	NNP	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
hyperdynamic	JJ	B-PROBLEM
(	(	O
EF	NNP	B-TEST
>	NNP	O
75%	CD	O
)	)	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
ventricular	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

The	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

Right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
borderline	JJ	O
normal	JJ	O
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Impression	NN	O
:	:	O
mildly	RB	B-PROBLEM
dilated	VBD	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
;	:	O
small	JJ	B-PROBLEM
,	,	I-PROBLEM
hyperdynamic	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricle	NN	I-PROBLEM
;	:	O
at	IN	O
least	JJS	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM

3.	CD	O
BILATERAL	NNP	B-TEST
LENI	NNP	I-TEST
's	POS	I-TEST

No	DT	O
evidence	NN	O
of	IN	O
DVT	NNP	B-PROBLEM
in	IN	I-PROBLEM
either	CC	I-PROBLEM
lower	JJR	I-PROBLEM
limb	NN	I-PROBLEM
.	.	O

OSH	NNP	B-TEST
IMAGING	NN	I-TEST
:	:	O

-	:	O
saddle	NN	B-PROBLEM
PE	NNP	I-PROBLEM
,	,	O
no	DT	O
CD	NN	O
or	CC	O
report	NN	O
sent	VBD	O

EKG	NN	B-TEST
:	:	O

-	:	O
Sinus	NN	B-PROBLEM
Tach	NNP	I-PROBLEM
,	,	O
normal	JJ	O
axis	NN	O
HR	NNP	B-TEST
119	CD	O
ST	NNP	B-PROBLEM
Depression	NNP	I-PROBLEM
V3-V5	NNP	I-PROBLEM
;	:	O
S1Q3T3	NNP	B-PROBLEM
,	,	O
p-pulmonale	NN	B-PROBLEM
.	.	O

01-11	JJ	O
MRI	NNP	B-TEST
Left	NNP	I-TEST
Knee	NNP	I-TEST
w/o	VBD	I-TEST
Contrast	NNP	I-TEST

1.	CD	O
Bucket	NNP	B-PROBLEM
handle	JJ	I-PROBLEM
medial	JJ	I-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
with	IN	O
flipped	JJ	B-PROBLEM
fragment	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
intercondylar	JJ	I-PROBLEM
notch	NN	I-PROBLEM
.	.	O

Complex	JJ	B-PROBLEM
tear	NN	I-PROBLEM
involving	VBG	O
the	DT	O
posterior	JJ	O
Ellison	NNP	O
and	CC	O
body	NN	O
.	.	O

2.	CD	O
Moderate	NNP	B-PROBLEM
knee	NN	I-PROBLEM
joint	NN	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
possible	JJ	O
ganglion	NN	B-PROBLEM
cyst	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
insertion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
PCL	NNP	I-PROBLEM
.	.	O

3.	CD	O
Discoid	NNP	B-PROBLEM
lateral	JJ	I-PROBLEM
meniscus	NN	I-PROBLEM
.	.	O

Mr.	NNP	O
Anders	NNP	O
was	VBD	O
admitted	VBN	O
for	IN	O
anticoagulation	NN	B-TREATMENT
and	CC	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
saddle	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
knee	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

#.	JJ	O
PE	NNP	B-PROBLEM
:	:	O

Given	VBN	O
no	DT	O
other	JJ	O
risk	NN	O
factors	NNS	O
or	CC	O
likely	JJ	O
causes	NNS	O
,	,	O
the	DT	O
most	RBS	O
likely	JJ	O
etiology	NN	O
for	IN	O
his	PRP$	B-PROBLEM
embolus	NN	I-PROBLEM
is	VBZ	O
DVT	NNP	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
clotting	VBG	I-PROBLEM
disorder	NN	I-PROBLEM
but	CC	O
did	VBD	O
have	VB	O
trauma	NN	B-PROBLEM
to	TO	I-PROBLEM
leg	VB	I-PROBLEM
prompting	VBG	O
immobility	NN	B-PROBLEM
and	CC	O
stasis	NN	B-PROBLEM
.	.	O

He	PRP	O
remained	VBD	O
hemodynmically	RB	O
stable	JJ	O
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
and	CC	O
did	VBD	O
not	RB	O
have	VB	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
upon	IN	O
discharge	NN	O
.	.	O

Given	VBN	O
no	DT	O
evidence	NN	O
of	IN	O
hemodynamic	JJ	B-PROBLEM
instability	NN	I-PROBLEM
,	,	O
lysis	NN	B-TREATMENT
was	VBD	O
not	RB	O
required	VBN	O
.	.	O

He	PRP	O
was	VBD	O
anticoagulated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
.	.	O

He	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
hematology	NN	O
for	IN	O
an	DT	B-TEST
outpatient	JJ	I-TEST
thrombophilia	NN	I-TEST
work-up	NN	I-TEST
(	(	O
not	RB	O
done	VBN	O
as	RB	O
inpatient	JJ	O
as	IN	O
results	NNS	O
would	MD	O
not	RB	O
change	VB	O
acute	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
PE	NNP	B-PROBLEM
).	NNP	O

He	PRP	O
will	MD	O
also	RB	O
require	VB	O
close	RB	O
follow	VB	O
up	RP	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
provider	NN	O
for	IN	O
coumadin	NN	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

Duration	NN	O
of	IN	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
be	VB	O
determined	VBN	O
by	IN	O
hematology	NN	O
,	,	O
but	CC	O
likely	JJ	O
to	TO	O
be	VB	O
at	IN	O
least	JJS	O
6	CD	O
months	NNS	O
in	IN	O
duration	NN	O
.	.	O

#.	JJ	O
Syncope	NN	B-PROBLEM
:	:	O

In	IN	O
setting	VBG	O
of	IN	O
PE	NNP	B-PROBLEM
.	.	O

Remainder	NN	O
of	IN	O
his	PRP$	B-TEST
cardiac	JJ	I-TEST
workup	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

He	PRP	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
troponin	NN	I-PROBLEM
leak	NN	I-PROBLEM
,	,	O
felt	VBD	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
strain	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
P-pulmonale	NNP	B-PROBLEM
related	JJ	O
to	TO	O
clot	VB	B-PROBLEM
burden	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
tronponin	NN	I-TEST
quickly	RB	O
trended	VBD	O
down	RB	O
and	CC	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
EKG	NNP	B-TEST
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

An	DT	B-TEST
ECHO	NNP	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
related	VBN	O
to	TO	O
ischemia	NN	B-PROBLEM
.	.	O

#.	JJ	O
Hematocrit	NN	B-TEST
:	:	O

Dropped	VBD	O
from	IN	O
42.7	CD	O
to	TO	O
36	CD	O
in	IN	O
setting	NN	O
of	IN	O
anticoagulation	NN	B-TREATMENT
for	IN	O
saddle	JJ	B-PROBLEM
PE	NNP	I-PROBLEM
and	CC	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

No	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
noted	VBD	O
.	.	O

Pt	NNP	O
asymptomatic	JJ	B-PROBLEM
.	.	O

#.	JJ	O
L	NNP	B-PROBLEM
knee	NN	I-PROBLEM
injury	NN	I-PROBLEM
:	:	O

Given	VBN	O
his	PRP$	O
history	NN	O
and	CC	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
Mr.	NNP	O
Anders	NNP	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
injury	NN	I-PROBLEM
most	RBS	O
consistent	JJ	O
with	IN	O
meniscal	JJ	B-PROBLEM
tear	NN	I-PROBLEM
.	.	O

In	IN	O
order	NN	O
to	TO	O
facilitate	VB	O
therapy	NN	B-TREATMENT
and	CC	O
to	TO	O
promote	VB	O
mobility	NN	O
,	,	O
an	DT	B-TEST
MRI	NNP	I-TEST
of	IN	I-TEST
the	DT	I-TEST
knee	NN	I-TEST
was	VBD	O
done	VBN	O
.	.	O

He	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
physical	JJ	O
therapy	NN	O
and	CC	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
orthopaedics	NNS	O
upon	IN	O
discharge	NN	O
for	IN	O
repeat	NN	B-TEST
evaluation	NN	I-TEST
.	.	O

-	:	O
Claritin	NN	B-TREATMENT
prn	NN	O

-	:	O
Flonase	NN	B-TREATMENT
prn	NN	O

Pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM

Left	NNP	B-PROBLEM
knee	VBZ	I-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM

You	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

You	PRP	O
were	VBD	O
treated	VBN	O
with	IN	O
blood	NN	B-TREATMENT
thinners	NNS	I-TREATMENT
.	.	O

You	PRP	O
have	VBP	O
been	VBN	O
started	VBN	O
on	IN	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
blood	NN	I-TREATMENT
thinner	NN	I-TREATMENT
called	VBN	O
Coumadin	NNP	B-TREATMENT
(	(	I-TREATMENT
Warfarin	NNP	I-TREATMENT
).	NNP	O

Please	NNP	O
continue	VBP	O
to	TO	O
take	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

You	PRP	O
must	MD	O
have	VB	O
your	PRP$	B-TEST
INR	NNP	I-TEST
(	(	O
blood	NN	B-TEST
levels	NNS	I-TEST
)	)	O
checked	VBD	O
on	IN	O
a	DT	O
regular	JJ	O
basis	NN	O
until	IN	O
your	PRP$	B-TEST
INR	NNP	I-TEST
levels	NNS	I-TEST
remain	VBP	O
01-19	JJ	O
.	.	O

The	DT	B-TEST
MRI	NNP	I-TEST
of	IN	I-TEST
your	PRP$	I-TEST
knee	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
.	.	O

Please	NNP	O
schedule	VBD	O
an	DT	O
appointment	NN	O
with	IN	O
your	PRP$	O
orthopedic	JJ	O
surgeon	NN	O
to	TO	O
determine	VB	O
a	DT	O
plan	NN	O
for	IN	O
treatment	NN	B-TREATMENT
.	.	O

Please	VB	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
55-year-old	JJ	O
female	NN	O
with	IN	O
multiple	JJ	O
prior	JJ	O
admissions	NNS	O
for	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
COPD	NNP	B-PROBLEM
,	,	O
asthma	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
,	,	O
over	IN	O
3	CD	O
weeks	NNS	O
of	IN	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
like	IN	I-PROBLEM
infection	NN	I-PROBLEM
unremitting	VBG	O
with	IN	O
increased	JJ	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
at	IN	O
home	NN	O
.	.	O

The	DT	O
patient	NN	O
saw	VBD	O
her	PRP$	O
PCP	NNP	O
and	CC	O
was	VBD	O
known	VBN	O
to	TO	O
have	VB	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
82	CD	O
to	TO	O
85	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

In	IN	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
Zithromax	NNP	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
and	CC	O
Flagyl	NNP	B-TREATMENT
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
was	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	O
questionable	JJ	O
left	NN	B-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
nebulizer	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
oxygen	NN	B-TEST
saturations	NNS	I-TEST
increasing	VBG	O
up	RB	O
to	TO	O
98	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Asthma	NNP	B-PROBLEM
/	NNP	O
COPD	NNP	B-PROBLEM
on	IN	O
BiPAP	NNP	B-TREATMENT
,	,	O
history	NN	O
of	IN	O
intubation	NN	B-TREATMENT
.	.	O

Restrictive	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
inflammatory	NN	I-PROBLEM
demyelinating	VBG	I-PROBLEM
polyradiculopathy	NN	I-PROBLEM
.	.	O

Gastritis	NN	B-PROBLEM
and	CC	O
duodenitis	NN	B-PROBLEM
.	.	O

Question	NN	O
of	IN	O
Tyrone	NNP	B-PROBLEM
esophagus	NN	I-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
.	.	O

Chronic	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
spasms	NNS	I-PROBLEM
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
negative	JJ	O
stress	NN	B-TEST
echo	NN	I-TEST
on	IN	O
10-12	NNS	O
.	.	O

History	NN	O
of	IN	O
syncope	NN	B-PROBLEM
.	.	O

Adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

Depression	NNP	B-PROBLEM
and	CC	O
anxiety	NN	B-PROBLEM
.	.	O

Hyperthyroidism	NN	B-PROBLEM
.	.	O

IgG	NNP	B-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

Status	NNP	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
and	CC	O
appendectomy	NN	B-TREATMENT
.	.	O

Anemia	NNP	B-PROBLEM
of	IN	O
chronic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

AZMACORT	NNP	B-TREATMENT
,	,	O
CLINDAMYCIN	NNP	B-TREATMENT
,	,	O
VERSED	NNP	B-TREATMENT
,	,	O
FENTANYL	NNP	B-TREATMENT
,	,	O
and	CC	O
MORPHINE	NNP	B-TREATMENT
.	.	O

Married	VBN	O
with	IN	O
children	NNS	O
,	,	O
wheelchair	NN	B-PROBLEM
bound	NN	I-PROBLEM
mostly	RB	O
.	.	O

From	IN	O
admission	NN	O
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
98.3	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
128/74	CD	O
,	,	O
68	CD	O
to	TO	O
112	CD	O
is	VBZ	O
her	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
24	CD	O
,	,	O
100	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

She	PRP	O
is	VBZ	O
a	DT	O
chronically	RB	O
ill-appearing	JJ	O
female	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
exam	NN	I-TEST
:	:	O

Pulmonary	JJ	B-TEST
exam	NN	I-TEST
:	:	O

Diffuse	NNP	B-PROBLEM
bronchial	JJ	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
.	.	O

Abdominal	JJ	B-TEST
exam	NN	I-TEST
:	:	O

Extremity	NN	B-TEST
exam	NN	I-TEST
:	:	O

No	DT	O
edema	NN	B-PROBLEM
.	.	O

Left	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weaker	NN	I-PROBLEM
at	IN	O
3/5	CD	O
compared	VBN	O
to	TO	O
right	VB	O
upper	JJ	O
extremity	NN	O
and	CC	O
right	JJ	O
lower	JJR	O
extremity	NN	O
,	,	O
chronic	JJ	O
according	VBG	O
to	TO	O
the	DT	O
patient	NN	O
.	.	O

1.	CD	O
Vitamin	NNP	B-TREATMENT
D	NNP	I-TREATMENT
400	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
Levoxyl	NNP	B-TREATMENT
50	CD	O
mcg	NN	O
q.d.	NN	O

3.	CD	O
Baclofen	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
Florinef	NNP	B-TREATMENT
0.1	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O

5.	CD	O
Klonopin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
t.i.d.	NN	O

6.	CD	O
BuSpar	NNP	B-TREATMENT
10	CD	O
mg	NN	O
t.i.d.	NN	O

7.	CD	O
Zanaflex	NNP	B-TREATMENT
8	CD	O
mg	NN	O
q.4	NN	O
h.	NN	O

8.	CD	O
Oxazepam	NNP	B-TREATMENT
30	CD	O
mg	NN	O
p.r.n.	NN	O

9.	CD	O
Singulair	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.p.m.	NN	O

10.	CD	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.p.m.	NN	O

11.	CD	O
Ativan	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.r.n.	NN	O

12.	CD	O
Protonix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
Sucralfate	NNP	B-TREATMENT
2	CD	O
mg	NN	O
b.i.d.	NN	O

14.	CD	O
Albuterol	NNP	B-TREATMENT
nebulizer	JJ	I-TREATMENT
q.03-14	NN	O
h.	NN	O
p.r.n.	NN	O

15.	CD	O
Pamidronate	NNP	B-TREATMENT
30	CD	O
mg	NN	O
IV	NNP	O
every	DT	O
month	NN	O
.	.	O

Shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
albuterol	NN	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
and	CC	O
Ipratropium	NNP	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
,	,	O
as	IN	O
this	DT	O
was	VBD	O
apparently	RB	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Given	VBN	O
the	DT	O
presence	NN	O
of	IN	O
consolidation	NN	B-PROBLEM
on	IN	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
,	,	O
however	RB	O
,	,	O
and	CC	O
previous	JJ	O
history	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
of	IN	O
Zithromax	NNP	B-TREATMENT
500	CD	O
mg	JJ	O
daily	JJ	O
and	CC	O
ceftriaxone	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
Solu-Medrol	NNP	B-TREATMENT
IV	NNP	I-TREATMENT
for	IN	O
active	JJ	B-PROBLEM
airway	NN	I-PROBLEM
disease	NN	I-PROBLEM
component	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
sputum	NN	O
production	NN	O
was	VBD	O
maximized	VBN	O
with	IN	O
the	DT	O
help	NN	O
of	IN	O
an	DT	B-TREATMENT
Acapella	NNP	I-TREATMENT
device	NN	I-TREATMENT
and	CC	O
respiratory	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

Mucomyst	NN	B-TREATMENT
was	VBD	O
also	RB	O
considered	VBN	O
as	IN	O
a	DT	B-TREATMENT
mucolytic	JJ	I-TREATMENT
component	NN	I-TREATMENT
towards	NNS	O
secretions	NNS	B-PROBLEM
.	.	O

Adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
IV	NNP	B-TREATMENT
Solu	NNP	I-TREATMENT
-	:	I-TREATMENT
Medrol	NN	I-TREATMENT
60	CD	O
mg	NN	O
q.	NN	O
8	CD	O
h.	NN	O

Chest	NNP	B-PROBLEM
soreness	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
describes	VBZ	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
without	IN	O
any	DT	B-PROBLEM
significant	JJ	I-PROBLEM
EKG	NNP	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
Percocet	NNP	B-TREATMENT
p.r.n.	NN	O
for	IN	O
pain	NN	B-TREATMENT
relief	NN	I-TREATMENT
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
rib	NN	I-PROBLEM
factors	NNS	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
PPI	NNP	B-TREATMENT
for	IN	O
reflux	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
known	VBN	B-PROBLEM
gastritis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
and	CC	O
,	,	O
therefore	RB	O
,	,	O
she	PRP	O
required	VBD	O
a	DT	B-TREATMENT
Foley	NNP	I-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
on	IN	O
Levoxyl	NNP	B-TREATMENT
at	IN	O
home	NN	O
as	IN	O
her	PRP$	O
home	NN	O
dose	NN	O
for	IN	O
hyperthyroidism	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
2012-05-22	JJ	O
to	TO	O
the	DT	O
ICU	NNP	O
given	VBN	O
persistent	JJ	B-PROBLEM
carbon	NN	I-PROBLEM
dioxide	NN	I-PROBLEM
retention	NN	I-PROBLEM
and	CC	O
respiratory	JJ	B-PROBLEM
acidosis	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
intermittent	JJ	I-PROBLEM
mental	NN	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
had	VBN	O
ABG	NNP	B-TEST
on	IN	O
the	DT	O
floor	NN	O
,	,	O
which	WDT	O
prompted	VBD	O
her	PRP	O
to	TO	O
transfer	VB	O
to	TO	O
the	DT	O
ICU	NNP	O
.	.	O

Her	PRP$	B-TEST
pH	NN	I-TEST
was	VBD	O
7.23	CD	O
,	,	O
PCO2	NNP	B-TEST
73	CD	O
,	,	O
PO2	NNP	B-TEST
146	CD	O
on	IN	O
a	DT	B-TREATMENT
nonrebreather	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
BiPAP	NNP	B-TREATMENT
initiated	VBN	O
once	RB	O
she	PRP	O
reached	VBD	O
the	DT	O
unit	NN	O
,	,	O
but	CC	O
did	VBD	O
not	RB	O
tolerate	VB	O
it	PRP	O
,	,	O
becoming	VBG	O
apneic	NN	B-PROBLEM
and	CC	O
obstructing	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
switched	VBN	O
to	TO	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
oxygen	NN	O
saturating	NN	O
at	IN	O
98	CD	O
to	TO	O
100	CD	O
percent	NN	O
.	.	O

After	IN	O
BiPAP	NNP	B-TREATMENT
was	VBD	O
initiated	VBN	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
down	RB	O
to	TO	O
75/28	CD	O
and	CC	O
bradycardiac	NN	B-PROBLEM
,	,	O
responding	VBG	O
to	TO	O
3	CD	B-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
night	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Florinef	NNP	B-TREATMENT
for	IN	O
concern	NN	O
of	IN	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
that	IN	O
morning	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
out	IN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

It	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
have	VB	O
been	VBN	O
mucous	JJ	B-PROBLEM
plugging	VBG	I-PROBLEM
during	IN	O
her	PRP$	O
stay	NN	O
in	IN	O
the	DT	O
ICU	NNP	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
MCV	NNP	I-PROBLEM
and	CC	O
megaloblastic	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
on	IN	O
smear	NN	B-TEST
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
anemia	NN	B-PROBLEM
;	:	O
question	NN	O
B12	NNP	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
borderline	NN	B-PROBLEM
low	JJ	I-PROBLEM
B12	NNP	I-PROBLEM
levels	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
for	IN	O
B12	NNP	B-PROBLEM
deficiency	NN	I-PROBLEM
due	JJ	O
to	TO	O
her	PRP$	O
long	JJ	O
history	NN	O
of	IN	O
poor	JJ	B-PROBLEM
p.o.	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
.	.	O

Methylmalonic	NNP	B-TEST
acid	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
sent	VBN	O
,	,	O
the	DT	O
results	NNS	O
are	VBP	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

Asthma	NNP	B-PROBLEM
flare	NN	I-PROBLEM
and	CC	O
bronchitis	NN	B-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Demyelinating	VBG	B-PROBLEM
polyradiculopathy	NN	I-PROBLEM
.	.	O

Anxiety	NN	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
stable	JJ	O
without	IN	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

1.	CD	O
Cholecalciferol	NNP	B-TREATMENT
.	.	O

2.	CD	O
Vitamin	NNP	B-TREATMENT
D	NNP	I-TREATMENT
.	.	O

3.	CD	O
Levothyroxine	NNP	B-TREATMENT
50	CD	O
mcg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
Baclofen	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

5.	CD	O
Clonazepam	NNP	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

6.	CD	O
Buspirone	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

7.	CD	O
Montelukast	NNP	B-TREATMENT
sodium	NN	I-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

8.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

9.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

10.	CD	O
Albuterol	NNP	B-TREATMENT
sulfate	JJ	I-TREATMENT
solution	NN	I-TREATMENT
q.05-15	NN	O
h.	NN	O
p.r.n.	NN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

11.	CD	O
Tizanidine	NNP	B-TREATMENT
8	CD	O
mg	NN	O
p.o.	NN	O
q.6	NN	O
h.	NN	O

12.	CD	O
Acetaminophen	NNP	B-TREATMENT
p.r.n.	NN	O

13.	CD	O
Prednisone	NNP	B-TREATMENT
taper	NN	I-TREATMENT
for	IN	O
3	CD	O
days	NNS	O
.	.	O

14.	CD	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
10	CD	O
more	JJR	O
days	NNS	O
.	.	O

15.	CD	O
Florinef	NNP	B-TREATMENT
Acetate	NNP	I-TREATMENT
0.1	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

MEDICINE	NN	B-TREATMENT

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	O
Drugs	VB	B-TREATMENT

Shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM

Mr.	NNP	O
Mcelveen	NNP	O
is	VBZ	O
a	DT	O
51	CD	O
year-old	JJ	O
male	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
RCC	NNP	I-PROBLEM
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radical	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
in	IN	O
2018-03-21	JJ	O
,	,	O
status	NN	O
post	NN	O
Avastin	NNP	B-TREATMENT
and	CC	O
sorafenib	NN	B-TREATMENT
,	,	O
most	RBS	O
recently	RB	O
on	IN	O
Sutent	NNP	B-TREATMENT
monotherapy	NN	I-TREATMENT
since	IN	O
2018-12-21	JJ	O
,	,	O
with	IN	O
mild	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
who	WP	O
presented	VBD	O
from	IN	O
home	NN	O
on	IN	O
2019-06-14	JJ	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
fever	NN	B-PROBLEM
.	.	O

Of	IN	O
note	NN	O
,	,	O
he	PRP	O
was	VBD	O
hospitalized	VBN	O
at	IN	O
Dana-Farber	NNP	O
Cancer	NNP	O
Institute	NNP	O
from	IN	O
9/25-10/6	JJ	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
reportedly	RB	O
had	VBD	O
cardiac	JJ	B-TEST
enzymes	RB	I-TEST
,	,	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
and	CC	O
a	DT	B-TEST
pharmacological	JJ	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
performed	VBD	O
.	.	O

It	PRP	O
is	VBZ	O
unclear	JJ	O
from	IN	O
history	NN	O
what	WP	O
these	DT	B-TEST
studies	NNS	I-TEST
revealed	VBD	O
.	.	O

He	PRP	O
reports	VBZ	O
that	IN	O
he	PRP	O
felt	VBD	O
fatigued	VBN	B-PROBLEM
during	IN	O
the	DT	O
week	NN	O
prior	RB	O
to	TO	O
the	DT	O
current	JJ	O
admission	NN	O
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
he	PRP	O
felt	VBD	O
"	NNP	O
congested	VBD	B-PROBLEM
"	NN	O
in	IN	O
his	PRP$	O
chest	NN	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
fever	NN	I-PROBLEM
.	.	O

Patrick	NNP	O
reports	VBZ	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
cough	NN	I-PROBLEM
for	IN	O
2	CD	O
days	NNS	O
PTA	NNP	O
,	,	O
non-productive	JJ	B-PROBLEM
.	.	O

He	PRP	O
denies	VBZ	O
a	DT	O
history	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
events	NNS	I-PROBLEM
or	CC	O
choking	VBG	B-PROBLEM
with	IN	O
food	NN	O
intake	NN	O
.	.	O

He	PRP	O
describes	VBZ	O
mild	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
at	IN	O
night	NN	O
.	.	O

Further	RB	B-TEST
ROS	NNP	I-TEST
reveals	NNS	O
mild	VBP	B-PROBLEM
SOB	NNP	I-PROBLEM
in	IN	O
the	DT	O
days	NNS	O
preceding	VBG	O
admission	NN	O
,	,	O
but	CC	O
he	PRP	O
tells	VBZ	O
me	PRP	O
that	IN	O
he	PRP	O
was	VBD	O
surprised	VBN	O
to	TO	O
find	VB	O
out	RP	O
about	IN	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
oxygen	NN	I-PROBLEM
saturation	NN	I-PROBLEM
because	IN	O
he	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
bad	JJ	O
.	.	O

He	PRP	O
denies	VBZ	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
LE	NNP	B-PROBLEM
swelling	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
Deanna	NNP	O
,	,	O
Tmax	NNP	B-TEST
102.8	CD	O
,	,	O
BP	NNP	B-TEST
100	CD	O
-	:	O
140/60	CD	O
s,	NN	O
HR	NNP	B-TEST
80	CD	O
s,	NN	O
RR	NNP	B-TEST
20	CD	O
s,	NN	O
Sat	NNP	B-TEST
75%	CD	O
on	IN	O
RA	NNP	B-TREATMENT
in	IN	O
triage	NN	O
,	,	O
up	RB	O
to	TO	O
100%	CD	O
on	IN	O
NRB	NNP	B-TREATMENT
.	.	O

CXR	NN	B-TEST
with	IN	O
bibasilar	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Levo	NNP	B-TREATMENT
750	CD	O
mg	NN	O
PO	NNP	O
X1	NNP	O
,	,	O
and	CC	O
Flagyl	NNP	B-TREATMENT
500	CD	O
mg	NN	O
PO	NNP	O
X1	NNP	O
.	.	O

His	PRP$	B-TEST
BP	NNP	I-TEST
decreased	VBD	O
to	TO	O
100	CD	O
systolic	JJ	O
despite	IN	O
hydration	NN	B-TREATMENT
with	IN	O
2L	CD	O
of	IN	O
NS	NNP	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
subsquently	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
ICU	NNP	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
Levo	NNP	B-TREATMENT
and	CC	O
Ceftriaxone	NNP	B-TREATMENT
.	.	O

A	DT	B-TEST
cosyntropin	NN	I-TEST
stimulation	NN	I-TEST
test	NN	I-TEST
revealed	VBD	O
cortisol	NN	B-TEST
32.1	CD	O
-->	NN	O
36.4	CD	O
.	.	O

His	PRP$	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
decreased	VBN	O
,	,	O
and	CC	O
his	PRP$	O
overall	JJ	O
status	NN	O
improved	VBD	O
quickly	RB	O
.	.	O

He	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
ongoing	VBG	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

1.	CD	O
Metastatic	JJ	B-PROBLEM
renal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
diagnosed	VBN	O
in	IN	O
2018-03-21	JJ	O
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radical	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
at	IN	O
St.	NNP	O
Margaret's	NNP	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
in	IN	O
03/2006	CD	O
.	.	O

Path	NNP	O
consistent	NN	O
with	IN	O
renal	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
chromophobe	NN	I-PROBLEM
type	NN	I-PROBLEM
with	IN	O
Carter	NNP	B-PROBLEM
nuclear	JJ	I-PROBLEM
grade	NN	I-PROBLEM
of	IN	O
4/4	CD	O
.	.	O

Lymphovascular	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

He	PRP	O
later	RB	O
presented	VBD	O
with	IN	O
increasing	VBG	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
documented	VBN	O
.	.	O

He	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
Avastin	NNP	B-TREATMENT
plus	CC	O
sorafenib	NN	B-TREATMENT
,	,	O
protocol	JJ	O
#04-393	NN	O
,	,	O
discontinued	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O

ongoing	VBG	B-PROBLEM
grade	NN	I-PROBLEM
III	NNP	I-PROBLEM
rash	NN	I-PROBLEM
,	,	O
involving	VBG	O
the	DT	O
hands	NNS	O
and	CC	O
feet	NNS	O
in	IN	O
addition	NN	O
proteinuria	NNS	B-PROBLEM
secondary	JJ	O
to	TO	O
the	DT	O
Avastin	NNP	B-TREATMENT
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
single	JJ	B-TREATMENT
Timlin	NNP	I-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
Sutent	NNP	B-TREATMENT
50	CD	O
mg	JJ	O
daily	RB	O
as	IN	O
of	IN	O
2018-12-21	JJ	O
and	CC	O
has	VBZ	O
completed	VBN	O
nearly	RB	O
6	CD	O
cycles	NNS	O
.	.	O

He	PRP	O
has	VBZ	O
mild	VBN	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
Sutent	NNP	B-TREATMENT
.	.	O

2.	CD	O
Seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

VITALS	NNS	B-TEST
:	:	O
T	NNP	B-TEST
96.9	CD	O
,	,	O
BP	NNP	B-TEST
110/70	CD	O
,	,	O
HR	NNP	B-TEST
84	CD	O
,	,	O
RR	NNP	B-TEST
20	CD	O
,	,	O
Sat	NNP	B-TEST
97%	CD	O
on	IN	O
4L	CD	O
.	.	O

GEN	NN	O
:	:	O
In	IN	O
NAD	NNP	B-PROBLEM
.	.	O

HEENT	NN	O
:	:	O
Flushed	VBN	B-PROBLEM
cheeks	NN	I-PROBLEM
.	.	O

Slightly	RB	B-PROBLEM
dry	JJ	I-PROBLEM
MM	NNP	I-PROBLEM
.	.	O

NECK	NN	O
:	:	O
JVP	NNP	B-TEST
not	RB	O
elevated	VBD	B-PROBLEM
.	.	O

RESP	NN	O
:	:	O
Decreased	VBN	B-PROBLEM
air	NN	I-PROBLEM
entry	NN	I-PROBLEM
and	CC	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
both	DT	I-PROBLEM
lung	NN	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

+	NN	O
Egophony	NNP	B-PROBLEM
.	.	O

No	DT	O
S3	NNP	B-PROBLEM
,	,	O
S4	NNP	B-PROBLEM
.	.	O

No	DT	O
murmur	NN	B-PROBLEM
or	CC	O
rub	NN	B-PROBLEM
.	.	O

Abdomen	NNS	O
soft	JJ	O
and	CC	O
non-tender	NN	B-PROBLEM
.	.	O

EXT	NN	O
:	:	O
Without	IN	O
edema	NN	B-PROBLEM
.	.	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
WBC	NNP	B-TEST
-	:	O
8.0	CD	O
RBC	NNP	B-TEST
-	:	O
4.22	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
12.9	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
41.7	CD	O
MCV	NNP	B-TEST
-	:	O
99	CD	O
*	NN	O
MCH	NNP	B-TEST
-	:	O
30.5	CD	O
MCHC	NNP	B-TEST
-	:	O
30.8	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
16.8	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
797	CD	O
*#	NN	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
WBC	NNP	B-TEST
-	:	O
11.1	CD	O
*	NN	O
RBC	NNP	B-TEST
-	:	O
3.47	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
10.9	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
34.1	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
98	CD	O
MCH	NNP	B-TEST
-	:	O
31.3	CD	O
MCHC	NNP	B-TEST
-	:	O
31.9	CD	O
RDW	NNP	B-TEST
-	:	O
16.7	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
604	CD	O
*	NN	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
PT	NNP	B-TEST
-	:	O
11.2	CD	O
PTT	NNP	B-TEST
-	:	O
23.9	CD	O
INR(PT)	NNP	B-TEST
-	:	O
0.9	CD	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
797	CD	O
*#	NN	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
134	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
39	CD	O
*	NN	O
Creat	NNP	B-TEST
-	:	O
2.1	CD	O
*	NN	O
Na	NNP	B-TEST
-	:	O
133	CD	O
K	NNP	B-TEST
-	:	O
7.9	CD	O
*	NN	O
Cl	NNP	B-TEST
-	:	O
94	CD	O
*	NN	O
HCO3	NNP	B-TEST
-	:	O
28	CD	O
AnGap	NNP	B-TEST
-	:	O
19	CD	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
73	CD	O
UreaN	NNP	B-TEST
-	:	O
20	CD	O
Creat	NNP	B-TEST
-	:	O
1.1	CD	O
Na	NNP	B-TEST
-	:	O
136	CD	O
K	NNP	B-TEST
-	:	O
5.0	CD	O
Cl	NNP	B-TEST
-	:	O
101	CD	O
HCO3	NNP	B-TEST
-	:	O
27	CD	O
AnGap	NNP	B-TEST
-	:	O
13	CD	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
ALT	NNP	B-TEST
-	:	O
34	CD	O
AST	NNP	B-TEST
-	:	O
167	CD	O
*	NN	O
CK(CPK)	NNP	B-TEST
-	:	O
313	CD	O
*	NN	O
AlkPhos	NNP	B-TEST
-	:	O
383	CD	O
*	JJ	O
Amylase	NNP	B-TEST
-	:	O
44	CD	O
TotBili	NNP	B-TEST
-	:	O
0.7	CD	O

2019-06-14	JJ	O
06:03	CD	O
PM	NNP	O
BLOOD	NNP	O
CK(CPK)	NNP	B-TEST
-	:	O
194	CD	O
*	NN	O

2019-06-14	JJ	O
10:30	CD	O
AM	NNP	O
BLOOD	NNP	O
CK-MB	NNP	B-TEST
-	:	O
3	CD	O
cTropnT	NN	B-TEST
-	:	O
0.05	CD	O
*	NN	O

2019-06-14	JJ	O
06:03	CD	O
PM	NNP	O
BLOOD	NNP	O
CK-MB	NNP	B-TEST
-4	NNP	O
cTropnT	VBD	B-TEST
-	:	O
0.03	CD	O
*	NN	O

2019-06-17	JJ	O
05:30	CD	O
AM	NNP	O
BLOOD	NNP	O
proBNP	NN	B-TEST
-	:	O
258	CD	O
*	NN	O

2019-06-14	JJ	O
06:03	CD	O
PM	NNP	O
BLOOD	NNP	O
Calcium	NNP	B-TEST
-	:	O
8.3	CD	O
*	NN	O
Phos	NNP	B-TEST
-	:	O
4.3	CD	O
Mg	NNP	B-TEST
-	:	O
1.9	CD	O

2019-06-18	JJ	O
07:55	CD	O
AM	NNP	O
BLOOD	NNP	O
calTIBC	NN	B-TEST
-	:	O
229	CD	O
Ferritn	NNP	B-TEST
-	:	O
GREATER	NNP	O
TH	NNP	O
TRF	NNP	O
-	:	O
176	CD	O
*	NN	O

2019-06-16	JJ	O
07:35	CD	O
AM	NNP	O
BLOOD	NNP	O
TSH	NNP	B-TEST
-	:	O
43	CD	O
*	NN	O

2019-06-16	JJ	O
07:35	CD	O
AM	NNP	O
BLOOD	NNP	O
Free	NNP	B-TEST
T4	NNP	I-TEST
-	:	O
0.36	CD	O
*	NN	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
WBC	NNP	B-TEST
-	:	O
11.1	CD	O
*	NN	O
RBC	NNP	B-TEST
-	:	O
3.47	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
10.9	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
34.1	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
98	CD	O
MCH	NNP	B-TEST
-	:	O
31.3	CD	O
MCHC	NNP	B-TEST
-	:	O
31.9	CD	O
RDW	NNP	B-TEST
-	:	O
16.7	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
604	CD	O
*	NN	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
Neuts	NNP	B-TEST
-	:	O
77.0	CD	O
*	NN	O
Bands	NNP	B-TEST
-	:	O
5.0	CD	O
Lymphs	NNP	B-TEST
-	:	O
11.0	CD	O
*	JJ	O
Monos	NNP	B-TEST
-	:	O
3.0	CD	O
Eos	NNP	B-TEST
-	:	O
0	CD	O
Baso	NNP	B-TEST
-	:	O
0	CD	O
Atyps	NNP	B-TEST
-	:	O
1.0	CD	O
*	NN	O
Metas	NNP	B-TEST
-	:	O
2.0	CD	O
*	NN	O
Myelos	NNP	B-TEST
-	:	O
1.0	CD	O
*	NN	O

2019-06-18	JJ	O
07:55	CD	O
AM	NNP	O
BLOOD	NNP	O
PT	NNP	B-TEST
-	:	O
11.5	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.0	CD	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
Glucose	NNP	B-TEST
-	:	O
73	CD	O
UreaN	NNP	B-TEST
-	:	O
20	CD	O
Creat	NNP	B-TEST
-	:	O
1.1	CD	O
Na	NNP	B-TEST
-	:	O
136	CD	O
K	NNP	B-TEST
-	:	O
5.0	CD	O
Cl	NNP	B-TEST
-	:	O
101	CD	O
HCO3	NNP	B-TEST
-	:	O
27	CD	O
AnGap	NNP	B-TEST
-	:	O
13	CD	O

2019-06-19	JJ	O
07:20	CD	O
AM	NNP	O
BLOOD	NNP	O
Calcium	NNP	B-TEST
-	:	O
8.0	CD	O
*	NN	O
Phos	NNP	B-TEST
-	:	O
3.3	CD	O
Mg	NNP	B-TEST
-	:	O
2.0	CD	O

1)	CD	O
Bilateral	NNP	B-TEST
LE	NNP	I-TEST
doppler	NN	I-TEST
(	(	O
06-14	JJ	O
):	NN	O
No	NNP	O
evidence	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

2)	CD	O
Cxray	NNP	B-TEST
(	(	O
06-14	JJ	O
):	NNP	O
New	NNP	B-PROBLEM
bibasilar	JJ	I-PROBLEM
consolidations	NNS	I-PROBLEM
are	VBP	O
demonstrated	VBN	O
accompanied	VBN	O
by	IN	O
bilateral	JJ	B-PROBLEM
small	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

The	DT	O
lung	NN	O
volumes	NNS	O
are	VBP	O
slightly	RB	B-PROBLEM
increased	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
identified	VBN	O
.	.	O

3)	CD	O
CT	NNP	B-TEST
Torso	NNP	I-TEST
(	(	O
06-17	CD	O
):	NN	O

1.	CD	O
Marked	NNP	B-PROBLEM
interval	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiac	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
.	.	O

Together	RB	O
with	IN	O
the	DT	O
interval	NN	O
development	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
this	DT	O
indicates	VBZ	O
cardiac	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
(	(	O
or	CC	O
alternatively	RB	O
volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
)	)	O
and	CC	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
may	MD	O
be	VB	O
indicated	VBN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

2.	CD	O
Bilateral	NNP	B-PROBLEM
basilar	JJ	I-PROBLEM
compressive	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

Superimposed	VBN	B-PROBLEM
infectious	JJ	I-PROBLEM
consolidation	NN	I-PROBLEM
is	VBZ	O
likely	JJ	O
.	.	O

3.	CD	O
Interval	NNP	O
development	NN	O
of	IN	O
tree-in-Eric	JJ	B-PROBLEM
nodular	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
and	CC	O
scattered	VBN	B-PROBLEM
ground	NN	I-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
involving	VBG	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
concerning	VBG	O
for	IN	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

The	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
this	DT	O
is	VBZ	O
wide	JJ	O
including	VBG	O
viral	JJ	B-PROBLEM
,	,	I-PROBLEM
fungal	JJ	I-PROBLEM
and	CC	I-PROBLEM
atypical	JJ	I-PROBLEM
mycobacterial	JJ	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

Drug	NN	B-PROBLEM
toxicity	NN	I-PROBLEM
would	MD	O
be	VB	O
a	DT	O
consideration	NN	O
,	,	O
although	IN	O
somewhat	RB	O
less	RBR	O
likely	JJ	O
given	VBN	O
the	DT	O
unilaterality	NN	O
of	IN	O
the	DT	O
findings	NNS	O
.	.	O

4.	CD	O
New	NNP	B-PROBLEM
jejunal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
thickening	VBG	I-PROBLEM
with	IN	O
persistent	JJ	B-PROBLEM
distal	JJ	I-PROBLEM
ileal	NN	I-PROBLEM
wall	NN	I-PROBLEM
thickening	NN	I-PROBLEM
and	CC	O
diffuse	NN	B-PROBLEM
mesenteric	NN	I-PROBLEM
stranding	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
reflecting	VBG	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
etiology	NN	I-PROBLEM
.	.	O

5.	CD	O
Overall	JJ	O
stability	NN	O
in	IN	O
metastatic	JJ	B-PROBLEM
burden	NN	I-PROBLEM
.	.	O

4)	CD	O
ECHO	NNP	B-TEST
(	(	O
06-18	JJ	O
):	NNP	O
Mild	NNP	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
preserved	JJ	O
biventricular	JJ	O
systolic	JJ	O
function	NN	O
.	.	O

Mild	NNP	B-PROBLEM
posterior	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

Small	NNP	B-PROBLEM
(	(	I-PROBLEM
0.6	CD	I-PROBLEM
cm	NN	I-PROBLEM
)	)	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
largest	JJS	O
around	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
.	.	O

5)	CD	O
L	NNP	B-TEST
femur	NN	I-TEST
xray	NN	I-TEST
(	(	O
06-18	JJ	O
):	NNP	O
Predominantly	NNP	B-PROBLEM
sclerotic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
interval	JJ	B-PROBLEM
periosteal	JJ	I-PROBLEM
new	JJ	I-PROBLEM
bone	NN	I-PROBLEM
formation	NN	I-PROBLEM
involving	VBG	O
the	DT	O
intertrochanteric	NN	O
and	CC	O
subtrochanteric	JJ	O
regions	NNS	O
.	.	O

No	DT	O
displaced	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
is	VBZ	O
demonstrated	VBN	O
.	.	O

Mr.	NNP	O
Mcelveen	NNP	O
51	CD	O
year-old	JJ	O
male	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
RCC	NNP	I-PROBLEM
on	IN	O
Sutent	NNP	B-TREATMENT
since	IN	O
2018-12-21	CD	O
,	,	O
admitted	VBN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
hypoxemia	NN	B-PROBLEM
,	,	O
and	CC	O
bibasilar	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

1)	CD	O
Bibasilar	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
:	:	O
Patient	NN	O
was	VBD	O
treated	VBN	O
for	IN	O
community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
initially	RB	O
placed	VBN	O
on	IN	O
Ceftriaxone	NNP	B-TREATMENT
,	,	O
Levaquin	NNP	B-TREATMENT
,	,	O
and	CC	O
Flagyl	NNP	B-TREATMENT
in	IN	O
the	DT	O
ICU	NNP	O
but	CC	O
then	RB	O
changed	VBD	O
to	TO	O

Azithromycin	NNP	B-TREATMENT
&	CC	O
CTX	NNP	B-TREATMENT
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
oncology	NN	O
service	NN	O
.	.	O

He	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
and	CC	O
CT	NNP	B-TEST
scan	JJ	I-TEST
suggested	VBD	O
ground	NN	B-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
,	,	O
suggestive	NN	O
of	IN	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

ECHO	NNP	B-TEST
was	VBD	O
done	VBN	O
and	CC	O
confirmed	VBN	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
.	.	O

His	PRP$	O
respiratory	NN	O
status	NN	O
improved	VBD	O
slowly	RB	O
,	,	O
oxygen	NN	B-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
course	NN	O
of	IN	O
Levaquin	NNP	B-TREATMENT
.	.	O

2)	CD	O
Metastatic	JJ	B-PROBLEM
RCC	NNP	I-PROBLEM
:	:	O
Sutent	NN	B-TREATMENT
was	VBD	O
held	VBN	O
on	IN	O
admission	NN	O
in	IN	O
light	NN	O
of	IN	O
acute	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

He	PRP	O
underwent	VBD	O
a	DT	B-TEST
staging	NN	I-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
torso	NN	I-TEST
which	WDT	O
suggested	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	I-PROBLEM
tumor	NN	I-PROBLEM
burden	NN	I-PROBLEM
.	.	O

Patient	NN	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
abnormal	JJ	B-PROBLEM
TFTs	NNP	I-PROBLEM
on	IN	O
Sutent	NNP	B-TREATMENT
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
replacement	NN	B-TREATMENT

therapy	NN	B-TREATMENT
.	.	O

He	PRP	O
will	MD	O
need	VB	O
follow-up	JJ	B-TEST
bloodwork	NN	I-TEST
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

Recent	JJ	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
showed	VBD	O
destruction	NN	B-PROBLEM
of	IN	I-PROBLEM
L	NNP	I-PROBLEM
femoral	JJ	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

He	PRP	O
underwent	VBD	O
an	DT	B-TEST
xray	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
L	NNP	I-TEST
femur	NN	I-TEST
which	WDT	O
did	VBD	O
not	RB	O
suggest	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
restart	VB	O
Sutent	NNP	B-TREATMENT
next	JJ	O
Monday	NNP	O
.	.	O

3)	CD	O
Renal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
:	:	O
Creatinine	NNP	B-TEST
improved	VBD	O
from	IN	O
2.1	CD	O
to	TO	O
1.3	CD	O
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

Likely	RB	O
related	VBN	O
to	TO	O
underlying	VBG	B-PROBLEM
malignancy	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
prerenal	JJ	B-PROBLEM
component	NN	I-PROBLEM
given	VBN	O
improvement	NN	O
with	IN	O
gentle	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

MEDICATIONS	NNP	O
ON	NNP	O
ADMISSION	NNP	O
:	:	O
He	PRP	O
takes	VBZ	O
Imodium	NN	B-TREATMENT
and	CC	O
Lomotil	NNP	B-TREATMENT
while	IN	O
on	IN	O
Sutent	NNP	B-TREATMENT
for	IN	O
diarrhea	NN	B-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
MS	NNP	B-TREATMENT
Contin	NNP	I-TREATMENT
45	CD	O
mg	NN	O
PO	NNP	O
q12	NN	O
hours	NNS	O
(	(	O
confirmed	VBN	O
with	IN	O
wife	NN	O
)	)	O
and	CC	O
MSIR	$	B-TREATMENT
15	CD	O
mg	NN	O
every	DT	O
4	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

Heparin	NNP	B-TREATMENT
5000	CD	O
UNIT	NNP	O
SC	NNP	O
TID	NNP	O

Albuterol	$	B-TREATMENT
0.083%	CD	O
Neb	NNP	O
Soln	NNP	O
1	CD	O
NEB	NNP	O
IH	NNP	O
Q6H	NNP	O

Ipratropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
Neb	NNP	I-TREATMENT
1	CD	O
NEB	NNP	O
IH	NNP	O
Q6H	NNP	O

CeftriaXONE	NNP	B-TREATMENT
1	CD	O
gm	NN	O
IV	NNP	O
Q24H	NNP	O

Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
PO	NNP	O
Q24H	NNP	O

Morphine	JJ	B-TREATMENT
Sulfate	NNP	I-TREATMENT
2-4	JJ	O
mg	NN	O
IV	NNP	O
Q4H	NNP	O
:	:	O
PRN	NN	O

Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
PO	NNP	O
BID	NNP	O

Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
PO	NNP	O
Q24H	NNP	O

Fluticasone	CD	B-TREATMENT
Propionate	NNP	I-TREATMENT
110mcg	CD	O
2	CD	O
PUFF	NNP	O
IH	NNP	O
BID	NNP	O

1.	CD	O
Levothyroxine	NNP	B-TREATMENT
50	CD	O
mcg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
:	:	O
last	JJ	O
dose	NN	O
will	MD	O
be	VB	O
Nolen	NNP	O
,	,	O
06-23	NN	O
.	.	O

3.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
):	NNP	O
Take	NNP	O
as	IN	O
necessary	JJ	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

4.	CD	O
SUTENT	NNP	B-TREATMENT
50	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
Every	NNP	O
other	JJ	O
day	NN	O
:	:	O
Please	NNP	O
restart	VB	O
on	IN	O
Wallace	NNP	O
,	,	O
06-24	NN	O
.	.	O

5.	CD	O
Morphine	NNP	B-TREATMENT
15	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
Pain	NNP	B-PROBLEM
.	.	O

6.	CD	O
Morphine	NNP	B-TREATMENT
15	CD	O
mg	NN	O
Tablet	NNP	O
Sustained	NNP	O
Release	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Tablet	NN	O
Sustained	VBN	O
Release	NNP	O
PO	NNP	O
Q12H	NNP	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

1)	CD	O
Pneumonia	NNP	B-PROBLEM

2)	CD	O
Acute	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM

3)	CD	O
Metastatic	JJ	B-PROBLEM
renal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM

4)	CD	O
Hypoxemia	NN	B-PROBLEM

1)	CD	O
Please	NNP	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
listed	VBN	O
in	IN	O
the	DT	O
discharge	NN	O
instructions	NNS	O
.	.	O

2)	CD	O
You	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
started	VBD	O
on	IN	O
an	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
called	VBD	O
Levaquin	NNP	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

You	PRP	O
should	MD	O
continue	VB	O
taking	VBG	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
and	CC	O
your	PRP$	O
last	JJ	O
day	NN	O
will	MD	O
be	VB	O
Nolen	NNP	O
,	,	O
06-23	NN	O
.	.	O

3)	CD	O
When	WRB	O
you	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
your	PRP$	B-TREATMENT
Sutent	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

You	PRP	O
should	MD	O
resume	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
starting	VBG	O
Wallace	NNP	O
,	,	O
06-24	NN	O
.	.	O

You	PRP	O
should	MD	O
take	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
every	DT	O
other	JJ	O
day	NN	O
.	.	O

4)	CD	O
During	IN	O
your	PRP$	O
hospital	NN	O
stay	NN	O
you	PRP	O
were	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
low	JJ	B-PROBLEM
thyroid	NNS	I-PROBLEM
hormone	NN	I-PROBLEM
levels	NNS	I-PROBLEM
.	.	O

As	IN	O
a	DT	O
result	NN	O
,	,	O
you	PRP	O
were	VBD	O
started	VBN	O
on	IN	O
thyroid	NN	B-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

You	PRP	O
should	MD	O
have	VB	O
follow-up	JJ	B-TEST
blood	NN	I-TEST
tests	NNS	I-TEST
by	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
B	NNP	O
3	CD	O
months	NNS	O
.	.	O

6)	CD	O
If	IN	O
you	PRP	O
experience	VBP	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

Patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	B-TREATMENT
on	IN	O
2013-06-25	JJ	O
.	.	O

Discharge	NN	O
was	VBD	O
delayed	VBN	O
by	IN	O
one	CD	O
day	NN	O
to	TO	O
ensure	VB	O
patient	NN	O
could	MD	O
tolerate	VB	O
P.O.	NNP	O
which	WDT	O
patient	NN	O
did	VBD	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

Please	NNP	O
see	VBP	O
original	JJ	O
Discharge	NNP	O
Summary	NNP	O
for	IN	O
discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

By	IN	O
report	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
awake	JJ	O
,	,	O
but	CC	O
confused	VBD	B-PROBLEM
at	IN	O
the	DT	O
scene	NN	O
of	IN	O
the	DT	O
accident	NN	O
with	IN	O
no	DT	O
memory	NN	O
of	IN	O
the	DT	O
incident	NN	O
.	.	O

She	PRP	O
was	VBD	O
immobilized	VBN	O
in	IN	O
the	DT	B-TREATMENT
C-spine	JJ	I-TREATMENT
collar	NN	I-TREATMENT
at	IN	O
the	DT	O
scene	NN	O
of	IN	O
the	DT	O
accident	NN	O
and	CC	O
subsequently	RB	O
transported	VBN	O
by	IN	O
EMS	NNP	O
to	TO	O
the	DT	O
New	NNP	O
England	NNP	O
Sinai	NNP	O
Hospital	NNP	O
&	CC	O
Rehab	NNP	O
Center	NNP	O
Emergency	NNP	O
Department	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

Examination	NN	B-TEST
on	IN	O
presentation	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

Temperature	NN	B-TEST
35.4	CD	O
Celsius	NNP	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
116/63	CD	O
,	,	O
pulse	RB	B-TEST
105	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Boston	NNP	B-TEST
Coma	NNP	I-TEST
Scale	NNP	I-TEST
of	IN	O
15	CD	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
lung	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
lungs	NNS	O
to	TO	O
be	VB	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
no	DT	O
crepitus	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
deformity	NN	I-PROBLEM
was	VBD	O
grossly	RB	O
apparent	JJ	O
on	IN	O
examination	NN	B-TEST
.	.	O

Cardiac	JJ	B-TEST
examination	NN	I-TEST
demonstrated	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Soft	NNP	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

Examination	NN	B-TEST
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
with	IN	O
good	JJ	O
rectal	NN	O
tone	NN	O
.	.	O

The	DT	O
patient	NN	O
's	POS	O
pelvis	NN	O
was	VBD	O
stable	JJ	O
to	TO	O
AP	NNP	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
compression	NN	I-TEST
.	.	O

A	DT	B-PROBLEM
5	CD	I-PROBLEM
cm	NN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
over	IN	O
the	DT	O
patient	NN	O
's	POS	O
occiput	NN	O
on	IN	O
further	JJ	B-TEST
inspection	NN	I-TEST
with	IN	O
no	DT	O
exposed	JJ	B-PROBLEM
underlying	VBG	I-PROBLEM
bone	NN	I-PROBLEM
.	.	O

Right	RB	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
intact	JJ	O
motor	NN	O
,	,	O
sensory	NN	O
,	,	O
and	CC	O
vascular	JJ	O
function	NN	O
.	.	O

Left	NNP	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
no	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
,	,	O
tenderness	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
in	IN	I-TEST
the	DT	I-TEST
mid	NN	I-TEST
forearm	NN	I-TEST
,	,	O
intact	JJ	O
motor	NN	O
function	NN	O
in	IN	O
the	DT	O
median	NN	O
,	,	O
radial	JJ	O
,	,	O
and	CC	O
ulnar	JJ	O
nerve	NN	O
distributions	NNS	O
,	,	O
intact	JJ	O
sensation	NN	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
in	IN	O
the	DT	O
median	JJ	O
and	CC	O
radial	JJ	O
nerve	NN	O
distributions	NNS	O
,	,	O
decreased	VBN	B-PROBLEM
sensation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ulnar-nerve	JJ	I-PROBLEM
distribution	NN	I-PROBLEM
,	,	O
warm	NN	O
and	CC	O
well	RB	O
perfused	JJ	O
limb	NN	O
with	IN	O
2+	CD	O
radial	JJ	B-TEST
pulses	NNS	I-TEST
.	.	O

Right	NNP	B-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
mild	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
ecchymosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
thigh	NN	I-PROBLEM
and	CC	O
approximately	RB	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
cm	NN	I-PROBLEM
laceration	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
,	,	O
expressive	NN	O
of	IN	O
moderate	JJ	O
amounts	NNS	O
of	IN	O
standard	NN	O
sterile	NN	O

No	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
.	.	O

Motor	NNP	B-TEST
,	,	I-TEST
sensory	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
vascular	JJ	I-TEST
examinations	NNS	I-TEST
were	VBD	O
intact	JJ	O
in	IN	O
all	DT	O
distributions	NNS	O
.	.	O

Left	NNP	B-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
no	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
and	CC	O
intact	JJ	O
motor	NN	O
,	,	O
sensory	NN	O
,	,	O
and	CC	O
vascular	JJ	O
examinations	NNS	O
in	IN	O
all	DT	O
distributions	NNS	O
.	.	O

Radiographic	JJ	B-TEST
studies	NNS	I-TEST
demonstrated	VBD	O
an	DT	B-PROBLEM
inferior	NN	I-PROBLEM
displaced	VBD	I-PROBLEM
left	VBD	I-PROBLEM
midclavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O

pneumothorax	NN	B-PROBLEM
.	.	O

Trauma	NNP	B-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Head	NNP	B-TEST
CT	NNP	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
intracranial	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Trauma	NNP	B-TEST
CT	NNP	I-TEST
demonstrated	VBD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
contusions	NNS	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
pelvic	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Cervical	JJ	B-TEST
spine	NN	I-TEST
imaging	VBG	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
spine	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

Right	RB	B-TEST
tibial-fibular	JJ	I-TEST
film	NN	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

Left	NNP	B-TEST
humerus	NN	I-TEST
film	NN	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
or	CC	O
displacement	NN	B-PROBLEM
.	.	O

Right	JJ	B-TEST
foot	NN	I-TEST
and	CC	I-TEST
femur	JJ	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

Left	NNP	B-TEST
forearm	NN	I-TEST
and	CC	I-TEST
wrist	JJ	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
transverse	JJ	B-PROBLEM
mid	NN	I-PROBLEM
shaft	NN	I-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
ulnar	JJ	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

Diagnosis	NNP	B-TEST
peritoneum	NN	I-TEST
lavage	NN	I-TEST
times	NNS	O
two	CD	O
was	VBD	O
negative	JJ	O
for	IN	O
any	DT	O
signs	NNS	O
of	IN	O
intra-abdominal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Studies	NNS	B-TEST
on	IN	O
admission	NN	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
12.9	CD	O
,	,	O
hemoglobin	NN	B-TEST
11.5	CD	O
,	,	O
hematocrit	NN	B-TEST
32.8	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
197,000	CD	O
,	,	O
sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
3.6	CD	O
,	,	O
chloride	RB	B-TEST
110	CD	O
,	,	O
bicarbonate	NN	B-TEST
21	CD	O
,	,	O
BUN	NNP	B-TEST
20	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
189	CD	O
,	,	O
PT	NNP	B-TEST
13.3	CD	O
,	,	O
INR	NNP	B-TEST
1.2	CD	O
,	,	O
PTT	NNP	B-TEST
30.0	CD	O
,	,	O
amylase	NN	B-TEST
57	CD	O
,	,	O
arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
7.32	CD	O
,	,	O
35	CD	O
,	,	O
159	CD	O
,	,	O
19	CD	O
,	,	O
-7	NN	O
.	.	O

Urinalysis	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
with	IN	O
6	CD	O
to	TO	O
10	CD	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

Toxicology	NNP	B-TEST
screen	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

crystalloid	NN	B-TREATMENT
and	CC	O
four	CD	O
units	NNS	O
packed	VBD	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
the	DT	O
above-described	JJ	O
diagnostic	JJ	B-TEST
procedures	NNS	I-TEST
,	,	O
which	WDT	O
demonstrated	VBD	O
injuries	NNS	B-PROBLEM
limited	VBN	O
to	TO	O
a	DT	B-PROBLEM
posterior	JJ	I-PROBLEM
scalp	NN	I-PROBLEM
laceration	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
fractured	JJ	I-PROBLEM
clavicle	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
fractured	JJ	I-PROBLEM
radius	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
thigh	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
and	CC	O
right	JJ	B-PROBLEM
leg	NN	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

Given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
right	JJ	I-PROBLEM
thigh	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
duplex	JJ	I-TEST
evaluation	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2010-06-28	JJ	O
and	CC	O
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
major	JJ	B-PROBLEM
arterial	JJ	I-PROBLEM
or	CC	I-PROBLEM
venous	JJ	I-PROBLEM
injury	NN	I-PROBLEM
in	IN	O
the	DT	O
level	NN	O
of	IN	O

On	IN	O
06-28	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
cleared	VBN	O
for	IN	O
removal	NN	O
of	IN	O
her	PRP$	B-TREATMENT
C-spine	JJ	I-TREATMENT
collar	NN	I-TREATMENT
and	CC	O
deemed	VBD	O
stable	JJ	O
for	IN	O
transfer	NN	O
to	TO	O
the	DT	O
Orthopedic	NNP	O
Service	NNP	O
under	IN	O
the	DT	O
direction	NN	O
of	IN	O
Dr.	NNP	O
Ronda	NNP	O
Lopez	NNP	O
.	.	O

The	DT	O
patient	NN	O
remained	VBD	O
stable	JJ	O
through	IN	O
2010-06-29	JJ	O
at	IN	O
which	WDT	O
point	NN	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
undergo	VB	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
radial	JJ	I-TREATMENT
fracture	NN	I-TREATMENT
open	JJ	I-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
demonstrated	VBD	O
a	DT	B-TEST
postoperative	JJ	I-TEST
hematocrit	NN	I-TEST
of	IN	O
40.9	CD	O
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	B-PROBLEM
scalp	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
lacerations	NNS	I-PROBLEM
were	VBD	O
closed	VBN	O
primarily	RB	O
by	IN	O
the	DT	O
trauma	NN	O
team	NN	O
on	IN	O
admission	NN	O
and	CC	O
on	IN	O
hospital	JJ	O
day	NN	O
#1	NNP	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
.	.	O

Nonoperative	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
was	VBD	O
elected	VBN	O
for	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
#1	NNP	O
,	,	O
2010-06-30	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clinically	RB	O
stable	JJ	O
,	,	O
tolerating	VBG	O
oral	JJ	O
intake	NN	O
,	,	O
and	CC	O
expressive	NN	O
of	IN	O
adequate	JJ	O
amounts	NNS	O
of	IN	O
urine	JJ	O
independent	JJ	O
of	IN	O
a	DT	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
head	NN	I-PROBLEM
wound	IN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
and	CC	O
dry	JJ	O
with	IN	O
intact	JJ	B-TREATMENT
staples	NNS	I-TREATMENT
.	.	O

There	EX	O
was	VBD	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
purulence	NN	B-PROBLEM
.	.	O

The	DT	O
left	JJ	O
clavicle	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
continued	VBN	B-PROBLEM
ecchymosis	NN	I-PROBLEM
decreased	VBN	O
from	IN	O
prior	JJ	B-TEST
examination	NN	I-TEST
with	IN	O
a	DT	B-PROBLEM
minor	JJ	I-PROBLEM
stepoff	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
decreased	VBN	O
from	IN	O
prior	JJ	B-TEST
examinations	NNS	I-TEST
.	.	O

The	DT	B-TREATMENT
left	JJ	I-TREATMENT
forearm	NN	I-TREATMENT
dressing	NN	I-TREATMENT
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
place	NN	O
,	,	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
with	IN	O
no	DT	O
saturation	NN	B-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
swelling	VBG	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
left	JJ	O
hand	NN	O
.	.	O

Fingers	NNS	O
were	VBD	O
warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
with	IN	O
capillary	JJ	B-TEST
refill	NN	I-TEST
less	JJR	O
than	IN	O
3	CD	O
seconds	NNS	O
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
right	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
tibial	NN	I-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
with	IN	O
sutures	NNS	B-TREATMENT
intact	JJ	O
and	CC	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
purulence	NN	B-PROBLEM
noted	VBN	O
.	.	O

On	IN	O
06-30	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
Occupational	NNP	O
Therapy	NNP	O
and	CC	O
fitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
splint	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
administered	VBN	O
adaptive	JJ	B-TREATMENT
training	NN	I-TREATMENT
for	IN	O
activities	NNS	B-TREATMENT
of	IN	I-TREATMENT
daily	JJ	I-TREATMENT
life	NN	I-TREATMENT
and	CC	O
advised	VBD	O
regarding	VBG	O
wound	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
fitted	VBN	O
with	IN	O
a	DT	B-TREATMENT
figure-of-eight	JJ	I-TREATMENT
clavicular	JJ	I-TREATMENT
splint	NN	I-TREATMENT
and	CC	O
instructed	VBN	O
in	IN	O
its	PRP$	O

1.	CD	O
Left	NNP	B-PROBLEM
transverse	NN	I-PROBLEM
mid	NN	I-PROBLEM
shaft	NN	I-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
ulnar	JJ	B-PROBLEM
displacement	NN	I-PROBLEM
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radial	JJ	I-TREATMENT
open	JJ	I-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
.	.	O

2.	CD	O
Left	NNP	B-PROBLEM
midclavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
managed	VBD	O
nonoperatively	RB	O
.	.	O

3.	CD	O
Occipital	JJ	B-PROBLEM
scalp	NN	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

4.	CD	O
Right	NNP	B-PROBLEM
anterior	JJ	I-PROBLEM
tibial	JJ	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

Percocet	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
PO	NNP	O
q.4h.	NN	O
to	TO	O
6h.p.r.n.	CD	O
pain	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
maintain	VB	O
her	PRP$	B-TREATMENT
figure-of-eight	JJ	I-TREATMENT
clavicular	JJ	I-TREATMENT
splint	NN	I-TREATMENT
and	CC	O
left	VBD	B-TREATMENT
posterior	JJ	I-TREATMENT
forearm	JJ	I-TREATMENT
splint	NN	I-TREATMENT
in	IN	O
place	NN	O
for	IN	O
fourteen	JJ	O
days	NNS	O
following	VBG	O
discharge	NN	O
.	.	O

The	DT	B-PROBLEM
left	JJ	I-PROBLEM
forearm	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
wound	NN	I-PROBLEM
should	MD	O
be	VB	O
kept	VBN	O
clean	JJ	O
and	CC	O
dry	JJ	O
with	IN	O
regular	JJ	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
with	IN	O
dry	JJ	B-TREATMENT
gauze	NN	I-TREATMENT
once	RB	O
per	IN	O
day	NN	O
.	.	O

Scalp	NNP	B-PROBLEM
laceration	NN	I-PROBLEM
should	MD	O
be	VB	O
kept	VBN	O
clean	JJ	O
and	CC	O
dry	JJ	O
for	IN	O
five	CD	O
days	NNS	O
following	VBG	O
discharge	NN	O
after	IN	O
which	WDT	O
point	VBP	O
the	DT	O
patient	NN	O
may	MD	O
once	RB	O
wash	VB	O
her	PRP$	O
hair	NN	O
.	.	O

Percocet	NNP	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
as	IN	O
needed	VBN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
followup	VB	O
with	IN	O
an	DT	O
orthopedist	NN	O
in	IN	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
fourteen	JJ	O
days	NNS	O
following	VBG	O
discharge	NN	O
at	IN	O
which	WDT	O
point	NN	O
repeat	NN	B-TEST
x-rays	NNS	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
left	JJ	I-TEST
forearm	NN	I-TEST
should	MD	O
be	VB	O
obtained	VBN	O
and	CC	O
her	PRP$	B-TREATMENT
left	JJ	I-TREATMENT
forearm	NN	I-TREATMENT
scalp	NN	I-TREATMENT
and	CC	I-TREATMENT
right	JJ	I-TREATMENT
lower	JJR	I-TREATMENT
leg	NN	I-TREATMENT
sutures	NNS	I-TREATMENT
and	CC	O
staples	NNS	B-TREATMENT
may	MD	O
be	VB	O
removed	VBN	O
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

Explained	VBN	O
to	TO	O
pt	VB	O
which	WDT	O
of	IN	O
the	DT	B-TREATMENT
meds	NNS	I-TREATMENT
he	PRP	O
should	MD	O
no	RB	O
longer	RBR	O
take	VB	O
that	IN	O
he	PRP	O
was	VBD	O
taking	VBG	O
pre-admission	NN	O
.	.	O

Also	RB	O
,	,	O
explained	VBD	O
which	WDT	O
meds	NNS	B-TREATMENT
are	VBP	O
new	JJ	O
.	.	O

1.	CD	O
Diltiazem	NNP	B-TREATMENT
HCl	NNP	O
240	CD	O
mg	NN	O
Capsule	NNP	O
,	,	O
Sustained	VBD	O
Release	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NN	O
,	,	O
Sustained	VBD	O
Release	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Simvastatin	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig:	NNP	O
One	NNP	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

3.	CD	O
Albuterol-Ipratropium	JJ	B-TREATMENT
103-18	JJ	O
mcg	NN	O
/	NNP	O
Actuation	NNP	O
Aerosol	NNP	O
Sig	NNP	O
:	:	O
02-26	JJ	O
Puffs	NNP	O
Inhalation	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
Fluticasone-Salmeterol	JJ	B-TREATMENT
250-50	JJ	O
mcg	NN	O
/	NNP	O
Dose	NNP	O
Disk	NNP	O
with	IN	O
Device	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Disk	NN	O
with	IN	O
Device	NNP	O
Inhalation	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
Terazosin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

6.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
Nimodipine	NNP	B-TREATMENT
30	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

8.	CD	O
Ferrous	JJ	B-TREATMENT
Sulfate	NNP	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

9.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Chewable	JJ	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Chewable	JJ	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

10.	CD	O
Ipratropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
0.02	CD	O
%	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Inhalation	NN	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
Simvastatin	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

12.	CD	O
Hydralazine	NNP	B-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

13.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

14.	CD	O
Isosorbide	NNP	B-TREATMENT
Dinitrate	NNP	I-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

15.	CD	O
Clopidogrel	NNP	B-TREATMENT
75	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

16.	CD	O
Glipizide	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
on	IN	O
several	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
included	VBD	O
Cefepime	NNP	B-TREATMENT
,	,	O
Vancomycin	NNP	B-TREATMENT
,	,	O
Ciprofloxacin	NNP	B-TREATMENT
,	,	O
Ambazone	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
HSV	NNP	I-TEST
antibody	NN	I-TEST
titer	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
and	CC	O
the	DT	O
patient	NN	O
's	POS	O
Acyclovir	NNP	B-TREATMENT
was	VBD	O
not	RB	O
restarted	VBN	O
.	.	O

Infectious	JJ	O
disease	NN	O
continued	VBD	O
to	TO	O
follow	VB	O
and	CC	O
on	IN	O
2012-02-29	JJ	O
,	,	O
the	DT	O
patient	NN	O
spiked	VBD	O
again	RB	O
which	WDT	O
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
resited	VBN	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
Vancomycin	NNP	I-TREATMENT
.	.	O

Over	IN	O
the	DT	O
following	JJ	O
days	NNS	O
until	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
on	IN	O
2012-03-09	JJ	O
,	,	O
in	IN	O
fact	NN	O
all	PDT	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

As	IN	O
for	IN	O
the	DT	O
patient	NN	O
's	POS	O
ALL	NNP	B-PROBLEM
and	CC	O
AML	NNP	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
new	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
protocol	NN	I-TREATMENT
called	VBN	O
hyper-CVAD	NN	B-TREATMENT
on	IN	O
2012-03-06	JJ	O
.	.	O

After	IN	O
the	DT	O
patient	NN	O
began	VBD	O
on	IN	O
this	DT	B-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	VBP	I-TEST
steadily	RB	O
began	VBD	O
to	TO	O
climb	VB	O
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
no	RB	O
longer	JJR	O
neutropenic	JJ	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
's	POS	O
also	RB	O
began	VBD	O
to	TO	O
climb	VB	O
and	CC	O
the	DT	B-TEST
percent	NN	I-TEST
blasts	NNS	I-TEST
in	IN	O
his	PRP$	B-TEST
differential	NN	I-TEST
decreased	VBD	O
significantly	RB	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
and	CC	O
on	IN	O
2012-03-10	JJ	O
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
2.3	CD	O
,	,	O
neutrophils	RB	B-TEST
50%	CD	O
,	,	O
bands	VBZ	B-TEST
2%	CD	O
,	,	O
lymphocytes	VBZ	B-TEST
5%	CD	O
,	,	O
monocytes	VBZ	B-TEST
40%	CD	O
,	,	O
and	CC	O
blasts	VBZ	B-TEST
1%	CD	O
.	.	O

Platelet	NNP	B-TEST
count	NN	I-TEST
was	VBD	O
759,000	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
instructions	NNS	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
Monday	NNP	O
,	,	O
2012-03-12	JJ	O
,	,	O
for	IN	O
follow-up	JJ	O
and	CC	O
laboratory	JJ	B-TEST
checks	NNS	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
told	VBN	O
to	TO	O
continue	VB	O
on	IN	O
a	DT	B-TREATMENT
neutropenic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
told	VBD	O
that	IN	O
he	PRP	O
would	MD	O
have	VB	O
to	TO	O
be	VB	O
admitted	VBN	O
for	IN	O
several	JJ	O
days	NNS	O
during	IN	O
his	PRP$	B-TREATMENT
next	JJ	I-TREATMENT
cycle	NN	I-TREATMENT
of	IN	I-TREATMENT
CVAD	NNP	I-TREATMENT
.	.	O

1.	CD	O
Bactrim	NNP	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
q.	NN	O
Monday	NNP	O
,	,	O
Wednesday	NNP	O
and	CC	O
Friday	NNP	O
.	.	O

2.	CD	O
Compazine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
6hours	CD	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
.	.	O

3.	CD	O
Anzemet	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	JJ	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
.	.	O

Mr.	NNP	O
Robert	NNP	O
Mackey	NNP	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
22	CD	O
year	NN	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
,	,	O
kidney	NN	B-TREATMENT
transplantation	NN	I-TREATMENT
in	IN	O
2003	CD	O
secondary	JJ	O
to	TO	O
diabetic	JJ	B-PROBLEM
nephropathy	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
throat	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
2004	CD	O
treated	VBD	O
with	IN	O
local	JJ	B-TREATMENT
resection	NN	I-TREATMENT
and	CC	O
radical	JJ	B-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
postoperative	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
.	.	O

Mr.	NNP	O
Mackey	NNP	O
also	RB	O
had	VBD	O
signs	NNS	B-PROBLEM
and	CC	I-PROBLEM
symptoms	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
cervical	JJ	B-PROBLEM
myelopathy	NN	I-PROBLEM
;	:	O
a	DT	B-TEST
cervical	JJ	I-TEST
MRI	NNP	I-TEST
scan	NN	I-TEST
showed	VBD	O
very	RB	O
impressive	JJ	B-PROBLEM
disc	NN	I-PROBLEM
herniations	NNS	I-PROBLEM
at	IN	I-PROBLEM
C5-C6	NNP	I-PROBLEM
,	,	O
less	RBR	O
so	RB	O
at	IN	O
C4-C5	NNP	O
,	,	O
with	IN	O
clear	JJ	B-PROBLEM
cut	NN	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
,	,	O
particularly	RB	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
C5-C6	NNP	O
.	.	O

Therefore	RB	O
,	,	O
he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
C4-C5	NNP	B-TREATMENT
and	CC	I-TREATMENT
C5-C6	NNP	I-TREATMENT
anterior	JJ	I-TREATMENT
diskectomy	NN	I-TREATMENT
with	IN	O
autologous	JJ	B-TREATMENT
bone	NN	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
instrumented	JJ	B-TREATMENT
fusion	NN	I-TREATMENT
.	.	O

Postoperative	JJ	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
at	IN	O
97	CD	O
degrees	NNS	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
145/80	CD	O
;	:	O
pulse	JJ	B-TEST
60	CD	O
;	:	O
respiratory	NN	B-TEST
rate	NN	I-TEST
10	CD	O
;	:	O
100%	CD	O
on	IN	O
a	DT	B-TREATMENT
non-rebreather	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
,	,	O
uncomfortable	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
incisional	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
at	IN	O
neck	NN	B-PROBLEM
site	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
right	JJ	B-PROBLEM
iliac	NN	I-PROBLEM
graft	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
wounds	NNS	I-PROBLEM
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
,	,	O
and	CC	O
flat	JJ	O
.	.	O

While	IN	O
in	IN	O
the	DT	O
PACU	NNP	O
,	,	O
Anesthesia	NNP	O
was	VBD	O
called	VBN	O
because	IN	O
the	DT	O
patient	NN	O
became	VBD	O
dyspneic	JJ	B-PROBLEM
and	CC	O
tachypneic	NN	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
SAO2	NNP	I-TEST
dropped	VBD	O
to	TO	O
89%	CD	O
.	.	O

His	PRP$	B-TEST
respiratory	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
30	CD	O
on	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
.	.	O

Interoperatively	RB	O
,	,	O
he	PRP	O
was	VBD	O
positive	JJ	O
two	CD	O
liters	NNS	O
with	IN	O
a	DT	O
stable	JJ	O
blood	NN	O
pressure	NN	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
,	,	O
although	IN	O
requiring	VBG	O
some	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
interoperatively	RB	O
.	.	O

He	PRP	O
responded	VBD	O
to	TO	O
intravenous	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
with	IN	O
3.2	CD	O
liters	NNS	O
of	IN	O
urine	JJ	B-TEST
output	NN	I-TEST
as	RB	O
well	RB	O
as	IN	O
marked	JJ	O
clinical	JJ	O
improvement	NN	O
.	.	O

The	DT	O
etiology	NN	O
for	IN	O
his	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
was	VBD	O
determined	VBN	O
likely	RB	O
to	TO	O
be	VB	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
from	IN	O
increased	VBN	B-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
excess	JJ	B-PROBLEM
volume	NN	I-PROBLEM
.	.	O

No	DT	O
definite	JJ	O
evidence	NN	O
for	IN	O
significant	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
ischemia	NN	I-PROBLEM
,	,	O
although	IN	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
sent	VBN	O
and	CC	O
he	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Lasix	NNP	B-TREATMENT
to	TO	O
continue	VB	O
to	TO	O
diurese	VB	O
the	DT	B-PROBLEM
excess	JJ	I-PROBLEM
volume	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
put	VBN	O
on	IN	O
Lopressor	NNP	B-TREATMENT
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

Also	RB	O
in	IN	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
,	,	O
O2	NNP	B-TEST
saturation	NN	I-TEST
was	VBD	O
closely	RB	O
monitored	VBN	O
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
agitated	VBN	B-PROBLEM
with	IN	O
both	DT	O
tent	JJ	B-TREATMENT
and	CC	O
Bi-PAP	JJ	B-TREATMENT
machine	NN	I-TREATMENT
,	,	O
although	IN	O
continued	VBN	O
to	TO	O
saturate	VB	O
well	RB	O
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
Medicine	VB	O
the	DT	O
morning	NN	O
of	IN	O
2010-08-30	JJ	O
,	,	O
for	IN	O
continued	VBN	B-TREATMENT
medical	JJ	I-TREATMENT
management	NN	I-TREATMENT
post	NN	O
surgery	NN	O
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
transfer	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
with	IN	O
waxing	NN	B-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
sensorium	NN	I-PROBLEM
;	:	O
thus	RB	O
,	,	O
a	DT	B-TEST
delirium	NN	I-TEST
work-up	NN	I-TEST
was	VBD	O
initiated	VBN	O
looking	VBG	O
for	IN	O
precipitants	NNS	O
.	.	O

1.	CD	O
When	WRB	O
his	PRP$	B-TEST
O2	NNP	I-TEST
saturation	NN	I-TEST
was	VBD	O
monitored	VBN	O
,	,	O
his	PRP$	B-TEST
pulse	JJ	I-TEST
oximetry	NN	I-TEST
remained	VBD	O
in	IN	O
the	DT	O
90s	CD	O
during	IN	O
his	PRP$	O
stay	NN	O
.	.	O

2.	CD	O
His	PRP$	B-TREATMENT
non-essential	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
that	WDT	O
may	MD	O
have	VB	O
been	VBN	O
contributing	VBG	O
to	TO	O
his	PRP$	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
were	VBD	O
discontinued	VBN	O
;	:	O
those	DT	O
included	JJ	O
Temocillin	NNP	B-TREATMENT
,	,	O
Nortriptyline	NNP	B-TREATMENT
,	,	O
Haldol	NNP	B-TREATMENT
,	,	O
Lorazepam	NNP	B-TREATMENT
,	,	O
Venlafaxine	NNP	B-TREATMENT
,	,	O
Bupropion	NNP	B-TREATMENT
,	,	O
and	CC	O
Gabapentin	NNP	B-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
his	PRP$	B-TEST
cyclosporin	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
checked	VBN	O
.	.	O

3.	CD	O
Hypo	NNP	B-PROBLEM
or	CC	I-PROBLEM
hyperglycemia	NN	I-PROBLEM
:	:	O

Mahoney	NNP	O
had	VBD	O
been	VBN	O
following	VBG	O
with	IN	O
their	PRP$	O
appreciated	JJ	O
recommendations	NNS	O
on	IN	O
glucose	JJ	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

Finger	NN	B-TEST
sticks	NNS	I-TEST
were	VBD	O
in	IN	O
the	DT	O
150	CD	O
s	NN	O
when	WRB	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
,	,	O
therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
not	RB	O
determined	VBN	O
that	IN	O
glucose	JJ	B-TEST
levels	NNS	I-TEST
were	VBD	O
contributory	NN	O
.	.	O

4.	CD	O
Infectious	JJ	B-PROBLEM
causes	NNS	I-PROBLEM
were	VBD	O
evaluated	VBN	O
.	.	O

He	PRP	O
was	VBD	O
febrile	RB	B-PROBLEM
in	IN	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
to	TO	O
101.0	CD	O
F.	NNP	O
;	:	O
yet	RB	O
,	,	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
,	,	O
blood	NN	B-TEST
cultures	NNS	I-TEST
,	,	O
urinalysis	NN	B-TEST
and	CC	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
for	IN	O
sources	NNS	O
.	.	O

A	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
was	VBD	O
considered	VBN	O
,	,	O
although	IN	O
not	RB	O
performed	VBN	O
due	JJ	O
to	TO	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
cerebrospinal	JJ	O
fluid	NN	O
was	VBD	O
not	RB	O
breached	VBN	O
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

5.	CD	O
Mass	NNP	B-PROBLEM
effect	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
,	,	O
although	IN	O
no	DT	O
focal	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
were	VBD	O
ever	RB	O
noted	VBN	O
on	IN	O
examination	NN	B-TEST
and	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
fluctuating	NN	I-PROBLEM
sensorium	NN	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
severe	JJ	B-PROBLEM
underlying	VBG	I-PROBLEM
structural	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
,	,	I-TEST
non-contrast	JJ	I-TEST
,	,	O
were	VBD	O
ordered	VBN	O
though	IN	O
to	TO	O
evaluate	VB	O
for	IN	O
such	JJ	B-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

No	DT	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
or	CC	O
midline	JJ	B-PROBLEM
shifts	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
,	,	O
although	IN	O
a	DT	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
C2	NNP	O
.	.	O

6.	CD	O
Trauma	NNP	B-PROBLEM
was	VBD	O
also	RB	O
considered	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
out	IN	O
of	IN	O
bed	NN	O
but	CC	O
no	DT	O
signs	NNS	O
of	IN	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
,	,	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
.	.	O

Throughout	IN	O
his	PRP$	O
stay	NN	O
,	,	O
Chem-10	NNP	B-TEST
was	VBD	O
monitored	VBN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
electrolytes	NNS	B-PROBLEM
or	CC	I-PROBLEM
mineral	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
that	WDT	O
could	MD	O
explain	VB	O
his	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

Liver	NNP	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
checked	VBN	O
,	,	O
only	RB	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
1.6	CD	O
.	.	O

TSH	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
as	IN	O
was	VBD	O
B12	NNP	B-TEST
and	CC	O
folate	NN	B-TEST
.	.	O

RPR	NNP	B-TEST
evaluating	VBG	I-TEST
for	IN	O
possible	JJ	O
neurologic	JJ	B-PROBLEM
syphilis	NN	I-PROBLEM
was	VBD	O
also	RB	O
checked	VBN	O
.	.	O

The	DT	B-TEST
assay	NN	I-TEST
was	VBD	O
nonreactive	JJ	O
.	.	O

An	DT	B-TEST
EEG	NNP	I-TEST
was	VBD	O
also	RB	O
considered	VBN	O
to	TO	O
rule	VB	O
out	IN	O
non-convulsive	JJ	B-PROBLEM
status	NN	I-PROBLEM
epilepticus	NN	I-PROBLEM
,	,	O
although	IN	O
again	RB	O
this	DT	O
did	VBD	O
not	RB	O
seem	VB	O
to	TO	O
be	VB	O
a	DT	O
likely	JJ	O
cause	NN	O
.	.	O

On	IN	O
the	DT	O
evening	NN	O
of	IN	O
the	DT	O
22nd	CD	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
,	,	O
threatening	VBG	O
to	TO	O
leave	VB	O
,	,	O
and	CC	O
also	RB	O
threatening	VBG	O
to	TO	O
harm	VB	O
those	DT	O
nurses	NNS	O
and	CC	O
physicians	NNS	O
that	WDT	O
were	VBD	O
attempting	VBG	O
to	TO	O
prevent	VB	O
him	PRP	O
from	IN	O
leaving	VBG	O
.	.	O

restraints	NNS	B-TREATMENT
,	,	O
for	IN	O
the	DT	O
safety	NN	O
of	IN	O
both	CC	O
the	DT	O
patient	NN	O
and	CC	O
the	DT	O
staff	NN	O
of	IN	O
the	DT	O
hospital	NN	O
.	.	O

The	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
were	VBD	O
weaned	VBN	O
off	RB	O
overnight	JJ	O
although	IN	O
he	PRP	O
became	VBD	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
and	CC	O
they	PRP	O
were	VBD	O
replaced	VBN	O
early	RB	O
on	IN	O
08-31	NN	O
.	.	O

Later	RB	O
in	IN	O
the	DT	O
morning	NN	O
on	IN	O
08-31	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
more	RBR	O
oriented	JJ	O
and	CC	O
alert	JJ	O
,	,	O
and	CC	O
asked	VBD	O
to	TO	O
have	VB	O
the	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
removed	VBD	O
.	.	O

The	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
do	VB	O
well	RB	O
and	CC	O
did	VBD	O
not	RB	O
require	VB	O
restraints	NNS	B-TREATMENT
after	IN	O
that	DT	B-PROBLEM
event	NN	I-PROBLEM
.	.	O

Intramuscular	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
intravenous	JJ	B-TREATMENT
Haldol	NNP	I-TREATMENT
were	VBD	O
ordered	VBN	O
p.r.n.	NN	O
for	IN	O
emergency	NN	O
use	NN	O
should	MD	O
he	PRP	O
become	VB	O
acutely	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
.	.	O

haldol	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
the	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
were	VBD	O
not	RB	O
required	VBN	O
after	IN	O
the	DT	O
morning	NN	O
of	IN	O
the	DT	O
23rd	CD	O
.	.	O

Each	DT	O
progressive	JJ	O
day,	NN	O
Mr.	NNP	O
Donald	NNP	O
delirium	VBZ	B-PROBLEM
abated	VBN	O
with	IN	O
return	NN	O
to	TO	O
baseline	VB	O
mental	JJ	O
status	NN	O
early	RB	O
on	IN	O
09-01	NN	O
.	.	O

The	DT	O
likely	JJ	O
cause	NN	O
of	IN	O
the	DT	B-PROBLEM
delirium	NN	I-PROBLEM
was	VBD	O
a	DT	O
combination	NN	O
of	IN	O
surgery	NN	B-TREATMENT
and	CC	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
stay	NN	O
in	IN	O
addition	NN	O
to	TO	O
poly-pharmacy	NN	B-TREATMENT
.	.	O

Other	JJ	O
concerns	NNS	O
during	IN	O
his	PRP$	O
stay	NN	O
was	VBD	O
his	PRP$	B-TEST
kidney	NN	I-TEST
function	NN	I-TEST
,	,	O
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
2003	CD	O
.	.	O

His	PRP$	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
throughout	IN	O
his	PRP$	O
stay	NN	O
;	:	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
remained	VBD	O
approximately	RB	O
2.3	CD	O
to	TO	O
2.4	CD	O
;	:	O
he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
baseline	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

With	IN	O
this	DT	O
in	IN	O
mind	NN	O
,	,	O
when	WRB	O
obtaining	VBG	O
a	DT	B-TEST
CT	JJ	I-TEST
scan	JJ	I-TEST
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
contrast	NN	B-TREATMENT
would	MD	O
not	RB	O
be	VB	O
the	DT	O
best	JJS	O
option	NN	O
.	.	O

While	IN	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
restraints	NNS	B-TREATMENT
,	,	O
gentle	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
since	IN	O
p.o.	NN	B-TEST
intake	NN	I-TEST
was	VBD	O
not	RB	B-PROBLEM
adequate	JJ	I-PROBLEM
.	.	O

As	IN	O
for	IN	O
his	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
,	,	O
the	DT	O
Mahoney	NNP	O
Team	NNP	O
provided	VBD	O
updated	JJ	O
recommendations	NNS	O
each	DT	O
day	NN	O
,	,	O
adjusting	VBG	O
for	IN	O
the	DT	O
changing	VBG	O
p.o.	JJ	O
intake	NN	O
.	.	O

The	DT	O
only	JJ	O
other	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
from	IN	O
Mr.	NNP	O
Mackey	NNP	O
during	IN	O
his	PRP$	O
stay	NN	O
were	VBD	O
:	:	O

Soreness	NN	B-PROBLEM
at	IN	O
his	PRP$	B-PROBLEM
operative	JJ	I-PROBLEM
sites	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
given	VBN	O
p.r.n.	JJ	B-TREATMENT
Tylenol	NNP	I-TREATMENT
once	RB	O
his	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
swallowing	NN	I-PROBLEM
,	,	O
necessitating	VBG	O
only	RB	O
soft	JJ	B-TREATMENT
and	CC	I-TREATMENT
liquid	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

This	DT	O
was	VBD	O
attributed	VBN	O
to	TO	O
postoperative	VB	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
changes	NNS	O
from	IN	O
his	PRP$	B-TREATMENT
diskectomy	NN	I-TREATMENT
performed	VBD	O
2010-08-27	JJ	O
.	.	O

3.	CD	O
He	PRP	O
was	VBD	O
also	RB	O
discharged	VBN	O
home	NN	O
with	IN	O
Visiting	NNP	O
Nurse	NNP	O
Association	NNP	O
for	IN	O
Physical	NNP	B-TEST
Therapy	NNP	I-TEST
evaluation	NN	I-TEST
of	IN	O
home	NN	O
safety	NN	O
.	.	O

1.	CD	O
Venlafaxine	NNP	B-TREATMENT
XR	NNP	I-TREATMENT
75	CD	O
mg	NN	O
q.	CD	O
a.m.	NN	O

2.	CD	O
Furosemide	NNP	B-TREATMENT
20	CD	O
mg	NN	O
q.o.d.	NN	O

3.	CD	O
Metoprolol	NNP	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
Nitroglycerin	NNP	B-TREATMENT
sublingual	JJ	I-TREATMENT
0.3	CD	O
mg	NN	O
p.r.n.	NN	O

5.	CD	O
Cyclosporin	NNP	B-TREATMENT
microemulsion	NN	I-TREATMENT
.	.	O

6.	CD	O
Neoral	JJ	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
Zithropren	NNP	B-TREATMENT
50	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

8.	CD	O
Prednisone	CD	B-TREATMENT
10	CD	O
mg	NNS	O
q.	JJ	O
day	NN	O
.	.	O

9.	CD	O
Minoxidil	NNP	B-TREATMENT
10	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

11.	CD	O
NPH	NNP	B-TREATMENT
30	CD	O
units	NNS	O
q.	RB	O
a.m.	RB	O
,	,	O
5	CD	O
to	TO	O
6	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

12.	CD	O
Regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
5	CD	O
units	NNS	O
q.	JJ	O
a.m.	RB	O
and	CC	O
3	CD	O
to	TO	O
5	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

13.	CD	O
Wellbutrin	NNP	B-TREATMENT
100	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

14.	CD	O
Zocor	NNP	B-TREATMENT
60	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

15.	CD	O
Nitroglycerin	NNP	B-TREATMENT
SR	NNP	I-TREATMENT
2.5	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

He	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
hold	VB	O
the	DT	O
following	JJ	O
three	CD	O
medications	NNS	B-TREATMENT
that	IN	O
he	PRP	O
took	VBD	O
prior	RB	O
to	TO	O
admission	NN	O
:	:	O

Nortriptyline	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
;	:	O
Flomax	NNP	B-TREATMENT
0.4	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
;	:	O
Neurontin	NNP	B-TREATMENT
600	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

1.	CD	O
C4-C5	JJ	B-TREATMENT
,	,	I-TREATMENT
C5-C6	NNP	I-TREATMENT
,	,	I-TREATMENT
anterior	JJ	I-TREATMENT
microdiscectomy	NN	I-TREATMENT
and	CC	I-TREATMENT
fusion	NN	I-TREATMENT
with	IN	O
right	JJ	B-TREATMENT
iliac	NN	I-TREATMENT
bone	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

1.	CD	O
End-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
type	VB	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
;	:	O
status	NN	O
post	NN	O
renal	JJ	B-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
2003	CD	O
.	.	O

2.	CD	O
History	NNP	O
of	IN	O
multiple	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

3.	CD	O
Pyelonephritis	NNP	B-PROBLEM
.	.	O

4.	CD	O
Creatinine	NNP	B-TEST
2.2	CD	O
to	TO	O
2.5	CD	O
.	.	O

5.	CD	O
Right	NNP	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
stent	NN	I-TREATMENT
in	IN	O
2008	CD	O
;	:	O
ejection	NN	B-TEST
fraction	NN	I-TEST
60	CD	O
to	TO	O
65%	CD	O
.	.	O

6.	CD	O
Type	NNP	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
with	IN	O
triopathy	NN	B-PROBLEM
,	,	O
retinopathy	NN	B-PROBLEM
,	,	O
neuropathy	JJ	B-PROBLEM
,	,	O
nephropathy	JJ	B-PROBLEM
.	.	O

7.	CD	O
Benign	NNP	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
status	NN	O
post	NN	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
;	:	O
self	CC	B-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

8.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

9.	CD	O
Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

10.	CD	O
Hepatitis	NNP	B-PROBLEM
B	NNP	I-PROBLEM
.	.	O

11.	CD	O
Throat	NNP	B-PROBLEM
cancer	NN	I-PROBLEM
status	NN	O
post	NN	O
right	RB	B-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
and	CC	O
XRT	NN	B-TREATMENT
in	IN	O
2004	CD	O
.	.	O

12.	CD	O
Cerebral	JJ	B-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

13.	CD	O
Left	NNP	B-TREATMENT
prosthetic	JJ	I-TREATMENT
CMED	NNP	O
CCU	NNP	O
.	.	O

Gentamicin	NNP	B-TREATMENT
,	,	O
and	CC	O
ibuprofen	NN	B-TREATMENT
.	.	O

Mr.	NNP	O
Cordano	NNP	O
is	VBZ	O
a	DT	O
58-year-old	JJ	O
gentlemen	NNS	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
primary	JJ	B-PROBLEM
sclerosing	VBG	I-PROBLEM
cholangitis	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
percutaneous	JJ	B-TEST
transhepatic	JJ	I-TEST
cholangiogram	NN	I-TEST
.	.	O

The	DT	B-TREATMENT
most	RBS	I-TREATMENT
recent	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
was	VBD	O
done	VBN	O
in	IN	O
2009-07-25	JJ	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
an	DT	B-TREATMENT
8	CD	I-TREATMENT
Caucasian	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
common	JJ	O
hepatic/bioduct	NN	O
for	IN	O
external	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

The	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
also	RB	O
showed	VBD	O
the	DT	O
presence	NN	O
proximal	JJ	O
common	JJ	O
bile	NN	O
duct	NN	O
.	.	O

Nodularities	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
visualized	VBN	O
by	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
was	VBD	O
also	RB	O
worrisome	JJ	O
for	IN	O
cholangiocarcinoma	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Blue	NNP	O
General	NNP	O
Surgery	NNP	O
Service	NNP	O
for	IN	O
possible	JJ	O
surgical	JJ	B-TREATMENT
interventions	NNS	I-TREATMENT
.	.	O

Ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
primary	JJ	B-PROBLEM
sclerosing	VBG	I-PROBLEM
cholangitis	NN	I-PROBLEM
.	.	O

Status	NNP	O
post	NN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
with	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
8	CD	I-TREATMENT
Caucasian	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
catheter	NN	I-TREATMENT
in	IN	O
the	DT	O
common	JJ	O
bile	NN	O
duct	NN	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Ursodiol	NNP	B-TREATMENT
600	CD	O
mg	NN	O
t.i.d.	NN	O

2.	CD	O
Ambien	NNP	B-TREATMENT
5	CD	O
mg	NN	O
q.h.s.	NN	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
jaundiced	JJ	O
looking	VBG	O
gentlemen	NNS	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

The	DT	O
head	NN	O
is	VBZ	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
and	CC	O
eyes	NNS	O
are	VBP	O
icteric	JJ	B-PROBLEM
.	.	O

The	DT	O
neck	NN	O
is	VBZ	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

The	DT	O
chest	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Rectal	JJ	B-TEST
exam	NN	I-TEST
showed	VBD	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
is	VBZ	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

Neurological	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
grossly	RB	O
intact	JJ	O
.	.	O

A	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
14.2	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
35.3	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
449,000	CD	O
.	.	O

Sodium	NN	B-TEST
of	IN	O
130	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
93	CD	O
,	,	O
bicarbonate	NN	B-TEST
28	CD	O
,	,	O
BUN	NNP	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
1.1,	CD	O
prothrombin	NN	B-TEST
time	NN	I-TEST
14.1	CD	O
,	,	O
partial	JJ	B-TEST
thrombin	NN	I-TEST
time	NN	I-TEST
29.7	CD	O
.	.	O

INR	NNP	B-TEST
1.4	CD	O
.	.	O

ALT	NNP	B-TEST
106	CD	O
,	,	O
AST	NNP	B-TEST
149	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
242	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
10.1	CD	O
,	,	O
amylase	NN	B-TEST
90	CD	O
and	CC	O
lipase	VBD	B-TEST
112	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
minimal	JJ	B-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
and	CC	O
elevation	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
with	IN	I-TEST
po	NN	I-TEST
contrast	NN	I-TEST
showed	VBD	O
dilation	NN	B-PROBLEM
of	IN	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
improved	VBN	O
from	IN	O
previous	JJ	B-TEST
studies	NNS	I-TEST
.	.	O

It	PRP	O
is	VBZ	O
also	RB	O
noted	VBN	O
that	IN	O
there	EX	O
was	VBD	O
splenomegaly	NN	B-PROBLEM
.	.	O

Mr.	NNP	O
Cordano	NNP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2009-08-17	JJ	O
for	IN	O
a	DT	B-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
cholangiogram	NN	B-TEST
confirmed	VBD	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
distal	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
.	.	O

An	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
also	RB	O
demonstrated	VBD	O
similar	JJ	O
findings	NNS	O

and	CC	O
it	PRP	O
is	VBZ	O
noted	VBN	O
there	EX	O
was	VBD	O
nodularity	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
worrisome	JJ	O
for	IN	O
cholangiocarcinoma	NN	B-PROBLEM
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
on	IN	O
2009-08-24	JJ	O
for	IN	O
a	DT	B-TREATMENT
Whipple	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
versus	NN	O
hepaticojejunostomy	NN	B-TREATMENT
.	.	O

On	IN	O
exploration	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
revealed	VBD	O
significant	JJ	B-PROBLEM
nodularity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
indicating	NN	O
of	IN	O
advanced	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

region	NN	B-PROBLEM
nodularity	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
identified	VBN	O
previously	RB	O
by	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
,	,	O
and	CC	O
regional	JJ	O
lymph	NN	O
nodes	NNS	O
were	VBD	O
all	DT	O
sent	VBN	O
to	TO	O
pathology	NN	B-TEST
.	.	O

They	PRP	O
were	VBD	O
all	DT	O
negative	JJ	O
for	IN	O
malignancy	NN	B-PROBLEM
and	CC	O
therefore	VB	O
a	DT	B-TREATMENT
hepaticojejunostomy	NN	I-TREATMENT

Cholangiogram	NNP	B-TEST
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
leakage	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
anastomosis	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
he	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

The	DT	O
patient	NN	O
's	POS	O
postoperative	JJ	O
course	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
an	DT	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	O
peaking	VBG	O
at	IN	O
30.0	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Unasyn	NNP	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

At	IN	O
the	DT	O
time	NN	O
,	,	O
blood	NN	O
,	,	O
urine	JJ	O
and	CC	O
bile	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
culture	NN	B-TEST
,	,	O
which	WDT	O
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

A	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
also	RB	O
negative	JJ	O
for	IN	O
any	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Postoperatively	RB	O
,	,	O
Mr.	NNP	O
Cordano	NNP	O
also	RB	O
suffered	VBD	O
from	IN	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
ranges	VBZ	O
between	IN	O
25	CD	O
to	TO	O
30	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
.	.	O

Fractional	JJ	B-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
1%	CD	O
suggesting	VBG	O
a	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
etiology	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
sodium	NN	I-TEST
creatinine	NN	I-TEST
peaked	VBD	O
at	IN	O
2.0	CD	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
boluses	NNS	B-TREATMENT
of	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
fluid	NN	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
albumin	NN	I-TREATMENT
infusion	NN	I-TREATMENT
was	VBD	O
also	RB	O
administered	VBN	O
.	.	O

He	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
made	VBD	O
adequate	JJ	O
urine	JJ	O
output	NN	O
.	.	O

At	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
developed	VBD	O
distentions	NNS	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
accumulation	NN	B-PROBLEM
of	IN	I-PROBLEM
ascitic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
significant	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
scrotum	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
eight	CD	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
dropped	VBD	O
to	TO	O
85%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Surgical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
fluid	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
and	CC	O
sputum	JJ	B-TEST
culture	NN	I-TEST
obtained	VBN	O
at	IN	O
the	DT	O
time	NN	O
were	VBD	O
negative	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
100%	CD	B-TREATMENT
nonrebreather	NN	I-TREATMENT
which	WDT	O
improved	VBD	O
his	PRP$	B-TEST
oxygenation	NN	I-TEST
.	.	O

While	IN	O
he	PRP	O
is	VBZ	O
in	IN	O
the	DT	O
Surgical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
,	,	O
paracentesis	NN	B-TEST
was	VBD	O
performed	VBN	O
and	CC	O
it	PRP	O

revealed	VBD	O
greater	JJR	O
than	IN	O
24,000	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
in	IN	O
the	DT	B-PROBLEM
ascites	NNS	I-PROBLEM
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
SVT	NNP	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Zosyn	NNP	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

Gram	NNP	B-TEST
stain	NN	I-TEST
and	CC	O
culture	NN	B-TEST
of	IN	O
the	DT	B-PROBLEM
ascites	NNS	I-PROBLEM
failed	VBD	O
to	TO	O
identify	VB	O
any	DT	B-PROBLEM
organism	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
oxygen	NN	B-PROBLEM
requirement	NN	I-PROBLEM
and	CC	O
was	VBD	O
continued	VBN	O
on	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
and	CC	O

intravenous	JJ	B-TREATMENT
albumin	NN	I-TREATMENT
for	IN	O
treatment	NN	O
of	IN	O
prerenal	JJ	B-PROBLEM
azotemia	NN	I-PROBLEM
.	.	O

Somatostatin	NNP	B-TREATMENT
and	CC	O
midodrine	NN	B-TREATMENT
were	VBD	O
also	RB	O
given	VBN	O
for	IN	O
this	DT	B-PROBLEM
condition	NN	I-PROBLEM
and	CC	O
he	PRP	O
also	RB	O
received	VBD	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
ten	NN	O
,	,	O
the	DT	O
patient	NN	O
returned	VBD	O
to	TO	O
the	DT	O
floor	NN	O
with	IN	O
improved	JJ	O
renal	JJ	O
function	NN	O
and	CC	O
without	IN	O
oxygen	NN	B-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
somatostatin	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
midodrine	NN	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
regimen	NNS	O
of	IN	O
Lasix	NNP	B-TREATMENT
and	CC	O
spironolactone	NN	B-TREATMENT
was	VBD	O
started	VBN	O
for	IN	O
diuresis	NN	B-TREATMENT
.	.	O

His	PRP$	B-TEST
creatinine	NN	I-TEST
levels	NNS	I-TEST
trended	VBN	O
toward	IN	O
normal	JJ	O
and	CC	O
the	DT	B-TEST
fractional	JJ	I-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
also	RB	O
increased	VBD	O
indicating	VBG	O
a	DT	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
kidney	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
PICC	NNP	I-TREATMENT
line	NN	I-TREATMENT
in	IN	O
place	NN	O
for	IN	O
continued	JJ	O
treatment	NN	O
with	IN	O
Rocephin	NNP	B-TREATMENT
and	CC	O
he	PRP	O
will	MD	O
have	VB	O
a	DT	O
visiting	NN	O
nurse	NN	O
to	TO	O
help	VB	O
him	PRP	O
to	TO	O
administer	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

While	IN	O
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
initial	JJ	B-TEST
work-up	JJ	I-TEST
including	VBG	O
echocardiogram	NN	B-TEST
,	,	O
electrocardiogram	NN	B-TEST
and	CC	O
serology	NN	B-TEST
studies	NNS	I-TEST
to	TO	O
be	VB	O
listed	VBN	O
for	IN	O
liver	NN	B-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

1.	CD	O
Rocephin	NNP	B-TREATMENT
1	CD	O
gram	NN	O
q.d.	NN	O

2.	CD	O
Furosemide	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
Spironolactone	CD	B-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
Ursodiol	NNP	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O

PSC	NNP	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
hepaticojejunostomy	NN	B-TREATMENT
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
56	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
history	NN	O
of	IN	O
hypercholesterolemia	NN	B-PROBLEM
and	CC	O
type	NN	B-PROBLEM
II	NNP	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
a	DT	O
recent	JJ	O
history	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
on	IN	O
exertional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
increased	VBN	O
over	IN	O
the	DT	O
last	JJ	O
several	JJ	O
weeks	NNS	O
and	CC	O
is	VBZ	O
relieved	VBN	O
by	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
.	.	O

On	IN	O
2016-06-26	JJ	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
test	NN	I-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
catheterization	NN	I-TEST
at	IN	O
the	DT	O
end	NN	O
of	IN	O
October	NNP	O
revealed	VBD	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
to	TO	O
4.4	CD	O
cm	NNS	O
and	CC	O
80%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
at	IN	O
the	DT	O
bifurcation	NN	O
involving	VBG	O
the	DT	O
diagonal	JJ	O
branch	NN	O
,	,	O
70%	CD	B-PROBLEM
stenoses	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
circumflex	NN	I-PROBLEM
and	CC	I-PROBLEM
oblique	JJ	I-PROBLEM
marginal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
90%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
atrioventricular	JJ	I-TEST
valve	NN	I-TEST
gradient	NN	I-TEST
was	VBD	O
27	CD	O
with	IN	O
an	DT	B-TEST
AV	NNP	I-TEST
surface	NN	I-TEST
area	NN	I-TEST
of	IN	O
.91	NNP	O
.	.	O

Review	NNP	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
shows	VBZ	O
that	IN	O
the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
orthopnea	NN	I-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
no	DT	O
bleeding	NN	B-PROBLEM
or	CC	O
clotting	VBG	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

Juanita	NNP	O
does	VBZ	O
not	RB	O
feel	VB	O
any	DT	B-PROBLEM
palpitations	NNS	I-PROBLEM
.	.	O

He	PRP	O
does	VBZ	O
not	RB	O
have	VB	O
wheezing	NN	B-PROBLEM
,	,	O
claudication	NN	B-PROBLEM
or	CC	O
gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Nor	CC	O
does	VBZ	O
he	PRP	O
have	VB	O
any	DT	O
history	NN	O
of	IN	O
stroke	NN	B-PROBLEM
like	IN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

Type	NNP	B-PROBLEM
II	NNP	I-PROBLEM
diabetes	VBZ	I-PROBLEM
.	.	O

Recent	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Recent	JJ	B-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
associated	VBN	O
with	IN	O
the	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Gastroesophageal	NNP	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

One	CD	O
aspirin	VBZ	B-TREATMENT
a	DT	O
day	NN	O
.	.	O

Nexium	NN	B-TREATMENT
40	CD	O
mg	NN	O
a	DT	O
day	NN	O
.	.	O

Carvedilol	NNP	B-TREATMENT
6.125	CD	O
mg	VBD	O
a	DT	O
day	NN	O
.	.	O

Glucophage	NN	B-TREATMENT
25	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

On	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

Weight	NNP	B-TEST
is	VBZ	O
82	CD	O
kilograms	NNS	O
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
126/66	CD	O
.	.	O

Head	NN	B-TEST
and	CC	I-TEST
neck	NN	I-TEST
examination	NN	I-TEST
:	:	O

No	DT	O
bruits	NNS	B-PROBLEM
appreciated	VBN	O
.	.	O

Lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

3/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
throughout	IN	O
his	PRP$	O
precordium	NN	O
.	.	O

His	PRP$	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

No	DT	O
hepatosplenomegaly	NN	B-PROBLEM
and	CC	O
no	DT	O
CVA	NNP	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Extremities	NNS	O
are	VBP	O
warm	JJ	O
,	,	O
well	RB	O
perfused	VBN	O
,	,	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	NN	B-PROBLEM
or	CC	O

edema	NN	B-PROBLEM
.	.	O

No	DT	O
varicosities	NNS	B-PROBLEM
noted	VBD	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
for	IN	O
an	DT	B-TREATMENT
elected	JJ	I-TREATMENT
Bental	NNP	I-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
homograft	NN	B-TREATMENT
and	CC	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

Once	RB	O
consent	NN	O
and	CC	O
preoperative	JJ	B-TEST
evaluation	NN	I-TEST
was	VBD	O
complete	JJ	O
,	,	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
.	.	O

Briefly	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
repair	VB	B-TREATMENT
his	PRP$	B-PROBLEM
critical	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
his	PRP$	B-PROBLEM
significantly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
ascending	VBG	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
tissue	NN	I-TREATMENT
valve	NN	I-TREATMENT
,	,	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
procedure	NN	I-TREATMENT
where	WRB	O
five	CD	B-TREATMENT
grafts	NNS	I-TREATMENT
were	VBD	O
performed	VBN	O
.	.	O

The	DT	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
was	VBD	O
connected	VBN	O
to	TO	O
the	DT	O
proximal	JJ	O
left	VBD	O
anterior	JJ	O
descending	NN	O
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NNS	I-TREATMENT
grafts	NNS	I-TREATMENT
were	VBD	O
connected	VBN	O
to	TO	O
the	DT	O
posterior	JJ	O
descending	NN	O
artery	NN	O
,	,	O
diagonal	JJ	O
branch	NN	O
,	,	O
obtuse	IN	O
marginal	JJ	O
and	CC	O
distal	JJ	O
left	VBD	O
anterior	JJ	O
descending	NN	O
.	.	O

Finally	RB	O
,	,	O
a	DT	B-TREATMENT
super	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
arch	NN	I-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
implanted	VBN	O
.	.	O

This	DT	O
was	VBD	O
a	DT	B-TREATMENT
....................	JJ	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

Cardiopulmonary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
time	NN	O
was	VBD	O
234	CD	O
minutes	NNS	O
.	.	O

His	PRP$	O
aorta	NN	O
was	VBD	O
cross	NN	B-TREATMENT
clamped	VBD	I-TREATMENT
for	IN	O
168	CD	O
minutes	NNS	O
.	.	O

He	PRP	O
had	VBD	O
pharmacologic	JJ	B-TREATMENT
circulatory	NN	I-TREATMENT
arrest	NN	I-TREATMENT
for	IN	O
18	CD	O
minutes	NNS	O
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
unit	NN	O
,	,	O
intubated	VBN	B-TREATMENT
on	IN	O
Milrinone	NNP	B-TREATMENT
,	,	O
Levophed	NNP	B-TREATMENT
and	CC	O
Propofol	NNP	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
remained	VBD	O
intubated	JJ	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
.	.	O

After	IN	O
that	DT	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
major	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
with	IN	I-PROBLEM
his	PRP$	I-PROBLEM
lungs	NNS	I-PROBLEM
.	.	O

His	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
remained	VBD	O
good	JJ	O
and	CC	O
he	PRP	O
did	VBD	O
not	RB	O
require	VB	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
more	JJR	O
than	IN	O
a	DT	O
couple	NN	O
of	IN	O
days	NNS	O
after	IN	O
his	PRP$	O
extubation	NN	O
.	.	O

After	IN	O
an	DT	O
extended	JJ	O
stay	NN	O
for	IN	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
and	CC	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
to	TO	O
maintain	VB	O
his	PRP$	O
perfusion	NN	O
.	.	O

The	DT	B-PROBLEM
major	JJ	I-PROBLEM
neurologic	JJ	I-PROBLEM
event	NN	I-PROBLEM
of	IN	O
this	DT	O
hospital	NN	O
course	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
slow	JJ	B-PROBLEM
to	TO	I-PROBLEM
awake	VB	I-PROBLEM
after	IN	O
his	PRP$	B-TREATMENT
Propofol	NNP	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

Because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
confusion	NN	I-PROBLEM
,	,	O
a	DT	O
neurology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
subsequent	JJ	B-TEST
radiographic	NN	I-TEST
imaging	VBG	I-TEST
revealed	VBD	O
chronic	JJ	B-PROBLEM
appearing	VBG	I-PROBLEM
infarcts	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
both	DT	O
cerebellar	JJ	O
hemispheres	NNS	O
,	,	O
suggestive	NN	O
of	IN	O
more	JJR	B-PROBLEM
chronic	JJ	I-PROBLEM
infarcts	NNS	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
area	NN	O
in	IN	O
the	DT	O
left	NN	O
corona	NN	O
radiata	NN	O
,	,	O
adjacent	JJ	O
to	TO	O
the	DT	O
left	JJ	O
lateral	JJ	O
ventricle	NN	O
which	WDT	O
may	MD	O
or	CC	O
may	MD	O
not	RB	O
be	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
CAT	NNP	I-TEST
scan	NN	I-TEST
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
12-31	CD	O
.	.	O

As	IN	O
the	DT	O
patient	NN	O
became	VBD	O
more	RBR	O
awake	NN	O
,	,	O
he	PRP	O
still	RB	O
remained	VBD	O
somewhat	RB	B-PROBLEM
confused	JJ	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
little	JJ	I-PROBLEM
bit	NN	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
it	PRP	I-PROBLEM
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
right	NN	I-PROBLEM
sided	VBN	I-PROBLEM
hemiplegia	NN	I-PROBLEM
.	.	O

Over	IN	O
his	PRP$	O
postoperative	JJ	O
course	NN	O
,	,	O
Mr.	NNP	O
Douglass	NNP	O
has	VBZ	O
gradually	RB	O
been	VBN	O
able	JJ	O
to	TO	O
utilize	VB	O
more	JJR	O
and	CC	O
more	JJR	O
of	IN	O
his	PRP$	O
right	JJ	O
side	NN	O
and	CC	O
with	IN	O
the	DT	O
assistance	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
he	PRP	O
has	VBZ	O
4	CD	O
to	TO	O
5	CD	O
+	JJ	O
strength	NN	O
in	IN	O
his	PRP$	O
right	JJ	O
hand	NN	O
and	CC	O
arm	NN	O
and	CC	O
about	IN	O
4	CD	O
+	JJ	O
strength	NN	O
in	IN	O
his	PRP$	O
right	JJ	O
leg	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
Mr.	NNP	O
Douglass	NNP	O
is	VBZ	O
given	VBN	O
Trazodone	NNP	B-TREATMENT
to	TO	O
help	VB	O
him	PRP	O
sleep	VB	O
at	IN	O
night	NN	O
.	.	O

A	DT	O
psychiatric	JJ	O
consult	NN	O
was	VBD	O
also	RB	O
obtained	VBN	O
due	JJ	O
to	TO	O
his	PRP$	O
mental	JJ	O
status	NN	O
and	CC	O
confusion	NN	B-PROBLEM
postoperatively	RB	O
but	CC	O
his	PRP$	B-PROBLEM
psychiatric	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
are	VBP	O
mostly	RB	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
neurologic	JJ	I-PROBLEM
insults	NNS	I-PROBLEM
and	CC	O
he	PRP	O
has	VBZ	O
no	DT	O
distinctive	JJ	B-PROBLEM
psychiatric	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
except	IN	O
for	IN	O
perhaps	RB	O
postoperative	JJ	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

Cardiovascularly	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
extremely	RB	O
well	RB	O
following	VBG	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
Levophed	NNP	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
.	.	O

Milrinone	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
at	IN	O
which	WDT	O
point	NN	O
he	PRP	O
was	VBD	O
having	VBG	O
good	JJ	O
enough	RB	O
cardiac	JJ	O
output	NN	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
need	VB	O
these	DT	B-TREATMENT
drips	NNS	I-TREATMENT
to	TO	O
help	VB	O
maintain	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
anymore	RB	O
.	.	O

He	PRP	O
has	VBZ	O
remained	VBN	O
without	IN	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
following	VBG	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
his	PRP$	B-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
is	VBZ	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
has	VBZ	O
hypertension	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
receives	VBZ	O
Metoprolol	NNP	B-TREATMENT
and	CC	O
he	PRP	O
has	VBZ	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
receives	VBZ	O
nothing	NN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

The	DT	O
patient	NN	O
remained	VBD	O
intubated	JJ	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
gastroesophageal	VBN	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
Zantac	NNP	B-TREATMENT
as	IN	O
an	DT	O
inpatient	NN	O
.	.	O

We	PRP	O
will	MD	O
put	VB	O
him	PRP	O
back	RB	O
on	IN	O
his	PRP$	B-TREATMENT
Nexium	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
over	IN	O
the	DT	O
last	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
appear	VB	O
a	DT	B-PROBLEM
little	JJ	I-PROBLEM
bit	NN	I-PROBLEM
icteric	JJ	I-PROBLEM
.	.	O

Liver	NNP	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
obtained	VBN	O
and	CC	O
they	PRP	O
were	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
and	CC	O
ALT	NNP	B-TEST
was	VBD	O
44	CD	O
,	,	O
AST	NNP	B-TEST
was	VBD	O
34	CD	O
;	:	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
199	CD	O
,	,	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
2.8	CD	O
.	.	O

Amylase	NNP	B-TEST
was	VBD	O
108	CD	O
and	CC	O
lipase	NN	B-TEST
was	VBD	O
213	CD	O
.	.	O

A	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
gallstones	NNS	I-PROBLEM
or	CC	O
common	JJ	B-PROBLEM
bile	JJ	I-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
indicative	NN	O
of	IN	O
cholecystitis	NN	B-PROBLEM
or	CC	O
cholelithiasis	NN	B-PROBLEM
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
and	CC	O
has	VBZ	O
required	VBN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
and	CC	O
basal	NN	B-TREATMENT
insulin	NN	I-TREATMENT
to	TO	O
maintain	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
at	IN	O
a	DT	O
more	RBR	O
appropriate	JJ	O
level	NN	O
.	.	O

Please	NNP	O
stay	VB	O
on	IN	O
top	NN	O
of	IN	O
the	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
so	IN	O
that	IN	O
the	DT	O
patient	NN	O
can	MD	O
keep	VB	O
a	DT	O
euglycemic	JJ	O
level	NN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
during	IN	O
this	DT	O
admission	NN	O
,	,	O
required	VBN	O
transfusion	NN	O
of	IN	O
three	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
to	TO	O
maintain	VB	O
adequate	JJ	O
hematocrit	NN	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
Mr.	NNP	O
Norman	NNP	O
hematocrit	VBZ	B-TEST
is	VBZ	O
at	IN	O
40.7	CD	O
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
receive	VB	O
a	DT	O
significant	JJ	O
amount	NN	O
of	IN	O
diuresis	NN	B-TREATMENT
postoperatively	RB	O
and	CC	O
is	VBZ	O
well	RB	O
below	IN	O
his	PRP$	O
baseline	NN	O
with	IN	O
weight	NN	B-TEST
,	,	O
most	RBS	O
likely	JJ	O
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
inability	NN	I-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

declared	VBD	O
him	PRP	O
at	IN	O
first	RB	O
an	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

As	IN	O
Mr.	NNP	O
Douglass	NNP	O
has	VBZ	O
improved	VBN	O
from	IN	O
his	PRP$	B-PROBLEM
initial	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
,	,	O
he	PRP	O
has	VBZ	O
become	VBN	O
more	RBR	O
lucid	JJ	O

and	CC	O
is	VBZ	O
less	JJR	O
of	IN	O
an	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
going	VBG	O
out	RP	O
on	IN	O
a	DT	B-TREATMENT
cardiac	JJ	I-TREATMENT
healthy	JJ	I-TREATMENT
,	,	I-TREATMENT
diabetic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
,	,	O
as	IN	O
tolerated	VBN	O
with	IN	O
Boost	NNP	B-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
and	CC	I-PROBLEM
urine	JJ	I-PROBLEM
cultures	NNS	I-PROBLEM
on	IN	O
01-05	JJ	O
for	IN	O
history	NN	O
of	IN	O
Methicillin	NNP	B-PROBLEM
resistant	JJ	I-PROBLEM
Staphylococcus	NNP	I-PROBLEM
aureus	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
pan	RB	B-TEST
sensitive	JJ	I-TEST
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Oct.	NNP	O
25	CD	O
for	IN	O
this	DT	B-PROBLEM
bug	NN	I-PROBLEM
.	.	O

On	IN	O
01-08	NN	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
central	JJ	I-TREATMENT
venous	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

The	DT	B-TEST
catheterization	NN	I-TEST
tip	NN	I-TEST
also	RB	O
grew	VBD	O
out	RP	O
Serratia	NNP	B-PROBLEM
.	.	O

On	IN	O
the	DT	O
16th	CD	O
,	,	O
a	DT	B-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
did	VBD	O
grow	VB	O
out	RP	O
greater	JJR	O
than	IN	O
100,000	CD	O
colonies	NNS	O
of	IN	O
E.	NNP	B-PROBLEM
coli	NNS	I-PROBLEM
which	WDT	O
was	VBD	O
intermittently	RB	B-PROBLEM
resistant	JJ	I-PROBLEM
to	TO	O
Ciprofloxacin	NNP	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Bactrim	NNP	B-TREATMENT
for	IN	O
that	DT	O
.	.	O

Please	NNP	O
continue	VBP	O
Mr.	NNP	O
David	NNP	O
Montero	NNP	O
for	IN	O
one	CD	O
month	NN	O
to	TO	O
fight	VB	O
his	PRP$	B-PROBLEM
blood	NN	I-PROBLEM
borne	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
to	TO	O
prevent	VB	O
seeding	NN	O
of	IN	O
his	PRP$	B-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
continue	VB	O
Bactrim	NNP	B-TREATMENT
for	IN	O
ten	JJ	O
days	NNS	O
after	IN	O
discharge	NN	O
to	TO	O
treat	VB	O
the	DT	B-PROBLEM
E.	NNP	I-PROBLEM
coli	NNS	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

Critical	NNP	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

Aortic	JJ	B-PROBLEM
arch	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
arch	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

Acute	NNP	B-PROBLEM
postoperative	JJ	I-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

Perioperative	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

Chronic	JJ	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-TREATMENT
RBC	NNP	I-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

Urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

Type	NNP	B-PROBLEM
II	NNP	I-PROBLEM
diabetes	VBZ	I-PROBLEM
.	.	O

Gastroesophageal	NNP	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Metoprolol	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

Captopril	NNP	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

Aspirin	$	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Heparin	NNP	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

Metformin	NNP	B-TREATMENT
1000	CD	O
mg	NN	O
extended	VBD	O
release	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Humalog	NNP	B-TREATMENT
Max	NNP	I-TREATMENT
75/25	CD	O
,	,	O
20	CD	O
units	NNS	O
subcutaneous	JJ	O
once	RB	O
a	DT	O
day	NN	O
in	IN	O
the	DT	O
morning	NN	O
.	.	O

Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Bactrim	NNP	B-TREATMENT
DS	NNP	I-TREATMENT
tabs	NN	I-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
for	IN	O
ten	JJ	O
days	NNS	O
.	.	O

Colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

Hold	NN	O
for	IN	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

Nexium	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Trazodone	CD	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
h.s.	NN	O
as	IN	O
needed	VBN	O
for	IN	O
sleep	NN	O
.	.	O

Lasix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
for	IN	O
one	CD	O
week	NN	O
.	.	O

KCl	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
for	IN	O
one	CD	O
week	NN	O
.	.	O

Sulfa	NNP	B-TREATMENT
(	(	I-TREATMENT
Sulfonamides	NNP	I-TREATMENT
)	)	I-TREATMENT

Nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
Abdominal	NNP	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
distention	NN	B-PROBLEM
.	.	O

1.	CD	O
Subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
end	NN	B-TREATMENT
ileostomy	NN	I-TREATMENT
,	,	O
Hartmann's	NNP	B-TREATMENT
pouch	RB	I-TREATMENT
,	,	O
G-tube	NNP	B-TREATMENT

2.	CD	O
Completion	NNP	B-TREATMENT
sigmoid	NN	I-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
,	,	O
small	JJ	B-TREATMENT
bowel	NN	I-TREATMENT
repair	NN	I-TREATMENT

Ms	NNP	O
Crossman	NNP	O
is	VBZ	O
an	DT	O
84	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
complaints	NNS	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
x	RB	O
1	CD	O
week	NN	O
,	,	O
who	WP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

She	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
Arbour	NNP	O
Hospital	NNP	O
on	IN	O
2015-02-21	JJ	O
for	IN	O
bowel	NN	B-PROBLEM
obstruction	NN	I-PROBLEM
,	,	O
ischemia	NN	B-PROBLEM
and	CC	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
.	.	O

CAD	NNP	B-PROBLEM
s/p	NN	O
MI	NNP	B-PROBLEM
,	,	O
HTN	NNP	B-PROBLEM
,	,	O
DMII	NNP	B-PROBLEM

The	DT	O
other	JJ	O
daughter	NN	O
was	VBD	O
recently	RB	O
in	IN	O
a	DT	O
car	NN	O
accident	NN	O
and	CC	O
underwent	JJ	O
surgery	NN	B-TREATMENT
at	IN	O
Saint	NNP	O
Vincent	NNP	O
Hospital	NNP	O
.	.	O

Afebrile	NNP	B-PROBLEM
,	,	O
VSS	NNP	O

A&O	NNP	O
X	NNP	O
3	CD	O
,	,	O
NAD	NNP	B-PROBLEM

CTAB	NNP	O
,	,	O
mildly	RB	B-PROBLEM
decreased	VBD	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
b/l	VBP	I-PROBLEM

Abd	NNP	O
soft	JJ	O
,	,	O
NT/ND	NNP	B-PROBLEM
,	,	O
+	NNP	O
bs	NN	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
ostomy	NN	B-TREATMENT
in	IN	I-TREATMENT
RLQ	NNP	I-TREATMENT
pink	NN	O
,	,	O
with	IN	O
stool	NN	O

G-tube	NNP	B-TREATMENT
in	IN	O
place	NN	O

LE	NNP	B-PROBLEM
trace	NN	I-PROBLEM
edema	NN	I-PROBLEM

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
10.2	CD	O
RBC	NNP	B-TEST
-	:	O
5.32	CD	O
Hgb	NNP	B-TEST
-	:	O
14.9	CD	O
Hct	NNP	B-TEST
-	:	O
43.4	CD	O
MCV	NNP	B-TEST
-	:	O
82	CD	O
MCH	NNP	B-TEST
-	:	O
28.0	CD	O
MCHC	NNP	B-TEST
-	:	O
34.4	CD	O
RDW	NNP	B-TEST
-	:	O
16.0	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
204	CD	O

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
12.9	CD	O
PTT	NNP	B-TEST
-	:	O
32.5	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.1	CD	O

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
345	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
34	CD	O
*	NN	O
Creat	NNP	B-TEST
-	:	O
1.0	CD	O
Na	NNP	B-TEST
-	:	O
137	CD	O
K	NNP	B-TEST
-	:	O
4.3	CD	O
Cl	NNP	B-TEST
-	:	O
99	CD	O
HCO3	NNP	B-TEST
-	:	O
24	CD	O
AnGap	NNP	B-TEST
-	:	O
18	CD	O

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
ALT	NNP	B-TEST
-	:	O
17	CD	O
AST	NNP	B-TEST
-	:	O
27	CD	O
AlkPhos	NNP	B-TEST
-	:	O
119	CD	O
*	JJ	O
Amylase	NNP	B-TEST
-	:	O
27	CD	O
TotBili	NNP	B-TEST
-	:	O
0.9	CD	O

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Lipase	NNP	B-TEST
-	:	O
11	CD	O

2014-02-21	JJ	O
12:20	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
7	CD	O
cTropnT	NN	B-TEST
-<	CD	O
0.01	CD	O

2014-03-09	JJ	O
02:59	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
cTropnT	NN	B-TEST
-	:	O
0.21	CD	O
*	NN	O

2014-03-09	JJ	O
11:29	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
35	CD	O
*	JJ	O
MB	NNP	B-TEST
Indx	NNP	I-TEST
-	:	O
25.5	CD	O
*	NN	O
cTropnT	NN	B-TEST
-	:	O
0.45	CD	O
*	NN	O

2014-03-09	JJ	O
07:52	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
NotDone	NN	O
cTropnT	NN	B-TEST
-	:	O
0.55	CD	O
*	NN	O

2014-03-10	JJ	O
05:25	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
cTropnT	SYM	B-TEST
-	:	O
0.42	CD	O
*	NN	O

2014-03-11	JJ	O
02:00	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
cTropnT	NN	B-TEST
-	:	O
0.45	CD	O
*	NN	O

2014-03-19	JJ	O
07:13	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
3	CD	O
cTropnT	NN	B-TEST
-	:	O
0.19	CD	O
*	NN	O

2014-03-19	JJ	O
01:33	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
NotDone	NN	O
cTropnT	NN	B-TEST
-	:	O
0.17	CD	O
*	NN	O

2014-03-21	JJ	O
09:58	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
CK-MB	NNP	B-TEST
-	:	O
NotDone	NN	O
cTropnT	NN	B-TEST
-	:	O
0.06	CD	O
*	NN	O

03-07	JJ	O
wound	NN	B-TEST
swab	NN	I-TEST
:	:	O
VRE	NN	B-PROBLEM

CT	NNP	B-TEST
Abd	NNP	I-TEST
02-21	NN	O
:	:	O

1.	CD	O
Markedly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
colon	NN	I-PROBLEM
throughout	IN	O
ascending	VBG	O
,	,	O
transverse	NN	O
,	,	O
and	CC	O
descending	VBG	O
colon	NN	O
with	IN	O
air-fluid	JJ	B-PROBLEM
levels	NNS	I-PROBLEM
,	,	O
overall	RB	O
unchanged	JJ	O
since	IN	O
prior	JJ	B-TEST
study	NN	I-TEST
performed	VBD	O
on	IN	O
the	DT	O
same	JJ	O
day	NN	O
with	IN	O
pneumatosis	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ascending	NN	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

Sigmoid	JJ	B-PROBLEM
diverticulosis	NN	I-PROBLEM
with	IN	O
focal	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
sigmoid	JJ	I-PROBLEM
colon	NN	I-PROBLEM
just	RB	O
distal	JJ	O
to	TO	O
the	DT	B-PROBLEM
dilatation	NN	I-PROBLEM
with	IN	O
wall	NN	B-PROBLEM
thickening	NN	I-PROBLEM
,	,	O
due	JJ	O
to	TO	O
diverticulitis	VB	B-PROBLEM
.	.	O

This	DT	O
area	NN	O
can	MD	O
be	VB	O
a	DT	O
leading	JJ	O
point	NN	O
of	IN	O
obstruction	NN	B-PROBLEM
.	.	O

An	DT	B-PROBLEM
underlying	JJ	I-PROBLEM
mass	NN	I-PROBLEM
lesion	NN	I-PROBLEM
or	CC	O
cancer	NN	B-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
in	IN	O
this	DT	O
area	NN	O
,	,	O
and	CC	O
further	RB	B-TEST
clinical	JJ	I-TEST
investigation	NN	I-TEST
is	VBZ	O
recommended	VBN	O
.	.	O

2.	CD	O
Limited	JJ	B-TEST
evaluation	NN	I-TEST
for	IN	O
known	VBN	B-PROBLEM
sigmoid-vesicle	NN	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

3.	CD	O
Small	JJ	B-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
ascites	NNS	I-PROBLEM
,	,	O
somewhat	RB	O
increased	VBD	O
anterior	JJ	O
to	TO	O
the	DT	O
liver	NN	O
.	.	O

4.	CD	O
Bilateral	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
cysts	NNS	I-PROBLEM
.	.	O

5.	CD	O
Heavy	NNP	B-PROBLEM
calcification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aorta	NN	I-PROBLEM
and	CC	I-PROBLEM
SMA	NNP	I-PROBLEM
and	CC	I-PROBLEM
its	PRP$	I-PROBLEM
branches	NNS	I-PROBLEM
.	.	O

Due	JJ	O
to	TO	O
atherosclerosis	VB	B-PROBLEM
,	,	O
assessment	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
intraluminal	JJ	I-TEST
process	NN	I-TEST
of	IN	O
these	DT	O
branches	NNS	O
is	VBZ	O
limited	JJ	O
.	.	O

CTA/CT	NNP	B-TEST
abd	VBZ	I-TEST
03-07	NN	O
:	:	O

1.	CD	O
No	DT	O
evidence	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

Small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
with	IN	O
compressive	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

2.	CD	O
Left	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
thick-walled	JJ	I-PROBLEM
peripherally	RB	I-PROBLEM
enhancing	VBG	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
,	,	O
which	WDT	O
appears	VBZ	O
to	TO	O
communicate	VB	O
with	IN	O
the	DT	O
sutured	JJ	O
end	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
sigmoid	NN	O
colon	NN	O
via	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
collection	NN	I-PROBLEM
of	IN	I-PROBLEM
extraluminal	JJ	I-PROBLEM
gas	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
correct	JJ	O
clincial	JJ	O
setting	NN	O
,	,	O
this	DT	O
could	MD	O
be	VB	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

3.	CD	O
Moderate	NNP	B-PROBLEM
intraabdominal	JJ	I-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

4.	CD	O
Status	NNP	O
post	NN	O
ileostomy	NN	B-TREATMENT
without	IN	O
evidence	NN	O
of	IN	O
small-bowel	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

5.	CD	O
Distended	VBD	B-PROBLEM
gallbladder	NN	I-PROBLEM
.	.	O

6.	CD	O
Diverticulosis	NNP	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
remnant	NN	I-PROBLEM
sigmoid	NN	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

03-21	JJ	O
VCUG	NNP	B-TEST
-	:	O
no	DT	O
leak	NN	B-PROBLEM

Neuro	NN	O
:	:	O
Developed	JJ	O
confusion	NN	B-PROBLEM
during	IN	O
her	PRP$	O
first	JJ	O
5	CD	O
days	NNS	O
in	IN	O
the	DT	O
ICU	NNP	O
.	.	O

Intermitent	NNP	B-PROBLEM
delirium	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

Required	VBN	O
restraints	NNS	B-TREATMENT
to	TO	O
prevent	VB	O
DC	NNP	O
of	IN	O
pertinent	JJ	B-TREATMENT
therapies	NNS	I-TREATMENT
while	IN	O
in	IN	O
the	DT	O
ICU	NNP	O
.	.	O

Cardiovascular	JJ	O
:	:	O
Complained	VBN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
first	JJ	O
few	JJ	O
days	NNS	O
of	IN	O
admission	NN	O
,	,	O
a	DT	O
cardiology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

She	PRP	O
recieved	VBD	O
serial	JJ	B-TEST
enzymes	NNS	I-TEST
and	CC	O
EKGs	NNP	B-TEST
.	.	O

Troponins	NNS	B-TEST
remained	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
as	RB	O
high	JJ	O
as	IN	O
0.6	CD	O
throughout	IN	O
her	PRP$	O
admission	NN	O
,	,	O
and	CC	O
most	JJS	O
recent	JJ	O
result	NN	O
now	RB	O
0.1	CD	O
.	.	O

She	PRP	O
was	VBD	O
treated	VBN	O
in	IN	O
IUC	NNP	O
for	IN	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
nitroglycerin	NN	B-TREATMENT
.	.	O

It	PRP	O
was	VBD	O
recommended	VBN	O
to	TO	O
maximize	VB	O
her	PRP$	B-TREATMENT
medical	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
Beta	NNP	B-TREATMENT
blockers	NNS	I-TREATMENT
,	,	O
aspirin	NN	B-TREATMENT
,	,	O
a	DT	B-TREATMENT
statin	NN	I-TREATMENT
and	CC	O
an	DT	B-TREATMENT
ACE	NNP	I-TREATMENT
Inhibitor	NNP	I-TREATMENT
.	.	O

Required	VBN	O
diuresis	NN	B-TREATMENT
of	IN	O
>	$	O
9	CD	O
L	NNP	O
while	IN	O
in	IN	O
the	DT	O
ICU	NNP	O
,	,	O
after	IN	O
2nd	CD	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Continues	NNS	O
to	TO	O
have	VB	O
trace	NN	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
recieves	VBZ	O
lasix	JJ	B-TREATMENT
po	NN	I-TREATMENT
.	.	O

Respiratory	NN	O
:	:	O
She	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
briefly	IN	O
post-op	JJ	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
and	CC	O
again	RB	O
for	IN	O
several	JJ	O
days	NNS	O
after	IN	O
second	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Recieved	VBN	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
post-op	NN	O
in	IN	O
the	DT	O
ICU	NNP	O
,	,	O
after	IN	O
successfully	RB	O
extubated	VBN	O
.	.	O

Gastrointestinal	JJ	O
:	:	O
Her	PRP$	B-TEST
initial	JJ	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
showed	VBD	O
dilated	JJ	B-PROBLEM
Turner	NNP	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O
wall	NN	B-PROBLEM
thickening	NN	I-PROBLEM
and	CC	O
pneumatosis	NN	B-PROBLEM
see	VBP	O
pertinent	JJ	O
results	NNS	O
.	.	O

She	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
nonoperatively	RB	O
with	IN	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
antibiotics	NNS	B-TREATMENT
,	,	O
serial	JJ	B-TEST
exams	NN	I-TEST
and	CC	O
NGT	NNP	B-TREATMENT
decompression	NN	I-TREATMENT
.	.	O

On	IN	O
HD#5	NNP	O
flexible	JJ	B-TEST
sigmoidoscopy	NN	I-TEST
was	VBD	O
performed	VBN	O
for	IN	O
colonic	JJ	B-TREATMENT
decompression	NN	I-TREATMENT
.	.	O

On	IN	O
HD#6	NNP	O
,	,	O
colonscopy	NN	B-TEST
was	VBD	O
performed	VBN	O
for	IN	O
decompression	NN	B-TREATMENT
,	,	O
and	CC	O
revealed	VBD	O
pseudomembrane	NN	B-PROBLEM
and	CC	O
friable	JJ	B-PROBLEM
colonic	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
.	.	O

Her	PRP$	O
abdomen	NNS	O
remained	VBD	O
tender	NN	B-PROBLEM
and	CC	O
distended	VBD	B-PROBLEM
despite	IN	O
attempted	JJ	O
decompression	NN	B-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
OR	NNP	O
for	IN	O
Subtotal	NNP	B-TREATMENT
Colectomy	NNP	I-TREATMENT
,	,	O
G	NNP	B-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
ileostomy	NN	B-TREATMENT
due	JJ	O
to	TO	O
unresponsiveness	JJ	B-PROBLEM
to	TO	O
non-operative	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

Ileostomy	NN	B-TREATMENT
remains	VBZ	O
pink	JJ	O
and	CC	O
intact	JJ	O
,	,	O
draining	VBG	O
green-brown	JJ	O
soft	JJ	O
stool	NN	O
.	.	O

She	PRP	O
developed	VBD	O
additional	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
distention	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
HCT	NNP	I-TEST
dropped	NN	O
and	CC	O
she	PRP	O
recieved	VBD	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
PRBCs	NNP	I-TREATMENT
.	.	O

On	IN	O
POD#8	NNP	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
an	DT	B-PROBLEM
abcess	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
colovesicular	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
OR	NNP	O
for	IN	O
exploration	NN	B-TEST
and	CC	O
drainage	NN	B-TREATMENT
.	.	O

She	PRP	O
recieved	VBD	O
further	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
remaining	VBG	I-TREATMENT
colon	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
leak	NN	I-PROBLEM
from	IN	I-PROBLEM
Relaford	NNP	I-PROBLEM
pouch	JJ	I-PROBLEM
and	CC	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

After	IN	O
her	PRP$	B-TREATMENT
2nd	CD	I-TREATMENT
surgery	NN	I-TREATMENT
she	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
ICU	NNP	O
and	CC	O
improved	VBN	O
steadily	RB	O
.	.	O

Abdomen	NNS	O
remained	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

She	PRP	O
remained	VBD	O
on	IN	O
IV	NNP	B-TREATMENT
antibiotics	NNS	I-TREATMENT
x	VBP	O
14	CD	O
days	NNS	O
and	CC	O
required	JJ	O
pressors	NNS	B-TREATMENT
for	IN	O
the	DT	O
first	JJ	O
few	JJ	O
days	NNS	O
post-op	RB	O
.	.	O

Her	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
has	VBZ	O
remained	VBN	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
intact	JJ	O
,	,	O
with	IN	O
staples	NNS	B-TREATMENT
removed	VBN	O
on	IN	O
POD#	NNP	O
27/18	CD	O
.	.	O

Genitourinary	JJ	O
:	:	O
She	PRP	O
had	VBD	O
a	DT	B-TREATMENT
foley	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
from	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

POD#	$	O
23/14	CD	O
she	PRP	O
recieved	VBD	O
a	DT	B-TEST
cystoscopy	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
leak	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
subsequently	RB	O
dc	JJ	O
'd	MD	O
.	.	O

Musculoskeletal	NN	O
:	:	O
Has	NNP	O
suffered	VBN	O
significant	JJ	B-PROBLEM
deconditioning	NN	I-PROBLEM
since	IN	O
admission	NN	O
,	,	O
but	CC	O
has	VBZ	O
consisitently	RB	O
recieved	VBN	O
PT	NNP	B-TREATMENT
.	.	O

See	VB	O
PT	NNP	O
note	VB	O
for	IN	O
further	JJ	B-TEST
assessment	NN	I-TEST
and	CC	O
discussion	NN	O
.	.	O

Nutrition	NN	O
:	:	O
She	PRP	O
was	VBD	O
held	VBN	O
NPO	NNP	B-TREATMENT
at	IN	O
admission	NN	O
,	,	O
and	CC	O
initiated	VBN	O
on	IN	O
TPN	NNP	B-TREATMENT
by	IN	O
HD#3	NNP	O
.	.	O

Post-operatively	RB	O
she	PRP	O
began	VBD	O
on	IN	O
TF	NNP	B-TREATMENT
s,	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
TPN	NNP	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
.	.	O

By	IN	O
POD#	NNP	O
05-29	JJ	O
she	PRP	O
was	VBD	O
having	VBG	O
high	JJ	B-PROBLEM
residuals	NNS	I-PROBLEM
on	IN	O
TF	NNP	B-TREATMENT
s,	NN	I-TREATMENT
so	RB	O
TPN	NNP	B-TREATMENT
was	VBD	O
reinitiated	VBN	O
.	.	O

Tf	NNP	B-TREATMENT
's	POS	I-TREATMENT
were	VBD	O
dc	JJ	O
'ed	JJ	O
prior	RB	O
to	TO	O
second	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

POD#	NNP	O
15/6	CD	O
,	,	O
she	PRP	O
resumed	VBD	O
TF	NNP	B-TREATMENT
's	POS	I-TREATMENT
and	CC	O
TPN	NNP	B-TREATMENT
was	VBD	O
tapered	VBN	O
again	RB	O
.	.	O

TF	JJ	O
goals	NNS	O
were	VBD	O
achieved	VBN	O
and	CC	O
TPN	NNP	B-TREATMENT
dc	VBP	O
'ed.	''	O

At	IN	O
time	NN	O
of	IN	O
discharge	NN	O
she	PRP	O
is	VBZ	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
with	IN	O
TF	NNP	B-TREATMENT
's	POS	I-TREATMENT
at	IN	O
goal	NN	O
.	.	O

Patient	NNP	O
is	VBZ	O
an	DT	B-PROBLEM
insulin	JJ	I-PROBLEM
dependent	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
Cape	NNP	O
Cod	NNP	O
Hospital	NNP	O
Clinic	NNP	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
persistent	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM
.	.	O

Pain	NN	B-PROBLEM
:	:	O
Her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
IV	NNP	B-TREATMENT
pain	VBP	I-TREATMENT
medicines	NNS	I-TREATMENT
while	IN	O
in	IN	O
ICU	NNP	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
adequately	RB	O
controlled	VBN	O
with	IN	O
Tylenol	NNP	B-TREATMENT
,	,	O
Motrin	NNP	B-TREATMENT
&	CC	O
Oxycodone	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
,	,	O
per	IN	O
recommendations	NNS	O
by	IN	O
Geriatrics	NNS	O
.	.	O

POD#	NNP	O
22/15	CD	O
Ms	NNP	O
Crossman	NNP	O
was	VBD	O
transferred	VBN	O
to	TO	O
3	CD	O
North	NN	O
where	WRB	O
she	PRP	O
continued	VBD	O
to	TO	O
progress	VB	O
well	RB	O
with	IN	O
PT	NNP	B-TREATMENT
,	,	O
increasing	VBG	O
PO	NNP	O
intake	NN	O
,	,	O
tolerating	VBG	O
TF	NNP	B-TREATMENT
s,	NN	I-TREATMENT
and	CC	O
weaning	VBG	O
from	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
remained	VBN	O
stable	JJ	O
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

Norvasc	NN	B-TREATMENT

Atenolol	NN	B-TREATMENT

Isosorbide	NN	B-TREATMENT

Lasix	NN	B-TREATMENT

Insulin	NN	B-TREATMENT

1.	CD	O
Heparin	NNP	B-TREATMENT
(	(	I-TREATMENT
Porcine	NNP	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
mL	NN	O
Injection	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
Polyvinyl	NNP	B-TREATMENT
Alcohol	NNP	I-TREATMENT
-	:	O
Povidone	CD	B-TREATMENT
1.4-0.6	JJ	O
%	NN	O
Dropperette	NNP	O
Sig	NNP	O
:	:	O
02-25	JJ	O
Drops	NNP	O
Ophthalmic	NNP	O
PRN	NNP	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

4.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Chewable	JJ	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Chewable	JJ	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

6.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

7.	CD	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

8.	CD	O
Furosemide	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
Ipratropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
17	CD	O
mcg	NN	O
/	NNP	O
Actuation	NNP	O
Aerosol	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Puff	NNP	O
Inhalation	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
Albuterol	NNP	B-TREATMENT
90	CD	O
mcg	NN	O
/	NNP	O
Actuation	NNP	O
Aerosol	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Puffs	NNP	O
Inhalation	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
Oxycodone	CD	B-TREATMENT
5	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q4-6H	NNP	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

12.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

13.	CD	O
Potassium	NNP	B-TREATMENT
Chloride	NNP	I-TREATMENT
20	CD	O
mEq	NN	O
Tab	NNP	O
Sust	NNP	O
.	.	O
Rel	NNP	O
.	.	O
Particle	NNP	O
/	NNP	O
Crystal	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tab	NNP	O
Sust	NNP	O
.	.	O
Rel	NNP	O
.	.	O
Particle	NNP	O
/	NNP	O
Crystal	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

14.	CD	O
Glargine	NNP	B-TREATMENT
Sig	NNP	O
:	:	O
Twenty	CD	O
Two	CD	O
(	(	O
22	CD	O
)	)	O
units	NNS	O
at	IN	O
bedtime	NN	O
.	.	O

15.	CD	O
Miconazole	NNP	B-TREATMENT
Nitrate	NNP	I-TREATMENT
2	CD	O
%	NN	O
Powder	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

16.	CD	O
Miconazole	NNP	B-TREATMENT
Nitrate	NNP	I-TREATMENT
2	CD	O
%	NN	O
Cream	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

17.	CD	O
Ibuprofen	NNP	B-TREATMENT
100	CD	O
mg/5	NN	O
mL	NN	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
Twenty	NNP	O
(	(	O
20	CD	O
)	)	O
mL	NN	O
PO	NNP	O
Q8H	NNP	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

18.	CD	O
Debrox	NNP	B-TREATMENT
6.5	CD	O
%	NN	O
Drops	NNP	O
Sig	NNP	O
:	:	O
Five	CD	O
(	(	O
5	CD	O
)	)	O
Drop	NNP	O
Otic	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
5	CD	O
days	NNS	O
:	:	O
both	DT	O
ears	NNS	O
.	.	O

19.	CD	O
Trazodone	CD	B-TREATMENT
50	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1	CD	O
/	IN	O
2-1	JJ	O
Tablet	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

Hurtado	NNP	B-PROBLEM
Colon	NNP	I-PROBLEM

Diverticulitis	NN	B-PROBLEM

S/P	NNP	O
Subtotal	NNP	B-TREATMENT
Colectomy	NNP	I-TREATMENT
,	,	O
Ileostomy	NNP	B-TREATMENT
,	,	O
Gastrostomy	NNP	B-TREATMENT
tube	NN	I-TREATMENT

S/P	NNP	O
Exploratory	NNP	B-TEST
laparotomy	NN	I-TEST
,	,	O
resection	NN	B-TREATMENT
of	IN	I-TREATMENT
small	JJ	I-TREATMENT
intestine	NN	I-TREATMENT
with	IN	O
primary	JJ	B-TREATMENT
anastomosis	NN	I-TREATMENT
,	,	O
Sigmoid	NNP	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM

Unstable	JJ	B-PROBLEM
Angina	NNP	I-PROBLEM

Please	VB	O
call	VB	O
the	DT	O
surgeon	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
if	IN	O
you	PRP	O
develop	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101.5	CD	I-PROBLEM
,	,	O
foul	JJ	B-PROBLEM
smelling	NN	I-PROBLEM
or	CC	I-PROBLEM
colorful	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
swelling	NN	B-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
distention	NN	B-PROBLEM
,	,	O
persistent	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
or	CC	I-PROBLEM
drink	VB	I-PROBLEM
,	,	O
or	CC	O
any	DT	O

other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
concerning	VBG	O
to	TO	O
you	PRP	O
.	.	O

If	IN	O
there	EX	O
is	VBZ	O
clear	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
cover	NN	O
with	IN	O
a	DT	B-TREATMENT
dry	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
.	.	O

Leave	NNP	O
white	JJ	B-TREATMENT
strips	NNS	I-TREATMENT
above	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
in	IN	O
place	NN	O
,	,	O
allow	VB	O
them	PRP	O
to	TO	O
fall	VB	O
off	RP	O
on	IN	O
their	PRP$	O
own	JJ	O
.	.	O

Medications	NNS	O
:	:	O
Resume	VB	O
your	PRP$	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

You	PRP	O
should	MD	O
take	VB	O
a	DT	B-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
,	,	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
daily	RB	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

You	PRP	O
will	MD	O
be	VB	O
given	VBN	O
pain	JJ	B-TREATMENT
medication	NN	I-TREATMENT
which	WDT	O
may	MD	O
make	VB	O
you	PRP	O
drowsy	VB	B-PROBLEM
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

Overdose	VB	B-PROBLEM

NG	NNP	B-TREATMENT
tube	NN	I-TREATMENT

Mr.	NNP	O
Vazquez	NNP	O
is	VBZ	O
a	DT	O
48	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hepatitis	NN	B-PROBLEM
C	NNP	I-PROBLEM
,	,	O
bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
with	IN	O
suicide	JJ	O
attempts	NNS	O
in	IN	O
the	DT	O
past	NN	O
,	,	O
recent	JJ	O
CMED	NNP	O
admit	NN	O
earlier	RBR	O
in	IN	O
4/05	CD	O
who	WP	O
was	VBD	O
found	VBN	O
alert	RB	O
approximately	RB	O
one	CD	O
hour	NN	O
after	IN	O
taking	VBG	O
an	DT	O
unspecified	JJ	O
number	NN	O
of	IN	O
pills	NNS	B-TREATMENT
.	.	O

Per	NNP	O
report	NN	O
,	,	O
there	EX	O
were	VBD	O
empty	JJ	O
bottles	NNS	O
of	IN	O
Inderal	NNP	B-TREATMENT
and	CC	O
Klonopin	NNP	B-TREATMENT
found	VBD	O
at	IN	O
bedside	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
02-26	JJ	O
full	JJ	O
bottles	NNS	O
of	IN	O
geodon	NN	B-TREATMENT
,	,	O
gabapentin	NN	B-TREATMENT
,	,	O
Lescol	NNP	B-TREATMENT
and	CC	O
paroxitine	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
reportedly	RB	O
alert	JJ	O
at	IN	O
scene	NN	O
,	,	O
and	CC	O
then	RB	O
became	VBD	O
unresponsive	JJ	B-PROBLEM
in	IN	O
route	NN	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

In	IN	O
the	DT	O
Rita	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
intubated	VBN	O
and	CC	O
given	VBN	O
activated	JJ	B-TREATMENT
charcoal	NN	I-TREATMENT
.	.	O

His	PRP$	B-TEST
initial	JJ	I-TEST
BP	NNP	I-TEST
was	VBD	O
60/P	CD	O
with	IN	O
a	DT	B-TEST
pulse	NN	I-TEST
in	IN	O
the	DT	O
60	CD	O
s.	NN	O

He	PRP	O
was	VBD	O
given	VBN	O
4	CD	O
amps	NNS	O
of	IN	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
,	,	O
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
Calcium	NNP	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
5mg	CD	O
of	IN	O
glucagon	NN	B-TREATMENT
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
glucagon	NN	I-TREATMENT
drip	NN	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

His	PRP$	B-TEST
urine	NN	I-TEST
and	CC	O
serum	NN	B-TEST
tox	NN	I-TEST
screens	NNS	I-TEST
were	VBD	O
notable	JJ	O
only	RB	O
for	IN	O
benzos	NN	B-TREATMENT
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
CMED	NNP	O
,	,	O
intubated	VBD	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
and	CC	O
started	VBN	O
on	IN	O
both	DT	O
a	DT	B-TREATMENT
calcium	NN	I-TREATMENT
and	CC	I-TREATMENT
glucagon	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

There	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
possible	JJ	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
CXR	NNP	B-TEST
,	,	O
though	IN	O
he	PRP	O
was	VBD	O
extubated	VBN	O
without	IN	O
incident	NN	O
on	IN	O
the	DT	O
AM	NNP	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
medicine	NN	O
floor	NN	O
.	.	O

Hep	NNP	B-PROBLEM
C	NNP	I-PROBLEM

Bipolar	JJ	B-PROBLEM
D/O	NNP	I-PROBLEM
with	IN	O
one	CD	O
suicide	NN	O
attempt	NN	O
by	IN	O
overdose	JJ	B-PROBLEM
several	JJ	O
years	NNS	O
ago	RB	O

Agoraphobia	NNP	B-PROBLEM

Panic	JJ	B-PROBLEM
disorder	NN	I-PROBLEM

Narcissism	NN	B-PROBLEM

No	DT	O
history	NN	O
of	IN	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
or	CC	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM

Reports	NNS	O
that	IN	O
he	PRP	O
has	VBZ	O
suffered	VBN	O
from	IN	O
anxiety	NN	B-PROBLEM
since	IN	O
childhood	NN	O
and	CC	O
needed	VBN	O
to	TO	O
drop	VB	O
out	IN	O
of	IN	O
college	NN	O
.	.	O

Vitals	NNS	B-TEST
:	:	O
99.3	CD	O
67	CD	O
(	(	O
60-70	JJ	O
)	)	O
99/53	CD	O
(	(	O
90-100	CD	O
s)	NN	O
96%	CD	O
on	IN	O
RA	NNP	O
3.7L	CD	O
+	NNP	O
LOS	NNP	O

Gen	NN	O
:	:	O
caucasian	JJ	O
man	NN	O
lying	VBG	O
in	IN	O
bed	NN	O
,	,	O
NAD	NNP	B-PROBLEM

HEENT	NN	O
:	:	O
NCAT	NNP	O
,	,	O
PERRL	NNP	O
,	,	O
EOMI	NNP	O
,	,	O
no	DT	O
icterus	NN	B-PROBLEM
,	,	O
OP	NNP	O
clear	JJ	O
,	,	O
MMM	NNP	O
,	,	O
no	DT	O
tongue	NN	B-PROBLEM
fasciculations	NNS	I-PROBLEM

Neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
LAD	NNP	B-PROBLEM
,	,	O
no	DT	O
JVD	NNP	B-PROBLEM

CV	NN	O
:	:	O
RRR	NNP	O
,	,	O
nl	JJ	O
s1	NN	O
s2	NN	O
,	,	O
no	DT	O
m/g/r	NN	B-PROBLEM

Lungs	NNS	O
:	:	O
?	.	O
decreased	VBD	B-PROBLEM
BS	NNP	I-PROBLEM
over	IN	I-PROBLEM
left	VBD	I-PROBLEM
middle	JJ	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
otherwise	RB	O
CTA	NNP	O

Abd	NNS	O
:	:	O
normal	JJ	O
size	NN	O
,	,	O
nd	RB	B-PROBLEM
,	,	O
no	DT	O
scars	NNS	B-PROBLEM
,	,	O
nl	JJ	O
bs	NN	O
,	,	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
palp	JJ	O
liver	NN	O

Ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM

Neuro	NN	O
:	:	O
no	DT	O
asterixis	NN	B-PROBLEM
,	,	O
CN	NNP	O
II-XII	NNP	O
intact	NN	O
,	,	O
5/5	CD	O
strength	NN	O
throughout	IN	O
,	,	O
sensation	NN	O
to	TO	O
LT	NNP	B-TEST
intact	NN	O
throughout	IN	O
,	,	O
gait	NN	O
deferred	VBD	O

CMED	NN	O
:	:	O
A+Ox3	NNP	O
,	,	O
mood	NN	O
"	NNP	O
great	JJ	O
,"	NNP	O
affect	NN	O
approp	NN	O
,	,	O
speech	NN	B-PROBLEM
stuttering	NN	I-PROBLEM
,	,	O
linear	JJ	O
TP	NNP	O
,	,	O
no	DT	O
SI	NNP	B-PROBLEM
or	CC	O
HI	NNP	B-PROBLEM

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
8.9	CD	O
RBC	NNP	B-TEST
-	:	O
4.94	CD	O
Hgb	NNP	B-TEST
-	:	O
15.8	CD	O
Hct	NNP	B-TEST
-	:	O
45.3	CD	O
MCV	NNP	B-TEST
-	:	O
92	CD	O
MCH	NNP	B-TEST
-	:	O
31.9	CD	O
MCHC	NNP	B-TEST
-	:	O
34.8	CD	O
RDW	NNP	B-TEST
-	:	O
12.4	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
175	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Neuts	NNP	B-TEST
-	:	O
49.9	CD	O
*	NN	O
Lymphs	NNP	B-TEST
-	:	O
42.4	CD	O
*	JJ	O
Monos	NNP	B-TEST
-	:	O
5.5	CD	O
Eos	NNP	B-TEST
-	:	O
1.6	CD	O
Baso	NNP	B-TEST
-	:	O
0.6	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
175	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
12.8	CD	O
PTT	NNP	B-TEST
-	:	O
25.7	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.0	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
108	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
13	CD	O
Creat	NNP	B-TEST
-	:	O
0.7	CD	O
Na	NNP	B-TEST
-	:	O
146	CD	O
*	NN	O
K	NNP	B-TEST
-	:	O
3.7	CD	O
Cl	NNP	B-TEST
-	:	O
109	CD	O
*	NN	O
HCO3	NNP	B-TEST
-	:	O
30	CD	O
*	NN	O
AnGap	NNP	B-TEST
-	:	O
11	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Albumin	NNP	B-TEST
-	:	O
3.9	CD	O
Calcium	NNP	B-TEST
-	:	O
8.5	CD	O
Phos	NNP	B-TEST
-	:	O
4.2	CD	O
Mg	NNP	B-TEST
-	:	O
2.0	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
ALT	NNP	B-TEST
-	:	O
44	CD	O
*	NN	O
AST	NNP	B-TEST
-	:	O
31	CD	O
AlkPhos	NNP	B-TEST
-	:	O
36	CD	O
*	NN	O
TotBili	NNP	B-TEST
-	:	O
0.2	CD	O

2012-06-07	JJ	O
09:55	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
ASA	NNP	B-TEST
-	:	O
NEG	NNP	O
Ethanol	NNP	B-TEST
-	:	O
NEG	NNP	O
Acetmnp	NNP	B-TEST
-	:	O
NEG	NNP	O
Bnzodzp	NNP	B-TEST
-	:	O
NEG	NNP	O
Barbitr	NNP	B-TEST
-	:	O
NEG	NNP	O
Tricycl	NNP	B-TEST
-	:	O
NEG	NN	O

2012-06-08	JJ	O
09:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
10.1	CD	O
RBC	NNP	B-TEST
-	:	O
4.35	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
14.2	CD	O
Hct	NNP	B-TEST
-	:	O
39.9	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
92	CD	O
MCH	NNP	B-TEST
-	:	O
32.6	CD	O
*	NN	O
MCHC	NNP	B-TEST
-	:	O
35.6	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
12.4	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
151	CD	O

2012-06-08	JJ	O
09:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
115	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
14	CD	O
Creat	NNP	B-TEST
-	:	O
0.8	CD	O
Na	NNP	B-TEST
-	:	O
142	CD	O
K	NNP	B-TEST
-	:	O
4.1	CD	O
Cl	NNP	B-TEST
-	:	O
112	CD	O
*	NN	O
HCO3	NNP	B-TEST
-	:	O
26	CD	O
AnGap	NNP	B-TEST
-	:	O
8	CD	O

2012-06-08	JJ	O
09:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Calcium	NNP	B-TEST
-	:	O
10.4	CD	O
*	NN	O
Phos	NNP	B-TEST
-	:	O
2.8	CD	O
Mg	NNP	B-TEST
-	:	O
1.8	CD	O

CXR	NN	B-TEST
:	:	O

An	DT	B-TREATMENT
endotracheal	JJ	I-TREATMENT
tube	NN	I-TREATMENT
terminates	VBZ	O
just	RB	O
above	IN	O
the	DT	O
thoracic	JJ	O
inlet	NN	O
approximately	RB	O
6.5	CD	O
cm	NNS	O
above	IN	O
the	DT	O
carina	NN	O
.	.	O

The	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
terminates	NNS	O
within	IN	O
the	DT	O
stomach	NN	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
patchy	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
increased	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
in	IN	O
the	DT	O
left	JJ	O
retrocardiac	JJ	O
region	NN	O
,	,	O
which	WDT	O
was	VBD	O
not	RB	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
earlier	JJR	I-TEST
study	NN	I-TEST
.	.	O

Left	NNP	O
costophrenic	JJ	O
angle	NN	O
has	VBZ	O
been	VBN	O
excluded	VBN	O
from	IN	O
the	DT	B-TEST
study	NN	I-TEST
and	CC	O
cannot	NN	O
be	VB	O
assessed	VBN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
or	CC	O
right	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

1)	CD	O
Endotracheal	NNP	B-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
slightly	RB	O
proximal	JJ	O
in	IN	O
location	NN	O
,	,	O
and	CC	O
could	MD	O
be	VB	O
advanced	VBN	O
approximately	RB	O
1.5	CD	O
cm	NN	O
for	IN	O
more	JJR	O
optimal	JJ	O
placement	NN	O
.	.	O

2)	CD	O
Patchy	NNP	B-PROBLEM
left	VBD	I-PROBLEM
retrocardiac	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
which	WDT	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
patchy	VB	B-PROBLEM
atelectasis	NN	I-PROBLEM
,	,	O
aspiration	NN	B-PROBLEM
,	,	O
or	CC	O
early	RB	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Followup	NNP	B-TEST
radiograph	NN	I-TEST
suggested	VBD	O

A/P	NN	O
:	:	O
48yo	CD	O
man	NN	O
with	IN	O
h/o	JJ	O
HCV	NNP	B-PROBLEM
,	,	O
bipolar	JJ	B-PROBLEM
DO	NNP	I-PROBLEM
,	,	O
h/o	VB	O
suicide	NN	O
attempts	NNS	O
,	,	O
a/w	VBP	O
overdose	NN	B-PROBLEM
of	IN	O
Inderal	NNP	B-TREATMENT
,	,	O
Klonopin	NNP	B-TREATMENT
,	,	O
Geodon	NNP	B-TREATMENT
,	,	O
s/T	NN	O
Jackson	NNP	O
stay	NN	O
with	IN	O
intubation	NN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
,	,	O
with	IN	O
question	NN	O
of	IN	O
L	NNP	B-PROBLEM
retrocardiac	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
,	,	O
now	RB	O
doing	VBG	O
well	RB	O
.	.	O

-	:	O
monitor	NN	O
on	IN	O
tele	NN	B-TEST
overnight	NN	O

-	:	O
if	IN	O
HR	NNP	B-TEST
drops	NNS	O
,	,	O
restart	NN	O
glucagon	NN	B-TREATMENT
gtt	NN	I-TREATMENT

-	:	O
watch	NN	O
for	IN	O
BZD	NNP	B-PROBLEM
withdrawal	NN	I-PROBLEM
,	,	O
agitation	NN	B-PROBLEM

Bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
:	:	O

-	:	O
suicide	NN	B-TREATMENT
precautions	NNS	I-TREATMENT

PPX	NN	O
:	:	O
SC	NNP	B-TREATMENT
heparin	NN	I-TREATMENT
,	,	O
bowel	NN	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
nicotine	JJ	B-TREATMENT
patch	NN	I-TREATMENT

Neurontin	RB	B-TREATMENT
800	CD	O
mg	NNS	O
tid	NN	O

Ziprasidone	CD	B-TREATMENT
bid	NN	O

Propanolol	NNP	B-TREATMENT
20	CD	O
mg	NN	O
tid	NN	O

Klonopin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
tid	NN	O

Paxil	NNP	B-TREATMENT
30	CD	O
mg	NN	O
qd	NN	O

Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
qd	NN	O

Folate	NNP	B-TREATMENT
1	CD	O
mg	NN	O
qd	NN	O

Lescol	NNP	B-TREATMENT
40	CD	O
qd	NN	O

Depression	NN	B-PROBLEM

Depressed	VBN	B-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
tires	NNS	B-PROBLEM
easily	RB	I-PROBLEM
with	IN	O
exertion	NN	O
.	.	O

Admitted	VBN	O
to	TO	O
Bay	NNP	O
State	NNP	O
Medical	NNP	O
Center	NNP	O
Hospital	NNP	O
in	IN	O
2012-10-22	JJ	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

Via	NNP	O
echocardiogram	NN	B-TEST
,	,	O
found	VBN	O
to	TO	O
have	VB	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Referred	VBN	O
to	TO	O
Memorial	NNP	O
Hospital	NNP	O
(	(	O
Worcester	NNP	O
)	)	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
to	TO	O
further	JJ	O
evaluate	VB	O
her	PRP$	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
catheterization	NN	I-TEST
done	VBN	O
on	IN	O
01-07	NN	O
showed	VBD	O
an	DT	B-TEST
aortic	JJ	I-TEST
valve	NN	I-TEST
area	NN	I-TEST
of	IN	O
.38	NNP	O
cm.sq.	NN	O
,	,	O
with	IN	O
a	DT	B-TEST
mean	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
62	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
85	CD	O
.	.	O

Moderate	NNP	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
PA	NNP	B-TEST
pressure	NN	I-TEST
48/24	CD	O
,	,	O
1+	CD	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
LVEDP	NNP	I-TEST
of	IN	O
19	CD	O
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
43%	CD	O
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
referred	VBN	O
to	TO	O
Cardiothoracic	NNP	O
Surgery	NNP	O
for	IN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

1.	CD	O
Aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

2.	CD	O
Diabetes	NNPS	B-PROBLEM
mellitus	VBP	I-PROBLEM
Type	CD	I-PROBLEM
2	CD	I-PROBLEM

3.	CD	O
Right	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT

4.	CD	O
Noninsulin	NNP	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM

Include	NNP	O
Glucovance	NNP	B-TREATMENT
5/500	CD	O
one	CD	O
tablet	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Univasc	NNP	B-TREATMENT
7.5	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
every	DT	O
other	JJ	O
day	NN	O
,	,	O
and	CC	O
aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
once	RB	O
daily	RB	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Significant	NN	O
for	IN	O
her	PRP$	O
father	NN	O
,	,	O
who	WP	O
died	VBD	O
at	IN	O
50	CD	O
years	NNS	O
from	IN	O
myocarditis	NN	B-PROBLEM
.	.	O

Heart	NNP	B-TEST
rate	NN	I-TEST
108	CD	O
and	CC	O
regular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
145/76	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
height	VBD	B-TEST
5'2"	CD	O
,	,	O
weight	VBD	B-TEST
141	CD	O
pounds	NNS	O
.	.	O

Healthy-appearing	NNP	O
woman	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

No	DT	O
lesions	NNS	B-PROBLEM
or	CC	O
rashes	NNS	B-PROBLEM
.	.	O

Pupils	NNP	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
extraocular	JJ	O
movements	NNS	O
intact	JJ	O
,	,	O
anicteric	JJ	B-PROBLEM
,	,	O
not	RB	O
injected	VBN	B-PROBLEM
.	.	O

Supple	NNP	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

Clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
S1	NNP	O
,	,	O
S2	NNP	O
,	,	O
with	IN	O
III/VI	NNP	B-PROBLEM
blowing	VBG	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

Soft	NNP	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
with	IN	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
.	.	O

Strength	NNP	B-TEST
5/5	CD	O
in	IN	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

Pulses	NNS	B-TEST
:	:	O

Femoral	JJ	B-TEST
2	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
dorsalis	NNS	B-TEST
pedis	VBP	I-TEST
1	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
posterior	JJ	B-TEST
tibial	JJ	I-TEST
1	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
and	CC	O
radial	JJ	B-TEST
2	CD	O
+	NNP	O
bilaterally	RB	O
.	.	O

No	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

White	NNP	B-TEST
count	NN	I-TEST
5.3	CD	O
,	,	O
hematocrit	NN	B-TEST
43	CD	O
,	,	O
platelets	NNS	B-TEST
200	CD	O
.	.	O

Sodium	NN	B-TEST
138	CD	O
,	,	O
potassium	NN	B-TEST
4.9	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
CO2	NNP	B-TEST
25	CD	O
,	,	O
BUN	NNP	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
glucose	VBD	B-TEST
309	CD	O
.	.	O

Electrocardiogram	NN	B-TEST
:	:	O

Rate	NN	B-TEST
of	IN	O
91	CD	O
,	,	O
first	RB	B-PROBLEM
degree	JJ	I-PROBLEM
AV	NNP	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
intervals	NNS	B-TEST
.22	VBP	O
,	,	O
.92	NNP	O
,	,	O
.36	NNP	O
,	,	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
is	VBZ	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
physical	JJ	B-TEST
.	.	O

aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

In	IN	O
summary	JJ	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
#21	JJ	I-TREATMENT
mosaic	NN	I-TREATMENT
porcine	NN	I-TREATMENT
valve	NN	I-TREATMENT
.	.	O

She	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
well	RB	O
,	,	O
and	CC	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
the	DT	O
Cardiothoracic	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
well	RB	O
in	IN	O
the	DT	O
immediate	JJ	O
postoperative	JJ	O
period	NN	O
,	,	O
however	RB	O
,	,	O
her	PRP	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
remained	VBD	O
somewhat	RB	B-PROBLEM
labile	JJ	I-PROBLEM
.	.	O

Therefore	RB	O
,	,	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	B-TREATMENT
Neo-Synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
to	TO	O
maintain	VB	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
greater	JJR	O
than	IN	O
110	CD	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
she	PRP	O
was	VBD	O
slow	JJ	O
to	TO	O
awaken	VB	O
after	IN	O
her	PRP$	B-TREATMENT
anesthesia	NN	I-TREATMENT
was	VBD	O
reversed	VBN	O
,	,	O
and	CC	O
in	IN	O
several	JJ	O
attempts	NNS	O
to	TO	O
wean	VB	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
,	,	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

She	PRP	O
therefore	RB	O
remained	VBD	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
throughout	IN	O
the	DT	O
day	NN	O
of	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
.	.	O

Her	PRP$	B-TREATMENT
Neo-Synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
to	TO	O
off	RP	O
.	.	O

She	PRP	O
was	VBD	O
again	RB	O
weaned	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
,	,	O
and	CC	O
successfully	RB	O
extubated	VBN	O
.	.	O

Her	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tubes	NN	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
,	,	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
day	NN	O
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
Cardiothoracic	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
continuing	VBG	B-TREATMENT
postoperative	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

Her	PRP$	O
respiratory	JJ	O
condition	NN	O
remained	VBD	O
stable	JJ	O
and	CC	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
,	,	O
she	PRP	O
was	VBD	O
deemed	VBN	O
stable	JJ	O
and	CC	O
ready	JJ	O
to	TO	O
be	VB	O
transferred	VBN	O
to	TO	O
rehabilitation	VB	O
for	IN	O
continuing	VBG	B-TREATMENT
postoperative	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
physical	JJ	O

therapy	NN	B-TREATMENT
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
as	IN	O
follows	VBZ	O
:	:	O

Temperature	NN	B-TEST
98.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
78	CD	O
and	CC	O
sinus	JJ	B-TEST
rhythm	NN	I-TEST
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
106/50	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Weight	NNP	B-TEST
preoperatively	RB	O
was	VBD	O
67	CD	O
kg	NN	O
,	,	O
at	IN	O
discharge	NN	O
is	VBZ	O
70.9	CD	O
kg	NN	O
.	.	O

Laboratory	NNP	B-TEST
data	NNS	I-TEST
on	IN	O
02-15	NN	O
:	:	O

White	NNP	B-TEST
count	NN	I-TEST
4.1	CD	O
,	,	O
hematocrit	NN	B-TEST
23	CD	O
,	,	O
platelets	NNS	B-TEST
144	CD	O
.	.	O

Sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.3	CD	O
,	,	O
chloride	RB	B-TEST
108	CD	O
,	,	O
CO2	NNP	B-TEST
25	CD	O
,	,	O
BUN	NNP	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
140	CD	O
.	.	O

Scattered	VBN	B-PROBLEM
rhonchi	NNS	I-PROBLEM
with	IN	O
diminished	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
S1	NNP	O
,	,	O
S2	NNP	O
,	,	O
with	IN	O
soft	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

Incision	NN	B-PROBLEM
with	IN	O
staples	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

Soft	NNP	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

Warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
with	IN	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

Ranitidine	NNP	B-TREATMENT
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
325	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
Glucovance	NNP	B-TREATMENT
5/500	CD	O
one	CD	O
tablet	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Furosemide	NNP	B-TREATMENT
20	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
for	IN	O
14	CD	O
days	NNS	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
mEq	NN	O
once	RB	O
daily	JJ	O
for	IN	O
14	CD	O
days	NNS	O
,	,	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Niferex	NNP	B-TREATMENT
150	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
Percocet	NNP	B-TREATMENT
5/325	CD	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
,	,	O
ibuprofen	JJ	B-TREATMENT
400	CD	O
mg	NN	O
every	DT	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

1.	CD	O
Aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
#21	JJ	I-TREATMENT
mosaic	NN	I-TREATMENT
porcine	NN	I-TREATMENT
valve	NN	I-TREATMENT

2.	CD	O
Diabetes	NNPS	B-PROBLEM
mellitus	VBP	I-PROBLEM
Type	CD	I-PROBLEM
2	CD	I-PROBLEM

3.	CD	O
Right	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT

Mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52	CD	O
year	NN	O
old	JJ	O
Czech	NNP	O
speaking	NN	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
severe	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

For	IN	O
the	DT	O
past	JJ	O
several	JJ	O
years	NNS	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
significant	JJ	B-PROBLEM
exercise	NN	I-PROBLEM
intolerance	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
limited	VBN	O
his	PRP$	O
ability	NN	O
to	TO	O
work	VB	O
.	.	O

He	PRP	O
reports	VBZ	O
severe	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	O
recent	JJ	O
admission	NN	O
earlier	RBR	O
in	IN	O
the	DT	O
month	NN	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
2015-09-10	JJ	O
,	,	O
after	IN	O
undergoing	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

This	DT	O
was	VBD	O
significant	JJ	O
for	IN	O
demonstrating	VBG	O
no	DT	O
flow-limited	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
coronaries	NNS	I-PROBLEM
but	CC	O
several	JJ	B-PROBLEM
fistulae	NNS	I-PROBLEM

Several	JJ	O
of	IN	O
these	DT	O
were	VBD	O
coil	NNS	B-TREATMENT
embolized	VBN	I-TREATMENT
during	IN	O
this	DT	O
admission	NN	O
.	.	O

He	PRP	O
tolerated	VBD	O
this	DT	O
well	NN	O
,	,	O
was	VBD	O
sent	VBN	O
home	NN	O
,	,	O
and	CC	O
now	RB	O
returns	VBZ	O
for	IN	O
his	PRP$	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

1.	CD	O
Mitral	NNP	B-PROBLEM
valve	NN	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

1.	CD	O
Atenolol	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
Enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
Nitroglycerin	NNP	B-TREATMENT
sublingual	JJ	I-TREATMENT
p.r.n.	NN	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
is	VBZ	O
98.3	CD	O
F.	NNP	O
;	:	O
pulse	NN	B-TEST
is	VBZ	O
76	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
113/52	CD	O
;	:	O
breathing	VBG	B-TEST
18	CD	O
;	:	O
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
missing	VBG	B-PROBLEM
many	JJ	I-PROBLEM
teeth	NNS	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
cervical	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

Heart	NNP	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
III/VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

His	PRP$	O
lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
in	IN	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
include	VBP	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
5.6	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
32.5	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
202	CD	O
.	.	O

Sodium	NN	B-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
3.5	CD	O
,	,	O
BUN	NNP	B-TEST
of	IN	O
4	CD	O
,	,	O
creatinine	NN	B-TEST
of	IN	O
0.6	CD	O
,	,	O
glucose	NN	B-TEST
of	IN	O
137	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
shows	VBZ	O
no	DT	O
infiltrate	NN	B-PROBLEM
or	CC	O
pneumothorax	NN	B-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
catheterization	NN	I-TEST
demonstrates	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
coronary	JJ	I-PROBLEM
arteries	NNS	I-PROBLEM
.	.	O

Two	CD	O
branches	NNS	O
of	IN	O
an	DT	B-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
to	TO	I-PROBLEM
PA	NNP	I-PROBLEM
fistula	NN	I-PROBLEM
which	WDT	O
was	VBD	O
successfully	RB	O
coiled	VBN	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
flow	NN	I-PROBLEM
through	IN	O
an	DT	O
inferior	JJ	O
branch	NN	O
of	IN	O
the	DT	O
left	JJ	O
anterior	JJ	O
descending	VBG	O
to	TO	O
PA	NNP	B-PROBLEM
fistula	NN	I-PROBLEM
and	CC	O
a	DT	O
persistent	JJ	O
branch	NN	O
of	IN	O
the	DT	B-PROBLEM
circumflex	NN	I-PROBLEM
to	TO	I-PROBLEM
PA	NNP	I-PROBLEM
branch	NN	I-PROBLEM
fistula	NN	I-PROBLEM
which	WDT	O
anatomically	RB	O
were	VBD	O
not	RB	O
suitable	JJ	O
for	IN	O
coil	NN	B-TREATMENT
embolization	NN	I-TREATMENT
.	.	O

Ejection	NNP	B-TEST
fraction	NN	I-TEST
was	VBD	O
60%	CD	O
.	.	O

mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

He	PRP	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
cardiothoracic	NN	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
minimal	JJ	B-TREATMENT
pressor	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
successfully	RB	O
weaned	VBN	O
off	RP	O
this	DT	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
fully	RB	O
weaned	VBN	O
from	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
acidemia	NN	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
treated	VBN	O
with	IN	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
Swan-Ganz	NNP	I-TREATMENT
was	VBD	O
placed	VBN	O
to	TO	O
provide	VB	O
close	JJ	B-TEST
hemodynamic	JJ	I-TEST
monitoring	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
stable	JJ	O
hemodynamics	NNS	O
with	IN	O
appropriate	JJ	O
mixed	JJ	O
venous	JJ	B-TEST
saturations	NNS	I-TEST
in	IN	O
the	DT	O
70%	CD	O
range	NN	O
.	.	O

He	PRP	O
was	VBD	O
then	RB	O
weaned	VBN	O
off	IN	O
of	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
and	CC	O
was	VBD	O
successfully	RB	O
extubated	VBN	O
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
bit	NN	I-PROBLEM
of	IN	I-PROBLEM
confusion	NN	I-PROBLEM
early	JJ	O
in	IN	O
post-extubation	NN	O
course	NN	O
which	WDT	O
cleared	VBD	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
early	JJ	O
postoperative	JJ	O
course	NN	O
had	VBD	O
a	DT	O
tremendous	JJ	O
urine	NN	B-TEST
output	NN	I-TEST
.	.	O

It	PRP	O
was	VBD	O
equally	RB	O
up	RB	O
to	TO	O
700	CD	O
cc.	NNS	O
an	DT	O
hour	NN	O
and	CC	O
a	DT	B-TEST
renal	JJ	I-TEST
consultation	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

He	PRP	O
underwent	VBD	O
a	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
intracranial	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
leading	VBG	O
to	TO	O
diabetes	NNS	B-PROBLEM
insipidus	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
serum	NN	I-TEST
and	CC	O
urine	JJ	B-TEST
electrolytes	NNS	I-TEST
indicated	VBD	O
that	IN	O
this	DT	B-TREATMENT
diuresis	NN	I-TREATMENT
was	VBD	O
appropriate	JJ	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
urine	JJ	I-TEST
output	NN	I-TEST
has	VBZ	O
decreased	VBN	O
and	CC	O
his	PRP$	B-TEST
BUN	NNP	I-TEST
and	CC	O
creatinine	NN	B-TEST
remained	VBD	O
normal	JJ	O
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
Foley	NNP	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

He	PRP	O
had	VBD	O
developed	VBN	O
some	DT	B-PROBLEM
hematuria	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
resolved	VBN	O
.	.	O

1.	CD	O
Mitral	NNP	B-PROBLEM
regurgitation	NN	I-PROBLEM
status	NN	O
post	NN	O
minimally	RB	B-TREATMENT
invasive	JJ	I-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

1.	CD	O
Lopressor	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
Percocet	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
p.o.	NNS	O
q.	RB	O
four	CD	O
hours	NNS	O
p.r.n.	VBP	O

4.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
The	DT	O
patient	NN	O
will	MD	O
call	VB	O
for	IN	O
any	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
difficulties	NNS	B-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
wound	NN	I-PROBLEM
care	NN	I-PROBLEM
,	,	O
and	CC	O
will	MD	O
be	VB	O
instructed	VBN	O
with	IN	O
an	DT	O
interpreter	NN	O
present	NN	O
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
requiring	VBG	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT

CABG	NNP	B-TREATMENT
x	VBZ	O
5	CD	O

Mr.	NNP	O
Andersen	NNP	O
is	VBZ	O
a	DT	O
71-year-old	JJ	O
male	NN	O
with	IN	O
worsening	VBG	B-PROBLEM
anginal	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
who	WP	O
underwent	VBP	O
catheterization	NN	B-TEST
that	WDT	O
showed	VBD	O
severe	JJ	B-PROBLEM
three-vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
presenting	VBG	O
for	IN	O
revascularization	NN	B-TREATMENT
.	.	O

DM2	NNP	B-PROBLEM
-	:	O
dx	NN	O
'd	MD	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
48	CD	O

Arthritis	NN	B-PROBLEM

HTN	NN	B-PROBLEM

Tonsillectomy	NN	B-TREATMENT
around	IN	O
the	DT	O
age	NN	O
of	IN	O
10	CD	O

Father	NNP	O
died	VBD	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Mother	NN	O
with	IN	O
pacemaker	NN	B-TREATMENT
,	,	O
alive	JJ	O
at	IN	O
91	CD	O
years	NNS	O
old	JJ	O
.	.	O

Awake	NNP	O
and	CC	O
alert	NN	O
,	,	O
NAD	NNP	B-PROBLEM

HEENT	NN	O
:	:	O
PERRLA	NNP	O
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM

CV	NN	O
:	:	O
RRR	NNP	O
,	,	O
no	DT	O
M/R/G	NNP	B-PROBLEM

Abd	NNS	O
:	:	O
Soft	NNP	O
,	,	O
NT/ND	NNP	B-PROBLEM
,	,	O
NABS	NNP	O

Ext	NN	O
:	:	O
cool	NN	O
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
,	,	O
1+	CD	O
pedal	NN	B-TEST
pulses	NNS	I-TEST

2013-10-29	JJ	O
11:37	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
11.4	CD	O
*#	NN	O
RBC	NNP	B-TEST
-	:	O
3.09	CD	O
*#	NN	O
Hgb	NNP	B-TEST
-	:	O
9.1	CD	O
*#	NN	O
Hct	NNP	B-TEST
-	:	O
27.5	CD	O
*#	NN	O
MCV	NNP	B-TEST
-	:	O
89	CD	O
MCH	NNP	B-TEST
-	:	O
29.5	CD	O
MCHC	NNP	B-TEST
-	:	O
33.3	CD	O
RDW	NNP	B-TEST
-	:	O
14.6	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
180	CD	O

2013-10-29	JJ	O
11:37	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
16.2	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
29.0	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.7	CD	O

2013-10-29	JJ	O
11:37	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
180	CD	O

2013-10-29	JJ	O
01:09	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
172	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
11	CD	O
Creat	NNP	B-TEST
-	:	O
0.9	CD	O
Na	NNP	B-TEST
-	:	O
142	CD	O
Cl	NNP	B-TEST
-	:	O
111	CD	O
*	NN	O
HCO3	NNP	B-TEST
-	:	O
22	CD	O

2013-10-29	JJ	O
01:09	CD	O
PM	NNP	O
BLOOD	NNP	B-TEST
Mg	NNP	B-TEST
-	:	O
2.6	CD	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2013-10-29	JJ	O
for	IN	O
a	DT	B-TREATMENT
CABG	NNP	I-TREATMENT
x5	NN	O
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

His	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
#2	NNP	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

On	IN	O
post-op	JJ	O
day	NN	O
#3	NNP	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
,	,	O
and	CC	O
his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

On	IN	O
post-op	JJ	O
day	NN	O
#4	NNP	O
,	,	O
the	DT	O
patient	NN	O
failed	VBD	O
the	DT	O
first	JJ	O
of	IN	O
his	PRP$	B-TEST
void	NN	I-TEST
trials	NNS	I-TEST
.	.	O

He	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
post-op	JJ	O
day	NN	O
#6	NNP	O
in	IN	O
stable	JJ	O
condition	NN	O
with	IN	O
a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
leg	NN	B-TREATMENT
bag	NN	I-TREATMENT
.	.	O

Avandia	NNP	B-TREATMENT
8	CD	O
mg	NNS	O
daily	RB	O

Glipizide	RB	B-TREATMENT
10	CD	O
mg	NNS	O
bid	NN	O

Diovan	NNP	B-TREATMENT
160	CD	O
mg	NNS	O
daily	RB	O

Metformin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
two	CD	O
tabs	NNS	O
bid	VBD	O

Omeprazole	$	B-TREATMENT
20	CD	O
mg	NN	O
q	NN	O
PM	NNP	O

1.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

2.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

3.	CD	O
Oxycodone	NNP	B-TREATMENT
-	:	O
Acetaminophen	NNP	B-TREATMENT
5-325	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
for	IN	O
30	CD	O
doses	NNS	O
.	.	O

4.	CD	O
Atorvastatin	NNP	B-TREATMENT
Calcium	NNP	I-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

5.	CD	O
Rosiglitazone	NNP	B-TREATMENT
Maleate	NNP	I-TREATMENT
8	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

6.	CD	O
Glipizide	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
Tamsulosin	NNP	B-TREATMENT
0.4	CD	O
mg	NN	O
Capsule	NNP	O
,	,	O
Sust.	NNP	O
Release	NNP	O
24	CD	O
HR	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NN	O
,	,	O
Sust	NNP	O
.	.	O
Release	NNP	O
24	CD	O
HR	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

8.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
Furosemide	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
every	DT	O
twelve	NN	O
(	(	O
12	CD	O
)	)	O
hours	NNS	O
.	.	O

10.	CD	O
Pantoprazole	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
Potassium	NNP	B-TREATMENT
Chloride	NNP	I-TREATMENT
10	CD	O
mEq	NN	O
Capsule	NNP	O
,	,	O
Sustained	VBD	O
Release	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Capsule	NN	O
,	,	O
Sustained	VBD	O
Release	NNP	O
PO	NNP	O
Q12H	NNP	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

Please	VB	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
or	CC	O
call	VB	O
Dr.	NNP	O
Alvarado	NNP	O
's	POS	O
office	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
chills	NNS	B-PROBLEM
or	CC	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM
degrees	NNS	I-PROBLEM
F.	NNP	I-PROBLEM

Please	VB	O
call	VB	O
if	IN	O
you	PRP	O
notice	VBP	O
redness	RB	B-PROBLEM
,	,	O
swelling	VBG	B-PROBLEM
,	,	O
or	CC	O
tenderness	NN	B-PROBLEM
of	IN	O
your	PRP$	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
or	CC	O
if	IN	O
it	PRP	O
begins	VBZ	O
to	TO	O
drain	VB	O
pus	NN	B-PROBLEM
.	.	O

Wash	NNP	O
incision	NN	B-PROBLEM
with	IN	O
mild	JJ	O
soap	NN	O
and	CC	O
water	NN	O
,	,	O
then	RB	O
pat	VBZ	O
dry	NN	O
.	.	O

You	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
/	NNP	O
urologist	NN	O
prior	RB	O
to	TO	O
removal	VB	O
of	IN	O
your	PRP$	B-TREATMENT
urinary	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

Penicillins	NNS	B-TREATMENT

Transfer	NN	O
from	IN	O
Newton-Wellesley	NNP	O
Hospital	NNP	O
hospital	NN	O
for	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM

1.	CD	O
Partial	JJ	B-TREATMENT
vertebrectomy	NN	I-TREATMENT
of	IN	I-TREATMENT
L3	NNP	I-TREATMENT
and	CC	I-TREATMENT
L4	NNP	I-TREATMENT
.	.	O

2.	CD	O
Fusion	NN	B-TREATMENT
at	IN	I-TREATMENT
L3-L4	NNP	I-TREATMENT
.	.	O

3.	CD	O
Vertebral	JJ	B-TREATMENT
Spacer	NNP	I-TREATMENT
at	IN	I-TREATMENT
L3-L4	NNP	I-TREATMENT
.	.	O

4.	CD	O
Anterior	JJ	B-TREATMENT
instrumentation	NN	I-TREATMENT
L3-L4	NNP	I-TREATMENT
.	.	O

5.	CD	O
Autograft	NNP	B-TREATMENT
,	,	O
bone	NN	B-TREATMENT
morphogenic	JJ	I-TREATMENT
protein	NN	I-TREATMENT
,	,	O
and	CC	O
allograft	NN	B-TREATMENT
.	.	O

6.	CD	O
Debridement	NN	B-TREATMENT

7.	CD	O
Incision	NNP	B-TREATMENT
and	CC	O
drainage	NN	B-TREATMENT

8.	CD	O
Echocardiogram	NNP	B-TEST

73	CD	O
yo	JJ	O
M	NNP	O
transferred	VBD	O
from	IN	O
Newton-Wellesley	NNP	O
Hospital	NNP	O
hospital	NN	O
for	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

Pt	NNP	O
has	VBZ	O
h/o	VBN	O
colon	NN	B-PROBLEM
can	MD	I-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
,	,	O
s/p	VB	O
resxn	NN	B-TREATMENT
with	IN	O
serosal	JJ	B-PROBLEM
implants	NNS	I-PROBLEM
in	IN	O
9/03	CD	O
.	.	O

Pt	NNP	O
states	VBZ	O
he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
chemotherapy	NN	B-TREATMENT
up	RB	O
until	IN	O
1	CD	O
week	NN	O
ago	RB	O
.	.	O

States	NNS	O
he	PRP	O
first	RB	O
developed	VBD	O
back	RB	B-PROBLEM
pain	RB	I-PROBLEM
5	CD	O
weeks	NNS	O
ago	RB	O
but	CC	O
was	VBD	O
still	RB	O
able	JJ	O
to	TO	O
ambulate	VB	O
with	IN	O
his	PRP$	B-TREATMENT
cane	NN	I-TREATMENT
.	.	O

An	DT	B-TEST
MRI	NNP	I-TEST
was	VBD	O
done	VBN	O
and	CC	O
this	DT	O
showed	VBD	O
a	DT	B-PROBLEM
signal	JJ	I-PROBLEM
abno	NN	I-PROBLEM
in	IN	I-PROBLEM
L3	NNP	I-PROBLEM
L4	NNP	I-PROBLEM
?	.	O
disciitis	NN	B-PROBLEM
vs	NN	O
osteo	NN	B-PROBLEM
without	IN	O
a	DT	B-PROBLEM
definitive	JJ	I-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

Initially	RB	O
on	IN	O
Vanc	NNP	B-TREATMENT
and	CC	O
Cipro	NNP	B-TREATMENT
on	IN	O
Friday	NNP	O
but	CC	O
then	RB	O
seen	VBN	O
by	IN	O
ID	NNP	O
who	WP	O
reccommended	VBD	O
no	DT	O
abx	NN	B-TREATMENT
but	CC	O
a	DT	B-TEST
bone	NN	I-TEST
biopsy	NN	I-TEST
,	,	O
blood	NN	B-TEST
cx	NN	I-TEST
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
spine	NN	O
who	WP	O
repeated	VBD	O
the	DT	B-TEST
MRI	NNP	I-TEST
and	CC	O
this	DT	O
showed	VBD	O
L3-4	NNP	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
and	CC	O
discitis	NN	B-PROBLEM
and	CC	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
,	,	O
5cm	CD	O
.	.	O

He	PRP	O
was	VBD	O
subsequently	RB	O
restared	VBN	O
on	IN	O
Vancomycin	NNP	B-TREATMENT
for	IN	O
Corynebacterium	NNP	B-PROBLEM
in	IN	O
blood	NN	B-TEST
cx	NN	I-TEST
from	IN	O
Fri	NNP	O
;	:	O
Followup	NNP	B-TEST
cx	NN	I-TEST
has	VBZ	O
been	VBN	O
NGTD	NNP	O
.	.	O

CXR	NNP	B-TEST
also	RB	O
showed	VBD	O
small	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
attempt	NN	O
was	VBD	O
made	VBN	O
to	TO	O
tap	VB	B-TREATMENT
it	PRP	O
,	,	O
but	CC	O
pt	RB	O
did	VBD	O
not	RB	O
tolerate	VB	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
asked	VBD	O
that	IN	O
it	PRP	O
be	VB	O
deferred	VBN	O
.	.	O

He	PRP	O
did	VBD	O
undergo	VB	O
a	DT	B-TEST
CT-guided	JJ	I-TEST
aspiration	NN	I-TEST
/	NNP	I-TEST
biopsy	NN	I-TEST
at	IN	I-TEST
the	DT	I-TEST
L3-4	NNP	I-TEST
disc	NN	I-TEST
space	NN	I-TEST
on	IN	O
2020-03-11	JJ	O
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Mediplex	NNP	O
Rehab	NNP	O
Hospital	NNP	O
immediately	RB	O
following	VBG	O
this	DT	O
.	.	O

Currently	RB	O
pt	JJ	O
denies	NNS	O
sensory	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
.	.	O

States	NNS	O
he	PRP	O
is	VBZ	O
not	RB	O
able	JJ	O
to	TO	O
walk	VB	O
because	IN	O
of	IN	O
severe	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

States	NNS	O
pain	VBP	B-PROBLEM
is	VBZ	O
worst	RB	O
when	WRB	O
he	PRP	O
sits	VBZ	O
up	RP	O
or	CC	O
twists	VBZ	O
his	PRP$	O
back	NN	O
.	.	O

No	DT	O
bowel	NN	B-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

-	:	O
epidural	NN	B-PROBLEM
abscess	NN	I-PROBLEM

-	:	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
s/p	JJ	O
resection	NN	B-TREATMENT
09-07	NN	O
.	.	O

-	:	O
CAD	NN	B-PROBLEM
s/p	NN	O
CABG	NNP	B-TREATMENT
x4	NNP	O
in	IN	O
'	POS	O
03	CD	O
.	.	O

-	:	O
hypercholesterolemia	NN	B-PROBLEM

-	:	O
DM	NN	B-PROBLEM
with	IN	O
neuropathy	JJ	B-PROBLEM
.	.	O

-	:	O
persistent	NN	B-PROBLEM
R	NNP	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM

he	PRP	O
states	VBZ	O
he	PRP	O
gives	VBZ	O
her	PRP$	O
one	CD	O
of	IN	O
his	PRP$	O
pensions	NNS	O
and	CC	O
she	PRP	O
helps	VBZ	O
him	PRP	O
with	IN	O
medicines	NNS	B-TREATMENT
etc	NNS	O
.	.	O

Gen	NN	O
:	:	O
in	IN	O
NAD	NNP	B-PROBLEM
,	,	O
but	CC	O
winces	NNS	O
in	IN	O
pain	NN	B-PROBLEM
with	IN	O
movements	NNS	O
of	IN	O
his	PRP$	O
back	NN	O
.	.	O

HEENT	NN	O
:	:	O
Clear	JJ	O
OP	NNP	O
,	,	O
MM	NNP	B-PROBLEM
very	RB	I-PROBLEM
dry	RB	I-PROBLEM
.	.	O

NECK	NN	O
:	:	O
Supple	NN	O
,	,	O
No	NNP	O
LAD	NNP	B-PROBLEM
,	,	O
No	NNP	O
JVD	NNP	B-PROBLEM

CHEST	NN	O
:	:	O
Port	VB	B-TREATMENT
a	DT	I-TREATMENT
cath	NN	I-TREATMENT
in	IN	I-TREATMENT
R	NNP	I-TREATMENT
chest	NN	I-TREATMENT
,	,	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

II/VI	NNP	B-PROBLEM
SEM	NNP	I-PROBLEM
at	IN	I-PROBLEM
LSB	NNP	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
apex	VB	I-PROBLEM
.	.	O

LUNGS	NN	O
:	:	O
+	JJ	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
L	NNP	I-PROBLEM
base	NN	I-PROBLEM
>	NNP	O
R	NNP	O
base	NN	O
.	.	O

ABD	NN	O
:	:	O
Pt	NNP	O
very	RB	B-PROBLEM
tense	RB	I-PROBLEM
in	IN	I-PROBLEM
abdomen	NNS	I-PROBLEM
(	(	O
states	NNS	O
belly	RB	O
is	VBZ	O
fine	JJ	O
,	,	O
but	CC	O
he	PRP	O
is	VBZ	O
weary	JJ	O
of	IN	O
his	PRP$	O
back	NN	O
).	NN	O

Well	RB	B-PROBLEM
healed	VBN	I-PROBLEM
midline	NN	I-PROBLEM
scar	NN	I-PROBLEM
from	IN	O
chest	VBG	O
down	RP	O
to	TO	O
pubis	VB	O
.	.	O

No	DT	O
HSM	NNP	B-PROBLEM
.	.	O

EXT	NN	O
:	:	O
No	DT	O
edema	NN	B-PROBLEM
.	.	O

Dressing	VBG	B-TREATMENT
c/d/i	NN	O
over	IN	O
R	NNP	B-PROBLEM
LE	NNP	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

1	CD	O
+	JJ	O
DP	NNP	B-TEST
pulses	NNS	I-TEST
BL	NNP	O

Back	RB	O
:	:	O
+	NN	O
ttp	NN	B-PROBLEM
of	IN	I-PROBLEM
lumbar	NN	I-PROBLEM
spine	NN	I-PROBLEM
and	CC	I-PROBLEM
paraspinal	JJ	I-PROBLEM
muscles	NNS	I-PROBLEM
,	,	O
R	NNP	O
>	NNP	O
L	NNP	O
.	.	O

No	DT	O
erythema	NN	B-PROBLEM
or	CC	O
swelling	VBG	B-PROBLEM
noted	VBN	O
.	.	O

Na	NN	B-TEST
:	:	O
135	CD	O
,	,	O
K	NNP	B-TEST
4.5	CD	O
,	,	O
Cl	NNP	B-TEST
96	CD	O
,	,	O
CO2	NNP	B-TEST
27	CD	O
,	,	O
BUN	NNP	B-TEST
12	CD	O
,	,	O
Cr	NNP	B-TEST
0.7	CD	O
,	,	O
Glu	NNP	B-TEST
167	CD	O
,	,	O
Ca	NNP	B-TEST
8.4	CD	O
,	,	O
Vanco	NNP	B-TEST
trough	IN	I-TEST
13	CD	O
,	,	O
WBC	NNP	B-TEST
5.3	CD	O
,	,	O
Hct	NNP	B-TEST
32.0	CD	O
,	,	O
plt	NN	B-TEST
330	CD	O
,	,	O
INR	NNP	B-TEST
1.0	CD	O
.	.	O

No	DT	O
culture	NN	B-TEST
data	NNS	I-TEST
was	VBD	O
sent	VBN	O
.	.	O

MRI	NNP	B-TEST
lumbar	NN	I-TEST
spine	NN	I-TEST
(	(	O
Youville	NNP	O
Hospital	NNP	O
2020-03-10	JJ	O
):	NNP	O
L3-4	NNP	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
,	,	O
discitis	NN	B-PROBLEM
,	,	O
and	CC	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

Degenerative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
including	VBG	O
multilevel	JJ	B-PROBLEM
central	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Impression	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
aspect	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
at	IN	I-PROBLEM
T11-12	NNP	I-PROBLEM
by	IN	O
disc	NN	B-PROBLEM
bulge	NN	I-PROBLEM
.	.	O

Addendum	NN	O
:	:	O
Findings	NNS	O
are	VBP	O
c/w	JJ	O
paraspinous	JJ	B-PROBLEM
extension	NN	I-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
anteriorly	RB	O
and	CC	O
laterally	RB	O
into	IN	O
the	DT	O
medial	JJ	O
aspects	NNS	O
of	IN	O
the	DT	O
psoas	NN	O
muscles	VBZ	O
bilaterally	RB	O
at	IN	O
the	DT	O
L3	NNP	O
and	CC	O
L4	NNP	O
levels	NNS	O
.	.	O

CXR	NNP	B-TEST
(	(	O
Youville	NNP	O
Hospital	NNP	O
2020-03-09	JJ	O
):	NNP	O
Persistent	NNP	B-PROBLEM
unchanged	JJ	I-PROBLEM
L	NNP	I-PROBLEM
mid	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
lung	NN	I-PROBLEM
field	NN	I-PROBLEM
airspace	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
L	NNP	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

73	CD	O
yo	JJ	O
M	NNP	O
transferred	VBD	O
from	IN	O
Youville	NNP	O
Hospital	NNP	O
with	IN	O
h/o	JJ	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
known	VBN	B-PROBLEM
liver	JJ	I-PROBLEM
mets	NNS	I-PROBLEM
now	RB	O
with	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
corynebacterium	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM
:	:	O

#	#	O
Epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
orthopedic	JJ	O
spine	NN	O
consult	NN	O
service	NN	O
and	CC	O
ID	NNP	O
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
IV	NNP	B-TREATMENT
vancomycin	NN	I-TREATMENT
throughout	IN	O
his	PRP$	O
course	NN	O
and	CC	O
had	VBD	O
therapeutic	JJ	O
troughs	NNS	B-TEST
.	.	O

Please	NNP	O
see	VB	O
the	DT	O
operation	NN	O
notes	NNS	O
for	IN	O
details	NNS	O
about	IN	O
the	DT	B-TREATMENT
surgeries	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
briefly	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
ICU	NNP	O
for	IN	O
low	JJ	B-PROBLEM
hematocrit	NN	I-PROBLEM
and	CC	O
hyponatremia	NN	B-PROBLEM
immediately	RB	O
following	VBG	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
but	CC	O
was	VBD	O
then	RB	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
PICC	NNP	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
and	CC	O
will	MD	O
continue	VB	O
a	DT	B-TREATMENT
8	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
will	MD	O
also	RB	O
wear	VB	O
a	DT	B-TREATMENT
back	JJ	I-TREATMENT
brace	NN	I-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
while	IN	O
out	IN	O
of	IN	O
bed	NN	O
.	.	O

#	#	O
Candidemia	NN	B-PROBLEM
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	O
positive	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST
from	IN	O
03-12	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Diflucan	NNP	B-TREATMENT
.	.	O

Ophthalmology	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
ruled	VBN	O
out	RP	O
ocular	JJ	B-PROBLEM
spread	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
portocath	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

The	DT	O
tip	NN	O
was	VBD	O
culture	NN	B-TEST
negative	JJ	O
.	.	O

The	DT	O
patient	NN	O
will	MD	O
get	VB	O
a	DT	O
total	NN	O
of	IN	O
a	DT	B-TREATMENT
two	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
Diflucan	NNP	I-TREATMENT
.	.	O

#	#	O
Corynebacterium	NNP	B-PROBLEM
bacteremia	NN	I-PROBLEM
:	:	O
presumably	RB	O
Corynebacterium	NNP	B-PROBLEM
in	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
as	RB	O
well	RB	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
blood	NN	B-TEST
cultures	NNS	I-TEST
to	TO	O
grow	VB	O
corynebacterium	NN	B-PROBLEM
while	IN	O
hospitalized	VBN	O
.	.	O

#	#	O
Pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
have	VBP	O
an	DT	B-PROBLEM
effusion	NN	I-PROBLEM
on	IN	O
CXR	NNP	B-TEST
.	.	O

IP	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
did	VBD	O
a	DT	B-TEST
thoracentesis	NN	I-TEST
.	.	O

The	DT	B-TEST
tap	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
malignant	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

A	DT	B-TEST
repeat	NN	I-TEST
CT	NNP	I-TEST
was	VBD	O
done	VBN	O
showing	VBG	O
nodular	JJ	B-PROBLEM
thickening	NN	I-PROBLEM
along	IN	O
the	DT	O
right	JJ	O
major	JJ	O
and	CC	O
minor	JJ	O
fissure	NN	O
,	,	O
concerning	VBG	O
for	IN	O
intrapleural	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
implants	NNS	I-PROBLEM
.	.	O

IP	NNP	O
reviewed	VBD	O
the	DT	B-TEST
films	NNS	I-TEST
and	CC	O
recommended	VBD	O
continue	NN	O
oncologic	NN	B-TREATMENT
care	NN	I-TREATMENT
according	VBG	O
to	TO	O

outpatient	JJ	O
course	NN	O
and	CC	O
pleurodesis	NN	B-TREATMENT
if	IN	O
the	DT	O
pt	NN	O
becomes	VBZ	O
symptomatic	JJ	B-PROBLEM
02-07	JJ	O
fluid	NN	B-PROBLEM
accumulation	NN	I-PROBLEM
.	.	O

#	#	O
Foot	NNP	B-PROBLEM
ulcer	NN	I-PROBLEM
:	:	O
diabetic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
s/p	NN	O
surgery	NN	B-TREATMENT
but	CC	O
never	RB	O
healed	VBD	O
.	.	O

Wound	NNP	O
care	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
made	VBN	O
recommendations	NNS	O
for	IN	O
ulcer	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

His	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
were	VBD	O
changed	VBN	O
by	IN	O
the	DT	O
nursing	NN	O
staff	NN	O
accordingly	RB	O
.	.	O

#	#	O
Anemia	NN	B-PROBLEM
:	:	O
His	PRP$	B-TEST
HCT	NNP	I-TEST
remained	VBD	O
stable	JJ	O
post-surgery	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
iron	NN	I-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

-	:	O
Iron	NN	B-TREATMENT
Sulfate	NNP	I-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
tid	NN	O

-	:	O
Procrit	NN	B-TREATMENT
40,000	CD	O
units	NNS	O
SC	NNP	O
q	NN	O
Friday	NNP	O

-	:	O
Lovenox	NN	B-TREATMENT
40	CD	O
mg	NN	O
SC	NNP	O
q24	NN	O
for	IN	O
DVT	NNP	O
ppx	NN	O

-	:	O
Albuterol	NN	B-TREATMENT
/	JJ	O
Atrovent	NNP	B-TREATMENT
nebs	NN	O
q4	NN	O

-	:	O
Morphine	NN	B-TREATMENT
2-4	JJ	O
mg	NN	O
IV	NNP	O
q3-4	NN	O
prn	NN	O

-	:	O
Mylanta	NN	B-TREATMENT
30	CD	O
cc	NN	O
po	NN	O
q6	NN	O
prn	NN	O

-	:	O
Pepcid	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

-	:	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

-	:	O
glipizide	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
bid	NN	O

-	:	O
metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
bid	NN	O

-	:	O
metoprolol	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

-	:	O
Vancomycin	NN	B-TREATMENT
1.5	CD	O
gm	NN	O
q	VBD	O
12	CD	O
hours	NNS	O

1.	CD	O
Albuterol	NNP	B-TREATMENT
Sulfate	NNP	I-TREATMENT
0.083	CD	O
%	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Inhalation	NN	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
Ipratropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
0.02	CD	O
%	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Inhalation	NN	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
Aluminum-Magnesium	JJ	B-TREATMENT
Hydroxide	NNP	I-TREATMENT
225-200	CD	O
mg	NN	O
/	$	O
5	CD	O
mL	JJ	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
15-30	JJ	O
MLs	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
Glipizide	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
Miconazole	NNP	B-TREATMENT
Nitrate	NNP	I-TREATMENT
2	CD	O
%	NN	O
Powder	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
Acetaminophen	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
fever	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
Cepacol	NNP	B-TREATMENT
2	CD	O
mg	NN	O
Lozenge	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Lozenge	NNP	O
Mucous	NNP	O
membrane	NN	O
PRN	NNP	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

9.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
Senna	NNP	B-TREATMENT
8.6	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
Oxycodone	CD	B-TREATMENT
5	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
for	IN	O
14	CD	O
days	NNS	O
.	.	O

12.	CD	O
Fluconazole	NNP	B-TREATMENT
200	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

13.	CD	O
Oxycodone	CD	B-TREATMENT
10	CD	O
mg	NNS	O
Tablet	NNP	O
Sustained	VBD	O
Release	NNP	O
12	CD	O
HR	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
Sustained	VBD	O
Release	NNP	O
12HR	CD	O
PO	NNP	O
Q12H	NNP	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

14.	CD	O
Bisacodyl	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

15.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Chewable	JJ	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Chewable	JJ	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

16.	CD	O
Vancomycin	NNP	B-TREATMENT
in	IN	I-TREATMENT
Dextrose	NNP	I-TREATMENT
1	CD	O
g	NN	O
/	VBD	O
200	CD	O
mL	NN	O
Piggyback	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Intravenous	NNP	O
Q	NNP	O
12H	CD	O
(	(	O
Every	DT	O
12	CD	O
Hours	NNP	O
):	NNP	O
To	TO	O
finish	VB	O
on	IN	O
2020-05-12	JJ	O
.	.	O

17.	CD	O
Pepcid	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

18.	CD	O
Heparin	NNP	B-TREATMENT
Lock	NNP	I-TREATMENT
Flush	NNP	I-TREATMENT
(	(	I-TREATMENT
Porcine	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Syringe	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
ML	NNP	O
Intravenous	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
as	IN	O
needed	VBN	O
:	:	O
10	CD	O
ml	NN	O
NS	NNP	B-TREATMENT
followed	VBN	O
by	IN	O
2	CD	O
ml	NNS	O
of	IN	O
100	CD	O
Units	NNS	O
/	VBP	O
ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
200	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	JJ	O
Daily	NNP	O
and	CC	O
PRN	NNP	O
.	.	O

19.	CD	O
Insulin	NNP	B-TREATMENT
Glargine	NNP	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
Four	CD	O
(	(	O
4	CD	O
)	)	O
units	NNS	O
Subcutaneous	NNP	O
at	IN	O
dinner	NN	O
time	NN	O
.	.	O

20.	CD	O
Insulin	NNP	B-TREATMENT
Lispro	NNP	I-TREATMENT
(	(	I-TREATMENT
Human	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Cartridge	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Subcutaneous	NNP	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
As	IN	O
directed	VBN	O
by	IN	O
sliding	VBG	B-TREATMENT
scale-please	JJ	I-TREATMENT
see	NN	O
attached	VBN	O
scale	NN	O
.	.	O

Primary	JJ	O
diagnosis	NN	O
:	:	O
Epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM

-	:	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
s/p	JJ	O
resection	NN	B-TREATMENT
09-07	NN	O
.	.	O

-	:	O
CAD	NN	B-PROBLEM
s/p	NN	O
CABG	NNP	B-TREATMENT
x4	NNP	O
in	IN	O
'	POS	O
03	CD	O
.	.	O

-	:	O
hypercholesterolemia	NN	B-PROBLEM

-	:	O
DM	NN	B-PROBLEM
with	IN	O
neuropathy	JJ	B-PROBLEM
.	.	O

-	:	O
persistent	NN	B-PROBLEM
R	NNP	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM

Stable	JJ	O
,	,	O
afebrile	JJ	B-PROBLEM

You	PRP	O
were	VBD	O
diagnosed	VBN	O
with	IN	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

Continue	VB	O
to	TO	O
take	VB	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
as	IN	O
directed	VBN	O
.	.	O

Take	VB	O
the	DT	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
as	IN	O
directed	VBN	O
and	CC	O
do	VBP	O
not	RB	O
drive	VB	O
while	IN	O
taking	VBG	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

-	:	O
fever	NN	B-PROBLEM
>	VBZ	O
102	CD	O

-	:	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

-	:	O
worsening	NN	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
legs	NNS	I-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
function	NN	I-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

Morphine	NNP	B-TREATMENT
/	NNP	O
Histamine	NNP	B-TREATMENT
H2	NNP	I-TREATMENT
Inhibitors	NNP	I-TREATMENT
/	NNP	O
Heparin	NNP	B-TREATMENT
Agents	NNS	I-TREATMENT

Increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM

4u	CD	B-TREATMENT
FFP	NNP	I-TREATMENT

Paracentesis	NN	B-TREATMENT

47	CD	O
female	JJ	O
with	IN	O
h/o	JJ	O
HCV	NNP	B-PROBLEM
cirrhosis	NN	I-PROBLEM
compocated	VBN	O
by	IN	O
encephalopathy	NN	B-PROBLEM
,	,	O
ascites	NNS	B-PROBLEM
,	,	O
and	CC	O
h/o	JJ	O
portal	JJ	B-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
(	(	O
right	JJ	O
anterior	NN	O
portal	JJ	O
vein	NN	O
)	)	O
and	CC	O
portalcaval	JJ	B-TREATMENT
shunt	NN	I-TREATMENT
(	(	O
reversed	VBN	O
flow	NN	O
in	IN	O
main	JJ	O
portal	JJ	O
vein	NN	O
)	)	O
presents	NNS	O
from	IN	O
liver	JJ	O
clinic	NN	O
with	IN	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM
.	.	O

She	PRP	O
also	RB	O
described	VBD	O
sob	JJ	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
lower	JJR	I-PROBLEM
ext	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

She	PRP	O
denied	VBD	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
but	CC	O
her	PRP$	B-TEST
INR	NNP	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
3.8	CD	O
.	.	O

She	PRP	O
received	VBD	O
4units	CD	O
of	IN	O
FFP	NNP	B-TREATMENT
which	WDT	O
decreased	VBD	O
her	PRP	B-TEST
INR	NNP	I-TEST
to	TO	O
2.2	CD	O
and	CC	O
then	RB	O
2	CD	O
more	JJR	O
units	NNS	O
during	IN	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

She	PRP	O
then	RB	O
had	VBD	O
6L	CD	O
of	IN	O
non-bloody	JJ	B-PROBLEM
ascitic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
removed	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

She	PRP	O
received	VBD	O
36gm	CD	O
of	IN	O
albumin	NN	B-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
BP	NNP	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
120/70	CD	O
and	CC	O
remained	VBD	O
stable	JJ	O
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
hours	NNS	O
,	,	O
pt	NN	O
complained	VBD	O
of	IN	O
abd	JJ	B-PROBLEM
pain	NN	I-PROBLEM
but	CC	O
this	DT	O
resolved	VBD	O
on	IN	O
its	PRP$	O
own	JJ	O
without	IN	O
medication	NN	B-TREATMENT
.	.	O

In	IN	O
the	DT	O
am	VBP	O
,	,	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
hct	NN	I-TEST
of	IN	O
24	CD	O
,	,	O
down	RB	O
from	IN	O
32	CD	O
and	CC	O
plts	NNS	B-TEST
35	CD	O
,	,	O
down	RB	O
from	IN	O
72	CD	O
.	.	O

She	PRP	O
received	VBD	O
2	CD	O
units	NNS	O
of	IN	O
plts	NNS	B-TREATMENT
and	CC	O
1	CD	O
unit	NN	O
of	IN	O
PRBC	NNP	B-TREATMENT
s.	NN	I-TREATMENT

Her	PRP$	B-TEST
BP	NNP	I-TEST
was	VBD	O
then	RB	O
noted	VBN	O
to	TO	O
be	VB	O
decreased	VBN	B-PROBLEM
at	IN	O
80/40	CD	O
which	WDT	O
improved	VBD	O
mildly	RB	O
to	TO	O
90/30	CD	O
with	IN	O
1.5L	CD	O
of	IN	O
NS	NNP	B-TREATMENT
.	.	O

Temp	NNP	B-TEST
noted	VBD	O
to	TO	O
be	VB	O
low	JJ	B-PROBLEM
at	IN	O
94	CD	O
and	CC	O
she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
bear	NN	B-TREATMENT
hugger	NN	I-TREATMENT
which	WDT	O
improved	VBD	O
temp	NNS	B-TEST
to	TO	O
96.7	CD	O
.	.	O

Her	PRP$	O
mental	JJ	O
status	NN	O
also	RB	O
had	VBD	O
decreased	VBN	B-PROBLEM
from	IN	O
admission	NN	O
and	CC	O
her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
was	VBD	O
minimal	JJ	B-PROBLEM
,	,	O
225cc	CD	O
over	IN	O
the	DT	O
past	JJ	O
12	CD	O
hours	NNS	O
.	.	O

Creatinine	NN	B-TEST
this	DT	O
am	VBP	O
was	VBD	O
1.9	CD	O
from	IN	O
0.9	CD	O
yesterday	NN	O
.	.	O

She	PRP	O
was	VBD	O
recently	RB	O
hospitalised	VBN	O
from	IN	O
02-23	JJ	O
/	JJ	O
03-04	NN	O
for	IN	O
abdominal	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
underwent	JJ	O
paracentesis	NN	B-TREATMENT
that	WDT	O
ruled	VBD	O
out	RP	O
SBP	NNP	B-PROBLEM
and	CC	O
relieved	VBD	O
her	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

She	PRP	O
also	RB	O
underwent	VBD	O
US	NNP	B-TEST
that	IN	O
revealed	VBD	O
patent	NN	O
portal	NN	O
and	CC	O
hepatic	JJ	O
vessels	NNS	O
.	.	O

While	IN	O
her	PRP$	O
discharge	NN	O
summary	JJ	O
maintains	NNS	O
that	IN	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
Furosemide	NNP	B-TREATMENT
/	NNP	O
Spirinolactone	NNP	B-TREATMENT
/	NNP	O
Propranolol	NNP	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	O
scripts	NNS	O
on	IN	O
discharge	NN	O
and	CC	O
as	IN	O
a	DT	O
result	NN	O
did	VBD	O
not	RB	O
take	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

Also	RB	O
,	,	O
due	JJ	O
to	TO	O
worsening	VBG	B-PROBLEM
renal	JJ	I-PROBLEM
function	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
octreotide	NN	B-TREATMENT
/	NNP	O
midodrine	NN	B-TREATMENT
/	NNP	O
albumin	NN	B-TREATMENT
for	IN	O
hepatorenal	JJ	O

syndrome	NN	B-PROBLEM
(	(	O
Cr	NNP	B-TEST
3.3	CD	O
at	IN	O
its	PRP$	O
worst	JJS	O
)	)	O
which	WDT	O
resolved	VBD	O
prior	RB	O
to	TO	O
her	PRP$	O
discharge	NN	O
.	.	O

The	DT	O
hospitalisation	NN	O
was	VBD	O
also	RB	O
significant	JJ	O
for	IN	O
mild	JJ	B-PROBLEM
DIC	NNP	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
received	VBD	O
cryoglobulins	NNS	B-TREATMENT
and	CC	O
UTI	NNP	B-PROBLEM
(+	NNP	O
Enterococcus	NNP	B-PROBLEM
and	CC	O
+	NNP	O
Klebsiella	NNP	B-PROBLEM
).	NN	O

She	PRP	O
received	VBD	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
of	IN	O
amoxicillin	NN	B-TREATMENT
for	IN	O
which	WDT	O
Enterococcus	NNP	B-PROBLEM
was	VBD	O
sensitive	JJ	O
but	CC	O
Klebsiella	NNP	B-PROBLEM
unknown	JJ	O
.	.	O

HCV	NNP	B-PROBLEM
cirrhosis	NN	I-PROBLEM
c/b	NN	O
esophageal	NN	B-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
ascites	NNS	B-PROBLEM
,	,	O
partial	JJ	B-PROBLEM
portal	NN	I-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM

h/o	NN	O
gastritis	NN	B-PROBLEM

morbid	NN	B-PROBLEM
obesity	NN	I-PROBLEM

recent	JJ	O
cholecystitis	NN	B-PROBLEM
08-10	NN	O

sickle	NN	B-PROBLEM
cell	NN	I-PROBLEM
trait	NN	I-PROBLEM

Physical	JJ	O
Exam	NN	O
:	:	O
T	NN	B-TEST
95	CD	O
,	,	O
BP	NNP	B-TEST
120/70	CD	O
,	,	O
HR	NNP	B-TEST
82	CD	O
,	,	O
RR	NNP	B-TEST
20	CD	O
,	,	O
96%	CD	O
RA	NNP	O
Wt	NNP	B-TEST
301.6	CD	O
lb	NN	O

HEENT	NN	O
:	:	O
+	JJ	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

No	DT	O
thrush	NN	B-PROBLEM
.	.	O

Cardiac	NN	O
:	:	O
RRR	NNP	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM

Abdomen	NNS	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
dull	NN	B-PROBLEM
to	TO	O
percussion	NN	B-TEST
throughout	IN	O
,	,	O
no	DT	O
tenderness	NN	B-PROBLEM
,	,	O
liver	RB	B-PROBLEM
non-palpable	JJ	I-PROBLEM
due	JJ	O
to	TO	O
large	JJ	B-PROBLEM
volume	NN	I-PROBLEM
of	IN	I-PROBLEM
ascited	JJ	I-PROBLEM

Extremities	NNS	O
:	:	O
05-09	JJ	O
+	NNP	O
pretibial	NN	B-PROBLEM
edema	NN	I-PROBLEM
extending	VBG	O
above	IN	O
knee	NN	O
R	NNP	O
>	NNP	O
L	NNP	O
,	,	O
no	DT	O
asterixis	NN	B-PROBLEM
.	.	O

No	DT	O
palmar	NN	B-PROBLEM
erythema	NN	I-PROBLEM

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
8.1	CD	O
RBC	NNP	B-TEST
-	:	O
3.69	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
11.0	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
32.4	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
88	CD	O
MCH	NNP	B-TEST
-	:	O
29.8	CD	O
MCHC	NNP	B-TEST
-	:	O
33.9	CD	O
RDW	NNP	B-TEST
-	:	O
26.0	CD	O
*	JJ	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
72	CD	O
*#	NN	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Neuts	NNP	B-TEST
-	:	O
68.3	CD	O
Bands	NNP	B-TEST
-	:	O
0	CD	O
Lymphs	NNP	B-TEST
-	:	O
19.8	CD	O
Monos	NNP	B-TEST
-	:	O
10.6	CD	O
Eos	NNP	B-TEST
-	:	O
1.1	CD	O
Baso	NNP	B-TEST
-	:	O
0.2	CD	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Hypochr	NNP	B-TEST
-	:	O
1	CD	O
+	NN	O
Anisocy	NNP	B-TEST
-	:	O
2	CD	O
+	NN	O
Poiklo	NNP	B-TEST
-	:	O
2	CD	O
+	NN	O
Macrocy	NNP	B-TEST
-	:	O
2	CD	O
+	NN	O
Microcy	NNP	B-TEST
-	:	O
NORMAL	NNP	O
Polychr	NNP	B-TEST
-	:	O
NORMAL	NNP	O
Ovalocy	NNP	B-TEST
-	:	O
OCCASIONAL	NNP	O
Target	NNP	B-TEST
-	:	O
OCCASIONAL	NNP	O
Schisto	NNP	B-TEST
-	:	O
OCCASIONAL	NN	O
Tear	NNP	O
Dr	NNP	O
Clark	NNP	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
23.0	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
63.2	CD	O
*	NN	O
INR(PT)	NNP	B-TEST
-	:	O
3.8	CD	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
76	CD	O
UreaN	NNP	B-TEST
-	:	O
17	CD	O
Creat	NNP	B-TEST
-	:	O
0.8	CD	O
Na	NNP	B-TEST
-	:	O
129	CD	O
*	NN	O
K	NNP	B-TEST
-	:	O
3.9	CD	O
Cl	NNP	B-TEST
-	:	O
101	CD	O
HCO3	NNP	B-TEST
-	:	O
19	CD	O
*	NN	O
AnGap	NNP	B-TEST
-	:	O
13	CD	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
ALT	NNP	B-TEST
-	:	O
33	CD	O
AST	NNP	B-TEST
-	:	O
65	CD	O
*	NN	O
AlkPhos	NNP	B-TEST
-	:	O
70	CD	O
TotBili	NNP	B-TEST
-	:	O
30.3	CD	O
*	NN	O
DirBili	NNP	B-TEST
-	:	O
20.8	CD	O
*	NN	O
IndBili	NNP	B-TEST
-	:	O
9.5	CD	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Albumin	NNP	B-TEST
-	:	O
3.1	CD	O
*	NN	O

2015-03-26	JJ	O
10:10	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Ammonia	NNP	B-TEST
-	:	O
39	CD	O

1.	CD	O
Small	NNP	B-PROBLEM
cirrhotic	JJ	I-PROBLEM
liver	NN	I-PROBLEM
with	IN	O
what	WP	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	B-TREATMENT
portocaval	JJ	I-TREATMENT
shunt	NN	I-TREATMENT
.	.	O

2.	CD	O
Moderate	NNP	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

3.	CD	O
Cholelithiasis	NN	B-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

4.	CD	O
No	DT	O
hydronephrosis	NN	B-PROBLEM
.	.	O

5.	CD	O
Borderline	NNP	B-PROBLEM
splenomegaly	NN	I-PROBLEM
.	.	O

A/P	NN	O
:	:	O
48	CD	O
yo	NNS	O
morbidly	RB	O
obese	JJ	O
woman	NN	O
with	IN	O
HCV	NNP	B-PROBLEM
cirrhosis	NN	I-PROBLEM
c/b	NN	O
encephalopathy	NN	B-PROBLEM
,	,	O
esophageal	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
and	CC	O
partial	JJ	B-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
(	(	O
but	CC	O
no	DT	O
hx	NN	O
of	IN	O
SBP	NNP	B-PROBLEM
)	)	O
presents	VBZ	O
with	IN	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
ascites	NNS	B-PROBLEM
.	.	O

Admitted	VBN	O
for	IN	O
diagnostic	JJ	B-TREATMENT
/	NNP	I-TREATMENT
therapeutic	JJ	I-TREATMENT
paracentesis	NN	I-TREATMENT
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
the	DT	O
ICU	NNP	O
for	IN	O
hypotension	NN	B-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
and	CC	O
anemia	NN	B-PROBLEM
.	.	O

#	#	O
Liver	NNP	B-PROBLEM
cirrhosis	NN	I-PROBLEM
:	:	O
MELD	NNP	B-TEST
score	NN	I-TEST
of	IN	O
34	CD	O
on	IN	O
admission	NN	O
.	.	O

Pt	NNP	O
became	VBD	O
more	RBR	B-PROBLEM
encephalopathic	JJ	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

She	PRP	O
was	VBD	O
not	RB	O
a	DT	O
transplant	JJ	O
candidate	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
obesity	NN	I-PROBLEM
.	.	O

After	IN	O
it	PRP	O
was	VBD	O
explained	VBN	O
that	IN	O
the	DT	B-PROBLEM
pt	NN	I-PROBLEM
's	POS	I-PROBLEM
prognosis	NN	I-PROBLEM
was	VBD	O
very	RB	O
poor	JJ	O
given	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
not	RB	O
a	DT	B-TREATMENT
transplant	JJ	I-TREATMENT
candidate	NN	O
,	,	O
the	DT	O

decision	NN	O
was	VBD	O
made	VBN	O
by	IN	O
the	DT	O
family	NN	O
and	CC	O
the	DT	O
medical	JJ	O
team	NN	O
to	TO	O
withdraw	VB	O
care	NN	B-TREATMENT
.	.	O

#	#	O
Recurrent	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
:	:	O
On	IN	O
the	DT	O
medical	JJ	O
floor	NN	O
,	,	O
pt	NN	O
had	VBD	O
a	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
(	(	O
6	CD	O
liters	NNS	O
)	)	O
followed	VBN	O
by	IN	O
replacement	NN	B-TREATMENT
with	IN	I-TREATMENT
albumin	NN	I-TREATMENT
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
SBP	NNP	B-PROBLEM
.	.	O

#	#	O
Hypotension	NN	B-PROBLEM
:	:	O
Pt	NNP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
following	VBG	O
the	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
despite	IN	O
replacement	NN	B-TREATMENT
with	IN	I-TREATMENT
albumin	NN	I-TREATMENT
.	.	O

This	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
04-09	JJ	O
the	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
tap	NN	I-TREATMENT
verses	VBZ	O
sepsis	NN	B-PROBLEM
though	IN	O
she	PRP	O
had	VBD	O
no	DT	O
other	JJ	O
evidence	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
pressors	NNS	B-TREATMENT
to	TO	O
maintain	VB	O
a	DT	B-TEST
MAP	NNP	I-TEST
>	NN	O
55	CD	O
.	.	O

Once	RB	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
withdraw	VB	O
care	NN	O
,	,	O
the	DT	B-TREATMENT
pressors	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

#	#	O
Anemia	NN	B-PROBLEM
:	:	O
Hct	NNP	B-PROBLEM
dropped	VBD	I-PROBLEM
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
and	CC	O
there	EX	O
was	VBD	O
concern	NN	O
for	IN	O
bleed	NN	B-PROBLEM
into	IN	I-PROBLEM
her	PRP$	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

She	PRP	O
received	VBD	O
one	CD	O
unit	NN	O
of	IN	O
PRBC	NNP	B-TREATMENT
s.	NN	I-TREATMENT

CT	NNP	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
bleed	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
at	IN	O
24-26	JJ	O
following	VBG	O
the	DT	B-PROBLEM
acute	JJ	I-PROBLEM
drop.	NN	I-PROBLEM

#	#	O
ARF	NNP	B-PROBLEM
:	:	O
Creatinine	NNP	B-TEST
has	VBZ	O
increased	VBN	O
from	IN	O
0.9	CD	O
on	IN	O
admission	NN	O
to	TO	O
1.9	CD	O
on	IN	O
admission	NN	O
to	TO	O
ICU	NNP	O
.	.	O

Urine	NN	B-TEST
lytes	VBZ	I-TEST
with	IN	O
Na	NNP	B-TEST
of	IN	O
10	CD	O
indicating	VBG	O
either	CC	O
pre-renal	JJ	B-PROBLEM
or	CC	O
hepatorenal	JJ	B-PROBLEM
.	.	O

Fluid	NNP	B-TEST
challenge	NN	I-TEST
with	IN	O
36gm	CD	O
of	IN	O
albumin	NN	B-TREATMENT
,	,	O
one	CD	O
unit	NN	O
of	IN	O
PRBCs	NNP	B-TREATMENT
and	CC	O
2L	CD	O
of	IN	O
NS	NNP	B-TREATMENT
.	.	O

Will	MD	O
check	VB	O
creatinine	VB	B-TEST
this	DT	O
afternoon	NN	O
.	.	O

Pt	NNP	O
previously	RB	O
diagnosed	VBD	O
with	IN	O
hepatorenal	JJ	B-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
midodrine	NN	B-TREATMENT
,	,	O
octreotide	RB	B-TREATMENT
and	CC	O
albumin	RB	B-TREATMENT
;	:	O
these	DT	O
were	VBD	O

Her	PRP$	B-TEST
creatinine	NN	I-TEST
continued	VBD	O
to	TO	O
increase	VB	O
,	,	O
likely	RB	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
worsening	VBG	I-PROBLEM
liver	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Rifaximine	NNP	B-TREATMENT
200	CD	O
mg	NN	O
tid	NN	O

Lactulose	RB	B-TREATMENT
30	CD	O
cc	NN	O
qid	NN	O
titrated	VBD	O
to	TO	O
3-4	JJ	O
BM	NNP	O
/	NNP	O
day	NN	O

Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O

expired	VBD	B-PROBLEM

Maternal	NNP	B-TEST
blood	NN	I-TEST
type	NN	I-TEST
0-positive	JJ	O
,	,	O
DAT	NNP	B-TEST
negative	JJ	O
,	,	O
negative	JJ	O
,	,	O
RPR	NNP	B-TEST
nonreactive	NN	O
.	.	O

1.	CD	O
Tuberculosis	NNP	B-PROBLEM
,	,	O
mother	NN	O
was	VBD	O
treated	VBN	O
in	IN	O
2001	CD	O
according	VBG	O
to	TO	O
chart	NN	O
with	IN	O
subsequent	JJ	O
negative	JJ	O
chest	NN	B-TEST
x-ray	NN	I-TEST
,	,	O
and	CC	O

2.	CD	O
Infertility	NNP	B-PROBLEM
.	.	O

The	DT	O
pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
twin	JJ	B-PROBLEM
gestation	NN	I-PROBLEM
and	CC	O
by	IN	O
polyhydramnios	NNS	B-PROBLEM
with	IN	O
apparent	JJ	O
duodenal	JJ	B-PROBLEM
atresia	NN	I-PROBLEM
and	CC	O
nuchal	NN	O

thickening	VBG	B-PROBLEM
consistent	JJ	O
with	IN	O
Trisomy	NNP	B-PROBLEM
21	CD	I-PROBLEM
in	IN	O
the	DT	O
B	NNP	O
co-twin	NN	O
.	.	O

Amniocentesis	NN	B-TEST
was	VBD	O
not	RB	O
performed	VBN	O
.	.	O

Maternal	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
doctor	NN	O
's	POS	O
office	NN	O
and	CC	O
Mom	NNP	O
was	VBD	O
referred	VBN	O
to	TO	O
nonreassuring	VBG	B-TEST
fetal	JJ	I-TEST
tracing	NN	I-TEST
,	,	O
necessitating	VBG	O
an	DT	B-TREATMENT
urgent	JJ	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
.	.	O

Twin	NNP	O
#1	NNP	O
cried	VBD	O
spontaneously	RB	O
at	IN	O
birth	NN	O
,	,	O
was	VBD	O
bulb	VBN	B-TREATMENT
suctioned	JJ	I-TREATMENT
and	CC	O
received	VBD	O
Blow-by	NNP	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

Apgars	NNS	B-TEST
were	VBD	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

Twin	NNP	O
#1	NNP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
a	DT	B-PROBLEM
breech	JJ	I-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

Sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
:	:	O

No	DT	O
fever	NN	B-PROBLEM
,	,	O
no	DT	O
fetal	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
at	IN	O
delivery	NN	O
.	.	O

Group	NNP	B-TEST
B	NNP	I-TEST
Streptococcus	NNP	I-TEST
status	NN	I-TEST
unknown	NN	O
.	.	O

Well-appearing	JJ	O
female	NN	O
without	IN	O
distress	NN	B-PROBLEM
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
Newborn	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
weight	NN	I-TEST
of	IN	O
1400	CD	O
gm	NN	O
,	,	O
length	NN	B-TEST
41.5	CD	O
cm	NN	O
and	CC	O
head	NN	B-TEST
circumference	NN	I-TEST
of	IN	O
29.25	CD	O
cm	NN	O
.	.	O

Anterior	NNP	O
fontanelle	NN	O
,	,	O
soft	JJ	O
and	CC	O
flat	JJ	O
,	,	O
palate	JJ	O
intact	NN	O
,	,	O
nondysmorphic	JJ	B-PROBLEM
features	NNS	I-PROBLEM
.	.	O

Lungs	NNS	O
:	:	O
breath	NN	B-TEST
sounds	VBZ	I-TEST
clear	JJ	O
and	CC	O
equal	JJ	O
bilaterally	RB	O
,	,	O
no	DT	O
retractions	NNS	B-PROBLEM
.	.	O

Heart	NN	O
:	:	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
pulses	VBZ	B-TEST
2	CD	O
+.	NN	O

Abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
.	.	O

Without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
without	IN	O
masses	NNS	B-PROBLEM
.	.	O

Positive	JJ	O
suck	NN	B-TEST
,	,	O
positive	JJ	O
grasp	NN	B-TEST
.	.	O

1.	CD	O
Respiratory	NNP	O
-	:	O
Gerardo	NNP	O
was	VBD	O
initially	RB	O
placed	VBN	O
in	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
maintain	VB	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
greater	JJR	O
than	IN	O
94	CD	O
.	.	O

On	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NNP	O
,	,	O
caffeine	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

Caffeine	NNP	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#19	NN	O
.	.	O

Breath	NNP	B-TEST
sounds	VBZ	I-TEST
,	,	O
clear	JJ	O
and	CC	O
equal	JJ	O
,	,	O
without	IN	O
retractions	NNS	B-PROBLEM
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
30	CD	O
s	NN	O
to	TO	O
60	CD	O
s.	NN	O

2.	CD	O
Cardiovascular	JJ	O
-	:	O
The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
cardiovascularly	RB	O
stable	JJ	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

3.	CD	O
Fluids	NNS	O
,	,	O
electrolytes	NNS	O
and	CC	O
nutrition	NN	O
-	:	O
Birthweight	NNP	B-TEST
was	VBD	O
1400	CD	O
gm	NN	O
,	,	O
25th	CD	O
percentile	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
D10	NNP	B-TREATMENT
/	NNP	I-TREATMENT
W	NNP	I-TREATMENT
at	IN	O
80	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

She	PRP	O
began	VBD	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#2	NNP	O
advancing	VBG	O
to	TO	O
mother	VB	O
's	POS	O
breastmilk	NN	O
30	CD	O
with	IN	O
ProMod	NNP	B-TREATMENT
at	IN	O
150	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

Baby	NNP	O
received	VBD	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
and	CC	O
lipids	NNS	B-TREATMENT
for	IN	O
four	CD	O
days	NNS	O
.	.	O

No	DT	O
hypoglycemia	NN	B-PROBLEM
issues	NNS	I-PROBLEM
noted	VBD	O
.	.	O

Baby	NNP	O
is	VBZ	O
presently	RB	O
tolerating	VBG	O
mother	NN	O
's	POS	O
breastmilk	NN	O
with	IN	O
Enfamil	NNP	B-TREATMENT
powder	NN	I-TREATMENT
to	TO	O
make	VB	O
24	CD	O
cal	JJ	O
/	NN	O
oz	NN	O
at	IN	O
130	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

4.	CD	O
Gastrointestinal	NNP	O
,	,	O
genitourinary	JJ	O
-	:	O
Peak	NNP	B-TEST
bilirubin	VBZ	I-TEST
8.5	CD	O
,	,	O
phototherapy	NN	B-TREATMENT
times	NNS	O
24	CD	O
hours	NNS	O
.	.	O

Rebound	NNP	B-TEST
bilirubin	VBD	I-TEST
6.4	CD	O
.	.	O

5.	CD	O
Hematology	NNP	O
-	:	O
Most	JJS	O
recent	JJ	O
hematocrit	NN	B-TEST
was	VBD	O
42.8	CD	O
on	IN	O
50-05-25	NNS	O
.	.	O

The	DT	O
baby	NN	O
received	VBD	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
.	.	O

6.	CD	O
Infectious	JJ	O
disease	NN	O
-	:	O
No	DT	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

Initial	JJ	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
with	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
14	CD	O
,	,	O
hemoglobin	NN	B-TEST
21.6	CD	O
,	,	O
hematocrit	NN	B-TEST
62.9	CD	O
,	,	O
65	CD	O
neutrophils	NNS	B-TEST
,	,	O
no	DT	O
bands	NNS	B-TEST
,	,	O
28	CD	O
lymphocytes	NNS	B-TEST
.	.	O

Blood	NNP	B-TEST
cultures	NNS	I-TEST
negative	JJ	O
.	.	O

8.	CD	O
Sensory	NNP	O
-	:	O
Audiology	NN	O
,	,	O
hearing	VBG	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

Baby	NNP	O
passed	VBD	O
hearing	VBG	B-TEST
test	NN	I-TEST
on	IN	O
2009-01-21	JJ	O
.	.	O

A	DT	B-TEST
follow	JJ	I-TEST
up	RP	I-TEST
examination	NN	I-TEST
is	VBZ	O
recommended	VBN	O
in	IN	O
six	CD	O
to	TO	O
eight	CD	O
months	NNS	O
.	.	O

1.	CD	O
Feeds	NNP	O
-	:	O
Breastfeeding	VBG	O
ad	NN	O
lib	NN	O
,	,	O
supplementing	VBG	O
with	IN	O
Enfamil	NNP	B-TREATMENT
24	CD	O
or	CC	O
breastmilk	VB	O
24	CD	O
cal	JJ	O
/	NN	O
oz	NN	O
made	VBD	O
with	IN	O
1	CD	O
tsp	NN	O
of	IN	O
Enfamil	NNP	B-TREATMENT
powder	NN	I-TREATMENT
per	IN	O
100	CD	O
cc	NN	O
of	IN	O
breastmilk	NN	O
.	.	O

2.	CD	O
Medications	NNPS	B-TREATMENT
-	:	O
Poly-Vi-James	JJ	B-TREATMENT
1	CD	O
cc	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
;	:	O
Iron	NNP	B-TREATMENT
or	CC	O
Fer-In-James	NNS	B-TREATMENT
0.2	CD	O
cc	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
to	TO	O
give	VB	O
2	CD	O
mg	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O

3.	CD	O
Car	NNP	B-TEST
seat	NN	I-TEST
screening	VBG	I-TEST
-	:	O
Passed	VBN	O
.	.	O

4.	CD	O
State	NNP	B-TEST
newborn	JJ	I-TEST
screening	VBG	I-TEST
-	:	O
Last	JJ	O
on	IN	O
2009-01-07	JJ	O
,	,	O
all	DT	O
within	IN	O
normal	JJ	O
range	NN	O
.	.	O

5.	CD	O
Immunizations	NNS	B-TREATMENT
received	VBD	O
-	:	O
Hepatitis	NN	B-TREATMENT
B	NNP	I-TREATMENT
vaccine	NN	I-TREATMENT
given	VBN	O
2009-01-22	CD	O
.	.	O

6.	CD	O
Immunizations	NNS	B-TREATMENT
recommended	VBD	O
-	:	O

Synagis	NNP	B-TREATMENT
respiratory	NN	I-TREATMENT
syncytial	JJ	I-TREATMENT
virus	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
October	NNP	O
through	IN	O
April	NNP	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O

3.	CD	O
With	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

After	IN	O
some	DT	O
debate	NN	O
,	,	O
we	PRP	O
concluded	VBD	O
that	IN	O
Vetrano	NNP	O
was	VBD	O
not	RB	O
at	IN	O
unusually	RB	O
high	JJ	O
risk	NN	O
from	IN	O
RSV	NNP	B-PROBLEM
,	,	O
but	CC	O
that	IN	O
her	PRP$	O
sister	NN	O
might	MD	O
be	VB	O
.	.	O

Vetrano	NN	O
probably	RB	O
does	VBZ	O
not	RB	O
need	VB	O
Synagis	NNP	B-TREATMENT
at	IN	O
least	JJS	O
until	IN	O
her	PRP$	O
sibling	NN	O
is	VBZ	O
discharged	VBN	O
from	IN	O
the	DT	O
hospital	NN	O
.	.	O

Influenza	NNP	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O

reach	NN	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
,	,	O
before	IN	O
this	DT	O
age	NN	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O

influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
Prematurity	NNP	B-PROBLEM
,	,	O
former	JJ	O
32	CD	O
4/7	CD	O
weeks	NNS	O
,	,	O
Twin	NNP	O
#1	NNP	O

2.	CD	O
Rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
III	NNP	O
,	,	O
para	NN	O
II	NNP	O
,	,	O
who	WP	O
was	VBD	O
sent	VBN	O
from	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
secondary	NN	O
to	TO	O
lower	VB	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
uterine	JJ	B-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
secondary	JJ	O
to	TO	O
fibroids	NNS	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
continuing	VBG	B-PROBLEM
vaginal	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
bacterial	JJ	B-PROBLEM
vaginosis	NN	I-PROBLEM
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
and	CC	O
was	VBD	O
given	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
Flagyl	NNP	B-TREATMENT
.	.	O

She	PRP	O
noted	VBD	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
which	WDT	O
became	VBD	O
more	RBR	O
severe	JJ	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

She	PRP	O
went	VBD	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
complaining	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
stated	VBD	O
was	VBD	O
constant	JJ	O
but	CC	O
intermittently	RB	O
sharper	JJR	O
at	IN	O
times	NNS	O
.	.	O

She	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
loose	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
100.4	CD	O
in	IN	O
the	DT	O
office	NN	O
,	,	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
chills	NNS	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
sent	VBN	O
for	IN	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
fluid	NN	B-PROBLEM
and	CC	O
question	NN	O
of	IN	O
gas	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
Pinewood	NNP	O
,	,	O
Norfolk	NNP	O
for	IN	O
treatment	NN	B-TREATMENT
and	CC	O
admission	NN	B-TREATMENT
.	.	O

Cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
spontaneous	JJ	B-PROBLEM
abortion	NN	I-PROBLEM
x	VBD	O
1	CD	O
.	.	O

Some	DT	B-PROBLEM
spotting	NN	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
but	CC	O
not	RB	O
a	DT	O
normal	JJ	O
period	NN	O
.	.	O

Lupron	NNP	B-TREATMENT
x	NNP	O
three	CD	O
months	NNS	O
prior	RB	O
to	TO	O
embolization	NN	B-TREATMENT
.	.	O

Fibroid	NNP	B-PROBLEM
uterus	NN	I-PROBLEM
status	NN	O
post	NN	O
embolization	NN	B-TREATMENT
on	IN	O
2009-01-07	JJ	O
.	.	O

Dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	VBP	O
1	CD	O
for	IN	O
SAB	NNP	B-PROBLEM
.	.	O

History	NN	O
of	IN	O
herpes	NNS	B-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
,	,	O
last	JJ	O
outbreak	NN	O
in	IN	O
2000	CD	O
.	.	O

No	DT	O
history	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
Pap	NNP	I-PROBLEM
smears	NNS	I-PROBLEM
.	.	O

Cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	NN	O
1	CD	O
,	,	O
neck	NN	B-TREATMENT
fusion	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
shoulder	NN	B-TREATMENT
surgery	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

Flagyl	NNP	B-TREATMENT
.	.	O

Temperature	NN	B-TEST
100.4	CD	O
,	,	O
pulse	RB	B-TEST
108	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
110/70	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
100%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Her	PRP$	O
abdomen	NNS	O
was	VBD	O
notable	JJ	O
for	IN	O
voluntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
but	CC	O
no	DT	O
involuntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM
,	,	O
mild	VB	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
greater	JJR	O
than	IN	O
left	VBD	O
lower	JJR	O
quadrant	NN	O
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
pelvic	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
some	DT	B-PROBLEM
brownish	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

Her	PRP$	O
uterus	NN	O
and	CC	O
adnexa	NN	O
were	VBD	O
difficult	JJ	O
to	TO	O
assess	VB	O
secondary	JJ	O
to	TO	O
voluntary	JJ	B-PROBLEM
tensing	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
III	NNP	O
,	,	O
para	NN	O
II	NNP	O
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
uterine	JJ	I-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
due	JJ	O
to	TO	O
uterine	JJ	B-PROBLEM
fibroids	NNS	I-PROBLEM
,	,	O
with	IN	O
continued	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
CT	NNP	B-TEST
scan	JJ	I-TEST
revealing	NN	O
fluid	NN	B-PROBLEM
and	CC	I-PROBLEM
gas	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
initial	JJ	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.3	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

Her	PRP$	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
110	CD	O
.	.	O

Her	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

She	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

On	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
positive	JJ	B-PROBLEM
in	IN	O
the	DT	B-TEST
anaerobic	JJ	I-TEST
culture	NN	I-TEST
for	IN	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
pairs	NNS	I-PROBLEM
and	CC	I-PROBLEM
clusters	NNS	I-PROBLEM
.	.	O

Further	JJ	B-TEST
identification	NN	I-TEST
revealed	VBD	O
staphylococcus	JJ	B-PROBLEM
coag-negative	JJ	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
gentamicin	VB	B-TREATMENT
and	CC	O
clindamycin	VB	B-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
afebrile	RB	B-PROBLEM
until	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
when	WRB	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
spike	NN	I-PROBLEM
to	TO	O
102.3	CD	O
.	.	O

Repeat	NNP	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

Her	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
12.8	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

At	IN	O
this	DT	O
time	NN	O
,	,	O
an	DT	O
Infectious	JJ	O
Disease	NNP	O
consult	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
the	DT	O
recommendation	NN	O
was	VBD	O
to	TO	O
discontinue	VB	O
the	DT	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
and	CC	O
start	VB	O
her	PRP$	O
on	IN	O
intravenous	JJ	B-TREATMENT
Unasyn	NNP	I-TREATMENT
.	.	O

She	PRP	O
underwent	VBD	O
a	DT	B-TEST
pelvic	JJ	I-TEST
ultrasound	NN	I-TEST
and	CC	O
an	DT	B-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
CT	NNP	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
continued	VBD	B-PROBLEM
air	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
vs.	NN	O
in	IN	O
the	DT	B-PROBLEM
fundal	JJ	I-PROBLEM
fibroid	NN	I-PROBLEM
.	.	O

Discussion	NN	O
was	VBD	O
had	VBN	O
at	IN	O
this	DT	O
time	NN	O
with	IN	O
the	DT	O
patient	NN	O
regarding	VBG	O
whether	IN	O
or	CC	O
not	RB	O
this	DT	O
represented	VBD	O
an	DT	B-PROBLEM
infected	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
vs.	IN	O
post-surgical	JJ	B-PROBLEM
change	NN	I-PROBLEM
.	.	O

possible	JJ	O
drainage	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
abscess	NN	I-PROBLEM
vs.	FW	O
hysterectomy	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
requested	VBD	O
an	DT	O
outside	JJ	O
second	JJ	O
opinion	NN	O
,	,	O
as	IN	O
she	PRP	O
was	VBD	O
reluctant	JJ	O
to	TO	O
undergo	VB	O
hysterectomy	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

She	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
eight	CD	O
,	,	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
to	TO	O
have	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
in	IN	O
one	CD	O
week	NN	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
to	TO	O
obtain	VB	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
the	DT	O
question	NN	O
of	IN	O
possible	JJ	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

Trazodone	CD	B-TREATMENT
/	JJ	O
Ambien	NNP	B-TREATMENT
/	NNP	O
Sinequan	NNP	B-TREATMENT

ACQUIRED	NNS	B-PROBLEM
DEFECT	NNP	I-PROBLEM
FROM	NNP	O
BASAL	NNP	B-TREATMENT
CELL	NNP	I-TREATMENT
CARCINOMA	NNP	I-TREATMENT
RESECTION	NNP	I-TREATMENT

RIGHT	RB	B-TREATMENT
NOSE	NNP	I-TREATMENT
/	NNP	I-TREATMENT
ALA	NNP	I-TREATMENT
RECONSTRUCTION	NNP	I-TREATMENT
USING	NNP	O
RIGHT	NNP	B-TREATMENT
CHEEK	NNP	I-TREATMENT
ADVANCEMENT	NNP	I-TREATMENT
AND	NNP	O
FOREHEAD	NNP	B-TREATMENT
LOCAL	NNP	I-TREATMENT
FLAP	NNP	I-TREATMENT

MS.	NNP	O
Marshall	NNP	O
IS	VBZ	O
A	DT	O
64-YEAR	JJ	O
OLD	NNP	O
,	,	O
MENTALLY	NNP	B-PROBLEM
RETARDED	NNP	I-PROBLEM
,	,	O
FEMALE	NNP	O
WHO	NNP	O
PRESENTED	NNP	O
WITH	NNP	O
AN	NNP	B-PROBLEM
AQUIRED	NNP	I-PROBLEM
DEFECT	NNP	I-PROBLEM
OF	IN	I-PROBLEM
THE	NNP	I-PROBLEM
RIGHT	NNP	I-PROBLEM
NASAL	NNP	I-PROBLEM
ALA	NNP	I-PROBLEM
AND	NNP	I-PROBLEM
MEDIAL	NNP	I-PROBLEM
CHEEK	NNP	I-PROBLEM
REGION	NNP	I-PROBLEM
AFTER	NNP	O
BASAL	NNP	B-PROBLEM
CELL	NNP	I-PROBLEM
CARCINOMA	NNP	I-PROBLEM
WAS	NNP	O
RESECTED	NNP	O
BY	NNP	O
DERMATOLOGY	NNP	O
.	.	O

MENTAL	NNP	B-PROBLEM
RETARDATION	NNP	I-PROBLEM

DIABETES	NNS	B-PROBLEM

BIPOLAR	NNP	B-PROBLEM
DISORDER	NNP	I-PROBLEM

ON	NNP	O
PRESENTATION	NNP	O
,	,	O
PT	NNP	O
WAS	NNP	O
AFEBRILE	NNP	B-PROBLEM
WITH	NNP	O
NORMAL	NNP	O
VITAL	NNP	O
SIGNS	NNP	O

GEN	NN	O
:	:	O
NO	DT	O
ACUTE	NNP	B-PROBLEM
DISTRESS	NNP	I-PROBLEM
,	,	O
ABLE	NNP	O
TO	NNP	O
COMMUNICATE	NNP	O
AND	NNP	O
FOLLOW	NNP	O
ORDERS	NNP	O

HEAD	NNP	O
AND	CC	O
NECK	NNP	O
:	:	O
5	CD	B-PROBLEM
CM	NNP	I-PROBLEM
CIRCULAR	NNP	I-PROBLEM
FULL	NNP	I-PROBLEM
THICKNESS	NNP	I-PROBLEM
DEFECT	NNP	I-PROBLEM
AT	NNP	O
THE	NNP	O
JUNCTION	NNP	O
OF	IN	O
THE	NNP	O
RIGHT	NNP	O
ALA	NNP	O
AND	NNP	O
CHEEK	NNP	O

LUNGS	NN	O
:	:	O
CLEAR	JJ	O
TO	NNP	O
ASCULATION	NNP	B-TEST

ABDOMEN	NNS	O
:	:	O
SOFT	NNP	O
,	,	O
NON-TENDER	NNP	B-PROBLEM
,	,	O
NON-DISTENDED	NNP	B-PROBLEM

EXTREMITIES	NNS	O
:	:	O
NO	DT	O
EDEMA	NNP	B-PROBLEM
,	,	O
CYANOSIS	NNP	B-PROBLEM
,	,	O
FULL	NNP	O
RANGE	NNP	O
OF	NNP	O
MOTION	NNP	O

UPON	NNP	O
ADMISSION	NNP	O
,	,	O
THE	NNP	O
PATIENT	NNP	O
WAS	NNP	O
PRE-OP	NNP	O
'D	POS	O
AND	NNP	O
MADE	NNP	O
NPO	NNP	B-TREATMENT
/	NNP	O
IVF	NNP	B-TREATMENT
.	.	O

SHE	NNP	O
WENT	NNP	O
TO	NNP	O
SURGERY	NNP	B-TREATMENT
THE	NNP	O
NEXT	NNP	O
MORNING	NNP	O
AND	NNP	O
TOLERATED	NNP	O
THE	NNP	B-TREATMENT
SURGERY	NNP	I-TREATMENT
WELL	NNP	O
.	.	O

HOWEVER	NNP	O
,	,	O
SHE	NNP	O
WAS	NNP	O
SLOW	NNP	O
TO	NNP	O
AWAKE	NNP	O
FROM	NNP	O
ANESTHESIA	NNP	B-TREATMENT
,	,	O
AND	NNP	O
WAS	NNP	O
ADMITTED	NNP	O
TO	NNP	O
THE	NNP	O
CMED	NNP	O
CCU	NNP	O
OBSERVATION	NNP	B-TEST
.	.	O

SHE	NNP	O
WAS	NNP	O
TRANSFERED	NNP	O
TO	NNP	O
THE	NNP	O
FLOOR	NNP	O
POST-OP	NNP	O
DAY	NNP	O
2	CD	O
WHERE	NNP	O
SHE	NNP	O
HAD	VBD	O
BEEN	NNP	O
AFEBRILE	NNP	B-PROBLEM
WITH	NNP	O
NORMAL	NNP	O
VITALS	NNP	O
,	,	O
MAKING	NNP	O
GOOD	NNP	O
URINE	NNP	O
,	,	O
AND	NNP	O
TOLERATING	NNP	O
A	NNP	O
REGULAR	NNP	O
DIET	NNP	O
.	.	O

HER	PRP$	B-PROBLEM
WOUND	NNP	I-PROBLEM
HAS	NNP	O
REMAIND	NNP	O
DRY	NNP	O
AND	NNP	O
CLOSED	NNP	O
,	,	O
WITHOUT	NNP	O
EVIDENCE	NNP	O
OF	NNP	O
INFECTION	NNP	B-PROBLEM
OR	NNP	O
BREAKDOWN	NNP	B-PROBLEM
.	.	O

SHE	NNP	O
WILL	MD	O
BE	VB	O
DISCHARGED	VBN	O
TODAY	NNP	O
BACK	NNP	O
TO	NNP	O
HER	NNP	O
NURSING	NNP	O
HOME	NNP	O
IN	NNP	O
GOOD	NNP	O
CONDITION	NNP	O
,	,	O
ON	NNP	O
PAIN	NNP	B-TREATMENT
MEDS	NNP	I-TREATMENT
,	,	O
ANTIBIOTICS	NNP	B-TREATMENT
,	,	O
AND	NNP	O
WITH	NNP	O
ANTICIPATED	NNP	O
1:1	CD	O
WATCH	NNP	O
.	.	O

STAGE	NNP	O
TWO	NNP	O
OF	IN	O
HER	NNP	B-TREATMENT
SURGERY	NNP	I-TREATMENT
WILL	MD	O
BE	VB	O
DONE	NNP	O
IN	NNP	O
3	CD	O
WEEKS	NNP	O
.	.	O

1.	CD	O
Paroxetine	NNP	B-TREATMENT
HCl	NNP	I-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
AM	NNP	O
().	NNP	O

2.	CD	O
Multivitamin	NNP	B-TREATMENT
Capsule	NNP	I-TREATMENT
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Cap	NNP	O
PO	NNP	O
QAM	NNP	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
morning	NN	O
)).	NN	O

3.	CD	O
Divalproex	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
QAM	NNP	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
morning	NN	O
)).	NN	O

4.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
:	:	O
constipation	NN	B-PROBLEM
.	.	O

5.	CD	O
Triamcinolone	NNP	B-TREATMENT
Acetonide	NNP	I-TREATMENT
0.1	CD	O
%	NN	O
Cream	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Appl	NNP	O
Topical	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
Divalproex	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
Oral	NNP	O

7.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
HS	NNP	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

8.	CD	O
Oxybutynin	NNP	B-TREATMENT
Chloride	NNP	I-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
QPM	NNP	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
evening	NN	O
)).	NN	O

9.	CD	O
Hydrocodone-Acetaminophen	JJ	B-TREATMENT
5-500	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
).	VBP	O

10.	CD	O
Bacitracin-Polymyxin-Neosp	JJ	B-TREATMENT
HC	NNP	I-TREATMENT
Ointment	NNP	I-TREATMENT
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Topical	NNP	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

AQUIRED	NNP	B-PROBLEM
DEFORMITY	NNP	I-PROBLEM
OF	IN	I-PROBLEM
THE	NNP	I-PROBLEM
RIGHT	NNP	I-PROBLEM
ALA	NNP	I-PROBLEM
/	NNP	I-PROBLEM
NOSE	NNP	I-PROBLEM
AND	NNP	I-PROBLEM
MEDIAL	NNP	I-PROBLEM
CHEEK	NNP	I-PROBLEM
FROM	NNP	O
BASAL	NNP	B-TREATMENT
CELL	NNP	I-TREATMENT
CARCINOMA	NNP	I-TREATMENT
RESECTION	NNP	I-TREATMENT

PLEASE	NNP	O
GIVE	NNP	O
PATIENT	NNP	O
MEDICATIONS	NNP	B-TREATMENT
AS	NNP	O
PRESCRIBED	NNP	O
AND	NNP	O
READ	NNP	O
WARNING	NNP	O
LABELS	NNP	O
CAREFULLY	NNP	O
.	.	O

IF	NNP	O
SIGNS	NNP	B-PROBLEM
AND	NNP	I-PROBLEM
SYMPTOMS	NNP	I-PROBLEM
OF	NNP	O
INFECTION	NNP	B-PROBLEM
,	,	O
SUCH	NNP	O
AS	IN	O
FEVERS	NNP	B-PROBLEM
/	NNP	O
CHILLS	NNP	B-PROBLEM
,	,	O
PURULENT	NNP	B-PROBLEM
DISCHARGE	NNP	I-PROBLEM
FROM	NNP	I-PROBLEM
WOUND	NNP	I-PROBLEM
/	NNP	I-PROBLEM
INCISION	NNP	I-PROBLEM
SITE	NNP	I-PROBLEM
,	,	O
INCREASED	NNP	B-PROBLEM
REDNESS	NNP	I-PROBLEM
,	,	O
INCREASED	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
,	,	O
PLEASE	NNP	O
CALL	NNP	O
OR	NNP	O
GO	NNP	O
TO	NNP	O
THE	NNP	O
EMERGENCY	NNP	O
ROOM	NNP	O
.	.	O

STAGE	NNP	O
2	CD	O
OF	IN	O
THE	DT	B-TREATMENT
SURGERY	NNP	I-TREATMENT
WILL	MD	O
BE	VB	O
DONE	NNP	O
IN	NNP	O
3	CD	O
WEEKS	NNP	O
.	.	O

PLEASE	NNP	O
CLEAN	NNP	O
INCISION	NNP	B-PROBLEM
SITE	NNP	I-PROBLEM
WITH	NNP	O
NORMAL	NNP	B-TREATMENT
SALINE	NNP	I-TREATMENT
OR	NNP	O
CLEAN	NNP	O
WATER	NNP	O
THREE	NNP	O
TIMES	NNP	O
A	NNP	O
DAY	NNP	O
AND	NNP	O
PLACE	NNP	O
ANTIBIOTIC	NNP	B-TREATMENT
OINTMENT	NNP	I-TREATMENT
(	(	O
GIVEN	NNP	O
)	)	O
ON	NNP	O
TOP	NNP	O
OF	NNP	O
WOUND	NNP	B-PROBLEM
.	.	O

MOST	JJS	O
IMPORTANTLY	NNP	O
,	,	O
THE	NNP	O
PATIENT	NNP	O
MUST	NNP	O
BE	NNP	O
WATCH	NNP	O
ONE-ON-ONE	NNP	O
SO	NNP	O
THAT	IN	O
SHE	NNP	O
DOES	NNP	O
NOT	NNP	O
PICK	NNP	O
AT	NNP	O
HER	NNP	B-PROBLEM
WOUND	NNP	I-PROBLEM
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

Hip	NNP	B-PROBLEM
fracture	NN	I-PROBLEM

1.	CD	O
Closed	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
of	IN	I-TREATMENT
right	JJ	I-TREATMENT
hip	NN	I-TREATMENT
with	IN	O
open	JJ	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
dynamic	JJ	I-TREATMENT
hip	NN	I-TREATMENT
screw	NN	I-TREATMENT
,	,	I-TREATMENT
right	JJ	I-TREATMENT
hip	NN	I-TREATMENT
.	.	O

2.	CD	O
Examination	NNP	B-TEST
under	IN	I-TEST
anesthesia	NN	I-TEST
with	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
splint	NN	I-TREATMENT
,	,	I-TREATMENT
right	JJ	I-TREATMENT
elbow	NN	I-TREATMENT
.	.	O

1.	CD	O
Exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
with	IN	O
drainage	NN	B-TREATMENT
of	IN	O
intra-abdominal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
peritonitis	NN	B-PROBLEM
with	IN	O
gross	JJ	B-PROBLEM
soilage	NN	I-PROBLEM
with	IN	I-PROBLEM
bile	NN	I-PROBLEM
and	CC	I-PROBLEM
gastric	JJ	I-PROBLEM
contents	NNS	I-PROBLEM
.	.	O

2.	CD	O
Exposure	NN	B-TREATMENT
and	CC	O
wide	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
of	IN	O
perforated	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
duodenal	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
internal	JJ	B-TREATMENT
and	CC	I-TREATMENT
external	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

3.	CD	O
Feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

4.	CD	O
Tube	NNP	B-TREATMENT
gastrostomy	NN	I-TREATMENT
.	.	O

5.	CD	O
Placement	NN	O
of	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
arterial	JJ	I-TREATMENT
line	NN	I-TREATMENT
.	.	O

90	CD	O
yo	NNS	O
F	NNP	O
with	IN	O
MMP	NNP	B-PROBLEM
(	(	O
see	VB	O
below	IN	O
)	)	O
who	WP	O
sustained	VBD	O
a	DT	B-PROBLEM
mechanical	JJ	I-PROBLEM
fall	NN	I-PROBLEM
down	RP	O
stairs	NNS	O
resulting	VBG	O
in	IN	O
a	DT	B-PROBLEM
hip	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Fall	NN	B-PROBLEM
was	VBD	O
witnessed	VBN	O
by	IN	O
daughter	NN	O
.	.	O

Nicholas	NNP	B-PROBLEM
seizures	NNS	I-PROBLEM
,	,	O
no	DT	O
LOC	NNP	B-PROBLEM
,	,	O
no	DT	O
head	NN	B-PROBLEM
or	CC	I-PROBLEM
neck	NN	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

Patient	JJ	O
denies	NNS	O
CP	NNP	B-PROBLEM
,	,	O
SOB	NNP	B-PROBLEM
,	,	O
light	JJ	B-PROBLEM
headedness	NN	I-PROBLEM
,	,	O
or	CC	O
dizziness	RB	B-PROBLEM
prior	JJ	O
to	TO	O
of	IN	O
after	IN	O
the	DT	B-PROBLEM
fall	NN	I-PROBLEM
.	.	O

She	PRP	O
fell	VBD	O
on	IN	O
her	PRP$	O
R	NNP	O
side	NN	O
and	CC	O
had	VBD	O
a	DT	O
great	JJ	O
deal	NN	O
of	IN	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
R	NNP	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

Presented	VBN	O
to	TO	O
Taunton	NNP	O
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
R	NNP	B-PROBLEM
humerus	NN	I-PROBLEM
and	CC	I-PROBLEM
R	NNP	I-PROBLEM
hip	NN	I-PROBLEM
fx	NN	I-PROBLEM
.	.	O

Ct	NNP	B-TEST
of	IN	I-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
neg	NN	O
for	IN	O
fx	NN	B-PROBLEM
,	,	O
bleed	NN	B-PROBLEM
,	,	O
and	CC	O
dislocation	NN	B-PROBLEM
.	.	O

1.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
non-ST-elevation	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2009-05-05	JJ	O
,	,	O
status	NN	O
post	NN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
with	IN	O
left	JJ	B-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	JJ	I-TREATMENT
stent	JJ	I-TREATMENT
placement	NN	I-TREATMENT
in	IN	O
05/2001	CD	O
.	.	O

2.	CD	O
CHF	NNP	B-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40-45%	JJ	O
02-09	JJ	O

3.	CD	O
Diabetes	VBZ	B-PROBLEM
type	JJ	I-PROBLEM
2	CD	I-PROBLEM
.	.	O

4.	CD	O
Anemia	NNP	B-PROBLEM
,	,	O
transfusion	NN	B-PROBLEM
dependent	NN	I-PROBLEM
every	DT	O
three	CD	O
months	NNS	O
.	.	O

Hct	$	B-TEST
28	CD	O
b/l	NN	O

5.	CD	O
Polymyalgia	NNP	B-PROBLEM
rheumatica	NN	I-PROBLEM
.	.	O

6.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

7.	CD	O
Hypothyroidism	NNP	B-PROBLEM
.	.	O

8.	CD	O
Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
b/l	JJ	I-TEST
creatinine	NN	I-TEST
of	IN	O
1.4	CD	O
.	.	O

9.	CD	O
History	NNP	O
of	IN	O
syncope	NN	B-PROBLEM
and	CC	O
first	JJ	B-PROBLEM
degree	JJ	I-PROBLEM
A-V	NNP	I-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

10.	CD	O
History	NN	O
of	IN	O
lower	JJR	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	O
2009-06-05	JJ	O
.	.	O

11.	CD	O
spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

12.	CD	O
Pacemaker	NNP	B-TREATMENT
-	:	O
DDD	NNP	B-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
rate	NN	I-TREATMENT
response	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
2011-08-22	JJ	O
for	IN	O
symptomatic	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM

T	$	B-TEST
96.0	CD	O
BP	NNP	B-TEST
177/61	CD	O
P	NNP	B-TEST
70	CD	O
R	NNP	B-TEST
18	CD	O
O2	NNP	B-TEST
97	CD	O
on	IN	O
RA	NNP	O

Gen	NNP	O
-	:	O
somnolent	NN	B-PROBLEM
,	,	O
confused	VBD	B-PROBLEM

Cor	NNP	O
-	:	O
rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

Abd	NNP	O
-	:	O
s/nt/nd	NN	B-PROBLEM
+BS	NN	O

Ext	NNP	O
-	:	O
2	CD	O
+	JJ	O
edema	NN	B-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
,	,	O
warm	JJ	O
2	CD	O
+	JJ	O
pulses	NNS	B-TEST
,	,	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
R	NNP	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
R	NNP	I-PROBLEM
hip	NN	I-PROBLEM

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
GLUCOSE	NNP	B-TEST
-	:	O
188	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
48	CD	O
*	NN	O
CREAT	NNP	B-TEST
-	:	O
1.3	CD	O
*	JJ	O
SODIUM	NNP	B-TEST
-	:	O
138	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
4.0	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
106	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
21	CD	O
*	JJ	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
15	CD	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
CK(CPK)	NNP	B-TEST
-	:	O
32	CD	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
CK-MB	NNP	B-TEST
-	:	O
NotDone	NN	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
WBC	NNP	B-TEST
-	:	O
14.9	CD	O
*#	NN	O
RBC	NNP	B-TEST
-	:	O
2.91	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
8.5	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
24.7	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
85	CD	O
MCH	NNP	B-TEST
-	:	O
29.3	CD	O
MCHC	NNP	B-TEST
-	:	O
34.5	CD	O
RDW	NNP	B-TEST
-	:	O
14.6	CD	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
NEUTS	NNP	B-TEST
-	:	O
87.9	CD	O
*	NN	O
BANDS	NNP	B-TEST
-	:	O
0	CD	O
LYMPHS	NNP	B-TEST
-	:	O
6.3	CD	O
*	JJ	O
MONOS	NNP	B-TEST
-	:	O
5.7	CD	O
EOS	NNP	B-TEST
-	:	O
0.1	CD	O
BASOS	NNP	B-TEST
-	:	O
0	CD	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
HYPOCHROM	NNP	B-TEST
-	:	O
1	CD	O
+	NN	O
ANISOCYT	NNP	B-TEST
-	:	O
NORMAL	NNP	O
POIKILOCY	NNP	B-TEST
-	:	O
NORMAL	NNP	O
MACROCYT	NNP	B-TEST
-	:	O
NORMAL	NNP	O
MICROCYT	NNP	B-TEST
-	:	O
NORMAL	NN	O
POLYCHROM	NNP	B-TEST
-	:	O
NORMAL	NN	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
PLT	NNP	B-TEST
SMR	NNP	I-TEST
-	:	O
NORMAL	NNP	O
PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
216	CD	O

2013-05-18	JJ	O
06:00	CD	O
PM	NNP	O
PT	NNP	B-TEST
-	:	O
13.3	CD	O
PTT	NNP	B-TEST
-	:	O
26.4	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.2	CD	O
EKG	NNP	B-TEST
-	:	O
NSR	NN	O
64	CD	O
,	,	O
1st	CD	B-PROBLEM
deg	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
LAD	NNP	B-PROBLEM
,	,	O
new	JJ	B-PROBLEM
TWI	NNP	I-PROBLEM
inf/lat	NN	I-PROBLEM
leads	VBZ	I-PROBLEM
,	,	O
new	JJ	B-PROBLEM
ST	NNP	I-PROBLEM
depressions	NNS	I-PROBLEM
V4-6	NNP	I-PROBLEM

Echo	NNP	B-TEST
02-09	NN	O

1.	CD	O
The	DT	O
left	NN	O
atrium	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

The	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
elongated	VBN	B-PROBLEM
.	.	O

2.	CD	O
The	DT	B-TEST
left	NN	I-TEST
ventricular	NN	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
regional	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

Overall	JJ	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

Resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
inferolateral	JJ	B-PROBLEM
,	,	I-PROBLEM
inferior	JJ	I-PROBLEM
and	CC	I-PROBLEM
mid	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

3.	CD	O
Right	NNP	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

Right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

4.	CD	O
The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

No	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
present	NN	O
.	.	O

5.	CD	O
The	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

Moderate	NNP	B-PROBLEM
(	(	I-PROBLEM
2	CD	I-PROBLEM
+)	RB	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

6.	CD	O
There	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

7.	CD	O
There	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Compared	VBN	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
tape	NN	O
reviewed	VBN	O
)	)	O
of	IN	O
2009-06-05	JJ	O
,	,	O
the	DT	B-TEST
LV	NNP	I-TEST
function	NN	I-TEST
has	VBZ	O
improved	VBN	O
with	IN	O
an	DT	O
improvementt	NN	O
in	IN	O
function	NN	O
of	IN	O
the	DT	O
apex	NN	O
,	,	O
septal	JJ	O
and	CC	O
anterior	JJ	O
walls	NNS	O
.	.	O

New	NNP	B-PROBLEM
inferior	JJ	I-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
with	IN	O
more	RBR	B-PROBLEM
severe	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
present	NN	O
.	.	O

Cath	NN	B-TEST
2001	CD	O

1.	CD	O
Coronary	JJ	B-TEST
angiography	NN	I-TEST
demonstrated	VBD	O
single	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
a	DT	I-PROBLEM
right	JJ	I-PROBLEM
dominant	NN	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

The	DT	O
LAD	NNP	O
had	VBD	O
serial	JJ	B-PROBLEM
90%	CD	I-PROBLEM
lesions	NNS	I-PROBLEM
proximally	RB	I-PROBLEM
,	,	O
involving	VBG	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
first	JJ	O
diagonal	NN	O
,	,	O
which	WDT	O
was	VBD	O
occluded	VBN	B-PROBLEM
and	CC	O
filled	VBN	O
via	IN	O
left	NN	O
to	TO	O
left	JJ	O
collaterals	NNS	O
.	.	O

The	DT	O
mid-distal	JJ	O
LAD	NNP	O
was	VBD	O
underfilled	VBN	B-PROBLEM
initially	RB	O
but	CC	O
was	VBD	O
without	IN	O
obstructive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
non-dominant	JJ	O
circumflex	NN	O
system	NN	O
had	VBD	O
no	DT	O
hemodynamically	RB	B-PROBLEM
significant	JJ	I-PROBLEM
stenoses	NNS	I-PROBLEM
.	.	O

The	DT	O
dominant	JJ	O
RCA	NNP	O
was	VBD	O
a	DT	O
large	JJ	O
vessel	NN	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
Resting	VBG	B-TEST
hemodynamics	NNS	I-TEST
revealed	VBD	O
elevated	VBN	B-PROBLEM
right	RB	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
sided	VBN	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
with	IN	O
a	DT	B-TEST
mean	JJ	I-TEST
RA	NNP	I-TEST
pressure	NN	I-TEST
of	IN	O
12	CD	O
mm	NNS	O
Hg	NNP	O
and	CC	O
a	DT	B-TEST
mean	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
24	CD	O
mm	NN	O
Hg	NNP	O
.	.	O

Moderate	NNP	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
present	JJ	O
with	IN	O
a	DT	B-TEST
PA	NNP	I-TEST
of	IN	O
52/28	CD	O
.	.	O

The	DT	B-TEST
cardiac	JJ	I-TEST
index	NN	I-TEST
was	VBD	O
preserved	VBN	O
at	IN	O
3.0	CD	O
L	NNP	O
/	NNP	O
min	NNP	O
/	NNP	O
m2	NN	O
.	.	O

3.	CD	O
Left	NNP	B-TEST
ventriculography	NN	I-TEST
was	VBD	O
not	RB	O
performed	VBN	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
moderate	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
(	(	O
creatinine	JJ	B-TEST
1.6	CD	O
).	NN	O

4.	CD	O
Successful	JJ	B-TREATMENT
PTCA	NNP	I-TREATMENT
and	CC	O
stenting	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
LAD	NNP	I-TREATMENT
with	IN	O
overlapping	VBG	B-TREATMENT
2.25	CD	I-TREATMENT
x	JJ	I-TREATMENT
13	CD	I-TREATMENT
mm	NN	I-TREATMENT
and	CC	I-TREATMENT
2.25	CD	I-TREATMENT
x	NNS	I-TREATMENT
18	CD	I-TREATMENT
mm	NNS	I-TREATMENT
Hepacoat	NNP	I-TREATMENT
stents	NNS	I-TREATMENT
with	IN	O
no	DT	O
residual	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
or	CC	O
dissection	NN	B-PROBLEM
and	CC	O
normal	JJ	O
flow	NN	O
(	(	O
see	VB	O
PTCA	NNP	B-TREATMENT
comments	NNS	O
).	VB	O

1.	CD	O
One	CD	B-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
Moderately	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
sided	VBN	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
.	.	O

3.	CD	O
Successful	JJ	B-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
LAD	NNP	I-TREATMENT
.	.	O

COMPLETE	JJ	B-TEST
BLOOD	NNP	I-TEST
COUNT	NNP	I-TEST
WBC	NNP	B-TEST
RBC	NNP	B-TEST
Hgb	NNP	B-TEST
Hct	NNP	B-TEST
MCV	NNP	B-TEST
MCH	NNP	B-TEST
MCHC	NNP	B-TEST
RDW	NNP	B-TEST
Plt	NNP	B-TEST
Ct	NNP	I-TEST

DIFFERENTIAL	NNP	B-TEST
Neuts	NNP	B-TEST
Bands	NNP	B-TEST
Lymphs	NNP	B-TEST
Monos	NNP	B-TEST
Eos	NNP	B-TEST
Baso	NNP	B-TEST
Atyps	NNP	B-TEST
Metas	NNP	B-TEST

RED	JJ	B-TEST
CELL	NNP	I-TEST
MORPHOLOGY	NNP	I-TEST
Hypochr	NNP	B-TEST
Anisocy	NNP	B-TEST
Poiklo	NNP	B-TEST
Macrocy	NNP	B-TEST
Microcy	NNP	B-TEST
Polychr	NNP	B-TEST

BASIC	NNP	B-TEST
COAGULATION	NNP	I-TEST
(	(	O
PT	NNP	B-TEST
,	,	O
PTT	NNP	B-TEST
,	,	O
PLT	NNP	B-TEST
,	,	O
INR	NNP	B-TEST
)	)	O
PT	NNP	B-TEST
PTT	NNP	B-TEST
Plt	NNP	B-TEST
Smr	NNP	I-TEST
Plt	NNP	B-TEST
Ct	NNP	I-TEST
INR(PT)	NNP	B-TEST
LPlt	NNP	B-TEST

Chemistry	NN	B-TEST

RENAL	NNP	O
&	CC	O
GLUCOSE	NNP	O
Glucose	NNP	B-TEST
UreaN	NNP	B-TEST
Creat	NNP	B-TEST
Na	NNP	B-TEST
K	NNP	B-TEST
Cl	NNP	B-TEST
HCO3	NNP	B-TEST
AnGap	NNP	B-TEST

ENZYMES	NNP	B-TEST
&	CC	O
BILIRUBIN	NNP	B-TEST
ALT	NNP	B-TEST
AST	NNP	B-TEST
LD(LDH)	NNP	B-TEST
CK(CPK)	NNP	B-TEST
AlkPhos	NNP	B-TEST
Amylase	NNP	B-TEST
TotBili	NNP	B-TEST
DirBili	NNP	B-TEST

OTHER	NNP	B-TEST
ENZYMES	NNP	I-TEST
&	CC	O
BILIRUBINS	NNP	B-TEST
Lipase	NNP	B-TEST

CPK	NNP	B-TEST
ISOENZYMES	NNP	B-TEST
CK-MB	NNP	B-TEST
MB	NNP	B-TEST
Indx	NNP	I-TEST
cTropnT	NN	B-TEST

1	CD	O
CTROPNT	NNP	B-TEST
>	VBD	O
0.10	CD	O
NG/ML	NNP	O
SUGGESTS	NNP	O
ACUTE	NNP	B-PROBLEM
MI	NNP	I-PROBLEM

CHEMISTRY	NNP	B-TEST
TotProt	NNP	B-TEST
Albumin	NNP	B-TEST
Globuln	NNP	B-TEST
Calcium	NNP	B-TEST
Phos	NNP	B-TEST
Mg	NNP	B-TEST
UricAcd	NNP	B-TEST
Iron	NNP	B-TEST
Cholest	NNP	B-TEST

LIPID	NNP	B-TEST
/	NNP	O
CHOLESTEROL	NNP	B-TEST
Triglyc	NNP	B-TEST
HDL	NNP	B-TEST
CHOL/HD	NNP	B-TEST
LDLcalc	NNP	B-TEST

2013-05-19	JJ	O
09:20	CD	O
AM	NNP	O
1603	CD	O
-	:	O
5419	CD	O
LDL(CALC)	NNP	B-TEST
INVALID	NNP	O
IF	NNP	O
TRIG	NNP	B-TEST
>	VBZ	O
400	CD	O
OR	NNP	O
NON-FASTING	JJ	O
SAMPLE	NNP	O
LAB	NNP	O
USE	NNP	O
ONLY	NNP	O
GreenHd	NNP	O

Blood	NNP	B-TEST
Gas	NNP	I-TEST

BLOOD	NNP	B-TEST
GASES	NNP	I-TEST
Type	NNP	B-TEST
Temp	NNP	B-TEST
Rates	NNP	B-TEST
Tidal	NNP	B-TEST
V	NNP	I-TEST
PEEP	NNP	B-TEST
FiO2	NNP	B-TEST
O2	NNP	B-TEST
Flow	NNP	B-TEST
pO2	NN	B-TEST
pCO2	NN	B-TEST
pH	NN	B-TEST
calHCO3	NN	B-TEST
Base	NNP	B-TEST
XS	NNP	I-TEST
AADO2	NNP	B-TEST
REQ	NNP	B-TREATMENT
O2	NNP	I-TREATMENT
Intubat	NNP	B-TREATMENT
Vent	NNP	B-TREATMENT

2013-05-24	JJ	O
07:58	CD	O
AM	NNP	O
ART	NNP	B-TEST
102	CD	O
36	CD	O
7.26	CD	O
*	JJ	O
17	CD	O
*	NN	O
-9	NN	O

2013-05-24	JJ	O
04:31	CD	O
AM	NNP	O
ART	NNP	B-TEST
36.4	CD	O
16	CD	O
/	JJ	O
662-15484	JJ	O
*	NN	O
7.26	CD	O
*	NN	O
16	CD	O
*	NN	O
-10	NN	O

ASSIST	NNP	O
/	NNP	O
CON1	NNP	O
INTUBATED	NNP	B-TREATMENT

WHOLE	NNP	O
BLOOD	NNP	O
,	,	O
MISCELLANEOUS	NNP	B-TEST
CHEMISTRY	NNP	I-TEST
Glucose	NNP	B-TEST
Lactate	NNP	B-TEST
Na	NNP	B-TEST
K	NNP	B-TEST
Cl	NNP	B-TEST
calHCO3	NN	B-TEST

HEMOGLOBLIN	NNP	B-TEST
FRACTIONS	NNP	I-TEST
(	(	O
COOXIMETRY	NNP	B-TEST
)	)	O
Hgb	NNP	B-TEST
calcHCT	NN	B-TEST
O2	NNP	B-TEST
Sat	NNP	I-TEST
COHgb	NNP	B-TEST
MetHgb	NNP	B-TEST

CALCIUM	NNP	B-TEST
freeCa	NN	B-TEST

CT	NNP	B-TEST
ABDOMEN	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST
2013-05-23	JJ	O
5:46	CD	O
PM	NN	O

CT	NNP	B-TEST
ABDOMEN	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST
;	:	O
CT	NNP	B-TEST
PELVIS	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

Reason	NN	O
:	:	O
Please	NNP	O
eval	NN	O
for	IN	O
perf	NN	B-PROBLEM
/	NNP	I-PROBLEM
ischemic	JJ	I-PROBLEM
bowel	NN	I-PROBLEM

92	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
MS	NNP	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
hypotension	NN	B-PROBLEM
and	CC	O
bloody	JJ	B-PROBLEM
lavage	NN	I-PROBLEM
on	IN	O
Lovenox+ASA	NNP	B-TREATMENT

Please	NNP	O
eval	NN	O
for	IN	O
perf	NN	B-PROBLEM
/	NNP	I-PROBLEM
ischemic	JJ	I-PROBLEM
bowel	NN	I-PROBLEM

CONTRAINDICATIONS	NNP	O
for	IN	O
IV	NNP	B-TEST
CONTRAST	NNP	I-TEST
:	:	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM

INDICATION	NN	O
:	:	O
94-year-old	JJ	O
woman	NN	O
with	IN	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
now	RB	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

TECHNIQUE	NN	O
:	:	O
A	DT	O
multidetector	NN	O
scanner	NN	O
was	VBD	O
used	VBN	O
to	TO	O
obtain	VB	O
contiguous	JJ	B-TEST
axial	JJ	I-TEST
images	NNS	I-TEST
from	IN	O
the	DT	O
lung	NN	O
bases	VBZ	O
to	TO	O
the	DT	O
pubic	JJ	O
symphysis	NN	O
.	.	O

Neither	DT	O
IV	NNP	B-TEST
nor	CC	I-TEST
oral	JJ	I-TEST
contrast	NN	I-TEST
were	VBD	O
used	VBN	O
.	.	O

CT	NNP	B-TEST
OF	IN	I-TEST
THE	NNP	I-TEST
ABDOMEN	NNP	I-TEST
WITHOUT	NNP	I-TEST
IV	NNP	I-TEST
CONTRAST	NN	I-TEST
:	:	O
There	EX	O
are	VBP	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
the	DT	O
left	NN	O
;	:	O
there	EX	O
is	VBZ	O
compressive	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

There	EX	O
are	VBP	O
coronary	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
calcifications	NNS	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
coiling	VBG	O
in	IN	O
the	DT	O
stomach	NN	O
.	.	O

A	DT	B-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
with	IN	O
leads	NNS	O
terminating	VBG	O
in	IN	O
the	DT	O
right	JJ	O
atrium	NN	O
and	CC	O
right	JJ	O
ventricle	NN	O
.	.	O

Nasogastric	NNP	B-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
coiling	VBG	O
in	IN	O
the	DT	O
stomach	NN	O
,	,	O
with	IN	O
its	PRP$	O
tip	NN	O
at	IN	O
the	DT	O
pylorus	NN	O
.	.	O

Allowing	VBG	O
for	IN	O
the	DT	O
limitations	NNS	O
of	IN	O
this	DT	B-TEST
noncontrast	NN	I-TEST
study	NN	I-TEST
,	,	O
the	DT	O
liver	NN	O
,	,	O
pancreas	NNS	O
,	,	O
adrenals	NNS	O
,	,	O
stomach	NN	O
are	VBP	O
unremarkable	JJ	O
.	.	O

A	DT	B-PROBLEM
1.8	CD	I-PROBLEM
cm	NN	I-PROBLEM
exophytic	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

A	DT	B-PROBLEM
similar	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
measuring	VBG	O
2.2	CD	O
cm	NN	O
.	.	O

The	DT	O
aorta	NN	O
is	VBZ	O
normal	JJ	O
in	IN	O
caliber	NN	O
,	,	O
with	IN	O
vascular	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
tracking	VBG	O
around	IN	O
the	DT	O
liver	NN	O
,	,	O
right	JJ	O
pericolic	NN	O
gutter	NN	O
,	,	O
along	IN	O
the	DT	O
mesentery	NN	O
and	CC	O
surrounding	VBG	O
the	DT	O
right	NN	O
colon	NN	O
,	,	O
which	WDT	O
is	VBZ	O
collapsed	VBN	O
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
nondependent	JJ	I-PROBLEM
free	JJ	I-PROBLEM
air	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
anterior	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
abdomen	NNS	O
.	.	O

The	DT	O
remainder	NN	O
of	IN	O
the	DT	O
bowel	NN	O
loops	NNS	O
are	VBP	O
fluid	JJ	O
filled	VBN	O
,	,	O
and	CC	O
nondilated	VBD	B-PROBLEM
.	.	O

CT	NNP	B-TEST
OF	IN	I-TEST
THE	NNP	I-TEST
PELVIS	NNP	I-TEST
WITHOUT	NNP	I-TEST
IV	NNP	I-TEST
CONTRAST	NNP	I-TEST
:	:	O
As	IN	O
previously	RB	O
noted	VBN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
surrounding	VBG	O
the	DT	O
right	NN	O
colon	NN	O
,	,	O
tracking	VBG	O
along	IN	O
the	DT	O
mesentery	NN	O
and	CC	O
into	IN	O
the	DT	O
pelvis	NN	O
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
air	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
nondependent	JJ	O
portion	NN	O
of	IN	O
the	DT	O
pelvis	NN	O
.	.	O

Vascular	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
in	IN	O
the	DT	O
abdominal	JJ	O
aorta	NN	O
and	CC	O
iliac	JJ	O
arteries	NNS	O
.	.	O

Subcutaneous	JJ	B-PROBLEM
edema	NN	I-PROBLEM
is	VBZ	O
noted	VBN	O
in	IN	O
the	DT	O
lower	JJR	O
abdomen	NNS	O
and	CC	O
pelvis	NN	O
.	.	O

A	DT	B-TREATMENT
catheter	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
entering	VBG	O
the	DT	O
left	JJ	O
inguinal	JJ	O
region	NN	O
and	CC	O
coursing	NN	O
along	IN	O
the	DT	O
iliac	NN	O
vessels	NNS	O
,	,	O
terminating	VBG	O
in	IN	O
the	DT	O
left	NN	O
pelvis	NN	O
.	.	O

Osseous	JJ	O
structures	NNS	O
are	VBP	O
remarkable	JJ	O
for	IN	O
degenerative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spine	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	NN	I-PROBLEM
humerus	NN	I-PROBLEM
,	,	O
with	IN	O
orthopedic	JJ	B-TREATMENT
hardware	NN	I-TREATMENT
causing	VBG	O
beam	NN	B-PROBLEM
hardening	VBG	I-PROBLEM
artifact	NN	I-PROBLEM
.	.	O

1.	CD	O
A	NNP	O
small	JJ	O
amount	NN	O
of	IN	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pelvis	NN	I-PROBLEM
and	CC	I-PROBLEM
abdomen	NNS	I-PROBLEM
,	,	O
mostly	RB	O
along	IN	O
the	DT	O
right	JJ	O
pericolic	NN	O
gutter	NN	O
and	CC	O
surrounding	VBG	O
the	DT	O
ascending	VBG	O
colon	NN	O
,	,	O
concerning	VBG	O
for	IN	O
perforation	NN	B-PROBLEM
.	.	O

Other	JJ	O
bowel	NN	O
loops	NNS	O
are	VBP	O
unremarkable	JJ	O
on	IN	O
this	DT	B-TEST
limited	JJ	I-TEST
study	NN	I-TEST
.	.	O

2.	CD	O
Bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	VBD	O
,	,	O
with	IN	O
left-sided	JJ	B-PROBLEM
compressive	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

3.	CD	O
Right	NNP	B-PROBLEM
proximal	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
status	NN	O
post	NN	O
fixation	NN	B-TREATMENT
.	.	O

The	DT	B-TEST
study	NN	I-TEST
and	CC	O
the	DT	O
report	NN	O
were	VBD	O
reviewed	VBN	O
by	IN	O
the	DT	O
staff	NN	O
radiologist	NN	O
.	.	O

95	CD	O
yo	NNS	O
F	NNP	O
with	IN	O
MMP	NNP	B-PROBLEM
who	WP	O
sustained	VBD	O
a	DT	B-PROBLEM
mechanical	JJ	I-PROBLEM
fall	NN	I-PROBLEM
down	RP	O
stairs	NNS	O
resulting	VBG	O
in	IN	O
a	DT	B-PROBLEM
hip	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

1)	CD	O
s/p	JJ	O
Fall	NNP	B-PROBLEM
-	:	O
unlikely	JJ	O
to	TO	O
be	VB	O
mechanical	JJ	O
in	IN	O
nature	NN	O
.	.	O

Patient	NN	O
has	VBZ	O
injuries	NNS	B-PROBLEM
to	TO	I-PROBLEM
her	PRP$	I-PROBLEM
shoulder	NN	I-PROBLEM
and	CC	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

2)	CD	O
CV	NNP	O
-	:	O
Patient	NN	O
has	VBZ	O
CAD	NNP	B-PROBLEM
and	CC	O
CHF	NNP	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hct	NN	I-PROBLEM
and	CC	O
major	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

She	PRP	O
also	RB	O
has	VBZ	O
new	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
on	IN	I-PROBLEM
EKG	NNP	I-PROBLEM
.	.	O

On	IN	O
pressor	NN	B-TREATMENT
to	TO	O
hold	VB	O
mean	JJ	O
60	CD	O
.	.	O

3)	CD	O
Anemia	NNP	B-PROBLEM
-	:	O
patient	NN	O
transfusion	NN	B-PROBLEM
dependant	NN	I-PROBLEM
with	IN	O
a	DT	O
baseline	NN	O
of	IN	O
28	CD	O
.	.	O

-	:	O
transfuse	NN	O
2	CD	O
units	NNS	O
today	NN	O
,	,	O
with	IN	O
lasix	NN	B-TREATMENT

4)	CD	O
GERD	NNP	B-PROBLEM
-	:	O
PPI	NN	B-TREATMENT

5)	CD	O
DM	NNP	B-PROBLEM
-	:	O
glipizide	NN	B-TREATMENT
,	,	O
ISS	NNP	B-TREATMENT

6)	CD	O
PMR	NNP	B-PROBLEM
-	:	O
cont	NN	O
prednisone	NN	B-TREATMENT

7)	CD	O
GI	NN	O
:	:	O
Ms.	NNP	O
Pimental	NNP	O
is	VBZ	O
an	DT	O
unfortunate	JJ	O
95	CD	O
year	NN	O
old	JJ	O
woman	NN	O
,	,	O
status	NN	O
post	NN	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
fall	NN	I-PROBLEM
necessitating	VBG	O
right	JJ	B-TREATMENT
ORIF	NNP	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
hip	NN	I-TREATMENT
and	CC	O
right	JJ	B-PROBLEM
wrist	NN	I-PROBLEM
fracture	NN	I-PROBLEM
ORIF	NNP	B-TREATMENT
,	,	O
who	WP	O
was	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
this	DT	O
event	NN	O
,	,	O
when	WRB	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
she	PRP	O
had	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
distention	NN	B-PROBLEM
and	CC	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
with	IN	O
worsening	VBG	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

CT	NNP	B-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
this	DT	O
revealed	VBD	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	O
massive	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

Pt	NNP	O
underwent	JJ	O
surgery	NN	B-TREATMENT
on	IN	O
05-23	NN	O

1.	CD	O
Exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
with	IN	O
drainage	NN	B-TREATMENT
of	IN	O
intra-abdominal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
peritonitis	NN	B-PROBLEM
with	IN	O
gross	JJ	B-PROBLEM
soilage	NN	I-PROBLEM
with	IN	I-PROBLEM
bile	NN	I-PROBLEM
and	CC	I-PROBLEM
gastric	JJ	I-PROBLEM
contents	NNS	I-PROBLEM
.	.	O

2.	CD	O
Exposure	NN	B-TREATMENT
and	CC	O
wide	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
of	IN	O
perforated	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
duodenal	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
internal	JJ	B-TREATMENT
and	CC	I-TREATMENT
external	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

3.	CD	O
Feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

4.	CD	O
Tube	NNP	B-TREATMENT
gastrostomy	NN	I-TREATMENT
.	.	O

Continue	NNP	O
to	TO	O
deteriorate	VB	O
spiking	VBG	B-PROBLEM
fevers	NNS	I-PROBLEM
with	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
on	IN	O
pressors	NNS	B-TREATMENT
to	TO	O
hold	VB	O
the	DT	B-TEST
bp.	NN	I-TEST
with	IN	O
no	DT	O
improvement	NN	O
in	IN	O
mental	JJ	O
staus	NN	O
was	VBD	O
made	VBN	O
CMO	NNP	O
5/20/5	CD	O
.	.	O

lasix	NN	B-TREATMENT
alt	VBD	O
40	CD	O
mg	NN	O
and	CC	O
20	CD	O
mg	NNS	O
qday	JJ	O

levothyrox	RB	B-TREATMENT
50	CD	O
mcg	NNS	O
qday	JJ	O

lisinopril	RB	B-TREATMENT
5	CD	O
mg	NNS	O
qday	JJ	O

famotidine	NN	B-TREATMENT
20	CD	O
mg	NN	O
qday	NN	O

fe	NN	B-TREATMENT
so4	VBZ	I-TREATMENT
325	CD	O
mg	NN	O
qday	NN	O

asa	RB	B-TREATMENT
325	CD	O
mg	NNS	O
qday	JJ	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
25	CD	O
mg	NN	O
qday	NN	O

glipizide	RB	B-TREATMENT
5	CD	O
mg	NNS	O
qday	JJ	O

imdur	NN	B-TREATMENT
60	CD	O
mg	NN	O
qdau	NN	O

prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
qday	NN	O

tylenol	NN	B-TREATMENT

Expired	VBD	B-PROBLEM

MULTIORGAN	NNP	B-PROBLEM
FAILURE	NNP	I-PROBLEM

DUODENAL	NNP	B-PROBLEM
PERFORATION	NNP	I-PROBLEM

MULTIPLE	NNP	B-PROBLEM
TRAUMA	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
originally	RB	O
for	IN	O
airway	RB	B-TEST
monitoring	NN	I-TEST
status	NN	O
post	NN	O
endoscopic	NN	O
retrograde	NN	O

cholangiopancreatography	NN	B-TEST
with	IN	O
adverse	JJ	B-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
Fentanyl	NNP	B-TREATMENT
and	CC	O
tongue	JJ	B-PROBLEM
injury	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
59	JJ	O
year-old	JJ	O
female	NN	O
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
done	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
possible	JJ	O
bile	NN	B-PROBLEM
leak	NN	I-PROBLEM
after	IN	O
cholecystectomy	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
four	CD	O
days	NNS	O
ago	RB	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
.	.	O

Her	PRP$	O
postop	JJ	O
course	NN	O
was	VBD	O
uneventful	JJ	O
until	IN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
developed	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
she	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
outside	JJ	O
hospital	NN	O
Emergency	NNP	O
Room	NNP	O
where	WRB	O
an	DT	B-TEST
abdominal	JJ	I-TEST
CT	NNP	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
"	NNP	O
thickened	VBD	B-PROBLEM
stomach	NN	I-PROBLEM
and	CC	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
."	NNS	O

She	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
New	NNP	O
England	NNP	O
Sinai	NNP	O
Hospital	NNP	O
&	CC	O
Rehab	NNP	O
Center	NNP	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
possible	JJ	O
stent	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
successful	JJ	I-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	I-PROBLEM
Luschka	NNP	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
successfully	RB	O
.	.	O

After	IN	O
her	PRP$	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	VBD	I-TEST
the	DT	O
patient	NN	O
developed	VBD	O
"	NNP	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
,	,	O
biting	VBG	B-PROBLEM
tongue	NN	I-PROBLEM
,	,	O
rigidity	NN	B-PROBLEM
and	CC	O
cold	JJ	B-PROBLEM
/	NN	I-PROBLEM
chills	NNS	I-PROBLEM
."	VBP	O

The	DT	O
patient	NN	O
received	VBD	O
ampicillin	RB	B-TREATMENT
,	,	O
Gentamycin	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
empirically	RB	O
as	RB	O
well	RB	O
as	IN	O
Narcan	NNP	B-TREATMENT
to	TO	O
reverse	VB	O
fentanyl	NN	B-TREATMENT
.	.	O

Because	IN	O
of	IN	O
the	DT	B-PROBLEM
tongue	JJ	I-PROBLEM
injury	NN	I-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
possible	JJ	O
infection	NN	B-PROBLEM
given	VBN	O
her	PRP$	B-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
chills	VBZ	B-PROBLEM
the	DT	O
GI	NNP	O
Service	NNP	O
transferred	VBD	O
the	DT	O
patient	NN	O
to	TO	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
for	IN	O
close	JJ	O
observation	NN	O
.	.	O

1.	CD	O
Hiatal	NNP	B-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

2.	CD	O
Status	NNP	O
post	NN	O
cholecystectomy	VB	B-TREATMENT
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

3.	CD	O
Urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
.	.	O

4.	CD	O
Mitral	NNP	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

5.	CD	O
Tubal	NNP	B-TREATMENT
ligation	NN	I-TREATMENT
many	JJ	O
years	NNS	O
ago	RB	O
.	.	O

1.	CD	O
Prempro	NNP	B-TREATMENT
.	.	O

2.	CD	O
CMED	NNP	B-TREATMENT
CCU	NNP	I-TREATMENT
drops	NNS	I-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
however	RB	O
,	,	O
it	PRP	O
is	VBZ	O
assumed	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
rigidity	NN	I-PROBLEM
and	CC	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
Fentanyl	NNP	B-TREATMENT
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
temperature	NN	B-TEST
100.6	CD	O
.	.	O

Heart	NNP	B-TEST
rate	NN	I-TEST
105	CD	O
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
162/76	CD	O
.	.	O

Respiratory	JJ	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

Sating	VBG	B-TEST
98%	CD	O
on	IN	O
3	CD	O
liters	NNS	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
groggy	JJ	B-PROBLEM
status	NN	O
post	NN	O
anesthesia	NN	B-TREATMENT
,	,	O
shivering	NN	B-PROBLEM
,	,	O
but	CC	O
awake	VBP	O
.	.	O

HEENT	NNP	O
showed	VBD	O
tongue	NN	O
with	IN	O
laceration	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
edge	NN	I-PROBLEM
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

No	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Abdomen	NNP	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

There	EX	O
were	VBD	O
post	NN	B-PROBLEM
laparoscopic	NN	I-PROBLEM
incisions	NNS	I-PROBLEM
without	IN	O
erythema	NN	B-PROBLEM
with	IN	O
Steri-Strips	NNP	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

The	DT	O
extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

Dorsalis	NNP	B-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
intact	JJ	O
bilaterally	RB	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
rashes	NNS	B-PROBLEM
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
9.0	CD	O
,	,	O
hematocrit	NN	B-TEST
39.3	CD	O
,	,	O
platelets	NNS	B-TEST
296	CD	O
,	,	O
neutrophil	RB	B-TEST
count	NN	I-TEST
82	CD	O
,	,	O
lymphocytes	VBZ	B-TEST
14	CD	O
,	,	O
4	CD	O
monocytes	NNS	B-TEST
,	,	O
troponin	NN	B-TEST
was	VBD	O
less	JJR	O
then	RB	O
0.3	CD	O
.	.	O

Sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
bicarb	NN	B-TEST
26	CD	O
,	,	O
BUN	NNP	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
141	CD	O
,	,	O
albumin	RB	B-TEST
4.1	CD	O
,	,	O
calcium	NN	B-TEST
8.9	CD	O
,	,	O
LDH	NNP	B-TEST
665	CD	O
,	,	O
AST	NNP	B-TEST
44	CD	O
,	,	O
ALT	NNP	B-TEST
of	IN	O
57	CD	O
,	,	O
amylase	NN	B-TEST
41	CD	O
,	,	O
CK	NNP	B-TEST
32	CD	O
.	.	O

Electrocardiogram	NNP	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
73	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
ST	NNP	B-PROBLEM
or	CC	I-PROBLEM
T	NNP	I-PROBLEM
wave	VBP	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

Abdominal	NNP	B-TEST
CT	NNP	I-TEST
showed	VBD	O
inflammation	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
,	,	O
small	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
circumferential	JJ	I-PROBLEM
thickening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
a	DT	O
tiny	JJ	O
amount	NN	O
of	IN	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
.	.	O

In	IN	O
summary	JJ	O
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
59	JJ	O
year-old	JJ	O
female	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
Quincy	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
for	IN	O
possible	JJ	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
cholecystectomy	VB	B-TREATMENT
performed	JJ	O
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

She	PRP	O
then	RB	O
suffered	VBD	O
rigidity	NN	B-PROBLEM
with	IN	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
and	CC	O
tongue	NN	B-PROBLEM
biting	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
Fentanyl	NNP	B-TREATMENT
administration	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
for	IN	O
close	JJ	O
observation	NN	O
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Ampicillin	NNP	B-TREATMENT
,	,	O
Gentamycin	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
and	CC	O
amylase	NN	B-TEST
and	CC	O
lipase	NN	B-TEST
were	VBD	O
followed	VBN	O
closely	RB	O
.	.	O

As	IN	O
stated	VBN	O
the	DT	O
patient	NN	O
was	VBD	O
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrograde	VBD	I-TEST
cholangiopancreatography	NN	I-TEST
with	IN	O
stent	NN	O

placement	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	I-PROBLEM
Luschka	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
Ampicillin	NNP	B-TREATMENT
,	,	O
Gentamycin	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
started	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
.	.	O

She	PRP	O
had	VBD	O
waxing	VBG	B-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
fevers	NNS	I-PROBLEM
.	.	O

However	RB	O
,	,	O
her	PRP	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
never	RB	O
really	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
and	CC	O
she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	B-PROBLEM
bandemia	NN	I-PROBLEM
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
General	NNP	O
Medical	NNP	O
Floor	NNP	O
the	DT	O
patient	NN	O
had	VBD	O
received	VBN	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
amylase	NN	I-TEST
and	CC	O
lipase	NN	B-TEST
on	IN	O
the	DT	O
day	NN	O
following	VBG	O
the	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST

were	VBD	O
elevated	VBN	B-PROBLEM
.	.	O

Amylase	NNP	B-TEST
was	VBD	O
2304	CD	O
with	IN	O
lipase	NN	B-TEST
being	VBG	O
7116	CD	O
.	.	O

Therefore	RB	O
she	PRP	O
was	VBD	O
made	VBN	O
NPO	NNP	B-TREATMENT
and	CC	O
given	VBN	O
aggressive	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

On	IN	O
the	DT	O
second	JJ	O
hospital	NN	O
day	NN	O
on	IN	O
the	DT	O
General	NNP	O
Medical	NNP	O
Floor	NNP	O
the	DT	O
patient	NN	O
had	VBD	O
marked	VBN	B-PROBLEM
rebound	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
.	.	O

She	PRP	O
was	VBD	O
followed	VBN	O
closely	RB	O
with	IN	O
serial	JJ	B-TEST
abdominal	JJ	I-TEST
examinations	NNS	I-TEST
.	.	O

Her	PRP$	B-TEST
amylase	NN	I-TEST
and	CC	O
lipase	NN	B-TEST
were	VBD	O
trending	VBG	O
down	RP	O
,	,	O
however	RB	O
.	.	O

An	DT	B-TEST
abdominal	JJ	I-TEST
CT	NNP	I-TEST
was	VBD	O
obtained	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
only	RB	O
mild	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
intra-abdominal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collections	NNS	I-PROBLEM
,	,	O
which	WDT	O
required	VBD	O
any	DT	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

On	IN	O
the	DT	O
third	JJ	O
hospital	NN	O
day	NN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
improving	VBG	O
and	CC	O
the	DT	B-PROBLEM
rebound	NN	I-PROBLEM
was	VBD	O
decreasing	VBG	O
.	.	O

Her	PRP$	B-TEST
enzymes	NNS	I-TEST
continued	VBN	O
to	TO	O
trend	NN	O
down	RP	O
.	.	O

She	PRP	O
received	VBD	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
in	IN	O
the	DT	O
evening	NN	O
and	CC	O
tolerated	VBN	O
these	DT	O
well	RB	O
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
a	DT	B-TREATMENT
BRAT	NNP	I-TREATMENT
diet	NN	I-TREATMENT
without	IN	O
significant	JJ	O
abdominal	JJ	O

pain	NN	B-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
rebound	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
temperature	NN	B-PROBLEM
spikes	VBZ	I-PROBLEM
in	IN	O
greater	JJR	O
then	RB	O
24	CD	O
hours	NNS	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
34.8	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

It	PRP	O
decreased	VBD	O
to	TO	O
30	CD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
aggressive	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
aggressively	RB	B-TREATMENT
hydrated	VBN	I-TREATMENT
given	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
NPO	NNP	B-TREATMENT
.	.	O

She	PRP	O
required	VBD	O
periodic	JJ	B-TREATMENT
repletion	NN	I-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
potassium	NN	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
bicarb	NN	I-TEST
began	VBD	O
to	TO	O
drop	VB	O
and	CC	O
she	PRP	O
developed	VBD	O
an	DT	B-PROBLEM
anion	NN	I-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
ketoacidosis	VB	B-PROBLEM
as	IN	O
she	PRP	O
had	VBD	O
no	DT	O
dextrose	NN	B-TREATMENT
in	IN	O
her	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

This	DT	O
was	VBD	O
added	VBN	O
on	IN	O
the	DT	O
evening	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
her	PRP$	B-PROBLEM
anion	NN	I-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

1.	CD	O
Levaquin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
one	CD	O
po	NN	O
q	NN	O
day	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
.	.	O

2.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
Percocet	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
po	VBP	O
q	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
prescription	NN	I-TREATMENT
for	IN	I-TREATMENT
ten	JJ	I-TREATMENT
pills	NNS	I-TREATMENT
.	.	O

4.	CD	O
Prempro	NNP	B-TREATMENT
as	IN	O
the	DT	O
patient	NN	O
was	VBD	O
formerly	RB	O
taking	VBG	O
.	.	O

5.	CD	O
Trazodone	NN	B-TREATMENT
at	IN	O
bedtime	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
to	TO	O
make	VB	O
an	DT	O
appointment	NN	O
with	IN	O
Dr.	NNP	O
Nicholson	NNP	O
within	IN	O
one	CD	O
to	TO	O
two	CD	O
months	NNS	O
after	IN	O
discharge	NN	O
for	IN	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
to	TO	O
continue	VB	O
on	IN	O
a	DT	B-TREATMENT
BRAT	NNP	I-TREATMENT
diet	NN	I-TREATMENT
over	IN	O
the	DT	O
weekend	NN	O
and	CC	O
two	CD	O
days	NNS	O
after	IN	O
discharge	NN	O
she	PRP	O
could	MD	O
advance	VB	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
no	DT	I-TREATMENT
dairy	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

1.	CD	O
Post	NNP	B-PROBLEM
endoscopic	NN	I-PROBLEM
retrograde	NN	I-PROBLEM
cholangiopancreatography	NN	I-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

2.	CD	O
Anemia	NNP	B-PROBLEM
.	.	O

3.	CD	O
Hypokalemia	NNP	B-PROBLEM
.	.	O

4.	CD	O
Anion	NNP	B-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

5.	CD	O
Bile	NNP	B-PROBLEM
leak	NN	I-PROBLEM
.	.	O

Again	RB	O
,	,	O
this	DT	O
was	VBD	O
a	DT	O
47-year-old	JJ	O
female	NN	O
admitted	VBN	O
with	IN	O
Berkitt's	NNP	B-PROBLEM
lymphoma	NN	I-PROBLEM
.	.	O

1.	CD	O
Liver	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
went	VBD	O
for	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
MRI	NNP	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
change	NN	O
in	IN	O
the	DT	B-PROBLEM
previously	RB	I-PROBLEM
noted	VBN	I-PROBLEM
enumerable	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
liver	NN	I-PROBLEM
.	.	O

A	DT	O
Hepatology	NNP	O
consult	NN	O
was	VBD	O
obtained	VBN	O
who	WP	O
felt	VBD	O
that	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
etiology	NN	O
of	IN	O
these	DT	B-PROBLEM
cysts	NNS	I-PROBLEM
were	VBD	O
from	IN	O
hepatic	JJ	B-PROBLEM
candidiasis	NN	I-PROBLEM
,	,	O
although	IN	O
one	CD	O
could	MD	O
not	RB	O
rule	VB	O
out	RP	O
lymphoma	NN	B-PROBLEM
involving	VBG	O
from	IN	O
Burkitt's	NNP	B-PROBLEM
.	.	O

She	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
AmBisome	NNP	B-TREATMENT
300	CD	O
mg	NN	O
IV	NNP	O
q.d.	NN	O
for	IN	O
treatment	NN	O
of	IN	O
her	PRP$	B-PROBLEM
hepatic	JJ	I-PROBLEM
candidiasis	NN	I-PROBLEM
.	.	O

This	DT	O
regimen	NN	O
,	,	O
that	IN	O
being	VBG	O
AmBisome	NNP	B-TREATMENT
,	,	O
was	VBD	O
recommended	VBN	O
by	IN	O
the	DT	O
Infectious	NNP	O
Disease	NNP	O
physicians	NNS	O
,	,	O
who	WP	O
felt	VBD	O
that	IN	O
AmBisome	NNP	B-TREATMENT
was	VBD	O
a	DT	O
better	JJR	O
drug	NN	O
of	IN	O
choice	NN	O
as	IN	O
compared	VBN	O
to	TO	O
fluconazole	VB	B-TREATMENT
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
platelets	NNS	I-TEST
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
,	,	O
and	CC	O
hematocrit	NNS	B-TEST
have	VBP	O
all	DT	O
been	VBN	O
stable	JJ	O
.	.	O

Her	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
remained	VBD	O
elevated	JJ	B-PROBLEM
despite	IN	O
discontinuing	VBG	O
her	PRP$	B-TREATMENT
G-CSF	NNP	I-TREATMENT
.	.	O

However	RB	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
febrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
should	MD	O
be	VB	O
continued	VBN	O
to	TO	O
be	VB	O
watched	VBN	O
.	.	O

3.	CD	O
On	IN	O
the	DT	O
morning	NN	O
of	IN	O
12-01	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
some	DT	O
transient	JJ	O
episodes	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
with	IN	O
SBP	NNP	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
70	CD	O
s.	NN	O

Her	PRP$	B-TREATMENT
captopril	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
two	CD	B-TREATMENT
IV	NNP	I-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
with	IN	O
appropriate	JJ	O
response	NN	O
.	.	O

Her	PRP$	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
and	CC	O
all	DT	O
of	IN	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
TPN	NNP	B-TREATMENT
over	IN	O
the	DT	O
past	JJ	O
couple	NN	O
days	NNS	O
.	.	O

She	PRP	O
is	VBZ	O
also	RB	O
started	VBN	O
on	IN	O
marinol	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
and	CC	O
encouraged	VBD	O
p.o.	NNS	O
intake	NN	O
.	.	O

Guarded	VBN	B-PROBLEM
,	,	O
but	CC	O
stable	JJ	O
.	.	O

1.	CD	O
Burkitt's	NNP	B-PROBLEM
lymphoma	NN	I-PROBLEM
.	.	O

2.	CD	O
Hepatic	JJ	B-PROBLEM
candidiasis	NN	I-PROBLEM
.	.	O

1.	CD	O
AmBisome	NNP	B-TREATMENT
300	CD	O
mg	NN	O
IV	NNP	O
q.d.	NN	O

2.	CD	O
Marinol	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
before	IN	O
breakfast	NN	O
and	CC	O
dinner	NN	O
.	.	O

3.	CD	O
Atarax	NNP	B-TREATMENT
25	CD	O
mg	NN	O
IV	NNP	O
/	NNP	O
p.o.	NN	O
q.	VBD	O
4-6	JJ	O
h.	NN	O
prn	NN	O
for	IN	O
itching	VBG	B-PROBLEM
.	.	O

4.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
/	NNP	O
IV	NNP	O
q.d.	NN	O

6.	CD	O
Nystatin	NNP	B-TREATMENT
06-18	JJ	O
mL	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
q.6.	NN	O
prn	NN	O
.	.	O

7.	CD	O
Peridex	NN	B-TREATMENT
15	CD	O
mL	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
prn	NN	O
.	.	O

Transfer	NN	O
from	IN	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
.	.	O

Mr.	NNP	O
Eugene	NNP	O
is	VBZ	O
a	DT	O
67	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
remote	JJ	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
due	JJ	O
to	TO	O
alcohol	VB	O
abuse	IN	O
30	CD	O
years	NNS	O
ago	RB	O
,	,	O
who	WP	O
is	VBZ	O
transferred	VBN	O
now	RB	O
from	IN	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
for	IN	O
an	DT	B-TEST
ERCP	NNP	I-TEST
and	CC	O
work-up	NN	B-TEST
for	IN	O
a	DT	B-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
at	IN	O
the	DT	O
head	NN	O
of	IN	O
his	PRP$	O
pancreas	NNS	O
on	IN	O
CT	NNP	B-TEST
scan	JJ	I-TEST
shown	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

The	DT	O
patient	NN	O
presented	VBD	O
initially	RB	O
to	TO	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
December	NNP	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
pancreatitis	NN	B-PROBLEM
.	.	O

During	IN	O
this	DT	O
admission	NN	O
,	,	O
two	CD	B-TEST
CT	NNP	I-TEST
scans	NNS	I-TEST
had	VBD	O
shown	VBN	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
pancreas	NNS	I-PROBLEM

versus	NN	O
early	JJ	B-PROBLEM
pseudocyst	NN	I-PROBLEM
.	.	O

On	IN	O
an	DT	O
office	NN	O
visit	NN	O
on	IN	O
01-14	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
significantly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
.	.	O

That	DT	O
evening	NN	O
,	,	O
the	DT	O
patient	NN	O
again	RB	O
developed	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
"	NNS	O
like	IN	O
his	PRP$	B-PROBLEM
pancreatitis	NN	I-PROBLEM
"	NN	O
with	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
.	.	O

His	PRP$	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
showed	VBD	O
11%	CD	B-PROBLEM
bandemia	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
total	JJ	I-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
10	CD	O
.	.	O

A	DT	B-TEST
HIDA	NNP	I-TEST
scan	NN	I-TEST
showed	VBD	O
no	DT	B-PROBLEM
flow	NN	I-PROBLEM
,	,	O
question	NN	O
of	IN	O
pancreatitis	NN	B-PROBLEM
versus	NN	O
common	JJ	B-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

A	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

During	IN	O
his	PRP$	O
admission	NN	O
to	TO	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
dropped	VBN	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
to	TO	O
the	DT	O
30	CD	O
s	NN	O
with	IN	O
recorded	JJ	B-PROBLEM
melena	NN	I-PROBLEM
.	.	O

He	PRP	O
received	VBD	O
an	DT	B-TEST
MRCP	NNP	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
evidence	NN	O
of	IN	O
stones	NNS	B-PROBLEM
.	.	O

An	DT	B-TEST
ultrasound	JJ	I-TEST
showed	VBD	O
normal	JJ	O
gallbladder	NN	O
with	IN	O
no	DT	O
wall	NN	B-PROBLEM
thickening	VBG	I-PROBLEM
but	CC	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
common	JJ	I-PROBLEM
bile	IN	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	O
8	CD	O
mm	NNS	O
measured	VBN	O
on	IN	O
CT	NNP	B-TEST
scan	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
attempted	JJ	I-TEST
ERCP	NN	I-TEST
on	IN	O
01-18	NN	O
,	,	O
which	WDT	O
was	VBD	O
unsuccessful	JJ	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
nipple	NN	I-PROBLEM
like	IN	I-PROBLEM
papilla	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
therefore	RB	O
transferred	VBN	O
to	TO	O
Saints	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
endoscopic	JJ	B-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
at	IN	O
outside	JJ	O
hospital	NN	O
grew	VBD	O
out	RP	O
Streptococcus	NNP	B-PROBLEM
sanguis-gordonii	NN	I-PROBLEM
on	IN	O
01-18	NN	O
.	.	O

This	DT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
Clindamycin	NNP	B-TREATMENT
,	,	O
Erythromycin	NNP	B-TREATMENT
,	,	O
penicillin	NN	B-TREATMENT
S	NNP	I-TREATMENT
and	CC	O
Vancomycin	NNP	B-TREATMENT
.	.	O

Prior	RB	O
to	TO	O
this	DT	O
result	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
already	RB	O
been	VBN	O
on	IN	O
Ampicillin	NNP	B-TREATMENT
,	,	O
Sulbactam	NNP	B-TREATMENT
and	CC	O
Gentamycin	NNP	B-TREATMENT
.	.	O

It	PRP	O
appears	VBZ	O
from	IN	O
the	DT	O
Discharge	NNP	O
summary	NN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
Unasyn	NNP	B-TREATMENT
3	CD	O
grams	NNS	O
intravenously	RB	O
every	DT	O
six	CD	O
hours	NNS	O
after	IN	O
his	PRP$	B-TEST
ERCP	NNP	I-TEST
.	.	O

1.	CD	O
Type	NNP	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

2.	CD	O
Right	NNP	B-PROBLEM
rotator	NN	I-PROBLEM
cuff	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

3.	CD	O
Gastroesophageal	NNP	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
esophageal	JJ	B-TREATMENT
dilatation	NN	I-TREATMENT
for	IN	O
stricture	NN	B-PROBLEM
.	.	O

4.	CD	O
Recent	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
;	:	O
prior	JJ	O
history	NN	O
for	IN	O
recurrent	NN	B-PROBLEM
pancreatitis	NN	I-PROBLEM
30	CD	O
years	NNS	O
ago	RB	O
from	IN	O
alcohol	NN	O
.	.	O

5.	CD	O
History	NNP	O
of	IN	O
Streptococcemia	NNP	B-PROBLEM
in	IN	O
the	DT	O
year	NN	O
2008	CD	O
;	:	O
source	NN	O
was	VBD	O
unclear	JJ	O
but	CC	O
presumed	VBN	O
to	TO	O
be	VB	O
urinary	JJ	O
.	.	O

6.	CD	O
Status	NNP	O
post	NN	O
tonsillectomy	NN	B-TREATMENT
as	IN	O
a	DT	O
child	NN	O
.	.	O

1.	CD	O
Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
Flomax	NNP	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
Humalog	NNP	B-TREATMENT
75/25	CD	O
,	,	O
subcutaneously	RB	O
.	.	O

4.	CD	O
Regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
15	CD	O
units	NNS	O
q.	JJ	O
a.m.	RB	O
and	CC	O
14	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

1.	CD	O
Unasyn	NNP	B-TREATMENT
3	CD	O
grams	NNS	O
intravenous	JJ	O
every	DT	O
six	CD	O
hours	NNS	O
.	.	O

2.	CD	O
NPH	NNP	B-TREATMENT
10	CD	O
units	NNS	O
subcutaneously	RB	O
every	DT	O
morning	NN	O
and	CC	O
8	CD	O
units	NNS	O
subcutaneously	RB	O
every	DT	O
evening	NN	O
.	.	O

3.	CD	O
Flomax	NNP	B-TREATMENT
0.4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
Prilosec	NNP	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
Regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

6.	CD	O
Tylenol	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
Ciprofloxacin	NNP	B-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
and	CC	O
Droperidol	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
lives	VBZ	O
with	IN	O
his	PRP$	O
disabled	JJ	O
wife	NN	O
who	WP	O
has	VBZ	O
a	DT	B-PROBLEM
psychiatric	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
showed	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
97.1	CD	O
F.	NNP	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
65	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
146/74	CD	O
;	:	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
20	CD	O
;	:	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
three	CD	O
liters	NNS	O
and	CC	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
,	,	O
awake	JJ	O
and	CC	O
oriented	VBN	O
,	,	O
pleasant	JJ	O
,	,	O
and	CC	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
examination	NN	I-TEST
revealed	VBD	O
mucous	JJ	O
membranes	NNS	O
that	WDT	O
were	VBD	O
moist	RBS	O
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
icterus	NN	B-PROBLEM
.	.	O

Cardiovascular	JJ	O
system	NN	O
revealed	VBD	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
and	CC	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

Pulmonary	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Abdominal	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	O
abdomen	NNS	O
that	WDT	O
is	VBZ	O
nondistended	VBN	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

His	PRP$	B-TEST
liver	NN	I-TEST
span	NN	I-TEST
was	VBD	O
8	CD	O
cm	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
rebound	NN	B-PROBLEM
;	:	O
no	DT	O
Munos	NNP	B-PROBLEM
sign	NN	I-PROBLEM
.	.	O

Extremities	NNS	O
reveal	VBP	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
swelling	VBG	B-PROBLEM
.	.	O

Neurologic	NNP	B-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	O
alert	NN	O
and	CC	O
oriented	VBN	O
individual	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
formal	JJ	B-TEST
strength	NN	I-TEST
test	NN	I-TEST
done	VBN	O
.	.	O

Studies	NNS	O
revealed	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
32.6	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
of	IN	O
6.0	CD	O
.	.	O

His	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
was	VBD	O
267	CD	O
.	.	O

His	PRP$	B-TEST
MCV	NNP	I-TEST
was	VBD	O
88	CD	O
,	,	O
red	JJ	B-TEST
cell	NN	I-TEST
distribution	NN	I-TEST
was	VBD	O
13.4	CD	O
.	.	O

Chemistry	NN	O
on	IN	O
admission	NN	O
showed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
141	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
4.3	CD	O
,	,	O
chloride	NN	B-TEST
of	IN	O
107	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
25	CD	O
,	,	O
BUN	NNP	B-TEST
of	IN	O
4	CD	O
,	,	O
creatinine	NN	B-TEST
of	IN	O
0.6	CD	O
and	CC	O
a	DT	B-TEST
sugar	NN	I-TEST
of	IN	O
177	CD	O
.	.	O

Liver	NNP	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
revealed	VBD	O
an	DT	B-TEST
ALT	NNP	I-TEST
of	IN	O
31	CD	O
,	,	O
AST	NNP	B-TEST
of	IN	O
36	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
of	IN	O
509	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.8	CD	O
.	.	O

Albumin	NNP	B-TEST
was	VBD	O
2.6	CD	O
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
drawn	VBN	O
and	CC	O
pending	VBG	O
.	.	O

Urinalysis	NN	B-TEST
revealed	VBD	O
trace	NN	B-PROBLEM
glucose	NN	I-PROBLEM
,	,	O
no	DT	O
ketones	NNS	B-PROBLEM
,	,	O
no	DT	O
red	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
no	DT	O
white	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
less	JJR	O
than	IN	O
one	CD	O
epithelial	JJ	O
cells	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
down	RB	O
to	TO	O
the	DT	B-TEST
endoscopic	NN	I-TEST
retrogram	NN	I-TEST
cholangiopancreatogram	NN	I-TEST
upon	IN	O
admission	NN	O
.	.	O

On	IN	O
this	DT	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mild	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

Cytology	NNP	B-TEST
was	VBD	O
obtained	VBN	O
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
dilated	VBN	B-PROBLEM
pancreatic	JJ	I-PROBLEM
ducts	NNS	I-PROBLEM
with	IN	O
calcifications	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
sphincterotomy	NN	I-TREATMENT
extended	VBD	O
to	TO	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
sphincterectomy	NN	I-TREATMENT
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
successful	JJ	B-TREATMENT
extraction	NN	I-TREATMENT
of	IN	O
stone	NN	B-PROBLEM
fragments	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
had	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
subsequently	RB	O
underwent	VBD	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
angiogram	NN	I-TEST
with	IN	O
Pancreas	NNP	B-TEST
protocol	NN	I-TEST
to	TO	O
assess	VB	O
the	DT	O
pseudocyst	NN	B-PROBLEM
versus	NN	O
enlarged	VBD	B-PROBLEM
pancreas	JJ	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

The	DT	O
results	NNS	O
of	IN	O
this	DT	B-TEST
study	NN	I-TEST
indicated	VBD	O
that	IN	O
this	DT	O
structure	NN	O
at	IN	O
the	DT	O
head	NN	O
of	IN	O
his	PRP$	O
pancreas	NN	O
is	VBZ	O
most	RBS	O
likely	JJ	O
a	DT	B-PROBLEM
forming	JJ	I-PROBLEM
pseudocyst	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	O
suspicion	NN	O
of	IN	O
malignancy	NN	B-PROBLEM
is	VBZ	O
still	RB	O
possible	JJ	O
and	CC	O
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
ultrasound	NN	I-TEST
guided	VBD	I-TEST
biopsy	NN	I-TEST
of	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
on	IN	O
2011-01-20	JJ	O
.	.	O

The	DT	O
cytology	NN	O
for	IN	O
this	DT	B-TEST
biopsy	NN	I-TEST
is	VBZ	O
still	RB	O
pending	VBG	O
.	.	O

The	DT	O
patient	NN	O
recovered	VBD	O
well	RB	O
status	NN	O
post	NN	O
these	DT	B-TEST
two	CD	I-TEST
procedures	NNS	I-TEST
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
and	CC	O
no	DT	O
subsequently	RB	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
alkaline	NN	I-TEST
phosphatase	NN	I-TEST
and	CC	O
all	PDT	B-PROBLEM
the	DT	I-PROBLEM
other	JJ	I-PROBLEM
abnormal	JJ	I-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
were	VBD	O
resolving	VBG	O
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
pain	NN	B-PROBLEM
and	CC	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
tolerating	VBG	O
food	NN	O
very	RB	O
well	RB	O
and	CC	O
was	VBD	O
afebrile	VBN	B-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

With	IN	O
regards	NNS	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
documented	JJ	I-PROBLEM
Strep	NNP	I-PROBLEM
septicemia	NN	I-PROBLEM
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
the	DT	O
Infectious	NNP	O
Disease	NNP	O
Team	NNP	O
was	VBD	O
formally	RB	O
consulted	VBN	O
.	.	O

Upon	IN	O
obtaining	VBG	O
more	JJR	O
information	NN	O
from	IN	O
Rehab	NNP	O
Hospital	NNP	O
of	IN	O
the	DT	O
Cape	NNP	O
&	CC	O
Islands	NNP	O
Hospital	NNP	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
two	CD	O
out	IN	O
of	IN	O
four	CD	O
bottles	NNS	O
growing	VBG	O
out	RP	O
Streptococcus	NNP	B-PROBLEM
sanguis	NN	I-PROBLEM
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

The	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
been	VBN	O
covered	VBN	O
by	IN	O
Ampicillin	NNP	B-TREATMENT
,	,	O
Gentamycin	NNP	B-TREATMENT
and	CC	O
then	RB	O
Unasyn	NNP	B-TREATMENT
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
on	IN	O
admission	NN	O
,	,	O
was	VBD	O
placed	VBN	O
on	IN	O
Ampicillin	NNP	B-TREATMENT
,	,	O
Gentamycin	NNP	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
.	.	O

With	IN	O
repeated	VBN	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
that	WDT	O
were	VBD	O
negative	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
single	JJ	O
Mckenzie	NNP	O
of	IN	O
intravenous	JJ	B-TREATMENT
Ampicillin	NNP	I-TREATMENT
.	.	O

For	IN	O
this	DT	B-PROBLEM
documented	JJ	I-PROBLEM
septicemia	NN	I-PROBLEM
,	,	O
this	DT	O
patient	NN	O
went	VBD	O
for	IN	O
a	DT	B-TEST
endocarditis	NN	I-TEST
work-up	NN	I-TEST
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
vegetations	NNS	B-PROBLEM
.	.	O

On	IN	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
of	IN	O
greater	JJR	O
than	IN	O
55%	CD	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
other	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
noted	VBN	O
on	IN	O
this	DT	B-TEST
study	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
transesophageal	JJ	I-TEST
echocardiogram	NN	I-TEST
on	IN	O
01-24	NN	O
.	.	O

On	IN	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
again	RB	O
noted	VBN	O
to	TO	O
not	RB	O
have	VB	O
any	DT	O
evidence	NN	O
for	IN	O
valvular	JJ	B-PROBLEM
vegetations	NNS	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
complex	JJ	I-PROBLEM
plaque	NN	I-PROBLEM
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
aortic	JJ	O
arch	NN	O
in	IN	O
the	DT	O
descending	NN	O
thoracic	NN	O
aorta	RB	O
,	,	O
although	IN	O
this	DT	B-PROBLEM
plaque	NN	I-PROBLEM
is	VBZ	O
non-mobile	JJ	O
.	.	O

There	EX	O
was	VBD	O
focal	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
noted	VBD	O
without	IN	O
pathologic	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
Panorex	NNP	I-TEST
x-ray	NN	I-TEST
of	IN	O
his	PRP$	O
two	CD	O
teeth	NNS	O
were	VBD	O
obtained	VBN	O
and	CC	O
a	DT	B-TEST
Dental	NNP	I-TEST
Consultation	NNP	I-TEST
was	VBD	O
done	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
have	VB	O
normal	JJ	O
dental	JJ	O
hygiene	NN	O
and	CC	O
low	JJ	O
suspicion	NN	O
for	IN	O
a	DT	O
source	NN	O
of	IN	O
his	PRP$	B-PROBLEM
alpha	NN	I-PROBLEM
septicemia	NN	I-PROBLEM
from	IN	I-PROBLEM
his	PRP$	I-PROBLEM
mouth	NN	I-PROBLEM
.	.	O

Infectious	JJ	O
Disease	NNP	O
Department	NNP	O
as	RB	O
well	RB	O
as	IN	O
Cardiology	NNP	O
had	VBD	O
recommended	VBN	O
a	DT	O
formal	JJ	O
14	CD	O
-	:	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
to	TO	O
treat	VB	O
a	DT	B-PROBLEM
documented	JJ	I-PROBLEM
alpha	JJ	I-PROBLEM
Streptococcal	NNP	I-PROBLEM
septicemia	NN	I-PROBLEM
from	IN	O
outside	JJ	O
hospital	NN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
.	.	O

The	DT	O
patient	NN	O
's	POS	O
insurance	NN	O
company	NN	O
,	,	O
however	RB	O
,	,	O
would	MD	O
not	RB	O
pay	VB	O
for	IN	O
home	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

After	IN	O
much	JJ	O
discussion	NN	O
with	IN	O
the	DT	O
patient	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
informed	VBN	O
of	IN	O
the	DT	O
risks	NNS	O
of	IN	O
not	RB	O
finishing	VBG	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
chose	VB	O
to	TO	O
go	VB	O
home	NN	O
.	.	O

He	PRP	O
had	VBD	O
three	CD	O
days	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
remaining	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

It	PRP	O
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
patient	NN	O
to	TO	O
send	VB	O
him	PRP	O
out	RP	O
on	IN	O
Augmentin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
for	IN	O
ten	RB	O
more	JJR	O
days	NNS	O
.	.	O

He	PRP	O
was	VBD	O
to	TO	O
follow-up	JJ	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
within	IN	O
two	CD	O
to	TO	O
three	CD	O
days	NNS	O
for	IN	O
repeat	NN	B-TEST
laboratory	NN	I-TEST
studies	NNS	I-TEST
and	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
.	.	O

He	PRP	O
was	VBD	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
with	IN	O
any	DT	O
signs	NNS	O
of	IN	O
shaking	VBG	B-PROBLEM
chills	NNS	B-PROBLEM
or	CC	O
fever	NN	B-PROBLEM
.	.	O

1.	CD	O
Pancreatitis	NNP	B-PROBLEM
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
sphincterotomy	NN	B-TREATMENT
.	.	O

2.	CD	O
Alpha	NNP	B-PROBLEM
Streptococcus	NNP	I-PROBLEM
septicemia	NN	I-PROBLEM
.	.	O

1.	CD	O
Augmentin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
times	NNS	O
ten	JJ	O
days	NNS	O
.	.	O

2.	CD	O
Flomax	NNP	B-TREATMENT
0.4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
Humalog	NNP	B-TREATMENT
and	CC	O
Regular	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
subcutaneously	RB	O
.	.	O

Respiratory	NNP	B-PROBLEM
distress	NN	I-PROBLEM
-	:	O
On	IN	O
10-12	NNS	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Medicine	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
secondary	JJ	O
to	TO	O
respiratory	VB	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
Medicine	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
placed	VBN	O
on	IN	O
high-flow	JJ	B-TREATMENT
60%	CD	I-TREATMENT
oxygen	NN	I-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
they	PRP	O
diuresed	VBD	O
approximately	RB	O
5	CD	O
liters	NNS	O
off	RB	O
into	IN	O
the	DT	B-TREATMENT
intravenous	JJ	I-TREATMENT
Lasix	NNP	I-TREATMENT
.	.	O

Since	IN	O
then	RB	O
the	DT	O
patient	NN	O
's	POS	O
oxygenation	NN	O
has	VBZ	O
been	VBN	O
improving	VBG	O
and	CC	O
today	NN	O
,	,	O
10-17	JJ	O
,	,	O
she	PRP	O
is	VBZ	O
requiring	VBG	O
.5	JJ	O
liters	NNS	O
of	IN	O
keep	VB	O
her	PRP$	B-TEST
saturations	NNS	I-TEST
above	IN	O
94	CD	O
.	.	O

The	DT	O
patient	NN	O
continues	VBZ	O
to	TO	O
be	VB	O
diuresed	VBN	O
with	IN	O
approximately	RB	O
20	CD	O
mg	NNS	O
of	IN	O
Lasix	NNP	B-TREATMENT
a	DT	O
day	NN	O
and	CC	O
she	PRP	O
has	VBZ	O
had	VBD	O
good	JJ	O
urine	JJ	O
output	NN	O
.	.	O

Anemia	NNP	B-PROBLEM
-	:	O
The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
in	IN	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
to	TO	O
the	DT	O
mid	NN	O
20s	CD	O
and	CC	O
she	PRP	O
received	VBD	O
one	CD	O
unit	NN	O
of	IN	O
packed	JJ	O

red	JJ	B-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
up	RB	O
to	TO	O
30	CD	O
.	.	O

Hypotension	NNP	B-PROBLEM
-	:	O
On	IN	O
the	DT	O
night	NN	O
of	IN	O
10-16	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
diuresed	VBN	O
with	IN	O
20	CD	O
mg	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
into	IN	O
the	DT	O
70	CD	O
s	NN	O
without	IN	O
any	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
were	VBD	O
greater	JJR	O
than	IN	O
94%	CD	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
250	CD	O
cc	NN	O
of	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
responded	VBD	O
coming	VBG	O
back	RB	O
up	RB	O
to	TO	O
the	DT	O
high	JJ	O
90	CD	O
s.	NN	O

No	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

Recent	JJ	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
shows	NNS	O
resolving	VBG	B-PROBLEM
right	RB	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

She	PRP	O
continues	VBZ	O
on	IN	O
her	PRP$	B-TREATMENT
Prednisone	NNP	I-TREATMENT
taper	NN	I-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
asthma	NN	I-PROBLEM
and	CC	O
this	DT	O
is	VBZ	O
day	NN	O
#	#	O
14	CD	O
of	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	O
Drugs	VB	B-TREATMENT

nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM

01-23	JJ	O
PORT	NNP	B-TREATMENT
line	NN	I-TREATMENT
removal	NN	I-TREATMENT
.	.	O

01-23	JJ	O
PICC	NNP	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

01-24	JJ	O
PICC	NNP	B-TREATMENT
removal	NN	I-TREATMENT
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
37	CD	O
y/o	JJ	O
male	JJ	O
patient	NN	O
with	IN	O
PMH	NNP	O
Type	NNP	B-PROBLEM
I	PRP	I-PROBLEM
DM	NNP	I-PROBLEM
,	,	O
HTN	NNP	B-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
,	,	O
ESRD	NNP	B-PROBLEM
on	IN	O
HD	NNP	B-TREATMENT
(	(	O
last	JJ	O
in	IN	O
12/26	CD	O
per	IN	O
patient	NN	O
)	)	O
who	WP	O
presents	VBZ	O
to	TO	O
CMED	NNP	O
CCU	NNP	O
with	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
unable	JJ	O
from	IN	O
the	DT	O
Larry	NNP	O
.	.	O

The	DT	O
patient	NN	O
early	RB	O
this	DT	O
morning	NN	O
to	TO	O
the	DT	O
Ruthie	NNP	O
with	IN	O
his	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
hypertensive	JJ	B-PROBLEM
to	TO	O
256/110	CD	O
,	,	O
HR	NNP	B-TEST
102	CD	O
,	,	O
T	NNP	B-TEST
99.2	CD	O
,	,	O
RR	NNP	B-TEST
22	CD	O
,	,	O
92%	CD	O
RA	NNP	O
.	.	O

History	NN	O
is	VBZ	O
difficult	JJ	O
to	TO	O
obtain	VB	O
from	IN	O
patient	JJ	O
d/t	NN	O
somnolence	NN	B-PROBLEM
and	CC	O
lack	NN	B-PROBLEM
of	IN	I-PROBLEM
desire	NN	I-PROBLEM
to	TO	O
participate	VB	O
in	IN	O
interview	NN	O
,	,	O
but	CC	O
per	IN	O
Frank	NNP	O
note	NN	O
he	PRP	O
was	VBD	O
diaphoretic	JJ	B-PROBLEM
and	CC	O
'	POS	O
writing	NN	O
in	IN	O
pain	NN	B-PROBLEM
',	CD	O
vomiting	VBG	O
clear	JJ	O
substance	NN	O
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
ativan	RP	B-TREATMENT
a	DT	O
total	NN	O
of	IN	O
4	CD	O
mg	NN	O
of	IN	O
ativan	NN	B-TREATMENT
,	,	O
6	CD	O
mg	NN	O
of	IN	O
dilaudid	NN	B-TREATMENT
,	,	O
labetolol	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
IV	NNP	O
x	VBZ	O
1	CD	O
and	CC	O
hydralazine	VB	B-TREATMENT
10	CD	O
mg	NN	O
IV	NNP	O
x	VBZ	O
1	CD	O
without	IN	O
good	JJ	O
response	NN	O
(	(	O
200/99	CD	O
).	NN	O

He	PRP	O
recieved	VBD	O
2L	CD	B-TREATMENT
NS	NNP	I-TREATMENT
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
labetolol	NN	B-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
BP	NNP	B-TEST
decreased	VBD	O
to	TO	O
161/79	CD	O
.	.	O

Tranferred	VBN	O
to	TO	O
CMED	NNP	O
CCU	NNP	O
for	IN	O
further	JJ	O
management	NN	O
while	IN	O
on	IN	O
labetolol	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

At	IN	O
that	DT	O
time	NN	O
BP	NNP	B-TEST
was	VBD	O
attributed	VBN	O
to	TO	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
inability	NN	O
to	TO	O
take	VB	O
PO	NNP	O
meds	NNS	O
d/t	VBP	O
nausea	NN	B-PROBLEM
/	NN	O
vomiting	NN	B-PROBLEM
.	.	O

Also	RB	O
had	VBD	O
labile	JJ	B-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
with	IN	O
repeated	JJ	O
episodes	NNS	O
of	IN	O
hypoglycemia	NN	B-PROBLEM
,	,	O
and	CC	O
Strickland	NNP	O
recommended	VBD	O
sugars	NNS	B-TEST
in	IN	O
the	DT	O
range	NN	O
of	IN	O
150-200	JJ	O
.	.	O

He	PRP	O
eloped	VBD	O
prior	RB	O
to	TO	O
formal	VB	O
discharge	NN	O
when	WRB	O
his	PRP$	B-TEST
FS	NNP	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
critically	RB	B-PROBLEM
high	JJ	I-PROBLEM
-	:	O
recommended	VBD	O
to	TO	O
patient	VB	O
that	IN	O
he	PRP	O
stay	VB	O
for	IN	O
repeat	NN	O
,	,	O
but	CC	O
left	VBD	O
AMA	NNP	O
without	IN	O
signing	VBG	O
any	DT	O
forms	NNS	O
.	.	O

Upon	IN	O
transfer	NN	O
to	TO	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
the	DT	O
patient	NN	O
appears	VBZ	O
somewhat	RB	B-PROBLEM
uncomfortable	JJ	I-PROBLEM
,	,	O
reporting	VBG	O
nausea	NN	B-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
but	CC	O
when	WRB	O
questioned	VBD	O
he	PRP	O
was	VBD	O
unable	JJ	O
/	JJ	O
unwilling	NN	O
to	TO	O
participate	VB	O
in	IN	O
HPI	NNP	O
or	CC	O
exam	VB	B-TEST
d/t	JJ	O
sleepiness	NN	B-PROBLEM
.	.	O

He	PRP	O
denied	VBD	O
CP	NNP	B-PROBLEM
,	,	O
SOB	NNP	B-PROBLEM
,	,	O
HA	NNP	B-PROBLEM
,	,	O
vision	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
neck	NN	B-PROBLEM
stiffness	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
he	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
to	TO	O
SBP	VB	B-TEST
80	CD	O
s.	NN	O

Labetalol	NNP	B-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
500	CD	I-TREATMENT
cc	NN	I-TREATMENT
fluid	NN	I-TREATMENT
bolus	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
rose	VBD	O
to	TO	O
SBP	NNP	B-TEST
90	CD	O
s.	NN	O

Cardiac	NNP	O
and	CC	O
infectious	JJ	O
sources	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
were	VBD	O
considered	VBN	O
,	,	O
but	CC	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
not	RB	O
changed	VBN	O
from	IN	O
prior	JJ	O
studies	NNS	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
localizing	JJ	B-PROBLEM
signs	NNS	I-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
;	:	O
blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
and	CC	O
a	DT	B-TEST
ultrasound	NN	I-TEST
of	IN	O
the	DT	B-TREATMENT
L	NNP	I-TREATMENT
arm	NN	I-TREATMENT
AVF	NNP	I-TREATMENT
ordered	VBD	O
to	TO	O
rule	VB	O
out	RP	O
abscess	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

He	PRP	O
received	VBD	O
a	DT	B-TREATMENT
partial	JJ	I-TREATMENT
HD	NNP	I-TREATMENT
session	NN	I-TREATMENT
,	,	O
limited	VBN	O
by	IN	O
hypotension	NN	B-PROBLEM
.	.	O

Over	IN	O
night	NN	O
,	,	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
trended	VBD	O
up	RB	O
to	TO	O
130	CD	O
s	NNS	O
systolic	JJ	O
.	.	O

He	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
to	TO	O
be	VB	O
called	VBN	O
out	RP	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
on	IN	O
2019-01-20	JJ	O
but	CC	O
became	VBD	O
somnolent	JJ	B-PROBLEM
after	IN	O
receiving	VBG	O
pain	NN	B-TREATMENT
and	CC	I-TREATMENT
anti-nausea	NN	I-TREATMENT
meds	NNS	I-TREATMENT
,	,	O
so	IN	O
he	PRP	O
stayed	VBD	O
in	IN	O
the	DT	O
ICU	NNP	O
for	IN	O
closer	JJR	O
monitoring	NN	O
of	IN	O
respiratory	NN	O
status	NN	O
,	,	O
which	WDT	O
spontaneously	RB	O
improved	VBN	O
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
at	IN	O
10	CD	O
pm	NN	O
was	VBD	O
low	JJ	O
at	IN	O
22	CD	O
and	CC	O
he	PRP	O
was	VBD	O
disoriented	VBN	B-PROBLEM
,	,	O
which	WDT	O
resolved	VBD	O
with	IN	O
two	CD	O
glasses	NNS	O
of	IN	O
juice	NN	O
;	:	O
he	PRP	O
did	VBD	O
not	RB	O
receive	VB	O
his	PRP$	O
standing	VBG	O
dose	NN	O
of	IN	O
NPH	NNP	B-TREATMENT
that	IN	O
evening	VBG	O
.	.	O

Blood	NNP	B-TEST
cultures	NNS	I-TEST
returned	VBD	O
positive	JJ	O
with	IN	O
GPC	NNP	B-PROBLEM
in	IN	I-PROBLEM
pairs	NNS	I-PROBLEM
and	CC	I-PROBLEM
clusters	NNS	I-PROBLEM
,	,	O
so	IN	O
a	DT	B-TEST
TTE	NNP	I-TEST
and	CC	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
ordered	VBN	O
and	CC	O
vancomycin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

1.	CD	O
DM	NNP	B-PROBLEM
type	NN	I-PROBLEM
I	PRP	O

2.	CD	O
ESRD	NNP	B-PROBLEM
on	IN	O
hemodialysis	NN	B-TREATMENT
started	VBN	O
2017-01-07	CD	O
on	IN	O
Tu	NNP	O
,	,	O
Th	NNP	O
,	,	O
Sat	NNP	O

3.	CD	O
Severe	JJ	B-PROBLEM
autonomic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
with	IN	O
multiple	JJ	O
hospitalizations	NNS	O
for	IN	O
hypertensive	JJ	B-PROBLEM
emergency	NN	I-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
,	,	O
and	CC	O
orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

4.	CD	O
History	NNP	O
of	IN	O
esophageal	JJ	B-PROBLEM
erosion	NN	I-PROBLEM
,	,	O
MW	NNP	B-PROBLEM
tear	VBP	I-PROBLEM

5.	CD	O
CAD	NNP	B-PROBLEM
with	IN	O
1-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
(	(	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
D1	NNP	I-PROBLEM
in	IN	O
2014-06-07	JJ	O
),	NNP	O
normal	JJ	O
stress	NN	O

6.	CD	O
hx	NN	O
of	IN	O
Foot	NNP	B-PROBLEM
Ulcer	NNP	I-PROBLEM

7.	CD	O
h/o	NN	O
clot	NN	B-PROBLEM
in	IN	O
AV	NNP	B-TREATMENT
graft	NN	I-TREATMENT
x2	NN	O
(	(	O
March	NNP	O
and	CC	O
2018-07-07	JJ	O
)	)	O

His	PRP$	O
father	NN	O
recently	RB	O
died	VBD	O
of	IN	O
ESRD	NNP	B-PROBLEM
and	CC	O
diabetes	NNS	B-PROBLEM
.	.	O

His	PRP$	O
mother	NN	O
is	VBZ	O
in	IN	O
her	PRP$	O
50	CD	O
s	NN	O
and	CC	O
has	VBZ	O
hypertension	NN	B-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
two	CD	O
sisters	NNS	O
,	,	O
one	CD	O
with	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
and	CC	O
six	CD	O
brothers	NNS	O
,	,	O
one	CD	O
with	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

Vitals	NNS	B-TEST
:	:	O
97.4	CD	O
,	,	O
164/90	CD	O
,	,	O
102	CD	O
,	,	O
10	CD	O
,	,	O
97%	CD	O
4L	CD	O

General	NNP	O
:	:	O
sleepy	NN	B-PROBLEM
,	,	O
arouses	VBZ	O
to	TO	O
voice	VB	O
but	CC	O
limited	JJ	O
participation	NN	O
with	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST

HEENT	NN	O
:	:	O
PERRL	NNP	O
,	,	O
left	VBD	B-PROBLEM
pupil	RP	I-PROBLEM
smaller	JJR	I-PROBLEM
than	IN	I-PROBLEM
right	NN	I-PROBLEM
,	,	O
pt	NN	O
will	MD	O
not	RB	O
participate	VB	O
in	IN	O
EOMI	NNP	O
,	,	O
sclera	NN	O
anicteric	NN	B-PROBLEM
,	,	O
MM	NNP	B-PROBLEM
dry	NN	I-PROBLEM
,	,	O
No	NNP	O
OP	NNP	B-PROBLEM
lesions	NNS	I-PROBLEM

Neck	NN	O
:	:	O
Supple	NN	O
,	,	O
no	DT	O
JVD	NNP	B-PROBLEM

CV	NN	O
:	:	O
RRR	NNP	O
,	,	O
nl	JJ	O
S1	NNP	O
,	,	O
S2	NNP	O
,	,	O
2/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
LUSB	NNP	I-PROBLEM

Chest	NN	O
:	:	O
HD	NNP	B-TREATMENT
line	NN	I-TREATMENT
in	IN	O
place	NN	O
without	IN	O
erythema	NN	B-PROBLEM

Abd	NNS	O
:	:	O
Soft	NNP	O
,	,	O
ND	NNP	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
+	NNP	O
BS	NNP	O
,	,	O
no	DT	O
guarding	NN	B-PROBLEM
,	,	O
no	DT	O
rebound	NN	B-PROBLEM
,	,	O
multiple	RB	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
scars	NNS	I-PROBLEM

Ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM
,	,	O
left	VBD	B-PROBLEM
arm	NN	I-PROBLEM
with	IN	I-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
good	JJ	O
thrill	NN	O

Skin	NN	O
:	:	O
no	DT	O
rashes	NNS	B-PROBLEM

Pt	NNP	O
admitted	VBD	O
to	TO	O
medical	JJ	O
floor	NN	O
in	IN	O
hemodynamically	RB	O
stable	JJ	O
condition	NN	O
without	IN	O
specific	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
.	.	O

#	#	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
:	:	O

Upon	IN	O
presentation	NN	O
it	PRP	O
was	VBD	O
unclear	JJ	O
when	WRB	O
last	JJ	O
time	NN	O
was	VBD	O
that	IN	O
patient	JJ	O
took	VBD	O
meds	NNS	B-TREATMENT
,	,	O
but	CC	O
hypertension	NN	B-PROBLEM
likely	RB	O
d/t	JJ	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
take	VB	I-PROBLEM
meds	NNS	I-PROBLEM
in	IN	O
setting	NN	O
of	IN	O
N/V	NNP	B-PROBLEM
.	.	O

Also	RB	O
contribution	NN	O
of	IN	O
autonomic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
active	JJ	B-PROBLEM
end	NN	I-PROBLEM
organ	JJ	I-PROBLEM
damage	NN	I-PROBLEM
.	.	O

Pt	NNP	O
was	VBD	O
treated	VBN	O
with	IN	O
labetalol	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
in	IN	O
CMED	NNP	O
CCU	NNP	O
which	WDT	O
was	VBD	O
weaned	VBN	O
off	RP	O
on	IN	O
01-20	NN	O
.	.	O

carduac	NN	B-PROBLEM
enzymes	NNS	I-PROBLEM
mildly	RB	I-PROBLEM
elevated	VBD	I-PROBLEM
,	,	O
felt	VBD	O
02-08	JJ	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
setting	VBG	O
of	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
,	,	O
CK	NNP	B-TEST
and	CC	O
MB	NNP	B-TEST
trended	VBD	O
Mcewen	NNP	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
floor	NN	O
.	.	O

Pt	NNP	B-PROBLEM
's	POS	I-PROBLEM
hypertensive	JJ	I-PROBLEM
urgency	NN	I-PROBLEM
was	VBD	O
resolved	VBN	O
upon	IN	O
admission	NN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
.	.	O

His	PRP$	B-TEST
SBP	NNP	I-TEST
s	NN	I-TEST
ranged	VBD	O
140	CD	O
s-	JJ	O
170	CD	O
s	NN	O
.	.	O

He	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	O
home	NN	O
regimen	NNS	O
of	IN	O
antihypertensives	NNS	B-TREATMENT
without	IN	O
difficulty	NN	O
(	(	O
metoprolol	JJ	B-TREATMENT
75	CD	O
tid	NN	O
,	,	O
clonidine	JJ	B-TREATMENT
patch	NN	I-TREATMENT
and	CC	I-TREATMENT
oral	JJ	I-TREATMENT
,	,	O
nifedipine	JJ	B-TREATMENT
30	CD	O
SR	NNP	O
q	JJ	O
daily	JJ	O
).	NN	O

#	#	O
bacteremia	NN	B-PROBLEM
:	:	O

pt	NN	O
with	IN	O
2/4	CD	O
bottles	NNS	O
coag	VBP	B-PROBLEM
neg	JJ	I-PROBLEM
staph	NN	I-PROBLEM
on	IN	O
01-19	NN	O
and	CC	O
again	RB	O
on	IN	O
01-20	NN	O
.	.	O

PORT	NNP	B-TREATMENT
was	VBD	O
felt	VBN	O
most	JJS	O
likely	JJ	O
source	NN	O
,	,	O
and	CC	O
pt	NN	O
has	VBZ	O
had	VBN	O
at	IN	O
least	JJS	O
2	CD	O
sets	NNS	O
of	IN	O
+	NNP	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
since	IN	O
it	PRP	O
was	VBD	O
placed	VBN	O
.	.	O

TTE	NNP	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
was	VBD	O
not	RB	O
concerning	VBG	O
for	IN	O
endocarditis	NN	B-PROBLEM
.	.	O

pt	NN	O
without	IN	O
stigmata	NN	B-PROBLEM
of	IN	I-PROBLEM
SBE	NNP	I-PROBLEM
.	.	O

ID	NNP	O
consult	NN	O
obtained	VBD	O
which	WDT	O
recommended	VBD	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
PORT	NNP	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
taken	VBN	O
out	RP	O
on	IN	O
01-23	NN	O
.	.	O

Pt	NNP	O
will	MD	O
compelete	VB	O
a	DT	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
at	IN	O
hemodialysis	NN	B-TREATMENT
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
arranged	VBN	O
by	IN	O
renal	JJ	O
service	NN	O
.	.	O

A	DT	B-TREATMENT
PICC	NNP	I-TREATMENT
was	VBD	O
breifly	NN	O
placed	VBN	O
,	,	O
however	RB	O
removed	VBN	O
as	IN	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
if	IN	O
pt	NNS	O
can	MD	O
reliably	RB	O
flush	VB	O
this	DT	O
.	.	O

PORT	NNP	B-TREATMENT
will	MD	O
be	VB	O
replaced	VBN	O
on	IN	O
2019-02-11	JJ	O
per	IN	O
IR	NNP	O
(	(	O
Dr.	NNP	O
Welsh	NNP	O
placed	VBD	O
last	JJ	O
PORT	NNP	B-TREATMENT
,	,	O
then	RB	O
removed	VBD	O
it	PRP	O
on	IN	O
01-23	JJ	O
),	NN	O
ordered	VBD	O
placed	VBN	O
in	IN	O
OMR	NNP	O
.	.	O

diabetic	JJ	B-PROBLEM
gastropathy	NN	I-PROBLEM
causing	VBG	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
toleral	JJ	I-PROBLEM
oral	JJ	I-PROBLEM
antihypertensive	JJ	I-PROBLEM
medication	NN	I-PROBLEM
prompting	VBG	O
repeated	VBN	O
Donald	NNP	O
presentation	NN	O
for	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
.	.	O

Pt	NNP	O
with	IN	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
port	VB	B-TEST
tip	NN	I-TEST
cultures	NNS	I-TEST
showing	VBG	O
NGTD	NNP	O
on	IN	O
01-24	NN	O
,	,	O
he	PRP	O
will	MD	O
have	VB	O
futher	JJR	B-TEST
surveillance	NN	I-TEST
cultures	NNS	I-TEST
drawn	VBN	O
at	IN	O
hemodialysis	NN	B-TREATMENT
and	CC	O
followed	VBN	O
by	IN	O
his	PRP$	O
nephrologist	NN	O
.	.	O

#	#	O
n/v/	JJ	B-PROBLEM
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
:	:	O
pt	NN	O
with	IN	O
multiple	JJ	O
admissions	NNS	O
with	IN	O
similar	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
,	,	O
etiology	NN	O
02-08	JJ	O
gastroparesis	NN	B-PROBLEM
,	,	O
improves	VBZ	O
considerably	RB	O
with	IN	O
ativan	NN	B-TREATMENT
,	,	O
dilaudid	NN	B-TREATMENT
,	,	O
reglan	NN	B-TREATMENT
,	,	O
pt	NN	O
was	VBD	O
tolerating	VBG	O
PO	NNP	B-TREATMENT
meds	NNS	I-TREATMENT
/	VBP	O
diet	JJ	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
service	NN	O
and	CC	O
was	VBD	O
restarted	VBN	O
on	IN	O
oral	JJ	B-TREATMENT
reglan	NN	I-TREATMENT
.	.	O

#	#	O
DMI	NNP	B-PROBLEM
:	:	O
Pt	NN	O
on	IN	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
as	IN	O
inpatient	NN	O
and	CC	O
taking	VBG	O
NPH	NNP	B-TREATMENT
2	CD	O
units	NNS	O
BID	NNP	O
at	IN	O
home	NN	O
.	.	O

pt	NN	O
with	IN	O
two	CD	O
episodes	NNS	O
of	IN	O
hypoglycemia	NN	B-PROBLEM
(	(	O
FSBS	NNP	B-TEST
22	CD	O
and	CC	O
27	CD	O
),	NNP	O
etiology	NN	O
unclear	JJ	O
,	,	O
pt	NN	O
followed	VBN	O
by	IN	O
Strickland	NNP	O
,	,	O
who	WP	O
recommend	VBP	O
no	DT	O
changes	NNS	O
to	TO	O
current	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

will	MD	O
discharge	VB	O
pt	NN	O
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
NPH	NNP	B-TREATMENT
2	CD	O
UNITS	NNP	O
BID	NNP	O
as	IN	O
Frederick	NNP	O
Tracey	NNP	O
recs	NN	O
.	.	O

#	#	O
CAD	NNP	B-PROBLEM
-	:	O
pt	NN	O
denied	VBD	O
cp	JJ	B-PROBLEM
/	NN	O
sob	NN	B-PROBLEM
throughout	IN	O
hospitalization	NN	O
.	.	O

Troponins	NNS	B-TEST
rose	VBD	O
at	IN	O
admission	NN	O
,	,	O
however	RB	O
CK	NNP	B-TEST
and	CC	O
MB	NNP	B-TEST
trending	VBG	O
Mcewen	NNP	O
wat	JJ	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
service	NN	O
.	.	O

Etiology	NNP	O
felt	VBD	O
most	JJS	O
likely	JJ	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
setting	VBG	O
of	IN	O
original	JJ	B-PROBLEM
hypertensive	JJ	I-PROBLEM
urgency	NN	I-PROBLEM
with	IN	O
persistent	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
of	IN	I-PROBLEM
trop	JJ	I-PROBLEM
02-08	JJ	O
ESRD	NNP	B-PROBLEM
.	.	O

Pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
.	.	O

#	#	O
ESRD	NN	B-PROBLEM
:	:	O
etiology	NN	O
likely	JJ	O
02-08	JJ	O
DM	NNP	B-PROBLEM
and	CC	O
HTN	NNP	B-PROBLEM
,	,	O
pt	NN	O
tolerating	VBG	O
HD	NNP	B-TREATMENT
well	RB	O
,	,	O
and	CC	O
underwent	JJ	O
dialysis	NN	B-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
on	IN	O
01-24	NN	O
.	.	O

pt	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
home	NN	O
with	IN	O
plan	NN	O
to	TO	O
continue	VB	O
current	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
schedule	NN	I-TREATMENT
(	(	O
Tue	NNP	O
/	NNP	O
Th	NNP	O
/	NNP	O
Sat	NNP	O
).	NN	O

In	IN	O
addition	NN	O
pt	NN	O
will	MD	O
be	VB	O
given	VBN	O
vancomycin	NNS	B-TREATMENT
at	IN	O
dialysis	NN	O
x	$	O
2	CD	O
week	NN	O
course	NN	O
(	(	O
last	JJ	O
day	NN	O
2019-02-05	JJ	O
)	)	O
given	VBN	O
his	PRP$	B-PROBLEM
PORT	NNP	I-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

He	PRP	O
will	MD	O
have	VB	O
levels	NNS	B-TEST
drawn	VBN	O
at	IN	O
dialysis	NN	B-TREATMENT
and	CC	O
be	VB	O
dosed	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
as	IN	O
appropriate	NN	O
.	.	O

Plan	NN	O
is	VBZ	O
for	IN	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
to	TO	O
be	VB	O
drawn	VBN	O
at	IN	O
dialysis	NN	B-TREATMENT
.	.	O

If	IN	O
negative	JJ	O
,	,	O
pt	NN	O
is	VBZ	O
scheduled	VBN	O
for	IN	O
presumptively	RB	B-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
PORT	NNP	I-TREATMENT
on	IN	O
2019-02-11	JJ	O
with	IN	O
interventional	JJ	B-TREATMENT
radiology	NN	I-TREATMENT
(	(	O
dr.	JJ	O
Arevalo	NNP	O
).	NN	O

Pt	NNP	O
continued	VBD	O
on	IN	O
home	NN	O
regimen	NNS	O
of	IN	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
,	,	O
3	CD	O
capsules	NNS	O
TID	NNP	O
.	.	O

#	#	O
AV	NNP	B-TREATMENT
fistula	NN	I-TREATMENT
:	:	O
pt	NN	O
with	IN	O
h/o	JJ	O
numerous	JJ	B-PROBLEM
clots	NNS	I-PROBLEM
in	IN	O
AV	NNP	B-TREATMENT
fistula	NN	I-TREATMENT
.	.	O

No	DT	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
presently	RB	O
,	,	O
and	CC	O
tolerating	VBG	O
dialysis	NN	B-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

Pt	NNP	O
was	VBD	O
subtherapeuticon	JJ	B-PROBLEM
INR	NNP	I-PROBLEM
on	IN	O
admission	NN	O
,	,	O
thus	RB	O
treated	VBN	O
with	IN	O
heparin	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

coumadin	NNS	B-TREATMENT
held	VBD	O
on	IN	O
01-22	NN	O
for	IN	O
PORT	NNP	B-TREATMENT
removal	NN	I-TREATMENT
,	,	O
and	CC	O
restarted	VBN	O
on	IN	O
01-24	NN	O
.	.	O

Pt	NNP	O
discharged	VBD	O
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
coumadin	JJ	B-TREATMENT
1.5	CD	O
mg	NN	O
po	NN	O
q	JJ	O
daily	JJ	O
with	IN	O
goal	NN	B-TEST
INR	NNP	I-TEST
02-09	NN	O
.	.	O

pt	NN	O
discharged	VBD	O
home	NN	O
on	IN	O
01-24	JJ	O
with	IN	O
instructions	NNS	O
to	TO	O
complete	VB	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
at	IN	O
hemodialysis	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
PORT	NNP	I-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

an	DT	O
appointment	NN	O
was	VBD	O
made	VBN	O
with	IN	O
interventional	JJ	O
radiology	NN	O
on	IN	O
2019-02-11	JJ	O
to	TO	O
replace	VB	O
his	PRP$	B-TREATMENT
PORT	NNP	I-TREATMENT
,	,	O
under	IN	O
the	DT	O
assumption	NN	O
that	IN	O
his	PRP$	B-TEST
surveillance	NN	I-TEST
cultures	NNS	I-TEST
from	IN	O
dialysis	NN	B-TREATMENT
remain	VBP	O
negative	JJ	O
.	.	O

Metoclopramide	RB	B-TREATMENT
10	CD	O
mg	NNS	O
PO	NNP	O
Q6	NNP	O

Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
75	CD	O
mg	NN	O
PO	NNP	O
TID	NNP	O

Calcium	NN	B-TREATMENT
Acetate	NNP	I-TREATMENT
1340	CD	O
mg	NN	O
tid	NN	O
with	IN	O
meals	NNS	O

Anzemet	$	B-TREATMENT
12.5	CD	O
IV	NNP	O
prn	NN	O

Prochlorperazine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
IV	NNP	O
Q6H	NNP	O
prn	NN	O

Ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
PO	NNP	O
Q6H	NNP	O
prn	NN	O

Dilaudid	NNP	B-TREATMENT
4mg	CD	O
PO	NNP	O
Q3-4H	NNP	O
prn	NN	O

Insulin	NNP	B-TREATMENT
NPH	NNP	I-TREATMENT
2	CD	O
units	NNS	O
Subcutaneous	NNP	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

Clonidine	NNP	B-TREATMENT
0.3	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
Patch	NNP	O
Weekly	NNP	O
Transdermal	NNP	O
QTHUR	NNP	O

Clonidine	NNP	B-TREATMENT
0.2	CD	O
mg	NN	O
PO	NNP	O
TID	NNP	O

Prochlorperazine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q	NN	O
6	CD	O
h	NN	O

Coumadin	NNP	B-TREATMENT
1.5	CD	O
mg	NN	O
PO	NNP	O
QHS	NNP	O

Nifedipine	NNP	B-TREATMENT
30	CD	O
SR	NNP	O
mg	NN	O
PO	NNP	O
QD	NNP	O

Bisacodyl	NNP	B-TREATMENT
prn	NN	O

Protonix	NNP	B-TREATMENT
40	CD	O
QD	NNP	O

1.	CD	O
Metoclopramide	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

2.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
Calcium	NNP	B-TREATMENT
Acetate	NNP	I-TREATMENT
667	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
Three	CD	O
(	(	O
3	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
TID	NNP	O
W/	NNP	O
MEALS	NNP	O
(	(	O
3	CD	O
TIMES	NNP	O
A	NNP	O
DAY	NNP	O
WITH	NNP	O
MEALS	NNP	O
).	NN	O

4.	CD	O
Ativan	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
q6h	NN	O
prn	NN	O
.	.	O

5.	CD	O
Dilaudid	NNP	B-TREATMENT
4	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
q3-4hr	JJ	O
prn	NN	O
.	.	O

6.	CD	O
Clonidine	NNP	B-TREATMENT
0.3	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
Patch	NNP	O
Weekly	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Patch	NNP	O
Weekly	NNP	O
Transdermal	NNP	O
Q	NNP	O
WED	NNP	O
(	(	O
every	DT	O
Wednesday	NNP	O
).	NN	O

7.	CD	O
Clonidine	NNP	B-TREATMENT
0.2	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
Warfarin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1.5	CD	O
Tablets	NNS	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

9.	CD	O
Nifedipine	NNP	B-TREATMENT
30	CD	O
mg	NN	O
Tablet	NNP	O
Sustained	NNP	O
Release	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
Sustained	VBN	O
Release	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

10.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
Bisacodyl	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

12.	CD	O
Vancomycin	NNP	B-TREATMENT
in	IN	I-TREATMENT
Dextrose	NNP	I-TREATMENT
1	CD	O
g	NN	O
/	VBD	O
200	CD	O
mL	NN	O
Piggyback	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Intravenous	JJ	O
QHD	NNP	O
(	(	O
each	DT	O
hemodialysis	NN	B-TREATMENT
):	VBD	O
2	CD	O
week	NN	O
course	NN	O
to	TO	O
be	VB	O
given	VBN	O
at	IN	O
dialysis	NN	O
,	,	O
last	JJ	O
day	NN	O
2019-02-05	JJ	O
.	.	O

13.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

14.	CD	O
Humalog	NNP	B-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
USE	NN	O
AS	IN	O
DIRECTED	NNP	O
Subcutaneous	NNP	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
please	NN	O
use	NN	O
attached	VBD	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
.	.	O

15.	CD	O
Insulin	NNP	B-TREATMENT
NPH	NNP	I-TREATMENT
Human	NNP	I-TREATMENT
Recomb	NNP	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
2	CD	O
UNITS	NNP	O
Subcutaneous	NNP	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

bacteremia	NN	B-PROBLEM
02-08	JJ	O
PORT	NNP	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM

hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM

diabetic	JJ	B-PROBLEM
gastropathy	NN	I-PROBLEM

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
all	DT	O
of	IN	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

you	PRP	O
were	VBD	O
started	VBN	O
on	IN	O
a	DT	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
to	TO	O
be	VB	O
given	VBN	O
at	IN	O
hemodialysis	NN	B-TREATMENT
for	IN	O
your	PRP$	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

you	PRP	O
will	MD	O
have	VB	O
your	PRP$	B-TREATMENT
PORT	NNP	I-TREATMENT
replaced	VBD	O
after	IN	O
2	CD	O
weeks	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
if	IN	O
your	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
remain	VBP	O
negative	JJ	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
recurrent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
naseau	NN	B-PROBLEM
,	,	O
vomitting	VBG	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
contact	VB	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
or	CC	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

please	VB	O
follow-up	JJ	O
with	IN	O
your	PRP$	O
dialysis	NN	O
physician	NN	O
regarding	VBG	O
replacing	VBG	O
your	PRP$	B-TREATMENT
PORT	NNP	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
stage	NN	B-PROBLEM
1	CD	I-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
buttocks	NNS	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
treated	VBN	O
with	IN	O
wound	NN	B-TREATMENT
care	NN	I-TREATMENT
using	VBG	O
Eucerin	NNP	B-TREATMENT
cream	NN	I-TREATMENT
and	CC	O
also	RB	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
lidocaine	NN	B-TREATMENT
jelly	RB	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
wound	NN	O
care	NN	O
nurse	NN	O
and	CC	O
the	DT	B-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
mild	JJ	O
,	,	O
but	CC	O
was	VBD	O
causing	VBG	O
the	DT	O
patient	NN	O
a	DT	O
lot	NN	O
of	IN	O
discomfort	NN	B-PROBLEM
and	CC	O
the	DT	O
wound	NN	O
care	NN	O
nurse	JJ	O
Ivy	NNP	O
Rose	NNP	O
lidocaine	NN	B-TREATMENT
jelly	RB	I-TREATMENT
.	.	O

With	IN	O
regard	NN	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
's	POS	O
respiratory	NN	O
status	NN	O
improved	VBN	O
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
cough	NN	B-PROBLEM
on	IN	O
discharge	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
oxygenating	VBG	O
well	RB	O
on	IN	O
her	PRP$	B-TREATMENT
home	NN	I-TREATMENT
O2	NNP	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
2	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
.	.	O

The	DT	O
patient	NN	O
overall	JJ	O
continued	VBD	O
to	TO	O
improve	VB	O
,	,	O
but	CC	O
remained	VBD	O
physically	RB	B-PROBLEM
decompensated	VBN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Waltham/Weston	NNP	O
Hospital	NNP	O
Rehabilitation	NNP	O
Hospital	NNP	O
for	IN	O
intensive	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

DISCHARGE	NNP	B-TREATMENT
MEDICATIONS	NNP	I-TREATMENT
are	VBP	O
the	DT	O
same	JJ	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
jelly	RB	I-TREATMENT
to	TO	O
be	VB	O
applied	VBN	O
to	TO	O
buttock	VB	O
prn	NN	O
and	CC	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
swish	NN	I-TREATMENT
and	CC	I-TREATMENT
swallow	JJ	I-TREATMENT
tid	NN	O
prn	NN	O
before	IN	O
meals	NNS	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
86-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
with	IN	O
a	DT	O
two	CD	O
day	NN	O
history	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
easy	JJ	B-PROBLEM
fatigability	NN	I-PROBLEM
.	.	O

She	PRP	O
also	RB	O
noted	VBD	O
increased	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

She	PRP	O
denies	VBZ	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
noted	VBN	O
some	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
intermittent	NN	O
times	NNS	O
a	DT	O
couple	NN	O
of	IN	O
days	NNS	O
,	,	O
none	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

Denied	NNP	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
bowel	FW	B-PROBLEM
movement	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
noted	VBN	O
increased	VBN	B-PROBLEM
urinary	JJ	I-PROBLEM
frequency	NN	I-PROBLEM
.	.	O

Denies	NNPS	O
fever	NN	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

Of	IN	O
note	NN	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
recent	JJ	B-TREATMENT
medication	NN	I-TREATMENT
changes	NNS	I-TREATMENT
which	WDT	O
included	VBD	O
discontinuing	VBG	O
Diovan	NNP	B-TREATMENT
and	CC	O
starting	VBG	O
terazosin	NN	B-TREATMENT
.	.	O

1.	CD	O
Diabetes	NNPS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

2.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

3.	CD	O
Osteoarthritis	NNP	B-PROBLEM
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
Norvasc	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
Isosorbide	NNP	B-TREATMENT
mononitrate	NN	I-TREATMENT
30	CD	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
Terazosin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

Positive	NNP	O
for	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

No	DT	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
151/61	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
75	CD	O
,	,	O
SaO2	NNP	B-TEST
93%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
patient	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Jugular	NNP	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
notable	JJ	O
at	IN	O
the	DT	O
mid	NN	O
neck	NN	O
upright	VBD	O
about	RB	O
80	CD	O
degree	JJ	O
angles	NNS	O
.	.	O

Cardiovascular	JJ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
1-2/6	JJ	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

Crackles	NNS	B-PROBLEM
bilaterally	RB	I-PROBLEM
one-third	JJ	O
to	TO	O
one-half	VB	O
the	DT	O
way	NN	O
up	RP	O
.	.	O

Bowel	NNP	B-TEST
sounds	VBZ	I-TEST
positive	JJ	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
.	.	O

1+	CD	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Included	VBN	O
normal	JJ	O
CBC	NNP	O
,	,	O
BUN	NNP	B-TEST
47	CD	O
,	,	O
creatinine	NN	B-TEST
2.4	CD	O
up	IN	O
from	IN	O
baseline	NN	O
of	IN	O
about	IN	O
1.5	CD	O
.	.	O

Troponin	NNP	B-TEST
4.7	CD	O
,	,	O
CK	NNP	B-TEST
101	CD	O
,	,	O
MB	NNP	B-TEST
3	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
patient	NN	O
was	VBD	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

ELECTROCARDIOGRAM	NN	B-TEST
:	:	O

Showed	NNP	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
107	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
with	IN	O
left	JJ	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
R-wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
no	DT	O
acute	NN	B-PROBLEM
changes	NNS	I-PROBLEM
were	VBD	O
apparent	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Cardiac	NNP	O
Medicine	NNP	O
Service	NNP	O
and	CC	O
treated	VBN	O
for	IN	O
presumed	JJ	O
diastolic	JJ	B-PROBLEM
and	CC	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

Echocardiogram	NNP	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
moderately	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
hypokinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
half	NN	I-PROBLEM
of	IN	I-PROBLEM
septum	NN	I-PROBLEM
and	CC	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

Also	RB	O
of	IN	O
note	NN	O
was	VBD	O
the	DT	B-PROBLEM
distal	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
new	JJ	O
.	.	O

It	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
a	DT	B-TEST
troponin	NN	I-TEST
on	IN	O
admission	NN	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	VBZ	I-PROBLEM
she	PRP	O
underwent	VBD	O
a	DT	B-PROBLEM
non-Q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
prior	RB	O
to	TO	O
resulted	VB	O
in	IN	O
her	PRP$	B-PROBLEM
current	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Throughout	IN	O
hospital	JJ	O
course	NN	O
patient	NN	B-TEST
's	POS	I-TEST
troponin	NN	I-TEST
trended	VBD	O
down	RB	O
to	TO	O
less	JJR	O
than	IN	O
0.3	CD	O
.	.	O

She	PRP	O
was	VBD	O
continued	VBN	O
with	IN	O
aggressive	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
_________	NN	O
with	IN	O
excellent	JJ	O
diuresis	NN	O
,	,	O
however	RB	O
,	,	O
her	PRP	B-PROBLEM
renal	JJ	I-PROBLEM
functioning	VBG	I-PROBLEM
worsening	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
was	VBD	O
deferred	VBN	O
until	IN	O
the	DT	B-PROBLEM
renal	JJ	I-PROBLEM
issue	NN	I-PROBLEM
could	MD	O
be	VB	O
resolved	VBN	O
.	.	O

However	RB	O
,	,	O
her	PRP	B-TEST
creatinine	VBP	I-TEST
continued	VBN	O
to	TO	O
increase	VB	O
.	.	O

Diuresis	NN	B-TREATMENT
was	VBD	O
halted	VBN	O
and	CC	O
without	IN	O
improvement	NN	O
in	IN	O
creatinine	NN	B-TEST
.	.	O

A	DT	B-TEST
renal	JJ	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

It	PRP	O
showed	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
kidney	NN	I-TEST
size	NN	I-TEST
of	IN	O
6.3	CD	O
cm	NN	O
and	CC	O
a	DT	B-TEST
left	JJ	I-TEST
kidney	NN	I-TEST
size	NN	I-TEST
of	IN	O
8.4	CD	O
cm	NN	O
.	.	O

Given	VBN	O
her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
which	WDT	O
was	VBD	O
very	RB	O
difficult	JJ	O
to	TO	O
control	VB	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
she	PRP	O
had	VBD	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
thus	RB	O
she	PRP	O
underwent	JJ	O
MRA	NNP	B-TEST
of	IN	I-TEST
the	DT	I-TEST
kidney	NN	I-TEST
which	WDT	O
showed	VBD	O
severe	JJ	B-PROBLEM
right	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
at	IN	I-PROBLEM
its	PRP$	I-PROBLEM
origin	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
also	RB	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
focal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
approximately	RB	O
1.3	CD	O
cm	NN	O
from	IN	O
its	PRP$	O
origin	NN	O
.	.	O

She	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
unit	NN	O
overnight	VBD	O
to	TO	O
assess	VB	O
volume	NN	B-TEST
which	WDT	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
optimal	JJ	O
.	.	O

On	IN	O
05-25	JJ	O
she	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
and	CC	O
subsequent	JJ	B-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
renal	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

Due	JJ	O
to	TO	O
dye	VB	B-TREATMENT
load	NN	I-TREATMENT
required	VBN	O
to	TO	O
assess	VB	O
the	DT	B-PROBLEM
coronary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
were	VBD	O
not	RB	O
visualized	VBN	O
.	.	O

After	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
.	.	O

However	RB	O
,	,	O
her	PRP	B-TEST
creatinine	NN	I-TEST
has	VBZ	O
worsened	VBN	B-PROBLEM
up	RP	O
to	TO	O
4.2	CD	O
.	.	O

However	RB	O
,	,	O
her	PRP	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
has	VBZ	O
improved	VBN	O
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
required	VBN	O
hemodialysis	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

1.	CD	O
Non-Q	JJ	B-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
Systolic	NNP	B-PROBLEM
and	CC	I-PROBLEM
diastolic	JJ	I-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

3.	CD	O
Bilateral	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
status	NN	O
post	NN	O
stent	NN	B-TREATMENT
left	VBD	I-TREATMENT
renal	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

4.	CD	O
Acute	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

5.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
Norvasc	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
Protonix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
Multivitamin	NNP	B-TREATMENT
one	CD	O
p.o.	NN	O
q.	NN	O
day	NN	O
.	.	O

6.	CD	O
Carvedilol	NNP	B-TREATMENT
3.125	CD	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
___________	JJ	O
dinitrate	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

8.	CD	O
Erythropoietin	NNP	B-TREATMENT
10,000	CD	O
units	NNS	O
two	CD	O
times	NNS	O
a	DT	O
week	NN	O
Tuesday	NNP	O
and	CC	O
Saturday	NNP	O
.	.	O

9.	CD	O
Calcium	NNP	B-TREATMENT
acetate	NN	I-TREATMENT
Tums	NNP	I-TREATMENT
one	CD	O
p.o.	NN	O
t.i.d.	NN	O
with	IN	O
meals	NNS	O
.	.	O

10.	CD	O
Tylenol	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
4-6	JJ	O
h.	NN	O
p.r.n.	NN	O

11.	CD	O
Iron	NNP	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

12.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
Hydralazine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
6h.	CD	O

14.	CD	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	VBZ	O
30	CD	O
days	NNS	O
.	.	O

22	CD	O
year	NN	O
old	JJ	O
female	NN	O
transfer	NN	O
from	IN	O
outside	JJ	O
hospital	NN	O
after	IN	O
a	DT	O
motor	NN	O
vehicle	NN	O
accident	NN	O
with	IN	O
diagnosed	JJ	B-PROBLEM
liver	NN	I-PROBLEM
laceration	NN	I-PROBLEM
by	IN	O
CT	NNP	B-TEST
scan	NN	I-TEST
.	.	O

Neck	NN	O
with	IN	O
cervical	JJ	B-TREATMENT
collar	NN	I-TREATMENT
.	.	O

Left	NNP	B-PROBLEM
forarm	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
knee	NN	I-PROBLEM
abrasions	NNS	I-PROBLEM
.	.	O

Chest	JJS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilateral	JJ	O
,	,	O
S1	NNP	O
S2	NNP	O
normal	JJ	O
and	CC	O
with	IN	O
no	DT	O
murmors	NNS	B-PROBLEM
.	.	O

Abdominal	NNP	B-PROBLEM
pain	NN	I-PROBLEM
predominally	RB	O
on	IN	O
the	DT	O
right	JJ	O
upper	NN	O
quadrant	NN	O
,	,	O
no	DT	O
signs	NNS	O
of	IN	O
peritoneal	JJ	B-PROBLEM
irritation	NN	I-PROBLEM
.	.	O

GLUCOSE	NNP	B-TEST
-	:	O
74	CD	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
9	CD	O
CREAT	NNP	B-TEST
-	:	O
0.7	CD	O
SODIUM	NNP	B-TEST
-	:	O
139	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
3.5	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
106	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
23	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
14	CD	O

ALT(SGPT)	NNP	B-TEST
-	:	O
241	CD	O
*	NN	O
AST(SGOT)	NNP	B-TEST
-	:	O
207	CD	O
*	JJ	O
ALK	NNP	B-TEST
PHOS	NNP	I-TEST
-	:	O
51	CD	O
TOT	NNP	B-TEST
BILI	NNP	I-TEST
-	:	O
0.8	CD	O

CALCIUM	NNP	B-TEST
-	:	O
8.2	CD	O
*	NN	O
PHOSPHATE	NNP	B-TEST
-	:	O
3.1	CD	O
MAGNESIUM	NNP	B-TEST
-	:	O
2.2	CD	O

GLUCOSE	NNP	B-TEST
-	:	O
75	CD	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
10	CD	O
CREAT	NNP	B-TEST
-	:	O
0.6	CD	O
SODIUM	NNP	B-TEST
-	:	O
137	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
3.7	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
103	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
23	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
15	CD	O

ALT(SGPT)	NNP	B-TEST
-	:	O
318	CD	O
*	NN	O
AST(SGOT)	NNP	B-TEST
-	:	O
307	CD	O
*	JJ	O
ALK	NNP	B-TEST
PHOS	NNP	I-TEST
-	:	O
61	CD	O
TOT	NNP	B-TEST
BILI	NNP	I-TEST
-	:	O
0.9	CD	O

WBC	NNP	B-TEST
-	:	O
8.3	CD	O
RBC	NNP	B-TEST
-	:	O
3.64	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
12.6	CD	O
HCT	NNP	B-TEST
-	:	O
36.1	CD	O
MCV	NNP	B-TEST
-	:	O
99	CD	O
*	NN	O
MCH	NNP	B-TEST
-	:	O
34.7	CD	O
*	NN	O
MCHC	NNP	B-TEST
-	:	O
35.0	CD	O
RDW	NNP	B-TEST
-	:	O
12.4	CD	O

PT	NNP	B-TEST
-	:	O
11.6	CD	O
PTT	NNP	B-TEST
-	:	O
26.0	CD	O
INR(PT)	NNP	B-TEST
-	:	O
0.9	CD	O

Patient	NN	O
was	VBD	O
admited	VBN	O
,	,	O
pain	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
a	DT	B-TREATMENT
PCA	NNP	I-TREATMENT
and	CC	O
later	RB	O
with	IN	O
PO	NNP	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

The	DT	B-PROBLEM
liver	NN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
stable	JJ	O
,	,	O
no	DT	O
sign	NN	O
of	IN	O
rupture	NN	B-PROBLEM
or	CC	O
further	JJ	B-PROBLEM
complication	NN	I-PROBLEM
,	,	O
did	VBD	O
not	RB	O
required	VBN	O
surgical	JJ	B-TREATMENT
managment	NN	I-TREATMENT
.	.	O

The	DT	B-TEST
liver	NN	I-TEST
enzimes	VBZ	I-TEST
come	VBP	O
down	RP	O
,	,	O
no	DT	O
signs	NNS	O
of	IN	O
biliary	JJ	B-PROBLEM
stasis	NN	I-PROBLEM
.	.	O

1.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
.	.	O

2.	CD	O
Hydromorphone	CD	B-TREATMENT
2	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q2H	NNP	O
(	(	O
every	DT	O
2	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
Pain	NNP	B-PROBLEM
for	IN	O
4	CD	O
days	NNS	O
.	.	O

-	:	O
Follow	VB	O
up	RP	O
with	IN	O
Trauma	NNP	O
Surgery	NNP	O
Clinic	NNP	O
with	IN	O
the	DT	O
Result	NN	O
from	IN	O
the	DT	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
abdomen	NNS	I-TEST

-	:	O
Call	NN	O
for	IN	O
appointment	NN	O
to	TO	O
(	(	O
289	CD	O
)	)	O
411-5387	NN	O
for	IN	O
the	DT	O
Trauma	NNP	O
Clinic	NNP	O
and	CC	O
Abdominal	NNP	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
Abdomen	NNP	I-TEST
in	IN	O
4	CD	O
weeks	NNS	O

-	:	O
If	IN	O
any	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
,	,	O
go	VB	O
to	TO	O
the	DT	O
Emergency	NNP	O
Room	NNP	O

-	:	O
Analgesic	NN	B-TREATMENT
(	(	I-TREATMENT
Percocet	NNP	I-TREATMENT
)	)	I-TREATMENT
as	IN	O
needed	VBN	O

-	:	O
Trauma	NN	O
Surgery	NNP	O
Clinic	NNP	O
in	IN	O
four	CD	O
weeks	NNS	O
with	IN	O
CT	NNP	B-TEST
abdomen	NNS	I-TEST
results	NNS	O
.	.	O

Call	VB	O
Trauma	NNP	O
Clinic	NNP	O
to	TO	O
coordinate	VB	O
the	DT	B-TEST
study	NN	I-TEST
,	,	O
result	NN	O
and	CC	O
appointment	NN	O
dates	NNS	O
((	VBP	O
289	CD	O
)	)	O
411-5387	CD	O
).	NN	O

He	PRP	O
is	VBZ	O
a	DT	O
39	CD	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
hyperlipidemia	NN	B-PROBLEM
and	CC	O
smoking	NN	O
who	WP	O
presented	VBD	O
with	IN	O
acute	JJ	O
onset	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
since	IN	O
five	CD	O
in	IN	O
the	DT	O
morning	NN	O
with	IN	O
radiation	NN	O
to	TO	O
the	DT	O
left	JJ	O
arm	NN	O
and	CC	O
nausea	NN	B-PROBLEM
.	.	O

Symptoms	NNS	B-PROBLEM
resolved	VBD	O
spontaneously	RB	O
.	.	O

Cath	NN	O
Lab	NNP	O
at	IN	O
the	DT	O
Pinewood	NNP	O
,	,	O
Norfolk	NNP	O
that	IN	O
evening	VBG	O
where	WRB	O
a	DT	B-TREATMENT
stent	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
RCA	NNP	I-TREATMENT
was	VBD	O
complicated	VBN	O
by	IN	O
guidewire	NN	O
entrapment	NN	O
inside	IN	O
of	IN	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
requiring	VBG	O
CT	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
to	TO	O
do	VB	O
a	DT	B-TREATMENT
thoracotomy	NN	I-TREATMENT
with	IN	O
bypass	NN	B-TREATMENT
and	CC	O
excision	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
wire	NN	I-TREATMENT
.	.	O

The	DT	O
case	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
an	DT	O
episode	NN	O
of	IN	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
bleed	NN	I-PROBLEM
from	IN	I-PROBLEM
femoral	JJ	I-PROBLEM
access	NN	I-PROBLEM
site	NN	I-PROBLEM
prior	RB	O
to	TO	O
CT	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Gastroenterology	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
they	PRP	O
recommended	VBD	O
Protonix	NNP	B-TREATMENT
and	CC	O
felt	VBD	O
it	PRP	O
was	VBD	O
due	JJ	O
to	TO	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
Hepatitis	NNP	B-PROBLEM
B	NNP	I-PROBLEM
.	.	O

2.	CD	O
Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

3.	CD	O
Fatty	NNP	B-PROBLEM
liver	RB	I-PROBLEM
resolved	VBD	O
.	.	O

Relatively	RB	O
unknown	JJ	O
other	JJ	O
than	IN	O
Lipitor	NNP	B-TREATMENT
.	.	O

ALLERGIES	NN	O
:	:	O
He	PRP	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

FAMILY	NNP	O
HISTORY	NNP	O
:	:	O
Not	RB	O
significant	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
emergently	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2009-05-02	JJ	O
for	IN	O
his	PRP$	B-TREATMENT
CABG	NNP	I-TREATMENT
,	,	O
right	RB	B-TREATMENT
coronary	JJ	I-TREATMENT
endarterectomy	NN	I-TREATMENT
,	,	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
RCA	NNP	I-TREATMENT
stents	NNS	I-TREATMENT
and	CC	O
retrieval	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
aortic	JJ	I-TREATMENT
guidewire	NN	I-TREATMENT
.	.	O

Postoperatively	RB	O
he	PRP	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Cardiac	NNP	O
Surgery	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
where	WRB	O
he	PRP	O
was	VBD	O
on	IN	O
pressor	JJ	B-TREATMENT
support	NN	I-TREATMENT
of	IN	O
Neo-Synephrine	NNP	B-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
extubated	VBN	O
.	.	O

The	DT	O
patient	NN	O
slowly	RB	O
weaned	VBD	O
off	RP	O
Neo-Synephrine	JJ	B-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

His	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
had	VBD	O
been	VBN	O
discontinued	VBN	O
.	.	O

Upon	IN	O
arrival	NN	O
to	TO	O
the	DT	O
floor	NN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
2009-05-05	JJ	O
and	CC	O
his	PRP$	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

His	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
repleted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
2009-05-06	JJ	O
after	IN	O
tolerating	VBG	O
a	DT	O
level	NN	O
V	NNP	O
.	.	O

MEDICATIONS	NN	O
:	:	O
His	PRP$	B-TREATMENT
prescriptions	NNS	I-TREATMENT
shall	MD	O
include	VB	O

1.	CD	O
Lopressor	NNP	B-TREATMENT
25	CD	O
milligrams	NNS	O
po	JJ	O
bid	NN	O
.	.	O

2.	CD	O
Lipitor	NNP	B-TREATMENT
20	CD	O
milligrams	NNS	O
po	VBP	O
q	JJ	O
HS	NNP	O
.	.	O

3.	CD	O
Niferex	NNP	B-TREATMENT
150	CD	O
milligrams	NNS	O
caplet	VBP	O
one	CD	O
cap	NN	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
Protonix	NNP	B-TREATMENT
40	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
.	.	O

5.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
milligrams	NNS	O
po	JJ	O
bid	NN	O
.	.	O

6.	CD	O
Percocet	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
q	VBP	O
four	CD	O
H	NNP	O
prn	NN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
Plavix	NNP	B-TREATMENT
75	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
times	NNS	O
three	CD	O
months	NNS	O
.	.	O

8.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
.	.	O

9.	CD	O
Lasix	NNP	B-TREATMENT
20	CD	O
milligrams	NNS	O
po	VBP	O
times	NNS	O
30	CD	O
days	NNS	O
.	.	O

10.	CD	O
KCL	NNP	B-TREATMENT
20	CD	O
milliequivalents	NNS	O
po	JJ	O
q	NN	O
d	NN	O
times	NNS	O
three	CD	O
days	NNS	O
.	.	O

Prostate	NNP	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Status	NNP	O
post	NN	O
radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
64	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
elevated	JJ	B-PROBLEM
PSA	NNP	I-PROBLEM
,	,	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
needle	JJ	B-TEST
biopsy	NN	I-TEST
on	IN	O
either	DT	O
side	NN	O
of	IN	O
the	DT	O
prostate	NN	O
with	IN	O
3+3	CD	O
equals	NNS	O
6	CD	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
and	CC	O
3+4	CD	O
equals	NNS	O
7	CD	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
.	.	O

The	DT	O
patient	JJ	O
underwent	JJ	O
radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
on	IN	O
2012-01-20	JJ	O
.	.	O

Dr.	NNP	O
Marie	NNP	O
Anderson	NNP	O
performed	VBD	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
he	PRP	O
was	VBD	O
administered	VBN	O
1	CD	B-TREATMENT
mg	JJ	I-TREATMENT
Coumadin	NNP	I-TREATMENT
per	FW	O
protocol	NN	O
as	RB	O
well	RB	O
as	IN	O
on	IN	O
the	DT	O
operative	JJ	O
day	NN	O
1	CD	O
mg	NN	O
of	IN	O
Coumadin	NNP	B-TREATMENT
.	.	O

His	PRP$	B-TEST
laboratories	NNS	I-TEST
were	VBD	O
checked	VBN	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
stable	JJ	O
.	.	O

His	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
well	RB	O
controlled	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
medication	NN	I-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

His	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

His	PRP$	B-TREATMENT
Penrose	NNP	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

He	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
with	IN	O
a	DT	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
he	PRP	O
will	MD	O
follow-up	VB	O
with	IN	O
Dr.	NNP	O
Ross	NNP	O
in	IN	O
one	CD	O
to	TO	O
two	CD	O
weeks	NNS	O
.	.	O

Iodine	NNP	B-TREATMENT
;	:	O
Iodine	NNP	B-TREATMENT
Containing	NNP	I-TREATMENT

Tracheostomy	CD	B-TREATMENT
2014-11-11	JJ	O

Bronchoscopy	NNP	B-TEST
2014-11-05	JJ	O

Atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
(	(	O
on	IN	O
Coumadin	NNP	B-TREATMENT
)	)	O

Coronary	JJ	B-PROBLEM
Artery	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM

Ulcerative	JJ	B-PROBLEM
Colitis	NNP	I-PROBLEM
w/	NN	O
colostomy	NN	B-TREATMENT

Hypertension	NN	B-PROBLEM

Pacemaker	NN	B-TREATMENT

CVA	NN	B-PROBLEM
2012	CD	O
w/	NN	O
right	RB	B-PROBLEM
sided	VBD	I-PROBLEM
weakness	NN	I-PROBLEM

Cataracts	NNS	B-PROBLEM
,	,	O
s/p	JJ	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT

s/p	NN	O
TURP	NNP	B-TREATMENT

GLUCOSE	NNP	B-TEST
-	:	O
126	CD	O
*	JJ	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
9	CD	O
CREAT	NNP	B-TEST
-	:	O
0.8	CD	O
SODIUM	NNP	B-TEST
-	:	O
135	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
3.4	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
99	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
25	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
14	CD	O

CALCIUM	NNP	B-TEST
-	:	O
8.2	CD	O
*	NN	O
PHOSPHATE	NNP	B-TEST
-	:	O
2.1	CD	O
*	JJ	O
MAGNESIUM	NNP	B-TEST
-	:	O
1.9	CD	O

WBC	NNP	B-TEST
-	:	O
6.5	CD	O
RBC	NNP	B-TEST
-	:	O
3.68	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
11.6	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
32.5	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
88	CD	O
MCH	NNP	B-TEST
-	:	O
31.5	CD	O
MCHC	NNP	B-TEST
-	:	O
35.6	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
13.6	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
207	CD	O

PT	NNP	B-TEST
-	:	O
15.0	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
31.3	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.5	CD	O

TYPE	NNP	O
-	:	O
ART	NNP	O
TEMP	NNP	B-TEST
-	:	O
36.6	CD	O
RATES	NNPS	B-TEST
-	:	O
14	CD	O
/	JJ	O
TIDAL	NNP	B-TEST
VOL	NNP	I-TEST
-	:	O
550	CD	O
PEEP	NNP	B-TREATMENT
-	:	O
5	CD	O
O2	NNP	B-TREATMENT
-	:	O
100	CD	O
PO2	NNP	B-TEST
-	:	O
416	CD	O
*	NN	O
PCO2	NNP	B-TEST
-	:	O
39	CD	O
PH	NNP	B-TEST
-	:	O
7.41	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
26	CD	O
BASE	NNP	B-TEST
XS	NNP	I-TEST
-	:	O
0	CD	O
AADO2	NNP	B-TEST
-	:	O
279	CD	O
REQ	NNP	B-TEST
O2	NNP	I-TEST
-	:	O
52	CD	O
-	:	O
ASSIST	NNP	O
/	NNP	O
CON	NNP	O
INTUBATED	NNP	O
-	:	O
INTUBATED	NN	O

ASA	NNP	B-TEST
-	:	O
NEG	NNP	O
ETHANOL	NNP	B-TEST
-	:	O
NEG	NNP	O
ACETMNPHN	NNP	B-TEST
-	:	O
NEG	NNP	O
bnzodzpn	SYM	B-TEST
-	:	O
NEG	NNP	O
barbitrt	SYM	B-TEST
-	:	O
NEG	NNP	O
tricyclic	JJ	B-TEST
-	:	O
NEG	NN	O

2014-10-21	JJ	O
09:35	CD	O
AM	NNP	O
URINE	NNP	B-TEST

bnzodzpn	SYM	B-TEST
-	:	O
NEG	NNP	O
barbitrt	SYM	B-TEST
-	:	O
NEG	NN	O
opiates	VBZ	B-TEST
-	:	O
NEG	NNP	O
cocaine	NN	B-TEST
-	:	O
NEG	NNP	O
amphetmn	SYM	B-TEST
-	:	O
NEG	NNP	O
mthdone	SYM	B-TEST
-	:	O
NEG	NN	O

CT	NNP	B-TEST
C	NNP	I-TEST
-	:	I-TEST
SPINE	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

CT	NNP	B-TEST
C	NNP	I-TEST
-	:	I-TEST
SPINE	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST
;	:	O
CT	NNP	O
RECONSTRUCTION	NNP	O

TECHNIQUE	NN	O
:	:	O
Noncontrast	NNP	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
CT	NNP	I-TEST
.	.	O

NOTE	NN	O
:	:	O
This	DT	B-TEST
study	NN	I-TEST
was	VBD	O
initially	RB	O
performed	VBN	O
on	IN	O
2014-10-21	JJ	O
.	.	O

Findings	NNS	O
were	VBD	O
discussed	VBN	O
with	IN	O
Dr.	NNP	O
Leanne	NNP	O
Vazquez	NNP	O
at	IN	O
the	DT	O
time	NN	O
this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
but	CC	O
the	DT	B-TEST
study	NN	I-TEST
was	VBD	O
not	RB	O
dictated	VBN	O
until	IN	O
the	DT	O
morning	NN	O
of	IN	O
2014-10-22	JJ	O
,	,	O
due	JJ	O
to	TO	O
PACS	NNP	O
malfunction	NN	O
.	.	O

NONCONTRAST	NNP	B-TEST
CERVICAL	NNP	I-TEST
SPINE	NNP	I-TEST
CT	NNP	I-TEST
:	:	O
There	EX	O
are	VBP	O
minimally	RB	B-PROBLEM
displaced	VBN	I-PROBLEM
and	CC	I-PROBLEM
comminuted	VBN	I-PROBLEM
fractures	NNS	I-PROBLEM
through	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
C7	NNP	I-PROBLEM
and	CC	I-PROBLEM
T1	NNP	I-PROBLEM
transverse	NN	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

Positioning	VBG	O
limits	NNS	O
assessment	NN	B-TEST
of	IN	I-TEST
alignment	NN	I-TEST
due	JJ	O
to	TO	O
extreme	JJ	B-PROBLEM
head	NN	I-PROBLEM
tilting	VBG	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
is	VBZ	O
likely	JJ	O
the	DT	O
best	JJS	O
obtainable	JJ	O
secondary	JJ	O
to	TO	O
intubation	NN	B-TREATMENT
and	CC	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
atlantoaxial	JJ	B-PROBLEM
subluxation	NN	I-PROBLEM
.	.	O

Prevertebral	JJ	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
secondary	JJ	O
to	TO	O
intubation	NN	B-TREATMENT
.	.	O

Extensive	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
arterial	JJ	I-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
bulb	NN	O
regions	NNS	O
bilaterally	RB	O
.	.	O

Biapical	NNP	B-PROBLEM
lung	NN	I-PROBLEM
scarring	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
bronchiectasis	NN	I-PROBLEM
are	VBP	O
present	JJ	O
.	.	O

Also	RB	O
noted	VBN	O
is	VBZ	O
sclerosis	JJ	B-PROBLEM
and	CC	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
visualized	JJ	I-PROBLEM
left	NN	I-PROBLEM
mastoid	NN	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
and	CC	I-PROBLEM
mastoid	JJ	I-PROBLEM
tip	NN	I-PROBLEM
,	,	O
likely	JJ	O
chronic	JJ	O
inflammatory	NN	O

disease	NN	B-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
Minimally	RB	B-PROBLEM
displaced	VBD	I-PROBLEM
,	,	I-PROBLEM
comminuted	VBD	I-PROBLEM
fractures	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
C7	NNP	I-PROBLEM
and	CC	I-PROBLEM
T1	NNP	I-PROBLEM
transverse	NN	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
extension	NN	B-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
foramina	JJ	I-PROBLEM
transversaria	NN	I-PROBLEM
.	.	O

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

Reason	NN	O
:	:	O
bleed	NN	B-PROBLEM
?	.	O

72	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
intraparenchymal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
s/p	NN	O
fall	NN	O

bleed	NN	B-PROBLEM
?	.	O

INDICATION	NN	O
:	:	O
Intraparenchymal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
after	IN	O
fall	NN	O
.	.	O

Assess	NNP	O
for	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

TECHNIQUE	NN	O
:	:	O
Non-contrast	JJ	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
.	.	O

COMPARISON	NN	O
:	:	O
No	DT	O
prior	JJ	B-TEST
studies	NNS	I-TEST
are	VBP	O
available	JJ	O
.	.	O

By	IN	O
report	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-TEST
outside	JJ	I-TEST
study	NN	I-TEST
.	.	O

Should	MD	O
this	DT	O
become	NN	O
available	JJ	O
,	,	O
an	DT	O
addendum	NN	O
will	MD	O
be	VB	O
issued	VBN	O
to	TO	O
this	DT	O
report	NN	O
following	VBG	O
the	DT	O
comparison	NN	O
with	IN	O
the	DT	B-TEST
outside	JJ	I-TEST
examination	NN	I-TEST
.	.	O

NOTE	NN	O
:	:	O
This	DT	B-TEST
study	NN	I-TEST
was	VBD	O
initially	RB	O
performed	VBN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
10-21	JJ	O
,	,	O
and	CC	O
is	VBZ	O
being	VBG	O
dictated	VBN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
10-22	NNS	O
due	JJ	O
to	TO	O
PACS	NNP	O
malfunction	NN	O
.	.	O

NON-CONTRAST	JJ	B-TEST
HEAD	NNP	I-TEST
CT	NNP	I-TEST
:	:	O
There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
within	IN	O
the	DT	O
occipital	JJ	O
horns	NNS	O
of	IN	O
both	DT	O
lateral	JJ	O
ventricles	NNS	O
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

Located	VBN	O
within	IN	O
the	DT	O
atrium	NN	O
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
is	VBZ	O
an	DT	B-PROBLEM
18	CD	I-PROBLEM
x	NN	I-PROBLEM
10	CD	I-PROBLEM
mm	NN	I-PROBLEM
nodular	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
increased	VBN	I-PROBLEM
density	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
separate	JJ	O
from	IN	O
the	DT	O
choroid	NN	O
plexus	NN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
diffuse	NN	B-PROBLEM
brain	NN	I-PROBLEM
atrophy	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
microvascular	NN	I-PROBLEM
infarction	NN	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
remote	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
acute	JJ	B-PROBLEM
major	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

The	DT	O
ventricles	NNS	O
do	VBP	O
not	RB	O
appear	VB	O
dilated	JJ	O
relative	NN	O
to	TO	O
the	DT	O
sulci	NN	O
,	,	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
skull	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
nasal	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
and	CC	I-PROBLEM
nasopharynx	NN	I-PROBLEM
but	CC	O
an	DT	B-TREATMENT
NG	NNP	I-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
is	VBZ	O
intubated	VBN	O
.	.	O

Opacified	NNP	B-PROBLEM
and	CC	I-PROBLEM
sclerotic	JJ	I-PROBLEM
left	NN	I-PROBLEM
mastoid	NN	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
noted	VBN	O
.	.	O

1.	CD	O
Small	JJ	O
amount	NN	O
of	IN	O
intraventricular	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
Ovoid	NNP	B-PROBLEM
18	CD	I-PROBLEM
-	:	I-PROBLEM
mm	NN	I-PROBLEM
density	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
atrium	NN	I-PROBLEM
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
.	.	O

This	DT	O
could	MD	O
represent	VB	O
either	CC	O
an	DT	B-PROBLEM
atypically	RB	I-PROBLEM
located	VBN	I-PROBLEM
blood	NN	I-PROBLEM
clot	NN	I-PROBLEM
or	CC	O
an	DT	B-PROBLEM
intraventricular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
and	CC	O
further	JJ	O
evaluation	NN	O
with	IN	O
contrast	NN	B-TEST
-	:	I-TEST
enhanced	JJ	I-TEST
MRI	NNP	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
,	,	O
when	WRB	O
clinically	RB	O
feasible	JJ	O
,	,	O
is	VBZ	O
recommended	VBN	O
.	.	O

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

Reason	NN	O
:	:	O
altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

INDICATION	NN	O
:	:	O
72-year-old	JJ	O
male	NN	O
with	IN	O
altered	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

TECHNIQUE	NN	O
:	:	O
Axial	JJ	B-TEST
noncontrast	NN	I-TEST
CT	NNP	I-TEST
scans	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
were	VBD	O
obtained	VBN	O
.	.	O

Comparison	NNP	O
is	VBZ	O
made	VBN	O
to	TO	O
a	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
from	IN	O
2014-10-27	JJ	O
.	.	O

There	EX	O
are	VBP	O
numerous	JJ	O
areas	NNS	O
of	IN	O
decreased	JJ	B-PROBLEM
attenuation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
subcortical	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
of	IN	O
both	DT	O
cerebral	JJ	O
hemispheres	NNS	O
,	,	O
indicating	VBG	O
chronic	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
also	RB	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
cortical	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
chronic	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
is	VBZ	O
also	RB	O
evident	JJ	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
blood	NN	I-PROBLEM
layering	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
ventricles	NNS	I-PROBLEM
,	,	O
and	CC	O
this	DT	O
has	VBZ	O
decreased	VBN	O
since	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
.	.	O

No	DT	O
new	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
observed	VBN	O
.	.	O

There	EX	O
is	VBZ	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mastoid	JJ	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
greater	JJR	O
on	IN	O
the	DT	O
left	NN	O
than	IN	O
the	DT	O
right	NN	O
.	.	O

There	EX	O
is	VBZ	O
some	DT	B-PROBLEM
fluid	NN	I-PROBLEM
or	CC	O
mucosal	NN	B-PROBLEM
thickening	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ethmoid	NN	I-PROBLEM
and	CC	I-PROBLEM
sphenoid	JJ	I-PROBLEM
sinuses	NNS	I-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
No	DT	O
new	JJ	B-PROBLEM
cortical	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
or	CC	O
hemorrhage	NN	B-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

There	EX	O
is	VBZ	O
decreased	JJ	B-PROBLEM
intraventricular	JJ	I-PROBLEM
blood	NN	I-PROBLEM
,	,	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
,	,	O
and	CC	O
there	EX	O
are	VBP	O
no	DT	O
signs	NNS	O
of	IN	O
hydrocephalus	NN	B-PROBLEM
.	.	O

CHEST	NNP	B-TEST
(	(	I-TEST
PORTABLE	NNP	I-TEST
AP	NNP	I-TEST
)	)	I-TEST

CHEST	NNP	B-TEST
(	(	I-TEST
PORTABLE	NNP	I-TEST
AP	NNP	I-TEST
)	)	I-TEST

Reason	NN	O
:	:	O
Fever	NN	B-PROBLEM
,	,	O
f/u	NN	O
infiltrte	NN	B-PROBLEM

72	CD	O
yo	NNS	O
M	NNP	O
with	IN	O
rib	NN	B-PROBLEM
fx	NN	I-PROBLEM
s/p	NN	O
trauma	NN	B-PROBLEM
,	,	O
failure	NN	O
on	IN	O
previous	JJ	B-TEST
CXR	NNP	I-TEST
,	,	O
now	RB	O
with	IN	O
fever	NN	B-PROBLEM
.	.	O

Fever	NNP	B-PROBLEM
,	,	O
f/u	NN	O
infiltrte	NN	B-PROBLEM

HISTORY	NN	O
:	:	O
Trauma	NN	B-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
.	.	O

Portable	JJ	B-TEST
supine	NN	I-TEST
chest	NN	I-TEST
radiograph	NN	I-TEST
shows	VBZ	O
improvement	NN	O
in	IN	O
edema	NN	B-PROBLEM
compared	VBN	O
to	TO	O
studies	NNS	B-TEST
from	IN	O
four	CD	O
and	CC	O
five	CD	O
days	NNS	O
earlier	RBR	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
radiographic	JJ	I-PROBLEM
change	NN	I-PROBLEM
in	IN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
consolidation	NN	I-PROBLEM
consistent	NN	O
with	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

Some	DT	B-PROBLEM
interstitial	JJ	I-PROBLEM
edema	NN	I-PROBLEM
still	RB	O
persists	VBZ	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
central	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
size	NN	I-TEST
is	VBZ	O
unchanged	JJ	O
.	.	O

The	DT	O
amount	NN	O
of	IN	O
fluid	NN	B-PROBLEM
layering	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apices	NNS	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
pleural	JJ	I-PROBLEM
spaces	NNS	I-PROBLEM
appear	VBP	O
slightly	RB	O
decreased	VBN	O
.	.	O

Multiple	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
.	.	O

Supporting	VBG	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	I-TREATMENT
lines	NNS	I-TREATMENT
are	VBP	O
in	IN	O
unchanged	JJ	O
position	NN	O
and	CC	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-TREATMENT
single	JJ	I-TREATMENT
lead	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
projected	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

Calcification	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
at	IN	O
both	DT	O
carotid	JJ	O
bifurcations	NNS	O
.	.	O

CONCLUSION	NN	O
:	:	O
Improvement	NN	O
in	IN	O
congestion	NN	B-PROBLEM
from	IN	O
edema	NN	B-PROBLEM
with	IN	O
no	DT	O
worsening	NN	O
,	,	O
but	CC	O
no	DT	O
significant	JJ	O
improvement	NN	O
,	,	O
in	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Supporting	VBG	B-TREATMENT
lines	NNS	I-TREATMENT
and	CC	I-TREATMENT
tubes	NNS	I-TREATMENT
in	IN	O
unchanged	JJ	O
position	NN	O
.	.	O

Admitted	VBN	O
to	TO	O
TSICU	NNP	O
for	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
and	CC	O
multiple	JJ	B-PROBLEM
spinal	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

Intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
for	IN	O
desats	NNS	B-PROBLEM
on	IN	O
2014-10-27	JJ	O
.	.	O

CT	NNP	B-TEST
head	NN	I-TEST
remained	VBD	O
stable	JJ	O
for	IN	O
SAH	NNP	B-PROBLEM
.	.	O

Evaluated	VBN	O
by	IN	O
orthopedic	JJ	O
spine	JJ	O
surgeons	NNS	O
with	IN	O
recommendations	NNS	O
for	IN	O
soft	JJ	B-TREATMENT
c-collar	JJ	I-TREATMENT
for	IN	O
comfort	NN	O
.	.	O

In	IN	O
TSICU	NNP	O
,	,	O
developed	VBD	O
MRSA	NNP	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
question	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
,	,	O
treated	VBD	O
Zosyn	NNP	B-TREATMENT
-->	NNP	O
vanc	NN	B-TREATMENT
/	NNP	O
levo	VBZ	B-TREATMENT
-->	NNP	O
then	RB	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
Linazolid	NNP	B-TREATMENT
with	IN	O
resolution	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
decreased	VBD	B-PROBLEM
pulmonary	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
.	.	O

2014-11-11	JJ	O
:	:	O
Tracheostomy	NN	B-TREATMENT
performed	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

Patient	NNP	O
tolerated	VBD	O
decreasing	VBG	B-TREATMENT
ventillary	JJ	I-TREATMENT
support.	NN	I-TREATMENT

Mental	JJ	O
status	NN	O
improved	VBN	O
with	IN	O
the	DT	O
discontinuation	NN	O
of	IN	O
his	PRP$	B-TREATMENT
bensodiazapines	NNS	I-TREATMENT
.	.	O

Failed	VBD	B-PROBLEM
swallow	NN	I-PROBLEM
study	NN	I-PROBLEM
x	VBD	O
2	CD	O
in	IN	O
early	JJ	O
November	NNP	O
.	.	O

Decision	NN	O
to	TO	O
continue	VB	O
Dobhoff	NNP	B-TREATMENT
at	IN	O
rehab	NN	O
given	VBN	O
continued	JJ	O
clinical	JJ	O
improvement	NN	O
and	CC	O
his	PRP$	O
poor	JJ	O
candidacy	NN	O
for	IN	O
G/J	NNP	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

Communicating	VBG	O
by	IN	O
speech	NN	O
s/p	NN	O
PMV	NNP	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

Occasionally	RB	O
required	VBN	O
Haldol	NNP	B-TREATMENT
/	NNP	O
ativan	NN	B-TREATMENT
at	IN	O
night	NN	O
for	IN	O
agitation	NN	B-PROBLEM
.	.	O

Progressed	VBN	O
adequately	RB	O
with	IN	O
physical	JJ	B-TREATMENT
/	NNP	I-TREATMENT
occupational	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
however	RB	O
was	VBD	O
noted	VBN	O
to	TO	O
develop	VB	O
an	DT	B-PROBLEM
early	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extermity	NN	I-PROBLEM
contracture	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
elbows	NNS	I-PROBLEM
and	CC	I-PROBLEM
wrists	NNS	I-PROBLEM
.	.	O

Serial	JJ	B-TEST
CT	NNP	I-TEST
head	NN	I-TEST
revealed	VBD	O
decreased	JJ	B-PROBLEM
blood	NN	I-PROBLEM
through	IN	O
2014-11-14	JJ	O
.	.	O

1.	CD	O
Heparin	NNP	B-TREATMENT
(	(	I-TREATMENT
Porcine	NNP	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit/mL	JJ	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Injection	NN	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
Lisinopril	NNP	B-TREATMENT
15	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

3.	CD	O
Lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
Susp	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
for	IN	O
Recon	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

4.	CD	O
Linezolid	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q12H	NNP	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
):	VBN	O
Last	JJ	O
dose	JJ	O
2014-11-20	JJ	O
.	.	O

5.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
TID	NNP	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
Digoxin	NNP	B-TREATMENT
125	CD	O
mcg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

7.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
150	CD	O
mg	NN	O
/	VBD	O
15	CD	O
mL	NN	O
Liquid	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
Bisacodyl	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

9.	CD	O
Magnesium	NNP	B-TREATMENT
Hydroxide	NNP	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
mL	JJ	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
Thirty	NNP	O
(	(	O
30	CD	O
)	)	O
ML	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
consitpation	NN	B-PROBLEM
.	.	O

Subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
w/	JJ	O
bilateral	JJ	B-PROBLEM
intraventricular	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM

Left	NNP	B-PROBLEM
T1	NNP	I-PROBLEM
transverse	NN	I-PROBLEM
process	NN	I-PROBLEM
fracture	NN	I-PROBLEM

C7	NNP	B-PROBLEM
&	CC	I-PROBLEM
T1	NNP	I-PROBLEM
mimimally	RB	I-PROBLEM
displaced	VBD	I-PROBLEM
transverse	JJ	I-PROBLEM
process	NN	I-PROBLEM
fracture	NN	I-PROBLEM

Left	NNP	B-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
05-22	VBP	O

You	PRP	O
must	MD	O
continue	VB	O
to	TO	O
wear	VB	O
your	PRP$	B-TREATMENT
cervical	JJ	I-TREATMENT
collar	NN	I-TREATMENT
for	IN	O
the	DT	O
next	JJ	O
4	CD	O
weeks	NNS	O
(	(	O
through	IN	O
12-11	CD	O
).	NNS	O

SURGERY	NN	B-TREATMENT

Sulfa	NNP	B-TREATMENT
(	(	I-TREATMENT
Sulfonamides	NNP	I-TREATMENT
)	)	I-TREATMENT
/	NN	O
Penicillins	NNS	B-TREATMENT

2015-10-27	JJ	O
Open	NNP	B-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
of	IN	O
right	JJ	B-PROBLEM
tib/fib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM

17	CD	O
yo	JJ	O
male	JJ	O
pedestrian	NN	O
who	WP	O
was	VBD	O
struck	VBN	O
by	IN	O
auto	NN	O
at	IN	O
unknown	JJ	O
speed	NN	O
;	:	O
+LOC	NNP	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
medflighted	VBN	O
to	TO	O
The	DT	O
Hospital	NNP	O
for	IN	O
Orthopedics	NNP	O
for	IN	O
ongoing	VBG	B-TREATMENT
trauma	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

Upon	IN	O
arrival	JJ	O
GCS	NNP	B-TEST
15	CD	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
x3	NN	O
.	.	O

Attention	NNP	B-PROBLEM
deficit	NN	I-PROBLEM
disorder	NN	I-PROBLEM
(	(	O
diagnosed	VBN	O
@	RB	O
14	CD	O
yrs	NN	O
of	IN	O
age	NN	O
)	)	O

GLUCOSE	NNP	B-TEST
-	:	O
101	CD	O
LACTATE	NNP	B-TEST
-	:	O
2.9	CD	O
*	NN	O
NA+	NNP	B-TEST
-	:	O
142	CD	O
K+	NNP	B-TEST
-	:	O
3.6	CD	O
CL-	JJ	B-TEST
-	:	O
102	CD	O
TCO2	NNP	B-TEST
-	:	O
26	CD	O

UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
12	CD	O
CREAT	NNP	B-TEST
-	:	O
1.0	CD	O

AMYLASE	NNP	B-TEST
-	:	O
44	CD	O

ASA	NNP	B-TEST
-	:	O
NEG	NNP	O
ETHANOL	NNP	B-TEST
-	:	O
NEG	NNP	O
ACETMNPHN	NNP	B-TEST
-	:	O
NEG	NNP	O
bnzodzpn	SYM	B-TEST
-	:	O
NEG	NNP	O
barbitrt	SYM	B-TEST
-	:	O
NEG	NNP	O
tricyclic	JJ	B-TEST
-	:	O
NEG	NN	O

WBC	NNP	B-TEST
-	:	O
16.0	CD	O
*	NN	O
RBC	NNP	B-TEST
-	:	O
4.89	CD	O
HGB	NNP	B-TEST
-	:	O
14.5	CD	O
HCT	NNP	B-TEST
-	:	O
40.4	CD	O
MCV	NNP	B-TEST
-	:	O
83	CD	O
MCH	NNP	B-TEST
-	:	O
29.7	CD	O
MCHC	NNP	B-TEST
-	:	O
35.9	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
13.4	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
247	CD	O

PT	NNP	B-TEST
-	:	O
12.7	CD	O
PTT	NNP	B-TEST
-	:	O
23.8	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.1	CD	O

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	I-TEST
CONTRAST	NNP	I-TEST

eval	NN	B-TEST
for	IN	O
bleed	NN	B-PROBLEM

TECHNIQUE	NN	O
:	:	O
Axial	JJ	B-TEST
MDCT	NNP	I-TEST
images	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
without	IN	O
IV	NNP	O
contrast	NN	O
.	.	O

FINDINGS	NN	O
:	:	O
There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
linear	JJ	I-PROBLEM
nondepressed	JJ	I-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	JJ	O
process	NN	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
components	NNS	O
of	IN	O
pneumocephalus	JJ	B-PROBLEM
tracking	VBG	O
from	IN	O
the	DT	O
mastoid	NN	O
air	NN	O
cells	NNS	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
also	RB	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
scalp	JJ	I-PROBLEM
contusion	NN	I-PROBLEM
but	CC	O
no	DT	O
associated	JJ	B-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Prominent	JJ	B-TREATMENT
sutures	NNS	I-TREATMENT
in	IN	O
this	DT	O
young	JJ	O
patient	NN	O
,	,	O
the	DT	B-TREATMENT
right	JJ	I-TREATMENT
calvarial	JJ	I-TREATMENT
suture	NN	I-TREATMENT
extending	VBG	O
into	IN	O
the	DT	O
right	JJ	O
temporal	JJ	O
bones	NNS	O
appears	VBZ	O
more	JJR	O
prominent	JJ	O
than	IN	O
its	PRP$	O
counterpart	NN	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
however	RB	O
,	,	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
represent	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

No	DT	O
other	JJ	B-PROBLEM
acute	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
appreciated	VBN	O
.	.	O

There	EX	O
is	VBZ	O
small	JJ	O
amount	NN	O
of	IN	O
mucosal	NN	B-PROBLEM
thickening	VBG	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
sphenoid	NN	I-PROBLEM
sinuses	VBZ	I-PROBLEM
.	.	O

No	DT	O
air-fluid	JJ	B-TEST
levels	NNS	I-TEST
to	TO	O
suggest	VB	O
occult	NN	B-PROBLEM
facial	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
Linear	JJ	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	JJ	O
process	NN	O
with	IN	O
small	JJ	B-PROBLEM
associated	VBN	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
convexity	NN	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
pneumocephalus	NN	B-PROBLEM
.	.	O

Discussed	VBN	O
with	IN	O
trauma	JJ	O
team	NN	O
during	IN	O
the	DT	B-TEST
study	NN	I-TEST
.	.	O

CT	NNP	B-TEST
C-SPINE	NNP	I-TEST
W/O	NNP	O
CONTRAST	NNP	O

eval	NN	B-TEST
for	IN	O
fx	NN	B-PROBLEM

Head	NNP	B-PROBLEM
injury	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
occiput	NN	I-PROBLEM
.	.	O

TECHNIQUE	NN	O
:	:	O
Axial	JJ	B-TEST
MDCT	NNP	I-TEST
images	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
with	IN	O
coronal	JJ	O
and	CC	O
sagittal	JJ	O
reformats	NNS	O
without	IN	O
IV	NNP	O
contrast	NN	O
.	.	O

There	EX	O
is	VBZ	O
normal	JJ	O
alignment	NN	O
of	IN	O
the	DT	O
cervical	JJ	O
vertebral	JJ	O
bodies	NNS	O
without	IN	O
acute	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
or	CC	O
traumatic	JJ	B-PROBLEM
malalignment	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
prevertebral	JJ	I-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
.	.	O

The	DT	O
lung	NN	O
apices	NNS	O
are	VBP	O
clear	JJ	O
without	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
linear	JJ	I-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
right	JJ	O
temporal	JJ	O
bones	NNS	O
.	.	O

Multiple	NNP	O
posterior	RB	O
right	RB	O
-	:	O
sided	VBN	O
mastoid	JJ	O
air	NN	O
cells	NNS	O
are	VBP	O
opacified	VBN	B-PROBLEM
with	IN	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

1)	CD	O
No	DT	O
acute	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
spine	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

2)	CD	O
Linear	JJ	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	NN	O
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
convexity	NN	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
pneumocephalus	NN	B-PROBLEM
;	:	O
see	VB	O
head	JJ	B-TEST
CT	NNP	I-TEST
report	NN	O
.	.	O

CHEST	NNP	B-TEST
(	(	I-TEST
PA	NNP	I-TEST
&	CC	I-TEST
LAT	NNP	I-TEST
)	)	I-TEST

Reason	NN	O
:	:	O
Please	NNP	O
r/o	VB	O
acute	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

17	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
post-op	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

Please	NNP	O
r/o	VB	O
acute	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

INDICATION	NN	O
:	:	O
Postoperative	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

TECHNIQUE	NN	O
:	:	O
PA	NNP	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
views	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
.	.	O

There	EX	O
are	VBP	O
no	DT	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
or	CC	O
focal	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
CHF	NNP	B-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
No	DT	O
evidence	NN	O
of	IN	O
significant	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

TIB	NNP	B-TEST
/	NNP	I-TEST
FIB	NNP	I-TEST
(	(	I-TEST
AP	NNP	I-TEST
&	CC	I-TEST
LAT	NNP	I-TEST
)	)	I-TEST
SOFT	NNP	O
TISSUE	NNP	O

Reason	NN	O
:	:	O
eval	NN	B-TEST
for	IN	I-TEST
alignment	NN	I-TEST
,	,	I-TEST
post	NN	I-TEST
op	NN	I-TEST
changes	NNS	I-TEST

56	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
open	JJ	B-PROBLEM
RLE	NNP	I-PROBLEM
fx	NN	I-PROBLEM
now	RB	O
s/p	VBZ	B-TREATMENT
fixation	NN	I-TREATMENT

eval	NN	B-TEST
for	IN	I-TEST
alignment	NN	I-TEST
,	,	I-TEST
post	NN	I-TEST
op	NN	I-TEST
changes	NNS	I-TEST

INDICATION	NN	O
:	:	O
Fracture	NN	B-PROBLEM
.	.	O
Assess	NNP	O
for	IN	O
alignment	NN	O
.	.	O

RIGHT	NNP	B-TEST
TIBIA	NNP	I-TEST
/	NNP	I-TEST
FIBULA	NNP	I-TEST
,	,	I-TEST
AP	NNP	I-TEST
AND	NNP	I-TEST
LATERAL	NNP	I-TEST
VIEWS	NNP	I-TEST
:	:	O
An	DT	B-TREATMENT
intramedullary	JJ	I-TREATMENT
rod	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
fixating	VBG	O
a	DT	B-PROBLEM
proximal	JJ	I-PROBLEM
diaphyseal	NN	I-PROBLEM
comminuted	VBN	I-PROBLEM
tibial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
six	CD	B-TREATMENT
proximal	JJ	I-TREATMENT
and	CC	I-TREATMENT
two	CD	I-TREATMENT
distal	JJ	I-TREATMENT
screws	NNS	I-TREATMENT
.	.	O

Additionally	RB	O
,	,	O
a	DT	B-TREATMENT
side	NN	I-TREATMENT
plate	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
medially	RB	O
fixating	VBG	O
the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
non-displaced	JJ	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
fibular	JJ	I-PROBLEM
diaphysis	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
surrounding	VBG	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
Comminuted	VBN	B-PROBLEM
proximal	JJ	I-PROBLEM
tibiofibular	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
ORIF	NNP	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
tibia	NN	I-TREATMENT
with	IN	O
an	DT	B-TREATMENT
intramedullary	JJ	I-TREATMENT
rod	NN	I-TREATMENT
and	CC	I-TREATMENT
side	NN	I-TREATMENT
plate	NN	I-TREATMENT
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
immediate	JJ	B-PROBLEM
hardware	NN	I-PROBLEM
complication	NN	I-PROBLEM
.	.	O

CT	NNP	B-TEST
HEAD	NNP	I-TEST
W/O	NNP	O
CONTRAST	NNP	O

Reason	NN	O
:	:	O
follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST

17	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
pneumocephalus	JJ	B-PROBLEM
s/p	NN	O
CMED	NNP	O
CCU	NNP	O
v.	NN	O
mvc	NN	O

follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST

CLINICAL	JJ	O
HISTORY	NN	O
:	:	O
History	NN	O
of	IN	O
pneumocephalus	NN	B-PROBLEM
status	NN	O
post	NN	O
pedestrian	JJ	O
versus	NN	O
motor	NN	O
vehicle	NN	O
collision	NN	O
.	.	O

Follow	NNP	B-TEST
up	RP	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
.	.	O

COMPARISON	NN	O
:	:	O
Non-contrast	JJ	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
from	IN	O
2015-10-27	JJ	O
.	.	O

TECHNIQUE	NN	O
:	:	O
Non-contrast	JJ	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
.	.	O

FINDINGS	NNS	O
:	:	O
The	DT	O
previously	RB	O
noted	VBN	O
subdural	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
fossa	NN	I-PROBLEM
appears	VBZ	O
less	RBR	O
conspicuous	JJ	O
.	.	O

The	DT	O
pneumocephalus	JJ	B-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	B-PROBLEM
linear	JJ	I-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM
appears	VBZ	O
to	TO	O
have	VB	O
decreased	VBN	O
in	IN	O
size	NN	O
.	.	O

There	EX	O
are	VBP	O
persistent	JJ	B-PROBLEM
bifrontal	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
contusions	NNS	I-PROBLEM
with	IN	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
possible	JJ	O
small	JJ	B-PROBLEM
left	VBD	I-PROBLEM
frontal	JJ	I-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
(	(	O
adjacent	JJ	O
to	TO	O
falx	VB	O
)	)	O
which	WDT	O
are	VBP	O
largely	RB	O
unchanged	JJ	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
or	CC	O
hydrocephalus	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
air-	JJ	I-TEST
fluid	NN	I-TEST
level	NN	I-TEST
in	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
sphenoid	NN	I-TEST
sinus	NN	I-TEST
and	CC	O
bilateral	JJ	B-PROBLEM
opacification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mastoid	JJ	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

1.	CD	O
Decreased	JJ	O
size	NN	O
of	IN	O
right	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
Multifocal	JJ	B-PROBLEM
hemorrhagic	NN	I-PROBLEM
contusions	NNS	I-PROBLEM
and	CC	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
are	VBP	O
largely	RB	O
unchanged	JJ	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
trauma	NN	O
service	NN	O
.	.	O
Orthopedics	NNS	O
and	CC	O
Neurosurgery	NNP	O
were	VBD	O
consulted	VBN	O
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
injuries	NNS	I-PROBLEM
.	.	O

His	PRP$	B-PROBLEM
Neurosurgical	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
were	VBD	O
nonoperative	JJ	O
;	:	O
he	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
Dilantin	NNP	B-TREATMENT
;	:	O
serial	JJ	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scans	NNS	I-TEST
were	VBD	O
performed	VBN	O
and	CC	O
were	VBD	O
stable	JJ	O
.	.	O

He	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
Dr.	NNP	O
Mckinney	NNP	O
in	IN	O
4	CD	O
weeks	NNS	O
for	IN	O
repeat	NN	B-TEST
head	NN	I-TEST
imaging	NN	I-TEST
and	CC	O
continue	NN	O
with	IN	O
Dilantin	NNP	B-TREATMENT
for	IN	O
one	CD	O
month	NN	O
.	.	O

His	PRP$	B-PROBLEM
right	JJ	I-PROBLEM
tib	NN	I-PROBLEM
/	NNP	I-PROBLEM
fib	NN	I-PROBLEM
fracture	NN	I-PROBLEM
was	VBD	O
repaired	VBN	O
by	IN	O
Orthopedics	NNS	O
on	IN	O
10-27	JJ	O
;	:	O
postoperatively	RB	O
there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
fitted	VBN	O
with	IN	O
a	DT	B-TREATMENT
hinged	JJ	I-TREATMENT
Mcdonald	NNP	I-TREATMENT
brace	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
LLE	NNP	I-PROBLEM
.	.	O

He	PRP	O
will	MD	O
need	VB	O
to	TO	O
continue	VB	O
on	IN	O
Lovenox	NNP	B-TREATMENT
injections	NNS	I-TREATMENT
for	IN	O
at	IN	O
least	JJS	O
4-6	JJ	O
weeks	NNS	O
.	.	O

He	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
3	CD	B-TREATMENT
u	JJ	I-TREATMENT
packed	VBD	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
21	CD	O
,	,	O
post	NN	B-TEST
transfusion	NN	I-TEST
HCT	NNP	I-TEST
was	VBD	O
26.1	CD	O
;	:	O
there	EX	O
was	VBD	O
a	DT	O
questionable	JJ	O
transfusion	NN	B-PROBLEM
reaction	NN	I-PROBLEM
at	IN	O
the	DT	O
end	NN	O
of	IN	O
his	PRP$	B-TREATMENT
first	JJ	I-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
cells	NNS	I-TREATMENT
;	:	O
he	PRP	O
did	VBD	O
subsequently	RB	O
receive	VB	O
the	DT	B-TREATMENT
remaining	VBG	I-TREATMENT
2	CD	I-TREATMENT
units	NNS	I-TREATMENT
without	IN	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

Allergic	NNP	B-PROBLEM
to	TO	O
PCN	NNP	B-TREATMENT
and	CC	O
Sulfa	NNP	B-TREATMENT

1.	CD	O
Phenytoin	NNP	B-TREATMENT
50	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Chewable	JJ	O
Sig	NN	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NN	O
,	,	O
Chewable	NNP	O
PO	NNP	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
for	IN	O
1	CD	O
months	NNS	O
.	.	O

2.	CD	O
Oxycodone	CD	B-TREATMENT
5	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

3.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
100	CD	O
mg	NN	O
Capsule	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Capsule	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
Magnesium	NNP	B-TREATMENT
Hydroxide	NNP	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
mL	JJ	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
Thirty	NNP	O
(	(	O
30	CD	O
)	)	O
ML	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

5.	CD	O
Lovenox	NNP	B-TREATMENT
40	CD	O
mg	NN	O
/	VBD	O
0.4	CD	O
mL	NN	O
Syringe	NNP	O
Sig	NNP	O
:	:	O
0.4	CD	O
ML	NNP	O
's	POS	O
Subcutaneous	NNP	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
30	CD	O
days	NNS	O
.	.	O

Subdural	JJ	B-PROBLEM
hematoma	NN	I-PROBLEM

Skull	JJ	B-PROBLEM
fracture	NN	I-PROBLEM

Right	RB	B-PROBLEM
comminuted	VBN	I-PROBLEM
tibia	JJ	I-PROBLEM
/	NNP	I-PROBLEM
fibula	NN	I-PROBLEM
fracture	NN	I-PROBLEM

Return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
disturbances	NNS	I-PROBLEM
,	,	O
nause	RB	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
and	CC	O
/	CD	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
that	WDT	O
are	VBP	O
concerning	VBG	O
to	TO	O
you	PRP	O
.	.	O

You	PRP	O
will	MD	O
need	VB	O
to	TO	O
conrtinue	VB	O
with	IN	O
your	PRP$	B-TREATMENT
Lovenox	NNP	I-TREATMENT
injections	NNS	I-TREATMENT
for	IN	O
at	IN	O
least	JJS	O
4-6	JJ	O
weeks	NNS	O
as	IN	O
instructed	VBN	O
by	IN	O
Orthopedics	NNS	O

Inform	NNP	O
the	DT	O
office	NN	O
that	IN	O
you	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
for	IN	O
this	DT	O
appointment	NN	O
.	.	O

Liver	NNP	B-TREATMENT
Transplant	NNP	I-TREATMENT
Surgery	NNP	I-TREATMENT
Service	NNP	O

Hepatitis	NNP	B-PROBLEM
C	NNP	I-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year-old	JJ	O
man	NN	O
with	IN	O
hepatitis	NN	B-PROBLEM
C	NNP	I-PROBLEM
cirrhosis	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
encephalopathy	NN	B-PROBLEM
,	,	O
positive	JJ	B-PROBLEM
esophageal	NN	I-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
now	RB	O
with	IN	O
worsening	VBG	B-PROBLEM
confusion	NN	I-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
admitted	VBN	O
5	CD	O
x	NN	O
in	IN	O
the	DT	O
past	NN	O
to	TO	O
Nantucket	NNP	O
Cottage	NNP	O
Hospital	NNP	O
since	IN	O
11-30	CD	O
for	IN	O
encephalopathy	NN	B-PROBLEM
.	.	O

Infectious	JJ	B-TEST
work-up	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

Trazodone	NN	B-TREATMENT
stopped	VBD	O
.	.	O

Patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Lactulose	NNP	B-TREATMENT
and	CC	O
Rifaximine	NNP	B-TREATMENT
which	WDT	O
improved	VBD	O
his	PRP$	O
mental	JJ	O
status	NN	O
.	.	O

Today	NN	O
,	,	O
on	IN	O
2014-03-03	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
clinic	JJ	O
with	IN	O
increased	JJ	B-PROBLEM
lethargy	NN	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
.	.	O

Wife	NNP	O
reports	NNS	O
that	IN	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
lethargy	NN	B-PROBLEM
and	CC	O
confusion	NN	B-PROBLEM
,	,	O
similar	JJ	O
to	TO	O
the	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
for	IN	O
which	WDT	O
the	DT	O
patient	NN	O
was	VBD	O
recently	RB	O
admitted	VBN	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
reports	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBN	O
"	VBN	O
yellowish	JJ	B-PROBLEM
eyes	NNS	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
shaking	NN	I-PROBLEM
and	CC	O
his	PRP$	O
breath	NN	O
smelled	VBD	O
more	RBR	O
like	IN	O
ammonia	NN	O
over	IN	O
the	DT	O
past	JJ	O
3	CD	O
days	NNS	O
."	VBP	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
compliant	JJ	O
with	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
2	CD	O
weeks	NNS	O
.	.	O

He	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

He	PRP	O
gets	VBZ	O
cold	JJ	B-PROBLEM
easily	RB	O
but	CC	O
denies	VBZ	O
fevers	NNS	B-PROBLEM
.	.	O

HCV	NNP	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

Underwent	JJ	O
treatment	NN	B-TREATMENT
with	IN	O
Interferon	NNP	B-TREATMENT
10	CD	O
years	NNS	O
ago	RB	O
.	.	O

He	PRP	O
stopped	VBD	O
secondary	JJ	O
to	TO	O
aggressive	JJ	B-PROBLEM
behavior	NN	I-PROBLEM
.	.	O

History	NN	O
of	IN	O
hepatic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

Esophageal	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
.	.	O

EGD	NN	B-TEST
on	IN	O
2013-12-08	JJ	O
demonstrated	JJ	O
5	CD	B-PROBLEM
cores	NNS	I-PROBLEM
of	IN	I-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
grade	VBD	O
1	CD	O
to	TO	O
2	CD	O
at	IN	O
the	DT	O
lower	JJR	O
third	NN	O
of	IN	O
the	DT	O
esophagus	NN	O
.	.	O

Four	CD	B-TREATMENT
bands	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
without	IN	O
difficulty	NN	O
.	.	O

Also	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
glucose	JJ	B-PROBLEM
intolerance	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
off	RB	O
of	IN	O
Neurontin	NNP	B-TREATMENT
because	IN	O
it	PRP	O
started	VBD	O
to	TO	O
worsen	VB	O
his	PRP$	O
mental	JJ	O
status	NN	O
.	.	O

Nadolol	RB	B-TREATMENT
20	CD	O
mg	NNS	O
q.	JJ	O
Day	NNP	O
.	.	O

Protonix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

Osamine	NNP	B-TREATMENT
200	CD	O
mg	NN	O
t.i.d.	NN	O

Lactulose	RB	B-TREATMENT
30	CD	O
mg	NNS	O
q.i.d.	NN	O

Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
q.	JJ	O
Day	NNP	O
.	.	O

Insulin	NNP	B-TREATMENT
regular	NN	I-TREATMENT
.	.	O

Amlodipine	$	B-TREATMENT
5	CD	O
mg	JJ	O
q.	JJ	O
Day	NNP	O
.	.	O

Retazepine	NNP	B-TREATMENT
50	CD	O
mg	NN	O
q	NN	O
h.s.	NN	O

Testosterone	CD	B-TREATMENT
4	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
contracted	VBD	O
HCV	NNP	B-PROBLEM
20	CD	O
years	NNS	O
ago	RB	O
secondary	JJ	O
to	TO	O
IV	NNP	O
drug	NN	O
use	NN	O
.	.	O

FAMILY	NNP	O
HISTORY	NNP	O
:	:	O
Father	NNP	O
died	VBD	O
of	IN	O
metastatic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Mother	NNP	O
died	VBD	O
of	IN	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

Weight	NNP	B-TEST
was	VBD	O
122.5	CD	O
.	.	O

General	JJ	O
:	:	O
Patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Lethargic	NNP	B-PROBLEM
,	,	O
occasionally	RB	O
falling	VBG	O
asleep	NN	O
.	.	O

Sclera	NNP	B-PROBLEM
mildly	RB	I-PROBLEM
icteric	JJ	I-PROBLEM
.	.	O

Neck	NN	O
:	:	O
No	DT	O
LAD	NNP	B-PROBLEM
.	.	O

Lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Normal	NNP	O
S1	NNP	O
and	CC	O
S2	NNP	O
without	IN	O
murmurs	NNS	B-PROBLEM
or	CC	O
rubs	NNS	B-PROBLEM
.	.	O

Positive	JJ	B-PROBLEM
gynecomastia	NN	I-PROBLEM
.	.	O

Abdomen	NNS	O
:	:	O
Positive	NNP	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

Obvious	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
asterixis	NN	I-PROBLEM
.	.	O

Patient	NNP	O
continued	VBD	O
on	IN	O
Lactulose	NNP	B-TREATMENT
.	.	O

Continue	VB	O
on	IN	O
Rifaximine	NNP	B-TREATMENT
.	.	O

Continue	NNP	O
Lasix	NNP	B-TREATMENT
.	.	O

On	IN	O
2014-04-02	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
,	,	O
taking	VBG	O
Lactulose	NNP	B-TREATMENT
.	.	O

Difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
word	NN	I-PROBLEM
finding	NN	I-PROBLEM
at	IN	O
times	NNS	O
.	.	O

Denies	VBZ	O
any	DT	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
discomfort	NN	B-PROBLEM
.	.	O

Abdomen	NNS	O
:	:	O
Slightly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

Ultrasound	NN	B-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2014-04-01	JJ	O
demonstrating	NN	O
severe	JJ	B-PROBLEM
portal	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
with	IN	O
massive	JJ	B-PROBLEM
peri	NN	I-PROBLEM
splenic	JJ	I-PROBLEM
varices	NNS	I-PROBLEM
and	CC	O
splenorenal	JJ	B-TREATMENT
shunt	NN	I-TREATMENT
.	.	O

Repeat	NNP	B-PROBLEM
hepato	PRP	I-PROBLEM
fungal	JJ	I-PROBLEM
flare	NN	I-PROBLEM
.	.	O

On	IN	O
2014-04-04	JJ	O
,	,	O
the	DT	O
transplant	NN	O
service	NN	O
was	VBD	O
consulted	VBN	O
because	IN	O
the	DT	O
patient	NN	O
was	VBD	O
possibly	RB	O
going	VBG	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
transplant	NN	B-TREATMENT
on	IN	O
2014-04-04	JJ	O
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
go	VB	O
to	TO	O
operating	VBG	O
room	NN	O
on	IN	O
2014-04-04	JJ	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
cadaveric	JJ	B-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
performed	VBN	O
by	IN	O
Dr.	NNP	O
Michael	NNP	O
Sanders	NNP	O
.	.	O

Please	NNP	O
see	VB	O
detailed	JJ	O
operative	JJ	O
note	NN	O
for	IN	O
more	JJR	O
information	NN	O
about	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
MMF	NNP	B-TREATMENT
1	CD	O
gram	NN	O
b.i.d.	NN	O
,	,	O
Flagyl	NNP	B-TREATMENT
500	CD	O
mg	NN	O
IV	NNP	O
x1	NNP	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
received	VBD	O
Unasyn	NNP	B-TREATMENT
for	IN	O
2	CD	O
days	NNS	O
,	,	O
Fluconazole	NNP	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
Protonix	NNP	B-TREATMENT
,	,	O
insulin	NN	B-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
,	,	O
Bactrim	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
on	IN	O
Propofol	NNP	B-TREATMENT
for	IN	O
2	CD	O
days	NNS	O
.	.	O

On	IN	O
2014-04-04	JJ	O
,	,	O
labs	NNS	B-TEST
were	VBD	O
as	IN	O
follows	VBZ	O
:	:	O

WBC	NNP	B-TEST
of	IN	O
8.3	CD	O
;	:	O
hematocrit	NN	B-TEST
of	IN	O
30.6	CD	O
;	:	O
platelets	NNS	B-TEST
69	CD	O
;	:	O
sodium	NN	B-TEST
132	CD	O
;	:	O
3.9	CD	O
,	,	O
102	CD	O
,	,	O
22	CD	O
,	,	O
serum	JJR	B-TEST
creatinine	NN	I-TEST
of	IN	O
13	CD	O
and	CC	O
1.1	CD	O
.	.	O

Glucose	RB	B-TEST
114	CD	O
.	.	O

AST	$	B-TEST
87	CD	O
.	.	O

ALT	$	B-TEST
44	CD	O
.	.	O

Alkaline	NNP	B-TEST
phosphatase	NN	I-TEST
169	CD	O
.	.	O

PT	NNP	B-TEST
of	IN	O
20.6	CD	O
.	.	O

PTT	NNP	B-TEST
of	IN	O
38.7	CD	O
.	.	O

INR	NNP	B-TEST
of	IN	O
2.0	CD	O
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
1	CD	O
,	,	O
duplex	JJ	B-TEST
ultrasound	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
patient	NN	I-TEST
's	POS	I-TEST
liver	NN	I-TEST
was	VBD	O
performed	VBN	O
demonstrating	VBG	O
normal	JJ	O
appearing	VBG	O
portal	JJ	O
veins	NNS	O
and	CC	O
hepatic	JJ	O
arteries	NNS	O
.	.	O

There	EX	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
and	CC	I-PROBLEM
sluggish	JJ	I-PROBLEM
flow	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
hepatic	JJ	I-PROBLEM
veins	NNS	I-PROBLEM
with	IN	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
normal	JJ	I-PROBLEM
respiratory	JJ	I-PROBLEM
variations	NNS	I-PROBLEM
,	,	I-PROBLEM
wave	VBP	I-PROBLEM
forms	NNS	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
portion	NN	I-PROBLEM
.	.	O

Additionally	RB	O
,	,	O
there	EX	O
is	VBZ	O
diminished	JJ	B-PROBLEM
color	NN	I-PROBLEM
flow	NN	I-PROBLEM
with	IN	O
confluence	NN	O
of	IN	O
the	DT	O
hepatic	JJ	O
veins	NNS	O
.	.	O

These	DT	O
findings	NNS	O
may	MD	O
reflect	VB	O
thrombus	NN	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
hepatic	NN	I-PROBLEM
veins	NNS	I-PROBLEM
.	.	O

Caval	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
,	,	O
most	RBS	O
likely	JJ	O
correlation	NN	O
to	TO	O
clinical	JJ	O
history	NN	O
is	VBZ	O
recommended	VBN	O
and	CC	O
further	JJ	O
evaluation	NN	O
of	IN	O
the	DT	B-TEST
CT	NNP	I-TEST
or	CC	O
short-term	JJ	B-TEST
ultrasounds	NNS	I-TEST
for	IN	O
follow-up	NN	O
was	VBD	O
recommended	VBN	O
.	.	O

The	DT	B-TREATMENT
Feeney	NNP	I-TREATMENT
Gann-Burlington	NNP	I-TREATMENT
drain	NN	I-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
demonstrated	VBD	O
medial	JJ	B-TEST
output	NN	I-TEST
of	IN	O
780	CD	O
with	IN	O
lateral	JJ	B-TEST
output	NN	I-TEST
of	IN	O
150	CD	O
.	.	O

Patient	NNP	O
continued	VBD	O
getting	VBG	O
Acyclovir	NNP	B-TREATMENT
,	,	O
Prednisone	NNP	B-TREATMENT
,	,	O
MMF	NNP	B-TREATMENT
one	CD	O
gram	NN	O
b.i.d	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
on	IN	O
FK	NNP	B-TREATMENT
2	CD	I-TREATMENT
and	CC	O
2	CD	O
that	WDT	O
was	VBD	O
started	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
2	CD	O
.	.	O

Waltham-Ludlow	JJ	B-TREATMENT
drains	NNS	I-TREATMENT
put	VBD	O
out	RP	O
on	IN	O
the	DT	O
13th	CD	O
620	CD	O
and	CC	O
380	CD	O
.	.	O

Omalley	NNP	O
was	VBD	O
consulted	VBN	O
on	IN	O
2014-04-08	JJ	O
for	IN	O
better	JJR	O
glucose	NN	B-TREATMENT
control	NN	I-TREATMENT
since	IN	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
steroids	NNS	B-TREATMENT
.	.	O

Patient	NN	O
was	VBD	O
transfused	VBN	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
platelets	NNS	I-TREATMENT
on	IN	O
2014-04-08	JJ	O
for	IN	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
66	CD	O
.	.	O

A	DT	B-TEST
heparin	JJ	I-TEST
independent	JJ	I-TEST
antibody	NN	I-TEST
was	VBD	O
sent	VBN	O
off	RP	O
on	IN	O
2014-04-07	JJ	O
which	WDT	O
was	VBD	O
unremarkable	JJ	O
.	.	O

On	IN	O
2014-04-09	JJ	O
,	,	O
patient	JJ	O
continued	VBD	O
to	TO	O
do	VB	O
very	RB	O
well	RB	O
,	,	O
ambulating	VBG	O
,	,	O
tolerating	VBG	O
a	DT	O
diet	JJ	O
,	,	O
urinating	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

Drains	NNS	B-TREATMENT
continued	VBD	O
to	TO	O
put	VB	O
out	RP	O
significant	JJ	O
amount	NN	O
of	IN	O
fluid	NN	O
.	.	O

Patient	NNP	B-TEST
's	POS	I-TEST
labs	NN	I-TEST
from	IN	O
2014-04-10	JJ	O
were	VBD	O
the	DT	O
following	NN	O
:	:	O

7.1	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
30.8	CD	O
,	,	O
platelets	NNS	B-TEST
90	CD	O
.	.	O

Sodium	NN	B-TEST
of	IN	O
138	CD	O
;	:	O
potassium	NN	B-TEST
3.5	CD	O
;	:	O
106	CD	O
,	,	O
28	CD	O
,	,	O
31	CD	O
,	,	O
1.0	CD	O
,	,	O
glucose	VBD	B-TEST
134	CD	O
.	.	O

AST	$	B-TEST
82	CD	O
.	.	O

ALT	$	B-TEST
176	CD	O
.	.	O

Alkaline	NNP	B-TEST
phosphatase	NN	I-TEST
78	CD	O
which	WDT	O
all	DT	O
have	VBP	O
significantly	RB	O
decreased	VBN	O
since	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
1	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.9	CD	O
.	.	O

On	IN	O
2014-04-09	JJ	O
,	,	O
FK	NNP	B-TEST
level	NN	I-TEST
was	VBD	O
10.3	CD	O
.	.	O

Protonix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
q.	NN	O
24	CD	O
.	.	O

Moltipine	NNP	B-TREATMENT
5	CD	O
mg	NN	O
q.	JJ	O
Day	NNP	O
.	.	O

Fluconazole	NNP	B-TREATMENT
400	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

Prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.	JJ	O
Day	NNP	O
.	.	O

MMF	NN	B-TREATMENT
1000	CD	O
mg	NN	O
b.i.d.	NN	O
.	.	O

Lopressor	NNP	B-TREATMENT
50	CD	O
m	NN	O
b.i.d.	NN	O

Percocet	$	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
tabs	NNS	O
q.	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	NN	O
.	.	O

Colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

Bactrim	NNP	B-TREATMENT
SS	NNP	O
1	CD	O
tab	NN	O
q.	JJ	O
Day	NNP	O
.	.	O

Tacrolimus	$	B-TREATMENT
3	CD	O
mg	NN	O
b.i.d.	NN	O

Lasix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
b.i.d.	NN	O

Valcyte	NNP	B-TREATMENT
900	CD	O
mg	NN	O
q.	JJ	O
Day	NNP	O
.	.	O

Patient	NN	O
is	VBZ	O
on	IN	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
fixed	JJ	O
dose	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
call	VB	O
787-984-9608	JJ	O
if	IN	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
take	VB	I-PROBLEM
medications	NNS	I-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
or	CC	I-PROBLEM
drink	VB	I-PROBLEM
.	.	O

Patient	JJ	O
needs	NNS	O
to	TO	O
have	VB	O
labs	VBN	B-TEST
every	DT	O
Monday	NNP	O
and	CC	O
Thursday	NNP	O
including	VBG	O
a	DT	B-TEST
CBC	NNP	I-TEST
,	,	O
chem-10	NN	B-TEST
,	,	O
AST	NNP	B-TEST
,	,	O
ALT	NNP	B-TEST
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
,	,	O
albumin	NN	B-TEST
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
and	CC	O
Prograf	NNP	B-TEST
level	VBP	I-TEST
need	NN	O
to	TO	O
be	VB	O
obtained	VBN	O
.	.	O

All	DT	B-TEST
cultures	NNS	I-TEST
have	VBP	O
been	VBN	O
unremarkable	JJ	O
.	.	O

Cultures	NNS	B-TEST
were	VBD	O
obtained	VBN	O
on	IN	O
2014-03-31	JJ	O
.	.	O

Urine	JJ	B-TEST
culture	NN	I-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
have	VBP	O
been	VBN	O
unremarkable	JJ	O
on	IN	O
2014-04-03	JJ	O
.	.	O

Hepatitis	NNP	B-TEST
viral	JJ	I-TEST
load	NN	I-TEST
was	VBD	O
76,500	CD	O
.	.	O

Pathology	NNP	O
demonstrates	VBZ	O
that	IN	O
the	DT	B-TEST
pathology	NN	I-TEST
results	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
liver	NN	I-TEST
were	VBD	O
not	RB	O
finalized	VBN	O
.	.	O

Fetal	JJ	B-TEST
screens	NNS	I-TEST
,	,	O
O	NNP	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
RPR	NNP	B-TEST
nonreactive	NN	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
hepatitis	NN	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
GBS	NNP	B-TEST
unknown	NN	O
.	.	O

IVF	NNP	B-PROBLEM
pregnancy	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
IUGR	NNP	B-PROBLEM
,	,	O
2	CD	B-PROBLEM
vessel	NN	I-PROBLEM
cord	NN	I-PROBLEM
,	,	O
normal	JJ	O
fetal	JJ	O
echo	JJ	O
reverse	NN	O
diastolic	NN	O
flow	NN	O
and	CC	O
demise	NN	B-PROBLEM
of	IN	I-PROBLEM
twin	NN	I-PROBLEM
A	NNP	I-PROBLEM
at	IN	O
27	CD	O
weeks	NNS	O
.	.	O

Twin	NNP	O
B	NNP	O
with	IN	O
normal	JJ	O
fetal	JJ	O
survey	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Boston	NNP	O
Medical	NNP	O
Center	NNP	O
at	IN	O
26	CD	O
and	CC	O
2/7	CD	O
weeks	NNS	O
with	IN	O
IUGR	NNP	B-PROBLEM
of	IN	I-PROBLEM
twin	NN	I-PROBLEM
A	NNP	I-PROBLEM
was	VBD	O
first	RB	O
noted	VBN	O
,	,	O
presented	VBN	O
with	IN	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
at	IN	O
31	CD	O
weeks	NNS	O
.	.	O

Betamethasone	NNP	B-TREATMENT
complete	NN	O
at	IN	O
approximately	RB	O
26	CD	O
weeks	NNS	O
and	CC	O
31	CD	O
weeks	NNS	O
.	.	O

Mother	NNP	O
was	VBD	O
on	IN	O
clindamycin	NN	B-TREATMENT
since	IN	O
11-04	CD	O
.	.	O

PPROM	NN	B-PROBLEM
with	IN	O
bleeding	NN	B-PROBLEM
and	CC	O
transverse	NN	B-PROBLEM
lie	NN	I-PROBLEM
prompted	VBD	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

Abruption	NNP	B-PROBLEM
noted	VBD	O
.	.	O

Apgars	NNS	B-TEST
were	VBD	O
6	CD	O
and	CC	O
9	CD	O
.	.	O

On	IN	O
admission	NN	O
weight	NN	B-TEST
1670	CD	O
grams	NNS	O
approximately	RB	O
50	CD	O
th	NNS	O
percentile	RB	O
,	,	O
length	VBD	B-TEST
43	CD	O
cm	NN	O
50	CD	O
th	NN	O
percentile	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
not	RB	O
done	VBN	O
.	.	O

Anterior	NNP	O
fontanel	NN	O
soft	NN	O
,	,	O
flat	JJ	O
,	,	O
cap	NN	O
and	CC	O
prong	JJ	B-TREATMENT
CPAP	NNP	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

Nondysmorphic	NNP	B-PROBLEM
intact	JJ	O
Veliz	NNP	O
.	.	O

No	DT	O
murmur	NN	B-PROBLEM
.	.	O

No	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Positive	JJ	O
vaginal	JJ	B-PROBLEM
tag	NN	I-PROBLEM
.	.	O

No	DT	O
hip	NN	B-PROBLEM
click	NN	I-PROBLEM
.	.	O

No	DT	O
sacral	JJ	B-PROBLEM
dimple	NN	I-PROBLEM
.	.	O

Decrease	NNP	B-PROBLEM
tone	NN	I-PROBLEM
,	,	O
ruddy	NN	O
,	,	O
warm	NN	O
,	,	O
well	RB	O
perfused	VBN	O
with	IN	O
peripheral	JJ	B-TREATMENT
IV	NNP	I-TREATMENT
in	IN	I-TREATMENT
left	JJ	I-TREATMENT
hand	NN	I-TREATMENT
.	.	O

Mills	NNS	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Infant	NN	O
placed	VBD	O
on	IN	O
CPAP	NNP	B-TREATMENT
.	.	O

X-ray	NN	B-TEST
revealed	VBD	O
mild	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

She	PRP	O
remained	VBD	O
on	IN	O
CPAP	NNP	B-TREATMENT
for	IN	O
a	DT	O
total	NN	O
of	IN	O
24	CD	O
hours	NNS	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
transitioned	VBD	O
to	TO	O
room	NN	O
air	NN	O
and	CC	O
continues	VBZ	O
to	TO	O
be	VB	O
stable	JJ	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

Caffeine	NNP	B-TREATMENT
citrate	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
on	IN	O
11-14	NN	O
for	IN	O
apnea	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

Heart	NNP	B-TEST
ranges	VBZ	I-TEST
130	CD	O
s	NN	O
to	TO	O
160	CD	O
s.	NN	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
most	RBS	O
recently	RB	O
60/37	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
44	CD	O
.	.	O

Birth	NNP	B-TEST
weight	NN	I-TEST
was	VBD	O
1670	CD	O
grams	NNS	O
50	CD	O
th	NN	O
percentile	NN	O
,	,	O
length	VBZ	B-TEST
43	CD	O
cm	NN	O
50	CD	O
th	NN	O
percentile	NN	O
.	.	O

Head	NNP	B-TEST
circumference	NN	I-TEST
not	RB	O
done	VBN	O
.	.	O

Infant	NNP	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
80	CD	O
cc	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
D10W	NNP	B-TREATMENT
.	.	O

Enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NN	O
.	.	O

Infant	NN	O
achieved	VBN	O
full	JJ	B-TREATMENT
enteral	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
6	CD	O
.	.	O

She	PRP	O
is	VBZ	O
currently	RB	O
receiving	VBG	O
150	CD	O
cc	JJ	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
Special	NNP	B-TREATMENT
Care	NNP	I-TREATMENT
20	CD	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
discharge	NN	I-TEST
weight	NN	I-TEST
is	VBZ	O
1477	CD	O
gm	NN	O
.	.	O

Her	PRP$	O
most	RBS	O
recent	JJ	O
set	NN	O
of	IN	O
electrolytes	NNS	O
were	VBD	O
on	IN	O
2015-11-13	JJ	O
with	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
143	CD	O
,	,	O
a	DT	B-TEST
potassium	NN	I-TEST
of	IN	O
6.3	CD	O
hemolyzed	NNS	O
,	,	O
a	DT	B-TEST
chloride	NN	I-TEST
of	IN	O
113	CD	O
and	CC	O
a	DT	B-TEST
total	JJ	I-TEST
CO2	NNP	I-TEST
of	IN	O
17	CD	O
.	.	O

She	PRP	O
will	MD	O
need	VB	O
advance	NN	B-TREATMENT
calorie	NN	I-TREATMENT
density	NN	I-TREATMENT
for	IN	O
better	JJR	O
growth	NN	O
.	.	O

GI	NNP	B-TEST
.	.	I-TEST
Bilirubin	NNP	I-TEST
peaked	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#2	NN	O
of	IN	O
9.0	CD	O
/	JJ	O
0.3	CD	O
.	.	O

Infant	NN	O
is	VBZ	O
under	IN	O
phototherapy	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
discontinued	VBN	O
on	IN	O
11-13	NNS	O
.	.	O

Most	JJS	B-TEST
recent	JJ	I-TEST
bilirubin	NN	I-TEST
was	VBD	O
on	IN	O
11-14	NN	O
of	IN	O
4.8	CD	O
/	JJ	O
0.3	CD	O
.	.	O

Hematocrit	NNP	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
53.7	CD	O
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
required	VBN	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

A	DT	B-TEST
CBC	NNP	I-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
obtained	VBN	O
on	IN	O
admission	NN	O
.	.	O

CBC	NNP	B-TEST
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9	CD	O
,	,	O
17	CD	O
polys	NN	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
,	,	O
platelets	NNS	B-TEST
of	IN	O
326	CD	O
.	.	O

She	PRP	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
with	IN	O
negative	JJ	O
blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

Head	NNP	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2015-11-16	JJ	O
and	CC	O
was	VBD	O
normal	JJ	O
.	.	O

Sensory	NNP	B-TEST
,	,	I-TEST
hearing	VBG	I-TEST
screen	NN	I-TEST
has	VBZ	O
not	RB	O
yet	RB	O
been	VBN	O
performed	VBN	O
,	,	O
but	CC	O
should	MD	O
be	VB	O
done	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

Continue	VB	O
150	CD	O
cc	NN	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
Special	NNP	B-TREATMENT
Care	NNP	I-TREATMENT
20	CD	I-TREATMENT
calories	NNS	I-TREATMENT
advancing	VBG	O
caloric	JJ	O
intake	NN	O
as	IN	O
required	VBN	O
to	TO	O
maintain	VB	O
weight	JJ	O
gain	NN	O
of	IN	O
3	CD	O
grams	NNS	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
.	.	O

Medications	NNS	B-TREATMENT
,	,	O
continue	VBP	O
caffeine	JJ	B-TREATMENT
citrate	NN	I-TREATMENT
of	IN	O
11	CD	O
mg	NNS	O
po	JJ	O
every	DT	O
day	NN	O
.	.	O

Car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
has	VBZ	O
not	RB	O
yet	RB	O
been	VBN	O
done	VBN	O
.	.	O

State	NNP	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#3	NN	O
and	CC	O
at	IN	O
discharge	NN	O
.	.	O

Immunizations	NNS	B-TREATMENT
received	VBD	O
,	,	O
infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
immunizations	NNS	I-TREATMENT
to	TO	O
date	NN	O
.	.	O

State	NNP	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
2015-11-12	JJ	O
.	.	O

Immunizations	NNS	B-TREATMENT
:	:	O
recommended	VBN	O
Synagis	NNP	B-TREATMENT
RSV	NNP	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
November	NNP	O
through	IN	O
March	NNP	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	VBG	O
3	CD	O
criteria	NNS	O
,	,	O
born	VBN	O
at	IN	O
less	JJR	O
than	IN	O
32	CD	O
weeks	NNS	O
,	,	O
born	VBN	O
between	IN	O
32	CD	O
and	CC	O
35	CD	O
weeks	NNS	O
with	IN	O
2	CD	O
of	IN	O
the	DT	O
following	JJ	O
,	,	O
daycare	JJ	O
during	IN	O
RSV	NNP	O
season	NN	O
,	,	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
weight	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
siblings	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Influenza	NNP	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	B-TREATMENT
child	NN	I-TREATMENT
's	POS	I-TREATMENT
life	NN	I-TREATMENT
immunizations	NNS	I-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
care	NN	O
givers	NNS	O
.	.	O

Premature	NN	B-PROBLEM
infant	NN	I-PROBLEM
born	VBN	O
at	IN	O
31	CD	O
and	CC	O
6/7	CD	O
weeks	NNS	O
gestation	NN	O
,	,	O
resolved	VBD	O
respiratory	JJ	B-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

Rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
with	IN	O
antibiotic	JJ	B-TREATMENT
.	.	O

Hyperbilirubinemia	NNP	B-PROBLEM
resolving	NN	O
.	.	O

Apnea	NNP	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

Codeine	NNP	B-TREATMENT
/	NNP	O
Iodine	NNP	B-TREATMENT

large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
transfer	NN	O
from	IN	O
OSH	NNP	O

Thoracentesis	NN	B-TREATMENT
2018-05-27	JJ	O

82	CD	O
F	NNP	O
with	IN	O
h/o	NN	O
COPD	NNP	B-PROBLEM
,	,	O
CAD	NNP	B-PROBLEM
,	,	O
pafib	NN	B-PROBLEM
and	CC	O
SSS	NNP	B-PROBLEM
s/p	VBP	O
pacer	NN	B-TREATMENT
on	IN	O
05-08	NN	O
for	IN	O
symptomatic	JJ	B-PROBLEM
pauses	NNS	I-PROBLEM
is	VBZ	O
transferred	VBN	O
for	IN	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
?	.	O
needing	JJ	O
drainage	NN	B-TREATMENT
and	CC	O
CHF	NNP	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
Cambridge	NNP	O
Hospital	NNP	O
2018-05-24	JJ	O
with	IN	O
ARF	NNP	B-PROBLEM
(	(	O
Cr	NNP	B-TEST
3.5	CD	O
up	RB	O
from	IN	O
0.9	CD	O
)	)	O
and	CC	O
SOB	NNP	B-PROBLEM
.	.	O

According	VBG	O
to	TO	O
her	PRP$	O
guardian	JJ	O
she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
her	PRP$	O
NH	NNP	O
for	IN	O
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
her	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
05-08	NN	O
,	,	O
which	WDT	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
PTX	NNP	I-PROBLEM
requiring	VBG	O
CT	NNP	B-TREATMENT
placement	NN	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
d/c	JJ	O
'd	MD	O
in	IN	O
the	DT	O
hospital	NN	O
after	IN	O
resolution	NN	O
of	IN	O
her	PRP$	B-PROBLEM
PTX	NNP	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
some	DT	O
nausea	NN	B-PROBLEM
/	VBD	O
vomiting	NN	B-PROBLEM
and	CC	O
generally	RB	O
was	VBD	O
taking	VBG	O
poor	JJ	O
pos	NN	O
at	IN	O
her	PRP$	O
NH	NNP	O
.	.	O

There	EX	O
had	VBD	O
been	VBN	O
some	DT	O
concern	NN	O
her	PRP$	B-PROBLEM
nausea	NN	I-PROBLEM
was	VBD	O
due	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
amiodarone	NN	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
discontinued	VBN	O
about	IN	O
1	CD	O
week	NN	O
ago	RB	O
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
sent	VBN	O
to	TO	O
Franklin	NNP	O
Medical	NNP	O
Center	NNP	O
05-24	NN	O
with	IN	O
lethargy	NN	B-PROBLEM
and	CC	O
n/v	NN	B-PROBLEM
.	.	O

At	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
she	PRP	O
was	VBD	O
discovered	VBN	O
to	TO	O
have	VB	O
ARF	NNP	B-PROBLEM
,	,	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
IVF	NNP	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
ARF	NNP	I-PROBLEM
.	.	O

She	PRP	O
underwent	VBD	O
a	DT	B-TEST
TTE	NNP	I-TEST
at	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
today	NN	O
(	(	O
05-26	JJ	O
)	)	O
showing	VBG	O
mod-lg	JJ	B-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
RV	NNP	B-PROBLEM
diastolic	JJ	I-PROBLEM
collapse	NN	I-PROBLEM
and	CC	O
no	DT	O
MV	NNP	O
inflow	JJ	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
pacer	NN	B-TREATMENT
wire	NN	I-TREATMENT
located	VBN	O
in	IN	O
RV	NNP	O
apex	NN	O
.	.	O

There	EX	O
was	VBD	O
still	RB	O
concern	NN	O
for	IN	O
her	PRP$	B-PROBLEM
effusion	NN	I-PROBLEM
contributing	NN	O
to	TO	O
her	PRP$	B-PROBLEM
SOB	NNP	I-PROBLEM
at	IN	O
the	DT	O
OSH	NNP	O
so	IN	O
she	PRP	O
was	VBD	O
transferred	VBN	O
for	IN	O
drainage	NN	B-TREATMENT
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
CHF	NNP	B-PROBLEM
.	.	O

Today	NN	O
she	PRP	O
only	RB	O
complains	VBZ	O
of	IN	O
some	DT	B-PROBLEM
SOB	NNP	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
says	VBZ	O
remains	VBZ	O
largely	RB	O
unchanged	JJ	O
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
.	.	O

She	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
CP	NNP	I-PROBLEM
/	NNP	O
cough	NN	B-PROBLEM
/	NN	O
fever	NN	B-PROBLEM
/	NNP	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
diarrhea	NN	B-PROBLEM
/	NNP	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
bloody	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
/	JJ	O
headache	NN	B-PROBLEM
.	.	O

htn	NN	B-PROBLEM

afib	NN	B-PROBLEM
,	,	O
SSS	NNP	B-PROBLEM

COPD	NN	B-PROBLEM

CAD	NN	B-PROBLEM

pacer	NN	B-TREATMENT
DDDR	NNP	I-TREATMENT
(	(	I-TREATMENT
Vitatron	NNP	I-TREATMENT
CL860	NNP	I-TREATMENT
)	)	I-TREATMENT
placed	VBD	O
05-08	NN	O
for	IN	O
SSS	NNP	B-PROBLEM
with	IN	O
symptomatic	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
,	,	O
c/b	NN	O
R	NNP	B-PROBLEM
PTX	NNP	I-PROBLEM
requiring	VBG	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT

GERD	NN	B-PROBLEM

CVA	NN	B-PROBLEM

hypothyroidism	NN	B-PROBLEM

legally	RB	B-PROBLEM
blind	VB	I-PROBLEM

Exam	NN	O
:	:	O
T	$	B-TEST
96.2	CD	O
HR	NNP	B-TEST
70	CD	O
BP	NNP	B-TEST
118/46	CD	O
R	NNP	B-TEST
24	CD	O
sat	VBD	B-TEST
90%	CD	O
on	IN	O
60%FM	CD	B-TREATMENT

pulsus	NN	B-PROBLEM
parodoxus	NN	I-PROBLEM
=	VBD	O
6-8	CD	O
mm	NN	O

gen	NN	O
:	:	O
mild	JJ	B-PROBLEM
resp	NN	I-PROBLEM
distress	NN	I-PROBLEM
speaking	NN	O
in	IN	O
full	JJ	O
sentences	NNS	O
but	CC	O
using	VBG	O
accessory	JJ	O
muscles	NNS	O

HEENT	NN	O
:	:	O
mmm	NN	O
,	,	O
JVP	NNP	B-TEST
at	IN	O
14	CD	O
cm	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
supple	NN	O

pulm	NN	O
:	:	O
no	DT	O
BS	NNP	B-TEST
01-15	CD	O
way	NN	O
up	IN	O
bilat	NN	O
,	,	O
no	DT	O
consolidation	NN	B-PROBLEM

abd	NN	O
:	:	O
s/nt/slightly	RB	O
distended	VBD	B-PROBLEM
,	,	O
dec	JJ	B-PROBLEM
BS	NNP	I-PROBLEM
,	,	O
no	DT	O
CVA	NNP	B-PROBLEM
tenderness	NN	I-PROBLEM

ext	NN	O
:	:	O
1+	CD	B-PROBLEM
LE	NNP	I-PROBLEM
edema	NN	I-PROBLEM

ECG	NN	B-TEST
:	:	O
a	DT	O
paced	VBN	O
at	IN	O
70	CD	O
bpm	NN	O
/	NNP	O
nml	NN	O
axis	NN	O
,	,	O
LBBB	NNP	B-PROBLEM
,	,	O
no	DT	O
ST	NNP	B-PROBLEM
or	CC	I-PROBLEM
TW	NNP	I-PROBLEM
changes	NNS	I-PROBLEM

CXR	NNP	B-TEST
at	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
05-26	NN	O
:	:	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
eff	NN	I-PROBLEM
and	CC	O
pericardial	JJ	B-PROBLEM
eff	NN	I-PROBLEM

CT	NNP	B-TEST
chest	NN	I-TEST
at	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
05-25	NN	O
:	:	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
bilat	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
eff	NN	I-PROBLEM
with	IN	O
underlying	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
which	WDT	O
could	MD	O
represent	VB	O
PNA	NNP	B-PROBLEM
vs.	FW	O
atelectasis	NN	B-PROBLEM

TTE	NN	B-TEST
at	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
05-26	NN	O
:	:	O
mod-lg	JJ	B-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	NN	I-PROBLEM
eff	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
RV	NNP	B-PROBLEM
diastolic	JJ	I-PROBLEM
collapse	NN	I-PROBLEM
,	,	O
no	DT	O
MV	NNP	O
inflow	JJ	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
pacer	JJ	B-TREATMENT
lead	NN	I-TREATMENT
located	VBN	O
in	IN	O
RV	NNP	O
apex	NN	O

head	NN	B-TEST
CT	NNP	I-TEST
at	IN	O
Erich	NNP	O
Lindemann	NNP	O
Mental	NNP	O
Health	NNP	O
Center	NNP	O
05-24	NN	O
:	:	O
atrophy	NN	B-PROBLEM
,	,	O
dense	JJ	B-PROBLEM
calcification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
tentorium	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
of	IN	O
metabolic	JJ	O
etiology	NN	O

IMAGING	NN	B-TEST
AT	NNP	O
Providence	NNP	O
Behavioral	NNP	O
Health	NNP	O
Hospital	NNP	O
:	:	O

ECHO	NNP	B-TEST
2018-05-28	JJ	O

IMPRESSION	NN	O
:	:	O
Moderate	NNP	B-PROBLEM
to	TO	I-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
(	(	O
minimal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
anteriorly	RB	I-PROBLEM
(	(	O
1cm	CD	O
),	NN	O
?	.	O
bloody	NN	B-PROBLEM
).	NN	O

No	DT	O
definite	NN	B-PROBLEM
tamponade	VBD	I-PROBLEM
physiology	NN	I-PROBLEM
.	.	O

Pacer	NNP	B-TREATMENT
seen	VBN	O
in	IN	O
RV	NNP	O
apex	NN	O
,	,	O
but	CC	O
cannot	JJ	O
exclude	JJ	O
perforation	NN	B-PROBLEM
.	.	O

CXR	NNP	B-TEST
2018-05-30	JJ	O

FINDINGS	NNS	O
:	:	O
The	DT	B-TEST
lung	NN	I-TEST
volumes	NNS	I-TEST
are	VBP	O
Moderate	NNP	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

Mild	NNP	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
.	.	O

Lung	NNP	B-TEST
volumes	NNS	I-TEST
are	VBP	O
low	JJ	B-PROBLEM
.	.	O

Bibasilar	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
.	.	O

IMPRESSION	NN	O
:	:	O
Unchanged	VBN	B-PROBLEM
moderate	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
CHF	NNP	I-PROBLEM
.	.	O

RENAL	NNP	B-TEST
US	NNP	I-TEST
2018-05-28	JJ	O

FINDINGS	NNS	O
:	:	O
The	DT	O
right	JJ	O
kidney	NN	O
measures	NNS	O
11	CD	O
cm	NN	O
in	IN	O
length	NN	B-TEST
,	,	O
the	DT	O
left	JJ	O
kidney	NN	O
measures	NNS	O
9.7	CD	O
cm	NN	O
in	IN	O
length	NN	B-TEST
.	.	O

No	DT	O
hydronephrosis	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

No	DT	O
urinary	JJ	B-PROBLEM
calculi	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
.	.	O

The	DT	O
bladder	NN	O
appears	VBZ	O
unremarkable	JJ	O
and	CC	O
contains	VBZ	O
a	DT	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

IMPRESSION	NN	O
:	:	O
No	DT	O
evidence	NN	O
of	IN	O
hydronephrosis	NN	B-PROBLEM
.	.	O

82	CD	O
y/o	JJ	O
f	NN	O
w	NN	O
h/o	NN	O
afib	NN	B-PROBLEM
,	,	O
SSS	NNP	B-PROBLEM
s/p	VBD	O
pacer	JJ	B-TREATMENT
05-08	JJ	O
c/b	NN	O
PTX	NNP	B-PROBLEM
requiring	VBG	O
CT	NNP	B-TREATMENT
,	,	O
CAD	NNP	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
readmitted	VBN	O
05-24	JJ	O
with	IN	O
ARF	NNP	B-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
,	,	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
with	IN	O
echo	JJ	B-TEST
showing	VBG	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
who	WP	O
is	VBZ	O
transferred	VBN	O
for	IN	O
possible	JJ	O
pericardial	JJ	B-TREATMENT
effusion	NN	I-TREATMENT
drainage	NN	I-TREATMENT
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
CHF	NNP	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
drainage	NN	B-TREATMENT
of	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
BNP	NNP	I-TEST
of	IN	O
>	JJ	O
5000	CD	O
on	IN	O
admission	NN	O
.	.	O

Since	IN	O
admission	NN	O
,	,	O
she	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
MI	NNP	B-PROBLEM
by	IN	O
enzymes	NNS	B-TEST
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
right	NN	I-TEST
sided	VBN	I-TEST
thoracentesis	NN	I-TEST
which	WDT	O
yielded	VBD	O
transudative	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

WBC	NNP	B-TEST
s	NN	I-TEST
since	IN	O
admission	NN	O
were	VBD	O
as	RB	O
high	JJ	O
as	IN	O
14,000	CD	O
but	CC	O
normalized	JJ	O
.	.	O

She	PRP	O
also	RB	O
had	VBD	O
2	CD	B-TEST
echocardiograms	NNS	I-TEST
which	WDT	O
revealed	VBD	O
persistent	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
gently	RB	O
diuresed	VBN	O
but	CC	O
has	VBZ	O
worsening	VBG	B-PROBLEM
ARF	NNP	I-PROBLEM
.	.	O

Her	PRP$	B-PROBLEM
O2	NNP	I-PROBLEM
requirement	NN	I-PROBLEM
has	VBZ	O
increased	VBN	O
despite	IN	O
diuresis	NN	B-TREATMENT
.	.	O

She	PRP	O
denies	VBZ	O
any	DT	O
CP	NNP	B-PROBLEM
/	NNP	O
cough	NN	B-PROBLEM
/	NN	O
fever	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
diarrhea	NN	B-PROBLEM
,	,	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
bloody	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
or	CC	O
headache	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
decreased	VBD	B-PROBLEM
to	TO	O
nearly	RB	O
zero	NN	O
.	.	O

In	IN	O
the	DT	O
setting	NN	O
of	IN	O
her	PRP$	B-PROBLEM
ongoing	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
for	IN	O
closer	JJR	O
observation	NN	O
to	TO	O
the	DT	O
CCU	NNP	O
.	.	O

The	DT	O
CCU	NNP	O
fellow	NN	O
and	CC	O
team	NN	O
declined	VBD	O
to	TO	O
do	VB	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
,	,	O
as	IN	O
the	DT	O
pt	NN	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
without	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
appearance	NN	I-PROBLEM
of	IN	I-PROBLEM
effusion	NN	I-PROBLEM
by	IN	O
echo	NN	B-TEST
performed	VBN	O
at	IN	O
bedside	NN	O
by	IN	O
cards	NNS	O
fellow	NN	O
.	.	O

As	IN	O
she	PRP	O
was	VBD	O
felt	VBN	O
by	IN	O
the	DT	O
CCU	NNP	O
to	TO	O
be	VB	O
a	DT	O
poor	JJ	O
candidate	NN	O
for	IN	O
right	JJ	B-TEST
heart	NN	I-TEST
cath	NN	I-TEST
,	,	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
110	CD	O
s-	JJ	O
120	CD	O
s	JJ	O
systolic	NN	B-TEST
and	CC	O
pulse	JJ	B-TEST
70	CD	O
s-	JJ	O
80	CD	O
s	NN	O
,	,	O
she	PRP	O
was	VBD	O
called	VBN	O
out	IN	O
of	IN	O
the	DT	O
CCU	NNP	O
and	CC	O
back	RB	O
to	TO	O
the	DT	O
cardiac	JJ	O
floor	NN	O
without	IN	O
intervention	NN	B-TREATMENT
.	.	O

The	DT	O
procedure	NN	O
team	NN	O
was	VBD	O
called	VBN	O
to	TO	O
consider	VB	O
doing	VBG	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
thoracentesis	NN	I-TREATMENT
,	,	O
but	CC	O
she	PRP	O
was	VBD	O
declined	VBN	O
because	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
effusions	NNS	I-PROBLEM
were	VBD	O
transudative	JJ	B-PROBLEM
,	,	O
secondary	JJ	O
to	TO	O
CHF	NNP	B-PROBLEM
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
recommended	VBN	O
to	TO	O
treat	VB	O
CHF	NNP	B-PROBLEM
.	.	O

The	DT	O
pt	NN	O
continued	VBD	O
to	TO	O
have	VB	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
lasix	JJ	I-TREATMENT
drip	NN	I-TREATMENT
IV	NNP	I-TREATMENT
upon	IN	O
call-out	NN	O
of	IN	O
the	DT	O
ICU	NNP	O
,	,	O
and	CC	O
additional	JJ	O
boluses	NNS	B-TREATMENT
of	IN	I-TREATMENT
IV	NNP	I-TREATMENT
lasix	NN	I-TREATMENT
,	,	O
200	CD	O
mg	NN	O
then	RB	O
300	CD	O
mg	NNS	O
IV	NNP	O
were	VBD	O
given	VBN	O
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
,	,	O
however	RB	O
,	,	O
she	PRP	O
remained	VBD	O
net	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
balance	NN	I-PROBLEM
.	.	O

Renal	JJ	O
consultants	NNS	O
did	VBD	O
not	RB	O
feel	VB	O
there	RB	O
was	VBD	O
an	DT	O
emergent	JJ	O
need	NN	O
for	IN	O
dialysis	NN	B-TREATMENT
.	.	O

A	DT	B-TREATMENT
nitro	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
started	VBN	O
in	IN	O
an	DT	O
effort	NN	O
to	TO	O
decrease	VB	O
her	PRP$	O
preload	NN	B-TEST
and	CC	O
afterload	NN	B-TEST
.	.	O

On	IN	O
call	NN	O
out	IN	O
from	IN	O
the	DT	O
CCU	NNP	O
,	,	O
the	DT	O
pt	NN	O
was	VBD	O
satting	VBG	B-TEST
93%	CD	O
on	IN	O
4-5L	JJ	O
NC	NNP	B-TREATMENT
,	,	O
and	CC	O
through	IN	O
the	DT	O
following	JJ	O
night	NN	O
,	,	O
her	PRP$	B-PROBLEM
oxygen	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
increased	VBD	O
to	TO	O
NRB	NNP	B-TREATMENT
,	,	O
wherein	VBD	O
she	PRP	O
was	VBD	O
satting	VBG	B-TEST
upper	JJ	O
80	CD	O
s-	JJ	O
low	JJ	O
90	CD	O
s.	NN	O

ABG	NNP	B-TEST
that	IN	O
evening	VBG	O
was	VBD	O
7.29/51/56	CD	O
on	IN	O
4L	CD	O
NC	NNP	B-TREATMENT
and	CC	O
early	RB	O
the	DT	O
next	JJ	O
morning	NN	O
,	,	O
was	VBD	O
7.25/62/64	CD	O
on	IN	O
NRB	NNP	B-TREATMENT
.	.	O

A	DT	B-TEST
CXR	NNP	I-TEST
was	VBD	O
performed	VBN	O
the	DT	O
evening	NN	O
of	IN	O
5/16	CD	O
,	,	O
showing	VBG	O
moderate	JJ	B-PROBLEM
sized	VBN	I-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
stable	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
and	CC	O
a	DT	O
possible	JJ	O
RLL	NNP	B-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

Vancomycin	NNP	B-TREATMENT
and	CC	O
Zosyn	NNP	B-TREATMENT
were	VBD	O
started	VBN	O
.	.	O

She	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

The	DT	O
morning	NN	O
of	IN	O
5/17	CD	O
,	,	O
her	PRP$	B-TEST
pulsus	NN	I-TEST
parodoxicus	NN	I-TEST
was	VBD	O
12	CD	O
.	.	O

Because	IN	O
of	IN	O
her	PRP$	B-TEST
ABG	NNP	I-TEST
,	,	O
and	CC	O
declining	VBG	O
clinical	JJ	O
status	NN	O
,	,	O
the	DT	O
CCU	NNP	O
was	VBD	O
notified	VBN	O
for	IN	O
possible	JJ	O
transfer	NN	O
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
given	VBN	O
her	PRP$	O
age	NN	O
,	,	O
multiple	JJ	B-PROBLEM
co-morbidities	NNS	I-PROBLEM
,	,	O
that	IN	O
her	PRP$	O
prognosis	NN	O
was	VBD	O
poor	JJ	O
even	RB	O
prior	VBP	O
to	TO	O
CCU	NNP	O
admission	NN	O
,	,	O
possible	JJ	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
or	CC	O
repeat	NN	B-TREATMENT
thoracenteses	NNS	I-TREATMENT
.	.	O

Explained	VBN	O
to	TO	O
Lewin	VB	O
that	DT	O
pt	NN	O
will	MD	O
likely	RB	O
need	VB	O
to	TO	O
be	VB	O
intubated	VBN	O
,	,	O
as	IN	O
she	PRP	O
cannot	VBZ	O
lie	JJ	O
flat	JJ	O
,	,	O
and	CC	O
most	JJS	O
likely	JJ	O
cannot	NN	O
undergo	JJ	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
,	,	O
thoracentesis	NN	B-TREATMENT
,	,	O
or	CC	O
right	JJ	B-TREATMENT
heart	NN	I-TREATMENT
cath	NN	I-TREATMENT
with	IN	O
BiPAP	NNP	B-TREATMENT
(	(	O
which	WDT	O
would	MD	O
have	VB	O
been	VBN	O
the	DT	O
next	JJ	O
measure	NN	O
after	IN	O
NRB	NNP	B-TREATMENT
,	,	O
and	CC	O
prior	RB	O
to	TO	O
intubation	NN	B-TREATMENT
).	NN	O

Explained	VBD	O
that	IN	O
despite	IN	O
these	DT	B-TREATMENT
invasive	JJ	I-TREATMENT
measures	NNS	I-TREATMENT
,	,	O
she	PRP	O
still	RB	O
has	VBZ	O
a	DT	O
very	RB	O
poor	JJ	O
prognosis	NN	O
.	.	O

Odell	NNP	O
does	VBZ	O
not	RB	O
believe	VB	O
the	DT	O
pt	NN	O
would	MD	O
want	VB	O
to	TO	O
be	VB	O
intubated	VBN	O
,	,	O
with	IN	O
central	JJ	B-TREATMENT
line	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
heart	NN	I-TREATMENT
cath	NN	I-TREATMENT
,	,	O
in	IN	O
the	DT	O
CCU	NNP	O
.	.	O

She	PRP	O
requested	VBD	O
the	DT	O
patient	NN	O
be	VB	O
made	VBN	O
Comfort	NNP	B-TREATMENT
Measures	NNP	I-TREATMENT
Only	RB	O
.	.	O

The	DT	O
pt	NN	O
will	MD	O
be	VB	O
made	VBN	O
comfortable	JJ	O
,	,	O
with	IN	O
goals	NNS	O
of	IN	O
care	NN	O
shifted	VBN	O
towards	NNS	O
suppressing	VBG	O
her	PRP$	B-PROBLEM
air	NN	I-PROBLEM
hunger	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
.	.	O

#.	JJ	O
SOB	NNP	B-PROBLEM
:	:	O
Most	JJS	O
consistent	JJ	O
with	IN	O
CHF	NNP	B-PROBLEM
by	IN	O
exam	NN	B-TEST
,	,	O
although	IN	O
unknown	JJ	O
what	WP	O
the	DT	O
severity	NN	O
of	IN	O
her	PRP$	B-PROBLEM
COPD	NNP	I-PROBLEM
is	VBZ	O
currently	RB	O
.	.	O

TTE	NNP	B-TEST
revealed	VBD	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Pt	NNP	O
is	VBZ	O
now	RB	O
s/p	JJ	O
drainage	NN	B-TREATMENT
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
diagnostic	JJ	O
and	CC	O
therapeutic	JJ	O
,	,	O
with	IN	O
studies	NNS	B-TEST
consistent	VBP	O
with	IN	O
transudate	NN	B-PROBLEM
,	,	O
etiology	NN	O
most	RBS	O
likely	JJ	O
02-15	JJ	O
CHF	NNP	B-PROBLEM
.	.	O

We	PRP	O
continued	VBD	O
her	PRP	B-TREATMENT
albuterol	NN	I-TREATMENT
/	JJ	O
atrovent	NN	B-TREATMENT
nebs	NN	I-TREATMENT
,	,	O
diuresis	NN	B-TREATMENT
with	IN	O
IV	NNP	B-TREATMENT
lasix	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
boluses	NNS	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
05-27	JJ	I-TEST
CXR	NNP	I-TEST
post	NN	O
procedure	NN	O
w/o	NN	O
PNX	NNP	B-PROBLEM
,	,	O
effusion	NN	B-PROBLEM
much	RB	O
improved	VBN	O
,	,	O
yet	RB	O
her	PRP$	B-TEST
05-28	JJ	I-TEST
CXR	NNP	I-TEST
worse	JJR	O
than	IN	O
05-27	NN	O
with	IN	O
some	DT	O
reaccumulation	NN	O
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Then	RB	O
,	,	O
on	IN	O
05-29	NN	O
,	,	O
she	PRP	O
demonstrated	VBD	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
(	(	O
reaccumulated	VBN	O
),	RB	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
(	(	O
started	VBN	O
on	IN	O
vanco	NN	B-TREATMENT
/	JJ	O
zosyn	CD	B-TREATMENT
)->	JJ	O
put	NN	O
on	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
,	,	O
given	VBN	O
lasix	VBP	B-TREATMENT
x	JJ	O
1	CD	O
bolus	JJ	O
100	CD	O
mg	NN	O
,	,	O
responded	VBD	O
somewhat	RB	O
and	CC	O
o2	JJ	B-TEST
sat	NN	I-TEST
stable	JJ	O
in	IN	O
low	JJ	O
90	CD	O
s.	NN	O

She	PRP	O
was	VBD	O
given	VBN	O
200	CD	B-TREATMENT
mg	JJ	I-TREATMENT
IV	NNP	I-TREATMENT
lasix	NN	I-TREATMENT
X	VBD	O
1	CD	O
with	IN	O
an	DT	O
additional	JJ	O
100	CD	O
cc	NN	O
of	IN	O
urine	JJ	B-TEST
output	NN	I-TEST
the	DT	O
evening	NN	O
of	IN	O
5/16	CD	O
.	.	O

Her	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
continued	VBD	O
during	IN	O
this	DT	O
time	NN	O
.	.	O

Her	PRP$	B-TEST
oxygen	NN	I-TEST
sats	NNS	I-TEST
did	VBD	O
not	RB	O
improve	VB	O
.	.	O

#.	JJ	O
Pericardial	NNP	B-PROBLEM
effusion	NN	I-PROBLEM
:	:	O
unclear	JJ	O
etiology	NN	O
,	,	O
OSH	NNP	O
had	VBD	O
raised	VBN	O
question	NN	O
of	IN	O
RV	NNP	B-PROBLEM
perforation	NN	I-PROBLEM
from	IN	O
pacer	NN	B-TREATMENT
,	,	O
however	RB	O
she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
echo	JJ	O
appearance	NN	O
of	IN	O
lead	NN	O
,	,	O
no	DT	O
tamponade	NN	B-PROBLEM
by	IN	O
exam	NN	B-TEST
.	.	O

This	DT	O
has	VBZ	O
still	RB	O
be	VB	O
known	VBN	O
to	TO	O
occur	VB	O
during	IN	O
the	DT	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
posthumously	RB	O
that	IN	O
her	PRP$	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
complication	NN	I-PROBLEM
of	IN	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
although	IN	O
this	DT	O
was	VBD	O
not	RB	O
seen	VBN	O
on	IN	O
imaging	NN	B-TEST
.	.	O

In	IN	O
the	DT	O
last	JJ	O
12	CD	O
hours	NNS	O
of	IN	O
her	PRP$	O
life	NN	O
,	,	O
her	PRP$	B-TEST
pulsus	NN	I-TEST
was	VBD	O
12	CD	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
likely	RB	O
to	TO	O
have	VB	O
aspect	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
physiology	NN	I-PROBLEM
,	,	O
since	IN	O
her	PRP$	B-TEST
preload	NN	I-TEST
was	VBD	O
reduced	VBN	O
.	.	O

#.	JJ	O
CHF	NNP	B-PROBLEM
:	:	O
normal	JJ	O
EF	NNP	O
on	IN	O
TTE	NNP	B-TEST
so	IN	O
possibly	RB	O
with	IN	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
for	IN	O
MI	NNP	B-PROBLEM

-	:	O
See	NN	O
course	NN	O
of	IN	O
diuresis	NN	B-TREATMENT
above	IN	O
.	.	O

-	:	O
We	PRP	O
continued	VBD	O
ASA	NNP	B-TREATMENT
/	NNP	O
imdur	NN	B-TREATMENT
/	NNP	O
CCB	NNP	B-TREATMENT
/	NNP	O
hold	VB	O
diovan	NN	B-TREATMENT
until	IN	O
pt	NN	O
was	VBD	O
made	VBN	O
CMO	NNP	O
.	.	O

#.	JJ	O
Pleural	NNP	B-PROBLEM
effusions	NNS	I-PROBLEM
:	:	O
Likely	RB	O
due	JJ	O
to	TO	O
CHF	NNP	B-PROBLEM
although	IN	O
had	VBD	O
some	DT	B-PROBLEM
leukocytosis	NN	I-PROBLEM
at	IN	O
admission	NN	O
to	TO	O
OSH	NNP	O
.	.	O

Mary	NNP	B-TEST
studies	NNS	I-TEST
c/w	VBP	O
transudate	NN	B-PROBLEM
.	.	O

-	:	O
After	IN	O
she	PRP	O
was	VBD	O
made	VBN	O
CMO	NNP	O
,	,	O
the	DT	O
pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Morphine	NNP	B-TREATMENT
gtt	NN	I-TREATMENT
to	TO	O
maximize	VB	O
comfort	NN	O
and	CC	O
minimize	VB	O
air	NN	B-PROBLEM
hunger	NN	I-PROBLEM
.	.	O

#.	JJ	O
Afib/SSS	NN	B-PROBLEM
:	:	O
She	PRP	O
was	VBD	O
A-paced	NNP	B-TREATMENT
,	,	O
pacer	NN	B-TREATMENT
placed	VBD	O
05-08	CD	O
in	IN	O
DDDR	NNP	B-TREATMENT
mode	NN	I-TREATMENT
,	,	O
complicated	VBN	O
by	IN	O
PTX	NNP	B-PROBLEM
requiring	VBG	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT
which	WDT	O
resolved	VBD	O
and	CC	O
tube	NN	B-TREATMENT
was	VBD	O
removed	VBN	O
during	IN	O
admit	NN	O
for	IN	O
pacer	NN	B-TREATMENT
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
PTX	NNP	B-PROBLEM
on	IN	O
most	JJS	B-TEST
recent	JJ	I-TEST
CXR	NNP	I-TEST
.	.	O

Her	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
correct	JJ	O
position	NN	O
.	.	O

We	PRP	O
continued	VBD	O
amiodarone	RB	B-TREATMENT
until	IN	O
pt	NN	O
was	VBD	O
made	VBN	O
CMO	NNP	O
.	.	O

Anticoagulation	NN	B-TREATMENT
has	VBZ	O
not	RB	O
been	VBN	O
given	VBN	O
this	DT	O
admission	NN	O
.	.	O

We	PRP	O
started	VBD	O
her	PRP	O
on	IN	O
dilt	NN	B-TREATMENT
for	IN	O
additional	JJ	B-TREATMENT
a	DT	I-TREATMENT
fib	NN	I-TREATMENT
control	NN	I-TREATMENT
(	(	O
revert	VB	O
back	RB	O
to	TO	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
on	IN	O
05-29	NNP	O
),	NNP	O
which	WDT	O
was	VBD	O
stopped	VBN	O
when	WRB	O
the	DT	O
pt	NN	O
was	VBD	O
made	VBN	O
CMO	NNP	O
.	.	O

#.	JJ	O
Oliguric	NNP	B-PROBLEM
ARF	NNP	I-PROBLEM
:	:	O
likely	JJ	O
prerenal	JJ	O
due	JJ	O
to	TO	O
n/v	JJ	B-PROBLEM
poor	JJ	B-PROBLEM
po	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
forward	RB	I-PROBLEM
flow	NN	I-PROBLEM
,	,	O
However	RB	O
,	,	O
need	VBP	O
to	TO	O
continue	VB	O
diuresis	NN	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
urine	JJ	I-TEST
lytes	NNS	I-TEST
consistent	JJ	O
with	IN	O
ATN	NNP	B-PROBLEM
,	,	O
FENA	NNP	B-TEST
4%	CD	O
.	.	O

Renal	JJ	B-TEST
u/s	JJ	I-TEST
negative	JJ	O
for	IN	O
hydronephrosis	NN	B-PROBLEM
.	.	O

Renal	JJ	O
consultants	NNS	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
there	EX	O
was	VBD	O
an	DT	O
indication	NN	O
for	IN	O
urgent	JJ	B-TREATMENT
hemodialysis	NN	I-TREATMENT
.	.	O

She	PRP	O
continued	VBD	O
to	TO	O
put	VB	O
out	RP	O
low	JJ	B-PROBLEM
amounts	NNS	I-PROBLEM
of	IN	I-PROBLEM
urine	NN	I-PROBLEM
throughout	IN	O
the	DT	O
admission	NN	O
,	,	O
despite	IN	O
aggressive	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
with	IN	O
IV	NNP	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
boluses	NNS	B-TREATMENT
.	.	O

#.	JJ	O
ID	NNP	O
:	:	O
initially	RB	O
had	VBD	O
leukocytosis	NN	B-PROBLEM
at	IN	O
admission	NN	O
,	,	O
with	IN	O
chest	JJ	B-TEST
CT	NNP	I-TEST
showing	VBG	O
possible	JJ	O
underlying	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
vs.	FW	O
atelectasis	NN	B-PROBLEM
,	,	O
levoflox	NN	B-TREATMENT
started	VBD	O
05-24	CD	O
and	CC	O
subsequently	RB	O
stopped	VBD	O
(	(	O
no	DT	O
consolidations	NNS	B-PROBLEM
on	IN	O
CXR	NNP	B-TEST
and	CC	O
afebrile	JJ	B-PROBLEM
).	NN	O

U/A	NN	B-TEST
on	IN	O
05-27	JJ	O
c/w	NN	O
UTI	NNP	B-PROBLEM
.	.	O

Pt	NNP	O
now	RB	O
on	IN	O
IV	NNP	B-TREATMENT
Ceftriaxone	NNP	I-TREATMENT
(	(	O
was	VBD	O
on	IN	O
levoflox	JJ	B-TREATMENT
since	IN	O
05-24	JJ	O
however	RB	O
UA	NNP	B-TEST
now	RB	O
floridly	RB	B-PROBLEM
positive	JJ	I-PROBLEM
(	(	O
more	RBR	O
so	RB	O
than	IN	O
UA	NNP	B-TEST
at	IN	O
OSH	NNP	O
)	)	O
so	RB	O
felt	VBD	O
possibly	RB	O
levo-resistant	JJ	B-PROBLEM
.	.	O

Pt	NNP	O
started	VBD	O
on	IN	O
CTX	NNP	B-TREATMENT
05-27	NN	O
.	.	O

She	PRP	O
was	VBD	O
empirically	RB	O
started	VBN	O
on	IN	O
vanco/zosyn	NN	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
hosp	NN	I-TREATMENT
acquired	VBD	I-TREATMENT
pna	JJ	I-TREATMENT
coverage	NN	I-TREATMENT

-	:	O
possible	JJ	O
opacity	NN	B-PROBLEM
on	IN	O
CXR	NNP	B-TEST
-	:	O
along	IN	O
w/	JJ	O
leukocytosis	NN	B-PROBLEM
.	.	O

#.	JJ	O
Anemia	NNP	B-PROBLEM
:	:	O
Unclear	JJ	O
source	NN	O
.	.	O

She	PRP	O
was	VBD	O
guiaic	JJ	B-TEST
negative	JJ	O
.	.	O

-	:	O
no	DT	O
transfusions	NNS	B-TREATMENT
,	,	O
CMO/DNR/DNI	NNP	O

#.	JJ	O
FEN	NNP	O
:	:	O
check	NN	O
lytes	NNS	B-TEST
,	,	O
most	JJS	O
recently	RB	O
normal	JJ	O
.	.	O

cardiac/renal	JJ	B-TREATMENT
diet	NN	I-TREATMENT

#.	JJ	O
Access	NNP	O
:	:	O
PIV	NN	B-TREATMENT

aranesp	RB	B-TREATMENT
100	CD	O
mcg	NN	O
(	(	O
X1	NNP	O
05-26	CD	O
)	)	O

diltiazem	JJ	B-TREATMENT
CD	NN	I-TREATMENT
240	CD	O
mg	NN	O

paxil	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

detrol	NN	B-TREATMENT
LA	NNP	I-TREATMENT
4	CD	O
mg	NNS	O
daily	RB	O

EC	NNP	B-TREATMENT
ASA	NNP	I-TREATMENT
81	CD	O
mg	NNS	O
daily	RB	O

pepcid	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

amiodarone	RB	B-TREATMENT
200	CD	O
mg	NNS	O
daily	RB	O

levofloxacin	RB	B-TREATMENT
250	CD	O
mg	NNS	O
IV	NNP	O
daily	RB	O
(	(	O
started	VBN	O
05-24	CD	O
)	)	O

levothyroxine	NN	B-TREATMENT
50	CD	O
mcg	JJ	O
daily	JJ	O

diovan	NN	B-TREATMENT
160	CD	O
mg	JJ	O
daily	JJ	O

imdur	NN	B-TREATMENT
60	CD	O
mg	JJ	O
daily	JJ	O

albuterol-ipratroprium	JJ	B-TREATMENT
INH	NNP	O
2	CD	O
sprays	NNS	O
tid	VBP	O
prn	NN	O

1.	CD	O
Pulmonary	NNP	B-PROBLEM
Edema	NNP	I-PROBLEM
and	CC	O
Hypoxic	NNP	B-PROBLEM
Respiratory	NNP	I-PROBLEM
Failure	NN	I-PROBLEM

2.	CD	O
Large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM

3.	CD	O
Moderate	NNP	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM

4.	CD	O
Congestive	JJ	B-PROBLEM
Heart	NNP	I-PROBLEM
Failure	NN	I-PROBLEM

5.	CD	O
Paroxysmal	NNP	B-PROBLEM
Atrial	NNP	I-PROBLEM
Fibrillation	NNP	I-PROBLEM

6.	CD	O
Sick	NNP	B-PROBLEM
sinus	VBD	I-PROBLEM
syndrome	JJ	I-PROBLEM
status	NN	O
post	NN	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT

7.	CD	O
Coronary	JJ	B-PROBLEM
Artery	NNP	I-PROBLEM
Disease	NNP	I-PROBLEM

Penicillins	NNS	B-TREATMENT

Dyspnea	NN	B-PROBLEM

46	CD	O
-	:	O
yo-man	JJ	O
w/	NN	O
active	JJ	O
cocaine	NN	O
use	NN	O
presents	NNS	O
w/	VBP	O
LE	NNP	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

10	CD	O
days	NNS	O
ago	RB	O
,	,	O
he	PRP	O
developed	VBD	O
b/l	VB	B-PROBLEM
LE	NNP	I-PROBLEM
edema	NN	I-PROBLEM
that	WDT	O
has	VBZ	O
gotten	VBN	O
progressively	RB	O
worse	RBR	O
until	IN	O
now	RB	O
.	.	O

Three	CD	O
days	NNS	O
ago	RB	O
,	,	O
he	PRP	O
developed	VBD	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
when	WRB	O
climbing	VBG	O
stairs	NNS	O
,	,	O
assoc	JJ	O
w/	JJ	O
2-pillow	JJ	B-PROBLEM
orthopnea	NN	I-PROBLEM
and	CC	O
PND	NNP	B-PROBLEM
.	.	O

He	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
recent	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
,	,	O
numbness	RB	B-PROBLEM
,	,	O
abd	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
hematuria	NNS	B-PROBLEM
.	.	O

No	DT	O
recent	JJ	B-PROBLEM
viral	JJ	I-PROBLEM
syndromes	NNS	I-PROBLEM
or	CC	O
URI	NNP	B-PROBLEM
s.	NN	I-PROBLEM

Today	NN	O
,	,	O
his	PRP$	O
wife	NN	O
convinced	VBD	O
him	PRP	O
to	TO	O
present	VB	O
to	TO	O
the	DT	O
Deanna	NNP	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

In	IN	O
the	DT	O
Deanna	NNP	O
,	,	O
his	PRP$	B-TEST
BP	NNP	I-TEST
was	VBD	O
230/170	CD	O
.	.	O

BNP	NNP	B-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
7500	CD	O
.	.	O

CXR	NNP	B-TEST
revealed	VBD	O
evidence	NN	O
of	IN	O
cardiomegaly	NN	B-PROBLEM
and	CC	O
pulm	NN	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
w/	JJ	O
ASA	NNP	B-TREATMENT
325	CD	O
mg	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
IV	NNP	O
,	,	O
and	CC	O
hydralazine	VB	B-TREATMENT
10	CD	O
mg	NN	O
IV	NNP	O
x	VBZ	O
2	CD	O
.	.	O

He	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
lasix	VB	B-TREATMENT
w/	RB	O
good	JJ	O
UOP	NNP	B-TEST
,	,	O
but	CC	O
diastolic	JJ	B-TEST
BP	NNP	I-TEST
remained	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
170	CD	O
,	,	O
prompting	VBG	O
initiation	NN	O
of	IN	O
nitroprusside	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

Drinks	NNS	O
3-4	JJ	O
beers	NNS	O
a	DT	O
few	JJ	O
times	NNS	O
weekly	RB	O
,	,	O
no	DT	O
h/o	NN	O
withdrawal	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
seizures	NNS	B-PROBLEM
or	CC	O
DT	NNP	B-PROBLEM
s.	NN	I-PROBLEM

There	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
premature	NN	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
sudden	JJ	B-PROBLEM
death	NN	I-PROBLEM
.	.	O

VS	NN	B-TEST
:	:	O
T,	NNP	B-TEST
BP	NNP	B-TEST
181/122	CD	O
,	,	O
HR	NNP	B-TEST
84	CD	O
,	,	O
RR	NNP	B-TEST
12	CD	O
,	,	O
O2	NNP	B-TEST
98%	CD	O
2L/m	CD	O

Gen	NN	O
:	:	O
lying	VBG	O
flat	JJ	O
in	IN	O
bed	NN	O
,	,	O
pleasant	NN	O
and	CC	O
conversational	JJ	O
,	,	O
NAD	NNP	B-PROBLEM

HEENT	NN	O
:	:	O
NCAT	NNP	B-PROBLEM
.	.	O

Sclera	NNP	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

Neck	NN	O
:	:	O
Supple	NN	O
with	IN	O
JVP	NNP	B-TEST
of	IN	O
8	CD	O
cm	NN	O
.	.	O

CV	NN	O
:	:	O
reg	NN	O
s1	NN	O
,	,	O
loud	JJ	B-PROBLEM
s2	NN	I-PROBLEM
,	,	O
+	VBZ	O
2/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
radiating	VBG	I-PROBLEM
to	TO	I-PROBLEM
axilla	VB	I-PROBLEM
,	,	O
no	DT	O
s3/s4/r	NN	B-PROBLEM

Pulm	NN	O
:	:	O
CTA	NNP	O
b/l	VBD	O
w/	JJ	O
no	DT	O
crackles	NNS	B-PROBLEM
or	CC	O
wheezing	VBG	B-PROBLEM

Abd	NN	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
+BS	NNP	O
,	,	O
soft	JJ	O
,	,	O
NTND	NNP	B-PROBLEM
.	.	O

Ext	NN	O
:	:	O
warm	NN	O
,	,	O
2+	CD	O
DP	NNP	B-TEST
b/l	NN	O
,	,	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
b/l	VB	I-PROBLEM

WBC	NNP	B-TEST
-	:	O
7.7	CD	O
RBC	NNP	B-TEST
-	:	O
5.00	CD	O
HGB	NNP	B-TEST
-	:	O
15.0	CD	O
HCT	NNP	B-TEST
-	:	O
42.8	CD	O
MCV	NNP	B-TEST
-	:	O
86	CD	O
MCH	NNP	B-TEST
-	:	O
30.0	CD	O
MCHC	NNP	B-TEST
-	:	O
35.0	CD	O
RDW	NNP	B-TEST
-	:	O
14.6	CD	O

PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
315	CD	O

CK-MB	NNP	B-TEST
-	:	O
4	CD	O
proBNP	NN	B-TEST
-	:	O
7489	CD	O
*	NN	O

cTropnT	SYM	B-TEST
-	:	O
0.02	CD	O
*	NN	O

ALT(SGPT)	NNP	B-TEST
-	:	O
77	CD	O
*	NN	O
AST(SGOT)	NNP	B-TEST
-	:	O
60	CD	O
*	NN	O
CK(CPK)	NNP	B-TEST
-	:	O
195	CD	O
*	JJ	O
ALK	NNP	B-TEST
PHOS	NNP	I-TEST
-	:	O
104	CD	O
AMYLASE	NNP	B-TEST
-	:	O
100	CD	O
TOT	NNP	B-TEST
BILI	NNP	I-TEST
-	:	O
0.4	CD	O

EKG	NNP	B-TEST
demonstrated	VBD	O
NSR	NNP	O
at	IN	O
87	CD	O
bpm	NN	O
,	,	O
nl	JJ	O
axis	NN	O
,	,	O
nl	JJ	O
int	NN	O
,	,	O
LVH	NNP	B-PROBLEM
w/	VBD	O
strain	NN	B-PROBLEM
pattern	NN	I-PROBLEM
,	,	O
no	DT	O
ischemic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

CXR	NN	B-TEST
:	:	O

Moderate	NNP	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiac	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
,	,	O
and	CC	O
particularly	RB	O
the	DT	O
left	NN	O
atrium	NN	O
accompanied	VBN	O
by	IN	O
pulmonary	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
consistent	NN	O
with	IN	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

The	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
cavity	NN	I-PROBLEM
dilation	NN	I-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

No	DT	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
thrombus	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

Tissue	NNP	B-TEST
Doppler	NNP	I-TEST
imaging	VBG	I-TEST
suggests	VBZ	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
left	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressure	NN	I-PROBLEM
(	(	O
PCWP	NNP	B-TEST
>	VBZ	O
18	CD	O
mmHg	NN	O
).	NN	O

The	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
free	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

The	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
minimally	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

No	DT	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
or	CC	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

There	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
small	JJ	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

IMPRESSION	NN	O
:	:	O
Moderate	NNP	B-PROBLEM
symmetric	NN	I-PROBLEM
eft	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
biventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
c/w	NN	O
diffuse	NN	B-PROBLEM
process	NN	I-PROBLEM
(	(	O
toxin	NN	B-PROBLEM
,	,	O
metabolic	NN	O
,	,	O
cannot	JJ	O
exclude	NN	O
myocarditis	NN	B-PROBLEM
;	:	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
LVH	NNP	B-PROBLEM
on	IN	O
ECG	NNP	B-TEST
,	,	O
an	DT	B-PROBLEM
infiltrative	JJ	I-PROBLEM
process	NN	I-PROBLEM
should	MD	O
also	RB	O
be	VB	O
considered	VBN	O
).	JJ	O

Mild	NNP	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

Moderate	NNP	B-PROBLEM
pulmonary	JJ	I-PROBLEM
arterial	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

Very	RB	B-PROBLEM
small	JJ	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

Possible	JJ	O
abnormality	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
as	IN	O
described	VBN	O
above	IN	O
without	IN	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

If	IN	O
clinically	RB	O
indicated	VBD	O
a	DT	B-TEST
TEE	NNP	I-TEST
would	MD	O
be	VB	O
better	RBR	O
able	JJ	O
to	TO	O
define	VB	O
an	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
.	.	O

46	CD	O
-	:	O
yo-man	JJ	O
w/	JJ	O
cocaine	NN	O
abuse	NN	O
presents	VBZ	O
w/	JJ	O
LE	NNP	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
DOE	NNP	B-PROBLEM
likely	RB	O
from	IN	O
diastolic	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
cocaine	NN	O
use	NN	O
complicated	VBN	O
by	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
.	.	O

Hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
:	:	O

BP	NNP	B-TEST
230/170	CD	O
on	IN	O
presentation	NN	O
,	,	O
most	RBS	O
likely	JJ	O
from	IN	O
chronic	JJ	B-PROBLEM
HTN	NNP	I-PROBLEM
exacerbated	VBN	O
by	IN	O
cocaine	NN	O
use	NN	O
.	.	O

No	DT	O
signs	NNS	O
of	IN	O
end-organ	JJ	B-PROBLEM
damage	NN	I-PROBLEM
at	IN	O
present	JJ	O
except	IN	O
for	IN	O
elevated	JJ	B-PROBLEM
creatinine	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
more	RBR	O
likely	JJ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
labetalol	NN	B-TREATMENT
and	CC	O
Lisinopril	NNP	B-TREATMENT
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
taken	VBN	O
down	RB	O
from	IN	O
230	CD	O
systolic	JJ	B-TEST
to	TO	O
approx	VB	O
160	CD	O
systolic	JJ	B-TEST
/	RB	O
100	CD	O
diastolic	NN	B-TEST
on	IN	O
discharge	NN	O
.	.	O

His	PRP$	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	VBZ	I-PROBLEM
improved	VBN	O
with	IN	O
diuresis	NN	B-TREATMENT
.	.	O

An	DT	B-TEST
echo	NN	I-TEST
performed	VBN	O
on	IN	O
admission	NN	O
showed	VBD	O
an	DT	B-TEST
LF	NNP	I-TEST
EF	NNP	I-TEST
of	IN	O
25%	CD	O
.	.	O

It	PRP	O
is	VBZ	O
hoped	VBN	O
with	IN	O
good	JJ	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
and	CC	O
use	NN	O
of	IN	O
an	DT	B-TREATMENT
ACE-I	JJ	I-TREATMENT
with	IN	O
follow	JJ	O
up	RP	O
in	IN	O
addition	NN	O
to	TO	O
cocaine	VB	O
abstaining	NN	O
will	MD	O
improved	VB	O
his	PRP$	O
cardiac	JJ	O
function	NN	O
.	.	O

Renal	JJ	B-PROBLEM
Failure	NN	I-PROBLEM
:	:	O
creatinine	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
1.6	CD	O
Likely	JJ	O
acute	JJ	B-PROBLEM
hypertensive	NN	I-PROBLEM
nephropathy	JJ	I-PROBLEM
plus	CC	O
probalbe	JJ	O
long-standing	JJ	B-PROBLEM
hypertensive	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

discharged	VBN	O
on	IN	O
ACE-I	NNP	B-TREATMENT
.	.	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Hydrochlorothiazide	NNP	B-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

3.	CD	O
Labetalol	NNP	B-TREATMENT
200	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
Lisinopril	NNP	B-TREATMENT
20	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

-	:	O
hypertensive	NN	B-PROBLEM
emergency	NN	I-PROBLEM

-	:	O
ARF	NN	B-PROBLEM

-	:	O
mild	NN	B-PROBLEM
transaminitis	NN	I-PROBLEM
likely	JJ	O
03-25	JJ	O
etoh	NN	O
and	CC	O
cocaine	NN	O
abuse	NN	O

-	:	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
improved	VBD	O

You	PRP	O
came	VBD	O
in	IN	O
with	IN	O
hypertensive	JJ	B-PROBLEM
emergency	NN	I-PROBLEM
.	.	O

You	PRP	O
were	VBD	O
treated	VBN	O
with	IN	O
medications	NNS	B-TREATMENT
to	TO	O
improve	VB	O
your	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

1.	CD	O
Lisinopril	NNP	B-TREATMENT
20	CD	O
mg	NNS	O
daily	RB	O

2.	CD	O
HCTZ	NNP	B-TREATMENT
25	CD	O
mg	NNS	O
daily	RB	O

3.	CD	O
Labetalol	NNP	B-TREATMENT
400	CD	O
mg	NN	O
bid	NN	O

4.	CD	O
ASA	NNP	B-TREATMENT
162mg	CD	O
daily	RB	O

It	PRP	O
is	VBZ	O
extremely	RB	O
important	JJ	O
for	IN	O
you	PRP	O
to	TO	O
take	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

Please	VB	O
return	NN	O
to	TO	O
the	DT	O
Deanna	NNP	O
if	IN	O
you	PRP	O
experience	VBP	O
SOB	NNP	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
decreased	VBN	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

Ken	NNP	O
Nansteel-Miller	NNP	O
is	VBZ	O
the	DT	O
triplet	NN	O
#3	NNP	O
of	IN	O
a	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
triamniotic-trichorionic	JJ	I-PROBLEM
triplet	NN	I-PROBLEM
pregnancy	NN	I-PROBLEM
born	VBN	O
to	TO	O
a	DT	O
39-year-old	JJ	O
G4	NNP	O
P1	NNP	O
spontaneous	JJ	O
abortion	NN	O
2	CD	O
woman	NN	O
.	.	O

Blood	NNP	B-TEST
type	NN	I-TEST
A	NNP	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
RPR	NNP	B-TEST
nonreactive	NN	O
,	,	O
hepatitis	NN	B-TEST
B	NNP	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
group	NN	B-TEST
beta	VBD	I-TEST
Strep	NNP	I-TEST
status	NN	I-TEST
unknown	NN	O
.	.	O

The	DT	O
mother	NN	O
was	VBD	O
followed	VBN	O
closely	RB	O
and	CC	O
received	VBD	O
betamethasone	RB	B-TREATMENT
2011-08-22	JJ	O
.	.	O

She	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2011-08-25	JJ	O
for	IN	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
shortened	JJ	I-PROBLEM
cervix	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
bed	NN	B-TREATMENT
rest	NN	I-TREATMENT
and	CC	O
prn	JJ	O
terbutaline	NN	B-TREATMENT
.	.	O

Other	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
Prozac	NNP	B-TREATMENT
.	.	O

The	DT	O
babies	NNS	O
were	VBD	O
born	VBN	O
by	IN	O
elective	JJ	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
at	IN	O
34	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

This	DT	O
triplet	NN	O
#3	VBZ	O
emerged	VBN	O
with	IN	O
spontaneous	JJ	O
respirations	NNS	O
,	,	O
and	CC	O
required	VBD	O
blow-by	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
.	.	O

Apgars	NNS	B-TEST
were	VBD	O
seven	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
eight	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Neonatal	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

Weight	NNP	B-TEST
1.7	CD	O
kg	NN	O
,	,	O
length	VBZ	B-TEST
41.5	CD	O
cm	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
29	CD	O
cm	NN	O
,	,	O
all	DT	O
10th-25th	JJ	O
percentile	NN	O
for	IN	O
34	CD	O
weeks	NNS	O
.	.	O

General	NNP	O
:	:	O
Nondysmorphic	JJ	B-PROBLEM
preterm	NNS	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Positive	JJ	O
red	JJ	B-TEST
reflex	NN	I-TEST
bilaterally	RB	O
.	.	O

Chest	NN	O
:	:	O
Mild	NNP	B-PROBLEM
intercostal	NN	I-PROBLEM
and	CC	I-PROBLEM
sternal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
.	.	O

Breath	NNP	B-TEST
sounds	VBZ	I-TEST
equal	JJ	O
with	IN	O
fair	JJ	O
aeration	NN	O
.	.	O

Cardiovascular	JJ	O
:	:	O
Regular	JJ	O
,	,	O
rate	NN	O
,	,	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

Femoral	JJ	B-TEST
pulses	NNS	I-TEST
+2	VBP	O
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

1.	CD	O
Respiratory	NN	O
:	:	O
Lincoln	NN	O
required	VBN	O
nasal	RB	B-TREATMENT
cannula	JJ	I-TREATMENT
O2	NNP	I-TREATMENT
for	IN	O
approximately	RB	O
the	DT	O
first	JJ	O
8-12	JJ	O
hours	NNS	O
of	IN	O
life	NN	O
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
episodes	NNS	O
of	IN	O
spontaneous	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
during	IN	O
admission	NN	O
.	.	O

2.	CD	O
Cardiovascular	JJ	O
:	:	O
Falmouth	NN	O
has	VBZ	O
maintained	VBN	O
normal	JJ	O
heart	NN	O
rates	NNS	O
and	CC	O
blood	NN	B-TEST
pressures	NNS	I-TEST
.	.	O

No	DT	O
murmurs	NNS	B-PROBLEM
have	VBP	O
been	VBN	O
noted	VBN	O
.	.	O

Beverly	NNP	O
was	VBD	O
initially	RB	O
NPO	NNP	B-TREATMENT
and	CC	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

Enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NNP	O
,	,	O
and	CC	O
gradually	RB	O
advanced	VBD	O
to	TO	O
full	JJ	O
volume	NN	O
.	.	O

Discharge	NNP	B-TEST
weight	NN	I-TEST
is	VBZ	O
1.89	CD	O
kg	NN	O
.	.	O

4.	CD	O
Gastrointestinal	JJ	O
:	:	O
Boston	NNP	O
required	VBD	O
treatment	NN	B-TREATMENT
for	IN	O
unconjungated	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
with	IN	O
phototherapy	NN	B-TREATMENT
.	.	O

His	PRP$	B-TEST
peak	NN	I-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
occurred	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
with	IN	O
a	DT	O
total	NN	O
of	IN	O
8.3	CD	O
/	JJ	O
0.2	CD	O
direct	JJ	O
,	,	O
8.1	CD	O
indirect	JJ	O
mg/dl	NN	O
.	.	O

He	PRP	O
received	VBD	O
phototherapy	NN	B-TREATMENT
for	IN	O
approximately	RB	O
72	CD	O
hours	NNS	O
.	.	O

Rebound	NNP	B-TEST
bilirubin	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#7	NNP	O
was	VBD	O
6.6	CD	O
,	,	O
and	CC	O
total	NN	O
was	VBD	O
0.2	CD	O
direct	JJ	O
.	.	O

Throughout	IN	O
admission	NN	O
,	,	O
there	EX	O
are	VBP	O
no	DT	O
neurological	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

Audiology	NN	O
:	:	O
Hearing	NN	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

2.	CD	O
Medications	NNS	B-TREATMENT
:	:	O
Ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
0.15	CD	O
cc	NN	O
po	NN	O
q	JJ	O
day	NN	O
25	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
dilution	NN	O
.	.	O

3.	CD	O
Car	NNP	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

Waltham	NNP	O
was	VBD	O
monitored	VBN	O
for	IN	O
90	CD	O
minutes	NNS	O
without	IN	O
any	DT	O
episodes	NNS	O
of	IN	O
apnea	NN	B-PROBLEM
or	CC	O
oxygen	NN	B-PROBLEM
desaturation	NN	I-PROBLEM
.	.	O

4.	CD	O
State	NNP	B-TEST
Newborn	NNP	I-TEST
Screens	NNP	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
09-27	JJ	O
and	CC	O
2011-10-05	JJ	O
with	IN	O
no	DT	O
notification	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
results	NNS	I-PROBLEM
to	TO	O
date	NN	O
.	.	O

5.	CD	O
No	DT	O
immunizations	NNS	B-TREATMENT
administered	VBD	O
.	.	O

Plan	NN	O
is	VBZ	O
to	TO	O
receive	VB	O
hepatitis	NN	B-TREATMENT
B	NNP	I-TREATMENT
in	IN	O
the	DT	O
pediatrician	NN	O
's	POS	O
office	NN	O
,	,	O
once	RB	O
he	PRP	O
reaches	VBZ	O
a	DT	O
weight	NN	O
of	IN	O
2	CD	O
kg	NNS	O
.	.	O

6.	CD	O
Immunizations	NNS	B-TREATMENT
recommended	VBD	O
:	:	O
Synagis	NNP	B-TREATMENT
RSV	NNP	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
October	NNP	O
through	IN	O
April	NNP	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

3)	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Influenza	NNP	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
Prematurity	NNP	B-PROBLEM
at	IN	I-PROBLEM
34	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
gestation	NN	I-PROBLEM
.	.	O

3.	CD	O
Unconjugated	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	I-PROBLEM
Drugs	VB	I-PROBLEM

exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM

10-01	JJ	O
CABG	NNP	B-TREATMENT
x	POS	O
3	CD	O

60	CD	O
yo	NNS	O
M	NNP	O
with	IN	O
exertional	JJ	B-PROBLEM
angina	NNS	I-PROBLEM
->	VBP	O
positive	JJ	B-PROBLEM
ETT	NNP	I-PROBLEM
->	NNP	O
cath	NN	B-TEST
with	IN	O
severe	JJ	B-PROBLEM
3VD	CD	I-PROBLEM

HTN	NN	B-PROBLEM

DM	NN	B-PROBLEM

cataracts	NNS	B-PROBLEM
s/p	VBP	O
removal	NN	B-TREATMENT
of	IN	O
in	IN	O
Mayotte	NNP	O
c/b	NN	O
enucleated	VBD	O
CMED	NNP	O
CSRU	NNP	O

urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM

father	NN	O
with	IN	O
?	.	O
Mi	NNP	B-PROBLEM
at	IN	O
unknown	JJ	O
age	NN	O

NAD	NNP	B-TEST
76	CD	O
184/87	CD	O
18	CD	O

Teeth	NNP	B-PROBLEM
in	IN	I-PROBLEM
poor	JJ	I-PROBLEM
repair	NN	I-PROBLEM

distant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
RRR	NNP	O

extrem	NN	B-PROBLEM
warm	NN	I-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
,	,	O
2+	CD	O
pedal	NN	B-TEST
pulses	NNS	I-TEST

2019-10-07	JJ	O
05:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
WBC	NNP	B-TEST
-	:	O
6.5	CD	O
RBC	NNP	B-TEST
-	:	O
3.23	CD	O
*	NN	O
Hgb	NNP	B-TEST
-	:	O
9.5	CD	O
*	NN	O
Hct	NNP	B-TEST
-	:	O
27.6	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
86	CD	O
MCH	NNP	B-TEST
-	:	O
29.4	CD	O
MCHC	NNP	B-TEST
-	:	O
34.4	CD	O
RDW	NNP	B-TEST
-	:	O
14.0	CD	O
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
356	CD	O
#	#	O

2019-10-07	JJ	O
05:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Plt	NNP	B-TEST
Ct	NNP	I-TEST
-	:	O
356	CD	O
#	#	O

2019-10-04	JJ	O
06:50	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
PT	NNP	B-TEST
-	:	O
13.2	CD	O
*	NN	O
PTT	NNP	B-TEST
-	:	O
32.1	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.2	CD	O
*	NN	O

2019-10-07	JJ	O
05:30	CD	O
AM	NNP	O
BLOOD	NNP	B-TEST
Glucose	NNP	B-TEST
-	:	O
156	CD	O
*	JJ	O
UreaN	NNP	B-TEST
-	:	O
20	CD	O
Creat	NNP	B-TEST
-	:	O
1.0	CD	O
Na	NNP	B-TEST
-	:	O
140	CD	O
K	NNP	B-TEST
-	:	O
3.8	CD	O
Cl	NNP	B-TEST
-	:	O
99	CD	O
HCO3	NNP	B-TEST
-	:	O
31	CD	O
AnGap	NNP	B-TEST
-	:	O
14	CD	O

He	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2019-10-01	JJ	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
CABG	NNP	I-TREATMENT
x	NN	O
3	CD	O
.	.	O

He	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
his	PRP$	B-TREATMENT
vasoactive	JJ	I-TREATMENT
drips	NNS	I-TREATMENT
and	CC	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
on	IN	O
POD	NNP	O
#2	NNP	O
.	.	O

He	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
speech	NN	O
and	CC	O
swallowing	NN	O
who	WP	O
recommended	VBD	O
NPO	NNP	B-TREATMENT
,	,	O
he	PRP	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
video	NN	I-TEST
swallow	NN	I-TEST
after	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
diet	NN	I-TREATMENT
of	IN	I-TREATMENT
thin	JJ	I-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	I-TREATMENT
soft	JJ	I-TREATMENT
solids	NNS	I-TREATMENT
,	,	O
and	CC	O
felt	VBD	O
that	IN	O
his	PRP$	O
eeating	NN	O
may	MD	O
be	VB	O
limited	VBN	O
by	IN	O
his	PRP$	B-PROBLEM
loose	JJ	I-PROBLEM
teeth	NNS	I-PROBLEM
.	.	O

lisinopril	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
glipizide	NN	B-TREATMENT
,	,	O
metformin	NN	B-TREATMENT
,	,	O
asa	NN	B-TREATMENT

1.	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
Q24H	NNP	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

3.	CD	O
Metoprolol	NNP	B-TREATMENT
Tartrate	NNP	I-TREATMENT
50	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
Docusate	NNP	B-TREATMENT
Sodium	NNP	I-TREATMENT
150	CD	O
mg	NN	O
/	VBD	O
15	CD	O
mL	NN	O
Liquid	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
Oxycodone	NNP	B-TREATMENT
-	:	O
Acetaminophen	NNP	B-TREATMENT
5-325	JJ	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
Clopidogrel	NNP	B-TREATMENT
75	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

7.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

8.	CD	O
Glipizide	NNP	B-TREATMENT
5	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
Lisinopril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

10.	CD	O
Hydrochlorothiazide	NNP	B-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

CAD	NN	B-PROBLEM

HTN	NN	B-PROBLEM

DM	NN	B-PROBLEM

cataracts	NNS	B-PROBLEM
s/p	VBP	O
removal	JJ	B-TREATMENT
c/b	NN	O
enucleated	VBD	O
left	VBD	O
CMED	NNP	O
CSRU	NNP	O

urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM

?	.	O
TIA	NN	B-PROBLEM

Call	NN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
from	IN	I-PROBLEM
incision	NN	I-PROBLEM
or	CC	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
more	JJR	O
than	IN	O
2	CD	O
pounds	NNS	O
in	IN	O
one	CD	O
day	NN	O
or	CC	O
five	CD	O
in	IN	O
one	CD	O
week	NN	O
.	.	O

Shower	NNP	O
,	,	O
no	DT	O
baths	NNS	O
,	,	O
no	DT	O
lotions	NNS	B-TREATMENT
,	,	O
creams	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
FOUND	NNP	B-PROBLEM
DOWN	NNP	I-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
's	POS	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
BRI	NNP	O
HEALTH	NNP	O
.	.	O

Your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
REEFRAUP	NNP	O
,	,	O
JA	NNP	O
Y	NNP	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
SYNCOPE	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
57	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
but	CC	O
no	DT	O
prior	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
history	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
reports	VBZ	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
began	VBD	O
at	IN	O
4:00	CD	O
p.m.	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

She	PRP	O
reports	VBZ	O
that	IN	O
it	PRP	O
had	VBD	O
essentially	RB	O
started	VBN	O
earlier	RBR	O
in	IN	O
the	DT	O
day	NN	O
with	IN	O
some	DT	B-PROBLEM
GERD-like	NNP	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
taken	VBN	O
Maalox	NNP	B-TREATMENT
but	CC	O
had	VBD	O
no	DT	O
relief	NN	O
with	IN	O
this	DT	O
.	.	O

The	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
intermittent	JJ	O
through	IN	O
the	DT	O
day	NN	O
and	CC	O
then	RB	O
at	IN	O
4:00	CD	O
p.m.	NN	O
increased	VBD	O
and	CC	O
was	VBD	O
also	RB	O
associated	VBN	O
with	IN	O
nausea	NN	B-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

She	PRP	O
reports	VBZ	O
that	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
shot	NN	O
through	IN	O
her	PRP$	O
back	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
never	RB	O
had	VBN	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
unremitting	VBG	O
.	.	O

In	IN	O
the	DT	O
Emergency	NNP	O
Room	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
Lopressor	NNP	B-TREATMENT
,	,	O
nitroglycerin	NN	B-TREATMENT
,	,	O
and	CC	O
aspirin	NN	B-TREATMENT
.	.	O

A	DT	B-TREATMENT
TP3A	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
not	RB	O
given	VBN	O
for	IN	O
concern	NN	O
for	IN	O
dissection	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
5057	CD	O
E.	NNP	O
Sixth	NNP	O
Blvd.	NNP	O
elevations	NNS	B-PROBLEM
in	IN	I-PROBLEM
I	PRP	I-PROBLEM
,	,	I-PROBLEM
aVL	RB	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
V1	NNP	I-PROBLEM
through	IN	I-PROBLEM
V2	NNP	I-PROBLEM
and	CC	O
ST	NNP	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
II	NNP	I-PROBLEM
,	,	I-PROBLEM
III	NNP	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
aVF	NN	I-PROBLEM
.	.	O

1.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

2.	CD	O
Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

3.	CD	O
Chondrocalcinosis	NN	B-PROBLEM
.	.	O

4.	CD	O
Carpal	NNP	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

5.	CD	O
GERD	NNP	B-PROBLEM
.	.	O

1.	CD	O
Atenolol	NNP	B-TREATMENT
25	CD	O
.	.	O

2.	CD	O
Crestor	NNP	B-TREATMENT
10	CD	O
q.d.	NN	O

3.	CD	O
Uniretic	JJ	B-TREATMENT
15/25	CD	O
.	.	O

ALLERGIES	NNS	O
:	:	O
The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
146/88	CD	O
,	,	O
pulse	RB	B-TEST
71	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
.	.	O

General	NNP	O
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
a	DT	O
well	RB	O
appearing	VBG	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

No	DT	O
murmurs	NNS	B-PROBLEM
were	VBD	O
appreciated	VBN	O
.	.	O

Lungs	NNS	O
:	:	O
Clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Abdomen	NNS	O
:	:	O
Soft	NNP	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
,	,	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

Extremities	NNS	O
:	:	O
There	EX	O
was	VBD	O
no	DT	O
edema	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

LABORATORY	NN	O
AND	CC	O
RADIOLOGIC	NNP	O
DATA	NNP	O
:	:	O
On	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
10.8	CD	O
,	,	O
hematocrit	NN	B-TEST
38.2	CD	O
,	,	O
platelets	NNS	B-TEST
324,000	CD	O
.	.	O

1.	CD	O
CORONARY	NNP	B-PROBLEM
ARTERY	NNP	I-PROBLEM
DISEASE	NNP	I-PROBLEM
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
Cardiac	NNP	B-TEST
Catheterization	NNP	I-TEST
where	WRB	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
two	CD	B-PROBLEM
vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
proximal	JJ	O
LAD	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
90%	CD	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
a	DT	O
septal	JJ	O
branch	NN	O
with	IN	O
a	DT	B-PROBLEM
95%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
diagonal	JJ	O
branch	NN	O
with	IN	O
99%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
twin	VBN	B-TREATMENT
LAD	NNP	I-TREATMENT
stents	NNS	I-TREATMENT
to	TO	O
the	DT	O
LAD	NNP	O
diagonal	NN	O
and	CC	O
LAD	NNP	O
septal	JJ	O
branches	NNS	O
with	IN	O
Taxus	NNP	B-TREATMENT
stents	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
also	RB	O
had	VBD	O
proximal	JJ	B-PROBLEM
RCA	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
of	IN	I-PROBLEM
80%	CD	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
mid	JJ	I-PROBLEM
RCA	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
of	IN	I-PROBLEM
80-90%	CD	I-PROBLEM
which	WDT	O
were	VBD	O
not	RB	O
intervened	VBN	O
upon	IN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
Plavix	NNP	B-TREATMENT
and	CC	O
in	IN	O
addition	NN	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
Elmore	NNP	I-TREATMENT
,	,	O
Maxine	NNP	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
,	,	O
and	CC	O
these	DT	O
were	VBD	O
titrated	VBN	O
up	RP	O
as	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
tolerated	VBD	O
.	.	O

Given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
issues	NNS	O
with	IN	O
muscle	NN	B-PROBLEM
cramping	VBG	I-PROBLEM
with	IN	O
Atorvastatin	NNP	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Pravastatin	NNP	B-TREATMENT
which	WDT	O
should	MD	O
give	VB	O
less	JJR	O
of	IN	O
these	DT	B-PROBLEM
side	NN	I-PROBLEM
effects	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
Cardiology	NNP	O
in	IN	O
one	CD	O
months	NNS	O
time	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
her	PRP$	B-PROBLEM
remaining	VBG	I-PROBLEM
RCA	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

2.	CD	O
PUMP	NN	O
:	:	O
The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
to	TO	O
assess	VB	O
her	PRP$	O
LV	NNP	O
function	NN	O
.	.	O

She	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
30-35%	JJ	O
as	RB	O
well	RB	O
as	IN	O
an	DT	B-PROBLEM
akinetic	JJ	I-PROBLEM
apex	NN	I-PROBLEM
and	CC	O
apical	JJ	B-PROBLEM
mid	NN	I-PROBLEM
and	CC	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

Given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
significant	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
with	IN	O
a	DT	O
transition	NN	O
to	TO	O
Coumadin	NNP	B-TREATMENT
for	IN	O
anticoagulation	NN	B-TREATMENT
for	IN	O
stroke	NN	B-TREATMENT
prevention	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

On	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
Lovenox	NNP	B-TREATMENT
injections	NNS	I-TREATMENT
which	WDT	O
should	MD	O
be	VB	O
continued	VBN	O
until	IN	O
the	DT	O
patient	NN	O
reaches	VBZ	O
a	DT	O
therapeutic	JJ	O
dose	NN	O
of	IN	O
Coumadin	NNP	B-TREATMENT
.	.	O

3.	CD	O
RHYTHM	NN	O
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
monitored	VBN	O
on	IN	O
telemetry	NN	B-TEST
throughout	IN	O
her	PRP$	O
hospitalization	NN	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
EP	NNP	I-TEST
evaluation	NN	I-TEST
and	CC	O
will	MD	O
be	VB	O
followed-up	JJ	O
by	IN	O
Dr.	NNP	O
Welch	NNP	O
.	.	O

14-087	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
signal-averaged	JJ	I-TEST
EKG	NNP	I-TEST
.	.	O

She	PRP	O
will	MD	O
follow-up	VB	O
with	IN	O
Dr.	NNP	O
Welch	NNP	O
with	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
2015-07-24	JJ	O
in	IN	O
a	DT	O
meeting	NN	O
to	TO	O
discuss	VB	O
risk	NN	O
stratification	NN	O
for	IN	O
sudden	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
death	NN	I-PROBLEM
and	CC	O
possible	JJ	O
ICD	NNP	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

4.	CD	O
NEUROLOGY	NN	O
:	:	O
The	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
left	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
with	IN	O
ambulation	NN	O
two	CD	O
days	NNS	O
after	IN	O
her	PRP$	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
evidence	NN	O
for	IN	O
weakness	NN	B-PROBLEM
on	IN	O
examination	NN	B-TEST
with	IN	O
good	JJ	O
proximal	NN	O
and	CC	O
distal	JJ	O
strength	NN	O
in	IN	O
the	DT	O
lower	JJR	O
extremities	NNS	O
as	RB	O
well	RB	O
as	IN	O
intact	JJ	O
sensation	NN	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
able	JJ	O
to	TO	O
ascend	VB	O
stairs	NNS	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
already	RB	O
on	IN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
Plavix	NNP	B-TREATMENT
should	MD	O
this	DT	O
represent	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
for	IN	O
neurologic	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
on	IN	O
examination	NN	B-TEST
and	CC	O
this	DT	O
will	MD	O
be	VB	O
followed-up	JJ	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
.	.	O

5.	CD	O
HEMATOLOGY	NN	O
:	:	O
The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
for	IN	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
stroke	NN	B-PROBLEM
risk	NN	I-PROBLEM
.	.	O

This	DT	O
will	MD	O
be	VB	O
further	RB	O
monitored	VBN	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Banks	NNP	O
,	,	O
who	WP	O
will	MD	O
adjust	VB	O
her	PRP$	B-TREATMENT
Coumadin	NNP	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

DISCHARGE	JJ	O
DIAGNOSIS	NNP	O
:	:	O
ST	NNP	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	JJ	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
q.d.	NN	O

2.	CD	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
q.d.	NN	O

3.	CD	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
100	CD	O
q.d.	NN	O

4.	CD	O
Coumadin	NNP	B-TREATMENT
5	CD	O
q.d.	NN	O

5.	CD	O
Plavix	NNP	B-TREATMENT
75	CD	O
q.d.	NN	O

6.	CD	O
Lovenox	NNP	B-TREATMENT
60	CD	O
mg	NN	O
b.i.d.	NN	O
until	IN	O
therapeutic	JJ	O
on	IN	O
Coumadin	NNP	B-TREATMENT
.	.	O

7.	CD	O
Pravastatin	NNP	B-TREATMENT
80	CD	O
q.d.	NN	O

FOLLOW-UP	JJ	O
PLANS	NNS	O
:	:	O
The	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
in	IN	O
the	DT	O
week	NN	O
following	VBG	O
discharge	NN	O
for	IN	O
further	JJ	O
monitoring	NN	O
of	IN	O
her	PRP$	B-TEST
INR	NNP	I-TEST
and	CC	O
adjustment	NN	O
of	IN	O
her	PRP$	B-TREATMENT
Coumadin	NNP	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
to	TO	O
this	DT	O
,	,	O
the	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
Cardiology	NNP	O
,	,	O
Dr.	NNP	O
Foster	NNP	O
,	,	O
and	CC	O
Dr.	NNP	O
Upshaw	NNP	O
,	,	O
on	IN	O
2015-07-06	JJ	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

Richard	NNP	O
Williams	NNP	O
,	,	O
Twin	NNP	O
number	NN	O
II	NNP	O
,	,	O
was	VBD	O
born	VBN	O
at	IN	O
31-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
for	IN	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
of	IN	O
Twin	NNP	O
number	NN	O
I	PRP	O
and	CC	O
progressive	JJ	B-PROBLEM
preterm	NN	I-PROBLEM
labor	NN	I-PROBLEM
.	.	O

Mother	NNP	O
is	VBZ	O
a	DT	O
37	CD	O
year	NN	O
old	JJ	O
Gravida	NNP	O
1	CD	O
,	,	O
Para	NNP	O
0	CD	O
now	RB	O
2	CD	O
woman	NN	O
whose	WP$	O
blood	NN	B-TEST
type	NN	I-TEST
is	VBZ	O
A	DT	O
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
RPR	NNP	B-TEST
nonreactive	NN	O
,	,	O
hepatitis	NN	B-TEST
B	NNP	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
and	CC	O
Group	NNP	B-TEST
B	NNP	I-TEST
Streptococcus	NNP	I-TEST
unknown	JJ	O
.	.	O

The	DT	O
mother	NN	O
had	VBD	O
received	VBN	O
a	DT	O
complete	JJ	O
course	NN	O
of	IN	O
betamethasone	NN	B-TREATMENT
prior	RB	O
to	TO	O
delivery	NN	O
.	.	O

This	DT	O
pregnancy	NN	O
was	VBD	O
achieved	VBN	O
with	IN	O
in	IN	O
Bartley	NNP	B-TREATMENT
fertilization	NN	I-TREATMENT
.	.	O

A	DT	B-TREATMENT
cerclage	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
18	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

Cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
under	IN	O
spinal	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

This	DT	O
infant	NN	O
emerged	VBD	O
with	IN	O
Apgars	NNP	B-TEST
of	IN	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

On	IN	O
admission	NN	O
,	,	O
revealed	VBD	O
a	DT	O
vigorous	JJ	O
non-dysmorphic	JJ	O
premature	NN	O
infant	NN	O
,	,	O
with	IN	O
moderate	JJ	B-PROBLEM
subcostal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
occasional	JJ	I-PROBLEM
grunting	NN	I-PROBLEM
,	,	O
normal	JJ	O
S1	NNP	O
,	,	O
S2	NNP	O
heart	NN	O
sounds	VBZ	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
birth	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
1,980	CD	O
grams	NNS	O
,	,	O
80th	CD	O
percentile	NN	O
.	.	O

The	DT	B-TEST
birth	NN	I-TEST
length	NN	I-TEST
was	VBD	O
44	CD	O
centimeters	NNS	O
,	,	O
the	DT	O
75th	CD	O
percentile	NN	O
and	CC	O
the	DT	B-TEST
birth	NN	I-TEST
head	NN	I-TEST
circumference	NN	I-TEST
was	VBD	O
30.6	CD	O
centimeters	NNS	O
,	,	O
in	IN	O
the	DT	O
65th	CD	O
percentile	NN	O

The	DT	O
infant	NN	O
was	VBD	O
intubated	VBN	O
soon	RB	O
after	IN	O
admission	NN	O
to	TO	O
the	DT	O
CMED	NNP	O
CSRU	NNP	O
and	CC	O
received	VBD	O
two	CD	O
doses	NNS	O
of	IN	O
surfactant	NN	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
respirations	NNS	I-TEST
are	VBP	O
comfortable	JJ	O
.	.	O

Her	PRP$	B-TEST
lung	NN	I-TEST
sounds	NNS	I-TEST
are	VBP	O
clear	JJ	O
and	CC	O
equal	JJ	O
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
apnea	NN	B-PROBLEM
,	,	O
bradycardia	NN	B-PROBLEM
or	CC	O
desaturation	NN	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
a	DT	O
normal	JJ	O
S1	NNP	O
,	,	O
S2	NNP	O
heart	NN	O
sound	NN	O
and	CC	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

She	PRP	O
started	VBD	O
on	IN	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
number	NN	O
two	CD	O
and	CC	O
progressed	VBD	O
without	IN	O
difficulty	NN	O
to	TO	O
full	JJ	B-TREATMENT
volume	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
and	CC	O
then	RB	O
was	VBD	O
advanced	VBN	O
to	TO	O
calorie	VB	B-TREATMENT
enhanced	JJ	I-TREATMENT
breast	NN	I-TREATMENT
milk	NN	I-TREATMENT
of	IN	O
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
taking	VBG	O
from	IN	O
130	CD	O
to	TO	O
160	CD	O
cc.	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
on	IN	O
an	DT	B-TREATMENT
ad	NN	I-TREATMENT
lib	NN	I-TREATMENT
feeding	NN	I-TREATMENT
plan	NN	I-TREATMENT
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
weight	NN	I-TEST
is	VBZ	O
2,200	CD	O
grams	NNS	O
;	:	O
her	PRP$	B-TEST
length	NN	I-TEST
is	VBZ	O
49.5	CD	O
centimeters	NNS	O
(	(	O
19.5	CD	O
inches	NNS	O
)	)	O
and	CC	O
her	PRP$	B-TEST
head	NN	I-TEST
circumference	NN	I-TEST
is	VBZ	O
30.5	CD	O
centimeters	NNS	O
.	.	O

Her	PRP$	B-TEST
peak	NN	I-TEST
bilirubin	NN	I-TEST
occurred	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
and	CC	O
was	VBD	O
total	JJ	B-TEST
12.1	CD	O
,	,	O
direct	JJ	B-TEST
0.3	CD	O
;	:	O
the	DT	B-TEST
last	JJ	I-TEST
bilirubin	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
was	VBD	O
total	JJ	B-TEST
11.1	CD	O
,	,	O
direct	JJ	B-TEST
0.4	CD	O
.	.	O

She	PRP	O
never	RB	O
required	VBD	O
phototherapy	NN	B-TREATMENT
.	.	O

Her	PRP$	B-TEST
hematocrit	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
45.4	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
360,000	CD	O
.	.	O

She	PRP	O
is	VBZ	O
receiving	VBG	O
supplemental	JJ	B-TREATMENT
iron	NN	I-TREATMENT
to	TO	O
provide	VB	O
2	CD	O
mg	NN	O
per	IN	O
kilo	FW	O
per	FW	O
day	NN	O
as	IN	O
elemental	JJ	B-TREATMENT
iron	NN	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
never	RB	O
received	VBN	O
any	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
during	IN	O
this	DT	O
CMED	NNP	O
CSRU	NNP	O
stay	NN	O
.	.	O

The	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Ampicillin	NNP	B-TREATMENT
and	CC	O
Gentamycin	NNP	B-TREATMENT
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
for	IN	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factor	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
after	IN	O
48	CD	O
hours	NNS	O
when	WRB	O
the	DT	O
infant	NN	O
was	VBD	O
clinically	RB	O
well	RB	O
and	CC	O
the	DT	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
on	IN	O
2013-05-02	JJ	O
,	,	O
that	WDT	O
was	VBD	O
completely	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

The	DT	O
infant	NN	O
is	VBZ	O
on	IN	O
breast	NN	B-TREATMENT
milk	NN	I-TREATMENT
with	IN	I-TREATMENT
Enfamil	NNP	I-TREATMENT
Powder	NNP	I-TREATMENT
to	TO	O
provide	VB	O
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
and	CC	O
on	IN	O
an	DT	B-TREATMENT
ad	NN	I-TREATMENT
lib	NN	I-TREATMENT
feeding	VBG	I-TREATMENT
schedule	NN	I-TREATMENT
.	.	O

Ferinsol	NNP	B-TREATMENT
0.2	CD	O
cc.	NN	O
to	TO	O
provide	VB	O
5	CD	O
mg	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
The	DT	O
infant	NN	O
passed	VBD	O
a	DT	B-TEST
car	NN	I-TEST
seat	NN	I-TEST
positioning	VBG	I-TEST
test	NN	I-TEST
on	IN	O
2013-05-11	JJ	O
.	.	O

4.	CD	O
State	NNP	B-TEST
Screens	NNPS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
04-27	JJ	O
and	CC	O
2013-05-08	JJ	O
.	.	O

5.	CD	O
The	DT	O
infant	NN	O
received	VBD	O
the	DT	B-TREATMENT
hepatitis	NN	I-TREATMENT
B	NNP	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2013-05-09	JJ	O
,	,	O
and	CC	O
Synagis	NNP	B-TREATMENT
on	IN	O
2013-05-11	JJ	O
.	.	O

1)	CD	O
Synagis	NNP	B-TREATMENT
RSV	NNP	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
October	NNP	O
through	IN	O
April	NNP	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
with	IN	O
preschool	JJ	O
siblings	NNS	O
,	,	O
or	CC	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O

2)	CD	O
Influenza	NNP	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
Fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
care	NN	O
givers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
Prematurity	NN	B-PROBLEM
at	IN	O
31-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
.	.	O

3.	CD	O
Sepsis	NNP	B-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
.	.	O

4.	CD	O
Status	NNP	O
post	NN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

Patient	NNP	O
recorded	VBD	O
as	IN	O
having	VBG	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNPS	I-PROBLEM
to	TO	O
Drugs	VB	B-TREATMENT

bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM

Colonoscopy	NN	B-TREATMENT

Virtual	JJ	B-TREATMENT
colonoscopy	NN	I-TREATMENT

55	CD	O
yo	JJ	O
M	NNP	O
w/	NN	O
h/o	NN	O
recurrent	NN	B-PROBLEM
bladder	NN	I-PROBLEM
ca	MD	I-PROBLEM
s/p	VB	O
cystectomy	JJ	B-TREATMENT
w/	JJ	O
ileal	NN	B-TREATMENT
conduit	NN	I-TREATMENT
p/w	NN	O
BRBPR	NNP	B-PROBLEM
to	TO	O
OSH	NNP	O
.	.	O

Hct	NNP	B-TEST
dropped	VBD	O
34	CD	O
->	JJ	O
22	CD	O
.	.	O

EGD	NNP	B-TEST
normal	JJ	O
.	.	O

Cscope	NNP	B-TEST
unable	JJ	O
to	TO	O
complete	VB	O
due	JJ	O
to	TO	O
blood	VB	B-PROBLEM
but	CC	O
tics	NNS	B-PROBLEM
seen	VBN	O
.	.	O

Tagged	VBN	O
RBC	NNP	B-TEST
+	NNP	O
activity	NN	O
in	IN	O
RLQ	NNP	O
.	.	O

Transferred	VBN	O
to	TO	O
Mediplex	NNP	O
Rehab	NNP	O
Hospital	NNP	O
ICU	NNP	O
where	WRB	O
Hct	NNP	B-TEST
has	VBZ	O
remained	VBN	O
stable	JJ	O
.	.	O

Seen	JJ	O
by	IN	O
GI	NNP	O
and	CC	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
holding	VBG	O
anticoagulation	NN	B-TREATMENT
and	CC	O
repeat	NN	B-TEST
scope	NN	I-TEST
on	IN	O
Monday	NNP	O
.	.	O

Pt	NNP	O
feeling	NN	O
well	RB	O
,	,	O
denies	VBZ	O
abd	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
N/V	NNP	B-PROBLEM
,	,	O
LH	NNP	B-PROBLEM
,	,	O
SOB	NNP	B-PROBLEM
,	,	O
CP	NNP	B-PROBLEM
.	.	O

Metastatic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
CA	NNP	I-PROBLEM
now	RB	O
in	IN	O
remission	NN	O
s/p	NN	O
chemo/xrt	NN	B-TREATMENT
s/p	NN	O
cystectomy	NN	B-TREATMENT
and	CC	O
ileal	JJ	B-TREATMENT
loop	NN	I-TREATMENT
urinary	JJ	I-TREATMENT
diversion	NN	I-TREATMENT
and	CC	O
also	RB	O
radical	JJ	B-TREATMENT
prstatectomy	NN	I-TREATMENT
with	IN	O
bilateral	JJ	B-TREATMENT
pelvic	JJ	I-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

b/l	NN	B-PROBLEM
DVT	NNP	I-PROBLEM
s,	VBZ	O
most	RBS	O
recent	JJ	O
seen	VBN	O
in	IN	O
IVC	NNP	O
to	TO	O
right	VB	O
femoral	JJ	O
vein	NNS	O
s/p	VBP	O
IVC	NNP	B-TREATMENT
filter	NN	I-TREATMENT
2015-01-15	JJ	O

Nephrolithiasis	NN	B-PROBLEM
.	.	O

Anemia	NNP	B-PROBLEM
-	:	O
baseline	NN	O
mid	NN	O
30	CD	O
s.	NN	O

denies	NNS	O
fh	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
or	CC	O
clotting	VBG	B-PROBLEM
disorders	NNS	I-PROBLEM
.	.	O

T	$	B-TEST
97.4	CD	O
BP	NNP	B-TEST
100/62	CD	O
P	NNP	B-TEST
56	CD	O
RR	NNP	B-TEST
16	CD	O

Mid	NNP	O
aged	VBD	O
man	NN	O
in	IN	O
NAD	NNP	B-PROBLEM

sclera	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
,	,	O
MMM	NNP	O

supple	NN	O
,	,	O
no	DT	O
LAD	NNP	B-PROBLEM

RRR	NNP	O
S1/S2	NNP	O
no	DT	O
M	NNP	B-PROBLEM

soft	JJ	O
,	,	O
+BS	NNP	O
,	,	O
NT	NNP	B-PROBLEM
,	,	O
Midline	NNP	B-PROBLEM
surgical	JJ	I-PROBLEM
scar	NN	I-PROBLEM
,	,	O
nephrostomy	JJ	B-TREATMENT
bag	NN	I-TREATMENT
draining	VBG	O

yellowish	JJ	B-PROBLEM
urine	NN	I-PROBLEM
in	IN	I-PROBLEM
RLQ	NNP	I-PROBLEM

no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
GLUCOSE	NNP	B-TEST
-	:	O
88	CD	O
UREA	NNP	B-TEST
N	NNP	I-TEST
-	:	O
12	CD	O
CREAT	NNP	B-TEST
-	:	O
1.0	CD	O
SODIUM	NNP	B-TEST
-	:	O
138	CD	O
POTASSIUM	NNP	B-TEST
-	:	O
3.3	CD	O
CHLORIDE	NNP	B-TEST
-	:	O
107	CD	O
TOTAL	NNP	B-TEST
CO2	NNP	I-TEST
-	:	O
25	CD	O
ANION	NNP	B-TEST
GAP	NNP	I-TEST
-	:	O
9	CD	O

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
estGFR	SYM	B-TEST
-	:	O
Using	NN	O
this	DT	O

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
CALCIUM	NNP	B-TEST
-	:	O
8.7	CD	O
PHOSPHATE	NNP	B-TEST
-	:	O
2.4	CD	O
*	JJ	O
MAGNESIUM	NNP	B-TEST
-	:	O
1.5	CD	O
*	NN	O

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
WBC	NNP	B-TEST
-	:	O
8.4	CD	O
RBC	NNP	B-TEST
-	:	O
2.98	CD	O
*	NN	O
HGB	NNP	B-TEST
-	:	O
9.3	CD	O
*	NN	O
HCT	NNP	B-TEST
-	:	O
26.3	CD	O
*	NN	O
MCV	NNP	B-TEST
-	:	O
88	CD	O
MCH	NNP	B-TEST
-	:	O
31.1	CD	O
MCHC	NNP	B-TEST
-	:	O
35.3	CD	O
*	NN	O
RDW	NNP	B-TEST
-	:	O
14.4	CD	O

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
PLT	NNP	B-TEST
COUNT	NNP	I-TEST
-	:	O
164	CD	O

2015-12-03	JJ	O
10:27	CD	O
PM	NNP	O
PT	NNP	B-TEST
-	:	O
11.4	CD	O
PTT	NNP	B-TEST
-	:	O
27.5	CD	O
INR(PT)	NNP	B-TEST
-	:	O
1.0	CD	O

55	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
recurrent	NN	B-PROBLEM
DVT	NNP	I-PROBLEM
s	NN	I-PROBLEM
on	IN	O
Lovenox	NNP	B-TREATMENT
admitted	VBD	O
with	IN	O
lower	JJR	B-PROBLEM
GI	NNP	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Right	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
source	NN	I-PROBLEM
of	IN	I-PROBLEM
bleed	NN	I-PROBLEM
on	IN	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
scan	JJ	I-TEST
.	.	O

Attempts	NNS	O
to	TO	O
visualize	VB	O
colon	NN	O
by	IN	O
conventional	JJ	B-TEST
and	CC	I-TEST
CT	NNP	I-TEST
virtual	JJ	I-TEST
colonoscopy	NN	I-TEST
failed	VBD	O
because	IN	O
of	IN	O
sigmoid	JJ	B-PROBLEM
angulation	NN	I-PROBLEM
and	CC	O
inadequate	JJ	O
preparation	NN	O
,	,	O
respectively	RB	O
.	.	O

On	IN	O
Ct	NNP	B-TEST
scan	JJ	I-TEST
,	,	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
psoas	NN	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
was	VBD	O
seen	VBN	O
.	.	O

Since	IN	O
the	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
outside	JJ	O
records	NNS	O
from	IN	O
2015-03-28	JJ	O
mentioned	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
pelvis	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
.	.	O

Lovenox	NNP	B-TREATMENT
was	VBD	O
held	VBN	O
until	IN	O
follow-up	JJ	O
with	IN	O
primary	JJ	O
care	NN	O
doctor	NN	O
.	.	O

Also	RB	O
,	,	O
a	DT	B-TEST
repeat	NN	I-TEST
outpatient	JJ	I-TEST
CT	NNP	I-TEST
colonoscopy	NN	I-TEST
with	IN	O
better	JJR	O
preparation	NN	O
should	MD	O
be	VB	O
considered	VBN	O
.	.	O

Lovenox	NNP	B-TREATMENT
0.6	CD	O
mg	NN	O
/	NNP	O
kg	NNP	O
SC	NNP	O
BID	NNP	O

1.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

cbc	NN	B-TEST
,	,	O
creatinine	NN	B-TEST

GIB	NN	B-PROBLEM

Metastatic	NNP	B-PROBLEM
,	,	I-PROBLEM
recurrent	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
cancer	NN	I-PROBLEM

h/o	NN	O
DVT	NNP	B-PROBLEM
s	NN	I-PROBLEM

We	PRP	O
recommend	VBP	O
that	IN	O
you	PRP	O
do	VBP	O
NOT	JJ	O
resume	VB	O
your	PRP$	B-TREATMENT
lovenox	NN	I-TREATMENT
until	IN	O
talking	VBG	O
to	TO	O
your	PRP$	O
PCP	NNP	O
,	,	O
Dr.	NNP	O
Jessie	NNP	O
.	.	O

You	PRP	O
likely	RB	O
have	VBP	O
a	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
source	NN	I-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
colon	NN	I-PROBLEM
that	IN	O
we	PRP	O
have	VBP	O
been	VBN	O
unable	JJ	O
to	TO	O
visualize	VB	O
.	.	O

The	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
has	VBZ	O
stopped	VBN	O
and	CC	O
you	PRP	O
have	VBP	O
remained	VBN	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
your	PRP$	B-TEST
hematocrit	NN	I-TEST
is	VBZ	O
stable	JJ	O
,	,	O
but	CC	O
you	PRP	O
are	VBP	O
at	IN	O
risk	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
from	IN	O
this	DT	O
source	NN	O
again	RB	O
with	IN	O
anticoagulation	NN	B-TREATMENT
.	.	O

A	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
your	PRP$	I-TEST
abdomen	NNS	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
pelvic	NN	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	RB	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
described	VBN	O
previously	RB	O
in	IN	O
2015-03-28	JJ	O
.	.	O

Please	NNP	O
continue	VBP	O
to	TO	O
take	VB	O
your	PRP$	B-TREATMENT
other	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

Please	NNP	O
see	VB	O
a	DT	O
doctor	NN	O
if	IN	O
you	PRP	O
feel	VBP	O
dizzy	JJ	B-PROBLEM
,	,	O
or	CC	O
have	VBP	O
blood	VBN	B-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
stool	NN	I-PROBLEM
again	RB	O
.	.	O

Please	NNP	O
go	VB	O
to	TO	O
Dr.	NNP	O
Colombo	NNP	O
office	NN	O
later	RB	O
this	DT	O
week	NN	O
to	TO	O
have	VB	O
your	PRP$	B-TEST
labs	NNS	I-TEST
drawn	VBN	O
and	CC	O
sent	VBN	O
to	TO	O
Dr.	NNP	O
Powell	NNP	O
.	.	O

Cardiothoracic	NNP	B-TREATMENT
Surgery	NNP	I-TREATMENT

This	DT	O
is	VBZ	O
a	DT	O
67	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
who	WP	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
2016-04-03	JJ	O
.	.	O

He	PRP	O
was	VBD	O
raking	VBG	O
leaves	NNS	O
on	IN	O
04-02	NN	O
and	CC	O
then	RB	O
developed	VBD	O
episodes	NNS	O
of	IN	O
mid	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
burning	NN	B-PROBLEM
which	WDT	O
radiated	VBD	O
to	TO	O
the	DT	O
left	JJ	O
arm	NN	O
.	.	O

That	DT	O
night	NN	O
he	PRP	O
reportedly	RB	O
stopped	VBD	O
breathing	VBG	B-PROBLEM
and	CC	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

His	PRP$	O
wife	NN	O
gave	VBD	O
him	PRP	O
mouth-to-mouth	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
he	PRP	O
regained	VBD	O
consciousness	NN	O
.	.	O

He	PRP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
thrombolytic	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

His	PRP$	B-TEST
troponin	NN	I-TEST
was	VBD	O
20	CD	O
and	CC	O
he	PRP	O
had	VBD	O
EKG	NNP	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

He	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
on	IN	O
2016-04-05	JJ	O
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
left	JJ	I-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
,	,	O
no	DT	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
insufficiency	NN	B-PROBLEM
or	CC	O
hypokinesis	NN	B-PROBLEM
.	.	O

Left	NNP	O
main	JJ	O
coronary	JJ	O
artery	NN	O
was	VBD	O
narrowed	VBN	B-PROBLEM
50-60%	JJ	O
,	,	O
left	VBD	O
anterior	RP	O
descending	VBG	O
coronary	JJ	O
artery	RB	O
70%	CD	O
proximally	RB	O
,	,	O
right	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
dominant	NN	I-PROBLEM
diseased	VBD	I-PROBLEM
up	RB	O
to	TO	O
90%	CD	O
proximally	RB	O
in	IN	O
the	DT	O
midportion	NN	O
,	,	O
70%	CD	O
distally	RB	O
.	.	O

1.	CD	O
History	NNP	O
of	IN	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

2.	CD	O
Hemorrhoidectomy	NNP	B-TREATMENT
.	.	O

3.	CD	O
Carotid	NNP	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
Lipitor	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
Lopressor	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
discontinued	VBN	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

Positive	NNP	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

In	IN	O
general	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
afebrile	NN	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
.	.	O

HEENT	NN	O
:	:	O
Normocephalic	NNP	O
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

Neck	NN	O
:	:	O
Supple	NN	O
with	IN	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
lymphadenopathy	JJ	B-PROBLEM
nor	CC	O
thyromegaly	JJ	B-PROBLEM
.	.	O

Carotids	NNS	B-TEST
were	VBD	O
1+	CD	O
bilaterally	RB	O
.	.	O

Positive	JJ	O
right	NN	B-PROBLEM
carotid	NN	I-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

Lungs	NNS	O
:	:	O
Clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Cardiovascular	JJ	O
:	:	O
Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

Abdomen	NNS	O
:	:	O
Positive	NNP	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

Extremities	NNS	O
:	:	O
Without	IN	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

Pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
throughout	IN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
on	IN	O
2016-04-06	JJ	O
the	DT	O
patient	JJ	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
x	$	O
4	CD	O
with	IN	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
to	TO	O
the	DT	O
left	VBN	O
anterior	JJ	O
descending	VBG	O
coronary	JJ	O
artery	NN	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
diagonal	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
obtuse	VB	I-TREATMENT
marginal	JJ	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
posterior	JJ	O
descending	VBG	O
coronary	JJ	O
artery	NN	O
.	.	O

The	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
tolerated	VBN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
postoperative	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
pacing	JJ	B-TREATMENT
wires	NNS	I-TREATMENT
and	CC	O
chest	JJS	B-TREATMENT
tubes	NNS	I-TREATMENT
in	IN	O
place	NN	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
stay	NN	O
were	VBD	O
removed	VBN	O
successfully	RB	O
.	.	O

They	PRP	O
requested	VBD	O
that	IN	O
he	PRP	O
follow	VB	O
up	RP	O
in	IN	O
three	CD	O
to	TO	O
five	CD	O
weeks	NNS	O
for	IN	O
endurance	NN	B-TREATMENT
training	NN	I-TREATMENT
,	,	O
however	RB	O
then	RB	O
physical	JJ	O
therapy	NN	O
followed	VBD	O
him	PRP	O
a	DT	O
number	NN	O
of	IN	O
times	NNS	O
afterward	RB	O
and	CC	O
decided	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
in	IN	O
good	JJ	O
condition	NN	O
and	CC	O
did	VBD	O
not	RB	O
need	VB	O
further	RB	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

He	PRP	O
may	MD	O
observe	VB	O
regular	JJ	O
activity	NN	O
although	IN	O
he	PRP	O
should	MD	O
avoid	VB	O
strenuous	JJ	O
activity	NN	O
and	CC	O
should	MD	O
not	RB	O
drive	VB	O
while	IN	O
on	IN	O
pain	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
Lasix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
.	.	O

2.	CD	O
Potassium	NNP	B-TREATMENT
20	CD	O
mEq	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
.	.	O

3.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
Percocet	NNP	B-TREATMENT
1-2	JJ	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
4	CD	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
Lopressor	NNP	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

Peggy	NNP	O
Hammock	NNP	O
is	VBZ	O
a	DT	O
full	JJ	O
term	NN	O
baby	NN	O
boy	VBD	O
born	VBN	O
at	IN	O
38	CD	O
1/7	CD	O
weeks	NNS	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
to	TO	O
a	DT	O
34	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
III	NNP	O
,	,	O
now	RB	O
para	VBZ	O
II	NNP	O
mother	NN	O
.	.	O

Serologies	NNS	B-TEST
include	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
O	NNP	O
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
RPR	NNP	B-TEST
nonreactive	NN	O
.	.	O

Hepatitis	NN	B-TEST
B	NNP	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rubella	JJ	B-TEST
immune	NN	O
.	.	O

Group	NNP	B-TEST
B	NNP	I-TEST
strep	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

Pregnancy	NN	O
was	VBD	O
uncomplicated	VBN	B-PROBLEM
until	IN	O
an	DT	O
occurrence	NN	O
of	IN	O
HSV	NNP	B-PROBLEM
outbreak	NN	I-PROBLEM
occurred	VBD	O
on	IN	O
2017-09-13	CD	O
approximately	RB	O
one	CD	O
week	NN	O
prior	RB	O
to	TO	O
delivery	NN	B-TREATMENT
.	.	O

Pregnancy	NN	O
was	VBD	O
also	RB	O
complicated	VBN	O
by	IN	O
maternal	JJ	O
history	NN	O
of	IN	O
depression	NN	B-PROBLEM
for	IN	O
which	WDT	O
mother	NN	O
received	VBD	O
Zoloft	NNP	B-TREATMENT
.	.	O

On	IN	O
day	NN	O
of	IN	O
delivery	NN	B-TREATMENT
mother	NN	O
presented	VBN	O
in	IN	O
spontaneous	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

GBS	NNP	B-TEST
negative	JJ	O
.	.	O

No	DT	O
maternal	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

Rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
at	IN	O
time	NN	O
of	IN	O
delivery	NN	B-TREATMENT
.	.	O

Delivery	NN	B-TREATMENT
was	VBD	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
and	CC	O
Apgars	NNP	B-TEST
of	IN	O
8	CD	O
and	CC	O
9	CD	O
were	VBD	O
given	VBN	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
.	.	O

Baby	NN	O
appeared	VBD	O
well	RB	O
and	CC	O
went	VBD	O
to	TO	O
the	DT	O
newborn	JJ	O
nursery	NN	O
and	CC	O
was	VBD	O
breast	VBN	O
feeding	NN	O
and	CC	O
undergoing	JJ	O
routine	NN	B-TREATMENT
newborn	VBN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

On	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
the	DT	O
mother	NN	O
called	VBD	O
the	DT	O
nurse	NN	O
for	IN	O
concern	NN	O
of	IN	O
baby	NN	O
turning	VBG	O
dusky	NN	B-PROBLEM
while	IN	O
feeding	VBG	O
.	.	O

This	DT	B-PROBLEM
episode	NN	I-PROBLEM
was	VBD	O
also	RB	O
accompanied	VBN	O
by	IN	O
gagging	VBG	B-PROBLEM
motions	NNS	I-PROBLEM
noted	VBN	O
of	IN	O
the	DT	O
infant	NN	O
.	.	O

A	DT	B-PROBLEM
second	JJ	I-PROBLEM
episode	NN	I-PROBLEM
occurred	VBD	O
where	WRB	O
the	DT	O
baby	NN	O
turned	VBD	O
pale	JJ	B-PROBLEM
.	.	O

The	DT	O
baby	NN	O
did	VBD	O
not	RB	O
turn	VB	O
blue	NN	B-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

The	DT	O
Neonatal	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
was	VBD	O
notified	VBN	O
and	CC	O
the	DT	O
baby	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Newborn	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

Full	JJ	O
term	NN	O
well	RB	O
appearing	VBG	O
infant	NN	O
with	IN	O
some	DT	B-PROBLEM
facial	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
,	,	O
overall	JJ	O
pink	NN	O
,	,	O
warm	NN	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
alert	JJ	O
and	CC	O
responsive	JJ	O
.	.	O

Red	JJ	B-TEST
reflexes	NNS	I-TEST
noted	VBD	O
bilaterally	RB	O
.	.	O

He	PRP	O
had	VBD	O
a	DT	O
left	VBN	O
pupil	NN	O
that	WDT	O
was	VBD	O
in	IN	O
unequal	JJ	B-PROBLEM
in	IN	I-PROBLEM
size	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
keyhole	JJ	I-PROBLEM
appearance	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
coloboma	NN	I-PROBLEM
.	.	O

His	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
equal	JJ	O
.	.	O

Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

2	CD	O
plus	CC	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
noted	VBN	O
.	.	O

Infant	NN	O
was	VBD	O
circumcised	VBN	B-TREATMENT
in	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
which	WDT	O
was	VBD	O
healing	VBG	O
well	RB	O
.	.	O

Tone	NN	B-TEST
was	VBD	O
appropriate	JJ	O
for	IN	O
gestational	JJ	O
age	NN	O
with	IN	O
equal	JJ	O
strength	NN	B-TEST
,	,	O
symmetric	JJ	O
reflexes	NNS	B-TEST
.	.	O

The	DT	O
infant	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TEST
cardiopulmonary	JJ	I-TEST
monitor	NN	I-TEST
upon	IN	O
admission	NN	O
to	TO	O
the	DT	O
Newborn	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
with	IN	O
pulse	JJ	B-TEST
oximetry	NN	I-TEST
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	O
episode	NN	O
of	IN	O
desaturation	NN	B-PROBLEM
related	VBN	O
to	TO	O
feeding	VBG	O
with	IN	O
desaturations	NNS	B-PROBLEM
in	IN	O
the	DT	O
70	CD	O
percent	NN	O
.	.	O

Jule	NN	O
remained	VBD	O
in	IN	O
room	NN	O
air	NN	O
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
was	VBD	O
without	IN	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
dusky	NN	I-PROBLEM
spells	NNS	I-PROBLEM
or	CC	O
pale	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
in	IN	O
the	DT	O
48	CD	O
hours	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

Renee	NNP	O
remained	VBD	O
cardiovascularly	RB	O
stable	JJ	O
with	IN	O
AP	NNP	B-TEST
s	NN	I-TEST
noted	VBD	O
to	TO	O
be	VB	O
120	CD	O
to	TO	O
130	CD	O
s.	NN	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
84/43	CD	O
with	IN	O
a	DT	B-TEST
mean	NN	I-TEST
of	IN	O
59	CD	O
.	.	O

He	PRP	O
was	VBD	O
fed	VBN	O
with	IN	O
a	DT	O
bottle	NN	O
occasionally	RB	O
by	IN	O
his	PRP$	O
dad	NN	O
and	CC	O
had	VBD	O
a	DT	O
vigorous	JJ	O
suck	NN	O
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
discoordination	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
suck	NN	I-PROBLEM
while	IN	O
breathing	VBG	O
at	IN	O
the	DT	O
initial	JJ	O
onset	NN	O
of	IN	O
feeding	JJ	O
time	NN	O
.	.	O

Breast	NNP	O
feeding	NN	O
was	VBD	O
limited	VBN	O
to	TO	O
four	CD	O
to	TO	O
five	CD	O
minutes	NNS	O
on	IN	O
each	DT	O
side	NN	O
per	IN	O
recommendation	NN	O
of	IN	O
neurology	NN	O
after	IN	O
their	PRP$	B-TEST
evaluation	NN	I-TEST
to	TO	O
try	VB	O
and	CC	O
minimize	VB	O
incidence	NN	O
of	IN	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
.	.	O

Weight	NNP	B-TEST
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
3.13	CD	O
kilograms	NNS	O
.	.	O

Birth	NNP	B-TEST
weight	NN	I-TEST
was	VBD	O
3.29	CD	O
kilograms	NNS	O
in	IN	O
the	DT	O
75th	CD	O
percentile	NN	O
.	.	O

Head	NNP	B-TEST
circumference	NN	I-TEST
was	VBD	O
34.5	CD	O
cm	NN	O
,	,	O
75th	CD	O
percentile	NN	O
,	,	O
and	CC	O
length	NN	B-TEST
was	VBD	O
50.7	CD	O
cm	NN	O
,	,	O
also	RB	O
the	DT	O
75th	CD	O
percentile	NN	O
.	.	O

Baby	NNP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
frequent	JJ	B-PROBLEM
spitting	VBG	I-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
minimized	VBN	O
with	IN	O
limitation	NN	B-TREATMENT
of	IN	I-TREATMENT
volume	NN	I-TREATMENT
at	IN	I-TREATMENT
each	DT	I-TREATMENT
feed	NN	I-TREATMENT
with	IN	O
frequent	JJ	B-TREATMENT
feeding	NN	I-TREATMENT
.	.	O

The	DT	O
baby	NN	O
demonstrated	VBD	O
mild	JJ	B-PROBLEM
physiologic	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
obtained	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
which	WDT	O
was	VBD	O
6.7	CD	O
with	IN	O
a	DT	O
direct	NN	O
of	IN	O
0.2	CD	O
.	.	O

Mother	NNP	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
O	NNP	O
negative	JJ	O
.	.	O

Infant	NNP	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
type	NN	I-TEST
was	VBD	O
O	NNP	O
positive	JJ	O
and	CC	O
Coombs	NNP	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

In	IN	O
addition	NN	O
a	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
obtained	VBN	O
on	IN	O
admission	NN	O
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
10.1	CD	O
with	IN	O
43	CD	O
polys	NNS	B-TEST
and	CC	O
0	CD	O
bands	NNS	B-TEST
.	.	I-TEST

Hematocrit	NNP	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
47.5	CD	O
with	IN	O
platelets	NNS	B-TEST
of	IN	O
257,000	CD	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
received	VBD	O
during	IN	O
hospitalization	NN	O
.	.	O

A	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
was	VBD	O
obtained	VBN	O
upon	IN	O
admission	NN	O
and	CC	O
Ampicillin	NNP	B-TREATMENT
and	CC	O
Gentamicin	NNP	B-TREATMENT
were	VBD	O
given	VBN	O
for	IN	O
48	CD	O
hours	NNS	O
with	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
remaining	VBG	O
sterile	NN	O
.	.	O

Antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
and	CC	O
infant	NN	O
has	VBZ	O
remained	VBN	O
clinically	RB	O
well	RB	O
off	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

Neurology	NNP	O
was	VBD	O
consulted	VBN	O
due	JJ	O
to	TO	O
the	DT	O
concern	NN	O
for	IN	O
seizures	NNS	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
dusky	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

An	DT	B-TEST
EEG	NNP	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

The	DT	B-TEST
EEG	NNP	I-TEST
showed	VBD	O
transient	JJ	B-PROBLEM
sharp	JJ	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
front	NN	I-PROBLEM
,	,	O
left	VBD	O
occipital	JJ	O
and	CC	O
right	JJ	O
parietal	NN	O
regions	NNS	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
electrographic	JJ	B-TEST
evidence	NN	I-TEST
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
noted	VBD	O
.	.	O

Hearing	VBG	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

Ophthalmology	NNP	O
was	VBD	O
consulted	VBN	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
coloboma	NN	I-PROBLEM
into	IN	O
the	DT	O
left	NN	O
CMED	NNP	O
.	.	O

Ophthalmology	NNP	O
noted	VBD	O
that	IN	O
this	DT	B-PROBLEM
left	VBD	I-PROBLEM
Martha	NNP	I-PROBLEM
coloboma	NN	I-PROBLEM
was	VBD	O
likely	RB	O
an	DT	B-PROBLEM
isolated	JJ	I-PROBLEM
anomaly	NN	I-PROBLEM
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
other	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

Medications	NNS	B-TREATMENT
are	VBP	O
Tri-Vi-Michael	JJ	B-TREATMENT
1	CD	O
cc	NN	O
by	IN	O
mouth	JJ	O
each	DT	O
day	NN	O
.	.	O

Newborn	NNP	B-TEST
state	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
.	.	O

Immunizations	NNS	B-TREATMENT
received	VBN	O
are	VBP	O
hepatitis	JJ	B-TREATMENT
B	NNP	I-TREATMENT
vaccine	NN	I-TREATMENT
given	VBN	O
on	IN	O
09-26	NN	O
.	.	O

Full	NNP	O
term	NN	O
male	NN	O
infant	NN	O
with	IN	O
cyanosis	NN	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

Rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

Left	NNP	B-PROBLEM
coloboma	NN	I-PROBLEM
.	.	O

Rule	NN	O
out	IN	O
seizures	NNS	B-PROBLEM
.	.	O

Mr.	NNP	O
Pohl	NNP	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
history	NN	O
of	IN	O
alcohol	NN	O
use	NN	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
found	VBN	O
in	IN	O
his	PRP$	O
apartment	NN	O
lobby	NN	O
"	NN	O
shouting	VBG	O
"	NNS	O
and	CC	O
very	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
.	.	O

He	PRP	O
by	IN	O
emergency	NN	O
room	NN	O
report	NN	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
his	PRP$	O
apartment	NN	O
lobby	NN	O
agitated	VBD	B-PROBLEM
.	.	O

Blood	NNP	B-TEST
alcohol	NN	I-TEST
level	NN	I-TEST
was	VBD	O
383	CD	O
.	.	O

Agitated	VBN	B-PROBLEM
in	IN	O
emergency	NN	O
room	NN	O
requiring	VBG	O
4	CD	B-TREATMENT
leather	NN	I-TREATMENT
restraints	NNS	I-TREATMENT
,	,	O
received	VBD	O
5	CD	O
mg	NN	O
of	IN	O
Haldol	NNP	B-TREATMENT
,	,	O
2	CD	O
mg	NN	O
of	IN	O
Ativan	NNP	B-TREATMENT
.	.	O

He	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
with	IN	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
80	CD	O
's	POS	O
and	CC	O
had	VBD	O
decreased	VBN	B-PROBLEM
respiratory	NN	I-PROBLEM
rate	NN	I-PROBLEM
.	.	O

He	PRP	O
received	VBD	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
of	IN	O
2	CD	O
liters	NNS	O
of	IN	O
good	JJ	O
blood	NN	O
pressure	NN	O
response	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
then	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
observation	NN	O
of	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
our	PRP$	O
service	NN	O
on	IN	O
medicine	NN	O
when	WRB	O
the	DT	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
remained	VBD	O
stable	JJ	O
overnight	NN	O
.	.	O

The	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

He	PRP	O
does	VBZ	O
complain	VB	O
of	IN	O
cold	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
times	NNS	O
one	CD	O
week	NN	O
.	.	O

The	DT	O
patient	NN	O
states	NNS	O
in	IN	O
the	DT	O
past	NN	O
that	IN	O
he	PRP	O
has	VBZ	O
participated	VBN	O
in	IN	O
several	JJ	O
alcohol	NN	B-TREATMENT
treatment	NN	I-TREATMENT
programs	NNS	I-TREATMENT
,	,	O
most	JJS	O
recently	RB	O
Star	NNP	O
which	WDT	O
is	VBZ	O
similar	JJ	O
Alcoholics	NNPS	O
Anonymous	NNP	O
.	.	O

His	PRP$	O
brother	NN	O
is	VBZ	O
mentally	RB	B-PROBLEM
handicapped	JJ	I-PROBLEM
and	CC	O
might	MD	O
be	VB	O
sent	VBN	O
away	RB	O
from	IN	O
his	PRP$	O
instate	JJ	O
institution	NN	O
.	.	O

In	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
has	VBZ	O
been	VBN	O
very	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
and	CC	O
has	VBZ	O
seen	VBN	O
a	DT	B-TREATMENT
counselor	NN	I-TREATMENT
at	IN	O
Greenfield	NNP	O
Community	NNP	O
College	NNP	O
Community	NNP	O
Health	NNP	O
.	.	O

1.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

2.	CD	O
History	NNP	O
of	IN	O
colonic	JJ	B-PROBLEM
polyps	NNS	I-PROBLEM
times	NNS	O
3	CD	O
,	,	O
benign	NN	O
in	IN	O
2007	CD	O
,	,	O
repeat	NN	B-TEST
colonoscopy	NN	I-TEST
due	JJ	O
to	TO	O
in	IN	O
2010	CD	O
.	.	O

3.	CD	O
History	NN	O
of	IN	O
right	JJ	B-PROBLEM
inguinal	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
in	IN	O
2002	CD	O
.	.	O

Positive	JJ	O
tobacco	NN	O
,	,	O
10	CD	O
pack	NN	O
year	NN	O
history	NN	O
,	,	O
quit	NN	O
for	IN	O
8	CD	O
years	NNS	O
in	IN	O
his	PRP$	O
40	CD	O
's	POS	O
and	CC	O
now	RB	O
no	DT	O
cigarettes	NNS	O
for	IN	O
one	CD	O
week	NN	O
using	VBG	O
no	DT	O
pharmacal	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
only	RB	O
male	JJ	O
sexual	JJ	O
partners	NNS	O
and	CC	O
in	IN	O
the	DT	O
last	JJ	O
six	CD	O
months	NNS	O
has	VBZ	O
two	CD	O
regular	JJ	O
partners	NNS	O
who	WP	O
reportedly	RB	O
are	VBP	O
human	JJ	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
virus	NN	I-PROBLEM
negative	JJ	O
and	CC	O
no	DT	O
IV	NNP	O
drug	NN	O
use	NN	O
.	.	O

He	PRP	O
uses	VBZ	O
condoms	NNS	B-TREATMENT
consistently	RB	O
.	.	O

Major	JJ	O
stressors	NNS	O
in	IN	O
his	PRP$	O
life	NN	O
include	VBP	O
unstable	JJ	O
job	NN	O
,	,	O
brother	NN	O
is	VBZ	O
mentally	RB	B-PROBLEM
handicapped	JJ	I-PROBLEM
,	,	O
war	NN	O
.	.	O

ALLERGIES	NNS	O
:	:	O
No	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
Mavik	NNP	B-TREATMENT
question	NN	O
of	IN	O
dosage	NN	O
.	.	O

3.	CD	O
Hydrochlorothiazide	NNP	B-TREATMENT
question	NN	O
of	IN	O
dosage	NN	O
.	.	O

1.	CD	O
Ranitidine	NNP	B-TREATMENT
150	CD	O
mg	NN	O
b.i.d.	NN	O

2.	CD	O
Thiamine	NNP	B-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
Folic	NNP	B-TREATMENT
acid	VBD	I-TREATMENT
1	CD	O
mg	NN	O
q.	NN	O
d.	NN	O

4.	CD	O
Multivitamin	NNP	B-TREATMENT

Vitals	NNS	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
:	:	O
Please	NNP	O
refer	VB	O
to	TO	O
addendum	VB	O
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

Systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
120	CD	O
's	POS	O
to	TO	O
130	CD	O
's.	NNS	O

Pulse	NNP	B-TEST
in	IN	O
the	DT	O
60	CD	O
's	POS	O
to	TO	O
70	CD	O
's.	NNS	O

The	DT	O
patient	NN	O
was	VBD	O
a	DT	O
thin	JJ	O
well-appearing	JJ	O
man	NN	O
who	WP	O
was	VBD	O
visibly	RB	B-PROBLEM
restless	JJ	I-PROBLEM
in	IN	O
bed	NN	O
.	.	O

He	PRP	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
3	CD	O
and	CC	O
with	IN	O
slightly	RB	B-PROBLEM
pressured	VBN	I-PROBLEM
speech	NN	I-PROBLEM
.	.	O

He	PRP	O
states	VBZ	O
that	IN	O
mood	NN	O
is	VBZ	O
depressed	VBN	B-PROBLEM
.	.	O

He	PRP	O
denies	VBZ	O
auditory	NN	B-PROBLEM
,	,	I-PROBLEM
visual	JJ	I-PROBLEM
or	CC	I-PROBLEM
tactile	JJ	I-PROBLEM
hallucinations	NNS	I-PROBLEM
.	.	O

Cranial	JJ	B-TEST
nerves	NNS	I-TEST
II-XII	NNP	I-TEST
are	VBP	O
grossly	RB	O
intact	JJ	O
,	,	O
5/5	CD	O
strength	NN	B-TEST
in	IN	I-TEST
all	DT	I-TEST
extremities	NNS	I-TEST
,	,	O
sensation	NN	B-TEST
is	VBZ	O
intact	JJ	O
in	IN	O
all	DT	O
extremities	NNS	O
.	.	O

Head	NNP	B-TEST
,	,	I-TEST
ears	VBZ	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	NN	I-TEST
:	:	O
Atraumatic	JJ	B-PROBLEM
and	CC	O
normocephalic	JJ	O
.	.	O

Sclerae	NNP	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

Oropharynx	NNP	O
was	VBD	O
benign	VBN	O
without	IN	O
exudate	NN	B-PROBLEM
.	.	O

NO	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Rare	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
,	,	O
otherwise	RB	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

Positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

No	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
Dorsalis	NNP	B-TEST
pedis	NN	I-TEST
in	IN	O
radial	JJ	B-TEST
pulses	NNS	I-TEST
,	,	O
hands	NNS	B-PROBLEM
and	CC	I-PROBLEM
feet	NNS	I-PROBLEM
notably	RB	I-PROBLEM
tremulous	JJ	I-PROBLEM
without	IN	O
asterixis	NN	B-PROBLEM
.	.	O

No	DT	O
stigmata	NN	B-PROBLEM
of	IN	O
IV	NNP	O
drug	NN	O
use	NN	O
.	.	O

CBC	NN	B-TEST
:	:	O
White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
8.8	CD	O
,	,	O
hematocrit	NN	B-TEST
35.5	CD	O
platelets	NNS	B-TEST
266	CD	O
,	,	O
PT	NNP	B-TEST
13	CD	O
,	,	O
PT-T	NNP	B-TEST
23.3	CD	O
,	,	O
INR	NNP	B-TEST
was	VBD	O
1.1	CD	O
.	.	O

Chem-7	NN	B-TEST
:	:	O
Sodium	NN	B-TEST
145	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
chloride	RB	B-TEST
116	CD	O
,	,	O
bicarb	NN	B-TEST
21	CD	O
,	,	O
BUN	NNP	B-TEST
12	CD	O
,	,	O
creatinine	NN	B-TEST
0.6	CD	O
,	,	O
glucose	RB	B-TEST
96	CD	O
,	,	O
calcium	NN	B-TEST
7.2	CD	O
,	,	O
phos	NN	B-TEST
3.6	CD	O
,	,	O
magnesium	NN	B-TEST
1.7	CD	O
.	.	O

Liver	NNP	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
:	:	O
ALT	NNP	B-TEST
38	CD	O
,	,	O
AST	NNP	B-TEST
34	CD	O
,	,	O
alk	NN	B-TEST
phos	NN	I-TEST
is	VBZ	I-TEST
107	CD	O
,	,	O
albumin	NN	B-TEST
is	VBZ	O
3.2	CD	O
,	,	O
peak	NN	B-TEST
bili	NN	I-TEST
is	VBZ	I-TEST
0.3	CD	O
,	,	O
amylase	NN	B-TEST
31	CD	O
,	,	O
and	CC	O
lipase	NN	B-TEST
is	VBZ	O
32	CD	O
.	.	O

UA	NNP	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

Urine	NNP	B-TEST
tox	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

Serum	NNP	B-TEST
tox	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
ETOH	NNP	B-TEST
at	IN	O
383	CD	O
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

Serum	NNP	B-TEST
osmolality	NN	I-TEST
was	VBD	O
38397	CD	O
,	,	O
calculated	VBN	B-TEST
osmolality	NN	I-TEST
gap	NN	I-TEST
was	VBD	O
21	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
from	IN	O
02-07	JJ	O
had	VBD	O
linear	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
band-like	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
which	WDT	O
was	VBD	O
evident	JJ	O
on	IN	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
on	IN	O
02-06	NN	O
.	.	O

CT	NNP	B-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
on	IN	O
02-06	NN	O
was	VBD	O
negative	JJ	O
for	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
bran	NN	B-PROBLEM
atrophy	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
temporal	JJ	I-PROBLEM
encephalomalacia	NN	I-PROBLEM
.	.	O

Mr.	NNP	O
Pohl	NNP	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
ETOH	NNP	O
,	,	O
hypertension	NN	B-PROBLEM
who	WP	O
presented	VBD	O
int	NN	O
he	PRP	O
emergency	NN	O
room	NN	O
with	IN	O
increased	JJ	B-PROBLEM
agitation	NN	I-PROBLEM
,	,	O
like	IN	O
secondary	JJ	O
to	TO	O
ETOH	NNP	B-PROBLEM
intoxication	NN	I-PROBLEM
and	CC	O
developed	VBD	O
subsequent	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
,	,	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80	CD	O
's,	POS	O
status	NN	O
post	NN	O
Ativan	NNP	B-TREATMENT
and	CC	O
Haldol	NNP	B-TREATMENT
,	,	O
but	CC	O
was	VBD	O
responsive	JJ	O

to	TO	O
fluid	VB	B-TREATMENT
resuscitation	NN	I-TREATMENT
at	IN	O
4	CD	O
liters	NNS	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
for	IN	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

Plan	NN	O
for	IN	O
patient	JJ	O
regarding	VBG	O
cardiac	NN	O
,	,	O
unlike	IN	O
hypotension	NN	B-PROBLEM
of	IN	I-PROBLEM
cardiac	JJ	I-PROBLEM
origin	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
responded	VBD	O
well	RB	O
to	TO	O
fluid	VB	B-TREATMENT
resuscitation	NN	I-TREATMENT
.	.	O

Elevated	VBN	B-PROBLEM
CK	NNP	I-PROBLEM
on	IN	O
02-07	NN	O
is	VBZ	O
likely	JJ	O
secondary	JJ	O
to	TO	O
mild	VB	B-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
.	.	O

We	PRP	O
decided	VBD	O
to	TO	O
discontinue	VB	O
telemetry	NN	B-TEST
and	CC	O
held	VBD	O
all	DT	B-TREATMENT
hypertension	NN	I-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
Lisinopril	NNP	B-TREATMENT
,	,	O
Mavik	NNP	B-TREATMENT
,	,	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

2.	CD	O
For	IN	O
pulmonary	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
good	JJ	O
O2	NNP	B-TEST
saturations	NNS	I-TEST
on	IN	O
room	NN	O
air	NN	O
.	.	O

He	PRP	O
had	VBD	O
atelectasis	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
by	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
on	IN	O
ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
for	IN	O
gastrointestinal	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

4.	CD	O
Urology	NN	O
:	:	O
Foley	NNP	B-TREATMENT
was	VBD	O
discontinued	VBN	O
in	IN	O
the	DT	O
CMED	NNP	O
CCU	NNP	O
at	IN	O
12	CD	O
p.m.	NN	O

The	DT	O
patient	NN	O
was	VBD	O
urinating	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

We	PRP	O
continued	VBD	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
at	IN	O
100	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
for	IN	O
one	CD	O
liter	NN	O
secondary	JJ	O
to	TO	O
a	DT	O
concern	NN	O
for	IN	O
rhabdomyolysis	NN	B-PROBLEM
plus	CC	O
kidney	NN	B-TREATMENT
protective	JJ	I-TREATMENT
effects	NNS	I-TREATMENT
.	.	O

K	NNP	B-TEST
was	VBD	O
3.4	CD	O
,	,	O
repleted	VBN	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
40	CD	O
mEq	NN	O
times	NNS	O
1	CD	O
dose	JJ	O
p.o.	NN	O

Calcium	NN	B-TEST
with	IN	O
7.2	CD	O
corrected	VBD	O
to	TO	O
less	JJR	O
than	IN	O
8.0,	CD	O
completed	VBD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
at	IN	O
500	CD	O
mg	NNS	O
blood	NN	B-TEST
pressure.o.	NN	I-TEST
t.i.d.	NN	O
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

Mag	NNP	B-TEST
was	VBD	O
1.7	CD	O
,	,	O
repleted	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
oxide	NN	I-TREATMENT
with	IN	O
400	CD	O
mg	NN	O
p.o.	NN	O
times	NNS	O
one	CD	O
dose	NN	O
.	.	O

The	DT	O
patient	NN	O
seemed	VBD	O
notably	RB	B-PROBLEM
anxious	JJ	I-PROBLEM
and	CC	O
depressed	JJ	B-PROBLEM
.	.	O

It	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
self	JJ	O
medicating	VBG	O
for	IN	O
underlying	VBG	B-PROBLEM
psychiatric	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

We	PRP	O
will	MD	O
monitor	VB	B-TEST
for	IN	O
signs	NNS	O
of	IN	O
alcohol	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
according	VBG	O
to	TO	O
the	DT	B-TEST
CIWA	NNP	I-TEST
scale	NN	I-TEST
.	.	O

We	PRP	O
will	MD	O
given	VBN	O
valium	VB	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
3	CD	O
hours	NNS	O
for	IN	O
withdrawal	NN	B-PROBLEM
.	.	O

We	PRP	O
will	MD	O
consider	VB	O
psychiatry	NN	O
consult	NN	O
in	IN	O
the	DT	O
future	NN	O
to	TO	O
assess	VB	O
for	IN	O
underlying	VBG	B-PROBLEM
anxiety	NN	I-PROBLEM
disorder	NN	I-PROBLEM
or	CC	O
depression	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
may	MD	O
be	VB	O
discharge	JJ	O
Harry	NNP	O
02-08	JJ	O
pending	JJ	O
observations	NNS	B-TEST
for	IN	O
delirium	NN	B-PROBLEM
tremens	NNS	I-PROBLEM
after	IN	O
discussion	NN	O
with	IN	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Blue	NNP	O
who	WP	O
knows	VBZ	O
the	DT	O
patient	NN	O
well	RB	O
.	.	O

1.	CD	O
Blood	NNP	B-TEST
pressure	NN	I-TEST
:	:	O

The	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
remained	VBD	O
stable	JJ	O
on	IN	O
hospital	JJ	O
day	NN	O
#2	NNP	O
through	IN	O
hospital	JJ	O
day	NN	O
#3	NNP	O
status	NN	O
post	NN	O
IV	NNP	B-TREATMENT
hydration	NN	I-TREATMENT
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
120	CD	O
's	POS	O
to	TO	O
130	CD	O
's.	NNS	O

We	PRP	O
continued	VBD	O
to	TO	O
hold	VB	O
the	DT	O
patient	NN	O
's	POS	O
home	NN	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
without	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
no	DT	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

On	IN	O
Hospital	NNP	O
day	NN	O
#2	NNP	O
through	IN	O
hospital	JJ	O
day	NN	O
#3	NNP	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
tremor	NN	I-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
,	,	O
but	CC	O
improved	VBD	O
over	IN	O
hospital	JJ	O
course	NN	O
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
notably	RB	B-PROBLEM
less	RBR	I-PROBLEM
anxious	JJ	I-PROBLEM
throughout	IN	O
hospital	JJ	O
stay	NN	O
.	.	O

CIWA	NNP	B-TEST
scale	NN	I-TEST
over	IN	O
night	NN	O
was	VBD	O
1	CD	O
for	IN	O
tremor	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	O
Valium	NNP	B-TREATMENT
for	IN	O
alcohol	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

Calcium	NNP	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
Mag	NNP	B-TREATMENT
oxide	RB	I-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
times	NNS	O
one	CD	O
dose	NN	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
repleted	VBD	O
40	CD	O
mEq	NN	O
times	NNS	O
one	CD	O
dose	NN	O
.	.	O

1.	CD	O
ETOH	NNP	B-PROBLEM
intoxication	NN	I-PROBLEM
.	.	O

2.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

3.	CD	O
History	NNP	O
of	IN	O
colonic	JJ	B-PROBLEM
polyp	NN	I-PROBLEM
times	NNS	O
3	CD	O
,	,	O
benign	NN	O
in	IN	O
2007	CD	O
,	,	O
repeat	NN	B-TEST
colonoscopy	NN	I-TEST
due	JJ	O
in	IN	O
2010	CD	O
.	.	O

4.	CD	O
History	NN	B-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
inguinal	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
in	IN	O
2002	CD	O
.	.	O

Return	NNP	O
to	TO	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
:	:	O

1.	CD	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.q.d.	NN	O

2.	CD	O
Mavik	NNP	B-TREATMENT
unknown	JJ	O
dosage	NN	O
.	.	O

3.	CD	O
Hydrochlorothiazide	NNP	B-TREATMENT
unknown	JJ	O
dosage	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
82	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
remote	VBP	O
tobacco	NN	O
abuse	NN	O
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
TIA	NNP	I-PROBLEM
who	WP	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
five	CD	O
nights	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
awoke	VBD	O
at	IN	O
midnight	NN	O
with	IN	O
severe	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
radiating	NN	O
to	TO	O
both	DT	O
arms	NNS	O
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
bilateral	JJ	B-PROBLEM
arm	NN	I-PROBLEM
numbness	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
associated	VBN	O
with	IN	O
diaphoresis	NN	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

After	IN	O
approximately	RB	O
one	CD	O
hour	NN	O
,	,	O
he	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
Bristol	NNP	O
County	NNP	O
Tuberculosis	NNP	O
Hospital	NNP	O
Dana-Farber	NNP	O
Cancer	NNP	O
Institute	NNP	O
Campus	NNP	O
where	WRB	O
he	PRP	O
ruled	VBD	O
in	IN	O
for	IN	O
a	DT	B-PROBLEM
non-ST	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
with	IN	O
a	DT	B-TEST
CK	NNP	I-TEST
of	IN	O
438	CD	O
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
CK	NNP	I-TEST
MB	NNP	I-TEST
of	IN	O
19.8	CD	O
and	CC	O
troponin	VB	B-TEST
that	DT	O
peaked	VBD	O
at	IN	O
10.2	CD	O
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
nitrates	NNS	B-TREATMENT
there	RB	O
as	RB	O
well	RB	O
as	IN	O
heparin	NN	B-TREATMENT
and	CC	O
Integrelin	NNP	B-TREATMENT
and	CC	O
remained	VBD	O
pain-free	JJ	B-PROBLEM
.	.	O

He	PRP	O
denied	VBD	O
any	DT	O
history	NN	O
of	IN	O
similar	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
and	CC	O
has	VBZ	O
had	VBN	O
no	DT	O
prior	JJ	O
history	NN	O
of	IN	O
angina	NN	B-PROBLEM
or	CC	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
Youville	NNP	O
Hospital	NNP	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
he	PRP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
CMI	NNP	O
Service	NNP	O
after	IN	O
undergoing	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
LAD	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
that	WDT	O
was	VBD	O
angioplastied	VBN	O
without	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
and	CC	O
a	DT	B-PROBLEM
total	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
RCA	NNP	I-PROBLEM
with	IN	O
collaterals	NNS	O
.	.	O

He	PRP	O
subsequently	RB	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
bradycardiac	NN	B-PROBLEM
in	IN	O
the	DT	O
Catheterization	NNP	O
Laboratory	NNP	O
which	WDT	O
responded	VBD	O
to	TO	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
dopamine	NN	B-TREATMENT
,	,	O
Atropine	NNP	B-TREATMENT
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
CCU	NNP	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
bedside	JJ	I-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
done	VBN	O
in	IN	O
the	DT	O
Cardiac	NNP	O
Catheterization	NNP	O
laboratory	NN	O
without	IN	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
Swan	NNP	I-TREATMENT
was	VBD	O
also	RB	O
placed	VBN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
stents	NNS	B-TREATMENT
deployed	VBN	O
at	IN	O
all	DT	O
throughout	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

By	IN	O
the	DT	O
time	NN	O
he	PRP	O
was	VBD	O
admitted	VBN	O
,	,	O
he	PRP	O
was	VBD	O
off	IN	O
pressors	NNS	B-TREATMENT
and	CC	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
pain-free	JJ	B-PROBLEM
.	.	O

TIA	NN	B-PROBLEM
in	IN	O
1998	CD	O
.	.	O

COPD	NNP	B-PROBLEM
with	IN	O
2	CD	O
liters	NNS	O
dependence	NN	O
of	IN	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
.	.	O

BPH	NNP	B-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

Gastritis	NN	B-PROBLEM
.	.	O

Asthma	NNP	B-PROBLEM
.	.	O

He	PRP	O
uses	VBZ	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
p.r.n.	NN	O
for	IN	O
walking	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
Metoprolol	NNP	B-TREATMENT
50	CD	O
mg	NN	O
b.i.d.	NN	O

3.	CD	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
MDI	NNP	B-TREATMENT
p.r.n.	NN	O

5.	CD	O
Heparin	NNP	B-TREATMENT
drip	NN	I-TREATMENT
on	IN	O
transfer	NN	O
.	.	O

6.	CD	O
Integrelin	NNP	B-TREATMENT
drip	NN	I-TREATMENT
on	IN	O
transfer	NN	O
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

Heart	NNP	B-TEST
rate	NN	I-TEST
91	CD	O
,	,	O
regular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
169/81	CD	O
from	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
groin	NN	I-TREATMENT
A	DT	I-TREATMENT
line	NN	I-TREATMENT
,	,	O
respirations	NNS	B-TEST
12	CD	O
,	,	O
oxygen	JJR	B-TEST
saturation	NN	I-TEST
of	IN	O
97	CD	O
percent	NN	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
a	DT	O
well	RB	O
appearing	VBG	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Crusting	VBG	B-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
eyelid	NN	I-PROBLEM
but	CC	O
the	DT	O
pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	NN	O
.	.	O

He	PRP	O
was	VBD	O
edentulous	JJ	B-PROBLEM
.	.	O

The	DT	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
lymphadenopathy	JJ	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

His	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
Anteriorly	NNP	O
and	CC	O
laterally	RB	O
.	.	O

Soft	NNP	O
,	,	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
normoactive	JJ	O
bowel	NN	B-TEST
sounds	NNS	I-TEST
.	.	O

There	EX	O
was	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
groin	NN	I-TREATMENT
A	DT	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
groin	NN	I-TREATMENT
venous	JJ	I-TREATMENT
sheath	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
Swan	NNP	I-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
evident	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
2+	CD	O
dorsalis	NNS	B-TEST
pedis	NN	I-TEST
and	CC	O
posterior	JJ	B-TEST
tibial	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	O
.	.	O

On	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
CBC	NNP	I-TEST
revealed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
7.4	CD	O
,	,	O
hematocrit	NN	B-TEST
39.7	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
217,000	CD	O
.	.	O

Serum	NNP	B-TEST
chemistries	NNS	I-TEST
revealed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
135,	CD	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
26	CD	O
,	,	O
BUN	NNP	B-TEST
29	CD	O
,	,	O
creatinine	NN	B-TEST
1.6	CD	O
,	,	O
and	CC	O
glucose	NN	B-TEST
of	IN	O
111	CD	O
.	.	O

The	DT	B-TEST
initial	JJ	I-TEST
EKG	NNP	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	B-TEST
rhythm	NN	I-TEST
at	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
71	CD	O
with	IN	O
a	DT	O
normal	JJ	O
axis	NN	B-TEST
and	CC	O
evidence	NN	O
of	IN	O
first-degree	JJ	B-PROBLEM
AV	NNP	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
prolonged	JJ	B-PROBLEM
PR	NNP	I-PROBLEM
interval	NN	I-PROBLEM
of	IN	O
238	CD	O
milliseconds	NNS	O
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
widened	JJ	I-PROBLEM
QRS	NNP	I-PROBLEM
of	IN	O
153	CD	O
milliseconds	NNS	O
,	,	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
acute	JJ	B-PROBLEM
ST	NNP	I-PROBLEM
or	CC	I-PROBLEM
T	NNP	I-PROBLEM
wave	VBP	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
EKG	NNP	I-TEST
was	VBD	O
prior	RB	O
to	TO	O
catheterization	NN	B-TEST
and	CC	O
the	DT	O
one	CD	O
post	NN	O
PTCA	NNP	B-TREATMENT
was	VBD	O
no	DT	O
different	JJ	O
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
bedside	JJ	I-TEST
echocardiogram	NN	I-TEST
done	VBN	O
in	IN	O
the	DT	O
Catheterization	NNP	O
Laboratory	NNP	O
which	WDT	O
showed	VBD	O
normal	JJ	O
LV	NNP	O
wall	NN	O
thickness	NN	O
and	CC	O
normal	JJ	O
LV	NNP	O
cavity	NN	O
size	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
effusion	NN	B-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
totally	RB	I-PROBLEM
occluded	JJ	I-PROBLEM
RCA	NNP	I-PROBLEM
with	IN	O
collaterals	NNS	O
,	,	O
an	DT	B-PROBLEM
80	CD	I-PROBLEM
percent	NN	I-PROBLEM
LAD	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
extending	VBG	O
distally	RB	O
which	WDT	O
was	VBD	O
angioplastied	VBN	O
but	CC	O
no	DT	O
stent	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

The	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
4	CD	O
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
of	IN	O
8	CD	O
,	,	O
and	CC	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
3.8	CD	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	B-TEST
RA	NNP	I-TEST
pressure	NN	I-TEST
of	IN	O
10	CD	O
,	,	O
RV	NNP	B-TEST
pressure	NN	I-TEST
of	IN	O
43/4	CD	O
,	,	O
PA	NNP	B-TEST
pressure	NN	I-TEST
of	IN	O
37/10	CD	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
82	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
prior	JJ	O
tobacco	NN	O
use	NN	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
COPD	NNP	B-PROBLEM
,	,	O
gastritis	NN	B-PROBLEM
,	,	O
and	CC	O
TIA	NNP	B-PROBLEM
who	WP	O
initially	RB	O
presented	VBD	O
to	TO	O
Braintree	NNP	O
with	IN	O
a	DT	B-PROBLEM
non-ST	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
and	CC	O
Guaiac	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
transferred	VBN	O
to	TO	O
St.	NNP	O
Margaret's	NNP	O
Center	NNP	O
for	IN	O
Women	NNP	O
&	CC	O
Infants	NNP	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
with	IN	O
PTCA	NNP	B-TREATMENT
to	TO	O
mid	VB	B-PROBLEM
LAD	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
hypotension	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
requiring	VBG	O
Atropine	NNP	B-TREATMENT
,	,	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
transient	JJ	B-TREATMENT
dopamine	NN	I-TREATMENT
possibly	RB	O
secondary	JJ	O
to	TO	O
vagal	VB	B-PROBLEM
reaction	NN	I-PROBLEM
,	,	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
CCU	NNP	O
for	IN	O
close	RB	B-TEST
monitoring	NN	I-TEST
,	,	O
hemodynamically	RB	O
stable	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
the	DT	O
CCU	NNP	O
.	.	O

As	IN	O
summarized	VBN	O
above	IN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
non-ST	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
with	IN	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
80	CD	I-PROBLEM
percent	NN	I-PROBLEM
mid	NN	I-PROBLEM
LAD	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
underwent	VBD	O
angioplasty	RB	B-TREATMENT
without	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
initially	RB	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
Plavix	NNP	B-TREATMENT
,	,	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
and	CC	O
ACE	NNP	B-TREATMENT
inhibitor	NN	I-TREATMENT
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
his	PRP$	B-TREATMENT
Plavix	NNP	I-TREATMENT
was	VBD	O
held	VBN	O
due	JJ	O
to	TO	O
Guaiac	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
and	CC	O
hematocrit	NN	B-PROBLEM
drop	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
transthoracic	JJ	I-TEST
echocardiogram	NN	I-TEST
the	DT	O
day	NN	O
after	IN	O
admission	NN	O
showing	VBG	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
60	CD	O
percent	NN	O
.	.	O

No	DT	O
focal	JJ	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
recurrent	NN	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

In	IN	O
regards	NNS	O
to	TO	O
his	PRP$	O
rhythm	NN	O
,	,	O
he	PRP	O
has	VBZ	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
right	JJ	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
first-degree	JJ	B-PROBLEM
AV	NNP	I-PROBLEM
block	NN	I-PROBLEM
which	WDT	O
were	VBD	O
stable	JJ	O
throughout	IN	O
this	DT	O
admission	NN	O
.	.	O

He	PRP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
COPD	NNP	B-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
is	VBZ	O
on	IN	O
baseline	NN	O
2	CD	O
liters	NNS	O
of	IN	O
02	CD	B-TREATMENT
by	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
at	IN	O
home	NN	O
and	CC	O
Albuterol	NNP	B-TREATMENT
and	CC	O
Atrovent	NNP	B-TREATMENT
MDI	NNP	I-TREATMENT
s	VBD	O
p.r.n.	NN	O
at	IN	O
home	NN	O
.	.	O

He	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
Flovent	NNP	B-TREATMENT
MDI	NNP	I-TREATMENT
at	IN	O
home	NN	O
as	RB	O
well	RB	O
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
MDI	NNP	I-TREATMENT
and	CC	O
was	VBD	O
at	IN	O
his	PRP$	B-PROBLEM
baseline	NN	I-PROBLEM
02	CD	I-PROBLEM
requirement	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

He	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
and	CC	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
1.6	CD	O
.	.	O

His	PRP$	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
post	NN	O
MI	NNP	B-PROBLEM
was	VBD	O
initially	RB	O
held	VBN	O
due	JJ	O
to	TO	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
.	.	O

However	RB	O
,	,	O
this	DT	O
responded	VBD	O
to	TO	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
restarted	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

He	PRP	O
will	MD	O
need	VB	O
close	JJ	B-TEST
monitoring	NN	I-TEST
of	IN	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
post	NN	O
discharge	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
reinstitution	NN	O
of	IN	O
his	PRP$	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
.	.	O

His	PRP$	O
stools	NNS	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
Guaiac	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
and	CC	O
there	EX	O
was	VBD	O
still	RB	O
concern	NN	O
for	IN	O
possible	JJ	O
GI	NNP	B-PROBLEM
bleed	NN	I-PROBLEM
given	VBN	O
continued	VBD	O
Guaiac	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
during	IN	O
this	DT	O
admission	NN	O
and	CC	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
drop	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
hematocrit	NN	I-PROBLEM
from	IN	O
39	CD	O
to	TO	O
33	CD	O
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
most	JJS	O
appropriate	JJ	O
for	IN	O
him	PRP	O
to	TO	O
have	VB	O
an	DT	B-TEST
outpatient	JJ	I-TEST
GI	NNP	I-TEST
workup	NN	I-TEST
,	,	O
and	CC	O
his	PRP$	O
PCP	NNP	O
was	VBD	O
contacted	VBN	O
and	CC	O
will	MD	O
arrange	VB	O
for	IN	O
outpatient	JJ	B-TEST
colonoscopy	NN	I-TEST
.	.	O

His	PRP$	B-TREATMENT
Plavix	NNP	I-TREATMENT
was	VBD	O
held	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
due	JJ	O
to	TO	O
a	DT	O
question	NN	O
of	IN	O
GI	NNP	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
not	RB	O
having	VBG	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
placed	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
catheterization	NN	B-TEST
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
however	RB	O
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
non-ST	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
80	CD	B-PROBLEM
percent	NN	I-PROBLEM
mid	NN	I-PROBLEM
LAD	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
now	RB	O
status	NN	O
post	NN	O
angioplasty	NN	B-TREATMENT
.	.	O

Hypertension	NN	B-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Guaiac	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

Anemia	NNP	B-PROBLEM
.	.	O

1.	CD	O
Lipitor	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
Lisinopril	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
Flovent	JJ	B-TREATMENT
110	CD	O
micrograms	NNS	O
aerosol	RB	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

4.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

5.	CD	O
Combivent	NNP	B-TREATMENT
MDI	NNP	O
p.r.n.	NN	O

6.	CD	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
without	IN	O
complaints	NNS	B-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
discussed	VBN	O
with	IN	O
him	PRP	O
the	DT	O
need	NN	O
to	TO	O
schedule	VB	O
follow-up	NN	O
for	IN	O
colonoscopy	NN	B-TEST
with	IN	O
his	PRP$	O
PCP	NN	O
as	RB	O
well	RB	O
.	.	O

Sulfa	NNP	B-TREATMENT
(	(	I-TREATMENT
Sulfonamides	NNP	I-TREATMENT
)	)	O
/	VBP	O
Penicillins	NNP	B-TREATMENT
/	NNP	O
Macrodantin	NNP	B-TREATMENT
/	NNP	O
Ivp	NNP	B-TREATMENT
Dye	NNP	I-TREATMENT
,	,	O
Iodine	NNP	B-TREATMENT
Containing	NNP	I-TREATMENT

Just	RB	O
prior	RB	O
to	TO	O
discharge	VB	O
on	IN	O
11-14	JJ	O
,	,	O
pt	NN	B-TEST
's	POS	I-TEST
BP	NNP	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
70/40	CD	O
P70	NNP	O
s	NN	O
just	RB	O
after	IN	O
receiving	VBG	O
her	PRP$	B-TREATMENT
am	VBP	I-TREATMENT
BP	NNP	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
.	.	O

1.	CD	O
Hypotension	NN	B-PROBLEM
:	:	O
The	DT	B-TREATMENT
patient	NN	I-TREATMENT
'd	MD	I-TREATMENT
pm	VB	I-TREATMENT
BP	NNP	I-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
11-14	JJ	O
and	CC	O
she	PRP	O
was	VBD	O
administered	VBN	O
1.5L	CD	O
NS	NNP	B-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
day	NN	O
with	IN	O
subsequent	JJ	O
SBP	NNP	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
high	JJ	O
90	CD	O
s,	RB	O
low	JJ	O
100	CD	O
s,.	NN	O

The	DT	B-PROBLEM
hypotension	NN	I-PROBLEM
was	VBD	O
likely	JJ	O
due	JJ	O
to	TO	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
caused	VBN	O
by	IN	O
her	PRP$	B-PROBLEM
diarrhea	NN	I-PROBLEM
/	NN	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
decreased	VBN	B-PROBLEM
PO	NNP	I-PROBLEM
intake	VBP	I-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
GERD	NNP	I-PROBLEM
and	CC	O
thrush	NN	B-PROBLEM
.	.	O

All	DT	O
of	IN	O
this	DT	O
occurred	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
aggressive	JJ	B-TREATMENT
BP	NNP	I-TREATMENT
management	NN	I-TREATMENT
with	IN	O
metoprolol	JJ	B-TREATMENT
25	CD	O
BID	NNP	O
,	,	O
HCTZ	NNP	B-TREATMENT
/	NNP	O
Triampterene	NNP	B-TREATMENT
(	(	O
as	IN	O
a	DT	O
replacment	NN	O
for	IN	O
lasix	NN	B-TREATMENT
due	JJ	O
to	TO	O
recurrent	VB	B-PROBLEM
hypokalemia	NN	I-PROBLEM
),	NNP	O
Benicar	NNP	B-TREATMENT
20	CD	O
mg	NN	O
QD	NNP	O
,	,	O
and	CC	O
Imdur	NNP	B-TREATMENT
30	CD	O
mg	NN	O
QD	NNP	O
.	.	O

Infection	NNP	B-PROBLEM
/	NNP	O
sepsis	NN	B-PROBLEM
was	VBD	O
not	RB	O
likely	JJ	O
given	VBN	O
she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
had	VBD	O
no	DT	O
localizing	VBG	B-PROBLEM
sx	NN	I-PROBLEM
with	IN	O
an	DT	O
improving	VBG	O
lung	NN	B-TEST
exam	NN	I-TEST
and	CC	O
02	CD	B-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

Given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
recent	JJ	I-PROBLEM
RP	NNP	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
there	EX	O
was	VBD	O
concern	NN	O
for	IN	O
a	DT	B-PROBLEM
recurrent	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
groin	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
unchanged	JJ	O
.	.	O

Her	PRP$	B-TEST
Hct	NNP	I-TEST
dropped	VBD	O
from	IN	O
Hct	NNP	B-TEST
38.9	CD	O
before	IN	O
fluids	NNS	B-TREATMENT
to	TO	O
35.5	CD	O
s/p	NNS	O
1.5L	CD	O
NS	NNP	B-TREATMENT
and	CC	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
dilutional	JJ	O
.	.	O

Repeat	NN	B-TEST
hcts	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
an	DT	O
additional	JJ	O
two	CD	O
days	NNS	O
to	TO	O
follow	VB	O
her	PRP$	B-TEST
hcts	NNS	I-TEST
and	CC	O
titrate	VB	O
her	PRP$	B-TREATMENT
BP	NNP	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

As	IN	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
the	DT	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
BP	NNP	I-PROBLEM
,	,	O
only	RB	O
the	DT	B-TREATMENT
BBlocker	NNP	I-TREATMENT
was	VBD	O
restarted	VBN	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
placed	VBN	O
on	IN	O
on	IN	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
spironolactone	NN	I-TREATMENT
as	IN	O
a	DT	B-TREATMENT
K	NNP	I-TREATMENT
sparing	VBG	I-TREATMENT
diuretic	JJ	I-TREATMENT
and	CC	O
for	IN	O
BP	NNP	B-TREATMENT
control	NN	I-TREATMENT
in	IN	O
addition	NN	O
to	TO	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
25	CD	O
mg	NN	O
QD	NNP	O
for	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

She	PRP	O
tolerated	VBD	O
these	DT	B-TREATMENT
meds	NNS	I-TREATMENT
with	IN	O
SBP	NNP	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
high	JJ	O
90	CD	O
s	NN	O
to	TO	O
100	CD	O
s	NNS	O
and	CC	O
was	VBD	O
therefore	RB	O
discharged	VBN	O
on	IN	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

She	PRP	O
will	MD	O
need	VB	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
PCP	NNP	O
within	IN	O
B	NNP	O
week	NN	O
after	IN	O
discharge	NN	O
from	IN	O
the	DT	O
extended	VBN	O
care	NN	O
facility	NN	O
for	IN	O
further	JJ	B-TREATMENT
BP	NNP	I-TREATMENT
titration	NN	I-TREATMENT
and	CC	O
monitoring	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
electrolytes	NNS	I-TEST
.	.	O

2.	CD	O
Thrush	NN	B-PROBLEM
:	:	O
This	DT	O
is	VBZ	O
likely	JJ	O
secondary	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
steroid	JJ	I-TREATMENT
inhalers	NNS	I-TREATMENT
and	CC	O
PO	NNP	B-TREATMENT
prednisone	NN	I-TREATMENT
for	IN	O
COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
nystatin	NN	B-TREATMENT
swish	JJ	O
and	CC	O
swallow	JJ	O
QID	NNP	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
encouraged	VBN	O
to	TO	O
take	VB	B-TREATMENT
PO	NNP	I-TREATMENT
liquids	NNS	I-TREATMENT
to	TO	O
prevent	VB	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
.	.	O

3.	CD	O
diarrhea	NN	B-PROBLEM
:	:	O
The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
having	VBG	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
at	IN	O
night	NN	O
and	CC	O
was	VBD	O
guiac	JJ	B-PROBLEM
pos	NN	I-PROBLEM
x	VBD	O
2	CD	O
.	.	O

Stool	NN	B-TEST
for	IN	I-TEST
C.diff	NNP	I-TEST
toxin	NN	I-TEST
was	VBD	O
sent	VBN	O
x	RB	O
1	CD	O
and	CC	O
was	VBD	O
negative	JJ	O
.	.	O

Her	PRP$	B-TREATMENT
bowel	NN	I-TREATMENT
regimen	NN	I-TREATMENT
is	VBZ	O
prn	JJ	O
.	.	O

Gastroenteritis	NNP	B-PROBLEM
is	VBZ	O
possible	JJ	O
but	CC	O
she	PRP	O
has	VBZ	O
no	DT	O
vomiting	NN	B-PROBLEM
and	CC	O
only	RB	O
occ	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
with	IN	O
meds	NNS	B-TREATMENT
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
obstruction	NN	B-PROBLEM
on	IN	O
AXR	NNP	B-TEST
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
mild	JJ	I-PROBLEM
diarrhea	NN	I-PROBLEM
(	(	O
few	JJ	B-PROBLEM
loose	RB	I-PROBLEM
BM	NNP	I-PROBLEM
/	NNP	O
liquid	JJ	B-PROBLEM
stool	NN	I-PROBLEM
/	NNP	O
night	NN	O
)	)	O
may	MD	O
be	VB	O
either	CC	O
viral	JJ	B-PROBLEM
or	CC	O
secondary	JJ	O
to	TO	O
resolving	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
resultant	JJ	O
irritation	NN	B-PROBLEM
of	IN	I-PROBLEM
GI	NNP	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

We	PRP	O
have	VBP	O
advised	VBN	O
a	DT	B-TREATMENT
BRAT	NNP	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

4.	CD	O
guiac	JJ	B-PROBLEM
pos	NN	I-PROBLEM
stool	NN	I-PROBLEM
:	:	O
Given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
sx	NN	O
of	IN	O
GERD	NNP	B-PROBLEM
,	,	O
current	JJ	O
PO	NNP	B-TREATMENT
steroid	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
and	CC	O
ASA	NNP	B-TREATMENT
for	IN	O
her	PRP$	B-TREATMENT
stents	NNS	I-TREATMENT
,	,	O
the	DT	O
ddx	NN	O
for	IN	O
her	PRP$	B-PROBLEM
guiac	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
would	MD	O
include	VB	O
gastritis	NN	B-PROBLEM
/	NNP	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
lower	VB	B-PROBLEM
GI	NNP	I-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
she	PRP	O
has	VBZ	O
no	DT	O
vomiting	NN	B-PROBLEM
and	CC	O
only	RB	B-PROBLEM
mild	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
with	IN	O
medications	NNS	B-TREATMENT
.	.	O

She	PRP	O
also	RB	O
has	VBZ	O
no	DT	O
gross	JJ	B-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
her	PRP$	B-TEST
hct	NN	I-TEST
is	VBZ	O
stable	JJ	O
.	.	O

Upon	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
BID	NNP	I-TREATMENT
protonix	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

She	PRP	O
will	MD	O
need	VB	O
outpatient	NN	O
follow	VB	O
up	RP	O
for	IN	O
her	PRP$	B-PROBLEM
guiac	JJ	I-PROBLEM
pos	NN	I-PROBLEM
stools	NNS	I-PROBLEM
with	IN	O
endoscopy	JJ	B-TEST
vs	NNS	O
EGD	NNP	B-TEST
+/-	JJ	O
H.pylori	NNP	B-TEST
serologies	NNS	I-TEST
.	.	O

1.	CD	O
Atorvastatin	NNP	B-TREATMENT
10	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

2.	CD	O
Pantoprazole	NNP	B-TREATMENT
40	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
Acetaminophen	NNP	B-TREATMENT
500	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

4.	CD	O
Oxycodone	CD	B-TREATMENT
5	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
Q4H	NNP	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
Fluticasone	CD	B-TREATMENT
50	CD	O
mcg	NN	O
/	NNP	O
Actuation	NNP	O
Aerosol	NNP	O
,	,	O
Spray	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Spray	NN	O
Nasal	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

6.	CD	O
Fluticasone	CD	B-TREATMENT
110	CD	O
mcg	NN	O
/	NNP	O
Actuation	NNP	O
Aerosol	NNP	O
Sig	NNP	O
:	:	O
Two	CD	O
(	(	O
2	CD	O
)	)	O
Puff	NNP	O
Inhalation	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
Tiotropium	NNP	B-TREATMENT
Bromide	NNP	I-TREATMENT
18	CD	O
mcg	NN	O
Capsule	NNP	O
,	,	O
w/	JJ	O
Inhalation	NNP	O
Device	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Cap	NNP	O
Inhalation	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

8.	CD	O
Clopidogrel	NNP	B-TREATMENT
75	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

9.	CD	O
Albuterol	NNP	B-TREATMENT
Sulfate	NNP	I-TREATMENT
0.083	CD	O
%	NN	O
Solution	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
puff	NN	O
Inhalation	NNP	O
Q6H	NNP	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
wheezing	NN	B-PROBLEM
.	.	O

10.	CD	O
Aluminum	NNP	B-TREATMENT
-	:	I-TREATMENT
Magnesium	NN	I-TREATMENT
Hydroxide	NNP	I-TREATMENT
225-200	CD	O
mg	NN	O
/	$	O
5	CD	O
mL	JJ	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
15-30	JJ	O
ML	NNP	O
s	NN	O
PO	NNP	O
PRN	NNP	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

11.	CD	O
Senna	NNP	B-TREATMENT
8.6	CD	O
mg	NN	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NNP	O
PO	NNP	O
BID	NNP	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

12.	CD	O
Prednisone	CD	B-TREATMENT
10	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
1-2	JJ	O
Tablets	NNS	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
:	:	O
Please	NNP	O
take	VB	O
two	CD	O
pills	NNS	O
for	IN	O
one	CD	O
day	NN	O
starting	VBG	O
11-17	JJ	O
,	,	O
then	RB	O
take	VB	O
one	CD	O
pill	NN	O
for	IN	O
three	CD	O
days	NNS	O
.	.	O

13.	CD	O
oxygen	NN	B-TREATMENT
continue	VBP	O
02	CD	B-TREATMENT
at	IN	O
1L/min	CD	O
continuous	JJ	O
to	TO	O
keep	VB	O
sats	NNS	B-TEST
in	IN	O
90	CD	O
's.	NNS	O

14.	CD	O
Spironolactone	CD	B-TREATMENT
25	CD	O
mg	NNS	O
Tablet	NNP	O
Sig	NNP	O
:	:	O
0.5	CD	O
Tablet	NNP	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

15.	CD	O
Metoprolol	NNP	B-TREATMENT
Succinate	NNP	I-TREATMENT
25	CD	O
mg	NN	O
Tablet	NNP	O
Sustained	NNP	O
Release	NNP	O
24HR	CD	O
Sig	NNP	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
Sustained	VBD	O
Release	NNP	O
24HR	CD	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

16.	CD	O
Nystatin	NNP	B-TREATMENT
100,000	CD	O
unit	NN	O
/	NNP	O
mL	NN	O
Suspension	NNP	O
Sig	NNP	O
:	:	O
Ten	CD	O
(	(	O
10	CD	O
)	)	O
ML	NNP	O
PO	NNP	O
QID	NNP	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

17.	CD	O
Aspirin	NNP	B-TREATMENT
325	CD	O
mg	NN	O
Tablet	NNP	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
Sig	NN	O
:	:	O
One	CD	O
(	(	O
1	CD	O
)	)	O
Tablet	NN	O
,	,	O
Delayed	NNP	O
Release	NNP	O
(	(	O
E.C.	NNP	O
)	)	O
PO	NNP	O
DAILY	NNP	O
(	(	O
Daily	NNP	O
).	NNP	O

1)	CD	O
Rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM

2)	CD	O
Retroperitoneal	NNP	B-PROBLEM
bleed	NN	I-PROBLEM

If	IN	O
you	PRP	O
experience	VBP	O
CP	NNP	B-PROBLEM
,	,	O
SOB	NNP	B-PROBLEM
,	,	O
dizzyness	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
that	IN	O
concern	NN	O
you	PRP	O
please	VBP	O
call	VB	O
your	PRP$	O
PCP	NNP	O
or	CC	O
return	VB	O
to	TO	O
the	DT	O
ER	NNP	O
.	.	O

Note	NN	O
:	:	O
you	PRP	O
have	VBP	O
had	VBN	O
a	DT	B-TREATMENT
cardiac	JJ	I-TREATMENT
stent	NN	I-TREATMENT
placed	VBD	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

You	PRP	O
must	MD	O
take	VB	O
your	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
plavix	JJ	B-TREATMENT
every	DT	O
day	NN	O
to	TO	O
prevent	VB	O
failure	NN	B-PROBLEM
of	IN	I-PROBLEM
these	DT	I-PROBLEM
stents	NNS	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
life	NN	O
threatening	VBG	O
.	.	O

Please	NNP	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

2)	CD	O
You	PRP	O
are	VBP	O
scheduled	VBN	O
to	TO	O
have	VB	O
your	PRP$	B-TREATMENT
staples	NNS	I-TREATMENT
removed	VBN	O
on	IN	O
2013-11-20	JJ	O
3:00	CD	O
with	IN	O
provider	NN	O
:	:	O
Leah	NNP	O
,	,	O
Paula	NNP	O
G.	NNP	O
Wilson	NNP	O
SURGERY	NNP	O
(	(	O
NHB	NNP	O
)	)	O

This	DT	O
is	VBZ	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
Caucasian	JJ	O
speaking	VBG	O
male	NN	O
who	WP	O
is	VBZ	O
a	DT	O
smoker	NN	O
and	CC	O
has	VBZ	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
personal	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
experienced	VBD	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
10/10	CD	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
down	RP	O
his	PRP$	O
left	JJ	O
arm	NN	O
last	JJ	O
night	NN	O
with	IN	O
his	PRP$	O
daily	JJ	O
activities	NNS	O
.	.	O

Each	DT	B-PROBLEM
episode	NN	I-PROBLEM
lasted	VBD	O
approximately	RB	O
15	CD	O
minutes	NNS	O
in	IN	O
duration	NN	O
and	CC	O
resolved	VBN	O
on	IN	O
their	PRP$	O
own	JJ	O
.	.	O

This	DT	O
morning	NN	O
while	IN	O
landscaping	VBG	O
the	DT	O
patient	NN	O
had	VBD	O
unremitting	JJ	B-PROBLEM
12-05	JJ	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

He	PRP	O
presented	VBD	O
to	TO	O
Deaconess-Nashoba	NNP	O
Hospital	NNP	O
Hospital	NNP	O
and	CC	O
the	DT	B-TEST
first	JJ	I-TEST
EKG	NNP	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
ST	NNP	B-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
V1-V3	NNP	I-PROBLEM
of	IN	O
1-2	JJ	O
mm	NN	O
with	IN	O
T	NNP	B-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	O
V4-6	NNP	O
,	,	O
I	PRP	O
and	CC	O
L	NNP	O
,	,	O
which	WDT	O
progressed	VBD	O
to	TO	O
3-0167	JJ	O
W.	NNP	O
Seventh	NNP	O
Ave.	NNP	O
elevations	NNS	O
within	IN	O
20	CD	O
minutes	NNS	O
.	.	O

Heparin	NNP	B-TREATMENT
and	CC	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
were	VBD	O
started	VBN	O
with	IN	O
10	CD	O
mg	NNS	O
of	IN	O
IV	NNP	B-TREATMENT
Retavase	NNP	I-TREATMENT
half	NN	O
dose	NN	O
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
North	NNP	O
Adams	NNP	O
Regional	NNP	O
Hospital	NNP	O
for	IN	O
catheterization	NN	B-TEST
.	.	O

Once	RB	O
at	IN	O
Hahnemann	NNP	O
General	NNP	O
Hospital	NNP	O
he	PRP	O
received	VBD	O
heparin	NN	B-TREATMENT
and	CC	O
Integrilin	NNP	B-TREATMENT
.	.	O

Coronary	JJ	B-TEST
angiography	NN	I-TEST
revealed	VBD	O
left	VBD	O
main	JJ	O
,	,	O
left	VBD	O
circumflex	JJ	O
and	CC	O
RCA	NNP	O
normal	JJ	O
and	CC	O
left	VBD	B-PROBLEM
LAD	NNP	I-PROBLEM
with	IN	I-PROBLEM
99%	CD	I-PROBLEM
midstenosis	NN	I-PROBLEM
.	.	O

A	DT	B-TREATMENT
Hepacoat	NNP	I-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
with	IN	O
no	DT	O
residuals	NNS	B-TEST
but	CC	O
good	JJ	O
flow	NN	O
after	IN	O
nitroglycerin	JJ	B-TREATMENT
and	CC	O
diltiazem	NN	B-TREATMENT
.	.	O

The	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
persisted	VBD	O
afterwards	NNS	O
and	CC	O
a	DT	B-TEST
relook	NN	I-TEST
catheterization	NN	I-TEST
was	VBD	O
performed	VBN	O
that	IN	O
revealed	VBD	O
no	DT	O
occlusions	NNS	B-PROBLEM
.	.	O

The	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
output	NN	I-TEST
index	NN	I-TEST
of	IN	O
4.11	CD	O
and	CC	O
2.15	CD	O
respectively	RB	O
.	.	O

RA	NNP	B-TEST
pressure	NN	I-TEST
was	VBD	O
13	CD	O
,	,	O
RV	NNP	B-TEST
pressure	NN	I-TEST
45/7	CD	O
,	,	O
wedge	NN	B-TEST
27	CD	O
and	CC	O
PA	NNP	B-TEST
pressures	NNS	I-TEST
of	IN	O
42/21	CD	O
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
CC	NNP	O
for	IN	O
monitoring	NN	B-TEST
and	CC	O
he	PRP	O
denied	VBD	O
having	VBG	O
further	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

At	IN	O
baseline	PDT	O
the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	O
previous	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
pressure	NN	B-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
PND	NNP	B-PROBLEM
or	CC	O
palpitations	NNS	B-PROBLEM
.	.	O

Only	RB	O
hypertension	NN	B-PROBLEM
.	.	O

Antihypertensive	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
that	IN	O
the	DT	O
patient	NN	O
could	MD	O
not	RB	O
identify	VB	O
.	.	O

The	DT	O
patient	NN	O
denies	VBZ	O
having	VBG	O
any	DT	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Significant	NNP	O
for	IN	O
a	DT	O
brother	NN	O
who	WP	O
had	VBD	O
an	DT	B-PROBLEM
MI	NNP	I-PROBLEM
at	IN	O
age	NN	O
61	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
156/67	CD	O
,	,	O
pulse	RB	B-TEST
80	CD	O
and	CC	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
14	CD	O
.	.	O

He	PRP	O
was	VBD	O
laying	VBG	O
flat	JJ	O
,	,	O
very	RB	B-PROBLEM
tense	JJ	I-PROBLEM
.	.	O

Skin	NNP	O
was	VBD	O
strong	JJ	O
build	NN	O
and	CC	O
was	VBD	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
anicteric	JJ	B-PROBLEM
with	IN	O
moist	JJ	O
mucous	JJ	O
membranes	NNS	O
.	.	O

No	DT	O
JVD	NNP	B-PROBLEM
or	CC	O
increased	VBD	B-PROBLEM
JVP	NNP	I-PROBLEM
was	VBD	O
appreciated	VBN	O
at	IN	O
0	CD	O
degrees	NNS	O
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
carotid	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
or	CC	O
femoral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

His	PRP$	B-TEST
PMI	NNP	I-TEST
was	VBD	O
two	CD	O
finger	JJR	B-TEST
breath	NN	I-TEST
width	NN	I-TEST
in	IN	O
the	DT	O
fifth	JJ	O
intercostal	JJ	O
space	NN	O
lateral	NN	O
to	TO	O
the	DT	O
midclavicular	JJ	O
line	NN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
lifts	NNS	B-PROBLEM
or	CC	O
heaves	NNS	B-PROBLEM
on	IN	O
examination	NN	B-TEST
.	.	O

His	PRP$	O
heart	NN	O
was	VBD	O
regular	JJ	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
radial	NN	I-TEST
and	CC	I-TEST
DP	NNP	I-TEST
pulses	NNS	I-TEST
were	VBD	O
both	DT	O
2+	CD	O
bilaterally	RB	O
and	CC	O
equal	JJ	O
.	.	O

His	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

His	PRP$	O
abdomen	NNS	O
was	VBD	O
scaphoid	JJ	B-PROBLEM
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	FW	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

His	PRP$	O
extremities	NNS	O
were	VBD	O
warm	JJ	O
,	,	O
pink	VB	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

The	DT	O
right	JJ	O
calf	NN	O
site	NN	O
had	VBD	O
minimal	JJ	B-PROBLEM
ooze	NN	I-PROBLEM
and	CC	O
no	DT	O
hematomas	NN	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
54	JJ	O
-	:	O
year-old	JJ	O
man	NN	O
with	IN	O
significant	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
,	,	O
positive	JJ	O
family	NN	O
history	NN	O
,	,	O
smoking	VBG	O
history	NN	O
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
gender	NN	O
who	WP	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
ST	NNP	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
status	NN	O
post	NN	O
LAD	NNP	B-TREATMENT
stent	NN	I-TREATMENT
,	,	O
complicated	VBN	O
by	IN	O
no	DT	O
residuals	NNS	B-PROBLEM
requiring	VBG	O
nitroglycerin	NN	B-TREATMENT
and	CC	O
diltiazem	NN	B-TREATMENT
for	IN	O
good	JJ	O
flow	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
pain	JJ	B-PROBLEM
free	JJ	O
and	CC	O
doing	VBG	O
well	RB	O
.	.	O

For	IN	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
aspirin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
325	CD	O
.	.	O

Plavix	NNP	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
75	CD	O
mg	NNS	O
a	DT	O
day	NN	O
,	,	O
Lipitor	NNP	B-TREATMENT
20	CD	O
mg	NN	O
per	IN	O
day	NN	O
,	,	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
to	TO	O
be	VB	O
titrated	VBN	O
up	RP	O
as	IN	O
tolerated	VBN	O
and	CC	O
on	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
an	DT	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

Captopril	NNP	B-TREATMENT
6.2	CD	O
3	CD	O
x	NNS	O
a	DT	O
day	NN	O
and	CC	O
titrated	VBD	O
up	RP	O
.	.	O

A	DT	B-TEST
lipid	JJ	I-TEST
panel	NN	I-TEST
was	VBD	O
checked	VBN	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
although	IN	O
it	PRP	O
was	VBD	O
noted	VBN	O
this	DT	O
was	VBD	O
in	IN	O
the	DT	O
post	NN	O
MI	NNP	O
setting	NN	O
and	CC	O
the	DT	B-TEST
lipid	JJ	I-TEST
panel	NN	I-TEST
could	MD	O
be	VB	O
falsely	RB	O
low	JJ	O
.	.	O

Serial	JJ	B-TEST
CK	NNP	I-TEST
s	NN	I-TEST
were	VBD	O
followed	VBN	O
with	IN	O
a	DT	B-TEST
CK	NNP	I-TEST
peak	NN	I-TEST
of	IN	O
433	CD	O
.	.	O

Hypertension	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
ACE	NNP	B-TREATMENT
inhibitor	NN	I-TREATMENT
and	CC	O
Integrilin	NNP	B-TREATMENT
was	VBD	O
continued	VBN	O
post	NN	O
MI	NNP	B-PROBLEM
for	IN	O
18	CD	O
hours	NNS	O
.	.	O

Rhythm	NNP	O
was	VBD	O
maintained	VBN	O
at	IN	O
normal	JJ	O
sinus	NN	O
,	,	O
monitored	VBD	O
on	IN	O
telemetry	NN	B-TEST
without	IN	O
ectopy	NN	B-PROBLEM
.	.	O

EKG	NNP	B-TEST
s	NN	I-TEST
were	VBD	O
followed	VBN	O
for	IN	O
normalization	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
,	,	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
LVH	NNP	I-PROBLEM
,	,	O
normal	JJ	O
LV	NNP	O
cavity	NN	O
size	NN	O
,	,	O
mild	JJ	B-PROBLEM
region	NN	I-PROBLEM
LV	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
arresting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
including	VBG	O
focal	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
a	DT	O
normal	JJ	O
right	JJ	O
ventricular	JJ	O
chamber	NN	O
size	NN	O
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
,	,	O
a	DT	B-PROBLEM
moderately	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
dilated	JJ	I-PROBLEM
ascending	VBG	I-PROBLEM
aorta	NN	I-PROBLEM
,	,	O
normal	JJ	O
aortic	JJ	O
valve	NN	O
leaflet	NN	O
,	,	O
normal	JJ	O
mitral	JJ	O
valve	NN	O
leaflet	NN	O
and	CC	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
normal	JJ	O
volume	NN	O
and	CC	O
displayed	VBD	O
no	DT	O
evidence	NN	O
CHF	NNP	B-PROBLEM
signs	NNS	I-PROBLEM
or	CC	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
were	VBD	O
addressed	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
repeatedly	RB	O
that	IN	O
he	PRP	O
needed	VBD	O
to	TO	O
stop	VB	O
smoking	NN	O
and	CC	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
nicotine	JJ	I-TREATMENT
patch	NN	I-TREATMENT
and	CC	O
his	PRP$	O
primary	JJ	O
care	NN	O
provider	NN	O
was	VBD	O
called	VBN	O
to	TO	O
discuss	VB	O
outpatient	JJ	O
plans	NNS	O
to	TO	O
help	VB	O
the	DT	O
patient	NN	O
stop	NN	O
smoking	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
advised	VBN	O
to	TO	O
have	VB	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	JJ	I-TREATMENT
/	NN	I-TREATMENT
low	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
diet	NN	I-TREATMENT
,	,	O
was	VBD	O
cleared	VBN	O
by	IN	O
PT	NNP	O
and	CC	O
advised	VBD	O
to	TO	O
do	VB	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
advised	VBN	O
the	DT	O
importance	NN	O
of	IN	O
each	DT	O
of	IN	O
his	PRP$	O
and	CC	O
compliance	NN	O
with	IN	O
each	DT	O
of	IN	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
was	VBD	O
told	VBN	O
he	PRP	O
needed	VBD	O
close	JJ	O
followup	NN	O
with	IN	O
a	DT	O
cardiologist	NN	O
.	.	O

For	IN	O
renal	JJ	O
,	,	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
was	VBD	O
monitored	VBN	O
and	CC	O
the	DT	B-TEST
dye	NN	I-TEST
load	NN	I-TEST
and	CC	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	JJ	I-TREATMENT
/	NN	I-TREATMENT
low	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

His	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
monitored	VBN	O
and	CC	O
repleted	VBN	O
carefully	RB	O
.	.	O

He	PRP	O
had	VBD	O
normal	JJ	O
bowel	NN	O
movements	NNS	O
and	CC	O
had	VBD	O
GI	NNP	B-TREATMENT
prophylaxis	NN	I-TREATMENT
throughout	IN	O
his	PRP$	O
stay	NN	O
.	.	O

For	IN	O
hematology	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
and	CC	O
platelets	NNS	B-TEST
were	VBD	O
monitored	VBN	O
after	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

They	PRP	O
were	VBD	O
normal	JJ	O
and	CC	O
did	VBD	O
not	RB	O
change	NN	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
pneumatic	JJ	B-TREATMENT
boots	NNS	I-TREATMENT
for	IN	O
DVT	NNP	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

On	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
ambulated	VBD	O
with	IN	O
PT	NNP	B-TREATMENT
and	CC	O
was	VBD	O
moved	VBN	O
to	TO	O
the	DT	O
regular	JJ	O
floor	NN	O
.	.	O

He	PRP	O
denied	VBD	O
ever	RB	O
having	VBG	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
.	.	O

He	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
if	IN	O
he	PRP	O
had	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
pressure	NN	B-PROBLEM
,	,	O
difficulty	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
light-headiness	JJ	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
advised	VBN	O
to	TO	O
take	VB	O
all	DT	O
of	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
ST	NNP	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

Cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
mid	NN	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

Aspirin	$	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Lipitor	NNP	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
nitroglycerin	RB	B-TREATMENT
0.3	CD	O
mg	NNS	O
sublingually	RB	O
p.r.n.	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
pressure	NN	B-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
lisinopril	JJ	B-TREATMENT
hydrochlorothiazide	NN	B-TREATMENT
20	CD	O
/	NN	O
12.5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
atenolol	RB	B-TREATMENT
25	CD	O
mg	NNS	O
q.d.	NN	O

The	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
he	PRP	O
could	MD	O
return	VB	O
to	TO	O
work	VB	O
after	IN	O
two	CD	O
weeks	NNS	O
of	IN	O
rest	NN	B-TREATMENT
,	,	O
given	VBN	O
that	IN	O
his	PRP$	O
work	NN	O
required	VBD	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
exertion	NN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
a	DT	B-TREATMENT
transdermal	JJ	I-TREATMENT
nicotine	JJ	I-TREATMENT
patch	NN	I-TREATMENT
14	CD	O
mg	VBD	O
the	DT	O
be	VB	O
used	VBN	O
for	IN	O
up	RB	O
to	TO	O
2	CD	O
weeks	NNS	O
until	IN	O
cravings	NNS	B-PROBLEM
remitted	VBN	O
.	.	O

C5-6	JJ	B-PROBLEM
disc	NN	I-PROBLEM
herniation	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
myelopathy	NN	B-PROBLEM
.	.	O

Microscopic	NNP	B-TREATMENT
anterior	JJ	I-TREATMENT
cervical	JJ	I-TREATMENT
diskectomy	NN	I-TREATMENT
at	IN	I-TREATMENT
C5-6	NNP	I-TREATMENT
and	CC	O
fusion	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
three-year	JJ	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
hand	NN	I-PROBLEM
numbness	NN	I-PROBLEM
and	CC	O
occasional	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

Within	IN	O
the	DT	O
past	JJ	O
year	NN	O
,	,	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
have	VBP	O
progressively	RB	O
gotten	VBN	O
worse	JJR	O
,	,	O
to	TO	O
encompass	VB	O
also	RB	O
her	PRP$	O
feet	NNS	O
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
workup	NN	I-TEST
by	IN	O
her	PRP$	O
neurologist	NN	O
and	CC	O
an	DT	B-TEST
MRI	NNP	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
C5-6	JJ	I-PROBLEM
disc	NN	I-PROBLEM
herniation	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
T2	NNP	I-PROBLEM
signal	JJ	I-PROBLEM
change	NN	I-PROBLEM
at	IN	O
that	DT	O
level	NN	O
.	.	O

Significant	NN	O
for	IN	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

Lipitor	NNP	B-TREATMENT
,	,	O
Flexeril	NNP	B-TREATMENT
,	,	O
hydrochlorothiazide	NN	B-TREATMENT
and	CC	O
Norvasc	NNP	B-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
Hoffman	NNP	I-TEST
&apos;s	NNP	I-TEST
sign	NN	I-TEST
greater	JJR	O
on	IN	O
the	DT	O
right	NN	O
than	IN	O
the	DT	O
left	NN	O
and	CC	O
she	PRP	O
had	VBD	O
10	CD	B-PROBLEM
beats	NNS	I-PROBLEM
of	IN	I-PROBLEM
clonus	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
foot	NN	O
and	CC	O
3-5	JJ	B-PROBLEM
beats	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
hyperreflexia	VBN	B-PROBLEM
in	IN	O
both	DT	O
the	DT	O
bilateral	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
a	DT	B-TREATMENT
C5-6	JJ	I-TREATMENT
ACDF	NNP	I-TREATMENT
by	IN	O
Dr.	NNP	O
Miezetri	NNP	O
Gach	NNP	O
quite	RB	O
well	RB	O
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
postoperative	JJ	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
that	WDT	O
revealed	VBD	O
partial	JJ	B-PROBLEM
decompression	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spinal	JJ	I-PROBLEM
canal	NN	I-PROBLEM
and	CC	O
good	JJ	O
placement	NN	O
of	IN	O
her	PRP$	B-TREATMENT
hardware	NN	I-TREATMENT
.	.	O

Immediately	RB	O
postop	NN	O
,	,	O
her	PRP$	B-TEST
exam	NN	I-TEST
only	RB	O
improved	VBD	O
slightly	RB	O
in	IN	O
her	PRP$	B-PROBLEM
hyperreflexia	NN	I-PROBLEM
.	.	O

Her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
under	IN	O
good	JJ	O
control	NN	O
with	IN	O
PO	NNP	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
deemed	VBN	O
suitable	JJ	O
for	IN	O
discharge	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
asked	VBN	O
to	TO	O
call	VB	O
Dr.	NNP	O
Miezetri	NNP	O
Gach	NNP	O
&apos;s	NNP	O
office	NN	O
for	IN	O
a	DT	O
follow-up	JJ	O
appointment	NN	O
and	CC	O
wound	NN	B-TEST
check	NN	I-TEST
.	.	O

She	PRP	O
is	VBZ	O
asked	VBN	O
to	TO	O
call	VB	O
with	IN	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
weakness	NN	I-PROBLEM
or	CC	O
numbness	NN	B-PROBLEM
or	CC	O
any	DT	O
bowel	NN	B-PROBLEM
and	CC	I-PROBLEM
bladder	NN	I-PROBLEM
disruption	NN	I-PROBLEM
.	.	O

1.	CD	O
Colace	NNP	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
PO	NNP	O
bid	NN	O
.	.	O

2.	CD	O
Zantac	NNP	B-TREATMENT
,	,	O
150	CD	O
mg	NN	O
PO	NNP	O
bid	NN	O
.	.	O

3.	CD	O
Percocet	NNP	B-TREATMENT
,	,	O
5/325	CD	O
,	,	O
1-2	JJ	O
tabs	NN	O
PO	NNP	O
q4-6h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM
.	.	O

4.	CD	O
Lipitor	NNP	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
PO	NNP	O
daily	RB	O
.	.	O

5.	CD	O
Hydrochlorothiazide	NNP	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
PO	NNP	O
daily	RB	O
.	.	O

6.	CD	O
Norvasc	NNP	B-TREATMENT
,	,	O
5	CD	O
mg	NN	O
PO	NNP	O
daily	RB	O
.	.	O

L	NNP	B-PROBLEM
SHOULDER	NNP	I-PROBLEM
INJ	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
neck	NN	B-PROBLEM
strains	NNS	I-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

Left	NNP	B-PROBLEM
Shoulder	NNP	I-PROBLEM
/	NNP	I-PROBLEM
Neck	NNP	I-PROBLEM
strain	NN	I-PROBLEM
/	NN	I-PROBLEM
sprain	NN	I-PROBLEM
.	.	O

Dilaudid	NNP	B-TREATMENT
2mg	CD	O
PO	NNP	O
x	VBD	O
1	CD	O
Flexeril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
x	CD	O
1	CD	O

Flexeril	NNP	B-TREATMENT
10mg	CD	O
TID	NNP	O

Take	VB	O
codeine	NN	B-TREATMENT
prescribed	VBN	O
by	IN	O
PCP	NNP	O
with	IN	O
food	NN	O
and	CC	O
water	NN	O
to	TO	O
prevent	VB	O
nausea	NN	B-PROBLEM
and	CC	O
constipation	NN	B-PROBLEM
.	.	O

Do	NNP	O
not	RB	O
drive	VB	O
if	IN	O
taking	VBG	O
flexeril	NN	B-TREATMENT
and	CC	O
codeine	NN	B-TREATMENT
.	.	O

NEAR	NNP	B-PROBLEM
SYNCOPE	NNP	I-PROBLEM
Standardized	NNP	O
Discharge	NNP	O
Instructions	NNS	O
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
dizziness	NN	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

near	IN	B-PROBLEM
syncope	NN	I-PROBLEM
,	,	O
dehydration	NN	B-PROBLEM
vs	NN	O
cardiogenic	NN	B-PROBLEM

IVF	NNP	B-TREATMENT
,	,	O
cbc	NN	B-TEST
(	(	O
hct	JJ	B-TEST
36	CD	O
)	)	O
,	,	O
normal	JJ	O
chem	NN	O
7	CD	O
,	,	O
negative	JJ	O
cardiac	JJ	O
enzymes	NNS	O
,	,	O
negative	JJ	O
stool	NN	O
guaiac	NN	O
,	,	O
normal	JJ	O
CXR	NNP	O

Dr.	NNP	O
Foutchner	NNP	O
will	MD	O
arrange	VB	O
for	IN	O
an	DT	B-TEST
outpatient	JJ	I-TEST
Holter	NNP	I-TEST
monitor	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
ED	NNP	O
for	IN	O
recurrent	NN	B-PROBLEM
dizziness	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
.	.	O

COPD	NNP	B-PROBLEM
flare	NN	I-PROBLEM

ACETYLSALICYLIC	NNP	B-TREATMENT
ACID	NNP	I-TREATMENT
81	CD	O
MG	NNP	O
PO	NNP	O
DAILY	NNP	O
ALBUTEROL	NNP	B-TREATMENT
NEBULIZER	NNP	I-TREATMENT
2.5	CD	O
MG	NNP	O
NEB	NNP	O
Q4H	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
03/17	CD	O
)	)	O
PRN	NNP	O
Shortness	NNP	B-PROBLEM
of	IN	I-PROBLEM
Breath	NNP	I-PROBLEM
LISINOPRIL	NNP	B-TREATMENT
10	CD	O
MG	NNP	O
PO	NNP	O
DAILY	NNP	O
NIFEREX-150	NNP	B-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PREDNISONE	NNP	B-TREATMENT
Taper	NNP	I-TREATMENT
PO	NNP	I-TREATMENT
Give	NNP	O
50	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
X	NNP	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
Give	VB	O
40	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
X	NNP	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
Give	VB	O
30	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
X	NNP	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
Give	VB	O
20	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
X	NNP	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
Give	VB	O
10	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
X	NNP	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
Starting	VBG	O
Today	NNP	O
(	(	O
03/17	CD	O
)	)	O
CLARITIN	NNP	B-TREATMENT
(	(	I-TREATMENT
LORATADINE	NNP	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
MG	NNP	O
PO	NNP	O
DAILY	NNP	O

Give	VB	O
on	IN	O
an	DT	O
empty	JJ	O
stomach	NN	O
(	(	O
give	JJ	O
1hr	CD	O
before	IN	O
or	CC	O
2hr	CD	O
after	IN	O
food	NN	O
)	)	O
SINGULAIR	NNP	B-TREATMENT
(	(	I-TREATMENT
MONTELUKAST	NNP	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
MG	NNP	O
PO	NNP	O
BEDTIME	NNP	O
ADVAIR	NNP	B-TREATMENT
DISKUS	NNP	I-TREATMENT
500/50	CD	I-TREATMENT
(	(	I-TREATMENT
FLUTICASONE	NNP	I-TREATMENT
PROPIONATE/...	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
PUFF	NNP	O
INH	NNP	O
BID	NNP	O
CALTRATE	NNP	B-TREATMENT
+	NNP	I-TREATMENT
D	NNP	I-TREATMENT
1	CD	O
TAB	NNP	O
PO	NNP	O
BID	NNP	O
LANTUS	NNP	B-TREATMENT
(	(	I-TREATMENT
INSULIN	NNP	I-TREATMENT
GLARGINE	NNP	I-TREATMENT
)	)	I-TREATMENT
35	CD	O
UNITS	NNP	O
SC	NNP	O
QAM	NNP	O
DUONEB	NNP	B-TREATMENT
(	(	I-TREATMENT
ALBUTEROL	NNP	I-TREATMENT
AND	NNP	I-TREATMENT
IPRATROPIUM	NNP	I-TREATMENT
NEBULIZER	NNP	I-TREATMENT
)	)	I-TREATMENT
3/0.5	CD	O
MG	NNP	O
NEB	NNP	O
Q6H	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
03/17	CD	O
)	)	O
PRN	NNP	O
Shortness	NNP	B-PROBLEM
of	IN	I-PROBLEM
Breath	NNP	I-PROBLEM
,	,	O
Wheezing	NNP	B-PROBLEM
NOVOLOG	NNP	B-TREATMENT
(	(	I-TREATMENT
INSULIN	NNP	I-TREATMENT
ASPART	NNP	I-TREATMENT
)	)	I-TREATMENT
4	CD	O
UNITS	NNP	O
SC	NNP	O
AC	NNP	O

standing	VBG	B-TREATMENT
pre-meal	JJ	I-TREATMENT
novolog	NN	I-TREATMENT
.	.	O

NOVOLOG	NNP	B-TREATMENT
(	(	I-TREATMENT
INSULIN	NNP	I-TREATMENT
ASPART	NNP	I-TREATMENT
)	)	I-TREATMENT
Sliding	VBG	O
Scale	NNP	O
(	(	O
subcutaneously	RB	O
)	)	O
SC	NNP	O
AC	NNP	O

give	VB	O
in	IN	O
addition	NN	O
to	TO	O
standing	VBG	B-TREATMENT
pre-meal	JJ	I-TREATMENT
novolog	NN	I-TREATMENT
when	WRB	O
patient	NN	O
will	MD	O
eat	VB	O
and	CC	O
food	NN	O
is	VBZ	O
in	IN	O
the	DT	O
room	NN	O
.	.	O

If	IN	O
BS	NNP	B-TEST
is	VBZ	O
less	JJR	O
than	IN	O
125	CD	O
,	,	O
then	RB	O
give	VB	O
0	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
125-150	JJ	O
,	,	O
then	RB	O
give	VB	O
2	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
151-200	CD	O
,	,	O
then	RB	O
give	VB	O
3	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
201-250	JJ	O
,	,	O
then	RB	O
give	VB	O
4	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
251-300	JJ	O
,	,	O
then	RB	O
give	VB	O
6	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
301-350	JJ	O
,	,	O
then	RB	O
give	VB	O
8	CD	O
units	NNS	O
subcutaneously	RB	O
If	IN	O
BS	NNP	B-TEST
is	VBZ	O
351-400	CD	O
,	,	O
then	RB	O
give	VB	O
10	CD	O
units	NNS	O
subcutaneously	RB	O
and	CC	O
call	VB	O
HO	NNP	O
Call	NNP	O
HO	NNP	O
if	IN	O
BS	NNP	B-TEST
is	VBZ	O
greater	JJR	O
than	IN	O
400	CD	O
PROTONIX	NNP	B-TREATMENT
(	(	I-TREATMENT
PANTOPRAZOLE	NNP	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
MG	NNP	O
PO	NNP	O
DAILY	NNP	O
COMBIVENT	NNP	B-TREATMENT
(	(	I-TREATMENT
IPRATROPIUM	NNP	I-TREATMENT
AND	NNP	I-TREATMENT
ALBUTEROL	NNP	I-TREATMENT
SULFATE	NNP	I-TREATMENT
)	)	I-TREATMENT
2	CD	O
PUFF	NNP	O
INH	NNP	O
QID	NNP	O
FOSAMAX	NNP	B-TREATMENT
(	(	I-TREATMENT
ALENDRONATE	NNP	I-TREATMENT
)	)	I-TREATMENT
70	CD	O
MG	NNP	O
PO	NNP	O
QWEEK	NNP	O

Take	VB	O
with	IN	O
8	CD	O
oz	NN	O
of	IN	O
plain	JJ	O
water	NN	O
SPIRIVA	NNP	B-TREATMENT
(	(	I-TREATMENT
TIOTROPIUM	NNP	I-TREATMENT
)	)	I-TREATMENT
18	CD	O

walk	NN	O
with	IN	O
assist	JJ	O
per	IN	O
PT	NNP	B-TEST
eval	NN	I-TEST

COPD	NNP	B-PROBLEM
flare	NN	I-PROBLEM

Responsible	JJ	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
COPD	NNP	B-PROBLEM
flare	NN	I-PROBLEM

COPD	NNP	B-PROBLEM
(	(	I-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	VBP	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
)	)	I-PROBLEM
DM	NNP	B-PROBLEM
cervical	JJ	B-PROBLEM
DJD	NNP	I-PROBLEM
(	(	O
)	)	O
iron	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
(	(	I-PROBLEM
iron	JJ	I-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
)	)	I-PROBLEM
cervical	NN	B-PROBLEM
and	CC	I-PROBLEM
lumbar	NN	I-PROBLEM
djd	NN	I-PROBLEM
(	(	O
12	CD	O
)	)	O
osa	NN	B-PROBLEM
(	(	I-PROBLEM
sleep	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
)	)	I-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
tb	NN	B-TREATMENT
treatment	NN	I-TREATMENT
(	(	O
5	CD	O
)	)	O

weakness	NN	B-PROBLEM

75	CD	O
y	JJ	O
/	NNP	O
o	MD	O
F	NNP	O
with	IN	O
DM	NNP	B-PROBLEM
,	,	O
COPD	NNP	B-PROBLEM
on	IN	O
2L	CD	B-TREATMENT
NC	NNP	I-TREATMENT
and	CC	O
Bipap	NNP	B-TREATMENT
at	IN	O
night	NN	O
p	NN	O
/	NNP	O
w	VBZ	O
generalized	VBN	B-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
and	CC	O
shaking	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
increased	VBN	B-PROBLEM
sputum	NN	I-PROBLEM
production	NN	I-PROBLEM
.	.	O

Per	NNP	O
daughter	NN	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
typical	JJ	O
of	IN	O
COPD	NNP	B-PROBLEM
flare	NN	I-PROBLEM
.	.	O

REc&apos;d	NNP	O
duonebs	NN	B-TREATMENT
,	,	O
solumedrol	NN	B-TREATMENT
125	CD	O

t97.5	NN	O
,	,	O
hr	NN	B-TEST
117	CD	O
,	,	O
bp156/81	NN	O
,	,	O
rr28	NN	O
,	,	O
o2	JJ	B-TEST
sats	NNS	I-TEST
87%	CD	O
RA	NNP	O
;	:	O
95%	CD	O
4L	CD	O

NAD	NNP	B-PROBLEM
,	,	O
pleasant	NN	O
,	,	O
speaking	VBG	O
in	IN	O
complete	JJ	O
sentences	NNS	O
,	,	O
poor	JJ	B-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
L	NNP	O
&gt;	NNP	O
R	NNP	O
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rales	NNS	B-PROBLEM
,	,	O
rrr	NN	O
,	,	O
distant	NN	O
,	,	O
abd	JJ	O
benign	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
times	NNS	O
three	CD	O
,	,	O
no	DT	O
focal	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
conversant	JJ	O
Studies	NNS	O
:	:	O

-	:	O
EKG	NN	B-TEST
sinus	NN	O
92	CD	O
,	,	O
no	DT	O
ST	NNP	B-PROBLEM
changes	NNS	I-PROBLEM

-	:	O
CXR	NN	B-TEST
no	DT	O
focal	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
,	,	O
old	JJ	B-PROBLEM
biapical	JJ	I-PROBLEM
scarring	NN	I-PROBLEM
ABG	NNP	B-TEST
7.34/79/74	CD	O
U	NNP	B-TEST
/	VBD	I-TEST
A	DT	I-TEST
negative	JJ	O

improving	NN	O
,	,	O
but	CC	O
still	RB	B-PROBLEM
poor	JJ	I-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
,	,	O
diffusely	RB	B-PROBLEM
wheezy	VBP	I-PROBLEM
on	IN	O
exam	NN	B-TEST
,	,	O
at	IN	O
baseline	NN	O
2L	CD	B-TREATMENT
o2	NN	I-TREATMENT
requirement	NN	I-TREATMENT

75	CD	O
y	JJ	O
/	NNP	O
o	MD	O
F	NNP	O
with	IN	O
h	JJ	O
/	JJ	O
o	NN	O
COPD	NNP	B-PROBLEM
c	NN	O
/	NN	O
b	NN	O
frequent	JJ	B-PROBLEM
exacerbations	NNS	I-PROBLEM
p	VBP	O
/	JJ	O
w	JJ	O
typical	JJ	B-PROBLEM
flare	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

CV	NNP	O
-	:	O
Ischemia	NNP	B-PROBLEM
ASA	NNP	B-TREATMENT
,	,	O
lisinopril	JJ	B-TREATMENT
Pump	NNP	I-TREATMENT
no	DT	O
evidence	NN	O
of	IN	O
failure	NN	B-PROBLEM

Rhythm	NNP	O
Resp	NNP	O
-	:	O
COPD	NN	B-PROBLEM

flare	NN	B-PROBLEM
-	:	O
steroids	NNS	B-TREATMENT
,	,	O
cont	VBP	O
prednisone	NN	B-TREATMENT
60	CD	O
,	,	O
taper	JJR	O
slowly	RB	O
as	IN	O
tolerated	VBN	O
,	,	O
duonebs	NN	B-TREATMENT
,	,	O
advair	NN	B-TREATMENT
,	,	O
singulair	NN	B-TREATMENT
,	,	O
spiriva	NN	B-TREATMENT
,	,	O
claritin	NN	B-TREATMENT
azithromycin	NN	B-TREATMENT
for	IN	O
atypical	JJ	B-PROBLEM
bronchitis	NN	I-PROBLEM
to	TO	O
complete	VB	O
a	DT	O
5	CD	O
day	NN	O
course	NN	O
,	,	O
keep	VB	O
o2	JJ	B-TEST
sat	JJ	I-TEST
90-94	CD	O
,	,	O
home	NN	B-TREATMENT
nocturnal	JJ	I-TREATMENT
CPAP	NNP	I-TREATMENT
not	RB	O
tolerated	VBD	O
in	IN	O
house	NN	O
,	,	O
does	VBZ	O
well	RB	O
on	IN	O
nc	NNS	B-TREATMENT
,	,	O
appears	VBZ	O
ato	RB	O
be	VB	O
at	IN	O
baseline	NN	O

Cr	NNP	B-TEST
0.8	CD	O
,	,	O
stress	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
by	IN	O
symptoms	NNS	B-PROBLEM
with	IN	O
increased	JJ	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
uti	JJ	B-PROBLEM
,	,	O
cont	NN	O
to	TO	O
closely	RB	O
monitor	VB	O

GI	NNP	O
-	:	O
Bowel	NNP	B-TREATMENT
regimen	NNS	I-TREATMENT

Heme	NNP	O
-	:	O
Chronic	NNP	B-PROBLEM
Fe	NNP	I-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
cont	NN	O
iron	NN	B-TREATMENT

Endo	NNP	O
-	:	O
DM	NN	B-PROBLEM
on	IN	O
insulin	NN	B-TREATMENT
with	IN	O
steroids	NNS	B-TREATMENT

ID	NNP	O
-	:	O
afebrile	NN	B-PROBLEM
,	,	O
no	DT	O
wbc	NN	B-TEST
,	,	O
started	VBD	O
on	IN	O
Azithromycin	NNP	B-TREATMENT
for	IN	O
COPD	NNP	B-PROBLEM
flare	NN	I-PROBLEM

PPx	NNP	O
-	:	O
Lovenox	NNP	B-TREATMENT
,	,	O
PPI	NNP	B-TREATMENT

Dispo	NNP	O
-	:	O
to	TO	O
rehab	VB	O
when	WRB	O
resp	NN	B-PROBLEM
status	NN	I-PROBLEM
improved	VBN	O
,	,	O
PT	NNP	O
consulted	VBD	O

f	JJ	O
/	NNP	O
u	NN	O
with	IN	O
PCP	NNP	O
and	CC	O
Dr.	NNP	O
Pump	NNP	O
as	IN	O
scheduled	VBN	O
,	,	O
return	VB	O
to	TO	O
ED	NNP	O
with	IN	O
worsening	VBG	B-PROBLEM
sob	NN	I-PROBLEM
or	CC	O
increased	JJ	B-PROBLEM
cough	NN	I-PROBLEM
or	CC	O
sputum	NN	B-PROBLEM
production	NN	I-PROBLEM

DIZZINESS	NN	B-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
dizziness	NN	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

Benign	NNP	B-PROBLEM
positional	JJ	I-PROBLEM
vertigo	NN	I-PROBLEM
vs	NN	O
labyrinthitis	NN	B-PROBLEM

Head	NNP	B-TEST
CT	NNP	I-TEST
negative	JJ	O
.	.	O

Meclizine	NNP	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

Return	NN	O
to	TO	O
ED	NNP	O
or	CC	O
call	VB	O
PCP	NNP	O
if	IN	O
symptoms	NNS	B-PROBLEM
worsen	VBP	O
or	CC	O
if	IN	O
fever	VBN	B-PROBLEM
with	IN	O
headache	NN	B-PROBLEM
.	.	O

SWOLLEN	NNP	B-PROBLEM
PAINFUL	NNP	I-PROBLEM
L	NNP	I-PROBLEM
SIDE	NNP	I-PROBLEM
FC	NNP	I-PROBLEM

L	NNP	B-PROBLEM
upper	JJ	I-PROBLEM
lip	NN	I-PROBLEM
/	NNP	I-PROBLEM
L	NNP	I-PROBLEM
nostril	NN	I-PROBLEM
abscess	NN	I-PROBLEM

5	CD	O
cc	NN	O
of	IN	O
purulent	JJ	B-PROBLEM
material	NN	I-PROBLEM
drained	VBN	O
by	IN	O
needle	JJ	B-TREATMENT
aspiration	NN	I-TREATMENT

Augmentin	$	B-TREATMENT
875	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
for	IN	O
10	CD	O
days	NNS	O
.	.	O

Return	NNP	O
immediately	RB	O
for	IN	O
worsening	VBG	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
(	(	O
increased	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
pain	NN	B-PROBLEM
,	,	O
redness	NN	B-PROBLEM
)	)	O
or	CC	O
for	IN	O
any	DT	B-PROBLEM
neurologic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
(	(	O
blurry	NN	B-PROBLEM
or	CC	I-PROBLEM
double	JJ	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
headaches	NNS	B-PROBLEM
,	,	O
trouble	NN	B-PROBLEM
walking	NN	I-PROBLEM
,	,	O
etc	NN	O
)	)	O
.	.	O

Right	JJ	B-PROBLEM
parietal	NN	I-PROBLEM
occipital	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

5/5/05	CD	O
right	JJ	B-TREATMENT
parietal	NN	I-TREATMENT
occipital	JJ	I-TREATMENT
craniotomy	NN	I-TREATMENT
and	CC	O
debulking	NN	B-TREATMENT
of	IN	I-TREATMENT
tumor	NN	I-TREATMENT
using	VBG	O
stulz	JJ	B-TREATMENT
neuro	JJ	I-TREATMENT
navigation	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
83-year-old	JJ	O
retired	JJ	O
psychiatrist	NN	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
gait	NN	B-PROBLEM
difficulty	NN	I-PROBLEM
for	IN	O
the	DT	O
last	JJ	O
five	CD	O
to	TO	O
six	CD	O
months	NNS	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
laryngeal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
2000	CD	O
and	CC	O
2001	CD	O
,	,	O
CVA	NNP	B-PROBLEM
in	IN	O
2001	CD	O
to	TO	O
2002	CD	O
and	CC	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
has	VBZ	O
a	DT	O
six	CD	O
month	NN	O
history	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
difficulty	NN	I-PROBLEM
in	IN	I-PROBLEM
ambulation	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
previously	RB	O
good	JJ	O
health	NN	O
when	WRB	O
he	PRP	O
reports	VBZ	O
starting	VBG	O
to	TO	O
notice	VB	O
problems	NNS	B-PROBLEM
ambulating	VBG	I-PROBLEM
about	IN	O
six	CD	O
months	NNS	O
ago	RB	O
.	.	O

His	PRP$	O
partner	NN	O
also	RB	O
reports	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
been	VBN	O
having	VBG	O
more	RBR	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
ADLs	NNP	I-PROBLEM
.	.	O

He	PRP	O
reported	VBD	O
that	IN	O
he	PRP	O
began	VBD	O
with	IN	O
difficulty	NN	B-PROBLEM
buttoning	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
shirt	NN	I-PROBLEM
for	IN	O
many	JJ	O
years	NNS	O
since	IN	O
after	IN	O
a	DT	B-PROBLEM
stroke	NN	I-PROBLEM
but	CC	O
now	RB	O
reports	VBZ	O
that	IN	O
on	IN	O
occasion	NN	O
she	PRP	O
would	MD	O
ask	VB	O
him	PRP	O
why	WRB	O
he	PRP	O
was	VBD	O
doing	VBG	O
certain	JJ	O
things	NNS	O
and	CC	O
he	PRP	O
could	MD	O
not	RB	O
give	VB	O
a	DT	O
concrete	JJ	O
example	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
having	VBG	O
a	DT	B-PROBLEM
hard	JJ	I-PROBLEM
time	NN	I-PROBLEM
walking	VBG	I-PROBLEM
and	CC	O
reports	NNS	O
that	IN	O
he	PRP	O
has	VBZ	O
felt	VBN	O
weaker	NN	O
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
uncoordination	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
and	CC	O
began	VBD	O
having	VBG	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
four	CD	O
to	TO	O
five	CD	O
months	NNS	O
ago	RB	O
with	IN	O
the	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
seen	VBN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
who	WP	O
referred	VBD	O
him	PRP	O
to	TO	O
physical	JJ	O
therapy	NN	O
for	IN	O
his	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
weakness	NN	I-PROBLEM
but	CC	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
failed	VBD	O
to	TO	O
improve	VB	O
.	.	O

He	PRP	O
continued	VBD	O
to	TO	O
progress	VB	O
until	IN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
bathtub	NN	O
,	,	O
unsteady	JJ	B-PROBLEM
and	CC	O
fell	VBD	O
trying	VBG	O
to	TO	O
steady	VB	O
himself	PRP	O
.	.	O

Since	IN	O
that	DT	O
time	NN	O
he	PRP	O
had	VBD	O
been	VBN	O
ambulating	VBG	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
and	CC	O
has	VBZ	O
had	VBN	O
increasing	VBG	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
falls	NNS	I-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
two	CD	O
weeks	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
again	RB	O
seen	VBN	O
by	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
a	DT	B-TEST
CG	NNP	I-TEST
scan	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
the	DT	O
Neurology	NNP	O
Service	NNP	O
for	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
of	IN	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
denied	VBD	O
blurry	JJ	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
paresthesias	NN	B-PROBLEM
,	,	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
or	CC	O
seizures	NNS	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
resection	NN	B-TREATMENT
and	CC	O
reconstruction	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
laryngeal	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Positive	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

Hypertension	NN	B-PROBLEM
,	,	O
CVA	NNP	B-PROBLEM
2001	CD	O
,	,	O
2002	CD	O
diabetes	NNS	B-PROBLEM
,	,	O
laryngeal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
right	JJ	B-TREATMENT
CEA	NNP	I-TREATMENT
,	,	O
prostatectomy	NN	B-TREATMENT
for	IN	O
BPH	NNP	B-PROBLEM
,	,	O
total	JJ	B-TREATMENT
knee	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
.	.	O

Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
Lipitor	NNP	B-TREATMENT
40	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
HCTZ	NNP	B-TREATMENT
50	CD	O
mg	NN	O
,	,	O
Monopril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
Viagra	NNP	B-TREATMENT
100	CD	O
mg	NN	O
prn	NN	O
.	.	O

NKDA	NNP	B-PROBLEM
.	.	O

Father	NN	O
with	IN	O
CAD	NNP	B-PROBLEM
at	IN	O
90	CD	O
,	,	O
diabetes	NNS	B-PROBLEM
,	,	O
CVA	NNP	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

Afebrile	NNP	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
but	CC	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
164/80	CD	O
.	.	O

Generally	RB	O
a	DT	O
well	NN	O
developed	VBD	O
elderly	JJ	O
man	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
sitting	VBG	O
in	IN	O
bed	NN	O
.	.	O

No	DT	O
nystagmus	NN	B-PROBLEM
.	.	O

No	DT	O
retinal	JJ	B-PROBLEM
hemorrhages	NNS	I-PROBLEM
.	.	O

Moist	NNP	O
buccal	JJ	O
mucosa	NN	O
,	,	O
poor	JJ	B-PROBLEM
dentition	NN	I-PROBLEM
,	,	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	I-PROBLEM
exudates	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
pharynx	NN	I-PROBLEM
.	.	O

Prominent	JJ	B-PROBLEM
salivary	JJ	I-PROBLEM
glands	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

No	DT	O
other	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
noted	VBN	O
.	.	O

No	DT	O
cervical	JJ	B-PROBLEM
,	,	I-PROBLEM
para-auricular	JJ	I-PROBLEM
or	CC	I-PROBLEM
clavicular	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

Crackles	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
field	NN	I-PROBLEM
.	.	O

No	DT	O
egophony	NN	B-PROBLEM
.	.	O

no	DT	O
palpable	JJ	B-PROBLEM
thrill	NN	I-PROBLEM
or	CC	O
heave	NN	B-PROBLEM
.	.	O

3/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
best	JJS	O
at	IN	O
the	DT	O
apex	NN	O
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

No	DT	O
hepato	NN	B-PROBLEM
or	CC	O
splenomegaly	NN	B-PROBLEM
.	.	O

Right	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
scar	NN	I-PROBLEM
and	CC	O
inferior	JJ	B-PROBLEM
midline	NN	I-PROBLEM
scar	NN	I-PROBLEM
that	WDT	O
are	VBP	O
well	RB	O
healed	VBN	O
.	.	O

No	DT	O
CVA	NNP	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

No	DT	O
petechiae	NN	B-PROBLEM
.	.	O

Cranial	JJ	O
nerves	NNS	O
II	NNP	O
through	IN	O
XII	NNP	O
grossly	RB	O
intact	JJ	O
with	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
uvula	NN	I-PROBLEM
and	CC	I-PROBLEM
tongue	NN	I-PROBLEM
to	TO	O
the	DT	O
right	NN	O
.	.	O

There	EX	O
is	VBZ	O
increased	JJ	B-PROBLEM
tone	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
left	NN	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-PROBLEM
intention	NN	I-PROBLEM
tremor	NN	I-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
hand	NN	I-PROBLEM
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
on	IN	O
admission	NN	O
6.1	CD	O
,	,	O
INR	NNP	B-TEST
on	IN	O
admission	NN	O
1.0	CD	O
,	,	O
relevant	JJ	B-TEST
imaging	NN	I-TEST
.	.	O

Echocardiogram	NNP	B-TEST
June	NNP	O
2004	CD	O
showed	VBD	O
an	DT	B-TEST
EF	NNP	I-TEST
of	IN	O
77%	CD	O
.	.	O

Chest	NNP	B-TEST
xray	NN	I-TEST
reveals	VBZ	O
no	DT	O
consolidation	NN	B-PROBLEM
or	CC	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

CT	NN	B-TEST
shows	VBZ	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
hyperdense	NN	I-PROBLEM
and	CC	I-PROBLEM
heterogenously	RB	I-PROBLEM
enhancing	VBG	I-PROBLEM
mass	NN	I-PROBLEM
measuring	VBG	O
6.5	CD	O
x	JJ	O
5	CD	O
cm	NN	O
with	IN	O
the	DT	B-PROBLEM
surrounding	VBG	I-PROBLEM
vasogenic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	O
effacement	NN	O
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
.	.	O

The	DT	O
finding	NN	O
was	VBD	O
most	RBS	O
consistent	JJ	O
with	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
less	RBR	O
likely	JJ	O
primary	JJ	B-PROBLEM
CNS	NNP	I-PROBLEM
neoplasm	NN	I-PROBLEM
such	JJ	O
as	IN	O
glioblastoma	NN	B-PROBLEM
.	.	O

MRI	NNP	B-TEST
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
heterogenous	JJ	I-PROBLEM
enhancing	VBG	I-PROBLEM
right	JJ	I-PROBLEM
parietal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
a	DT	O
possible	JJ	O
ependymal	JJ	B-PROBLEM
spread	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Neurologic	NNP	O
Service	NNP	O
for	IN	O
workup	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

The	DT	O
neuro-oncologist	JJ	O
felt	NN	O
that	IN	O
because	IN	O
of	IN	O
the	DT	B-PROBLEM
tremendous	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
burden	NN	I-PROBLEM
that	WDT	O
was	VBD	O
likely	JJ	O
causing	VBG	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
the	DT	O
patient	NN	O
will	MD	O
require	VB	O
open	JJ	B-TREATMENT
debulking	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
obtaining	VBG	O
issue	NN	O
for	IN	O
a	DT	B-TEST
pathologic	JJ	I-TEST
diagnosis	NN	I-TEST
.	.	O

On	IN	O
May	NNP	O
5	CD	O
,	,	O
2005	CD	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
parietal	NN	I-TREATMENT
occipital	JJ	I-TREATMENT
craniotomy	NN	I-TREATMENT
and	CC	O
debulking	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
using	VBG	O
stulz	JJ	B-TREATMENT
neuro	JJ	I-TREATMENT
navigation	NN	I-TREATMENT
.	.	O

Please	NNP	O
see	VB	O
the	DT	O
separately	RB	O
dictated	JJ	O
operative	JJ	O
report	NN	O
for	IN	O
further	JJ	O
details	NNS	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

Of	IN	O
note	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
cardiology	NN	O
for	IN	O
preoperative	JJ	B-TEST
assessment	NN	I-TEST
.	.	O

A	DT	B-TEST
postoperative	JJ	I-TEST
MRI	NNP	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
no	DT	O
remarkable	JJ	B-PROBLEM
findings	NNS	I-PROBLEM
but	CC	O
only	RB	O
post	RB	B-PROBLEM
surgical	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

Transcranial	JJ	B-TEST
Dopplers	NNS	I-TEST
were	VBD	O
checked	VBN	O
following	VBG	O
surgery	NN	B-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Decadron	NNP	B-TREATMENT
4	CD	O
mg	NN	O
q6	NN	O
to	TO	O
prevent	VB	O
swelling	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Fragmin	NNP	B-TREATMENT
for	IN	O
DVT	NNP	B-TREATMENT
prophylaxis	NN	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
Dilantin	NNP	B-TEST
levels	NNS	I-TEST
.	.	O

Of	IN	O
note	NN	O
on	IN	O
5/9/05	CD	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
Urology	NNP	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
inability	NN	I-PROBLEM
to	TO	I-PROBLEM
void	VB	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
16	CD	I-TREATMENT
French	JJ	I-TREATMENT
Coude	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

The	DT	O
patient	NN	O
then	RB	O
was	VBD	O
given	VBN	O
voiding	VBG	B-TREATMENT
trials	NNS	I-TREATMENT
but	CC	O
eventually	RB	O
he	PRP	O
needed	VBD	O
to	TO	O
be	VB	O
straight	VBN	O
cathed	JJ	O
prn	NN	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
a	DT	B-TREATMENT
16	CD	I-TREATMENT
Coude	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
in	IN	O
place	NN	O
and	CC	O
draining	VBG	O
well	RB	O
.	.	O

The	DT	O
patient	NN	O
can	MD	O
have	VB	O
voiding	VBG	B-TREATMENT
trials	NNS	I-TREATMENT
at	IN	O
rehab	NN	O
and	CC	O
he	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
Flomax	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	O
relatively	RB	O
unremarkable	JJ	O
course	NN	O
and	CC	O
his	PRP$	O
neurologic	JJ	O
status	NN	O
continued	VBD	O
to	TO	O
improve	VB	O
following	VBG	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

On	IN	O
5/11/05	CD	O
repeat	NN	B-TEST
imaging	NN	I-TEST
revealed	VBD	O
some	DT	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
mass	NN	B-PROBLEM
affect	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
IV	NNP	I-TREATMENT
load	NN	I-TREATMENT
of	IN	I-TREATMENT
Decadron	NNP	I-TREATMENT
and	CC	O
restarted	VBN	O
on	IN	O
IV	NNP	B-TREATMENT
Decadron	NNP	I-TREATMENT
which	WDT	O
was	VBD	O
eventually	RB	O
transferred	VBN	O
to	TO	O
po	VB	B-TREATMENT
Decadron	NNP	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
Mannitol	NNP	B-TREATMENT
.	.	O

His	PRP$	B-TEST
pathology	NN	I-TEST
came	VBD	O
back	RB	O
as	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
grade	NN	I-PROBLEM
IV	NNP	I-PROBLEM
glioma	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
initially	RB	O
controlled	VBN	O
with	IN	O
IV	NNP	B-TREATMENT
pain	VBP	I-TREATMENT
medications	NNS	I-TREATMENT
but	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
to	TO	O
the	DT	O
rehab	NN	O
facility	NN	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
control	VB	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
po	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-TEST
postoperative	JJ	I-TEST
serum	NN	I-TEST
sodium	NN	I-TEST
in	IN	O
the	DT	O
120s	CD	O
from	IN	O
the	DT	O
130s	CD	O
three	CD	O
days	NNS	O
postoperatively	RB	O
.	.	O

An	DT	O
endocrine	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
to	TO	O
help	VB	O
manage	VB	O
his	PRP$	B-TEST
serum	NN	I-TEST
electrolytes	NNS	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
three	CD	O
grams	NNS	O
of	IN	O
sodium	NN	B-TREATMENT
,	,	O
3x	CD	O
a	DT	O
day	NN	O
with	IN	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
his	PRP$	B-TEST
sodium	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
followed	VBN	O
and	CC	O
by	IN	O
5/12/05	CD	O
his	PRP$	B-TEST
plasma	NN	I-TEST
sodium	NN	I-TEST
was	VBD	O
back	RB	O
to	TO	O
136	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
off	RP	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

On	IN	O
5/14/05	CD	O
Mannitol	NNP	B-TREATMENT
was	VBD	O
tapered	VBN	O
and	CC	O
then	RB	O
d	VB	O
/	NNP	O
c&apos;d.	NN	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
needed	VBN	O
only	RB	O
physical	JJ	B-TREATMENT
and	CC	I-TREATMENT
occupational	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
hard	JJ	B-PROBLEM
of	IN	I-PROBLEM
hearing	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
complaints	NNS	B-PROBLEM
of	IN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

1.	CD	O
Lipitor	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

2.	CD	O
Captopril	NNP	B-TREATMENT
12.5	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

3.	CD	O
Nexium	NNP	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

4.	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

5.	CD	O
Ativan	NNP	B-TREATMENT
0.5	CD	O
mg	NN	O
po	NN	O
q4	NN	O
hours	NNS	O
prn	VBP	O
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

6.	CD	O
Allegra	NNP	B-TREATMENT
60	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

7.	CD	O
Dilantin	NNP	B-TREATMENT
100	CD	O
mg	NN	O
IV	NNP	O
tid	NN	O
which	WDT	O
can	MD	O
be	VB	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
po	JJ	I-TREATMENT
regimen	NN	I-TREATMENT
in	IN	O
seven	CD	O
days	NNS	O
.	.	O

8.	CD	O
Zinc	NNP	B-TREATMENT
220	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

9.	CD	O
Vitamin	NNP	B-TREATMENT
C	NNP	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

10.	CD	O
Flomax	NNP	B-TREATMENT
0.4	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

11.	CD	O
Fragmin	NNP	B-TREATMENT
2500	CD	O
units	NNS	O
subcut	VBD	O
every	DT	O
day	NN	O
.	.	O

12.	CD	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q	JJ	O
daily	JJ	O
x10	NNP	O
days	NNS	O
.	.	O

13.	CD	O
Dexamethasone	CD	B-TREATMENT
4	CD	O
mg	NN	O
po	NN	O
q6	NN	O
hours	NNS	O
.	.	O

14.	CD	O
The	DT	B-TREATMENT
steroid	NN	I-TREATMENT
will	MD	O
be	VB	O
kept	VBN	O
for	IN	O
now	RB	O
and	CC	O
tapered	VBN	O
at	IN	O
a	DT	O
later	JJ	O
date	NN	O
on	IN	O
follow	VB	O
up	RP	O
with	IN	O
Dr.	NNP	O
Coma	NNP	O
.	.	O

15.	CD	O
Regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
finger	NN	O
sticks	NNS	O
qac	NN	O
and	CC	O
qhs	NN	O
.	.	O

16.	CD	O
Neutra-Phos	JJ	B-TREATMENT
1.25	CD	O
grams	NNS	O
po	VBP	O
as	IN	O
needed	VBN	O
.	.	O

The	DT	B-TREATMENT
staples	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
asked	VBN	O
to	TO	O
see	VB	O
a	DT	O
physician	JJ	O
immediately	RB	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
nearest	JJS	O
emergency	NN	O
room	NN	O
if	IN	O
any	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
wound	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
fever	RB	B-PROBLEM
greater	JJR	O
than	IN	O
100.8	CD	O
,	,	O
intractable	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	I-PROBLEM
vomiting	NN	I-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
,	,	O
pain	NN	B-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
occurs	NNS	O
.	.	O

The	DT	O
patient	NN	O
instructed	VBD	O
to	TO	O
call	VB	O
Dr.	NNP	O
Coma	NNP	O
&apos;s	NNP	O
office	NN	O
at	IN	O
496-260-3297	JJ	O
to	TO	O
arrange	VB	O
for	IN	O
a	DT	O
follow	JJ	O
up	RP	O
appointment	NN	O
in	IN	O
the	DT	O
Saintaelfoote	NNP	O
Hospital	NNP	O
at	IN	O
the	DT	O
first	JJ	O
available	JJ	O
time	NN	O
,	,	O
one	CD	O
to	TO	O
two	CD	O
months	NNS	O
after	IN	O
surgery	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
asked	VBN	O
to	TO	O
take	VB	O
a	DT	O
course	NN	O
of	IN	O
Dilantin	NNP	B-TREATMENT
for	IN	O
ten	RB	O
more	JJR	O
days	NNS	O
.	.	O

Pancreatic	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

Laparoscopy	NN	B-TEST
with	IN	O
biopsy	NN	B-TEST
for	IN	O
diagnosis	NN	O
.	.	O

Ms.	NNP	O
Sterpkoteneish	NNP	O
is	VBZ	O
a	DT	O
69-year-old	JJ	O
woman	NN	O
,	,	O
who	WP	O
over	IN	O
the	DT	O
past	JJ	O
six	CD	O
months	NNS	O
has	VBZ	O
noted	VBN	O
increasing	VBG	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
the	DT	O
back	NN	O
.	.	O

She	PRP	O
described	VBD	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
being	VBG	O
exacerbated	VBN	O
by	IN	O
eating	VBG	O
and	CC	O
described	VBD	O
an	DT	B-PROBLEM
associated	JJ	I-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

She	PRP	O
presented	VBD	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Tlandtaze	NNP	O
,	,	O
in	IN	O
Aersing	NNP	O
Rocuch	NNP	O
Sun	NNP	O
,	,	O
who	WP	O
obtained	VBD	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
,	,	O
which	WDT	O
demonstrated	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	O
the	DT	O
tail	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
referred	VBN	O
to	TO	O
the	DT	O
Fairm	NNP	O
of	IN	O
Ijordcompmac	NNP	O
Hospital	NNP	O
under	IN	O
the	DT	O
El	NNP	O
Memorial	NNP	O
and	CC	O
was	VBD	O
seen	VBN	O
by	IN	O
Dr.	NNP	O
Blinjesc	NNP	O
,	,	O
who	WP	O
scheduled	VBD	O
her	PRP	O
for	IN	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparoscopy	NN	I-TEST
.	.	O

Is	VBZ	O
significant	JJ	O
for	IN	O
spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
series	NN	O
of	IN	O
operations	NNS	B-TREATMENT
including	VBG	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
ureteral	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
;	:	O
cataract	JJ	B-TREATMENT
implants	NNS	I-TREATMENT
;	:	O
two	CD	B-TREATMENT
partial	JJ	I-TREATMENT
hysterectomies	NNS	I-TREATMENT
;	:	O
and	CC	O
an	DT	B-TREATMENT
appendectomy	NN	I-TREATMENT
.	.	O

Oxycontin	$	B-TREATMENT
10	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
.	.	O

Darvocet	NNP	B-TREATMENT
.	.	O

Estratab	NNP	B-TREATMENT
.	.	O

Aspirin	$	B-TREATMENT
325	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
150/86	CD	O
;	:	O
pulse	JJ	B-TEST
82	CD	O
;	:	O
respirations	NNS	B-TEST
16	CD	O
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

regular	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
;	:	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

soft	JJ	O
;	:	O
nontender	CC	O
;	:	O
no	DT	O
palpable	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
through	IN	O
same	JJ	O
day	NN	O
surgery	NN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
Dr.	NNP	O
Blinjesc	NNP	O
,	,	O
assisted	VBN	O
by	IN	O
Dr.	NNP	O
Zockbeathe	NNP	O
,	,	O
performed	VBD	O
a	DT	B-TEST
diagnostic	JJ	I-TEST
laparoscopy	NN	I-TEST
with	IN	O
peritoneal	JJ	B-TREATMENT
washings	NNS	I-TREATMENT
.	.	O

Findings	NNS	O
included	VBD	O
no	DT	B-PROBLEM
gross	JJ	I-PROBLEM
evidence	NN	I-PROBLEM
seating	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
abdominal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
;	:	O
one	CD	B-PROBLEM
nodule	NN	I-PROBLEM
on	IN	O
the	DT	O
posterior	JJ	O
surface	NN	O
of	IN	O
the	DT	O
right	JJ	O
lobe	NN	O
of	IN	O
the	DT	O
liver	NN	O
;	:	O
one	CD	B-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
inferior	JJ	O
edge	NN	O
of	IN	O
the	DT	O
falciform	NN	O
ligament	NN	O
.	.	O

Specimens	NNS	B-TEST
sent	VBD	O
to	TO	O
pathology	VB	O
included	JJ	O
peritoneal	JJ	B-TEST
washings	NNS	I-TEST
and	CC	O
permanent	JJ	B-TEST
specimens	NNS	I-TEST
from	IN	I-TEST
the	DT	I-TEST
liver	NN	I-TEST
and	CC	O
falciform	NN	B-PROBLEM
nodules	NNS	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

Postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
some	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
bloating	NN	I-PROBLEM
with	IN	O
evidence	NN	O
of	IN	O
subcutaneous	JJ	B-PROBLEM
emphysema	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
uncomfortable	JJ	B-PROBLEM
and	CC	O
slow	JJ	O
to	TO	O
have	VB	O
bowel	NN	O
movements	NNS	O
,	,	O
although	IN	O
she	PRP	O
did	VBD	O
have	VB	O
flatus	NN	O
.	.	O

She	PRP	O
tolerated	VBD	O
a	DT	O
full	JJ	O
diet	NN	O
well	RB	O
,	,	O
but	CC	O
continued	VBD	O
to	TO	O
have	VB	O
abdominal	JJ	B-PROBLEM
cramping	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
ileus	NN	I-PROBLEM
for	IN	O
the	DT	O
following	JJ	O
three	CD	O
days	NNS	O
.	.	O

She	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
repeated	VBN	B-TREATMENT
Fleet	NNP	I-TREATMENT
&apos;s	NNP	I-TREATMENT
enemas	NN	I-TREATMENT
,	,	O
and	CC	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	O
number	NN	O
of	IN	O
bowel	NN	O
movements	NNS	O
,	,	O
was	VBD	O
considerably	RB	O
more	RBR	O
comfortable	JJ	O
,	,	O
and	CC	O
deemed	VBD	O
ready	JJ	O
for	IN	O
discharge	NN	O
.	.	O

Included	NNP	O
aspirin	VBZ	B-TREATMENT
325	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
.	.	O

Percocet	NNP	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
whenever	WRB	O
necessary	JJ	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

Estratab	NNP	B-TREATMENT
one	CD	O
PO	NNP	O
q.day	NN	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
cytopathology	NN	B-TEST
specimens	NNS	I-TEST
had	VBD	O
been	VBN	O
negative	JJ	O
,	,	O
and	CC	O
surgical	JJ	B-TEST
pathology	NN	I-TEST
specimens	NNS	I-TEST
were	VBD	O
still	RB	O
pending	VBG	O
.	.	O

She	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
call	VB	O
Dr.	NNP	O
Blinjesc	NNP	O
for	IN	O
the	DT	O
results	NNS	O
of	IN	O
these	DT	B-TEST
tests	NNS	I-TEST
and	CC	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
him	PRP	O
for	IN	O
further	JJ	O
management	NN	O
if	IN	O
necessary	JJ	O
.	.	O

HO	NNP	B-TEST
evaluation	NN	I-TEST

DOCUSATE	NNP	B-TREATMENT
SODIUM	NNP	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PRN	NNP	O
IBUPROFEN	NNP	B-TREATMENT
200-600	JJ	O
MG	NNP	O
PO	NNP	O
Q4-6H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

OB	NNP	O
Clinic	NNP	O
2	CD	O
weeks	NNS	O
and	CC	O
6	CD	O
weeks	NNS	O
,	,	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNS	I-PROBLEM

postdates	NNS	B-PROBLEM
pregnancy	NN	I-PROBLEM

Responsible	JJ	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
s	VBP	O
/	JJ	O
p	NN	O
NSVD	NNP	B-PROBLEM

Post	NN	B-PROBLEM
dates	NNS	I-PROBLEM

Initial	JJ	B-TEST
newborn	JJ	I-TEST
exam	NN	I-TEST
:	:	O

No	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

Apgars	NNS	B-TEST
8,9	CD	O

Weight	NN	B-TEST
:	:	O

Nothing	NN	O
in	IN	O
the	DT	O
vagina	NN	O
for	IN	O
6	CD	O
weeks	NNS	O
-	:	O
no	DT	O
tampons	NNS	B-TREATMENT
,	,	O
no	DT	O
douching	NN	B-TREATMENT
,	,	O
no	DT	O
intercourse	NN	O
.	.	O

If	IN	O
you	PRP	O
experience	VBP	O
fever	RB	B-PROBLEM
&gt;	RB	O
100.4	CD	O
,	,	O
bleeding	VBG	B-PROBLEM
&gt;	JJ	O
1	CD	O
pad	NN	O
/	FW	O
hour	NN	O
,	,	O
foul	JJ	B-PROBLEM
smelling	VBG	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
call	VB	O
your	PRP$	O
doctor	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

RIGHT	NNP	B-PROBLEM
OCCIPITAL	NNP	I-PROBLEM
HEMORRHAGIC	NNP	I-PROBLEM
STROKE	NNP	I-PROBLEM
.	.	O

Right	JJ	B-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhagic	NN	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

Ms.	NNP	O
Tlandkotesmitskote	NNP	O
is	VBZ	O
a	DT	O
patient	NN	O
who	WP	O
came	VBD	O
complaining	NN	O
of	IN	O
feeling	VBG	O
dizzy	NN	B-PROBLEM
and	CC	O
bumping	VBG	O
into	IN	O
objects	NNS	O
on	IN	O
her	PRP$	O
left	JJ	O
side	NN	O
.	.	O

She	PRP	O
is	VBZ	O
a	DT	O
seventy-one	JJ	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
is	VBZ	O
in	IN	O
otherwise	RB	O
good	JJ	O
health	NN	O
.	.	O

She	PRP	O
also	RB	O
felt	VBD	O
dizzy	JJ	B-PROBLEM
and	CC	O
the	DT	O
room	NN	O
was	VBD	O
spinning	VBG	O
.	.	O

She	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
a	DT	B-PROBLEM
dull	NN	I-PROBLEM
,	,	I-PROBLEM
right	RB	I-PROBLEM
sided	VBD	I-PROBLEM
headache	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
eyebrow	NN	I-PROBLEM
.	.	O

Symptoms	NNS	B-PROBLEM
lasted	VBD	O
about	IN	O
five	CD	O
hours	NNS	O
and	CC	O
then	RB	O
gradually	RB	O
resolved	VBN	O
except	IN	O
for	IN	O
the	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
.	.	O

She	PRP	O
denied	VBD	O
having	VBG	O
any	DT	O
weakness	NN	B-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
,	,	O
or	CC	O
pain	NN	B-PROBLEM
.	.	O

She	PRP	O
also	RB	O
denies	VBZ	O
having	VBG	O
hoarseness	NN	B-PROBLEM
,	,	O
difficulties	NNS	B-PROBLEM
in	IN	I-PROBLEM
finding	VBG	I-PROBLEM
words	NNS	I-PROBLEM
,	,	O
speaking	NN	O
,	,	O
hiccups	NNS	B-PROBLEM
,	,	O
or	CC	O
diplopia	NN	B-PROBLEM
.	.	O

The	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
hypertension	NN	B-PROBLEM
.	.	O

Atenolol	NNP	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
PO	NNP	O
qd	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

On	IN	O
review	NN	O
of	IN	O
systems	NNS	O
,	,	O
the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
history	NN	O
of	IN	O
transient	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
attacks	NNS	I-PROBLEM
.	.	O

Father	NNP	O
and	CC	O
mother	RB	O
died	VBD	O
in	IN	O
their	PRP$	O
eighties	NNS	O
of	IN	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

On	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
she	PRP	O
was	VBD	O
a	DT	O
very	RB	O
pleasant	JJ	O
,	,	O
moderately	RB	O
obese	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

The	DT	O
head	NN	O
was	VBD	O
normocephalic	JJ	O
and	CC	O
atraumatic	JJ	B-PROBLEM
.	.	O

The	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
without	IN	O
rales	NNS	B-PROBLEM
or	CC	O
wheezes	NNS	B-PROBLEM
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

Extremities	NNS	O
revealed	VBD	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

The	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
to	TO	O
person	NN	O
,	,	O
place	NN	O
and	CC	O
time	NN	O
.	.	O

She	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
subtract	VB	O
serial	JJ	O
sevens	NNS	O
,	,	O
remember	VB	O
three	CD	O
out	IN	O
of	IN	O
three	CD	O
objects	NNS	O
after	IN	O
five	CD	O
minutes	NNS	O
,	,	O
and	CC	O
there	RB	O
was	VBD	O
notable	JJ	B-PROBLEM
aphasia	NN	I-PROBLEM
or	CC	O
word	NN	B-PROBLEM
finding	NN	I-PROBLEM
difficulty	NN	I-PROBLEM
.	.	I-PROBLEM

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
dense	JJ	I-PROBLEM
hemianopsia	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

Sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pin	NN	B-TEST
prick	NN	I-TEST
bilaterally	RB	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
.	.	O

Sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
,	,	O
pin	NN	B-TEST
prick	NN	I-TEST
,	,	O
and	CC	O
proprioception	NN	B-TEST
.	.	O

Cerebellar	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
in	IN	O
intention	NN	B-PROBLEM
tremor	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
considerable	JJ	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
left	JJ	I-PROBLEM
finger-to-nose	JJ	I-PROBLEM
movement	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
hemianopsia	VB	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
nystagmus	NN	B-PROBLEM
,	,	O
except	IN	O
for	IN	O
some	DT	B-PROBLEM
fine	JJ	I-PROBLEM
fast	JJ	I-PROBLEM
beat	NN	I-PROBLEM
nystagmus	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
extremes	NNS	I-PROBLEM
of	IN	I-PROBLEM
abduction	NN	I-PROBLEM
.	.	O

patient	NN	O
had	VBD	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
tandem	JJ	I-PROBLEM
gait	NN	I-PROBLEM
and	CC	O
fell	VBD	O
forward	RB	O
while	IN	O
standing	VBG	O
on	IN	O
his	PRP$	O
his	PRP$	O
toes	NNS	O
.	.	O

Laboratory	NN	O
studies	NNS	O
on	IN	O
admission	NN	O
demonstrated	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
144	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
bicarbonate	NN	B-TEST
20.0	CD	O
,	,	O
BUN	NNP	B-TEST
and	CC	O
creatinine	VB	B-TEST
12/0.7	CD	O
,	,	O
glucose	RB	B-TEST
99	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
5.7	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
40.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
226	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
was	VBD	O
9.4	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
was	VBD	O
29	CD	O
.	.	O

The	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
seventy-one	JJ	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
now	RB	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
occipital	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
work	NN	B-TEST
up	RB	I-TEST
.	.	O

However	RB	O
,	,	O
she	PRP	O
was	VBD	O
soon	RB	O
moved	VBN	O
out	IN	O
of	IN	O
there	EX	O
as	IN	O
her	PRP$	B-TEST
examination	NN	I-TEST
appeared	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
.	.	O

A	DT	O
Neurosurgery	NNP	O
Service	NNP	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
no	DT	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
was	VBD	O
required	VBN	O
.	.	O

The	DT	O
patient	NN	O
underwent	NN	O
a	DT	O
number	NN	O
of	IN	O
tests	NNS	B-TEST
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
performed	VBD	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
clear	JJ	B-PROBLEM
enhancing	VBG	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
but	CC	O
follow	VBP	O
up	RP	O
was	VBD	O
suggested	VBN	O
.	.	O

So	RB	O
an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
MRA	NNP	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
ICA	NNP	I-PROBLEM
just	RB	O
distal	NN	O
to	TO	O
the	DT	O
bifurcation	NN	O
.	.	O

There	EX	O
was	VBD	O
also	RB	O
scattered	VBN	B-PROBLEM
T2	NNP	I-PROBLEM
hyperintense	NN	I-PROBLEM
foci	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
frontal	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
consistent	NN	O
with	IN	O
small	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
gliosis	NN	B-PROBLEM
or	CC	O
demyelination	NN	B-PROBLEM
.	.	O

A	DT	B-TEST
Holter	NNP	I-TEST
monitor	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

The	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
53	CD	O
to	TO	O
106	CD	O
.	.	O

There	EX	O
were	VBD	O
some	DT	B-PROBLEM
very	RB	I-PROBLEM
rare	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
premature	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
ventricular	JJ	B-PROBLEM
premature	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
.	.	O

An	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
that	IN	O
the	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
60%	CD	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
thrombus	NN	B-PROBLEM
.	.	O

Over	IN	O
the	DT	O
ensuing	JJ	O
days	NNS	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
confusion	NN	B-PROBLEM
at	IN	O
night	NN	O
.	.	O

She	PRP	O
also	RB	O
developed	VBD	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
urinary	JJ	B-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
was	VBD	O
placed	VBN	O
on	IN	O
PO	NNP	B-TREATMENT
Bactrim	NNP	I-TREATMENT
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

She	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
dense	NN	I-PROBLEM
left	VBD	I-PROBLEM
hemianopsia	NN	I-PROBLEM
,	,	O
but	CC	O
otherwise	RB	O
was	VBD	O
neurologically	RB	O
intact	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
Tenormin	NNP	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
PO	NNP	O
qd	NN	O
;	:	O
Bactrim	NNP	B-TREATMENT
DS	NNP	I-TREATMENT
,	,	O
one	CD	O
PO	NNP	O
bid	NN	O
x5	NNP	O
days	NNS	O
.	.	O

DEEP	NNP	B-PROBLEM
VENOUS	NNP	I-PROBLEM
THROMBOSIS	NNP	I-PROBLEM
OF	NNP	I-PROBLEM
RIGHT	NNP	I-PROBLEM
LOWER	NNP	I-PROBLEM
EXTREMITY	NNP	I-PROBLEM
.	.	O

Deep	NNP	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

Metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
second	JJ	O
Fairm	NNP	O
of	IN	O
Ijordcompmac	NNP	O
Hospital	NNP	O
admission	NN	O
for	IN	O
Taroby	NNP	O
Patient	NNP	O
,	,	O
a	DT	O
70	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
.	.	O

His	PRP$	B-PROBLEM
melanoma	NN	I-PROBLEM
was	VBD	O
originally	RB	O
diagnosed	VBN	O
last	JJ	O
fall	NN	O
when	WRB	O
he	PRP	O
presented	VBD	O
with	IN	O
lesions	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
and	CC	I-PROBLEM
spleen	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-TEST
chest	NN	I-TEST
CT	NN	I-TEST
showed	VBD	O
left	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
.	.	O

A	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
was	VBD	O
negative	JJ	O
,	,	O
but	CC	O
an	DT	B-TEST
MRI	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
spine	NN	I-TEST
showed	VBD	O
an	DT	O
L5	NNP	B-PROBLEM
metastasis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
and	CC	O
had	VBD	O
with	IN	O
epidural	JJ	B-PROBLEM
and	CC	I-PROBLEM
paraspinal	JJ	I-PROBLEM
extension	NN	I-PROBLEM
.	.	O

In	IN	O
addition	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
T11	NNP	I-PROBLEM
metastasis	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

Approximately	RB	O
one	CD	O
week	NN	O
ago	RB	O
,	,	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Fairm	NNP	O
of	IN	O
Ijordcompmac	NNP	O
Hospital	NNP	O
for	IN	O
chemotherapy	NN	B-TREATMENT
with	IN	O
DTIC	NNP	B-TREATMENT
and	CC	O
Tamoxifen	NNP	B-TREATMENT
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
he	PRP	O
also	RB	O
began	VBD	O
radiation	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
his	PRP$	O
lumbosacral	JJ	O
spine	NN	O
.	.	O

He	PRP	O
is	VBZ	O
continuing	VBG	O
on	IN	O
the	DT	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
date	NN	O
.	.	O

On	IN	O
February	NNP	O
23	CD	O
,	,	O
Mr.	NNP	O
Patient	NNP	O
presented	VBD	O
to	TO	O
Dr.	NNP	O
Patient	NNP	O
&apos;s	NNP	O
office	NN	O
with	IN	O
two	CD	B-PROBLEM
major	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

First	RB	O
,	,	O
he	PRP	O
had	VBD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
and	CC	O
lower	JJR	B-TEST
extremity	NN	I-TEST
noninvasives	NNS	I-TEST
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
of	IN	O
a	DT	B-PROBLEM
femoral	JJ	I-PROBLEM
deep	JJ	I-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

Second	JJ	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
witnessed	JJ	I-PROBLEM
episode	NN	I-PROBLEM
in	IN	O
which	WDT	O
his	PRP$	O
eyes	NNS	O
rolled	VBD	O
to	TO	O
the	DT	O
back	NN	O
of	IN	O
his	PRP$	O
head	NN	O
and	CC	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
some	DT	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
has	VBZ	O
not	RB	O
been	VBN	O
known	VBN	O
to	TO	O
have	VB	O
a	DT	O
history	NN	O
of	IN	O
CNS	NNP	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

The	DT	O
episode	NN	O
of	IN	O
potential	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
occurred	VBD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
a	DT	O
bowel	NN	O
movement	NN	O
and	CC	O
may	MD	O
have	VB	O
been	VBN	O
associated	VBN	O
with	IN	O
vasovagal	JJ	B-PROBLEM
activity	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
is	VBZ	O
negative	JJ	O
,	,	O
except	IN	O
as	IN	O
above	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
reveals	VBZ	O
a	DT	O
pleasant	NN	O
70	CD	O
year	NN	O
old	JJ	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
113/70	CD	O
,	,	O
pulse	RB	B-TEST
66	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
96.8	CD	O
.	.	O

HEENT	NNP	B-TEST
showed	VBD	O
pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
and	CC	O
extra	JJ	O
ocular	JJ	O
movements	NNS	O
intact	JJ	O
.	.	O

The	DT	O
neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
without	IN	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
or	CC	O
increased	VBN	B-PROBLEM
thyroid	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
appreciable	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
,	,	I-PROBLEM
supraclavicular	JJ	I-PROBLEM
,	,	I-PROBLEM
axillary	JJ	I-PROBLEM
,	,	I-PROBLEM
or	CC	I-PROBLEM
inguinal	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

The	DT	O
chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
I	PRP	I-PROBLEM
/	VBP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
extremity	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
extending	VBG	O
to	TO	O
the	DT	O
knee	NN	O
.	.	O

The	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

Mr.	NNP	O
Patient	NNP	O
underwent	JJ	O
venogram	NN	B-TEST
and	CC	O
inferior	JJ	B-TREATMENT
vena	NN	I-TREATMENT
cava	NN	I-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
on	IN	O
February	NNP	O
23	CD	O
,	,	O
1993	CD	O
and	CC	O
was	VBD	O
then	RB	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Fairm	NNP	O
of	IN	O
Ijordcompmac	NNP	O
Hospital	NNP	O
for	IN	O
postoperative	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

He	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
second	JJ	O
major	JJ	O
event	NN	O
that	WDT	O
had	VBD	O
occurred	VBN	O
yesterday	NN	O
was	VBD	O
a	DT	B-PROBLEM
neurologic	JJ	I-PROBLEM
event	NN	I-PROBLEM
of	IN	O
some	DT	O
kind	NN	O
.	.	O

Over	IN	O
the	DT	O
24	CD	O
hours	NNS	O
of	IN	O
in	IN	O
house	NN	O
hospitalization	NN	O
,	,	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
neurologic	JJ	I-PROBLEM
activity	NN	I-PROBLEM
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
ambulate	VB	O
without	IN	O
assistance	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

He	PRP	O
will	MD	O
be	VB	O
scheduled	VBN	O
for	IN	O
an	DT	B-TEST
MRI	NNP	I-TEST
scan	NN	I-TEST
,	,	O
Neurology	NNP	B-TEST
consult	NN	I-TEST
,	,	O
and	CC	O
an	DT	B-TEST
EEG	NNP	I-TEST
next	JJ	O
week	NN	O
as	IN	O
an	DT	O
out	IN	O
patient	NN	O
.	.	O

Mr.	NNP	O
Patient	NNP	O
was	VBD	O
a	DT	O
poor	JJ	O
candidate	NN	O
for	IN	O
anticoagulation	NN	B-TREATMENT
because	IN	O
of	IN	O
his	PRP$	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
and	CC	O
the	DT	O
question	NN	O
of	IN	O
CNS	NNP	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

An	DT	B-TREATMENT
IVC	NNP	I-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
was	VBD	O
accomplished	VBN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

IVC	NNP	B-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

Decadron	NNP	B-TREATMENT
4	CD	O
mg	NN	O
PO	NNP	O
bid	NN	O
,	,	O
Dilantin	NNP	B-TREATMENT
100	CD	O
mg	NN	O
PO	NNP	O
tid	NN	O
.	.	O

atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

ALBUTEROL	NNP	B-TREATMENT
INHALER	NNP	I-TREATMENT
2	CD	O
PUFF	NNP	O
INH	NNP	O
QID	NNP	O

PLEASE	NNP	O
USE	NNP	O
WITH	NNP	O
SPACER	NNP	B-TREATMENT
(	(	O
PLEASE	NNP	O
INSTRUCT	NNP	O
PATIENT	NNP	O
)	)	O
ECASA	NNP	B-TREATMENT
(	(	I-TREATMENT
ASPIRIN	NNP	I-TREATMENT
ENTERIC	NNP	I-TREATMENT
COATED	NNP	I-TREATMENT
)	)	I-TREATMENT
325	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
WELLBUTRIN	NNP	B-TREATMENT
(	(	I-TREATMENT
BUPROPION	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
GEMFIBROZIL	NNP	B-TREATMENT
600	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
ZESTRIL	NNP	B-TREATMENT
(	(	I-TREATMENT
LISINOPRIL	NNP	I-TREATMENT
)	)	I-TREATMENT
20	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
ZANTAC	NNP	B-TREATMENT
(	(	I-TREATMENT
RANITIDINE	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
SERZONE	NNP	B-TREATMENT
(	(	I-TREATMENT
NEFAZODONE	NNP	I-TREATMENT
)	)	I-TREATMENT
300	CD	O
MG	NNP	O
PO	NNP	O
QHS	NNP	O
ZYPREXA	NNP	B-TREATMENT
(	(	I-TREATMENT
OLANZAPINE	NNP	I-TREATMENT
)	)	I-TREATMENT
5	CD	O
MG	NNP	O
PO	NNP	O
QHS	NNP	O

GLUCOPHAGE	NNP	B-TREATMENT
(	(	I-TREATMENT
METFORMIN	NNP	I-TREATMENT
)	)	I-TREATMENT
850	CD	O
MG	NNP	O
PO	NNP	O
TID	NNP	O
Starting	VBG	O
ON	NNP	O
10/03/00	CD	O
(	(	O
10/03	CD	O
)	)	O
ACTOS	$	B-TREATMENT
30	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O

Penicillins	NNS	B-TREATMENT

atypical	JJ	B-PROBLEM
cp	NN	I-PROBLEM

PRINCIPAL	NNP	O
DISCHARGE	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Responsible	NNP	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

OTHER	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Conditions	NNP	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
dm	NN	B-PROBLEM
(	(	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
)	)	I-PROBLEM
anxiety	NN	B-PROBLEM
(	(	I-PROBLEM
anxiety	NN	I-PROBLEM
)	)	I-PROBLEM
htn	NN	B-PROBLEM
(	(	I-PROBLEM
hypertension	NN	I-PROBLEM
)	)	I-PROBLEM
gerd	NN	B-PROBLEM
(	(	I-PROBLEM
esophageal	JJ	I-PROBLEM
reflux	NN	I-PROBLEM
)	)	I-PROBLEM

41	CD	O
yo	JJ	O
man	NN	O
with	IN	O
CRFs	NNP	B-PROBLEM
of	IN	O
DM	NNP	B-PROBLEM
Type	NNP	I-PROBLEM
II	NNP	I-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
smoking	VBG	O
history	NN	O
,	,	O
family	NN	O
hx	NN	O
,	,	O
HTN	NNP	B-PROBLEM
p	VBZ	O
/	NNP	O
w	NNP	O
episodes	NNS	B-PROBLEM
of	IN	I-PROBLEM
atypical	JJ	I-PROBLEM
CP	NNP	I-PROBLEM
x	NNP	I-PROBLEM
1	CD	I-PROBLEM
week	NN	I-PROBLEM
,	,	O
with	IN	O
rest	NN	O
and	CC	O
exertion	NN	O
.	.	O

also	RB	O
has	VBZ	O
h	VBN	O
/	NNP	O
o	JJ	O
anxiety	NN	B-PROBLEM
and	CC	O
GERD	NNP	B-PROBLEM
.	.	O

No	DT	O
assoicated	JJ	B-PROBLEM
Sx	NNP	I-PROBLEM
.	.	O

Here	RB	O
,	,	O
had	VBD	O
T	NNP	B-PROBLEM
wave	VBP	I-PROBLEM
flattening	VBG	I-PROBLEM
laterally	RB	I-PROBLEM
and	CC	I-PROBLEM
inferiorly	RB	I-PROBLEM
with	IN	O
pain	NN	B-PROBLEM
that	WDT	O
resolved	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
,	,	O
but	CC	O
not	RB	O
clear	JJ	O
that	IN	O
lead	JJ	B-TEST
placement	NN	I-TEST
is	VBZ	O
the	DT	O
same	JJ	O
.	.	O

Had	NNP	O
Chest	NNP	B-TEST
CT	NNP	I-TEST
to	TO	O
r	VB	O
/	NNP	O
o	JJ	O
dissection	NN	B-PROBLEM
(	(	O
due	JJ	O
to	TO	O
back	VB	B-PROBLEM
pain	NN	I-PROBLEM
)	)	O
which	WDT	O
was	VBD	O
neg.	NN	O

Ruled	VBN	O
out	RP	O
for	IN	O
MI	NNP	B-PROBLEM
.	.	O

Will	MD	O
plan	VB	O
on	IN	O
ETT	NNP	B-TEST
.	.	O

Holding	VBG	O
Metformin	NNP	B-TREATMENT
until	IN	O
Friday	NNP	O
due	JJ	O
to	TO	O
CT	NNP	B-TEST
with	IN	I-TEST
contrast	NN	I-TEST
.	.	O

PROSTATE	NN	B-PROBLEM
CANCER	NNP	I-PROBLEM
.	.	O

Prostate	NNP	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
67	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
recent	JJ	O
history	NN	O
of	IN	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
Q2-3H	NNP	O
,	,	O
stranguria	NN	B-PROBLEM
,	,	O
nocturia	JJ	B-PROBLEM
x	JJ	O
3-4	JJ	O
per	IN	O
night	NN	O
.	.	O

He	PRP	O
was	VBD	O
found	VBN	O
on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
to	TO	O
have	VB	O
an	DT	B-PROBLEM
asymmetric	JJ	I-PROBLEM
prostate	NN	I-PROBLEM
with	IN	O
prominence	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

Repeat	NNP	B-TEST
exam	CC	I-TEST
one	CD	O
month	NN	O
later	RB	O
showed	VBD	O
a	DT	B-PROBLEM
firm	JJ	I-PROBLEM
left-sided	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

Transrectal	NNP	B-TEST
ultrasound	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
hypoechoic	JJ	I-PROBLEM
left-sided	JJ	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
peripheral	JJ	I-PROBLEM
zone	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
biopsy	NN	I-TEST
showed	VBD	O
moderately	RB	B-PROBLEM
to	TO	I-PROBLEM
poorly	RB	I-PROBLEM
differentiated	VBN	I-PROBLEM
Grade	NNP	I-PROBLEM
III-IV	NNP	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
a	DT	O
3-4	JJ	O
year	NN	O
history	NN	O
of	IN	O
impotence	NN	B-PROBLEM
.	.	O

Significant	NN	O
for	IN	O
non-insulin	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
takes	VBZ	O
Diabeta	NNP	B-TREATMENT
,	,	O
one	CD	O
QD	NNP	O
;	:	O
right	JJ	B-PROBLEM
eye	NN	I-PROBLEM
cataract	NN	I-PROBLEM
,	,	O
operated	VBN	O
on	IN	O
three	CD	O
years	NNS	O
ago	RB	O
.	.	O

He	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
Motrin	NNP	B-TREATMENT
.	.	O

Diabeta	NNP	B-TREATMENT
,	,	O
one	CD	O
QD	NNP	O
.	.	O

His	PRP$	O
neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

Chest	NNP	O
was	VBD	O
clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	I-PROBLEM

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	JJ	B-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
organomegaly	NN	B-PROBLEM
.	.	O

No	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
genitourinary	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
an	DT	O
uncircumcised	JJ	O
male	NN	O
with	IN	O
normal	JJ	O
scrotal	JJ	O
contents	NNS	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
firm	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
left	JJ	O
lobe	NN	O
of	IN	O
the	DT	O
prostate	NN	O
in	IN	O
the	DT	O
lateral	JJ	O
aspect	NN	O
.	.	O

No	DT	O
clubbing	NN	B-PROBLEM
,	,	I-PROBLEM
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

Pulses	NNS	B-TEST
2+	CD	O
.	.	O

Sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
bicarbonate	NN	B-TEST
28.8	CD	O
,	,	O
BUN	NNP	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
glucose	VBD	B-TEST
118	CD	O
.	.	O

His	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
7100	CD	O
,	,	O
hematocrit	VBD	B-TEST
35.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
258,000	CD	O
.	.	O

PT	NNP	B-TEST
9.4/10.3	CD	O
,	,	O
PTT	NNP	B-TEST
27	CD	O
.	.	O

His	PRP$	B-TEST
urinalysis	NN	I-TEST
showed	VBD	O
marked	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
and	CC	O
positive	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
screen	NN	I-PROBLEM
but	CC	O
was	VBD	O
otherwise	RB	O
negative	JJ	O
.	.	O

His	PRP$	B-TEST
chest	JJS	I-TEST
X-ray	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

EKG	NN	B-TEST
:	:	O

A	DT	B-TREATMENT
radical	JJ	I-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
with	IN	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
was	VBD	O
done	VBN	O
.	.	O

He	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
postoperatively	RB	O
with	IN	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
.	.	O

His	PRP$	B-TEST
potassium	NN	I-TEST
was	VBD	O
3.7	CD	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
33	CD	O
.	.	O

His	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
temperature	NN	I-PROBLEM
to	TO	O
101.7	CD	O
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
and	CC	O
chest	JJS	B-TEST
X-ray	JJ	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

His	PRP$	B-TREATMENT
Jackson-Pratt	NNP	I-TREATMENT
drained	VBD	O
about	IN	O
35-40	JJ	O
cc	NNS	O
per	IN	O
day	NN	O
and	CC	O
was	VBD	O
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
3	CD	O
.	.	O

His	PRP$	B-TEST
hematocrit	NN	I-TEST
on	IN	O
07/03	CD	O
was	VBD	O
28.1	CD	O
.	.	O

On	IN	O
that	DT	O
day	NN	O
he	PRP	O
was	VBD	O
slightly	RB	B-PROBLEM
diaphoretic	JJ	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
tachycardia	NN	I-PROBLEM
to	TO	O
100	CD	O
.	.	O

The	DT	O
remaining	VBG	O
unit	NN	O
of	IN	O
autologous	JJ	B-TREATMENT
packed	NNS	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
was	VBD	O
transfused	VBN	O
.	.	O

A	DT	B-TEST
cardiology	NN	I-TEST
consult	NN	I-TEST
was	VBD	O
obtained	VBN	O
for	IN	O
this	DT	O
episode	NN	O
of	IN	O
diaphoresis	NN	B-PROBLEM
with	IN	O
tachycardia	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
for	IN	O
an	DT	B-TEST
EKG	NNP	I-TEST
being	VBG	O
read	VBN	O
as	IN	O
having	VBG	O
anterolateral	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
symptoms	NNS	B-PROBLEM
of	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
myocardial	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
repeat	NN	I-TEST
EKG	NNP	I-TEST
showed	VBD	O
no	DT	O
changes	NNS	B-PROBLEM
.	.	O

He	PRP	O
subsequently	RB	O
did	VBD	O
well	RB	O
,	,	O
with	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
hematocrit	NN	I-TEST
of	IN	O
34.3	CD	O
after	IN	O
the	DT	B-TEST
transfusion	NN	I-TEST
.	.	O

His	PRP$	B-TEST
creatinine	NN	I-TEST
was	VBD	O
1.2	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
5	CD	O
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
6	CD	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
temperature	NN	I-PROBLEM
resolved	VBN	O
.	.	O

His	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

He	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
Percocet	NNP	B-TREATMENT
and	CC	O
Keflex	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
58	CD	O
year	NN	O
old	JJ	O
right	JJ	O
hand	NN	O
dominant	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
changed	VBD	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
from	IN	O
Aldomet	NNP	B-TREATMENT
to	TO	O
Clonidine	NNP	B-TREATMENT
six	CD	O
weeks	NNS	O
ago	RB	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
adult	NN	B-PROBLEM
onset	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RBR	I-PROBLEM
,	,	O
ankylosing	VBG	B-PROBLEM
spondylitis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
&apos;96	NNP	O
(	(	O
?	.	O
)	)	O
now	RB	O
with	IN	O
acute	JJ	O
onset	NN	O
of	IN	O
left	JJ	B-PROBLEM
face	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
leg	JJR	I-PROBLEM
hemiplegia	NN	I-PROBLEM
and	CC	O
primary	JJ	B-PROBLEM
hemisensory	JJ	I-PROBLEM
loss	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

His	PRP$	O
voice	NN	O
became	VBD	O
slurred	JJ	B-PROBLEM
and	CC	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
central	JJ	I-PROBLEM
dull	NN	I-PROBLEM
headache	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
move	VB	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
his	PRP$	O
body	NN	O
and	CC	O
felt	VBD	O
numb	NNS	B-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
Wayskemedcalltown	NNP	O
Talmi	NNP	O
and	CC	O
transferred	VBN	O
to	TO	O
Heaonboburg	NNP	O
Linpack	NNP	O
Grant	NNP	O
Medical	NNP	O
Center	NNP	O
with	IN	O
a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
showing	VBG	O
a	DT	B-PROBLEM
1x2	CD	I-PROBLEM
thalamic	JJ	I-PROBLEM
capsular	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
without	IN	O
superficial	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
220/110	CD	O
there	RB	O
.	.	O

He	PRP	O
denies	VBZ	O
any	DT	O
visual	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
or	CC	O
cortical-type	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

Vasotec	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.day	NN	O
,	,	O
Soma	NNP	B-TREATMENT
1	CD	O
tablet	NN	O
q.day	NN	O
,	,	O
Demerolprn	NNP	B-TREATMENT
,	,	O
Clonidine	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	O
family	NN	O
history	NN	O
is	VBZ	O
positive	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
positive	JJ	O
for	IN	O
cancer	NN	B-PROBLEM
.	.	O

On	IN	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
,	,	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/80	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
and	CC	O
regular	JJ	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

Cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
I/VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

His	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	JJ	B-PROBLEM
,	,	O
obese	JJ	B-PROBLEM
,	,	O
with	IN	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

Back	RB	O
and	CC	O
neck	NN	O
were	VBD	O
stiff	JJ	B-PROBLEM
and	CC	O
sore	NN	B-PROBLEM
,	,	O
without	IN	O
localizing	VBG	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

On	IN	O
neurological	JJ	B-TEST
examination	NN	I-TEST
,	,	O
mental	JJ	O
status	NN	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	NNP	O
three	CD	O
,	,	O
good	JJ	O
memory	NN	O
,	,	O
fluent	JJ	O
speech	NN	O
,	,	O
good	JJ	O
repetition	NN	O
and	CC	O
naming	NN	O
.	.	O

The	DT	O
cranial	JJ	O
nerves	NNS	O
showed	VBD	O
full	JJ	O
visual	JJ	O
fields	NNS	O
without	IN	O
extinction	NN	B-PROBLEM
,	,	O
pupils	VBZ	O
5	CD	O
to	TO	O
3	CD	O
bilaterally	RB	O
and	CC	O
equal	JJ	O
,	,	O
disks	NNS	O
flat	JJ	O
,	,	O
lower	JJR	B-PROBLEM
left	VBD	I-PROBLEM
facial	JJ	I-PROBLEM
decreased	JJ	I-PROBLEM
sensation	NN	I-PROBLEM
to	TO	I-PROBLEM
temperature	NN	I-PROBLEM
,	,	O
pin	NN	B-TEST
prick	NN	I-TEST
on	IN	O
the	DT	O
left	NN	O
V1	NNP	O
through	IN	O
V3	NNP	O
,	,	O
tongue	NN	O
deviates	NNS	O
to	TO	O
the	DT	O
left	NN	O
,	,	O
good	JJ	O
gag	NN	O
,	,	O
decreased	VBN	B-PROBLEM
shrug	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

Motor	NNP	B-TEST
examination	NN	I-TEST
showed	VBD	O
full	JJ	O
power	NN	O
on	IN	O
the	DT	O
right	JJ	O
arm	NN	O
and	CC	O
leg	NN	O
,	,	O
could	MD	O
barely	RB	O
flex	JJ	O
fingers	NNS	O
of	IN	O
the	DT	O
left	JJ	O
hand	NN	O
,	,	O
pulls	NNS	O
left	VBD	O
arm	NN	O
medially	RB	O
only	RB	O
.	.	O

On	IN	O
sensory	JJ	B-TEST
examination	NN	I-TEST
,	,	O
had	VBD	O
decreased	VBN	O
pin	NN	O
prick	NN	O
,	,	O
temperature	NN	O
,	,	O
vibration	NN	O
in	IN	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
the	DT	O
body	NN	O
.	.	O

The	DT	B-TEST
finger-to-nose	NN	I-TEST
was	VBD	O
okay	VBN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

On	IN	O
reflex	JJ	B-TEST
examination	NN	I-TEST
,	,	O
2	CD	O
on	IN	O
the	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
,	,	O
2+	CD	O
on	IN	O
the	DT	O
left	JJ	O
upper	JJ	O
extremity	NN	O
,	,	O
2	CD	O
on	IN	O
the	DT	O
right	JJ	O
knee	NN	O
,	,	O
0	CD	O
on	IN	O
the	DT	O
right	JJ	O
ankle	NN	O
,	,	O
with	IN	O
down	RP	O
going	VBG	O
toe	NN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

Three	CD	O
on	IN	O
the	DT	O
left	NN	O
knee	NN	O
,	,	O
4	CD	O
on	IN	O
the	DT	O
left	NN	O
ankle	NN	O
with	IN	O
upgoing	JJ	O
toe	NN	O
and	CC	O
clonus	NN	B-PROBLEM
on	IN	O
the	DT	O
left	NN	O
.	.	O

Electrolytes	NNS	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
glucose	JJ	B-TEST
192	CD	O
,	,	O
BUN	NNP	B-TEST
and	CC	O
creatinine	VB	B-TEST
9/0.7	CD	O
,	,	O
hematocrit	NN	B-TEST
49.5	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
7.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
166,000	CD	O
,	,	O
65%	CD	O
polys	NN	B-TEST
,	,	O
3	CD	O
bands	NNS	B-TEST
,	,	O
24%	CD	O
lymphs	NN	B-TEST
.	.	O

The	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
old	JJ	B-PROBLEM
Q	NNP	I-PROBLEM
wave	NN	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Head	NNP	B-TEST
computerized	VBD	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
showed	VBD	O
1.5	CD	B-PROBLEM
to	TO	I-PROBLEM
2	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
thalamus	NN	I-PROBLEM
extending	VBG	O
to	TO	O
the	DT	O
internal	JJ	O
capsule	NN	O
with	IN	O
mild	JJ	B-PROBLEM
distortion	NN	I-PROBLEM
only	RB	O
,	,	O
no	DT	O
shift	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
chest	JJS	I-TEST
X-ray	NN	I-TEST
was	VBD	O
clear	JJ	O
.	.	O

The	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
on	IN	O
discharge	NN	O
was	VBD	O
no	DT	O
movement	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
hand	NN	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
or	CC	O
arm	NN	O
.	.	O

On	IN	O
the	DT	O
lower	JJR	O
extremity	NN	O
,	,	O
could	MD	O
wiggle	VB	B-TEST
toes	NNS	I-TEST
,	,	O
flexor	NN	B-TEST
and	CC	O
plantar	NN	B-TEST
,	,	O
3+/5	CD	O
,	,	O
quadriceps	VBZ	O
4/5	CD	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
managed	VBN	O
with	IN	O
Vasotec	NNP	B-TREATMENT
,	,	O
Nifedipine	NNP	B-TREATMENT
and	CC	O
Clonidine	NNP	B-TREATMENT
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
under	IN	O
good	JJ	O
control	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
average	JJ	O
125	CD	O
systolic	JJ	B-TEST
,	,	O
70	CD	O
diastolic	NN	B-TEST
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
72	CD	O
.	.	O

Also	RB	O
managed	VBN	O
with	IN	O
Valium	NNP	B-TREATMENT
5	CD	O
mg	NN	O
PO	NNP	O
t.i.d.	NN	O

Muscle	NN	B-PROBLEM
spasms	NNS	I-PROBLEM
were	VBD	O
managed	VBN	O
with	IN	O
Flexeril	NNP	B-TREATMENT
10	CD	O
PO	NNP	O
t.i.d.	NN	O

3.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
2.5	CD	O
of	IN	O
Micronase	NNP	B-TREATMENT
with	IN	O
resulting	VBG	B-TEST
sugars	NNS	I-TEST
as	RB	O
low	JJ	O
as	IN	O
63	CD	O
,	,	O
decreased	VBD	O
to	TO	O
1.25	CD	O
mg	NNS	O
q.day	RB	O
.	.	O

Vasotec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O
Clonidine	NNP	B-TREATMENT
0.2	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O
Nifedipine	NNP	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
t.i.d.	NN	O
,	,	O
Flexeril	NNP	B-TREATMENT
10	CD	O
mg	NN	O
PO	NNP	O
t.i.d.	NN	O
,	,	O
Valium	NNP	B-TREATMENT
5	CD	O
mg	NN	O
PO	NNP	O
t.i.d.	NN	O
,	,	O
Micronase	NNP	B-TREATMENT
1.25	CD	O
mg	NN	O
q.day	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
allergic	JJ	B-PROBLEM
to	TO	O
Percocet	NNP	B-TREATMENT
and	CC	O
Percodan	NNP	B-TREATMENT
during	IN	O
his	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

Right	JJ	B-PROBLEM
thalamic	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

MITRAL	NNP	B-PROBLEM
STENOSIS	NNP	I-PROBLEM

Mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

Tricuspid	NNP	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
ectopy	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Epistaxis	NNP	B-PROBLEM
to	TO	O
Coumadin	NNP	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

Cardiac	NNP	B-TEST
catheterization	NN	I-TEST
11/03	CD	O
.	.	O

Pulmonary	JJ	B-TEST
function	NN	I-TEST
test	NN	I-TEST
11/04	CD	O
.	.	O

This	DT	O
68-year-old	JJ	O
patient	NN	O
of	IN	O
Dr.	NNP	O
Naka	NNP	O
Jesc	NNP	O
had	VBD	O
two	CD	O
episodes	NNS	O
of	IN	O
rheumatic	JJ	B-PROBLEM
fever	NN	I-PROBLEM
as	IN	O
a	DT	O
teenager	NN	O
.	.	O

She	PRP	O
has	VBZ	O
had	VBN	O
chronic	VBN	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

Coumadin	NNP	B-TREATMENT
has	VBZ	O
caused	VBN	O
bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
mouth	NN	I-PROBLEM
and	CC	I-PROBLEM
nose	VB	I-PROBLEM
on	IN	O
two	CD	O
occasions	NNS	O
,	,	O
on	IN	O
one	CD	O
occasion	NN	O
with	IN	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
13	CD	O
,	,	O
and	CC	O
has	VBZ	O
been	VBN	O
replaced	VBN	O
by	IN	O
anti-platelet	JJ	B-TREATMENT
agents	NNS	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
had	VBN	O
recurrent	VBN	B-PROBLEM
syncope	NN	I-PROBLEM
since	IN	O
age	NN	O
6	CD	O
.	.	O

She	PRP	O
has	VBZ	O
now	RB	O
had	VBN	O
progressive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
Holter	NNP	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
period	NN	O
of	IN	O
ventricular	JJ	B-PROBLEM
bigemini	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
hypertension	NN	B-PROBLEM
or	CC	O
diabetes	NNS	B-PROBLEM
,	,	O
and	CC	O
says	VBZ	O
he	PRP	O
has	VBZ	O
lowered	VBN	O
her	PRP$	B-TEST
cholesterol	NN	I-TEST
from	IN	O
333	CD	O
to	TO	O
197	CD	O
by	IN	O
changing	VBG	O
her	PRP$	O
diet	NN	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
Vanceril	NNP	B-TREATMENT
for	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
one	CD	O
gram	NN	O
per	IN	O
day	NN	O
proteinuria	NN	B-TREATMENT
with	IN	O
normal	JJ	O
creatinine	NN	O
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TREATMENT
partial	JJ	I-TREATMENT
gastrectomy	NN	I-TREATMENT
in	IN	O
1972	CD	O
for	IN	O
a	DT	B-PROBLEM
&quot;	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
an	DT	B-TREATMENT
appendectomy	NN	I-TREATMENT
and	CC	O
cholecystectomy	NN	B-TREATMENT
.	.	O

Digoxin	NNP	B-TREATMENT
0.125	CD	O
mg	NN	O
po	NN	O
q.d.	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
aspirin	JJ	B-TREATMENT
held	NN	O
,	,	O
and	CC	O
Vanceril	NNP	B-TREATMENT
three	CD	O
puffs	NNS	O
b.i.d.	VBP	O

Transdermal	NNP	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
caused	VBD	O
headache	NN	B-PROBLEM
.	.	O

Heart	NNP	B-TEST
rate	NN	I-TEST
86	CD	O
,	,	O
irregularly	RB	O
irregular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
142/86	CD	O
.	.	O

Neck	NN	B-PROBLEM
veins	NNS	I-PROBLEM
distended	VBD	I-PROBLEM
.	.	O

Apical	NNP	B-TEST
impulse	MD	I-TEST
not	RB	O
palpable	VB	O
.	.	O

Right	RB	B-PROBLEM
ventricular	JJ	I-PROBLEM
heave	NN	I-PROBLEM
.	.	O

S2	NNP	O
narrowly	RB	B-PROBLEM
physiologically	RB	I-PROBLEM
split	VBN	I-PROBLEM
with	IN	O
accentuation	NN	B-PROBLEM
of	IN	O
P2	NNP	O
.	.	O

No	DT	O
S3	NNP	B-PROBLEM
or	CC	O
opening	VBG	B-PROBLEM
snap	NN	I-PROBLEM
.	.	O

Grade	NNP	B-PROBLEM
II	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

Grade	NNP	B-PROBLEM
II	NNP	I-PROBLEM
decrescendo	VBZ	I-PROBLEM
diastolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

Diastolic	NNP	B-PROBLEM
rumble	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

Liver	NNP	B-PROBLEM
slightly	RB	I-PROBLEM
pulsatile	RB	I-PROBLEM
but	CC	O
no	DT	O
enlarged	NN	B-PROBLEM
.	.	O

Pulses	NNS	B-TEST
normal	JJ	O
to	TO	O
the	DT	O
femorals	NNS	O
with	IN	O
weak	JJ	B-PROBLEM
dorsalis	NN	I-PROBLEM
pedis	NN	I-PROBLEM
pulses	NNS	I-PROBLEM
.	.	O

Superficial	NNP	B-PROBLEM
varicose	NN	I-PROBLEM
veins	NNS	I-PROBLEM
.	.	O

No	DT	O
edema	NN	B-PROBLEM
.	.	O

Hematocrit	NNP	B-TEST
44	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
BUN	NNP	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
115	CD	O
,	,	O
Digoxin	NNP	B-TEST
1.4	CD	O
.	.	O

Electrocardiogram	NNP	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
,	,	O
incomplete	JJ	B-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
axis	NN	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
possible	JJ	O
apical	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
left	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
pulmonary	JJ	I-PROBLEM
arterial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
and	CC	O
interstitial	JJ	B-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
small	JJ	B-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

Cardiac	JJ	B-TREATMENT
catheterization	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
without	IN	O
complication	NN	B-PROBLEM
from	IN	O
the	DT	O
right	JJ	O
neck	NN	O
and	CC	O
right	JJ	O
groin	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

Right	JJ	B-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
12	CD	O
with	IN	O
a	DT	O
wave	NN	O
form	NN	O
consistent	NN	O
with	IN	O
tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
tricuspid	JJ	B-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

Pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
markedly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
120/60	CD	O
.	.	O

Pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
markedly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
38	CD	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
large	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
little	JJ	O
or	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

Fich	NNP	B-TEST
cardiac	VBD	I-TEST
output	NN	I-TEST
was	VBD	O
3.0	CD	O
and	CC	O
indexed	JJ	O
2.0	CD	O
.	.	O

Arterial	JJ	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
85	CD	O
percent	NN	O
.	.	O

There	EX	O
was	VBD	O
minimal	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
calcification	NN	I-PROBLEM
,	,	O
normal	JJ	O
left	VBD	O
ventricular	JJ	O
contraction	NN	O
,	,	O
and	CC	O
2+	CD	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
into	IN	I-PROBLEM
a	DT	I-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
minimal	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
calcification	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
______________	NNP	I-PROBLEM
thickening	NN	I-PROBLEM
,	,	O
normal	JJ	O
open	JJ	O
,	,	O
and	CC	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
atherosclerosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
.	.	O

FVC	NNP	B-TEST
was	VBD	O
1.6	CD	O
or	CC	O
58	CD	O
percent	NN	O
of	IN	O
predicted	VBN	O
and	CC	O
FEV1	NNP	B-TEST
0.95	CD	O
or	CC	O
45	CD	O
percent	NN	O
of	IN	O
predicted	VBN	O
.	.	O

Room	NNP	B-TEST
air	NN	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
56/40/7.45	CD	O
.	.	O

Because	IN	O
it	PRP	O
would	MD	O
be	VB	O
ideal	JJ	O
to	TO	O
place	VB	O
a	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT
if	IN	O
valve	JJ	B-TREATMENT
replacement	NN	I-TREATMENT
rather	RB	O
that	IN	O
commissurotomy	NN	B-TREATMENT
is	VBZ	O
needed	VBN	O
,	,	O
she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
Dr.	NNP	O
Ca	NNP	O
Shuff	NNP	O
of	IN	O
ENT	NNP	O
for	IN	O
her	PRP$	O
history	NN	O
of	IN	O
epistaxis	NN	B-PROBLEM
.	.	O

He	PRP	O
identified	VBD	O
no	DT	O
bleeding	NN	B-PROBLEM
source	NN	I-PROBLEM
,	,	O
but	CC	O
felt	VBD	O
that	IN	O
the	DT	O
risk	NN	O
of	IN	O
nasal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
on	IN	O
Coumadin	NNP	B-TREATMENT
could	MD	O
be	VB	O
minimized	VBN	O
interventional	JJ	B-TREATMENT
neuroradiology	NN	I-TREATMENT
occlusion	NN	I-TREATMENT
of	IN	O
the	DT	O
arteries	NNS	O
to	TO	O
the	DT	O
nose	JJ	O
bilaterally	RB	O
.	.	O

The	DT	B-TREATMENT
procedure	NN	I-TREATMENT
could	MD	O
not	RB	O
be	VB	O
scheduled	VBN	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
discharged	VBD	O
after	IN	O
a	DT	O
three	CD	O
day	NN	O
hospitalization	NN	O
,	,	O
with	IN	O
plans	NNS	O
for	IN	O
re-admission	NN	O
for	IN	O
the	DT	B-TREATMENT
neuroradiology	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

This	DT	O
will	MD	O
be	VB	O
followed	VBN	O
by	IN	O
a	DT	O
trial	NN	O
of	IN	O
Coumadin	NNP	B-TREATMENT
,	,	O
and	CC	O
then	RB	O
by	IN	O
mitral	JJ	B-TREATMENT
commissurotomy	NN	I-TREATMENT
or	CC	O
replacement	NN	B-TREATMENT
and	CC	O
probable	JJ	O
tricuspid	JJ	B-TREATMENT
annuloplasty	NN	I-TREATMENT
by	IN	O
Dr.	NNP	O
Riemund	NNP	O
C.	NNP	O
Wave	NNP	O
.	.	O

In	IN	O
the	DT	O
meantime	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
dosage	NN	O
is	VBZ	O
increased	VBN	O
.	.	O

Potassium	NN	B-TREATMENT
replacement	NN	I-TREATMENT
has	VBZ	O
caused	VBN	O
,	,	O
according	VBG	O
to	TO	O
the	DT	O
patient	NN	O
,	,	O
marked	VBD	B-PROBLEM
hyperkalemia	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

Digoxin	NNP	B-TREATMENT
0.125	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
80	CD	O
mg	NN	O
q.a.m.	NN	O
and	CC	O
40	CD	O
mg	NN	O
q.p.m.	NN	O
aspirin	VBD	B-TREATMENT
1	CD	O
q.d.	NN	O
,	,	O
and	CC	O
Vanceril	NNP	B-TREATMENT
three	CD	O
puffs	NNS	O
b.i.d.	VBP	O

FLANK	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
URI	NNP	B-PROBLEM
?	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
(	(	O
Portugese	JJ	O
)	)	O
.	.	O

Urinary	JJ	B-PROBLEM
Tract	NNP	I-PROBLEM
Infection	NNP	I-PROBLEM

Exam	NNP	B-TEST
,	,	O
urinalysis	NN	B-TEST
,	,	O
medication	NN	B-TREATMENT

Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
every	DT	O
day	NN	O
for	IN	O
7	CD	O
days	NNS	O

Return	NN	O
to	TO	O
the	DT	O
ER	NNP	O
for	IN	O
high	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
uncontrolled	JJ	B-PROBLEM
pains	NNS	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
as	IN	O
needed	VBN	O
.	.	O

CHRONIC	NNP	B-PROBLEM
MYELOGENOUS	NNP	I-PROBLEM
LEUKEMIA	NNP	I-PROBLEM

CML	NNP	B-PROBLEM
.	.	O

1.	CD	O
STATUS	NNP	O
POST	NNP	O
BONE	NNP	B-TREATMENT
MARROW	NNP	I-TREATMENT
TRANSPLANT	NNP	I-TREATMENT
.	.	O

2.	CD	O
INTRAPARENCHYMAL	NNP	B-PROBLEM
BLEED	NNP	I-PROBLEM
.	.	O

Mr.	NNP	O
Larsen	NNP	O
was	VBD	O
a	DT	O
50-year-old	JJ	O
salesman	NN	O
who	WP	O
in	IN	O
12/26	CD	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
of	IN	O
778,000	CD	O
.	.	O

He	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
CML	NNP	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
06/07/00	CD	O
for	IN	O
a	DT	B-TREATMENT
matched	VBN	I-TREATMENT
,	,	I-TREATMENT
unrelated	JJ	I-TREATMENT
donor	NN	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
24.409	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
956,000	CD	O
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
his	PRP$	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
on	IN	O
06/12/00	CD	O
.	.	O

His	PRP$	O
course	NN	O
was	VBD	O
then	RB	O
complicated	VBN	O
by	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
neutropenia	NN	B-PROBLEM
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
erythroderm	NN	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
drug	NN	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

On	IN	O
06/24/00	CD	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
pulmonary	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
hemoptysis	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
bronchoscopy	NN	I-TEST
was	VBD	O
done	VBN	O
and	CC	O
there	EX	O
was	VBD	O
blood	NN	B-PROBLEM
found	VBN	O
in	IN	O
the	DT	O
upper	JJ	O
airways	NNS	O
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
blood	NN	B-PROBLEM
in	IN	I-PROBLEM
alveoli	NNS	I-PROBLEM
so	IN	O
it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
DAH	NNP	B-PROBLEM
.	.	O

On	IN	O
06/26/00	CD	O
due	JJ	O
to	TO	O
agitation	NN	B-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
the	DT	B-PROBLEM
changing	VBG	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
might	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
combination	NN	O
of	IN	O
medication	NN	B-TREATMENT
and	CC	O
worsening	VBG	B-PROBLEM
mucositis	NN	I-PROBLEM
.	.	O

Although	IN	O
the	DT	B-TREATMENT
patient	JJ	I-TREATMENT
&apos;s	NN	I-TREATMENT
pain	NN	I-TREATMENT
and	CC	I-TREATMENT
sedation	NN	I-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
adjusted	VBN	O
he	PRP	O
continued	VBD	O
to	TO	O
be	VB	O
agitated	VBN	B-PROBLEM
and	CC	O
there	EX	O
was	VBD	O
difficulty	NN	O
weaning	VBG	O
him	PRP	O
off	RP	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
.	.	O

Because	IN	O
of	IN	O
this	DT	B-PROBLEM
continued	JJ	I-PROBLEM
agitation	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
07/01/00	CD	O
and	CC	O
it	PRP	O
revealed	VBD	O
an	DT	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

Neurosurgery	NN	O
was	VBD	O
consulted	VBN	O
but	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
severity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
bleed	NN	I-PROBLEM
surgery	NN	B-TREATMENT
was	VBD	O
not	RB	O
considered	VBN	O
an	DT	O
option	NN	O
.	.	O

The	DT	O
patient	NN	O
gradually	RB	O
lost	VBD	O
brain	NN	O
systolic	JJ	O
ejection	NN	O
murmur	NN	O
function	NN	O
and	CC	O
was	VBD	O
pronounced	VBN	O
dead	JJ	B-PROBLEM
on	IN	O
07/02/00	CD	O
.	.	O

RIGHT	RB	B-PROBLEM
CAPSULAR	NNP	I-PROBLEM
PUTAMENAL	NNP	I-PROBLEM
HEMORRHAGE	NNP	I-PROBLEM
.	.	O

Right	RB	B-PROBLEM
capsular	JJ	I-PROBLEM
putamenal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

Mrs.	NNP	O
Dua	NNP	O
is	VBZ	O
a	DT	O
34	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
an	DT	O
unclear	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
for	IN	O
at	IN	O
least	JJS	O
five	CD	O
years	NNS	O
.	.	O

She	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
around	IN	O
12:40	CD	O
on	IN	O
October	NNP	O
19	CD	O
,	,	O
when	WRB	O
while	NN	O
on	IN	O
the	DT	O
phone	NN	O
,	,	O
started	VBD	O
to	TO	O
have	VB	O
difficulty	NN	B-PROBLEM
in	IN	I-PROBLEM
talking	VBG	I-PROBLEM
.	.	O

Her	PRP$	O
speech	NN	O
became	VBD	O
slurred	JJ	B-PROBLEM
,	,	O
this	DT	O
was	VBD	O
followed	VBN	O
a	DT	O
few	JJ	O
seconds	NNS	O
after	IN	O
by	IN	O
weakness	NN	B-PROBLEM
and	CC	I-PROBLEM
numbness	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

She	PRP	O
did	VBD	O
not	RB	O
complain	VB	O
of	IN	O
headache	NN	B-PROBLEM
,	,	O
diplopia	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
neurological	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
seen	VBN	O
at	IN	O
A	NNP	O
Memorial	NNP	O
Hospital	NNP	O
where	WRB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
measured	VBN	O
at	IN	O
240/120	CD	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
left	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
Ro	NNP	O
Woodma	NNP	O
Healthcare	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

She	PRP	O
does	VBZ	O
not	RB	O
smoke	VB	O
,	,	O
does	VBZ	O
not	RB	O
use	VB	O
birth	NN	B-TREATMENT
control	NN	I-TREATMENT
pills	NNS	I-TREATMENT
,	,	O
does	VBZ	O
not	RB	O
use	VB	O
drugs	NNS	O
.	.	O

Father	NNP	O
and	CC	O
brother	RB	O
died	VBD	O
of	IN	O
PE	NNP	B-PROBLEM
.	.	O

A	DT	O
34	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
lying	NN	O
in	IN	O
bed	NN	O
,	,	O
anxious	JJ	B-PROBLEM
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
220/120	CD	O
,	,	O
afebrile	NN	B-PROBLEM
.	.	O

no	DT	O
lesions	NNS	B-PROBLEM
.	.	O

normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
,	,	O
anicteric	JJ	B-PROBLEM
.	.	O

supple	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

regular	JJ	O
rhythm	NN	O
with	IN	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

bowel	NN	O
sounds	VBZ	O
present	JJ	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
guaiac	JJ	O
negative	JJ	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	I-PROBLEM
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

Her	PRP$	O
speech	NN	O
was	VBD	O
fluent	JJ	O
with	IN	O
no	DT	O
phasic	NN	B-PROBLEM
or	CC	I-PROBLEM
praxic	NN	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
dysarthric	NN	B-PROBLEM
.	.	O

Visual	JJ	O
fields	NNS	O
were	VBD	O
full	JJ	O
to	TO	O
confrontation	NN	B-TEST
.	.	O

Pupils	NNS	O
were	VBD	O
2	CD	O
millimeters	NNS	O
down	RB	O
to	TO	O
1	CD	O
millimeter	NN	O
by	IN	O
direct	JJ	B-TEST
and	CC	I-TEST
consensual	JJ	I-TEST
stimuli	NN	I-TEST
.	.	O

V1	NNP	O
through	IN	O
V3	NNP	O
,	,	O
diminished	VBD	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pinprick	NN	B-TEST
in	IN	O
the	DT	O
left	JJ	O
side	NN	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
central	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
paresis	NN	I-PROBLEM
.	.	O

Gag	NNP	B-TEST
was	VBD	O
symmetric	JJ	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
pronator	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
2+	CD	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
,	,	O
1+	CD	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

On	IN	O
sensory	JJ	B-TEST
exam	NN	I-TEST
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
diminution	NN	I-PROBLEM
of	IN	I-PROBLEM
light	JJ	I-PROBLEM
touch	NN	I-PROBLEM
,	,	I-PROBLEM
pinprick	NN	I-PROBLEM
,	,	I-PROBLEM
position	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
vibration	NN	I-PROBLEM
sense	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

the	DT	O
fine	JJ	O
motor	NN	O
movements	NNS	O
of	IN	O
the	DT	O
left	JJ	O
hand	NN	O
were	VBD	O
diminished	VBN	B-PROBLEM
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
dysmetria	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
to	TO	O
finger	VB	B-TEST
/	NNP	I-TEST
nose	JJ	I-TEST
and	CC	O
heel	JJ	B-TEST
/	NNP	I-TEST
shin	NN	I-TEST
.	.	O

The	DT	B-PROBLEM
walk	NN	I-PROBLEM
was	VBD	I-PROBLEM
paretic	JJ	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
CO2	NNP	B-TEST
25.4	CD	O
,	,	O
BUN	NNP	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
.8	NNP	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
130	CD	O
.	.	O

Uric	JJ	B-TEST
acid	NN	I-TEST
4.7	CD	O
,	,	O
cholesterol	NN	B-TEST
150	CD	O
,	,	O
triglycerides	NNS	B-TEST
74	CD	O
,	,	O
HDL	NNP	B-TEST
44	CD	O
,	,	O
LDL	NNP	B-TEST
91	CD	O
.	.	O

Urine	NN	B-TEST
and	CC	I-TEST
serum	NN	I-TEST
toxicology	NN	I-TEST
screen	JJ	I-TEST
negative	JJ	O
.	.	O

Thyroid	NNP	B-TEST
stimulation	NN	I-TEST
hormone	NN	I-TEST
1.9	CD	O
.	.	O

Dexamethasone	NNP	B-TEST
suppression	NN	I-TEST
test	NN	I-TEST
negative	JJ	O
with	IN	O
a	DT	B-TEST
cortisol	JJ	I-TEST
level	NN	I-TEST
at	IN	O
8	CD	O
a.m.	NN	O
of	IN	O
1.7	CD	O
.	.	O

Twenty-four	CD	B-TEST
urine	NN	I-TEST
for	IN	O
catecholamine	NN	B-TEST
,	,	O
metanephrines	NNS	B-TEST
,	,	O
and	CC	O
VMA	NNP	B-TEST
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
9.8	CD	O
,	,	O
hematocrit	NN	B-TEST
44.1	CD	O
,	,	O
platelets	NNS	B-TEST
262	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
10.4/	CD	O
10.3	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
25.9	CD	O
.	.	O

urinalysis	NN	B-TEST
:	:	O

specific	JJ	B-TEST
gravity	NN	I-TEST
125	CD	O
,	,	O
PH	NNP	O
6	CD	O
.	.	O

Urine	JJ	B-TEST
culture	NN	I-TEST
negative	JJ	O
.	.	O

Sedimentation	NN	B-TEST
rate	NN	I-TEST
2	CD	O
,	,	O
antithrombin	RB	B-TEST
3	CD	O
.	.	O

Protein	NNP	B-TEST
C	NNP	I-TEST
,	,	O
protein	NN	B-TEST
S	NNP	I-TEST
and	CC	O
plasminogen	NN	B-TEST
level	NN	I-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

Electrocardiogram	NN	B-TEST
:	:	O

sinus	NN	B-TEST
rhythm	NN	I-TEST
at	IN	O
116	CD	O
,	,	O
axis	NN	B-TEST
of	IN	O
23	CD	O
,	,	O
intervals	NNS	B-TEST
of	IN	O
.14/	NNP	O
.07/	NNP	O
.42	NNP	O
,	,	O
no	DT	O
ST-segment	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
x-ray	JJ	I-TEST
negative	NN	O
.	.	O

Head	NNP	B-TEST
computerized	VBD	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
on	IN	O
10/19	CD	O
:	:	O
3	CD	B-PROBLEM
centimeter	NN	I-PROBLEM
hyperdensity	NN	I-PROBLEM
within	IN	O
the	DT	O
right	JJ	O
putamenal	JJ	O
area	NN	O
in	IN	O
the	DT	O
right	JJ	O
external	JJ	O
capsusle	NN	O
consistent	JJ	O
with	IN	O
intra-parenchymal	JJ	B-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
local	JJ	I-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
and	CC	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

No	DT	O
other	JJ	O
areas	NNS	O
of	IN	O
hemorrhage	NN	B-PROBLEM
identified	VBN	O
.	.	O

Head	NNP	B-TEST
computerized	VBD	I-TEST
tomography	JJ	I-TEST
scan	NN	I-TEST
of	IN	O
10/23	CD	O
:	:	O

the	DT	O
area	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
the	DT	O
same	JJ	O
,	,	O
slightly	RB	B-PROBLEM
more	RBR	I-PROBLEM
edema	JJ	I-PROBLEM
and	CC	I-PROBLEM
mass	JJ	I-PROBLEM
effect	NN	I-PROBLEM
.	.	O

Pulmonary	JJ	B-TEST
angiogram	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

Given	VBN	O
the	DT	O
localization	NN	O
of	IN	O
the	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
the	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
the	DT	O
most	RBS	O
likely	JJ	O
cause	NN	O
for	IN	O
Mrs.	NNP	O
Dua	NNP	O
&apos;s	NNP	O
cerebellar	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
hypertension	NN	B-PROBLEM
.	.	O

A	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
will	MD	O
be	VB	O
scheduled	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
in	IN	O
three	CD	O
months	NNS	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
if	IN	O
responsible	JJ	O
for	IN	O
the	DT	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
now	RB	O
able	JJ	O
to	TO	O
walk	VB	O
fitfully	RB	O
and	CC	O
use	VB	O
her	PRP$	O
left	JJ	O
hand	NN	O
with	IN	O
no	DT	O
problem	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
exam	NN	I-TEST
is	VBZ	O
remarkable	JJ	O
for	IN	O
a	DT	B-PROBLEM
mild	NN	I-PROBLEM
leftsided	VBD	I-PROBLEM
face	NN	I-PROBLEM
,	,	O
arm	NN	B-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
sensory	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
that	WDT	O
should	MD	O
further	RB	O
improve	VB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
help	NN	O
.	.	O

Her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
difficult	JJ	O
to	TO	O
manage	VB	O
initially	RB	O
and	CC	O
required	VBD	O
three	CD	O
days	NNS	O
of	IN	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
with	IN	O
A-line	NNP	B-TREATMENT
and	CC	O
Nipride	NNP	B-TREATMENT
intravenously	RB	I-TREATMENT
.	.	O

It	PRP	O
was	VBD	O
finally	RB	O
under	IN	O
control	NN	O
with	IN	O
high	JJ	O
doses	NNS	O
of	IN	O
Captopril	NNP	B-TREATMENT
,	,	O
Nifedipine	NNP	B-TREATMENT
,	,	O
and	CC	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

The	DT	B-TEST
workup	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
secondary	JJ	B-PROBLEM
cause	NN	I-PROBLEM
of	IN	O
hypertension	NN	B-PROBLEM
given	VBN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
young	JJ	O
age	NN	O
and	CC	O
the	DT	O
difficulty	NN	O
controlling	VBG	O
the	DT	O
blood	NN	O
pressure	NN	O
was	VBD	O
started	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
and	CC	O
will	MD	O
be	VB	O
completed	VBN	O
by	IN	O
Dr.	NNP	O
______________as	NNP	O
an	DT	O
outpatient	NN	O
.	.	O

So	RB	O
far	RB	O
no	DT	O
secondary	JJ	B-PROBLEM
causes	NNS	I-PROBLEM
of	IN	O
hypertension	NN	B-PROBLEM
were	VBD	O
identified	VBN	O
but	CC	O
causes	VBZ	O
like	IN	O
lymphocytic	JJ	B-PROBLEM
?	.	I-PROBLEM
chromocytoma	NN	I-PROBLEM
or	CC	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
have	VBP	O
not	RB	O
been	VBN	O
ruled	VBN	O
out	RP	O
yet	RB	O
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg.	NNS	O
po	JJ	O
q.day	NN	O
,	,	O
Captopril	NNP	B-TREATMENT
75	CD	O
mg.	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
Nifedipine	NNP	B-TREATMENT
40	CD	O
mg.	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

Will	MD	O
be	VB	O
reassessed	VBN	O
after	IN	O
a	DT	O
month	NN	O
of	IN	O
intensive	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

Vaginal	JJ	B-TREATMENT
Delivery	NNP	I-TREATMENT
With	IN	O
Second	NNP	B-PROBLEM
Degree	NNP	I-PROBLEM
Laceration	NNP	I-PROBLEM

Abnormal	NNP	B-PROBLEM
Laboratory	NNP	I-PROBLEM
Result	NNP	I-PROBLEM
;	:	O
Abnormal	NNP	B-PROBLEM
Pap	NNP	I-PROBLEM
Test	NNP	I-PROBLEM
;	:	O
Monilial	NNP	B-PROBLEM
Vaginitis	NNP	I-PROBLEM

Spontaneous	JJ	B-TREATMENT
Vertex	NNP	I-TREATMENT
Vaginal	NNP	I-TREATMENT
Delivery	NNP	I-TREATMENT

Routine	JJ	B-TREATMENT
Post	NNP	I-TREATMENT
Partum	NNP	I-TREATMENT
Care	NNP	I-TREATMENT

Premature	JJ	B-PROBLEM
Rupture	NNP	I-PROBLEM
Of	IN	I-PROBLEM
Membranes	NNP	I-PROBLEM

HEIGHT	$	O
63	CD	O
HEENT	NNP	B-TEST
NORMAL	NNP	O
MOUTH	NNP	O
NORMAL	NNP	O
NECK	NNP	O
NORMAL	NNP	O
BREASTS	NNP	O
NORMAL	NNP	O
No	NNP	O
masses	VBZ	B-PROBLEM
NIPPLES	NNP	O
NORMAL	NNP	O
CHEST	NNP	O
NORMAL	NNP	O
CTA	NNP	B-TEST
bilat	NN	O
,	,	O
neg	JJ	O
wheezing	VBG	B-PROBLEM
COR	NNP	O
NORMAL	NNP	O
NSR	NNP	O
,	,	O
no	DT	O
murmur	JJ	B-PROBLEM
ABDOMEN	NNP	O
Gravid	NNP	B-PROBLEM
,	,	O
vtx	NN	O
.	.	O

EFW	NNP	B-TEST
=	VBD	O
7#	CD	O
.	.	O

FHTs	NNP	B-TEST
140s	CD	O
w/	NN	O
reactivity	NN	O
.	.	O

Mild	NNP	B-PROBLEM
irreg.	JJ	I-PROBLEM
ctx	NN	I-PROBLEM
.	.	O

EXTREM	NNP	B-TEST
NORMAL	NNP	O
SKIN	NNP	O
NORMAL	NNP	O
NODES	NNP	O
NORMAL	NNP	O
VULVA	NNP	O
NORMAL	NNP	O
VAGINA	NNP	O
Leaking	NNP	O
copious	JJ	B-PROBLEM
amounts	NNS	I-PROBLEM
clear	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

Fluid	NNP	B-TEST
amnioswab	NN	I-TEST
and	CC	O
fern	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

SSE	NNP	B-TEST
and	CC	O
digital	JJ	B-TEST
exam	NN	I-TEST
deferred	VBD	O
CERVIX	NNP	B-TEST
digital	JJ	I-TEST
exam	NN	I-TEST
deferred	VBN	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
OS	NNP	B-TEST
NORMAL	NNP	O
see	VBP	O
above	IN	O
ADNEXAE	NNP	B-TEST
NORMAL	NNP	O
non-palp	JJ	O
d	NN	O
/	NNP	O
t	NN	O
advanced	VBD	B-PROBLEM
gest	JJS	I-PROBLEM
UTERUS	NNP	I-PROBLEM
Gravid	NNP	I-PROBLEM
,	,	O
vtx	NN	O
.	.	O

EFW	NNP	B-TEST
=	VBD	O
7#	CD	O
.	.	O

FHTs	NNP	B-TEST
140s	CD	O
w/	NN	O
reactivity	NN	O
.	.	O

Ctx	NNP	B-TEST
q	VBD	O
6	CD	O
&apos;	NN	O
.	.	O

UTERINE	NNP	B-TEST
SIZE	NNP	I-TEST
IN	NNP	O
WEEKS	NNP	O
38	CD	O

premature	JJ	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

She	PRP	O
delivered	VBD	O
a	DT	O
3235	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
11/01/2004	CD	O
at	IN	O
09:31	CD	O
am	VBP	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
39.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

Multivitamins	NNS	B-TREATMENT
And	CC	O
Folate	NNP	B-TREATMENT

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
FEVER	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
PH	NNP	O
UNIVERSITY	NNP	O
OF	NNP	O
MEDICAL	NNP	O
CENTER	NNP	O
.	.	O

Your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
ANER	NNP	O
,	,	O
AEA	NNP	O
M	NNP	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
LINE	NNP	B-PROBLEM
SEPSIS	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
68	CD	O
year	NN	O
old	JJ	O
,	,	O
right	RB	O
handed	VBN	O
caucasian	JJ	O
female	NN	O
,	,	O
former	JJ	O
R.N.	NNP	O
who	WP	O
complained	VBD	O
of	IN	O
several	JJ	O
days	NNS	O
of	IN	O
vertigo	NN	B-PROBLEM
,	,	O
one	CD	O
day	NN	O
of	IN	O
double	JJ	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dysarthria	NN	B-PROBLEM
and	CC	O
worsening	NN	O
of	IN	O
vertigo	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
seen	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
and	CC	O
put	VB	O
on	IN	O
aspirin	NN	B-TREATMENT
for	IN	O
two	CD	O
days	NNS	O
.	.	O

An	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
showed	VBD	O
basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
questionable	JJ	O
aneurysm	NN	B-PROBLEM
.	.	O

An	DT	B-TEST
angiogram	NN	I-TEST
on	IN	O
11/3	CD	O
was	VBD	O
consistent	JJ	O
with	IN	O
thrombosis	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
basilar	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
put	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
and	CC	O
was	VBD	O
stable	JJ	O
since	IN	O
.	.	O

Hypertension	NN	B-PROBLEM
for	IN	O
20	CD	O
years	NNS	O
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
episodes	NNS	O
of	IN	O
angina	NN	B-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
exercise	NN	B-TEST
treadmill	NN	I-TEST
or	CC	O
evaluation	NN	B-TEST
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
an	DT	B-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

A	DT	B-TREATMENT
left	JJ	I-TREATMENT
breast	NN	I-TREATMENT
lumpectomy	NN	I-TREATMENT
was	VBD	O
reportedly	RB	O
benign	JJ	B-TEST
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Mevicor	NNP	B-TREATMENT
60	CD	O
mg.	NN	O
PO	NNP	O
q.d.	NN	O
,	,	O
Cardizem	NNP	B-TREATMENT
90	CD	O
mg.	NN	O
w	NN	O
release	NN	O
PO	NNP	O
q.d.	NN	O
,	,	O
Questran	NNP	B-TREATMENT
one	CD	O
pack	NN	O
q.i.d.	NN	O
,	,	O
Niacin	NNP	B-TREATMENT
500	CD	O
mg.	NN	O
PO	NNP	O
b.i.d.	NN	O

Her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
190/90	CD	O
when	WRB	O
I	PRP	O
first	RB	O
saw	VBD	O
her	PRP	O
on	IN	O
her	PRP$	O
second	JJ	O
hospital	JJ	O
day	NN	O
.	.	O

She	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
in	IN	O
sinus	NN	O
rhythm	NN	O
,	,	O
pulse	RB	O
60	CD	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
without	IN	O
ectopy	NN	B-PROBLEM
.	.	O

A	DT	B-PROBLEM
II	NNP	I-PROBLEM
/	NNP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
is	VBZ	O
at	IN	O
the	DT	O
base	NN	O
,	,	O
minimal	JJ	B-PROBLEM
radiation	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
carotids	NNS	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

normal	JJ	O
pulses	NNS	O
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
:	:	O

post	NN	O
angiogram	IN	B-TEST
her	PRP$	O
eyes	NNS	O
were	VBD	O
closed	VBN	O
.	.	O

She	PRP	O
was	VBD	O
very	RB	O
responsive	JJ	O
,	,	O
somewhat	RB	O
sleepy	JJ	O
,	,	O
she	PRP	O
complained	VBD	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
diffuse	NN	O
,	,	O
non-localizing	JJ	O
without	IN	O
electrocardiogram	JJ	O
changes	NNS	O
and	CC	O
persisted	VBN	O
for	IN	O
several	JJ	O
days	NNS	O
and	CC	O
then	RB	O
went	VBD	O
away	RB	O
completely	RB	O
.	.	O

The	DT	B-TEST
cranial	JJ	I-TEST
nerve	NN	I-TEST
exam	NN	I-TEST
:	:	O

pupils	NNS	O
reactive	VBP	O
to	TO	O
light	NN	O
,	,	O
extra	JJ	B-TEST
ocular	JJ	I-TEST
movements	NNS	I-TEST
show	VBP	O
good	JJ	O
upgaze	NN	O
up	RB	O
to	TO	O
3	CD	O
mm.	NNS	O
,	,	O
good	JJ	O
down	RP	O
gaze	NN	O
.	.	O

Right	RB	B-TEST
lateral	JJ	I-TEST
gaze	NN	I-TEST
,	,	O
the	DT	O
right	NN	O
eye	NN	O
had	VBD	O
2	CD	O
mm.	NN	O
of	IN	O
sclera	NN	O
showing	NN	O
,	,	O
the	DT	O
left	NN	O
eye	NN	O
was	VBD	O
normal	JJ	O
,	,	O
and	CC	O
there	EX	O
are	VBP	O
a	DT	O
few	JJ	O
beats	NNS	O
of	IN	O
right	JJ	B-PROBLEM
beading	VBG	I-PROBLEM
nystagmus	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
left	JJ	I-TEST
lateral	JJ	I-TEST
gaze	NN	I-TEST
,	,	O
the	DT	O
left	NN	O
eye	NN	O
had	VBD	O
1	CD	O
mm.	NN	O
of	IN	O
lateral	JJ	O
sclera	NN	O
showing	NN	O
.	.	O

Sensory	JJ	O
limb	NN	O
of	IN	O
the	DT	O
right	JJ	O
eye	NN	O
corneal	NN	B-TEST
reflex	NN	I-TEST
is	VBZ	O
slowed	VBN	O
,	,	O
otherwise	RB	O
normal	JJ	O
.	.	O

Seventh	NNP	B-PROBLEM
nerve	NN	I-PROBLEM
weakness	NN	I-PROBLEM
on	IN	O
the	DT	O
right	NN	O
in	IN	O
a	DT	O
central	JJ	O
pattern	NN	O
is	VBZ	O
present	JJ	O
.	.	O

Sensory	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
not	RB	O
remarkable	JJ	O
,	,	O
cerebellar	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
not	RB	O
possible	JJ	O
.	.	O

Motor	NNP	B-TEST
exam	NN	I-TEST
showed	VBD	O
greater	JJR	O
than	IN	O
4+	CD	O
strength	NN	O
bilateral	JJ	O
upper	JJ	O
extremities	NNS	O
and	CC	O
psoas	NN	O
unable	JJ	O
to	TO	O
lift	VB	O
off	RP	O
bed	NN	O
.	.	O

Quadraceps	NNS	B-TEST
2+	CD	O
on	IN	O
the	DT	O
left	NN	O
and	CC	O
3+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

Gastroc.	NNP	B-TEST
3	CD	O
on	IN	O
the	DT	O
left	NN	O
and	CC	O
4+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

Tibialis	$	B-TEST
3	CD	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
5+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

Reflexes	NNS	B-TEST
were	VBD	O
diffuse	RB	O
3+	CD	O
,	,	O
toes	NNS	O
upgoing	VBG	O
bilaterally	RB	O
.	.	O

On	IN	O
admission	NN	O
,	,	O
electrocardiogram	NN	B-TEST
showed	VBD	O
less	JJR	O
than	IN	O
1	CD	O
mm.	NN	O
of	IN	O
ST	NNP	B-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
V4	NNP	I-PROBLEM
to	TO	I-PROBLEM
V6	NNP	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
likely	JJ	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
baseline	NN	O
.	.	O

CK	NNP	B-TEST
&apos;s	NNP	I-TEST
were	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
but	CC	O
the	DT	B-TEST
MB	NNP	I-TEST
fractions	NNS	I-TEST
were	VBD	O
not	RB	O
remarkable	JJ	O
.	.	O

A	DT	B-TEST
chest	NN	I-TEST
X-ray	NN	I-TEST
showed	VBD	O
some	DT	B-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

Admitting	VBG	B-TEST
creatinine	NN	I-TEST
was	VBD	O
.7	NNP	O
,	,	O
glucose	VBD	B-TEST
131	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
10,000	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
40	CD	O
,	,	O
liver	RB	B-TEST
enzymes	VBZ	I-TEST
normal	JJ	O
range	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
after	IN	O
her	PRP$	B-TEST
angiogram	NN	I-TEST
.	.	O

She	PRP	O
was	VBD	O
aggressively	RB	O
anticoagulated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
intimal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
in	IN	O
the	DT	O
arch	NN	O
of	IN	O
the	DT	O
aorta	NN	O
during	IN	O
the	DT	B-TEST
angiogram	NN	I-TEST
,	,	O
was	VBD	O
without	IN	O
sequelae	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
at	IN	O
least	JJS	O
4+	CD	O
strength	NN	O
in	IN	O
all	DT	O
of	IN	O
her	PRP$	O
extremities	NNS	O
,	,	O
when	WRB	O
on	IN	O
11/13	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
drop	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
70	CD	O
for	IN	O
unclear	JJ	O
reasons	NNS	O
and	CC	O
without	IN	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

This	DT	O
was	VBD	O
accompanied	VBN	O
by	IN	O
substantial	JJ	B-PROBLEM
decrement	NN	I-PROBLEM
in	IN	I-PROBLEM
neurologic	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

For	IN	O
a	DT	O
short	JJ	O
time	NN	O
,	,	O
she	PRP	O
seemed	VBD	O
&quot;	JJ	B-PROBLEM
locked	VBN	I-PROBLEM
in	IN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
drowsy	VBN	B-PROBLEM
at	IN	O
times	NNS	O
,	,	O
but	CC	O
generally	RB	O
alert	JJ	O
,	,	O
responsive	JJ	O
,	,	O
interactive	JJ	O
,	,	O
able	JJ	O
to	TO	O
talk	VB	O
in	IN	O
two	CD	O
to	TO	O
three	CD	O
word	NN	O
sentences	NNS	O
when	WRB	O
she	PRP	O
wants	VBZ	O
to	TO	O
.	.	O

She	PRP	O
has	VBZ	O
severe	JJ	B-PROBLEM
memory	NN	I-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
but	CC	O
nevertheless	RB	O
,	,	O
is	VBZ	O
able	JJ	O
to	TO	O
engage	VB	O
in	IN	O
conversation	NN	O
,	,	O
answers	NNS	O
questions	NNS	O
,	,	O
names	NNS	O
things	NNS	O
well	RB	O
,	,	O
does	VBZ	O
calculations	NNS	O
and	CC	O
recognizes	VBZ	O
family	NN	O
members	NNS	O
and	CC	O
states	NNS	O
preferences	NNS	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
working	VBG	O
with	IN	O
Speech	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
,	,	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
closely	RB	O
and	CC	O
should	MD	O
continue	VB	O
to	TO	O
show	VB	O
improvement	NN	O
.	.	O

She	PRP	O
is	VBZ	O
anticoagulated	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
and	CC	O
this	DT	O
has	VBZ	O
been	VBN	O
stable	JJ	O
.	.	O

Follow	NNP	O
up	RP	O
computerized	JJ	B-TEST
tomography	NN	I-TEST
scans	NNS	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
studies	NNS	I-TEST
have	VBP	O
shown	VBN	O
infarction	NN	B-PROBLEM
in	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
basis	NN	I-PROBLEM
pontis	NN	I-PROBLEM
,	,	I-PROBLEM
mid	NN	I-PROBLEM
brain	NN	I-PROBLEM
,	,	I-PROBLEM
the	DT	I-PROBLEM
superior	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
areas	NNS	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
thalamus	NN	I-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobes	NNS	I-PROBLEM
medially	RB	I-PROBLEM
and	CC	I-PROBLEM
inferiorly	RB	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
posterior	JJ	I-PROBLEM
communicating	VBG	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
fevers	NNS	B-PROBLEM
sporadically	RB	O
during	IN	O
this	DT	O
hospitalization	NN	O
with	IN	O
rising	VBG	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
counts	NNS	I-PROBLEM
.	.	O

A	DT	B-TEST
chest	JJ	I-TEST
X-ray	NN	I-TEST
documented	VBD	O
a	DT	B-PROBLEM
progressing	NN	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

Initially	RB	O
this	DT	O
improved	VBN	O
on	IN	O
Clindamycin	NNP	B-TREATMENT
and	CC	O
Cefotetan	NNP	B-TREATMENT
,	,	O
but	CC	O
fevers	NNS	B-PROBLEM
recurred	VBD	O
on	IN	O
this	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

Sputum	NNP	B-TEST
grew	VBD	O
out	RP	O
Klebsiella	NNP	B-PROBLEM
pneumoniae	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
Gentamicin	NNP	B-TREATMENT
and	CC	O
Ancef	NNP	B-TREATMENT
for	IN	O
14	CD	O
days	NNS	O
intravenous	JJ	O
(	(	O
bug	JJ	B-PROBLEM
being	VBG	O
sensitive	JJ	O
to	TO	O
these	DT	B-TREATMENT
two	CD	I-TREATMENT
drugs	NNS	I-TREATMENT
)	)	O
.	.	O

A	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
developed	VBD	O
and	CC	O
this	DT	O
was	VBD	O
tapped	VBN	O
with	IN	O
ultrasound	JJ	B-TEST
guidance	NN	I-TEST
,	,	O
and	CC	O
found	VBD	O
to	TO	O
be	VB	O
sterile	JJ	O
,	,	O
and	CC	O
without	IN	O
evidence	NN	O
of	IN	O
empyema	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
Ciprofloxacin	NNP	B-TREATMENT
.	.	O

The	DT	O
day	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
day	NN	O
#3	NNP	O
of	IN	O
7	CD	O
,	,	O
after	IN	O
which	WDT	O
antibiotics	NNS	B-TREATMENT
should	MD	O
be	VB	O
totally	RB	O
discontinued	VBN	O
.	.	O

She	PRP	O
has	VBZ	O
developed	VBN	O
bad	JJ	B-PROBLEM
thrush	NN	I-PROBLEM
in	IN	O
this	DT	O
setting	NN	O
,	,	O
she	PRP	O
is	VBZ	O
not	RB	O
yet	RB	O
able	JJ	O
to	TO	O
swallow	VB	O
and	CC	O
so	RB	O
she	PRP	O
is	VBZ	O
on	IN	O
Nystatin	NNP	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
spit	JJ	I-TREATMENT
five	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

She	PRP	O
also	RB	O
gets	VBZ	O
Peridex	NNP	B-TREATMENT
to	TO	O
clean	VB	O
out	RP	O
her	PRP$	O
mouth	NN	O
.	.	O

Once	RB	O
her	PRP$	B-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
are	VBP	O
completely	RB	O
normal	JJ	O
,	,	O
a	DT	O
seven	CD	O
day	NN	O
course	NN	O
of	IN	O
Fluconazol	NNP	B-TREATMENT
may	MD	O
be	VB	O
helpful	JJ	O
if	IN	O
the	DT	B-PROBLEM
thrush	NN	I-PROBLEM
is	VBZ	O
not	RB	O
spontaneously	RB	O
resolving	VBG	O
off	IN	O
of	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
afebrile	RB	B-PROBLEM
for	IN	O
greater	JJR	O
than	IN	O
10	CD	O
days	NNS	O
,	,	O
including	VBG	O
several	JJ	O
days	NNS	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
elevated	VBN	O
mid	JJ	O
way	NN	O
through	IN	O
her	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
,	,	O
to	TO	O
about	IN	O
three	CD	O
times	NNS	O
normal	JJ	O
,	,	O
especially	RB	O
the	DT	O
SGOT	NNP	B-TEST
and	CC	O
SGPT	NNP	B-TEST
.	.	O

A	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
documented	VBD	O
gallstones	NNS	B-PROBLEM
,	,	O
without	IN	O
evidence	NN	O
of	IN	O
common	JJ	B-PROBLEM
bile	JJ	I-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
or	CC	O
active	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

The	DT	O
exact	JJ	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
enzyme	DT	I-PROBLEM
elevation	NN	I-PROBLEM
is	VBZ	O
unclear	JJ	O
,	,	O
but	CC	O
we	PRP	O
are	VBP	O
being	VBG	O
careful	JJ	O
about	IN	O
administering	VBG	O
drugs	NNS	B-TREATMENT
,	,	O
which	WDT	O
might	MD	O
irritate	VB	O
the	DT	O
liver	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
steady	JJ	I-PROBLEM
decline	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
during	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

Iron	NNP	B-TEST
studies	NNS	I-TEST
are	VBP	O
all	DT	O
entirely	RB	O
normal	JJ	O
,	,	O
her	PRP$	B-PROBLEM
anemia	NN	I-PROBLEM
is	VBZ	O
attributed	VBN	O
to	TO	O
anemia	VB	B-PROBLEM
or	CC	O
chronic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
hypoproliferation	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
multiple	JJ	B-TEST
phlebotomies	NNS	I-TEST
.	.	O

The	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
give	VB	O
her	PRP$	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
,	,	O
but	CC	O
not	RB	O
iron	NN	B-TREATMENT
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
potassiums	NNS	I-TEST
have	VBP	O
been	VBN	O
repeatedly	RB	O
low	JJ	O
and	CC	O
require	JJ	O
daily	JJ	B-TEST
checks	NNS	I-TEST
and	CC	O
repletion	NN	B-TREATMENT
.	.	O

This	DT	O
is	VBZ	O
thought	VBN	O
due	RB	O
to	TO	O
the	DT	O
extensive	JJ	O
course	NN	O
of	IN	O
Gentamicin	NNP	B-TREATMENT
which	WDT	O
she	PRP	O
received	VBD	O
.	.	O

This	DT	O
must	MD	O
be	VB	O
carefully	RB	O
checked	VBN	O
despite	IN	O
the	DT	O
standing	VBG	O
order	NN	O
for	IN	O
potassium	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
low	JJ	B-PROBLEM
sodiums	NNS	I-PROBLEM
during	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

This	DT	O
may	MD	O
due	VB	O
to	TO	O
her	PRP$	B-PROBLEM
central	JJ	I-PROBLEM
nervous	JJ	I-PROBLEM
system	NN	I-PROBLEM
process	NN	I-PROBLEM
or	CC	O
her	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
with	IN	O
fluids	NNS	B-TREATMENT
administered	VBN	I-TREATMENT
as	IN	O
described	NN	O
,	,	O
she	PRP	O
should	MD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
from	IN	O
this	DT	O
.	.	O

Her	PRP$	B-TEST
sodiums	NNS	I-TEST
were	VBD	O
never	RB	O
below	IN	O
130	CD	O
.	.	O

She	PRP	O
does	VBZ	O
well	RB	O
with	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

Her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
orders	NNS	O
are	VBP	O
as	IN	O
follow	NN	O
:	:	O

full	JJ	O
strength	NN	O
Replete	NNP	O
with	IN	O
fiber	NN	B-TREATMENT
at	IN	O
70	CD	O
cc.	NNS	O
per	IN	O
hour	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	JJ	O
gets	VBZ	O
250	CD	O
cc.	NN	O
of	IN	O
juice	NN	B-TREATMENT
(	(	O
not	RB	O
water	NN	O
)	)	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

She	PRP	O
also	RB	O
gets	VBZ	O
Lactinex	NNP	B-TREATMENT
granules	NNS	I-TREATMENT
three	CD	O
packages	NNS	O
in	IN	O
each	DT	O
bottle	NN	O
of	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

She	PRP	O
also	RB	O
gets	VBZ	O
Metamucil	NNP	B-TREATMENT
one	CD	O
teaspoon	NN	O
with	IN	O
the	DT	O
first	JJ	O
bolus	NN	O
of	IN	O
juice	NN	B-TREATMENT
each	DT	O
day	NN	O
.	.	O

Please	NNP	O
note	NN	O
that	IN	O
evaluation	NN	B-TEST
by	IN	I-TEST
the	DT	I-TEST
swallowing	VBG	I-TEST
therapist	NN	I-TEST
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
aspirating	VBG	O
at	IN	O
this	DT	O
time	NN	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
great	JJ	O
hope	NN	O
from	IN	O
the	DT	O
nature	NN	O
of	IN	O
her	PRP$	B-PROBLEM
deficit	NN	I-PROBLEM
and	CC	O
the	DT	O
good	JJ	O
movements	NNS	O
of	IN	O
her	PRP$	O
tongue	NN	O
that	IN	O
normal	JJ	O
swallowing	NN	O
should	MD	O
return	VB	O
soon	RB	O
.	.	O

It	PRP	O
is	VBZ	O
for	IN	O
this	DT	O
reason	NN	O
that	IN	O
she	PRP	O
is	VBZ	O
discharged	VBN	O
with	IN	O
an	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
that	IN	O
no	DT	O
plans	NNS	O
for	IN	O
G	NNP	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
are	VBP	O
made	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

She	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
of	IN	O
angina	NN	B-PROBLEM
without	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
that	WDT	O
has	VBZ	O
not	RB	O
been	VBN	O
worked	VBN	O
up	RP	O
.	.	O

She	PRP	O
did	VBD	O
have	VB	O
brief	NN	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
twice	RB	O
during	IN	O
this	DT	O
admission	NN	O
that	WDT	O
did	VBD	O
not	RB	O
correlate	VB	O
with	IN	O
electrocardiogram	JJ	O
changes	NNS	O
.	.	O

In	IN	O
the	DT	O
first	JJ	O
week	NN	O
of	IN	O
November	NNP	O
,	,	O
her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
T	NNP	B-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
,	,	O
correlating	VBG	O
with	IN	O
an	DT	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	O
the	DT	B-TEST
LDH	NNP	I-TEST
,	,	O
but	CC	O
not	RB	O
CK	NNP	B-TEST
.	.	O

This	DT	O
did	VBD	O
not	RB	O
normalize	VB	O
with	IN	O
administration	NN	O
of	IN	O
Isordil	NNP	B-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
denied	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

As	IN	O
of	IN	O
4/7	CD	O
,	,	O
her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
had	VBD	O
reverted	VBN	O
back	RB	O
to	TO	O
normal	JJ	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
or	CC	O
continued	VBN	O
electrocardiogram	JJ	O
changes	NNS	O
,	,	O
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
absent	JJ	O
.	.	O

Her	PRP$	B-TEST
cholesterol	NN	I-TEST
was	VBD	O
350	CD	O
here	RB	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
off	IN	O
of	IN	O
her	PRP$	B-TREATMENT
hypercholesterol	NN	I-TREATMENT
medicines	NNS	I-TREATMENT
.	.	O

These	DT	O
can	MD	O
be	VB	O
restarted	VBN	O
when	WRB	O
it	PRP	O
is	VBZ	O
deemed	VBN	O
reasonable	JJ	O
,	,	O
in	IN	O
view	NN	O
of	IN	O
her	PRP$	B-PROBLEM
acute	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
recently	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
liver	JJ	I-PROBLEM
enzymes	NNS	I-PROBLEM
.	.	O

Note	NN	O
that	IN	O
the	DT	B-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
were	VBD	O
normal	JJ	O
on	IN	O
admission	NN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
was	VBD	O
taking	VBG	O
all	DT	O
of	IN	O
the	DT	B-TREATMENT
above	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
medicines	NNS	I-TREATMENT
.	.	O

Metamucil	NNP	B-TREATMENT
1	CD	O
teaspoon	NN	O
q.d.	NN	O
,	,	O
with	IN	O
first	JJ	O
bolus	NN	O
of	IN	O
juice	NN	B-TREATMENT
,	,	O
juice	NN	B-TREATMENT
250	CD	O
cc.	NN	O
down	RB	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.	NN	O
,	,	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
as	IN	O
above	IN	O
,	,	O
Lactinex	NNP	B-TREATMENT
as	IN	O
above	IN	O
,	,	O
Tagamet	NNP	B-TREATMENT
800	CD	O
mg.	NN	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
qhs	NN	O
,	,	O
Nystatin	NNP	B-TREATMENT
swish	NN	I-TREATMENT
and	CC	I-TREATMENT
spit	NN	I-TREATMENT
10	CD	O
cc.	NN	O
five	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
Cardizem	NNP	B-TREATMENT
slow	VB	I-TREATMENT
release	NN	I-TREATMENT
90	CD	O
mg.	NN	O
PO	NNP	O
q.d.	NN	O
,	,	O
Folic	NNP	B-TREATMENT
Acid	NNP	I-TREATMENT
1	CD	O
mg.	NN	O
PO	NNP	O
q.d.	NN	O
,	,	O
Ciprofloxacin	NNP	B-TREATMENT
500	CD	O
mg.	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O
discontinue	NN	O
on	IN	O
12/10/92	CD	O
KayCiel	NNP	B-TREATMENT
30	CD	O
mEq.	VBD	O
down	RB	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
q.d.	NN	O
,	,	O
Peridex	NNP	B-TREATMENT
10	CD	O
cc.	NN	O
swish	NN	O
and	CC	O
spit	NN	O
q.i.d.	NN	O
,	,	O
Coumadin	NNP	B-TREATMENT
4	CD	O
mg.	NN	O
nasogastric	JJ	O
tube	NN	O
on	IN	O
odd	JJ	O
days	NNS	O
,	,	O
alternating	VBG	O
with	IN	O
5	CD	O
mg.	NNS	O
nasogastric	JJ	O
tube	NN	O
on	IN	O
even	JJ	O
days	NNS	O
,	,	O
once	RB	O
daily	JJ	O
,	,	O
Tylenol	NNP	B-TREATMENT
650	CD	O
mg.	NN	O
PO	NNP	O
and	CC	O
PR	NNP	O
q6hours	NNS	O
PRN	NNP	O
pain	NN	B-PROBLEM
,	,	O
Nystatin	NNP	B-TREATMENT
powder	NN	I-TREATMENT
to	TO	O
axilla	VB	O
and	CC	O
groin	VB	O
as	IN	O
needed	VBN	O
.	.	O

Basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
basilar	JJ	B-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
&quot;	NNP	B-PROBLEM
top	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
basilar	JJ	I-PROBLEM
&quot;	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

Includes	NNP	O
recent	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
to	TO	I-PROBLEM
pons	NNS	I-PROBLEM
,	,	I-PROBLEM
mid	NN	I-PROBLEM
brain	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
thalamus	NN	I-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobes	NNS	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
visual	JJ	I-PROBLEM
cortex	NN	I-PROBLEM
,	,	O
on	IN	O
Coumadin	NNP	B-TREATMENT
.	.	O

Left	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
resolving	VBG	O
now	RB	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

Gallstones	NNS	B-PROBLEM
,	,	O
thought	VBN	O
to	TO	O
be	VB	O
inactive	JJ	O
.	.	O

Improving	VBG	O
liver	NN	B-PROBLEM
enzyme	DT	I-PROBLEM
elevation	NN	I-PROBLEM
.	.	O

Anemia	NNP	B-PROBLEM
,	,	O
discharge	NN	B-TEST
hematocrit	NN	I-TEST
28	CD	O
,	,	O
not	RB	O
iron	VB	B-PROBLEM
deficient	NN	I-PROBLEM
.	.	O

Low	JJ	B-PROBLEM
potassium	NN	I-PROBLEM
,	,	O
thought	VBD	O
due	JJ	O
to	TO	O
Gentamicin	NNP	B-TREATMENT
.	.	O

Low	JJ	B-PROBLEM
sodium	NN	I-PROBLEM
,	,	O
responsive	JJ	O
to	TO	O
fluid	VB	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

History	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Thrush	NN	B-PROBLEM
.	.	O

High	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
needs	VBZ	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
checked	VBD	O
daily	RB	O
,	,	O
patient	JJ	O
needs	NNS	O
potassium	NN	B-TEST
checked	VBD	O
daily	RB	O
,	,	O
patient	JJ	O
needs	NNS	O
sodium	NN	B-TEST
checked	VBN	O
at	IN	O
least	JJS	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

RLQ	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
kidney	NN	B-PROBLEM
stones	NNS	I-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

likely	RB	O
recently	RB	B-PROBLEM
passed	VBN	I-PROBLEM
kidney	NN	I-PROBLEM
stone	NN	I-PROBLEM

history	NN	O
,	,	O
physical	JJ	B-TEST
,	,	O
lab	NN	B-TEST
,	,	O
Abdominal	NNP	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST

Motrin	NNP	B-TREATMENT
as	IN	O
needed	VBN	O

Also	RB	O
please	NN	O
follow	VB	O
up	RP	O
with	IN	O
urology	NN	O
regarding	VBG	O
management	NN	B-TREATMENT
of	IN	O
your	PRP$	B-PROBLEM
kidney	NN	I-PROBLEM
stones	NNS	I-PROBLEM
.	.	O

Please	NNP	O
return	VB	O
if	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
return	VBP	O
,	,	O
you	PRP	O
develop	VBP	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
IV	NNP	B-TREATMENT
FLUIDS	NNP	I-TREATMENT
.	.	O

Following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
LEFT	NNP	O
WITHOUT	NNP	O
TREATMENT	NNP	B-TREATMENT
.	.	O

LEFT	NNP	B-PROBLEM
KNEE	NNP	I-PROBLEM
OSTEOARTHRITIS	NNP	I-PROBLEM
.	.	O

LEFT	NNP	B-TREATMENT
TOTAL	NNP	I-TREATMENT
KNEE	NNP	I-TREATMENT
ARTHROPLASTY	NNP	I-TREATMENT
ON	NNP	O
6/26/90	CD	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
78-year-old	JJ	O
female	NN	O
who	WP	O
has	VBZ	O
had	VBN	O
osteoarthritis	VBN	B-PROBLEM
and	CC	O
noted	VBD	O
the	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
left	JJ	B-PROBLEM
knee	NN	I-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
09/89	CD	O
.	.	O

Since	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
has	VBZ	O
used	VBN	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
Dr.	NNP	O
Koors	NNP	O
.	.	O

MRI	NNP	B-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
condyle	NN	I-PROBLEM
osteonecrotic	JJ	I-PROBLEM
defect	NN	I-PROBLEM
and	CC	O
degenerative	JJ	B-PROBLEM
meniscus	NN	I-PROBLEM
.	.	O

She	PRP	O
climbs	VBZ	O
stairs	JJ	O
one	CD	O
at	IN	O
a	DT	O
time	NN	O
and	CC	O
denied	VBD	O
rest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

She	PRP	O
can	MD	O
one	CD	O
walk	NN	O
without	IN	O
difficulties	NNS	B-PROBLEM
.	.	O

She	PRP	O
presented	VBD	O
for	IN	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
left	NN	I-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
.	.	O

Pneumonia	NNP	B-PROBLEM
one	CD	O
and	CC	O
a	DT	O
half	JJ	O
years	NNS	O
ago	RB	O
.	.	O

Hepatitis	$	B-PROBLEM
35	CD	O
years	NNS	O
ago	RB	O
.	.	O

Anxiety	NN	B-PROBLEM
neurosis	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
has	VBZ	O
received	VBN	O
shock	NN	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

Total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

On	IN	O
admission	NN	O
included	VBD	O
Tylenol	NNP	B-TREATMENT
.	.	O

DOXEPIN	NNP	B-TREATMENT
CAUSES	NNP	O
ITCHING	NNP	B-PROBLEM
.	.	O

On	IN	O
admission	NN	O
was	VBD	O
only	RB	O
significant	JJ	O
for	IN	O
her	PRP$	B-TEST
orthopaedic	JJ	I-TEST
exam	NN	I-TEST
.	.	O

Her	PRP$	O
left	JJ	O
knee	NN	O
had	VBD	O
5	CD	O
degrees	NNS	O
of	IN	O
valgus	NN	B-PROBLEM
,	,	O
120	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	O
,	,	O
full	JJ	O
extension	NN	O
and	CC	O
slight	JJ	B-PROBLEM
valgus	NN	I-PROBLEM
instability	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
Lachmann	NNP	O
or	CC	O
anterior	JJ	O
drawer	NN	O
,	,	O
she	PRP	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
included	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
34.2	CD	O
.	.	O

Potassium	NN	B-TEST
4.4	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
cleared	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
by	IN	O
Dr.	NNP	O
Lupevickette	NNP	O
Ca	NNP	O
.	.	O

Her	PRP$	B-TEST
EKG	NNP	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

She	PRP	O
was	VBD	O
therefore	RB	O
taken	VBN	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NNP	O
on	IN	O
6/26	CD	O
and	CC	O
underwent	VB	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
losing	VBG	O
200	CD	O
cc	NN	O
of	IN	O
blood	NN	O
in	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
left	VBN	O
in	IN	O
which	WDT	O
were	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
.	.	O

She	PRP	O
was	VBD	O
slightly	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
on	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
but	CC	O
this	DT	O
resolved	VBN	O
by	IN	O
the	DT	O
second	JJ	O
postoperative	JJ	O
day	NN	O
.	.	O

Her	PRP$	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
6/29	CD	O
.	.	O

The	DT	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
6/29	CD	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
difficulties	NNS	B-PROBLEM
voiding	VBG	I-PROBLEM
.	.	O

Psychiatry	NNP	O
Service	NNP	O
saw	VBD	O
her	PRP$	O
on	IN	O
6/28	CD	O
and	CC	O
recommended	VBD	O
avoiding	VBG	O
benzodiazepines	NNS	B-TREATMENT
and	CC	O
Haldol	NNP	B-TREATMENT
for	IN	O
agitation	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
prophylaxed	VBN	O
with	IN	O
Kefzol	NNP	B-TREATMENT
perioperatively	RB	O
and	CC	O
with	IN	O
Coumadin	NNP	B-TREATMENT
postoperatively	RB	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
whiskey	JJ	B-TREATMENT
spirits	NNS	I-TREATMENT
because	IN	O
of	IN	O
the	DT	O
fact	NN	O
that	IN	O
she	PRP	O
drank	VBD	O
one	CD	O
to	TO	O
two	CD	O
drinks	NNS	O
of	IN	O
scotch	NN	O
per	IN	O
day	NN	O
.	.	O

Her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31.4	CD	O
on	IN	O
6/29	CD	O
with	IN	O
a	DT	B-TEST
PT	NNP	I-TEST
of	IN	O
18.2	CD	O

Her	PRP$	B-TEST
PT	NNP	I-TEST
drifted	VBD	O
down	RB	O
to	TO	O
a	DT	O
level	NN	O
of	IN	O
12.9	CD	O
by	IN	O
7/3	CD	O
and	CC	O
therefore	JJR	O
she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
with	IN	O
4	CD	O
mg	NNS	O
of	IN	O
Coumadin	NNP	B-TREATMENT
per	IN	O
day	NN	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
Coumadin	NNP	O
Clinic	NNP	O
at	IN	O
Cowerin	NNP	O
Tonli	NNP	O
Medical	NNP	O
Center	NNP	O
.	.	O

She	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
a	DT	O
prescription	NN	O
for	IN	O
Tylenol	NNP	B-TREATMENT
#3	NNP	I-TREATMENT
with	IN	O
Physical	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
.	.	O

She	PRP	O
did	VBD	O
quite	RB	O
well	RB	O
with	IN	O
Physical	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
and	CC	O
was	VBD	O
ambulating	VBG	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
and	CC	O
crutches	NNS	B-TREATMENT
by	IN	O
7/3/90	CD	O
.	.	O

She	PRP	O
developed	VBD	O
no	DT	O
problems	NNS	O
with	IN	O
edema	NN	B-PROBLEM
or	CC	O
with	IN	O
her	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

LEFT	NNP	B-PROBLEM
PROXIMAL	NNP	I-PROBLEM
HUMERUS	NNP	I-PROBLEM
FRACTURE	NNP	I-PROBLEM
.	.	O

Left	NNP	B-PROBLEM
proximal	JJ	I-PROBLEM
humerus	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Adult-onset	NNP	B-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	JJ	I-PROBLEM
x	$	O
40	CD	O
years	NNS	O
,	,	O
history	NN	O
of	IN	O
silent	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
(	(	O
three	CD	O
vessels	NNS	O
in	IN	O
1987	CD	O
)	)	O
,	,	O
history	NN	O
of	IN	O
chronic	NN	B-PROBLEM
,	,	I-PROBLEM
stable	JJ	I-PROBLEM
angina	NN	I-PROBLEM
pectoris	NN	I-PROBLEM
,	,	O
Fournier	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
gangrene	NN	I-PROBLEM
versus	NN	O
necrotizing	VBG	B-PROBLEM
fasciitis	NN	I-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
03/97	CD	O
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-PROBLEM
rib	NN	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
glaucoma	NN	B-PROBLEM
,	,	O
diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM
with	IN	O
blindness	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
gastric	JJ	B-TREATMENT
stapling	NN	I-TREATMENT
,	,	O
left	VBD	B-PROBLEM
rib	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
right	JJ	B-TREATMENT
femur	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Left	NNP	B-TREATMENT
shoulder	NN	I-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
.	.	O

Upper	NNP	B-TREATMENT
endoscopy	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypassgraft	NN	I-TREATMENT
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
admitted	VBN	O
for	IN	O
preoperative	JJ	B-TEST
and	CC	I-TEST
orthopedic	JJ	I-TEST
evaluations	NNS	I-TEST
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	B-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	NN	I-PROBLEM
humerus	NN	I-PROBLEM
when	WRB	O
he	PRP	O
slipped	VBD	O
over	IN	O
the	DT	O
stairs	NNS	O
,	,	O
about	IN	O
to	TO	O
board	NN	O
an	DT	O
airplane	NN	O
back	RB	O
to	TO	O
Jeglas	NNP	O
Blvd.	NNP	O
,	,	O
Jolouisrowarlihis	NNP	O
,	,	O
Alabama	NNP	O
86071	CD	O
.	.	O

The	DT	B-PROBLEM
fracture	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
by	IN	O
Orthopedics	NNS	O
and	CC	O
was	VBD	O
reduced	VBN	O
.	.	O

During	IN	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
bigeminy	NN	B-PROBLEM
(	(	O
the	DT	O
patient	NN	O
was	VBD	O
sedated	VBN	O
,	,	O
did	VBD	O
not	RB	O
feel	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
)	)	O
.	.	O

The	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
Bri	NNP	O
Health	NNP	O
in	IN	O
order	NN	O
to	TO	O
be	VB	O
evaluated	VBN	O
for	IN	O
preoperative	JJ	B-TEST
clearance	NN	I-TEST
.	.	O

He	PRP	O
was	VBD	O
reported	VBN	O
to	TO	O
have	VB	O
had	VBN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
(	(	O
EKG	NNP	B-TEST
positive	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
,	,	O
exercise	NN	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
positive	JJ	O
,	,	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
positive	JJ	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
now	RB	O
status	NN	O
posta	JJ	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1987	CD	O
)	)	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
hada	JJ	O
history	NN	O
of	IN	O
arrhythmia	NN	B-PROBLEM
,	,	O
found	VBD	O
approximately	RB	O
ten	JJ	O
years	NNS	O
ago	RB	O
,	,	O
unknown	RP	O
what	WP	O
type	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
on	IN	O
coumadin	NN	B-TREATMENT
recently	RB	O
,	,	O
?	.	O
whether	IN	O
for	IN	O
the	DT	O
arrhythmia	NN	B-PROBLEM
.	.	O

Coumadin	NNP	B-TREATMENT
was	VBD	O
reportedly	RB	O
discontinued	VBN	O
approximately	RB	O
six	CD	O
months	NNS	O
ago	RB	O
secondary	JJ	O
to	TO	O
planned	VBN	O
surgery	NN	B-TREATMENT
for	IN	O
diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM
and	CC	O
glaucoma	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
until	IN	O
approximately	RB	O
1-1/2	CD	O
years	NNS	O
ago	RB	O
,	,	O
when	WRB	O
he	PRP	O
began	VBD	O
to	TO	O
have	VB	O
chest	JJS	B-PROBLEM
tightness	NN	I-PROBLEM
(	(	I-PROBLEM
pressure	NN	I-PROBLEM
)	)	I-PROBLEM
approximately	RB	O
every	DT	O
three	CD	O
months	NNS	O
with	IN	O
stress	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
when	WRB	O
walking	VBG	O
slowly	RB	O
and	CC	O
can	MD	O
walk	VB	O
approximately	RB	O
1.5	CD	O
miles	NNS	O
.	.	O

He	PRP	O
can	MD	O
climb	VB	O
approximately	RB	O
three	CD	O
flights	NNS	O
of	IN	O
stairs	NNS	O
before	IN	O
becoming	VBG	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

He	PRP	O
does	VBZ	O
become	VB	O
slightly	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
when	WRB	O
lifting	VBG	O
furniture	NN	O
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
when	WRB	O
he	PRP	O
fell	VBD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
experiencing	VBG	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
and	CC	O
had	VBD	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
no	DT	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
with	IN	I-PROBLEM
fall	NN	I-PROBLEM
.	.	O

No	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
stable	JJ	B-PROBLEM
three-pillow	JJ	I-PROBLEM
orthopnea	NN	I-PROBLEM
and	CC	O
occasional	JJ	B-PROBLEM
paroxysmal	JJ	I-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
cough	NN	I-PROBLEM
with	IN	O
clear	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

No	DT	O
hemoptysis	NN	B-PROBLEM
,	,	O
hematemesis	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
tarry	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
dysuria	NNS	B-PROBLEM
/	VBP	O
frequency/urgency	NN	B-PROBLEM
.	.	O

Some	DT	O
type	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
arrhythmia	NN	I-PROBLEM
,	,	O
diagnosed	VBD	O
approximately	RB	O
ten	JJ	O
years	NNS	O
ago	RB	O
.	.	O

History	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
silent	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
and	CC	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1987	CD	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
experiencing	VBG	O
chronic	JJ	B-PROBLEM
,	,	I-PROBLEM
stable	JJ	I-PROBLEM
angina	NN	I-PROBLEM
pectoris	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
one	CD	O
to	TO	O
one	CD	O
and	CC	O
a	DT	O
half	JJ	O
years	NNS	O
approximately	RB	O
once	RB	O
every	DT	O
three	CD	O
months	NNS	O
.	.	O

History	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
diagnosed	VBD	O
approximately	RB	O
eight	CD	O
years	NNS	O
ago	RB	O
.	.	O

Diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
for	IN	O
approximately	RB	O
40	CD	O
years	NNS	O
.	.	O

Fournier	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
gangrene	NN	I-PROBLEM
versus	NN	O
necrotizing	VBG	B-PROBLEM
fasciitis	NN	I-PROBLEM
.	.	O

Glaucoma	NNP	B-PROBLEM
.	.	O

Diabetic	NNP	B-PROBLEM
retinopathy	NN	I-PROBLEM
with	IN	O
the	DT	O
patient	NN	O
blind	NN	B-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
eye	NN	I-PROBLEM
.	.	O

Cholecystectomy	NNP	B-TREATMENT
.	.	O

Status	NNP	O
post	NN	O
gastric	NN	B-TREATMENT
stapling	NN	I-TREATMENT
.	.	O

Left	NNP	B-PROBLEM
rib	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Right	RB	B-TREATMENT
femur	NN	I-TREATMENT
surgery	NN	I-TREATMENT
approximately	RB	O
two	CD	O
years	NNS	O
ago	RB	O
.	.	O

Righteye	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
glaucoma	NN	B-PROBLEM
in	IN	O
05/97	CD	O
.	.	O

Laser	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
retinopathy	NN	B-PROBLEM
.	.	O

Humulin	NNP	B-TREATMENT
70/30	CD	O
with	IN	O
30	CD	O
units	NNS	O
subq.q.a.m.	RB	O
and	CC	O
20	CD	O
units	NNS	O
subq.q.p.m.	RB	O
Vasotec	NNP	B-TREATMENT
20	CD	O
mg.	NN	O
q.	NN	O
a.m.	RB	O
Prozac	NNP	B-TREATMENT
40	CD	O
mg.	NN	O
q.d.	NN	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg.	NN	O
q.d.	JJ	O
K-Dur	NNP	B-TREATMENT
approximately	RB	O
28	CD	O
?	.	O
mEq	NN	O
q.d.	NN	O
Atropine	NNP	B-TREATMENT
1%	CD	O
1	CD	O
GTT	NNP	O
OD	NNP	O
b.i.d.	VBD	O
Ocufen	NNP	B-TREATMENT
0.03%	CD	O
1	CD	O
GTT	NNP	O
OD	NNP	O
t.i.d.	JJ	O
Ventolin	NNP	B-TREATMENT
metered-dose	JJ	O
inhaler	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
retired	VBN	O
,	,	O
lives	VBZ	O
with	IN	O
his	PRP$	O
wife	NN	O
and	CC	O
one	CD	O
son	NN	O
,	,	O
who	WP	O
is	VBZ	O
47	CD	O
years	NNS	O
old	JJ	O
and	CC	O
had	VBD	O
multiple	VBN	B-PROBLEM
myeloma	NN	I-PROBLEM
and	CC	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
alert	JJ	O
and	CC	O
oriented	VBN	O
and	CC	O
has	VBZ	O
a	DT	B-TREATMENT
sling	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
120/70	CD	O
,	,	O
temperature	NN	B-TEST
97.8	CD	O
F	NNP	O
,	,	O
pulse	RB	B-TEST
68	CD	O
,	,	O
respirations	NNS	B-TEST
22	CD	O
,	,	O
Sa02	NNP	B-TEST
on	IN	O
2	CD	O
L	NNP	O
94%	CD	O
.	.	O

Right-sided	JJ	B-PROBLEM
ptosis	NN	I-PROBLEM
,	,	O
right	RB	O
eye	NN	O
not	RB	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
cataract	JJ	B-PROBLEM
present	JJ	O
,	,	O
patient	JJ	O
blind	NN	B-PROBLEM
in	IN	I-PROBLEM
that	DT	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
left	VBD	O
eye	NN	O
reactive	NN	O
to	TO	O
light	NN	O
,	,	O
cataract	NN	B-PROBLEM
also	RB	O
present	JJ	O
in	IN	O
that	DT	O
eye	NN	O
.	.	O

Extraocular	JJ	B-TEST
movements	NNS	I-TEST
-	:	O
conjugated	VBN	O
eye	NN	O
movement	NN	O
intact	JJ	O
.	.	O

Oropharynx	NNP	O
moist	NN	O
,	,	O
without	IN	O
lesions	NNS	B-PROBLEM
.	.	O

Mild	NNP	B-PROBLEM
right	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

No	DT	O
slurred	JJ	B-PROBLEM
speech	NN	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
appreciated	VBD	O
,	,	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
diffusely	RB	B-PROBLEM
wheezy	JJ	I-PROBLEM
upon	IN	O
presentation	NN	O
.	.	O

Abdomen	NNS	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
,	,	O
bowel	VB	B-TEST
sounds	NNS	I-TEST
present	JJ	O
,	,	O
nohepatosplenomegaly	JJ	B-PROBLEM
.	.	O

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
pulses	NNS	B-TEST
present	VBP	O
bilaterally	RB	O
.	.	O

No	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Guaiac	NNP	B-TEST
negative	JJ	O
.	.	O

Non-focal	JJ	O
,	,	O
except	IN	O
unable	JJ	O
to	TO	O
assess	VB	O
left	JJ	O
upper	JJ	O
extremity	NN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
broken	VBZ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

sodium	NN	B-TEST
135	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
C02	NNP	B-TEST
28.4	CD	O
,	,	O
BUN	NNP	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
,	,	O
glucose	RB	B-TEST
302	CD	O
,	,	O
calcium	NN	B-TEST
8.6	CD	O
,	,	O
phosphorus	NN	B-TEST
2.5	CD	O
,	,	O
magnesium	NN	B-TEST
1.6	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.7	CD	O
,	,	O
albumin	RB	B-TEST
3.3	CD	O
,	,	O
globulin	NN	B-TEST
3.4	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
6.3	CD	O
,	,	O
totalbilirubin	NN	B-TEST
.7	NNP	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
93	CD	O
,	,	O
SGOT	NNP	B-TEST
20	CD	O
,	,	O
LDH	NNP	B-TEST
258	CD	O
,	,	O
CPK	NNP	B-TEST
95	CD	O
,	,	O
whiteblood	NN	B-TEST
count	NN	I-TEST
15.3	CD	O
,	,	O
hematocrit	NN	B-TEST
49.7	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
159	CD	O
,	,	O
MCV	NNP	B-TEST
98	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	JJ	I-TEST
10/10/97	CD	O
:	:	O

Elevated	VBN	B-PROBLEM
left	VBD	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
of	IN	O
uncertain	JJ	O
etiology	NN	O
or	CC	O
duration	NN	O
.	.	O

Postoperative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
sternum	NN	I-PROBLEM
and	CC	I-PROBLEM
media	NNS	I-PROBLEM
stinum	NN	I-PROBLEM
were	VBD	O
seen	VBN	O
and	CC	O
no	DT	O
acute	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
visualized	VBN	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	B-TEST
shoulder	NN	I-TEST
film	NN	I-TEST
done	VBN	O
on	IN	O
10/10/97	CD	O
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
with	IN	O
proximal	JJ	B-PROBLEM
distraction	NN	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
lucency	NN	I-PROBLEM
and	CC	I-PROBLEM
irregularity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
glenoid	NN	I-PROBLEM
,	,	O
possibly	RB	O
representing	VBG	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
was	VBD	O
also	RB	O
seen	VBN	O
,	,	O
and	CC	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
was	VBD	O
therefore	RB	O
obtained	VBN	O
in	IN	O
order	NN	O
to	TO	O
evaluate	VB	O
this	DT	O
area	NN	O
.	.	O

This	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
,	,	O
done	VBN	O
also	RB	O
on	IN	O
10/10/97	CD	O
,	,	O
again	RB	O
showed	VBD	O
the	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
.	.	O

Two	CD	B-PROBLEM
major	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
at	IN	O
the	DT	O
humeral	JJ	O
head	NN	O
,	,	O
articulating	VBG	O
with	IN	O
the	DT	O
glenoid	NN	O
fossa	NN	O
.	.	O

The	DT	B-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
retained	VBD	O
their	PRP$	O
proper	JJ	O
site	NN	O
of	IN	O
articulation	NN	O
with	IN	O
the	DT	O
glenoid	NN	O
fossa	NN	O
.	.	O

Innumerable	JJ	B-PROBLEM
smaller	JJR	I-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
were	VBD	O
interposed	VBN	O
between	IN	O
the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
fragment	NN	I-PROBLEM
and	CC	O
the	DT	O
distal	JJ	O
humeral	JJ	O
shaft	NN	O
.	.	O

No	DT	O
scapular	JJ	B-PROBLEM
fractures	NNS	I-PROBLEM
were	VBD	O
present	JJ	O
.	.	O

EKG	NN	B-TEST
:	:	O

normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
72	CD	O
beats	NNS	B-TEST
/	VBP	I-TEST
minute	NN	I-TEST
,	,	O
intraventricular	JJ	B-PROBLEM
conduction	NN	I-PROBLEM
delay	NN	I-PROBLEM
,	,	O
Q	NNP	O
-	:	O
waves	NNS	O
seen	VBN	O
in	IN	O
II	NNP	O
,	,	O
III	NNP	O
,	,	O
and	CC	O
AVF	NNP	O
with	IN	O
probable	JJ	O
old	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Ventricular	JJ	B-PROBLEM
bigeminy	NN	I-PROBLEM
was	VBD	O
also	RB	O
seen	VBN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
on	IN	O
10/17/97	CD	O
.	.	O

He	PRP	O
received	VBD	O
Ancef	NNP	B-TREATMENT
preoperatively	RB	O
.	.	O

Physical	JJ	O
Therapy	NNP	O
has	VBZ	O
been	VBN	O
seeing	VBG	O
the	DT	O
patient	NN	O
and	CC	O
putting	VBG	O
him	PRP	O
through	IN	O
passive	JJ	B-TREATMENT
external	JJ	I-TREATMENT
rotation	NN	I-TREATMENT
to	TO	O
the	DT	O
neutral	JJ	O
position	NN	O
of	IN	O
the	DT	O
left	JJ	O
shoulder	NN	O
and	CC	O
forward	JJ	O
flexion	NN	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
assistance	NN	I-TREATMENT
.	.	O

Brittle	NNP	B-PROBLEM
bones	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
during	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

A	DT	B-TEST
bone	NN	I-TEST
density	NN	I-TEST
scan	NN	I-TEST
would	MD	O
be	VB	O
recommended	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
evaluate	VB	O
this	DT	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ptosis	NN	I-PROBLEM
,	,	O
stable	JJ	O
and	CC	O
present	JJ	O
for	IN	O
greater	JJR	O
than	IN	O
one	CD	O
year	NN	O
.	.	O

No	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
1+	CD	B-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
given	VBN	O
his	PRP$	B-PROBLEM
fall	NN	I-PROBLEM
at	IN	O
the	DT	O
airport	NN	O
and	CC	O
bigeminy	NN	B-PROBLEM
seen	VBN	O
on	IN	O
electrocardiogram	NN	B-TEST
that	IN	O
he	PRP	O
developed	VBD	O
during	IN	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
during	IN	O
reduction	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
fracture	NN	I-TREATMENT
.	.	O

Cardiology	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
aspirin	JJ	B-TREATMENT
and	CC	O
beta	JJ	B-TREATMENT
blocker	NN	I-TREATMENT
added	VBD	O
to	TO	O
his	PRP$	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
chest	JJS	B-TREATMENT
wall	NN	I-TREATMENT
nitroglycerin	NN	I-TREATMENT
around	IN	O
the	DT	O
time	NN	O
of	IN	O
surgery	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
subsequently	RB	O
discontinued	VBN	O
.	.	O

An	DT	B-TEST
adenosine	NN	I-TEST
SESTAMIBI	NNP	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
10/12/97	CD	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	O
negative	JJ	O
electrocardiogram	NN	O
for	IN	O
ischemia	NN	B-PROBLEM
and	CC	O
cardiac	JJ	B-TEST
perfusion	NN	I-TEST
scans	NNS	I-TEST
,	,	O
with	IN	O
a	DT	B-PROBLEM
moderate-sized	JJ	I-PROBLEM
,	,	I-PROBLEM
dense	NN	I-PROBLEM
,	,	I-PROBLEM
fixed	VBN	I-PROBLEM
inferior	JJ	I-PROBLEM
defect	JJ	I-PROBLEM
indicative	NN	O
of	IN	O
scar	NN	B-PROBLEM
.	.	O

A	DT	B-PROBLEM
small	JJ	I-PROBLEM
/	JJ	I-PROBLEM
moderate-sized	JJ	I-PROBLEM
,	,	I-PROBLEM
mild-intensity	NN	I-PROBLEM
,	,	I-PROBLEM
reversible	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
defect	NN	I-PROBLEM
was	VBD	O
also	RB	O
seen	VBN	O
,	,	O
indicative	JJ	O
of	IN	O
mild	JJ	B-PROBLEM
/	NNP	I-PROBLEM
moderate	NN	I-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

An	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
Columbus	NNP	O
Day	NNP	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
thickening	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
wall	NN	I-PROBLEM
consistent	NN	O
with	IN	O
atherosclerotic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
left	VBD	O
ventricle	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

Cardiac	NNP	B-TEST
monitor	NN	I-TEST
was	VBD	O
placed	VBN	O
on	IN	O
the	DT	O
patient	NN	O
,	,	O
given	VBN	O
the	DT	B-PROBLEM
bigeminy	NN	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
did	VBD	O
rule	VB	O
out	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Cardiology	NNP	O
recommended	VBD	O
that	IN	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	B-TREATMENT
medications	NNS	I-TREATMENT
already	RB	O
stated	VBN	O
above	IN	O
,	,	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
be	VB	O
kept	VBN	O
greater	JJR	O
than	IN	O
30	CD	O
.	.	O

After	IN	O
his	PRP$	B-TREATMENT
procedure	NN	I-TREATMENT
on	IN	O
10/17/97	CD	O
,	,	O
elevated	VBN	B-PROBLEM
CPKs	NNP	I-PROBLEM
were	VBD	O
noted	VBN	O
on	IN	O
10/19/97	CD	O
to	TO	O
10/20/97	CD	O
,	,	O
and	CC	O
the	DT	O
first	JJ	O
level	NN	O
was	VBD	O
744	CD	O
,	,	O
CPK	NNP	B-TEST
#	#	O
2	CD	O
635	CD	O
,	,	O
and	CC	O
CPK	NNP	B-TEST
#	#	O
3	CD	O
461	CD	O
.	.	O

MB	NNP	B-PROBLEM
fractionations	NNS	I-PROBLEM
of	IN	O
the	DT	B-TEST
CPKs	NNP	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
and	CC	O
were	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
the	DT	O
patient	NN	O
&apos;s	NN	O
beginning	VBG	O
physical	JJ	O
therapy	NN	O
on	IN	O
10/19/97	CD	O
,	,	O
and	CC	O
all	DT	O
muscular	NN	O
in	IN	O
origin	NN	O
.	.	O

GI	NNP	O
was	VBD	O
consulted	VBN	O
on	IN	O
10/15/97	CD	O
for	IN	O
melena	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
hematocrit	NN	I-PROBLEM
prior	RB	O
to	TO	O
his	PRP$	B-TREATMENT
humeral	JJ	I-TREATMENT
fixation	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Upper	NNP	B-TEST
endoscopy	NN	I-TEST
x	VBD	I-TEST
2	CD	I-TEST
were	VBD	O
done	VBN	O
.	.	O

The	DT	O
first	JJ	O
was	VBD	O
on	IN	O
10/15/97	CD	O
,	,	O
which	WDT	O
showed	VBD	O
clotted	VBD	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
esophagus	NN	I-PROBLEM
.	.	O

The	DT	O
stomach	NN	O
had	VBD	O
evidence	NN	O
of	IN	O
prior	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
old	JJ	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
the	DT	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
esophagus	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
a	DT	O
possible	JJ	O
Mallory-Weiss	JJ	B-PROBLEM
tear	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
second	JJ	I-TEST
endoscopy	NN	I-TEST
was	VBD	O
also	RB	O
performed	VBN	O
several	JJ	O
days	NNS	O
later	RB	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
and	CC	O
also	RB	O
because	IN	O
the	DT	O
patient	NN	O
had	VBD	O
had	VBN	O
another	DT	O
episode	NN	O
of	IN	O
melena	NN	B-PROBLEM
.	.	O

A	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
found	VBN	O
and	CC	O
this	DT	O
was	VBD	O
biopsied	VBN	O
and	CC	O
pathology	NN	B-TEST
is	VBZ	O
pending	VBG	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
needs	VBZ	O
a	DT	B-TEST
repeat	NN	I-TEST
endoscopy	NN	I-TEST
and	CC	O
a	DT	B-TEST
GI	NNP	I-TEST
follow-up	JJ	I-TEST
appointment	NN	O
inapproximately	RB	O
two	CD	O
months	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
on	IN	O
Cimetidine	NNP	B-TREATMENT
and	CC	O
Carafate	NNP	B-TREATMENT
here	RB	O
at	IN	O
Bri	NNP	O
Health	NNP	O
,	,	O
and	CC	O
then	RB	O
switched	VBD	O
to	TO	O
Prilosec	VB	B-TREATMENT
20	CD	O
mg	JJ	O
bid	NN	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
admitting	VBG	I-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
left	NN	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
atelectasis	NN	B-PROBLEM
versus	NN	O
splinting	VBG	B-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

Incentive	JJ	B-TREATMENT
spirometry	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

Albuterol	NNP	B-TREATMENT
and	CC	I-TREATMENT
Atrovent	NNP	I-TREATMENT
nebulizers	NNS	I-TREATMENT
were	VBD	O
done	VBN	O
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
chest	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
bid	NN	O
.	.	O

The	DT	O
patient	NN	O
needs	VBZ	O
still	RB	O
better	RBR	O
diabetes	NNS	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

His	PRP$	B-TREATMENT
NPH	NNP	I-TREATMENT
was	VBD	O
recently	RB	O
increased	VBN	O
today	NN	O
(	(	O
10/23/97	CD	O
)	)	O
to	TO	O
24	CD	O
units	NNS	O
in	IN	O
the	DT	O
a.m.	NN	O
and	CC	O
14	CD	O
units	NNS	O
in	IN	O
the	DT	O
p.m.	NN	O
with	IN	O
CZI	NNP	B-TREATMENT
sliding-scale	JJ	I-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

The	DT	B-TEST
patient	JJ	I-TEST
urinalysis	NN	I-TEST
on	IN	O
10/19/97	CD	O
showed	VBD	O
moderate	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
,	,	O
pH	NN	B-TEST
5	CD	O
,	,	O
albumin	RB	B-TEST
1+	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
present	JJ	O
,	,	O
2-50	JJ	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
,	,	O
10-20	JJ	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
few	JJ	B-PROBLEM
bacteria	NNS	I-PROBLEM
,	,	O
and	CC	O
moderate	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
epithelial	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

Floxin	NN	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
bid	NN	O
was	VBD	O
begun	VBN	O
.	.	O

However	RB	O
,	,	O
his	PRP$	B-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
from	IN	O
the	DT	O
same	JJ	O
day	NN	O
remained	VBD	O
negative	JJ	O
,	,	O
and	CC	O
this	DT	O
was	VBD	O
discontinued	VBN	O
two	CD	O
days	NNS	O
later	RB	O
.	.	O

A	DT	B-TEST
repeat	NN	I-TEST
urinalysis	NN	I-TEST
on	IN	O
10/22/97	CD	O
was	VBD	O
negative	JJ	O
.	.	O

After	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
he	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
IV	NNP	O
x	VBZ	O
1	CD	O
and	CC	O
also	RB	O
had	VBD	O
Nitro	NNP	B-TREATMENT
paste	NN	I-TREATMENT
around	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
slightly	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
on	IN	O
the	DT	O
night	NN	O
of	IN	O
10/18/97	CD	O
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80s	CD	O
to	TO	O
90s.	CD	O

His	PRP$	B-TEST
BUN/	NNP	I-TEST
creatinine	NN	I-TEST
rose	VBD	O
from	IN	O
16/1.2	CD	O
on	IN	O
10/18/97	CD	O
to	TO	O
25/1.9	CD	O
on	IN	O
10/18/97	CD	O
to	TO	O
22/9.1	CD	O
to	TO	O
today	NN	O
&apos;s	NNP	O
labs	NN	O
,	,	O
which	WDT	O
are	VBP	O
15/0.7	CD	O
on	IN	O
10/23/97	CD	O
.	.	O

The	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
on	IN	O
10/15/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
27.6	CD	O
.	.	O

The	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
of	IN	O
10/16/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
30.03	CD	O
.	.	O

The	DT	O
patient	NN	O
transfused	VBD	O
1	CD	O
unit	NN	O
on	IN	O
10/18/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29.4	CD	O
.	.	O

The	DT	O
patient	NN	O
transfused	VBD	O
1	CD	O
unit	NN	O
on	IN	O
10/19/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
27.9	CD	O
.	.	O

The	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
on	IN	O
10/20/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
28.2.10	CD	O
.	.	O

Repleting	VBG	O
potassium	NN	B-TREATMENT
,	,	O
magnesium	NN	B-TREATMENT
,	,	O
phosphorus	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
slightly	RB	B-PROBLEM
hyponatremic	JJ	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
,	,	O
with	IN	O
sodiums	NNS	B-TEST
in	IN	O
the	DT	O
128-132	JJ	O
range	NN	O
,	,	O
but	CC	O
this	DT	O
was	VBD	O
secondary	JJ	O
to	TO	O
elevated	VBN	B-PROBLEM
glucose	JJ	I-PROBLEM
fingerstick	JJ	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
.	.	O

NPH	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
24	CD	O
units	NNS	O
subq.	VBP	O
q.	JJ	O
a.m.	RB	O
NPH	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
14	CD	O
units	NNS	O
subq.	VBP	O
q.	JJ	O
p.m.	NN	O
CZI	NNP	B-TREATMENT
sliding	VBG	O
scale	NN	O
on	IN	O
a	DT	O
q.	JJ	O
a.c.	NN	O
and	CC	O
q.	JJ	O
h.s.	NN	O
fingerstick	JJ	O
basis	NN	O
with	IN	O
the	DT	O
following	VBG	O
scale	NN	O
:	:	O

FBS	NNP	B-TEST
less	JJR	O
than	IN	O
200	CD	O
=	JJ	O
0	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
FBS	NNP	B-TEST
201-250	JJ	O
=	NNP	O
2	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
FBS	NNP	B-TEST
251-300	JJ	O
=	NNP	O
4	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
FBS	NNP	B-TEST
301-350	JJ	O
=	NNP	O
6	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
FBS	NNP	B-TEST
351-400	JJ	O
=	NNP	O
8	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
FBS	NNP	B-TEST
greater	JJR	O
than	IN	O
400	CD	O
=	JJ	O
10	CD	O
units	NNS	O
of	IN	O
CZI	NNP	B-TREATMENT
.	.	O

Atropine	NNP	B-TREATMENT
sulfate	NN	I-TREATMENT
1	CD	O
GTT	NNP	O
1%	CD	O
OD	NNP	O
b.i.d.	NN	O

Ocufen	NNP	B-TREATMENT
0.03%	CD	O
1	CD	O
GTT	NNP	O
OD	NNP	O
t.i.d.	VBD	O
Vasotec	NNP	B-TREATMENT
20	CD	O
mg.	NN	O
p.o.q.	NN	O
a.m.	RB	O
Prozac	NNP	B-TREATMENT
40	CD	O
mg.p.o.q.	NN	O
a.m.	NN	O

Oxygen	NNP	B-TREATMENT
2-4	JJ	O
L	NNP	O
to	TO	O
keep	VB	O
Sa02	NNP	B-TEST
greater	JJR	O
than	IN	O
or	CC	O
equal	JJ	O
to	TO	O
94-95%	CD	O
and	CC	O
wean	JJ	O
as	IN	O
tolerated	VBN	O
.	.	O

Colace	NN	B-TREATMENT
100	CD	O
mg.	NN	O
p.o.	NN	O
t.i.d.	NN	O
Senokot	NNP	B-TREATMENT
1	CD	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
Nystatin	NNP	B-TREATMENT
powder	NN	O
to	TO	O
affected	JJ	B-PROBLEM
area	NN	I-PROBLEM
t.i.d.	NN	O
Lopressor	NNP	B-TREATMENT
25	CD	O
mg.	NN	O
p.o.	NN	O
b.i.d.	NN	O
Atrovent	NNP	B-TREATMENT
0.8/2.5	CD	O
c.c.	NN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
q.	VBP	O
8	CD	O
h.	NNS	O
Albuterol	NNP	B-TREATMENT
2.5/5	CD	O
c.c.	NN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
q.	VBP	O
4	CD	O
h.	NN	O
with	IN	O
q.	JJ	O
2	CD	O
h.	JJ	O
p.r.n.	NN	O
Percocet	NNP	B-TREATMENT
1-2	JJ	O
p.o.	NN	O
q.	NN	O
4	CD	O
h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

Prilosec	NNP	B-TREATMENT
20	CD	O
mg.	NN	O
p.o.	NN	O
b.i.d.	NN	O
Vexol	NNP	B-TREATMENT
1%	CD	O
1	CD	O
GTT	NNP	O
OD	NNP	O
b.i.d.	VBD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg.	NN	O
p.o.	NN	O
q.d.	NN	O
KCl	NNP	B-TREATMENT
20	CD	O
mEq	NN	O
p.o.	NN	O
q.d.	NN	O
Tylenol	NNP	B-TREATMENT
650	CD	O
mg.	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
h.	NN	O
p.r.n.	NN	O
Ativan	NNP	B-TREATMENT
1	CD	O
mg.	NN	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

LEFT	NNP	B-PROBLEM
ROTATOR	NNP	I-PROBLEM
CUFF	NNP	I-PROBLEM
TEAR	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52-year-old	JJ	O
right	NN	O
handed	VBN	O
male	NN	O
with	IN	O
a	DT	O
many	JJ	O
year	NN	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
shoulder	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

He	PRP	O
has	VBZ	O
steroid	JJ	B-TREATMENT
injections	NNS	I-TREATMENT
in	IN	O
the	DT	O
right	NN	O
and	CC	O
in	IN	O
the	DT	O
left	NN	O
four	CD	O
times	NNS	O
.	.	O

Arthrogram	NNP	B-TEST
in	IN	O
the	DT	O
distant	JJ	O
past	NN	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
rotator	NN	I-PROBLEM
cuff	NN	I-PROBLEM
tear	NN	I-PROBLEM
and	CC	O
he	PRP	O
now	RB	O
has	VBZ	O
increased	VBN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
.	.	O

MRI	NNP	B-TEST
by	IN	O
report	NN	O
showed	VBD	O
bilateral	JJ	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repairs	NNS	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
repair	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
.	.	O

Back	RB	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Ankle	NNP	B-TREATMENT
surgery	NN	I-TREATMENT
times	RB	O
two	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

Pilonidal	NNP	B-TREATMENT
cyst	NN	I-TREATMENT
removal	NN	I-TREATMENT
.	.	O

On	IN	O
admission	NN	O
included	VBD	O
Naprosyn	NNP	B-TREATMENT
.	.	O

NO	DT	O
KNOWN	NNP	B-PROBLEM
DRUG	NNP	I-PROBLEM
ALLERGIES	NNP	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
white	JJ	O
male	NN	O
with	IN	O
no	DT	O
palpable	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

HEENT	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

Lungs	NNS	O
revealed	VBD	O
occasional	JJ	B-PROBLEM
wheezing	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
at	IN	O
both	DT	O
bases	NNS	O
.	.	O

Heart	NNP	O
was	VBD	O
regular	JJ	O
with	IN	O
a	DT	B-PROBLEM
I	PRP	I-PROBLEM
/	VBP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
without	IN	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

Pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

Abdomen	NNP	O
was	VBD	O
obese	JJ	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

Examination	NN	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
shoulder	NN	I-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
able	JJ	O
to	TO	O
flex	VB	O
his	PRP$	O
right	JJ	O
arm	NN	O
to	TO	O
170	CD	O
degrees	NNS	O
,	,	O
internally	RB	O
rotate	VB	O
to	TO	O
10	CD	O
degrees	NNS	O
and	CC	O
externally	RB	O
rotate	VB	O
to	TO	O
40	CD	O
degrees	NNS	O
with	IN	O
positive	JJ	B-PROBLEM
joint	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
the	DT	B-TEST
assessment	NN	I-TEST
of	IN	O
left	JJ	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repair	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
where	WRB	O
he	PRP	O
underwent	JJ	O
left	VBD	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repair	NN	I-TREATMENT
under	IN	O
general	JJ	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

There	EX	O
were	VBD	O
no	DT	O
intraoperative	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

Occupational	JJ	O
therapy	NN	O
became	VBD	O
involved	VBN	O
initially	RB	O
and	CC	O
he	PRP	O
remained	VBD	O
on	IN	O
patient	NN	B-TREATMENT
controlled	VBN	I-TREATMENT
analgesia	RB	I-TREATMENT
secondary	JJ	O
to	TO	O
problems	NNS	O
with	IN	O
left	JJ	B-PROBLEM
shoulder	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

His	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
remained	VBD	O
clean	JJ	O
and	CC	O
dry	JJ	O
and	CC	O
showed	VBD	O
no	DT	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
healed	VBN	O
well	RB	O
.	.	O

However	RB	O
,	,	O
his	PRP$	O
course	NN	O
was	VBD	O
otherwise	RB	O
complicated	VBN	O
by	IN	O
discovery	NN	O
of	IN	O
persistently	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
and	CC	O
Endocrinology	NNP	O
was	VBD	O
consulted	VBN	O
to	TO	O
rule	VB	O
out	IN	O
possible	JJ	O
newly	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

His	PRP$	B-TEST
hemoglobin	NN	I-TEST
A1C	NNP	I-TEST
levels	NNS	I-TEST
actually	RB	O
came	VBD	O
back	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
however	RB	O
,	,	O
the	DT	B-PROBLEM
wide	JJ	I-PROBLEM
excursions	NNS	I-PROBLEM
of	IN	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
were	VBD	O
consistent	JJ	O
with	IN	O
possible	JJ	O
diabetes	NNS	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
diabetic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
did	VBD	O
show	VB	O
some	DT	O
improvement	NN	O
.	.	O

It	PRP	O
was	VBD	O
not	RB	O
necessary	JJ	O
to	TO	O
start	VB	O
him	PRP	O
on	IN	O
oral	JJ	B-TREATMENT
hypoglycemics	NNS	I-TREATMENT
or	CC	O
insulin	NN	B-TREATMENT
.	.	O

He	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
occasional	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
and	CC	O
jitteriness	NN	B-PROBLEM
and	CC	O
some	DT	B-PROBLEM
orthostatic	JJ	I-PROBLEM
dizziness	NN	I-PROBLEM
and	CC	O
thus	RB	O
Neurology	NNP	O
was	VBD	O
consulted	VBN	O
and	CC	O
EMG	NNP	B-TEST
&apos;s	NNP	I-TEST
were	VBD	O
performed	VBN	O
which	WDT	O
were	VBD	O
normal	JJ	O
.	.	O

His	PRP$	O
neurologist	NN	O
was	VBD	O
contacted	VBN	O
,	,	O
Dr.	NNP	O
Cap	NNP	O
,	,	O
and	CC	O
the	DT	O
exact	NN	O
of	IN	O
his	PRP$	O
problems	NNS	O
was	VBD	O
not	RB	O
demonstrated	VBN	O
during	IN	O
this	DT	O
hospitalization	NN	O
,	,	O
however	RB	O
,	,	O
they	PRP	O
felt	VBD	O
that	IN	O
this	DT	O
could	MD	O
possibly	RB	O
be	VB	O
an	DT	B-PROBLEM
autonomic	JJ	I-PROBLEM
type	NN	I-PROBLEM
neuropathy	JJ	I-PROBLEM
maybe	RB	O
secondary	JJ	O
to	TO	O
some	DT	B-PROBLEM
underlying	JJ	I-PROBLEM
diabetic	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

Further	JJ	B-TEST
work-up	NN	I-TEST
of	IN	O
his	PRP$	B-PROBLEM
neurologic	JJ	I-PROBLEM
conditions	NNS	I-PROBLEM
were	VBD	O
planned	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

Thus	RB	O
,	,	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
eight	CD	O
in	IN	O
good	JJ	O
condition	NN	O
with	IN	O
a	DT	B-PROBLEM
well	NN	I-PROBLEM
healed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
shoulder	NN	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
doing	VBG	O
well	RB	O
with	IN	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
plans	NNS	O
for	IN	O
him	PRP	O
to	TO	O
follow-up	NN	O
with	IN	O
Dr.	NNP	O
Necessary	NNP	O
.	.	O

On	IN	O
discharge	NN	O
included	VBD	O
Valium	NNP	B-TREATMENT
,	,	O
2	CD	O
mg	NN	O
po	NN	O
t.i.d.;	NN	O
Naprosyn	NNP	B-TREATMENT
,	,	O
500	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
________________________________	NNP	O
ZV061/6138	NNP	O
TICENA	NNP	O
NECESSARY	NNP	O
,	,	O
M.D.	NNP	O
WO00	NNP	O

1.	CD	O
INSULIN	NNP	B-PROBLEM
DEPENDENT	NNP	I-PROBLEM
DIABETES	NNP	I-PROBLEM
MELLITUS	NNP	I-PROBLEM

2.	CD	O
PRIOR	NNP	O
HISTORY	NNP	O
OF	NNP	O
ANTERIOR	NNP	B-PROBLEM
MYOCARDIAL	NNP	I-PROBLEM
INFARCTION	NNP	I-PROBLEM

3.	CD	O
EPISODE	NNP	O
OF	NNP	O
PULMONARY	NNP	B-PROBLEM
EDEMA	NNP	I-PROBLEM

4.	CD	O
HYPERCHOLESTEROLEMIA	NNP	B-PROBLEM

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
40	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
prior	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
after	IN	O
an	DT	O
episode	NN	O
of	IN	O
acute	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
four	CD	O
years	NNS	O
ago	RB	O
of	IN	O
being	VBG	O
admitted	VBN	O
to	TO	O
the	DT	O
Etearal	NNP	O
Etsystems/	NNP	O
Hospital	NNP	O
after	IN	O
suffering	VBG	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

The	DT	O
course	NN	O
had	VBD	O
multiple	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
requiring	VBG	O
pressors	NNS	B-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
performed	VBD	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
three	CD	I-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
occluded	JJ	I-PROBLEM
RCA	NNP	I-PROBLEM
,	,	O
70%-80%	JJ	B-PROBLEM
proximal	NN	I-PROBLEM
LAD	NNP	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
grade	NN	I-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
after	IN	I-PROBLEM
the	DT	I-PROBLEM
OM	NNP	I-PROBLEM
with	IN	O
distal	JJ	B-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
medically	RB	O
management	NN	O
after	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
and	CC	O
has	VBZ	O
done	VBN	O
very	RB	O
well	RB	O
.	.	O

His	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
echocardiogram	NN	I-TEST
in	IN	O
April	NNP	O
of	IN	O
1996	CD	O
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
20%	CD	O
with	IN	O
a	DT	B-PROBLEM
thin	JJ	I-PROBLEM
fibrotic	JJ	I-PROBLEM
septum	NN	I-PROBLEM
with	IN	O
akinesis	NN	B-PROBLEM
and	CC	O
moderately	RB	B-PROBLEM
severe	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
in	IN	I-PROBLEM
all	DT	I-PROBLEM
other	JJ	I-PROBLEM
regions	NNS	I-PROBLEM
except	IN	O
for	IN	O
the	DT	O
lateral	JJ	O
wall	NN	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
had	VBD	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
in	IN	O
April	NNP	O
of	IN	O
1996	CD	O
which	WDT	O
was	VBD	O
negative	JJ	O
following	NN	O
,	,	O
however	RB	O
was	VBD	O
at	IN	O
a	DT	O
low	JJ	O
workload	NN	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NN	O
was	VBD	O
most	RBS	O
recently	RB	O
admitted	VBN	O
to	TO	O
Centdick	NNP	O
Naco	NNP	O
Hospital	NNP	O
Medical	NNP	O
Center	NNP	O
on	IN	O
Martin	NNP	O
Luther	NNP	O
King	NNP	O
Day	NNP	O
after	IN	O
becoming	VBG	O
acutely	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
after	IN	O
a	DT	O
five	CD	O
minute	NN	O
walk	NN	O
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
or	CC	O
nausea	NN	B-PROBLEM
.	.	O

He	PRP	O
called	VBD	O
the	DT	O
EMT	NNP	O
&apos;s	NNP	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
by	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
at	IN	O
Centdick	NNP	O
Naco	NNP	O
Hospital	NNP	O
Medical	NNP	O
Center	NNP	O
.	.	O

He	PRP	O
was	VBD	O
diuresed	VBN	B-TREATMENT
and	CC	O
ruled	VBN	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
ECG	NNP	I-TEST
showed	VBD	O
no	DT	O
ischemic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

(1)	JJ	O
Insulin	NNP	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
x	JJ	O
15	CD	O
years	NNS	O
with	IN	O
no	DT	O
retinopathy	NN	B-PROBLEM
or	CC	O
foot	NN	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

(2)	JJ	O
Bilateral	NNP	B-PROBLEM
cataracts	NNS	I-PROBLEM
.	.	O

(3)	NN	O
In	IN	O
1967	CD	O
he	PRP	O
had	VBD	O
an	DT	B-TREATMENT
orchiopexy	NN	I-TREATMENT
for	IN	O
undescended	JJ	B-PROBLEM
testicle	NN	I-PROBLEM
.	.	O

(4)	JJ	O
Coronary	NNP	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
as	IN	O
above	NN	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Aspirin	$	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
Capoten	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.8h.	NN	O
,	,	O
NPH	NNP	B-TREATMENT
insulin	VBZ	I-TREATMENT
28	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
10	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
Regular	NNP	B-TREATMENT
insulin	NN	I-TREATMENT
4	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
4	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
simvastatin	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg.	NN	O

His	PRP$	O
mother	NN	O
and	CC	O
father	NN	O
both	DT	O
died	VBD	O
secondary	JJ	O
to	TO	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

One	CD	O
of	IN	O
his	PRP$	O
brothers	NNS	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
100.3	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
76	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
100/78	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
16	CD	O
,	,	O
and	CC	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
96%	CD	O
on	IN	O
two	CD	O
liters	NNS	O
.	.	O

No	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

Clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
with	IN	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rales	NNS	B-PROBLEM
.	.	O

Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
extra	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
and	CC	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

No	DT	O
edema	NN	B-PROBLEM
with	IN	O
2+	CD	O
pulses	NNS	O
.	.	O

BUN	NNP	B-TEST
25	CD	O
and	CC	O
creatinine	VB	B-TEST
1.4	CD	O
.	.	O

White	NNP	B-TEST
count	NN	I-TEST
6	CD	O
and	CC	O
hematocrit	$	B-TEST
41.5	CD	O
.	.	O

PT	$	B-TEST
14.1	CD	O
with	IN	O
an	DT	B-TEST
INR	NNP	I-TEST
of	IN	O
1.4	CD	O
,	,	O
PTT	NNP	B-TEST
36.7	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
infiltrates	NNS	B-PROBLEM
and	CC	O
no	DT	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Urinalysis	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

Electrocardiogram	NNP	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
63	CD	O
with	IN	O
normal	JJ	O
intervals	NNS	O
.	.	O

He	PRP	O
had	VBD	O
flat	JJ	B-PROBLEM
T	NNP	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
I	PRP	I-PROBLEM
and	CC	I-PROBLEM
aVL	NN	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
unchanged	JJ	O
from	IN	O
previous	JJ	B-TEST
ECG	NNP	I-TEST
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
possibly	RB	O
had	VBD	O
a	DT	O
worsening	NN	O
of	IN	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
therefore	RB	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
01/17/96	CD	O
.	.	O

At	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
he	PRP	O
had	VBD	O
an	DT	B-TEST
RA	NNP	I-TEST
pressure	NN	I-TEST
of	IN	O
8	CD	O
,	,	O
an	DT	B-TEST
RV	NNP	I-TEST
pressure	NN	I-TEST
of	IN	O
52/10	CD	O
,	,	O
PA	NNP	B-TEST
pressure	NN	I-TEST
of	IN	O
60/25	CD	O
,	,	O
and	CC	O
wedge	NN	B-TEST
of	IN	O
26	CD	O
.	.	O

His	PRP$	O
coronary	JJ	O
arteries	NNS	O
revealed	VBD	O
an	DT	B-PROBLEM
80%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
OM	NNP	I-PROBLEM
.	.	O

The	DT	O
dominant	JJ	O
left	VBD	O
circumflex	NN	O
was	VBD	O
occluded	VBN	B-PROBLEM
with	IN	O
left-to-left	JJ	B-PROBLEM
filling	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
50%	CD	I-PROBLEM
LAD	NNP	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
100%	CD	I-PROBLEM
large	JJ	I-PROBLEM
DT	NNP	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
nondominant	JJ	O
RCA	NNP	O
with	IN	O
left	JJ	O
RCA	NNP	O
collaterals	NNS	O
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
was	VBD	O
not	RB	O
significantly	RB	O
changed	VBN	O
from	IN	O
his	PRP$	B-TEST
previous	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

Given	VBN	O
his	PRP$	B-PROBLEM
high	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Lasix	NNP	B-TREATMENT
for	IN	O
diuresis	NN	B-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
Captopril	NNP	I-TREATMENT
was	VBD	O
increased	VBN	O
for	IN	O
greater	JJR	B-TREATMENT
afterload	NN	I-TREATMENT
reduction	NN	I-TREATMENT
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
have	VB	O
an	DT	B-TREATMENT
augmented	JJ	I-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
as	IN	O
an	DT	O
outpatient	NN	O
undergo	NN	O
an	DT	B-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	O
viability	NN	B-TEST
evaluation	NN	I-TEST
to	TO	O
determine	VB	O
whether	IN	O
he	PRP	O
would	MD	O
benefit	VB	O
from	IN	O
revascularization	NN	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
and	CC	O
started	VBD	O
on	IN	O
diuresis	NN	B-TREATMENT
with	IN	O
IV	NNP	B-TREATMENT
Lasix	NNP	I-TREATMENT
for	IN	O
two	CD	O
days	NNS	O
and	CC	O
then	RB	O
switched	VBD	O
to	TO	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
Lasix	NNP	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

Insulin	NNP	B-TREATMENT
NPH	NNP	I-TREATMENT
10	CD	O
units	NNS	O
q.p.m.	RB	O
and	CC	O
28	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
insulin	NN	B-TREATMENT
Regular	JJ	I-TREATMENT
4	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
4	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
aspirin	VBZ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
simvastatin	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
captopril	VBP	B-TREATMENT
37.5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
Coumadin	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

He	PRP	O
is	VBZ	O
to	TO	O
see	VB	O
Dr.	NNP	O
Ench	NNP	O
in	IN	O
two	CD	O
weeks	NNS	O
to	TO	O
check	VB	O
his	PRP$	B-TEST
PT	NNP	I-TEST
and	CC	O
INR	NNP	B-TEST
,	,	O
also	RB	O
to	TO	O
check	VB	O
for	IN	O
potassium	NN	B-TEST
.	.	O

RIGHT	NNP	B-PROBLEM
HIP	NNP	I-PROBLEM
,	,	I-PROBLEM
OSTEOARTHRITIS	NNP	I-PROBLEM
.	.	O

Right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
,	,	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
generally	RB	O
healthy	JJ	O
85	CD	O
year	NN	O
old	JJ	O
female	NN	O
,	,	O
who	WP	O
has	VBZ	O
had	VBD	O
a	DT	O
five	CD	O
year	NN	O
history	NN	O
of	IN	O
right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
worsening	VBG	O
over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
.	.	O

Her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
located	VBN	O
in	IN	O
the	DT	O
groin	NN	O
and	CC	O
thigh	NN	O
.	.	O

It	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
rest	NN	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
well	RB	O
.	.	O

She	PRP	O
uses	VBZ	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
or	CC	O
walker	NN	B-TREATMENT
for	IN	O
ambulation	NN	O
,	,	O
and	CC	O
is	VBZ	O
limited	VBN	O
to	TO	O
one	CD	O
to	TO	O
two	CD	O
blocks	NNS	O
.	.	O

She	PRP	O
has	VBZ	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
shoes	NNS	I-PROBLEM
and	CC	I-PROBLEM
socks	NNS	I-PROBLEM
and	CC	I-PROBLEM
foot	NN	I-PROBLEM
care	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
pain	NN	I-PROBLEM
has	VBZ	O
not	RB	O
been	VBN	O
relieved	VBN	O
by	IN	O
Darvocet	NNP	B-TREATMENT
and	CC	O
Advil	NNP	B-TREATMENT
.	.	O

Radiographs	NNP	B-TEST
demonstrate	NN	O
right	NN	B-PROBLEM
hip	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

Having	VBG	O
failed	VBD	O
conservative	JJ	B-TREATMENT
management	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
presented	VBD	O
for	IN	O
elective	JJ	B-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

Hypertension	NNP	B-PROBLEM
,	,	O
possible	JJ	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
1959	CD	O
,	,	O
history	NN	O
of	IN	O
left	JJ	B-PROBLEM
ankle	NN	I-PROBLEM
and	CC	I-PROBLEM
knee	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
,	,	O
1980	CD	O
.	.	O

Recent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
E.	NNP	B-PROBLEM
coli	VBZ	I-PROBLEM
03/93	CD	O
.	.	O

Recent	JJ	B-PROBLEM
herpes	NNS	I-PROBLEM
zoster	NN	I-PROBLEM
.	.	O

cholecystectomy	NN	B-TREATMENT
,	,	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
cataract	JJ	B-TREATMENT
excision	NN	I-TREATMENT
.	.	O

MEDICATIONS	NNP	B-TREATMENT
ON	NNP	I-TREATMENT
ADMISSION	NNP	I-TREATMENT
:	:	O

hydrochlorothiazide	RB	B-TREATMENT
50	CD	O
mg.	NNS	O
PO	NNP	O
qday	NN	O
,	,	O
KayCiel	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
an	DT	O
elderly	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

The	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

left	VBD	O
hip	NN	O
110	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	B-TEST
,	,	O
0	CD	O
degrees	NNS	O
of	IN	O
extension	NN	B-TEST
,	,	O
30	CD	O
degrees	NNS	O
of	IN	O
abduction	NN	B-TEST
,	,	O
45	CD	O
degrees	NNS	O
of	IN	O
adduction	NN	B-TEST
,	,	O
10	CD	O
degrees	NNS	O
of	IN	O
internal	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
,	,	O
45	CD	O
degrees	NNS	O
of	IN	O
external	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
.	.	O

Right	NNP	O
hip	NN	O
90	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	B-TEST
,	,	O
minus	CC	O
30	CD	O
degrees	NNS	O
of	IN	O
extension	NN	B-TEST
,	,	O
20	CD	O
degrees	NNS	O
of	IN	O
abduction	NN	B-TEST
,	,	O
30	CD	O
degrees	NNS	O
of	IN	O
adduction	NN	B-TEST
,	,	O
less	JJR	O
than	IN	O
5	CD	O
degrees	NNS	O
of	IN	O
internal	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
and	CC	O
less	JJR	O
than	IN	O
5	CD	O
degrees	NNS	O
of	IN	O
external	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
.	.	O

There	EX	O
was	VBD	O
no	DT	O
leg	JJ	B-PROBLEM
length	NN	I-PROBLEM
discrepancy	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
used	VBD	O
the	DT	B-TREATMENT
cane	NN	I-TREATMENT
in	IN	O
her	PRP$	O
left	JJ	O
hand	NN	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
neurovascular	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
intact	JJ	O
.	.	O

the	DT	B-TEST
sodium	NN	I-TEST
was	VBD	O
140	CD	O
,	,	O
potassium	NN	B-TEST
3.7	CD	O
,	,	O
chloride	RB	B-TEST
96	CD	O
,	,	O
bicarbonate	NN	B-TEST
30	CD	O
,	,	O
BUN	NNP	B-TEST
and	CC	O
creatinine	VB	B-TEST
14/0.9	CD	O
,	,	O
glucose	RB	B-TEST
105	CD	O
,	,	O
hematocrit	NN	B-TEST
42	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
8.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
644,000	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
10.4	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
28.7	CD	O
,	,	O
urinalysis	JJ	B-TEST
trace	NN	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
slight	JJ	B-PROBLEM
occult	NN	I-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
80	CD	O
with	IN	O
intraventricular	JJ	B-PROBLEM
conduction	NN	I-PROBLEM
delay	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
R	NNP	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
acute	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
chest	JJS	I-TEST
X-ray	JJ	I-TEST
showed	VBD	O
borderline	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
but	CC	O
no	DT	O
acute	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
or	CC	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
his	PRP$	O
impression	NN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
on	IN	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

Given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
low	JJ	I-PROBLEM
potassium	NN	I-PROBLEM
level	NN	I-PROBLEM
of	IN	O
2.4	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
he	PRP	O
suggested	VBD	O
supplementation	NN	O
with	IN	O
potassium	NN	B-TREATMENT
.	.	O

On	IN	O
the	DT	O
following	JJ	O
morning	NN	O
4/17/93	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
using	VBG	O
a	DT	B-TREATMENT
hybrid	JJ	I-TREATMENT
S-ROM	JJ	I-TREATMENT
system	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
physical	JJ	O
therapy	NN	O
service	NN	O
initially	RB	O
for	IN	O
routine	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
after	IN	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

Her	PRP$	B-TREATMENT
hemovac	NN	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
2	CD	O
as	IN	O
was	VBD	O
her	PRP$	B-TREATMENT
Foley	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
in	IN	O
the	DT	O
low	JJ	O
to	TO	O
mid	VB	O
30	CD	O
&apos;s	NN	O
and	CC	O
she	PRP	O
did	VBD	O
not	RB	O
require	VB	O
a	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
have	VB	O
postoperatively	RB	B-PROBLEM
hypokalemia	VBN	I-PROBLEM
to	TO	O
a	DT	O
level	NN	O
of	IN	O
2.7	CD	O
and	CC	O
subsequently	RB	O
was	VBD	O
corrected	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
and	CC	I-TREATMENT
intravenous	JJ	I-TREATMENT
potassium	NN	I-TREATMENT
on	IN	O
4/22/93	CD	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TEST
duplex	JJ	I-TEST
ultrasound	NN	I-TEST
examination	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
Coumadin	NNP	I-TREATMENT
was	VBD	O
thus	RB	O
stopped	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
switched	VBN	O
to	TO	O
Bufferin	NNP	B-TREATMENT
.	.	O

Right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
total	JJ	I-TREATMENT
hip	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
on	IN	O
4/17/93	CD	O
.	.	O

Hypertension	NN	B-PROBLEM
.	.	O

Postoperative	JJ	B-PROBLEM
hypokalemia	NN	I-PROBLEM
,	,	O
resolved	VBN	O
.	.	O

Postoperative	JJ	B-PROBLEM
confusion	NN	I-PROBLEM
,	,	O
transient	NN	O
and	CC	O
resolved	VBD	O
spontaneously	RB	O
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
50	CD	O
mg.	NNS	O
PO	NNP	O
qday	NN	O
,	,	O
KayCiel	NNP	B-TREATMENT
40	CD	O
mEq.	NN	O
b.i.d.	NN	O
,	,	O
Ecotrin	NNP	B-TREATMENT
1	CD	O
tablet	NN	O
qday	NN	O
,	,	O
Ferrous	NNP	B-TREATMENT
sulfate	VBP	I-TREATMENT
325	CD	O
mg.	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O
Folate	NNP	B-TREATMENT
1	CD	O
mg.	NN	O
PO	NNP	O
qday	NN	O
,	,	O
multivitamins	VBZ	B-TREATMENT
one	CD	O
tablet	NN	O
qday	NN	O
,	,	O
Tylenol	NNP	B-TREATMENT
#	#	I-TREATMENT
3	CD	I-TREATMENT
1	CD	O
to	TO	O
2	CD	O
PO	NNP	O
q3hours	NNS	O
PRN	NNP	O
.	.	O

There	EX	O
she	PRP	O
should	MD	O
received	VB	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
consist	VB	O
of	IN	O
a	DT	B-TREATMENT
routine	JJ	I-TREATMENT
post	NN	I-TREATMENT
total	JJ	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
rehabilitation	NN	I-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
with	IN	O
emphasis	NN	O
on	IN	O
gait	NN	B-TREATMENT
training	NN	I-TREATMENT
,	,	O
partial	JJ	O
weight	NN	O
bearing	NN	O
on	IN	O
the	DT	O
right	NN	O
lower	JJR	O
extremity	NN	O
,	,	O
using	VBG	O
a	DT	O
walker	NN	B-TREATMENT
or	CC	O
crutches	NNS	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
should	MD	O
also	RB	O
have	VB	O
her	PRP$	B-TEST
potassium	NN	I-TEST
levels	NNS	I-TEST
checked	VBD	O
two	CD	O
times	NNS	O
per	IN	O
week	NN	O
to	TO	O
insure	VB	O
that	IN	O
she	PRP	O
is	VBZ	O
not	RB	O
becoming	VBG	O
hypokalemic	NN	B-PROBLEM
.	.	O

VAG	NNP	B-PROBLEM
BLEEDING	NNP	I-PROBLEM

dysfunctional	JJ	B-PROBLEM
uterine	NN	I-PROBLEM
bleeding	NN	I-PROBLEM

pelvic	NN	B-TEST
ultrasound	SYM	I-TEST
-	:	O
normal	JJ	O
ovaries	NNS	O
,	,	O
thickened	VBD	B-PROBLEM
endometrium	NN	I-PROBLEM
hematocrit	NN	B-TEST
-	:	O
33	CD	O

percocet	NN	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
pain	NN	B-PROBLEM

Please	VB	O
follow	VB	O
up	RP	O
with	IN	O
gynecology	NN	O
-	:	O
you	PRP	O
will	MD	O
need	VB	O
to	TO	O
have	VB	O
your	PRP$	B-PROBLEM
uterine	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
evaluted	VBD	O

Please	VB	O
return	NN	O
to	TO	O
the	DT	O
ED	NNP	O
if	IN	O
you	PRP	O
develop	VBP	O
any	DT	B-PROBLEM
worsening	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
fevers	NNS	B-PROBLEM
&gt;	VBP	O
101	CD	O
.	.	O

If	IN	O
you	PRP	O
are	VBP	O
unable	JJ	O
to	TO	O
keep	VB	O
down	RP	O
liquids	NNS	O
or	CC	O
have	VBP	O
any	DT	B-PROBLEM
fainting	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
we	PRP	O
should	MD	O
see	VB	O
you	PRP	O
again	RB	O
as	RB	O
well	RB	O
.	.	O

Otherwise	RB	O
you	PRP	O
need	VBP	O
to	TO	O
see	VB	O
a	DT	O
gynecologist	NN	O
to	TO	O
evaluate	VB	O
this	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Attending	VBG	B-TEST
evaluation	NN	I-TEST

TYLENOL	NNP	B-TREATMENT
(	(	I-TREATMENT
ACETAMINOPHEN	NNP	I-TREATMENT
)	)	I-TREATMENT
650	CD	O
MG	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM
COLACE	NNP	B-TREATMENT
(	(	I-TREATMENT
DOCUSATE	NNP	I-TREATMENT
SODIUM	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PRN	NNP	O
Constipation	NNP	B-PROBLEM
IBUPROFEN	NNP	B-TREATMENT
600	CD	O
MG	NNP	O
PO	NNP	O
Q4-6H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM
MILK	NNP	B-TREATMENT
OF	NNP	I-TREATMENT
MAGNESIA	NNP	I-TREATMENT
(	(	I-TREATMENT
MAGNESIUM	NNP	I-TREATMENT
HYDROXIDE	NNP	I-TREATMENT
)	)	I-TREATMENT
30	CD	O
MILLILITERS	NNP	O
PO	NNP	O
QD	NNP	O
PRN	NNP	O
Constipation	NNP	B-PROBLEM
PERCOCET	NNP	B-TREATMENT
1-2	JJ	O
TAB	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

Houghtbreun	$	O
6	CD	O
weeks	NNS	O
,	,	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNS	I-PROBLEM

Repeat	NNP	B-PROBLEM
C	NNP	I-PROBLEM
/	NNP	I-PROBLEM
S	NNP	I-PROBLEM
PPS	NNP	I-PROBLEM

Responsible	JJ	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
IUP	NNP	B-PROBLEM
at	IN	O
36	CD	O
weeks	NNS	O
,	,	O
delivered	VBD	O

Conditions	NNS	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
IUP	NNP	B-PROBLEM
at	IN	O
36	CD	O
weeks	NNS	O
.	.	O

insulin	NN	B-PROBLEM
dependent	JJ	I-PROBLEM
gestational	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
,	,	O
prior	JJ	B-PROBLEM
C	NNP	I-PROBLEM
/	NNP	I-PROBLEM
S	NNP	I-PROBLEM
,	,	O
RSAP	NNP	B-PROBLEM

Apgars	NNS	B-TEST
9,9	CD	O

Weight	NN	B-TEST
:	:	O

BILIARY	NNP	B-PROBLEM
OBSTRUCTION	NNP	I-PROBLEM

1.	CD	O
RECTAL	NNP	B-PROBLEM
CARCINOMA	NNP	I-PROBLEM
,	,	O
STATUS	NNP	O
POST	NNP	O
PARTIAL	NNP	B-TREATMENT
COLECTOMY	NNP	I-TREATMENT
.	.	O

2.	CD	O
METASTATIC	NNP	B-PROBLEM
COLON	NNP	I-PROBLEM
CARCINOMA	NNP	I-PROBLEM
.	.	O

3.	CD	O
HYPERTENSION	NNP	B-PROBLEM
.	.	O

4.	CD	O
AORTIC	NNP	B-PROBLEM
STENOSIS	NNP	I-PROBLEM
WITH	NNP	O
PORCINE	NNP	B-TREATMENT
VALVE	NNP	I-TREATMENT
.	.	O

5.	CD	O
URINARY	NNP	B-PROBLEM
TRACT	NNP	I-PROBLEM
INFECTION	NNP	I-PROBLEM
.	.	O

6.	CD	O
CHOLANGITIS	NNP	B-PROBLEM
.	.	O

7.	CD	O
ANEMIA	NNP	B-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
70	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
rectal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
biliary	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
had	VBD	O
biliary	JJ	B-TREATMENT
stents	NNS	I-TREATMENT
placed	VBD	O
which	WDT	O
clotted	VBD	O
off	RP	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Short	NNP	O
Stay	NNP	O
Unit	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

The	DT	O
day	NN	O
prior	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
endoscopic	VBN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
done	VBN	O
with	IN	O
dilated	JJ	B-PROBLEM
ducts	NNS	I-PROBLEM
times	NNS	O
two	CD	O
and	CC	O
eventually	RB	O
had	VBD	O
interventional	JJ	B-TREATMENT
radiology	NN	I-TREATMENT
attempt	NN	O
to	TO	O
place	NN	O
percutaneous	JJ	B-TREATMENT
drains	NNS	I-TREATMENT
to	TO	O
decompress	VB	O
his	PRP$	B-PROBLEM
biliary	JJ	I-PROBLEM
tree	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
placed	VBN	O
after	IN	O
a	DT	B-TREATMENT
prolonged	JJ	I-TREATMENT
course	NN	I-TREATMENT
and	CC	O
difficult	JJ	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

After	IN	O
being	VBG	O
transferred	VBN	O
from	IN	O
the	DT	O
interventional	JJ	O
radiology	NN	O
table	NN	O
to	TO	O
the	DT	O
stretcher	NN	O
,	,	O
one	CD	O
of	IN	O
his	PRP$	B-TREATMENT
lateral	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
drains	NNS	I-TREATMENT
had	VBD	O
been	VBN	O
pulled	VBN	O
out	RP	O
inadvertently	RB	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Short	NNP	O
Stay	NNP	O
Unit	NNP	O
,	,	O
given	VBN	O
Ancef	NNP	B-TREATMENT
and	CC	O
Gentamicin	NNP	B-TREATMENT
per	IN	O
the	DT	O
team	NN	O
for	IN	O
antibiotic	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
and	CC	O
observed	VBD	O
overnight	RB	O
.	.	O

Cipro	NNP	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
Vasotec	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

Significant	NNP	O
for	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
was	VBD	O
99.1	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
132/74	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
,	,	O
02	CD	B-TEST
sat	VBD	I-TEST
99%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
an	DT	O
alert	NN	O
,	,	O
jaundiced	VBD	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

had	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
II	NNP	I-PROBLEM
/	NNP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
with	IN	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

He	PRP	O
had	VBD	O
midline	NN	B-TREATMENT
catheter	NN	I-TREATMENT
that	WDT	O
was	VBD	O
still	RB	O
in	IN	O
place	NN	O
and	CC	O
was	VBD	O
draining	VBG	O
bile	NN	O
.	.	O

were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

exam	RB	B-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

White	NNP	B-TEST
count	NN	I-TEST
was	VBD	O
8.2	CD	O
,	,	O
hematocrit	NN	B-TEST
35	CD	O
.	.	O

AST	NNP	B-TEST
was	VBD	O
175	CD	O
,	,	O
ALT	NNP	B-TEST
76	CD	O
,	,	O
LDH	NNP	B-TEST
454	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
12	CD	O
and	CC	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
8	CD	O
.	.	O

Alkaline	NNP	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
372	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Short	NNP	O
Stay	NNP	O
Unit	NNP	O
and	CC	O
continued	VBN	O
to	TO	O
receive	VB	O
antibiotics	NNS	B-TREATMENT
overnight	JJ	O
.	.	O

The	DT	O
next	JJ	O
morning	NN	O
,	,	O
he	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
the	DT	B-TREATMENT
intact	JJ	I-TREATMENT
drain	NN	I-TREATMENT
draining	VBG	O
bilious	JJ	B-PROBLEM
material	NN	I-PROBLEM
without	IN	O
any	DT	O
difficulty	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
minimal	JJ	O
to	TO	O
no	DT	O
belly	RB	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
back	RB	O
to	TO	O
surgery	NN	O
by	IN	O
the	DT	O
interventional	JJ	O
radiology	NN	O
team	NN	O
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
second	JJ	I-TREATMENT
drain	NN	I-TREATMENT
placed	VBD	O
without	IN	O
any	DT	O
difficulty	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
Short	NNP	O
Stay	NNP	O
Unit	NNP	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
observed	VBN	O
overnight	RB	O
without	IN	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

He	PRP	O
will	MD	O
continue	VB	O
Cipro	NNP	B-TREATMENT
p.o.	NN	I-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
.	.	O

He	PRP	O
is	VBZ	O
also	RB	O
to	TO	O
have	VB	O
AH	NNP	B-TREATMENT
for	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
stent	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

CHRONIC	NNP	B-PROBLEM
OBSTRUCTIVE	NNP	I-PROBLEM
PULMONARY	NNP	I-PROBLEM
DISEASE	NNP	I-PROBLEM

Chronic	NNP	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

Steroid	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
,	,	O
including	VBG	O
cataract	NN	B-PROBLEM
,	,	O
osteoporosis	NN	B-PROBLEM
,	,	O
diffuse	NN	B-PROBLEM
fibrocystic	JJ	I-PROBLEM
breast	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
trigeminal	JJ	B-PROBLEM
neuralgia	NN	I-PROBLEM
.	.	O

Mrs.	NNP	O
Cast	NNP	O
is	VBZ	O
a	DT	O
50	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
evidence	NN	O
of	IN	O
severe	JJ	B-PROBLEM
lobular	JJ	I-PROBLEM
emphysema	NN	I-PROBLEM
,	,	O
who	WP	O
has	VBZ	O
progressive	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
inability	NN	O
to	TO	O
carry	VB	O
on	IN	O
with	IN	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
without	IN	O
assistance	NN	O
.	.	O

She	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-TEST
pre	NN	I-TEST
lung	NN	I-TEST
transplant	JJ	I-TEST
evaluation	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
steroid	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
for	IN	O
two	CD	O
years	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
intubated	VBN	B-TREATMENT
in	IN	O
the	DT	O
past	JJ	O
only	RB	O
once	RB	O
for	IN	O
a	DT	B-TREATMENT
surgical	JJ	I-TREATMENT
repair	NN	I-TREATMENT
of	IN	I-TREATMENT
trigeminal	JJ	I-TREATMENT
neuralgia	NN	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
asbestos	NN	B-PROBLEM
exposure	NN	I-PROBLEM
or	CC	O
tuberculosis	NN	B-PROBLEM
exposure	NN	I-PROBLEM
.	.	O

Notable	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
trigeminal	JJ	B-PROBLEM
neuralgia	NN	I-PROBLEM
,	,	O
left	VBD	B-TREATMENT
shoulder	NN	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
fibrocystic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
endometriosis	NN	B-PROBLEM
and	CC	O
status	NN	O
post	NN	O
total	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
hysterectomy	NN	I-PROBLEM
.	.	O

History	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
intolerance	NN	I-PROBLEM
to	TO	O
Tetracycline	NNP	B-TREATMENT
,	,	O
Erythromycin	NNP	B-TREATMENT
,	,	O
declomycin	NN	B-TREATMENT
associated	VBN	O
with	IN	O
edema	NN	B-PROBLEM
and	CC	O
rash	NN	B-PROBLEM
,	,	O
Talwin	NNP	B-TREATMENT
associated	VBN	O
with	IN	O
disorientation	NN	B-PROBLEM
and	CC	O
gastrointestinal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
Dilantin	NNP	B-TREATMENT
has	VBZ	O
caused	VBN	O
rash	NN	B-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
,	,	O
morphine	NN	B-TREATMENT
associated	VBN	O
with	IN	O
itching	NN	B-PROBLEM
and	CC	O
gastrointestinal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
Demerol	NNP	B-TREATMENT
unclear	VBP	O
.	.	O

Notable	JJ	O
for	IN	O
her	PRP$	B-PROBLEM
diffuse	NN	I-PROBLEM
expiratory	NN	I-PROBLEM
wheezes	NNS	I-PROBLEM
and	CC	O
scattered	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

Cranial	JJ	O
nerves	NNS	O
were	VBD	O
intact	JJ	O
except	IN	O
for	IN	O
paresthesias	NN	B-PROBLEM
on	IN	O
the	DT	O
left	NN	O
in	IN	O
the	DT	O
VII	NNP	O
and	CC	O
VIII	NNP	O
distribution	NN	O
.	.	O

The	DT	O
breasts	NNS	O
were	VBD	O
notable	JJ	O
for	IN	O
fibrocystic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

Serum	NNP	B-TEST
sodium	NN	I-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
C02	NNP	B-TEST
29.6	CD	O
,	,	O
calcium	NN	B-TEST
9.2	CD	O
,	,	O
phosphorus	NN	B-TEST
3.6	CD	O
.	.	O

Magnesium	NN	B-TEST
1.7	CD	O
.	.	O

BUN	NNP	B-TEST
12	CD	O
,	,	O
creatinine	NN	B-TEST
0.6	CD	O
,	,	O
glucose	RB	B-TEST
92	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
3.3.	CD	O
Cholesterol	NNP	B-TEST
236	CD	O
,	,	O
triglycerides	NNS	B-TEST
115	CD	O
,	,	O
HDL	NNP	B-TEST
99	CD	O
,	,	O
LDL	NNP	B-TEST
114	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.2	CD	O
,	,	O
globulin	NN	B-TEST
2.6	CD	O
,	,	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
0	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
59	CD	O
,	,	O
amylase	NN	B-TEST
64	CD	O
,	,	O
SGOT	NNP	B-TEST
16	CD	I-TEST
,	,	O
LDH	NNP	B-TEST
141	CD	I-TEST
,	,	O
CPK	NNP	B-TEST
57	CD	O
.	.	O

The	DT	B-TEST
LH	NNP	I-TEST
was	VBD	O
4.9	CD	O
,	,	O
FSH	NNP	B-TEST
3.3	CD	O
.	.	O

TSH	NNP	B-TEST
was	VBD	O
124	CD	O
,	,	O
cortisol	NN	B-TEST
2.1	CD	O
,	,	O
25	CD	B-TEST
hydroxy	NN	I-TEST
vitamin	NN	I-TEST
D	NNP	I-TEST
,	,	I-TEST
and	CC	I-TEST
125	CD	I-TEST
dihydroxy	JJ	I-TEST
vitamin	NN	I-TEST
D	NNP	I-TEST
levels	NNS	I-TEST
were	VBD	O
pending	VBG	O
.	.	O

Urine	NNP	B-TEST
cotenine	VBP	I-TEST
level	NN	O
none	NN	O
detected	VBN	O
.	.	O

Estradialol	NNP	B-TEST
pending	NN	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
9.6	CD	O
,	,	O
hematocrit	NN	B-TEST
38.8	CD	O
,	,	O
platelet	NN	B-TEST
348,000	CD	O
,	,	O
mean	JJ	B-TEST
corpuscular	JJ	I-TEST
volume	NN	I-TEST
85	CD	O
and	CC	O
86	CD	O
,	,	O
MCH	NNP	B-TEST
29	CD	O
,	,	O
MCHC	NNP	B-TEST
34	CD	O
.	.	O

PT	NNP	B-TEST
9.5/10.0	CD	O
,	,	O
PTT	NNP	B-TEST
23.9	CD	O
.	.	O

Urinalysis	NN	B-TEST
was	VBD	O
normal	JJ	O
.	.	O

Sed	NNP	B-TEST
rate	NN	I-TEST
6	CD	O
.	.	O

Varicella	NNP	B-TEST
antibody	NN	I-TEST
positive	JJ	O
,	,	O
CMV	NNP	B-TEST
antibody	NN	I-TEST
positive	JJ	O
,	,	O
toxo	JJ	B-TEST
negative	JJ	O
,	,	O
RPR	NNP	B-TEST
non	RB	O
reactive	VBP	O
.	.	O

FEV1	NNP	B-TEST
0.78	CD	O
liters	NNS	O
,	,	O
vital	JJ	B-TEST
capacity	NN	I-TEST
2.12	CD	O
liters	NNS	O
,	,	O
total	JJ	B-TEST
lung	NN	I-TEST
capacity	NN	I-TEST
5.51	CD	O
liters	NNS	O
,	,	O
single	JJ	B-TEST
breath	NN	I-TEST
DLCO	NNP	I-TEST
5.3	CD	O
(	(	O
25%	CD	O
predicted	VBN	O
)	)	O
.	.	O

Cardiopulmonary	NNP	B-TEST
exercise	NN	I-TEST
study	NN	I-TEST
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

Echocardiogram	NNP	B-TEST
showed	VBD	O
normal	JJ	O
right	JJ	O
ventricular	NN	O
and	CC	O
left	VBD	O
ventricular	JJ	O
size	NN	O
and	CC	O
systolic	JJ	O
function	NN	O
.	.	O

A	DT	B-TEST
left	NN	I-TEST
and	CC	I-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
coronary	JJ	B-TEST
angiogram	NN	I-TEST
revealed	VBD	O
aortic	JJ	B-TEST
120/70	CD	O
,	,	O
mean	JJ	B-TEST
95	CD	O
,	,	O
PA	NNP	B-TEST
26/10	CD	O
,	,	O
mean	JJ	B-TEST
17	CD	O
,	,	O
PC	NN	B-TEST
7	CD	O
,	,	O
RV	NNP	B-TEST
26/6	CD	O
,	,	O
RA	NNP	B-TEST
4	CD	O
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
5.7	CD	O
,	,	O
index	NN	B-TEST
3.8	CD	O
.	.	O

Systemic	NNP	B-TEST
arterial	JJ	I-TEST
resistance	NN	I-TEST
12/81	CD	O
.	.	O

The	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
short	JJ	I-PROBLEM
PR	NNP	I-PROBLEM
interval	NN	I-PROBLEM
with	IN	O
no	DT	O
delta	NN	B-PROBLEM
wave	NN	I-PROBLEM
,	,	O
clockwise	NN	B-PROBLEM
rotation	NN	I-PROBLEM
present	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
quantitative	JJ	I-TEST
VQ	NNP	I-TEST
scan	NN	I-TEST
of	IN	O
the	DT	O
lung	NN	O
showed	VBD	O
42%	CD	O
ventilation	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
left	NN	I-TEST
,	,	O
57%	CD	O
ventilation	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
right	NN	I-TEST
,	,	O
42%	CD	O
perfusion	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
left	NN	I-TEST
,	,	O
57%	CD	O
perfusion	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
right	NN	I-TEST
.	.	O

Abdominal	NNP	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

HIV	NNP	B-TEST
testing	VBG	I-TEST
results	NNS	O
pending	VBG	O
.	.	O

Hepatitis	NNP	B-TEST
serologies	NNS	I-TEST
pending	VBG	O
.	.	O

She	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
mild	JJ	B-PROBLEM
cataracts	NNS	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
chronic	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
subtle	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
disc	NN	I-PROBLEM
pallor	NN	I-PROBLEM
OD	NNP	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
previous	JJ	O
episode	NN	O
of	IN	O
optic	JJ	B-PROBLEM
neuritis	NN	I-PROBLEM
.	.	O

No	DT	O
acute	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
and	CC	O
no	DT	O
treatment	NN	B-PROBLEM
was	VBD	O
necessary	JJ	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

Dr.	NNP	O
Koteelks	NNP	O
indicated	VBD	O
that	IN	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
sinus	VBN	B-PROBLEM
problems	NNS	I-PROBLEM
currently	RB	O
but	CC	O
thought	VBD	O
that	IN	O
the	DT	B-PROBLEM
trigeminal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
might	MD	O
be	VB	O
investigated	VBN	O
further	RBR	O
and	CC	O
that	IN	O
the	DT	B-PROBLEM
sphenoid	NN	I-PROBLEM
might	MD	O
account	VB	O
for	IN	O
some	DT	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

Dr.	NNP	O
Tikkerth	NNP	O
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
adjustment	NN	I-PROBLEM
related	VBN	I-PROBLEM
anxiety	NN	I-PROBLEM
under	IN	O
good	JJ	O
control	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
tobacco	NN	O
abuse	NN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

The	DT	O
patient	NN	O
completed	VBD	O
the	DT	B-TEST
studies	NNS	I-TEST
and	CC	O
to	TO	O
be	VB	O
informed	VBN	O
of	IN	O
the	DT	O
results	NNS	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

She	PRP	O
knows	VBZ	O
to	TO	O
return	VB	O
to	TO	O
her	PRP$	O
local	JJ	O
physician	NN	O
for	IN	O
her	PRP$	B-TREATMENT
routine	JJ	I-TREATMENT
care	NN	I-TREATMENT
with	IN	O
her	PRP$	B-PROBLEM
condition	NN	I-PROBLEM
unchanged	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

CHEST	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
/	NNP	O
SOB	NNP	B-PROBLEM

R	NNP	B-PROBLEM
Lung	NNP	I-PROBLEM
Mass	NNP	I-PROBLEM
,	,	O
likely	JJ	O
cancer	NN	B-PROBLEM

Physical	JJ	B-TEST
Examination	NNP	I-TEST
,	,	O
Laboratory	NNP	B-TEST
Evaluation	NNP	I-TEST
,	,	O
CXR	NNP	B-TEST
,	,	O
Chest	NNP	B-TEST
CT	NNP	I-TEST

Vicodin	NNP	B-TREATMENT
1-2	JJ	O
TABS	NNP	O
PO	NNP	O
Q6H	NNP	O
PRN	NNP	O
pain	NN	B-PROBLEM
,	,	O
#	#	O
50	CD	O
,	,	O
no	DT	O
refills	NNS	O

We	PRP	O
are	VBP	O
scheduling	VBG	O
you	PRP	O
for	IN	O
a	DT	B-TEST
needle	JJ	I-TEST
biopsy	NN	I-TEST
by	IN	O
interventional	JJ	O
radiology	NN	O
for	IN	O
some	DT	O
time	NN	O
in	IN	O
the	DT	O
next	JJ	O
week	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
July	NNP	O
12th	CD	O
for	IN	O
a	DT	B-TREATMENT
chole	NN	I-TREATMENT
with	IN	O
a	DT	O
principle	JJ	O
diagnosis	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
42	CD	O
year	NN	O
old	JJ	O
with	IN	O
recurrent	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBN	O
ultrasound	VBN	B-PROBLEM
proven	RB	I-PROBLEM
gallstones	NNS	I-PROBLEM
for	IN	O
ten	JJ	O
years	NNS	O
,	,	O
seen	VBN	O
on	IN	O
an	DT	B-TEST
earlier	JJR	I-TEST
obstetric	JJ	I-TEST
ultrasound	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
symptoms	NNS	B-PROBLEM
until	IN	O
approximately	RB	O
two	CD	O
years	NNS	O
ago	RB	O
when	WRB	O
she	PRP	O
began	VBD	O
having	VBG	O
classic	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
midback	VB	O
with	IN	O
nausea	NN	B-PROBLEM
,	,	O
but	CC	O
without	IN	O
vomiting	VBG	B-PROBLEM
.	.	O

Episodes	NNS	B-PROBLEM
have	VBP	O
been	VBN	O
increasing	VBG	O
in	IN	O
frequency	NN	O
over	IN	O
the	DT	O
last	JJ	O
few	JJ	O
months	NNS	O
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
respiratory	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
or	CC	O
melena	NN	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
found	VBN	O
any	DT	O
relieve	NN	O
with	IN	O
any	DT	O
over	IN	B-TREATMENT
the	DT	I-TREATMENT
counter	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
gallbladder	NN	B-PROBLEM
or	CC	O
pancreatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
significant	JJ	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
.	.	O

No	DT	O
anorexia	NN	B-PROBLEM
.	.	O

An	DT	B-TEST
ultrasound	NN	I-TEST
on	IN	O
1/25/00	CD	O
showed	VBD	O
six	CD	B-PROBLEM
gallstones	NNS	I-PROBLEM
without	IN	O
cholecystitis	NN	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
liver	NN	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
.	.	O

Significant	NNP	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
ear	NN	I-TREATMENT
operation	NN	I-TREATMENT
approximately	RB	O
30	CD	O
years	NNS	O
ago	RB	O
with	IN	O
left	JJ	B-TREATMENT
TM	NNP	I-TREATMENT
reconstruction	NN	I-TREATMENT
in	IN	O
December	NNP	O
1999	CD	O
at	IN	O
Hitch	NNP	O
Hospital	NNP	O
.	.	O

Only	RB	O
multivitamins	NNS	B-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
healthy	JJ	O
appearing	VBG	O
female	JJ	O
looking	VBG	O
her	PRP$	O
stated	JJ	O
age	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
anicteric	JJ	B-PROBLEM
without	IN	O
rash	NN	B-PROBLEM
or	CC	O
HEENT	NNP	O
.	.	O

Significant	NN	O
for	IN	O
left	JJ	B-PROBLEM
TM	NNP	I-PROBLEM
scarring	VBG	I-PROBLEM
without	IN	O
acute	JJ	B-PROBLEM
inflammation	NN	I-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
.	.	O

No	DT	O
lymphadenopathy	NN	B-PROBLEM
is	VBZ	O
noted	VBN	O
.	.	O

She	PRP	O
is	VBZ	O
without	IN	O
bruits	NNS	B-PROBLEM
or	CC	O
JVD	NNP	B-PROBLEM
.	.	O

Lungs	NNS	O
are	VBP	O
bilaterally	RB	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

Cardiac	NNP	B-TEST
exam	NN	I-TEST
;	:	O
she	PRP	O
has	VBZ	O
positive	JJ	O
S1	NNP	O
,	,	O
S2	NNP	O
without	IN	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

Rate	NNP	B-TEST
was	VBD	O
75	CD	O
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
mass	NN	B-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
rectal	JJ	I-TEST
exam	NN	I-TEST
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
the	DT	B-TREATMENT
lap	NN	I-TREATMENT
coli	NN	I-TREATMENT
with	IN	O
an	DT	B-TEST
intraoperative	JJ	I-TEST
cholangiogram	NN	I-TEST
by	IN	O
Dr.	NNP	O
Sterp	NNP	O
under	IN	O
general	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

Operative	JJ	O
course	NN	O
and	CC	O
recovery	NN	O
were	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

Percocet	NNP	B-TREATMENT
5	CD	O
mg	NN	O
in	IN	O
325	CD	O
mg	NN	O
one	CD	O
to	TO	O
two	CD	O
tabs	NNS	O
po	VBP	O
q4	NN	O
to	TO	O
6	CD	O
prn	NN	O
pain	NN	B-PROBLEM
.	.	O

DERMOPLAST	NNP	B-TREATMENT
TOPICAL	NNP	I-TREATMENT
TP	NNP	O
Q12H	NNP	O
PRN	NNP	O
Pain	NNP	B-PROBLEM
DOCUSATE	NNP	B-TREATMENT
SODIUM	NNP	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PRN	NNP	O
Constipation	NNP	B-PROBLEM
IBUPROFEN	NNP	B-TREATMENT
400-600	JJ	O
MG	NNP	O
PO	NNP	O
Q6H	NNP	O
PRN	NNP	O
Pain	NNP	B-PROBLEM

Take	VB	O
with	IN	O
food	NN	O
PRENATAL	NNP	B-TREATMENT
MULTIVITAMINS	NNP	I-TREATMENT
(	(	I-TREATMENT
STUARTNATAL	NNP	I-TREATMENT
1+1	CD	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
TAB	NNP	O
PO	NNP	O
QD	NNP	O
TUCKS	NNP	B-TREATMENT
(	(	I-TREATMENT
WITCH	NNP	I-TREATMENT
HAZEL	NNP	I-TREATMENT
)	)	I-TREATMENT
TOPICAL	NNP	O
TP	NNP	O
Q4H	NNP	O
PRN	NNP	O
Pain	NNP	B-PROBLEM

NKA	NN	B-PROBLEM

labor	NN	B-PROBLEM
at	IN	I-PROBLEM
term	NN	I-PROBLEM

Initial	JJ	B-TEST
newborn	JJ	I-TEST
exam	NN	I-TEST
:	:	O

No	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

ENDOMETRIAL	NNP	B-PROBLEM
CANCER	NNP	I-PROBLEM
.	.	O

Total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo	NN	I-TREATMENT
oophorectomy	IN	I-TREATMENT
2-19-91	JJ	O
by	IN	O
Dr.	NNP	O
Lako	NNP	O
Coma	NNP	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
81-year-old	JJ	O
who	WP	O
presented	VBD	O
with	IN	O
postmenopausal	NN	B-PROBLEM
spotting	NN	I-PROBLEM
and	CC	O
had	VBD	O
an	DT	B-TEST
endometrial	JJ	I-TEST
biopsy	NN	I-TEST
which	WDT	O
was	VBD	O
read	VBN	O
at	IN	O
the	DT	O
Etearal	NNP	O
Etsystems/	NNP	O
Hospital	NNP	O
as	IN	O
showing	VBG	O
grade	NN	B-PROBLEM
I	PRP	I-PROBLEM
adenocarcinoma	VBP	I-PROBLEM
.	.	O

Accordingly	RB	O
she	PRP	O
presents	VBZ	O
for	IN	O
operative	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

Abdomen	NNS	B-PROBLEM
obese	JJ	I-PROBLEM
,	,	O
no	DT	O
scars	NNS	B-PROBLEM
.	.	O

Pelvic	NNP	B-TEST
exam	NN	I-TEST
showed	VBD	O
a	DT	O
small	JJ	O
mobile	JJ	O
uterus	NN	O
.	.	O

Extremities	NNS	O
show	VBP	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
on	IN	O
2-19-91	JJ	O
where	WRB	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
,	,	O
TAH	NNP	B-TREATMENT
/	NNP	I-TREATMENT
BSO	NNP	I-TREATMENT
,	,	O
and	CC	O
omental	JJ	B-TEST
biopsy	NN	I-TEST
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-TEST
normal	JJ	I-TEST
abdominal	JJ	I-TEST
exploration	NN	I-TEST
of	IN	O
a	DT	O
small	JJ	O
uterus	NN	O
with	IN	O
superficial	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
on	IN	O
gross	JJ	B-TEST
examination	NN	I-TEST
,	,	O
normal	JJ	O
ovaries	NNS	O
.	.	O

Washings	NNS	B-TEST
were	VBD	O
sent	VBN	O
.	.	O

A	DT	B-TREATMENT
subfascial	JJ	I-TREATMENT
J-P	NNP	I-TREATMENT
was	VBD	O
left	VBN	O
.	.	O

Subfascia	NNP	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
postoperative	JJ	B-TEST
Hct	NNP	I-TEST
was	VBD	O
34	CD	O
.	.	O

GAIT	NNP	B-PROBLEM
DISORDER	NNP	I-PROBLEM
.	.	O

Gait	NNP	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
31-year-old	JJ	O
right-handed	JJ	O
female	NN	O
with	IN	O
right-sided	JJ	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
left-sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
difficulty	NN	B-PROBLEM
walking	VBG	I-PROBLEM
for	IN	O
several	JJ	O
days	NNS	O
.	.	O

She	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
3/20/97	CD	O
when	WRB	O
she	PRP	O
experienced	VBD	O
the	DT	O
fairly	RB	O
sudden	JJ	O
onset	NN	O
of	IN	O
predominantly	RB	O
right-sided	JJ	B-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
ataxia	NN	B-PROBLEM
.	.	O

She	PRP	O
evidently	RB	O
recovered	VBD	O
from	IN	O
the	DT	B-PROBLEM
episode	NN	I-PROBLEM
after	IN	O
a	DT	O
number	NN	O
of	IN	O
minutes	NNS	O
.	.	O

The	DT	O
following	JJ	O
day	NN	O
,	,	O
she	PRP	O
remained	VBD	O
in	IN	O
bed	NN	O
through	IN	O
essentially	RB	O
all	DT	O
of	IN	O
the	DT	O
day	NN	O
due	JJ	O
to	TO	O
malaise	VB	B-PROBLEM
with	IN	O
no	DT	O
specific	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
being	VBG	O
noted	VBN	O
.	.	O

In	IN	O
the	DT	O
subsequent	JJ	O
two	CD	O
days	NNS	O
,	,	O
she	PRP	O
had	VBD	O
several	JJ	O
small	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
of	IN	I-PROBLEM
&quot;	JJ	I-PROBLEM
imbalance	NN	I-PROBLEM
&quot;	NNP	O
,	,	O
particularly	RB	O
towards	IN	O
the	DT	O
right	NN	O
,	,	O
and	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
included	VBN	O
diffuse	NN	B-PROBLEM
and	CC	I-PROBLEM
mainly	RB	I-PROBLEM
frontal	JJ	I-PROBLEM
headaches	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
neck	NN	I-PROBLEM
soreness	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
diplopia	NN	B-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
speech	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
or	CC	O
sensory	JJ	B-PROBLEM
change	NN	I-PROBLEM
in	IN	O
her	PRP$	O
history	NN	O
.	.	O

Is	VBZ	O
notable	JJ	O
for	IN	O
depression	NN	B-PROBLEM
,	,	O
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
followed	VBN	O
regularly	RB	O
by	IN	O
Dr.	NNP	O
Freiermchird	NNP	O
of	IN	O
Nash	NNP	O
Health	NNP	O
for	IN	O
several	JJ	O
months	NNS	O
with	IN	O
pharmacologic	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
,	,	O
which	WDT	O
is	VBZ	O
apparently	RB	O
working	VBG	O
well	RB	O
.	.	O

Her	PRP$	B-TREATMENT
Doxepin	NNP	I-TREATMENT
has	VBZ	O
recently	RB	O
been	VBN	O
increased	VBN	O
.	.	O

She	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
and	CC	O
otherwise	RB	O
has	VBZ	O
no	DT	O
remarkable	JJ	O
past	JJ	O
medical	JJ	O
history	NN	O
.	.	O

Quinine	JJ	B-TREATMENT
gives	VBZ	O
her	PRP$	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

The	DT	O
only	JJ	O
medications	NNS	B-TREATMENT
she	PRP	O
is	VBZ	O
on	IN	O
are	VBP	O
Paxil	NNP	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
Doxepin	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
and	CC	O
Klonopin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

She	PRP	O
was	VBD	O
pleasant	JJ	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
130/60	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
66	CD	O
;	:	O
respirations	NNS	B-TEST
18	CD	O
;	:	O
temperature	NN	B-TEST
98	CD	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
carotid	NN	B-PROBLEM
or	CC	I-PROBLEM
cervical	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
and	CC	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
.	.	O

Her	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Her	PRP$	O
extremities	NNS	O
were	VBD	O
without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
edema	NN	B-PROBLEM
,	,	O
or	CC	O
rash	NN	B-PROBLEM
;	:	O
there	EX	O
were	VBD	O
some	DT	O
older	JJR	O
hematomas	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bilaterally	RB	I-PROBLEM
shins	VBZ	I-PROBLEM
.	.	O

Her	PRP$	O
affect	NN	O
was	VBD	O
slightly	RB	B-PROBLEM
inappropriate	JJ	I-PROBLEM
at	IN	O
times	NNS	O
;	:	O
for	IN	O
example	NN	O
,	,	O
singing	VBG	B-PROBLEM
or	CC	I-PROBLEM
humming	VBG	I-PROBLEM
along	RB	I-PROBLEM
while	IN	O
performing	VBG	O
some	DT	O
of	IN	O
the	DT	B-TEST
motor	NN	I-TEST
tasks	NNS	I-TEST
and	CC	O
giving	VBG	O
the	DT	O
impression	NN	O
of	IN	O
indifference	NN	B-PROBLEM
to	TO	O
the	DT	B-PROBLEM
deficits	NNS	I-PROBLEM
that	WDT	O
were	VBD	O
demonstrated	VBN	O
on	IN	O
the	DT	B-TEST
examination	NN	I-TEST
.	.	O

There	EX	O
was	VBD	O
no	DT	O
nystagmus	NN	B-PROBLEM
and	CC	O
no	DT	O
ptosis	NN	B-PROBLEM
.	.	O

Motor	NNP	B-TEST
examination	NN	I-TEST
revealed	VBD	O
5/5	CD	O
power	NN	O
in	IN	O
all	DT	O
groups	NNS	O
in	IN	O
the	DT	O
proximal	NN	O
and	CC	O
distal	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
drift	NN	B-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
slightly	RB	B-PROBLEM
slow	JJ	I-PROBLEM
fine	NN	I-PROBLEM
finger	NN	I-PROBLEM
motility	NN	I-PROBLEM
approximately	RB	O
equal	JJ	O
bilaterally	RB	O
,	,	O
although	IN	O
this	DT	O
was	VBD	O
extremely	RB	O
difficult	JJ	O
to	TO	O
reproduce	VB	O
.	.	O

Reflexes	NNS	B-TEST
were	VBD	O
2+	CD	O
throughout	IN	O
in	IN	O
the	DT	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
,	,	O
and	CC	O
toes	NNS	O
were	VBD	O
downgoing	VBG	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
jaw	NN	B-PROBLEM
jerk	NN	I-PROBLEM
and	CC	O
no	DT	O
Hoffman	NNP	O
&apos;s	NNP	O
sign	NN	O
.	.	O

Coordination	NNP	O
-	:	O
toe	NN	B-TEST
tap	NN	I-TEST
was	VBD	O
slow	JJ	B-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
although	IN	O
difficult	JJ	O
to	TO	O
reproduce	VB	O
,	,	O
and	CC	O
at	IN	O
best	JJS	O
,	,	O
was	VBD	O
essentially	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

On	IN	O
standing	NN	O
,	,	O
she	PRP	O
tended	VBD	O
to	TO	O
fall	VB	O
to	TO	O
the	DT	O
front	NN	O
,	,	O
back	RB	O
or	CC	O
sides	NNS	O
without	IN	O
trying	VBG	O
to	TO	O
stop	VB	O
her	PRP$	O
fall	NN	O
initially	RB	O
,	,	O
and	CC	O
extensive	JJ	B-TEST
gait	NN	I-TEST
testing	NN	I-TEST
was	VBD	O
deferred	VBN	O
due	JJ	O
to	TO	O
concerns	NNS	O
for	IN	O
safety	NN	O
.	.	O

Her	PRP$	B-TEST
heel-to-shin	JJ	I-TEST
and	CC	I-TEST
finger-to-nose	JJ	I-TEST
testing	NN	I-TEST
was	VBD	O
fully	RB	O
intact	JJ	O
bilaterally	RB	O
without	IN	O
ataxia	NN	B-PROBLEM
or	CC	O
tremor	NN	B-PROBLEM
.	.	O

Were	NNP	O
unremarkable	JJ	O
with	IN	O
normal	JJ	O
electrolytes	NNS	B-TEST
and	CC	O
complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
parameters	NNS	I-TEST
.	.	O

Her	PRP$	B-TEST
erythrocyte	JJ	I-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
12	CD	O
.	.	O

Her	PRP$	B-TEST
coagulation	NN	I-TEST
parameters	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

Head	NNP	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
without	IN	I-TEST
contrast	NN	I-TEST
showed	VBD	O
normal	JJ	O
brain	NN	O
parenchyma	NN	O
and	CC	O
no	DT	O
intracranial	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
her	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
disorder	NN	I-PROBLEM
with	IN	O
other	JJ	O
notable	JJ	B-PROBLEM
findings	NNS	I-PROBLEM
on	IN	O
examination	NN	B-TEST
including	VBG	O
anisocoria	NNS	B-PROBLEM
,	,	O
which	WDT	O
,	,	O
by	IN	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
report	NN	O
,	,	O
had	VBD	O
been	VBN	O
noted	VBN	O
several	JJ	O
months	NNS	O
earlier	RB	O
.	.	O

A	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
angiogram	NN	I-TEST
study	NN	I-TEST
was	VBD	O
obtained	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
clear	JJ	O
evidence	NN	O
of	IN	O
arterial	JJ	B-PROBLEM
dissections	NNS	I-PROBLEM
or	CC	O
infarction	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
pathologic	JJ	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
been	VBN	O
placed	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
initially	RB	O
,	,	O
but	CC	O
this	DT	O
was	VBD	O
discontinued	VBN	O
after	IN	O
the	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
results	NNS	O
were	VBD	O
obtained	VBN	O
.	.	O

Posterior	NNP	B-TEST
transcranial	JJ	I-TEST
Doppler	NNP	I-TEST
studies	NNS	I-TEST
showed	VBD	O
normal	JJ	O
studies	NNS	O
of	IN	O
both	DT	O
vertebral	JJ	O
arteries	NNS	O
,	,	O
and	CC	O
carotid	VB	B-TEST
non-invasive	JJ	I-TEST
studies	NNS	I-TEST
showed	VBD	O
normal	JJ	O
right	NN	O
and	CC	O
left	VBD	O
carotid	JJ	O
bifurcations	NNS	O
.	.	O

On	IN	O
the	DT	O
second	JJ	O
hospital	NN	O
day	NN	O
,	,	O
her	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
continued	VBD	O
to	TO	O
be	VB	O
markedly	RB	B-PROBLEM
unstable	JJ	I-PROBLEM
,	,	O
although	IN	O
with	IN	O
no	DT	O
consistent	JJ	O
pattern	NN	O
in	IN	O
terms	NNS	O
of	IN	O
weakness	NN	B-PROBLEM
or	CC	O
directionality	NN	O
of	IN	O
falling	VBG	O
,	,	O
and	CC	O
she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
no	DT	O
reproducible	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
or	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
ataxia	NN	I-PROBLEM
or	CC	O
dysmetria	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
Psychiatry	NNP	B-TREATMENT
Service	NNP	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
acutely	RB	B-PROBLEM
suicidal	JJ	I-PROBLEM
or	CC	O
otherwise	RB	O
in	IN	O
need	NN	O
of	IN	O
acute	JJ	B-TREATMENT
psychiatric	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

The	DT	O
psychiatrist	NN	O
also	RB	O
noted	VBD	O
the	DT	O
indifference	NN	O
the	DT	O
patient	NN	O
evinced	VBD	O
regarding	VBG	O
her	PRP$	B-PROBLEM
own	JJ	I-PROBLEM
symptomatology	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
neurology	NN	O
conferences	NNS	O
for	IN	O
several	JJ	O
hours	NNS	O
,	,	O
and	CC	O
during	IN	O
this	DT	O
time	NN	O
,	,	O
showed	VBD	O
significant	JJ	O
improvement	NN	O
while	IN	O
receiving	VBG	O
gait	JJ	B-TREATMENT
training	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
evaluation	NN	B-TEST
;	:	O
in	IN	O
particular	NN	O
,	,	O
she	PRP	O
became	VBD	O
more	RBR	O
stable	JJ	O
with	IN	O
counter-balancing	JJ	B-TREATMENT
methods	NNS	I-TREATMENT
.	.	O

She	PRP	O
will	MD	O
continue	VB	O
on	IN	O
her	PRP	B-TREATMENT
previous	JJ	I-TREATMENT
outpatient	JJ	I-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

ABD	NNP	B-PROBLEM
PAIN/	NNP	I-PROBLEM
PELVIC	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

Abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
Treatment	NNP	O
Rendered	NNP	O
:	:	O

Ct	NNP	B-TEST
scan	JJ	I-TEST
shows	NNS	O
ovarian	JJ	B-PROBLEM
cyst	NN	I-PROBLEM

Vicodin	NN	B-TREATMENT

If	IN	O
you	PRP	O
have	VBP	O
continued	VBN	O
fevers	NNS	B-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
discharge	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
SDH	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
FAIRM	NNP	O
OF	NNP	O
IJORDCOMPMAC	NNP	O
HOSPITAL	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
GLYNCRED	NNP	O
,	,	O
NABETH	NNP	O
N	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
SDH	NNP	B-PROBLEM
.	.	O

s	NN	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

Attending	VBG	B-TEST
evaluation	NN	I-TEST

COLACE	NNP	B-TREATMENT
(	(	I-TREATMENT
DOCUSATE	NNP	I-TREATMENT
SODIUM	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
IBUPROFEN	NNP	B-TREATMENT
600	CD	O
MG	NNP	O
PO	NNP	O
Q6H	NNP	O
PRN	NNP	O
PAIN	NNP	O
ALDOMET	NNP	B-TREATMENT
(	(	I-TREATMENT
METHYLDOPA	NNP	I-TREATMENT
)	)	I-TREATMENT
250	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PERCOCET	NNP	B-TREATMENT
1-2	JJ	O
TAB	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

Your	PRP$	O
obstetrician	JJ	O
6	CD	O
weeks	NNS	O
,	,	O
No	NNP	O
Known	NNP	B-PROBLEM
Allergies	NNS	I-PROBLEM

s	NN	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

PRINCIPAL	NNP	O
DISCHARGE	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Responsible	NNP	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
s	VBP	O
/	JJ	O
p	NN	O
cesarean	NN	B-TREATMENT

OTHER	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Conditions	NNP	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
s	RB	O
/	VBZ	O
p	JJ	O
cesarean	NN	B-TREATMENT

Epidural	JJ	B-TREATMENT
Vaginal	NNP	O
delivery	NN	O
:	:	O

Non-reassuring	JJ	B-PROBLEM
fetal	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
Uterine	NNP	O

IV	NNP	B-TREATMENT
ABX	NNP	I-TREATMENT

Post	NN	B-PROBLEM
dates	NNS	I-PROBLEM

,	,	O
Other	JJ	O
-	:	O
bradycardia	NN	B-PROBLEM

No	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

12/02/03	CD	O
03:20	CD	O
PM	NNP	O
Apgars	NNP	B-TEST
7,8	CD	O

Weight	NN	B-TEST
:	:	O

no	DT	O
heavy	JJ	O
lifting	NN	O
;	:	O
nothing	NN	O
in	IN	O
the	DT	O
vagina	NN	O
for	IN	O
6	CD	O
weeks	NNS	O
--	:	O
no	DT	O
intercourse	NN	O
,	,	O
no	DT	O
douching	NN	O
,	,	O
no	DT	O
tampons	NNS	O
;	:	O
call	VB	O
for	IN	O
fever	NN	B-PROBLEM
above	IN	I-PROBLEM
100.5	CD	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
heavy	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concern	NN	I-PROBLEM
;	:	O
no	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
percocet	NN	B-TREATMENT

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
-	:	O
trauma	NN	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
sprains	NNS	B-PROBLEM
,	,	O
fractures	NNS	B-PROBLEM
and	CC	O
bruises	NNS	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

s	NN	O
/	NNP	O
p	NN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
muscle	NN	B-PROBLEM
contusions	NNS	I-PROBLEM

xray	SYM	B-TEST
-	:	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM

motrin	NN	B-TREATMENT
600	CD	O
mg	NN	O
every	DT	O
8	CD	O
hours	NNS	O
for	IN	O
pain	NN	B-PROBLEM
-	:	O
please	NN	O
take	VB	O
with	IN	O
food	NN	O
in	IN	O
your	PRP$	O
stomach	NN	O

Please	NNP	O
use	NN	O
ice	NN	B-TREATMENT
to	TO	O
sore	VB	B-PROBLEM
areas	NNS	I-PROBLEM
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

If	IN	O
you	PRP	O
develop	VBP	O
trouble	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerns	NNS	I-PROBLEM
please	VB	O
return	NN	O
to	TO	O
the	DT	O
ED	NNP	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

Alzheimer	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
secondary	NN	O
to	TO	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
44	CD	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
with	IN	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
falling	VBG	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
activities	NNS	I-PROBLEM
of	IN	O
daily	JJ	O
living	NN	O
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
44	CD	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
with	IN	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
increased	JJ	B-PROBLEM
falling	VBG	I-PROBLEM
and	CC	O
gait	NN	B-PROBLEM
unsteadiness	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
inability	NN	I-PROBLEM
to	TO	O
perform	VB	O
her	PRP$	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
over	IN	O
the	DT	O
past	JJ	O
three	CD	O
years	NNS	O
.	.	O

The	DT	O
diagnosis	NN	O
of	IN	O
Alzheimer	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
was	VBD	O
made	VBN	O
in	IN	O
1998	CD	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
MRI	NNP	I-TEST
at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
which	WDT	O
showed	VBD	O
enlarged	JJ	B-PROBLEM
lateral	JJ	I-PROBLEM
ventricles	NNS	I-PROBLEM
and	CC	O
the	DT	O
possible	JJ	O
diagnosis	NN	O
of	IN	O
normal	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
hydrocephalus	NN	I-PROBLEM
was	VBD	O
entertained	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
diagnostic	JJ	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
.	.	O

Notable	JJ	O
for	IN	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
Altzheimer	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
secondary	NN	O
to	TO	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
diagnosed	VBD	O
in	IN	O
1998	CD	O
,	,	O
status	NN	O
post	NN	O
multiple	NN	B-PROBLEM
falls	VBZ	I-PROBLEM
,	,	O
no	DT	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
ankle	NN	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
EEG	NNP	I-PROBLEM
.	.	O

Include	NNP	O
Lamictal	NNP	B-TREATMENT
50	CD	O
mgs	NN	O
bid	NN	O
,	,	O
Aricept	NNP	B-TREATMENT
10	CD	O
mgs	NN	O
qhs	NN	O
,	,	O
BuSpar	NNP	B-TREATMENT
15	CD	O
mgs	NN	O
bid	NN	O
,	,	O
Trazodone	CD	B-TREATMENT
100	CD	O
mgs	NN	O
qhs	NN	O
.	.	O

There	EX	O
are	VBP	O
no	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Notable	JJ	O
for	IN	O
decreased	JJ	B-PROBLEM
ability	NN	I-PROBLEM
to	TO	O
do	VB	O
her	PRP$	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
,	,	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
language	NN	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
accidents	NNS	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
falls	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
poor	JJ	I-PROBLEM
gait	NN	I-PROBLEM
.	.	O

Noted	VBN	O
for	IN	O
friendly	JJ	O
,	,	O
jovial	JJ	O
44	CD	O
year-old	JJ	O
woman	NN	O
with	IN	O
Down	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
150/82	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
88	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

HEENT	NNP	B-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
esotropia	NN	I-PROBLEM
.	.	O

Chest	NNP	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

Cardiac	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

Abdominal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

Left	NNP	O
ankle	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
swelling	VBG	B-PROBLEM
secondary	JJ	O
to	TO	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
ankle	RP	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
back	RP	B-PROBLEM
folliculitis	NN	I-PROBLEM
.	.	O

Neuro	NNP	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	O
patient	NN	O
who	WP	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	$	O
1	CD	O
.	.	O

Cranial	JJ	O
nerves	NNS	O
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
esotropia	NN	I-PROBLEM
.	.	O

Reflexes	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
with	IN	O
down	RP	O
going	VBG	O
toes	NNS	O
.	.	O

The	DT	O
patient	NN	O
walked	VBD	O
with	IN	O
her	PRP$	B-PROBLEM
feet	NNS	I-PROBLEM
externally	RB	I-PROBLEM
rotated	VBN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
wide	JJ	I-PROBLEM
based	VBN	I-PROBLEM
gait	NN	I-PROBLEM
with	IN	O
shuffling	VBG	B-PROBLEM
short	JJ	I-PROBLEM
steps	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
tendency	NN	I-PROBLEM
to	TO	I-PROBLEM
fall	VB	I-PROBLEM
back	RB	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
walk	VB	O
without	IN	O
assist	NN	O
.	.	O

MRI	NNP	B-TEST
,	,	O
as	IN	O
discussed	VBN	O
,	,	O
was	VBD	O
done	VBN	O
at	IN	O
outside	JJ	O
hospital	NN	O
and	CC	O
demonstrated	VBD	O
large	JJ	B-PROBLEM
ventricles	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Arkzie-	NNP	O
Memorial	NNP	O
for	IN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
.	.	O

On	IN	O
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
was	VBD	O
attempted	VBN	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
but	CC	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
get	VB	O
cerebral	JJ	O
spinal	JJ	O
fluid	NN	O
due	JJ	O
to	TO	O
difficulty	NN	O
with	IN	O
compliance	NN	O
with	IN	O
the	DT	O
patient	NN	O
who	WP	O
was	VBD	O
severely	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
and	CC	O
would	MD	O
not	RB	O
comply	VB	O
with	IN	O
the	DT	B-TEST
examination	NN	I-TEST
.	.	O

On	IN	O
hospital	JJ	O
day	NN	O
the	DT	O
patient	NN	O
underwent	JJ	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
in	IN	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

Opening	VBG	B-TEST
pressure	NN	I-TEST
was	VBD	O
17	CD	O
and	CC	O
approximately	RB	O
20-25	JJ	O
cc	NN	O
of	IN	O
CSF	NNP	O
was	VBD	O
removed	VBN	O
.	.	O

CSF	NNP	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
sugar	JJ	B-TEST
level	NN	I-TEST
of	IN	O
65	CD	O
and	CC	O
total	JJ	B-TEST
protein	JJ	I-TEST
level	NN	I-TEST
of	IN	O
56	CD	O
.	.	O

Vitamin	NNP	B-TEST
B12	NNP	I-TEST
of	IN	O
855	CD	O
,	,	O
folic	JJ	B-TEST
acid	NN	I-TEST
of	IN	O
15.4	CD	O
.	.	O

Chem-7	NNP	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

Tube	NNP	O
and	CC	O
requisition	NN	O
of	IN	O
the	DT	O
CSF	NNP	B-TEST
labeled	VBD	I-TEST
tube	RB	I-TEST
#	#	I-TEST
1	CD	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
color	NN	B-TEST
pink	NN	O
,	,	O
turbidity	NN	B-TEST
slight	NN	O
,	,	O
xanthochromia	NNP	B-TEST
yes	UH	O
,	,	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3,800	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3	CD	O
,	,	O
neutrophils	RB	B-TEST
58	CD	O
,	,	O
bands	VBZ	B-TEST
4	CD	O
,	,	O
lymphs	VBD	B-TEST
29	CD	O
,	,	O
monos	FW	B-TEST
6	CD	O
,	,	O
eos	VBD	B-TEST
2	CD	O
and	CC	O
basos	$	B-TEST
1	CD	O
.	.	O

CSF	NNP	B-TEST
tube	NN	I-TEST
labeled	VBD	I-TEST
#	#	I-TEST
4	CD	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
CSF	NNP	B-TEST
color	NN	I-TEST
pink	NN	O
,	,	O
CSF	NNP	B-TEST
turbidity	NN	I-TEST
slight	NN	O
,	,	O
CSF	NNP	B-TEST
xanthochromia	NNP	I-TEST
yes	UH	O
,	,	O
CSF	NNP	B-TEST
RBCs	NNP	I-TEST
3,900	CD	O
,	,	O
CSF	NNP	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3	CD	O
,	,	O
CSF	NNP	B-TEST
neutrophils	VBZ	I-TEST
61	CD	O
,	,	O
CSF	NNP	B-TEST
bands	VBZ	I-TEST
3	CD	O
,	,	O
CSF	NNP	B-TEST
lymphs	VBZ	I-TEST
31	CD	O
,	,	O
CSF	NNP	B-TEST
monos	VBD	I-TEST
1	CD	O
,	,	O
CSF	NNP	B-TEST
eos	VBZ	I-TEST
3	CD	O
,	,	O
CSF	NNP	B-TEST
basos	VBD	I-TEST
1	CD	O
.	.	O

CSF	NNP	B-TEST
gram	NN	I-TEST
stain	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
no	DT	O
polys	NN	B-PROBLEM
and	CC	O
no	DT	O
organisms	JJ	B-PROBLEM
seen	VBN	O
.	.	O

The	DT	B-TEST
fluid	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
no	DT	O
growth	NN	O
to	TO	O
date	NN	O
.	.	O

One	CD	O
day	NN	O
prior	RB	O
to	TO	O
lumbar	VB	B-TEST
puncture	NN	I-TEST
,	,	O
an	DT	B-TEST
aerobic	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
similarly	RB	O
pending	JJ	O
.	.	O

Lyme	NNP	B-TEST
capture	NN	I-TEST
was	VBD	O
pending	VBG	O
and	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

RPR	NNP	B-TEST
card	NN	I-TEST
test	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

Because	IN	O
of	IN	O
poor	JJ	O
compliance	NN	O
with	IN	O
the	DT	B-TEST
gait	NN	I-TEST
examination	NN	I-TEST
it	PRP	O
was	VBD	O
very	RB	O
difficult	JJ	O
to	TO	O
assess	VB	O
changing	VBG	B-PROBLEM
gait	JJ	I-PROBLEM
post	NN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
.	.	O

Her	PRP$	O
mental	JJ	O
status	NN	O
remained	VBD	O
similarly	RB	O
to	TO	O
her	PRP$	B-TEST
admission	NN	I-TEST
examination	NN	I-TEST
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
neuro	CC	I-TEST
examination	NN	I-TEST
was	VBD	O
largely	RB	O
unchanged	JJ	O
from	IN	O
the	DT	B-TEST
admission	NN	I-TEST
neuro	DT	I-TEST
examination	NN	I-TEST
.	.	O

cnm	NN	B-TEST
evaluation	NN	I-TEST

DOCUSATE	NNP	B-TREATMENT
SODIUM	NNP	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PRN	NNP	O
Constipation	NNP	B-PROBLEM
IBUPROFEN	NNP	B-TREATMENT
400-600	JJ	O
MG	NNP	O
PO	NNP	O
Q6H	NNP	O
PRN	NNP	O
Pain	NNP	B-PROBLEM

Take	VB	O
with	IN	O
food	NN	O
PRENATAL	NNP	B-TREATMENT
MULTIVITAMINS	NNP	I-TREATMENT
(	(	I-TREATMENT
STUARTNATAL	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
TAB	NNP	O
PO	NNP	O
QD	NNP	O
MAALOX-TABLETS	NNP	B-TREATMENT
QUICK	NNP	I-TREATMENT
DISSOLVE	NNP	I-TREATMENT
/	NNP	I-TREATMENT
CHEWABLE	NNP	I-TREATMENT
1-2	JJ	O
TAB	NNP	O
PO	NNP	O
Q6H	NNP	O
PRN	NNP	O
Upset	NNP	B-PROBLEM
Stomach	NNP	I-PROBLEM

pregnancy	NN	B-PROBLEM
,	,	I-PROBLEM
term	NN	I-PROBLEM

Laceration	NN	B-PROBLEM
:	:	O

Perineal	NNP	B-PROBLEM
,	,	I-PROBLEM
1st	CD	I-PROBLEM
degree	NN	I-PROBLEM

repair	NN	B-TREATMENT
of	IN	O
first	JJ	B-PROBLEM
degree	JJ	I-PROBLEM
perineal	NN	I-PROBLEM
laceration	NN	I-PROBLEM

No	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

Apgars	NNS	B-TEST
9,9	CD	O

Weight	NN	B-TEST
:	:	O

This	DT	O
85	CD	O
year	NN	O
old	JJ	O
man	NN	O
was	VBD	O
admitted	VBN	O
because	IN	O
of	IN	O
the	DT	O
new	JJ	O
onset	NN	O
of	IN	O
focal	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
seizure	NN	I-PROBLEM
and	CC	O
unresponsiveness	NN	B-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
a	DT	O
past	JJ	O
history	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
10	CD	O
,	,	O
mild	FW	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
territory	NN	I-PROBLEM
stroke	NN	I-PROBLEM
in	IN	O
07/94	CD	O
.	.	O

He	PRP	O
was	VBD	O
at	IN	O
Orlak	NNP	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
and	CC	O
was	VBD	O
found	VBN	O
unresponsive	JJ	B-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
tonic-clonic	JJ	I-PROBLEM
movements	NNS	I-PROBLEM
,	,	O
greater	JJR	O
in	IN	O
the	DT	O
arms	NNS	O
than	IN	O
in	IN	O
the	DT	O
legs	NN	O
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
Fairm	NNP	O
of	IN	O
Ijordcompmac	NNP	O
Hospital	NNP	O
,	,	O
where	WRB	O
seizures	NNS	B-PROBLEM
were	VBD	O
stopped	VBN	O
with	IN	O
2	CD	O
mg	NNS	O
of	IN	O
Ativan	NNP	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
IV	NNP	B-TREATMENT
Dilantin	NNP	I-TREATMENT
.	.	O

He	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
with	IN	O
poor	JJ	B-PROBLEM
airway	NN	I-PROBLEM
protection	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
flaccid	VBN	B-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
oculocephalic	JJ	B-PROBLEM
reflexes	NNS	I-PROBLEM
.	.	O

After	IN	O
one	CD	O
hour	NN	O
his	PRP$	O
eyes	NNS	O
were	VBD	O
midline	JJ	O
and	CC	O
he	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

An	DT	B-TEST
electroencephalogram	NN	I-TEST
revealed	VBD	O
generalized	JJ	B-PROBLEM
slowing	NN	I-PROBLEM
without	IN	I-PROBLEM
ictal	JJ	I-PROBLEM
events	NNS	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
stertorous	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
positional	JJ	B-PROBLEM
tremors	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
spastic	JJ	I-PROBLEM
left	NN	I-PROBLEM
hemiparesis	NN	I-PROBLEM
in	IN	I-PROBLEM
flexion	NN	I-PROBLEM
.	.	O

He	PRP	O
withdrew	VBD	O
both	DT	O
legs	NNS	O
to	TO	O
painful	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

The	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
was	VBD	O
flaccid	JJ	B-PROBLEM
and	CC	O
paresthetic	JJ	B-PROBLEM
.	.	O

At	IN	O
1:15	CD	O
PM	NNP	O
on	IN	O
10/06/94	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
unresponsive	JJ	B-PROBLEM
with	IN	O
no	DT	O
heart	NN	B-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
carotid	NN	B-PROBLEM
pulse	NN	I-PROBLEM
,	,	O
respiratory	JJ	B-PROBLEM
excursions	NNS	I-PROBLEM
,	,	O
or	CC	O
pupillary	JJ	B-PROBLEM
reactions	NNS	I-PROBLEM
.	.	O

Consent	NN	O
for	IN	O
autopsy	NN	B-TEST
was	VBD	O
denied	VBN	O
.	.	O

1.	CD	O
Left	NNP	B-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
territory	NN	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
Cardiomyopathy	NNP	B-PROBLEM
.	.	O

3.	CD	O
Residual	NNP	O
of	IN	O
previous	JJ	B-PROBLEM
right	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

Abnormal	NNP	B-PROBLEM
Fetal	NNP	I-PROBLEM
Heart	NNP	I-PROBLEM
Rate	NNP	I-PROBLEM
/	NNP	I-PROBLEM
Rhythm	NNP	I-PROBLEM
-	:	O
Delivered	VBD	O

Abnormal	NNP	B-PROBLEM
Pap	NNP	I-PROBLEM
Test	NNP	I-PROBLEM
,	,	O
history	NN	O
of	IN	O

Vacuum	NNP	B-TREATMENT
Extraction	NNP	I-TREATMENT

Routine	JJ	B-TREATMENT
Post	NNP	I-TREATMENT
Partum	NNP	I-TREATMENT
Care	NNP	I-TREATMENT

Active	JJ	B-PROBLEM
Labor	NN	I-PROBLEM

HEIGHT	$	B-TEST
49	CD	O
HEENT	NNP	B-TEST
NORMAL	NNP	O
MOUTH	NNP	O
NORMAL	NNP	O
NECK	NNP	O
NORMAL	NNP	O
BREASTS	NNP	O
NORMAL	NNP	O
NIPPLES	NNP	O
NORMAL	NNP	O
CHEST	NNP	O
NORMAL	NNP	O
COR	NNP	O
NORMAL	NNP	O
ABDOMEN	NNP	O
NORMAL	NNP	O
gravid	NN	O
,	,	O
+	NNP	O
FHR	NNP	O
,	,	O
NT	NNP	O
EXTREM	NNP	O
NORMAL	NNP	O
SKIN	NNP	O
NORMAL	NNP	O
NODES	NNP	O
NORMAL	NNP	O
VULVA	NNP	O
NORMAL	NNP	O
VAGINA	NNP	O
NORMAL	NNP	O
CERVIX	NNP	O
NORMAL	NNP	O
4-5/100%	JJ	O
OS	NNP	O
NORMAL	NNP	O
closed	VBD	O
,	,	O
firm	NN	O
,	,	O
-CMT	NNP	O
ADNEXAE	NNP	O
NORMAL	NNP	O
UTERUS	NNP	O
NORMAL	NNP	O
term	NN	O
7-7.5	JJ	O
#	#	O
vtx	JJ	O
UTERINE	NNP	O
SIZE	NNP	O
IN	NNP	O
WEEKS	NNP	O
NORMAL	NNP	O
term	NN	O

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

She	PRP	O
delivered	VBD	O
a	DT	O
3263	CD	O
gram	NN	O
female	JJ	O
infant	NN	O
at	IN	O
06/14/2001	CD	O
at	IN	O
06:40	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
8	CD	O
and	CC	O
8	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.3	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
vacuum	NN	B-TREATMENT
extraction	NN	I-TREATMENT
.	.	O

fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
,	,	O
times	CC	O
two	CD	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
81	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
breast	NN	I-PROBLEM
mass	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
mammogram	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
breast	NN	I-TEST
with	IN	O
shadow	JJ	B-TEST
biopsy	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

In	IN	O
the	DT	O
fall	NN	O
of	IN	O
1991	CD	O
,	,	O
nipple	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
discomfort	NN	B-PROBLEM
was	VBD	O
again	RB	O
noted	JJ	O
.	.	O

A	DT	B-TEST
mmamogram	NN	I-TEST
showed	VBD	O
no	DT	O
change	NN	O
on	IN	O
right	NN	O
,	,	O
but	CC	O
new	JJ	B-TEST
biopsy	NN	I-TEST
was	VBD	O
positive	JJ	O
.	.	O

On	IN	O
the	DT	O
left	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
shawdown	NN	I-PROBLEM
but	CC	O
the	DT	B-TEST
biopsy	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

The	DT	O
patient	JJ	O
presents	NNS	O
now	RB	O
for	IN	O
right	JJ	B-TREATMENT
modified	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
with	IN	O
impant	NN	B-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Clear	JJ	O
lungs	NNS	O
,	,	O
normal	JJ	O
heart	NN	O
,	,	O
Pagett	NNP	B-TEST
&apos;s	NNP	I-TEST
type	NN	O
changes	NNS	O
on	IN	O
the	DT	O
right	JJ	O
breast	NN	O
and	CC	O
left	VBD	O
breast	NN	O
without	IN	O
apparent	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
with	IN	O
scarring	VBG	B-PROBLEM
supra-areolar	JJ	I-PROBLEM
and	CC	I-PROBLEM
infra-areolar	JJ	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
biopsy	NN	I-PROBLEM
scar	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
breast	NN	I-PROBLEM
from	IN	O
1990	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
Operting	NNP	O
Room	NNP	O
on	IN	O
8/7/92	CD	O
,	,	O
where	WRB	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
modified	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

Subsequently	RB	O
a	DT	B-TREATMENT
saline-filled	JJ	I-TREATMENT
right	NN	I-TREATMENT
breast	NN	I-TREATMENT
implant	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
extremely	RB	O
well	RB	O
.	.	O

Two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
used	VBN	O
.	.	O

One	CD	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
and	CC	O
the	DT	B-TREATMENT
second	JJ	I-TREATMENT
drain	NN	I-TREATMENT
she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
.	.	O

Discharge	NNP	B-TREATMENT
medications	NNS	I-TREATMENT
include	VBP	O
Percocet	NNP	B-TREATMENT
and	CC	O
Colace	NNP	B-TREATMENT
.	.	O

MENTAL	NNP	B-PROBLEM
STATUS	NNP	I-PROBLEM
CHANGE	NNP	I-PROBLEM
,	,	O
CELLULITIS	NNP	B-PROBLEM

MENTAL	NNP	B-PROBLEM
STATUS	NNP	I-PROBLEM
CHANGES	NNP	I-PROBLEM
.	.	O

1)	CD	O
AORTIC	NNP	B-PROBLEM
STENOSIS	NNP	I-PROBLEM
.	.	O

2)	CD	O
MITRAL	NNP	B-PROBLEM
REGURGITATION	NNP	I-PROBLEM
.	.	O

3)	CD	O
STATUS	NNP	O
POST	NNP	O
FALL	NNP	B-PROBLEM
.	.	O

4)	CD	O
HISTORY	NNP	O
OF	NNP	O
TRANSIENT	NNP	B-PROBLEM
ISCHEMIC	NNP	I-PROBLEM
ATTACK	NNP	I-PROBLEM
/	NNP	O
CEREBROVASCULAR	NNP	B-PROBLEM
ACCIDENT	NNP	I-PROBLEM
.	.	O

5)	CD	O
RIGHT	NNP	B-PROBLEM
LOWER	NNP	I-PROBLEM
EXTREMITY	NNP	I-PROBLEM
WOUND	NNP	I-PROBLEM
.	.	O

6)	CD	O
ATRIAL	NNP	B-PROBLEM
FIBRILLATION	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
88	CD	O
year-old	JJ	O
woman	NN	O
undergoing	VBG	O
treatment	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
Child	NNP	O
for	IN	O
worsening	VBG	B-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
new	JJ	B-PROBLEM
confusion	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
was	VBD	O
recently	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
a	DT	O
Nafcillin	NNP	B-PROBLEM
sensitive	JJ	I-PROBLEM
Staphylococcus	NNP	I-PROBLEM
aureus	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
Nafcillin	NNP	I-TREATMENT
and	CC	O
Levofloxacin	NNP	B-TREATMENT
.	.	O

There	EX	O
was	VBD	O
also	RB	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
that	WDT	O
was	VBD	O
incised	VBN	O
and	CC	O
drained	VBN	O
on	IN	O
August	NNP	O
1	CD	O
,	,	O
1998	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
rehabilitation	VB	B-TREATMENT
on	IN	O
Levofloxacin	NNP	B-TREATMENT
orally	RB	O
.	.	O

Although	IN	O
details	NNS	O
were	VBD	O
not	RB	O
available	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
apparently	RB	O
,	,	O
she	PRP	O
had	VBD	O
done	VBN	O
well	RB	O
until	IN	O
the	DT	O
24	CD	O
hours	NNS	O
proceeding	VBG	O
admission	NN	O
when	WRB	O
the	DT	B-PROBLEM
cellulitis	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
worsening	VBG	O
.	.	O

She	PRP	O
had	VBD	O
also	RB	O
been	VBN	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
and	CC	O
combative	JJ	B-PROBLEM
during	IN	O
that	DT	O
24	CD	O
hour	NN	O
period	NN	O
.	.	O

1)	CD	O
Aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	I-PROBLEM
severe	JJ	I-PROBLEM
,	,	O
echocardiogram	JJ	B-TEST
in	IN	O
July	NNP	O
of	IN	O
1998	CD	O
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
6-8	JJ	O
mm	NN	O
of	IN	O
mercury	NN	O
,	,	O
aortic	JJ	B-TEST
valve	NN	I-TEST
area	NN	I-TEST
calculated	VBD	O
to	TO	O
be	VB	O
0.5	CD	O
cm	NN	O
squared	VBN	O
by	IN	O
the	DT	O
continuity	NN	B-TEST
equation	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Calculated	VBN	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
45-50%	JJ	O
.	.	O

2)	CD	O
Mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
2+	CD	O
on	IN	O
July	NNP	O
of	IN	O
1998	CD	O
echocardiogram	NN	B-TEST
.	.	O

3)	CD	O
History	NNP	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

4)	CD	O
History	NNP	O
of	IN	O
cerebrovascular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5)	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

6)	CD	O
History	NNP	O
of	IN	O
temporal	JJ	B-PROBLEM
arteritis	NN	I-PROBLEM
on	IN	O
chronic	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

7)	CD	O
History	NNP	O
of	IN	O
colitis	NN	B-PROBLEM
.	.	O

8)	CD	O
History	NNP	O
of	IN	O
vertebral	JJ	B-PROBLEM
body	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

1)	CD	O
Digoxin	NNP	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2)	CD	O
Lasix	NNP	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3)	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4)	CD	O
Coumadin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

5)	CD	O
Zaroxolyn	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

6)	CD	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7)	CD	O
Potassium	NNP	B-TREATMENT
20	CD	O
mEq	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8)	CD	O
Prednisone	CD	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.o.d.	NN	O

9)	CD	O
Fosamax	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

10)	CD	O
Levofloxacin	NNP	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11)	CD	O
Axid	NNP	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

12)	CD	O
Buspar	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

13)	CD	O
Zyrtec	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Physical	JJ	B-TEST
examination	NN	I-TEST
on	IN	O
admission	NN	O
revealed	VBD	O
an	DT	O
elderly	JJ	O
woman	NN	O
,	,	O
sleeping	NN	O
,	,	O
responsive	JJ	O
only	RB	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
after	IN	O
having	VBG	O
received	VBD	O
some	DT	B-TREATMENT
sedation	NN	I-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

Heart	NNP	B-TEST
rate	NN	I-TEST
60	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
116/80	CD	O
,	,	O
temperature	NN	B-TEST
97.1	CD	O
degrees	NNS	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
93%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Head	NN	B-TEST
and	CC	I-TEST
neck	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

Skin	NNP	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-PROBLEM
leg	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
cellulitis	NN	B-PROBLEM
to	TO	O
be	VB	O
delineated	VBN	O
below	IN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
spider	NN	B-PROBLEM
angiomata	NN	I-PROBLEM
.	.	O

Neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

The	DT	B-TEST
heart	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
sustained	VBN	I-PROBLEM
PMI	NNP	I-PROBLEM
which	WDT	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
left	NN	O
mid	NN	O
clavicular	JJ	O
line	NN	O
,	,	O
S1	NNP	O
,	,	O
near	IN	B-PROBLEM
complete	JJ	I-PROBLEM
obliteration	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
second	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
by	IN	O
a	DT	B-PROBLEM
two	CD	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
six	CD	I-PROBLEM
high	JJ	I-PROBLEM
pitched	VBN	I-PROBLEM
murmur	NN	I-PROBLEM
peaking	VBG	O
at	IN	O
mid	NN	O
to	TO	O
late	VB	O
systole	NN	O
and	CC	O
heard	NN	O
across	IN	O
the	DT	O
precordium	NN	O
.	.	O

There	EX	O
was	VBD	O
also	RB	O
a	DT	B-PROBLEM
blowing	VBG	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
at	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
apex	NN	O
to	TO	O
axilla	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
S3	NNP	B-PROBLEM
appreciated	VBD	O
.	.	O

Vascular	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
1+	CD	B-PROBLEM
carotid	NN	I-PROBLEM
impulses	NNS	I-PROBLEM
which	WDT	O
were	VBD	O
diminished	VBN	O
and	CC	O
delayed	VBN	O
and	CC	O
the	DT	O
above	NN	O
mentioned	VBD	O
transmitted	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
murmurs	NN	I-PROBLEM
.	.	O

Abdominal	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
no	DT	O
organomegaly	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
erythema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
calf	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
a	DT	O
relatively	RB	O
clean	JJ	O
base	NN	O
.	.	O

Neurological	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
quite	RB	B-PROBLEM
sedated	VBN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
having	VBG	O
received	VBN	O
some	DT	O
medications	NNS	B-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
arousable	JJ	O
only	RB	O
to	TO	O
painful	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

She	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
move	VB	O
all	DT	O
four	CD	O
of	IN	O
her	PRP$	O
extremities	NNS	O
in	IN	O
response	NN	O
to	TO	O
pain	VB	B-TEST
.	.	O

Her	PRP$	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
slightly	RB	O
diminished	VBN	O
at	IN	O
1+	CD	O
bilaterally	RB	O
,	,	O
but	CC	O
symmetric	JJ	O
.	.	O

Sodium	NN	B-TEST
was	VBD	O
142	CD	O
,	,	O
potassium	NN	B-TEST
3.3	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
BUN	NNP	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
.	.	O

AST	NNP	B-TEST
was	VBD	O
25	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
130	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
3.2	CD	O
,	,	O
albumin	RB	B-TEST
3.4	CD	O
,	,	O
calcium	NN	B-TEST
8.8	CD	O
.	.	O

Digoxin	NNP	B-TEST
level	NN	I-TEST
was	VBD	O
0.8	CD	O
.	.	O

Hematocrit	NNP	B-TEST
was	VBD	O
33.0	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
627	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10,000	CD	O
,	,	O
MCV	NNP	B-TEST
79.8	CD	O
.	.	O

Coagulation	NN	B-TEST
studies	NNS	I-TEST
revealed	VBD	O
a	DT	O
PT	NNP	B-TEST
of	IN	O
17.4	CD	O
seconds	NNS	O
with	IN	O
an	DT	B-TEST
INR	NNP	I-TEST
of	IN	O
2.1	CD	O
,	,	O
PTT	NNP	B-TEST
25.5	CD	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
admission	NN	I-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
revealed	VBD	O
no	DT	O
infiltrate	NN	B-PROBLEM
,	,	O
no	DT	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Head	NNP	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
performed	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
revealed	VBD	O
no	DT	O
bleed	NN	B-PROBLEM
.	.	O

Urinalysis	NN	B-TEST
revealed	VBD	O
trace	NN	B-PROBLEM
microscopic	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
with	IN	O
47	CD	O
red	JJ	O
blood	NN	O
cells	NNS	O
per	IN	O
high	JJ	O
powered	JJ	O
field	NN	O
,	,	O
1+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
somewhat	RB	O
argumentative	JJ	B-PROBLEM
and	CC	O
confused	VBD	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
uncooperative	JJ	B-PROBLEM
with	IN	I-PROBLEM
procedures	NNS	I-PROBLEM
.	.	O

A	DT	B-TEST
neurologic	JJ	I-TEST
work-up	NN	I-TEST
was	VBD	O
undertaken	JJ	O
which	WDT	O
included	VBD	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
acute	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
72	CD	O
,	,	O
protein	RB	B-TEST
65	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
19	CD	O
,	,	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11,500	CD	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
xanthrochromasia	NN	B-PROBLEM
.	.	O

The	DT	O
Neurology	NNP	O
Service	NNP	O
evaluated	VBD	O
the	DT	O
patient	NN	O
who	WP	O
felt	VBD	O
that	IN	O
her	PRP$	B-PROBLEM
agitation	NN	I-PROBLEM
was	VBD	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
infection	NN	B-PROBLEM
,	,	O
her	PRP$	B-TREATMENT
multiple	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
or	CC	O
her	PRP$	B-PROBLEM
metabolic	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
revealed	VBD	O
no	DT	O
abnormality	NN	B-PROBLEM
and	CC	O
imaging	NN	B-TEST
included	VBD	O
a	DT	B-TEST
head	NN	I-TEST
scan	JJ	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
bleed	NN	B-PROBLEM
and	CC	O
a	DT	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
series	NN	I-TEST
which	WDT	O
revealed	VBD	O
degenerative	JJ	B-PROBLEM
joint	JJ	I-PROBLEM
disease	NN	I-PROBLEM
but	CC	O
no	DT	O
obvious	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
decided	VBD	O
not	RB	O
to	TO	O
pursue	VB	O
further	JJ	B-TEST
testing	VBG	I-TEST
with	IN	O
a	DT	B-TEST
neck	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
.	.	O

2)	CD	O
Right	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
Surgical	NNP	O
Service	NNP	O
who	WP	O
felt	VBD	O
that	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
clean	JJ	O
with	IN	O
some	DT	B-PROBLEM
erythema	NN	I-PROBLEM
but	CC	O
without	IN	O
evidence	NN	O
of	IN	O
true	JJ	B-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NN	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
with	IN	O
the	DT	O
thought	NN	O
that	WDT	O
prolonged	VBD	B-TREATMENT
antibiotics	NNS	I-TREATMENT
only	RB	O
put	VBD	O
her	PRP	O
at	IN	O
more	JJR	O
risk	NN	O
for	IN	O
infection	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
critical	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

4)	CD	O
Status	NNP	O
post	NN	O
fall	NN	B-PROBLEM
:	:	O

A	DT	B-TEST
head	NN	I-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
and	CC	O
cervical	JJ	B-TEST
spine	NN	I-TEST
series	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

The	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
no	DT	O
deficits	NNS	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

5)	CD	O
Atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
:	:	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
Coumadin	NNP	I-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

6)	CD	O
Abnormal	NNP	B-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
:	:	O

On	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
bilirubins	NNS	I-PROBLEM
in	IN	O
the	DT	O
3	CD	O
range	NN	O
and	CC	O
mildly	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	O
cholestatic	JJ	B-PROBLEM
picture	NN	I-PROBLEM
.	.	O

These	DT	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
will	MD	O
be	VB	O
followed	VBN	O
closely	RB	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

1)	CD	O
Aspirin	NNP	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2)	CD	O
Digoxin	NNP	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
AM	NNP	O
.	.	O

3)	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4)	CD	O
Zaroxolyn	NNP	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5)	CD	O
Prednisone	CD	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.o.d.	NN	O

6)	CD	O
Coumadin	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

7)	CD	O
Kay	NNP	B-TREATMENT
Ciel	NNP	I-TREATMENT
20	CD	O
mEq	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8)	CD	O
Fosamax	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

9)	CD	O
Amitriptyline	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

10)	CD	O
Buspar	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

The	DT	O
patient	NN	O
will	MD	O
be	VB	O
followed	VBN	O
at	IN	O
rehabilitation	NN	B-TREATMENT
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Both	NNP	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
R	NNP	B-PROBLEM
THUMB	NNP	I-PROBLEM
INJURY	NNP	I-PROBLEM
.	.	O

Following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
LEFT	NNP	O
WITHOUT	NNP	O
TREATMENT	NNP	B-TREATMENT
.	.	O

ACUTE	NNP	B-PROBLEM
LEUKEMIA	NNP	I-PROBLEM

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
68	CD	O
year	NN	O
old	JJ	O
with	IN	O
acute	JJ	B-PROBLEM
leukemia	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
about	IN	O
three	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
began	VBD	O
to	TO	O
notice	VB	O
increased	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
bruising	NN	B-PROBLEM
.	.	O

Platelets	NNS	B-TEST
were	VBD	O
9,000	CD	O
,	,	O
hemoglobin	NN	B-TEST
9.5	CD	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
100.4	CD	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
smear	NN	I-TEST
there	RB	O
consistent	JJ	O
with	IN	O
ALL	DT	B-PROBLEM
.	.	O

No	DT	O
headache	NN	B-PROBLEM
,	,	O
no	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

Some	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
allergies	NNS	B-PROBLEM
,	,	O
particularly	RB	O
cats	NNS	O
.	.	O

No	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
allergies	NNS	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
and	CC	O
anxiety	NN	B-PROBLEM
,	,	O
pleural	JJ	B-PROBLEM
thickening	VBG	I-PROBLEM
/	JJ	O
asbestosis	NN	B-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
tonsillectomy	NN	B-TREATMENT
,	,	O
adenoidectomy	NN	B-TREATMENT
,	,	O
vein	NN	B-TREATMENT
stripping	NN	I-TREATMENT
(	(	O
1968	CD	O
)	)	O
,	,	O
left	VBD	B-PROBLEM
wrist	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
(	(	O
1994	CD	O
)	)	O
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
include	VBP	O
a	DT	O
questionable	JJ	O
penicillin	NN	B-PROBLEM
reaction	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
tolerated	VBD	O
Ampicillin	NNP	B-TREATMENT
well	RB	O
.	.	O

The	DT	O
patient	NN	O
does	VBZ	O
not	RB	O
recollect	VB	O
what	WP	O
her	PRP$	B-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
penicillin	NN	B-TREATMENT
was	VBD	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
platelet	NN	B-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	JJ	O
family	NN	O
history	NN	O
was	VBD	O
significant	JJ	O
for	IN	O
a	DT	O
brother	NN	O
with	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
98.2	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/80	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
,	,	O
pulse	RB	B-TEST
102	CD	O
.	.	O

HEENT	NNP	B-TEST
examination	NN	I-TEST
was	VBD	O
normocephalic	JJ	O
and	CC	O
atraumatic	JJ	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
decreased	VBN	B-PROBLEM
hearing	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

The	DT	O
oropharynx	NN	O
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
with	IN	O
fillings	NNS	O
and	CC	O
a	DT	B-PROBLEM
partial	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
plate	NN	I-PROBLEM
.	.	O

The	DT	O
neck	NN	O
had	VBD	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
chest	JJS	I-TEST
exam	NN	I-TEST
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

Cardiac	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
an	DT	O
S1	NNP	O
and	CC	O
an	DT	O
S2	NNP	O
and	CC	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
2/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBN	B-PROBLEM
with	IN	O
no	DT	O
guarding	NN	B-PROBLEM
and	CC	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
skin	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
right	JJ	O
breast	NN	O
had	VBD	O
a	DT	B-PROBLEM
dark	JJ	I-PROBLEM
two	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
ecchymosis	NN	I-PROBLEM
and	CC	O
the	DT	O
left	JJ	O
medial	JJ	O
thigh	NN	O
had	VBD	O
two	CD	O
pale	JJ	B-PROBLEM
blue	JJ	I-PROBLEM
two	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
macules	NNS	I-PROBLEM
.	.	O

Admitting	VBG	B-TEST
labs	NNS	I-TEST
were	VBD	O
:	:	O

Sodium	NN	B-TEST
138	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
,	,	O
BUN	NNP	B-TEST
21	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
117	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
13,200	CD	O
,	,	O
hematocrit	NN	B-TEST
22.5	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
40,000	CD	O
.	.	O

AST	$	B-TEST
29	CD	O
,	,	O
ALK	NNP	B-TEST
151	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
7.2	CD	O
,	,	O
albumin	RB	B-TEST
4.3	CD	O
,	,	O
globulins	VBZ	B-TEST
2.9	CD	O
,	,	O
calcium	NN	B-TEST
8.9	CD	O
.	.	O

PT	NNP	B-TEST
12.8	CD	O
,	,	O
PTT	NNP	B-TEST
19.1	CD	O
.	.	O

Peripheral	JJ	B-TEST
smear	NN	I-TEST
revealed	VBD	O
blasts	NNS	B-TEST
of	IN	O
62%	CD	O
.	.	O

A	DT	B-TREATMENT
Hickman	NNP	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

The	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
included	VBD	O
cyclophosphamide	NN	B-TREATMENT
,	,	O
daunorubicin	NN	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
,	,	O
Vincristine	NNP	B-TREATMENT
and	CC	O
PEG-asparaginase	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
chemotherapy	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
well	RB	O
.	.	O

The	DT	O
patient	NN	O
began	VBD	O
neutropenic	JJ	B-PROBLEM
on	IN	O
day	NN	O
five	CD	O
of	IN	O
induction	NN	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
began	VBD	O
to	TO	O
rise	VB	O
and	CC	O
she	PRP	O
began	VBD	O
to	TO	O
experience	VB	O
pulmonary	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
including	VBG	O
increased	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
began	VBD	O
to	TO	O
spike	VB	O
and	CC	O
a	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
grew	VBD	O
out	RP	O
Staphylococcusaureus	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
Gentamicin	NNP	B-TREATMENT
,	,	O
Vancomycin	NNP	B-TREATMENT
and	CC	O
Piperacillin	NNP	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
changed	VBN	O
to	TO	O
Gentamicin	NNP	B-TREATMENT
and	CC	O
Ceftazidime	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
spike	VB	O
and	CC	O
was	VBD	O
enrolled	VBN	O
in	IN	O
a	DT	O
randomized	JJ	O
trial	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
randomized	VBN	O
to	TO	O
AmBisome	NNP	B-TREATMENT
antifungal	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

An	DT	B-TEST
abdominal	JJ	I-TEST
MRI	NNP	I-TEST
was	VBD	O
performed	VBN	O
to	TO	O
assess	VB	O
continued	VBN	O
elevated	JJ	B-PROBLEM
liver	NN	I-PROBLEM
enzymes	NNS	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	B-TEST
MRI	NNP	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
Nafcillin	NNP	B-TREATMENT
due	JJ	O
to	TO	O
continued	JJ	O
spiking	NN	O
.	.	O

The	DT	O
patient	NN	O
began	VBD	O
to	TO	O
experience	VB	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
and	CC	O
was	VBD	O
straight	VBN	O
catheterized	VBN	O
.	.	O

Thepatient	NNP	O
developed	VBD	O
a	DT	O
possible	JJ	O
drug	NN	B-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
Nafcillin	NNP	B-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
Ancef	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
became	VBD	O
constipated	VBN	B-PROBLEM
;	:	O
this	DT	O
resolved	VBN	O
with	IN	O
laxatives	NNS	B-TREATMENT
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
discharge	NN	I-TREATMENT
medications	NNS	I-TREATMENT
include	VBP	O
the	DT	O
following	NN	O
:	:	O

1)	CD	O
Albuterol	NNP	B-TREATMENT
inhaler	NN	I-TREATMENT
two	CD	O
puffs	NNS	O
q.i.d.	JJ	O
p.r.n.	JJ	O
breathing	NN	B-PROBLEM
difficulties	NNS	I-PROBLEM
.	.	O

2)	CD	O
Calcium	NNP	B-TREATMENT
gluconate	NN	I-TREATMENT
1000	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

3)	CD	O
Cefazolin	NNP	B-TREATMENT
one	CD	O
gram	NN	O
IV	NNP	O
q.8h.	NN	O
x	VBD	O
13days	CD	O
.	.	O

4)	CD	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5)	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

6)	CD	O
Lactulose	JJ	B-TREATMENT
30	CD	O
milliliters	NNS	O
p.o.	VBP	O
q.2h.	JJ	O
p.r.n.	NN	O
constipation	NN	B-PROBLEM
.	.	O

7)	CD	O
Magnesium	NNP	B-TREATMENT
hydroxide	NN	I-TREATMENT
30	CD	O
milliliters	NNS	O
p.o.	JJ	O
q	JJ	O
day	NN	O
.	.	O

8)	CD	O
Miracle	NNP	B-TREATMENT
Creamtopical	NNP	I-TREATMENT
q	NN	O
day	NN	O
p.r.n.	VB	O
skin	JJ	B-PROBLEM
irritation	NN	I-PROBLEM
.	.	O

9)	CD	O
Sarna	NNP	B-TREATMENT
topical	JJ	I-TREATMENT
b.i.d.	NN	O
p.r.n.	NN	O
itching	NN	B-PROBLEM
.	.	O

10)	CD	O
Senna	NNP	B-TREATMENT
tablets	NNS	I-TREATMENT
,	,	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
b.i.d.	NN	O

11)	CD	O
Simethicone	CD	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
p.r.n.	NN	O
gas	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

12)	CD	O
Citrucel	NNP	B-TREATMENT
one	CD	O
tablespoon	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

13)	CD	O
K-Dur	JJ	B-TREATMENT
10	CD	O
mEq	NN	O
x	NNP	O
three	CD	O
,	,	O
p.o.	VBZ	O
b.i.d.	NN	O

14)	CD	O
Zoloft	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

15)	CD	O
Peridex	NN	B-TREATMENT
30	CD	O
cc	NN	O
p.o.	NN	O
b.i.d.	NN	O
x	$	O
14	CD	O
days	NNS	O
.	.	O

16)	CD	O
Robituss	NNP	B-TREATMENT
in	IN	I-TREATMENT
AC	NNP	I-TREATMENT
five	CD	O
to	TO	O
ten	VB	O
milliliters	NNS	O
p.o.	VBP	O
q.h.s.	JJ	O
p.r.n.	JJ	O
cough	NN	B-PROBLEM
.	.	O

1.	CD	O
Carotid	NNP	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

2.	CD	O
Aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

3.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
76-year-old	JJ	O
female	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
on	IN	O
04-29-92	JJ	O
with	IN	O
a	DT	O
past	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
who	WP	O
presented	VBD	O
for	IN	O
evaluation	NN	B-TEST
for	IN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replace-ment	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM
and	CC	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
associated	VBN	O
with	IN	O
light-headedness	NN	B-PROBLEM
for	IN	O
nine	CD	O
years	NNS	O
which	WDT	O
was	VBD	O
noted	VBN	O
to	TO	O
increase	VB	O
in	IN	O
frequency	NN	O
over	IN	O
the	DT	O
past	JJ	O
year	NN	O
,	,	O
then	RB	O
upon	IN	O
admission	NN	O
had	VBD	O
light-headedness	JJ	B-PROBLEM
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
dull	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
to	TO	O
her	PRP$	O
substernal	JJ	O
area	NN	O
,	,	O
with	IN	O
only	RB	O
minimal	JJ	O
exertion	NN	O
such	JJ	O
as	IN	O
&quot;	JJ	O
walking	VBG	O
across	IN	O
the	DT	O
room	NN	O
&quot;	NN	O
.	.	O

She	PRP	O
states	VBZ	O
this	DT	O
light-headedness	NN	B-PROBLEM
is	VBZ	O
often	RB	O
associated	VBN	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
occasionally	RB	O
with	IN	O
nausea	NN	B-PROBLEM
.	.	O

She	PRP	O
denies	VBZ	O
any	DT	O
vomiting	NN	B-PROBLEM
,	,	O
states	VBZ	O
that	IN	O
the	DT	B-PROBLEM
episodes	NNS	I-PROBLEM
usually	RB	O
last	JJ	O
about	IN	O
five	CD	O
minutes	NNS	O
and	CC	O
are	VBP	O
relieved	VBN	O
with	IN	O
rest	NN	O
.	.	O

The	DT	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
light-headedness	NN	B-PROBLEM
is	VBZ	O
now	RB	O
severely	RB	O
lifestyle	JJ	O
limiting	NN	O
and	CC	O
the	DT	O
patient	NN	O
requested	VBD	O
evaluation	NN	B-TEST
for	IN	O
possible	JJ	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

Cardiac	NNP	O
risk	NN	O
factors	NNS	O
hypercholesterolemia	VBP	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
tobacco	NN	O
use	NN	O
,	,	O
diabetes	VBZ	B-PROBLEM
or	CC	O
family	NN	O
history	NN	O
.	.	O

Past	NNP	O
medical	JJ	O
history	NN	O
is	VBZ	O
as	RB	O
stated	VBN	O
above	IN	O
,	,	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
found	VBN	O
to	TO	O
be	VB	O
critical	JJ	O
on	IN	O
echocardiogram	NN	B-TEST
on	IN	O
4-13-92	JJ	O
,	,	O
done	VBN	O
in	IN	O
Otte	NNP	O
A	NNP	O
,	,	O
New	NNP	O
Jersey	NNP	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
left	VBN	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
58%	CD	O
,	,	O
no	DT	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
wall	DT	I-PROBLEM
motion	NN	I-PROBLEM
abnormali-ties	NNS	I-PROBLEM
and	CC	O
an	DT	B-TEST
aortic	JJ	I-TEST
valve	NN	I-TEST
gradient	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
100	CD	O
.	.	O

She	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
uterine	JJ	B-PROBLEM
fibroids	NNS	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

She	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
bilateral	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
stated	VBN	O
to	TO	O
be	VB	O
greater	JJR	O
than	IN	O
70%	CD	O
bilaterally	RB	O
.	.	O

She	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
glaucoma	NN	B-PROBLEM
and	CC	O
a	DT	O
questionable	JJ	O
history	NN	O
of	IN	O
claudication	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
legs	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
.	.	O

Medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
admission	NN	I-TREATMENT
were	VBD	O
only	RB	O
aspirin	JJ	B-TREATMENT
p.r.n.	NN	O
and	CC	O
Timoptic	NNP	B-TREATMENT
solution	NN	I-TREATMENT
0.5%	CD	I-TREATMENT
to	TO	O
the	DT	O
left	NN	O
eye	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

On	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
with	IN	O
a	DT	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
170/100	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
70	CD	O
.	.	O

HEENT	NNP	B-TEST
examination	NN	I-TEST
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
arcussenilis	NNS	I-PROBLEM
but	CC	O
otherwise	RB	O
unremarkable	JJ	O
.	.	O

Her	PRP$	O
neck	NN	O
showed	VBD	O
no	DT	O
JVD	NNP	B-PROBLEM
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
slow	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
upstroke	VBD	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
there	EX	O
were	VBD	O
bilateral	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
bruits	NNS	I-PROBLEM
versus	VBP	O
transmitted	VBN	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

Chest	NNP	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Cardiac	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
3/6	CD	O
systolic	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
,	,	O
no	DT	O
gallop	NN	B-PROBLEM
was	VBD	O
detected	VBN	O
.	.	O

Her	PRP$	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
with	IN	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
peripheral	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
trace	JJ	O
palpable	JJ	O
.	.	O

Sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
5.0	CD	O
,	,	O
BUN	NNP	B-TEST
18	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
,	,	O
PT	NNP	B-TEST
12.3	CD	O
,	,	O
PTT	NNP	B-TEST
24	CD	O
,	,	O
WBC	NNP	B-TEST
7.6	CD	O
,	,	O
hematocrit	NN	B-TEST
41	CD	O
,	,	O
platelets	NNS	B-TEST
278,000	CD	O
.	.	O

EKG	NNP	B-TEST
revealed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
with	IN	O
a	DT	O
rate	NN	O
of	IN	O
69	CD	O
,	,	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
hyper-trophy	NN	I-PROBLEM
with	IN	O
poor	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
progression	NN	I-PROBLEM
of	IN	I-PROBLEM
R-waves	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
admitted	VBN	O
and	CC	O
evaluated	VBN	O
by	IN	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
after	IN	O
having	VBG	O
undergone	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	O
70%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
circumflex	JJ	I-PROBLEM
artery	NN	I-PROBLEM
,	,	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
and	CC	O
10%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

Carotid	NNP	B-TEST
angiography	NN	I-TEST
revealed	VBD	O
left	VBD	B-PROBLEM
internal	JJ	I-PROBLEM
carotid	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
90%	CD	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
&quot;	NNP	I-PROBLEM
critical	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

On	IN	O
05-01-92	JJ	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	O
#	#	B-TREATMENT
19	CD	I-TREATMENT
St.	NNP	I-TREATMENT
Jude	NNP	I-TREATMENT
valve	NN	I-TREATMENT
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
one	CD	O
with	IN	O
saphenous	JJ	B-TREATMENT
vein	NNS	I-TREATMENT
graft	NN	I-TREATMENT
from	IN	O
the	DT	O
posterior	JJ	O
descending	NN	O
artery	NN	O
to	TO	O
the	DT	O
obtuse	NN	O
marginal	JJ	O
and	CC	O
right	JJ	B-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
found	VBN	O
postoperatively	RB	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
on	IN	O
proximal	NN	O
greater	JJR	O
than	IN	O
distal	JJ	O
musculature	NN	O
.	.	O

She	PRP	O
was	VBD	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
and	CC	O
otherwise	RB	O
had	VBD	O
an	DT	O
unremarkable	JJ	O
postoperative	JJ	O
course	NN	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

On	IN	O
05-04-92	JJ	O
she	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
neurology	NN	O
service	NN	O
,	,	O
who	WP	O
recommended	VBD	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
,	,	O
however	RB	O
no	DT	O
evidence	NN	O
of	IN	O
infarction	NN	B-PROBLEM
was	VBD	O
detected	VBN	O
.	.	O

There	EX	O
was	VBD	O
only	RB	O
diffuse	RB	B-PROBLEM
small	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
noted	VBD	O
.	.	O

On	IN	O
05-05-92	JJ	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
convert	VB	O
to	TO	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
resolved	VBD	O
spontaneously	RB	O
a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
.	.	O

However	RB	O
,	,	O
on	IN	O
05-07-92	NN	O
there	EX	O
was	VBD	O
a	DT	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
event	NN	I-PROBLEM
with	IN	O
addition	NN	O
to	TO	O
the	DT	B-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
noted	VBD	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
discoordination	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
begun	VBN	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

On	IN	O
5-9-92	JJ	O
the	DT	B-PROBLEM
right-sided	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
worsened	VBD	O
and	CC	O
she	PRP	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
elements	NNS	I-PROBLEM
of	IN	I-PROBLEM
aphasia	NN	I-PROBLEM
.	.	O

She	PRP	O
underwent	JJ	O
angiography	NN	B-TEST
on	IN	O
5-9-92	JJ	O
which	WDT	O
showed	VBD	O
the	DT	O
right	JJ	O
internal	JJ	O
carotid	NN	O
artery	NN	O
to	TO	O
be	VB	O
patent	NN	O
,	,	O
however	RB	O
there	EX	O
was	VBD	O
highly	RB	O
significant	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
later	RB	O
that	DT	O
day	NN	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
taken	VBN	O
postoperatively	RB	O
the	DT	O
ICU	NNP	O
where	WRB	O
she	PRP	O
was	VBD	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
and	CC	O
by	IN	O
5-11-92	JJ	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
markedly	RB	O
increased	VBN	O
use	NN	O
of	IN	O
her	PRP$	O
right	JJ	O
side	NN	O
,	,	O
resolving	VBG	O
aphasia	NN	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
with	IN	O
the	DT	B-PROBLEM
residual	JJ	I-PROBLEM
deficit	NN	I-PROBLEM
only	RB	O
noted	VBD	O
to	TO	O
be	VB	O
some	DT	B-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
worked	VBN	O
up	RP	O
aggressively	RB	O
with	IN	O
the	DT	O
physical	JJ	O
therapy	NN	O
and	CC	O
occupational	JJ	O
services	NNS	O
,	,	O
made	VBD	O
good	JJ	O
progress	NN	O
and	CC	O
began	VBD	O
ambulating	VBG	O
with	IN	O
assistance	NN	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
but	CC	O
with	IN	O
minimal	JJ	O
assistance	NN	O
from	IN	O
an	DT	O
aid	NN	O
.	.	O

She	PRP	O
was	VBD	O
feeding	VBG	O
herself	PRP	O
and	CC	O
was	VBD	O
very	RB	O
enthusiastic	JJ	O
and	CC	O
energetic	JJ	O
in	IN	O
her	PRP$	O
participation	NN	O
in	IN	O
her	PRP$	B-TREATMENT
rehabilitation	NN	I-TREATMENT
activities	NNS	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
initially	RB	O
but	CC	O
this	DT	O
was	VBD	O
quickly	RB	O
switched	VBN	O
over	IN	O
to	TO	O
Coumadin	NNP	B-TREATMENT
anticoagulation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
which	WDT	O
she	PRP	O
will	MD	O
need	VB	O
to	TO	O
be	VB	O
on	IN	O
long-term	JJ	O
for	IN	O
her	PRP$	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

She	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
Rockdempbanri	NNP	O
Hospital	NNP	O
on	IN	O
05-28-92	NN	O
to	TO	O
continue	VB	O
her	PRP$	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

Lopressor	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
;	:	O
Nifedipine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
;	:	O
Timoptic	NNP	B-TREATMENT
solution	NN	I-TREATMENT
0.5%	CD	O
OS	NNP	O
b.i.d.	NN	O
;	:	O
Coumadin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
alternating	VBG	O
with	IN	O
1.5	CD	O
mg	NNS	O
q.o.d.	RB	O
at	IN	O
q.h.s.	NN	O
and	CC	O
Haldol	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
p.r.n.	NN	O
in	IN	O
the	DT	O
evening	NN	O
,	,	O
only	RB	O
for	IN	O
agitation	NN	B-PROBLEM
associated	VBN	O
with	IN	O
confusion	NN	B-PROBLEM
.	.	O

Upon	IN	O
discharge	NN	O
it	PRP	O
was	VBD	O
the	DT	O
recommendation	NN	O
of	IN	O
the	DT	O
cardiology	NN	O
team	NN	O
that	IN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
be	VB	O
monitored	VBN	O
weekly	JJ	O
and	CC	O
be	VB	O
kept	VBN	O
at	IN	O
a	DT	O
ratio	NN	O
of	IN	O
3-4	JJ	O
IU	NNP	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
ABD	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
PH	NNP	O
UNIVERSITY	NNP	O
OF	NNP	O
MEDICAL	NNP	O
CENTER	NNP	O
.	.	O

Your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
FONG	NNP	O
,	,	O
CONEY	NNP	O
N	NNP	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
PERFORATION	NNP	B-PROBLEM
.	.	O

head	NN	B-PROBLEM
trauma	SYM	I-PROBLEM
-	:	O
mva	NN	O

Treatment	NN	B-TREATMENT
Rendered	VBD	O
:	:	O

history	NN	O
,	,	O
physical	JJ	B-TEST
,	,	O
neuro	JJ	B-TEST
exam	NN	I-TEST
normal	JJ	O

tylenol	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

refrain	NN	O
from	IN	O
motrin	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

monitor	NN	O
/	JJ	O
return	NN	O
for	IN	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
/	NNP	I-PROBLEM
mental	NN	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
.	.	O

HYPERPARATHYROIDISM	NNP	B-PROBLEM
.	.	O

hyperparathyroidism	NN	B-PROBLEM
.	.	O

1.	CD	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O

2.	CD	O
hypertension	NN	B-PROBLEM
,	,	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O

4.	CD	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O

5.	CD	O
osteoarthritis	NN	B-PROBLEM
,	,	O

6.	CD	O
right	JJ	B-PROBLEM
cheek	NN	I-PROBLEM
basal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O

7.	CD	O
glaucoma	NN	B-PROBLEM
,	,	O

8.	CD	O
non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O

9.	CD	O
status	NN	O
post	NN	O
laparoscopic	NN	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
,	,	O

10.	CD	O
status	NN	O
post	NN	O
dilation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
,	,	O

11.	CD	O
status	NN	O
post	NN	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
,	,	O

12.	CD	O
status	NN	O
post	NN	O
left	VBD	B-TEST
breast	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

Parathyroidectomy	NN	B-TREATMENT
on	IN	O
12-27-96	JJ	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
83-year-old	JJ	O
female	NN	O
who	WP	O
presents	VBZ	O
for	IN	O
surgical	JJ	B-TEST
evaluation	NN	I-TEST
for	IN	O
her	PRP$	B-PROBLEM
hyperparathyroidism	NN	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
83-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1988	CD	O
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

In	IN	O
August	NNP	O
of	IN	O
1996	CD	O
while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
at	IN	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
replacement	NN	B-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
knees	NNS	I-TREATMENT
bilaterally	RB	I-TREATMENT
,	,	O
and	CC	O
on	IN	O
preoperative	JJ	B-TEST
evaluation	NN	I-TEST
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
calcium	NN	I-PROBLEM
and	CC	O
therefore	RB	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
was	VBD	O
canceled	VBN	O
.	.	O

Further	RB	B-TEST
testing	VBG	I-TEST
revealed	VBD	O
hyperparathyroidism	NN	B-PROBLEM
as	IN	O
evidenced	VBN	O
by	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
PTH	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
reports	VBZ	O
no	DT	O
masses	NNS	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
noticed	VBN	O
some	DT	O
generalized	JJ	B-PROBLEM
hoarseness	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
voice	NN	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
5-6	JJ	O
months	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
she	PRP	O
has	VBZ	O
some	DT	B-PROBLEM
dysphagia	NN	I-PROBLEM
,	,	O
particularly	RB	O
has	VBZ	O
had	VBN	O
some	DT	B-PROBLEM
difficulties	NNS	I-PROBLEM
with	IN	I-PROBLEM
swallowing	NN	I-PROBLEM
.	.	O

1.	CD	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1988	CD	O
.	.	O

She	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
St.	NNP	I-TREATMENT
Jude	NNP	I-TREATMENT
&apos;s	NNP	I-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT
and	CC	O
has	VBZ	O
been	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
since	IN	O
then	RB	O
,	,	O

2.	CD	O
hypertension	NN	B-PROBLEM
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
hypertension	NN	B-PROBLEM
for	IN	O
15	CD	O
years	NNS	O
,	,	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
cardioversion	NN	B-TREATMENT
3-25-94	CD	O
,	,	O

4.	CD	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O

5.	CD	O
osteoarthritis	NN	B-PROBLEM
;	:	O
she	PRP	O
is	VBZ	O
to	TO	O
receive	VB	O
bilateral	JJ	B-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
replacements	NNS	I-TREATMENT
at	IN	O
some	DT	O
time	NN	O
in	IN	O
the	DT	O
near	JJ	O
future	NN	O
,	,	O

6.	CD	O
right	JJ	B-PROBLEM
cheek	NN	I-PROBLEM
basal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
to	TO	O
be	VB	O
removed	VBN	O
in	IN	O
the	DT	O
future	NN	O
,	,	O

7.	CD	O
history	NN	O
of	IN	O
glaucoma	NN	B-PROBLEM
,	,	O

8.	CD	O
non	JJ	B-PROBLEM
insulin	NN	I-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	CD	I-PROBLEM
which	WDT	O
was	VBD	O
diagnosed	VBN	O
in	IN	O
March	NNP	O
,	,	O
1995	CD	O
,	,	O

9.	CD	O
shingles	NNS	B-PROBLEM
.	.	O

1.	CD	O
laparoscopic	JJ	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
03/93	CD	O
by	IN	O
Dr.	NNP	O
Sapmal	NNP	O
,	,	O

2.	CD	O
dilation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
in	IN	O
1992	CD	O
for	IN	O
polyps	NNS	B-PROBLEM
,	,	O

3.	CD	O
left	VBD	B-TEST
breast	NN	I-TEST
biopsy	NN	I-TEST
which	WDT	O
was	VBD	O
benign	NN	O
,	,	O

4.	CD	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
Lopid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O

2.	CD	O
K-Dur	JJ	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

3.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

4.	CD	O
Coumadin	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
which	WDT	O
was	VBD	O
last	JJ	O
taken	VBN	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O

5.	CD	O
Norvasc	NNP	B-TREATMENT
500	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

6.	CD	O
Digoxin	NNP	B-TREATMENT
.25	NNP	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

7.	CD	O
Lopressor	NNP	B-TREATMENT
50	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O

8.	CD	O
Glucotrol	NNP	B-TREATMENT
10	CD	O
XL	NNP	O
qam	NN	O
,	,	O

9.	CD	O
Timoptic	JJ	B-TREATMENT
0.5%	CD	O
b.i.d.	NN	O
to	TO	O
both	DT	O
eyes	NNS	O
,	,	O

10.	CD	O
Pilocarpine	NNP	B-TREATMENT
gel	NN	I-TREATMENT
qhs	NN	O
to	TO	O
both	DT	O
eyes	NNS	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
parathyroid	NN	B-PROBLEM
or	CC	I-PROBLEM
thyroid	NN	I-PROBLEM
diseases	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
is	VBZ	O
significant	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	I-PROBLEM
exertion	NN	I-PROBLEM
.	.	O

At	IN	O
present	JJ	O
,	,	O
she	PRP	O
can	MD	O
walk	VB	O
one	CD	O
to	TO	O
two	CD	O
blocks	NNS	O
before	IN	O
having	VBG	O
to	TO	O
stop	VB	O
because	IN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

When	WRB	O
walking	VBG	O
outside	RB	O
,	,	O
she	PRP	O
stops	VBZ	O
multiple	JJ	O
times	NNS	O
because	IN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

She	PRP	O
gets	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
walking	VBG	O
up	RP	O
steps	NNS	O
.	.	O

On	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
she	PRP	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
pulse	NN	I-TEST
is	VBZ	O
72	CD	O
,	,	O
irregularly	RB	O
irregular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
96/60	CD	O
,	,	O
temperature	NN	B-TEST
97.9	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
.	.	O

The	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
pupils	NNS	O
which	WDT	O
have	VBP	O
irregular	JJ	B-PROBLEM
border	NN	I-PROBLEM
and	CC	O
are	VBP	O
very	RB	B-PROBLEM
sluggishly	RB	I-PROBLEM
reactive	JJ	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
reports	NNS	O
that	IN	O
she	PRP	O
will	MD	O
have	VB	O
revision	NN	B-TREATMENT
of	IN	I-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

Cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

III	NNP	B-PROBLEM
/	NNP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
click	NN	I-PROBLEM
and	CC	O
irregularly	RB	B-PROBLEM
irregular	JJ	I-PROBLEM
rhythm	NN	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
on	IN	O
rectal	JJ	B-TEST
examination	NN	I-TEST
.	.	O

Admission	NNP	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
4.3	CD	O
,	,	O
hematocrit	NN	B-TEST
31.0	CD	O
,	,	O
electrolytes	NNS	B-TEST
were	VBD	O
all	DT	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
glucose	JJ	B-TEST
218	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
15.1	CD	O
with	IN	O
INR	NNP	B-TEST
of	IN	O
1.5	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
23.3	CD	O
.	.	O

The	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
slow	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
digitalis	JJ	B-PROBLEM
effect	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
left	VBN	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

Impression	NN	O
was	VBD	O
that	IN	O
this	DT	O
was	VBD	O
an	DT	O
83-year-old	JJ	O
female	NN	O
with	IN	O
cardiac	JJ	B-PROBLEM
history	NN	I-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	I-PROBLEM
exertion	NN	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
calcium	NN	I-PROBLEM
and	CC	O
hyperparathyroidism	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

The	DT	O
right	JJ	O
superior	JJ	O
parathyroid	NN	O
gland	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
markedly	RB	B-PROBLEM
enlarged	VBN	I-PROBLEM
and	CC	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
adenoma	NN	I-PROBLEM
.	.	O

Postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
cough	VB	O
and	CC	O
phonate	VB	O
completely	RB	O
with	IN	O
no	DT	O
changes	NNS	B-PROBLEM
from	IN	O
preoperative	NN	O
.	.	O

The	DT	O
plan	NN	O
was	VBD	O
to	TO	O
start	VB	O
her	PRP$	O
on	IN	O
heparin	NN	B-TREATMENT
and	CC	O
Coumadin	NNP	B-TREATMENT
and	CC	O
discontinue	VB	O
her	PRP$	B-TREATMENT
heparin	NN	I-TREATMENT
when	WRB	O
her	PRP$	B-TEST
Coumadin	NNP	I-TEST
levels	NNS	I-TEST
became	VBD	O
therapeutic	JJ	O
as	IN	O
judged	VBN	O
by	IN	O
the	DT	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
/	NNP	O
INR	NNP	B-TEST
.	.	O

However	RB	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
in	IN	O
the	DT	O
afternoon	NN	O
noticed	VBD	O
some	DT	B-PROBLEM
tingling	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	O
also	RB	O
some	DT	B-PROBLEM
tingling	VBG	I-PROBLEM
hear	JJ	I-PROBLEM
her	PRP$	I-PROBLEM
perioral	JJ	I-PROBLEM
region	NN	I-PROBLEM
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
muscular	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
noted	VBD	O
.	.	O

An	DT	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
was	VBD	O
drawn	VBN	O
which	WDT	O
was	VBD	O
low	JJ	O
at	IN	O
1.0	CD	O
.	.	O

As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Os-Cal	NNP	B-TREATMENT
250	CD	O
mg	NN	O
PO	NNP	O
q.i.d.	NN	O
On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
her	PRP$	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
was	VBD	O
1.06	CD	O
and	CC	O
her	PRP$	B-TREATMENT
Os-Cal	NNP	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
500	CD	O
q.i.d.	NNS	O

However	RB	O
,	,	O
her	PRP	B-PROBLEM
ionized	JJ	I-PROBLEM
calcium	NN	I-PROBLEM
decreased	VBD	I-PROBLEM
to	TO	O
0.97	CD	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
one	CD	O
amp	NN	O
of	IN	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
the	DT	O
patient	NN	O
felt	VBD	O
fine	JJ	O
and	CC	O
had	VBD	O
an	DT	B-TEST
INR	NNP	I-TEST
of	IN	O
1.9	CD	O
with	IN	O
a	DT	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
of	IN	O
16.6	CD	O
.	.	O

Her	PRP$	B-TEST
calcium	NN	I-TEST
was	VBD	O
8.5	CD	O
,	,	O
albumin	RB	B-TEST
3.6	CD	O
,	,	O
and	CC	O
phosphate	VB	B-TEST
4.5	CD	O
.	.	O

She	PRP	O
had	VBD	O
had	VBN	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
tingling	VBG	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
fingers	NNS	I-PROBLEM
after	IN	O
the	DT	O
initial	JJ	O
episode	NN	O
which	WDT	O
had	VBD	O
prompted	VBN	O
us	PRP	O
originally	RB	O
to	TO	O
draw	VB	O
the	DT	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
.	.	O

1.	CD	O
Coumadin	NNP	B-TREATMENT
5	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O
then	RB	O
she	PRP	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
decide	VB	O
the	DT	O
dosage	NN	O
thereafter	RB	O
,	,	O

2.	CD	O
Lopid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O

3.	CD	O
K-Dur	JJ	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

4.	CD	O
Os-Cal	JJ	B-TREATMENT
500	CD	O
mg	NN	O
PO	NNP	O
q.i.d.	NN	O
,	,	O

5.	CD	O
Rocaltrol	NNP	B-TREATMENT
0.25	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O

6.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

7.	CD	O
Norvasc	NNP	B-TREATMENT
5	CD	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

8.	CD	O
Digoxin	NNP	B-TREATMENT
.25	NNP	O
mg	NN	O
PO	NNP	O
q.day	NN	O
,	,	O

9.	CD	O
Lopressor	NNP	B-TREATMENT
50	CD	O
mg	NN	O
PO	NNP	O
b.i.d.	NN	O
,	,	O

10.	CD	O
Glucotrol	NNP	B-TREATMENT
10	CD	O
mg	NN	O
qam	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
she	PRP	O
is	VBZ	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
to	TO	O
check	VB	O
her	PRP$	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
/	JJ	O
INR	NNP	B-TEST
as	RB	O
well	RB	O
as	IN	O
calcium	NN	B-TEST
,	,	I-TEST
albumin	NN	I-TEST
and	CC	I-TEST
phosphate	NN	I-TEST
levels	NNS	I-TEST
.	.	O

Left	NNP	B-PROBLEM
sided	VBD	I-PROBLEM
spastic	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
surgical	JJ	B-TREATMENT
correction	NN	I-TREATMENT
of	IN	I-TREATMENT
C-1	NNP	I-TREATMENT
,	,	I-TREATMENT
C-2	NNP	I-TREATMENT
dural	JJ	I-TREATMENT
AVM	NNP	I-TREATMENT
.	.	O

Ms.	NNP	O
Breunlinke	NNP	O
is	VBZ	O
a	DT	O
69	JJ	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
,	,	O
status	NN	O
post	NN	O
surgical	JJ	B-TREATMENT
correction	NN	I-TREATMENT
of	IN	I-TREATMENT
a	DT	I-TREATMENT
C-1	JJ	I-TREATMENT
to	TO	I-TREATMENT
C-2	JJ	I-TREATMENT
dural	JJ	I-TREATMENT
AVM	NNP	I-TREATMENT
in	IN	O
January	NNP	O
,	,	O
1998	CD	O
,	,	O
now	RB	O
presenting	VBG	O
with	IN	O
a	DT	O
one	CD	O
month	NN	O
history	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
left	VBN	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
with	IN	O
spasticity	NN	B-PROBLEM
,	,	O
occasional	JJ	O
difficulty	NN	B-PROBLEM
swallowing	VBG	I-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
originally	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
Verg	NNP	O
Medical	NNP	O
Center	NNP	O
in	IN	O
January	NNP	O
,	,	O
1998	CD	O
,	,	O
because	IN	O
of	IN	O
a	DT	O
one	CD	O
year	NN	O
history	NN	O
of	IN	O
left	NN	B-PROBLEM
sided	VBN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
spasticity	NN	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
intermedullary	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
at	IN	I-PROBLEM
C1-2	NNP	I-PROBLEM
level	NN	I-PROBLEM
which	WDT	O
on	IN	O
biopsy	NN	B-TEST
showed	VBD	O
abnormal	JJ	B-PROBLEM
vasculature	NN	I-PROBLEM
,	,	O
hemosiderin	JJ	B-PROBLEM
deposit	NN	I-PROBLEM
,	,	O
leading	VBG	O
in	IN	O
turn	NN	O
to	TO	O
the	DT	O
discovery	NN	O
of	IN	O
a	DT	B-PROBLEM
dural	JJ	I-PROBLEM
arteriovenous	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
at	IN	O
that	DT	O
level	NN	O
which	WDT	O
was	VBD	O
surgically	RB	O
corrected	VBN	O
.	.	O

The	DT	O
postoperative	JJ	O
period	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
transient	NN	B-PROBLEM
swallowing	VBG	I-PROBLEM
difficulty	NN	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
left	VBN	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
.	.	O

As	IN	O
of	IN	O
the	DT	O
beginning	NN	O
of	IN	O
September	NNP	O
,	,	O
1999	CD	O
,	,	O
she	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
swallow	VB	O
without	IN	O
difficulty	NN	O
,	,	O
urinate	NN	O
without	IN	O
difficulty	NN	O
(	(	O
although	IN	O
bowel	NN	O
movements	NNS	O
have	VBP	O
been	VBN	O
problematic	JJ	B-PROBLEM
)	)	O
.	.	O

Functionally	RB	O
,	,	O
she	PRP	O
was	VBD	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
pre-gait	JJ	B-TREATMENT
training	NN	I-TREATMENT
and	CC	O
able	JJ	O
to	TO	O
stand	VB	O
and	CC	O
take	VB	O
several	JJ	O
steps	NNS	O
with	IN	O
upper	JJ	B-TREATMENT
body	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

Over	IN	O
the	DT	O
past	JJ	O
4-5	JJ	O
weeks	NNS	O
her	PRP$	B-PROBLEM
functional	JJ	I-PROBLEM
level	NN	I-PROBLEM
has	VBZ	O
progressively	RB	O
deteriorated	VBN	O
.	.	O

Her	PRP$	O
left	JJ	O
arm	NN	O
has	VBZ	O
developed	VBN	O
a	DT	B-PROBLEM
flexure	NN	I-PROBLEM
contraction	NN	I-PROBLEM
and	CC	O
she	PRP	O
reports	VBZ	O
intermitttent	NN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
which	WDT	O
occurs	VBZ	O
both	DT	O
spontaneously	RB	O
and	CC	O
is	VBZ	O
also	RB	O
triggered	VBN	O
by	IN	O
contact	NN	O
.	.	O

She	PRP	O
has	VBZ	O
developed	VBN	O
some	DT	O
new	JJ	B-PROBLEM
swallowing	VBG	I-PROBLEM
difficulty	NN	I-PROBLEM
and	CC	O
since	IN	O
her	PRP$	O
transfer	NN	O
to	TO	O
a	DT	O
long	JJ	O
term	NN	O
inpatient	NN	O
care	NN	O
facility	NN	O
,	,	O
she	PRP	O
has	VBZ	O
lost	VBN	O
ten	JJ	O
pounds	NNS	O
.	.	O

She	PRP	O
denies	VBZ	O
dysuria	NNS	B-PROBLEM
or	CC	O
excessive	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
frequency	NN	I-PROBLEM
.	.	O

Over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
weeks	NNS	O
she	PRP	O
has	VBZ	O
also	RB	O
developed	VBN	O
severe	JJ	B-PROBLEM
intermittent	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
localized	VBN	O
to	TO	O
the	DT	O
suprapubic	JJ	O
area	NN	O
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	RB	O
,	,	O
occurring	VBG	O
intermittently	RB	O
.	.	O

The	DT	O
patient	NN	O
feels	NNS	O
this	DT	O
is	VBZ	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
hemorrhoids	NNS	I-PROBLEM
,	,	O
although	IN	O
it	PRP	O
does	VBZ	O
not	RB	O
clearly	RB	O
localize	VB	O
to	TO	O
the	DT	O
rectum	NN	O
.	.	O

This	DT	B-PROBLEM
pain	NN	I-PROBLEM
often	RB	O
follows	VBZ	O
bowel	JJ	O
movement	NN	O
but	CC	O
does	VBZ	O
occur	VB	O
spontaneously	RB	O
.	.	O

Significant	NN	O
for	IN	O
Insulin	NNP	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
,	,	O
frequent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
osteoporosis	NN	B-PROBLEM
.	.	O

On	IN	O
admission	NN	O
include	VBP	O
Cozaar	NNP	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Coumadin	NNP	B-TREATMENT
2	CD	O
mg/1	NN	O
mg	NN	O
alternate	NN	O
days	NNS	O
,	,	O
Synthroid	NNP	B-TREATMENT
175	CD	O
mcg	NN	O
q.d.	NN	O
,	,	O
Zoloft	NNP	B-TREATMENT
50	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Zantac	NNP	B-TREATMENT
150	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
Diabeta	NNP	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Proctofoam	NNP	B-TREATMENT
1%	CD	O
q.i.d.	NN	O
,	,	O
Demerol	NNP	B-TREATMENT
100	CD	O
mg	NN	O
q	NN	O
6	CD	O
p.r.n.	NN	O
,	,	O
OsCal	NNP	B-TREATMENT
2	CD	O
tabs	NN	O
t.i.d.	NN	O
,	,	O
multivitamins	NNS	B-TREATMENT
and	CC	O
KCl	NNP	B-TREATMENT
supplements	NNS	I-TREATMENT
,	,	O
Dulcolax	NNP	B-TREATMENT
5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Senokot	NNP	B-TREATMENT
2	CD	O
tabs	NN	O
q	NN	O
h.s.	NN	O
,	,	O
Metamucil	NNP	B-TREATMENT
1	CD	O
tablespoon	NN	O
b.i.d.	NN	O
,	,	O
Detrol	NNP	B-TREATMENT
2	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
Neurontin	NNP	B-TREATMENT
200	CD	O
mg	NN	O
t.i.d.	NN	O
,	,	O
HydroDIURIL	NNP	B-TREATMENT
12.5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
Valium	NNP	B-TREATMENT
10	CD	O
mg	NN	O
q	NN	O
8	CD	O
p.r.n.	NN	O
muscle	NN	B-PROBLEM
spasm	NN	I-PROBLEM
,	,	O
Insulin	NNP	B-TREATMENT
by	IN	O
sliding	VBG	O
scale	NN	O
and	CC	O
levofloxacin	$	B-TREATMENT
500	CD	O
mg	NN	O
q.d.	NN	O
beginning	VBG	O
October	NNP	O
23	CD	O
,	,	O
1999	CD	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
Hydralazine	NNP	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
,	,	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
Nifedipine	NNP	B-TREATMENT
and	CC	O
Percocet	NNP	B-TREATMENT
.	.	O

On	IN	O
admission	NN	O
,	,	O
heart	NN	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

Lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
with	IN	O
marked	JJ	B-PROBLEM
suprapubic	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
reduced	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

Anal	NNP	O
tone	NN	O
is	VBZ	O
reduced	VBN	B-PROBLEM
.	.	O

Rectal	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
nontender	JJ	B-PROBLEM
and	CC	O
stool	NN	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
.	.	O

pupils	NNS	O
are	VBP	O
4-6	JJ	O
mm	NN	O
bilaterally	RB	O
,	,	O
extraocular	JJ	O
movements	NNS	O
were	VBD	O
full	JJ	O
without	IN	O
nystagmus	NN	B-PROBLEM
.	.	O

The	DT	O
tone	NN	O
is	VBZ	O
markedly	RB	B-PROBLEM
increased	VBN	I-PROBLEM
in	IN	I-PROBLEM
bot	NN	I-PROBLEM
legs	NN	I-PROBLEM
with	IN	O
left	NN	O
greater	JJR	O
than	IN	O
right	NN	O
.	.	O

Left	NNP	O
arm	NN	O
shows	VBZ	O
a	DT	B-PROBLEM
flexor	JJ	I-PROBLEM
contracture	NN	I-PROBLEM
and	CC	O
markedly	RB	B-PROBLEM
increased	VBD	I-PROBLEM
tone	NN	I-PROBLEM
.	.	O

The	DT	O
right	JJ	O
arm	NN	O
shows	NNS	O
moderate	VBP	B-PROBLEM
increased	VBN	I-PROBLEM
tone	NN	I-PROBLEM
.	.	O

The	DT	O
left	JJ	O
upper	JJ	O
extremity	NN	O
shows	NNS	O
reduction	NN	B-PROBLEM
in	IN	I-PROBLEM
motor	NN	I-PROBLEM
power	NN	I-PROBLEM
ranging	VBG	O
from	IN	O
2/5	CD	O
in	IN	O
the	DT	O
triceps	NNS	O
,	,	O
4/5	CD	O
in	IN	O
the	DT	O
biceps	NNS	O
,	,	O
and	CC	O
3-4/5	NNS	O
in	IN	O
the	DT	O
wrists	NNS	O
and	CC	O
hand	NN	O
intrinsics	NNS	O
.	.	O

The	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
shows	NNS	O
generalized	VBN	B-PROBLEM
reduction	NN	I-PROBLEM
in	IN	I-PROBLEM
strength	NN	I-PROBLEM
,	,	O
4/5	CD	O
in	IN	O
all	DT	O
joints	NNS	O
.	.	O

Upper	IN	O
extremities	NNS	O
are	VBP	O
very	RB	O
brisk	JJ	O
bilaterally	RB	O
and	CC	O
symmetrical	JJ	O
3+.	CD	O
There	EX	O
is	VBZ	O
positive	JJ	B-PROBLEM
tremor	NN	I-PROBLEM
reflex	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
absent	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

Lower	JJR	O
extremities	NNS	O
show	VBP	O
patellar	JJ	B-TEST
reflexes	NNS	I-TEST
3+	CD	O
left	VBD	O
,	,	O
4+	CD	O
right	NN	O
,	,	O
no	DT	O
cross	NN	B-TEST
deductor	NN	I-TEST
reflexes	NNS	I-TEST
and	CC	O
absent	JJ	O
ankle	NN	O
jerks	NNS	O
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
clonus	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
but	CC	O
sustained	VBD	B-PROBLEM
clonus	NNS	I-PROBLEM
(	(	I-PROBLEM
10-12	JJ	I-PROBLEM
beats	NNS	I-PROBLEM
)	)	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
diminished	VBN	B-PROBLEM
vibration	NN	I-PROBLEM
and	CC	I-PROBLEM
propioception	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
decreased	JJ	B-PROBLEM
temperature	NN	I-PROBLEM
,	,	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pinprick	JJ	B-TEST
sensation	NN	I-TEST
in	IN	O
the	DT	O
right	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremity	NN	O
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
cervical	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
sensory	JJ	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

Cerebellar	NN	O
;	:	O
The	DT	O
patient	NN	O
demonstrates	VBZ	O
an	DT	B-PROBLEM
intention	NN	I-PROBLEM
tremor	NN	I-PROBLEM
on	IN	O
finger	NN	B-TEST
to	TO	I-TEST
nose	VB	I-TEST
with	IN	O
the	DT	O
left	JJ	O
hand	NN	O
.	.	O

Fine	NNP	O
motor	NN	O
movements	NNS	O
are	VBP	O
slow	JJ	B-PROBLEM
but	CC	O
accurate	NN	O
in	IN	O
the	DT	O
left	NN	O
and	CC	O
right	JJ	O
hands	NNS	O
.	.	O

Sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
30	CD	O
,	,	O
BUN	NNP	B-TEST
of	IN	O
13	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
serum	VBD	B-TEST
glucose	JJ	I-TEST
228	CD	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
7,000	CD	O
.	.	O

Hematocrit	NNP	B-TEST
is	VBZ	O
37.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
is	VBZ	O
148,000	CD	O
.	.	O

Prothrombin	NNP	B-TEST
time	NN	I-TEST
is	VBZ	O
15.9	CD	O
with	IN	O
an	DT	B-TEST
INR	NNP	I-TEST
of	IN	O
1.7	CD	O
.	.	O

PTT	NNP	B-TEST
is	VBZ	O
24	CD	O
.	.	O

Urinalysis	NN	B-TEST
from	IN	O
October	NNP	O
21	CD	O
,	,	O
is	VBZ	O
positive	JJ	O
for	IN	O
Citrobacter	NNP	B-PROBLEM
susceptible	JJ	O
to	TO	O
ciprofloxacin	VB	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
,	,	O
nitrofurantoin	RB	B-TREATMENT
,	,	O
tetracycline	NN	B-TREATMENT
and	CC	O
Bactrim	NNP	B-TREATMENT
.	.	O

Electrocardiogram	NNP	B-TEST
shows	VBZ	O
no	DT	O
P-waves	NNS	B-PROBLEM
.	.	O

On	IN	O
admission	NN	O
,	,	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
with	IN	O
and	CC	O
without	IN	O
contrast	NN	O
was	VBD	O
performed	VBN	O
,	,	O
showing	VBG	O
a	DT	B-PROBLEM
missing	VBG	I-PROBLEM
posterior	JJ	I-PROBLEM
arch	NN	I-PROBLEM
at	IN	I-PROBLEM
C-1	NNP	I-PROBLEM
and	CC	O
metallic	JJ	B-TREATMENT
clips	NNS	I-TREATMENT
at	IN	I-TREATMENT
the	DT	I-TREATMENT
craniocervical	JJ	I-TREATMENT
junction	NN	I-TREATMENT
consistent	NN	O
with	IN	O
prior	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

No	DT	O
arteriovenous	JJ	B-PROBLEM
malformations	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
;	:	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
recurrence	NN	B-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
former	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
.	.	O

No	DT	O
intraspinal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
.	.	O

Upon	IN	O
further	JJ	O
review	NN	O
of	IN	O
Dr.	NNP	O
Laymie	NNP	O
Fields	NNP	O
,	,	O
Department	NNP	O
of	IN	O
Neuroradiology	NNP	O
,	,	O
review	NN	O
of	IN	O
the	DT	O
cervical	JJ	O
spine	NN	O
on	IN	O
CT	NNP	B-TEST
reveals	VBZ	O
no	DT	O
extrinsic	JJ	B-PROBLEM
compressive	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
impacting	VBG	O
the	DT	O
spinal	JJ	O
cord	NN	O
and	CC	O
no	DT	O
enhancing	VBG	B-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
with	IN	O
contrast	NN	B-TEST
.	.	O

Angiography	NNP	B-TEST
performed	VBD	O
on	IN	O
October	NNP	O
31	CD	O
,	,	O
1999	CD	O
,	,	O
showed	VBD	O
normal	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
distribution	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
and	CC	I-PROBLEM
neck	NN	I-PROBLEM
with	IN	O
no	DT	O
recurrence	NN	B-PROBLEM
of	IN	I-PROBLEM
arteriovenous	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
.	.	O

During	IN	O
this	DT	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Baclofen	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
spasticity	NN	B-PROBLEM
.	.	O

Coumadin	NNP	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
Valium	NNP	B-TREATMENT
5-10	JJ	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
muscle	NN	B-PROBLEM
spasm	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
Demerol	NNP	B-TREATMENT
50	CD	O
mg	NN	O
q	JJ	O
6-8	JJ	O
hours	NNS	O
p.r.n.	NN	O
for	IN	O
left	JJ	B-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Upon	IN	O
further	JJ	O
review	NN	O
of	IN	O
CT	NNP	B-TEST
and	CC	O
angiography	NN	B-TEST
results	NNS	O
with	IN	O
Neuroradiology	NNP	O
and	CC	O
Neurology	NNP	O
service	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
CT	NNP	B-TEST
myelography	NN	I-TEST
was	VBD	O
not	RB	O
indicated	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

Note	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
a	DT	O
candidate	NN	O
for	IN	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
secondary	JJ	O
to	TO	O
ferromagnetic	JJ	B-TREATMENT
intracardiac	NN	I-TREATMENT
pacing	VBG	I-TREATMENT
device	NN	I-TREATMENT
.	.	O

We	PRP	O
recommend	VBP	O
daily	JJ	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
maximize	VB	O
functional	JJ	B-PROBLEM
capacity	NN	I-PROBLEM
with	IN	O
optimization	NN	O
of	IN	O
pharmacological	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
for	IN	O
spasticity	NN	B-PROBLEM
including	VBG	O
Baclofen	NNP	B-TREATMENT
,	,	O
Valium	NNP	B-TREATMENT
and	CC	O
adequate	JJ	B-TREATMENT
analgesia	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
EPIGASTRIC	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
/	NNP	O
ABD	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
RO	NNP	O
WOODMA	NNP	O
HEALTHCARE	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
PRIESDOUET	NNP	O
,	,	O
CH	NNP	O
J	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
CHOLECYSTITIS	NNP	B-PROBLEM
.	.	O

Vaginal	JJ	B-TREATMENT
Delivery	NNP	I-TREATMENT
With	IN	O
Second	NNP	B-PROBLEM
Degree	NNP	I-PROBLEM
Laceration	NNP	I-PROBLEM

Low	JJ	B-PROBLEM
Lying	NNP	I-PROBLEM
Placenta	NNP	I-PROBLEM
;	:	O
Past	NNP	O
Medical	NNP	O
History	NNP	O
,	,	O
history	NN	O
of	IN	O
;	:	O
Urinary	NNP	B-PROBLEM
Tract	NNP	I-PROBLEM
Infection	NNP	I-PROBLEM
,	,	O
history	NN	O
of	IN	O

Spontaneous	JJ	B-TREATMENT
Vertex	NNP	I-TREATMENT
Vaginal	NNP	I-TREATMENT
Delivery	NNP	I-TREATMENT

Routine	JJ	B-TREATMENT
Post	NNP	I-TREATMENT
Partum	NNP	I-TREATMENT
Care	NNP	I-TREATMENT

Active	JJ	B-PROBLEM
Labor	NN	I-PROBLEM

HEIGHT	$	B-TEST
66	CD	O
HEENT	NNP	B-TEST
NORMAL	NNP	O
NECK	NNP	O
NORMAL	NNP	O
BREASTS	NNP	O
NORMAL	NNP	O
NIPPLES	NNP	O
NORMAL	NNP	O
CHEST	NNP	O
NORMAL	NNP	O
COR	NNP	O
NORMAL	NNP	O
ABDOMEN	NNP	O
NORMAL	NNP	O
EXTREM	NNP	O
NORMAL	NNP	O
SKIN	NNP	O
NORMAL	NNP	O
NODES	NNP	O
NORMAL	NNP	O
VULVA	NNP	O
NORMAL	NNP	O
VAGINA	NNP	O
NORMAL	NNP	O
CERVIX	NNP	O
NORMAL	NNP	O
OS	NNP	O
NORMAL	NNP	O
ADNEXAE	NNP	O
NORMAL	NNP	O
UTERUS	NNP	O
NORMAL	NNP	O
UTERINE	NNP	O
SIZE	NNP	O
IN	NNP	O
WEEKS	NNP	O
NORMAL	NNP	O
12	CD	O

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

She	PRP	O
delivered	VBD	O
a	DT	O
3550	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
08/31/2004	CD	O
at	IN	O
09:33	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
41.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

chorioamnionitis	NN	B-PROBLEM
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
.	.	O

Multivitamins	NNS	B-TREATMENT
And	CC	O
Folate	NNP	B-TREATMENT
(	(	I-TREATMENT
Fam	NNP	I-TREATMENT
Pren	NNP	I-TREATMENT
Forte	NNP	I-TREATMENT
)	)	I-TREATMENT

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
ABD	NNP	B-PROBLEM
PAIN	NNP	I-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
TREATED	NNP	O
AND	NNP	O
RELEASED	NNP	O
.	.	O

1)	CD	O
ACQUIRED	NNP	B-PROBLEM
IMMUNODEFICIENCY	NNP	I-PROBLEM
SYNDROME	NNP	I-PROBLEM
.	.	O

2)	CD	O
PNEUMOCYSTIS	NNP	B-PROBLEM
CARINII	NNP	I-PROBLEM
PNEUMONIA	NNP	I-PROBLEM
.	.	O

3)	CD	O
ADULT	NNP	B-PROBLEM
RESPIRATORY	NNP	I-PROBLEM
DISTRESS	NNP	I-PROBLEM
SYNDROME	NNP	I-PROBLEM
.	.	O

Mr.	NNP	O
Breutzfarstxei	NNP	O
is	VBZ	O
a	DT	O
30	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
recently	RB	O
diagnosed	VBN	O
acquired	VBN	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
Pneumocystis	NNP	B-PROBLEM
carinii	VBP	I-PROBLEM
pneumonia	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
developed	VBD	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
and	CC	O
died	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
after	IN	O
failed	VBD	O
efforts	NNS	O
of	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

Mr.	NNP	O
Breutzfarstxei	NNP	O
was	VBD	O
recently	RB	O
diagnosed	VBN	O
with	IN	O
acquired	JJ	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
when	WRB	O
he	PRP	O
had	VBD	O
Pneumocystis	NNP	B-PROBLEM
carinii	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
01/17/91	CD	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
at	IN	O
that	DT	O
time	NN	O
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
Bactrim	NNP	B-TREATMENT
and	CC	O
steroids	NNS	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
actually	RB	O
intubated	VBN	O
and	CC	O
underwent	JJ	O
bronchoscopy	NN	B-TREATMENT
where	WRB	O
the	DT	O
diagnosis	NN	O
was	VBD	O
made	VBN	O
with	IN	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
toluidine	NN	I-PROBLEM
blue	NN	I-PROBLEM
study	NN	I-PROBLEM
.	.	O

He	PRP	O
initially	RB	O
did	VBD	O
well	RB	O
after	IN	O
extubation	NN	B-TREATMENT
and	CC	O
completed	VBD	O
approximately	RB	O
two	CD	O
weeks	NNS	O
of	IN	O
Bactrim	NNP	B-TREATMENT
and	CC	O
a	DT	B-TREATMENT
steroid	JJ	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

At	IN	O
discharge	NN	O
after	IN	O
about	IN	O
two	CD	O
weeks	NNS	O
post-extubation	NN	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	O
O2	NNP	B-TEST
saturation	NN	I-TEST
of	IN	O
approximately	RB	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

On	IN	O
02/06/91	CD	O
,	,	O
he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
FLFDMC	NNP	O
and	CC	O
at	IN	O
that	DT	O
point	NN	O
,	,	O
his	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
101.4	CD	O
and	CC	O
he	PRP	O
had	VBD	O
malaise	NN	B-PROBLEM
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
only	RB	O
90%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
his	PRP$	B-TEST
chest	NN	I-TEST
X-Ray	NN	I-TEST
showed	VBD	O
no	DT	O
change	NN	O
.	.	O

Cultures	NNS	B-TEST
were	VBD	O
taken	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
sent	VBN	O
out	RP	O
.	.	O

On	IN	O
02/08/91	CD	O
,	,	O
the	DT	O
patient	NN	O
called	VBD	O
Dr.	NNP	O
Seen	NNP	O
because	IN	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
malaise	NN	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
FLFDMC	NNP	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
jaundice	NN	B-PROBLEM
and	CC	O
newly	RB	B-PROBLEM
palpable	JJ	I-PROBLEM
liver	NN	I-PROBLEM
edge	NN	I-PROBLEM
.	.	O

Review	NNP	O
of	IN	O
liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
cholestatic	JJ	I-PROBLEM
picture	NN	I-PROBLEM
which	WDT	O
was	VBD	O
not	RB	O
previously	RB	O
found	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
was	VBD	O
secondary	JJ	O
to	TO	O
the	DT	B-TREATMENT
Bactrim	NNP	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
recently	RB	O
stopped	VBD	O
anyway	RB	O
.	.	O

His	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
only	RB	O
86%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
he	PRP	O
was	VBD	O
admitted	VBN	O
.	.	O

1)	CD	O
HIV	NNP	B-PROBLEM
positive	JJ	I-PROBLEM
with	IN	O
a	DT	B-TEST
CD4	NNP	I-TEST
count	NN	I-TEST
of	IN	O
74	CD	O
.	.	O

2)	CD	O
Recent	JJ	B-PROBLEM
PCP	NNP	I-PROBLEM
.	.	O

3)	CD	O
Status	NNP	O
post	NN	O
right	RB	B-TREATMENT
elbow	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

4)	CD	O
Venereal	JJ	B-PROBLEM
disease	NN	I-PROBLEM
history	NN	I-PROBLEM
.	.	O

5)	CD	O
PPD	NNP	B-PROBLEM
anergic	NN	I-PROBLEM
.	.	O

On	IN	O
presentation	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
young	JJ	O
appearing	VBG	O
Hispanic	JJ	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
140/90	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
120	CD	O
,	,	O
respirations	NNS	B-TEST
32	CD	O
,	,	O
and	CC	O
temperature	NN	B-TEST
101	CD	O
.	.	O

Revealed	VBN	O
icteric	JJ	B-PROBLEM
sclerae	NN	I-PROBLEM
,	,	O
the	DT	B-PROBLEM
oropharynx	NN	I-PROBLEM
with	IN	I-PROBLEM
extensive	JJ	I-PROBLEM
thrush	NN	I-PROBLEM
,	,	O
and	CC	O
an	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
under	IN	I-PROBLEM
his	PRP$	I-PROBLEM
tongue	NN	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
no	DT	O
cervical	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
and	CC	O
his	PRP$	O
neck	NN	O
was	VBD	O
supple	NN	O
.	.	O

Had	NNP	O
tubular	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
especially	RB	O
in	IN	O
the	DT	O
lower	JJR	O
lung	NN	O
fields	NNS	O
.	.	O

Showed	NNP	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Soft	JJ	O
with	IN	O
bowel	NN	O
sounds	NNS	O
and	CC	O
there	EX	O
was	VBD	O
mid	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

His	PRP$	O
penis	NN	O
had	VBD	O
a	DT	O
1/2	CD	B-PROBLEM
cm	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
yellowish	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

On	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
7.2	CD	O
with	IN	O
57%	CD	O
neutrophils	NNS	B-TEST
,	,	O
40%	CD	O
lymphocytes	NNS	B-TEST
,	,	O
l	NN	O
mononuclear	NN	B-TEST
cell	NN	I-TEST
,	,	O
and	CC	O
1.6	CD	O
eosinophils	NNS	B-TEST
.	.	O

PT	NNP	B-TEST
was	VBD	O
12.6	CD	O
and	CC	O
PTT	NNP	B-TEST
was	VBD	O
29	CD	O
.	.	O

Sodium	NN	B-TEST
was	VBD	O
133	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
4.2	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
CO2	NNP	B-TEST
19	CD	O
,	,	O
BUN	NNP	B-TEST
21	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
and	CC	O
glucose	RB	B-TEST
122	CD	O
.	.	O

ALT	NNP	B-TEST
was	VBD	O
181	CD	O
,	,	O
AST	NNP	B-TEST
was	VBD	O
156	CD	O
,	,	O
LDH	NNP	B-TEST
was	VBD	O
336	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
214	CD	O
,	,	O
and	CC	O
bilirubin	NN	B-TEST
was	VBD	O
12.7	CD	O
total	NN	O
.	.	O

(	(	O
On	IN	O
02/06	CD	O
,	,	O
his	PRP$	B-TEST
bilirubin	NN	I-TEST
had	VBD	O
been	VBN	O
7.2	CD	O
with	IN	O
6	CD	O
direct	JJ	O
)	)	O
.	.	O

His	PRP$	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
on	IN	O
50%	CD	O
was	VBD	O
pO2	JJ	B-TEST
92	CD	O
,	,	O
pCO2	NN	B-TEST
24	CD	O
,	,	O
and	CC	O
pH	RB	B-TEST
7.46	CD	O
.	.	O

His	PRP$	B-TEST
chest	JJS	I-TEST
X-Ray	NN	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
nodular	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
work-up	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
cholestatic	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
picture	NN	I-PROBLEM
along	IN	O
with	IN	O
work-up	NN	B-TEST
for	IN	O
his	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
both	DT	O
.	.	O

In	IN	O
terms	NNS	O
of	IN	O
pulmonary	JJ	O
function	NN	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
one	CD	O
possibility	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	B-PROBLEM
Bactrim	JJ	I-PROBLEM
failure	NN	I-PROBLEM
for	IN	O
PCP	NNP	B-PROBLEM
although	IN	O
this	DT	O
was	VBD	O
unusual	JJ	O
.	.	O

He	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Pentamidine	NNP	B-TREATMENT
,	,	O
especially	RB	O
in	IN	O
light	NN	O
of	IN	O
the	DT	O
fact	NN	O
that	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
his	PRP$	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
due	JJ	O
possibly	RB	O
to	TO	O
Bactrim	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
covered	VBN	O
with	IN	O
Erythromycin	NNP	B-TREATMENT
and	CC	O
Gentamicin	NNP	B-TREATMENT
for	IN	O
coverage	NN	O
of	IN	O
community	NN	B-PROBLEM
acquired	VBN	I-PROBLEM
pneumonias	NN	I-PROBLEM
and	CC	O
gram	NN	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

In	IN	O
terms	NNS	O
of	IN	O
his	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
viral	JJ	B-PROBLEM
hepatitis	NN	I-PROBLEM
was	VBD	O
in	IN	O
the	DT	O
differential	NN	O
as	RB	O
well	RB	O
as	IN	O
several	JJ	B-PROBLEM
opportunistic	JJ	I-PROBLEM
infections	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
but	CC	O
also	RB	O
was	VBD	O
felt	VBN	O
that	IN	O
Bactrim	NNP	B-TREATMENT
could	MD	O
be	VB	O
a	DT	O
cause	NN	O
of	IN	O
these	DT	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

Titers	NNS	B-TEST
for	IN	O
CMV	NNP	B-PROBLEM
and	CC	O
Epstein-Barr	NNP	B-PROBLEM
virus	NN	I-PROBLEM
were	VBD	O
sent	VBN	O
and	CC	O
a	DT	B-TEST
titer	NN	I-TEST
for	IN	O
toxoplasma	NN	B-PROBLEM
was	VBD	O
sent	VBN	O
.	.	O

Stool	NNP	B-TEST
was	VBD	O
sent	VBN	O
for	IN	O
ova	NN	B-PROBLEM
and	CC	O
parasites	NNS	B-PROBLEM
.	.	O

Initially	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
in	IN	O
terms	NNS	O
of	IN	O
his	PRP$	O
pre-status	NN	O
and	CC	O
required	VBN	O
less	JJR	O
oxygen	NN	B-TREATMENT
.	.	O

However	RB	O
,	,	O
on	IN	O
02/10/91	CD	O
,	,	O
his	PRP$	B-TEST
respiratory	JJ	I-TEST
rate	NN	I-TEST
increased	VBD	O
and	CC	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
decreased	VBD	O
.	.	O

Actually	RB	O
in	IN	O
reviewing	VBG	O
the	DT	O
records	NNS	O
at	IN	O
this	DT	O
point	NN	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
Pentamidine	NNP	B-TREATMENT
was	VBD	O
not	RB	O
started	VBN	O
initially	RB	O
so	RB	O
on	IN	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
of	IN	O
Erythromycin	NNP	B-TREATMENT
and	CC	O
Gentamicin	NNP	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
respiratory	NN	O
status	NN	O
worsened	VBD	O
and	CC	O
his	PRP$	B-TEST
LDH	NNP	I-TEST
climbed	VBD	O
so	RB	O
he	PRP	O
began	VBD	O
Pentamidine	NNP	B-TREATMENT
on	IN	O
02/10/91	CD	O
.	.	O

On	IN	O
02/11/91	CD	O
,	,	O
the	DT	O
patient	NN	O
again	RB	O
appeared	VBD	O
more	RBR	O
comfortable	JJ	O
this	DT	O
time	NN	O
with	IN	O
50%	CD	B-TREATMENT
facemask	NNS	I-TREATMENT
but	CC	O
then	RB	O
required	VBD	O
more	RBR	O
oxygen	JJ	B-TREATMENT
,	,	O
dropped	VBD	O
his	PRP$	B-TEST
O2	JJ	I-TEST
saturations	NNS	I-TEST
,	,	O
and	CC	O
was	VBD	O
intubated	VBN	O
on	IN	O
02/11/91	CD	O
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
on	IN	O
12/12/90	CD	O
on	IN	O
Gentamicin	NNP	B-TREATMENT
,	,	O
Vancomycin	NNP	B-TREATMENT
,	,	O
Pentamidine	NNP	B-TREATMENT
,	,	O
and	CC	O
Prednisone	NNP	B-TREATMENT
.	.	O

Also	RB	O
of	IN	O
note	NN	O
at	IN	O
that	DT	O
point	NN	O
,	,	O
hepatitis	NN	B-TEST
C	NNP	I-TEST
virus	NN	I-TEST
serologies	NNS	I-TEST
had	VBD	O
come	VBN	O
back	RB	O
positive	JJ	O
.	.	O

However	RB	O
,	,	O
at	IN	O
this	DT	O
point	NN	O
,	,	O
his	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
test	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
appeared	VBD	O
more	RBR	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
cholestatic	JJ	I-PROBLEM
picture	NN	I-PROBLEM
with	IN	O
his	PRP$	B-TEST
direct	JJ	I-TEST
bilirubin	NN	I-TEST
being	VBG	O
12.1	CD	O
and	CC	O
total	JJ	B-TEST
being	VBG	O
14.1	CD	O
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
abdominal	JJ	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
showed	VBD	O
no	DT	O
liver	NN	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
no	DT	O
obstruction	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
appeared	VBD	O
to	TO	O
improve	VB	O
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
penile	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
cultured	VBN	O
and	CC	O
grew	VBD	O
positive	JJ	B-PROBLEM
herpes	NNS	I-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Acyclovir	NNP	B-TREATMENT
.	.	O

On	IN	O
02/13/91	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
bronchoalveolar	JJ	I-TEST
lavage	NN	I-TEST
performed	VBD	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
toluidine	NN	I-PROBLEM
blue	NN	I-PROBLEM
with	IN	O
many	JJ	B-PROBLEM
pneumocysts	NNS	I-PROBLEM
noted	VBD	O
.	.	O

No	DT	O
other	JJ	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
and	CC	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
clinical	JJ	O
status	NN	O
deteriorated	VBN	O
.	.	O

The	DT	O
patient	NN	O
required	VBD	O
100%	CD	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
maintain	VB	O
adequate	JJ	O
oxygen	NN	O
saturations	NNS	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

He	PRP	O
required	VBD	O
elevated	JJ	B-TREATMENT
ventilatory	NN	I-TREATMENT
pressures	NNS	I-TREATMENT
with	IN	O
PIPS	NNP	B-TEST
often	RB	O
above	IN	O
60	CD	O
.	.	O

Fortunately	RB	O
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
baratroma	NN	B-PROBLEM
was	VBD	O
ever	RB	O
discerned	VBN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
respiratory	NN	O
status	NN	O
continued	VBD	O
to	TO	O
decline	VB	O
and	CC	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
maintain	VB	O
oxygen	JJ	B-TEST
saturations	NNS	I-TEST
above	IN	O
80%	CD	O
even	RB	O
using	VBG	O
reverse	NN	B-TREATMENT
I	PRP	I-TREATMENT
to	TO	I-TREATMENT
E	NNP	I-TREATMENT
ventilation	NN	I-TREATMENT
,	,	O
paralysis	NN	B-TREATMENT
,	,	O
sedation	NN	B-TREATMENT
,	,	O
and	CC	O
other	JJ	B-TREATMENT
modes	NNS	I-TREATMENT
of	IN	I-TREATMENT
ventilation	NN	I-TREATMENT
.	.	O

Patient	JJ	O
underwent	JJ	O
liver	NN	B-TEST
biopsy	NN	I-TEST
on	IN	O
02/16/91	CD	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
this	DT	O
were	VBD	O
pending	VBG	O
when	WRB	O
the	DT	O
patient	NN	O
died	VBD	O
.	.	O

The	DT	O
patient	NN	O
actually	RB	O
developed	VBD	O
decreasing	VBG	B-PROBLEM
counts	NNS	I-PROBLEM
with	IN	O
white	JJ	B-TEST
count	NN	I-TEST
as	RB	O
low	JJ	O
as	IN	O
1.75	CD	O
,	,	O
hematocrit	NN	B-TEST
as	RB	O
low	JJ	O
as	IN	O
26	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
as	RB	O
low	JJ	O
as	IN	O
68	CD	O
noted	VBD	O
on	IN	O
02/15/91	CD	O
.	.	O

These	DT	O
were	VBD	O
supported	VBN	O
with	IN	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
and	CC	O
Hematology	NNP	O
was	VBD	O
consulted	VBN	O
.	.	O

They	PRP	O
felt	VBD	O
that	IN	O
it	PRP	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
Bactrim	NNP	B-TREATMENT
and	CC	O
these	DT	O
actually	RB	O
were	VBD	O
getting	VBG	O
better	RB	O
when	WRB	O
the	DT	O
patient	NN	O
died	VBD	O
.	.	O

Bone	NNP	B-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
was	VBD	O
not	RB	O
attempted	VBN	O
.	.	O

Discussions	NNS	O
were	VBD	O
begun	VBN	O
with	IN	O
the	DT	O
family	NN	O
regarding	VBG	O
limits	NNS	O
of	IN	O
supportive	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

Due	JJ	O
to	TO	O
continued	VB	B-PROBLEM
worsening	VBG	I-PROBLEM
pulmonary	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
an	DT	O
overall	JJ	O
grim	JJ	O
prognosis	NN	O
,	,	O
the	DT	O
family	NN	O
decided	VBD	O
,	,	O
in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
Medical	NNP	O
Team	NNP	O
,	,	O
to	TO	O
withdraw	VB	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

Patient	NN	O
expired	VBD	O
after	IN	O
the	DT	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
withdrawn	VBN	O
at	IN	O
6:40	CD	O
p.m.	NN	O

An	DT	B-TEST
autopsy	NN	I-TEST
will	MD	O
be	VB	O
performed	VBN	O
.	.	O

An	DT	B-TEST
autopsy	NN	I-TEST
was	VBD	O
performed	VBN	O
as	IN	O
per	IN	O
the	DT	O
family	NN	O
&apos;s	NN	O
wishes	NNS	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
HEMATURIA	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
DAUGHTERSVILLSHAMEN&apos;S	NNP	O
HOSPITAL	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
LINKETHORE	NNP	O
,	,	O
HANSVERLLEN	NNP	O
G	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
HEMATURIA	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
71-year-old	JJ	O
police	NN	O
chief	NN	O
who	WP	O
presents	VBZ	O
with	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
x1	NNP	O
day	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
generally	RB	O
in	IN	O
excellent	JJ	O
health	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
only	RB	O
for	IN	O
noninsulin	JJ	B-PROBLEM
dependent	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
who	WP	O
was	VBD	O
presented	VBN	O
with	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
x2	NNP	O
days	NNS	O
.	.	O

He	PRP	O
also	RB	O
noted	VBD	O
a	DT	B-PROBLEM
23	CD	I-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
11	CD	O
months	NNS	O
despite	IN	O
having	VBG	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
appetite	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
also	RB	O
complained	VBD	O
of	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
&quot;	NN	B-PROBLEM
feeling	VBG	I-PROBLEM
down	RP	I-PROBLEM
&quot;	NNP	I-PROBLEM
.	.	O

His	PRP$	O
wife	NN	O
noted	VBD	O
personality	NN	B-PROBLEM
changes	NNS	I-PROBLEM
with	IN	O
increased	JJ	B-PROBLEM
irritability	NN	I-PROBLEM
.	.	O

Patient	JJ	O
denies	NNS	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
month	NN	O
.	.	O

The	DT	O
patient	NN	O
denies	VBZ	O
melena	RBS	B-PROBLEM
,	,	O
hematochezia	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
he	PRP	O
is	VBZ	O
occasionally	RB	B-PROBLEM
constipated	VBN	I-PROBLEM
.	.	O

Also	RB	O
denies	VBZ	O
tenesmus	NN	B-PROBLEM
.	.	O

On	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
noted	VBD	O
that	IN	O
&quot;	NN	O
he	PRP	O
looked	VBD	O
yellow	JJ	B-PROBLEM
&quot;	NN	O
and	CC	O
presented	VBN	O
to	TO	O
the	DT	O
Lorough	NNP	O
Medical	NNP	O
Center	NNP	O
&apos;s	NNP	O
Emergency	NNP	O
Department	NNP	O
this	DT	O
after	IN	O
noon	NN	O
.	.	O

1.	CD	O
Type	NNP	B-PROBLEM
II	NNP	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
diagnosed	VBD	O
06/94	CD	O
,	,	O
well-controlled	JJ	O
with	IN	O
last	JJ	B-TEST
hemoglobin	NN	I-TEST
A1C	NNP	I-TEST
6.2	CD	O

2.	CD	O
Vocal	NNP	B-PROBLEM
cord	NN	I-PROBLEM
polyps	NN	I-PROBLEM

3.	CD	O
Question	NN	O
of	IN	O
history	NN	O
of	IN	O
AVN	NNP	B-PROBLEM
or	CC	O
osseous	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM

4.	CD	O
History	NNP	O
of	IN	O
hyperkalemia	NN	B-PROBLEM
.	.	O

Question	NN	O
RTA	NNP	B-PROBLEM
type	NN	I-PROBLEM
4	CD	I-PROBLEM

Glucotrol	NNP	B-TREATMENT
10	CD	O
q.a.m.	NN	O
and	CC	O
vitamins	NNS	B-TREATMENT

The	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
MSG	NNP	O
from	IN	O
which	WDT	O
he	PRP	O
gets	VBZ	O
hives	NNS	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NN	O
father	NN	O
died	VBD	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
83	CD	O
of	IN	O
CHF	NNP	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
with	IN	O
a	DT	O
complaint	NN	O
of	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
,	,	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

Abdominal	NNP	B-TEST
CT	NNP	I-TEST
while	IN	O
in	IN	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
revealed	VBD	O
likely	JJ	O
primary	JJ	B-PROBLEM
colorectal	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
liver	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

Hematocrit	NNP	B-TEST
was	VBD	O
24	CD	O
in	IN	O
the	DT	O
Emergency	NNP	O
Department	NNP	O
.	.	O

The	DT	O
patient	NN	O
received	VBD	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
the	DT	B-TEST
hematocrit	NN	I-TEST
rose	VBD	O
to	TO	O
30	CD	O
the	DT	O
following	JJ	O
day	NN	O
.	.	O

Biopsy	NNP	B-TEST
was	VBD	O
taken	VBN	O
at	IN	O
colonoscopy	NN	B-TEST
on	IN	O
7/5/99	CD	O
.	.	O

Head	NNP	B-TEST
CT	NNP	I-TEST
was	VBD	O
done	VBN	O
with	IN	O
final	JJ	O
results	NNS	O
pending	VBG	O
on	IN	O
discharge	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
to	TO	O
follow-up	JJ	O
with	IN	O
the	DT	O
Petersly	NNP	O
Hospital	NNP	O
And	CC	O
Medical	NNP	O
Center	NNP	O
as	IN	O
an	DT	O
outpatient	NN	O
for	IN	O
further	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

His	PRP$	O
condition	NN	O
is	VBZ	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
:	:	O

Iron	NNP	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
Glucotrol	NNP	B-TREATMENT
,	,	O
Acel	NNP	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
and	CC	O
Bactrim	NNP	B-TREATMENT
SS	NNP	I-TREATMENT
1	CD	O
tablet	NN	O
p.o.	NN	O
b.i.d.	NN	O

Ovarian	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Hypertension	NN	B-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
,	,	O
obesity	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
hemorrhoids	NNS	B-PROBLEM
,	,	O
whooping	VBG	B-PROBLEM
cough	NN	I-PROBLEM
as	IN	O
a	DT	O
child	NN	O
.	.	O

Total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingooophorectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
omentectomy	NN	B-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
removal	NN	B-TREATMENT
of	IN	O
mass	NN	B-PROBLEM
from	IN	O
surface	NN	O
of	IN	O
transverse	JJ	O
colon	NN	O
.	.	O

64-year-old	JJ	O
G5P5	NNP	O
postmenopausal	NN	O
for	IN	O
10	CD	O
years	NNS	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
two	CD	O
months	NNS	O
of	IN	O
progressive	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
crampy	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
not	RB	O
obtained	VBN	O
gynecologic	NNS	B-TREATMENT
care	NN	I-TREATMENT
for	IN	O
32	CD	O
years	NNS	O
until	IN	O
April	NNP	O
2004	CD	O
when	WRB	O
an	DT	O
increase	NN	O
in	IN	O
abdominal	JJ	B-PROBLEM
GERD	NNP	I-PROBLEM
and	CC	O
urinary	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
lead	VBP	O
her	PRP$	O
to	TO	O
initial	JJ	O
consultation	NN	O
with	IN	O
Dr.	NNP	O
Lentny	NNP	O
Farstnappsshee	NNP	O
in	IN	O
Gobrew	NNP	O
Street	NNP	O
,	,	O
Denlandcobridclevena	NNP	O
,	,	O
West	NNP	O
Virginia	NNP	O
28880	CD	O
.	.	O

At	IN	O
that	DT	O
time	NN	O
a	DT	B-TEST
pelvic	JJ	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
showing	VBG	O
extensive	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
and	CC	O
clear	JJ	B-PROBLEM
mass	NN	I-PROBLEM
within	IN	O
the	DT	O
pelvi-abdominal	JJ	O
cavity	NN	O
.	.	O

MRI	NNP	B-TEST
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
filled	VBN	I-PROBLEM
abdomen	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
relatively	RB	I-PROBLEM
small	JJ	I-PROBLEM
mass	NN	I-PROBLEM
measuring	VBG	O
about	RB	O
5	CD	O
to	TO	O
6	CD	O
cm	NN	O
in	IN	O
the	DT	O
right	JJ	O
pelvis	NN	O
.	.	O

At	IN	O
this	DT	O
point	NN	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
CA	NNP	I-PROBLEM
125	CD	O
at	IN	O
440	CD	O
and	CC	O
came	VBD	O
to	TO	O
Dr.	NNP	O
Chabechird	NNP	O
for	IN	O
further	JJ	O
consultation	NN	O
.	.	O

Hypertension	NN	B-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
for	IN	O
10	CD	O
years	NNS	O
,	,	O
no	DT	O
hospitalizations	NNS	B-TREATMENT
,	,	O
obesity	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
hemorrhoids	NNS	B-PROBLEM
and	CC	O
whooping	JJ	B-PROBLEM
cough	NN	I-PROBLEM
as	IN	O
a	DT	O
child	NN	O
.	.	O

Tonsillectomy	NN	B-TREATMENT
in	IN	O
1947	CD	O
,	,	O
removal	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
renal	JJ	I-PROBLEM
calculus	NN	I-PROBLEM
in	IN	O
1979	CD	O
,	,	O
cholecystectomy	NN	B-TREATMENT
in	IN	O
1986	CD	O
.	.	O

G5	NNP	O
,	,	O
P5	NNP	O
normal	JJ	O
Pap	NNP	O
smears	NNS	O
,	,	O
sexual	JJ	O
active	JJ	O
without	IN	O
dyspareunia	NN	B-PROBLEM
.	.	O

No	DT	O
regular	JJ	B-TEST
breast	NN	I-TEST
self	NN	I-TEST
examination	NN	I-TEST
,	,	O
has	VBZ	O
not	RB	O
had	VBN	O
a	DT	B-TEST
mammogram	NN	I-TEST
.	.	O

Included	VBD	O
Prinzide	NNP	B-TREATMENT
12.5	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
,	,	O
albuterol	VB	B-TREATMENT
inhaler	NN	I-TREATMENT
prn	NN	O

Demerol	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
developed	VBD	O
ulceration	NN	B-PROBLEM
after	IN	O
IM	NNP	B-TREATMENT
injection	NN	I-TREATMENT
.	.	O

She	PRP	O
also	RB	O
has	VBZ	O
food	NN	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
raw	VB	O
vegetables	NNS	O
as	RB	O
well	RB	O
as	IN	O
some	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
throat	NN	B-PROBLEM
constriction	NN	I-PROBLEM
with	IN	O
shrimp	NN	O
.	.	O

Remarkable	JJ	O
for	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
her	PRP$	O
mother	NN	O
and	CC	O
maternal	JJ	O
grandfather	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
05/16/2004	CD	O
for	IN	O
bowel	NN	B-TREATMENT
preparation	NN	I-TREATMENT
before	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

On	IN	O
05/17/2004	CD	O
the	DT	O
patient	NN	O
underwent	JJ	O
atotal	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingooophorectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
omentectomy	NN	B-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
removal	NN	B-TREATMENT
of	IN	O
mass	NN	B-PROBLEM
from	IN	O
surface	NN	O
of	IN	O
transverse	JJ	O
colon	NN	O
.	.	O

The	DT	O
report	NN	O
from	IN	O
the	DT	B-TEST
frozen	JJ	I-TEST
section	NN	I-TEST
sent	VBN	O
in	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
came	VBD	O
back	RB	O
with	IN	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
,	,	O
possibly	RB	O
serous	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ovary	JJ	I-PROBLEM
.	.	O

In	IN	O
the	DT	O
postoperative	JJ	O
recovery	NN	O
room	NN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29.2	CD	O
with	IN	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
given	VBN	O
1	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cell	NN	I-TREATMENT
.	.	O

Her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
subsequently	RB	O
increased	VBD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
came	VBD	O
back	RB	O
with	IN	O
moderate	JJ	B-PROBLEM
E.	NNP	I-PROBLEM
coli	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Levofloxacin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
her	PRP$	B-TREATMENT
Foley	NNP	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
port	NN	I-TREATMENT
placed	VBN	O
.	.	O

She	PRP	O
also	RB	O
had	VBD	O
one	CD	O
episode	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Achest	NNP	B-TEST
x-ray	NN	I-TEST
done	VBN	O
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
left	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
not	RB	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
her	PRP	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
and	CC	O
she	PRP	O
maintained	VBD	O
a	DT	O
good	JJ	O
urine	NN	B-TEST
output	NN	I-TEST
.	.	O

She	PRP	O
also	RB	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
nausea	NN	B-PROBLEM
with	IN	O
some	DT	B-PROBLEM
emesis	NN	I-PROBLEM
,	,	O
after	IN	O
being	VBG	O
treated	VBN	O
with	IN	O
Zofran	NNP	B-TREATMENT
with	IN	O
no	DT	B-PROBLEM
relief	NN	I-PROBLEM
,	,	O
a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
which	WDT	O
drained	VBD	O
1200	CD	O
cc	NN	O
of	IN	O
bilious	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

A	DT	B-TEST
repeat	NN	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
done	VBN	O
for	IN	O
dyspnea	NN	B-PROBLEM
showed	VBD	O
persistent	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
atelectasis	NN	B-PROBLEM
versus	NN	O
pneumonia	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TREATMENT
levofloxacin	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
nasogastric	JJ	B-TEST
tube	NN	I-TEST
clamping	VBG	I-TEST
trials	NNS	I-TEST
with	IN	O
high	JJ	B-PROBLEM
residuals	NNS	I-PROBLEM
in	IN	O
the	DT	O
600	CD	O
cc	NN	O
range	NN	O
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
clear	JJ	O
fluids	NNS	O
with	IN	O
a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
clamped	NN	O
.	.	O

She	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
Decadron	NNP	B-TREATMENT
in	IN	O
preparation	NN	O
for	IN	O
her	PRP$	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
eight	CD	O
which	WDT	O
is	VBZ	O
Memorial	JJ	O
Day	NNP	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Carboplatin-Taxolchemo	NNP	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
which	WDT	O
she	PRP	O
tolerated	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
nine	CD	O
,	,	O
her	PRP$	B-TREATMENT
JP	NNP	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

Dilaudid	$	B-TREATMENT
2	CD	O
to	TO	O
4	CD	O
mg	NNS	O
po	JJ	O
q3h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM
,	,	O
Ativan	NNP	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
q12h	NN	O
prn	NN	O
anxiety	NN	B-PROBLEM
,	,	O
Zofran	NNP	B-TREATMENT
8	CD	O
mg	NN	O
po	NN	O
q8h	NN	O
prn	NN	O
nausea	NN	B-PROBLEM
,	,	O
Compazine	NNP	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
nausea	NN	B-PROBLEM
,	,	O
Decadron	NNP	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
x	VBD	O
2	CD	O
doses	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
take	VB	O
20	CD	O
mg	NNS	O
at	IN	O
11	CD	O
pm	NN	O
the	DT	O
night	NN	O
before	IN	O
her	PRP$	B-TREATMENT
next	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
and	CC	O
8	CD	O
am	VBP	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

Colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
Albuterol	NNP	B-TREATMENT
inhalers	VBZ	I-TREATMENT
two	CD	O
puffs	NNS	O
inhaled	VBD	O
qid	JJ	O
prn	NN	O
wheezing	NN	B-PROBLEM
and	CC	O
asthma	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
make	VB	O
an	DT	O
appointment	NN	O
two	CD	O
weeks	NNS	O
after	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
removal	NN	B-TREATMENT
of	IN	O
her	PRP$	B-TREATMENT
retention	NN	I-TREATMENT
sutures	NNS	I-TREATMENT
.	.	O

PANCREATIC	NNP	B-PROBLEM
CANCER	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
for	IN	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
workup	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
61	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
C	NNP	I-PROBLEM
,	,	O
and	CC	O
asthma	NN	B-PROBLEM
who	WP	O
was	VBD	O
diagnosed	VBN	O
recently	RB	O
with	IN	O
pancreatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
after	IN	O
he	PRP	O
presented	VBD	O
to	TO	O
Seph&apos;sju	NNP	O
Memorial	NNP	O
after	IN	O
a	DT	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

Chest	NNP	B-TEST
CT	NNP	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

Abdominal	NNP	B-TEST
CT	NNP	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
3.0	CD	I-PROBLEM
to	TO	I-PROBLEM
4.0	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreatic	JJ	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

An	DT	B-TEST
ERCP	NNP	I-TEST
performed	VBD	O
there	EX	O
showed	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
segment	NN	I-PROBLEM
of	IN	I-PROBLEM
distal	JJ	I-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bileduct	NN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
there	RB	O
on	IN	O
December	NNP	O
29	CD	O
.	.	O

On	IN	O
January	NNP	O
1	CD	O
,	,	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
for	IN	O
a	DT	B-PROBLEM
loculated	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

On	IN	O
January	NNP	O
2	CD	O
,	,	O
pleurodesis	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

On	IN	O
January	NNP	O
4	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
desaturation	NN	I-PROBLEM
.	.	O

VQ	NNP	B-TEST
was	VBD	O
indeterminate	NN	O
.	.	O

LENIs	NNP	B-TEST
were	VBD	O
negative	JJ	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

On	IN	O
January	NNP	O
5	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
chest	JJ	I-TEST
xray	NN	I-TEST
with	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
apicalpneumothorax	NN	I-PROBLEM
but	CC	O
was	VBD	O
stable	JJ	O
on	IN	O
chest	JJS	B-TEST
xray	NN	I-TEST
of	IN	O
January	NNP	O
7	CD	O
.	.	O

Brain	NNP	B-TEST
CT	NNP	I-TEST
was	VBD	O
negative	JJ	O
,	,	O
as	IN	O
was	VBD	O
a	DT	B-TEST
bronchoscopy	NN	I-TEST
with	IN	O
lavage	NN	B-TREATMENT
.	.	O

His	PRP$	B-TEST
CA99	NNP	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
reported	VBN	O
an	DT	O
approximately	RB	O
30	CD	B-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	I-PROBLEM
six	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
experienced	VBN	O
some	DT	B-PROBLEM
constipation	NN	I-PROBLEM
for	IN	O
the	DT	O
few	JJ	O
months	NNS	O
prior	RB	O
with	IN	O
lighter	JJR	B-PROBLEM
colored	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
darkened	VBN	B-PROBLEM
urine	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
for	IN	O
months	NNS	O
with	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

He	PRP	O
denied	VBD	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
.	.	O

Significant	NN	O
for	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Diabetes	NNS	B-PROBLEM
.	.	O

Hypertension	NN	B-PROBLEM
.	.	O

Gout	NN	B-PROBLEM
.	.	O

Hypercholesterolemia	NNP	B-PROBLEM
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Asthma	NNP	B-PROBLEM
.	.	O

Hepatitis	NNP	B-PROBLEM
C	NNP	I-PROBLEM
.	.	O

Psoriasis	NN	B-PROBLEM
.	.	O

Lasix	NNP	B-TREATMENT
,	,	O
80	CD	O
;	:	O
Avandia	NNP	B-TREATMENT
,	,	O
4	CD	O
b.i.d.	NN	O
;	:	O
Glipizide	NNP	B-TREATMENT
,	,	O
10	CD	O
b.i.d.;	NN	O
Imdur	NNP	B-TREATMENT
,	,	O
30	CD	O
;	:	O
Allopurinol	NNP	B-TREATMENT
;	:	O
Zocor	NNP	B-TREATMENT
,	,	O
20	CD	O
;	:	O
Prilosec	NNP	B-TREATMENT
,	,	O
20	CD	O
,	,	O
potassium	NN	B-TREATMENT
,	,	O
40	CD	O
;	:	O
Oxycontin	NNP	B-TREATMENT
,	,	O
30	CD	O
b.i.d.;	NN	O
subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
;	:	O
Unasyn	NNP	B-TREATMENT
,	,	O
1.5	CD	O
grams	NNS	O
q	RB	O
6	CD	O
;	:	O
Combivent	NNP	B-TREATMENT
and	CC	O
morphine	JJ	B-TREATMENT
prn	NN	O
.	.	O

Mother	NN	O
and	CC	O
father	NN	O
died	VBD	O
of	IN	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Theyalso	NNP	O
had	VBD	O
diabetes	NNS	B-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

Sister	NN	O
with	IN	O
stomach	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

Heart	NNP	B-TEST
rate	NN	I-TEST
was	VBD	O
78	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
98/50	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
32	CD	O
,	,	O
satting	VBG	B-TEST
91%	CD	O
on	IN	O
four	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

In	IN	O
general	JJ	O
,	,	O
this	DT	O
is	VBZ	O
an	DT	O
obese	JJ	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

HEENT	NNP	O
-	:	O
normocephalic	JJ	O
/	NNP	O
atraumatic	NN	B-PROBLEM
,	,	O
extraocular	JJ	O
movements	NNS	O
are	VBP	O
intact	JJ	O
,	,	O
pupils	JJ	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
.	.	O

Chest	NNP	O
had	VBD	O
diffuse	NN	B-PROBLEM
crackles	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
halfway	VBP	O
up	RP	O
.	.	O

Coronary	NNP	O
-	:	O
irregular	JJ	B-PROBLEM
PVCs	NNP	I-PROBLEM
,	,	O
S1	NNP	O
,	,	O
S2	NNP	O
normal	JJ	O
,	,	O
positive	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
radiating	VBG	O
throughout	IN	O
.	.	O

Abdomen	NNP	O
was	VBD	O
distended	VBN	B-PROBLEM
,	,	O
tympanitic	JJ	B-PROBLEM
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
epigastrium	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

No	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

Extremities	NNS	O
had	VBD	O
2+	CD	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
.	.	O

No	DT	O
clubbing	NN	B-PROBLEM
or	CC	O
cyanosis	NN	B-PROBLEM
.	.	O

Neurologic	NNP	B-TEST
examination	NN	I-TEST
-	:	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	NNP	O
3	CD	O
,	,	O
slurred	VBN	B-PROBLEM
and	CC	I-PROBLEM
slow	JJ	I-PROBLEM
speech	NN	I-PROBLEM
,	,	O
distractable	JJ	B-PROBLEM
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
4.36	CD	O
,	,	O
hematocrit	VBD	B-TEST
26.1	CD	O
with	IN	O
platelets	NNS	B-TEST
of	IN	O
107,000	CD	O
,	,	O
MCV	NNP	B-TEST
81	CD	O
.	.	O

Sodium	NN	B-TEST
137	CD	O
,	,	O
potassium	NN	B-TEST
4.5	CD	O
,	,	O
chloride97	NN	B-TEST
,	,	O
bicarb	NN	B-TEST
24	CD	O
,	,	O
BUN	NNP	B-TEST
124	CD	O
,	,	O
creatinine	NN	B-TEST
4.1	CD	O
,	,	O
glucose	RB	B-TEST
144	CD	O
,	,	O
AST	NNP	B-TEST
49	CD	O
,	,	O
ALT33	NNP	B-TEST
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
253	CD	O
,	,	O
total	JJ	B-TEST
bili	NN	I-TEST
1.6	CD	O
,	,	O
calcium	NN	B-TEST
9.2	CD	O
,	,	O
magnesium	NN	B-TEST
2.3	CD	O
,	,	O
albumin	RB	B-TEST
3.4	CD	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
bilirubin	NN	I-PROBLEM
on	IN	O
admission	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
output	NN	I-PROBLEM
of	IN	O
biliary	JJ	B-TREATMENT
drain	NN	I-TREATMENT
.	.	O

The	DT	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
replaced	VBN	O
over	IN	O
the	DT	O
wire	NN	O
,	,	O
8-10	JJ	O
by	IN	O
IR	NNP	O
,	,	O
when	WRB	O
it	PRP	O
was	VBD	O
accidentally	RB	O
removed	VBN	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
signs	NNS	B-PROBLEM
and	CC	O
symptoms	NNS	B-PROBLEM
develop	VB	O
of	IN	O
SBP	NNP	B-PROBLEM
,	,	O
also	RB	O
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
white	JJ	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
broadly	RB	O
with	IN	O
amp	NN	B-TREATMENT
,	,	O
levo	NN	B-TREATMENT
and	CC	O
Flagyl	NNP	B-TREATMENT
.	.	O

Cultures	NNS	B-TEST
were	VBD	O
negative	JJ	O
and	CC	O
onlyon	JJ	O
one	CD	B-TEST
gram	NN	I-TEST
stain	NN	I-TEST
did	VBD	O
it	PRP	O
show	VB	O
rare	JJ	B-PROBLEM
gram	NN	I-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
abdominal	JJ	I-TEST
fluid	NN	I-TEST
cell	NN	I-TEST
counts	VBZ	I-TEST
showed	JJ	O
2400	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
500	CD	O
red	JJ	B-TEST
cells	NNS	I-TEST
with	IN	O
82	CD	O
polyps	NNS	B-TEST
,	,	O
11	CD	O
lymphs	NN	B-TEST
,	,	O
7	CD	O
monos	NNS	B-TEST
.	.	O

Clinically	RB	O
,	,	O
this	DT	O
was	VBD	O
consistent	JJ	O
with	IN	O
SBP	NNP	B-PROBLEM
,	,	O
although	IN	O
unfortunately	RB	O
,	,	O
fluid	NN	O
was	VBD	O
never	RB	O
sent	VBN	O
for	IN	O
cytology	NN	B-TEST
and	CC	O
a	DT	O
lot	NN	O
of	IN	O
those	DT	B-PROBLEM
white	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

He	PRP	B-TREATMENT
underwent	VBD	I-TREATMENT
abdominal	JJ	I-TREATMENT
paracentesis	NN	I-TREATMENT
approximately	RB	O
two	CD	O
times	NNS	O
a	DT	O
week	NN	O
for	IN	O
therapeutic	JJ	O
.	.	O

This	DT	O
had	VBD	O
to	TO	O
be	VB	O
performed	VBN	O
by	IN	O
IR	NNP	O
because	IN	O
the	DT	B-PROBLEM
pocket	NN	I-PROBLEM
was	VBD	O
too	RB	O
deep	JJ	O
to	TO	O
access	NN	O
from	IN	O
the	DT	O
bedside	NN	O
.	.	O

He	PRP	O
received	VBD	O
a	DT	O
two	CD	O
week	NN	O
course	NN	O
of	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
Levofloxacin	NNP	B-TREATMENT
IV	NNP	I-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
SBP	NNP	B-PROBLEM
.	.	O

From	IN	O
a	DT	O
pulmonary	JJ	O
standpoint	NN	O
,	,	O
he	PRP	O
continued	VBD	O
to	TO	O
complain	VB	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

His	PRP$	B-PROBLEM
apical	JJ	I-PROBLEM
pneumothorax	NN	I-PROBLEM
from	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
had	VBD	O
resolved	VBN	O
.	.	O

Chest	NNP	B-TEST
xray	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
pleurodesis	NN	B-PROBLEM
.	.	O

However	RB	O
,	,	O
with	IN	O
persistent	JJ	B-PROBLEM
abdomen	NNS	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
there	EX	O
is	VBZ	O
likely	JJ	O
restrictive	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
and	CC	O
,	,	O
in	IN	O
addition	NN	O
,	,	O
after	IN	O
each	DT	O
tap	NN	B-TEST
,	,	O
he	PRP	O
at	IN	O
times	NNS	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
with	IN	O
some	DT	B-TREATMENT
mild	JJ	I-TREATMENT
fluid	JJ	I-TREATMENT
resuscitation	NN	I-TREATMENT
decompensated	VBN	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
requiring	VBG	O
both	DT	O
albumin	NN	B-TREATMENT
and	CC	O
Lasix	NNP	B-TREATMENT
to	TO	O
try	VB	O
to	TO	O
mobilize	VB	O
third	JJ	B-PROBLEM
space	NN	I-PROBLEM
fluids	NNS	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
xray	NN	I-TEST
is	VBZ	O
still	RB	O
consistent	JJ	O
with	IN	O
volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

The	DT	O
plan	NN	O
will	MD	O
be	VB	O
to	TO	O
continue	VB	O
to	TO	O
try	VB	O
to	TO	O
alternate	VB	O
albumin	NN	B-TREATMENT
and	CC	O
Lasix	NNP	B-TREATMENT
to	TO	O
mobilize	VB	O
his	PRP$	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
without	IN	O
subsequent	JJ	B-PROBLEM
fall	NN	I-PROBLEM
in	IN	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
at	IN	O
the	DT	O
beginning	NN	O
of	IN	O
his	PRP$	O
admission	NN	O
.	.	O

He	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

Echocardiogram	NNP	B-TEST
showed	VBD	O
50%	CD	O
ejection	NN	O
fraction	NN	O
with	IN	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

He	PRP	O
did	VBD	O
not	RB	O
show	VB	O
any	DT	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
his	PRP$	B-TREATMENT
hospital	NN	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

Diabetes	NNS	B-PROBLEM
.	.	O

His	PRP$	B-TREATMENT
Avandia	NNP	I-TREATMENT
was	VBD	O
discontinued	VBN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
side	NN	I-PROBLEM
effect	NN	I-PROBLEM
profile	NN	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
glipizide	NN	B-TREATMENT
and	CC	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
.	.	O

From	IN	O
a	DT	O
heme	NN	O
standpoint	NN	O
,	,	O
he	PRP	O
presented	VBD	O
anemic	JJ	B-PROBLEM
and	CC	O
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
PT	NNP	I-PROBLEM
INR	NNP	I-PROBLEM
.	.	O

He	PRP	O
required	VBD	O
a	DT	B-TREATMENT
few	JJ	I-TREATMENT
transfusions	NNS	I-TREATMENT
during	IN	O
his	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

He	PRP	O
also	RB	O
required	VBD	O
FFP	NNP	B-TREATMENT
initially	RB	O
to	TO	O
reverse	VB	O
his	PRP$	B-PROBLEM
coagulopathy	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
this	DT	O
resolved	VBN	O
on	IN	O
its	PRP$	O
own	JJ	O
over	IN	O
the	DT	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

His	PRP$	B-TEST
INR	NNP	I-TEST
normalized	NN	O
,	,	O
however	RB	O
,	,	O
unfortunately	RB	O
,	,	O
he	PRP	O
developed	VBD	O
bilateral	JJ	B-PROBLEM
deep	RB	I-PROBLEM
venous	JJ	I-PROBLEM
thromboses	NNS	I-PROBLEM
during	IN	O
his	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
Lovenox	NNP	B-TREATMENT
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
4.0	CD	O
on	IN	O
admission	NN	O
and	CC	O
this	DT	O
decreased	VBD	O
down	RB	O
to	TO	O
the	DT	O
mid	JJ	O
ones	NNS	O
with	IN	O
fluid	NN	B-TREATMENT
,	,	O
currently	RB	O
at	IN	O
1.7	CD	O
on	IN	O
discharge	NN	O
.	.	O

From	IN	O
his	PRP$	B-TEST
urinalysis	NN	I-TEST
,	,	O
he	PRP	O
has	VBZ	O
mostly	RB	O
a	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

However	RB	O
,	,	O
he	PRP	O
does	VBZ	O
require	VB	O
diuresis	NN	B-TREATMENT
to	TO	O
prevent	VB	O
increased	JJ	B-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
in	IN	O
his	PRP$	O
lungs	NNS	O
from	IN	O
his	PRP$	B-PROBLEM
hypoalbunemic	JJ	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

His	PRP$	O
appetite	NN	O
is	VBZ	O
decreasing	VBG	O
somewhat	RB	O
as	IN	O
his	PRP$	B-PROBLEM
disease	NN	I-PROBLEM
process	NN	I-PROBLEM
progresses	VBZ	O
,	,	O
therefore	RB	O
,	,	O
we	PRP	O
have	VBP	O
liberalized	VBN	O
his	PRP$	O
diet	NN	O
for	IN	O
him	PRP	O
to	TO	O
take	VB	O
what	WP	O
he	PRP	O
wishes	VBZ	O
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
for	IN	O
clinical	JJ	B-PROBLEM
SBP	NNP	I-PROBLEM
.	.	O

He	PRP	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
Levofloxacin	NNP	B-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
SBP	NNP	B-PROBLEM
.	.	O

Given	VBN	O
that	IN	O
he	PRP	O
will	MD	O
need	VB	O
continued	JJ	B-TEST
taps,	NN	I-TEST

The	DT	O
patient	NN	O
initially	RB	O
came	VBD	O
for	IN	O
workup	NN	B-TEST
of	IN	O
pancreatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
a	DT	O
questions	NNS	O
of	IN	O
palliative	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

However	RB	O
,	,	O
given	VBN	O
his	PRP$	B-PROBLEM
rapid	JJ	I-PROBLEM
clinical	JJ	I-PROBLEM
decline	NN	I-PROBLEM
,	,	O
this	DT	O
was	VBD	O
deferred	VBN	O
and	CC	O
I	PRP	O
do	VBP	O
not	RB	O
suspect	VB	O
that	IN	O
he	PRP	O
will	MD	O
be	VB	O
a	DT	O
candidate	NN	O
for	IN	O
this	DT	O
,	,	O
as	IN	O
the	DT	O
degree	NN	O
of	IN	O
his	PRP$	B-PROBLEM
decline	NN	I-PROBLEM
bodes	VBZ	O
a	DT	O
poor	JJ	O
prognosis	NN	O
for	IN	O
him	PRP	O
.	.	O

His	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
here	RB	O
has	VBZ	O
been	VBN	O
controlled	VBN	O
,	,	O
initially	RB	O
on	IN	O
Oxycontin	NNP	B-TREATMENT
with	IN	O
morphine	NN	B-TREATMENT
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

As	IN	O
he	PRP	O
becomes	VBZ	O
progressively	RB	B-PROBLEM
more	RBR	I-PROBLEM
somnolent	JJ	I-PROBLEM
,	,	O
this	DT	O
will	MD	O
likely	RB	O
need	VB	O
to	TO	O
be	VB	O
switched	VBN	O
to	TO	O
IV	NNP	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
only	RB	O
.	.	O

Discussion	NN	O
,	,	O
at	IN	O
that	DT	O
point	NN	O
in	IN	O
time	NN	O
,	,	O
should	MD	O
occur	VB	O
with	IN	O
the	DT	O
family	NN	O
about	IN	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
and	CC	O
about	IN	O
weaning	VBG	O
him	PRP	O
from	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
to	TO	O
make	VB	O
him	PRP	O
more	RBR	O
comfortable	JJ	O
.	.	O

Tylenol	NNP	B-TREATMENT
,	,	O
650	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
4	CD	O
prn	NN	O
;	:	O
Allopurinol	NNP	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
Peridex	NNP	B-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
10	CD	O
ml	NN	O
b.i.d.;	NN	O
cholysteramineresin	NN	B-TREATMENT
,	,	O
4	CD	O
grams	NNS	O
p.o.	JJ	O
q.d.	NN	O
;	:	O
clotrimazole	NN	B-TREATMENT
,	,	O
one	CD	O
troche	NN	O
p.o.	NN	O
q.i.d.	NN	O
;	:	O
Fentanyl	NNP	B-TREATMENT
patch	NN	I-TREATMENT
,	,	O
100	CD	O
mcg	NN	O
per	IN	O
hour	NN	O
topical	JJ	O
q	NN	O
72	CD	O
hours	NNS	O
;	:	O
glipizide	VB	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
Atarax	NNP	B-TREATMENT
,	,	O
25	CD	O
operating	NN	O
table	NN	O
50	CD	O
mg	NN	O
p.o.	NN	O
q	$	O
6	CD	O
to	TO	O
8	CD	O
hours	NNS	O
prn	JJ	O
itching	NN	B-PROBLEM
;	:	O
regular	JJ	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
;	:	O
KBL	NNP	B-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
15	CD	O
ccp	NN	O
.o.	NNP	O
q.d.	NN	O
prn	NN	O
mouth	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
;	:	O
Lactulose	NNP	B-TREATMENT
,	,	O
30	CD	O
ml	NN	O
p.o.	NN	O
q.i.d.	NN	O
that	WDT	O
was	VBD	O
started	VBN	O
on	IN	O
January	NNP	O
30	CD	O
,	,	O
for	IN	O
no	DT	O
bowel	NN	B-PROBLEM
movements	NNS	I-PROBLEM
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
until	IN	O
bowel	JJ	O
movement	NN	O
and	CC	O
then	RB	O
decrease	VB	O
to	TO	O
b.i.d.	VB	O
or	CC	O
q.d.	VB	O
;	:	O
Lidocaine	NNP	B-TREATMENT
,	,	O
2%	CD	O
,	,	O
10	CD	O
ml	NN	O
UR	NNP	O
q	VBZ	O
3	CD	O
to	TO	O
4	CD	O
hours	NNS	O
prn	NN	O
for	IN	O
pain	NN	B-PROBLEM
around	IN	I-PROBLEM
Foley	NNP	I-PROBLEM
site	NN	I-PROBLEM
;	:	O
Ativan	NNP	B-TREATMENT
,	,	O
0.25	CD	O
to	TO	O
0.5	CD	O
mg	NNS	O
IV	NNP	O
q	VBD	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	JJ	O
anxiety	NN	B-PROBLEM
with	IN	O
instructions	NNS	O
to	TO	O
use	VB	O
caution	NN	O
.	.	O

The	DT	O
patient	JJ	O
gets	VBZ	O
very	RB	B-PROBLEM
somnolent	JJ	I-PROBLEM
with	IN	O
Ativan	NNP	B-TREATMENT
.	.	O

Maalox	NNP	B-TREATMENT
Plus	NNP	I-TREATMENT
,	,	I-TREATMENT
Extra	NNP	I-TREATMENT
Strength	NNP	I-TREATMENT
,	,	O
15	CD	O
cc	NN	O
p.o.	NN	O
q	VBD	O
6	CD	O
hours	NNS	O
prn	JJ	O
indigestion	NN	B-PROBLEM
;	:	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
;	:	O
sliding	VBG	O
scale	NN	O
IV	NNP	O
and	CC	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
,	,	O
sliding	VBG	O
scale	JJ	O
IV	NNP	O
.	.	O

He	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
Reglan	NNP	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q	NN	O
h	NN	O
;	:	O
Miracle	NNP	B-TREATMENT
topical	JJ	I-TREATMENT
cream	NN	I-TREATMENT
to	TO	O
affected	JJ	B-PROBLEM
area	NN	I-PROBLEM
;	:	O
also	RB	O
Sarna	NNP	B-TREATMENT
,	,	I-TREATMENT
topical	JJ	I-TREATMENT
cream	NN	I-TREATMENT
,	,	O
b.i.d.	NN	O

He	PRP	O
has	VBZ	O
Nystatin	VBN	B-TREATMENT
suspension	NN	I-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
10	CD	O
cc	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
q.i.d.	NN	O
He	PRP	O
gets	VBZ	O
Serax	NNP	B-TREATMENT
,	,	O
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
h.s.	NN	O
prni	NN	O
nsomnia	NN	B-PROBLEM
.	.	O

Ocean	NNP	B-TREATMENT
Spray	NNP	I-TREATMENT
q.i.d.	NN	O
to	TO	O
nares	NNS	O
prn	VB	O
nasal	JJ	B-PROBLEM
dryness	NN	I-PROBLEM
.	.	O

Multivitamin	NNP	B-TREATMENT
,	,	O
one	CD	O
tab	NN	O
q.d.	NN	O
Morphine	NNP	B-TREATMENT
immediate	NN	I-TREATMENT
release	NN	I-TREATMENT
,	,	O
MSIR	NNP	B-TREATMENT
,	,	O
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q	RB	O
2	CD	O
to	TO	O
3	CD	O
hours	NNS	O
prn	JJ	O
pain	NN	B-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
a	DT	B-TREATMENT
Fentanyl	NNP	I-TREATMENT
patch	NN	I-TREATMENT
,	,	O
100	CD	O
mcg	NN	O
q	NN	O
72	CD	O
hours	NNS	O
.	.	O

The	DT	B-TREATMENT
morphine	NN	I-TREATMENT
is	VBZ	O
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Hydrocortisone	NNP	B-TREATMENT
,	,	O
1%	CD	O
topical	JJ	O
cream	NN	O
q	RB	O
6	CD	O
to	TO	O
8	CD	O
hours	NNS	O
prn	JJ	O
itching	NN	B-PROBLEM
.	.	O

Levofloxacin	NNP	B-TREATMENT
,	,	O
250	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
Albuterol	NNP	B-TREATMENT
and	CC	I-TREATMENT
Atrovent	NNP	I-TREATMENT
nebs	RB	I-TREATMENT
q	VBD	O
4	CD	O
to6	NN	O
hours	NNS	O
as	IN	O
needed	VBN	O
prn	NN	O
wheeze	NN	B-PROBLEM
.	.	O

gastritis	NN	B-PROBLEM

AMOXICILLIN	$	B-TREATMENT
1,000	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
X	NNP	O
28	CD	O
doses	NNS	O

for	IN	O
H.Pylori	NNP	B-PROBLEM
.	.	O

CLARITHROMYCIN	NNP	B-TREATMENT
500	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
X	NNP	O
28	CD	O
doses	NNS	O

h.pylori	NN	B-TREATMENT
tx	NN	I-TREATMENT
.	.	O

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
CLARITHROMYCIN	NNP	B-TREATMENT

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
CLARITHROMYCIN	NNP	B-TREATMENT

HYDROCHLOROTHIAZIDE	$	B-TREATMENT
25	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
ZOCOR	NNP	B-TREATMENT
(	(	I-TREATMENT
SIMVASTATIN	NNP	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
MG	NNP	O
PO	NNP	O
QHS	NNP	O

Override	NNP	O
added	VBD	O
on	IN	O
01/23/05	CD	O
by	IN	O
DAINSAYLESNOORT	NNP	O
,	,	O
AGER	NNP	O
,	,	O
M.D.	NNP	O
,	,	O
PH.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
CLARITHROMYCIN	NNP	B-TREATMENT
PO	NNP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
99052380	CD	O
)	)	O

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
CLARITHROMYCIN	NNP	B-TREATMENT

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
CLARITHROMYCIN	NNP	B-TREATMENT

POTASSIUM	NNP	B-TREATMENT
CHLORIDE	NNP	I-TREATMENT
SLOW	NNP	I-TREATMENT
REL.	NNP	I-TREATMENT
(	(	I-TREATMENT
KCL	NNP	I-TREATMENT
SLOW	NNP	I-TREATMENT
RELEASE	NNP	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
MEQ	NNP	O
PO	NNP	O
QD	NNP	O
As	IN	O
per	IN	O
SC	NNP	O

each	DT	O
20	CD	O
mEq	NNS	O
dose	VB	O
to	TO	O
be	VB	O
given	VBN	O
with	IN	O
4	CD	O
oz	NNS	O
of	IN	O
fluid	NN	O
COZAAR	NNP	B-TREATMENT
(	(	I-TREATMENT
LOSARTAN	NNP	I-TREATMENT
)	)	I-TREATMENT
50	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O

LAMICTAL	NNP	B-TREATMENT
(	(	I-TREATMENT
LAMOTRIGINE	NNP	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O

WELLBUTRIN	NNP	B-TREATMENT
SR	NNP	I-TREATMENT
(	(	I-TREATMENT
BUPROPION	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
SUSTAINED	NNP	I-TREATMENT
RELEASE	NNP	I-TREATMENT
)	)	I-TREATMENT
200	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O

ESOMEPRAZOLE	RB	B-TREATMENT
20	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
X	NNP	O
28	CD	O
doses	NNS	O

H.	NNP	B-TREATMENT
Pylori	NNP	I-TREATMENT
tx	NN	I-TREATMENT
.	.	O

PERCOCET	NNP	B-TREATMENT
,	,	O
IV	NNP	B-TREATMENT
Contrast	NNP	I-TREATMENT
,	,	O
LISINOPRIL	NNP	B-TREATMENT
,	,	O
ATENOLOL	NNP	B-TREATMENT

Gastritis	NN	B-PROBLEM

PRINCIPAL	NNP	O
DISCHARGE	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Responsible	NNP	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
gastritis	NN	B-PROBLEM

OTHER	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Conditions	NNP	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
Obesity	NNP	B-PROBLEM
HTN	NNP	B-PROBLEM
High	NNP	B-PROBLEM
Cholesterol	NNP	I-PROBLEM
Tobacco	NNP	O
Fhx	NNP	O
of	IN	O
CAD	NNP	B-PROBLEM
ETT	NNP	B-TREATMENT
12/94	CD	O
(	(	O
-	:	O
)	)	O
ischemia	NN	B-PROBLEM
ECHO	NNP	B-TEST
02/89	CD	O
nl	NN	B-TEST
ETT	NNP	I-TEST
03/89	CD	O
,	,	O
07/90	CD	O
c	NN	O
/	NNP	O
w	NN	O
ND	NNP	B-PROBLEM
ische	NN	I-PROBLEM

Takes	NNP	O
hubby	NN	O
&apos;s	NNP	O
sl	NN	B-TREATMENT
ntg	NN	I-TREATMENT
Barium	NNP	B-TEST
Swallow	NNP	I-TEST
04/89	CD	O
(	(	O
-	:	O
)	)	O
UGI	IN	B-TEST
06/91	CD	O
(	(	O
-	:	O
)	)	O

MRI	NNP	B-TEST
HIDA	NNP	B-TEST
CT	NNP	B-TEST

The	DT	O
pt	NN	O
is	VBZ	O
a	DT	O
55yo	JJ	O
F	NNP	O
s	NN	O
/	NNP	O
p	NN	O
Roux	NNP	B-TREATMENT
en	VBZ	I-TREATMENT
Y	NNP	I-TREATMENT
GBP	NNP	I-TREATMENT
in	IN	O
12/20	CD	O
presenting	NN	O
to	TO	O
the	DT	O
ED	NNP	O
this	DT	O
AM	NNP	O
c	VBZ	O
/	JJ	O
o	JJ	O
mod	NN	B-PROBLEM
severe	JJ	I-PROBLEM
midepigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

She	PRP	O
notes	VBZ	O
that	IN	O
she	PRP	O
has	VBZ	O
had	VBD	O
this	DT	B-PROBLEM
pain	NN	I-PROBLEM
since	IN	O
Thursday	NNP	O
,	,	O
and	CC	O
that	IN	O
it	PRP	O
becomes	VBZ	O
much	JJ	O
worse	JJR	O
within	IN	O
15	CD	O
min	NN	O
of	IN	O
consuming	VBG	O
a	DT	O
meal	NN	O
.	.	O

She	PRP	O
has	VBZ	O
also	RB	O
had	VBN	O
intermittent	JJ	B-PROBLEM
post-prandial	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
/	NNP	I-PROBLEM
satiety	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
had	VBD	O
been	VBN	O
scheduled	VBN	O
for	IN	O
an	DT	B-TEST
outpt	JJ	I-TEST
EGD	NNP	I-TEST
with	IN	O
GI	NNP	B-TEST
on	IN	O
2/8	CD	O
.	.	O

She	PRP	O
describes	VBZ	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
band-like	JJ	O
/	NN	O
radiating	NN	O
to	TO	O
both	DT	O
sides	NNS	O
but	CC	O
not	RB	O
the	DT	O
back	NN	O
.	.	O

Her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
currently	RB	O
is	VBZ	O
5/10	CD	O
.	.	O

ROS	NNP	O
(	(	O
-	:	O
)	)	O
emesis	NN	B-PROBLEM
/	JJ	O
BRBPR/melena	NNP	B-PROBLEM
/	NNP	O
fever/chills	VBZ	B-PROBLEM
/	JJ	O
sob	NN	B-PROBLEM
.	.	O

Pt	NNP	O
was	VBD	O
seen	VBN	O
by	IN	O
GI	NNP	O
on	IN	O
13	CD	O
EGD	NNP	B-TEST
was	VBD	O
performed	VBN	O
HD2	NNP	O
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
gastritis	NN	B-PROBLEM
,	,	O
stricture	NN	B-PROBLEM
or	CC	O
ulcer	NN	B-PROBLEM
.	.	O

Pt	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
H.	NNP	B-PROBLEM
Pylori	NNP	I-PROBLEM
positive	JJ	I-PROBLEM
and	CC	O
therefore	NN	O
was	VBD	O
started	VBN	O
on	IN	O
empiric	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

Afferent	NNP	O
limb	NN	O
of	IN	O
the	DT	O
roux	NN	B-TREATMENT
en	FW	I-TREATMENT
y	FW	I-TREATMENT
anastamosis	NN	I-TREATMENT
was	VBD	O
visualized	VBN	O
however	RB	O
the	DT	O
efferent	NN	O
limb	NN	O
could	MD	O
not	RB	O
be	VB	O
explored	VBN	O
.	.	O

Pt	NNP	O
had	VBD	O
HIDA	NNP	B-TEST
scan	JJ	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
obstruction	NN	B-PROBLEM
,	,	O
and	CC	O
CT	NNP	B-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

Pt	NNP	O
was	VBD	O
tolerating	VBG	O
regular	JJ	O
diet	JJ	O
by	IN	O
HD4	NNP	O
,	,	O
and	CC	O
GI	NNP	O
felt	VBD	O
that	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
could	MD	O
be	VB	O
continued	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

Plans	NNS	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
outpatient	JJ	B-TEST
MRA	NNP	I-TEST
to	TO	O
rule	VB	O
out	RP	O
ischemic	JJ	O
causes	NNS	O
of	IN	O
post	NN	B-PROBLEM
prandial	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
HIDA	NNP	B-TEST
with	IN	I-TEST
CK	NNP	I-TEST
challenge	NN	I-TEST
to	TO	O
evaluate	VB	O
for	IN	O
biliary	JJ	B-PROBLEM
dyskinesia	NN	I-PROBLEM
without	IN	O
stasis	NN	O
.	.	O

Pt	NNP	O
will	MD	O
finish	VB	O
course	NN	O
of	IN	O
H.	NNP	B-TREATMENT
pylori	FW	I-TREATMENT
treatment	NN	I-TREATMENT
as	RB	O
well	RB	O
.	.	O

If	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	I-PROBLEM
food	NN	I-PROBLEM
please	NN	O
call	NN	O
Dr.	NNP	O
Gaetzfreierm	NNP	O
&apos;s	NNP	O
office	NN	O
or	CC	O
PCP	NNP	O
.	.	O

If	IN	O
severe	JJ	O
,	,	O
then	RB	O
proceed	VB	O
to	TO	O
ER	NNP	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

Will	MD	O
need	VB	O
to	TO	O
call	VB	O
for	IN	O
outpatient	JJ	O
MRA	NNP	B-TEST
and	CC	O
HIDA	NNP	B-TEST
with	IN	I-TEST
CCK	NNP	I-TEST
challenge	NN	I-TEST
to	TO	O
evaluate	VB	O
biliary	JJ	O
system	NN	O
and	CC	O
mesenteric	JJ	O
vasculature	NN	O
.	.	O

Please	NNP	O
continue	VBP	O
taking	VBG	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
H.	NNP	B-PROBLEM
Pylori	NNP	I-PROBLEM
for	IN	O
full	JJ	O
course	NN	O
(	(	O
26	CD	O
more	JJR	O
days	NNS	O
)	)	O
.	.	O

Non-toxic	JJ	B-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
.	.	O

Left	NNP	B-PROBLEM
thyroid	NN	I-PROBLEM
occult	NN	I-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

Chronic	NNP	B-PROBLEM
lymphocytic	JJ	I-PROBLEM
thyroiditis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	JJ	B-TREATMENT
total	NN	I-TREATMENT
and	CC	I-TREATMENT
left	VBD	I-TREATMENT
subtotal	JJ	I-TREATMENT
oophorectomy	NN	I-TREATMENT
,	,	O
asthma	NN	B-PROBLEM
,	,	O
migraine	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
Droperidol	NNP	B-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

Thyroidectomy	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
51	CD	O
year-old	JJ	O
female	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
non-toxic	JJ	I-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
developed	VBN	O
symptoms	NNS	B-PROBLEM
from	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
dominant	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
with	IN	O
pressure	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
no	DT	O
dyspnea	NN	B-PROBLEM
or	CC	O
dysphagia	NN	B-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
thyroid	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
received	VBN	O
prior	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
exposure	NN	I-TREATMENT
.	.	O

On	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
she	PRP	O
is	VBZ	O
a	DT	O
healthy-appearing	JJ	O
female	NN	O
with	IN	O
a	DT	O
normal	JJ	O
voice	NN	O
and	CC	O
no	DT	O
exophthalmos	NN	B-PROBLEM
.	.	O

Vital	JJ	B-TEST
Signs	NNS	I-TEST
:	:	O

include	VBP	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
174/84	CD	O
,	,	O
respirations	NNS	B-TEST
14	CD	O
,	,	O
pulse	RB	B-TEST
89	CD	O
,	,	O
temperature	NN	B-TEST
98.9	CD	O
,	,	O
O2	NNP	B-TEST
sat	VBD	I-TEST
98%	CD	O
.	.	O

Palpation	NN	B-TEST
of	IN	O
the	DT	O
neck	NN	O
discloses	VBZ	O
a	DT	B-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
,	,	O
larger	JJR	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
,	,	O
with	IN	O
no	DT	O
associated	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

Carotid	NNP	O
pulsations	NNS	O
are	VBP	O
normal	JJ	O
without	IN	O
bruit	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

Bilaterally	RB	O
without	IN	O
stridor	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
heart	NN	I-TEST
rhythm	NN	I-TEST
is	VBZ	O
regular	JJ	O
with	IN	O
a	DT	O
normal	JJ	O
S1-S2	NNP	O
,	,	O
and	CC	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
with	IN	O
no	DT	O
organomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
are	VBP	O
symmetric	JJ	O
.	.	O

On	IN	O
5-29-00	JJ	O
,	,	O
she	PRP	O
underwent	JJ	O
thyroidectomy	NN	B-TREATMENT
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
3.3	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
right	RB	I-PROBLEM
lobe	VBZ	I-PROBLEM
microfollicular	JJ	I-PROBLEM
adenoma	NN	I-PROBLEM
and	CC	O
left	VBD	O
lobe	NN	O
6	CD	O
mm	NN	O
.	.	O

papillary	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
middle	JJ	I-PROBLEM
compartment	NN	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
or	CC	O
spread	NN	O
of	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
outside	IN	O
the	DT	O
thyroid	NN	O
.	.	O

Her	PRP$	B-TREATMENT
sutures	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
one	CD	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
went	VBD	O
home	NN	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
.	.	O

1.	CD	O
Synthroid	JJ	B-TREATMENT
0.125	CD	O
mg.	JJ	O
daily	RB	O
.	.	O

3.	CD	O
She	PRP	O
will	MD	O
remove	VB	O
the	DT	B-TREATMENT
neck	NN	I-TREATMENT
suture	NN	I-TREATMENT
lines	NNS	I-TREATMENT
Steri-Strips	NNP	I-TREATMENT
in	IN	O
10	CD	O
days	NNS	O
.	.	O

Vaginal	JJ	B-TREATMENT
Delivery	NNP	I-TREATMENT
With	IN	O
Second	NNP	B-PROBLEM
Degree	NNP	I-PROBLEM
Laceration	NNP	I-PROBLEM

Abnormal	NNP	B-PROBLEM
Pap	NNP	I-PROBLEM
Test	NNP	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
Bacterial	NNP	B-PROBLEM
Vaginitis	NNP	I-PROBLEM
;	:	O
Contraception	NNP	B-TREATMENT
Management	NNP	I-TREATMENT
;	:	O
Hiv	NNP	O
Counseled	VBD	O

Spontaneous	JJ	B-TREATMENT
Vertex	NNP	I-TREATMENT
Vaginal	NNP	I-TREATMENT
Delivery	NNP	I-TREATMENT

Antimicrobial	JJ	B-TREATMENT
Therapy	NN	I-TREATMENT

Srom	NN	B-PROBLEM
In	IN	O
Labor	NNP	B-PROBLEM

MOUTH	NNP	O
NORMAL	NNP	O
NECK	NNP	O
NORMAL	NNP	O
thyroid	NN	O
wnl	NN	O
BREASTS	NNP	O
NORMAL	NNP	O
no	DT	O
distinct	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
NIPPLES	NNP	O
NORMAL	NNP	O
inverted	VBD	B-PROBLEM
[	NNP	O
b	NN	O
]	NN	O
,	,	O
evert	JJ	B-TREATMENT
w	NN	I-TREATMENT
/	NNP	I-TREATMENT
stimulation	NN	I-TREATMENT
CHEST	NNP	O
NORMAL	NNP	O
LCTA	NNP	O
COR	NNP	O
NORMAL	NNP	O
RRR	NNP	O
ABDOMEN	NNP	O
NORMAL	NNP	O
gravid	JJ	O
EXTREM	NNP	O
NORMAL	NNP	O
SKIN	NNP	O
NORMAL	NNP	O
NODES	NNP	O
NORMAL	NNP	O
VULVA	NNP	O
NORMAL	NNP	O
no	DT	O
lesions	NNS	B-PROBLEM
,	,	O
white	JJ	B-PROBLEM
d	NN	I-PROBLEM
/	NN	I-PROBLEM
c	NN	I-PROBLEM
at	IN	I-PROBLEM
introitus	JJ	I-PROBLEM
VAGINA	NNP	O
NORMAL	NNP	O
sml	VBD	B-PROBLEM
amt	RB	I-PROBLEM
thin	JJ	I-PROBLEM
white	JJ	I-PROBLEM
d	NN	I-PROBLEM
/	NNP	I-PROBLEM
c	VBZ	I-PROBLEM
ph	JJ	B-TEST
4.5	CD	O
,	,	O
koh	FW	B-TEST
+amine	NN	O
,	,	O
NS	NNP	B-TEST
+clue	NNP	O
,	,	O
neg	NN	O
trich	JJ	O
CERVIX	NNP	O
NORMAL	NNP	O
1/100/0	CD	O
srom	NN	B-PROBLEM
clear	JJ	O
OS	NNP	O
NORMAL	NNP	O
closed	VBD	O
ADNEXAE	NNP	O
NORMAL	NNP	O
no	DT	O
palp	NN	B-PROBLEM
masses	VBZ	I-PROBLEM
,	,	O
NT	NNP	O
UTERUS	NNP	O
NORMAL	NNP	O
gravid	JJ	O
UTERINE	NNP	O
SIZE	NNP	O
IN	NNP	O
WEEKS	NNP	O
NORMAL	NNP	O
term	NN	O
RECTUM	NNP	O
NORMAL	NNP	O
no	DT	O
ext	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM

srom	NN	B-PROBLEM
in	IN	O
labor	NN	B-PROBLEM
.	.	O

She	PRP	O
delivered	VBD	O
a	DT	O
3680	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
10/12/2004	CD	O
at	IN	O
10:17	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

srom	NN	B-PROBLEM
.	.	O

Metronidazole	NNP	B-TREATMENT
Tablets	NNP	I-TREATMENT
(	(	I-TREATMENT
Flagyl	NNP	I-TREATMENT
)	)	I-TREATMENT
;	:	O
Multivitamins	NNP	B-TREATMENT
And	CC	I-TREATMENT
Folate	NNP	I-TREATMENT
Capsules	NNP	I-TREATMENT
(	(	I-TREATMENT
Stuart	NNP	I-TREATMENT
Prenatal	NNP	I-TREATMENT
With	IN	I-TREATMENT
Folate	NNP	I-TREATMENT
)	)	I-TREATMENT

TCA	NNP	B-PROBLEM
overdose	NN	I-PROBLEM

Rehabilitation	NN	B-TREATMENT

FOLATE	NNP	B-TREATMENT
(	(	I-TREATMENT
FOLIC	NNP	I-TREATMENT
ACID	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
ZANTAC	NNP	B-TREATMENT
(	(	I-TREATMENT
RANITIDINE	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
MVI	NNP	B-TREATMENT
THERAPEUTIC	NNP	I-TREATMENT
W	NNP	I-TREATMENT
/	NNP	I-TREATMENT
MINERALS	NNP	I-TREATMENT
(	(	I-TREATMENT
THERAP	NNP	I-TREATMENT
VITS	NNP	I-TREATMENT
/	NNP	I-TREATMENT
MINERALS	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
TAB	NNP	O
PO	NNP	O
QD	NNP	O
THIAMINE	NNP	B-TREATMENT
HCL	NNP	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O

Dr.	NNP	O
Ee	NNP	O
,	,	O
patient	NN	O
to	TO	O
arrange	VB	O
,	,	O
No	DT	O
Known	NNP	B-PROBLEM
Allergies	NNS	I-PROBLEM

TCA	NNP	B-PROBLEM
overdose	NN	I-PROBLEM

PRINCIPAL	NNP	O
DISCHARGE	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Responsible	NNP	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
TCA	NNP	B-PROBLEM
overdose	VBP	I-PROBLEM

OTHER	NNP	O
DIAGNOSIS	NNP	O
;	:	O
Conditions	NNP	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
depression	NN	B-PROBLEM
(	(	I-PROBLEM
depression	NN	I-PROBLEM
)	)	I-PROBLEM

32	CD	O
y	JJ	O
/	NNP	O
o	MD	O
woman	NN	O
with	IN	O
h	JJ	O
/	JJ	O
o	NN	O
anxiety	NN	B-PROBLEM
and	CC	O
depression	NN	B-PROBLEM
and	CC	O
prior	JJ	B-PROBLEM
suicide	NN	I-PROBLEM
attempt	NN	I-PROBLEM
presents	NNS	O
with	IN	O
TCA	NNP	B-PROBLEM
and	CC	I-PROBLEM
celexa	NN	I-PROBLEM
overdose	RB	I-PROBLEM
,	,	O
tremulous	JJ	B-PROBLEM
/	CD	O
light-headed	JJ	B-PROBLEM
,	,	O
felt	VBD	O
better	RBR	O
post	NN	O
charcoal	NN	B-TREATMENT
.	.	O

No	DT	O
EKG	NNP	O
changes	NNS	O
,	,	O
marijuana	NN	B-TEST
in	IN	I-TEST
urine	NN	I-TEST
,	,	O
HCO3	NNP	B-TEST
22	CD	O
.	.	O

Transferred	VBN	O
to	TO	O
floor	NN	O
on	IN	O
day	NN	O
of	IN	O
admission	NN	O
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
;	:	O
awaiting	VBG	O
psych	NN	B-TEST
eval	NN	I-TEST
.	.	O

Not	RB	O
actively	RB	B-PROBLEM
suicidal	JJ	I-PROBLEM
.	.	O

3/7	CD	O
--	:	O
repeat	NN	B-TEST
HCO3	NNP	I-TEST
24	CD	O
and	CC	O
26	CD	O
without	IN	O
bicarb	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

EKG	NN	B-TEST
without	IN	O
changes	NNS	O
.	.	O

BEST	NNP	B-TEST
team	NN	I-TEST
eval	NN	I-TEST
found	VBD	O
bed	NN	O
at	IN	O
psych	NN	O
rehab	NN	O
facility	NN	O
.	.	O

OF	IN	O
NOTE	NNP	O
,	,	O
Nortriptyline	NNP	B-TEST
level	NN	I-TEST
came	VBD	O
back	RB	O
as	IN	O
43	CD	O
(	(	O
SUBTHERAPEUTIC	NNP	O
--	:	O
NORMAL	NNP	O
50-150	JJ	O
)	)	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
WHEEZES	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
HEAONBOBURG	NNP	O
LINPACK	NNP	O
GRANT	NNP	O
MEDICAL	NNP	O
CENTER	NNP	O
.	.	O

Your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
SAPSCLYSS	NNP	O
,	,	O
LEO	NNP	O
R	NNP	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
PNEUMONIA	NNP	B-PROBLEM
,	,	O
.	.	O

1.	CD	O
RIGHT	NNP	B-TREATMENT
SIDED	NNP	I-TREATMENT
SCIATICA	NNP	I-TREATMENT
PROCEDURE	NNP	I-TREATMENT
:	:	O

Right	JJ	B-TREATMENT
laminectomy	NN	I-TREATMENT
and	CC	O
discectomy	NN	B-TREATMENT
by	IN	O
Dr.	NNP	O
Small	NNP	O
,	,	O
Neurosurgery	NNP	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
42	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
suffered	VBD	O
lower	JJR	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
an	DT	O
accident	NN	O
at	IN	O
work	NN	O
in	IN	O
1990	CD	O
.	.	O

This	DT	O
gradually	RB	O
increased	VBN	O
until	IN	O
June	NNP	O
1992	CD	O
where	WRB	O
he	PRP	O
had	VBD	O
recurrent	NN	B-PROBLEM
severe	RB	I-PROBLEM
right	RB	I-PROBLEM
sided	VBN	I-PROBLEM
sciatica	NN	I-PROBLEM
.	.	O

In	IN	O
September	NNP	O
1992	CD	O
CT	NNP	B-TEST
myelogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
lateral	JJ	I-PROBLEM
L-1	JJ	I-PROBLEM
S-1	NNP	I-PROBLEM
disc	NN	I-PROBLEM
bulge	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
L-4-4	NNP	I-PROBLEM
bulge	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
change	NN	O
in	IN	O
pain	NN	B-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
few	JJ	O
months	NNS	O
.	.	O

His	PRP$	B-TEST
examination	NN	I-TEST
was	VBD	O
completely	RB	O
unremarkable	JJ	O
.	.	O

He	PRP	O
was	VBD	O
admitted	VBN	O
,	,	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
L5-S1	NNP	B-TREATMENT
right	JJ	I-TREATMENT
hemilaminectomy	NN	I-TREATMENT
and	CC	O
discectomy	NN	B-TREATMENT
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
three	CD	O
days	NNS	O
he	PRP	O
increased	VBD	O
his	PRP$	O
activity	NN	O
gradually	RB	O
,	,	O
was	VBD	O
able	JJ	O
to	TO	O
do	VB	O
stairs	NNS	O
with	IN	O
Physical	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
and	CC	O
had	VBD	O
pain	NN	B-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
controlled	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
analgesics	NNS	I-TREATMENT
.	.	O

He	PRP	O
is	VBZ	O
discharged	VBN	O
on	IN	O
Percocet	NNP	B-TREATMENT
,	,	O
Colace	NNP	B-TREATMENT
and	CC	O
Motrin	NNP	B-TREATMENT
.	.	O

Normal	NNP	B-TREATMENT
Vaginal	NNP	I-TREATMENT
Delivery	NNP	I-TREATMENT

Current	JJ	O
Smoker	NNP	O
,	,	O
history	NN	O
of	IN	O
;	:	O
Depression	NNP	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
Isoimmunization	NNP	B-PROBLEM
,	,	I-PROBLEM
Rh	NNP	I-PROBLEM
;	:	O
Undesired	NNP	B-PROBLEM
Fertility	NNP	I-PROBLEM

Spontaneous	JJ	B-TREATMENT
Vertex	NNP	I-TREATMENT
Vaginal	NNP	I-TREATMENT
Delivery	NNP	I-TREATMENT

Pp	NNP	B-TREATMENT
Sterilization	NNP	I-TREATMENT

Early	JJ	B-PROBLEM
Labor	NNP	I-PROBLEM
/	NNP	O
Rule	NNP	O
Out	NNP	O
Labor	NNP	B-PROBLEM

This	DT	O
22	CD	O
year	NN	O
old	JJ	O
Gravida	NNP	O
4	CD	O
Para	NNP	O
2012	CD	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Naliheall	NNP	O
County	NNP	O
Memorial	NNP	O
Hospital	NNP	O
Obstetrical	NNP	O
service	NN	O
on	IN	O
10/29/2003	CD	O
at	IN	O
11:14	CD	O
pm	NN	O
for	IN	O
the	DT	O
indication	NN	O
(	(	O
s	JJ	O
)	)	O
:	:	O
early	JJ	B-PROBLEM
labor	NN	I-PROBLEM
/	NNP	O
rule	NN	O
out	IN	O
labor	NN	B-PROBLEM
.	.	O

She	PRP	O
delivered	VBD	O
a	DT	O
3263	CD	O
gram	NN	O
female	JJ	O
infant	NN	O
on	IN	O
10/30/2003	CD	O
at	IN	O
05:03	CD	O
am	VBP	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
8	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.1	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
,	,	O
x	JJ	O
1-	JJ	O
reduced	VBN	O
prior	JJ	O
to	TO	O
delivery	NN	B-TREATMENT
.	.	O

DISCHARGE	JJ	O
ORDERS	NNP	O
(	(	O
medications	NNS	B-TREATMENT
instructions	NNS	O
to	TO	O
patient	VB	O
,	,	O
follow-up	JJ	O
care	NN	O
)	)	O
:	:	O

Home	NN	O
With	IN	O
Self-Care	NNP	B-TREATMENT
(	(	O
Routine	NNP	O
Discharge	NNP	O
)	)	O

Multivitamins	NNS	B-TREATMENT
And	CC	O
Folate	NNP	B-TREATMENT

Severe	NNP	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

Right	NNP	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Atonic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
with	IN	O
suprapubic	JJ	B-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

Anxiety	NN	B-PROBLEM
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

History	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
status	NN	O
post	NN	O
hemicolectomy	NN	B-TREATMENT
.	.	O

This	DT	O
is	VBZ	O
a	DT	O
76	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
severe	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
has	VBZ	O
had	VBN	O
several	JJ	O
recent	JJ	O
admissions	NNS	O
to	TO	O
Oaksgekesser/	NNP	O
Memorial	NNP	O
Hospital	NNP	O
for	IN	O
respiratory	NN	B-PROBLEM
insuffiencey	NN	I-PROBLEM
most	RBS	O
often	RB	O
secondary	JJ	O
to	TO	O
pneumonia	VB	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
doing	VBG	O
relatively	RB	O
at	IN	O
home	NN	O
until	IN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
complained	VBD	O
discomfort	NN	B-PROBLEM
over	IN	O
a	DT	B-TREATMENT
suprapubic	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
area	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
missed	VBN	O
his	PRP$	O
usual	JJ	O
monthly	JJ	O
change	NN	O
of	IN	O
his	PRP$	B-TREATMENT
suprapubic	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
felt	VBD	O
discomfort	NN	B-PROBLEM
and	CC	O
noticed	VBD	O
some	DT	B-PROBLEM
blood	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
site	NN	I-PROBLEM
of	IN	O
the	DT	O
catheter	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
Emergency	NNP	O
Room	NNP	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
Urology	NNP	O
and	CC	O
had	VBD	O
his	PRP$	B-TREATMENT
catheter	NN	I-TREATMENT
changed	VBD	O
.	.	O

The	DT	O
patient	NN	O
at	IN	O
that	DT	O
time	NN	O
noted	VBD	O
slight	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
was	VBD	O
sent	VBN	O
home	NN	O
anyway	RB	O
.	.	O

On	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
the	DT	O
patient	NN	O
noticed	VBD	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
and	CC	O
to	TO	O
be	VB	O
disoriented	VBN	B-PROBLEM
toward	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
day	NN	O
after	IN	O
complaining	VBG	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
day	NN	O
.	.	O

The	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	O
recent	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
no	DT	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
cough	NN	I-PROBLEM
,	,	O
sputum	NN	B-PROBLEM
.	.	O

He	PRP	O
also	RB	O
denies	VBZ	O
any	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

No	DT	O
orthopnea	NN	B-PROBLEM
.	.	O

No	DT	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
taking	VBG	O
his	PRP$	B-TREATMENT
usual	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
using	VBG	O
his	PRP$	B-TREATMENT
nasal	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
at	IN	I-TREATMENT
home	NN	I-TREATMENT
.	.	O

By	IN	O
the	DT	O
time	NN	O
the	DT	O
patient	NN	O
arrived	VBD	O
at	IN	O
the	DT	O
Oaksgekesser/	NNP	O
Memorial	NNP	O
Hospital	NNP	O
Emergency	NNP	O
Room	NNP	O
he	PRP	O
was	VBD	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
initial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
on	IN	O
40%	CD	B-TREATMENT
02	CD	I-TREATMENT
was	VBD	O
P02	NNP	B-TEST
102	CD	O
,	,	O
PC02	NNP	B-TEST
115	CD	O
,	,	O
PH	NNP	B-TEST
7.11	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
respiratory	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
way	NN	O
of	IN	O
nebulizer	NN	B-TREATMENT
treatments	NNS	I-TREATMENT
in	IN	O
the	DT	O
Oaksgekesser/	NNP	O
Memorial	NNP	O
Hospital	NNP	O
Emergency	NNP	O
Room	NNP	O
because	IN	O
of	IN	O
a	DT	O
longstanding	JJ	O
desire	NN	O
by	IN	O
patient	NN	O
and	CC	O
family	NN	O
to	TO	O
refrain	VB	O
from	IN	O
intubation	NN	B-TREATMENT
to	TO	O
be	VB	O
considered	VBN	O
Do	NNP	O
Not	RB	O
Resuscitate	NNP	O
.	.	O

However	RB	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Medical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
where	WRB	O
he	PRP	O
received	VBD	O
continuous	JJ	B-TREATMENT
respiratory	NN	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
theway	NN	O
of	IN	O
Albuterol	NNP	B-TREATMENT
nebulizers	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
nasal	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
,	,	O
intravenous	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

A	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
in	IN	O
the	DT	O
Oaksgekesser/	NNP	O
Memorial	NNP	O
Hospital	NNP	O
Emergency	NNP	O
Room	NNP	O
showed	VBD	O
new	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
on	IN	O
his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
on	IN	O
top	NN	O
of	IN	O
his	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
severe	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
emphysema_____	NN	I-PROBLEM
with	IN	O
scarring	NN	B-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lungs	NNS	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
new	JJ	B-PROBLEM
air	NN	I-PROBLEM
space	NN	I-PROBLEM
opacifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
apex	NN	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

These	DT	O
were	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
consistent	JJ	O
either	CC	O
with	IN	O
pneumonia	NN	B-PROBLEM
or	CC	O
asymmetric	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Associated	NNP	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
include	VBP	O
:	:	O

1.	CD	O
Atonic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
suprapubic	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

2.	CD	O
Anxiety	NNP	B-PROBLEM
.	.	O

3.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
a	DT	O
history	NN	O
of	IN	O
angina	NN	B-PROBLEM
in	IN	O
the	DT	O
distant	JJ	O
past	NN	O
.	.	O

4.	CD	O
History	NNP	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
colectomy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

1.	CD	O
Ativan	NNP	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
Trusopt	NNP	B-TREATMENT
1	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
Xalatan	$	B-TREATMENT
0.005%	CD	O
one	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
qhs	NN	O
.	.	O

4.	CD	O
Brimonidine	NNP	B-TREATMENT
1	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
Combivent	JJ	B-TREATMENT
3	CD	O
puffs	NNS	O
four	CD	O
times	NNS	O
per	IN	O
day	NN	O
.	.	O

6.	CD	O
Aerobid	NNP	B-TREATMENT
three	CD	O
puffs	NNS	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
Sorbitol	NNP	B-TREATMENT
30	CD	O
cc	NN	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

He	PRP	O
was	VBD	O
an	DT	O
elderly	JJ	O
frail	NN	O
gentleman	NN	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

He	PRP	O
had	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
110/70	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
110	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
and	CC	O
regular	JJ	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
25	CD	O
.	.	O

He	PRP	O
was	VBD	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

His	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
98F	CD	O
.	.	O

He	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
exam	NN	I-TEST
.	.	O

Neck	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

Lung	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
crackles	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rhonchi	NN	B-PROBLEM
.	.	O

Heart	NNP	B-TEST
exam	VBZ	I-TEST
revealed	VBD	O
a	DT	O
soft	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
was	VBD	O
heard	VBN	O
,	,	O
no	DT	O
S3	NNP	B-PROBLEM
.	.	O

Abdomen	NNP	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	FW	B-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
palpable	RB	I-PROBLEM
.	.	O

Rectal	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
with	IN	O
stool	JJ	B-TEST
heme	NN	I-TEST
negative	JJ	O
.	.	O

Neurological	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
an	DT	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	$	O
3	CD	O
elderly	JJ	O
male	NN	O
.	.	O

Deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
symmetrical	JJ	O
in	IN	O
all	DT	O
extremities	NNS	O
.	.	O

Sodium	NN	B-TEST
148	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
glucose	RB	B-TEST
174	CD	O
,	,	O
P02	NNP	B-TEST
102	CD	O
,	,	O
PC02	NNP	B-TEST
115	CD	O
,	,	O
PH	NNP	B-TEST
7.11	CD	O
on	IN	O
40%	CD	B-TREATMENT
02	CD	I-TREATMENT
.	.	O

Blood	NNP	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
11	CD	O
,	,	O
creatinine	NN	B-TEST
.6	NN	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
3.0	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
78	CD	O
,	,	O
creatinine	NN	B-PROBLEM
phosphokinase	NN	I-PROBLEM
isoenzymes	VBZ	I-PROBLEM
too	RB	I-PROBLEM
low	JJ	I-PROBLEM
,	,	O
hematocrit	JJ	B-TEST
41	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.6	CD	O
.	.	O

Urine	NN	B-TEST
analysis	NN	I-TEST
showed	VBD	O
20-50	JJ	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
and	CC	O
3-5	JJ	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

Electrocardiogram	NNP	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
123	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
compared	VBN	O
to	TO	O
previous	JJ	B-TEST
electrocardiogram	NN	I-TEST
of	IN	O
1/29	CD	O
there	EX	O
were	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

During	IN	O
that	DT	O
period	NN	O
of	IN	O
time	NN	O
he	PRP	O
received	VBD	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
with	IN	O
Albuterol	NNP	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
Ticarcillin	NNP	I-TREATMENT
for	IN	O
possible	JJ	O
gram	NN	B-PROBLEM
negative	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
diuresed	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
to	TO	O
which	WDT	O
he	PRP	O
responded	VBD	O
with	IN	O
at	IN	O
lease	NN	O
a	DT	O
2L	CD	O
urine	JJ	B-TEST
output	NN	I-TEST
on	IN	O
the	DT	O
first	JJ	O
day	NN	O
and	CC	O
1.5L	CD	O
the	DT	O
second	JJ	O
day	NN	O
.	.	O

After	IN	O
one	CD	O
day	NN	O
in	IN	O
the	DT	O
Medical	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
enough	RB	O
to	TO	O
go	VB	O
to	TO	O
the	DT	O
floor	NN	O
where	WRB	O
he	PRP	O
continued	VBD	O
the	DT	O
rest	NN	O
of	IN	O
his	PRP$	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

This	DT	O
consisted	VBD	O
of	IN	O
continued	JJ	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
Solu-Medrol	NNP	I-TREATMENT
.	.	O

As	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NN	I-TREATMENT
diuresis	NN	I-TREATMENT
continued	VBD	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
improved	VBN	O
.	.	O

A	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
clearing	NN	O
of	IN	O
the	DT	B-PROBLEM
opacities	NNS	I-PROBLEM
in	IN	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
that	WDT	O
were	VBD	O
consistent	JJ	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
because	IN	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
for	IN	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

The	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
chosen	NN	O
was	VBD	O
Levaquin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
1	CD	O
tab	NN	O
per	IN	O
day	NN	O
.	.	O

The	DT	B-TREATMENT
Ticarcillin	NNP	I-TREATMENT
was	VBD	O
stopped	VBN	O
after	IN	O
two	CD	O
days	NNS	O
when	WRB	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	B-PROBLEM
serious	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
continued	VBD	O
to	TO	O
improve	VB	O
but	CC	O
towards	IN	O
the	DT	O
last	JJ	O
2-3	JJ	O
days	NNS	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
the	DT	O
amount	NN	O
of	IN	O
improvement	NN	O
was	VBD	O
minimal	JJ	O
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
maximally	RB	O
treated	VBN	O
by	IN	O
then	RB	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
major	JJ	O
improvement	NN	O
came	VBD	O
after	IN	O
the	DT	O
first	JJ	O
two	CD	O
days	NNS	O
with	IN	O
brisk	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
with	IN	O
Lasix	NNP	B-TREATMENT
.	.	O

While	IN	O
in	IN	O
the	DT	O
Oaksgekesser/	NNP	O
Memorial	NNP	O
Hospital	NNP	O
the	DT	O
patient	NN	O
on	IN	O
4/4/99	CD	O
complained	NNS	O
of	IN	O
mild	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
because	IN	O
he	PRP	O
was	VBD	O
put	VBN	O
in	IN	O
Cimetidine	NNP	B-TREATMENT
while	IN	O
in	IN	O
the	DT	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
upgraded	VBN	O
to	TO	O
Prilosec	VB	B-TREATMENT
20	CD	O
mg	NNS	O
per	IN	O
day	NN	O
for	IN	O
possible	JJ	O
treatment	NN	O
of	IN	O
gastritis	NN	B-PROBLEM
or	CC	O
gastroesophageal	NN	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
did	VBD	O
have	VB	O
any	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
evidence	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
should	MD	O
be	VB	O
followed	VBN	O
over	IN	O
the	DT	O
next	JJ	O
week	NN	O
or	CC	O
so	RB	O
in	IN	O
case	NN	O
it	PRP	O
does	VBZ	O
not	RB	O
respond	VB	O
to	TO	O
Prilosec	NNP	B-TREATMENT
.	.	O

It	PRP	O
is	VBZ	O
hoped	VBN	O
that	IN	O
when	WRB	O
he	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
a	DT	O
rehab	NN	O
facility	NN	O
that	IN	O
he	PRP	O
will	MD	O
continue	VB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
regain	VB	O
his	PRP$	O
strength	NN	O
and	CC	O
regain	NN	O
independence	NN	O
in	IN	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
.	.	O

They	PRP	O
wanted	VBD	O
the	DT	O
patient	NN	O
to	TO	O
return	VB	O
to	TO	O
his	PRP$	O
home	NN	O
after	IN	O
a	DT	O
stay	NN	O
at	IN	O
a	DT	B-TREATMENT
rehab	NN	I-TREATMENT
facility	NN	I-TREATMENT
.	.	O

I	PRP	O
think	VBP	O
his	PRP$	O
breathing	NN	O
was	VBD	O
as	RB	O
good	JJ	O
as	IN	O
to	TO	O
be	VB	O
expected	VBN	O
with	IN	O
the	DT	O
amount	NN	O
of	IN	O
severe	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
he	PRP	O
had	VBD	O
.	.	O

He	PRP	O
needed	VBD	O
to	TO	O
go	VB	O
to	TO	O
a	DT	B-TREATMENT
rehab	NN	I-TREATMENT
facility	NN	I-TREATMENT
for	IN	O
continued	JJ	B-TREATMENT
respiratory	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
for	IN	O
Physical	NNP	B-TREATMENT
Therapy	NNP	I-TREATMENT
to	TO	O
increase	VB	O
his	PRP$	O
muscle	NN	O
strength	NN	O
.	.	O

1.	CD	O
Albuterol	NNP	B-TREATMENT
2.5	CD	O
mg	NN	O
in	IN	O
2.5	CD	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
q4h	NN	O
.	.	O

2.	CD	O
Heparin	NNP	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneously	RB	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
Ativan	NNP	B-TREATMENT
.5	NNP	O
mg	NNP	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
Nasal	NNP	B-TREATMENT
oxygen	NN	I-TREATMENT
3L	CD	O
per	IN	O
minute	NN	O
.	.	O

5.	CD	O
Levaquin	NNP	B-TREATMENT
500	CD	O
mg	NN	O
per	IN	O
day	NN	O
to	TO	O
be	VB	O
continued	VBN	O
until	IN	O
4/12/99	CD	O
.	.	O

6.	CD	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
per	IN	O
day	NN	O
.	.	O

7.	CD	O
Prednisone	CD	B-TREATMENT
40	CD	O
mg	NNS	O
per	IN	O
day	NN	O
to	TO	O
be	VB	O
tapered	VBN	O
over	IN	O
two	CD	O
weeks	NNS	O
.	.	O

8.	CD	O
Xalatan	NNP	B-TREATMENT
eyedrops	NNS	I-TREATMENT
1	CD	O
gtt	NN	O
in	IN	O
left	JJ	O
eye	NN	O
per	IN	O
day	NN	O
.	.	O

9.	CD	O
Alphagan	NNP	B-TREATMENT
1	CD	O
gtt	NN	O
in	IN	O
left	NN	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
Trusopt	NNP	B-TREATMENT
1gtt	CD	O
in	IN	O
left	NN	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

11.	CD	O
Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
per	IN	O
day	NN	O
.	.	O

CP	NN	B-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

Noncardiac	NNP	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM

Labs	NNP	B-TEST
stable	JJ	O
,	,	O
NTG	NNP	B-TREATMENT
sublingual	JJ	I-TREATMENT
,	,	O
stress	JJ	B-TEST
MIBI	NNP	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

Continue	NNP	O
current	JJ	B-TREATMENT
medication	NN	I-TREATMENT

Return	NN	O
to	TO	O
the	DT	O
ED	NNP	O
for	IN	O
worsening	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
fever	RB	B-PROBLEM
/	NNP	O
chills	NNS	B-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
/	NNP	O
dizziness/numbness	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

Anxiety	NN	B-PROBLEM
NOS	NNP	I-PROBLEM

psychological	JJ	B-TEST
assessment	NN	I-TEST
,	,	O
past	JJ	O
medication	NN	O
responses	NNS	O
discussed	VBN	O
.	.	O

No	DT	O
new	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
for	IN	O
now	RB	O

Continuing	VBG	O
taking	VBG	O
meds	NNS	B-TREATMENT
she	PRP	O
prescribed	VBD	O
.	.	O

COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
with	IN	O
NSTEMI	NNP	B-PROBLEM

Attending	VBG	B-TEST
evaluation	NN	I-TEST

VITAMIN	NNP	B-TREATMENT
C	NNP	I-TREATMENT
(	(	I-TREATMENT
ASCORBIC	NNP	I-TREATMENT
ACID	NNP	I-TREATMENT
)	)	I-TREATMENT
1,000	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
ECASA	NNP	B-TREATMENT
(	(	I-TREATMENT
ASPIRIN	NNP	I-TREATMENT
ENTERIC	NNP	I-TREATMENT
COATED	NNP	I-TREATMENT
)	)	I-TREATMENT
81	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
CALCIUM	NNP	B-TREATMENT
CARBONATE	NNP	I-TREATMENT
(	(	I-TREATMENT
500	CD	I-TREATMENT
MG	NNP	I-TREATMENT
ELEMENTAL	NNP	I-TREATMENT
CA++	NNP	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
PREDNISONE	NNP	B-TREATMENT
20	CD	O
MG	NNP	O
PO	NNP	O
QAM	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
12/09	CD	O
)	)	O

taper	NN	O
over	IN	O
2	CD	O
weeks	NNS	O
MULTIVITAMIN	NNP	B-TREATMENT
THERAPEUTIC	NNP	I-TREATMENT
(	(	I-TREATMENT
THERAPEUTIC	NNP	I-TREATMENT
MULTIVI	NNP	I-TREATMENT
...	:	I-TREATMENT
)	)	I-TREATMENT
5	CD	O
MILLILITERS	NNP	O
PO	NNP	O
QD	NNP	O

Override	NNP	O
added	VBD	O
on	IN	O
12/07/05	CD	O
by	IN	O
BELB	NNP	O
,	,	O
BRITHERL	NNP	O
,	,	O
M.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
ATORVASTATIN	NNP	B-TREATMENT
PO	NNP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
33823759	CD	O
)	)	O

NIACIN	NNP	B-TREATMENT
,	,	O
VIT	NNP	B-TREATMENT
.	.	O

B-3	NNP	B-TREATMENT
and	CC	O
ATORVASTATIN	NNP	B-TREATMENT
CALCIUM	NNP	I-TREATMENT

Override	NNP	O
added	VBD	O
on	IN	O
12/06/05	CD	O
by	IN	O
BELB	NNP	O
,	,	O
BRITHERL	NNP	O
,	,	O
M.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
ZOCOR	NNP	B-TREATMENT
PO	NNP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
33033281	CD	O
)	)	O

NIACIN	NNP	B-TREATMENT
,	,	O
VIT	NNP	B-TREATMENT
.	.	O

B-3	NNP	B-TREATMENT
and	CC	O
SIMVASTATIN	NNP	B-TREATMENT

FLOVENT	NNP	B-TREATMENT
(	(	I-TREATMENT
FLUTICASONE	NNP	I-TREATMENT
PROPIONATE	NNP	I-TREATMENT
)	)	I-TREATMENT
44	CD	O
MCG	NNP	O
INH	NNP	O
BID	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
12/09	CD	O
)	)	O
LEVAQUIN	NNP	B-TREATMENT
(	(	I-TREATMENT
LEVOFLOXACIN	NNP	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O

Administer	NNP	O
iron	NN	B-TREATMENT
products	NNS	I-TREATMENT
a	DT	O
minimum	NN	O
of	IN	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
after	IN	O
a	DT	O
levofloxacin	NN	B-TREATMENT
or	CC	O
ciprofloxacin	NN	B-TREATMENT
dose	VBP	O
dose	NN	O

If	IN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
please	VB	O
cycle	NN	O
(	(	O
hold	VB	O
1	CD	O
hr	NN	O
before	IN	O
to	TO	O
2	CD	O
hr	NNS	O
after	IN	O
)	)	O

SALMETEROL	NNP	B-TREATMENT
XINAFOATE	NNP	I-TREATMENT
and	CC	O
LEVOFLOXACIN	NNP	B-TREATMENT

SEREVENT	NNP	B-TREATMENT
DISKUS	NNP	I-TREATMENT
(	(	I-TREATMENT
SALMETEROL	NNP	I-TREATMENT
DISKUS	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
PUFF	NNP	O
INH	NNP	O
BID	NNP	O

Override	NNP	O
added	VBD	O
on	IN	O
12/06/05	CD	O
by	IN	O
BELB	NNP	O
,	,	O
BRITHERL	NNP	O
,	,	O
M.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
LEVAQUIN	NNP	B-TREATMENT
PO	NNP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
57095042	CD	O
)	)	O

SALMETEROL	NNP	B-TREATMENT
XINAFOATE	NNP	I-TREATMENT
and	CC	O
LEVOFLOXACIN	NNP	B-TREATMENT

LISINOPRIL	NNP	B-TREATMENT
5	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O

POTASSIUM	NNP	B-TREATMENT
CHLORIDE	NNP	I-TREATMENT
and	CC	O
LISINOPRIL	NNP	B-TREATMENT

TOPROL	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
(	(	I-TREATMENT
METOPROLOL	NNP	I-TREATMENT
SUCCINATE	NNP	I-TREATMENT
EXTENDED	NNP	I-TREATMENT
RELEASE	NNP	I-TREATMENT
)	)	I-TREATMENT
25	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
12/09	CD	O
)	)	O

ALENDRONATE	RB	B-TREATMENT
70	CD	O
MG	NNP	O
PO	NNP	O
QWEEK	NNP	O

Take	VB	O
with	IN	O
8	CD	O
oz	NN	O
of	IN	O
plain	JJ	O
water	NN	O
ALBUTEROL	NNP	B-TREATMENT
INHALER	NNP	I-TREATMENT
2	CD	O
PUFF	NNP	O
INH	NNP	O
QID	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
12/09	CD	O
)	)	O
ATROVENT	NNP	B-TREATMENT
INHALER	NNP	I-TREATMENT
(	(	I-TREATMENT
IPRATROPIUM	NNP	I-TREATMENT
INHALER	NNP	I-TREATMENT
)	)	I-TREATMENT
2	CD	O
PUFF	NNP	O
INH	NNP	O
QID	NNP	O
Starting	VBG	O
Today	NNP	O
(	(	O
12/09	CD	O
)	)	O

NKA	NNP	B-PROBLEM
ADMIT	NNP	O
DIAGNOSIS	NNP	O
:	:	O

COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM

Responsible	JJ	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
with	IN	O
NSTEMI	NNP	B-PROBLEM

severe	JJ	B-PROBLEM
COPD	NNP	I-PROBLEM
Pneumonia	NNP	B-PROBLEM
recovering	VBG	O
alcoholic	JJ	O
recovering	VBG	O
barbituate	NN	O
abuse	NN	O
unexplained	VBD	B-PROBLEM
hct	JJ	I-PROBLEM
drop	NN	I-PROBLEM
poor	JJ	B-PROBLEM
appetite	JJ	I-PROBLEM
x	NN	O
1	CD	O
week	NN	O

STEROID	NNP	B-PROBLEM
PSYCHOSIS	NNP	I-PROBLEM
NO	NNP	O
BENZOS	NNP	B-TREATMENT

Heparin	NNP	B-TREATMENT
while	IN	O
having	VBG	O
a	DT	B-PROBLEM
demand	NN	I-PROBLEM
ischemic	JJ	I-PROBLEM
episode	NN	I-PROBLEM

82F	CD	O
with	IN	O
COPD	NNP	B-PROBLEM
exacerpation	NN	I-PROBLEM

COPD	NNP	B-PROBLEM
exacerpation	NN	I-PROBLEM
with	IN	O
troponin	NN	B-PROBLEM
leak	NN	I-PROBLEM
likely	JJ	O
NSTEMI	NNP	B-PROBLEM
secondary	JJ	O
to	TO	O
demand	VB	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

4	CD	O
days	NNS	O
of	IN	O
worsening	VBG	B-PROBLEM
SOB	NNP	I-PROBLEM
with	IN	O
sore	NN	B-PROBLEM
throat	NN	I-PROBLEM
and	CC	O
cough	JJ	B-PROBLEM
productive	NN	I-PROBLEM
of	IN	I-PROBLEM
yellow	JJ	I-PROBLEM
/	NNP	I-PROBLEM
green	JJ	I-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

Fatigue	NNP	B-PROBLEM
secondary	JJ	O
to	TO	O
worsening	VBG	B-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

took	VBD	O
Prednisone	NNP	B-TREATMENT
40	CD	I-TREATMENT
at	IN	O
home	NN	O
and	CC	O
presented	VBN	O
to	TO	O
ED	NNP	O
where	WRB	O
found	VBN	O
to	TO	O
have	VB	O
1mm	CD	B-PROBLEM
lateral	JJ	I-PROBLEM
ST	NNP	I-PROBLEM
depressions	NNS	I-PROBLEM
and	CC	O
slight	JJ	B-PROBLEM
troponin	NN	I-PROBLEM
and	CC	I-PROBLEM
MB	NNP	I-PROBLEM
leak	NN	I-PROBLEM
.	.	O

no	DT	O
N	NNP	B-PROBLEM
/	NNP	O
V/HA	NNP	B-PROBLEM
/	NNP	O
D	NNP	B-PROBLEM
no	DT	O
sweats	NNS	B-PROBLEM
,	,	O
no	DT	O
chills	NNS	B-PROBLEM
,	,	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
pleuricy	NN	B-PROBLEM
,	,	O
no	DT	O
LEE	NNP	B-PROBLEM
,	,	O
no	DT	O
paresthesias	NN	B-PROBLEM
,	,	O
no	DT	O
numbness	NN	B-PROBLEM
,	,	O
no	DT	O
shoulder	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
jaw	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

COPD	NNP	B-PROBLEM
(	(	O
s	JJ	O
/	NN	O
p	NN	O
lung	NN	B-TREATMENT
resection	NN	I-TREATMENT
FEV1	NNP	B-TEST
25%	CD	O
)	)	O
,	,	O
chronic	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
PVD	NNP	B-PROBLEM
,	,	O
R	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
osteoporosis	NN	B-PROBLEM
,	,	O
presbylaryngis	NN	B-PROBLEM

98.4	CD	O
,	,	O
94	CD	O
,	,	O
22	CD	O
,	,	O
120/96	CD	O
,	,	O
98%	CD	O
on	IN	O
2L.	CD	O
NAD	NNP	B-PROBLEM
,	,	O
using	VBG	O
scalenes	NNS	B-TEST
,	,	O
AT	NNP	O
/	NNP	O
NC	NNP	O
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
Bibasilar	NNP	B-PROBLEM
rales	VBZ	I-PROBLEM
otherwise	RB	O
clear	JJ	O
,	,	O
good	JJ	O
air	NN	O
movement	NN	O
,	,	O
RRR	NNP	O
,	,	O
no	DT	O
MRG	NNP	O
,	,	O
NTND	NNP	O
+BS	NNP	O
,	,	O
no	DT	O
CCE	NNP	O
,	,	O
2+	CD	O
DPs	NNP	O
.	.	O

WBC	$	B-TEST
12.91	CD	O

small	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
flat	JJ	O
diaphrams	VBZ	O
no	DT	O
acute	NN	B-PROBLEM
changes	NNS	I-PROBLEM

Echo	NNP	B-TEST
-	:	O

likely	RB	O
having	VBG	O
a	DT	B-PROBLEM
NSTEMI	NNP	I-PROBLEM
secondary	JJ	O
to	TO	O
demand	VB	B-PROBLEM
.	.	O

Cardiac	NNP	B-TEST
enzymes	VBZ	I-TEST
trending	VBG	O
down	RP	O
on	IN	O
12.7.05	CD	O
,	,	O
anticoagulated	VBN	O
while	IN	O
having	VBG	O
leak	NN	B-TEST
.	.	O

I	PRP	O
-	:	O
heparin	NN	B-TREATMENT
for	IN	O
PTT	NNP	B-PROBLEM
50-70	JJ	O
durin	NN	O
enzyme	NN	B-PROBLEM
leak	NN	I-PROBLEM
.	.	O
metoprolol	CC	B-TREATMENT
12	CD	O
QID	NNP	O
.	.	O

Cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
BID	NNP	O
while	IN	O
actively	RB	O
having	VBG	O
leak	NN	B-PROBLEM
,	,	O
ASA	NNP	B-TREATMENT

R	NNP	O
-	:	O
monitor	NN	O
on	IN	O
telemetry	NN	B-TREATMENT

P	NNP	O
-	:	O
no	DT	O
evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
failure	NN	I-PROBLEM

likely	JJ	O
exacerbation	NN	B-PROBLEM
possibly	RB	O
from	IN	O
URI	NNP	B-PROBLEM
/	NNP	O
pneumonia	NN	B-PROBLEM
.	.	O

Aputum	NNP	B-TEST
cultures	VBZ	I-TEST
pending	VBG	O
.	.	O

atrovent	NN	B-TREATMENT
NEB	NNP	I-TREATMENT
QID	NNP	O
,	,	O
albuterol	NN	B-TREATMENT
Neb	NNP	I-TREATMENT
QID	NNP	O
,	,	O
ipratropium	NN	B-TREATMENT
NEB	NNP	I-TREATMENT
BID	NNP	O
,	,	O
flovent	JJ	B-TREATMENT
INH	NNP	I-TREATMENT
BID	NNP	O
,	,	O
Serevent	NNP	B-TREATMENT
INH	NNP	I-TREATMENT
BID	NNP	O
,	,	O
and	CC	O
prednisone	RB	B-TREATMENT
30	CD	O
QD	NNP	O
taper	NN	O
.	.	O

Levaquin	NNP	B-TREATMENT
500	CD	O
QD	NNP	O
empirically	RB	O

PPI	NNP	B-TREATMENT
prophylaxis	NN	I-TREATMENT

MVI	NNP	B-PROBLEM
,	,	O
Cardiac	NNP	O
diet	NN	O

Please	NNP	O
taper	VBD	O
off	RP	O
your	PRP$	O
prednisone	NN	B-TREATMENT
within	IN	O
2	CD	O
weeks	NNS	O

please	VB	O
evaluate	JJ	O
ambutlation	NN	O
ability	NN	O
and	CC	O
O2	NNP	B-TEST
requirement	NN	I-TEST

Please	VB	O
evaluate	JJ	O
resolution	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
troponin	NN	I-PROBLEM
leak	NN	I-PROBLEM
and	CC	O
stable	JJ	O
EKG	NNP	O
.	.	O

Please	VB	O
evaluate	JJ	O
resolution	NN	O
of	IN	O
COPD	NNP	B-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
need	NN	O
for	IN	O
any	DT	B-TREATMENT
further	JJ	I-TREATMENT
antibiocis	NN	I-TREATMENT

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
known	VBN	O
history	NN	O
of	IN	O
pancreatic	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

He	PRP	O
is	VBZ	O
admitted	VBN	O
at	IN	O
this	DT	O
time	NN	O
because	IN	O
of	IN	O
significant	JJ	B-PROBLEM
GI	NNP	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Significant	NN	O
for	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
abdominal	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

Insulin	NNP	B-TREATMENT
,	,	O
Celexa	NNP	B-TREATMENT
,	,	O
Protonix	NNP	B-TREATMENT
,	,	O
Ambien	NNP	B-TREATMENT
and	CC	O
Pancreas	NNP	B-TREATMENT
.	.	O

Vital	JJ	B-TEST
signs	NNS	I-TEST
showed	VBD	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
be	VB	O
slightly	RB	B-PROBLEM
decreased	VBN	I-PROBLEM
at	IN	O
120/60	CD	O
,	,	O
pulse	RB	B-TEST
64	CD	O
,	,	O
respirations	NNS	B-TEST
16	CD	O
,	,	O
temperature	NN	B-TEST
98.8	CD	O
,	,	O
O2	NNP	B-TEST
sat	VBD	I-TEST
95	CD	O
.	.	O

Evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
anemia	NN	I-PROBLEM
with	IN	O
being	VBG	B-PROBLEM
pale	JJ	I-PROBLEM
,	,	O
but	CC	O
anicteric	RB	O
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

Back	RB	O
without	IN	O
CVA	NNP	B-PROBLEM
or	CC	I-PROBLEM
spinal	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Bowel	NNP	O
sounds	VBZ	O
positive	JJ	O
,	,	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
epigastrium	NN	I-PROBLEM
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
mass	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

Trace	NNP	B-PROBLEM
edema	NN	I-PROBLEM
without	IN	O
cyanosis	NN	B-PROBLEM
or	CC	O
clubbing	NN	B-PROBLEM
.	.	O

His	PRP$	B-TEST
hematocrit	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
20.5	CD	O
,	,	O
after	IN	O
having	VBG	O
been	VBN	O
32	CD	O
one	CD	O
week	NN	O
earlier	RBR	O
.	.	O

The	DT	B-TEST
assessment	NN	I-TEST
was	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
GI	NNP	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

Endoscopy	NN	B-TEST
showed	VBD	O
multiple	JJ	B-PROBLEM
angio	NN	I-PROBLEM
ectasias	NN	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

He	PRP	O
received	VBD	O
multiple	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
for	IN	O
this	DT	O
over	IN	O
the	DT	O
succeeding	JJ	O
weeks	NNS	O
.	.	O

His	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
was	VBD	O
maintained	VBN	O
with	IN	O
platelet	NN	B-TREATMENT
transfusion	NN	I-TREATMENT
as	IN	O
necessary	JJ	O
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
Octreotide	NNP	B-TREATMENT
to	TO	O
try	VB	O
to	TO	O
slow	VB	O
down	RP	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

Despite	IN	O
all	PDT	O
these	DT	O
measures	NNS	O
,	,	O
his	PRP$	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
never	RB	O
totally	RB	O
controlled	VBN	O
.	.	O

He	PRP	O
then	RB	O
had	VBD	O
an	DT	B-TREATMENT
angiogram	NN	I-TREATMENT
with	IN	I-TREATMENT
Gel	NNP	I-TREATMENT
foam	NN	I-TREATMENT
to	TO	O
try	VB	O
to	TO	O
control	VB	O
his	PRP$	B-PROBLEM
GI	NNP	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

At	IN	O
that	DT	O
point	NN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
was	VBD	O
no	RB	B-PROBLEM
longer	RB	I-PROBLEM
responsive	VB	I-PROBLEM
.	.	O

The	DT	O
cause	NN	O
of	IN	O
death	NN	B-PROBLEM
was	VBD	O
a	DT	O
combination	NN	O
of	IN	O
GI	NNP	B-PROBLEM
bleeding	VBG	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
ultimately	RB	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
known	VBN	I-PROBLEM
metastatic	JJ	I-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

R	NNP	B-PROBLEM
ELBOW	NNP	I-PROBLEM
INJURY	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
sprains	NNS	B-PROBLEM
,	,	O
fractures	NNS	B-PROBLEM
and	CC	O
bruises	NNS	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

R	NNP	B-PROBLEM
elbow	NN	I-PROBLEM
strain	NN	I-PROBLEM

xray	SYM	B-TEST
-	:	O
no	DT	O
evidence	NN	O
of	IN	O
effusion	NN	B-PROBLEM
or	CC	O
fracture	NN	B-PROBLEM

motrin	JJ	B-TREATMENT
400-600	JJ	O
mg	NN	O
every	DT	O
8	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM

It	PRP	O
is	VBZ	O
recommended	VBN	O
that	IN	O
you	PRP	O
receive	VBP	O
follow-up	JJ	O
care	NN	O
with	IN	O
the	DT	O
Department	NNP	O
of	IN	O
Orthopaedics	NNPS	O
if	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
not	RB	O
improved	VBN	O
in	IN	O
5-7	JJ	O
days	NNS	O
.	.	O

Use	NNP	O
ice	NN	B-TREATMENT
to	TO	O
sore	VB	B-PROBLEM
areas	NNS	I-PROBLEM
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

Do	VB	O
no	DT	O
strenuous	JJ	O
activity	NN	O
until	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
improved	VBN	O
.	.	O

Do	VB	O
gentle	JJ	B-TREATMENT
range	NN	I-TREATMENT
of	IN	I-TREATMENT
motion	NN	I-TREATMENT
exercises	NNS	I-TREATMENT
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

Chest	NNP	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
hypertension	NN	B-PROBLEM
;	:	O
hyperlipidemia	NN	B-PROBLEM
;	:	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
;	:	O
diabetes	VBZ	B-PROBLEM
type	IN	I-PROBLEM
2	CD	I-PROBLEM
.	.	O

Adenosine	NNP	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
.	.	O

Part	NN	B-TEST
1	CD	I-TEST
of	IN	I-TEST
a	DT	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
.	.	O

Coronary	JJ	B-TEST
angiogram	NN	I-TEST
.	.	O

Chest	NNP	B-TEST
CT	NNP	I-TEST
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
55-year-old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
CAD	NNP	B-PROBLEM
status	NN	O
post	NN	O
non	NN	B-PROBLEM
ST	NNP	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
in	IN	O
11/17	CD	O
who	WP	O
presents	VBZ	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
X	VBD	O
48	CD	O
hours	NNS	O
.	.	O

He	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
,	,	O
and	CC	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

In	IN	O
2003	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
non	JJ	I-PROBLEM
ST	NNP	I-PROBLEM
elevation	NN	I-PROBLEM
MI	NNP	I-PROBLEM
,	,	O
came	VBD	O
to	TO	O
the	DT	O
RWH	NNP	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
cath	NN	I-TEST
done	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
40%	CD	I-PROBLEM
RCA	NNP	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
hazy	NN	B-PROBLEM
.	.	O

An	DT	B-TEST
IVUS	NNP	I-TEST
was	VBD	O
done	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
it	PRP	O
was	VBD	O
more	RBR	O
severe	JJ	O
.	.	O

He	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
PTC	NNP	I-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
an	DT	I-TREATMENT
RCA	NNP	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
Vision	NNP	I-TREATMENT
stent	NN	I-TREATMENT
,	,	O
3	CD	O
x	NN	O
18	CD	O
.	.	O

Diagonal	JJ	O
1	CD	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
99%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
other	JJ	B-PROBLEM
noted	VBD	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Since	IN	O
then	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
occasional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
emotional	JJ	B-PROBLEM
stress	NN	I-PROBLEM
,	,	O
when	WRB	O
he	PRP	O
is	VBZ	O
angry	JJ	O
or	CC	O
upset	JJ	O
.	.	O

Yesterday	NN	O
morning	NN	O
,	,	O
he	PRP	O
developed	VBD	O
intermittent	JJ	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
shoulder	NN	I-PROBLEM
that	WDT	O
worsened	VBD	O
with	IN	O
any	DT	O
activity	NN	O
and	CC	O
any	DT	O
motion	NN	O
of	IN	O
his	PRP$	O
shoulders	NNS	O
.	.	O

He	PRP	O
also	RB	O
became	VBD	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
climbing	VBG	O
a	DT	O
flight	NN	O
of	IN	O
stairs	NNS	O
.	.	O

He	PRP	O
denies	VBZ	O
diaphoresis	NN	B-PROBLEM
or	CC	O
nausea	NN	B-PROBLEM
.	.	O

He	PRP	O
went	VBD	O
to	TO	O
the	DT	O
Padrugmoff	NNP	O
Hospital	NNP	O
Emergency	NNP	O
Room	NNP	O
after	IN	O
trying	VBG	O
nitroglycerin	NN	B-TREATMENT
at	IN	O
home	NN	O
.	.	O

However	RB	O
,	,	O
his	PRP$	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
was	VBD	O
old	JJ	O
and	CC	O
the	DT	B-TREATMENT
script	NN	I-TREATMENT
was	VBD	O
expired	VBN	O
.	.	O

In	IN	O
the	DT	O
ER	NNP	O
,	,	O
he	PRP	O
received	VBD	O
3	CD	B-TREATMENT
sublingual	JJ	I-TREATMENT
nitroglycerins	NNS	I-TREATMENT
and	CC	O
1	CD	O
mg	NN	O
of	IN	O
Dilaudid	NNP	B-TREATMENT
.	.	O

After	IN	O
that	DT	O
,	,	O
he	PRP	O
was	VBD	O
pain-free	JJ	B-PROBLEM
.	.	O

Lopressor	NNP	B-TREATMENT
IV	NNP	I-TREATMENT
was	VBD	O
given	VBN	O
to	TO	O
control	VB	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
.	.	O

He	PRP	O
also	RB	O
received	VBD	O
Lipitor	NNP	B-TREATMENT
80	CD	O
mg	NN	O
,	,	O
Plavix	NNP	B-TREATMENT
300	CD	O
,	,	O
heparin	NN	B-TREATMENT
IV	NNP	I-TREATMENT
,	,	O
integrelin	NN	B-TREATMENT
double	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
,	,	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

Apparently	RB	O
once	RB	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
free	JJ	O
,	,	O
his	PRP$	B-TEST
EKG	NNP	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
hyperacute	JJ	B-PROBLEM
T-wave	NNP	I-PROBLEM
anteriorly	RB	I-PROBLEM
without	IN	O
progression	NN	B-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Ro	NNP	O
Woodma	NNP	O
Healthcare	NNP	O
for	IN	O
further	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

Diabetes	NNS	B-PROBLEM
;	:	O
hypertension	NN	B-PROBLEM
;	:	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

Include	NNP	O
Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
nitroglycerin	CC	B-TREATMENT
sublingual	JJ	I-TREATMENT
p.r.n.;	NN	O
Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
Avandia	NNP	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
Lipitor	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
TriCor	NNP	B-TREATMENT
145	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

He	PRP	O
does	VBZ	O
have	VB	O
a	DT	O
lot	NN	O
of	IN	O
anxiety	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
an	DT	B-PROBLEM
MI	NNP	I-PROBLEM
with	IN	O
negative	JJ	O
CK	NNP	O
X4	NNP	O
and	CC	O
negative	JJ	O
troponin	NN	O
X4	NNP	O
.	.	O

He	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
Cardiac	NNP	O
Catheterization	NNP	O
Lab	NNP	O
where	WRB	O
cath	NN	B-TEST
showed	VBD	O
top-normal	JJ	O
LVEDP	NNP	O
at	IN	O
12	CD	O
;	:	O
no	DT	O
AF	NNP	B-PROBLEM
;	:	O
widely	RB	B-PROBLEM
patent	NN	I-PROBLEM
RCA	NNP	I-PROBLEM
stent	NN	I-PROBLEM
;	:	O
mild	JJ	B-PROBLEM
CAD	NNP	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
symptom	NN	I-PROBLEM
;	:	O
widely	RB	B-PROBLEM
patent	VBP	I-PROBLEM
diagonal	JJ	I-PROBLEM
1	CD	I-PROBLEM
at	IN	O
the	DT	O
site	NN	O
of	IN	O
prior	JJ	B-TREATMENT
PTCA	NNP	I-TREATMENT
.	.	O

He	PRP	O
received	VBD	O
an	DT	B-TREATMENT
Angio-Seal	JJ	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
common	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

He	PRP	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
PE	NNP	I-PROBLEM
.	.	O

He	PRP	O
underwent	VBD	O
lower	JJR	B-TEST
extremity	NN	I-TEST
study	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
DVT	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
legs	NNS	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	O
episode	NN	O
of	IN	O
desaturation	NN	B-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
80%	CD	I-PROBLEM
range	NN	I-PROBLEM
while	IN	O
sleeping	VBG	O
.	.	O

Pulmonary	JJ	B-TEST
consult	NN	I-TEST
was	VBD	O
done	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
undergo	VB	O
a	DT	B-TEST
formal	JJ	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
,	,	O
full	JJ	B-TEST
PFTs	NNP	I-TEST
,	,	O
and	CC	O
a	DT	B-TEST
repeat	NN	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
in	IN	O
1	CD	O
year	NN	O
to	TO	O
assess	VB	O
for	IN	O
pulmonary	JJ	B-PROBLEM
nodule	NN	I-PROBLEM
that	WDT	O
was	VBD	O
seen	VBN	O
.	.	O

However	RB	O
,	,	O
please	VB	O
note	NN	O
that	IN	O
this	DT	B-PROBLEM
nodule	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
stable	JJ	O
over	IN	O
time	NN	O
.	.	O

The	DT	O
patient	NN	O
also	RB	O
complained	VBD	O
of	IN	O
intermittent	NN	B-PROBLEM
right	NN	I-PROBLEM
neck	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
,	,	O
and	CC	O
recommendations	NNS	O
are	VBP	O
to	TO	O
consider	VB	O
a	DT	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
with	IN	I-TEST
contrast	NN	I-TEST
to	TO	O
evaluate	VB	O
nodes	NNS	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

On	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
today	NN	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
states	VBZ	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
the	DT	B-PROBLEM
swelling	NN	I-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

The	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
adenosine	JJ	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
,	,	O
where	WRB	O
he	PRP	O
exercised	VBD	O
for	IN	O
4	CD	O
minutes	NNS	O
,	,	O
reaching	VBG	O
65%	CD	O
of	IN	O
predicted	JJ	O
heart	NN	O
rate	NN	O
.	.	O

He	PRP	O
did	VBD	O
not	RB	O
have	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

EKG	NNP	B-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
myocardial	JJ	I-TEST
perfusion	NN	I-TEST
images	NNS	I-TEST
show	VBP	O
no	DT	O
definite	JJ	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
LV	NNP	I-TEST
contractile	NN	I-TEST
function	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
vasal	NN	I-PROBLEM
thinning	NN	I-PROBLEM
.	.	O

He	PRP	O
underwent	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
EF	NNP	I-TEST
of	IN	O
60%	CD	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
MVP	NNP	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
trace	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
LA	NNP	B-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
LV	NNP	B-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
segmental	JJ	B-PROBLEM
wall-motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

The	DT	O
right	JJ	O
ventricle	NN	O
was	VBD	O
not	RB	O
dilated	VBN	B-PROBLEM
.	.	O

The	DT	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

The	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TEST
sleep	NN	I-TEST
study	NN	I-TEST
,	,	O
the	DT	O
first	JJ	O
part	NN	O
,	,	O
which	WDT	O
showed	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
75	CD	B-PROBLEM
respiratory	JJ	I-PROBLEM
events	NNS	I-PROBLEM
observed	VBN	O
with	IN	O
apnea	NN	B-PROBLEM
,	,	O
hypopnea	NN	B-TEST
index	NN	I-TEST
of	IN	O
11	CD	O
an	DT	O
hour	NN	O
.	.	O

The	DT	B-TEST
mean	JJ	I-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
68	CD	O
.	.	O

They	PRP	O
felt	VBD	O
that	IN	O
there	EX	O
was	VBD	O
obstruction	NN	B-PROBLEM
and	CC	O
possible	JJ	O
obstruction	NN	B-PROBLEM
to	TO	I-PROBLEM
airflow	VB	I-PROBLEM
generating	VBG	O
some	DT	B-PROBLEM
obstructive	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
partial	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
events	NNS	I-PROBLEM
.	.	O

They	PRP	O
recommended	VBD	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
benefit	VB	O
from	IN	O
a	DT	O
trial	NN	O
of	IN	O
continuous	JJ	B-TREATMENT
positive	JJ	I-TREATMENT
pressure	NN	I-TREATMENT
at	IN	I-TREATMENT
the	DT	I-TREATMENT
bedside	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
scheduled	VBN	O
to	TO	O
have	VB	O
the	DT	O
second	JJ	O
part	NN	O
of	IN	O
the	DT	B-TEST
sleep	NN	I-TEST
study	NN	I-TEST
done	VBN	O
on	IN	O
June	NNP	O
18	CD	O
,	,	O
2006	CD	O
,	,	O
at	IN	O
8:30	CD	O
p.m.	NN	O
at	IN	O
RWH	NNP	O
in	IN	O
the	DT	O
Esley	NNP	O
Community	NNP	O
Hospital	NNP	O
,	,	O
10th	CD	O
floor	NN	O
sleep	NN	O
lab	NN	O
,	,	O
phone	NN	O
number	NN	O
133-225-1257	JJ	O
.	.	O

Prior	RB	O
to	TO	O
discharge	VB	O
today	NN	O
,	,	O
he	PRP	O
underwent	JJ	O
PFTs	NNP	B-TEST
.	.	O

The	DT	O
results	NNS	O
of	IN	O
the	DT	B-TEST
PFTs	NNP	I-TEST
are	VBP	O
unavailable	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

Based	VBN	O
on	IN	O
all	PDT	B-TEST
the	DT	I-TEST
tests	NNS	I-TEST
above	IN	I-TEST
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
for	IN	O
discharge	NN	O
home	NN	O
.	.	O

His	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
114	CD	O
to	TO	O
123/62	CD	O
.	.	O

Heart	NNP	B-TEST
rate	NN	I-TEST
69	CD	O
to	TO	O
80	CD	O
.	.	O

Room	NNP	B-TEST
air	NN	I-TEST
saturation	NN	I-TEST
96%	CD	O
.	.	O

Temperature	NN	B-TEST
97.9	CD	O
.	.	O

Lung	NNP	B-TEST
sounds	VBZ	I-TEST
clear	JJ	O
bilaterally	RB	O
.	.	O

Regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
;	:	O
S1-S2	NNP	O
;	:	O
positive	JJ	O
S4	NNP	O
;	:	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

Soft	NNP	O
,	,	O
nontender	NN	O
,	,	O
nondistended	VBD	O
;	:	O
no	DT	O
guarding	NN	B-PROBLEM
;	:	O
no	DT	O
masses	NNS	B-PROBLEM
;	:	O
positive	JJ	O
bowel	NN	B-TEST
sounds	VBZ	I-TEST
X4	NNP	O
.	.	O

Right	RB	O
groin	NN	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
catheterization	NN	I-PROBLEM
showed	VBD	O
no	DT	O
hematoma	NN	B-PROBLEM
or	CC	O
bruit	NN	B-PROBLEM
.	.	O

Lower	JJR	B-TEST
extremity	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
intact	JJ	O
without	IN	O
any	DT	O
edema	NN	B-PROBLEM
.	.	O

Sodium	NN	B-TEST
139	CD	O
;	:	O
potassium	NN	B-TEST
4.1	CD	O
;	:	O
BUN	NNP	B-TEST
15	CD	O
;	:	O
creatinine	NN	B-TEST
1.1	CD	O
;	:	O
magnesium	NN	B-TEST
1.6	CD	O
;	:	O
SGPT	NNP	B-TEST
19	CD	O
;	:	O
SGOT	NNP	B-TEST
20	CD	O
;	:	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
66	CD	O
;	:	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.6	CD	O
;	:	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
;	:	O
total	JJ	B-TEST
cholesterol	NN	I-TEST
234	CD	O
;	:	O
triglycerides	NNS	B-TEST
274	CD	O
;	:	O
HDL	NNP	B-TEST
44	CD	O
;	:	O
LDL	NNP	B-TEST
135	CD	O
;	:	O
hemoglobin	NN	B-TEST
A1c	NNP	B-TEST
6.7	CD	O
;	:	O
white	JJ	B-TEST
cell	NN	I-TEST
count	NN	I-TEST
6.1	CD	O
;	:	O
hematocrit	NN	B-TEST
36.4	CD	O
;	:	O
platelet	NN	B-TEST
count	NN	I-TEST
201	CD	O
.	.	O

During	IN	O
the	DT	O
hospital	NN	O
course	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
PPI	NNP	I-TREATMENT
,	,	O
Nexium	NNP	B-TREATMENT
,	,	O
for	IN	O
concerns	NNS	O
of	IN	O
acid	NN	B-PROBLEM
reflux	NN	I-PROBLEM
.	.	O

Also	RB	O
,	,	O
a	DT	O
long	JJ	O
discussion	NN	O
was	VBD	O
taken	VBN	O
with	IN	O
the	DT	O
patient	NN	O
as	IN	O
most	JJS	O
of	IN	O
his	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
discomfort	NN	I-PROBLEM
happens	VBZ	O
when	WRB	O
he	PRP	O
is	VBZ	O
quite	RB	O
anxious	JJ	B-PROBLEM
.	.	O

He	PRP	O
used	VBD	O
Ativan	NNP	B-TREATMENT
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
which	WDT	O
helped	VBD	O
him	PRP	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
advised	VBN	O
that	IN	O
he	PRP	O
needs	VBZ	O
to	TO	O
speak	VB	O
with	IN	O
his	PRP$	O
PCP	NN	O
about	IN	O
medication	NN	B-TREATMENT
for	IN	I-TREATMENT
antianxiety	NN	I-TREATMENT
and	CC	O
/	NN	O
or	CC	O
further	JJ	B-TEST
testing	NN	I-TEST
or	CC	O
counseling	NN	B-TREATMENT
to	TO	O
help	VB	O
control	VB	O
his	PRP$	B-PROBLEM
anxiety	NN	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

Nitroglycerin	RB	B-TREATMENT
1	CD	O
tablet	NN	O
sublingual	JJ	O
q.	NN	O
5	CD	O
minutes	NNS	O
X3	NNP	O
p.r.n.	NN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

TriCor	$	B-TREATMENT
145	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Lipitor	NNP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Plavix	NNP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Aspirin	$	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Lisinopril	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Avandia	NNP	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Toprol	NNP	B-TREATMENT
XL	NNP	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

Ativan	$	B-TREATMENT
0.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
anxiety	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
that	IN	O
he	PRP	O
should	MD	O
discus	VB	O
with	IN	O
his	PRP$	O
PCP	NNP	O
further	RB	B-TEST
GI	NNP	I-TEST
testing	VBG	I-TEST
,	,	O
as	RB	O
well	RB	O
as	IN	O
medications	NNS	B-TREATMENT
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
will	MD	O
need	VB	O
to	TO	O
have	VB	O
a	DT	B-TEST
followup	JJ	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
done	VBN	O
as	IN	O
above	IN	O
per	IN	O
the	DT	O
recommendations	NNS	O
based	VBN	O
on	IN	O
the	DT	O
results	NNS	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
CP	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
Ro	NNP	O
Woodma	NNP	O
Healthcare	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
KOTEDAIZREKE	NNP	O
,	,	O
LILA	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
admitting	NN	O
diagnosis	NN	O
is	VBZ	O
CP	NNP	B-PROBLEM
.	.	O

ACUTE	NNP	B-PROBLEM
MYOCARDIAL	NNP	I-PROBLEM
INFARCTION	NNP	I-PROBLEM
.	.	O

Acute	NNP	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

1.	CD	O
Coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O

2.	CD	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
(	(	I-PROBLEM
postmyocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
angina	NN	I-PROBLEM
)	)	I-PROBLEM
,	,	O

3.	CD	O
Parkinson	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
Percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
coronary	JJ	B-TREATMENT
atherectomy	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
8-17-93	CD	O
,	,	O

2.	CD	O
relook	NN	O
coronary	JJ	B-TEST
angiogram	NN	I-TEST
,	,	O
08-18-93	NN	O
.	.	O

Ecotrin	NNP	B-TREATMENT
1	CD	O
tablet	NN	O
PO	NNP	O
qd	NN	O
,	,	O
Captopril	NNP	B-TREATMENT
6.25	CD	O
mg	NN	O
PO	NNP	O
tid	NN	O
,	,	O
K-Dur	NNP	B-TREATMENT
20	CD	O
mEq.	NN	O
PO	NNP	O
qd	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
20	CD	O
mg	NN	O
PO	NNP	O
qd	NN	O
,	,	O
Isordil	NNP	B-TREATMENT
10	CD	O
mg	NN	O
PO	NNP	O
tid	NN	O
,	,	O
Sinemet	NNP	B-TREATMENT
1/2	CD	O
tablet	NN	O
PO	NNP	O
bid	NN	O
,	,	O
Symmetrel	NNP	B-TREATMENT
100	CD	O
mg	NN	O
PO	NNP	O
bid	NN	O
,	,	O
Parloder	NNP	B-TREATMENT
2.5mg	CD	O
PO	NNP	O
qd	NN	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
58	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
Parkinson	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
for	IN	O
more	JJR	O
than	IN	O
twenty	CD	O
years	NNS	O
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
Gemenadentoolpai	NNP	O
Medical	NNP	O
Center	NNP	O
with	IN	O
a	DT	B-PROBLEM
revolving	VBG	I-PROBLEM
anterolateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
on	IN	O
08-01-93	NN	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
Dr.	NNP	O
Aalv	NNP	O
Manual	NNP	O
and	CC	O
was	VBD	O
referred	VBN	O
here	RB	O
for	IN	O
further	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
prior	JJ	O
significant	JJ	O
cardiac	JJ	O
history	NN	O
and	CC	O
presented	VBD	O
to	TO	O
her	PRP$	O
local	JJ	O
medical	JJ	O
doctor	NN	O
&apos;s	NNP	O
office	NN	O
with	IN	O
an	DT	O
episode	NN	O
of	IN	O
severe	JJ	B-PROBLEM
retrosternal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
anterior	JJ	I-PROBLEM
hemiblock	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
was	VBD	O
remarkable	JJ	O
for	IN	O
ruling	VBG	O
in	IN	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
CPK	NNP	I-TEST
of	IN	O
9,379	CD	O
units	NNS	O
with	IN	O
a	DT	O
5.9%	CD	O
MB	NNP	O
fraction	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
on	IN	O
telemetry	NN	B-TEST
she	PRP	O
developed	VBD	O
complete	JJ	B-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
requiring	VBG	O
temporary	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wire	NN	I-TREATMENT
and	CC	O
then	RB	O
a	DT	B-TREATMENT
permanent	JJ	I-TREATMENT
pacemaker	NN	I-TREATMENT
implantation	NN	I-TREATMENT
on	IN	O
08-03-93	NN	O
.	.	O

She	PRP	O
developed	VBD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
required	VBD	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

She	PRP	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
8-15-93	JJ	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
end	NN	I-TEST
diastolic	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
28	CD	O
millimeters	NNS	O
of	IN	O
mercury	NN	O
.	.	O

She	PRP	O
had	VBD	O
a	DT	B-PROBLEM
dominant	JJ	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
with	IN	O
minor	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
main	JJ	O
left	VBD	O
coronary	JJ	O
artery	NN	O
had	VBD	O
a	DT	B-PROBLEM
20%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

The	DT	O
left	JJ	O
anterior	JJ	O
descending	NN	O
had	VBD	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
80%	CD	I-PROBLEM
proximal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
filling	VBG	I-PROBLEM
defect	JJ	I-PROBLEM
consistent	NN	O
with	IN	O
intraluminal	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
.	.	O

The	DT	O
circumflex	JJ	O
artery	NN	O
had	VBD	O
a	DT	B-PROBLEM
minor	JJ	I-PROBLEM
40%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

Cine	NNP	B-TEST
left	VBD	I-TEST
ventriculogram	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
left	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
anterolateral	JJ	I-PROBLEM
,	,	I-PROBLEM
apical	JJ	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
estimated	VBN	O
to	TO	O
38%	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Heaonboburg	NNP	O
Linpack	NNP	O
Grant	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
consideration	NN	O
of	IN	O
coronary	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

Her	PRP$	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
included	VBD	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
family	NN	I-PROBLEM
history	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
cholesterol	NN	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

Her	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
remarkable	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
Parkinson	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
pleasant	JJ	O
lady	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

The	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
120/70	CD	O
millimeters	NNS	O
of	IN	O
mercury	NN	O
.	.	O

Her	PRP$	B-TEST
pulse	NN	I-TEST
was	VBD	O
regular	JJ	O
at	IN	O
80	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

The	DT	B-TEST
jugular	JJ	I-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
6	CD	O
cm	NNS	O
above	IN	O
the	DT	O
sternal	JJ	O
angle	NN	O
.	.	O

The	DT	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
anapical	JJ	B-PROBLEM
impulse	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
fifth	NN	I-PROBLEM
left	VBD	I-PROBLEM
intercostal	JJ	I-PROBLEM
space	NN	I-PROBLEM
,	,	O
left	VBD	O
to	TO	O
mid	VB	O
clavicular	JJ	O
line	NN	O
.	.	O

She	PRP	O
had	VBD	O
no	DT	O
murmurs	NNS	B-PROBLEM
and	CC	O
no	DT	O
gallops	NNS	B-PROBLEM
.	.	O

The	DT	B-TEST
examination	NN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

The	DT	B-TEST
examination	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
extremities	NNS	I-TEST
showed	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
poor	JJ	B-PROBLEM
R-wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
in	IN	O
V1	NNP	O
through	IN	O
V4	NNP	O
,	,	O
consistent	NN	O
with	IN	O
marked	JJ	O
clockwise	NN	O
rotation	NN	O
,	,	O
cannot	NN	O
rule	NN	O
out	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
anteroseptal	NN	I-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
prominent	JJ	B-PROBLEM
Q-waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
AVL	NNP	I-PROBLEM
,	,	O
consistent	NN	O
with	IN	O
lateral	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

There	EX	O
were	VBD	O
non-specific	JJ	B-PROBLEM
ST-T	JJ	I-PROBLEM
wave	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
Neurology	NNP	O
Department	NNP	O
because	IN	O
of	IN	O
the	DT	O
history	NN	O
of	IN	O
Parkinson	NNP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

On	IN	O
8-17-93	JJ	O
,	,	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
laboratory	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
.	.	O

Following	VBG	O
balloon	NN	B-TREATMENT
angioplasty	RB	I-TREATMENT
,	,	O
there	EX	O
was	VBD	O
a	DT	B-TREATMENT
local	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
with	IN	O
evidence	NN	O
of	IN	O
intraluminal	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
10%	CD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
initial	JJ	I-PROBLEM
gain	NN	I-PROBLEM
following	VBG	O
coronary	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

Therefore	RB	O
,	,	O
directional	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
atherectomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
with	IN	O
an	DT	O
excellent	JJ	O
angiographic	JJ	O
outcome	NN	O
,	,	O
and	CC	O
a	DT	B-PROBLEM
less	JJR	I-PROBLEM
than	IN	I-PROBLEM
10%	CD	I-PROBLEM
residual	JJ	I-PROBLEM
narrowing	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

She	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
and	CC	O
was	VBD	O
brought	VBN	O
back	RB	O
to	TO	O
the	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
laboratory	NN	I-TEST
on	IN	O
08-18-93	NN	O
for	IN	O
a	DT	B-TEST
relook	NN	I-TEST
coronary	JJ	I-TEST
angiography	NN	I-TEST
.	.	O

Coronary	JJ	B-TEST
angiography	NN	I-TEST
demonstrated	VBD	O
ongoing	JJ	O
benefit	NN	O
of	IN	O
the	DT	B-TREATMENT
initial	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
atherectomy	NN	I-TREATMENT
.	.	O

Specifically	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
decrease	NN	O
in	IN	O
the	DT	O
initial	JJ	O
gain	NN	O
that	IN	O
she	PRP	O
achieved	VBD	O
after	IN	O
directional	JJ	B-TREATMENT
atherectomy	NN	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
transferred	VBN	O
in	IN	O
stable	JJ	O
condition	NN	O
to	TO	O
the	DT	O
Pasi	NNP	O
for	IN	O
further	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

1)	CD	O
RIGHT	NNP	B-PROBLEM
LOWER	NNP	I-PROBLEM
EXTREMITY	NNP	I-PROBLEM
PSEUDOMONAS	NNP	I-PROBLEM
CELLULITIS	NNP	I-PROBLEM
.	.	O

2)	CD	O
PAROXYSMAL	NNP	B-PROBLEM
ATRIAL	NNP	I-PROBLEM
FIBRILLATION	NNP	I-PROBLEM
.	.	O

3)	CD	O
CORD	NNP	B-PROBLEM
COMPRESSION	NNP	I-PROBLEM
.	.	O

4)	CD	O
STEROID	NNP	B-PROBLEM
INDUCED	NNP	I-PROBLEM
DIABETES	NNP	I-PROBLEM
MELLITUS	NNP	I-PROBLEM
.	.	O

5)	CD	O
PLASMACYTOMA	NNP	B-PROBLEM
.	.	O

6)	CD	O
POOR	NNP	B-PROBLEM
NUTRITIONAL	NNP	I-PROBLEM
STATUS	NNP	I-PROBLEM
.	.	O

7)	CD	O
THROMBOCYTOPENIA	NNP	B-PROBLEM
STATUS	NNP	O
POST	NNP	O
BONE	NNP	B-TREATMENT
MARROW	NNP	I-TREATMENT
TRANSPLANT	NNP	I-TREATMENT
.	.	O

8)	CD	O
MULTIPLE	NNP	B-PROBLEM
MYELOMA	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
multiple	VBN	B-PROBLEM
myeloma	NNS	I-PROBLEM
since	IN	O
1990	CD	O
.	.	O

He	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
autologous	JJ	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
10/92	CD	O
at	IN	O
Petersly	NNP	O
Hospital	NNP	O
And	CC	O
Medical	NNP	O
Center	NNP	O
.	.	O

At	IN	O
that	DT	O
time	NN	O
he	PRP	O
received	VBD	O
total	JJ	B-TREATMENT
body	NN	I-TREATMENT
irradiation	NN	I-TREATMENT
of	IN	O
1400	CD	O
cGy	NN	O
.	.	O

This	DT	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
did	VBD	O
not	RB	O
produce	VB	O
remission	NN	O
and	CC	O
then	RB	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
three	CD	B-TREATMENT
cycles	NNS	I-TREATMENT
of	IN	I-TREATMENT
VAD	NNP	I-TREATMENT
subsequently	RB	O
.	.	O

In	IN	O
08/94	CD	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
lower	JJR	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
workup	NN	I-TEST
done	VBN	O
in	IN	O
DE	NNP	O
is	VBZ	O
not	RB	O
available	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

According	VBG	O
to	TO	O
her	PRP$	O
scanty	NN	O
records	NNS	O
,	,	O
an	DT	B-TEST
MRI	NNP	I-TEST
of	IN	I-TEST
the	DT	I-TEST
spine	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
spinal	JJ	I-PROBLEM
column	NN	I-PROBLEM
involvement	NN	I-PROBLEM
with	IN	O
lesions	NNS	B-PROBLEM
in	IN	I-PROBLEM
T4	NNP	I-PROBLEM
and	CC	I-PROBLEM
T8	NNP	I-PROBLEM
with	IN	O
no	DT	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

He	PRP	O
was	VBD	O
then	RB	O
treated	VBN	O
with	IN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
from	IN	O
T3	NNP	O
to	TO	O
T9	NNP	O
receiving	VBG	O
2500	CD	O
cGy	NN	O
from	IN	O
08/94	CD	O
to	TO	O
09/94	CD	O
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
Decadron	NNP	B-TREATMENT
since	IN	O
08/94	CD	O
.	.	O

About	RB	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	VB	O
the	DT	O
patient	NN	O
developed	VBD	O
mid	VB	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
burning	VBG	O
in	IN	O
nature	NN	O
with	IN	O
radiation	NN	O
around	IN	O
the	DT	O
right	NN	O
lower	JJR	O
ribs	NN	O
.	.	O

He	PRP	O
also	RB	O
began	VBD	O
to	TO	O
develop	VB	O
noticeably	RB	B-PROBLEM
increasing	VBG	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
possibly	RB	O
numbness	RB	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

He	PRP	O
stated	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
difficulty	NN	B-PROBLEM
rising	VBG	I-PROBLEM
from	IN	I-PROBLEM
a	DT	I-PROBLEM
chair	NN	I-PROBLEM
.	.	O

An	DT	B-TEST
MRI	NNP	I-TEST
without	IN	I-TEST
gadolinium	NN	I-TEST
done	VBN	O
on	IN	O
11/20/94	CD	O
of	IN	O
the	DT	O
spine	NN	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
extending	VBG	O
from	IN	O
T9	NNP	O
to	TO	O
T12	NNP	O
.	.	O

There	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

The	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
Decadron	NNP	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
12	CD	O
mg	NNS	O
q	JJ	O
day	NN	O
and	CC	O
he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
MS	NNP	B-TREATMENT
Contin	NNP	I-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
being	VBG	O
planned	VBN	O
and	CC	O
arranged	VBN	O
at	IN	O
the	DT	O
Petersly	NNP	O
Hospital	NNP	O
And	CC	O
Medical	NNP	O
Center	NNP	O
.	.	O

However	RB	O
,	,	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	VB	O
the	DT	O
patient	NN	O
developed	VBD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
could	MD	O
not	RB	O
walk	VB	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Over	IN	O
the	DT	O
next	JJ	O
12	CD	O
hours	NNS	O
while	IN	O
in	IN	O
transit	NN	O
to	TO	O
the	DT	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NN	O
right	RB	O
lower	JJR	O
extremity	NN	O
became	VBD	O
red	JJ	B-PROBLEM
,	,	O
swollen	VBN	B-PROBLEM
,	,	O
and	CC	O
increasingly	RB	B-PROBLEM
painful	JJ	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
chronic	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
since	IN	O
his	PRP$	B-TREATMENT
transplant	NN	I-TREATMENT
but	CC	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	NN	I-PROBLEM
was	VBD	O
noticeably	RB	O
increased	VBN	O
.	.	O

He	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
fecal	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
without	IN	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
presentation	NN	O
the	DT	O
patient	NN	O
denied	VBD	O
headache	NN	B-PROBLEM
,	,	O
arm	NN	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dysarthria	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
chest	VBP	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
Huyychestleme	NNP	O
Health	NNP	O
Of	IN	O
in	IN	O
Scoo	NNP	O
,	,	O
Utah	NNP	O
where	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
99.9	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
90/50	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
128	CD	O
,	,	O
and	CC	O
O2	NNP	B-TEST
sat	VBD	I-TEST
of	IN	O
91%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Blood	NN	B-TEST
cultures	NNS	I-TEST
,	,	O
urine	JJ	B-TEST
culture	NN	I-TEST
,	,	O
and	CC	O
UA	NNP	B-TEST
were	VBD	O
all	DT	O
done	VBN	O
.	.	O

Blood	NN	B-TEST
cultures	NNS	I-TEST
drawn	VBN	O
on	IN	O
admission	NN	O
subsequently	RB	O
grew	VBD	O
Pseudomonas	NNP	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
Ceftazidime	NNP	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
Vancomycin	NNP	B-TREATMENT
and	CC	O
also	RB	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
Dopamine	NNP	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
treatment	NN	O
of	IN	O
his	PRP$	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
Swan	NNP	I-TEST
was	VBD	O
placed	VBN	O
and	CC	O
initial	JJ	O
readings	NNS	O
were	VBD	O
CVP	NNP	B-TEST
of	IN	O
6	CD	O
,	,	O
wedge	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
10	CD	O
to	TO	O
12	CD	O
,	,	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
4.7	CD	O
,	,	O
and	CC	O
SVR	NNP	B-TEST
of	IN	O
438	CD	O
all	DT	O
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
Pseudomonas	NNP	I-PROBLEM
sepsis	NN	I-PROBLEM
picture	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
stress	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
Lorough	NNP	O
Medical	NNP	O
Center	NNP	O
&apos;s	NNP	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

1)	CD	O
Multiple	JJ	B-PROBLEM
myeloma	NN	I-PROBLEM
.	.	O

2)	CD	O
Paroxysmal	NNP	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

3)	CD	O
Plasmacytoma	NNP	B-PROBLEM
of	IN	I-PROBLEM
T9	NNP	I-PROBLEM
through	IN	I-PROBLEM
T12	NNP	I-PROBLEM
.	.	O

4)	CD	O
Chronic	NNP	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

5)	CD	O
Chronically	RB	B-PROBLEM
low	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

6)	CD	O
Failed	VBD	B-TREATMENT
autologous	JJ	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
10/92	CD	O
.	.	O

7)	CD	O
Hypothyroidism	NNP	B-PROBLEM
.	.	O

Positive	NNP	O
for	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

Question	NN	O
of	IN	O
penicillin	NN	B-TREATMENT
and	CC	O
sulfa	NN	B-TREATMENT
drugs	NNS	I-TREATMENT
leading	VBG	O
to	TO	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

On	IN	O
transfer	NN	O
include	VBP	O
Vancomycin	NNP	B-TREATMENT
,	,	O
Ceftazidime	NNP	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
Solu	NNP	B-TREATMENT
Cortef	NNP	I-TREATMENT
100	CD	O
mg	NN	O
q8h	NN	O
,	,	O
Lasix	NNP	B-TREATMENT
,	,	O
Synthroid	NNP	B-TREATMENT
,	,	O
insulin	NN	B-TREATMENT
,	,	O
MS	NNP	B-TREATMENT
Contin	NNP	I-TREATMENT
60	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
MSO4	NNP	B-TREATMENT
2	CD	O
mg	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
IV	NNP	O
,	,	O
Dopamine	NNP	B-TREATMENT
12	CD	O
mcg	NN	O
per	IN	O
minute	NN	O
.	.	O

On	IN	O
admission	NN	O
showed	VBD	O
a	DT	O
non-toxic	JJ	O
appearing	VBG	O
male	NN	O
with	IN	O
temperature	NN	B-TEST
99.5	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
82/50	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
118	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
15	CD	O
.	.	O

HEENT	NNP	B-TEST
exam	CC	I-TEST
atraumatic	JJ	B-PROBLEM
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

Neck	NNP	O
supple	NN	O
,	,	O
carotids	NNS	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

Cardiac	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
regular	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

Chest	JJS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
with	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
fine	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

Abdomen	NNP	O
non-distended	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

Rectal	NNP	O
normal	JJ	O
tone	NN	O
,	,	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
brown	NN	I-PROBLEM
stool	NN	I-PROBLEM
,	,	O
no	DT	O
perirectal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
or	CC	O
erythema	NN	B-PROBLEM
.	.	O

Extremities	NNS	O
reveal	VBP	O
the	DT	O
right	NN	O
lower	JJR	O
extremity	NN	O
was	VBD	O
tense	JJ	B-PROBLEM
,	,	O
purple-red	JJ	B-PROBLEM
,	,	O
swollen	JJ	B-PROBLEM
,	,	O
and	CC	O
was	VBD	O
warm	VBN	O
from	IN	O
the	DT	O
knee	NN	O
to	TO	O
the	DT	O
ankle	NN	O
and	CC	O
extremely	RB	B-PROBLEM
tender	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
of	IN	I-PROBLEM
both	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
cellulitis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

Neurological	JJ	B-TEST
exam	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
revealed	VBD	O
he	PRP	O
was	VBD	O
drowsy	RB	B-PROBLEM
but	CC	O
easily	RB	O
arousable	JJ	O
to	TO	O
voice	NN	O
,	,	O
oriented	VBN	O
to	TO	O
person	NN	O
,	,	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
,	,	O
and	CC	O
date	NN	O
,	,	O
able	JJ	O
to	TO	O
say	VB	O
no	DT	O
but	CC	O
mildly	RB	B-PROBLEM
inattentive	JJ	I-PROBLEM
during	IN	O
examination	NN	B-TEST
.	.	O

Motor	NNP	B-TEST
exam	VBP	I-TEST
normal	JJ	O
tone	NN	O
,	,	O
positive	JJ	B-PROBLEM
asterixis	NN	I-PROBLEM
,	,	O
no	DT	O
drift	NN	O
.	.	O

Deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
2+	CD	O
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
,	,	O
1+	CD	O
in	IN	O
the	DT	O
patella	NN	B-TEST
reflexes	NNS	I-TEST
,	,	O
no	DT	B-PROBLEM
reflexes	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
upgoing	VBG	O
Babinski	NNP	O
toes	NNS	O
bilaterally	RB	O
.	.	O

On	IN	O
admission	NN	O
revealed	VBN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
4.2	CD	O
,	,	O
Hct	NNP	B-TEST
27	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
28	CD	O
.	.	O

Glucose	RB	B-TEST
191	CD	O
.	.	O

PT	NNP	B-TEST
17.6	CD	O
,	,	O
PTT	NNP	B-TEST
48.7	CD	O
,	,	O
fibrinogen	NN	B-TEST
686	CD	O
,	,	O
TT	NNP	B-TEST
39.2	CD	O
.	.	O

Magnesium	NN	B-TEST
1.7	CD	O
.	.	O

UA	NNP	B-TEST
showed	VBD	O
no	DT	O
white	JJ	O
blood	NN	O
cells	NNS	O
,	,	O
positive	JJ	B-PROBLEM
granular	JJ	I-PROBLEM
casts	NNS	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
was	VBD	O
without	IN	O
infiltrates	NNS	B-PROBLEM
,	,	O
wand	NN	O
in	IN	O
good	JJ	O
position	NN	O
.	.	O

An	DT	B-TEST
MRI	NNP	I-TEST
was	VBD	O
performed	VBN	O
upon	IN	O
admission	NN	O
and	CC	O
showed	VBD	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
at	IN	O
the	DT	O
right	JJ	O
posterior	JJ	O
lateral	JJ	O
T9	NNP	O
to	TO	O
T12	NNP	O
area	NN	O
invading	VBG	O
the	DT	O
neural	JJ	O
foramina	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
CSF	NNP	B-PROBLEM
density	NN	I-PROBLEM
.	.	O

These	DT	B-PROBLEM
findings	NNS	I-PROBLEM
were	VBD	O
consistent	JJ	O
with	IN	O
the	DT	B-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
clinical	JJ	I-PROBLEM
situation	NN	I-PROBLEM
was	VBD	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
Pseudomonas	NNP	I-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
subsequent	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

Blood	NN	B-TEST
cultures	NNS	I-TEST
drawn	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
grew	VBD	O
out	RP	O
Pseudomonas	NNP	B-PROBLEM
that	WDT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
Imipenem	NNP	B-TREATMENT
and	CC	O
Tobramycin	NNP	B-TREATMENT
.	.	O

There	EX	O
were	VBD	O
cultures	NNS	B-TEST
obtained	VBN	O
seeping	VBG	O
from	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
at	IN	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
and	CC	O
those	DT	O
also	RB	O
grew	VBD	O
out	RP	O
Pseudomonas	NNP	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
organism	NN	I-PROBLEM
grown	VBN	O
at	IN	O
this	DT	O
institution	NN	O
was	VBD	O
sensitive	JJ	O
to	TO	O
Imipenem	NNP	B-TREATMENT
,	,	O
Ceftazidime	NNP	B-TREATMENT
,	,	O
Amikacin	NNP	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
Ciprofloxacin	NNP	B-TREATMENT
,	,	O
Tobramycin	NNP	B-TREATMENT
but	CC	O
was	VBD	O
resistant	JJ	O
to	TO	O
Cefotetan	NNP	B-TREATMENT
,	,	O
Ceftriaxone	NNP	B-TREATMENT
,	,	O
Mezlocillin	NNP	B-TREATMENT
,	,	O
Bactrim	NNP	B-TREATMENT
,	,	O
Ampicillin	NNP	B-TREATMENT
,	,	O
chloramphenicol	NN	B-TREATMENT
,	,	O
and	CC	O
sulbactam	NN	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
initially	RB	O
with	IN	O
Ceftazidime	NNP	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
but	CC	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
about	IN	O
the	DT	B-PROBLEM
organism	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
susceptibility	NN	I-PROBLEM
from	IN	O
lab	NN	B-TEST
studies	NNS	I-TEST
done	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

He	PRP	O
was	VBD	O
subsequently	RB	O
switched	VBN	O
to	TO	O
Imipenem	NNP	B-TREATMENT
and	CC	O
Tobramycin	NNP	B-TREATMENT
and	CC	O
was	VBD	O
maintained	VBN	O
on	IN	O
those	DT	B-TREATMENT
medications	NNS	I-TREATMENT
throughout	IN	O
the	DT	O
hospital	NN	O
course	NN	O
.	.	O

The	DT	B-TREATMENT
Tobramycin	NNP	I-TREATMENT
and	CC	O
Imipenem	NNP	B-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
11/25/94	CD	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
a	DT	O
five	CD	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
IgG	NNP	I-TREATMENT
to	TO	O
improve	VB	O
infection	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

Vancomycin	NNP	B-TREATMENT
was	VBD	O
also	RB	O
added	VBN	O
to	TO	O
his	PRP$	B-TREATMENT
regimen	NNS	I-TREATMENT
on	IN	O
11/28/94	CD	O
and	CC	O
this	DT	O
was	VBD	O
primarily	RB	O
to	TO	O
provide	VB	O
improved	JJ	B-TREATMENT
MRSA	NNP	I-TREATMENT
coverage	NN	I-TREATMENT
as	IN	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
erythema	VBN	B-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
Surgery	NNP	O
Department	NNP	O
and	CC	O
it	PRP	O
is	VBZ	O
there	RB	O
feeling	VBG	O
that	IN	O
there	EX	O
is	VBZ	O
no	DT	O
indication	NN	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
/	POS	O
amputation	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

He	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
with	IN	O
twice	JJ	O
daily	JJ	O
Xeroform	NN	B-TREATMENT
with	IN	O
Betadine	NNP	B-TREATMENT
changes	NNS	O
.	.	O

These	DT	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
are	VBP	O
applied	VBN	O
by	IN	O
applying	VBG	O
the	DT	O
Xeroform	NN	B-TREATMENT
on	IN	O
Betadine	NNP	B-TREATMENT
initially	RB	O
and	CC	O
then	RB	O
changing	VBG	O
it	PRP	O
with	IN	O
sterile	JJ	B-TREATMENT
dry	JJ	I-TREATMENT
bandages	NNS	I-TREATMENT
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
extreme	JJ	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
these	DT	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
requires	VBZ	O
parenteral	JJ	B-TREATMENT
morphine	NN	I-TREATMENT
sulfate	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
control	NN	I-PROBLEM
during	IN	I-PROBLEM
dressing	VBG	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

The	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
complete	VB	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
Imipenem	NNP	B-TREATMENT
and	CC	O
Tobramycin	NNP	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
Pseudomonas	NNP	I-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

As	IN	O
mentioned	VBN	O
earlier	RBR	O
he	PRP	O
continues	VBZ	O
to	TO	O
have	VB	O
erythema	NN	B-PROBLEM
tracking	VBG	O
up	RP	O
his	PRP$	O
leg	NN	O
and	CC	O
up	RB	O
to	TO	O
his	PRP$	O
lateral	JJ	O
thigh	NN	O
.	.	O

The	DT	O
cause	NN	O
of	IN	O
this	DT	B-PROBLEM
erythema	NN	I-PROBLEM
is	VBZ	O
not	RB	O
know	VBN	O
at	IN	O
this	DT	O
time	NN	O
but	CC	O
has	VBZ	O
not	RB	O
shown	VBN	O
extensive	JJ	O
progression	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
Dopamine	NNP	B-TREATMENT
which	WDT	O
was	VBD	O
subsequently	RB	O
weaned	VBN	O
off	RP	O
after	IN	O
his	PRP$	B-PROBLEM
sepsis	NN	I-PROBLEM
improved	VBD	O
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
rapid	JJ	B-PROBLEM
AF	NNP	I-PROBLEM
on	IN	O
several	JJ	O
episodes	NNS	O
receiving	VBG	O
5	CD	B-TREATMENT
mg	JJ	I-TREATMENT
IV	NNP	I-TREATMENT
Lopressor	NNP	I-TREATMENT
each	DT	O
time	NN	O
with	IN	O
improvement	NN	O
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
in	IN	O
and	CC	O
out	IN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

An	DT	B-TEST
echocardiogram	NN	I-TEST
performed	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
while	IN	O
he	PRP	O
was	VBD	O
septic	JJ	B-PROBLEM
showed	VBD	O
decreased	JJ	B-PROBLEM
global	JJ	I-PROBLEM
EF	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
Digoxin	NNP	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
paroxysmal	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
significant	JJ	O
episode	NN	O
of	IN	O
tachycardia	NN	B-PROBLEM
or	CC	O
blood	NN	B-PROBLEM
pressure	NN	I-PROBLEM
alteration	NN	I-PROBLEM
during	IN	O
the	DT	O
final	JJ	O
days	NNS	O
of	IN	O
hospitalization	NN	O
.	.	O

The	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
Digoxin	NNP	I-TREATMENT
and	CC	O
to	TO	O
recheck	VB	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
to	TO	O
assess	VB	O
his	PRP$	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
when	WRB	O
he	PRP	O
is	VBZ	O
clinically	RB	O
better	RBR	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
plasmacytoma	NN	I-PROBLEM
affecting	VBG	O
the	DT	O
spine	NN	O
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
that	DT	O
area	NN	O
during	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

The	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
complete	VB	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
XRT	NNP	B-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
spinal	JJ	I-TREATMENT
region	NN	I-TREATMENT
for	IN	O
the	DT	B-PROBLEM
plasmacytoma	NN	I-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
compressing	VBG	O
his	PRP$	O
thoracic	NN	O
spine	NN	O
was	VBD	O
never	RB	O
biopsied	VBN	O
,	,	O
however	RB	O
,	,	O
the	DT	B-TEST
MRI	NNP	I-TEST
appearance	NN	O
does	VBZ	O
not	RB	O
seem	VB	O
to	TO	O
be	VB	O
infectious	JJ	B-PROBLEM
and	CC	O
is	VBZ	O
most	RBS	O
consistent	JJ	O
with	IN	O
plasmacytoma	NN	B-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
is	VBZ	O
receiving	VBG	O
the	DT	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

As	IN	O
mentioned	VBN	O
above	IN	O
he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
is	VBZ	O
on	IN	O
steroids	NNS	B-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
IV	NNP	B-TREATMENT
Decadron	NNP	I-TREATMENT
10	CD	O
mg	NN	O
up	RB	O
front	RB	O
and	CC	O
then	RB	O
6	CD	O
mg	NNS	O
q6h.	NN	O

His	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
remained	VBD	O
stable	JJ	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

His	PRP$	B-TREATMENT
Decadron	NNP	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
titrated	VBN	O
down	RB	O
to	TO	O
5	CD	O
mg	NNS	O
IV	NNP	O
q6h	NN	O
on	IN	O
12/3/94	CD	O
.	.	O

His	PRP$	B-TREATMENT
Decadron	NNP	I-TREATMENT
dose	NN	I-TREATMENT
will	MD	O
be	VB	O
slowly	RB	O
titrated	VBN	O
down	RP	O
over	IN	O
time	NN	O
following	VBG	O
his	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
closely	RB	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
steroid	VBN	B-PROBLEM
induced	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RBR	I-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
increasing	VBG	B-TREATMENT
doses	NNS	I-TREATMENT
of	IN	I-TREATMENT
insulin	NN	I-TREATMENT
receiving	VBG	O
NPH	NNP	B-TREATMENT
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
night	NN	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	B-TREATMENT
CZI	NNP	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
on	IN	O
a	DT	O
q6h	JJ	O
basis	NN	O
.	.	O

The	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
supplemental	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
while	IN	O
he	PRP	O
is	VBZ	O
on	IN	O
steroids	NNS	B-TREATMENT
and	CC	O
while	IN	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
remain	VBP	O
high	JJ	O
.	.	O

He	PRP	O
initially	RB	O
required	VBD	O
a	DT	B-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
saturation	NN	I-TEST
above	IN	O
90%	CD	O
.	.	O

However	RB	O
,	,	O
with	IN	O
increasing	VBG	B-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
improving	VBG	B-PROBLEM
septic	JJ	I-PROBLEM
pictures	NNS	I-PROBLEM
his	PRP$	B-TEST
O2	NNP	I-TEST
saturations	NNS	I-TEST
have	VBP	O
improved	VBN	O
and	CC	O
he	PRP	O
is	VBZ	O
now	RB	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
sat	NN	I-TEST
above	IN	O
93%	CD	O
.	.	O

He	PRP	O
can	MD	O
be	VB	O
given	VBN	O
intravenous	JJ	B-TREATMENT
Lasix	NNP	I-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
any	DT	O
evidence	NN	O
of	IN	O
respiratory	JJ	B-PROBLEM
compromise	NN	I-PROBLEM
or	CC	O
increasing	VBG	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
poor	JJ	I-PROBLEM
nutritional	JJ	I-PROBLEM
status	NN	I-PROBLEM
with	IN	O
hypoalbuminemia	NN	B-PROBLEM
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
and	CC	O
that	DT	O
should	MD	O
be	VB	O
continued	VBN	O
.	.	O

He	PRP	O
should	MD	O
also	RB	O
be	VB	O
encouraged	VBN	O
to	TO	O
eat	VB	O
as	RB	O
much	JJ	O
as	IN	O
possible	JJ	O
orally	RB	O
in	IN	O
addition	NN	O
to	TO	O
this	DT	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
and	CC	O
aspiration	NN	B-TREATMENT
precaution	NN	I-TREATMENT
should	MD	O
be	VB	O
maintained	VBN	O
.	.	O

8)	CD	O
ELEVATED	NNP	B-PROBLEM
PT	NNP	I-PROBLEM
and	CC	I-PROBLEM
PTT	NNP	I-PROBLEM
:	:	O

Both	DT	O
of	IN	O
these	DT	O
responded	VBN	O
to	TO	O
three	CD	O
day	NN	O
course	NN	O
of	IN	O
vitamin	JJ	B-TREATMENT
K	NNP	I-TREATMENT
10	CD	O
mg	NNS	O
each	DT	O
day	NN	O
.	.	O

His	PRP$	B-TEST
PT	NNP	I-TEST
and	CC	O
PTT	NNP	B-TEST
are	VBP	O
now	RB	O
normal	JJ	O
,	,	O
however	RB	O
,	,	O
he	PRP	O
continues	VBZ	O
to	TO	O
run	VB	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

This	DT	O
has	VBZ	O
been	VBN	O
evident	JJ	O
since	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

We	PRP	O
have	VBP	O
been	VBN	O
transfusing	VBG	O
him	PRP	O
with	IN	O
platelets	NNS	B-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
counts	NNS	I-TEST
above	IN	O
20,000	CD	O
to	TO	O
reduce	VB	O
his	PRP$	B-PROBLEM
bleeding	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

He	PRP	O
also	RB	O
received	VBD	O
several	JJ	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
while	IN	O
here	RB	O
to	TO	O
maintain	VB	O
his	PRP$	B-TEST
Hct	NNP	I-TEST
around	IN	O
30	CD	O
.	.	O

Thrombocytopenic	JJ	B-TREATMENT
inducing	VBG	I-TREATMENT
drugs	NNS	I-TREATMENT
should	MD	O
be	VB	O
avoided	VBN	O
if	IN	O
possible	JJ	O
on	IN	O
this	DT	O
patient	NN	O
.	.	O

Tylenol	$	B-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
p.r.n.	NN	O
,	,	O
Dulcolax	NNP	B-TREATMENT
10	CD	O
mg	NN	O
per	IN	O
rectum	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
,	,	O
Decadron	NNP	B-TREATMENT
5	CD	O
mg	NN	O
IV	NNP	O
q6h	NN	O
,	,	O
Digoxin	NNP	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
Colace	NNP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
Florinef	NNP	B-TREATMENT
0.1	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
for	IN	O
presumed	JJ	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
Imipenem	NNP	B-TREATMENT
500	CD	O
mg	NN	O
IV	NNP	O
q6h	NN	O
,	,	O
insulin	NN	B-TREATMENT
NPH	NNP	I-TREATMENT
60	CD	O
units	NNS	O
subcu	VBP	O
q	JJ	O
a.m.	NN	O
,	,	O
insulin	NN	B-TREATMENT
NPH	NNP	I-TREATMENT
20	CD	O
units	NNS	O
subcu	VBP	O
q	JJ	O
p.m.	NN	O
,	,	O
insulin	NN	B-TREATMENT
CZI	NNP	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
regular	JJ	I-TREATMENT
,	,	O
Synthroid	NNP	B-TREATMENT
125	CD	O
mcg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
magnesium	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
,	,	O
potassium	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
today	NN	O
,	,	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
IV	NNP	I-TREATMENT
p.r.n.	NN	O
dressing	NN	B-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
Carafate	NNP	B-TREATMENT
1	CD	O
gm	NN	O
po	NN	O
q.i.d.	NN	O
,	,	O
Tobramycin	NNP	B-TREATMENT
200	CD	O
mg	NN	O
IV	NNP	O
q30h	NN	O
,	,	O
Vancomyin	NNP	B-TREATMENT
1	CD	O
mg	NN	O
IV	NNP	O
q18h.	NN	O

Obstructive	JJ	B-PROBLEM
Sleep	NNP	I-PROBLEM
Apnea	NNP	I-PROBLEM

WELLBUTRIN	NNP	B-TREATMENT
(	(	I-TREATMENT
BUPROPION	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
FOLATE	NNP	B-TREATMENT
(	(	I-TREATMENT
FOLIC	NNP	I-TREATMENT
ACID	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
ATIVAN	NNP	B-TREATMENT
(	(	I-TREATMENT
LORAZEPAM	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
MG	NNP	O
PO	NNP	O
Q12H	NNP	O
X	NNP	O
1	CD	O
Days	NNP	O
ATIVAN	NNP	B-TREATMENT
(	(	I-TREATMENT
LORAZEPAM	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
MG	NNP	O
PO	NNP	O
QHS	NNP	O
X	NNP	O
7	CD	O
Days	NNPS	O
Starting	VBG	O
on	IN	O
11/5	CD	O
MVI	NNP	B-TREATMENT
THERAPEUTIC	NNP	I-TREATMENT
W	NNP	I-TREATMENT
/	NNP	I-TREATMENT
MINERALS	NNP	I-TREATMENT
(	(	I-TREATMENT
THERAP	NNP	I-TREATMENT
VITS	NNP	I-TREATMENT
/	NNP	I-TREATMENT
MINERALS	NNP	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
TAB	NNP	O
PO	NNP	O
QD	NNP	O

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
NIACIN	NNP	B-TREATMENT
,	,	O
VIT.	NNP	B-TREATMENT

B-3	NNP	B-TREATMENT
Reason	NNP	O
for	IN	O
override	NN	O
:	:	O

indicated	VBN	O
THIAMINE	NNP	B-TREATMENT
(	(	I-TREATMENT
THIAMINE	NNP	I-TREATMENT
HCL	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
SIMVASTATIN	NNP	B-TREATMENT
40	CD	O
MG	NNP	O
PO	NNP	O
QHS	NNP	O

Override	NNP	O
added	VBD	O
on	IN	O
11/03/00	CD	O
by	IN	O
TWADA	NNP	O
,	,	O
STASTERL	NNP	O
ETHESHI	NNP	O
,	,	O
M.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
MVI	NNP	B-TREATMENT
THERAPEUTIC	NNP	I-TREATMENT
W	NNP	I-TREATMENT
/	NNP	I-TREATMENT
MINERALS	NNP	I-TREATMENT
PO	NNP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
90299469	CD	O
)	)	O

SIMVASTATIN	NNP	B-TREATMENT
and	CC	O
NIACIN	NNP	B-TREATMENT
,	,	O
VIT.	NNP	B-TREATMENT
B-3	NNP	I-TREATMENT

indicated	VBN	O
LISINOPRIL	NNP	B-TREATMENT
10	CD	O
MG	NNP	O
PO	NNP	O
QD	NNP	O
NICOTINE	NNP	B-TREATMENT
PATCH	NNP	I-TREATMENT
(	(	I-TREATMENT
NICOTINE	NNP	I-TREATMENT
)	)	I-TREATMENT
21	CD	O
MG/DAY	NNP	O
TP	NNP	O
Q24H	NNP	O

Firmert	NNP	O
Hospital	NNP	O
11/6	CD	O
at	IN	O
9am	CD	O
scheduled	JJ	O
,	,	O
Cialneinsisters	NNP	O
Hospital	NNP	O
And	CC	O
Medical	NNP	O
Center	NNP	O
11/16	CD	O
at	IN	O
8:15pm	CD	O
scheduled	JJ	O
,	,	O
Dr.	NNP	O
Condnort	NNP	O
12/04	CD	O
at	IN	O
2pm	CD	O
scheduled	JJ	O
,	,	O
Dr.	NNP	O
Lila	NNP	O
Spielbjaque	NNP	O
12/01	CD	O
at	IN	O
1:50pm	CD	O
scheduled	VBN	O
,	,	O
No	DT	O
Known	NNP	B-PROBLEM
Allergies	NNS	I-PROBLEM

r	NN	O
/	''	O
o	JJ	O
MI	NNP	B-PROBLEM

Responsible	JJ	O
After	IN	O
Study	NNP	O
for	IN	O
Causing	NNP	O
Admission	NNP	O
)	)	O
Obstructive	NNP	B-PROBLEM
Sleep	NNP	I-PROBLEM
Apnea	NNP	I-PROBLEM

Conditions	NNS	O
,	,	O
Infections	NNP	O
,	,	O
Complications	NNP	O
,	,	O
affecting	VBG	O
Treatment	NNP	O
/	NNP	O
Stay	NNP	O
HTN	NNP	B-PROBLEM
tobacco	NN	O
EtOh	NNP	O
abuse	NN	O
sinus	NN	B-PROBLEM
bradycardia	NN	I-PROBLEM

50	CD	O
yo	JJ	O
M	NNP	O
from	IN	O
Taheimpromong	NNP	O
admitted	VBD	O
w	JJ	O
/	NNP	O
CP	NNP	B-PROBLEM
for	IN	O
r	NN	O
/	NNP	O
o	NN	O
MI	NNP	B-PROBLEM
.	.	O

Has	NNP	O
significant	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM

FH	NNP	O
,	,	O
HTN	NNP	B-PROBLEM
,	,	O
tobacco	NN	O
.	.	O

Presented	VBN	O
w	JJ	O
/	NNP	O
epigastric	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
SOB	NNP	B-PROBLEM
at	IN	O
work	NN	O
.	.	O

ETT	NNP	B-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

Echo	NNP	B-TEST
showed	VBD	O
ef	JJ	B-TEST
45-50%	JJ	O
,	,	O
with	IN	O
mild	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
and	CC	O
no	DT	O
significant	JJ	B-PROBLEM
valvular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
nl	JJ	O
PAP	NNP	O
.	.	O

During	IN	O
this	DT	O
hospitalization	NN	O
,	,	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
sinus	VBN	B-PROBLEM
bradycardia	NN	I-PROBLEM
and	CC	O
pauses	NNS	B-PROBLEM
,	,	O
associated	VBN	O
with	IN	O
desaturations	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
70	CD	I-PROBLEM
&apos;s	NN	I-PROBLEM
.	.	O

CPAP	NNP	B-TREATMENT
at	IN	O
5	CD	O
was	VBD	O
attempted	VBN	O
,	,	O
but	CC	O
pt	RB	O
did	VBD	O
not	RB	O
tolerate	VB	O
this	DT	O
.	.	O

He	PRP	O
will	MD	O
have	VB	O
outpt	JJ	B-TREATMENT
fitting	NN	I-TREATMENT
at	IN	O
the	DT	O
sleep	NN	O
center	NN	O
in	IN	O
Sabo	NNP	O
.	.	O

MIGRAINES	NNP	B-PROBLEM
FOR	NNP	O
10	CD	O
DAYS	NNP	O

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
headache	NN	B-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

Headache	NN	B-PROBLEM

MD	NNP	B-TREATMENT
evaluation	NN	I-TREATMENT
,	,	O
head	NN	B-TEST
CT	NNP	I-TEST

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
SOB	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
ADMITTED	NNP	O
AS	IN	O
AN	NNP	O
INPATIENT	NNP	O
TO	NNP	O
OAKSGEKESSER/	NNP	O
MEMORIAL	NNP	O
HOSPITAL	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
BRITTSFYFEAST	NNP	O
,	,	O
SHER	NNP	O
T	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
S	NNP	O
/	NNP	O
SOB	NNP	B-PROBLEM
.	.	O

TYLENOL	NNP	B-TREATMENT
(	(	I-TREATMENT
ACETAMINOPHEN	NNP	I-TREATMENT
)	)	I-TREATMENT
650	CD	O
MG	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

ACETAMINOPHEN	NNP	B-TREATMENT
and	CC	O
ACETAMINOPHEN	NNP	B-TREATMENT

COLACE	NNP	B-TREATMENT
(	(	I-TREATMENT
DOCUSATE	NNP	I-TREATMENT
SODIUM	NNP	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
MG	NNP	O
PO	NNP	O
BID	NNP	O
IBUPROFEN	NNP	B-TREATMENT
600	CD	O
MG	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

Take	VB	O
with	IN	O
food	NN	O
MILK	NNP	B-TREATMENT
OF	NNP	I-TREATMENT
MAGNESIA	NNP	I-TREATMENT
(	(	I-TREATMENT
MAGNESIUM	NNP	I-TREATMENT
HYDROXIDE	NNP	I-TREATMENT
)	)	I-TREATMENT
30	CD	O
MILLILITERS	NNP	O
PO	NNP	O
BID	NNP	O
PRN	NNP	O
Constipation	NNP	B-PROBLEM
PERCOCET	NNP	B-TREATMENT
1-2	JJ	O
TAB	NNP	O
PO	NNP	O
Q4H	NNP	O
PRN	NNP	O
PAIN	NNP	B-PROBLEM

Override	NNP	O
added	VBD	O
on	IN	O
10/01/03	CD	O
by	IN	O
KOTEJOASTHOREUPHKAYS	NNP	O
,	,	O
GAI	NNP	O
,	,	O
M.D.	NNP	O
on	IN	O
order	NN	O
for	IN	O
TYLENOL	NNP	B-TREATMENT
PO	NNP	O
650	CD	O
MG	NNP	O
Q4H	NNP	O
(	(	O
ref	JJ	O
#	#	O
85225311	CD	O
)	)	O

ACETAMINOPHEN	NNP	B-TREATMENT
and	CC	O
ACETAMINOPHEN	NNP	B-TREATMENT

Sulfa	NNP	B-TREATMENT
,	,	O
Bactrim	NNP	B-TREATMENT

Pregnancy	NN	B-PROBLEM

Undelivered	VBN	B-PROBLEM

Breech	NNP	B-PROBLEM
,	,	O
Multiple	NNP	B-PROBLEM
gestation	NN	I-PROBLEM
,	,	O

No	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

Apgars	NNS	B-TEST
8,9	CD	O

Weight	NN	B-TEST
:	:	O

Apgars	NNS	B-TEST
8,8	CD	O

Weight	NN	B-TEST
:	:	O

PNEUMONIA	NN	B-PROBLEM

Shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
38-year-old	JJ	O
gentleman	NN	O
,	,	O
Spanish-speaking	NNP	O
,	,	O
from	IN	O
the	DT	O
Taheimpromong	NNP	O
,	,	O
with	IN	O
no	DT	O
significant	JJ	O
past	JJ	O
medical	JJ	O
history	NN	O
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
x	$	O
2	CD	O
months	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
cough	NN	I-PROBLEM
x	RB	O
1	CD	O
month	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
two	CD	O
months	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
began	VBD	O
to	TO	O
notice	VB	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
on	IN	O
climbing	VBG	O
flights	NNS	O
of	IN	O
stairs	NNS	O
.	.	O

He	PRP	O
stated	VBD	O
that	IN	O
this	DT	O
became	VBD	O
worse	JJR	O
over	IN	O
the	DT	O
last	JJ	O
month	NN	O
until	IN	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
at	IN	O
rest	NN	O
.	.	O

He	PRP	O
also	RB	O
states	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
and	CC	I-PROBLEM
nonproductive	JJ	I-PROBLEM
cough	NN	I-PROBLEM
for	IN	O
one	CD	O
month	NN	O
.	.	O

He	PRP	O
denied	VBD	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
or	CC	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
.	.	O

No	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
or	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

He	PRP	O
did	VBD	O
note	VB	O
some	DT	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
,	,	O
though	IN	O
the	DT	O
amount	NN	O
was	VBD	O
unknown	JJ	O
.	.	O

He	PRP	O
did	VBD	O
drink	VB	O
alcohol	NN	O
three	CD	O
drinks	NNS	O
per	IN	O
day	NN	O
,	,	O
no	DT	O
withdrawal	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

In	IN	O
emergency	NN	O
room	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
afebrile	JJ	O
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
,	,	O
was	VBD	O
treated	VBN	O
with	IN	O
IV	NNP	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
azithromycin	NN	B-TREATMENT
,	,	O
and	CC	O
cefuroxime	NN	B-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Sister	NN	O
with	IN	O
bone	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
97.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
100	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
142/89	CD	O
,	,	O
and	CC	O
O2	NNP	B-TEST
saturation	NN	I-TEST
94%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

General	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

HEENT	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
sclerae	NN	B-PROBLEM
to	TO	O
be	VB	O
injected	VBN	O
.	.	O

No	DT	O
lymphadenopathy	NN	B-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
neck	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
right	JJ	B-PROBLEM
axillary	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

Chest	NNP	B-TEST
exam	NN	I-TEST
reveals	NNS	O
coarse	VBP	B-PROBLEM
rhonchi	NN	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
bibasilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

Abdominal	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
soft	JJ	O
,	,	O
nontender	NN	O
,	,	O
and	CC	O
nondistended	VBD	O
abdomen	NNS	O
.	.	O

Heart	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
tachycardic	JJ	B-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
flat	JJ	I-PROBLEM
jugular	NN	I-PROBLEM
venous	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
.	.	O

His	PRP$	O
extremities	NNS	O
were	VBD	O
without	IN	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

His	PRP$	O
skin	NN	O
was	VBD	O
clear	JJ	O
,	,	O
without	IN	O
rashes	NNS	B-PROBLEM
.	.	O

There	EX	O
is	VBZ	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
noted	VBD	O
on	IN	O
abdominal	JJ	B-TEST
exam	NN	I-TEST
.	.	O

Neuro	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	$	O
3	CD	O
.	.	O

Sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
103	CD	O
,	,	O
bicarbonate	NN	B-TEST
25	CD	O
,	,	O
BUN	NNP	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
and	CC	O
glucose	RB	B-TEST
83	CD	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.2	CD	O
,	,	O
hematocrit	NN	B-TEST
43.2	CD	O
,	,	O
and	CC	O
platelets	VBZ	B-TEST
447,000	CD	O
.	.	O

Sinus	NNP	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
100	CD	O
.	.	O

Diffuse	NNP	B-PROBLEM
interstitial	JJ	I-PROBLEM
process	NN	I-PROBLEM
/	NNP	O
consolidation	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
differential	JJ	O
diagnosis	NN	O
included	VBD	O
initially	RB	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
atypical	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
or	CC	O
PCP	NNP	B-PROBLEM
.	.	O

His	PRP$	B-TEST
PPD	NNP	I-TEST
has	VBZ	O
been	VBN	O
negative	JJ	O
one	CD	O
year	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
PPD	NNP	B-TEST
was	VBD	O
rechecked	VBN	O
during	IN	O
this	DT	O
admission	NN	O
and	CC	O
was	VBD	O
negative	JJ	O
.	.	O

He	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
tuberculosis	NN	B-PROBLEM
with	IN	O
an	DT	B-TEST
induced	JJ	I-TEST
sputum	NN	I-TEST
x	VBD	O
3	CD	O
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
AFB	NNP	B-PROBLEM
.	.	O

Chest	NNP	B-TEST
CT	NNP	I-TEST
showed	VBD	O
bibasilar	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
,	,	O
PCP	NNP	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

Thus	RB	O
initially	RB	O
he	PRP	O
had	VBD	O
been	VBN	O
started	VBN	O
on	IN	O
prednisone	NN	B-TREATMENT
and	CC	O
Bactrim	NNP	B-TREATMENT
,	,	O
this	DT	O
was	VBD	O
discontinued	VBN	O
.	.	O

He	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
azithromycin	NN	B-TREATMENT
and	CC	O
cefuroxime	NN	B-TREATMENT
until	IN	O
bronchoscopy	JJ	O
results	NNS	O
were	VBD	O
known	VBN	O
,	,	O
negative	JJ	O
.	.	O

He	PRP	O
initially	RB	O
had	VBD	O
refused	VBN	O
HIV	NNP	B-TEST
testing	NN	I-TEST
,	,	O
however	RB	O
,	,	O
was	VBD	O
finally	RB	O
consented	VBN	O
,	,	O
HIV	NNP	B-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

Pulmonary	JJ	O
consult	NN	O
was	VBD	O
invited	VBN	O
,	,	O
initially	RB	O
the	DT	O
patient	NN	O
refused	VBD	O
bronchoscopy	NN	B-TEST
,	,	O
however	RB	O
,	,	O
did	VBD	O
agree	VB	O
to	TO	O
it	PRP	O
during	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

The	DT	O
results	NNS	O
were	VBD	O
negative	JJ	O
for	IN	O
Micro	NNP	B-PROBLEM
,	,	O
most	JJS	O
likely	JJ	O
diagnosis	NN	O
as	IN	O
per	IN	O
review	NN	B-TEST
of	IN	I-TEST
pathology	NN	I-TEST
is	VBZ	O
organizing	VBG	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
possible	JJ	O
diagnosis	NN	O
of	IN	O
BOOP	NNP	B-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
inhalational	JJ	I-PROBLEM
injury	NN	I-PROBLEM
was	VBD	O
a	DT	O
possibility	NN	O
.	.	O

The	DT	O
patient	NN	O
required	VBN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
greater	JJR	O
than	IN	O
93%	CD	O
.	.	O

Ambulatory	NNP	B-TEST
saturation	NN	I-TEST
was	VBD	O
82%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
supportive	JJ	B-TREATMENT
medical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
cough	NN	I-PROBLEM
.	.	O

Echocardiogram	NNP	B-TEST
was	VBD	O
checked	VBN	O
to	TO	O
rule	VB	O
out	IN	O
CHF	NNP	B-PROBLEM
,	,	O
showed	VBD	O
LVH	NNP	B-PROBLEM
and	CC	O
trace	NN	B-PROBLEM
TR	NNP	I-PROBLEM
,	,	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
60%	CD	O
without	IN	O
any	DT	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

Hepatitis	NN	B-TEST
serologies	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

His	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
repeated	VBN	O
p.r.n.	NN	O

Lovenox	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
with	IN	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

Multiple	JJ	O
conversations	NNS	O
were	VBD	O
had	VBN	O
with	IN	O
the	DT	O
patient	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
interpreter	NN	O
stating	VBG	O
the	DT	O
importance	NN	O
of	IN	O
not	RB	O
smoking	VBG	O
and	CC	O
keeping	VBG	O
flames	NNS	O
away	RB	O
from	IN	O
his	PRP$	B-TREATMENT
oxygen	NN	I-TREATMENT
tank	NN	I-TREATMENT
.	.	O

He	PRP	O
was	VBD	O
sent	VBN	O
home	NN	O
with	IN	O
LDAMC	NNP	O
services	NNS	O
to	TO	O
help	VB	O
with	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
oxygen	NN	O
education	NN	O
.	.	O

He	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
call	VB	O
a	DT	O
doctor	NN	O
or	CC	O
come	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
should	MD	O
he	PRP	O
have	VB	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
troubles	NNS	I-PROBLEM
,	,	O
breathing	NN	O
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
fevers	NNS	B-PROBLEM
.	.	O

1.	CD	O
Prednisone	CD	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O

2.	CD	O
Bactrim	NNP	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
PCP	NNP	B-TREATMENT
prophylaxis	NN	I-TREATMENT
during	IN	O
his	PRP$	B-TREATMENT
steroid	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
CP	NNP	B-PROBLEM
SOB	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
Ro	NNP	O
Woodma	NNP	O
Healthcare	NNP	O
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
DREISSNEIGH	NNP	O
,	,	O
LIRU	NNP	O
and	CC	O
the	DT	O
preliminary	JJ	O
admitting	NN	O
diagnosis	NN	O
is	VBZ	O
CP	NNP	B-PROBLEM
,	,	O
R	NNP	O
/	NNP	O
O	NNP	O
MI	NNP	B-PROBLEM
.	.	O

R	NNP	O
/	NNP	O
O	NNP	O
HEMMOROIDS	NNP	B-PROBLEM

perianal	JJ	B-PROBLEM
and	CC	I-PROBLEM
perivaginal	JJ	I-PROBLEM
pruritis	NN	I-PROBLEM

pelvic	JJ	B-TEST
exam	NN	I-TEST

Please	VB	O
call	NN	O
(	(	O
994	CD	O
)	)	O
944-4238	CD	O
in	IN	O
2-3	JJ	O
days	NNS	O
to	TO	O
obtain	VB	O
results	NNS	O
of	IN	O
the	DT	B-TEST
lab	NN	I-TEST
tests	NNS	I-TEST
that	WDT	O
were	VBD	O
ordered	VBN	O
.	.	O

If	IN	O
tests	NNS	O
are	VBP	O
positive	JJ	B-PROBLEM
,	,	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
doctor	NN	O
of	IN	O
gynecologist	NN	O
.	.	O

METASTATIC	NNP	B-PROBLEM
ADENOCARCINOMA	NNP	I-PROBLEM
OF	NNP	I-PROBLEM
UNKNOWN	NNP	I-PROBLEM
PRIMARY	NNP	I-PROBLEM
.	.	O

INTRAUTERINE	NNP	B-PROBLEM
PREGNANCY	NNP	I-PROBLEM
AT	NNP	I-PROBLEM
23	CD	I-PROBLEM
WEEKS	NNP	I-PROBLEM
.	.	O

HYPERCALCEMIA	NNP	B-PROBLEM
.	.	O

INFERIOR	NNP	B-PROBLEM
VENA	NNP	I-PROBLEM
CAVA	NNP	I-PROBLEM
OBSTRUCTION	NNP	I-PROBLEM
.	.	O

IMPENDING	NNP	B-PROBLEM
SPINAL	NNP	I-PROBLEM
CORD	NNP	I-PROBLEM
COMPRESSION	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
34-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	B-PROBLEM
22	CD	I-PROBLEM
week	NN	I-PROBLEM
intrauterine	JJ	I-PROBLEM
pregnancy	NN	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
Bri	NNP	O
Health	NNP	O
with	IN	O
diffuse	NN	B-PROBLEM
metastatic	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
unknown	JJ	I-PROBLEM
primary	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
excellent	JJ	O
health	NN	O
until	IN	O
July	NNP	O
of	IN	O
1991	CD	O
when	WRB	O
she	PRP	O
first	RB	O
noted	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

Subsequently	RB	O
,	,	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
continued	VBD	O
to	TO	O
increase	VB	O
in	IN	O
size	NN	O
.	.	O

On	IN	O
12/23	CD	O
,	,	O
she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
Dr.	NNP	O
Stonge	NNP	O
at	IN	O
Bri	NNP	O
Health	NNP	O
where	WRB	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
x	NN	I-PROBLEM
7	CD	I-PROBLEM
cm	NN	I-PROBLEM
left	VBD	I-PROBLEM
mid	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

A	DT	B-TEST
fine	JJ	I-TEST
needle	JJ	I-TEST
aspirate	NN	I-TEST
of	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
reportedly	RB	O
revealed	VBD	O
giant	JJ	B-PROBLEM
cell	NN	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
told	VBD	O
that	IN	O
this	DT	O
was	VBD	O
a	DT	B-PROBLEM
benign	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
and	CC	O
that	IN	O
it	PRP	O
could	MD	O
simply	RB	O
be	VB	O
watched	VBN	O
and	CC	O
definitively	RB	O
treated	VBN	O
after	IN	O
the	DT	B-TREATMENT
delivery	NN	I-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
baby	NN	I-TREATMENT
.	.	O

Subsequently	RB	O
,	,	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
progressively	RB	O
increased	VBN	O
in	IN	O
size	NN	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
developed	VBN	O
significant	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
this	DT	I-PROBLEM
region	NN	I-PROBLEM
.	.	O

On	IN	O
1/5	CD	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
local	JJ	I-TREATMENT
tumor	NN	I-TREATMENT
debulking	VBG	I-TREATMENT
at	IN	O
Bri	NNP	O
Health	NNP	O
under	IN	O
local	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

The	DT	B-TEST
pathology	NN	I-TEST
,	,	O
unfortunately	RB	O
,	,	O
revealed	VBD	O
an	DT	B-PROBLEM
aggressive	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
(	(	O
micropapillary	JJ	O
type	NN	O
;	:	O
mucin	CC	O
producing	VBG	O
)	)	O
.	.	O

This	DT	O
prompted	VBD	O
further	JJ	B-TEST
staging	VBG	I-TEST
work-up	NN	I-TEST
.	.	O

The	DT	O
patient	NN	O
subsequently	RB	O
had	VBD	O
a	DT	B-TEST
limited	JJ	I-TEST
chest	NN	I-TEST
CT	NN	I-TEST
at	IN	O
Bri	NNP	O
Health	NNP	O
which	WDT	O
showed	VBD	O
diffuse	IN	B-PROBLEM
bilateral	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
,	,	O
metastases	NNS	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
sternum	NN	I-PROBLEM
,	,	I-PROBLEM
rib	NN	I-PROBLEM
,	,	I-PROBLEM
multiple	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
levels	NNS	I-PROBLEM
;	:	O
internal	JJ	B-PROBLEM
mammary	NN	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

The	DT	O
poor	JJ	O
prognosis	NN	O
for	IN	O
the	DT	O
patient	NN	O
and	CC	O
child	NN	O
were	VBD	O
discussed	VBN	O
and	CC	O
after	IN	O
the	DT	O
patient	NN	O
decided	VBD	O
to	TO	O
have	VB	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
abortion	NN	I-TREATMENT
,	,	O
an	DT	B-TEST
abdominal	JJ	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
diffuse	NN	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liverspine	NN	I-PROBLEM
,	,	I-PROBLEM
ribs	NN	I-PROBLEM
and	CC	I-PROBLEM
most	JJS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lymph	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
obvious	JJ	B-PROBLEM
GIor	NNP	I-PROBLEM
pancreatic	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
identified	VBD	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
firm	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
at	IN	O
the	DT	O
vertex	NN	O
of	IN	O
her	PRP$	O
calvarium	NN	O
.	.	O

A	DT	O
specimen	NN	O
was	VBD	O
obtained	VBN	O
by	IN	O
fine	JJ	B-TEST
needle	JJ	I-TEST
aspiration	NN	I-TEST
and	CC	O
the	DT	B-TEST
pathology	NN	I-TEST
of	IN	O
this	DT	O
was	VBD	O
consistent	JJ	O
with	IN	O
adenocarcinoma	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
Nimaconwood	NNP	O
Valley	NNP	O
Hospital	NNP	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
termination	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pregnancy	NN	I-PROBLEM
.	.	O

Over	IN	O
the	DT	O
past	JJ	O
four	CD	O
weeks	NNS	O
,	,	O
the	DT	O
patient	NN	O
reported	VBD	O
progressive	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
mid	NN	B-PROBLEM
thoracic	NN	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
motor	NN	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
abnormal	JJ	B-PROBLEM
sensation	NN	I-PROBLEM
,	,	O
numbness	RB	B-PROBLEM
,	,	O
tingling	VBG	B-PROBLEM
or	CC	O
incontinence	NN	B-PROBLEM
of	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
.	.	O

She	PRP	O
denied	VBD	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
sweats	NNS	B-PROBLEM
.	.	O

There	EX	O
has	VBZ	O
been	VBN	O
no	DT	O
GI	NNP	B-PROBLEM
or	CC	I-PROBLEM
GU	NNP	I-PROBLEM
symptoms	NNS	I-PROBLEM
except	IN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

On	IN	O
admission	NN	O
included	VBD	O
Percocet	NNP	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
multivitamins	NNS	B-TREATMENT
.	.	O

NO	DT	O
KNOWN	NNP	B-PROBLEM
DRUG	NNP	I-PROBLEM
ALLERGIES	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NN	O
father	NN	O
died	VBD	O
at	IN	O
age	NN	O
69	CD	O
with	IN	O
metastatic	JJ	B-PROBLEM
prostate	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
&apos;s	NN	O
sister	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
any	DT	O
alcoholic	JJ	O
beverages	NNS	O
during	IN	O
this	DT	B-PROBLEM
pregnancy	NN	I-PROBLEM
.	.	O

Blood	NNP	B-TEST
pressure	NN	I-TEST
was	VBD	O
98/64	CD	O
.	.	O

Pulse	RB	B-TEST
82	CD	O
.	.	O

Respiratory	JJ	B-TEST
rate	NN	I-TEST
20	CD	O
.	.	O

Skin	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
parietal	JJ	I-PROBLEM
scalp	NN	I-PROBLEM
nodle	JJ	I-PROBLEM
measuring	VBG	O
2	CD	O
x	JJ	O
3	CD	O
cm	NN	O
which	WDT	O
was	VBD	O
very	RB	O
firm	JJ	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
firm	NN	I-PROBLEM
nodule	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
thoracic	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	O
the	DT	O
back	NN	O
between	IN	O
the	DT	O
midline	NN	O
and	CC	O
the	DT	O
scapula	NN	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
firm	NN	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
upper	JJ	O
quadrant	NN	O
of	IN	O
the	DT	O
abdomen	NNS	O
.	.	O

HEENT	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

Back	RB	O
was	VBD	O
without	IN	O
CVA	NNP	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
scapular	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

There	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
thoracic	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

There	EX	O
were	VBD	O
no	DT	O
rales	NNS	B-PROBLEM
or	CC	O
wheezes	NNS	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
egophony	NN	B-PROBLEM
.	.	O

Cardiac	NNP	B-TEST
exam	NN	I-TEST
was	VBD	O
tachycardic	JJ	B-PROBLEM
and	CC	O
regular	JJ	O
,	,	O
normal	JJ	O
S1	NNP	O
and	CC	O
S2	NNP	O
.	.	O

There	EX	O
was	VBD	O
a	DT	B-PROBLEM
II	NNP	I-PROBLEM
/	NNP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
loudest	NN	O
at	IN	O
the	DT	O
left	JJ	O
upper	JJ	O
sternal	JJ	O
border	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
heave	NN	B-PROBLEM
.	.	O

Abdomen	NNP	O
was	VBD	O
gravid	NN	B-PROBLEM
.	.	O

The	DT	O
abdomen	NNS	O
was	VBD	O
tympanitic	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

The	DT	O
liver	NN	O
was	VBD	O
11	CD	O
cm	NN	O
by	IN	O
percussion	NN	B-TEST
.	.	O

Extremities	NNS	O
revealed	VBD	O
1+	CD	B-PROBLEM
bipedal	JJ	I-PROBLEM
edema	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

Neurological	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
.	.	O

Sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
.	.	O

Deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
1-2+	JJ	O
and	CC	O
symmetric	JJ	O
bilaterally	RB	O
.	.	O

On	IN	O
admission	NN	O
included	VBD	O
an	DT	B-TEST
ALT	NNP	I-TEST
of	IN	O
108	CD	O
,	,	O
AST	NNP	B-TEST
of	IN	O
286	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
3.0	CD	O
,	,	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
of	IN	O
2.0	CD	O
.	.	O

Alkaline	NNP	B-TEST
phosphatase	NN	I-TEST
1148	CD	O
.	.	O

LDH	NNP	B-TEST
806	CD	O
.	.	O

Calcium	NN	B-TEST
11.8	CD	O
.	.	O

Albumin	$	B-TEST
2.3	CD	O
.	.	O

Hematocrit	NNP	B-TEST
was	VBD	O
30.6	CD	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.14	CD	O
.	.	O

PT	NNP	B-TEST
was	VBD	O
13.2	CD	O
.	.	O

PTT	NNP	B-TEST
was	VBD	O
29.8	CD	O
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
termination	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
pregnancy	NN	I-PROBLEM
on	IN	O
1/13/91	CD	O
.	.	O

The	DT	B-TEST
work-up	NN	I-TEST
for	IN	O
the	DT	O
extent	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
included	VBD	O
MRI	NNP	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
cervical	JJ	I-TEST
and	CC	I-TEST
thoracic	JJ	I-TEST
spine	NN	I-TEST
which	WDT	O
revealed	VBD	O
multiple	JJ	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
vertebral	JJ	I-PROBLEM
bodies	NNS	I-PROBLEM
;	:	O
a	DT	B-PROBLEM
T3	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
extending	VBG	O
from	IN	O
the	DT	O
body	NN	O
to	TO	O
the	DT	O
right	JJ	O
neural	NN	O
for	IN	O
amina	NN	O
with	IN	O
foraminal	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

An	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
present	JJ	O
at	IN	O
T10	NNP	O
which	WDT	O
was	VBD	O
extending	VBG	O
from	IN	O
the	DT	O
lamina	NN	O
or	CC	O
spinous	JJ	O
process	NN	O
anteriorly	RB	O
and	CC	O
almost	RB	O
compressing	VBG	O
the	DT	O
spinal	JJ	O
cord	NN	O
.	.	O

An	DT	B-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvic	JJ	I-TEST
CT	NNP	I-TEST
scan	NN	I-TEST
with	IN	I-TEST
IV	NNP	I-TEST
contrast	NN	I-TEST
revealed	VBD	O
bilateral	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodules	NNS	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
extensive	JJ	B-PROBLEM
liver	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
,	,	O
narrowing	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
intra	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
IVC	NNP	I-PROBLEM
and	CC	O
distention	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
azygous	JJ	I-PROBLEM
system	NN	I-PROBLEM
suggestive	NN	O
of	IN	O
IVC	NNP	B-PROBLEM
obstruction	NN	I-PROBLEM
by	IN	O
liver	NN	B-PROBLEM
metastases	NNS	I-PROBLEM
;	:	O
ascites	NNS	B-PROBLEM
;	:	O
multiple	JJ	B-PROBLEM
bony	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
;	:	O
and	CC	O
an	DT	B-PROBLEM
isolated	JJ	I-PROBLEM
splenic	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

A	DT	B-TEST
bone	NN	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
increased	JJ	B-PROBLEM
uptake	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
chest	NN	I-PROBLEM
wall	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
ribs	NNS	I-PROBLEM
four	CD	I-PROBLEM
to	TO	I-PROBLEM
six	CD	I-PROBLEM
,	,	O
and	CC	O
increased	VBD	B-PROBLEM
uptake	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
skull	NN	I-PROBLEM
in	IN	O
the	DT	O
area	NN	O
of	IN	O
the	DT	O
parotids	NNS	O
.	.	O

Ahead	NNP	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
vertex	NN	O
of	IN	O
the	DT	O
calvarium	NN	O
but	CC	O
no	DT	O
intracranial	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

Work-up	NNP	B-TEST
for	IN	O
the	DT	O
source	NN	O
of	IN	O
the	DT	B-PROBLEM
primary	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
still	RB	O
unknown	JJ	O
included	VBD	O
a	DT	B-TEST
mammogram	NN	I-TEST
which	WDT	O
identified	VBD	O
no	DT	O
suspicious	JJ	B-PROBLEM
microcalcifications	NNS	I-PROBLEM
and	CC	O
no	DT	O
dominant	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvic	JJ	I-TEST
CT	NNP	I-TEST
scans	NNS	I-TEST
showed	VBD	O
no	DT	O
suspicious	JJ	B-PROBLEM
GI	NNP	I-PROBLEM
masses	NNS	I-PROBLEM
,	,	O
no	DT	O
pancreatic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
;	:	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
cm	NN	I-PROBLEM
ovarian	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
.	.	O

The	DT	O
review	NN	O
of	IN	O
the	DT	B-TEST
pathology	NN	I-TEST
from	IN	O
Bri	NNP	O
Health	NNP	O
confirmed	VBD	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
grade	NN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

Erica	NNP	B-TEST
and	CC	I-TEST
basic	JJ	I-TEST
cystic	JJ	I-TEST
protein	NN	I-TEST
stains	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
.	.	O

Serum	NN	B-TEST
markers	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

The	DT	B-TEST
CEA	NNP	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
0.7	CD	O
.	.	O

The	DT	B-TEST
hCG	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
was	VBD	O
30,710	CD	O
and	CC	O
on	IN	O
1/19	CD	O
was	VBD	O
805	CD	O
.	.	O

The	DT	B-TEST
CA-125	NNP	I-TEST
was	VBD	O
still	RB	O
pending	VBG	O
and	CC	O
alphafeto	JJ	B-TEST
protein	NN	I-TEST
is	VBZ	O
still	RB	O
pending	VBG	O
.	.	O

Hypercalcemia	NN	B-PROBLEM
:	:	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	B-TEST
serum	JJ	I-TEST
calcium	NN	I-TEST
of	IN	O
11.8	CD	O
and	CC	O
an	DT	B-TEST
albumin	NN	I-TEST
of	IN	O
2.3	CD	O
on	IN	O
admission	NN	O
.	.	O

She	PRP	O
received	VBD	O
three	CD	O
days	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
etidronate	NN	I-TREATMENT
with	IN	O
normal	JJ	B-TREATMENT
saline	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
the	DT	B-TEST
serum	NN	I-TEST
calcium	NN	I-TEST
subsequently	RB	O
decreased	VBD	O
to	TO	O
9.0	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
then	RB	O
switched	VBN	O
to	TO	O
po	VB	B-TREATMENT
etidronate	NN	I-TREATMENT
.	.	O

IVC	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
has	VBZ	O
extensive	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
and	CC	O
by	IN	O
CT	NNP	B-TEST
scan	JJ	I-TEST
there	EX	O
is	VBZ	O
obstruction	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
IVC	NNP	I-PROBLEM
.	.	O

This	DT	O
has	VBZ	O
resulted	VBN	O
in	IN	O
marked	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
presacral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
ascites	NNS	B-PROBLEM
.	.	O

The	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
low	JJ	I-PROBLEM
serum	NN	I-PROBLEM
albumin	NN	I-PROBLEM
is	VBZ	O
also	RB	O
contributing	VBG	O
to	TO	O
her	PRP$	B-PROBLEM
extensive	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

Hypoxia	NNP	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
:	:	O

Although	IN	O
the	DT	B-TEST
patient	JJ	I-TEST
&apos;s	NN	I-TEST
room	NN	I-TEST
air	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
during	IN	O
this	DT	O
admission	NN	O
,	,	O
she	PRP	O
subjectively	RB	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

It	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
extensive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
resulted	VBD	O
in	IN	O
increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
respiration	NN	I-PROBLEM
and	CC	O
a	DT	O
sensation	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Impending	VBG	B-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
:	:	O

The	DT	O
patient	NN	O
had	VBD	O
back	RP	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
admission	NN	O
without	IN	O
any	DT	B-PROBLEM
focal	JJ	I-PROBLEM
neurological	JJ	I-PROBLEM
signs	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
MRI	NNP	I-TEST
scan	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
impending	JJ	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
at	IN	O
the	DT	O
level	NN	O
of	IN	O
T10	NNP	O
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Decadron	NNP	B-TREATMENT
and	CC	O
on	IN	O
1/17	CD	O
began	VBD	O
the	DT	O
first	JJ	O
of	IN	O
ten	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
to	TO	O
two	CD	O
fields	NNS	O
(	(	O
T2	NNP	O
to	TO	O
T5	NNP	O
and	CC	O
T9	NNP	O
to	TO	O
T11	NNP	O
)	)	O
.	.	O

Per	IN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
wishes	NNS	O
,	,	O
Dr.	NNP	O
Dalywoo	NNP	O
Droreite	NNP	O
the	DT	O
Windgo	NNP	O
Hospital	NNP	O
was	VBD	O
consulted	VBN	O
for	IN	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
the	DT	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
malignancy	NN	I-PROBLEM
.	.	O

Dr.	NNP	O
Linke	NNP	O
recommended	VBD	O
chemotherapy	NN	B-TREATMENT
with	IN	I-TREATMENT
PFL	NNP	I-TREATMENT
.	.	O

Per	IN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
wishes	NNS	O
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
Windgo	NNP	O
Hospital	NNP	O
for	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

ALT	NNP	B-TEST
was	VBD	O
53	CD	O
.	.	O

AST	NNP	B-TEST
was	VBD	O
89	CD	O
.	.	O

Her	PRP$	B-TEST
LDH	NNP	I-TEST
was	VBD	O
394	CD	O
.	.	O

Her	PRP$	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
was	VBD	O
1514	CD	O
.	.	O

Total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
2.1	CD	O
.	.	O

Direct	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
1.4	CD	O
.	.	O

Albumin	NNP	B-TEST
was	VBD	O
2.3	CD	O
.	.	O

Calcium	NN	B-TEST
9.1	CD	O
.	.	O

Hematocrit	NNP	B-TEST
was	VBD	O
32.5	CD	O
.	.	O

White	NNP	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
16.89	CD	O
.	.	O

PT	NNP	B-TEST
was	VBD	O
12.9	CD	O
.	.	O

PTT	NNP	B-TEST
was	VBD	O
27.3	CD	O
.	.	O

On	IN	O
discharge	NN	O
included	VBD	O
etidronate	NN	B-TREATMENT
,	,	O
475	CD	O
mg	NN	O
IV	NNP	O
q	NNP	O
day	NN	O
;	:	O
heparin	NN	B-TREATMENT
,	,	O
5000	CD	O
units	NNS	O
subcutaneously	RB	O
b.i.d.	VBP	O
;	:	O
Decadron	NNP	B-TREATMENT
,	,	O
4	CD	O
mg	NN	O
po	NN	O
q	NN	O
six	CD	O
hours	NNS	O
;	:	O
MS	NNP	B-TREATMENT
Contin	NNP	I-TREATMENT
,	,	O
45	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
;	:	O
Pepcid	NNP	B-TREATMENT
,	,	O
20	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
;	:	O
Senekot	NNP	B-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
po	NN	O
t.i.d.	NN	O
;	:	O
Bronkosol	NNP	B-TREATMENT
,	,	O
0.25	CD	O
cc	NN	O
q	RB	O
four	CD	O
hours	NNS	O
.	.	O

It	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
have	VB	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
medical	JJ	I-PROBLEM
and	CC	I-PROBLEM
oncological	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
managed	VBN	O
at	IN	O
Windgo	NNP	O
Hospital	NNP	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

1.	CD	O
Undesired	NNP	B-PROBLEM
fertility	NN	I-PROBLEM
.	.	O

2.	CD	O
Undesired	NNP	B-PROBLEM
adiposity	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
30	CD	O
-year-old	JJ	O
Gravida	NNP	O
III	NNP	O
,	,	O
Para	NNP	O
II	NNP	O
who	WP	O
presented	VBD	O
desiring	VBG	O
definitive	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
sterilization	NN	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
extensively	RB	O
counseled	VBN	O
regarding	VBG	O
other	JJ	O
methods	NNS	O
of	IN	O
birth	NN	B-TREATMENT
control	NN	I-TREATMENT
and	CC	O
desired	VBD	O
to	TO	O
proceed	VB	O
with	IN	O
definitive	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
desired	VBD	O
liposuction	NN	B-TREATMENT
of	IN	I-TREATMENT
varying	VBG	I-TREATMENT
areas	NNS	I-TREATMENT
as	RB	O
well	RB	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
consented	VBN	O
for	IN	O
both	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
and	CC	O
brought	VBD	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NNP	O
.	.	O

Appendectomy	NN	B-TREATMENT
at	IN	O
the	DT	O
age	NN	O
of	IN	O
14	CD	O
,	,	O
open	JJ	O
.	.	O

Spontaneous	JJ	B-PROBLEM
vaginal	JJ	I-PROBLEM
delivery	NN	I-PROBLEM
x	NN	O
2	CD	O
.	.	O

Regular	JJ	O
menses	NNS	O
,	,	O
on	IN	O
Ortho-Tri-Cyclen	NNP	B-TREATMENT
.	.	O

No	DT	O
history	NN	O
of	IN	O
sexually	RB	B-PROBLEM
transmitted	VBN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
domestic	JJ	O
violence	NN	O
.	.	O

1.	CD	O
Ortho	NNP	B-TREATMENT
Tri-Cyclen	NNP	I-TREATMENT
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Height	$	B-TEST
5	CD	O
&apos;	$	O
1	CD	O
&quot;	NNP	O
,	,	O
weight	VBD	B-TEST
138	CD	O
lb.	NN	O

Blood	NN	B-TEST
pressure	NN	I-TEST
:	:	O

130/82	CD	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
bilaterally	RB	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

Pelvic	NNP	B-TEST
exam	NN	I-TEST
revealed	VBD	O
normal	JJ	O
vulva	NN	O
,	,	O
vagina	FW	O
normal	JJ	O
,	,	O
cervix	JJ	O
normal	JJ	O
,	,	O
uterus	JJ	O
anteverted	VBD	O
,	,	O
small	JJ	O
,	,	O
nontender	NN	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
Operating	NN	O
Room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
unremarkable	JJ	I-TREATMENT
laparoscopic	NN	I-TREATMENT
tubal	JJ	I-TREATMENT
ligation	NN	I-TREATMENT
.	.	O

This	DT	O
was	VBD	O
done	VBN	O
with	IN	O
Falope	NNP	B-TREATMENT
rings	NNS	I-TREATMENT
.	.	O

The	DT	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
minimal	JJ	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
600	CD	O
cc.	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
negative	JJ	O
urine	JJ	O
pregnancy	NN	O
test	NN	O
prior	RB	O
to	TO	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
then	RB	O
underwent	JJ	O
liposuction	NN	B-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
abdomen	NNS	I-TREATMENT
,	,	I-TREATMENT
inner	JJ	I-TREATMENT
thighs	NNS	I-TREATMENT
,	,	I-TREATMENT
hips	NNS	I-TREATMENT
,	,	I-TREATMENT
flanks	NNS	I-TREATMENT
,	,	I-TREATMENT
chest	NN	I-TREATMENT
and	CC	I-TREATMENT
arms	NNS	I-TREATMENT
with	IN	O
Dr.	NNP	O
Chain	NNP	O
.	.	O

She	PRP	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
GYN	NNP	O
Service	NNP	O
postoperatively	RB	O
because	IN	O
the	DT	O
patient	NN	O
had	VBD	O
persistent	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
#one	NN	O
,	,	O
she	PRP	O
was	VBD	O
then	RB	O
stable	JJ	O
with	IN	O
no	DT	O
complaints	NNS	B-PROBLEM
.	.	O

She	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

Her	PRP$	B-TREATMENT
Foley	NNP	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

Motrin	NNP	B-TREATMENT
and	CC	O
Percocet	NNP	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

EVAL	NN	B-TEST

PTSD	NN	B-PROBLEM

.5	NNS	B-TREATMENT
Risperdal	NNP	I-TREATMENT

Continue	NNP	O
w/	VBD	O
Risperdal	NNP	B-TREATMENT
per	IN	O
new	JJ	O
psychiatrist	NN	O

B	NNP	B-TREATMENT
and	CC	I-TREATMENT
W	NNP	I-TREATMENT
and	CC	O
work	NN	O
w/	NNS	O
therapist	VBP	O
re:	JJ	O
historical	JJ	O
issues	NNS	O
.	.	O

If	IN	O
symptoms	NNS	B-PROBLEM
continue	VBP	O
to	TO	O
be	VB	O
overwhelming	VBG	B-PROBLEM
return	NN	O
to	TO	O
V	NNP	O
or	CC	O
call	VB	O
1-903-263-5797	JJ	O

PROSTATE	NN	B-PROBLEM
CANCER	NNP	I-PROBLEM
AND	NNP	O
RENAL	NNP	B-PROBLEM
FAILURE	NNP	I-PROBLEM

ACUTE	NNP	B-PROBLEM
RENAL	NNP	I-PROBLEM
FAILURE	NNP	I-PROBLEM
.	.	O

SIGNIFICANT	JJ	B-PROBLEM
PROBLEMS	NNP	I-PROBLEM
:	:	O

1.	CD	O
METASTATIC	NNP	B-PROBLEM
PROSTATE	NNP	I-PROBLEM
CA	NNP	I-PROBLEM
.	.	O

2.	CD	O
OBSTRUCTIVE	NNP	B-PROBLEM
UROPATHY	NNP	I-PROBLEM
,	,	O
STATUS	NNP	B-PROBLEM
POST	NNP	I-PROBLEM
LEFT	NNP	I-PROBLEM
NEPHROSTOMY	NNP	I-PROBLEM
.	.	O

3.	CD	O
HYPERTENSION	NNP	B-PROBLEM
.	.	O

4.	CD	O
ANEMIA	NNP	B-PROBLEM
.	.	O

5.	CD	O
GASTROESOPHAGEAL	NNP	B-PROBLEM
REFLUX	NNP	I-PROBLEM
DISEASE	NNP	I-PROBLEM
.	.	O

This	DT	O
88-year-old	JJ	O
male	NN	O
with	IN	O
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
CA	NNP	I-PROBLEM
was	VBD	O
admitted	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
secondary	JJ	O
to	TO	O
persistent	JJ	B-PROBLEM
hematuria	NN	I-PROBLEM
status	NN	O
post	NN	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
transferred	VBD	O
to	TO	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

HISTORY	NN	O
OF	NNP	O
PRESENT	NNP	B-PROBLEM
ILLNESS	NNP	I-PROBLEM
:	:	O

Mr.	NNP	O
Prehekote	NNP	O
is	VBZ	O
an	DT	O
88-year-old	JJ	O
Portuguese	JJ	O
speaking	VBG	O
only	RB	O
male	NN	O
who	WP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
adenocarcinoma	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
prostate	NN	I-PROBLEM
in	IN	O
1998	CD	O
.	.	O

He	PRP	O
received	VBD	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
one	CD	O
year	NN	O
ago	RB	O
because	IN	O
of	IN	O
persistent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
retention	NN	I-PROBLEM
.	.	O

After	IN	O
that	DT	O
,	,	O
he	PRP	O
was	VBD	O
on	IN	O
Lupron	NNP	B-TREATMENT
and	CC	O
Nilandron	NNP	B-TREATMENT
hormone	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
February	NNP	O
23	CD	O
,	,	O
1999	CD	O
to	TO	O
Eifro	NNP	O
Medical	NNP	O
Center	NNP	O
because	IN	O
of	IN	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
thrive	VB	I-PROBLEM
and	CC	O
decreased	JJ	B-PROBLEM
hematocrit	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
BUN	NNP	B-TEST
and	CC	O
creatinine	NN	B-TEST
.	.	O

BUN	NNP	B-TEST
was	VBD	O
34	CD	O
and	CC	O
creatinine	NN	B-TEST
was	VBD	O
2.6	CD	O
,	,	O
up	RB	O
from	IN	O
his	PRP$	O
baseline	NN	O
of	IN	O
1.0	CD	O
.	.	O

Prostate	NNP	B-TEST
specific	JJ	I-TEST
antigen	NN	I-TEST
increased	VBD	O
from	IN	O
77.9	CD	O
to	TO	O
88	CD	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
and	CC	O
body	NN	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

Further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
his	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
has	VBZ	O
bilateral	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
obstructive	JJ	B-PROBLEM
uropathy	JJ	I-PROBLEM
due	JJ	O
to	TO	O
prostate	VB	B-PROBLEM
CA	NNP	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pelvic	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

Because	IN	O
of	IN	O
the	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
creatinine	NN	I-PROBLEM
to	TO	O
8.0	CD	O
on	IN	O
February	NNP	O
28	CD	O
,	,	O
1999	CD	O
,	,	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

However	RB	O
after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
hematocrit	NN	I-PROBLEM
dropped	VBD	I-PROBLEM
to	TO	O
24	CD	O
and	CC	O
he	PRP	O
was	VBD	O
transfused	VBN	O
two	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

His	PRP$	B-TEST
hematocrit	NN	I-TEST
increased	VBD	O
to	TO	O
about	IN	O
30	CD	O
,	,	O
but	CC	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
hematuria	NNS	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
renal	JJ	I-TEST
function	NN	I-TEST
only	RB	O
improved	VBD	O
very	RB	O
slowly	RB	O
.	.	O

He	PRP	O
also	RB	O
received	VBD	O
Kayexalate	NNP	B-TREATMENT
for	IN	O
hyperkalemia	NN	B-PROBLEM
.	.	O

Due	JJ	O
to	TO	O
the	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
Eifro	NNP	O
Medical	NNP	O
Center	NNP	O
to	TO	O
the	DT	O
Retelk	NNP	O
County	NNP	O
Medical	NNP	O
Center	NNP	O
for	IN	O
angiographic	JJ	B-TEST
studies	NNS	I-TEST
to	TO	O
rule	VB	O
out	RP	O
any	DT	O
vascular	JJ	B-PROBLEM
injuries	NNS	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
constipation	NN	B-PROBLEM
with	IN	O
dysuria	NN	B-PROBLEM
,	,	O
but	CC	O
no	DT	O
fever	NN	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

No	DT	O
cough	NN	B-PROBLEM
.	.	O

No	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

No	DT	O
palpitations	NNS	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
body	NN	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

No	DT	O
headache	NN	B-PROBLEM
.	.	O

No	DT	O
bone	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

1)	CD	O
Hypertension	NNP	B-PROBLEM
.	.	O

2)	CD	O
Gastroesophageal	NNP	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3)	CD	O
Anemia	NNP	B-PROBLEM
.	.	O

4)	CD	O
Prostate	NNP	B-PROBLEM
CA	NNP	I-PROBLEM
.	.	O

ALLERGIES	NNS	B-PROBLEM
:	:	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

Clonidine	NNP	B-TREATMENT
2.5	CD	O
milligrams	NNS	O
topical	JJ	O
q.	NN	O
week	NN	O
,	,	O
Nitropaste	NNP	B-TREATMENT
2	CD	O
inches	NNS	O
q.4h.	RB	O
,	,	O
Nilandron	NNP	B-TREATMENT
50	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
Lupron	NNP	B-TREATMENT
,	,	O
Dulcolax	NNP	B-TREATMENT
p.r.n.	NN	O
,	,	O
Colace	NNP	B-TREATMENT
100	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
Ferrous	NNP	B-TREATMENT
sulfate	VBP	I-TREATMENT
300	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
Lansopiacole	NNP	B-TREATMENT
15	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
bethanechol	NN	B-TREATMENT
25	CD	O
milligrams	NNS	O
p.o.	VBP	O
t.i.d.	NN	O

On	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
frail	NN	O
looking	VBG	O
elderly	JJ	O
male	NN	O
lying	VBG	O
in	IN	O
bed	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Temperature	NN	B-TEST
95.4	CD	O
,	,	O
pulse	RB	B-TEST
120	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
150/80	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
24	CD	O
,	,	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

Isocoric	NNP	B-PROBLEM
cataract	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

Mucous	JJ	B-PROBLEM
membranes	NNS	I-PROBLEM
slightly	RB	I-PROBLEM
dry	VBP	I-PROBLEM
.	.	O

No	DT	O
oral	JJ	B-PROBLEM
ulcers	NNS	I-PROBLEM
.	.	O

No	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

Chest	NNP	B-TEST
examination	NN	I-TEST
showed	VBD	O
some	DT	B-PROBLEM
basilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

Heart	NNP	O
initially	RB	O
tachycardia	VBD	B-PROBLEM
,	,	O
grade	VBD	B-PROBLEM
II	NNP	I-PROBLEM
/	NNP	I-PROBLEM
VI	NNP	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

Traced	NNP	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

No	DT	O
cyanosis	NN	B-PROBLEM
and	CC	O
no	DT	O
clubbing	NN	B-PROBLEM
.	.	O

Peripheral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
very	RB	O
strong	JJ	O
and	CC	O
bounding	NN	O
.	.	O

No	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

Homan	NNP	B-TEST
&apos;s	NNP	I-TEST
sign	NN	I-TEST
negative	JJ	O
.	.	O

Examination	NN	B-TEST
was	VBD	O
limited	VBN	O
because	IN	O
the	DT	O
patient	NN	O
speaks	VBZ	O
only	RB	O
Portuguese	JJ	O
.	.	O

On	IN	O
admission	NN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
biochemistry	NN	O
showed	VBD	O
sodium	NN	B-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
bicarb	NN	B-TEST
14	CD	O
,	,	O
BUN	NNP	B-TEST
63	CD	O
,	,	O
creatinine	NN	B-TEST
5.8	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
133	CD	O
.	.	O

Liver	NNP	B-TEST
function	NN	I-TEST
test	NN	I-TEST
showed	VBD	O
AST	NNP	B-TEST
21	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
70	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.3	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.5	CD	O
,	,	O
albumin	RB	B-TEST
3.9	CD	O
,	,	O
globulin	NN	B-TEST
2.6	CD	O
.	.	O

CBC	NN	B-TEST
:	:	O

WBC	NNP	B-TEST
8.4	CD	O
,	,	O
hematocrit	NN	B-TEST
32.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
194,000	CD	O
.	.	O

PT	NNP	B-TEST
11.9	CD	O
,	,	O
INR	NNP	B-TEST
1.0	CD	O
,	,	O
PTT	NNP	B-TEST
28.4	CD	O
.	.	O

Chest	NNP	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cardiomegaly	NN	B-PROBLEM
.	.	O

No	DT	O
lung	NN	B-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

CT	NNP	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
renal	JJ	I-TEST
area	NN	I-TEST
showed	VBD	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
which	WDT	O
extends	VBZ	O
to	TO	O
an	DT	B-PROBLEM
asymmetrically	RB	I-PROBLEM
thickened	JJ	I-PROBLEM
urinary	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
wall	NN	I-PROBLEM
.	.	O

A	DT	B-PROBLEM
mass	NN	I-PROBLEM
like	IN	I-PROBLEM
thickening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
urinary	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
suggestive	NN	O
of	IN	O
either	DT	O
detrusor	NN	B-PROBLEM
hypertrophy	NN	I-PROBLEM
or	CC	O
possibly	RB	O
tumor	NN	B-PROBLEM
.	.	O

The	DT	B-TEST
CT	NNP	I-TEST
scan	JJ	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
cavitary	JJ	I-PROBLEM
lung	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
compatible	JJ	O
with	IN	O
metastatic	JJ	O
or	CC	O
septic	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
.	.	O

EKG	NN	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
LVH	NNP	B-PROBLEM
,	,	O
nonspecific	JJ	B-PROBLEM
ST-T	NNP	I-PROBLEM
changes	NNS	I-PROBLEM
either	CC	O
due	JJ	O
to	TO	O
digitalis	VB	B-PROBLEM
affect	NN	I-PROBLEM
.	.	O

CK	NNP	B-TEST
enzymes	VBZ	I-TEST
146	CD	O
.	.	O

Troponin	NNP	B-TEST
I	PRP	I-TEST
on	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
was	VBD	O
1.18	CD	O
.	.	O

The	DT	O
specialist	NN	O
concluded	VBD	O
that	IN	O
because	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
seemed	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
and	CC	O
hematocrit	NN	B-TEST
to	TO	O
maintain	VB	O
at	IN	O
about	RB	O
29-30	JJ	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
urgent	JJ	O
need	NN	O
to	TO	O
do	VB	O
an	DT	B-TEST
arteriogram	NN	I-TEST
which	WDT	O
may	MD	O
cause	VB	O
further	JJ	B-PROBLEM
damage	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
kidney	NN	I-PROBLEM
.	.	O

Urology	NNP	B-TEST
consultation	NN	I-TEST
thinks	VBZ	O
that	IN	O
cystoscopy	NN	B-TREATMENT
would	MD	O
not	RB	O
add	VB	O
any	DT	O
benefit	NN	O
to	TO	O
the	DT	O
management	NN	O
and	CC	O
only	RB	O
would	MD	O
consider	VB	O
a	DT	B-TREATMENT
right	NN	I-TREATMENT
nephrostomy	NN	I-TREATMENT
if	IN	O
renal	JJ	B-PROBLEM
function	NN	I-PROBLEM
failed	VBD	O
to	TO	O
improve	VB	O
.	.	O

After	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
conservatively	RB	O
to	TO	O
correct	VB	O
his	PRP$	B-PROBLEM
electrolyte	NN	I-PROBLEM
and	CC	I-PROBLEM
metabolic	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

He	PRP	O
was	VBD	O
given	VBN	O
blood	NN	B-TREATMENT
transfusion	NN	I-TREATMENT
,	,	O
two	CD	O
units	NNS	O
when	WRB	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
to	TO	O
29.4	CD	O
.	.	O

After	IN	O
transfusion	NN	B-TREATMENT
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
hematocrit	NN	I-TEST
rose	VBD	O
to	TO	O
37.7	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
to	TO	O
correct	VB	O
his	PRP$	B-PROBLEM
metabolic	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

He	PRP	O
continued	VBD	O
to	TO	O
pass	VB	O
about	IN	O
1500-2000	CD	O
cc	NN	O
of	IN	O
urine	JJ	O
a	DT	O
day	NN	O
and	CC	O
his	PRP$	B-TEST
renal	JJ	I-TEST
function	NN	I-TEST
improved	VBD	O
slowly	RB	O
with	IN	O
creatinine	NN	B-TEST
decreased	VBN	O
to	TO	O
4.2	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

During	IN	O
this	DT	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
developed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
ventricular	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
about	IN	O
70-80	NNP	O
.	.	O

CPK	NNP	B-TEST
was	VBD	O
tracked	VBN	O
,	,	O
but	CC	O
was	VBD	O
totally	RB	O
normal	JJ	O
.	.	O

No	DT	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
were	VBD	O
given	VBN	O
.	.	O

A	DT	O
long	JJ	O
discussion	NN	O
amongst	IN	O
the	DT	O
specialist	NN	O
,	,	O
nephrology	NN	O
,	,	O
urology	NN	O
,	,	O
interventional	JJ	O
radiology	NN	O
,	,	O
primary	JJ	O
oncology	NN	O
as	RB	O
well	RB	O
with	IN	O
the	DT	O
family	NN	O
lead	NN	O
to	TO	O
the	DT	O
conclusion	NN	O
that	WDT	O
conservative	JJ	B-TREATMENT
management	NN	I-TREATMENT
may	MD	O
give	VB	O
the	DT	O
patient	NN	O
more	JJR	O
comfort	NN	O
than	IN	O
crisis	NN	B-TREATMENT
treatment	NN	I-TREATMENT
in	IN	O
this	DT	B-PROBLEM
well	NN	I-PROBLEM
advanced	VBD	I-PROBLEM
prostate	NN	I-PROBLEM
CA	NNP	I-PROBLEM
.	.	O

Dr.	NNP	O
Lucreamull	NNP	O
discussed	VBD	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
clinical	JJ	O
status	NN	O
and	CC	O
overall	JJ	O
situation	NN	O
with	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
and	CC	O
the	DT	O
family	NN	O
decided	VBD	O
that	IN	O
Mr.	NNP	O
Prehekote	NNP	O
could	MD	O
return	VB	O
home	NN	O
with	IN	O
hospice	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
&apos;s	NNP	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
Dr.	NNP	O
Tomedankell	NNP	O
Flowayles	NNP	O
will	MD	O
manage	VB	O
the	DT	B-TREATMENT
hospice	NN	I-TREATMENT
issues	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
for	IN	O
hospice	NN	B-TREATMENT
on	IN	O
March	NNP	O
8	CD	O
,	,	O
1999	CD	O
.	.	O

Bethanechol	NNP	B-TREATMENT
25	CD	O
milligrams	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
,	,	O
Clonidine	NNP	B-TREATMENT
2.5	CD	O
milligrams	NNS	O
topical	JJ	O
q.	NN	O
week	NN	O
,	,	O
apply	VB	O
every	DT	O
Sunday	NNP	O
,	,	O
Colace	NNP	B-TREATMENT
100	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
Haldol	NNP	B-TREATMENT
0.5-1	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.6-8h.	JJ	O
p.r.n.	NN	O
agitation	NN	B-PROBLEM
,	,	O
Niferex	NNP	B-TREATMENT
150	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
nitroglycerin	JJ	B-TREATMENT
paste	NN	I-TREATMENT
2%	CD	O
,	,	O
2	CD	O
inches	NNS	O
topical	JJ	O
q.8h.	NN	O
,	,	O
Prilosec	NNP	B-TREATMENT
20	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
Senna	NNP	B-TREATMENT
tablets	VBZ	I-TREATMENT
2	CD	O
tablets	NNS	O
b.i.d.	RB	O
,	,	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
650	CD	O
milligrams	NNS	O
p.o.	VBP	O
t.i.d.	NN	O
for	IN	O
five	CD	O
days	NNS	O
,	,	O
Proscar	NNP	B-TREATMENT
5	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
Casodex	NNP	B-TREATMENT
50	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
Nephrocaps	NNP	B-TREATMENT
1	CD	O
tablets	NNS	O
p.o.	VBP	O
q.d.	NN	O

Home	NN	O
with	IN	O
hospice	NN	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
AF-RESOLVED	NNP	B-PROBLEM
.	.	O

Following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
TREATED	NNP	O
AND	NNP	O
RELEASED	NNP	O
.	.	O

EXTERNAL	NNP	B-PROBLEM
WOUND	NNP	I-PROBLEM
INFECTIONS	NNP	I-PROBLEM

STERNAL	NNP	B-PROBLEM
WOUND	NNP	I-PROBLEM
INFECTION	NNP	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
74-year-old	JJ	O
woman	NN	O
,	,	O
well	RB	O
known	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
,	,	O
readmitted	VBN	O
from	IN	O
Glasmif/putdi	NNP	O
Health	NNP	O
Network	NNP	O
with	IN	O
sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
previously	RB	O
hospitalized	VBN	O
on	IN	O
12	CD	O
April	NNP	O
1998	CD	O
for	IN	O
the	DT	B-PROBLEM
same	JJ	I-PROBLEM
diagnosis	NN	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
now	RB	O
coming	VBG	O
for	IN	O
surgical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
,	,	O
wound	NN	B-TREATMENT
debridement	NN	I-TREATMENT
,	,	O
and	CC	O
possible	JJ	O
wound	NN	B-TREATMENT
closure	NN	I-TREATMENT
with	IN	I-TREATMENT
bilateral	JJ	I-TREATMENT
pectoralis	NNS	I-TREATMENT
flap	NN	I-TREATMENT
.	.	O

She	PRP	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
two	CD	O
with	IN	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
on	IN	O
29	CD	O
March	NNP	O
1998	CD	O
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
lymphoma	NN	I-PROBLEM
with	IN	O
treatment	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
six	CD	O
years	NNS	O
ago	RB	O
,	,	O
and	CC	O
is	VBZ	O
an	DT	B-PROBLEM
insulin-dependent	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
.	.	O

Insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
lymphoma	NN	B-PROBLEM
as	IN	O
above	IN	O
,	,	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
melanoma	NN	B-PROBLEM
status	NN	O
post	NN	O
excision	NN	B-TREATMENT
in	IN	I-TREATMENT
right	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
and	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
bypass	NN	B-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

She	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
knee	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
status	NN	O
post	NN	O
multiple	JJ	B-TREATMENT
prior	JJ	I-TREATMENT
surgeries	NNS	I-TREATMENT
and	CC	O
reconstruction	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
knee	NN	I-TREATMENT
.	.	O

Status	NNP	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
lumbar	NN	B-TREATMENT
diskectomy	NN	I-TREATMENT
,	,	O
and	CC	O
tonsillectomy	NN	B-TREATMENT
with	IN	O
adenoidectomy	NN	B-TREATMENT
.	.	O

Erythromycin	NNP	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
and	CC	O
Bacitracin	NNP	B-TREATMENT
.	.	O

Elavil	RB	B-TREATMENT
50	CD	O
mg	NNS	O
p.o.	JJ	O
q.h.s.	NN	O
,	,	O
coated	VBD	B-TREATMENT
aspirin	RB	I-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
p.day	NN	O
,	,	O
Tegretol	NNP	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
Ancef	NNP	B-TREATMENT
1	CD	O
gm	NN	O
IV	NNP	O
q.12h.	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
,	,	O
Vasotec	NNP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
Synthroid	NNP	B-TREATMENT
0.025	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
Asacol	NNP	B-TREATMENT
400	CD	O
mg	NN	O
q.a.m.	NN	O
and	CC	O
800	CD	O
mg	NN	O
q.p.m.	NN	O
,	,	O
Lopressor	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
Prilosec	NNP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
and	CC	O
insulin	VBZ	B-TREATMENT
70/30	CD	O
26	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
12	CD	O
units	NNS	O
at	IN	O
night	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
140/80	CD	O
,	,	O
temperature	NN	B-TEST
101.3	CD	O
,	,	O
pulse	RB	B-TEST
84	CD	O
,	,	O
and	CC	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
obese	JJ	B-PROBLEM
with	IN	O
unremarkable	JJ	O
physical	JJ	O
examination	NN	O
except	IN	O
for	IN	O
a	DT	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
I	PRP	B-PROBLEM
/	VBP	I-PROBLEM
VI	NNP	I-PROBLEM
and	CC	I-PROBLEM
erythema	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
upper	JJ	O
third	NN	O
.	.	O

The	DT	B-PROBLEM
wound	NN	I-PROBLEM
had	VBD	O
a	DT	B-PROBLEM
beefy	NN	I-PROBLEM
red	JJ	I-PROBLEM
cellulitic	JJ	I-PROBLEM
area	NN	I-PROBLEM
surrounding	VBG	O
an	DT	O
open	JJ	O
area	NN	O
,	,	O
blanching	VBG	O
to	TO	O
touch	VB	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
purulence	NN	B-PROBLEM
or	CC	O
discharge	NN	B-PROBLEM
noted	VBN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
IV	NNP	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
Ancef	NNP	B-TREATMENT
1	CD	O
gm	NN	O
q.8h.	NN	O

On	IN	O
10	CD	O
May	NNP	O
1998	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
sternal	JJ	B-TREATMENT
wound	NN	I-TREATMENT
debridement	NN	I-TREATMENT
and	CC	I-TREATMENT
closure	NN	I-TREATMENT
,	,	O
performed	VBN	O
by	IN	O
Dr.	NNP	O
Falccouette	NNP	O
and	CC	O
Dr.	NNP	O
Shuffzeln	NNP	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
switched	VBN	O
to	TO	O
ampicillin	VB	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
according	VBG	O
to	TO	O
the	DT	B-TEST
culture	NN	I-TEST
,	,	O
Enterococci	NNP	B-PROBLEM
and	CC	O
Staphylococcus	NNP	B-PROBLEM
in	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

Due	JJ	O
to	TO	O
the	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
the	DT	O
patient	JJ	O
underwent	JJ	O
vancomycin	NN	B-TREATMENT
desensitization	NN	I-TREATMENT
in	IN	O
the	DT	O
surgical	JJ	O
Intensive	NNP	O
Care	NNP	O
Unit	NNP	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
change	NN	I-TREATMENT
of	IN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
to	TO	O
vancomycin	VB	B-TREATMENT
and	CC	O
levofloxacin	VB	B-TREATMENT
.	.	O

Further	JJ	B-TEST
cultures	NNS	I-TEST
from	IN	I-TEST
sputum	NN	I-TEST
and	CC	I-TEST
urine	NN	I-TEST
revealed	VBN	O
yeast	RB	B-PROBLEM
sensitive	JJ	O
to	TO	O
Diflucan	NNP	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
administered	VBN	O
shortly	RB	O
after	IN	O
.	.	O

Because	IN	O
of	IN	O
expected	VBN	B-TREATMENT
long	JJ	I-TREATMENT
term	NN	I-TREATMENT
antibiotic	JJ	I-TREATMENT
administration	NN	I-TREATMENT
,	,	O
a	DT	B-TREATMENT
PICC	NNP	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
prepared	VBN	O
for	IN	O
transfer	NN	O
back	RB	O
to	TO	O
Fo	NNP	O
Hospital	NNP	O
.	.	O

As	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
complication	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
opened	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
ankle	NN	I-PROBLEM
wound	IN	I-PROBLEM
post	NN	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
harvest	NN	I-TREATMENT
,	,	O
which	WDT	O
persists	VBZ	O
up	RP	O
until	IN	O
now	RB	O
and	CC	O
is	VBZ	O
of	IN	O
a	DT	O
size	NN	O
2	CD	O
x	NN	O
1	CD	O
cm	NN	O
.	.	O

Due	JJ	O
to	TO	O
difficult	JJ	B-PROBLEM
ambulation	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
sacral	JJ	I-PROBLEM
area	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
Duoderm	NNP	B-TREATMENT
dressing	VBG	I-TREATMENT
.	.	O

Elavil	NN	B-TREATMENT
by	IN	O
mouth	NN	O
15	CD	O
mg	NN	O
every	DT	O
night	NN	O
,	,	O
Dulcolax	NNP	B-TREATMENT
rectally	RB	O
10	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
Tegretol	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Benadryl	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
Colace	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
200	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Vasotec	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
10	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
EOC	NNP	B-TREATMENT
/	NNP	I-TREATMENT
LOC	NNP	I-TREATMENT
p.r./p.o.	VBP	O
one	CD	O
each	DT	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
,	,	O
Lasix	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
80	CD	O
mg	NN	O
every	DT	O
morning	NN	O
,	,	O
insulin	NN	B-TREATMENT
regular	JJ	O
according	VBG	O
to	TO	O
insulin	VB	O
scale	NN	O
,	,	O
Synthroid	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mcg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
Maalox	NNP	B-TREATMENT
Plus	NNP	I-TREATMENT
Extra	NNP	I-TREATMENT
Strength	NNP	I-TREATMENT
by	IN	O
mouth	NN	O
15	CD	O
ml	NN	O
every	DT	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
,	,	O
Milk	NNP	O
of	IN	O
Magnesia	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
30	CD	O
ml	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
,	,	O
Asacol	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
400	CD	O
mg	NN	O
every	DT	O
morning	NN	O
,	,	O
Asacol	NNP	B-TREATMENT
800	CD	O
mg	NN	O
every	DT	O
night	NN	O
,	,	O
Lopressor	NNP	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
Miracle	NNP	B-TREATMENT
cream	NN	I-TREATMENT
topically	RB	O
on	IN	O
skin	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
nystatin	JJ	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
swallow	JJ	I-TREATMENT
by	IN	O
mouth	NN	O
5	CD	O
ml	NN	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
Percocet	NNP	B-TREATMENT
by	IN	O
mouth	VBG	O
one	CD	O
tab	NN	O
every	DT	O
four	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
by	IN	O
infusion	NN	O
1	CD	O
gm	NN	O
every	DT	O
18	CD	O
hours	NNS	O
;	:	O
instructions	NNS	O
in	IN	O
250	CD	O
ml	NNS	O
slow	JJ	B-TREATMENT
IV	NNP	I-TREATMENT
infusion	NN	I-TREATMENT
over	IN	O
one	CD	O
hour	NN	O
.	.	O

Note	NN	O
,	,	O
please	VB	O
draw	JJ	O
blood	NN	O
for	IN	O
vancomycin	NN	B-TEST
levels	NNS	I-TEST
on	IN	O
25	CD	O
May	NNP	O
1998	CD	O
,	,	O
before	IN	O
the	DT	O
next	JJ	O
dose	NN	O
,	,	O
to	TO	O
get	VB	O
the	DT	B-TEST
trough	JJ	I-TEST
level	NN	I-TEST
.	.	O

Keep	NNP	O
vancomycin	NN	B-TEST
trough	NN	I-TEST
between	IN	O
10-20	JJ	O
,	,	O
but	CC	O
not	RB	O
less	JJR	O
due	JJ	O
to	TO	O
desensitization	NN	B-PROBLEM
.	.	O

Vancomycin	NNP	B-TEST
levels	NNS	I-TEST
should	MD	O
be	VB	O
checked	VBN	O
every	DT	O
third	JJ	O
day	NN	O
for	IN	O
four	CD	O
to	TO	O
six	CD	O
weeks	NNS	O
,	,	O
according	VBG	O
to	TO	O
IMD	NNP	O
.	.	O

Nizatidine	NN	B-TREATMENT
by	IN	O
mouth	NN	O
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
insulin	NN	B-TREATMENT
70/30	CD	O
human	JJ	O
injection	NN	O
under	IN	O
skin	JJ	O
12	CD	O
units	NNS	O
every	DT	O
night	NN	O
,	,	O
insulin	NN	B-TREATMENT
70/30	CD	O
human	JJ	O
injection	NN	O
subcutaneous	JJ	O
26	CD	O
units	NNS	O
every	DT	O
morning	NN	O
,	,	O
Lovenox	NNP	B-TREATMENT
injection	NN	O
under	IN	O
skin	NN	O
40	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
and	CC	O
levofloxacin	NN	B-TREATMENT
by	IN	O
mouth	NN	O
250	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

Non-healing	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

Right	RB	B-TREATMENT
fem	NN	I-TREATMENT
to	TO	I-TREATMENT
below	IN	I-TREATMENT
knee	NNS	I-TREATMENT
pop	VBP	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

This	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
seventy	NN	O
eight	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
above	IN	B-TREATMENT
knee	NN	I-TREATMENT
to	TO	I-TREATMENT
fem	VB	I-TREATMENT
pop	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
with	IN	O
6	CD	B-TREATMENT
millimeter	NN	I-TREATMENT
PTFE	NNP	I-TREATMENT
.	.	O

This	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
for	IN	O
two	CD	O
months	NNS	O
of	IN	O
increased	JJ	B-PROBLEM
rest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

Her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
resolved	VBD	O
after	IN	O
surgery	NN	B-TREATMENT
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
doing	VBG	O
well	RB	O
since	IN	O
,	,	O
although	IN	O
at	IN	O
baseline	NN	O
now	RB	O
she	PRP	O
is	VBZ	O
minimally	RB	B-PROBLEM
ambulatory	JJ	I-PROBLEM
from	IN	O
bed	NN	O
to	TO	O
commode	VB	O
.	.	O

For	IN	O
the	DT	O
past	JJ	O
couple	NN	O
of	IN	O
months	NNS	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
a	DT	B-PROBLEM
non-healing	JJ	I-PROBLEM
right	NN	I-PROBLEM
dorsal	NN	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
been	VBN	O
increasing	VBG	O
in	IN	O
size	NN	O
and	CC	O
started	VBD	O
as	IN	O
a	DT	B-PROBLEM
pin	NN	I-PROBLEM
hole	NN	I-PROBLEM
and	CC	O
she	PRP	O
does	VBZ	O
not	RB	O
recollect	VB	O
any	DT	B-PROBLEM
trauma	NN	I-PROBLEM
,	,	O
as	IN	O
similar	JJ	B-PROBLEM
small	JJ	I-PROBLEM
ulcers	NNS	I-PROBLEM
developed	VBN	O
on	IN	O
the	DT	O
left	JJ	O
foot	NN	O
as	IN	O
well	RB	O
around	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
but	CC	O
that	DT	O
has	VBZ	O
subsequently	RB	O
healed	VBN	O
.	.	O

The	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
managed	VBN	O
conservatively	RB	O
at	IN	O
Har	NNP	O
Hospital	NNP	O
by	IN	O
Dr.	NNP	O
Holes	NNP	O
with	IN	O
Silvadene	NNP	B-TREATMENT
b.i.d.	VBP	O
lower	JJR	B-TEST
extremity	NN	I-TEST
non-invasive	JJ	I-TEST
study	NN	I-TEST
obtained	VBN	O
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
poor	JJ	B-PROBLEM
distal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
perfusion	NN	I-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
back	RB	O
to	TO	O
Dr.	NNP	O
Pop	NNP	O
for	IN	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	B-TREATMENT
revascularization	NN	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

She	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
angiography	NN	B-TEST
today	NN	O
.	.	O

She	PRP	O
has	VBZ	O
just	RB	O
finished	VBN	O
a	DT	O
ten	JJ	O
day	NN	O
course	NN	O
of	IN	O
Ciprofloxacin	NNP	B-TREATMENT
.	.	O

She	PRP	O
denies	VBZ	O
any	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

She	PRP	O
does	VBZ	O
have	VB	O
rest	VBN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
and	CC	I-PROBLEM
ankle	NN	I-PROBLEM
.	.	O

Significant	NN	O
for	IN	O
Guillain-Barr	NNP	B-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
Lupus	NNP	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
multiple	NN	B-PROBLEM
decubiti	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
total	JJ	I-TREATMENT
knee	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
goiter	NN	B-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
lung	NN	I-PROBLEM
fibrosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
methicillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
Staphylococcus	NNP	I-PROBLEM
aureus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

Prednisone	RB	B-TREATMENT
5	CD	O
every	DT	O
other	JJ	O
day	NN	O
,	,	O
alternating	VBG	O
with	IN	O
ten	JJ	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

Trental	JJ	B-TREATMENT
400	CD	O
milligrams	NNS	O
t.i.d.	RB	O
,	,	O
Cytotec	NNP	B-TREATMENT
100	CD	O
milligrams	NNS	O
t.i.d.	RB	O
,	,	O
Ativan	NNP	B-TREATMENT
2	CD	O
milligrams	NNS	O
q.h.s.	VBP	O
Darvon	NNP	B-TREATMENT
65	CD	O
milligrams	NNS	O
two	CD	O
q.i.d	NNS	O
,	,	O
Relafen	NNP	B-TREATMENT
500	CD	O
milligrams	NNS	O
b.i.d	RB	O
,	,	O
Vitamin	NNP	B-TREATMENT
E	NNP	I-TREATMENT
,	,	O
Prilosec	NNP	B-TREATMENT
20	CD	O
milligrams	NNS	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
Zantac	NNP	B-TREATMENT
150	CD	O
milligrams	NNS	O
b.i.d	RB	O
,	,	O
Lasix	NNP	B-TREATMENT
120	CD	O
milligrams	NNS	O
every	DT	O
other	JJ	O
day	NN	O
PRN	NNP	O
edema	NN	B-PROBLEM
.	.	O

Didronel	NNP	B-TREATMENT
1	CD	O
q	NN	O
day	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
on	IN	O
hold	NN	O
.	.	O

Proventil	NNP	B-TREATMENT
inhaler	NN	I-TREATMENT
via	IN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
0.5	CD	O
milligrams	NNS	O
with	IN	O
Atrovent	NNP	B-TREATMENT
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
Ampicillin	NNP	B-TREATMENT
,	,	O
Tylenol	NNP	B-TREATMENT
,	,	O
Clinoril	NNP	B-TREATMENT
,	,	O
Biaxin	NNP	B-TREATMENT
,	,	O
Codeine	NNP	B-TREATMENT
,	,	O
Sulfa	NNP	B-TREATMENT
and	CC	O
Aminophylline	NNP	B-TREATMENT
.	.	O

She	PRP	O
is	VBZ	O
afebrile	JJ	O
,	,	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

Neck	NN	O
,	,	O
she	PRP	O
has	VBZ	O
II+	VBN	O
bilateral	JJ	O
carotids	NNS	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

Lungs	NNS	O
decreased	VBD	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
bases	NNS	I-PROBLEM
with	IN	O
minimal	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

Abdomen	NNS	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

Extremities	NNS	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
she	PRP	O
has	VBZ	O
a	DT	O
II+	NNP	O
femoral	NN	O
,	,	O
no	DT	O
distal	JJ	B-PROBLEM
pulses	VBZ	I-PROBLEM
beyond	IN	O
that	DT	O
.	.	O

On	IN	O
the	DT	O
left	NN	O
she	PRP	O
has	VBZ	O
a	DT	O
II+	NNP	O
femoral	JJ	O
and	CC	O
II+	NNP	O
popliteal	NN	O
,	,	O
no	DT	O
distal	JJ	B-PROBLEM
pulses	VBZ	I-PROBLEM
beyond	IN	O
that	DT	O
.	.	O

She	PRP	O
has	VBZ	O
on	IN	O
her	PRP$	O
right	JJ	O
ankle	NN	O
anteriorly	RB	O
a	DT	B-PROBLEM
four	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	I-PROBLEM
necrotic	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

Minimal	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
erythema	NN	I-PROBLEM
.	.	O

Her	PRP$	B-TEST
angiography	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
proximal	NN	I-PROBLEM
popliteal	NN	I-PROBLEM
occlusion	NN	I-PROBLEM
,	,	O
anterior	JJ	B-PROBLEM
tibial	JJ	I-PROBLEM
dominant	JJ	I-PROBLEM
foot	NN	I-PROBLEM
vessel	NN	I-PROBLEM
.	.	O

Small	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
tibial	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
calf	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
peroneal	NN	I-PROBLEM
goes	VBZ	O
down	RB	O
to	TO	O
the	DT	O
ankle	NN	O
.	.	O

On	IN	O
a	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
she	PRP	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
no	DT	O
gluteal	JJ	B-PROBLEM
ulcers	NNS	I-PROBLEM
or	CC	O
decubiti	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
the	DT	O
following	JJ	O
day	NN	O
and	CC	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
fem	NN	I-TREATMENT
to	TO	I-TREATMENT
below	IN	I-TREATMENT
knee	NNS	I-TREATMENT
popliteal	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
using	VBG	O
a	DT	B-TREATMENT
six	CD	I-TREATMENT
millimeter	NN	I-TREATMENT
ring	VBG	I-TREATMENT
PTFE	NNP	I-TREATMENT
.	.	O

She	PRP	O
was	VBD	O
afebrile	RB	O
,	,	O
her	PRP	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

Her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
26.8	CD	O
and	CC	O
she	PRP	O
was	VBD	O
transfused	VBN	O
1	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

On	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
swelling	VBG	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-TEST
PVR	NNP	I-TEST
cuff	NN	I-TEST
.	.	O

There	EX	O
is	VBZ	O
mild	JJ	O
amount	NN	O
of	IN	O
surrounding	VBG	B-PROBLEM
erythema	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Ancef	NNP	B-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

The	DT	O
area	NN	O
of	IN	O
erythema	NN	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
leg	NN	I-PROBLEM
enlarged	VBD	O
slightly	RB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
Vancomycin	NNP	B-TREATMENT
for	IN	O
several	JJ	O
days	NNS	O
after	IN	O
which	WDT	O
time	NN	O
her	PRP$	B-PROBLEM
erythema	NN	I-PROBLEM
again	RB	O
began	VBD	O
to	TO	O
decrease	VB	O
.	.	O

She	PRP	O
had	VBD	O
wounds	NNS	B-PROBLEM
which	WDT	O
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
from	IN	O
a	DT	O
respiratory	NN	O
standpoint	NN	O
using	VBG	O
her	PRP$	B-TREATMENT
respirator	NN	I-TREATMENT
at	IN	O
night	NN	O
.	.	O

The	DT	O
patient	NN	O
required	VBD	O
an	DT	B-TREATMENT
additional	JJ	I-TREATMENT
blood	NN	I-TREATMENT
transfusion	NN	I-TREATMENT
during	IN	O
her	PRP$	O
hospital	JJ	O
stay	NN	O
as	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
had	VBD	O
decreased	VBN	O
to	TO	O
27	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
.	.	O

She	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
PO	NNP	B-TREATMENT
Keflex	NNP	I-TREATMENT
that	IN	O
she	PRP	O
was	VBD	O
to	TO	O
take	VB	O
for	IN	O
the	DT	O
next	JJ	O
ten	JJ	O
days	NNS	O
.	.	O

The	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
SOB	NNP	B-PROBLEM
.	.	O

Following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
left	VBD	O
without	IN	O
being	VBG	O
seen	VBN	O
.	.	O

ATRIAL	NNP	B-PROBLEM
FIBRILLATION	NNP	I-PROBLEM
.	.	O

Atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

History	NN	O
of	IN	O
multinodular	JJ	B-PROBLEM
goiter	NN	I-PROBLEM
;	:	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
;	:	O
history	NN	O
of	IN	O
subtotal	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

Electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
.	.	O

Ms.	NNP	O
Lenkpruskihkooglekih	NNP	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
lady	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
frequent	JJ	B-PROBLEM
premature	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
and	CC	O
infrequent	JJ	B-PROBLEM
short	JJ	I-PROBLEM
runs	NNS	I-PROBLEM
of	IN	I-PROBLEM
non-sustained	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
(	(	O
one	CD	O
four-beat	NN	O
run	NN	O
)	)	O
in	IN	O
1991	CD	O
,	,	O
for	IN	O
which	WDT	O
several	JJ	O
antiarrhythmic	JJ	O
agents	NNS	O
including	VBG	O
Propranolol	NNP	B-TREATMENT
,	,	O
Quinidine	NNP	B-TREATMENT
,	,	O
Procainamide	NNP	B-TREATMENT
,	,	O
Tenormin	NNP	B-TREATMENT
,	,	O
Norpace	NNP	B-TREATMENT
,	,	O
Corgard	NNP	B-TREATMENT
,	,	O
and	CC	O
Flecainide	NNP	B-TREATMENT
were	VBD	O
used	VBN	O
,	,	O
but	CC	O
were	VBD	O
stopped	VBN	O
because	IN	O
of	IN	O
intolerance	NN	B-PROBLEM
.	.	O

At	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
had	VBD	O
clear	JJ	O
coronary	JJ	O
arteries	NNS	O
on	IN	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
greater	JJR	O
than	IN	O
50%	CD	O
.	.	O

She	PRP	O
did	VBD	O
well	RB	O
off	IN	O
antiarrhythmic	JJ	B-TREATMENT
agents	NNS	I-TREATMENT
until	IN	O
October	NNP	O
of	IN	O
this	DT	O
year	NN	O
when	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
rapid	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
rate	NN	I-PROBLEM
after	IN	O
several	JJ	O
days	NNS	O
of	IN	O
decreased	JJ	B-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
and	CC	O
had	VBD	O
a	DT	O
failed	JJ	O
attempt	NN	O
at	IN	O
DC	NNP	B-TREATMENT
electrical	JJ	I-TREATMENT
cardioversion	NN	I-TREATMENT
on	IN	O
11/16/96	CD	O
.	.	O

She	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
Coumadin	NNP	B-TREATMENT
since	IN	O
and	CC	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
occasional	JJ	B-PROBLEM
palpitations	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

Includes	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
;	:	O
multinodular	JJ	B-PROBLEM
goiter	NN	I-PROBLEM
;	:	O
subtotal	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

Include	NNP	O
Cardizem	NNP	B-TREATMENT
CD	NNP	I-TREATMENT
180	CD	O
mg	JJ	O
daily	RB	O
;	:	O
Monopril	NNP	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
;	:	O
Digoxin	NNP	B-TREATMENT
.25	NNP	O
mg	JJ	O
daily	RB	O
;	:	O
and	CC	O
Lasix	NNP	B-TREATMENT
40	CD	O
mg	NN	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

To	TO	O
Quinidine	NNP	B-TREATMENT
,	,	O
Procardia	NNP	B-TREATMENT
,	,	O
and	CC	O
sulfa	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

On	IN	O
examination	NN	B-TEST
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
200/100	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
120	CD	O
per	IN	O
minute	NN	O
(	(	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
)	)	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
anxious	JJ	B-PROBLEM
.	.	O

There	EX	O
was	VBD	O
no	DT	O
neck	NN	B-PROBLEM
vein	VBZ	I-PROBLEM
distension	NN	I-PROBLEM
or	CC	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

The	DT	B-TEST
abdominal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

A	DT	B-TEST
12-lead	JJ	I-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
a	DT	O
QT	NNP	O
interval	NN	O
of	IN	O
.46	JJ	O
seconds	NNS	O
.	.	O

There	EX	O
were	VBD	O
diffuse	NN	B-PROBLEM
ST	NNP	I-PROBLEM
segment	NN	I-PROBLEM
and	CC	I-PROBLEM
T-wave	NNP	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
nonspecific	NNS	O
.	.	O

A	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
,	,	O
electrolytes	VBZ	B-TEST
,	,	O
BUN	NNP	B-TEST
and	CC	O
creatinine	NN	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

INR	NNP	B-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
2.5	CD	O
.	.	O

An	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
completely	RB	O
normal	JJ	O
left	VBD	O
ventricular	JJ	O
systolic	JJ	O
function	NN	O
with	IN	O
an	DT	O
ejection	NN	O
fraction	NN	O
calculated	VBD	O
at	IN	O
.74	NNP	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
or	CC	O
asymmetric	JJ	B-PROBLEM
septal	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
an	DT	O
issue	NN	O
that	WDT	O
had	VBD	O
been	VBN	O
raised	VBN	O
on	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
in	IN	O
Ownra	NNP	O
Cin	NNP	O
,	,	O
New	NNP	O
Mexico	NNP	O
on	IN	O
12/06/96	CD	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
Propafenone	NN	B-TREATMENT
300	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
and	CC	O
underwent	NN	O
an	DT	O
attempt	NN	O
at	IN	O
electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
after	IN	O
seven	CD	O
doses	NNS	O
of	IN	O
this	DT	O
.	.	O

The	DT	O
Propafenone	NNP	B-TREATMENT
was	VBD	O
stopped	VBN	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
to	TO	O
Amiodarone	VB	B-TREATMENT
400	CD	O
mg	NN	O
t.i.d.	NN	O
,	,	O
which	WDT	O
was	VBD	O
continued	VBN	O
for	IN	O
two	CD	O
days	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
Amiodarone	NNP	B-TREATMENT
200	CD	O
mg	JJ	O
daily	RB	O
on	IN	O
12/29/96	CD	O
.	.	O

An	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
QT	NNP	B-PROBLEM
prolongation	NN	I-PROBLEM
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
and	CC	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
will	MD	O
be	VB	O
performed	VBN	O
before	IN	O
the	DT	O
patient	NN	O
goes	VBZ	O
home	RB	O
today	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
she	PRP	O
will	MD	O
return	VB	O
to	TO	O
this	DT	O
hospital	NN	O
in	IN	O
early	JJ	O
February	NNP	O
for	IN	O
repeat	NN	O
attempt	NN	O
at	IN	O
electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
on	IN	O
Amiodarone	NNP	B-TREATMENT
.	.	O

She	PRP	O
will	MD	O
continue	VB	O
her	PRP$	O
Coumadin	NNP	B-TREATMENT
until	IN	O
then	RB	O
and	CC	O
arrangements	NNS	O
for	IN	O
her	PRP$	O
readmission	NN	O
can	MD	O
be	VB	O
made	VBN	O
through	IN	O
Dr.	NNP	O
Iceca	NNP	O
Rhaltkaaispehbreun	NNP	O
's	POS	O
office	NN	O
here	RB	O
.	.	O

Other	JJ	O
than	IN	O
the	DT	O
addition	NN	O
of	IN	O
Amiodarone	NNP	B-TREATMENT
200	CD	O
mg	JJ	O
daily	JJ	O
,	,	O
will	MD	O
be	VB	O
the	DT	O
same	JJ	O
as	IN	O
her	PRP$	B-TREATMENT
admission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

BODY	NNP	B-PROBLEM
SHAKING	NNP	I-PROBLEM

The	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
English	NNP	O
)	)	O
.	.	O

back	RB	B-PROBLEM
pain/	JJ	I-PROBLEM
mechanical	JJ	B-PROBLEM
fall	NN	I-PROBLEM

Pt	NNP	B-TEST
&apos;s	NNP	I-TEST
labs	NNS	I-TEST
were	VBD	O
checked	VBN	O
,	,	O
he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
Neurology	NNP	O
,	,	O
and	CC	O
he	PRP	O
received	VBD	O
a	DT	B-TEST
spine	NN	I-TEST
MRI	NNP	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

He	PRP	O
received	VBD	O
Rx	NNP	B-TREATMENT
for	IN	O
potassium	NN	B-TREATMENT
to	TO	O
help	VB	O
with	IN	O
cramps	NNS	B-PROBLEM
.	.	O

Advised	VBN	O
to	TO	O
contact	VB	O
Pain	NNP	O
service	NN	O
for	IN	O
repeat	NN	B-TREATMENT
injections	NNS	I-TREATMENT
,	,	O
F	NNP	O
/	NNP	O
U	NNP	O
with	IN	O
Neurology	NNP	O
,	,	O
explore	RB	O
PT	NNP	B-TREATMENT
,	,	O
massage	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

K-Dur	NNP	B-TREATMENT
20meq	CD	O
PO	NNP	O
QD	NNP	O

Colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

History	NN	O
of	IN	O
diverticulitis	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
,	,	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

Transverse	NNP	B-TREATMENT
colectomy	NN	I-TREATMENT
for	IN	O
tumor	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
84-year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diverticulitis	NN	B-PROBLEM
who	WP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
on	IN	O
colonoscopy	NN	B-TEST
,	,	O
which	WDT	O
was	VBD	O
performed	VBN	O
in	IN	O
March	NNP	O
of	IN	O
2004	CD	O
.	.	O

An	DT	B-PROBLEM
invasive	JJ	I-PROBLEM
moderately	RB	I-PROBLEM
differentiated	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
transverse	NN	O
colon	NN	O
at	IN	O
80	CD	O
cm	NN	O
.	.	O

The	DT	O
patient	NN	O
reports	VBZ	O
a	DT	O
history	NN	O
of	IN	O
bloating	NN	B-PROBLEM
and	CC	O
flatulence	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
increased	VBN	B-PROBLEM
fatigue	NN	I-PROBLEM
.	.	O

She	PRP	O
has	VBZ	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
abdomen	NNS	I-PROBLEM
and	CC	O
notes	NNS	O
diarrhea	VBP	B-PROBLEM
every	DT	O
4-5	JJ	O
days	NNS	O
.	.	O

She	PRP	O
says	VBZ	O
that	IN	O
her	PRP$	O
appetite	NN	O
is	VBZ	O
good	JJ	O
and	CC	O
has	VBZ	O
noted	VBN	O
no	DT	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
.	.	O

Cholecystectomy	NN	B-TREATMENT
in	IN	O
1994	CD	O
,	,	O
colonoscopy	NN	B-TREATMENT
2004	CD	O
,	,	O
status	NN	O
post	NN	O
tonsillectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
ORIF	NNP	B-TREATMENT
of	IN	I-TREATMENT
left	JJ	I-TREATMENT
wrist	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
ear	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
NSVD	NNP	B-TREATMENT
x5	NNP	O
,	,	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

Premarin	NNP	B-TREATMENT
vaginal	JJ	I-TREATMENT
once	RB	O
a	DT	O
month	NN	O
,	,	O
enalapril	NN	B-TREATMENT
,	,	O
Tylenol	NNP	B-TREATMENT
,	,	O
vitamins	NNS	B-TREATMENT
,	,	O
and	CC	O
Halcion	NNP	B-TREATMENT
at	IN	O
night	NN	O
.	.	O

No	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

On	IN	O
exam	NN	B-TEST
she	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

Her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

Baseline	NNP	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
144/61	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
73	CD	O
,	,	O
and	CC	O
oxygen	JJ	B-TEST
saturation	NN	I-TEST
of	IN	O
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

She	PRP	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
well	NN	O
appearing	VBG	O
elderly	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

Lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

Heart	NNP	O
is	VBZ	O
regular	JJ	O
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

Abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

Her	PRP$	O
extremities	NNS	O
are	VBP	O
without	IN	O
edema	NN	B-PROBLEM
and	CC	O
are	VBP	O
warm	JJ	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
consented	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
transverse	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
for	IN	O
tumor	NN	B-PROBLEM
.	.	O

The	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
there	EX	O
are	VBP	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
and	CC	O
PCA	NNP	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
control	NN	I-PROBLEM
.	.	O

She	PRP	O
was	VBD	O
kept	VBN	O
NPO	NNP	B-TREATMENT
initially	RB	O
and	CC	O
her	PRP$	O
diet	NN	O
was	VBD	O
slowly	RB	O
advanced	JJ	O
as	IN	O
tolerated	VBN	O
.	.	O

When	WRB	O
she	PRP	O
was	VBD	O
taking	VBG	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
,	,	O
her	PRP$	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
was	VBD	O
switched	VBN	O
to	TO	O
p.o.	VB	B-TREATMENT
pain	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
with	IN	O
good	JJ	O
affect	NN	O
.	.	O

For	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
metoprolol	NN	B-TREATMENT
at	IN	O
the	DT	O
request	NN	O
of	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
enalapril	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

With	IN	O
the	DT	O
help	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
the	DT	O
patient	NN	O
was	VBD	O
ambulated	VBN	O
and	CC	O
on	IN	O
postoperative	JJ	O
seven	CD	O
,	,	O
with	IN	O
the	DT	O
patient	NN	O
tolerating	VBG	O
a	DT	B-TREATMENT
post	NN	I-TREATMENT
surgical	JJ	I-TREATMENT
soft	JJ	I-TREATMENT
diet	NNS	I-TREATMENT
and	CC	O
with	IN	O
pain	NN	B-PROBLEM
well	RB	O
controlled	VBN	O
on	IN	O
oral	JJ	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	O
facility	NN	O
.	.	O

1.	CD	O
Tylenol	NNP	B-TREATMENT
650	CD	O
mg	NN	O
p.o.	NN	O
q.4.h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

2.	CD	O
Metoprolol	NNP	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3.	CD	O
Motrin	NNP	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

4.	CD	O
Halcion	NNP	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
at	IN	O
night	NN	O
.	.	O

5.	CD	O
Dulcolax	NNP	B-TREATMENT
10	CD	O
to	TO	O
20	CD	O
mg	NNS	O
PR	NNP	O
b.i.d.	NN	O
p.r.n.	NN	O
constipation	NN	B-PROBLEM
.	.	O

6.	CD	O
Senna	NNP	B-TREATMENT
2	CD	O
tablets	NNS	O
p.o.	VBP	O
b.i.d.	NN	O

She	PRP	O
is	VBZ	O
to	TO	O
also	RB	O
call	VB	O
the	DT	O
office	NN	O
if	IN	O
she	PRP	O
has	VBZ	O
any	DT	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM
,	,	O
bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
surgical	JJ	I-PROBLEM
wounds	NNS	I-PROBLEM
,	,	O
or	CC	O
pus	NN	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
wounds	NNS	I-PROBLEM
.	.	O

She	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
maintained	VBN	O
on	IN	O
metoprolol	NN	B-TREATMENT
for	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
and	CC	O
the	DT	O
restarting	NN	O
of	IN	O
her	PRP$	B-TREATMENT
ACE	NNP	I-TREATMENT
inhibitor	NN	I-TREATMENT
is	VBZ	O
to	TO	O
be	VB	O
decided	VBN	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
.	.	O
